Citrus Sinensis ID: 007253
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 611 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SCS2 | 601 | CDPK-related kinase 5 OS= | yes | no | 0.972 | 0.988 | 0.819 | 0.0 | |
| P53681 | 602 | CDPK-related protein kina | N/A | no | 0.968 | 0.983 | 0.797 | 0.0 | |
| O80673 | 576 | CDPK-related kinase 1 OS= | no | no | 0.942 | 1.0 | 0.701 | 0.0 | |
| Q9LET1 | 577 | CDPK-related kinase 7 OS= | no | no | 0.944 | 1.0 | 0.7 | 0.0 | |
| Q9LJL9 | 599 | CDPK-related kinase 2 OS= | no | no | 0.959 | 0.978 | 0.677 | 0.0 | |
| Q10KY3 | 600 | Calcium/calmodulin-depend | yes | no | 0.880 | 0.896 | 0.750 | 0.0 | |
| Q9FX86 | 606 | CDPK-related kinase 8 OS= | no | no | 0.968 | 0.976 | 0.672 | 0.0 | |
| Q9ZUZ2 | 595 | CDPK-related kinase 3 OS= | no | no | 0.959 | 0.984 | 0.605 | 0.0 | |
| Q9FIM9 | 594 | CDPK-related kinase 4 OS= | no | no | 0.857 | 0.882 | 0.611 | 0.0 | |
| Q9SG12 | 594 | CDPK-related kinase 6 OS= | no | no | 0.857 | 0.882 | 0.616 | 0.0 |
| >sp|Q9SCS2|CAMK5_ARATH CDPK-related kinase 5 OS=Arabidopsis thaliana GN=CRK5 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1030 bits (2662), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 501/611 (81%), Positives = 550/611 (90%), Gaps = 17/611 (2%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAV 60
MGLC SKP+S++S D +N+P+PA+ + P+ S +N E Q N
Sbjct: 1 MGLCTSKPNSSNS----DQTPARNSPLPASESVKPSSSSVNGEDQCVTTTNN-------- 48
Query: 61 IEGKKSPFFPFYSPSPAHYFFSKKS---SPARSSANSTPNRFFKRPFPPPSPAKHIKAVL 117
EGKKSPFFPFYSPSPAHYFFSKK+ SPA +S NSTP RFFKRPFPPPSPAKHI+AVL
Sbjct: 49 -EGKKSPFFPFYSPSPAHYFFSKKTPARSPATNSTNSTPKRFFKRPFPPPSPAKHIRAVL 107
Query: 118 ARRHGSVKPNEAAIPEGSEPEPAA-GLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKF 176
ARRHGSVKPN +AIPEGSE E GL+KSFGFSK FA+KYELG+EVGRGHFGYTCAAKF
Sbjct: 108 ARRHGSVKPNSSAIPEGSEAEGGGVGLDKSFGFSKSFASKYELGDEVGRGHFGYTCAAKF 167
Query: 177 KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236
KKG+ KGQQVAVKVIPK KMTTAIAIEDVRREVKILRAL+GHNNL F+DAYED DNVY+
Sbjct: 168 KKGDNKGQQVAVKVIPKAKMTTAIAIEDVRREVKILRALSGHNNLPHFYDAYEDHDNVYI 227
Query: 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296
VMELCEGGELLDRILSRGGKYTE+DAK VMIQILNVVAFCHLQGVVHRDLKPENFLFT+K
Sbjct: 228 VMELCEGGELLDRILSRGGKYTEEDAKTVMIQILNVVAFCHLQGVVHRDLKPENFLFTSK 287
Query: 297 DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLC 356
++ S LKAIDFGLSD+VRPDERLNDIVGSAYYVAPEVLHRSYSTEAD+WS+GVI YILLC
Sbjct: 288 EDTSQLKAIDFGLSDYVRPDERLNDIVGSAYYVAPEVLHRSYSTEADIWSVGVIVYILLC 347
Query: 357 GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416
GSRPFWARTESGIFRAVLKADPSFD+ PWP LSSEARDFVKRLLNKDPRKRLTAAQALSH
Sbjct: 348 GSRPFWARTESGIFRAVLKADPSFDDPPWPLLSSEARDFVKRLLNKDPRKRLTAAQALSH 407
Query: 417 PWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALRALSKTLTVDELFYLKEQYALLEPN 476
PWIK+SND KVP+D+++FKLM+AY+RSSSLRKAALRALSKTLTVDELFYL+EQ+ALLEP+
Sbjct: 408 PWIKDSNDAKVPMDILVFKLMRAYLRSSSLRKAALRALSKTLTVDELFYLREQFALLEPS 467
Query: 477 KNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEAL 536
KNGTISLEN+KSALMK ATDAMKDSRIP+FL L++LQYRRMDFEEFCAAALSVHQLEAL
Sbjct: 468 KNGTISLENIKSALMKMATDAMKDSRIPEFLGQLSALQYRRMDFEEFCAAALSVHQLEAL 527
Query: 537 DRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGKLSFLGFV 596
DRWEQHARCAYELFEK+GNR I+I+ELASELGLGP+VPVHAVLHDW+RHTDGKLSFLGFV
Sbjct: 528 DRWEQHARCAYELFEKEGNRPIMIDELASELGLGPSVPVHAVLHDWLRHTDGKLSFLGFV 587
Query: 597 KLLHGVSSRAL 607
KLLHGVSSR +
Sbjct: 588 KLLHGVSSRTI 598
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|P53681|CRK_DAUCA CDPK-related protein kinase OS=Daucus carota GN=CRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 1006 bits (2600), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 495/621 (79%), Positives = 539/621 (86%), Gaps = 29/621 (4%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPA------PSPLNAESQSNNNRTNVK 54
MG+C SKPS P+ DL N +T +P N T +P P + +Q NN
Sbjct: 1 MGICVSKPS-----PEPDL-HNHHTSIPVNDTSLPPQDNSIPPKDIAIPAQDNNKPP--- 51
Query: 55 GNDDAVIEGKKSPFFPFYSPSPAHYFFSKKS----SPARSSANSTPNRFFKRPFPPPSPA 110
GKKSPF PFYSPSPAH+ FSKKS SPA S+NSTP R F PFPPPSPA
Sbjct: 52 --------GKKSPFLPFYSPSPAHFLFSKKSPAVGSPAAGSSNSTPKRLF--PFPPPSPA 101
Query: 111 KHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGY 170
KHIKA ARRHGSVKPNEAAIPE +E + AGL+KSFGFSK F +K+E+GEEVGRGHFGY
Sbjct: 102 KHIKAAWARRHGSVKPNEAAIPENNEVDGGAGLDKSFGFSKKFGSKFEVGEEVGRGHFGY 161
Query: 171 TCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230
TC AKFKKGE KGQ VAVKVIPK KMTTAIAIEDVRREVKILRALTGHNNLV+F+DA+ED
Sbjct: 162 TCRAKFKKGEFKGQDVAVKVIPKAKMTTAIAIEDVRREVKILRALTGHNNLVQFYDAFED 221
Query: 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290
NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN
Sbjct: 222 HTNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 281
Query: 291 FLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVI 350
FLF +KDE+S LKAIDFGLSD+V+PDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVI
Sbjct: 282 FLFKSKDEDSQLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVI 341
Query: 351 AYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTA 410
+YILLCGSRPFWARTESGIFRAVLKA+ SFDE PWPS+SSEA+DFVKRLLNKDPRKR+TA
Sbjct: 342 SYILLCGSRPFWARTESGIFRAVLKANLSFDEPPWPSVSSEAKDFVKRLLNKDPRKRMTA 401
Query: 411 AQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALRALSKTLTVDELFYLKEQY 470
AQAL H WIKNSND+K PLD+++FKLMK YMRSS LRKAALRALSKTLTVDELFYLKEQ+
Sbjct: 402 AQALCHSWIKNSNDIKFPLDILVFKLMKVYMRSSPLRKAALRALSKTLTVDELFYLKEQF 461
Query: 471 ALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV 530
LLEP KNGTISLEN+K ALM+N+TDAMKDSR+ D L SLN+LQYRRMDFEEFCAAALSV
Sbjct: 462 VLLEPTKNGTISLENIKQALMRNSTDAMKDSRVLDLLVSLNALQYRRMDFEEFCAAALSV 521
Query: 531 HQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGKL 590
HQLEALDRWEQHARCAY+LFEKDGNRAI+IEELASELGLGP++PVHAVLHDWIRHTDGKL
Sbjct: 522 HQLEALDRWEQHARCAYDLFEKDGNRAIMIEELASELGLGPSIPVHAVLHDWIRHTDGKL 581
Query: 591 SFLGFVKLLHGVSSRALAKAQ 611
SFLG+VKLLHGVS+RA+AKAQ
Sbjct: 582 SFLGYVKLLHGVSTRAIAKAQ 602
|
Daucus carota (taxid: 4039) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O80673|CAMK1_ARATH CDPK-related kinase 1 OS=Arabidopsis thaliana GN=CRK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 866 bits (2238), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 428/610 (70%), Positives = 499/610 (81%), Gaps = 34/610 (5%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAV 60
MG+C+ KP S KS + + P N P PA
Sbjct: 1 MGICHGKPVEQQS--KSLPVSGETNEAPTNSQP-PA------------------------ 33
Query: 61 IEGKKSPFFPFYSPSPAHYFFSKKSSPARSSANSTPNRFFKRPFPPPSPAKHIKAVLARR 120
KS FPFYSPSP F K S SS +STP R FKRPFPPPSPAKHI+A LARR
Sbjct: 34 ----KSSGFPFYSPSPVPSLF-KSSPSVSSSVSSTPLRIFKRPFPPPSPAKHIRAFLARR 88
Query: 121 HGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGE 180
+GSVKPNE +IPEG E E GL+KSFGFSK FA+ YE+ EVGRGHFGYTC+AK KKG
Sbjct: 89 YGSVKPNEVSIPEGKECE--IGLDKSFGFSKQFASHYEIDGEVGRGHFGYTCSAKGKKGS 146
Query: 181 LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240
LKGQ+VAVKVIPK KMTTAIAIEDV REVK+LRALTGH NLV+F+DA+ED +NVY+VMEL
Sbjct: 147 LKGQEVAVKVIPKSKMTTAIAIEDVSREVKMLRALTGHKNLVQFYDAFEDDENVYIVMEL 206
Query: 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS 300
C+GGELLD+IL RGGKY+EDDAK VM+QIL+VVA+CHLQGVVHRDLKPENFLF+TKDE S
Sbjct: 207 CKGGELLDKILQRGGKYSEDDAKKVMVQILSVVAYCHLQGVVHRDLKPENFLFSTKDETS 266
Query: 301 VLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRP 360
LKAIDFGLSD+V+PDERLNDIVGSAYYVAPEVLHR+Y TEAD+WSIGVIAYILLCGSRP
Sbjct: 267 PLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRP 326
Query: 361 FWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
FWARTESGIFRAVLKA+P+F+EAPWPSLS EA DFVKRLLNKD RKRLTAAQAL HPW+
Sbjct: 327 FWARTESGIFRAVLKAEPNFEEAPWPSLSPEAVDFVKRLLNKDYRKRLTAAQALCHPWLV 386
Query: 421 NSNDVKVPLDVIIFKLMKAYMRSSSLRKAALRALSKTLTVDELFYLKEQYALLEPNKNGT 480
S+++K+P D+II+KL+K Y+ S+SLRK+AL AL+KTLTV +L YL+EQ+ LL P+KNG
Sbjct: 387 GSHELKIPSDMIIYKLVKVYIMSTSLRKSALAALAKTLTVPQLAYLREQFTLLGPSKNGY 446
Query: 481 ISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWE 540
IS++N K+A++K++TDAMKDSR+ DF+ ++ LQY+++DFEEFCA+ALSV+QLEA++ WE
Sbjct: 447 ISMQNYKTAILKSSTDAMKDSRVFDFVHMISCLQYKKLDFEEFCASALSVYQLEAMETWE 506
Query: 541 QHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGKLSFLGFVKLLH 600
QHAR AYELFEKDGNR I+IEELASELGLGP+VPVH VL DWIRH+DGKLSFLGFV+LLH
Sbjct: 507 QHARRAYELFEKDGNRPIMIEELASELGLGPSVPVHVVLQDWIRHSDGKLSFLGFVRLLH 566
Query: 601 GVSSRALAKA 610
GVSSR L KA
Sbjct: 567 GVSSRTLQKA 576
|
May play a role in signal transduction pathways that involve calcium as a second messenger (By similarity). Serine/threonine kinase that phosphorylates histone H3. Confers thermotolerance; involved in the heat-shock-mediated calmodulin-dependent signal transduction leading to the activation of heat-shock transcription factors (HSFs); phosphorylates HSFA1A. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LET1|CAMK7_ARATH CDPK-related kinase 7 OS=Arabidopsis thaliana GN=CRK7 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 863 bits (2231), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 427/610 (70%), Positives = 498/610 (81%), Gaps = 33/610 (5%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAV 60
MGLC+ KP S KN P+ P S A
Sbjct: 1 MGLCHGKPIEQQS---------KNLPISNEIEETPKNSSQKA------------------ 33
Query: 61 IEGKKSPFFPFYSPSPAHYFFSKKSSPARSSANSTPNRFFKRPFPPPSPAKHIKAVLARR 120
KS FPFYSPSP F + + SS +STP R FKRPFPPPSPAKHI+A+LARR
Sbjct: 34 ----KSSGFPFYSPSPLPSLFKTSPAVSSSSVSSTPLRIFKRPFPPPSPAKHIRALLARR 89
Query: 121 HGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGE 180
HGSVKPNEA+IPEGSE E GL+K FGFSK FA+ YE+ EVGRGHFGYTC+AK KKG
Sbjct: 90 HGSVKPNEASIPEGSECE--VGLDKKFGFSKQFASHYEIDGEVGRGHFGYTCSAKGKKGS 147
Query: 181 LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240
LKGQ VAVKVIPK KMTTAIAIEDVRREVKILRALTGH NLV+F+DA+ED +NVY+VMEL
Sbjct: 148 LKGQDVAVKVIPKSKMTTAIAIEDVRREVKILRALTGHKNLVQFYDAFEDDENVYIVMEL 207
Query: 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS 300
C+GGELLD+IL RGGKY+E DAK VMIQIL+VVA+CHLQGVVHRDLKPENFLFTTKDE+S
Sbjct: 208 CQGGELLDKILQRGGKYSEVDAKKVMIQILSVVAYCHLQGVVHRDLKPENFLFTTKDESS 267
Query: 301 VLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRP 360
LKAIDFGLSD+VRPDERLNDIVGSAYYVAPEVLHR+Y TEAD+WSIGVIAYILLCGSRP
Sbjct: 268 PLKAIDFGLSDYVRPDERLNDIVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRP 327
Query: 361 FWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
FWAR+ESGIFRAVLKA+P+F+EAPWPSLS +A DFVKRLLNKD RKRLTAAQAL HPW+
Sbjct: 328 FWARSESGIFRAVLKAEPNFEEAPWPSLSPDAVDFVKRLLNKDYRKRLTAAQALCHPWLV 387
Query: 421 NSNDVKVPLDVIIFKLMKAYMRSSSLRKAALRALSKTLTVDELFYLKEQYALLEPNKNGT 480
S+++K+P D+II+KL+K Y+ SSSLRK+AL AL+KTLTV +L YL+EQ+ LL P+KNG
Sbjct: 388 GSHELKIPSDMIIYKLVKVYIMSSSLRKSALAALAKTLTVPQLTYLQEQFNLLGPSKNGY 447
Query: 481 ISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWE 540
IS++N K+A++K++T+A KDSR+ DF+ ++ LQY+++DFEEFCA+ALSV+QLEA++ WE
Sbjct: 448 ISMQNYKTAILKSSTEATKDSRVLDFVHMISCLQYKKLDFEEFCASALSVYQLEAMETWE 507
Query: 541 QHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGKLSFLGFVKLLH 600
QHAR AYEL+EKDGNR I+IEELA+ELGLGP+VPVH VL DWIRH+DGKLSFLGFV+LLH
Sbjct: 508 QHARRAYELYEKDGNRVIMIEELATELGLGPSVPVHVVLQDWIRHSDGKLSFLGFVRLLH 567
Query: 601 GVSSRALAKA 610
GVSSR L KA
Sbjct: 568 GVSSRTLQKA 577
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LJL9|CAMK2_ARATH CDPK-related kinase 2 OS=Arabidopsis thaliana GN=CRK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 845 bits (2183), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 423/624 (67%), Positives = 493/624 (79%), Gaps = 38/624 (6%)
Query: 1 MGLCNSKPSS----NSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGN 56
MG C SKPSS N +PK +++N ++ PA+ P SP+ +
Sbjct: 1 MGGCTSKPSSSVKPNPYAPKDAVLQNDDS-TPAH----PGKSPVRSSPAV---------- 45
Query: 57 DDAVIEGKKSPFFPFYSPSPAHYFFSKKSSPA---RSSANSTPNRFFKRPFPPPSPAKHI 113
K SPFFPFY+PSPA + +K S STP R R F PPSPA+HI
Sbjct: 46 -------KASPFFPFYTPSPARHRRNKSRDGGGGESKSVTSTPLRQLARAFHPPSPARHI 98
Query: 114 KAVLARRHGSVKPNEAAIPEGSEPEPA-----AGLNKSFGFSKHFANKYELGEEVGRGHF 168
+ VL RR + EAA+P + + GL+K FGFSK ++ ELGEE+GRGHF
Sbjct: 99 RDVLRRRK---EKKEAALPAARQQKEEEEREEVGLDKRFGFSKELQSRIELGEEIGRGHF 155
Query: 169 GYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228
GYTC+AKFKKGELK Q+VAVKVIPK KMT+AI+IEDVRREVKILRAL+GH NLV+F+DA+
Sbjct: 156 GYTCSAKFKKGELKDQEVAVKVIPKSKMTSAISIEDVRREVKILRALSGHQNLVQFYDAF 215
Query: 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKP 288
ED NVY+VMELC GGELLDRIL+RGGKY+EDDAKAV+IQILNVVAFCHLQGVVHRDLKP
Sbjct: 216 EDNANVYIVMELCGGGELLDRILARGGKYSEDDAKAVLIQILNVVAFCHLQGVVHRDLKP 275
Query: 289 ENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIG 348
ENFL+T+K+ENS+LK IDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSY+TEADVWSIG
Sbjct: 276 ENFLYTSKEENSMLKVIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYTTEADVWSIG 335
Query: 349 VIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL 408
VIAYILLCGSRPFWARTESGIFRAVLKADPSFDE PWPSLS EA+DFVKRLL KDPRKR+
Sbjct: 336 VIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPWPSLSFEAKDFVKRLLYKDPRKRM 395
Query: 409 TAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALRALSKTLTVDELFYLKE 468
TA+QAL HPWI + +P D++IFK +KAY+RSSSLRKAAL ALSKTLT DEL YLK
Sbjct: 396 TASQALMHPWIAGYKKIDIPFDILIFKQIKAYLRSSSLRKAALMALSKTLTTDELLYLKA 455
Query: 469 QYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAAL 528
Q+A L PNKNG I+L++++ AL NAT+AMK+SRIPDFL+ LN LQY+ MDFEEFCAA++
Sbjct: 456 QFAHLAPNKNGLITLDSIRLALATNATEAMKESRIPDFLALLNGLQYKGMDFEEFCAASI 515
Query: 529 SVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDG 588
SVHQ E+LD WEQ R AYELFE +GNR IVIEELASELG+G ++PVH +L+DWIRHTDG
Sbjct: 516 SVHQHESLDCWEQSIRHAYELFEMNGNRVIVIEELASELGVGSSIPVHTILNDWIRHTDG 575
Query: 589 KLSFLGFVKLLHGVSSR-ALAKAQ 611
KLSFLGFVKLLHGVS+R +LAK +
Sbjct: 576 KLSFLGFVKLLHGVSTRQSLAKTR 599
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q10KY3|CAMK1_ORYSJ Calcium/calmodulin-dependent serine/threonine-protein kinase 1 OS=Oryza sativa subsp. japonica GN=CAMK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 843 bits (2177), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 407/542 (75%), Positives = 481/542 (88%), Gaps = 4/542 (0%)
Query: 69 FPFYSPSPAHYFFSKKSSPARSSANSTPNRF-FKRPFPPPSPAKHIKAVLARRHGSVKPN 127
FPFY PSP S K SPA SS STP R FKRPFPPPSPAKHI+A+LARRHGSVKPN
Sbjct: 61 FPFYLPSPLPAS-SYKGSPANSSVASTPARGGFKRPFPPPSPAKHIRALLARRHGSVKPN 119
Query: 128 EAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVA 187
EA+IPE EP L+K FGFS+HFA KYELG EVGRGHFGYTCAA KKGELKG VA
Sbjct: 120 EASIPESGEP--GVALDKGFGFSRHFAAKYELGREVGRGHFGYTCAATCKKGELKGDDVA 177
Query: 188 VKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELL 247
VKVIPK KMTTAIAIEDVRREV+IL +L GH+NLV+F+DAYED +NVY+VMELC+GGELL
Sbjct: 178 VKVIPKAKMTTAIAIEDVRREVRILSSLAGHSNLVQFYDAYEDEENVYIVMELCKGGELL 237
Query: 248 DRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307
DRIL+RGGKY+E+DAK VM QIL+V +FCHLQGVVHRDLKPENFLF++KDENS +K IDF
Sbjct: 238 DRILARGGKYSEEDAKVVMRQILSVASFCHLQGVVHRDLKPENFLFSSKDENSAMKVIDF 297
Query: 308 GLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTES 367
GLSDFV+PDERLNDIVGSAYYVAPEVLHRSY TEAD+WSIGVI YILLCGSRPFWARTES
Sbjct: 298 GLSDFVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIVYILLCGSRPFWARTES 357
Query: 368 GIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKV 427
GIFRAVLKADPSF+EAPWP+LS+EA+DFV+RLLNKD RKR+TAAQAL HPWI+ + +VK+
Sbjct: 358 GIFRAVLKADPSFEEAPWPTLSAEAKDFVRRLLNKDYRKRMTAAQALCHPWIRGTEEVKL 417
Query: 428 PLDVIIFKLMKAYMRSSSLRKAALRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVK 487
PLD+II++LM+AY+ SSSLR+AALRAL+KTLT D+++YL+EQ+ L+ PNK+ I+L+N+K
Sbjct: 418 PLDMIIYRLMRAYISSSSLRRAALRALAKTLTTDQIYYLREQFELIGPNKSDLITLQNLK 477
Query: 488 SALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAY 547
+ALMKN+T+AMKDSR+ DF+++++++QYR++DFEEF AAA+SV+Q+E L+ WEQHAR AY
Sbjct: 478 TALMKNSTNAMKDSRVVDFVNTISNIQYRKLDFEEFSAAAISVYQMEGLETWEQHARQAY 537
Query: 548 ELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGKLSFLGFVKLLHGVSSRAL 607
E F+K+GNR IVI+ELASELGLGP+VP+H VL DWIRH DGKLSFLGF+KLLHGVSSR +
Sbjct: 538 EFFDKEGNRPIVIDELASELGLGPSVPLHVVLQDWIRHPDGKLSFLGFMKLLHGVSSRTI 597
Query: 608 AK 609
K
Sbjct: 598 PK 599
|
Possesses kinase activity in vitro. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 7 |
| >sp|Q9FX86|CAMK8_ARATH CDPK-related kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 842 bits (2176), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 417/620 (67%), Positives = 487/620 (78%), Gaps = 28/620 (4%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAV 60
MG C SKPS++S P N + P SP+ S +
Sbjct: 1 MGGCTSKPSTSSGRPNPFAPGNDYPQIDDFAPDHPGKSPIPTPSAA-------------- 46
Query: 61 IEGKKSPFFPFYSPSPAHYFFSKK----SSPARSSANSTPNRFFKRPFPPPSPAKHIKAV 116
K SPFFPFY+PSPA + +K S STP R +R F PPSPAKHI+A
Sbjct: 47 ---KASPFFPFYTPSPARHRRNKSRDVGGGGESKSLTSTPLRQLRRAFHPPSPAKHIRAA 103
Query: 117 LARRHGSVKPNEAAIPEGSEPEP------AAGLNKSFGFSKHFANKYELGEEVGRGHFGY 170
L RR G + + + + + P GL+K FGFSK F ++ ELGEE+GRGHFGY
Sbjct: 104 LRRRKGKKEAALSGVTQLTTEVPQREEEEEVGLDKRFGFSKEFHSRVELGEEIGRGHFGY 163
Query: 171 TCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230
TC+AKFKKGELKGQ VAVK+IPK KMTTAIAIEDVRREVKIL+AL+GH NLV+F+DA+ED
Sbjct: 164 TCSAKFKKGELKGQVVAVKIIPKSKMTTAIAIEDVRREVKILQALSGHKNLVQFYDAFED 223
Query: 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290
NVY+ MELCEGGELLDRIL+RGGKY+E+DAK V+IQILNVVAFCH QGVVHRDLKPEN
Sbjct: 224 NANVYIAMELCEGGELLDRILARGGKYSENDAKPVIIQILNVVAFCHFQGVVHRDLKPEN 283
Query: 291 FLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVI 350
FL+T+K+ENS LKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSY+TEADVWSIGVI
Sbjct: 284 FLYTSKEENSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYTTEADVWSIGVI 343
Query: 351 AYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTA 410
AYILLCGSRPFWARTESGIFRAVLKADPSFDE PWP LSS+A+DFVKRLL KDPR+R++A
Sbjct: 344 AYILLCGSRPFWARTESGIFRAVLKADPSFDEPPWPFLSSDAKDFVKRLLFKDPRRRMSA 403
Query: 411 AQALSHPWIKNSN-DVKVPLDVIIFKLMKAYMRSSSLRKAALRALSKTLTVDELFYLKEQ 469
+QAL HPWI+ N D+ +P D++IF+ MKAY+RSSSLRKAALRALSKTL DE+ YLK Q
Sbjct: 404 SQALMHPWIRAYNTDMNIPFDILIFRQMKAYLRSSSLRKAALRALSKTLIKDEILYLKTQ 463
Query: 470 YALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALS 529
++LL PNK+G I+++ ++ AL NAT+AMK+SRIP+FL+ LN LQYR MDFEEFCAAA++
Sbjct: 464 FSLLAPNKDGLITMDTIRMALASNATEAMKESRIPEFLALLNGLQYRGMDFEEFCAAAIN 523
Query: 530 VHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGK 589
VHQ E+LD WEQ R AYELF+K+GNRAIVIEELASELG+GP++PVH+VLHDWIRHTDGK
Sbjct: 524 VHQHESLDCWEQSIRHAYELFDKNGNRAIVIEELASELGVGPSIPVHSVLHDWIRHTDGK 583
Query: 590 LSFLGFVKLLHGVSSRALAK 609
LSF GFVKLLHGVS RA K
Sbjct: 584 LSFFGFVKLLHGVSVRASGK 603
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUZ2|CAMK3_ARATH CDPK-related kinase 3 OS=Arabidopsis thaliana GN=CRK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 701 bits (1809), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/609 (60%), Positives = 458/609 (75%), Gaps = 23/609 (3%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNT-PVPANGTPIPAPSPLNAESQSNN--NRTNVKGND 57
MG C K N S + N T V +G I +P+N N +N
Sbjct: 1 MGQCYGK--VNQSKQNGEEEANTTTYVVSGDGNQIQPLTPVNYGRAKNTPARSSNPSPWP 58
Query: 58 DAVIEGKKSPFFPFYSPSPAHYFFSKKSSPARSSANSTPNRFFKRPFPPPSPAKHIKAVL 117
G SP SPSPA STP RFF+RPFPPPSPAKHIKA L
Sbjct: 59 SPFPHGSASPLPSGVSPSPAR--------------TSTPRRFFRRPFPPPSPAKHIKASL 104
Query: 118 ARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFK 177
+R G VKP E IPE EP L+KSFG+ K+F KYELG+EVGRGHFG+TC+ + K
Sbjct: 105 IKRLG-VKPKEGPIPEERGTEPEQSLDKSFGYGKNFGAKYELGKEVGRGHFGHTCSGRGK 163
Query: 178 KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVV 237
KG++K +AVK+I K KMTTAIAIEDVRREVK+L++L+GH L+K++DA ED +NVY+V
Sbjct: 164 KGDIKDHPIAVKIISKAKMTTAIAIEDVRREVKLLKSLSGHKYLIKYYDACEDANNVYIV 223
Query: 238 MELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD 297
MELC+GGELLDRIL+RGGKY EDDAKA+++QIL VV+FCHLQGVVHRDLKPENFLFT+
Sbjct: 224 MELCDGGELLDRILARGGKYPEDDAKAIVVQILTVVSFCHLQGVVHRDLKPENFLFTSSR 283
Query: 298 ENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCG 357
E+S LK IDFGLSDF+RPDERLNDIVGSAYYVAPEVLHRSYS EAD+WSIGVI YILLCG
Sbjct: 284 EDSDLKLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVITYILLCG 343
Query: 358 SRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHP 417
SRPFWARTESGIFR VL+ +P++D+ PWPS SSE +DFVKRLLNKD RKR++A QAL+HP
Sbjct: 344 SRPFWARTESGIFRTVLRTEPNYDDVPWPSCSSEGKDFVKRLLNKDYRKRMSAVQALTHP 403
Query: 418 WIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALRALSKTLTVDELFYLKEQYALLEPNK 477
W+++ + V +PLD++I+KL+KAY+ ++ LR+AAL+AL+K LT +EL YL+ Q+ LL PNK
Sbjct: 404 WLRDDSRV-IPLDILIYKLVKAYLHATPLRRAALKALAKALTENELVYLRAQFMLLGPNK 462
Query: 478 NGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALD 537
+G++SLEN K+ALM+NATDAM++SR+P+ L ++ SL YR+M FEEFCAAA+S+HQLEA+D
Sbjct: 463 DGSVSLENFKTALMQNATDAMRESRVPEILHTMESLAYRKMYFEEFCAAAISIHQLEAVD 522
Query: 538 RWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGKLSFLGFVK 597
WE+ A ++ FE +GNR I IEELA EL +G + H L DW+R +DGKLS+LGF K
Sbjct: 523 AWEEIATAGFQHFETEGNRVITIEELARELNVGASAYGH--LRDWVRSSDGKLSYLGFTK 580
Query: 598 LLHGVSSRA 606
LHGV+ RA
Sbjct: 581 FLHGVTLRA 589
|
May play a role in signal transduction pathways that involve calcium as a second messenger (By similarity). Serine/threonine kinase that phosphorylates histone H3 an GLN1-1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIM9|CAMK4_ARATH CDPK-related kinase 4 OS=Arabidopsis thaliana GN=CRK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 655 bits (1691), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 334/546 (61%), Positives = 427/546 (78%), Gaps = 22/546 (4%)
Query: 70 PFYSPSPAHYFFSKKSSPARSSANSTPNRFFKRPFPPPSPAKHIKAVLARRHGSV-KPNE 128
PF SP PA SPAR TP R FK PFPPPSPAK I A L RR G+ +P +
Sbjct: 56 PFQSPLPA----GVAPSPAR-----TPGRKFKWPFPPPSPAKPIMAALRRRRGAPPQPRD 106
Query: 129 AAIPEGSEPEPAAG--------LNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGE 180
IPE SE G L+K+FGF K+F KYELG+EVGRGHFG+TC AK KKG+
Sbjct: 107 EPIPEDSEDVVDHGGDSGGGERLDKNFGFGKNFEGKYELGKEVGRGHFGHTCWAKAKKGK 166
Query: 181 LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240
+K Q VAVK+I K KMT+ ++IEDVRREVK+L+AL+GH ++VKF+D YED DNV+VVMEL
Sbjct: 167 MKNQTVAVKIISKAKMTSTLSIEDVRREVKLLKALSGHRHMVKFYDVYEDADNVFVVMEL 226
Query: 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS 300
CEGGELLDRIL+RGG+Y E DAK +++QIL+ AF HLQGVVHRDLKPENFLFT+++E++
Sbjct: 227 CEGGELLDRILARGGRYPEVDAKRILVQILSATAFFHLQGVVHRDLKPENFLFTSRNEDA 286
Query: 301 VLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRP 360
+LK IDFGLSDF+R D+RLND+VGSAYYVAPEVLHRSYSTEAD+WSIGVI+YILLCGSRP
Sbjct: 287 ILKVIDFGLSDFIRYDQRLNDVVGSAYYVAPEVLHRSYSTEADMWSIGVISYILLCGSRP 346
Query: 361 FWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
F+ RTES IFR VL+A+P+F++ PWPS+S A+DFVKRLLNKD RKR+TAAQAL+HPW++
Sbjct: 347 FYGRTESAIFRCVLRANPNFEDMPWPSISPTAKDFVKRLLNKDHRKRMTAAQALAHPWLR 406
Query: 421 NSNDVKVPLDVIIFKLMKAYMRSSSLRKAALRALSKTLTVDELFYLKEQYALLEPNKNGT 480
+ N + LD ++KL+K+Y+R+S R++AL+ALSK + +EL +LK Q+ LL+P K+G
Sbjct: 407 DENP-GLLLDFSVYKLVKSYIRASPFRRSALKALSKAIPDEELVFLKAQFMLLDP-KDGG 464
Query: 481 ISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWE 540
+SL AL + ATDAM +SR+PD L+++ L +++DFEEFCAAA+SV+QLEAL+ WE
Sbjct: 465 LSLNCFTMALTRYATDAMMESRLPDILNTMQPLAQKKLDFEEFCAAAVSVYQLEALEEWE 524
Query: 541 QHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGKLSFLGFVKLLH 600
Q A A+E FE +GNR I ++ELA E+ +GP+ + +L DWIR +DGKLSFLG+ K LH
Sbjct: 525 QIATSAFEHFEHEGNRIISVQELAGEMSVGPS--AYPLLKDWIRSSDGKLSFLGYAKFLH 582
Query: 601 GVSSRA 606
GV+ R+
Sbjct: 583 GVTVRS 588
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SG12|CAMK6_ARATH CDPK-related kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 639 bits (1647), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 335/543 (61%), Positives = 429/543 (79%), Gaps = 19/543 (3%)
Query: 70 PFYSPSPAHYFFSKKSSPARSSANSTPNRFFKRPFPPPSPAKHIKAVLARRHGSV-KPNE 128
PF SP PA SPAR TP R FK PFPPPSPAK I A L RR G+ P +
Sbjct: 58 PFQSPLPA----GVAPSPAR-----TPGRKFKWPFPPPSPAKPIMAALRRRRGTAPHPRD 108
Query: 129 AAIPEGSEPEPAAG-----LNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKG 183
IPE SE + G L+K+FGF+K+F KYELG EVGRGHFG+TC AK KKG++KG
Sbjct: 109 GPIPEDSEAGGSGGGIGERLDKNFGFAKNFEGKYELGREVGRGHFGHTCWAKAKKGKIKG 168
Query: 184 QQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEG 243
Q VAVK+I K KMT+A++IEDVRREVK+L+AL+GH+++VKF+D +ED+DNV+VVMELCEG
Sbjct: 169 QTVAVKIISKSKMTSALSIEDVRREVKLLKALSGHSHMVKFYDVFEDSDNVFVVMELCEG 228
Query: 244 GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303
GELLD IL+RGG+Y E +AK +++QIL+ AF HLQGVVHRDLKPENFLFT+K+E++VLK
Sbjct: 229 GELLDSILARGGRYPEAEAKRILVQILSATAFFHLQGVVHRDLKPENFLFTSKNEDAVLK 288
Query: 304 AIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWA 363
IDFGLSD+ R D+RLND+VGSAYYVAPEVLHRSYSTEAD+WSIGVI+YILLCGSRPF+
Sbjct: 289 VIDFGLSDYARFDQRLNDVVGSAYYVAPEVLHRSYSTEADIWSIGVISYILLCGSRPFYG 348
Query: 364 RTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423
RTES IFR VL+A+P+FD+ PWPS+S A+DFVKRLLNKD RKR+TAAQAL+HPW+++ N
Sbjct: 349 RTESAIFRCVLRANPNFDDLPWPSISPIAKDFVKRLLNKDHRKRMTAAQALAHPWLRDEN 408
Query: 424 DVKVPLDVIIFKLMKAYMRSSSLRKAALRALSKTLTVDELFYLKEQYALLEPNKNGTISL 483
+ LD I+KL+K+Y+R+S R+AAL++LSK + +EL +LK Q+ LLEP ++G + L
Sbjct: 409 P-GLLLDFSIYKLVKSYIRASPFRRAALKSLSKAIPEEELVFLKAQFMLLEP-EDGGLHL 466
Query: 484 ENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHA 543
N +AL + ATDAM +SR+PD L+ + L ++++DFEEFCAA++SV+QLEAL+ WEQ A
Sbjct: 467 HNFTTALTRYATDAMIESRLPDILNMMQPLAHKKLDFEEFCAASVSVYQLEALEEWEQIA 526
Query: 544 RCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603
A+E FE +G+RAI ++ELA E+ LGP + +L DWIR DGKL+FLG+ K LHGV+
Sbjct: 527 TVAFEHFESEGSRAISVQELAEEMSLGPN--AYPLLKDWIRSLDGKLNFLGYAKFLHGVT 584
Query: 604 SRA 606
R+
Sbjct: 585 VRS 587
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 611 | ||||||
| 224081597 | 607 | CPK related kinase 5 [Populus trichocarp | 0.983 | 0.990 | 0.841 | 0.0 | |
| 224096786 | 606 | CPK related protein kinase 7 [Populus tr | 0.981 | 0.990 | 0.836 | 0.0 | |
| 73761697 | 617 | CDPK-related protein kinase [Gossypium h | 0.998 | 0.988 | 0.841 | 0.0 | |
| 297816306 | 597 | hypothetical protein ARALYDRAFT_485401 [ | 0.965 | 0.988 | 0.823 | 0.0 | |
| 15229785 | 601 | CDPK-related kinase [Arabidopsis thalian | 0.972 | 0.988 | 0.819 | 0.0 | |
| 16904214 | 601 | calcium/calmodulin-dependent protein kin | 0.972 | 0.988 | 0.818 | 0.0 | |
| 16904226 | 602 | calcium/calmodulin-dependent protein kin | 0.978 | 0.993 | 0.803 | 0.0 | |
| 334185866 | 632 | CDPK-related kinase [Arabidopsis thalian | 0.972 | 0.939 | 0.780 | 0.0 | |
| 449460636 | 621 | PREDICTED: CDPK-related protein kinase-l | 0.990 | 0.974 | 0.789 | 0.0 | |
| 1706130 | 602 | RecName: Full=CDPK-related protein kinas | 0.968 | 0.983 | 0.797 | 0.0 |
| >gi|224081597|ref|XP_002306462.1| CPK related kinase 5 [Populus trichocarpa] gi|222855911|gb|EEE93458.1| CPK related kinase 5 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1055 bits (2728), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 519/617 (84%), Positives = 550/617 (89%), Gaps = 16/617 (2%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAV 60
MG+C SKPS NS+ I+ K+ +P N T P P A + N+T V+
Sbjct: 1 MGICTSKPSPNSTLFSPVAIQAKDNSIPTNDTA--KPDPATASLNDHTNKTTVE------ 52
Query: 61 IEGKKSPFFPFYSPSPAHYFFSKKSSPARS------SANSTPNRFFKRPFPPPSPAKHIK 114
KKSP FPFYSPSPAH FFSKKSSPARS SANSTP RFFKRPFPPPSPAKHI+
Sbjct: 53 -PVKKSPLFPFYSPSPAHRFFSKKSSPARSPARNAASANSTPKRFFKRPFPPPSPAKHIR 111
Query: 115 AVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAA 174
AVLARRHGSVKPNEAAIPEGSE GL+KSFGFSKHF NKYELG+EVGRGHFGYTC A
Sbjct: 112 AVLARRHGSVKPNEAAIPEGSE-TGGEGLDKSFGFSKHFGNKYELGDEVGRGHFGYTCQA 170
Query: 175 KFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234
KFKKGELKGQQVAVKVIPK KMTTAIAIEDVRREVKILRALTGHNNLV F+DAYED DNV
Sbjct: 171 KFKKGELKGQQVAVKVIPKAKMTTAIAIEDVRREVKILRALTGHNNLVHFYDAYEDHDNV 230
Query: 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294
Y+VMELCEGGELLDRIL+RGGKY+EDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT
Sbjct: 231 YIVMELCEGGELLDRILARGGKYSEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 290
Query: 295 TKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYIL 354
+KDENS LKAIDFGLSDFV+PDERLNDIVGSAYYVAPEVLHRSY TEADVWSIGVIAYIL
Sbjct: 291 SKDENSQLKAIDFGLSDFVKPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYIL 350
Query: 355 LCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
LCGSRPFWARTESGIFRAVLKADPSFDE PWPSLS EA+DFVK+LLNKDPRKRLTAAQAL
Sbjct: 351 LCGSRPFWARTESGIFRAVLKADPSFDETPWPSLSPEAKDFVKQLLNKDPRKRLTAAQAL 410
Query: 415 SHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALRALSKTLTVDELFYLKEQYALLE 474
SHPWIKNSND+KVPLD+ IFKLMKAYMRS+SLRKAAL+ALSKTLTVDELFYLKEQ+ALLE
Sbjct: 411 SHPWIKNSNDLKVPLDLHIFKLMKAYMRSTSLRKAALKALSKTLTVDELFYLKEQFALLE 470
Query: 475 PNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLE 534
PNKN ISLEN+K+ALMKN TDAMKDS IPDF++SLN+LQYRRMDFEEFCAAALSVHQLE
Sbjct: 471 PNKNDAISLENIKAALMKNGTDAMKDSHIPDFIASLNALQYRRMDFEEFCAAALSVHQLE 530
Query: 535 ALDRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGKLSFLG 594
ALDRWEQ ARCAYELFEKDGNRAIVIEELASELGLGP+VP+HAVLHDWIRHTDGKLSFLG
Sbjct: 531 ALDRWEQRARCAYELFEKDGNRAIVIEELASELGLGPSVPLHAVLHDWIRHTDGKLSFLG 590
Query: 595 FVKLLHGVSSRALAKAQ 611
FVKLL G SSR LAKAQ
Sbjct: 591 FVKLLRGASSRILAKAQ 607
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224096786|ref|XP_002310736.1| CPK related protein kinase 7 [Populus trichocarpa] gi|222853639|gb|EEE91186.1| CPK related protein kinase 7 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1046 bits (2704), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 516/617 (83%), Positives = 547/617 (88%), Gaps = 17/617 (2%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAV 60
MG+C SKPS NS+ I+ + +P TP P P N Q NN T ++
Sbjct: 1 MGICTSKPSPNSTLSSPIAIQANDNSIPTKDTPRPDPRTPNVNDQ--NNSTGLESV---- 54
Query: 61 IEGKKSPFFPFYSPSPAHYFFSKKSSPARS------SANSTPNRFFKRPFPPPSPAKHIK 114
KKSPF F+SPSPAHYFFSKKSSPARS SANSTP R FKRPFPPPSPAKHI+
Sbjct: 55 ---KKSPF-NFFSPSPAHYFFSKKSSPARSPARNAASANSTPKRLFKRPFPPPSPAKHIR 110
Query: 115 AVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAA 174
AVLARRHGSVKPNEA IPEG E E AAGL KSFGFSKHF NKYELG+EVGRGHFGYTC A
Sbjct: 111 AVLARRHGSVKPNEATIPEGGEAE-AAGLVKSFGFSKHFGNKYELGDEVGRGHFGYTCQA 169
Query: 175 KFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234
KFKKGELKGQQVAVKVIPK KMTTAIAIEDVRREV ILRAL GHNNLV+F+DAYED DNV
Sbjct: 170 KFKKGELKGQQVAVKVIPKAKMTTAIAIEDVRREVNILRALNGHNNLVQFYDAYEDHDNV 229
Query: 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294
Y+VMELCEGGELLDRIL+RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT
Sbjct: 230 YIVMELCEGGELLDRILARGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 289
Query: 295 TKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYIL 354
+KDE+S LKAIDFGLSDFV+PDERLNDIVGSAYYVAPEVLHRSY TEADVWSIGVIAYIL
Sbjct: 290 SKDEDSQLKAIDFGLSDFVKPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYIL 349
Query: 355 LCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
LCGSRPFWARTESGIFRAVLKADPSFDE PWPSLS EA+DFVKRLLNKDPRKRLTAAQAL
Sbjct: 350 LCGSRPFWARTESGIFRAVLKADPSFDETPWPSLSPEAKDFVKRLLNKDPRKRLTAAQAL 409
Query: 415 SHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALRALSKTLTVDELFYLKEQYALLE 474
SHPWIK+SN+VKVPLD++I KLMKAYMRSSSLRKAAL ALSKTLTVDELFYLKEQ+ LLE
Sbjct: 410 SHPWIKSSNEVKVPLDILILKLMKAYMRSSSLRKAALWALSKTLTVDELFYLKEQFVLLE 469
Query: 475 PNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLE 534
PNKNGTISLEN+K+ LMKN+TDAMK+SRIPDFL+SLN+LQYRRM+FEEF AAALSVHQLE
Sbjct: 470 PNKNGTISLENIKTTLMKNSTDAMKESRIPDFLASLNALQYRRMNFEEFSAAALSVHQLE 529
Query: 535 ALDRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGKLSFLG 594
ALDRWEQHARCAYELFEK GNRAIVIEELASELGLGP+VPVHAVLHDWIRHTDGKLSFLG
Sbjct: 530 ALDRWEQHARCAYELFEKAGNRAIVIEELASELGLGPSVPVHAVLHDWIRHTDGKLSFLG 589
Query: 595 FVKLLHGVSSRALAKAQ 611
FVKLLHG SSR LAK Q
Sbjct: 590 FVKLLHGASSRTLAKPQ 606
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|73761697|gb|AAZ83348.1| CDPK-related protein kinase [Gossypium hirsutum] | Back alignment and taxonomy information |
|---|
Score = 1038 bits (2684), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 520/618 (84%), Positives = 559/618 (90%), Gaps = 8/618 (1%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPV---PANGTPIPAPSPLNAESQSNNNRTNVKGND 57
MGLC SKPS N S + I +N + P + + P P +N++ K +
Sbjct: 1 MGLCTSKPSPNPSDSTNASINTRNNDIYRKPNSVSASPLPDGVNSKEDQGKQGEEEKESS 60
Query: 58 DAVIEGKKSPFFPFYSPSPAHYFFSKKSSPARSSANSTPNRFFKRPFPPPSPAKHIKAVL 117
+ EGKKSPFFPFYSPSPAHY FSKKS PARSS NSTP RFF+RPFPPPSPAKHI+AVL
Sbjct: 61 NPNNEGKKSPFFPFYSPSPAHYLFSKKS-PARSSTNSTPKRFFRRPFPPPSPAKHIRAVL 119
Query: 118 ARRHGSVKPNEAAIPEGSEPEPAA----GLNKSFGFSKHFANKYELGEEVGRGHFGYTCA 173
ARRHGSVKPNEAAIPEGS+ E A GL+KSFGFSKHF +KYELG+EVGRGHFGYTC
Sbjct: 120 ARRHGSVKPNEAAIPEGSDAEAAGATGTGLDKSFGFSKHFGSKYELGDEVGRGHFGYTCT 179
Query: 174 AKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233
AKFKKGELKGQQVAVKVIPK KMTTAIAIEDVRREVKILRAL+GH+NLV+F+DAYED DN
Sbjct: 180 AKFKKGELKGQQVAVKVIPKAKMTTAIAIEDVRREVKILRALSGHSNLVQFYDAYEDHDN 239
Query: 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLF 293
VY+VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLF
Sbjct: 240 VYIVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLF 299
Query: 294 TTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYI 353
T+KDENS LKAIDFGLSDFV+PDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYI
Sbjct: 300 TSKDENSQLKAIDFGLSDFVKPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYI 359
Query: 354 LLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQA 413
LLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQA
Sbjct: 360 LLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQA 419
Query: 414 LSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALRALSKTLTVDELFYLKEQYALL 473
LSHPWIK NDVKVPLD++IFKLMKAY+RSSSLRKAALRALSKTLTVDELFYLKEQ+ALL
Sbjct: 420 LSHPWIKKYNDVKVPLDILIFKLMKAYLRSSSLRKAALRALSKTLTVDELFYLKEQFALL 479
Query: 474 EPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQL 533
EPNKNGTISLEN+K+ LMKNATDAMKD+RIP+FL+SLN+LQYRRMDF+EFCAAAL+VHQL
Sbjct: 480 EPNKNGTISLENIKAVLMKNATDAMKDARIPEFLASLNALQYRRMDFDEFCAAALTVHQL 539
Query: 534 EALDRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGKLSFL 593
EALDRWEQHARCAYE+FEK+GNR IVIEELASELGL P+VPVHAVLHDWIRHTDGKLSFL
Sbjct: 540 EALDRWEQHARCAYEIFEKEGNRPIVIEELASELGLSPSVPVHAVLHDWIRHTDGKLSFL 599
Query: 594 GFVKLLHGVSSRALAKAQ 611
GFVKLLHGVSSR +AKAQ
Sbjct: 600 GFVKLLHGVSSRTIAKAQ 617
|
Source: Gossypium hirsutum Species: Gossypium hirsutum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297816306|ref|XP_002876036.1| hypothetical protein ARALYDRAFT_485401 [Arabidopsis lyrata subsp. lyrata] gi|297321874|gb|EFH52295.1| hypothetical protein ARALYDRAFT_485401 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1033 bits (2670), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 503/611 (82%), Positives = 549/611 (89%), Gaps = 21/611 (3%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAV 60
MGLC SKP+S P SD I +N+P+PA+ + P S SN ++ N
Sbjct: 1 MGLCTSKPNS----PNSDQIPARNSPLPASESVKP--------SSSNEDQCVTTNN---- 44
Query: 61 IEGKKSPFFPFYSPSPAHYFFSKKS---SPARSSANSTPNRFFKRPFPPPSPAKHIKAVL 117
EGKKSPFFPFYSPSPAHYFFSKK+ SPA +S NSTP RFFKRPFPPPSPAKHI+AVL
Sbjct: 45 -EGKKSPFFPFYSPSPAHYFFSKKTPARSPATNSTNSTPKRFFKRPFPPPSPAKHIRAVL 103
Query: 118 ARRHGSVKPNEAAIPEGSEPEPAA-GLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKF 176
ARRHGSVKPN AAIPEGSE E GL+KSFGFSK FA+KYELG+EVGRGHFGYTCAAKF
Sbjct: 104 ARRHGSVKPNSAAIPEGSEAEGGGVGLDKSFGFSKSFASKYELGDEVGRGHFGYTCAAKF 163
Query: 177 KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236
KKG+ KGQQVAVKVIPK KMTTAIAIEDVRREVKILRAL+GHNNL F+DAYED DNVY+
Sbjct: 164 KKGDNKGQQVAVKVIPKAKMTTAIAIEDVRREVKILRALSGHNNLPHFYDAYEDHDNVYI 223
Query: 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296
VMELCEGGELLDRILSRGGKYTE+DAK VMIQILNVVAFCHLQGVVHRDLKPENFLFT+K
Sbjct: 224 VMELCEGGELLDRILSRGGKYTEEDAKTVMIQILNVVAFCHLQGVVHRDLKPENFLFTSK 283
Query: 297 DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLC 356
++ S LKAIDFGLSD+VRPDERLNDIVGSAYYVAPEVLHRSYSTEAD+WS+GVI YILLC
Sbjct: 284 EDTSQLKAIDFGLSDYVRPDERLNDIVGSAYYVAPEVLHRSYSTEADIWSVGVIVYILLC 343
Query: 357 GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416
GSRPFWARTESGIFRAVLKADPSFD+ PWP LSSEARDFVKRLLNKDPRKRLTAAQALSH
Sbjct: 344 GSRPFWARTESGIFRAVLKADPSFDDPPWPLLSSEARDFVKRLLNKDPRKRLTAAQALSH 403
Query: 417 PWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALRALSKTLTVDELFYLKEQYALLEPN 476
PWIK+SN+ KVPLD+++FKLM+AY+RSSSLRKAALRALSKTLTVDELFYL+EQ+ALLEP+
Sbjct: 404 PWIKDSNNAKVPLDILVFKLMRAYLRSSSLRKAALRALSKTLTVDELFYLREQFALLEPS 463
Query: 477 KNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEAL 536
KNGTISLEN+KSALMK ATDAMKDSRIP+FL L++LQYRRMDFEEFCAAALSVHQLEAL
Sbjct: 464 KNGTISLENIKSALMKMATDAMKDSRIPEFLGQLSALQYRRMDFEEFCAAALSVHQLEAL 523
Query: 537 DRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGKLSFLGFV 596
DRWEQHARCAYELFEK+GNR I+I+ELASELGLGP+VPVHAVLHDW+RHTDGKLSFLGFV
Sbjct: 524 DRWEQHARCAYELFEKEGNRPIMIDELASELGLGPSVPVHAVLHDWLRHTDGKLSFLGFV 583
Query: 597 KLLHGVSSRAL 607
KLLHGVSSR +
Sbjct: 584 KLLHGVSSRTI 594
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15229785|ref|NP_190622.1| CDPK-related kinase [Arabidopsis thaliana] gi|75337058|sp|Q9SCS2.1|CAMK5_ARATH RecName: Full=CDPK-related kinase 5; Short=AtCRK5; AltName: Full=Calcium/calmodulin-dependent protein kinase 1 gi|6561993|emb|CAB62482.1| CDPK-related protein kinase [Arabidopsis thaliana] gi|332645155|gb|AEE78676.1| CDPK-related kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1030 bits (2662), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 501/611 (81%), Positives = 550/611 (90%), Gaps = 17/611 (2%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAV 60
MGLC SKP+S++S D +N+P+PA+ + P+ S +N E Q N
Sbjct: 1 MGLCTSKPNSSNS----DQTPARNSPLPASESVKPSSSSVNGEDQCVTTTNN-------- 48
Query: 61 IEGKKSPFFPFYSPSPAHYFFSKKS---SPARSSANSTPNRFFKRPFPPPSPAKHIKAVL 117
EGKKSPFFPFYSPSPAHYFFSKK+ SPA +S NSTP RFFKRPFPPPSPAKHI+AVL
Sbjct: 49 -EGKKSPFFPFYSPSPAHYFFSKKTPARSPATNSTNSTPKRFFKRPFPPPSPAKHIRAVL 107
Query: 118 ARRHGSVKPNEAAIPEGSEPEPAA-GLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKF 176
ARRHGSVKPN +AIPEGSE E GL+KSFGFSK FA+KYELG+EVGRGHFGYTCAAKF
Sbjct: 108 ARRHGSVKPNSSAIPEGSEAEGGGVGLDKSFGFSKSFASKYELGDEVGRGHFGYTCAAKF 167
Query: 177 KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236
KKG+ KGQQVAVKVIPK KMTTAIAIEDVRREVKILRAL+GHNNL F+DAYED DNVY+
Sbjct: 168 KKGDNKGQQVAVKVIPKAKMTTAIAIEDVRREVKILRALSGHNNLPHFYDAYEDHDNVYI 227
Query: 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296
VMELCEGGELLDRILSRGGKYTE+DAK VMIQILNVVAFCHLQGVVHRDLKPENFLFT+K
Sbjct: 228 VMELCEGGELLDRILSRGGKYTEEDAKTVMIQILNVVAFCHLQGVVHRDLKPENFLFTSK 287
Query: 297 DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLC 356
++ S LKAIDFGLSD+VRPDERLNDIVGSAYYVAPEVLHRSYSTEAD+WS+GVI YILLC
Sbjct: 288 EDTSQLKAIDFGLSDYVRPDERLNDIVGSAYYVAPEVLHRSYSTEADIWSVGVIVYILLC 347
Query: 357 GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416
GSRPFWARTESGIFRAVLKADPSFD+ PWP LSSEARDFVKRLLNKDPRKRLTAAQALSH
Sbjct: 348 GSRPFWARTESGIFRAVLKADPSFDDPPWPLLSSEARDFVKRLLNKDPRKRLTAAQALSH 407
Query: 417 PWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALRALSKTLTVDELFYLKEQYALLEPN 476
PWIK+SND KVP+D+++FKLM+AY+RSSSLRKAALRALSKTLTVDELFYL+EQ+ALLEP+
Sbjct: 408 PWIKDSNDAKVPMDILVFKLMRAYLRSSSLRKAALRALSKTLTVDELFYLREQFALLEPS 467
Query: 477 KNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEAL 536
KNGTISLEN+KSALMK ATDAMKDSRIP+FL L++LQYRRMDFEEFCAAALSVHQLEAL
Sbjct: 468 KNGTISLENIKSALMKMATDAMKDSRIPEFLGQLSALQYRRMDFEEFCAAALSVHQLEAL 527
Query: 537 DRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGKLSFLGFV 596
DRWEQHARCAYELFEK+GNR I+I+ELASELGLGP+VPVHAVLHDW+RHTDGKLSFLGFV
Sbjct: 528 DRWEQHARCAYELFEKEGNRPIMIDELASELGLGPSVPVHAVLHDWLRHTDGKLSFLGFV 587
Query: 597 KLLHGVSSRAL 607
KLLHGVSSR +
Sbjct: 588 KLLHGVSSRTI 598
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|16904214|gb|AAL30814.1|AF435446_1 calcium/calmodulin-dependent protein kinase CaMK1 [Arabidopsis thaliana] gi|2154715|emb|CAA70572.1| CDPK-related protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1028 bits (2657), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 500/611 (81%), Positives = 549/611 (89%), Gaps = 17/611 (2%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAV 60
MGLC SKP+S++S D +N+P+PA+ + P+ S +N E Q N
Sbjct: 1 MGLCTSKPNSSNS----DQTPARNSPLPASESVKPSSSSVNGEDQCVTTTNN-------- 48
Query: 61 IEGKKSPFFPFYSPSPAHYFFSKKS---SPARSSANSTPNRFFKRPFPPPSPAKHIKAVL 117
EGKKSPFFPFYSPSPAHYFFSKK+ SPA +S NSTP RFFKRPFPPPSPAKHI+AVL
Sbjct: 49 -EGKKSPFFPFYSPSPAHYFFSKKTPARSPATNSTNSTPKRFFKRPFPPPSPAKHIRAVL 107
Query: 118 ARRHGSVKPNEAAIPEGSEPEPAA-GLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKF 176
ARRHGSVKPN +AIPEGSE E GL+KSFGFSK FA+KYELG+EVGRGHFGYTCAAKF
Sbjct: 108 ARRHGSVKPNSSAIPEGSEAEGGGVGLDKSFGFSKSFASKYELGDEVGRGHFGYTCAAKF 167
Query: 177 KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236
KKG+ KGQQVAVKVIPK KMTTAIAIEDVRREVKILRAL+GHNNL F+DAYED DNVY+
Sbjct: 168 KKGDNKGQQVAVKVIPKAKMTTAIAIEDVRREVKILRALSGHNNLPHFYDAYEDHDNVYI 227
Query: 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296
VMELCEGGELLDRILSRGGKYTE+DAK VMIQILNVVAFCHLQGVVHRDLKPENFLFT+K
Sbjct: 228 VMELCEGGELLDRILSRGGKYTEEDAKTVMIQILNVVAFCHLQGVVHRDLKPENFLFTSK 287
Query: 297 DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLC 356
++ S LKAIDFGLSD+VRPDERLNDIVGSAYYVAPEVLHRSYSTEAD+WS+GVI YILLC
Sbjct: 288 EDTSQLKAIDFGLSDYVRPDERLNDIVGSAYYVAPEVLHRSYSTEADIWSVGVIVYILLC 347
Query: 357 GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416
GSRPFWARTESGIFRAVLKADPSFD+ PWP LSSEARDFVKRLLNKDPRKRLTAAQALSH
Sbjct: 348 GSRPFWARTESGIFRAVLKADPSFDDPPWPLLSSEARDFVKRLLNKDPRKRLTAAQALSH 407
Query: 417 PWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALRALSKTLTVDELFYLKEQYALLEPN 476
PWIK+SND KVP+D+++FKLM+AY+RSSSLRKAALRALSKTLTVDELFYL+EQ+ALLEP+
Sbjct: 408 PWIKDSNDAKVPMDILVFKLMRAYLRSSSLRKAALRALSKTLTVDELFYLREQFALLEPS 467
Query: 477 KNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEAL 536
KNGTISLEN+KSALMK ATDAMKDSRIP+FL L++LQYRRMDFEEFCAAALSVHQLEAL
Sbjct: 468 KNGTISLENIKSALMKMATDAMKDSRIPEFLGQLSALQYRRMDFEEFCAAALSVHQLEAL 527
Query: 537 DRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGKLSFLGFV 596
DRWEQHARCAYELFEK+GNR I+I+ELASELGLGP+VPVHAVLHDW+RHTDGKLSFLGFV
Sbjct: 528 DRWEQHARCAYELFEKEGNRPIMIDELASELGLGPSVPVHAVLHDWLRHTDGKLSFLGFV 587
Query: 597 KLLHGVSSRAL 607
KL HGVSSR +
Sbjct: 588 KLQHGVSSRTI 598
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|16904226|gb|AAL30820.1|AF435452_1 calcium/calmodulin-dependent protein kinase CaMK3 [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 1025 bits (2650), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 494/615 (80%), Positives = 550/615 (89%), Gaps = 17/615 (2%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAV 60
MG C SKPS+ S + V +G P S + + N+++T ND+
Sbjct: 1 MGACTSKPSNFSVD---------DITVAGDGAIFPVKSGPSNDDDVNSHQTK---NDEPS 48
Query: 61 IEGKKSPFFPFYSPSPAHYFFSKKSSPARSSANSTPNRFFKRPFPPPSPAKHIKAVLARR 120
+ GKKSPFFPFYSPSPAHY FSKKS +S+NSTP RFFKRPFPPPSPAKHI+++LARR
Sbjct: 49 V-GKKSPFFPFYSPSPAHYLFSKKSPATNASSNSTPMRFFKRPFPPPSPAKHIRSLLARR 107
Query: 121 HGSVKPNEAAIPEGSEPE----PAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKF 176
HG+VKPNE+AIPEG+E E AGL+KSFGFSK+F NKYE+GEEVGRGHFGYTC AKF
Sbjct: 108 HGTVKPNESAIPEGNESEVGDGGGAGLDKSFGFSKNFVNKYEMGEEVGRGHFGYTCKAKF 167
Query: 177 KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236
KKGE+KGQ+VAVKVIPK KMTTAIAIEDVRREVKILRALTGHNNLVKF+DAYED +NVY+
Sbjct: 168 KKGEVKGQEVAVKVIPKSKMTTAIAIEDVRREVKILRALTGHNNLVKFYDAYEDPNNVYI 227
Query: 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296
VMELCEGGELLDRILSRGGKYTEDDAK+VMIQIL VVAFCHLQGVVHRDLKPENFLFT+K
Sbjct: 228 VMELCEGGELLDRILSRGGKYTEDDAKSVMIQILKVVAFCHLQGVVHRDLKPENFLFTSK 287
Query: 297 DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLC 356
DEN+ LKAIDFGLSDFV+PDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLC
Sbjct: 288 DENAQLKAIDFGLSDFVKPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLC 347
Query: 357 GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416
GSRPFWARTESGIFRAVLKADPSFDE PWP+LSSEA+DFVKRLLNKDPRKR+TAAQAL H
Sbjct: 348 GSRPFWARTESGIFRAVLKADPSFDEQPWPTLSSEAKDFVKRLLNKDPRKRMTAAQALGH 407
Query: 417 PWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALRALSKTLTVDELFYLKEQYALLEPN 476
PWIKNS++++ PLD++IFKLMKAYMRSS+LRKAALRALSKTLTVDELFYLKEQ+ALLEPN
Sbjct: 408 PWIKNSHNMEEPLDILIFKLMKAYMRSSALRKAALRALSKTLTVDELFYLKEQFALLEPN 467
Query: 477 KNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEAL 536
KNGTIS N+K+ALMK+ATDAMK++R+ DFL+SLN+LQYRRMDFEEFCAAALSVHQLEAL
Sbjct: 468 KNGTISFNNIKTALMKHATDAMKEARMHDFLASLNALQYRRMDFEEFCAAALSVHQLEAL 527
Query: 537 DRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGKLSFLGFV 596
DRWEQHARCAYE+FEK+GNRAI+IEELASELGL P+VPVHAVLHDW+RHTDGKLSFLGF
Sbjct: 528 DRWEQHARCAYEIFEKEGNRAIMIEELASELGLSPSVPVHAVLHDWLRHTDGKLSFLGFA 587
Query: 597 KLLHGVSSRALAKAQ 611
KLLHGVSSR++ K Q
Sbjct: 588 KLLHGVSSRSITKVQ 602
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|334185866|ref|NP_001190048.1| CDPK-related kinase [Arabidopsis thaliana] gi|332645156|gb|AEE78677.1| CDPK-related kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1014 bits (2622), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 501/642 (78%), Positives = 550/642 (85%), Gaps = 48/642 (7%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAV 60
MGLC SKP+S++S D +N+P+PA+ + P+ S +N E Q N
Sbjct: 1 MGLCTSKPNSSNS----DQTPARNSPLPASESVKPSSSSVNGEDQCVTTTNN-------- 48
Query: 61 IEGKKSPFFPFYSPSPAHYFFSKKS---SPARSSANSTPNRFFKRPFPPPSPAKHIKAVL 117
EGKKSPFFPFYSPSPAHYFFSKK+ SPA +S NSTP RFFKRPFPPPSPAKHI+AVL
Sbjct: 49 -EGKKSPFFPFYSPSPAHYFFSKKTPARSPATNSTNSTPKRFFKRPFPPPSPAKHIRAVL 107
Query: 118 ARRHGSVKPNEAAIPEGSEPEPAA-GLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKF 176
ARRHGSVKPN +AIPEGSE E GL+KSFGFSK FA+KYELG+EVGRGHFGYTCAAKF
Sbjct: 108 ARRHGSVKPNSSAIPEGSEAEGGGVGLDKSFGFSKSFASKYELGDEVGRGHFGYTCAAKF 167
Query: 177 KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236
KKG+ KGQQVAVKVIPK KMTTAIAIEDVRREVKILRAL+GHNNL F+DAYED DNVY+
Sbjct: 168 KKGDNKGQQVAVKVIPKAKMTTAIAIEDVRREVKILRALSGHNNLPHFYDAYEDHDNVYI 227
Query: 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296
VMELCEGGELLDRILSRGGKYTE+DAK VMIQILNVVAFCHLQGVVHRDLKPENFLFT+K
Sbjct: 228 VMELCEGGELLDRILSRGGKYTEEDAKTVMIQILNVVAFCHLQGVVHRDLKPENFLFTSK 287
Query: 297 DENSVLKAIDFGLSDFVRP-------------------------------DERLNDIVGS 325
++ S LKAIDFGLSD+VRP DERLNDIVGS
Sbjct: 288 EDTSQLKAIDFGLSDYVRPGKALRLYAICKLRFQNLETSICLYALTIAFADERLNDIVGS 347
Query: 326 AYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385
AYYVAPEVLHRSYSTEAD+WS+GVI YILLCGSRPFWARTESGIFRAVLKADPSFD+ PW
Sbjct: 348 AYYVAPEVLHRSYSTEADIWSVGVIVYILLCGSRPFWARTESGIFRAVLKADPSFDDPPW 407
Query: 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSS 445
P LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK+SND KVP+D+++FKLM+AY+RSSS
Sbjct: 408 PLLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKDSNDAKVPMDILVFKLMRAYLRSSS 467
Query: 446 LRKAALRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPD 505
LRKAALRALSKTLTVDELFYL+EQ+ALLEP+KNGTISLEN+KSALMK ATDAMKDSRIP+
Sbjct: 468 LRKAALRALSKTLTVDELFYLREQFALLEPSKNGTISLENIKSALMKMATDAMKDSRIPE 527
Query: 506 FLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELAS 565
FL L++LQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEK+GNR I+I+ELAS
Sbjct: 528 FLGQLSALQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKEGNRPIMIDELAS 587
Query: 566 ELGLGPAVPVHAVLHDWIRHTDGKLSFLGFVKLLHGVSSRAL 607
ELGLGP+VPVHAVLHDW+RHTDGKLSFLGFVKLLHGVSSR +
Sbjct: 588 ELGLGPSVPVHAVLHDWLRHTDGKLSFLGFVKLLHGVSSRTI 629
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449460636|ref|XP_004148051.1| PREDICTED: CDPK-related protein kinase-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1006 bits (2602), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 492/623 (78%), Positives = 540/623 (86%), Gaps = 18/623 (2%)
Query: 1 MGLCNSKPSSNSS---------SPKSDLIRNKNTPVPANG--TPIPAPSPLNAESQSNNN 49
MGLCNSKPS NS +P + V A G +P+P PS N N
Sbjct: 1 MGLCNSKPSPNSDLFAEKSGSRTPNEGSNSTQPNSVTAMGGASPLP-PSSENGRDGRAGN 59
Query: 50 RTNVKGNDDAVIEGKKSPFFPFYSPSPAHYFFSKKS---SPARSSANSTPNRFFKRPFPP 106
R N D V KKSPFFPFYSPSPAHY FSKKS SPA +SANSTP RFF++PFPP
Sbjct: 60 RRNESHEMDNV---KKSPFFPFYSPSPAHYLFSKKSPARSPANASANSTPKRFFRKPFPP 116
Query: 107 PSPAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRG 166
PSPAKHI+AVLARRHGSVKPNE +IPEG+E E GL+K+FGFSKH +KYELGEEVGRG
Sbjct: 117 PSPAKHIRAVLARRHGSVKPNEVSIPEGTEAEGVTGLDKNFGFSKHLGSKYELGEEVGRG 176
Query: 167 HFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFD 226
HFGYTCAAKFKKGELKGQQVAVK+IPK KMTTAIAIEDVRREVKIL++L+GH NLV F+D
Sbjct: 177 HFGYTCAAKFKKGELKGQQVAVKIIPKSKMTTAIAIEDVRREVKILKSLSGHKNLVNFYD 236
Query: 227 AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDL 286
AYED DNVY+VMELCEGGELLDRILSRGGKYTE+DA+AVM QIL VVAFCHLQGVVHRDL
Sbjct: 237 AYEDHDNVYIVMELCEGGELLDRILSRGGKYTEEDARAVMTQILYVVAFCHLQGVVHRDL 296
Query: 287 KPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWS 346
KPENFLFT++DENS LKAIDFGLSDF +PDERLNDIVGSAYYVAPEVLHRSYSTEADVWS
Sbjct: 297 KPENFLFTSRDENSPLKAIDFGLSDFAKPDERLNDIVGSAYYVAPEVLHRSYSTEADVWS 356
Query: 347 IGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRK 406
IGVIAYILLCGSRPFWARTESGIF+AVLKADP FDE PWPSLSSEA+DFVKRLL KDPRK
Sbjct: 357 IGVIAYILLCGSRPFWARTESGIFKAVLKADPIFDEPPWPSLSSEAKDFVKRLLVKDPRK 416
Query: 407 RLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALRALSKTLTVDELFYL 466
R++AAQALSHPWIKNS DVK PLD++IFKLMK YMRSS LRKAALRA+S+TLT+DELFYL
Sbjct: 417 RMSAAQALSHPWIKNSMDVKAPLDILIFKLMKIYMRSSYLRKAALRAVSRTLTIDELFYL 476
Query: 467 KEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAA 526
K Q++LLEP+KNGTI++EN+K ALMKN T+ MK+SRIPD L+SL++LQYRRMDFEEFCAA
Sbjct: 477 KMQFSLLEPSKNGTINIENIKEALMKNITNGMKESRIPDLLTSLSALQYRRMDFEEFCAA 536
Query: 527 ALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHT 586
A+S+HQLEALDRWEQHAR AY+LFEKDGNR IVIEELASELGL P+VPVHAVLHDWIRHT
Sbjct: 537 AVSIHQLEALDRWEQHARYAYDLFEKDGNRPIVIEELASELGLSPSVPVHAVLHDWIRHT 596
Query: 587 DGKLSFLGFVKLLHGVSSRALAK 609
DGKLSFLGFVKLLHG SSR LAK
Sbjct: 597 DGKLSFLGFVKLLHGPSSRTLAK 619
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|1706130|sp|P53681.1|CRK_DAUCA RecName: Full=CDPK-related protein kinase; AltName: Full=PK421 gi|1103386|emb|CAA58750.1| CDPK-related protein kinase [Daucus carota] | Back alignment and taxonomy information |
|---|
Score = 1006 bits (2600), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 495/621 (79%), Positives = 539/621 (86%), Gaps = 29/621 (4%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPA------PSPLNAESQSNNNRTNVK 54
MG+C SKPS P+ DL N +T +P N T +P P + +Q NN
Sbjct: 1 MGICVSKPS-----PEPDL-HNHHTSIPVNDTSLPPQDNSIPPKDIAIPAQDNNKPP--- 51
Query: 55 GNDDAVIEGKKSPFFPFYSPSPAHYFFSKKS----SPARSSANSTPNRFFKRPFPPPSPA 110
GKKSPF PFYSPSPAH+ FSKKS SPA S+NSTP R F PFPPPSPA
Sbjct: 52 --------GKKSPFLPFYSPSPAHFLFSKKSPAVGSPAAGSSNSTPKRLF--PFPPPSPA 101
Query: 111 KHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGY 170
KHIKA ARRHGSVKPNEAAIPE +E + AGL+KSFGFSK F +K+E+GEEVGRGHFGY
Sbjct: 102 KHIKAAWARRHGSVKPNEAAIPENNEVDGGAGLDKSFGFSKKFGSKFEVGEEVGRGHFGY 161
Query: 171 TCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230
TC AKFKKGE KGQ VAVKVIPK KMTTAIAIEDVRREVKILRALTGHNNLV+F+DA+ED
Sbjct: 162 TCRAKFKKGEFKGQDVAVKVIPKAKMTTAIAIEDVRREVKILRALTGHNNLVQFYDAFED 221
Query: 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290
NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN
Sbjct: 222 HTNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 281
Query: 291 FLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVI 350
FLF +KDE+S LKAIDFGLSD+V+PDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVI
Sbjct: 282 FLFKSKDEDSQLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVI 341
Query: 351 AYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTA 410
+YILLCGSRPFWARTESGIFRAVLKA+ SFDE PWPS+SSEA+DFVKRLLNKDPRKR+TA
Sbjct: 342 SYILLCGSRPFWARTESGIFRAVLKANLSFDEPPWPSVSSEAKDFVKRLLNKDPRKRMTA 401
Query: 411 AQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALRALSKTLTVDELFYLKEQY 470
AQAL H WIKNSND+K PLD+++FKLMK YMRSS LRKAALRALSKTLTVDELFYLKEQ+
Sbjct: 402 AQALCHSWIKNSNDIKFPLDILVFKLMKVYMRSSPLRKAALRALSKTLTVDELFYLKEQF 461
Query: 471 ALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV 530
LLEP KNGTISLEN+K ALM+N+TDAMKDSR+ D L SLN+LQYRRMDFEEFCAAALSV
Sbjct: 462 VLLEPTKNGTISLENIKQALMRNSTDAMKDSRVLDLLVSLNALQYRRMDFEEFCAAALSV 521
Query: 531 HQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGKL 590
HQLEALDRWEQHARCAY+LFEKDGNRAI+IEELASELGLGP++PVHAVLHDWIRHTDGKL
Sbjct: 522 HQLEALDRWEQHARCAYDLFEKDGNRAIMIEELASELGLGPSIPVHAVLHDWIRHTDGKL 581
Query: 591 SFLGFVKLLHGVSSRALAKAQ 611
SFLG+VKLLHGVS+RA+AKAQ
Sbjct: 582 SFLGYVKLLHGVSTRAIAKAQ 602
|
Source: Daucus carota Species: Daucus carota Genus: Daucus Family: Apiaceae Order: Apiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 611 | ||||||
| TAIR|locus:2063197 | 576 | CRK1 "AT2G41140" [Arabidopsis | 0.859 | 0.911 | 0.746 | 4.4e-215 | |
| TAIR|locus:2103655 | 577 | AT3G56760 [Arabidopsis thalian | 0.859 | 0.909 | 0.746 | 9e-215 | |
| TAIR|locus:2012232 | 606 | AT1G49580 [Arabidopsis thalian | 0.816 | 0.823 | 0.751 | 7.7e-206 | |
| TAIR|locus:2094053 | 599 | AT3G19100 [Arabidopsis thalian | 0.816 | 0.833 | 0.753 | 4.2e-205 | |
| TAIR|locus:2062764 | 595 | CRK3 "AT2G46700" [Arabidopsis | 0.806 | 0.828 | 0.668 | 8.5e-186 | |
| TAIR|locus:2082931 | 594 | AT3G49370 [Arabidopsis thalian | 0.806 | 0.829 | 0.622 | 1.4e-170 | |
| TAIR|locus:2152876 | 594 | AT5G24430 [Arabidopsis thalian | 0.806 | 0.829 | 0.616 | 1.6e-169 | |
| TAIR|locus:2827826 | 571 | CPK16 "AT2G17890" [Arabidopsis | 0.752 | 0.805 | 0.515 | 9.2e-123 | |
| TAIR|locus:2156947 | 523 | CPK28 "calcium-dependent prote | 0.756 | 0.883 | 0.502 | 9.1e-116 | |
| TAIR|locus:2177023 | 528 | CPK17 "calcium-dependent prote | 0.707 | 0.818 | 0.438 | 6.6e-97 |
| TAIR|locus:2063197 CRK1 "AT2G41140" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2054 (728.1 bits), Expect = 4.4e-215, Sum P(2) = 4.4e-215
Identities = 394/528 (74%), Positives = 462/528 (87%)
Query: 84 KSSPA-RSSANSTXXXXXXXXXXXXXXAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAAG 142
KSSP+ SS +ST AKHI+A LARR+GSVKPNE +IPEG E E G
Sbjct: 51 KSSPSVSSSVSSTPLRIFKRPFPPPSPAKHIRAFLARRYGSVKPNEVSIPEGKECE--IG 108
Query: 143 LNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAI 202
L+KSFGFSK FA+ YE+ EVGRGHFGYTC+AK KKG LKGQ+VAVKVIPK KMTTAIAI
Sbjct: 109 LDKSFGFSKQFASHYEIDGEVGRGHFGYTCSAKGKKGSLKGQEVAVKVIPKSKMTTAIAI 168
Query: 203 EDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDA 262
EDV REVK+LRALTGH NLV+F+DA+ED +NVY+VMELC+GGELLD+IL RGGKY+EDDA
Sbjct: 169 EDVSREVKMLRALTGHKNLVQFYDAFEDDENVYIVMELCKGGELLDKILQRGGKYSEDDA 228
Query: 263 KAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI 322
K VM+QIL+VVA+CHLQGVVHRDLKPENFLF+TKDE S LKAIDFGLSD+V+PDERLNDI
Sbjct: 229 KKVMVQILSVVAYCHLQGVVHRDLKPENFLFSTKDETSPLKAIDFGLSDYVKPDERLNDI 288
Query: 323 VGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 382
VGSAYYVAPEVLHR+Y TEAD+WSIGVIAYILLCGSRPFWARTESGIFRAVLKA+P+F+E
Sbjct: 289 VGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKAEPNFEE 348
Query: 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMR 442
APWPSLS EA DFVKRLLNKD RKRLTAAQAL HPW+ S+++K+P D+II+KL+K Y+
Sbjct: 349 APWPSLSPEAVDFVKRLLNKDYRKRLTAAQALCHPWLVGSHELKIPSDMIIYKLVKVYIM 408
Query: 443 SSSLRKAALRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSR 502
S+SLRK+AL AL+KTLTV +L YL+EQ+ LL P+KNG IS++N K+A++K++TDAMKDSR
Sbjct: 409 STSLRKSALAALAKTLTVPQLAYLREQFTLLGPSKNGYISMQNYKTAILKSSTDAMKDSR 468
Query: 503 IPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEE 562
+ DF+ ++ LQY+++DFEEFCA+ALSV+QLEA++ WEQHAR AYELFEKDGNR I+IEE
Sbjct: 469 VFDFVHMISCLQYKKLDFEEFCASALSVYQLEAMETWEQHARRAYELFEKDGNRPIMIEE 528
Query: 563 LASELGLGPAVPVHAVLHDWIRHTDGKLSFLGFVKLLHGVSSRALAKA 610
LASELGLGP+VPVH VL DWIRH+DGKLSFLGFV+LLHGVSSR L KA
Sbjct: 529 LASELGLGPSVPVHVVLQDWIRHSDGKLSFLGFVRLLHGVSSRTLQKA 576
|
|
| TAIR|locus:2103655 AT3G56760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2052 (727.4 bits), Expect = 9.0e-215, Sum P(2) = 9.0e-215
Identities = 395/529 (74%), Positives = 463/529 (87%)
Query: 84 KSSPA--RSSANSTXXXXXXXXXXXXXXAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAA 141
K+SPA SS +ST AKHI+A+LARRHGSVKPNEA+IPEGSE E
Sbjct: 51 KTSPAVSSSSVSSTPLRIFKRPFPPPSPAKHIRALLARRHGSVKPNEASIPEGSECE--V 108
Query: 142 GLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIA 201
GL+K FGFSK FA+ YE+ EVGRGHFGYTC+AK KKG LKGQ VAVKVIPK KMTTAIA
Sbjct: 109 GLDKKFGFSKQFASHYEIDGEVGRGHFGYTCSAKGKKGSLKGQDVAVKVIPKSKMTTAIA 168
Query: 202 IEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDD 261
IEDVRREVKILRALTGH NLV+F+DA+ED +NVY+VMELC+GGELLD+IL RGGKY+E D
Sbjct: 169 IEDVRREVKILRALTGHKNLVQFYDAFEDDENVYIVMELCQGGELLDKILQRGGKYSEVD 228
Query: 262 AKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND 321
AK VMIQIL+VVA+CHLQGVVHRDLKPENFLFTTKDE+S LKAIDFGLSD+VRPDERLND
Sbjct: 229 AKKVMIQILSVVAYCHLQGVVHRDLKPENFLFTTKDESSPLKAIDFGLSDYVRPDERLND 288
Query: 322 IVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381
IVGSAYYVAPEVLHR+Y TEAD+WSIGVIAYILLCGSRPFWAR+ESGIFRAVLKA+P+F+
Sbjct: 289 IVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRPFWARSESGIFRAVLKAEPNFE 348
Query: 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYM 441
EAPWPSLS +A DFVKRLLNKD RKRLTAAQAL HPW+ S+++K+P D+II+KL+K Y+
Sbjct: 349 EAPWPSLSPDAVDFVKRLLNKDYRKRLTAAQALCHPWLVGSHELKIPSDMIIYKLVKVYI 408
Query: 442 RSSSLRKAALRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDS 501
SSSLRK+AL AL+KTLTV +L YL+EQ+ LL P+KNG IS++N K+A++K++T+A KDS
Sbjct: 409 MSSSLRKSALAALAKTLTVPQLTYLQEQFNLLGPSKNGYISMQNYKTAILKSSTEATKDS 468
Query: 502 RIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIE 561
R+ DF+ ++ LQY+++DFEEFCA+ALSV+QLEA++ WEQHAR AYEL+EKDGNR I+IE
Sbjct: 469 RVLDFVHMISCLQYKKLDFEEFCASALSVYQLEAMETWEQHARRAYELYEKDGNRVIMIE 528
Query: 562 ELASELGLGPAVPVHAVLHDWIRHTDGKLSFLGFVKLLHGVSSRALAKA 610
ELA+ELGLGP+VPVH VL DWIRH+DGKLSFLGFV+LLHGVSSR L KA
Sbjct: 529 ELATELGLGPSVPVHVVLQDWIRHSDGKLSFLGFVRLLHGVSSRTLQKA 577
|
|
| TAIR|locus:2012232 AT1G49580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1991 (705.9 bits), Expect = 7.7e-206, P = 7.7e-206
Identities = 382/508 (75%), Positives = 440/508 (86%)
Query: 110 AKHIKAVLARRHGS-------VKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEE 162
AKHI+A L RR G V +P+ E E GL+K FGFSK F ++ ELGEE
Sbjct: 97 AKHIRAALRRRKGKKEAALSGVTQLTTEVPQREEEEEV-GLDKRFGFSKEFHSRVELGEE 155
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRGHFGYTC+AKFKKGELKGQ VAVK+IPK KMTTAIAIEDVRREVKIL+AL+GH NLV
Sbjct: 156 IGRGHFGYTCSAKFKKGELKGQVVAVKIIPKSKMTTAIAIEDVRREVKILQALSGHKNLV 215
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+F+DA+ED NVY+ MELCEGGELLDRIL+RGGKY+E+DAK V+IQILNVVAFCH QGVV
Sbjct: 216 QFYDAFEDNANVYIAMELCEGGELLDRILARGGKYSENDAKPVIIQILNVVAFCHFQGVV 275
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEA 342
HRDLKPENFL+T+K+ENS LKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSY+TEA
Sbjct: 276 HRDLKPENFLYTSKEENSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYTTEA 335
Query: 343 DVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNK 402
DVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE PWP LSS+A+DFVKRLL K
Sbjct: 336 DVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPWPFLSSDAKDFVKRLLFK 395
Query: 403 DPRKRLTAAQALSHPWIKNSN-DVKVPLDVIIFKLMKAYMRSSSLRKAALRALSKTLTVD 461
DPR+R++A+QAL HPWI+ N D+ +P D++IF+ MKAY+RSSSLRKAALRALSKTL D
Sbjct: 396 DPRRRMSASQALMHPWIRAYNTDMNIPFDILIFRQMKAYLRSSSLRKAALRALSKTLIKD 455
Query: 462 ELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFE 521
E+ YLK Q++LL PNK+G I+++ ++ AL NAT+AMK+SRIP+FL+ LN LQYR MDFE
Sbjct: 456 EILYLKTQFSLLAPNKDGLITMDTIRMALASNATEAMKESRIPEFLALLNGLQYRGMDFE 515
Query: 522 EFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHD 581
EFCAAA++VHQ E+LD WEQ R AYELF+K+GNRAIVIEELASELG+GP++PVH+VLHD
Sbjct: 516 EFCAAAINVHQHESLDCWEQSIRHAYELFDKNGNRAIVIEELASELGVGPSIPVHSVLHD 575
Query: 582 WIRHTDGKLSFLGFVKLLHGVSSRALAK 609
WIRHTDGKLSF GFVKLLHGVS RA K
Sbjct: 576 WIRHTDGKLSFFGFVKLLHGVSVRASGK 603
|
|
| TAIR|locus:2094053 AT3G19100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1984 (703.5 bits), Expect = 4.2e-205, P = 4.2e-205
Identities = 383/508 (75%), Positives = 439/508 (86%)
Query: 110 AKHIKAVLARRHGSVKPNEAAIPEG-----SEPEPAAGLNKSFGFSKHFANKYELGEEVG 164
A+HI+ VL RR + EAA+P E GL+K FGFSK ++ ELGEE+G
Sbjct: 95 ARHIRDVLRRRK---EKKEAALPAARQQKEEEEREEVGLDKRFGFSKELQSRIELGEEIG 151
Query: 165 RGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKF 224
RGHFGYTC+AKFKKGELK Q+VAVKVIPK KMT+AI+IEDVRREVKILRAL+GH NLV+F
Sbjct: 152 RGHFGYTCSAKFKKGELKDQEVAVKVIPKSKMTSAISIEDVRREVKILRALSGHQNLVQF 211
Query: 225 FDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHR 284
+DA+ED NVY+VMELC GGELLDRIL+RGGKY+EDDAKAV+IQILNVVAFCHLQGVVHR
Sbjct: 212 YDAFEDNANVYIVMELCGGGELLDRILARGGKYSEDDAKAVLIQILNVVAFCHLQGVVHR 271
Query: 285 DLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADV 344
DLKPENFL+T+K+ENS+LK IDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSY+TEADV
Sbjct: 272 DLKPENFLYTSKEENSMLKVIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYTTEADV 331
Query: 345 WSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDP 404
WSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE PWPSLS EA+DFVKRLL KDP
Sbjct: 332 WSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPWPSLSFEAKDFVKRLLYKDP 391
Query: 405 RKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALRALSKTLTVDELF 464
RKR+TA+QAL HPWI + +P D++IFK +KAY+RSSSLRKAAL ALSKTLT DEL
Sbjct: 392 RKRMTASQALMHPWIAGYKKIDIPFDILIFKQIKAYLRSSSLRKAALMALSKTLTTDELL 451
Query: 465 YLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFC 524
YLK Q+A L PNKNG I+L++++ AL NAT+AMK+SRIPDFL+ LN LQY+ MDFEEFC
Sbjct: 452 YLKAQFAHLAPNKNGLITLDSIRLALATNATEAMKESRIPDFLALLNGLQYKGMDFEEFC 511
Query: 525 AAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIR 584
AA++SVHQ E+LD WEQ R AYELFE +GNR IVIEELASELG+G ++PVH +L+DWIR
Sbjct: 512 AASISVHQHESLDCWEQSIRHAYELFEMNGNRVIVIEELASELGVGSSIPVHTILNDWIR 571
Query: 585 HTDGKLSFLGFVKLLHGVSSR-ALAKAQ 611
HTDGKLSFLGFVKLLHGVS+R +LAK +
Sbjct: 572 HTDGKLSFLGFVKLLHGVSTRQSLAKTR 599
|
|
| TAIR|locus:2062764 CRK3 "AT2G46700" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1786 (633.8 bits), Expect = 8.5e-186, Sum P(2) = 8.5e-186
Identities = 332/497 (66%), Positives = 415/497 (83%)
Query: 110 AKHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFG 169
AKHIKA L +R G VKP E IPE EP L+KSFG+ K+F KYELG+EVGRGHFG
Sbjct: 97 AKHIKASLIKRLG-VKPKEGPIPEERGTEPEQSLDKSFGYGKNFGAKYELGKEVGRGHFG 155
Query: 170 YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229
+TC+ + KKG++K +AVK+I K KMTTAIAIEDVRREVK+L++L+GH L+K++DA E
Sbjct: 156 HTCSGRGKKGDIKDHPIAVKIISKAKMTTAIAIEDVRREVKLLKSLSGHKYLIKYYDACE 215
Query: 230 DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPE 289
D +NVY+VMELC+GGELLDRIL+RGGKY EDDAKA+++QIL VV+FCHLQGVVHRDLKPE
Sbjct: 216 DANNVYIVMELCDGGELLDRILARGGKYPEDDAKAIVVQILTVVSFCHLQGVVHRDLKPE 275
Query: 290 NFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGV 349
NFLFT+ E+S LK IDFGLSDF+RPDERLNDIVGSAYYVAPEVLHRSYS EAD+WSIGV
Sbjct: 276 NFLFTSSREDSDLKLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGV 335
Query: 350 IAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT 409
I YILLCGSRPFWARTESGIFR VL+ +P++D+ PWPS SSE +DFVKRLLNKD RKR++
Sbjct: 336 ITYILLCGSRPFWARTESGIFRTVLRTEPNYDDVPWPSCSSEGKDFVKRLLNKDYRKRMS 395
Query: 410 AAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALRALSKTLTVDELFYLKEQ 469
A QAL+HPW+++ + V +PLD++I+KL+KAY+ ++ LR+AAL+AL+K LT +EL YL+ Q
Sbjct: 396 AVQALTHPWLRDDSRV-IPLDILIYKLVKAYLHATPLRRAALKALAKALTENELVYLRAQ 454
Query: 470 YALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALS 529
+ LL PNK+G++SLEN K+ALM+NATDAM++SR+P+ L ++ SL YR+M FEEFCAAA+S
Sbjct: 455 FMLLGPNKDGSVSLENFKTALMQNATDAMRESRVPEILHTMESLAYRKMYFEEFCAAAIS 514
Query: 530 VHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGK 589
+HQLEA+D WE+ A ++ FE +GNR I IEELA EL +G + H L DW+R +DGK
Sbjct: 515 IHQLEAVDAWEEIATAGFQHFETEGNRVITIEELARELNVGASAYGH--LRDWVRSSDGK 572
Query: 590 LSFLGFVKLLHGVSSRA 606
LS+LGF K LHGV+ RA
Sbjct: 573 LSYLGFTKFLHGVTLRA 589
|
|
| TAIR|locus:2082931 AT3G49370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1639 (582.0 bits), Expect = 1.4e-170, Sum P(2) = 1.4e-170
Identities = 313/503 (62%), Positives = 407/503 (80%)
Query: 110 AKHIKAVLARRHGSVK-PNEAAIPEGSEPEPAAG-----LNKSFGFSKHFANKYELGEEV 163
AK I A L RR G+ P + IPE SE + G L+K+FGF+K+F KYELG EV
Sbjct: 89 AKPIMAALRRRRGTAPHPRDGPIPEDSEAGGSGGGIGERLDKNFGFAKNFEGKYELGREV 148
Query: 164 GRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVK 223
GRGHFG+TC AK KKG++KGQ VAVK+I K KMT+A++IEDVRREVK+L+AL+GH+++VK
Sbjct: 149 GRGHFGHTCWAKAKKGKIKGQTVAVKIISKSKMTSALSIEDVRREVKLLKALSGHSHMVK 208
Query: 224 FFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVH 283
F+D +ED+DNV+VVMELCEGGELLD IL+RGG+Y E +AK +++QIL+ AF HLQGVVH
Sbjct: 209 FYDVFEDSDNVFVVMELCEGGELLDSILARGGRYPEAEAKRILVQILSATAFFHLQGVVH 268
Query: 284 RDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEAD 343
RDLKPENFLFT+K+E++VLK IDFGLSD+ R D+RLND+VGSAYYVAPEVLHRSYSTEAD
Sbjct: 269 RDLKPENFLFTSKNEDAVLKVIDFGLSDYARFDQRLNDVVGSAYYVAPEVLHRSYSTEAD 328
Query: 344 VWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKD 403
+WSIGVI+YILLCGSRPF+ RTES IFR VL+A+P+FD+ PWPS+S A+DFVKRLLNKD
Sbjct: 329 IWSIGVISYILLCGSRPFYGRTESAIFRCVLRANPNFDDLPWPSISPIAKDFVKRLLNKD 388
Query: 404 PRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALRALSKTLTVDEL 463
RKR+TAAQAL+HPW+++ N + LD I+KL+K+Y+R+S R+AAL++LSK + +EL
Sbjct: 389 HRKRMTAAQALAHPWLRDENPGLL-LDFSIYKLVKSYIRASPFRRAALKSLSKAIPEEEL 447
Query: 464 FYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEF 523
+LK Q+ LLEP ++G + L N +AL + ATDAM +SR+PD L+ + L ++++DFEEF
Sbjct: 448 VFLKAQFMLLEP-EDGGLHLHNFTTALTRYATDAMIESRLPDILNMMQPLAHKKLDFEEF 506
Query: 524 CAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWI 583
CAA++SV+QLEAL+ WEQ A A+E FE +G+RAI ++ELA E+ LGP + +L DWI
Sbjct: 507 CAASVSVYQLEALEEWEQIATVAFEHFESEGSRAISVQELAEEMSLGPNA--YPLLKDWI 564
Query: 584 RHTDGKLSFLGFVKLLHGVSSRA 606
R DGKL+FLG+ K LHGV+ R+
Sbjct: 565 RSLDGKLNFLGYAKFLHGVTVRS 587
|
|
| TAIR|locus:2152876 AT5G24430 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1629 (578.5 bits), Expect = 1.6e-169, Sum P(2) = 1.6e-169
Identities = 312/506 (61%), Positives = 406/506 (80%)
Query: 110 AKHIKAVLARRHGSV-KPNEAAIPEGSEP------EPAAG--LNKSFGFSKHFANKYELG 160
AK I A L RR G+ +P + IPE SE + G L+K+FGF K+F KYELG
Sbjct: 87 AKPIMAALRRRRGAPPQPRDEPIPEDSEDVVDHGGDSGGGERLDKNFGFGKNFEGKYELG 146
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+EVGRGHFG+TC AK KKG++K Q VAVK+I K KMT+ ++IEDVRREVK+L+AL+GH +
Sbjct: 147 KEVGRGHFGHTCWAKAKKGKMKNQTVAVKIISKAKMTSTLSIEDVRREVKLLKALSGHRH 206
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
+VKF+D YED DNV+VVMELCEGGELLDRIL+RGG+Y E DAK +++QIL+ AF HLQG
Sbjct: 207 MVKFYDVYEDADNVFVVMELCEGGELLDRILARGGRYPEVDAKRILVQILSATAFFHLQG 266
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYST 340
VVHRDLKPENFLFT+++E+++LK IDFGLSDF+R D+RLND+VGSAYYVAPEVLHRSYST
Sbjct: 267 VVHRDLKPENFLFTSRNEDAILKVIDFGLSDFIRYDQRLNDVVGSAYYVAPEVLHRSYST 326
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
EAD+WSIGVI+YILLCGSRPF+ RTES IFR VL+A+P+F++ PWPS+S A+DFVKRLL
Sbjct: 327 EADMWSIGVISYILLCGSRPFYGRTESAIFRCVLRANPNFEDMPWPSISPTAKDFVKRLL 386
Query: 401 NKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALRALSKTLTV 460
NKD RKR+TAAQAL+HPW+++ N + LD ++KL+K+Y+R+S R++AL+ALSK +
Sbjct: 387 NKDHRKRMTAAQALAHPWLRDENPGLL-LDFSVYKLVKSYIRASPFRRSALKALSKAIPD 445
Query: 461 DELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDF 520
+EL +LK Q+ LL+P K+G +SL AL + ATDAM +SR+PD L+++ L +++DF
Sbjct: 446 EELVFLKAQFMLLDP-KDGGLSLNCFTMALTRYATDAMMESRLPDILNTMQPLAQKKLDF 504
Query: 521 EEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLH 580
EEFCAAA+SV+QLEAL+ WEQ A A+E FE +GNR I ++ELA E+ +GP+ + +L
Sbjct: 505 EEFCAAAVSVYQLEALEEWEQIATSAFEHFEHEGNRIISVQELAGEMSVGPSA--YPLLK 562
Query: 581 DWIRHTDGKLSFLGFVKLLHGVSSRA 606
DWIR +DGKLSFLG+ K LHGV+ R+
Sbjct: 563 DWIRSSDGKLSFLGYAKFLHGVTVRS 588
|
|
| TAIR|locus:2827826 CPK16 "AT2G17890" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1207 (429.9 bits), Expect = 9.2e-123, P = 9.2e-123
Identities = 242/469 (51%), Positives = 333/469 (71%)
Query: 142 GLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIA 201
G FG++K F ++Y +G+ +G G FGYT A KK G +VAVK I K KMT IA
Sbjct: 93 GKRVDFGYAKDFDHRYTIGKLLGHGQFGYTYVATDKK---TGDRVAVKKIDKAKMTIPIA 149
Query: 202 IEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR-GGKYTED 260
+EDV+REVKIL+ALTGH N+V+F++A+ED ++VY+VMELCEGGELLDRIL+R +Y+E
Sbjct: 150 VEDVKREVKILQALTGHENVVRFYNAFEDKNSVYIVMELCEGGELLDRILARKDSRYSER 209
Query: 261 DAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLN 320
DA V+ Q+L V A CHL+G+VHRD+KPENFLF + +E+S LKA DFGLSDF++P ++ +
Sbjct: 210 DAAVVVRQMLKVAAECHLRGLVHRDMKPENFLFKSTEEDSPLKATDFGLSDFIKPGKKFH 269
Query: 321 DIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 380
DIVGSAYYVAPEVL R E+DVWSIGVI+YILLCG RPFW +TE GIF+ VLK P F
Sbjct: 270 DIVGSAYYVAPEVLKRRSGPESDVWSIGVISYILLCGRRPFWDKTEDGIFKEVLKNKPDF 329
Query: 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV-KVPLDVIIFKLMKA 439
PWP++S+ A+DFVK+LL KDPR RLTAAQALSHPW++ D ++P+D+ + M+
Sbjct: 330 RRKPWPTISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQ 389
Query: 440 YMRSSSLRKAALRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMK 499
+++ S L++ ALRAL+ TL +EL L++Q+ ++ +KNG ISLE ++ AL K+ +K
Sbjct: 390 FVKFSRLKQFALRALATTLDEEELADLRDQFDAIDVDKNGVISLEEMRQALAKDHPWKLK 449
Query: 500 DSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALD--RWEQHARCAYELFEKDGNRA 557
D+R+ + L +++S +DF EF AAAL V+QLE D +W+Q +R A+E F+ DG+
Sbjct: 450 DARVAEILQAIDSNTDGFVDFGEFVAAALHVNQLEEHDSEKWQQRSRAAFEKFDIDGDGF 509
Query: 558 IVIEELASELGLGPAVPVHAVLHDWIRHTDGKLSFLGFVKLLHGVSSRA 606
I EEL GL ++ +L + DGK+S F +LL S ++
Sbjct: 510 ITAEELRMHTGLKGSI--EPLLEEADIDNDGKISLQEFRRLLRTASIKS 556
|
|
| TAIR|locus:2156947 CPK28 "calcium-dependent protein kinase 28" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1141 (406.7 bits), Expect = 9.1e-116, P = 9.1e-116
Identities = 238/474 (50%), Positives = 317/474 (66%)
Query: 134 GSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPK 193
GS P G FG+SK F + Y +G+ +G G FGYT A + G +VAVK + K
Sbjct: 42 GSIP---CGKRTDFGYSKDFHDHYTIGKLLGHGQFGYTYVAIHRPN---GDRVAVKRLDK 95
Query: 194 HKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR 253
KM IA+EDV+REV+IL AL+GH N+V+F +A+ED D VY+VMELCEGGELLDRILS+
Sbjct: 96 SKMVLPIAVEDVKREVQILIALSGHENVVQFHNAFEDDDYVYIVMELCEGGELLDRILSK 155
Query: 254 -GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312
G +Y+E DA V+ Q+L V CHL G+VHRD+KPENFLF + +S LKA DFGLSDF
Sbjct: 156 KGNRYSEKDAAVVVRQMLKVAGECHLHGLVHRDMKPENFLFKSAQLDSPLKATDFGLSDF 215
Query: 313 VRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRA 372
++P +R +DIVGSAYYVAPEVL R E+DVWSIGVI YILLCG RPFW RTE GIF+
Sbjct: 216 IKPGKRFHDIVGSAYYVAPEVLKRRSGPESDVWSIGVITYILLCGRRPFWDRTEDGIFKE 275
Query: 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS-NDVKVPLDV 431
VL+ P F PW ++S A+DFVK+LL KDPR RLTAAQALSH W++ N +P+D+
Sbjct: 276 VLRNKPDFSRKPWATISDSAKDFVKKLLVKDPRARLTAAQALSHAWVREGGNATDIPVDI 335
Query: 432 IIFKLMKAYMRSSSLRKAALRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALM 491
+ ++ ++R S L++ ALRAL+ TL E+ L++Q+ ++ +KNG ISLE ++ AL
Sbjct: 336 SVLNNLRQFVRYSRLKQFALRALASTLDEAEISDLRDQFDAIDVDKNGVISLEEMRQALA 395
Query: 492 KNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALD--RWEQHARCAYEL 549
K+ +KDSR+ + L +++S +DF EF AAAL VHQLE D +W+ +R A+E
Sbjct: 396 KDLPWKLKDSRVAEILEAIDSNTDGLVDFTEFVAAALHVHQLEEHDSEKWQLRSRAAFEK 455
Query: 550 FEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603
F+ D + I EEL GL ++ +L + DGK+S F +LL S
Sbjct: 456 FDLDKDGYITPEELRMHTGLRGSID--PLLDEADIDRDGKISLHEFRRLLRTAS 507
|
|
| TAIR|locus:2177023 CPK17 "calcium-dependent protein kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 963 (344.1 bits), Expect = 6.6e-97, P = 6.6e-97
Identities = 197/449 (43%), Positives = 283/449 (63%)
Query: 157 YELGEEVGRGHFGYT--CAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
Y LG+E+GRG FG T C K G Q A K I K K+ IEDVRREV+I+
Sbjct: 73 YSLGKELGRGQFGVTHLCTQK-----ATGHQFACKTIAKRKLVNKEDIEDVRREVQIMHH 127
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
LTG N+V+ AYED +V++VMELC GGEL DRI+++G Y+E A +++ I+ +V
Sbjct: 128 LTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKG-HYSERAAASLLRTIVQIVH 186
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL 334
CH GV+HRDLKPENFL KDENS LKA DFGLS F +P E DIVGSAYY+APEVL
Sbjct: 187 TCHSMGVIHRDLKPENFLLLNKDENSPLKATDFGLSVFYKPGEVFKDIVGSAYYIAPEVL 246
Query: 335 HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARD 394
R Y EAD+WSIGV+ YILLCG PFWA +E+GIF A+L+ F PWPS+S +A+D
Sbjct: 247 KRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILRGHVDFSSDPWPSISPQAKD 306
Query: 395 FVKRLLNKDPRKRLTAAQALSHPWIKNSNDVK-VPLDVIIFKLMKAYMRSSSLRKAALRA 453
VK++LN DP++RLTAAQ L+HPWIK + VPLD + +K + ++ +K ALR
Sbjct: 307 LVKKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLKQFKAMNNFKKVALRV 366
Query: 454 LSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSL 513
++ L+ +E+ LKE + ++ + +GTI+LE ++ L K T + + + + + ++
Sbjct: 367 IAGCLSEEEIMGLKEMFKGMDTDSSGTITLEELRQGLAKQGT-RLSEYEVQQLMEAADAD 425
Query: 514 QYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELAS---ELGLG 570
+D+ EF AA + +++L DR E+H A++ F+KD + I +EEL E G+
Sbjct: 426 GNGTIDYGEFIAATMHINRL---DR-EEHLYSAFQHFDKDNSGYITMEELEQALREFGMN 481
Query: 571 PAVPVHAVLHDWIRHTDGKLSFLGFVKLL 599
+ ++ + DG++++ FV ++
Sbjct: 482 DGRDIKEIISEVDGDNDGRINYDEFVAMM 510
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9SCS2 | CAMK5_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8199 | 0.9721 | 0.9883 | yes | no |
| P53681 | CRK_DAUCA | 2, ., 7, ., 1, 1, ., 1 | 0.7971 | 0.9689 | 0.9833 | N/A | no |
| O80673 | CAMK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7016 | 0.9427 | 1.0 | no | no |
| Q10KY3 | CAMK1_ORYSJ | 2, ., 7, ., 1, 1, ., 1, 7 | 0.7509 | 0.8805 | 0.8966 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.994 |
| 3rd Layer | 2.7.11 | 0.998 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | CRK5 | CPK related kinase 5 (607 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | grail3.0049009101 | elongation factor 1-alpha; This protein promotes the GTP-dependent binding of aminoacyl-tRNA to [...] (450 aa) | • | 0.510 | |||||||
 | grail3.0049008501 | RecName- Full=Elongation factor 1-alpha;; This protein promotes the GTP-dependent binding of am [...] (449 aa) | • | 0.510 | |||||||
 | grail3.0028013201 | RecName- Full=Elongation factor 1-alpha;; This protein promotes the GTP-dependent binding of am [...] (447 aa) | • | 0.510 | |||||||
 | grail3.0022037901 | elongation factor 1-alpha; This protein promotes the GTP-dependent binding of aminoacyl-tRNA to [...] (449 aa) | • | 0.510 | |||||||
 | grail3.0022037501 | RecName- Full=Elongation factor 1-alpha;; This protein promotes the GTP-dependent binding of am [...] (449 aa) | • | 0.510 | |||||||
 | eugene3.00102124 | RecName- Full=Elongation factor 1-alpha;; This protein promotes the GTP-dependent binding of am [...] (450 aa) | • | 0.510 | |||||||
 | estExt_Genewise1_v1.C_LG_VIII1205 | RecName- Full=Elongation factor 1-alpha;; This protein promotes the GTP-dependent binding of am [...] (450 aa) | • | 0.510 | |||||||
 | eugene3.00770028 | hypothetical protein (487 aa) | • | 0.423 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 611 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-102 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-89 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-62 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-61 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-59 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-58 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-56 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-54 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-53 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-51 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-51 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-49 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-47 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-46 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-46 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-46 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-45 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-43 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-43 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-43 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-42 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-42 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-41 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-41 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-40 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-40 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-38 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-38 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-38 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-38 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-37 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-37 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-36 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-36 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-36 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-36 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-36 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-36 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-35 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-34 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-34 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-34 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-34 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-33 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-33 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-32 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-32 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-32 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-32 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-32 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-32 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-32 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-32 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-31 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-31 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-31 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-31 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-30 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-30 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-30 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-30 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-30 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-30 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-30 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-30 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-30 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-30 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-29 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-29 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-29 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-29 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-28 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-28 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-28 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-28 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-28 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-28 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-28 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-28 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-28 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-28 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-28 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-28 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-27 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-27 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-27 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-27 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-27 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-27 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-27 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-27 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-27 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-27 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-27 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-26 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-26 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-26 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-26 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-26 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-26 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-26 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-26 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-25 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-25 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-25 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-25 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-25 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-25 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-25 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-25 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-25 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-25 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-25 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-25 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-24 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-24 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-24 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-24 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-24 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-24 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-24 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-24 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-24 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-24 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-24 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-23 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-23 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-23 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-23 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-23 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-23 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-23 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-23 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-23 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-23 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-22 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-22 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-22 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-22 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-22 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-22 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-22 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-22 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-22 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-22 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-22 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-22 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-22 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-22 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-22 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-21 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-21 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-21 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-21 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-21 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-21 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-21 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-21 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-21 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-21 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-21 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-21 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-21 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-20 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-20 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-20 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-20 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-20 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-20 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-20 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-20 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-20 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-20 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-19 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-19 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-19 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-19 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-19 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-18 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-18 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-18 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-18 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-17 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-17 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-17 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-17 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-17 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-16 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-16 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-16 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-15 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-15 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-14 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-14 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-14 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-13 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-12 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-12 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-11 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-11 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-08 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 4e-06 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 6e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-05 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 2e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-05 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 7e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-04 | |
| PTZ00184 | 149 | PTZ00184, PTZ00184, calmodulin; Provisional | 3e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-04 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 5e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 5e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 308 bits (792), Expect = e-102
Identities = 116/265 (43%), Positives = 165/265 (62%), Gaps = 13/265 (4%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
YE+ E++G G FG A+ KK G+ VA+KVI K K+ E + RE+KIL+ L
Sbjct: 1 YEILEKLGEGSFGKVYLARDKK---TGKLVAIKVIKKKKIKKDR--ERILREIKILKKL- 54
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N+V+ +D +ED D +Y+VME CEGG+L D + RG + +ED+A+ + QIL+ + +
Sbjct: 55 KHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG-RLSEDEARFYLRQILSALEYL 113
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-H 335
H +G+VHRDLKPEN L DE+ +K DFGL+ + P E+L VG+ Y+APEVL
Sbjct: 114 HSKGIVHRDLKPENILL---DEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLG 170
Query: 336 RSYSTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDEAPWPSLSSEARD 394
+ Y D+WS+GVI Y LL G PF + +F+ + K P F P +S EA+D
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP-PEWDISPEAKD 229
Query: 395 FVKRLLNKDPRKRLTAAQALSHPWI 419
+++LL KDP KRLTA +AL HP+
Sbjct: 230 LIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 276 bits (709), Expect = 3e-89
Identities = 121/269 (44%), Positives = 159/269 (59%), Gaps = 15/269 (5%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
YEL ++G G FG AK K G+ VAVK++ K + RRE++ILR L
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGT---GKIVAVKILKKRSEKSKKDQTA-RREIRILRRL- 55
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N+V+ DA+ED D++Y+VME CEGG+L D LSRGG +ED+AK + +QIL + +
Sbjct: 56 SHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFD-YLSRGGPLSEDEAKKIALQILRGLEYL 114
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL- 334
H G++HRDLKPEN L DEN V+K DFGL+ ++ L VG+ +Y+APEVL
Sbjct: 115 HSNGIIHRDLKPENILL---DENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLL 171
Query: 335 -HRSYSTEADVWSIGVIAYILLCGSRPFWARTESG---IFRAVLKADPSFDEAPWPSLSS 390
Y + DVWS+GVI Y LL G PF + R +L FDE W S S
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSE 231
Query: 391 EARDFVKRLLNKDPRKRLTAAQALSHPWI 419
EA+D +K+ LNKDP KR TA + L HPW
Sbjct: 232 EAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 205 bits (524), Expect = 1e-62
Identities = 92/258 (35%), Positives = 140/258 (54%), Gaps = 46/258 (17%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G G FG A+ KK G++VA+K+I K ++ + E++ RE++IL+ L H N+V
Sbjct: 1 LGEGGFGTVYLARDKK---TGKKVAIKIIKKEDSSSLL--EELLREIEILKKLN-HPNIV 54
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
K + +ED +++Y+VME CEGG L D + GK +ED+ +++QIL + + H G++
Sbjct: 55 KLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER-LNDIVGSAYYVAPEVLH--RSYS 339
HRDLKPEN L +N +K DFGLS + D+ L IVG+ Y+APEVL YS
Sbjct: 115 HRDLKPENILLD--SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 340 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399
++D+WS+GVI Y L E +D ++++
Sbjct: 173 EKSDIWSLGVILYEL-----------------------------------PELKDLIRKM 197
Query: 400 LNKDPRKRLTAAQALSHP 417
L KDP KR +A + L H
Sbjct: 198 LQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 202 bits (517), Expect = 5e-61
Identities = 91/261 (34%), Positives = 136/261 (52%), Gaps = 17/261 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG + K G+ A+KV+ K K+ +E E IL + H +V
Sbjct: 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIV 56
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
K A++ + +Y+V+E GGEL LS+ G+++E+ A+ +I+ + + H G++
Sbjct: 57 KLHYAFQTEEKLYLVLEYAPGGELFSH-LSKEGRFSEERARFYAAEIVLALEYLHSLGII 115
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHRS-YST 340
+RDLKPEN L D + +K DFGL+ + R N G+ Y+APEVL Y
Sbjct: 116 YRDLKPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGK 172
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D WS+GV+ Y +L G PF+A I+ +LK F E LS EARD + LL
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE----FLSPEARDLISGLL 228
Query: 401 NKDPRKRLTAAQA---LSHPW 418
KDP KRL + A +HP+
Sbjct: 229 QKDPTKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 199 bits (509), Expect = 1e-59
Identities = 83/270 (30%), Positives = 143/270 (52%), Gaps = 18/270 (6%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
KYE+ +++G+G FG ++ G+ +K I M+ ED EVKIL+ L
Sbjct: 1 KYEIIKQIGKGSFG--KVYLVRRKS-DGKLYVLKEIDLSNMS-EKEREDALNEVKILKKL 56
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNV 272
H N++K+++++E+ + +VME +GG+L +I + G + E+ +Q+
Sbjct: 57 N-HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA 115
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL-NDIVGSAYYVAP 331
+ + H + ++HRD+KP+N T+ ++K DFG+S + L +VG+ YY++P
Sbjct: 116 LKYLHSRKILHRDIKPQNIFLTSNG---LVKLGDFGISKVLSSTVDLAKTVVGTPYYLSP 172
Query: 332 EVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS-LS 389
E+ ++ Y+ ++D+WS+G + Y L PF + +LK P PS S
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY----PPIPSQYS 228
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
SE R+ V LL KDP +R + AQ L P+I
Sbjct: 229 SELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 9e-58
Identities = 93/266 (34%), Positives = 145/266 (54%), Gaps = 16/266 (6%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+E+ E++G+G FG A+ K+ G++VA+KVI E + E++IL+
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKR---TGKEVAIKVIKLESKE---KKEKIINEIQILKKC 54
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N+VK++ +Y D +++VME C GG L D + S TE V ++L + +
Sbjct: 55 K-HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEY 113
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH 335
H G++HRD+K N L T+ E +K IDFGLS + + N +VG+ Y++APEV++
Sbjct: 114 LHSNGIIHRDIKAANILLTSDGE---VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVIN 170
Query: 336 R-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK-ADPSFDEAPWPSLSS-EA 392
Y +AD+WS+G+ A L G P+ +E +A+ K A P S E
Sbjct: 171 GKPYDYKADIWSLGITAIELAEGKPPY---SELPPMKALFKIATNGPPGLRNPEKWSDEF 227
Query: 393 RDFVKRLLNKDPRKRLTAAQALSHPW 418
+DF+K+ L K+P KR TA Q L HP+
Sbjct: 228 KDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 3e-56
Identities = 88/274 (32%), Positives = 141/274 (51%), Gaps = 24/274 (8%)
Query: 156 KYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
++ GE +GRG FG Y K G+ +AVK + + +E + RE++IL
Sbjct: 1 EWTRGELLGRGSFGSVYLALDK-----DTGELMAVKSVELSGDSEE-ELEALEREIRILS 54
Query: 214 ALTGHNNLVKFFDAY--EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
+L H N+V+++ + E+ + + + +E GG L +L + GK E + QIL
Sbjct: 55 SLQ-HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSS-LLKKFGKLPEPVIRKYTRQILE 112
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS---DFVRPDERLNDIVGSAYY 328
+A+ H G+VHRD+K N L D + V+K DFG + + E + G+ Y+
Sbjct: 113 GLAYLHSNGIVHRDIKGANILV---DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169
Query: 329 VAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW-P 386
+APEV+ Y AD+WS+G + G P W+ + + A L S E P P
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP-WSELGNPM--AALYKIGSSGEPPEIP 226
Query: 387 S-LSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
LS EA+DF+++ L +DP+KR TA + L HP++
Sbjct: 227 EHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 2e-54
Identities = 96/270 (35%), Positives = 149/270 (55%), Gaps = 22/270 (8%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
Y+LG+ +GRG FG KG G VA+K I K+ A++ + +E+ +L+
Sbjct: 1 NYQLGDLIGRGAFG-----VVYKGLNLETGDFVAIKQISLEKIKEE-ALKSIMQEIDLLK 54
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
L H N+VK+ + E +D++Y+++E E G L +I+ + G + E + Q+L +
Sbjct: 55 NLK-HPNIVKYIGSIETSDSLYIILEYAENGSLR-QIIKKFGPFPESLVAVYVYQVLQGL 112
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER-LNDIVGSAYYVAPE 332
A+ H QGV+HRD+K N L TTKD V+K DFG++ + + +VG+ Y++APE
Sbjct: 113 AYLHEQGVIHRDIKAANIL-TTKDG--VVKLADFGVATKLNDVSKDDASVVGTPYWMAPE 169
Query: 333 VLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDEAPWPS-LS 389
V+ S ST +D+WS+G LL G+ P++ + +FR V D P P +S
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-----QDDHPPLPEGIS 224
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
E +DF+ + KDP R TA Q L HPWI
Sbjct: 225 PELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 187 bits (475), Expect = 1e-53
Identities = 105/370 (28%), Positives = 179/370 (48%), Gaps = 32/370 (8%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
Y + ++G G FG A+ +K VA+KV+ K + + +E RE++IL +L
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK------LVALKVLAKKLESKSKEVERFLREIQILASL 54
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRI--LSRGGKYTEDDAKAVMIQILNVV 273
N+VK +D ++D ++Y+VME +GG L D + + R G +E +A ++ QIL+ +
Sbjct: 55 NHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-------PDERLNDIVGSA 326
+ H +G++HRD+KPEN L + V+K IDFGL+ + + VG+
Sbjct: 115 EYLHSKGIIHRDIKPENILLD--RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 327 YYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPF----WARTESGIFRAVLKADP 378
Y+APEVL S+ +D+WS+G+ Y LL G PF + S + +L+
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232
Query: 379 SFDEAPW-----PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVII 433
+P +S A D +K+LL KDP+ RL+++ LSH + + + L ++
Sbjct: 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLL 292
Query: 434 FKLMKAYMRSSSLRK--AALRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALM 491
A +R S A + +L+ L + E NG S + S+L+
Sbjct: 293 KPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLL 352
Query: 492 KNATDAMKDS 501
+ + + S
Sbjct: 353 LSTASSKRSS 362
|
Length = 384 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 2e-51
Identities = 83/290 (28%), Positives = 146/290 (50%), Gaps = 37/290 (12%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ ++ G+ +G G F AK K+ ++ A+K++ K ++ ++ V+ E ++L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKET---NKEYAIKILDKRQLIKEKKVKYVKIEKEVLTR 57
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L GH ++K + ++D +N+Y V+E GELL I G E + +IL +
Sbjct: 58 LNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSL-DEKCTRFYAAEILLALE 116
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE----------------- 317
+ H +G++HRDLKPEN L D++ +K DFG + + P+
Sbjct: 117 YLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 318 ----RLNDIVGSAYYVAPEVLHRSYSTEA-DVWSIGVIAYILLCGSRPFWARTESGIFRA 372
R VG+A YV+PE+L+ + ++ D+W++G I Y +L G PF E F+
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233
Query: 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTA----AQALSHPW 418
+LK + SF P+ +A+D +++LL DP+ RL + +HP+
Sbjct: 234 ILKLEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 2e-51
Identities = 92/274 (33%), Positives = 133/274 (48%), Gaps = 23/274 (8%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+ +G +G AK KK G A+KVI K M ++ V E IL +V
Sbjct: 1 ISKGAYGRVFLAK-KK--STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVV 56
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
K + +++ N+Y+VME GG+L +L G ED A+ + +I+ + + H G++
Sbjct: 57 KLYYSFQGKKNLYLVMEYLPGGDLA-SLLENVGSLDEDVARIYIAEIVLALEYLHSNGII 115
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDF---------VRPDERLNDIVGSAYYVAPEV 333
HRDLKP+N L D N LK DFGLS ++ IVG+ Y+APEV
Sbjct: 116 HRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 334 -LHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392
L + +S D WS+G I Y L G PF T IF+ +L + E +S EA
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEA 230
Query: 393 RDFVKRLLNKDPRKRLTAA---QALSHPWIKNSN 423
D + +LL DP KRL A + +HP+ K +
Sbjct: 231 IDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 6e-49
Identities = 86/270 (31%), Positives = 141/270 (52%), Gaps = 20/270 (7%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+EL +G+G FG C + + + A+K + K K ++ +V E +IL+ L
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRD---TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN 58
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRI-LSRGGKYTEDDAKAVMIQILNVVAF 275
H LV + +++D +N+Y+V++L GG+L R LS+ K++E+ K + +I+ + +
Sbjct: 59 -HPFLVNLWYSFQDEENMYLVVDLLLGGDL--RYHLSQKVKFSEEQVKFWICEIVLALEY 115
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL- 334
H +G++HRD+KP+N L DE + DF ++ V PD G+ Y+APEVL
Sbjct: 116 LHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLC 172
Query: 335 HRSYSTEADVWSIGVIAYILLCGSRPFWART---ESGIFRAVLKADPSFDEAPWPSLSSE 391
+ YS D WS+GV AY L G RP+ + I AD + + S+E
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLY----PATWSTE 228
Query: 392 ARDFVKRLLNKDPRKRL--TAAQALSHPWI 419
A D + +LL +DP+KRL +HP+
Sbjct: 229 AIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (424), Expect = 3e-47
Identities = 99/300 (33%), Positives = 148/300 (49%), Gaps = 56/300 (18%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR--REVKILRA 214
Y++ +++G G FG A+ K+ G+ VA+K + K K + E+ REVK LR
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKE---TGELVAIKKM-KKKFYS---WEECMNLREVKSLRK 53
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVV 273
L H N+VK + + + D +Y V E EG L + R GK +E ++++ QIL +
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGL 112
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV 333
A H G HRDLKPEN L + + V+K DFGL+ +R D V + +Y APE+
Sbjct: 113 AHIHKHGFFHRDLKPENLLVSGPE---VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEI 169
Query: 334 L--HRSYSTEADVWSIGVIA---YILLCGSRP-FWARTESG-IFR--AVLKADPSFDEAP 384
L SYS+ D+W++G I Y L RP F +E +++ +VL + +
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTL----RPLFPGSSEIDQLYKICSVLG---TPTKQD 222
Query: 385 W--------------------------PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
W P+ S EA D +K +L DP+KR TA+QAL HP+
Sbjct: 223 WPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 3e-46
Identities = 91/293 (31%), Positives = 141/293 (48%), Gaps = 41/293 (13%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
YE E++G G +G A+ KK G+ VA+K I I +R E+ +L+ L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKK---TGEIVALKKIRLDNEEEGIPSTALR-EISLLKELK 56
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRIL-SRGGKYTEDDAKAVMIQILNVVAF 275
H N+VK D +Y+V E C+ L + L R G + + K++M Q+L +A+
Sbjct: 57 -HPNIVKLLDVIHTERKLYLVFEYCD--MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL 334
CH ++HRDLKP+N L + + VLK DFGL+ F P V + +Y APE+L
Sbjct: 114 CHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEIL 170
Query: 335 --HRSYSTEADVWSIGVIAYILLCGSRPFWARTESG----IFRAVL-----KADPSFDEA 383
+ YST D+WS+G I ++ G F +E IF+ +L ++ P +
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ-ILGTPTEESWPGVTKL 229
Query: 384 PW-----------------PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
P P L E D + ++L +P KR++A +AL HP+
Sbjct: 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 5e-46
Identities = 83/276 (30%), Positives = 136/276 (49%), Gaps = 26/276 (9%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E + +G G FG + K G+ A+K++ K K+ +E V E +IL+++
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR 59
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H LV + +++D N+Y+VME GGEL L + G++ E A+ Q++ + +
Sbjct: 60 -HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSH-LRKSGRFPEPVARFYAAQVVLALEYL 117
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV-LH 335
H +V+RDLKPEN L D + +K DFG + V R + G+ Y+APE+ L
Sbjct: 118 HSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRV--KGRTYTLCGTPEYLAPEIILS 172
Query: 336 RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD---PSFDEAPWPSLSSEA 392
+ Y D W++G++ Y +L G PF+ I+ +L+ PSF S +A
Sbjct: 173 KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSF-------FSPDA 225
Query: 393 RDFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423
+D ++ LL D KRL +HPW +
Sbjct: 226 KDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 5e-46
Identities = 98/310 (31%), Positives = 151/310 (48%), Gaps = 62/310 (20%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDV----R--REV 209
+YEL + +G G +G C+A K+ G++VA+K I +D+ R RE+
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKR---TGRKVAIKKISN-------VFDDLIDAKRILREI 50
Query: 210 KILRALTGHNNLVKFFD-----AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKA 264
K+LR L H N++ D + ED ++VY+V EL E L +++ T+D +
Sbjct: 51 KLLRHL-RHENIIGLLDILRPPSPEDFNDVYIVTELMETD--LHKVIKSPQPLTDDHIQY 107
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER----LN 320
+ QIL + + H V+HRDLKP N L + N LK DFGL+ V PDE L
Sbjct: 108 FLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVDPDEDEKGFLT 164
Query: 321 DIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWA--------------- 363
+ V + +Y APE+L Y+ D+WS+G I LL +P +
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL-TRKPLFPGRDYIDQLNLIVEVL 223
Query: 364 --RTESGI-------FRAVLKADPSFDEAPW----PSLSSEARDFVKRLLNKDPRKRLTA 410
+E + R LK+ P + P P S EA D ++++L DP+KR+TA
Sbjct: 224 GTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITA 283
Query: 411 AQALSHPWIK 420
+AL+HP++
Sbjct: 284 DEALAHPYLA 293
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 6e-45
Identities = 88/280 (31%), Positives = 138/280 (49%), Gaps = 32/280 (11%)
Query: 156 KYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+++ G ++G G FG YT GEL +AVK I I+++ E+K+L
Sbjct: 1 RWQRGNKIGGGTFGKVYTAV-NLDTGEL----MAVKEIRIQDNDPKT-IKEIADEMKVLE 54
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDA--KAVMIQILN 271
L H NLVK++ + VY+ ME C GG L + L G+ D+ + +Q+L
Sbjct: 55 LLK-HPNLVKYYGVEVHREKVYIFMEYCSGGTLEE--LLEHGR-ILDEHVIRVYTLQLLE 110
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV-----RPDERLNDIVGSA 326
+A+ H G+VHRD+KP N D N V+K DFG + + E + + G+
Sbjct: 111 GLAYLHSHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTP 167
Query: 327 YYVAPEVLHRSYSTE----ADVWSIGVIAYILLCGSRPFWARTESG---IFRAVLKADPS 379
Y+APEV+ AD+WS+G + + G RP W+ ++ +F P
Sbjct: 168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP-WSELDNEFQIMFHVGAGHKPP 226
Query: 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
++ LS E +DF+ R L DP+KR TA++ L HP++
Sbjct: 227 IPDSL--QLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 1e-43
Identities = 82/270 (30%), Positives = 131/270 (48%), Gaps = 18/270 (6%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIP-KHKMTTAIAIEDVRREVKILRALT 216
E + +G+G G + K G+ A+K I + + RE+K LR+
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKP---TGKIYALKKIHVDGDEEF---RKQLLRELKTLRS-C 56
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
+VK + A+ + +V+E +GG L +L + GK E + QIL + +
Sbjct: 57 ESPYVVKCYGAFYKEGEISIVLEYMDGGSL-ADLLKKVGKIPEPVLAYIARQILKGLDYL 115
Query: 277 HLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERLNDIVGSAYYVAPEVL 334
H + ++HRD+KP N L +K E +K DFG+S + ++ N VG+ Y++PE +
Sbjct: 116 HTKRHIIHRDIKPSNLLINSKGE---VKIADFGISKVLENTLDQCNTFVGTVTYMSPERI 172
Query: 335 H-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS--LSSE 391
SYS AD+WS+G+ G PF + F +++A P+ S E
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF-ELMQAICDGPPPSLPAEEFSPE 231
Query: 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
RDF+ L KDP+KR +AA+ L HP+IK
Sbjct: 232 FRDFISACLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 5e-43
Identities = 86/267 (32%), Positives = 129/267 (48%), Gaps = 14/267 (5%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+ + +G FG AK + G A+KV+ K M + +V+ E I+
Sbjct: 2 KPISKGAFGSVYLAKKR---STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPY 58
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
+ K + +++ D +Y+VME GG+ I + GG ED AK + +++ V H +G
Sbjct: 59 VAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG-LPEDWAKQYIAEVVLGVEDLHQRG 117
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYST 340
++HRD+KPEN L D+ LK DFGLS R VG+ Y+APE +
Sbjct: 118 IIHRDIKPENLLI---DQTGHLKLTDFGLS---RNGLENKKFVGTPDYLAPETILGVGDD 171
Query: 341 EA-DVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399
+ D WS+G + + L G PF A T +F +L ++ E S EA D + RL
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRL 231
Query: 400 LNKDPRKRLTA---AQALSHPWIKNSN 423
L DP KRL A + SHP+ K+ N
Sbjct: 232 LCMDPAKRLGANGYQEIKSHPFFKSIN 258
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 6e-43
Identities = 80/276 (28%), Positives = 132/276 (47%), Gaps = 24/276 (8%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIP--KHKMTTAIAIEDVRREVKI 211
Y+ E++G G G A + G++VA+K + K I E+ I
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRA---TGKEVAIKKMRLRKQNKELII------NEILI 68
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
++ H N+V ++D+Y D ++VVME +GG L D I + E V ++L
Sbjct: 69 MKDCK-HPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQ 127
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVA 330
+ + H Q V+HRD+K +N L + +K DFG + + + N +VG+ Y++A
Sbjct: 128 GLEYLHSQNVIHRDIKSDNILLSKDGS---VKLADFGFAAQLTKEKSKRNSVVGTPYWMA 184
Query: 331 PEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESG---IFRAVLKADPSFDEAPWP 386
PEV+ R Y + D+WS+G++ + G P+ E +F K P
Sbjct: 185 PEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYL--REPPLRALFLITTKGIPPLKNPE-- 240
Query: 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422
S E +DF+ + L KDP KR +A + L HP++K +
Sbjct: 241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 1e-42
Identities = 78/275 (28%), Positives = 135/275 (49%), Gaps = 24/275 (8%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQV--AVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+G G FG + + ++K + A+K + K + E + E +IL H
Sbjct: 1 LGVGGFG-----RVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEIL-EECNHPF 54
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
+VK + ++D +Y++ME C GGEL IL G + E A+ + ++ + H +G
Sbjct: 55 IVKLYRTFKDKKYIYMLMEYCLGGELWT-ILRDRGLFDEYTARFYIACVVLAFEYLHNRG 113
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV-LHRSYS 339
+++RDLKPEN L D N +K +DFG + ++ ++ G+ YVAPE+ L++ Y
Sbjct: 114 IIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD 170
Query: 340 TEADVWSIGVIAYILLCGSRPFWARTES--GIFRAVLKADPSFDEAPWPS-LSSEARDFV 396
D WS+G++ Y LL G PF E I+ +LK + + +P+ + A+D +
Sbjct: 171 FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN---GKLEFPNYIDKAAKDLI 227
Query: 397 KRLLNKDPRKRLTAAQA-----LSHPWIKNSNDVK 426
K+LL ++P +RL + H W +
Sbjct: 228 KQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWEG 262
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 5e-42
Identities = 93/306 (30%), Positives = 140/306 (45%), Gaps = 59/306 (19%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT--------TAIAIEDVRR 207
+YE G+++G G + A+ K+ G+ VA+K I + TA+ R
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKE---TGRIVAIKKIKLGERKEAKDGINFTAL------R 51
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGG-ELL--DRILSRGGKYTEDDAKA 264
E+K+L+ L H N++ D + N+ +V E E E + D+ + T D K+
Sbjct: 52 EIKLLQELK-HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIV----LTPADIKS 106
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIV 323
M+ L + + H ++HRDLKP N L + VLK DFGL+ F P+ ++ V
Sbjct: 107 YMLMTLRGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSFGSPNRKMTHQV 163
Query: 324 GSAYYVAPEVLH--RSYSTEADVWSIGVI-AYILLCGSRPFWARTE-----SGIFRA--- 372
+ +Y APE+L R Y D+WS+G I A +LL PF IF A
Sbjct: 164 VTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLL--RVPFLPGDSDIDQLGKIFEALGT 221
Query: 373 -------VLKADPS---FDEAPWPSL-------SSEARDFVKRLLNKDPRKRLTAAQALS 415
+ + P F P L S +A D ++RLL +P KR+TA QAL
Sbjct: 222 PTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281
Query: 416 HPWIKN 421
HP+ N
Sbjct: 282 HPYFSN 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 94/295 (31%), Positives = 136/295 (46%), Gaps = 44/295 (14%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR--REVKILRA 214
Y+ ++G G +G A+ K L G+ VA+K K K+ RE+K+L+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDK---LTGEIVAIK---KIKLRFESEGIPKTALREIKLLKE 54
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L H N++K D + ++Y+V E + +L I R E K+ + Q+L +A
Sbjct: 55 LN-HPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLA 112
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER-LNDIVGSAYYVAPEV 333
FCH G++HRDLKPEN L T VLK DFGL+ R V + +Y APE+
Sbjct: 113 FCHSHGILHRDLKPENLLINT---EGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPEL 169
Query: 334 LHRS--YSTEADVWSIGVIAYILLCGSRPFWARTE-----SGIF---------------- 370
L YST D+WS+G I LL RP + IF
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSR-RPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS 228
Query: 371 --RAVLKADPSFDEAPW----PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
R + P P P+ S +A D + ++L+ DP KR+TA QAL+HP+
Sbjct: 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 4e-41
Identities = 93/293 (31%), Positives = 139/293 (47%), Gaps = 39/293 (13%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+Y++ +G G G AK ++ G+ VA+K + ++ I RE+K L+A
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRE---TGETVALKKVALRRLEGGIP-NQALREIKALQAC 56
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H +VK D + +VME +L + + E K+ M +L VA+
Sbjct: 57 -QHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAY 114
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD-FVRPDERL-NDIVGSAYYVAPEV 333
H G++HRDLKP N L + VLK DFGL+ F + RL + V + +Y APE+
Sbjct: 115 MHANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPEL 171
Query: 334 LH--RSYSTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAV----------LKAD 377
L+ R Y D+W++G I LL GS F + + +FR + L +
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231
Query: 378 P-----SFDEA---PW----PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
P +F E+ P P S EA D +K LL DP KRL+AA+AL HP+
Sbjct: 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 1e-40
Identities = 99/303 (32%), Positives = 142/303 (46%), Gaps = 55/303 (18%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR----REVK 210
NKYE+ VG G +G + K G+ VA+K K + EDV+ REVK
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKA---TGEIVAIK-----KFKESEDDEDVKKTALREVK 52
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGG--ELLDRILSRGGKYTEDDAKAVMIQ 268
+LR L H N+V +A+ +Y+V E E ELL+ S GG D ++ + Q
Sbjct: 53 VLRQLR-HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGG-LPPDAVRSYIWQ 108
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV--RPDERLNDIVGSA 326
+L +A+CH ++HRD+KPEN L E+ VLK DFG + + RP L D V +
Sbjct: 109 LLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPASPLTDYVATR 165
Query: 327 YYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTES-----GIFRA------- 372
+Y APE+L +Y DVW+IG I LL G P + I +
Sbjct: 166 WYRAPELLVGDTNYGKPVDVWAIGCIMAELLDG-EPLFPGDSDIDQLYLIQKCLGPLPPS 224
Query: 373 ---VLKADPSFDEAPWPS--------------LSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ ++P F +P +SS A DF+K L DP++RLT + L
Sbjct: 225 HQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284
Query: 416 HPW 418
HP+
Sbjct: 285 HPY 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 9e-40
Identities = 86/288 (29%), Positives = 140/288 (48%), Gaps = 39/288 (13%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+EL E +G G +G A+ KK GQ VA+K++ E+++ E ILR
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKK---TGQLVAIKIMD----IIEDEEEEIKEEYNILR 57
Query: 214 ALTGHNNLVKFFDAY------EDTDNVYVVMELCEGG---ELLDRILSRGGKYTEDDAKA 264
+ H N+ F+ A+ + D +++VMELC GG +L+ + +G + E+
Sbjct: 58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY 117
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIV 323
++ + L +A+ H V+HRD+K +N L T +N+ +K +DFG+S R N +
Sbjct: 118 ILRETLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLVDFGVSAQLDSTLGRRNTFI 174
Query: 324 GSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 377
G+ Y++APEV+ SY +DVWS+G+ A L G P + RA+ K
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL---CDMHPMRALFKIP 231
Query: 378 PSFDEAPWPSLSSEAR------DFVKRLLNKDPRKRLTAAQALSHPWI 419
+ P P+L S DF+ L K+ +R + L HP+I
Sbjct: 232 RN----PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 1e-38
Identities = 87/271 (32%), Positives = 136/271 (50%), Gaps = 20/271 (7%)
Query: 156 KYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIP--KHKMTTAIAIEDVRREVKI 211
++ GE +G G FG Y G+ AVK + T A++ + +E+ +
Sbjct: 1 RWRKGELLGSGSFGSVYE-GLNLDDGDF----FAVKEVSLADDGQTGQEAVKQLEQEIAL 55
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
L L H N+V++ + DN+Y+ +EL GG L ++L + G + E + QIL
Sbjct: 56 LSKLQ-HPNIVQYLGTEREEDNLYIFLELVPGGSLA-KLLKKYGSFPEPVIRLYTRQILL 113
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAP 331
+ + H + VHRD+K N L D N V+K DFG++ V GS Y++AP
Sbjct: 114 GLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAP 170
Query: 332 EVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP-SL 388
EV+ + Y AD+WS+G + + +P W++ E AV K S + P P L
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTV-LEMATGKPPWSQLEG--VAAVFKIGRSKELPPIPDHL 227
Query: 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
S EA+DF+ + L +DP R TAA+ L HP++
Sbjct: 228 SDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 96/287 (33%), Positives = 139/287 (48%), Gaps = 45/287 (15%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
YE+ E +G+G FG + K G+ + K I MT + V EV ILR L
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKS---DGKILVWKEIDYGNMTEKEKQQLVS-EVNILREL 56
Query: 216 TGHNNLVKFFDAYEDTDN--VYVVMELCEGGELLDRILSR----GGKYTEDDAKAVMIQI 269
H N+V+++D D N +Y+VME CEGG+L +++ + E+ ++ Q+
Sbjct: 57 K-HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDL-AQLIQKCKKERKYIEEEFIWRILTQL 114
Query: 270 LNVVAFCHLQG-----VVHRDLKPEN-FLFTTKDENSVLKAIDFGLSDFVRPDERL-NDI 322
L + CH + V+HRDLKP N FL D N+ +K DFGL+ + D
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFL----DANNNVKLGDFGLAKILGHDSSFAKTY 170
Query: 323 VGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWART--------ESGIFRAV 373
VG+ YY++PE L H SY ++D+WS+G + Y L S PF AR + G FR
Sbjct: 171 VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR-- 228
Query: 374 LKADPSFDEAPWPSL-SSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
P SSE + +K +LN DP KR + + L P I
Sbjct: 229 ----------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 3e-38
Identities = 86/279 (30%), Positives = 139/279 (49%), Gaps = 35/279 (12%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ L E +G+G FG A K+ Q VA+KVI + I ED+++E++ L
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKR---TNQVVAIKVIDLEEAEDEI--EDIQQEIQFLSQ 55
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
+ K++ ++ ++++ME C GG LD L + GK E ++ ++L +
Sbjct: 56 CRS-PYITKYYGSFLKGSKLWIIMEYCGGGSCLD--LLKPGKLDETYIAFILREVLLGLE 112
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEV 333
+ H +G +HRD+K N L + E +K DFG+S + N VG+ +++APEV
Sbjct: 113 YLHEEGKIHRDIKAANILLS---EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEV 169
Query: 334 LHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGI--FRAVL---KADPSFDEAPWPS 387
+ +S Y +AD+WS+G+ A L G P S + R + K +P PS
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEPPL-----SDLHPMRVLFLIPKNNP-------PS 217
Query: 388 L-----SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
L S +DFV LNKDP++R +A + L H +IK
Sbjct: 218 LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKK 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 6e-38
Identities = 82/277 (29%), Positives = 131/277 (47%), Gaps = 22/277 (7%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ YEL E +G G AA ++VA+K I K T++ +++R+EV+ + +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLP---NNEKVAIKRIDLEKCQTSV--DELRKEVQAM-S 54
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD---RILSRGGKYTEDDAKAVMIQILN 271
H N+VK++ ++ D +++VM GG LLD RGG E V+ ++L
Sbjct: 55 QCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG-LDEAIIATVLKEVLK 113
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV-----RPDERLNDIVGSA 326
+ + H G +HRD+K N L E+ +K DFG+S + R + VG+
Sbjct: 114 GLEYLHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTP 170
Query: 327 YYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF--DE 382
++APEV+ Y +AD+WS G+ A L G+ P+ + L+ DP
Sbjct: 171 CWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETG 230
Query: 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
A + S R + L KDP KR TA + L H +
Sbjct: 231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 92/277 (33%), Positives = 139/277 (50%), Gaps = 21/277 (7%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+++ +VG+G +G AK K G+ VA+K + K + + V E IL
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKD---TGEIVALKRMKKSLLFKLNEVRHVLTERDIL-T 56
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
T LVK A++D + +Y+ ME GG+ +L+ G +ED A+ M ++ V
Sbjct: 57 TTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDF-RTLLNNLGVLSEDHARFYMAEMFEAVD 115
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEV 333
H G +HRDLKPENFL D + +K DFGLS V N +VGS Y+APEV
Sbjct: 116 ALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIV---TYANSVVGSPDYMAPEV 169
Query: 334 LH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK-----ADPSFDEAPWPS 387
L + Y D WS+G + Y LCG PF T + + + P +D+ P +
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDD-PRFN 228
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQAL-SHPWIKNSN 423
LS EA D + +L+N DP +R + + + +HP+ K +
Sbjct: 229 LSDEAWDLITKLIN-DPSRRFGSLEDIKNHPFFKEVD 264
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 7e-37
Identities = 87/274 (31%), Positives = 141/274 (51%), Gaps = 33/274 (12%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR---------EVKIL 212
++G G G C A K G+QVAVK KM D+R+ EV I+
Sbjct: 26 KIGEGSTGIVCIATDKS---TGRQVAVK-----KM-------DLRKQQRRELLFNEVVIM 70
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
R H N+V+ + +Y D ++VVME EGG L D I++ + E+ V + +L
Sbjct: 71 RDYQ-HPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHT-RMNEEQIATVCLAVLKA 127
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAP 331
++F H QGV+HRD+K ++ L T+ + +K DFG V + R +VG+ Y++AP
Sbjct: 128 LSFLHAQGVIHRDIKSDSILLTS---DGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAP 184
Query: 332 EVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390
EV+ R Y TE D+WS+G++ ++ G P++ + + P + +S
Sbjct: 185 EVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNL-HKVSP 243
Query: 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424
R F+ R+L +DP +R TAA+ L+HP++ +
Sbjct: 244 RLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 82/277 (29%), Positives = 143/277 (51%), Gaps = 39/277 (14%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+++ E++G G +G A K+ GQ VA+KV+P + + +++ +E+ IL+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKET---GQVVAIKVVP---VEEDL--QEIIKEISILKQ-C 55
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
+VK++ +Y ++++VME C G + D + TE++ A++ Q L + +
Sbjct: 56 DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYL 115
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND-------IVGSAYYV 329
H +HRD+K N L +E K DFG+S +L D ++G+ +++
Sbjct: 116 HSNKKIHRDIKAGNILL---NEEGQAKLADFGVS------GQLTDTMAKRNTVIGTPFWM 166
Query: 330 APEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL----KADPSFDEAP 384
APEV+ Y+ +AD+WS+G+ A I + +P ++ RA+ K P+ + P
Sbjct: 167 APEVIQEIGYNNKADIWSLGITA-IEMAEGKPPYSDIHP--MRAIFMIPNKPPPTLSD-P 222
Query: 385 --WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
W S E DFVK+ L KDP +R +A Q L HP+I
Sbjct: 223 EKW---SPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 88/305 (28%), Positives = 131/305 (42%), Gaps = 60/305 (19%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-----TAIAIEDVRREVKI 211
YE ++G G +G A+ KK G+ VA+K I TAI RE+K+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKK---TGELVALKKIRMENEKEGFPITAI------REIKL 51
Query: 212 LRALTGHNNLVKFFDAY--EDTDNVYVVMELCE----GGELLDRILSRGGKYTEDDAKAV 265
L+ L H N+V+ + + ++Y+V E + G LLD S K+TE K
Sbjct: 52 LQKLR-HPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG--LLD---SPEVKFTESQIKCY 105
Query: 266 MIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV--RPDERLNDIV 323
M Q+L + + H G++HRD+K N L + + VLK DFGL+ R + V
Sbjct: 106 MKQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRNSADYTNRV 162
Query: 324 GSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381
+ +Y PE+L Y E D+WS+G I L G F TE + + S
Sbjct: 163 ITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPT 222
Query: 382 EAPWPSL---------------------------SSEARDFVKRLLNKDPRKRLTAAQAL 414
+ WP + A D + +LL DP+KR++A QAL
Sbjct: 223 DENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQAL 282
Query: 415 SHPWI 419
H +
Sbjct: 283 QHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 82/281 (29%), Positives = 148/281 (52%), Gaps = 27/281 (9%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL--TGH 218
E +GRG +G A K G+ VA+K+I + T + D++REV +L L +
Sbjct: 7 ELIGRGAYG---AVYRGKHVPTGRVVALKII--NLDTPDDDVSDIQREVALLSQLRQSQP 61
Query: 219 NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL 278
N+ K++ +Y ++++ME EGG + R L + G E ++ ++L + + H
Sbjct: 62 PNITKYYGSYLKGPRLWIIMEYAEGGSV--RTLMKAGPIAEKYISVIIREVLVALKYIHK 119
Query: 279 QGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLH-- 335
GV+HRD+K N L T +K DFG++ + + + VG+ Y++APEV+
Sbjct: 120 VGVIHRDIKAANILVTNTGN---VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176
Query: 336 RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL----KADPSFDEAPWPSLSSE 391
+ Y T+AD+WS+G+ Y + G+ P+ ++ FRA++ P ++ + S
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPY---SDVDAFRAMMLIPKSKPPRLEDNGY---SKL 230
Query: 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVI 432
R+FV L+++P++RL+A + L WIK + K P+ ++
Sbjct: 231 LREFVAACLDEEPKERLSAEELLKSKWIKAHS--KTPVSIL 269
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 93/304 (30%), Positives = 142/304 (46%), Gaps = 51/304 (16%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ +E+ + +GRG FG + K GQ A+KV+ K M I VR E IL
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKD---TGQVYAMKVLRKSDMIKRNQIAHVRAERDIL-- 55
Query: 215 LTGHNN--LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAK---AVMIQI 269
++ +VK + +++D +++Y+VME GG+L+ +L R + E+ A+ A ++
Sbjct: 56 -ADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLM-NLLIRKDVFPEETARFYIAELVLA 113
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS--------DFVRPDERLND 321
L+ V H G +HRD+KP+N L D + +K DFGL ++ N
Sbjct: 114 LDSV---HKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAKDREYYLNDSHNL 167
Query: 322 ----------------------IVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGS 358
VG+ Y+APEVL Y E D WS+GVI Y +L G
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227
Query: 359 RPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAA-QALSHP 417
PF++ T + ++ S P P +S EA D + RLL DP RL + + SHP
Sbjct: 228 PPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLL-CDPEDRLGSFEEIKSHP 286
Query: 418 WIKN 421
+ K
Sbjct: 287 FFKG 290
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 5e-36
Identities = 86/275 (31%), Positives = 130/275 (47%), Gaps = 30/275 (10%)
Query: 156 KYELGEEVGRGHFGYTCAAK-FKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
YEL + +G G +G A+ GEL VA+KVI K+ E +++E+ +L+
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGEL----VAIKVI---KLEPGDDFEIIQQEISMLKE 56
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
H N+V +F +Y D +++VME C GG L D G +E V + L +A
Sbjct: 57 CR-HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLA 115
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEV 333
+ H G +HRD+K N L T E+ +K DFG+S + +G+ Y++APEV
Sbjct: 116 YLHETGKIHRDIKGANILLT---EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEV 172
Query: 334 L----HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP----- 384
Y + D+W++G+ A L P + + RA+ S P
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIELAELQPPMF---DLHPMRALFLISKSNFPPPKLKDK 229
Query: 385 --WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHP 417
W S DF+K+ L KDP+KR TA + L HP
Sbjct: 230 EKW---SPVFHDFIKKCLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 9e-36
Identities = 87/285 (30%), Positives = 142/285 (49%), Gaps = 22/285 (7%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+ E+G G FG A+ K+ G A K+I ++ + +ED E+ IL +
Sbjct: 7 WEIIGELGDGAFGKVYKAQHKE---TGLFAAAKII---QIESEEELEDFMVEIDIL-SEC 59
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N+V ++AY + +++++E C+GG L +L TE + V Q+L + F
Sbjct: 60 KHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFL 119
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL- 334
H V+HRDLK N L T + +K DFG+S ++ + +G+ Y++APEV+
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGD---VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVA 176
Query: 335 -----HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP--WPS 387
Y +AD+WS+G+ L P + +LK++P + P W
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKW-- 234
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVI 432
SS DF+K L KDP R TAA+ L HP++ + +D K D++
Sbjct: 235 -SSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKAIKDLL 278
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 8e-35
Identities = 90/308 (29%), Positives = 139/308 (45%), Gaps = 50/308 (16%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKI 211
++Y+ E +G G +G C+A + G++VA+K IP H + RE+KI
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTR---SGKKVAIKKIP-HAFDVPTLAKRTLRELKI 57
Query: 212 LRALTGHNNLVKFFDAY----EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
LR H+N++ D D +VYVVM+L E L I+ TE+ + +
Sbjct: 58 LRHFK-HDNIIAIRDILRPPGADFKDVYVVMDLMESD--LHHIIHSDQPLTEEHIRYFLY 114
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV--RPDER---LNDI 322
Q+L + + H V+HRDLKP N L +E+ L+ DFG++ + P E + +
Sbjct: 115 QLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGLSSSPTEHKYFMTEY 171
Query: 323 VGSAYYVAPE---VLHRSYSTEADVWSIG-----------------------VIAYILLC 356
V + +Y APE L Y+T D+WS+G +I +L
Sbjct: 172 VATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGS 230
Query: 357 GSRPFWARTESGIFRAVLKADPSFDEAPW----PSLSSEARDFVKRLLNKDPRKRLTAAQ 412
S R S R ++ P PW P S EA D + ++L DP +R+T Q
Sbjct: 231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQ 290
Query: 413 ALSHPWIK 420
AL HP++
Sbjct: 291 ALQHPFLA 298
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 80/267 (29%), Positives = 133/267 (49%), Gaps = 20/267 (7%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG A+ K + AVKV+ K + +E E ++L H L
Sbjct: 3 LGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ ++ D ++ VME GG+L+ I R G++ E A+ +I+ + F H +G++
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQ-RSGRFDEPRARFYAAEIVLGLQFLHERGII 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL-HRSYST 340
+RDLK +N L D +K DFG+ + + + G+ Y+APE+L ++ Y
Sbjct: 119 YRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGP 175
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP-SLSSEARDFVKRL 399
D W++GV+ Y +L G PF E +F+++L+ DE +P LS EA+ +K
Sbjct: 176 AVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE-----DEVRYPRWLSKEAKSILKSF 230
Query: 400 LNKDPRKRL----TAAQAL-SHPWIKN 421
L K+P KRL T Q + HP+ +
Sbjct: 231 LTKNPEKRLGCLPTGEQDIKGHPFFRE 257
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 91/309 (29%), Positives = 143/309 (46%), Gaps = 49/309 (15%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
KHF + + +G+G G + K G+ A+KV+ K +M ++ V E +
Sbjct: 1 KHF----KKIKLLGKGDVGRVFLVRLKG---TGKLFALKVLDKKEMIKRNKVKRVLTEQE 53
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQI 269
IL L H L + +++ + +VM+ C GGEL + + GK +E+ A+ ++
Sbjct: 54 ILATLD-HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEV 112
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS------------------- 310
L + + HL G+V+RDLKPEN L E+ + DF LS
Sbjct: 113 LLALEYLHLLGIVYRDLKPENILLH---ESGHIMLSDFDLSKQSDVEPPPVSKALRKGSR 169
Query: 311 ---------DFVR--PDERLNDIVGSAYYVAPEVLHRSYSTEA-DVWSIGVIAYILLCGS 358
+ P R N VG+ Y+APEV+ A D W++G++ Y +L G+
Sbjct: 170 RSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229
Query: 359 RPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL----TAAQAL 414
PF F +LK + +F P +SS ARD +++LL KDP KRL AA+
Sbjct: 230 TPFKGSNRDETFSNILKKEVTF--PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIK 287
Query: 415 SHPWIKNSN 423
HP+ + N
Sbjct: 288 QHPFFRGVN 296
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 1e-34
Identities = 88/282 (31%), Positives = 143/282 (50%), Gaps = 25/282 (8%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT-AIAIEDVRREVKILRAL 215
+EL +G G +G + G G+ A+KV+ K + A E R E ++L A+
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
LV A++ ++++++ GGEL + R +TE + + + +I V+A
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEI--VLAL 118
Query: 276 CHLQ--GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAP 331
HL G+++RD+K EN L D + DFGLS +E R G+ Y+AP
Sbjct: 119 DHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
Query: 332 EVLHR---SYSTEADVWSIGVIAYILLCGSRPFWA----RTESGIFRAVLKADPSFDEAP 384
EV+ + D WS+GV+ + LL G+ PF ++S I R +LK+ P F
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFP--- 232
Query: 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQA---LSHPWIKNSN 423
++S+EARDF+++LL KDP+KRL A A +HP+ + +
Sbjct: 233 -KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 9e-34
Identities = 95/309 (30%), Positives = 148/309 (47%), Gaps = 45/309 (14%)
Query: 147 FGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR 206
FG N+Y + VG G FG C+A+ +L GQ VA+K I K T +A +
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSAR---DQLTGQNVAIKKIMKPFSTPVLA-KRTY 57
Query: 207 REVKILRALTGHNNLVKFFDAY-EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV 265
RE+K+L+ L H N++ D + +++Y V EL G L R+L+ + +
Sbjct: 58 RELKLLKHLR-HENIISLSDIFISPLEDIYFVTELL--GTDLHRLLT-SRPLEKQFIQYF 113
Query: 266 MIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERLNDIVG 324
+ QIL + + H GVVHRDLKP N L +EN LK DFGL+ R D ++ V
Sbjct: 114 LYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLA---RIQDPQMTGYVS 167
Query: 325 SAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL-------- 374
+ YY APE++ + Y E D+WS G I +L G F + F +
Sbjct: 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPD 227
Query: 375 ---------------KADPSFDEAP----WPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
++ P + P + + A D ++++L DP+KR++AA+AL+
Sbjct: 228 DVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287
Query: 416 HPWIKNSND 424
HP++ +D
Sbjct: 288 HPYLAPYHD 296
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 78/269 (28%), Positives = 122/269 (45%), Gaps = 32/269 (11%)
Query: 158 ELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
LG+++G G FG K K KG K +VAVK + + IE+ RE +I+R L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDAS--EQQIEEFLREARIMRKL- 58
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N+VK + + +Y+VME EGG+LL + K + D + +QI + +
Sbjct: 59 DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------- 329
+ +HRDL N L EN V+K DFGLS + D+ YY
Sbjct: 119 ESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYDDD---------YYRKRGGKLP 166
Query: 330 ----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADPSFDEA 383
APE L +++++DVWS GV+ + I G +P+ + + +
Sbjct: 167 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG--YRLPQ 224
Query: 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQ 412
P P+ E D + + +DP R T ++
Sbjct: 225 P-PNCPPELYDLMLQCWAEDPEDRPTFSE 252
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 6e-33
Identities = 76/271 (28%), Positives = 120/271 (44%), Gaps = 35/271 (12%)
Query: 158 ELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
LG+++G G FG Y K K K +VAVK + + I E+ RE +I+R L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDG-KEVEVAVKTLKEDASEQQI--EEFLREARIMRKL 58
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVVA 274
H N+VK + + + +VME GG+LLD + K + D + +QI +
Sbjct: 59 -DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGME 117
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV----- 329
+ + +HRDL N L EN V+K DFGLS + D+ YY
Sbjct: 118 YLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYDDD---------YYKVKGGK 165
Query: 330 ------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADPSFD 381
APE L +++++DVWS GV+ + I G P+ + + + + K
Sbjct: 166 LPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGY--RL 223
Query: 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQ 412
P P+ E + + +DP R T ++
Sbjct: 224 PKP-PNCPPELYKLMLQCWAEDPEDRPTFSE 253
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 83/266 (31%), Positives = 145/266 (54%), Gaps = 27/266 (10%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
++G G G C A+ K G+QVAVK++ K E + EV I+R H N+
Sbjct: 28 KIGEGSTGIVCIAREKH---SGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQ-HQNV 80
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
V+ + +Y + ++V+ME +GG L D I+S+ + E+ V +L + + H QGV
Sbjct: 81 VEMYKSYLVGEELWVLMEFLQGGALTD-IVSQT-RLNEEQIATVCESVLQALCYLHSQGV 138
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAPEVLHRS-YS 339
+HRD+K ++ L T + +K DFG + D + +VG+ Y++APEV+ R+ Y
Sbjct: 139 IHRDIKSDSILLTL---DGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYG 195
Query: 340 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL------SSEAR 393
TE D+WS+G++ ++ G P+++ + ++A ++P P L S R
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPYFSDSP-------VQAMKRLRDSPPPKLKNAHKISPVLR 248
Query: 394 DFVKRLLNKDPRKRLTAAQALSHPWI 419
DF++R+L ++P++R TA + L HP++
Sbjct: 249 DFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 80/253 (31%), Positives = 126/253 (49%), Gaps = 15/253 (5%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+GE +G G FG AK K G+ A+K + K ++ ++ V +E IL L+
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H +V +++D + VY ++E GGEL L + G++ D AK +++ +
Sbjct: 77 -HPFIVNMMCSFQDENRVYFLLEFVVGGELFTH-LRKAGRFPNDVAKFYHAELVLAFEYL 134
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH- 335
H + +++RDLKPEN L D +K DFG + V +R + G+ Y+APEV+
Sbjct: 135 HSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVP--DRTFTLCGTPEYLAPEVIQS 189
Query: 336 RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395
+ + D W++GV+ Y + G PF+ T I+ +L F W ARD
Sbjct: 190 KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--W--FDGRARDL 245
Query: 396 VKRLLNKDPRKRL 408
VK LL D KRL
Sbjct: 246 VKGLLQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 86/305 (28%), Positives = 146/305 (47%), Gaps = 53/305 (17%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPK---HKMTTAIAIEDVRREVKILR 213
YEL +E+G+G +G C+A+ + + + VA+K I K+ A+ RE+K+LR
Sbjct: 2 YELIKELGQGAYGIVCSARNAETS-EEETVAIKKITNVFSKKILAKRAL----RELKLLR 56
Query: 214 ALTGHNNLVKFFDA----YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
GH N+ +D + + +Y+ EL E L +I+ G T+ ++ + QI
Sbjct: 57 HFRGHKNITCLYDMDIVFPGNFNELYLYEELMEAD--LHQIIRSGQPLTDAHFQSFIYQI 114
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-----DFVRPDERLNDIVG 324
L + + H V+HRDLKP N L E LK DFGL+ + + + V
Sbjct: 115 LCGLKYIHSANVLHRDLKPGNLLVNADCE---LKICDFGLARGFSENPGENAGFMTEYVA 171
Query: 325 SAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFW-------------------- 362
+ +Y APE++ +SY+ DVWS+G I LL G +P +
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQLNQILQVLGTPD 230
Query: 363 ----ARTESGIFRAVLKADPSFDEAPWPSL----SSEARDFVKRLLNKDPRKRLTAAQAL 414
+R S + +++ P+ + P+ S+ + A D +++LL DP KR++ +AL
Sbjct: 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290
Query: 415 SHPWI 419
HP++
Sbjct: 291 EHPYL 295
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 74/264 (28%), Positives = 138/264 (52%), Gaps = 14/264 (5%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
Y +G+G FG A +++ E V K + +++ D E+ IL +L
Sbjct: 2 YIPIRVLGKGAFGE--ATLYRRTE-DDSLVVWKEVNLTRLSEKER-RDALNEIVIL-SLL 56
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGK-YTEDDAKAVMIQILNVVAF 275
H N++ +++ + D + + + ME GG L D+I+ + G+ + E+ + QI++ V++
Sbjct: 57 QHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSY 116
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND-IVGSAYYVAPEVL 334
H G++HRD+K N +F TK ++K DFG+S + + + + +VG+ YY++PE+
Sbjct: 117 IHKAGILHRDIKTLN-IFLTKA--GLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELC 173
Query: 335 H-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393
Y+ ++D+W++G + Y LL R F A + +++ + + + + SSE
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY---SSELI 230
Query: 394 DFVKRLLNKDPRKRLTAAQALSHP 417
V LL +DP KR TA + L P
Sbjct: 231 SLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 81/270 (30%), Positives = 133/270 (49%), Gaps = 21/270 (7%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG A+ K+ G+ AVKV+ K + +E E +IL H L
Sbjct: 3 LGKGSFGKVMLARLKE---SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ + ++ D ++ VME GG+L+ I + ++ E A+ +I + + F H +G++
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEARARFYAAEITSALMFLHDKGII 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLHRS-YST 340
+RDLK +N L D K DFG+ + + + + G+ Y+APE+L Y
Sbjct: 119 YRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGP 175
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS-LSSEARDFVKRL 399
D W++GV+ Y +LCG PF A E +F A+L DE +P+ LS +A D +K
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-----DEVVYPTWLSQDAVDILKAF 230
Query: 400 LNKDPRKRLTA------AQALSHPWIKNSN 423
+ K+P RL + L HP+ K +
Sbjct: 231 MTKNPTMRLGSLTLGGEEAILRHPFFKELD 260
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 77/283 (27%), Positives = 129/283 (45%), Gaps = 45/283 (15%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIP---KHKMTTAIAIEDVRREVKILRALTGH 218
E+G G+ G + G+ +AVK I + I RE+ IL
Sbjct: 8 ELGAGNSGVVSKVLHRP---TGKIMAVKTIRLEINEAIQKQIL-----RELDILHKCN-S 58
Query: 219 NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYT-EDDAKAVMIQILNVVAFCH 277
+V F+ A+ + ++ + ME +GG L D+IL E + + +L + + H
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 278 LQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI----VGSAYYVAPE 332
+ ++HRD+KP N L ++ + +K DFG+S + +N + VG++ Y+APE
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQ---IKLCDFGVSG-----QLVNSLAKTFVGTSSYMAPE 169
Query: 333 VLH-RSYSTEADVWSIGVIAYILLCGSRPF--WARTESGIF---RAVLKADPSFDEAPWP 386
+ YS ++D+WS+G+ L G P+ GIF + ++ P P
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP-------P 222
Query: 387 SL-----SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424
L S + +DFV L KDPR+R + + L HP+IK
Sbjct: 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYES 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 7e-32
Identities = 72/264 (27%), Positives = 127/264 (48%), Gaps = 14/264 (5%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+ ++G+G FG K + A+K I KM E + E ++L L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKA---DKRVYAMKQIDLSKMNRREREEAID-EARVLAKLD 57
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILS-RGGKYTEDDAKAVMIQILNVVAF 275
+ ++++++++ D + +VME E G+L + RG ED IQIL +A
Sbjct: 58 -SSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL-NDIVGSAYYVAPEVL 334
H + ++HRD+K N LF +N +K D G++ + + N IVG+ YY++PE+
Sbjct: 117 LHSKKILHRDIKSLN-LFLDAYDN--VKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELC 173
Query: 335 H-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393
+ Y+ ++DVW++GV+ Y G PF A + + +++ F S +
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG--VFPPVSQM-YSQQLA 230
Query: 394 DFVKRLLNKDPRKRLTAAQALSHP 417
+ + L KD R+R Q L +P
Sbjct: 231 QLIDQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 7e-32
Identities = 77/274 (28%), Positives = 138/274 (50%), Gaps = 21/274 (7%)
Query: 160 GEEVGRGHFGYT-CAAKFKKGEL---KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
GE +G+G +G A GE+ K ++ + +H ++ +R E++ L+ L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 216 TGHNNLVKFFDAYEDTDNVY-VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
H N+V++ +E T+ + +E GG + L G++ E + Q+L +A
Sbjct: 66 D-HLNIVQYL-GFETTEEYLSIFLEYVPGGSI-GSCLRTYGRFEEQLVRFFTEQVLEGLA 122
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL---SDFVRPDERLNDIVGSAYYVAP 331
+ H +G++HRDLK +N L D + + K DFG+ SD + +++ + GS +++AP
Sbjct: 123 YLHSKGILHRDLKADNLLV---DADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 332 EVLH---RSYSTEADVWSIGVIAYILLCGSRPFWARTES--GIFR-AVLKADPSFDEAPW 385
EV+H + YS + D+WS+G + + G RP W+ E+ +F+ ++ P
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-WSDEEAIAAMFKLGNKRSAPPIPPDVS 238
Query: 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
+LS A DF+ +P R TA + L HP+I
Sbjct: 239 MNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 87/311 (27%), Positives = 150/311 (48%), Gaps = 60/311 (19%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT----TAIAIEDVRREVK 210
++Y+ VG G +G C+A K G++VA+K K++ +AI + RE++
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKT---GRKVAIK-----KLSRPFQSAIHAKRTYRELR 66
Query: 211 ILRALTGHNNLVKFFDAY------EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKA 264
+L+ + H N++ D + ED +VY+V L G L+ I+ + K ++D +
Sbjct: 67 LLKHMD-HENVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIV-KCQKLSDDHIQF 122
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERLNDIV 323
++ QIL + + H G++HRDLKP N +E+ LK +DFGL+ R D+ + V
Sbjct: 123 LVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGLA---RHTDDEMTGYV 176
Query: 324 GSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCG-----------------------S 358
+ +Y APE++ Y+ D+WS+G I LL G
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD 236
Query: 359 RPFWARTESGIFRAVLKADP-----SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQA 413
+ S R +++ P F E + + A D ++++L DP KR+TAA+A
Sbjct: 237 EELLQKISSESARNYIQSLPQMPKKDFKEV-FSGANPLAIDLLEKMLVLDPDKRITAAEA 295
Query: 414 LSHPWIKNSND 424
L+HP++ +D
Sbjct: 296 LAHPYLAEYHD 306
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 7e-31
Identities = 71/263 (26%), Positives = 129/263 (49%), Gaps = 19/263 (7%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKH-------KMTTAIAIEDVRREV 209
Y + E +G G FG C K +K +A+K I H K +I D+ EV
Sbjct: 2 YAVLEHLGSGAFG--CVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEV 59
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEG---GELLDRILSRGGKYTEDDAKAVM 266
I++ H N+V+++ + + D +Y+VM+L EG GE + + + ++TE+ +
Sbjct: 60 TIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119
Query: 267 IQILNVVAFCHLQG-VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGS 325
+Q++ + + H + +VHRDL P N + D+ ++ DFGL+ +P+ +L +VG+
Sbjct: 120 VQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTI---TDFGLAKQKQPESKLTSVVGT 176
Query: 326 AYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384
Y PE++ + Y +ADVW+ G I Y + PF++ + +++A ++ P
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEA--VYEPLP 234
Query: 385 WPSLSSEARDFVKRLLNKDPRKR 407
S + D + L D R
Sbjct: 235 EGMYSEDVTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 8e-31
Identities = 89/297 (29%), Positives = 137/297 (46%), Gaps = 46/297 (15%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
YE E+G G +G A+ G+ VA+K + I + +R E+ +L+ L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLN---TGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLE 56
Query: 217 --GHNNLVKFFD--AYEDTDN---VYVVMELCEGGELLDRILSRGGK--YTEDDAKAVMI 267
H N+V+ D TD + +V E + + L LS+ K + K +M
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD--QDLATYLSKCPKPGLPPETIKDLMR 114
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY 327
Q+L V F H +VHRDLKP+N L T+ + +K DFGL+ + L +V + +
Sbjct: 115 QLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ---VKIADFGLARIYSFEMALTSVVVTLW 171
Query: 328 YVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRP-FWARTESG----IFR---------- 371
Y APEVL +S Y+T D+WS+G I L RP F +E+ IF
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAELF-RRRPLFRGTSEADQLDKIFDVIGLPSEEEW 230
Query: 372 ---AVLKADPSFD-------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
L SF ++ P + E D +K++L +P KR++A +AL HP+
Sbjct: 231 PRNVSLPRS-SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 8e-31
Identities = 77/270 (28%), Positives = 129/270 (47%), Gaps = 24/270 (8%)
Query: 156 KYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR----EV 209
KYE VGRG FG + C + + + V +K IP +MT +D R E
Sbjct: 1 KYEKIRVVGRGAFGIVHLC-----RRKADQKLVIIKQIPVEQMT-----KDERLAAQNEC 50
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQ 268
++L+ L+ H N++++++ + + + +VME GG L + I R ED +Q
Sbjct: 51 QVLKLLS-HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQ 109
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
IL + H + ++HRDLK +N L V+K DFG+S + + +VG+ Y
Sbjct: 110 ILLALHHVHTKLILHRDLKTQNILLDKH--KMVVKIGDFGISKILSSKSKAYTVVGTPCY 167
Query: 329 VAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
++PE+ + Y+ ++D+W++G + Y L R F A + VLK
Sbjct: 168 ISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VLKIMSGTFAPISDR 224
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHP 417
S + R + +LN DP KR +Q ++ P
Sbjct: 225 YSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 74/246 (30%), Positives = 121/246 (49%), Gaps = 35/246 (14%)
Query: 207 REVKILRALTGHNNLVKFFDAY--EDTDNVYVVMELCEGGEL---LDRILSRGGKYTEDD 261
RE++I ++ +VK++ A+ E + ++ + ME CEGG L ++ RGG+ E
Sbjct: 48 RELEINKS-CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKV 106
Query: 262 AKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND 321
+ +L +++ H + ++HRD+KP N L T K + +K DFG+S E +N
Sbjct: 107 LGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ---VKLCDFGVSG-----ELVNS 158
Query: 322 I----VGSAYYVAPE-VLHRSYSTEADVWSIGVIAYILLCGSRPFWARTE---------- 366
+ G+++Y+APE + + YS +DVWS+G+ + PF E
Sbjct: 159 LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS 218
Query: 367 --SGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424
+ LK +P + W S E +DF+K+ L KDP +R T L HPWIK
Sbjct: 219 YIVNMPNPELKDEPG-NGIKW---SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274
Query: 425 VKVPLD 430
KV +
Sbjct: 275 KKVNMA 280
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 92/317 (29%), Positives = 144/317 (45%), Gaps = 63/317 (19%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI-PKHKMTTAIAIEDVR--REVKILR 213
Y+ +G G +G C+A K G +VA+K I P T R RE+KILR
Sbjct: 7 YQNLSYIGEGAYGMVCSATHK---PTGVKVAIKKISPFEHQTFCQ-----RTLREIKILR 58
Query: 214 ALTGHNNLVKFFD-----AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQ 268
H N++ D ++E ++VY+V EL E L +++ + + D + + Q
Sbjct: 59 RFK-HENIIGILDIIRPPSFESFNDVYIVQELMETD--LYKLI-KTQHLSNDHIQYFLYQ 114
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER----LNDIVG 324
IL + + H V+HRDLKP N L T N LK DFGL+ P+ L + V
Sbjct: 115 ILRGLKYIHSANVLHRDLKPSNLLLNT---NCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 325 SAYYVAPEVL--HRSYSTEADVWSIGVI-AYILLCGSRPFW------------------- 362
+ +Y APE++ + Y+ D+WS+G I A +L RP +
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN--RPLFPGKDYLHQLNLILGVLGTP 229
Query: 363 -----ARTESGIFRAVLKADPSFDEAPWPSL----SSEARDFVKRLLNKDPRKRLTAAQA 413
S R +K+ P + PW L +A D + ++L +P KR+T +A
Sbjct: 230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEA 289
Query: 414 LSHPWIKNSNDVKVPLD 430
L+HP+++ +D P D
Sbjct: 290 LAHPYLEQYHD---PSD 303
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 69/225 (30%), Positives = 104/225 (46%), Gaps = 40/225 (17%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKG------QQVAVKVIPKHKMTTAIAIEDVRREVKI 211
ELG+++G G FG + KG LKG +VAVK + + + E+ E I
Sbjct: 2 ELGKKLGEGAFG-----EVYKGTLKGDGEGTETKVAVKTLKEG--ASEEEREEFLEEASI 54
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
++ L H N+V+ + +Y+V E GG+LLD + G K T D + +QI
Sbjct: 55 MKKL-SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAK 113
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV-- 329
+ + + VHRDL N L EN V+K DFGLS + D+ YY
Sbjct: 114 GMEYLESKNFVHRDLAARNCLV---TENLVVKISDFGLSRDIYEDD---------YYRKR 161
Query: 330 ----------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFW 362
APE L +++++DVWS GV+ + I G +P+
Sbjct: 162 GGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYP 206
|
Length = 258 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 84/291 (28%), Positives = 132/291 (45%), Gaps = 46/291 (15%)
Query: 161 EEVGRGHFGYTCAAKFK-KGELKGQQVAVKVI--PKHKMTTAIAIEDVRREVKILRALTG 217
E++G G T A +K + G+ VA+K I + T + AI RE+ +++ L
Sbjct: 6 EKLGEG----TYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI----REISLMKELK- 56
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG--GKYTEDDAKAVMIQILNVVAF 275
H N+V+ D + + +V E + +L + + G G + K+ Q+L +AF
Sbjct: 57 HENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL 334
CH V+HRDLKP+N L + E LK DFGL+ F P ++ V + +Y AP+VL
Sbjct: 116 CHENRVLHRDLKPQNLLINKRGE---LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVL 172
Query: 335 --HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS-- 390
R+YST D+WS+G I ++ G F + + + E+ WP +S
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP 232
Query: 391 -----------------------EARDFVKRLLNKDPRKRLTAAQALSHPW 418
D + RLL +P R++A AL HPW
Sbjct: 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 82/262 (31%), Positives = 136/262 (51%), Gaps = 17/262 (6%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
++G G G C A K G+QVAVK + K E + EV I+R H N+
Sbjct: 29 KIGEGSTGIVCIATEKH---TGKQVAVKKMDLRKQQRR---ELLFNEVVIMRDYH-HENV 81
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
V +++Y D ++VVME EGG L D + + E+ V + +L +++ H QGV
Sbjct: 82 VDMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQGV 139
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAPEVLHR-SYS 339
+HRD+K ++ L T+ + +K DFG V + + +VG+ Y++APEV+ R Y
Sbjct: 140 IHRDIKSDSILLTS---DGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYG 196
Query: 340 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA-DPSFDEAPWPSLSSEARDFVKR 398
TE D+WS+G++ ++ G P++ R + P ++ +SS R F+
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDS--HKVSSVLRGFLDL 254
Query: 399 LLNKDPRKRLTAAQALSHPWIK 420
+L ++P +R TA + L HP++K
Sbjct: 255 MLVREPSQRATAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 85/269 (31%), Positives = 132/269 (49%), Gaps = 17/269 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-TTAIAIEDVRREVKILRALTGHNNL 221
+G+G +G + G G+ A+KV+ K + + E IL A+ H +
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFI 62
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
V A++ +Y+++E GGEL L R G + ED A + +I + H QG+
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMH-LEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLHRSYST 340
++RDLKPEN L D +K DFGL + + + G+ Y+APE+L RS
Sbjct: 122 IYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHG 178
Query: 341 EA-DVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399
+A D WS+G + Y +L G+ PF A +LK + P L+ EARD +K+L
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLLKKL 234
Query: 400 LNKDPRKRL-----TAAQALSHPWIKNSN 423
L ++P RL AA+ SHP+ ++ N
Sbjct: 235 LKRNPSSRLGAGPGDAAEVQSHPFFRHVN 263
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 6e-30
Identities = 87/305 (28%), Positives = 136/305 (44%), Gaps = 63/305 (20%)
Query: 156 KYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVK---------VIPKHKMTTAIAIED 204
KYE ++G G +G + C + GQ VA+K VI K IA+
Sbjct: 2 KYEKLSKIGEGSYGVVFKC-----RNRETGQIVAIKKFVESEDDPVIKK------IAL-- 48
Query: 205 VRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKA 264
RE+++L+ L H NLV + + +++V E C+ +L+ + E K
Sbjct: 49 --REIRMLKQLK-HPNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKK 104
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV-RPDERLNDIV 323
++ Q L V FCH +HRD+KPEN L T + +K DFG + + P + D V
Sbjct: 105 IIWQTLQAVNFCHKHNCIHRDVKPENILIT---KQGQIKLCDFGFARILTGPGDDYTDYV 161
Query: 324 GSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWA------------RT---- 365
+ +Y APE+L Y DVW+IG + LL G +P W +T
Sbjct: 162 ATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG-QPLWPGKSDVDQLYLIRKTLGDL 220
Query: 366 ---------ESGIFRAVLKADPSFD---EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQA 413
+ F+ + +P E+ +P++SS A F+K L DP +RL+ +
Sbjct: 221 IPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEEL 280
Query: 414 LSHPW 418
L HP+
Sbjct: 281 LEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 6e-30
Identities = 77/267 (28%), Positives = 140/267 (52%), Gaps = 14/267 (5%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
KY +++G G FG K K+ G+Q +K I KM+ E+ R+EV +L +
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKE---DGKQYVIKEINISKMSPK-EREESRKEVAVLSNM 56
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILS-RGGKYTEDDAKAVMIQILNVVA 274
H N+V++ +++E+ N+Y+VM+ CEGG+L +I + RG + ED +QI +
Sbjct: 57 K-HPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK 115
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL-NDIVGSAYYVAPEV 333
H + ++HRD+K +N +F TKD +K DFG++ + L +G+ YY++PE+
Sbjct: 116 HVHDRKILHRDIKSQN-IFLTKD--GTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEI 172
Query: 334 L-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392
+R Y+ ++D+W++G + Y + F A + +++ S+ S +
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG--SYPPVS-SHYSYDL 229
Query: 393 RDFVKRLLNKDPRKRLTAAQALSHPWI 419
R+ V +L ++PR R + L +I
Sbjct: 230 RNLVSQLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 90/288 (31%), Positives = 143/288 (49%), Gaps = 40/288 (13%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI-PKHKMTTAIAIEDVRREVKIL 212
++ +E+ E +G+G +G KK G + AVK++ P H + E++ E IL
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKK---NGSKAAVKILDPIHDID-----EEIEAEYNIL 68
Query: 213 RALTGHNNLVKFFDAY-----EDTDNVYVVMELCEGGELLDRI---LSRGGKYTEDDAKA 264
+AL+ H N+VKF+ Y ++ D +++V+ELC GG + D + L RG + E
Sbjct: 69 KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY 128
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIV 323
++ + L + H+ +HRD+K N L TT+ +K +DFG+S R N V
Sbjct: 129 ILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG---VKLVDFGVSAQLTSTRLRRNTSV 185
Query: 324 GSAYYVAPEV------LHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 377
G+ +++APEV L +Y DVWS+G+ A L G P + RA+ K
Sbjct: 186 GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL---ADLHPMRALFK-- 240
Query: 378 PSFDEAPWPSL------SSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
P P+L S+E DF+++ L KD KR T + L H +I
Sbjct: 241 --IPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 8e-30
Identities = 87/266 (32%), Positives = 135/266 (50%), Gaps = 21/266 (7%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI--PKHKMTTAIAIEDVRREVKILR 213
+Y + VG G FG A + Q+ A+K I PK ++ A+ED R+E +L
Sbjct: 1 QYNVLRVVGEGSFG---RALLVQHVNSDQKYAMKEIRLPK----SSSAVEDSRKEA-VLL 52
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRI-LSRGGKYTEDDAKAVMIQILNV 272
A H N+V F +++E ++Y+VME C+GG+L+ +I L RG + ED +Q+
Sbjct: 53 AKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLG 112
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV-RPDERLNDIVGSAYYVAP 331
V H + V+HRD+K +N T +N +K DFG + + P VG+ YYV P
Sbjct: 113 VQHIHEKRVLHRDIKSKNIFLT---QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPP 169
Query: 332 EVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS-LS 389
E+ Y+ ++D+WS+G I Y L PF A + + V + P PS S
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK----PLPSHYS 225
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALS 415
E R +K++ ++PR R +A LS
Sbjct: 226 YELRSLIKQMFKRNPRSRPSATTILS 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 75/277 (27%), Positives = 132/277 (47%), Gaps = 22/277 (7%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
E + VG G FG + + E A+KV+ ++ + V E ++L+ ++
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISE---HYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS 59
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H +++ F D +Y++ME GGEL + + G +++ +I+ + +
Sbjct: 60 -HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYL 117
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR 336
H + +V+RDLKPEN L D+ +K DFG + +R +R + G+ Y+APEV+
Sbjct: 118 HSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLR--DRTWTLCGTPEYLAPEVIQS 172
Query: 337 S-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395
++ D W++G++ Y +L G PF+ GI+ +L F L A+D
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAKDL 228
Query: 396 VKRLLNKDPRKRL-----TAAQALSHPWIK--NSNDV 425
+K+LL D +RL A +H W K + +DV
Sbjct: 229 IKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDV 265
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 5e-29
Identities = 81/273 (29%), Positives = 137/273 (50%), Gaps = 22/273 (8%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+Y L + +G+G FG K KK + + +K IP ++ ++ +E ++L L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQ-ANQEAQLLSKL 59
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNV 272
H +VKF ++ + D ++ E CEG +L ++ G +E+ IQ+L
Sbjct: 60 D-HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL-NDIVGSAYYVAP 331
V + H + ++HRDLK +N +N++LK DFG+S + L G+ YY++P
Sbjct: 119 VHYMHQRRILHRDLKAKNIFL----KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSP 174
Query: 332 EVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL-- 388
E L H+ Y +++D+WS+G I Y + C + F VL+ E P PSL
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG---QNFLSVVLR----IVEGPTPSLPE 227
Query: 389 --SSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
S + ++ +LNKDP R +AA+ L +P+I
Sbjct: 228 TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 8e-29
Identities = 81/270 (30%), Positives = 131/270 (48%), Gaps = 23/270 (8%)
Query: 164 GRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL--TGHNNL 221
GRGHFG A++KK G+ A+K + K + +E + E +I H L
Sbjct: 8 GRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFL 64
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
V F ++ D+V VME GG+L+ I + ++E A ++ + + H +
Sbjct: 65 VNLFACFQTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKI 122
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVL-HRSYS 339
V+RDLK +N L T+ +K DFGL + + +R + G+ ++APEVL SY+
Sbjct: 123 VYRDLKLDNLLLDTE---GFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYT 179
Query: 340 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP-SLSSEARDFVKR 398
D W +GV+ Y +L G PF E +F +++ DE +P LS EA ++R
Sbjct: 180 RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-----DEVRYPRFLSREAISIMRR 234
Query: 399 LLNKDPRKRL-----TAAQALSHPWIKNSN 423
LL ++P +RL A P+ ++ N
Sbjct: 235 LLRRNPERRLGSGEKDAEDVKKQPFFRDIN 264
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 82/283 (28%), Positives = 142/283 (50%), Gaps = 25/283 (8%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-TAIAIEDVRREVKILRAL 215
+EL + +G G +G + G G+ A+KV+ K + A E R E ++L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
LV A++ ++++++ GGEL + R ++ E + + +I+ +
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEH 120
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPD-ERLNDIVGSAYYVAPEV 333
H G+++RD+K EN L D N + DFGLS +F + ER G+ Y+AP++
Sbjct: 121 LHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI 177
Query: 334 LH---RSYSTEADVWSIGVIAYILLCGSRPFWA----RTESGIFRAVLKADPSFDEAPWP 386
+ + D WS+GV+ Y LL G+ PF +++ I R +LK++P P+P
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP-----PYP 232
Query: 387 S-LSSEARDFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423
+S+ A+D ++RLL KDP+KRL A + HP+ + N
Sbjct: 233 QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 84/299 (28%), Positives = 130/299 (43%), Gaps = 49/299 (16%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI---PKHKMTTAIAIEDVRREVKI 211
KYE VG G +G K K+ GQ VA+K KM IA+ RE+++
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKE---TGQIVAIKKFLESEDDKMVKKIAM----REIRM 53
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
L+ L H NLV + + +Y+V E + +LD + E + + QIL
Sbjct: 54 LKQLR-HENLVNLIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILR 111
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERLNDIVGSAYYVA 330
+ FCH ++HRD+KPEN L + ++ V+K DFG + + P E D V + +Y A
Sbjct: 112 GIEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRA 168
Query: 331 PEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGI----------------FRA 372
PE+L Y D+W++G + +L G F +S I +
Sbjct: 169 PELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF--PGDSDIDQLYHIIKCLGNLIPRHQE 226
Query: 373 VLKADPSFD-------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
+ + +P F E +P LS D K+ L DP R +++Q L H +
Sbjct: 227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 1e-28
Identities = 68/269 (25%), Positives = 114/269 (42%), Gaps = 40/269 (14%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+++G G FG K K + K +VAVK + + + +D +E ++++ L GH N
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED--ASEEERKDFLKEARVMKKL-GHPN 57
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV--------MIQILNV 272
+V+ + + +Y+V+E EGG+LLD + + + + IQI
Sbjct: 58 VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV--- 329
+ + + VHRDL N L E+ V+K DFGLS V D+ YY
Sbjct: 118 MEYLASKKFVHRDLAARNCLVG---EDLVVKISDFGLSRDVYDDD---------YYRKKT 165
Query: 330 ---------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADP 378
APE L +++++DVWS GV+ + I G+ P+ + + + K
Sbjct: 166 GGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG-- 223
Query: 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKR 407
P E + + DP R
Sbjct: 224 YRLPKP-EYCPDELYELMLSCWQLDPEDR 251
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 81/277 (29%), Positives = 133/277 (48%), Gaps = 18/277 (6%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+ E+G G FG AK K+ G A KVI + + +ED E++IL A
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKE---TGALAAAKVI---ETKSEEELEDYMVEIEIL-ATC 66
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H +VK A+ +++++E C GG + +L TE + + Q+L + +
Sbjct: 67 NHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYL 126
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL- 334
H ++HRDLK N L T + +K DFG+S V+ +R + +G+ Y++APEV+
Sbjct: 127 HSMKIIHRDLKAGNVLLTLDGD---IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVM 183
Query: 335 -----HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
Y +AD+WS+G+ + P + + K++P P S
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQP-SKWS 242
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVK 426
E RDF+K L+K P R +AAQ L HP++ + +
Sbjct: 243 MEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR 279
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 1e-28
Identities = 88/275 (32%), Positives = 135/275 (49%), Gaps = 19/275 (6%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+ E+G G FG A+ K+ G A KVI + +ED E+ IL A
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKE---TGVLAAAKVI---DTKSEEELEDYMVEIDIL-ASC 59
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N+VK DA+ +N+++++E C GG + +L TE + V Q L + +
Sbjct: 60 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYL 119
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL- 334
H ++HRDLK N LFT + +K DFG+S R +R + +G+ Y++APEV+
Sbjct: 120 HENKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 176
Query: 335 -----HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
R Y +ADVWS+G+ + P + + K++P P S
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRWS 235
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIK-NSN 423
SE +DF+K+ L K+ R T Q L HP++ NSN
Sbjct: 236 SEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN 270
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-28
Identities = 85/266 (31%), Positives = 134/266 (50%), Gaps = 27/266 (10%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
++G G G C A K G+ VAVK + K E + EV I+R H N+
Sbjct: 27 KIGEGSTGIVCIATVKS---SGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQ-HENV 79
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
V+ +++Y D ++VVME EGG L D + + E+ AV + +L ++ H QGV
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQGV 137
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAPEVLHR-SYS 339
+HRD+K ++ L T + +K DFG V + R +VG+ Y++APE++ R Y
Sbjct: 138 IHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYG 194
Query: 340 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL------SSEAR 393
E D+WS+G++ ++ G P++ LKA + P L S +
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPYFNEPP-------LKAMKMIRDNLPPKLKNLHKVSPSLK 247
Query: 394 DFVKRLLNKDPRKRLTAAQALSHPWI 419
F+ RLL +DP +R TAA+ L HP++
Sbjct: 248 GFLDRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 81/266 (30%), Positives = 132/266 (49%), Gaps = 19/266 (7%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
VGRGHFG + + + G A+KV+ K + + E IL +++ +
Sbjct: 9 VGRGHFG---EVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDIL-SISNSPWIP 64
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGV 281
+ A++D DN+Y+VME GG+LL +L+R ++ ED A+ + +++ + H G
Sbjct: 65 QLQYAFQDKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGY 123
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI--VGSAYYVAPEVLHR--- 336
VHRD+KPEN L D +K DFG + + ++ +N VG+ Y+APEVL
Sbjct: 124 VHRDIKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNG 180
Query: 337 ----SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392
+Y E D WS+GVIAY ++ G PF T + + ++ P +SS+
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF 240
Query: 393 RDFVKRLLNKDPRKRLTAAQALSHPW 418
D ++ LL ++RL HP+
Sbjct: 241 LDLIQSLLC-GQKERLGYEGLCCHPF 265
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 80/289 (27%), Positives = 137/289 (47%), Gaps = 51/289 (17%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIP--KHKMTTAIAIEDVRREVK 210
+ G+ +G+G FG Y C G+++AVK +P T + + E++
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCY-----DVDTGRELAVKQVPFDPDSPETKKEVNALECEIQ 56
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG-------GKYTEDDAK 263
+L+ L H +V+++ D + + + ME GG + D++ + G KYT
Sbjct: 57 LLKNLQ-HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR---- 111
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI- 322
QIL V + H +VHRD+K N L +D +K DFG S +RL I
Sbjct: 112 ----QILEGVEYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGAS------KRLQTIC 158
Query: 323 ---------VGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE--SGIF 370
G+ Y+++PEV+ Y +ADVWS+G +L +P WA E + IF
Sbjct: 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT-EKPPWAEFEAMAAIF 217
Query: 371 RAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
+ + P+ + P +S +AR+F++R ++ +KR +A + L H ++
Sbjct: 218 K--IATQPTNPQLP-SHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 81/270 (30%), Positives = 133/270 (49%), Gaps = 23/270 (8%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL--TGHNN 220
+G+G FG + K G+ A+K++ K + IA ++V + R L T H
Sbjct: 3 LGKGTFGKVILVREKAT---GKYYAMKILKKEVI---IAKDEVAHTLTESRVLQNTRHPF 56
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
L +++ D + VME GGEL LSR ++ED A+ +I++ + + H
Sbjct: 57 LTALKYSFQTHDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEIVSALGYLHSCD 115
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLHRS-Y 338
VV+RDLK EN + D++ +K DFGL + + + G+ Y+APEVL + Y
Sbjct: 116 VVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 339 STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398
D W +GV+ Y ++CG PF+ + +F +L + F +LS EA+ +
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLAG 228
Query: 399 LLNKDPRKRL-----TAAQALSHPWIKNSN 423
LL KDP++RL A + + H + + N
Sbjct: 229 LLKKDPKQRLGGGPEDAKEIMEHRFFASIN 258
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 82/257 (31%), Positives = 130/257 (50%), Gaps = 24/257 (9%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR---EVKILRALTGHN 219
+G+G FG + G GQ A+KV+ K + + D R E IL A H
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKK----ATLKVRDRVRTKMERDIL-AEVNHP 58
Query: 220 NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
+VK A++ +Y++++ GG+L R LS+ +TE+D K + ++ + H
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDLFTR-LSKEVMFTEEDVKFYLAELALALDHLHSL 117
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR-S 337
G+++RDLKPEN L DE +K DFGLS + + +++ G+ Y+APEV++R
Sbjct: 118 GIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG 174
Query: 338 YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD---PSFDEAPWPSLSSEARD 394
++ AD WS GV+ + +L GS PF + +LKA P F LS EA+
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQF-------LSPEAQS 227
Query: 395 FVKRLLNKDPRKRLTAA 411
++ L ++P RL A
Sbjct: 228 LLRALFKRNPANRLGAG 244
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 95/309 (30%), Positives = 136/309 (44%), Gaps = 74/309 (23%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI---------PKHKMTTAIAIEDVRR 207
Y+ E++G G +G A+ K G+ VA+K I P +TAI R
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLT---GEIVALKKIRLETEDEGVP----STAI------R 47
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY---------T 258
E+ +L+ L H N+V+ D + +Y+V E LD L KY
Sbjct: 48 EISLLKELN-HPNIVRLLDVVHSENKLYLVFEF------LDLDLK---KYMDSSPLTGLD 97
Query: 259 EDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD-FVRPDE 317
K+ + Q+L +A+CH V+HRDLKP+N L D LK DFGL+ F P
Sbjct: 98 PPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI---DREGALKLADFGLARAFGVPVR 154
Query: 318 RLNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRP-FWARTESG----IF 370
V + +Y APE+L R YST D+WSIG I + + RP F +E IF
Sbjct: 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCI-FAEMVNRRPLFPGDSEIDQLFRIF 213
Query: 371 RAVLKAD--------------PSF-------DEAPWPSLSSEARDFVKRLLNKDPRKRLT 409
R + D P+F P+L + D + ++L DP KR++
Sbjct: 214 RTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS 273
Query: 410 AAQALSHPW 418
A AL HP+
Sbjct: 274 AKAALQHPY 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 73/273 (26%), Positives = 135/273 (49%), Gaps = 26/273 (9%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+++ +++G+G F A L G+ VA+K + +M A A +D +E+ +L+
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICL---LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQ 58
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV--------M 266
L H N++K+ ++ + + + +V+EL + G+L SR K+ + + +
Sbjct: 59 LD-HPNVIKYLASFIENNELNIVLELADAGDL-----SRMIKHFKKQKRLIPERTIWKYF 112
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGS 325
+Q+ + + H + ++HRD+KP N T V+K D GL F + +VG+
Sbjct: 113 VQLCSALEHMHSKRIMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGT 169
Query: 326 AYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384
YY++PE +H + Y+ ++D+WS+G + Y + PF+ + ++ K D P
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEKCDYPP 227
Query: 385 WPS--LSSEARDFVKRLLNKDPRKRLTAAQALS 415
P+ S E RD V R +N DP KR + L
Sbjct: 228 LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 6e-28
Identities = 81/273 (29%), Positives = 139/273 (50%), Gaps = 25/273 (9%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+YE+ +++G G FG K + + +K I KM E ++EV IL A
Sbjct: 1 RYEIIKKIGEGSFG---KIYLAKAKSDSEHCVIKEIDLTKMPVK-EKEASKKEV-ILLAK 55
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRI-LSRGGKYTEDDAKAVMIQILNVVA 274
H N+V FF ++++ +++VME C+GG+L+ RI RG ++ED + +QI +
Sbjct: 56 MKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND-------IVGSAY 327
H + ++HRD+K +N +F +K+ V K DFG++ +LND VG+ Y
Sbjct: 116 HIHDRKILHRDIKSQN-IFLSKN-GMVAKLGDFGIA------RQLNDSMELAYTCVGTPY 167
Query: 328 YVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386
Y++PE+ +R Y+ + D+WS+G + Y L PF + + + VLK + P
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF---EGNNLHQLVLKICQGYFAPISP 224
Query: 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
+ S + R + +L PR R + L P++
Sbjct: 225 NFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 82/270 (30%), Positives = 133/270 (49%), Gaps = 23/270 (8%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL--TGHNN 220
+G+G FG + K G+ A+K++ K + IA ++V V R L T H
Sbjct: 3 LGKGTFGKVILVREKA---TGRYYAMKILRKEVI---IAKDEVAHTVTESRVLQNTRHPF 56
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
L A++ D + VME GGEL LSR +TE+ A+ +I++ + + H +
Sbjct: 57 LTALKYAFQTHDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALEYLHSRD 115
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLH-RSY 338
VV+RD+K EN + D++ +K DFGL + + + G+ Y+APEVL Y
Sbjct: 116 VVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 339 STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398
D W +GV+ Y ++CG PF+ + +F +L + F +LS EA+ +
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAG 228
Query: 399 LLNKDPRKRL-----TAAQALSHPWIKNSN 423
LL KDP++RL A + + H + + N
Sbjct: 229 LLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 258
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 93/335 (27%), Positives = 145/335 (43%), Gaps = 73/335 (21%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR---- 206
KH KYE+ +++G+G +G A ++ + VA+K I A +
Sbjct: 3 KHILRKYEILQKLGKGAYGIVWKAIDRR---TKEVVALKKIFD-------AFRNATDAQR 52
Query: 207 --REVKILRALTGHNNLVKFFD---AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDD 261
RE+ L+ L H N+VK + A D D +Y+V E E L ++ R +
Sbjct: 53 TFREIMFLQELGDHPNIVKLLNVIKAENDKD-IYLVFEYMETD--LHAVI-RANILEDVH 108
Query: 262 AKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER--- 318
+ +M Q+L + + H V+HRDLKP N L + + +K DFGL+ + E
Sbjct: 109 KRYIMYQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLARSLSELEENPE 165
Query: 319 ---LNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWART-------- 365
L D V + +Y APE+L Y+ D+WS+G I +L G +P + T
Sbjct: 166 NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KPLFPGTSTLNQLEK 224
Query: 366 ----------------ESGIFRAVLKADPSFDEAP----WPSLSSEARDFVKRLLNKDPR 405
+S +L + PS P P S +A D +K+LL +P
Sbjct: 225 IIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPN 284
Query: 406 KRLTAAQALSHPWIKN----------SNDVKVPLD 430
KRLTA +AL HP++ + +PLD
Sbjct: 285 KRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPLD 319
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 80/278 (28%), Positives = 133/278 (47%), Gaps = 35/278 (12%)
Query: 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI---PKHKMTTAIAIEDVRREVKILRALT 216
GE +G+G +G +G+L +AVK + + + E ++ EV +L++L
Sbjct: 5 GEVLGKGAYGTVYCGLTNQGQL----IAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N+V++ D + + + ME GG + IL+R G E QIL+ VA+
Sbjct: 61 -HVNIVQYLGTCLDDNTISIFMEFVPGGSI-SSILNRFGPLPEPVFCKYTKQILDGVAYL 118
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFG-------LSDFVRPDERLNDIVGSAYYV 329
H VVHRD+K N + N ++K IDFG + L + G+ Y++
Sbjct: 119 HNNCVVHRDIKGNNVMLMP---NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 330 APEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTE--SGIF-----RAVLKADPSFD 381
APEV++ S Y ++D+WSIG + + G +P A + + +F R ++ P
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATG-KPPLASMDRLAAMFYIGAHRGLM---PRLP 231
Query: 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
+ S S+ A DFV L +D +R +A Q L H ++
Sbjct: 232 D----SFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 84/270 (31%), Positives = 136/270 (50%), Gaps = 21/270 (7%)
Query: 156 KYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
KY E++G+G G YT E+ +Q+ ++ PK ++ + E+ ++R
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL--------IINEILVMR 71
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
H N+V + D+Y D ++VVME GG L D + E AV + L +
Sbjct: 72 ENK-HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQAL 128
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER-LNDIVGSAYYVAPE 332
F H V+HRD+K +N L + SV K DFG + P++ + +VG+ Y++APE
Sbjct: 129 EFLHSNQVIHRDIKSDNILLGM--DGSV-KLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185
Query: 333 VLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP-SLSS 390
V+ R +Y + D+WS+G++A ++ G P+ E+ + L A E P LS+
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPELQNPEKLSA 243
Query: 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
RDF+ R L D KR +A + L HP++K
Sbjct: 244 IFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 89/293 (30%), Positives = 133/293 (45%), Gaps = 50/293 (17%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-----TAIAIEDVRREVKILRAL 215
E++G G +G A+ K G+ VA+K I T TAI RE+ +L+ L
Sbjct: 6 EKIGEGTYGVVYKARNKL---TGEVVALKKIRLDTETEGVPSTAI------REISLLKEL 56
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRIL--SRGGKYTEDDAKAVMIQILNVV 273
H N+VK D + +Y+V E + L + + S K+ + Q+L +
Sbjct: 57 N-HPNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASPLSGIPLPLIKSYLFQLLQGL 113
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD-FVRPDERLNDIVGSAYYVAPE 332
AFCH V+HRDLKP+N L + +K DFGL+ F P V + +Y APE
Sbjct: 114 AFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 170
Query: 333 VL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTESG----IFRAVLKAD----PSFDE 382
+L + YST D+WS+G I ++ F +E IFR + D P
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 230
Query: 383 AP--------W---------PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
P W P L + RD + ++L+ DP KR++A AL+HP+
Sbjct: 231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 87/291 (29%), Positives = 134/291 (46%), Gaps = 50/291 (17%)
Query: 166 GHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFF 225
G +G A+ KK G+ VA+K + K I +R E+ IL L H N+V
Sbjct: 16 GTYGVVYRARDKK---TGEIVALKKLKMEKEKEGFPITSLR-EINILLKL-QHPNIVTVK 70
Query: 226 DAY--EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVH 283
+ + D +Y+VME E +L + + + + + K +M+Q+L+ VA H ++H
Sbjct: 71 EVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILH 129
Query: 284 RDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL--HRSYST 340
RDLK N L + +LK DFGL+ ++ P + +V + +Y APE+L + YST
Sbjct: 130 RDLKTSNLLLNNR---GILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYST 186
Query: 341 EADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSFDEAPWP---------- 386
D+WS+G I LL F ++E + IF+ + P+ E WP
Sbjct: 187 AIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLL--GTPT--EKIWPGFSELPGAKK 242
Query: 387 ------------------SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
SLS D + RLL DP KR++A AL HP+
Sbjct: 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 75/264 (28%), Positives = 129/264 (48%), Gaps = 14/264 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG A+ K Q A+K + K + +E E ++L H L
Sbjct: 3 LGKGSFGKVFLAELKG---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ ++ +N++ VME GG+L+ I S K+ A +I+ + F H +G+V
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIV 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVL-HRSYST 340
+RDLK +N L D + +K DFG+ + + D + G+ Y+APE+L + Y+T
Sbjct: 119 YRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNT 175
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D WS GV+ Y +L G PF E +F+++ +P + W L+ EA+D + +L
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR--W--LTREAKDILVKLF 231
Query: 401 NKDPRKRL-TAAQALSHPWIKNSN 423
++P +RL HP+ + +
Sbjct: 232 VREPERRLGVKGDIRQHPFFREID 255
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 80/270 (29%), Positives = 131/270 (48%), Gaps = 19/270 (7%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR--ALTGHNN 220
+G+G FG + K + A+KV+ K ++ + E IL L
Sbjct: 1 IGKGTFGQVYQVRKKD---TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPF 57
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
+V +++ ++Y+V + GGEL L + G+++ED AK + +++ + H
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWH-LQKEGRFSEDRAKFYIAELVLALEHLHKYD 116
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGLSDF-VRPDERLNDIVGSAYYVAPEVL--HRS 337
+V+RDLKPEN L D + DFGLS + ++ N G+ Y+APEVL +
Sbjct: 117 IVYRDLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKG 173
Query: 338 YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397
Y+ D WS+GV+ + + CG PF+A ++R + F P LS E R FVK
Sbjct: 174 YTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF---PKNVLSDEGRQFVK 230
Query: 398 RLLNKDPRKRL----TAAQALSHPWIKNSN 423
LLN++P+ RL A + HP+ + +
Sbjct: 231 GLLNRNPQHRLGAHRDAVELKEHPFFADID 260
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 82/277 (29%), Positives = 137/277 (49%), Gaps = 31/277 (11%)
Query: 160 GEEVGRGHFGYT-CAAKFKKGELKG-QQVAVKVIP-KHKMTTAIAIEDVRREVKILRALT 216
G +G G FG GEL +QV + + K ++ + RE+ +L+ L
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N+V++ + D D++ + +E GG + +L+ G + E + + QIL + +
Sbjct: 65 -HENIVQYLGSSLDADHLNIFLEYVPGGSV-AALLNNYGAFEETLVRNFVRQILKGLNYL 122
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV------------RPDERLNDIVG 324
H +G++HRD+K N L D +K DFG+S + RP + G
Sbjct: 123 HNRGIIHRDIKGANILV---DNKGGIKISDFGISKKLEANSLSTKTNGARPS-----LQG 174
Query: 325 SAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDE 382
S +++APEV+ + SY+ +AD+WS+G + +L G PF T+ IF+ A P
Sbjct: 175 SVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPS 234
Query: 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
++SSEA DF+++ D KR TAA+ L HP++
Sbjct: 235 ----NISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 9e-27
Identities = 81/281 (28%), Positives = 138/281 (49%), Gaps = 22/281 (7%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT-AIAIEDVRREVKILRAL 215
+EL + +G G +G + G G+ A+KV+ K + A +E R E +L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
LV A++ ++++++ GGE+ + R ++ED+ + +I+ +
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEH 120
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPD-ERLNDIVGSAYYVAPEV 333
H G+V+RD+K EN L D + DFGLS +F+ + ER G+ Y+APE+
Sbjct: 121 LHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177
Query: 334 LH--RSYSTEADVWSIGVIAYILLCGSRPFWAR----TESGIFRAVLKADPSFDEAPWPS 387
+ + D WS+G++ + LL G+ PF T+S + R +LK DP F
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP----SF 233
Query: 388 LSSEARDFVKRLLNKDPRKRLTAA-----QALSHPWIKNSN 423
+ EA+D + +LL KDP+KRL A + HP+ K +
Sbjct: 234 IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 80/284 (28%), Positives = 133/284 (46%), Gaps = 55/284 (19%)
Query: 183 GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT----------- 231
++VAVK I +T +++ RE+KI+R L H+N+VK ++ +
Sbjct: 30 DKRVAVKKI---VLTDPQSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGSDLTEDVGSL 85
Query: 232 ---DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKP 288
++VY+V E E L +L +G +E+ A+ M Q+L + + H V+HRDLKP
Sbjct: 86 TELNSVYIVQEYMETD--LANVLEQG-PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKP 142
Query: 289 ENFLFTTKDENSVLKAIDFGLSDFVRPDER----LNDIVGSAYYVAPEVL--HRSYSTEA 342
N T E+ VLK DFGL+ V P L++ + + +Y +P +L +Y+
Sbjct: 143 ANVFINT--EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAI 200
Query: 343 DVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP------------------ 384
D+W+ G I +L G F E + +L++ P E
Sbjct: 201 DMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGE 260
Query: 385 --------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
P ++ EA DF++++L +P RLTA +AL HP++
Sbjct: 261 PRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 1e-26
Identities = 86/268 (32%), Positives = 135/268 (50%), Gaps = 17/268 (6%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
KY E++G+G G A GQ+VA+K I K E + E+ +++ L
Sbjct: 20 KYTRYEKIGQGASGTVFTAI---DVATGQEVAIKQINLQKQPKK---ELIINEILVMKEL 73
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
+ N+V F D++ D ++VVME GG L D + E AV + L + F
Sbjct: 74 K-NPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC--MDEAQIAAVCRECLQALEF 130
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVL 334
H V+HRD+K +N L + SV K DFG + P++ + + +VG+ Y++APEV+
Sbjct: 131 LHANQVIHRDIKSDNVLLGM--DGSV-KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187
Query: 335 HR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS-LSSEA 392
R +Y + D+WS+G++A ++ G P+ E+ + L A E P LS
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPELQNPEKLSPIF 245
Query: 393 RDFVKRLLNKDPRKRLTAAQALSHPWIK 420
RDF+ R L D KR +A + L HP++K
Sbjct: 246 RDFLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 87/292 (29%), Positives = 133/292 (45%), Gaps = 38/292 (13%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
KYE E++G G +G AK ++ + VA+K + + +R E+ +L+ L
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDDDDEGVPSSALR-EICLLKEL 56
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N+V+ +D + +V E C+ +L S G + K+ M Q+L +AF
Sbjct: 57 K-HKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAF 114
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL 334
CH V+HRDLKP+N L N LK DFGL+ F P + V + +Y P+VL
Sbjct: 115 CHSHNVLHRDLKPQNLLINK---NGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVL 171
Query: 335 --HRSYSTEADVWSIGVIAYILLCGSRPFWARTE-----SGIFRAV-------------- 373
+ YST D+WS G I L RP + + IFR +
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231
Query: 374 --LKADPSFD-----EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
K P + P L+S RD ++ LL +P +R++A +AL HP+
Sbjct: 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 95/306 (31%), Positives = 142/306 (46%), Gaps = 65/306 (21%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI---------PKHKMTTAIAIEDVR 206
Y E++G G +G + KK GQ VA+K I P +TAI
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKK---TGQIVAMKKIRLESEEEGVP----STAI------ 47
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL--CEGGELLDRILSRGGKYTEDD-AK 263
RE+ +L+ L H N+V D +Y++ E + + LD + G+Y + + K
Sbjct: 48 REISLLKELQ-HPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSL--PKGQYMDAELVK 104
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDI 322
+ + QIL + FCH + V+HRDLKP+N L D V+K DFGL+ F P
Sbjct: 105 SYLYQILQGILFCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIPVRVYTHE 161
Query: 323 VGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRP-FWARTESG----IFRAVLK 375
V + +Y APEVL S YST D+WSIG I + + +P F +E IFR +
Sbjct: 162 VVTLWYRAPEVLLGSPRYSTPVDIWSIGTI-FAEMATKKPLFHGDSEIDQLFRIFRIL-- 218
Query: 376 ADPSFDEAP--------------W---------PSLSSEARDFVKRLLNKDPRKRLTAAQ 412
P+ D P W +L + D ++++L DP KR++A +
Sbjct: 219 GTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKK 278
Query: 413 ALSHPW 418
AL+HP+
Sbjct: 279 ALNHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 89/317 (28%), Positives = 131/317 (41%), Gaps = 72/317 (22%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+KYE ++G+G FG A+ KK Q VA+K + I +R E+KIL+
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKK---TKQIVALKKVLMENEKEGFPITALR-EIKILQL 67
Query: 215 LTGHNNLVKF----------FDAYEDTDNVYVVMELCEGGELLDRILSRGG-KYTEDDAK 263
L H N+V ++ Y+ + Y+V E CE L +LS K+T + K
Sbjct: 68 LK-HENVVNLIEICRTKATPYNRYKGS--FYLVFEFCEHD--LAGLLSNKNVKFTLSEIK 122
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDE----R 318
VM +LN + + H ++HRD+K N L T ++ +LK DFGL+ F R
Sbjct: 123 KVMKMLLNGLYYIHRNKILHRDMKAANILIT---KDGILKLADFGLARAFSLSKNSKPNR 179
Query: 319 LNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIA---------------------YILL 355
+ V + +Y PE+L R Y D+W G I L
Sbjct: 180 YTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL 239
Query: 356 CGS-----------RPFWARTE--SGIFRAVLKADPSFDEAPWPSLSS-EARDFVKRLLN 401
CGS + + E G R V E P + A D + +LL
Sbjct: 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKV-------KERLKPYVKDPHALDLIDKLLV 292
Query: 402 KDPRKRLTAAQALSHPW 418
DP KR+ A AL+H +
Sbjct: 293 LDPAKRIDADTALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-26
Identities = 81/279 (29%), Positives = 130/279 (46%), Gaps = 26/279 (9%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G G FG A +K + VA+K K K+ ++ V E KIL + H V
Sbjct: 38 LGTGSFGRVILATYKNEDFP--PVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCV 94
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ +++D +Y+V+E GGE L R ++ D QI+ + + +V
Sbjct: 95 NLYGSFKDESYLYLVLEFVIGGEFFT-FLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIV 153
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYSTE 341
+RDLKPEN L D++ +K DFG + V D R + G+ Y+APE+L + +
Sbjct: 154 YRDLKPENLLL---DKDGFIKMTDFGFAKVV--DTRTYTLCGTPEYIAPEILLNVGHGKA 208
Query: 342 ADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLN 401
AD W++G+ Y +L G PF+A I++ +L+ F + L + + +K+LL+
Sbjct: 209 ADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKF----LDNNCKHLMKKLLS 264
Query: 402 KDPRKRL-----TAAQALSHPWIKN-------SNDVKVP 428
D KR A HPW N +V+VP
Sbjct: 265 HDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVP 303
|
Length = 340 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 88/309 (28%), Positives = 135/309 (43%), Gaps = 61/309 (19%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIED------VRRE 208
+ YE E++G G +G A+ K G+ VA+K T + +++ RE
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKN---TGKLVALK-------KTRLEMDEEGIPPTALRE 50
Query: 209 VKILRALTGHNNLVKFFDAYEDTDN------VYVVMELCEGGELLDRILSRGGKYT---- 258
+ +L+ L+ +V+ D E + +Y+V E + +L + S G
Sbjct: 51 ISLLQMLSESIYIVRLLDV-EHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLP 108
Query: 259 EDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDE 317
K+ M Q+L VA CH GV+HRDLKP+N L + +LK D GL F P +
Sbjct: 109 AKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLL--VDKQKGLLKIADLGLGRAFSIPVK 166
Query: 318 RLNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTES----GIFR 371
+ + +Y APEVL YST D+WS+G I + F +E IF+
Sbjct: 167 SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFK 226
Query: 372 AVLKADPSFDEAP-------W---------------PSLSSEARDFVKRLLNKDPRKRLT 409
L P+ P W P LS E D ++++L DP KR++
Sbjct: 227 --LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS 284
Query: 410 AAQALSHPW 418
A AL+HP+
Sbjct: 285 AKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 82/293 (27%), Positives = 131/293 (44%), Gaps = 26/293 (8%)
Query: 149 FSKHFANK-YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR 207
FSK K + E+G G FG A F + + VA+K + + +D+ +
Sbjct: 8 FSKDDPEKLFTDLREIGHGSFG---AVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEG--GELLDRILSRGGKYTEDDAKAV 265
EV+ L+ L H N +++ Y ++VME C G ++L+ + + E + A+
Sbjct: 65 EVRFLQQLR-HPNTIEYKGCYLREHTAWLVMEYCLGSASDILE-VHKKP--LQEVEIAAI 120
Query: 266 MIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGS 325
L +A+ H +HRD+K N L T E +K DFG + V P N VG+
Sbjct: 121 CHGALQGLAYLHSHERIHRDIKAGNILLT---EPGTVKLADFGSASLVSP---ANSFVGT 174
Query: 326 AYYVAPEVL----HRSYSTEADVWSIGVIAYILLCGSRP--FWARTESGIFRAVLKADPS 379
Y++APEV+ Y + DVWS+G I I L +P F S ++ P+
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNDSPT 233
Query: 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVI 432
W S R+FV L K P+ R ++ + L H ++ V +D+I
Sbjct: 234 LSSNDW---SDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIIDLI 283
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 76/264 (28%), Positives = 131/264 (49%), Gaps = 14/264 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG A+ K + A+K + K + +E E ++L H L
Sbjct: 3 LGKGSFGKVMLAELKG---TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
F ++ ++++ VME GG+L+ I S G ++ E A+ +I+ + F H +G++
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKKGII 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDF-VRPDERLNDIVGSAYYVAPEVLH-RSYST 340
+RDLK +N L D++ +K DFG+ + + + + G+ Y+APE+L + Y+
Sbjct: 119 YRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNE 175
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D WS GV+ Y +L G PF E +F ++L P F W +S EA+D + +L
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR--W--ISKEAKDCLSKLF 231
Query: 401 NKDPRKRL-TAAQALSHPWIKNSN 423
+DP KRL HP+ + +
Sbjct: 232 ERDPTKRLGVDGDIRQHPFFRGID 255
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 74/248 (29%), Positives = 122/248 (49%), Gaps = 14/248 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG + K G+ A+K++ K + + E ++L+ T H L
Sbjct: 3 LGKGTFGKVILVREKA---SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN-TRHPFLT 58
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+++ D + VME GGEL LSR ++ED + +I++ + + H +V
Sbjct: 59 SLKYSFQTKDRLCFVMEYVNGGELFFH-LSRERVFSEDRTRFYGAEIVSALDYLHSGKIV 117
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLH-RSYST 340
+RDLK EN + D++ +K DFGL + + + G+ Y+APEVL Y
Sbjct: 118 YRDLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W +GV+ Y ++CG PF+ + +F +L D F +LS++A+ + LL
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAKSLLSGLL 230
Query: 401 NKDPRKRL 408
KDP KRL
Sbjct: 231 IKDPNKRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 80/270 (29%), Positives = 126/270 (46%), Gaps = 26/270 (9%)
Query: 163 VGRGHFGYTCAAKFKKGELKG--QQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+G+G FG K ELKG + A+KV+ K + ++ E +IL H
Sbjct: 3 LGKGSFG-----KVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPF 57
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
L ++ D ++ VME GG+L+ +I R K+ E ++ ++ + F H G
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDLMFQI-QRSRKFDEPRSRFYAAEVTLALMFLHRHG 116
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLHR-SY 338
V++RDLK +N L D K DFG+ + + G+ Y+APE+L Y
Sbjct: 117 VIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEY 173
Query: 339 STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS-LSSEARDFVK 397
D W++GV+ Y ++ G PF A E +F ++L D+ +P LS EA +K
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH-----DDVLYPVWLSKEAVSILK 228
Query: 398 RLLNKDPRKRL--TAAQALS-----HPWIK 420
+ K+P KRL A+Q HP+ K
Sbjct: 229 AFMTKNPNKRLGCVASQGGEDAIKQHPFFK 258
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 79/281 (28%), Positives = 136/281 (48%), Gaps = 28/281 (9%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
A +EL E VG G +G + K GQ A+KV+ T E++++E+ +L+
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMD----VTGDEEEEIKQEINMLK 57
Query: 214 ALTGHNNLVKFFDAYEDT------DNVYVVMELCEGGELLDRIL-SRGGKYTEDDAKAVM 266
+ H N+ ++ A+ D +++VME C G + D I ++G E+ +
Sbjct: 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 117
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGS 325
+IL ++ H V+HRD+K +N L T EN+ +K +DFG+S R R N +G+
Sbjct: 118 REILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGT 174
Query: 326 AYYVAPEVL------HRSYSTEADVWSIGVIAYILLCGSRPFW-ARTESGIFRAVLKADP 378
Y++APEV+ +Y ++D+WS+G+ A + G+ P +F P
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP 234
Query: 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
W S + + F++ L K+ +R T Q + HP+I
Sbjct: 235 RLKSKKW---SKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 87/307 (28%), Positives = 132/307 (42%), Gaps = 59/307 (19%)
Query: 163 VGRGHFGYTC-AAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
+G G FG C K L A+K + K + V+ E IL A + +
Sbjct: 9 IGIGAFGEVCLVRKVDTNAL----YAMKTLRKADVLMRNQAAHVKAERDIL-AEADNEWV 63
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
VK + +++D DN+Y VM+ GG+++ +L R G + ED A+ + ++ + H G
Sbjct: 64 VKLYYSFQDKDNLYFVMDYIPGGDMMS-LLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGL--------------------SDFVRPDERLND 321
+HRD+KP+N L D + +K DFGL D + P E ++
Sbjct: 123 IHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 322 I------------------------VGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILLC 356
I VG+ Y+APEVL R+ Y+ D WS+GVI Y +L
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239
Query: 357 GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL---TAAQA 413
G PF A T + V+ + + LS EA D + RL RL A +
Sbjct: 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI 298
Query: 414 LSHPWIK 420
+HP+ K
Sbjct: 299 KAHPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 84/285 (29%), Positives = 129/285 (45%), Gaps = 32/285 (11%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI-PKHKMTTAIAIEDVRREVKIL 212
+ +E+ E +G+G +G KK G AVK++ P + E++ E IL
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKK---DGSLAAVKILDPISDVD-----EEIEAEYNIL 72
Query: 213 RALTGHNNLVKFFDAYEDTDN-----VYVVMELCEGG---ELLDRILSRGGKYTEDDAKA 264
++L H N+VKF+ + D +++V+ELC GG EL+ +L G + E
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIV 323
++ L + H ++HRD+K N L TT E V K +DFG+S R N V
Sbjct: 133 ILYGALLGLQHLHNNRIIHRDVKGNNILLTT--EGGV-KLVDFGVSAQLTSTRLRRNTSV 189
Query: 324 GSAYYVAPEVL------HRSYSTEADVWSIGVIAYILLCGSRP-FWARTESGIFRAVLKA 376
G+ +++APEV+ SY DVWS+G+ A L G P F +F+
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP 249
Query: 377 DPSF-DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
P+ W F+ + L KD R + L HP+IK
Sbjct: 250 PPTLLHPEKW---CRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 81/281 (28%), Positives = 133/281 (47%), Gaps = 28/281 (9%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
A +EL E VG G +G + K GQ A+KV+ T E+++ E+ +L+
Sbjct: 15 AGIFELVEVVGNGTYGQVYKGRHVK---TGQLAAIKVMD----VTEDEEEEIKLEINMLK 67
Query: 214 ALTGHNNLVKFFDAY------EDTDNVYVVMELCEGGELLDRIL-SRGGKYTEDDAKAVM 266
+ H N+ ++ A+ D +++VME C G + D + ++G ED +
Sbjct: 68 KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYIC 127
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGS 325
+IL +A H V+HRD+K +N L T EN+ +K +DFG+S R R N +G+
Sbjct: 128 REILRGLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGT 184
Query: 326 AYYVAPEVL------HRSYSTEADVWSIGVIAYILLCGSRPFW-ARTESGIFRAVLKADP 378
Y++APEV+ +Y +D+WS+G+ A + G+ P +F P
Sbjct: 185 PYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPP 244
Query: 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
W S + DF++ L K+ R + Q L HP+I
Sbjct: 245 KLKSKKW---SKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 91/311 (29%), Positives = 142/311 (45%), Gaps = 59/311 (18%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-----TTAIAIEDVRREV 209
++YE E++G G +G A+ + + + +A+K I + +TAI RE+
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDR---VTNETIALKKIRLEQEDEGVPSTAI------REI 52
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDA------K 263
+L+ + H N+V+ D +Y+V E LD L + + D A K
Sbjct: 53 SLLKEMQ-HGNIVRLQDVVHSEKRLYLVFEY------LDLDLKKHMDSSPDFAKNPRLIK 105
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD-FVRPDERLNDI 322
+ QIL +A+CH V+HRDLKP+N L + + LK DFGL+ F P
Sbjct: 106 TYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR--TNALKLADFGLARAFGIPVRTFTHE 163
Query: 323 VGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRP-FWARTE----SGIFRAV-- 373
V + +Y APE+L R YST D+WS+G I + + +P F +E IFR +
Sbjct: 164 VVTLWYRAPEILLGSRHYSTPVDIWSVGCI-FAEMVNQKPLFPGDSEIDELFKIFRILGT 222
Query: 374 --------LKADPSFDEA--PW---------PSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
+ + P + A W P+L D + ++L DP KR+TA AL
Sbjct: 223 PNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAAL 282
Query: 415 SHPWIKNSNDV 425
H + K+ D
Sbjct: 283 EHEYFKDLGDA 293
|
Length = 294 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 80/257 (31%), Positives = 120/257 (46%), Gaps = 41/257 (15%)
Query: 184 QQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN--LVKFFDAYEDTDNVYVVMELC 241
Q+ A+K I K + I+ V E IL T N +V F ++E ++ +VME
Sbjct: 27 QRFAMKKINKQNLILRNQIQQVFVERDIL---TFAENPFVVSMFCSFETKRHLCMVMEYV 83
Query: 242 EGGE---LLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE 298
EGG+ LL I G D A+ + + + + H G+VHRDLKP+N L T+
Sbjct: 84 EGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH 139
Query: 299 NSVLKAIDFGLSD-------------FVRPDERL---NDIVGSAYYVAPEV-LHRSYSTE 341
+K DFGLS + D R + G+ Y+APEV L + Y
Sbjct: 140 ---IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKP 196
Query: 342 ADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP----SLSSEARDFVK 397
D W++G+I Y L G PF+ T +F V+ D+ WP +L ++A+D +
Sbjct: 197 VDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS-----DDIEWPEGDEALPADAQDLIS 251
Query: 398 RLLNKDPRKRLTAAQAL 414
RLL ++P +RL A
Sbjct: 252 RLLRQNPLERLGTGGAF 268
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 79/293 (26%), Positives = 130/293 (44%), Gaps = 44/293 (15%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G G +G A+ G+ VA+K + I I +R E+ +L L H N+V
Sbjct: 15 IGEGTYGIVYRARDTT---SGEIVALKKVRMDNERDGIPISSLR-EITLLLNLR-HPNIV 69
Query: 223 KFFD--AYEDTDNVYVVMELCEG--GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL 278
+ + + D++++VME CE LLD + + ++E K +M+Q+L + + H
Sbjct: 70 ELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPT---PFSESQVKCLMLQLLRGLQYLHE 126
Query: 279 QGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL--H 335
++HRDLK N L T K LK DFGL+ + P + + V + +Y APE+L
Sbjct: 127 NFIIHRDLKVSNLLLTDK---GCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGC 183
Query: 336 RSYSTEADVWSIGVIAYILLCGSRPFWARTE-------------------------SGIF 370
+Y+T D+W++G I LL ++E +
Sbjct: 184 TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243
Query: 371 RAVLKADP-SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422
+ L P + + +P LS + LL DP+KR TA +AL + K
Sbjct: 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 75/249 (30%), Positives = 125/249 (50%), Gaps = 15/249 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG K K G+ A+K++ K + + E ++L+ + H L
Sbjct: 3 LGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLT 58
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GV 281
+++ D + VME GGEL LSR ++ED A+ +I++ + + H + V
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEIVSALDYLHSEKNV 117
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLH-RSYS 339
V+RDLK EN + D++ +K DFGL + ++ + G+ Y+APEVL Y
Sbjct: 118 VYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYG 174
Query: 340 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399
D W +GV+ Y ++CG PF+ + +F +L + F +LS EA+ + L
Sbjct: 175 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLSGL 230
Query: 400 LNKDPRKRL 408
L KDP++RL
Sbjct: 231 LKKDPKQRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 80/270 (29%), Positives = 136/270 (50%), Gaps = 21/270 (7%)
Query: 156 KYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
KY E++G+G G YT E+ +Q+ ++ PK ++ + E+ ++R
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--------IINEILVMR 72
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
+ N+V + D+Y D ++VVME GG L D + E AV + L +
Sbjct: 73 E-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQAL 129
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPE 332
F H V+HRD+K +N L + +K DFG + P++ + + +VG+ Y++APE
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186
Query: 333 VLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS-LSS 390
V+ R +Y + D+WS+G++A ++ G P+ E+ + L A E P LS+
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQNPEKLSA 244
Query: 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
RDF+ R L+ D KR +A + L H ++K
Sbjct: 245 IFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 94/330 (28%), Positives = 137/330 (41%), Gaps = 97/330 (29%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-----TTAIAIEDVRREVKI 211
YE+ ++G G FG A+ K G+ VA+K I H TA+ RE+KI
Sbjct: 10 YEILGKLGEGTFGEVYKARQIK---TGRVVALKKILMHNEKDGFPITAL------REIKI 60
Query: 212 LRALTGHNNLVKFFD-AYEDTDN-------VYVVM-----ELCEGGELLD--RILSRGGK 256
L+ L H N+V D A E D VY+V +L LL+ + K
Sbjct: 61 LKKLK-HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG---LLENPSV-----K 111
Query: 257 YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP- 315
TE K M+Q+L + + H ++HRD+K N L D +LK DFGL+ RP
Sbjct: 112 LTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADFGLA---RPY 165
Query: 316 --------------DERLNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSR 359
+ ++V + +Y PE+L R Y+T D+W IG + + R
Sbjct: 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-R 224
Query: 360 P-FWARTE----SGIFRAVLKADPSFDEAPWP--------------------------SL 388
P +++ IF+ P+ E WP L
Sbjct: 225 PILQGKSDIDQLHLIFKLC--GTPT--EETWPGWRSLPGCEGVHSFTNYPRTLEERFGKL 280
Query: 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
E D + +LL+ DP KRLTA+ AL HP+
Sbjct: 281 GPEGLDLLSKLLSLDPYKRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 80/270 (29%), Positives = 136/270 (50%), Gaps = 21/270 (7%)
Query: 156 KYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
KY E++G+G G YT E+ +Q+ ++ PK ++ + E+ ++R
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL--------IINEILVMR 71
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
+ N+V + D+Y D ++VVME GG L D + E AV + L +
Sbjct: 72 E-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQAL 128
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPE 332
F H V+HRD+K +N L + +K DFG + P++ + + +VG+ Y++APE
Sbjct: 129 DFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185
Query: 333 VLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS-LSS 390
V+ R +Y + D+WS+G++A ++ G P+ E+ + L A E P LS+
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPELQNPERLSA 243
Query: 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
RDF+ R L D +R +A + L HP++K
Sbjct: 244 VFRDFLNRCLEMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 77/265 (29%), Positives = 133/265 (50%), Gaps = 16/265 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN-L 221
+G+G FG A+ K KG+ AVK + K + +E E ++L AL N L
Sbjct: 3 LGKGSFGKVLLAELKG---KGEYFAVKALKKDVVLIDDDVECTMVEKRVL-ALAWENPFL 58
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
+ ++ ++++ VME GG+L+ I +G ++ A +I+ + F H +G+
Sbjct: 59 THLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHSKGI 117
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLH-RSYS 339
++RDLK +N + D + +K DFG+ + V D R + G+ Y+APE+L Y+
Sbjct: 118 IYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYT 174
Query: 340 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399
D WS GV+ Y +L G PF E +F ++ P + W ++ E++D +++L
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR--W--ITKESKDILEKL 230
Query: 400 LNKDPRKRLTAAQALS-HPWIKNSN 423
+DP +RL + HP+ K N
Sbjct: 231 FERDPTRRLGVVGNIRGHPFFKTIN 255
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 74/250 (29%), Positives = 120/250 (48%), Gaps = 13/250 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG A+ K E + AVKV+ K + + + E +L H LV
Sbjct: 3 IGKGSFGKVLLARHKAEE---KFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+++ D +Y V++ GGEL L R + E A+ +I + + + H +V
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGELFYH-LQRERCFLEPRARFYAAEIASALGYLHSLNIV 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLHRS-YST 340
+RDLKPEN L D + DFGL + + + + G+ Y+APEVLH+ Y
Sbjct: 119 YRDLKPENILL---DSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W +G + Y +L G PF++R + ++ +L P++++ AR ++ LL
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLL 231
Query: 401 NKDPRKRLTA 410
KD KRL A
Sbjct: 232 QKDRTKRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 73/250 (29%), Positives = 120/250 (48%), Gaps = 17/250 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQ--VAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+G+G FG K E KG A+K++ K + +E E ++L
Sbjct: 8 LGKGSFG-----KVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPF 62
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
L + ++ D +Y VME GG+L+ I + GK+ E A +I + F H +G
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGKFKEPHAVFYAAEIAIGLFFLHSKG 121
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPE-VLHRSY 338
+++RDLK +N + D +K DFG+ + + + G+ Y+APE + ++ Y
Sbjct: 122 IIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY 178
Query: 339 STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398
D W+ GV+ Y +L G PF E +F+++++ + S+ + SLS EA K
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKG 234
Query: 399 LLNKDPRKRL 408
LL K P KRL
Sbjct: 235 LLTKHPAKRL 244
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 88/314 (28%), Positives = 144/314 (45%), Gaps = 35/314 (11%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+ + +GRG FG K K GQ A+K++ K +M R E +L +
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKN---TGQVYAMKILNKWEMLKRAETACFREERDVL--VN 57
Query: 217 GHNNLV-KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
G + A++D +N+Y+VM+ GG+LL + + ED A+ + +++ +
Sbjct: 58 GDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDS 117
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAPEV 333
H G VHRD+KP+N L D+N ++ DFG + D + N VG+ Y++PE+
Sbjct: 118 VHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI 174
Query: 334 LHR------SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW-P 386
L Y E D WS+GV Y +L G PF+A + + ++ F P
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVT 234
Query: 387 SLSSEARDFVKRLLNKDPRKRL---TAAQALSHPW--------IKNSN-----DVKVPLD 430
+S EA+D ++RL+ P RL HP+ I+NS +V P D
Sbjct: 235 DVSEEAKDLIRRLICS-PETRLGRNGLQDFKDHPFFEGIDWDNIRNSTAPYVPEVSSPTD 293
Query: 431 VIIFKLMKAYMRSS 444
F + +R++
Sbjct: 294 TSNFDVDDDDLRNT 307
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 83/270 (30%), Positives = 141/270 (52%), Gaps = 27/270 (10%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQV-AVKVIPKHKMTTAIAIEDVRREVKILRALTGHN 219
E +G+G FG FK + + QQV A+K+I + I ED+++E+ +L +
Sbjct: 10 ERIGKGSFGEV----FKGIDNRTQQVVAIKIIDLEEAEDEI--EDIQQEITVL-SQCDSP 62
Query: 220 NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
+ K++ +Y ++++ME GG LD L R G + E ++ +IL + + H +
Sbjct: 63 YVTKYYGSYLKGTKLWIIMEYLGGGSALD--LLRAGPFDEFQIATMLKEILKGLDYLHSE 120
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLHRS- 337
+HRD+K N L + E +K DFG++ + + + N VG+ +++APEV+ +S
Sbjct: 121 KKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSA 177
Query: 338 YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE----AR 393
Y ++AD+WS+G+ A L G P ++ R VL P P+L+ E +
Sbjct: 178 YDSKADIWSLGITAIELAKGEPP---NSDMHPMR-VLFLIPKN---NPPTLTGEFSKPFK 230
Query: 394 DFVKRLLNKDPRKRLTAAQALSHPWI-KNS 422
+F+ LNKDP R TA + L H +I KN+
Sbjct: 231 EFIDACLNKDPSFRPTAKELLKHKFIVKNA 260
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 79/268 (29%), Positives = 125/268 (46%), Gaps = 14/268 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG CA + + G+ A K + K ++ E +IL + +V
Sbjct: 8 LGKGGFGEVCACQVRA---TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF-VV 63
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGK-YTEDDAKAVMIQILNVVAFCHLQGV 281
AYE D + +V+ + GG+L I + G + E+ A +IL + H +
Sbjct: 64 NLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENT 123
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYST 340
V+RDLKPEN L D+ ++ D GL+ + E + VG+ Y+APEVL ++ Y+
Sbjct: 124 VYRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTL 180
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W +G + Y ++ G PF R E V + +E S EA+ K LL
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLL 240
Query: 401 NKDPRKRL-----TAAQALSHPWIKNSN 423
KDP++RL A + HP+ +N N
Sbjct: 241 TKDPKQRLGCQEEGAGEVKRHPFFRNMN 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-24
Identities = 87/301 (28%), Positives = 142/301 (47%), Gaps = 47/301 (15%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIP----KHKMTTAIAIE-DVRREV 209
N+YE+ +++G G FG K K+ + + K I K + + + IE +V RE+
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQ---EFFCWKAISYRGLKEREKSQLVIEVNVMREL 69
Query: 210 KILRALTGHNNLVKFFDAYEDTDN--VYVVMELCEGGEL---LDRILSRGGKYTEDDAKA 264
K H N+V++ D + + N +Y++ME C+ G+L + + GK E
Sbjct: 70 K-------HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVD 122
Query: 265 VMIQILNVVAFCHL-------QGVVHRDLKPENFLFTTK--------------DENSVLK 303
+ Q+L+ +A+CH + V+HRDLKP+N +T + + K
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 304 AIDFGLSDFVRPDERLNDIVGSAYYVAPEVL---HRSYSTEADVWSIGVIAYILLCGSRP 360
DFGLS + + + VG+ YY +PE+L +SY ++D+W++G I Y L G P
Sbjct: 183 IGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
Query: 361 FWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
F + LK P + P S E +K LLN ++R +A Q L + IK
Sbjct: 243 FHKANNFSQLISELKRGP---DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIK 299
Query: 421 N 421
N
Sbjct: 300 N 300
|
Length = 1021 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 88/304 (28%), Positives = 140/304 (46%), Gaps = 58/304 (19%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG FG + K G A+K + K +M + VR E IL A + +V
Sbjct: 9 IGRGAFGEVRLVQKKD---TGHIYAMKKLRKSEMLEKEQVAHVRAERDIL-AEADNPWVV 64
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
K + +++D + +Y++ME GG+++ +L + +TE++ + + + + + H G +
Sbjct: 65 KLYYSFQDENYLYLIMEYLPGGDMMT-LLMKKDTFTEEETRFYIAETILAIDSIHKLGYI 123
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL---------SDFVR------PDERLNDI----- 322
HRD+KP+N L D +K DFGL ++F R P L+ I
Sbjct: 124 HRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180
Query: 323 -------------------VGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFW 362
VG+ Y+APEV ++ Y+ E D WS+GVI Y +L G PF
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240
Query: 363 ARTESGIFRAVL--KADPSF-DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQA---LSH 416
+ +R ++ K F DE P LS EA+D +KRL + +RL SH
Sbjct: 241 SDNPQETYRKIINWKETLQFPDEVP---LSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296
Query: 417 PWIK 420
P+ K
Sbjct: 297 PFFK 300
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 81/284 (28%), Positives = 131/284 (46%), Gaps = 39/284 (13%)
Query: 156 KYELGEE-----VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
+YE E +G+G +G AA+ ++ ++A+K IP+ ++ + E+
Sbjct: 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQV---RIAIKEIPERDSRY---VQPLHEEIA 57
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGG--KYTEDDAKAVMIQ 268
+ L H N+V++ + + + ME GG L + S+ G K E Q
Sbjct: 58 LHSYLK-HRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ 116
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI------ 322
IL + + H +VHRD+K +N L T + V+K DFG S +RL I
Sbjct: 117 ILEGLKYLHDNQIVHRDIKGDNVLVNTY--SGVVKISDFGTS------KRLAGINPCTET 168
Query: 323 -VGSAYYVAPEVLH---RSYSTEADVWSIGVIAYILLCGSRPFW--ARTESGIFR-AVLK 375
G+ Y+APEV+ R Y AD+WS+G + G PF ++ +F+ + K
Sbjct: 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK 228
Query: 376 ADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
P E SLS+EA++F+ R DP KR +A L P++
Sbjct: 229 IHPEIPE----SLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 82/305 (26%), Positives = 128/305 (41%), Gaps = 49/305 (16%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+K+++ ++G G +G A+ K G+ VA+K + I +R E+KILR
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDK---DTGELVALKKVRLDNEKEGFPITAIR-EIKILRQ 62
Query: 215 LTGHNNLVKF----------FDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKA 264
L H N+V D +D Y+V E + +L+ + S ++ED K+
Sbjct: 63 LN-HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKS 120
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER--LNDI 322
M Q+L + +CH + +HRD+K N L K + +K DFGL+ +E +
Sbjct: 121 FMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ---IKLADFGLARLYNSEESRPYTNK 177
Query: 323 VGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 380
V + +Y PE+L Y DVWS G I L F A E + + S
Sbjct: 178 VITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP 237
Query: 381 DEAPWPS--------------------------LSSEARDFVKRLLNKDPRKRLTAAQAL 414
A WP + + A D + +L DP KR TA +AL
Sbjct: 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEAL 297
Query: 415 SHPWI 419
+ PW+
Sbjct: 298 NSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 8e-24
Identities = 94/324 (29%), Positives = 138/324 (42%), Gaps = 70/324 (21%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI--PKHKMT----TAIAIEDVRREV 209
KYE+ +GRG +G AK K G+ G++ A+K K + T +A RE+
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGK-DGKEYAIKKFKGDKEQYTGISQSAC------REI 53
Query: 210 KILRALTGHNNLVKFFDAY-EDTD-NVYVVMELCEGGELLDRI----LSRGGKYTEDDAK 263
+LR L H N+V + + E D +VY++ + E +L I ++ K
Sbjct: 54 ALLRELK-HENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVK 111
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFT-TKDENSVLKAIDFGLSDFV----RPDER 318
+++ QILN V + H V+HRDLKP N L E V+K D GL+ +P
Sbjct: 112 SLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD 171
Query: 319 LNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTES--------- 367
L+ +V + +Y APE+L R Y+ D+W+IG I LL F R
Sbjct: 172 LDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR 231
Query: 368 ----GIFR-------------------AVLKADPSFDEAPWPSL----------SSEARD 394
IF L D P SL S+ D
Sbjct: 232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFD 291
Query: 395 FVKRLLNKDPRKRLTAAQALSHPW 418
+++LL DP KR+TA +AL HP+
Sbjct: 292 LLRKLLEYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 69/220 (31%), Positives = 109/220 (49%), Gaps = 34/220 (15%)
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
+V F+ A+ VY+ ME + G L D++ + GG TE + V+ +I V ++G
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYA-GGVATEGIPEDVLRRITYAV----VKG 114
Query: 281 ---------VVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVA 330
++HRD+KP N L + +K DFG+S + V + N +G Y+A
Sbjct: 115 LKFLKEEHNIIHRDVKPTNVLVNGNGQ---VKLCDFGVSGNLVASLAKTN--IGCQSYMA 169
Query: 331 PEVLHR-------SYSTEADVWSIGVIAYILLCGSRPFWARTESGIF---RAVLKADPSF 380
PE + +Y+ ++DVWS+G+ + G P+ T + IF A++ DP
Sbjct: 170 PERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP- 228
Query: 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
P S +A+DFV + LNK P +R T AQ L HPW+
Sbjct: 229 -TLP-SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLV 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 76/262 (29%), Positives = 136/262 (51%), Gaps = 18/262 (6%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQV-AVKVIPKHKMTTAIAIEDVRREVKILRALTGHN 219
E++G+G FG FK + + Q+V A+K+I + I ED+++E+ +L +
Sbjct: 10 EKIGKGSFGEV----FKGIDNRTQKVVAIKIIDLEEAEDEI--EDIQQEITVL-SQCDSP 62
Query: 220 NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
+ K++ +Y ++++ME GG LD L G E ++ +IL + + H +
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALD--LLEPGPLDETQIATILREILKGLDYLHSE 120
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLHRS- 337
+HRD+K N L + E+ +K DFG++ + + + N VG+ +++APEV+ +S
Sbjct: 121 KKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 338 YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397
Y ++AD+WS+G+ A L G P + + K +P E + S ++FV+
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNY---SKPLKEFVE 234
Query: 398 RLLNKDPRKRLTAAQALSHPWI 419
LNK+P R TA + L H +I
Sbjct: 235 ACLNKEPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 88/300 (29%), Positives = 136/300 (45%), Gaps = 49/300 (16%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
E +G G FG + + G++VA+K +P + ++ + V RE+K+L
Sbjct: 3 EPDRPIGYGAFGVVWSVTDPR---DGKRVALKKMP-NVFQNLVSCKRVFRELKMLCFFK- 57
Query: 218 HNNLVKFFDAYEDTD-----NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
H+N++ D + +YVV EL + L +I+ + D K + QIL
Sbjct: 58 HDNVLSALDILQPPHIDPFEEIYVVTELMQSD--LHKIIVSPQPLSSDHVKVFLYQILRG 115
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI--VGSAYYVA 330
+ + H G++HRD+KP N L + N VLK DFGL+ PDE + V + YY A
Sbjct: 116 LKYLHSAGILHRDIKPGNLLVNS---NCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172
Query: 331 PEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWART----------------------- 365
PE+L R Y++ D+WS+G I LL F A++
Sbjct: 173 PEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232
Query: 366 ----ESGIFRAVLKADPSFDEAPWPS--LSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
+ I R K PS S + EA + R+L DP KR++AA AL+HP++
Sbjct: 233 CEGARAHILRGPHKP-PSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYL 291
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 75/262 (28%), Positives = 134/262 (51%), Gaps = 18/262 (6%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQV-AVKVIPKHKMTTAIAIEDVRREVKILRALTGHN 219
E +G+G FG +K + + ++V A+K+I + I ED+++E+ +L +
Sbjct: 10 ERIGKGSFGEV----YKGIDNRTKEVVAIKIIDLEEAEDEI--EDIQQEITVL-SQCDSP 62
Query: 220 NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
+ +++ +Y ++++ME GG LD L + G E ++ +IL + + H +
Sbjct: 63 YITRYYGSYLKGTKLWIIMEYLGGGSALD--LLKPGPLEETYIATILREILKGLDYLHSE 120
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLHRS- 337
+HRD+K N L + E +K DFG++ + + + N VG+ +++APEV+ +S
Sbjct: 121 RKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 338 YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397
Y +AD+WS+G+ A L G P + + K P E + S ++FV+
Sbjct: 178 YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQY---SKPFKEFVE 234
Query: 398 RLLNKDPRKRLTAAQALSHPWI 419
LNKDPR R TA + L H +I
Sbjct: 235 ACLNKDPRFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 69/255 (27%), Positives = 124/255 (48%), Gaps = 20/255 (7%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG + + KK + Q A+KV+ K + I+ V+ E + + + LV
Sbjct: 3 IGRGSYAKVLLVRLKKND---QIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLV 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
++ T +++V+E GG+L+ + R K E+ A+ +I + F H +G++
Sbjct: 60 GLHSCFQTTSRLFLVIEYVNGGDLMFH-MQRQRKLPEEHARFYAAEICIALNFLHERGII 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLH-RSYST 340
+RDLK +N L D + +K D+G+ + + P + + G+ Y+APE+L Y
Sbjct: 119 YRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGF 175
Query: 341 EADVWSIGVIAYILLCGSRPF-------WARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393
D W++GV+ + ++ G PF TE +F+ +L+ LS +A
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR----FLSVKAS 231
Query: 394 DFVKRLLNKDPRKRL 408
+K LNKDP++RL
Sbjct: 232 HVLKGFLNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 3e-23
Identities = 84/277 (30%), Positives = 134/277 (48%), Gaps = 35/277 (12%)
Query: 157 YELGEEVGRGHFGYTCAAK-FKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+EL + +G G +G A+ GEL A+KVI K+ V++E+ +++
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGEL----AAIKVI---KLEPGEDFAVVQQEIIMMKDC 63
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H+N+V +F +Y D +++ ME C GG L D I G +E V + L + +
Sbjct: 64 K-HSNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYY 121
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAPEV- 333
H +G +HRD+K N L T +N +K DFG+S + + +G+ Y++APEV
Sbjct: 122 LHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVA 178
Query: 334 -LHRS--YSTEADVWSIGVIAYIL---------LCGSRPFWARTESGIFRAVLKADPSFD 381
+ R Y+ D+W++G+ A L L R + T+S LK D
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLK-----D 233
Query: 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
+ W S+ FVK L K+P+KR TA + L HP+
Sbjct: 234 KMKW---SNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 3e-23
Identities = 68/239 (28%), Positives = 117/239 (48%), Gaps = 13/239 (5%)
Query: 183 GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCE 242
Q A+K + M+ ED E++IL ++ H N++ + +A+ D + + +VME
Sbjct: 25 NQFYALKEVDLGSMSQK-EREDAVNEIRILASVN-HPNIISYKEAFLDGNKLCIVMEYAP 82
Query: 243 GGELLDRILSRGGK---YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN 299
G+L I R K E + + IQ+L + H Q ++HRDLK N L N
Sbjct: 83 FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV---AN 139
Query: 300 SVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGS 358
++K D G+S V +G+ +Y+APEV R YS ++D+WS+G + Y + +
Sbjct: 140 DLVKIGDLGISK-VLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
Query: 359 RPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHP 417
PF AR+ + V + + P P S + ++F++ +L P+ R + L+ P
Sbjct: 199 PPFEARSMQDLRYKVQRG--KYPPIP-PIYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 88/299 (29%), Positives = 131/299 (43%), Gaps = 51/299 (17%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK-ILR 213
N E E+G G G +FKK G +AVK + + + E K IL
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKK---TGHVMAVKQMRR---------TGNKEENKRILM 62
Query: 214 AL----TGHN--NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVM 266
L H+ +VK + + +V++ MEL LD++L R G ED +
Sbjct: 63 DLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMT 120
Query: 267 IQILNVVAFCHL---QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323
+ I+ A +L GV+HRD+KP N L D + +K DFG+S + +
Sbjct: 121 VAIVK--ALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSKAKTRSA 175
Query: 324 GSAYYVAPEVL-----HRSYSTEADVWSIGVIAYILLCGSRPF-WARTESGIFRAVLKAD 377
G A Y+APE + + Y ADVWS+G+ L G P+ +TE + +L+ +
Sbjct: 176 GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE 235
Query: 378 PSFDEAPWPSL------SSEARDFVKRLLNKDPRKRLTAAQALSHPWIK--NSNDVKVP 428
P PSL S + FV L KD RKR + L HP+I+ + +V V
Sbjct: 236 P-------PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEVDVA 287
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 97/353 (27%), Positives = 157/353 (44%), Gaps = 49/353 (13%)
Query: 85 SSPARSSANSTPNRFFKRP---FPPPSPAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAA 141
++ ++T +R +RP P P + L S + ++ S P+A
Sbjct: 10 VPLPSTARHTTKSRPRRRPDLTLPLPQRDPSLAVPLPLPPPSSSSSSSSSSSASGSAPSA 69
Query: 142 GLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI-PKHKMTTAI 200
+ S + E +G G G + G+ A+KVI H+ T
Sbjct: 70 AKSLS---------ELERVNRIGSGAGGTVYKVIHRP---TGRLYALKVIYGNHEDTVRR 117
Query: 201 AIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTED 260
I RE++ILR + H N+VK D ++ + V++E +GG L ++ + D
Sbjct: 118 QIC---REIEILRDVN-HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQ-FLAD 172
Query: 261 DAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV-RPDERL 319
A+ QIL+ +A+ H + +VHRD+KP N L + +K DFG+S + + +
Sbjct: 173 VAR----QILSGIAYLHRRHIVHRDIKPSNLLINSAKN---VKIADFGVSRILAQTMDPC 225
Query: 320 NDIVGSAYYVAPEVL-----HRSYSTEA-DVWSIGVIAYILLCGSRPF-------WARTE 366
N VG+ Y++PE + H +Y A D+WS+GV G PF WA
Sbjct: 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWA--- 282
Query: 367 SGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
+ A+ + P EAP + S E R F+ L ++P KR +A Q L HP+I
Sbjct: 283 -SLMCAICMSQPP--EAP-ATASREFRHFISCCLQREPAKRWSAMQLLQHPFI 331
|
Length = 353 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 6e-23
Identities = 68/270 (25%), Positives = 120/270 (44%), Gaps = 21/270 (7%)
Query: 160 GEEVGRGHFGYTC--AAKFKKGELKGQQVAVKVIPKHKMTTA---IAIEDVRREVKILRA 214
G+++G G F +C A K G L +AVK + + T++ +E +R+E++++
Sbjct: 5 GQQLGTGAFS-SCYQARDVKTGTL----MAVKQVTYVRNTSSEQEEVVEALRKEIRLMAR 59
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L H ++++ A + + + +E GG + +LS+ G + E Q+L ++
Sbjct: 60 LN-HPHIIRMLGATCEDSHFNLFVEWMAGGSV-SHLLSKYGAFKEAVIINYTEQLLRGLS 117
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL-----SDFVRPDERLNDIVGSAYYV 329
+ H ++HRD+K N L + + L+ DFG + E ++G+ ++
Sbjct: 118 YLHENQIIHRDVKGANLLIDSTGQR--LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 330 APEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS- 387
APEVL Y DVWS+G + + P+ A S + K + P
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEH 235
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHP 417
LS RD R L P R + + L HP
Sbjct: 236 LSPGLRDVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 92/312 (29%), Positives = 138/312 (44%), Gaps = 63/312 (20%)
Query: 163 VGRGHFGYTC-AAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
+G G FG C A K L A+K + K + + V+ E IL A + +
Sbjct: 9 LGIGAFGEVCLARKVDTKAL----YAMKTLRKKDVLLRNQVAHVKAERDIL-AEADNEWV 63
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
V+ + +++D DN+Y VM+ GG+++ +L R G + ED A+ + ++ V H G
Sbjct: 64 VRLYYSFQDKDNLYFVMDYIPGGDMMS-LLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGL---------------SDFVRPD---------- 316
+HRD+KP+N L D + +K DFGL D VR D
Sbjct: 123 IHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179
Query: 317 -------ERL----------------NDIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAY 352
+RL + +VG+ Y+APEVL R+ Y+ D WS+GVI Y
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239
Query: 353 ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL---T 409
+L G PF A+T V+ S P LS EA D + +L + P RL
Sbjct: 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNG 298
Query: 410 AAQALSHPWIKN 421
A + +HP+ K
Sbjct: 299 ADEIKAHPFFKT 310
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 1e-22
Identities = 74/276 (26%), Positives = 129/276 (46%), Gaps = 28/276 (10%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG + + KK E + A+KV+ K + I+ V+ E + + H LV
Sbjct: 3 IGRGSYAKVLLVRLKKTE---RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
++ ++ V+E GG+L+ + R K E+ A+ +I + + H +G++
Sbjct: 60 GLHSCFQTESRLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALNYLHERGII 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLH-RSYST 340
+RDLK +N L D +K D+G+ + +RP + + G+ Y+APE+L Y
Sbjct: 119 YRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 175
Query: 341 EADVWSIGVIAYILLCGSRPF---------WARTESGIFRAVLKADPSFDEAPWPSLSSE 391
D W++GV+ + ++ G PF TE +F+ +L+ SLS +
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVK 231
Query: 392 ARDFVKRLLNKDPRKRLTA------AQALSHPWIKN 421
A +K LNKDP++RL A HP+ +N
Sbjct: 232 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 87/318 (27%), Positives = 143/318 (44%), Gaps = 71/318 (22%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR------REV 209
KY + +GRG +G C+AK ++VA+K I A ++ RE+
Sbjct: 6 KYVPIKPIGRGAYGIVCSAK---NSETNEKVAIKKIAN-------AFDNRIDAKRTLREI 55
Query: 210 KILRALTGHNNLVKFFD--------AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDD 261
K+LR L H N++ D A+ D VY+V EL + L +I+ ++D
Sbjct: 56 KLLRHLD-HENVIAIKDIMPPPHREAFND---VYIVYELMDTD--LHQIIRSSQTLSDDH 109
Query: 262 AKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP----DE 317
+ + Q+L + + H V+HRDLKP N L + N LK DFGL+ R +
Sbjct: 110 CQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLA---RTTSEKGD 163
Query: 318 RLNDIVGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTE--------- 366
+ + V + +Y APE+L Y+T DVWS+G I LL G +P + +
Sbjct: 164 FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPGKDYVHQLKLIT 222
Query: 367 ---------------SGIFRAVLKADPSFDEAP----WPSLSSEARDFVKRLLNKDPRKR 407
+ R +++ P +P + A D ++++L DP KR
Sbjct: 223 ELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKR 282
Query: 408 LTAAQALSHPWIKNSNDV 425
+T +AL+HP++ + +D
Sbjct: 283 ITVEEALAHPYLASLHDP 300
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 71/263 (26%), Positives = 131/263 (49%), Gaps = 26/263 (9%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+++ +++GRG F A L + VA+K + +M A A +D +E+ +L+ L
Sbjct: 4 FQIEKKIGRGQFSEVYRATC---LLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV--------MIQ 268
H N++K+ D++ + + + +V+EL + G+L I KY + + + +Q
Sbjct: 61 -HPNVIKYLDSFIEDNELNIVLELADAGDLSQMI-----KYFKKQKRLIPERTVWKYFVQ 114
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER-LNDIVGSAY 327
+ + V H + V+HRD+KP N T V+K D GL F + +VG+ Y
Sbjct: 115 LCSAVEHMHSRRVMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 171
Query: 328 YVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386
Y++PE +H + Y+ ++D+WS+G + Y + PF+ + +F K + D P P
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLFSLCQKIEQC-DYPPLP 229
Query: 387 S--LSSEARDFVKRLLNKDPRKR 407
+ S + R+ V + DP +R
Sbjct: 230 TEHYSEKLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 2e-22
Identities = 85/308 (27%), Positives = 140/308 (45%), Gaps = 56/308 (18%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+Y+ VG G +G CAA K L+ VAVK + + + I + RE+++L+ +
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKKLSR-PFQSIIHAKRTYRELRLLKHM 73
Query: 216 TGHNNLVKFFDAY------EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
H N++ D + E+ ++VY+V L G L+ I+ + K T+D + ++ QI
Sbjct: 74 K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV-KCQKLTDDHVQFLIYQI 129
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
L + + H ++HRDLKP N +E+ LK +DFGL+ D+ + V + +Y
Sbjct: 130 LRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHT--DDEMTGYVATRWYR 184
Query: 330 APEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
APE++ Y+ D+WS+G I LL G F + +L+ P
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR----LVGTPGAE 240
Query: 388 L-----SSEAR--------------------------DFVKRLLNKDPRKRLTAAQALSH 416
L S AR D ++++L D KR+TAAQAL+H
Sbjct: 241 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300
Query: 417 PWIKNSND 424
+ +D
Sbjct: 301 AYFAQYHD 308
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-22
Identities = 72/259 (27%), Positives = 126/259 (48%), Gaps = 18/259 (6%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ + +++GRG F A L G VA+K + + A A D +E+ +L+ L
Sbjct: 4 FRIEKKIGRGQFSEVYRATCL---LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYT----EDDAKAVMIQILNV 272
H N++K++ ++ + + + +V+EL + G+L R++ K E +Q+ +
Sbjct: 61 -HPNVIKYYASFIEDNELNIVLELADAGDL-SRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER-LNDIVGSAYYVAP 331
+ H + V+HRD+KP N T V+K D GL F + +VG+ YY++P
Sbjct: 119 LEHMHSRRVMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 332 EVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS--L 388
E +H + Y+ ++D+WS+G + Y + PF+ + ++ K D P PS
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHY 233
Query: 389 SSEARDFVKRLLNKDPRKR 407
S E R V +N DP KR
Sbjct: 234 SEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 2e-22
Identities = 80/277 (28%), Positives = 123/277 (44%), Gaps = 21/277 (7%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
E+G G FG A F + VAVK + T +D+ +EVK L+ L H N
Sbjct: 28 EIGHGSFG---AVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNT 83
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
+++ Y ++VME C G D + E + A+ L +A+ H +
Sbjct: 84 IEYKGCYLKEHTAWLVMEYCLGSAS-DLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 142
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL----HRS 337
+HRD+K N L T E +K DFG + P N VG+ Y++APEV+
Sbjct: 143 IHRDIKAGNILLT---EPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAMDEGQ 196
Query: 338 YSTEADVWSIGVIAYILLCGSRP--FWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395
Y + DVWS+G I I L +P F S ++ P+ W + R F
Sbjct: 197 YDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW---TDSFRGF 252
Query: 396 VKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVI 432
V L K P++R +A+ L H +++ +V +D+I
Sbjct: 253 VDYCLQKIPQERPASAELLRHDFVRRDRPARVLIDLI 289
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 70/261 (26%), Positives = 113/261 (43%), Gaps = 55/261 (21%)
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
RE+KI+ + H N++ D Y + D + +VM++ L +++ R + TE K ++
Sbjct: 69 RELKIMNEIK-HENIMGLVDVYVEGDFINLVMDIMASD--LKKVVDRKIRLTESQVKCIL 125
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS---------------D 311
+QILN + H +HRDL P N +K + K DFGL+ +
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFINSK---GICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 312 FVRPDERLNDIVGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTE--- 366
++ E + V + +Y APE+L + Y D+WS+G I LL G F E
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ 242
Query: 367 -SGIFRAVLKADPSFDEAPWPSL------------------------SSEARDFVKRLLN 401
IF L P+ E WP S +A D ++ LL
Sbjct: 243 LGRIFE--LLGTPN--EDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLK 298
Query: 402 KDPRKRLTAAQALSHPWIKNS 422
+P +R++A +AL H + K+
Sbjct: 299 LNPLERISAKEALKHEYFKSD 319
|
Length = 335 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 81/269 (30%), Positives = 127/269 (47%), Gaps = 16/269 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG CA + K G+ A K + K ++ + E KIL +V
Sbjct: 1 LGKGGFGEVCACQVKA---TGKMYACKKLDKKRLKKRKGEQMALNEKKIL-EKVSSRFIV 56
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGK-YTEDDAKAVMIQILNVVAFCHLQGV 281
A+E D++ +VM L GG+L I + G + E A QI+ + H + +
Sbjct: 57 SLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRI 116
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS-YST 340
V+RDLKPEN L D++ ++ D GL+ ++ +++ G+ Y+APEVL Y
Sbjct: 117 VYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDF 173
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP-SLSSEARDFVKRL 399
D +++G Y ++ G PF R E + + LK +P S EA+D + L
Sbjct: 174 SVDWFALGCTLYEMIAGRSPFRQRKEK-VEKEELKRRTLEMAVEYPDKFSPEAKDLCEAL 232
Query: 400 LNKDPRKRL-----TAAQALSHPWIKNSN 423
L KDP KRL +A + HP K+ N
Sbjct: 233 LQKDPEKRLGCRGGSADEVREHPLFKDLN 261
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 2e-22
Identities = 74/250 (29%), Positives = 116/250 (46%), Gaps = 13/250 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG AK K G AVKV+ K + + E +L H LV
Sbjct: 3 IGKGSFGKVLLAKRKS---DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+++ + +Y V++ GGEL L R + E A+ ++ + + + H ++
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFH-LQRERCFLEPRARFYAAEVASAIGYLHSLNII 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLHRS-YST 340
+RDLKPEN L D + DFGL + V P+E + G+ Y+APEVL + Y
Sbjct: 119 YRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W +G + Y +L G PF++R S ++ +L + A D + LL
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLL 231
Query: 401 NKDPRKRLTA 410
+KD R+RL A
Sbjct: 232 HKDQRRRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-22
Identities = 74/268 (27%), Positives = 131/268 (48%), Gaps = 29/268 (10%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIED--VRREVKILRALTGHNN 220
VG+G +G + + G+Q VI K + A E +E ++L L H N
Sbjct: 8 VGKGSYGEVSLVRHRT---DGKQY---VIKKLNLRNASRRERKAAEQEAQLLSQLK-HPN 60
Query: 221 LVKFFDAYEDTDN-VYVVMELCEGGELLDRILSRGGK-YTEDDAKAVMIQILNVVAFCHL 278
+V + +++E D +Y+VM CEGG+L ++ + GK E+ +QI + + H
Sbjct: 61 IVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE 120
Query: 279 QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND----IVGSAYYVAPEVL 334
+ ++HRDLK +N T +++K D G++ R E D ++G+ YY++PE+
Sbjct: 121 KHILHRDLKTQNVFLT---RTNIIKVGDLGIA---RVLENQCDMASTLIGTPYYMSPELF 174
Query: 335 -HRSYSTEADVWSIGVIAYILLCGSRPFWAR-TESGIFRAVLKADPSFDEAPWPS-LSSE 391
++ Y+ ++DVW++G Y + F A+ S ++R + P P P S E
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP-----PMPKDYSPE 229
Query: 392 ARDFVKRLLNKDPRKRLTAAQALSHPWI 419
+ + +L+K P KR + L P+I
Sbjct: 230 LGELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 3e-22
Identities = 84/307 (27%), Positives = 143/307 (46%), Gaps = 53/307 (17%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+Y ++VG G +G C+A K+ G++VA+K + + + I + RE+ +L+ +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKR---TGEKVAIKKLSR-PFQSEIFAKRAYRELTLLKHM 71
Query: 216 TGHNNLVKFFD------AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
H N++ D + ++ + Y+VM + L +I G +ED + ++ Q+
Sbjct: 72 Q-HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKI--MGHPLSEDKVQYLVYQM 126
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
L + + H G++HRDLKP N +E+ LK +DFGL+ D + V + +Y
Sbjct: 127 LCGLKYIHSAGIIHRDLKPGNL---AVNEDCELKILDFGLAR--HADAEMTGYVVTRWYR 181
Query: 330 APEV----LHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD----PSF- 380
APEV +H Y+ D+WS+G I +L G F + +LK P F
Sbjct: 182 APEVILNWMH--YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239
Query: 381 ----DEAP------------------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
D+A +P S +A D ++++L D KRLTA +AL HP+
Sbjct: 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPY 299
Query: 419 IKNSNDV 425
+ D
Sbjct: 300 FDSFRDA 306
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 4e-22
Identities = 77/224 (34%), Positives = 115/224 (51%), Gaps = 18/224 (8%)
Query: 206 RREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGK---YTEDDA 262
R E+ L A H +VK FD ++ D + ++ME GG+L +I R + + E +
Sbjct: 113 RSELHCLAACD-HFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEV 171
Query: 263 KAVMIQILNVVAFCHLQGVVHRDLKPEN-FLFTTKDENSVLKAIDFGLS----DFVRPDE 317
+ QI+ + H + ++HRDLK N FL T ++K DFG S D V D
Sbjct: 172 GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT----GIIKLGDFGFSKQYSDSVSLDV 227
Query: 318 RLNDIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 376
+ G+ YY+APE+ R YS +AD+WS+GVI Y LL RPF ++ I + VL
Sbjct: 228 A-SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG 286
Query: 377 DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
+D P P +SS + + LL+K+P R T Q L ++K
Sbjct: 287 K--YDPFPCP-VSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 4e-22
Identities = 71/254 (27%), Positives = 122/254 (48%), Gaps = 18/254 (7%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+ + +GRG FG K K + + A+K++ K +M R E +L +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNAD---KVFAMKILNKWEMLKRAETACFREERDVL--VN 57
Query: 217 GHNNLVKFFD-AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
G N + A++D +N+Y+VM+ GG+LL + + ED A+ + +++ +
Sbjct: 58 GDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDS 117
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND--IVGSAYYVAPEV 333
H VHRD+KP+N L D N ++ DFG + D + VG+ Y++PE+
Sbjct: 118 VHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 174
Query: 334 LHR------SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD-EAPWP 386
L Y E D WS+GV Y +L G PF+A + + ++ F A
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVT 234
Query: 387 SLSSEARDFVKRLL 400
+S +A+D ++RL+
Sbjct: 235 DVSEDAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 6e-22
Identities = 77/272 (28%), Positives = 125/272 (45%), Gaps = 22/272 (8%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG CA + + G+ A K + K ++ E +IL + +V
Sbjct: 8 LGKGGFGEVCACQVR---ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF-VV 63
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGV 281
AYE D + +V+ L GG+L I + G + E+ A +I + H + +
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERI 123
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYST 340
V+RDLKPEN L D+ ++ D GL+ + E + VG+ Y+APEV+ + Y+
Sbjct: 124 VYRDLKPENILL---DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTF 180
Query: 341 EADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSFDEAPWPSLSSEARDFV 396
D W +G + Y ++ G PF R E + R V + + E S AR
Sbjct: 181 SPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSE----KFSEAARSIC 236
Query: 397 KRLLNKDPRKRL-----TAAQALSHPWIKNSN 423
++LL KDP RL A + +HP+ + +N
Sbjct: 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRTAN 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 8e-22
Identities = 73/257 (28%), Positives = 122/257 (47%), Gaps = 23/257 (8%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG A+ K + A+K++ K + +E E ++L L
Sbjct: 8 LGKGSFGKVMLAERKG---TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLT 64
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ ++ D +Y VME GG+L+ I + GK+ E A +I + F H +G++
Sbjct: 65 QLHSCFQTVDRLYFVMEYVNGGDLMYHI-QQVGKFKEPQAVFYAAEISVGLFFLHRRGII 123
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV------GSAYYVAPEVL-H 335
+RDLK +N + D +K DFG+ E + D V G+ Y+APE++ +
Sbjct: 124 YRDLKLDNVML---DSEGHIKIADFGMCK-----EHMVDGVTTRTFCGTPDYIAPEIIAY 175
Query: 336 RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395
+ Y D W+ GV+ Y +L G PF E +F+++++ + S+ + SLS EA
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSI 231
Query: 396 VKRLLNKDPRKRLTAAQ 412
K L+ K P KRL
Sbjct: 232 CKGLMTKHPSKRLGCGP 248
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 8e-22
Identities = 71/266 (26%), Positives = 127/266 (47%), Gaps = 17/266 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG + K+ + A+K I K + + + E +L A +V
Sbjct: 1 IGKGSFGKVMQVR-KRDTQR--IYALKTIRKAHIVSRSEVTHTLAERTVL-AQVNCPFIV 56
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+++ + +Y+V+ GGEL L R G++ A+ ++L + H V+
Sbjct: 57 PLKFSFQSPEKLYLVLAFINGGELFHH-LQREGRFDLSRARFYTAELLCALENLHKFNVI 115
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDF-VRPDERLNDIVGSAYYVAPEVLH-RSYST 340
+RDLKPEN L D + DFGL ++ D++ N G+ Y+APE+L Y+
Sbjct: 116 YRDLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTK 172
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W++GV+ Y +L G PF+ + ++R +L+ F + +A+D + LL
Sbjct: 173 AVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD----GFDRDAKDLLIGLL 228
Query: 401 NKDPRKRL---TAAQALSHPWIKNSN 423
++DP +RL A + +HP+ +
Sbjct: 229 SRDPTRRLGYNGAQEIKNHPFFSQLS 254
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 8e-22
Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 20/222 (9%)
Query: 159 LGEEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+E+G G FG G+ +G+ VA+K+I + M+ +D E K++ L+
Sbjct: 8 FLKELGSGQFGVV-----HLGKWRGKIDVAIKMIREGAMSE----DDFIEEAKVMMKLS- 57
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H NLV+ + +++V E G LL+ + R GK + + + + +
Sbjct: 58 HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE 117
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV---APEVL 334
G +HRDL N L E++V+K DFGL+ +V D+ + G+ + V PEV
Sbjct: 118 SNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQYTSS-QGTKFPVKWAPPEVF 173
Query: 335 HRS-YSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVL 374
S +S+++DVWS GV+ + + G P+ + S + +V
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS 215
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 8e-22
Identities = 82/275 (29%), Positives = 132/275 (48%), Gaps = 35/275 (12%)
Query: 157 YELGEEVGRGHFGYTCAA-KFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
YEL + VG G +G A GEL AVK+I K+ +++E+ +++
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGEL----AAVKII---KLEPGDDFSLIQQEIFMVKEC 63
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N+V +F +Y + +++ ME C GG L D I G +E V + L +A+
Sbjct: 64 K-HCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAY 121
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAPEVL 334
H +G +HRD+K N L T +N +K DFG++ + + +G+ Y++APEV
Sbjct: 122 LHSKGKMHRDIKGANILLT---DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVA 178
Query: 335 ----HRSYSTEADVWSIGVIAYIL---------LCGSRPFWARTESGIFRAVLKADPSFD 381
+ Y+ D+W++G+ A L L R + ++S LK D
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLK-----D 233
Query: 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416
+ W SS +FVK L K+P+KR TA + L+H
Sbjct: 234 KTKW---SSTFHNFVKISLTKNPKKRPTAERLLTH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 1e-21
Identities = 84/310 (27%), Positives = 136/310 (43%), Gaps = 51/310 (16%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+Y++ E +G+G +G C+A G++VA+K I + A + RE+K+LR L
Sbjct: 1 RYKIQEVIGKGSYGVVCSAI---DTHTGEKVAIKKINDVFEHVSDATR-ILREIKLLRLL 56
Query: 216 TGHNNLVKFFD-----AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQIL 270
H ++V+ + + ++YVV EL E L +++ T + + + Q+L
Sbjct: 57 R-HPDIVEIKHIMLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHHQFFLYQLL 113
Query: 271 NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER----LNDIVGSA 326
+ + H V HRDLKP+N L + + LK DFGL+ D D V +
Sbjct: 114 RALKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 327 YYVAPEV---LHRSYSTEADVWSIGVIAYILLCGSRPFW--------------------- 362
+Y APE+ Y+ D+WSIG I +L G +P +
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLITDLLGTPSP 229
Query: 363 ---ARTESGIFRAVL----KADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+R + R L K P +P+ A ++RLL DP+ R TA +AL+
Sbjct: 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289
Query: 416 HPWIKNSNDV 425
P+ K V
Sbjct: 290 DPYFKGLAKV 299
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 2e-21
Identities = 73/263 (27%), Positives = 125/263 (47%), Gaps = 24/263 (9%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+ + +GRG FG K K E + A+K++ K +M R E +L +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTE---RIYAMKILNKWEMLKRAETACFREERNVL--VN 57
Query: 217 GHNNLVKFFD-AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
G + A++D + +Y+VM+ GG+LL + + ED A+ + +++ +
Sbjct: 58 GDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHS 117
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND--IVGSAYYVAPEV 333
H VHRD+KP+N L D N ++ DFG + D + VG+ Y++PE+
Sbjct: 118 IHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 334 LHR------SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
L Y E D WS+GV Y +L G PF+A + + ++ + F +PS
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FPS 231
Query: 388 ----LSSEARDFVKRLLNKDPRK 406
+S EA+D ++RL+ R+
Sbjct: 232 HITDVSEEAKDLIQRLICSRERR 254
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 87/308 (28%), Positives = 138/308 (44%), Gaps = 70/308 (22%)
Query: 157 YELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVI--------PKHKMTTAIAIEDVRR 207
Y+ +++G G + A +K + +L GQ VA+K I P TAI R
Sbjct: 7 YKKLDKLGEG----SYATVYKGRSKLTGQLVALKEIRLEHEEGAP----FTAI------R 52
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
E +L+ L H N+V D + +V E + +L + GG + + + +
Sbjct: 53 EASLLKDLK-HANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLF 110
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR----PDERLNDIV 323
Q+L +A+CH + V+HRDLKP+N L + + E LK DFGL+ R P + ++ V
Sbjct: 111 QLLRGLAYCHQRRVLHRDLKPQNLLISERGE---LKLADFGLA---RAKSVPSKTYSNEV 164
Query: 324 GSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESG-----IFRAVLKA 376
+ +Y P+VL S YST D+W +G I Y + G F T+ IFR VL
Sbjct: 165 VTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFR-VL-G 222
Query: 377 DPSFDEAP------------------------WPSLS--SEARDFVKRLLNKDPRKRLTA 410
P+ + P P L + + L +P+KR++A
Sbjct: 223 TPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISA 282
Query: 411 AQALSHPW 418
A+A+ HP+
Sbjct: 283 AEAMKHPY 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-21
Identities = 75/267 (28%), Positives = 123/267 (46%), Gaps = 17/267 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG AK K L G+ AVKV+ K + + + E +L H LV
Sbjct: 3 IGKGSFGKVLLAKRK---LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+++ T+ +Y V++ GGEL L R + E A+ +I + + + H +V
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGGELFFH-LQRERSFPEPRARFYAAEIASALGYLHSINIV 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLHRS-YST 340
+RDLKPEN L D + DFGL + + + G+ Y+APEV+ + Y
Sbjct: 119 YRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W +G + Y +L G PF+ R + ++ +L P S A ++ LL
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELL 231
Query: 401 NKDPRKRLTAAQAL----SHPWIKNSN 423
KD ++RL A + HP+ ++ +
Sbjct: 232 EKDRQRRLGAKEDFLEIQEHPFFESLS 258
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 3e-21
Identities = 76/276 (27%), Positives = 125/276 (45%), Gaps = 34/276 (12%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL---RALTGHN 219
+GRG FG + + + Q A+K++ K +M R + R + H
Sbjct: 51 IGRGAFG---EVQLVRHKSSKQVYAMKLLSKFEMIK-------RSDSAFFWEERDIMAHA 100
Query: 220 N---LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
N +V+ A++D +Y+VME GG+L++ L E A+ +++ +
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN--LMSNYDIPEKWARFYTAEVVLALDAI 158
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE----RLNDIVGSAYYVAPE 332
H G +HRD+KP+N L D++ LK DFG ++ D R + VG+ Y++PE
Sbjct: 159 HSMGFIHRDVKPDNMLL---DKSGHLKLADFGTC--MKMDANGMVRCDTAVGTPDYISPE 213
Query: 333 VL-----HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
VL Y E D WS+GV Y +L G PF+A + G + ++ S
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIE 273
Query: 388 LSSEARDFVKRLLNKDPRK--RLTAAQALSHPWIKN 421
+S +A+D + L + R + SHP+ KN
Sbjct: 274 ISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 3e-21
Identities = 75/276 (27%), Positives = 128/276 (46%), Gaps = 28/276 (10%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG + + KK + A+KVI K + I+ V+ E + + H LV
Sbjct: 3 IGRGSYAKVLLVELKKTR---RIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLV 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
++ ++ V+E GG+L+ + R K E+ A+ +I + F H +G++
Sbjct: 60 GLHSCFQTESRLFFVIEFVSGGDLMFH-MQRQRKLPEEHARFYSAEISLALNFLHERGII 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLH-RSYST 340
+RDLK +N L D +K D+G+ + +RP + + G+ Y+APE+L Y
Sbjct: 119 YRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGF 175
Query: 341 EADVWSIGVIAYILLCGSRPF---------WARTESGIFRAVLKADPSFDEAPWPSLSSE 391
D W++GV+ + ++ G PF TE +F+ +L+ SLS +
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR----SLSVK 231
Query: 392 ARDFVKRLLNKDPRKRLTA------AQALSHPWIKN 421
A +K LNKDP++RL SHP+ +N
Sbjct: 232 ASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 4e-21
Identities = 78/274 (28%), Positives = 135/274 (49%), Gaps = 24/274 (8%)
Query: 157 YELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ LG+ +G+G FG Y C EL +QV P+ T+ + + E+++L+
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFD--PESPETSK-EVNALECEIQLLKN 60
Query: 215 LTGHNNLVKFFDAYEDT--DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
L H +V+++ D + + ME GG + D++ S G TE+ + QIL
Sbjct: 61 LL-HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA-LTENVTRKYTRQILEG 118
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR----PDERLNDIVGSAYY 328
V++ H +VHRD+K N L +D +K DFG S ++ + + G+ Y+
Sbjct: 119 VSYLHSNMIVHRDIKGANIL---RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175
Query: 329 VAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE--SGIFRAVLKADPSFDEAPW 385
++PEV+ Y +AD+WS+G +L +P WA E + IF+ + P+ P
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLT-EKPPWAEFEAMAAIFK--IATQPTNPVLP- 231
Query: 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
P +S RDF+KR+ + + R +A + L H ++
Sbjct: 232 PHVSDHCRDFLKRIF-VEAKLRPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 5e-21
Identities = 73/254 (28%), Positives = 128/254 (50%), Gaps = 25/254 (9%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN-L 221
+G+G FG A+ K + + A+K++ K + +E E ++L AL+G L
Sbjct: 8 LGKGSFGKVMLAERKGTD---ELYAIKILKKDVVIQDDDVECTMVEKRVL-ALSGKPPFL 63
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
+ ++ D +Y VME GG+L+ +I + G++ E A +I + F H +G+
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYQI-QQVGRFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV------GSAYYVAPEVL- 334
++RDLK +N + D +K DFG+ E + D V G+ Y+APE++
Sbjct: 123 IYRDLKLDNVML---DSEGHIKIADFGMCK-----ENMWDGVTTKTFCGTPDYIAPEIIA 174
Query: 335 HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARD 394
++ Y D W+ GV+ Y +L G PF E +F+++++ + ++ + S+S EA
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVA 230
Query: 395 FVKRLLNKDPRKRL 408
K L+ K P KRL
Sbjct: 231 ICKGLMTKHPGKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 5e-21
Identities = 80/306 (26%), Positives = 145/306 (47%), Gaps = 48/306 (15%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+Y ++VG G +G C+A ++ G +VA+K + + + A + RE+++L+ +
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRR---TGAKVAIKKLYRPFQSELFA-KRAYRELRLLKHM 71
Query: 216 TGHNNLVKFFDAY------EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
H N++ D + + + Y+VM G L +++ + K +ED + ++ Q+
Sbjct: 72 K-HENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLM-KHEKLSEDRIQFLVYQM 127
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
L + + H G++HRDLKP N +E+ LK +DFGL+ + D + V + +Y
Sbjct: 128 LKGLKYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLAR--QTDSEMTGYVVTRWYR 182
Query: 330 APEVLHR--SYSTEADVWSIGVIAYILLCG-----------------------SRPFWAR 364
APEV+ Y+ D+WS+G I +L G S+ F +
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242
Query: 365 TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNK----DPRKRLTAAQALSHPWIK 420
+S + +K P F + + SL A +L K D R+TAA+AL+HP+ +
Sbjct: 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE 302
Query: 421 NSNDVK 426
+D +
Sbjct: 303 EFHDPE 308
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 6e-21
Identities = 68/242 (28%), Positives = 107/242 (44%), Gaps = 14/242 (5%)
Query: 183 GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN-VYVVMELC 241
G +VA+K++ RRE + L H N+V D+ E ++ V E
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLY-HPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 242 EGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301
G L + L+ G + +M+Q+L+ +A H QG+VHRDLKP+N + +
Sbjct: 62 PGRTLREV-LAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 302 LKAIDFG----LSDFVRPDE----RLNDIVGSAYYVAPEVLHRSYST-EADVWSIGVIAY 352
K +DFG L D R +++G+ Y APE L T +D+++ G+I
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFL 180
Query: 353 ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQ 412
L G R + + I L PW + +++ LNKDPR+R +A
Sbjct: 181 ECLTGQRVVQGASVAEILYQQLSPVD-VSLPPWIA-GHPLGQVLRKALNKDPRQRAASAP 238
Query: 413 AL 414
AL
Sbjct: 239 AL 240
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 9e-21
Identities = 77/268 (28%), Positives = 121/268 (45%), Gaps = 14/268 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG CA + + G+ A K + K ++ E +IL + +V
Sbjct: 8 LGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF-VV 63
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGV 281
AYE D + +V+ L GG+L I G + E A +I + H + +
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERI 123
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYST 340
V+RDLKPEN L D++ ++ D GL+ V + + VG+ Y+APEV+ + Y+
Sbjct: 124 VYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTF 180
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W++G + Y ++ G PF R + V + E S +AR K LL
Sbjct: 181 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLL 240
Query: 401 NKDPRKRL-----TAAQALSHPWIKNSN 423
KDP++RL A + HP K N
Sbjct: 241 CKDPKERLGCQGGGAREVKEHPLFKQIN 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 9e-21
Identities = 74/250 (29%), Positives = 118/250 (47%), Gaps = 13/250 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG AK K G+ AVKV+ K + + + E +L H LV
Sbjct: 3 IGKGSFGKVLLAKHK---ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+++ D +Y V++ GGEL L R + E A+ +I + + + H ++
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGGELFFH-LQRERSFPEPRARFYAAEIASALGYLHSLNII 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLHRS-YST 340
+RDLKPEN L D + DFGL + + + + G+ Y+APEVL + Y
Sbjct: 119 YRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDR 175
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W +G + Y +L G PF++R + ++ +L P++S AR ++ LL
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLL 231
Query: 401 NKDPRKRLTA 410
KD KRL A
Sbjct: 232 QKDRTKRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 9e-21
Identities = 74/268 (27%), Positives = 120/268 (44%), Gaps = 14/268 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG CA + + G+ A K + K ++ E +IL + +V
Sbjct: 8 LGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNS-RFVV 63
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGK-YTEDDAKAVMIQILNVVAFCHLQGV 281
AYE D + +V+ + GG+L I + G + E A ++ + + +
Sbjct: 64 SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERI 123
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYST 340
V+RDLKPEN L D+ ++ D GL+ + E + VG+ Y+APEV+ + Y+
Sbjct: 124 VYRDLKPENILL---DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTF 180
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W +G + Y ++ G PF R E V + E S +A+ + LL
Sbjct: 181 SPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLL 240
Query: 401 NKDPRKRL-----TAAQALSHPWIKNSN 423
K+P++RL AA HP KN N
Sbjct: 241 TKNPKERLGCRGNGAAGVKQHPIFKNIN 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 77/277 (27%), Positives = 123/277 (44%), Gaps = 21/277 (7%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
E+G G FG A F + + VA+K + + +D+ +EV+ L+ L H N
Sbjct: 22 EIGHGSFG---AVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNT 77
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
+++ Y ++VME C G D + E + AV L +A+ H +
Sbjct: 78 IQYRGCYLREHTAWLVMEYCLGSAS-DLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL----HRS 337
+HRD+K N L + E ++K DFG + + P N VG+ Y++APEV+
Sbjct: 137 IHRDVKAGNILLS---EPGLVKLGDFGSASIMAP---ANXFVGTPYWMAPEVILAMDEGQ 190
Query: 338 YSTEADVWSIGVIAYILLCGSRP--FWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395
Y + DVWS+G+ I L +P F S ++ P+ W S R+F
Sbjct: 191 YDGKVDVWSLGITC-IELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNF 246
Query: 396 VKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVI 432
V L K P+ R T+ L H ++ V +D+I
Sbjct: 247 VDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI 283
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 87/301 (28%), Positives = 129/301 (42%), Gaps = 50/301 (16%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+YE E+G G +G A+ G VA+K + + + VR EV +L+ L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPH---SGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRL 56
Query: 216 TG--HNNLVKFFD--AYEDTD---NVYVVMELCEGG--ELLDRILSRGGKYTEDDAKAVM 266
H N+V+ D A TD V +V E + LD++ G + K +M
Sbjct: 57 EAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG--LPAETIKDLM 114
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSA 326
Q L + F H +VHRDLKPEN L T+ + +K DFGL+ L +V +
Sbjct: 115 RQFLRGLDFLHANCIVHRDLKPENILVTSGGQ---VKLADFGLARIYSCQMALTPVVVTL 171
Query: 327 YYVAPEVLHRS-YSTEADVWSIGVI------AYILLCGSRPFWARTESGIFRAVLKADPS 379
+Y APEVL +S Y+T D+WS+G I L CG+ A IF + P
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE--ADQLGKIFDLI--GLPP 227
Query: 380 FDEAPW---------------------PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
D+ P P + + +L +P KR++A +AL HP+
Sbjct: 228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF 287
Query: 419 I 419
Sbjct: 288 F 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-20
Identities = 90/314 (28%), Positives = 138/314 (43%), Gaps = 35/314 (11%)
Query: 126 PNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQ 185
+A I P K +K A KY + +G G G AK G+
Sbjct: 4 SGDAMIGRVCRTFPDT-FAKDEATAKEQAKKYWISRVLGSGATGTVLCAKRVS---DGEP 59
Query: 186 VAVKVIPKHKMTTAIAIEDVRREVKIL------RALTGHNNLVKFFDAYEDTDN------ 233
AVKV+ M+ A + EV L + H + A +D N
Sbjct: 60 FAVKVVDMEGMSEA-DKNRAQAEVCCLLNCDFFSIVKCHEDF-----AKKDPRNPENVLM 113
Query: 234 VYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290
+ +V++ G+L I SR + E +A + IQ+L V H + ++HRD+K N
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSAN 173
Query: 291 FLFTTKDENSVLKAIDFGLSDFVR---PDERLNDIVGSAYYVAPEVLHRS-YSTEADVWS 346
L + N ++K DFG S D+ G+ YYVAPE+ R YS +AD++S
Sbjct: 174 ILLCS---NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFS 230
Query: 347 IGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRK 406
+GV+ Y LL RPF + L +D P PS+S E ++ V LL+ DP++
Sbjct: 231 LGVLLYELLTLKRPFDGENMEEVMHKTLAG--RYDPLP-PSISPEMQEIVTALLSSDPKR 287
Query: 407 RLTAAQALSHPWIK 420
R ++++ L+ P K
Sbjct: 288 RPSSSKLLNMPICK 301
|
Length = 496 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 59/197 (29%), Positives = 89/197 (45%), Gaps = 21/197 (10%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+LG +G+G FG G+ +GQ+VAVK + K T A A E ++ L
Sbjct: 9 KLGATIGKGEFG-----DVMLGDYRGQKVAVKCL-KDDSTAAQAFLA---EASVMTTLR- 58
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVVAFC 276
H NLV+ + +Y+V E G L+D + SRG T + + + +
Sbjct: 59 HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL 118
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGS--AYYVAPEVL 334
+ VHRDL N L E+ V K DFGL+ + G + APE L
Sbjct: 119 EEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEAL 171
Query: 335 -HRSYSTEADVWSIGVI 350
+ +ST++DVWS G++
Sbjct: 172 REKKFSTKSDVWSFGIL 188
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 2e-20
Identities = 77/269 (28%), Positives = 128/269 (47%), Gaps = 22/269 (8%)
Query: 160 GEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
G+ +G+G FG Y C EL +QV P+ T+ + + E+++L+ L
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFD--PESPETSK-EVSALECEIQLLKNLQ- 62
Query: 218 HNNLVKFFDAYED--TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H +V+++ D + + ME GG + D++ + G TE + QIL +++
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA-LTESVTRKYTRQILEGMSY 121
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR----PDERLNDIVGSAYYVAP 331
H +VHRD+K N L +D +K DFG S ++ + + G+ Y+++P
Sbjct: 122 LHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178
Query: 332 EVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390
EV+ Y +ADVWS+G +L +P WA E+ A+ K PS S
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLT-EKPPWAEYEA--MAAIFKIATQPTNPQLPSHIS 235
Query: 391 E-ARDFVKRLLNKDPRKRLTAAQALSHPW 418
E ARDF+ + + R R +A + L HP+
Sbjct: 236 EHARDFLGCIF-VEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-20
Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 24/280 (8%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
A Y++ + +GRG FG + K + + A+K++ K +M E I+
Sbjct: 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQ---KVYAMKLLSKFEMIKRSDSAFFWEERDIM- 97
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
A +V+ F A++D +Y+VME GG+L++ L E AK +++ +
Sbjct: 98 AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN--LMSNYDVPEKWAKFYTAEVVLAL 155
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE----RLNDIVGSAYYV 329
H G++HRD+KP+N L D++ LK DFG ++ DE R + VG+ Y+
Sbjct: 156 DAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTC--MKMDETGMVRCDTAVGTPDYI 210
Query: 330 APEVLHRS-----YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384
+PEVL Y E D WS+GV + +L G PF+A + G + ++ S +
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPE 270
Query: 385 WPSLSSEARDFVKRLLNKDPRKRL---TAAQALSHPWIKN 421
+S A++ + L D RL + HP+ KN
Sbjct: 271 DVEISKHAKNLICAFLT-DREVRLGRNGVEEIKQHPFFKN 309
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 3e-20
Identities = 78/277 (28%), Positives = 122/277 (44%), Gaps = 21/277 (7%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
E+G G FG A F + + VA+K + + +D+ +EVK L+ + H N
Sbjct: 32 EIGHGSFG---AVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNS 87
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
+++ Y ++VME C G D + E + A+ L +A+ H +
Sbjct: 88 IEYKGCYLREHTAWLVMEYCLGSAS-DLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL----HRS 337
+HRD+K N L T E +K DFG + P N VG+ Y++APEV+
Sbjct: 147 IHRDIKAGNILLT---EPGQVKLADFGSASIASP---ANSFVGTPYWMAPEVILAMDEGQ 200
Query: 338 YSTEADVWSIGVIAYILLCGSRP--FWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395
Y + DVWS+G I I L +P F S ++ P+ W S R+F
Sbjct: 201 YDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW---SDYFRNF 256
Query: 396 VKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVI 432
V L K P+ R T+ + L H ++ V +D+I
Sbjct: 257 VDSCLQKIPQDRPTSEELLKHMFVLRERPETVLIDLI 293
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 5e-20
Identities = 79/276 (28%), Positives = 137/276 (49%), Gaps = 28/276 (10%)
Query: 157 YELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIP--KHKMTTAIAIEDVRREVKIL 212
+ LG+ +GRG FG Y C G+++AVK +P T+ + + E+++L
Sbjct: 4 WRLGKLLGRGAFGEVYLCY-----DADTGRELAVKQVPFDPDSQETSKEVNALECEIQLL 58
Query: 213 RALTGHNNLVKFFDAYEDTDN--VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQIL 270
+ L H+ +V+++ D + + + +E GG + D+ L G TE+ + QIL
Sbjct: 59 KNLR-HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQ-LKAYGALTENVTRRYTRQIL 116
Query: 271 NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR----PDERLNDIVGSA 326
V++ H +VHRD+K N L +D +K DFG S ++ + + G+
Sbjct: 117 QGVSYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173
Query: 327 YYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE--SGIFRAVLKADPSFDEA 383
Y+++PEV+ Y +ADVWS+ +L +P WA E + IF+ + P+
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLT-EKPPWAEYEAMAAIFK--IATQPTKPML 230
Query: 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
P +S RDF+K++ ++ R R TA L HP++
Sbjct: 231 P-DGVSDACRDFLKQIFVEEKR-RPTAEFLLRHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 5e-20
Identities = 76/294 (25%), Positives = 128/294 (43%), Gaps = 40/294 (13%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
NK+E+ VG G +G + K+ + + VA+K + + E RE+K+LR
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETK---EIVAIKKFKDSEENEEVK-ETTLRELKMLRT 56
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L N+V+ +A+ +Y+V E E +L+ + + ++ + Q++ +
Sbjct: 57 LK-QENIVELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVRSYIYQLIKAIH 114
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP--DERLNDIVGSAYYVAPE 332
+CH +VHRD+KPEN L + D VLK DFG + + + + V + +Y +PE
Sbjct: 115 WCHKNDIVHRDIKPENLLISHND---VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171
Query: 333 VLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK--------------AD 377
+L + Y D+WS+G I L G F +E + K ++
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231
Query: 378 PSFDEAPWPS--------------LSSEARDFVKRLLNKDPRKRLTAAQALSHP 417
P F +P+ LS D +K LL +P R Q L+HP
Sbjct: 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 5e-20
Identities = 78/307 (25%), Positives = 142/307 (46%), Gaps = 54/307 (17%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+Y+ VG G +G C+A + Q+VAVK + + + I RE+++L+ +
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLR---QKVAVKKLSR-PFQSLIHARRTYRELRLLKHM 71
Query: 216 TGHNNLVKFFDAY------EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
H N++ D + E+ + VY+V L G L+ I+ + K +++ + ++ Q+
Sbjct: 72 K-HENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIV-KCQKLSDEHVQFLIYQL 127
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
L + + H G++HRDLKP N +E+ L+ +DFGL+ + D+ + V + +Y
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNV---AVNEDCELRILDFGLAR--QADDEMTGYVATRWYR 182
Query: 330 APEVLHR--SYSTEADVWSIGVIAYILLCG-----------------------SRPFWAR 364
APE++ Y+ D+WS+G I LL G S +
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242
Query: 365 TESGIFRAVLKADPSFDEAPWPSLSSEAR-------DFVKRLLNKDPRKRLTAAQALSHP 417
S R +++ P P L R D ++++L D KR++A++AL+HP
Sbjct: 243 ISSEHARKYIQSLPHM---PQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHP 299
Query: 418 WIKNSND 424
+ +D
Sbjct: 300 YFSQYHD 306
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 6e-20
Identities = 63/214 (29%), Positives = 110/214 (51%), Gaps = 18/214 (8%)
Query: 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH 218
L +E+G G FG + L+ ++VA+K I + M+ ED E +++ L+ H
Sbjct: 8 LVQEIGSGQFGLV----WLGYWLEKRKVAIKTIREGAMSE----EDFIEEAQVMMKLS-H 58
Query: 219 NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL 278
LV+ + + + +V E E G L D + ++ GK++++ + + + +A+
Sbjct: 59 PKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES 118
Query: 279 QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV---APEVLH 335
V+HRDL N L EN V+K DFG++ FV D++ G+ + V +PEV
Sbjct: 119 SNVIHRDLAARNCLVG---ENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVFS 174
Query: 336 RS-YSTEADVWSIGVIAYILLC-GSRPFWARTES 367
S YS+++DVWS GV+ + + G P+ R+ S
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS 208
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 6e-20
Identities = 77/278 (27%), Positives = 127/278 (45%), Gaps = 20/278 (7%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
A YE+ + +GRG FG + + + + A+K++ K +M E I+
Sbjct: 42 AEDYEVVKVIGRGAFG---EVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM- 97
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
A +V+ F A++D +Y+VME GG+L++ L E A+ +++ +
Sbjct: 98 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN--LMSNYDVPEKWARFYTAEVVLAL 155
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAP 331
H G +HRD+KP+N L D++ LK DFG + + R + VG+ Y++P
Sbjct: 156 DAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 212
Query: 332 EVLHRS-----YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386
EVL Y E D WS+GV Y +L G PF+A + G + ++ S
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 272
Query: 387 SLSSEARDFVKRLLNKDPRKRL---TAAQALSHPWIKN 421
+S EA++ + L D RL + H + KN
Sbjct: 273 DISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKN 309
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 9e-20
Identities = 80/306 (26%), Positives = 135/306 (44%), Gaps = 49/306 (16%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ +E + +GRG FG + + + G A+K++ K M + +R E IL
Sbjct: 1 DDFESLKVIGRGAFG---EVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE 57
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
G +VK F +++D N+Y++ME GG+++ +L + +E+ + + + + +
Sbjct: 58 ADG-AWVVKMFYSFQDKRNLYLIMEFLPGGDMMT-LLMKKDTLSEEATQFYIAETVLAID 115
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL---------------------SDFV 313
H G +HRD+KP+N L K +K DFGL SDF
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGH---VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 314 -------RPDERLN--------DIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILLCG 357
R E VG+ Y+APEV ++ Y+ D WS+GVI Y +L G
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
Query: 358 SRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAA---QAL 414
PF + T +R V+ + P +S +A+D + R D R+ + +
Sbjct: 233 YPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIK 291
Query: 415 SHPWIK 420
SHP+ +
Sbjct: 292 SHPFFE 297
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 87/316 (27%), Positives = 141/316 (44%), Gaps = 66/316 (20%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI--PKHKMTTAIAIEDVRREVKIL 212
+Y+ + +G G G CAA + GQ VA+K + P +T A + RE+ ++
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAY---DTVTGQNVAIKKLSRPFQNVTHA---KRAYRELVLM 69
Query: 213 RALTGHNNLVKFFDAY------EDTDNVYVVMELCEGG--ELLDRILSRGGKYTEDDAKA 264
+ L H N++ + + E+ +VY+VMEL + +++ L +
Sbjct: 70 K-LVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLD------HERMSY 122
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVG 324
++ Q+L + H G++HRDLKP N + + + LK +DFGL+ + V
Sbjct: 123 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVV 179
Query: 325 SAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPF--------WAR------TESGI 369
+ YY APEV L Y D+WS+G I ++ G+ F W + T S
Sbjct: 180 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE 239
Query: 370 FRAVLK-------------ADPSFDEA------PWPSLS------SEARDFVKRLLNKDP 404
F + L+ A SF+E P S S S+ARD + ++L DP
Sbjct: 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDP 299
Query: 405 RKRLTAAQALSHPWIK 420
KR++ AL HP+I
Sbjct: 300 EKRISVDDALQHPYIN 315
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 75/261 (28%), Positives = 117/261 (44%), Gaps = 54/261 (20%)
Query: 201 AIEDVRREVKILRAL-TGHN----NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGG 255
A VR++ ILR L H +V F+ A+ + +N+ + ME + G L DRI +GG
Sbjct: 42 AKSSVRKQ--ILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGG 98
Query: 256 KYTEDDAKAVMIQILNVVAFCHLQG---------VVHRDLKPENFLFTTKDENSVLKAID 306
+ IL +A ++G ++HRD+KP N L ++ + +K D
Sbjct: 99 PIPVE--------ILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ---IKLCD 147
Query: 307 FGLSDFVRPDERLNDI----VGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPF 361
FG+S E +N I VG++ Y++PE + Y+ ++DVWS+G+ L G PF
Sbjct: 148 FGVSG-----ELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPF 202
Query: 362 WARTES--------GIF----RAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT 409
GI + V + P + +P + RDFV L KDP +R T
Sbjct: 203 AFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPE---DLRDFVDACLLKDPTERPT 259
Query: 410 AAQAL-SHPWIKNSNDVKVPL 429
Q P+I+ V L
Sbjct: 260 PQQLCAMPPFIQALRASNVDL 280
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 64/233 (27%), Positives = 102/233 (43%), Gaps = 44/233 (18%)
Query: 159 LGEEVGRGHFGYTCAAKFKKGELKGQ--QVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
L E+G G FG + E + VAVK + + + A +D RE ++L
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTL--KETASNDARKDFEREAELLTNF- 65
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG-------------GKYTEDDAK 263
H N+VKF+ + D +V E E G+L + S G G+ T
Sbjct: 66 QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323
+ +QI + + + Q VHRDL N L + V+K DFG+S D+
Sbjct: 126 QIAVQIASGMVYLASQHFVHRDLATRNCLVGY---DLVVKIGDFGMS---------RDVY 173
Query: 324 GSAYY------------VAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPFW 362
+ YY + PE +++R ++TE+DVWS GV+ + I G +P++
Sbjct: 174 TTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-19
Identities = 78/287 (27%), Positives = 123/287 (42%), Gaps = 59/287 (20%)
Query: 163 VGRGHFGYTC-AAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
+G G FG C A K L A+K + K + + V+ E IL A + +
Sbjct: 9 LGIGAFGEVCLACKVDTHAL----YAMKTLRKKDVLNRNQVAHVKAERDIL-AEADNEWV 63
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
VK + +++D DN+Y VM+ GG+++ +L R + E A+ + ++ + H G
Sbjct: 64 VKLYYSFQDKDNLYFVMDYIPGGDMMS-LLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGL--------------------SDFVRPDERLND 321
+HRD+KP+N L D + +K DFGL D + P + +D
Sbjct: 123 IHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 322 I----------------------------VGSAYYVAPEVLHRS-YSTEADVWSIGVIAY 352
+ VG+ Y+APEVL R Y+ D WS+GVI +
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239
Query: 353 ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399
+L G PF A T + V+ + + P LS EA D + +L
Sbjct: 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKL 286
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-19
Identities = 73/274 (26%), Positives = 122/274 (44%), Gaps = 45/274 (16%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG FG + + + G A+K++ K M + +R E IL +V
Sbjct: 9 IGRGAFG---EVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDIL-VEADSLWVV 64
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
K F +++D N+Y++ME GG+++ +L + TE++ + + + + + H G +
Sbjct: 65 KMFYSFQDKLNLYLIMEFLPGGDMMT-LLMKKDTLTEEETQFYIAETVLAIDSIHQLGFI 123
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL---------------------SDFV-------- 313
HRD+KP+N L +K +K DFGL SDF
Sbjct: 124 HRDIKPDNLLLDSKGH---VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 314 ------RPDERLN-DIVGSAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPFWART 365
R +L VG+ Y+APEV + Y+ D WS+GVI Y +L G PF + T
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 366 ESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399
++ V+ + P +S +A+D + R
Sbjct: 241 PQETYKKVMNWKETLIFPPEVPISEKAKDLILRF 274
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-19
Identities = 86/311 (27%), Positives = 140/311 (45%), Gaps = 61/311 (19%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI--PKHKMTTAIAIEDVRREVKILR 213
+Y+ + +G G G CAA + G VAVK + P T A + RE+ +L+
Sbjct: 22 RYQQLKPIGSGAQGIVCAAF---DTVLGINVAVKKLSRPFQNQTHA---KRAYRELVLLK 75
Query: 214 ALTGHNNLVKFFDAY------EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
+ H N++ + + E+ +VY+VMEL + L +++ + + ++
Sbjct: 76 CVN-HKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHM--ELDHERMSYLLY 130
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY 327
Q+L + H G++HRDLKP N + + + LK +DFGL+ + + V + Y
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTACTNFMMTPYVVTRY 187
Query: 328 YVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPF--------WAR------TESGIFRA 372
Y APEV L Y D+WS+G I L+ GS F W + T S F
Sbjct: 188 YRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247
Query: 373 VLKA-----------------DPSFDEAPWPSLS-------SEARDFVKRLLNKDPRKRL 408
L+ + F + +PS S S+ARD + ++L DP KR+
Sbjct: 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRI 307
Query: 409 TAAQALSHPWI 419
+ +AL HP+I
Sbjct: 308 SVDEALRHPYI 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 5e-19
Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 17/222 (7%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ L ++G G+FG +K +VA+K++ K + +D ++EV+ L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNR----VRVAIKIL---KSDDLLKQQDFQKEVQALKRLR 60
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI--QILNVVA 274
H +L+ F + VY++ EL E G LL + S G+ A + + Q+ +A
Sbjct: 61 -HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ-VLPVASLIDMACQVAEGMA 118
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY-YVAPEV 333
+ Q +HRDL N L E+ V K DFGL+ ++ D L+ Y + APE
Sbjct: 119 YLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEA 175
Query: 334 L-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
H ++ST++DVWS G++ Y + G P+ ++ +
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 82/284 (28%), Positives = 126/284 (44%), Gaps = 49/284 (17%)
Query: 171 TCAAKFK-KGELKGQQVAVKVIP-KHKM---TTAIAIEDVRREVKILRALTGHNNLVKFF 225
T A FK + +L VA+K I +H+ TAI REV +L+ L H N+V
Sbjct: 17 TYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI------REVSLLKNLK-HANIVTLH 69
Query: 226 DAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRD 285
D + +V E + +L + + G + + K M Q+L +++CH + ++HRD
Sbjct: 70 DIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRD 128
Query: 286 LKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERLNDIVGSAYYVAPEVLHRS--YSTEA 342
LKP+N L K E LK DFGL+ P + ++ V + +Y P+VL S YST
Sbjct: 129 LKPQNLLINEKGE---LKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPI 185
Query: 343 DVWSIGVIAYILLCGSRPFWARTESG----IFRAVLKADPSFDEAPW------------- 385
D+W +G I Y + G F T IFR L P+ + P
Sbjct: 186 DMWGVGCILYEMATGRPMFPGSTVKEELHLIFR--LLGTPTEETWPGITSNEEFRSYLFP 243
Query: 386 -----------PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
P L ++ D + LL + + R++A AL H +
Sbjct: 244 QYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 67/246 (27%), Positives = 109/246 (44%), Gaps = 44/246 (17%)
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR-----GGKYTEDD 261
REV +L+ L H N+V D ++ +V E LD+ L + G +
Sbjct: 53 REVSLLKDLK-HANIVTLHDIIHTEKSLTLVFEY------LDKDLKQYLDDCGNSINMHN 105
Query: 262 AKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERLN 320
K + Q+L + +CH + V+HRDLKP+N L + E LK DFGL+ P + +
Sbjct: 106 VKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYS 162
Query: 321 DIVGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378
+ V + +Y P++L S YST+ D+W +G I Y + G F T + +
Sbjct: 163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILG 222
Query: 379 SFDEAPWPS--------------------------LSSEARDFVKRLLNKDPRKRLTAAQ 412
+ E WP L S+ + + +LL + RKR++A +
Sbjct: 223 TPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEE 282
Query: 413 ALSHPW 418
A+ HP+
Sbjct: 283 AMKHPY 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 60/211 (28%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 162 EVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN 219
++G GHFG C G+QVAVK H D RE++ILR L H
Sbjct: 11 QLGEGHFGKVELCRYDPLGDN-TGEQVAVKS-LNHSGEEQ-HRSDFEREIEILRTLD-HE 66
Query: 220 NLVKFFDAYEDT--DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM--IQILNVVAF 275
N+VK+ E ++ ++ME G L R + + + + ++ QI + +
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSL--RDYLQRHRDQINLKRLLLFSSQICKGMDY 124
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE---RLNDIVGS-AYYVAP 331
Q +HRDL N L + ++K DFGL+ + D+ + + S ++ AP
Sbjct: 125 LGSQRYIHRDLAARNILV---ESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAP 181
Query: 332 EVLH-RSYSTEADVWSIGVIAYILLCGSRPF 361
E L +S+ +DVWS GV Y L P
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 3e-18
Identities = 77/310 (24%), Positives = 132/310 (42%), Gaps = 61/310 (19%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG + + + G+ A+K + K +M + V+ E +L A + +V
Sbjct: 9 IGKGAFG---EVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVL-AESDSPWVV 64
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ +++D +Y++ME GG+L+ +L + ++ED + M + + + H G +
Sbjct: 65 SLYYSFQDAQYLYLIMEFLPGGDLMT-MLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFI 123
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSD----------FVRP----------DERLNDI 322
HRD+KP+N L D +K DFGLS + + D R +
Sbjct: 124 HRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180
Query: 323 VGS---------------------AY-------YVAPEV-LHRSYSTEADVWSIGVIAYI 353
V S AY Y+APE+ L + Y E D WS+G I +
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240
Query: 354 LLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL---TA 410
L G PF + +R ++ + LS EA D ++RL+ + RL A
Sbjct: 241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGA 299
Query: 411 AQALSHPWIK 420
+ SHP+ +
Sbjct: 300 HEIKSHPFFR 309
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 7e-18
Identities = 82/285 (28%), Positives = 127/285 (44%), Gaps = 52/285 (18%)
Query: 177 KKGE------LK------GQQVAVKVIPKHKMTTAIAIEDVR--REVKILRALTGHNNLV 222
K GE LK G+ A+K + KH ++E V RE++ LR L+ H N++
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKH----FKSLEQVNNLREIQALRRLSPHPNIL 61
Query: 223 KFFDAYED--TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
+ + D T + +V EL + L + I R E K+ M Q+L + H G
Sbjct: 62 RLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS--Y 338
+ HRD+KPEN L KD+ +LK DFG + + + + +Y APE L Y
Sbjct: 121 IFHRDIKPENILI--KDD--ILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYY 176
Query: 339 STEADVWSIGVIAYILLCGSRPFWARTE----SGI--------------FRAVLKADPSF 380
+ D+W++G + + +L F E + I FR + +F
Sbjct: 177 GPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236
Query: 381 -----DEAPW--PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
P+ S+E D +K+LL DP +R+TA QAL HP+
Sbjct: 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 8e-18
Identities = 62/223 (27%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN 219
+E+G G FG G+ + Q +VA+K I + M+ ED E K++ L+ H
Sbjct: 10 KELGSGQFGVV-----HLGKWRAQIKVAIKAINEGAMSE----EDFIEEAKVMMKLS-HP 59
Query: 220 NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
LV+ + +Y+V E E G LL+ + R GK ++D ++ + + +
Sbjct: 60 KLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN 119
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV---APEVLHR 336
+HRDL N L + V+K DFG++ +V DE + G+ + V PEV +
Sbjct: 120 SFIHRDLAARNCLVS---STGVVKVSDFGMTRYVLDDEYTSS-SGAKFPVKWSPPEVFNF 175
Query: 337 S-YSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKAD 377
S YS+++DVWS GV+ + + G PF ++ + + +
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF 218
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 8e-18
Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN 219
+E+G G FG K G+ +GQ VA+K+I + M+ IE E K++ L+ H
Sbjct: 10 KELGTGQFGVV-----KYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMKLS-HE 59
Query: 220 NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
LV+ + +Y+V E G LL+ + G ++ + + +A+ +
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK 119
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV---APEVLHR 336
+HRDL N L D+ +K DFGLS +V DE + VGS + V PEVL
Sbjct: 120 QFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLLY 175
Query: 337 S-YSTEADVWSIGVIAY-ILLCGSRPF 361
S +S+++DVW+ GV+ + + G P+
Sbjct: 176 SKFSSKSDVWAFGVLMWEVYSLGKMPY 202
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 77/275 (28%), Positives = 135/275 (49%), Gaps = 32/275 (11%)
Query: 163 VGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+GRG FG Y C +K + G+ A+K + K ++ E + +I+ +L +
Sbjct: 2 IGRGGFGEVYGC----RKAD-TGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGD 55
Query: 221 ---LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
+V A+ D + +++L GG+L LS+ G ++E + + +I+ + H
Sbjct: 56 CPFIVCMSYAFHTPDKLSFILDLMNGGDL-HYHLSQHGVFSEAEMRFYAAEIILGLEHMH 114
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR 336
+ VV+RDLKP N L DE+ ++ D GL+ DF + ++ + VG+ Y+APEVL +
Sbjct: 115 NRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQK 169
Query: 337 --SYSTEADVWSIGVIAYILLCGSRPF---WARTESGIFRAVLKADPSFDEAPWPSLSSE 391
+Y + AD +S+G + + LL G PF + + I R L + S S E
Sbjct: 170 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD----SFSPE 225
Query: 392 ARDFVKRLLNKDPRKRL-----TAAQALSHPWIKN 421
R ++ LL +D +RL A + HP+ ++
Sbjct: 226 LRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 74/268 (27%), Positives = 121/268 (45%), Gaps = 50/268 (18%)
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR-----GGKYTEDD 261
REV +L+ L H N+V D ++ +V E LD+ L + G + +
Sbjct: 53 REVSLLKDLK-HANIVTLHDIVHTDKSLTLVFEY------LDKDLKQYMDDCGNIMSMHN 105
Query: 262 AKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERLN 320
K + QIL +A+CH + V+HRDLKP+N L + E LK DFGL+ P + +
Sbjct: 106 VKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTYS 162
Query: 321 DIVGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESG----IFRAVL 374
+ V + +Y P+VL S YST+ D+W +G I + + G F T IFR L
Sbjct: 163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFR--L 220
Query: 375 KADPSFDEAPW------------------------PSLSSEARDFVKRLLNKDPRKRLTA 410
P+ + P P L +E + + + L + +KR++A
Sbjct: 221 LGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISA 280
Query: 411 AQALSHPWIKN--SNDVKVPLDVIIFKL 436
+A+ H + ++ + +P + IF L
Sbjct: 281 EEAMKHAYFRSLGTRIHSLPESISIFSL 308
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 86/300 (28%), Positives = 134/300 (44%), Gaps = 49/300 (16%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELK--GQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+YE E+G G +G FK +LK G+ VA+K + + + +R EV +LR
Sbjct: 2 QYECVAEIGEGAYGKV----FKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLR 56
Query: 214 ALTG--HNNLVKFFD--AYEDTD---NVYVVMELCEGG--ELLDRILSRGGKYTEDDAKA 264
L H N+V+ FD TD + +V E + LD++ G + K
Sbjct: 57 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKD 114
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVG 324
+M Q+L + F H VVHRDLKP+N L T+ + +K DFGL+ L +V
Sbjct: 115 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVV 171
Query: 325 SAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPF---------------------- 361
+ +Y APEV L SY+T D+WS+G I + + +P
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCI-FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 230
Query: 362 --WARTESGIFRAVLKADPSFD-EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
W R + + R + + E + +D + + L +P KR++A ALSHP+
Sbjct: 231 EDWPR-DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 84/302 (27%), Positives = 133/302 (44%), Gaps = 46/302 (15%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI--PKHKMTTAIAIEDVRREVKI 211
A+ YE E++G G + K K + G+ VA+KVI + + T AI RE +
Sbjct: 4 ADSYEKLEKLGEGSYATVYKGKSK---VNGKLVALKVIRLQEEEGTPFTAI----REASL 56
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
L+ L H N+V D + + +V E +L + G ++ K + Q+L
Sbjct: 57 LKGLK-HANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLR 114
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERLNDIVGSAYYVA 330
+++ H + ++HRDLKP+N L + E LK DFGL+ P ++ V + +Y
Sbjct: 115 GLSYIHQRYILHRDLKPQNLLISDTGE---LKLADFGLARAKSVPSHTYSNEVVTLWYRP 171
Query: 331 PEVLHRS--YSTEADVWSIGVIAYILLCG--SRPFWARTESGIFRAVLK-ADPSFDEAP- 384
P+VL S YST D+W +G I ++ G + P + + R L P+ D P
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPG 231
Query: 385 -----------------------WPSLS--SEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
W LS + A D +LL P+ RL+A ALSH +
Sbjct: 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF 291
Query: 420 KN 421
+
Sbjct: 292 SD 293
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 18/199 (9%)
Query: 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH 218
L ++G G FG + +VAVK + M+ E +E +I++ L H
Sbjct: 10 LERKLGAGQFGEVWMGTW----NGTTKVAVKTLKPGTMSP----EAFLQEAQIMKKLR-H 60
Query: 219 NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI-QILNVVAFCH 277
+ LV+ + + + +Y+V E G LLD + S GK M QI +A+
Sbjct: 61 DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE 120
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPE-V 333
+ +HRDL N L EN V K DFGL+ + DE G+ + + APE
Sbjct: 121 SRNYIHRDLAARNILV---GENLVCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPEAA 176
Query: 334 LHRSYSTEADVWSIGVIAY 352
+ ++ ++DVWS G++
Sbjct: 177 NYGRFTIKSDVWSFGILLT 195
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-17
Identities = 82/310 (26%), Positives = 131/310 (42%), Gaps = 58/310 (18%)
Query: 147 FGFSKHFANKYELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIE-D 204
FG + + N +LGE + A +K + GQ VA+KVI M T +
Sbjct: 1 FGAATSYLNLEKLGEG--------SYATVYKGISRINGQLVALKVI---SMKTEEGVPFT 49
Query: 205 VRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKA 264
RE +L+ L H N+V D + + V E +L ++ G + +
Sbjct: 50 AIREASLLKGLK-HANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRL 107
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERLNDIV 323
M Q+L +A+ H Q ++HRDLKP+N L + E LK DFGL+ P + + V
Sbjct: 108 FMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE---LKLADFGLARAKSIPSQTYSSEV 164
Query: 324 GSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK-----A 376
+ +Y P+VL + YS+ D+W G I +I + +P + S +F + K
Sbjct: 165 VTLWYRPPDVLLGATDYSSALDIWGAGCI-FIEMLQGQPAFPGV-SDVFEQLEKIWTVLG 222
Query: 377 DPSFDEAPWPSLSS----------------------------EARDFVKRLLNKDPRKRL 408
P+ E WP +S +A D ++L P+ R+
Sbjct: 223 VPT--EDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRI 280
Query: 409 TAAQALSHPW 418
+A AL HP+
Sbjct: 281 SAQDALLHPY 290
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 7e-17
Identities = 77/324 (23%), Positives = 132/324 (40%), Gaps = 71/324 (21%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN-- 219
E+G G+ G + G +A K+I H + RE+K+L H
Sbjct: 8 ELGAGNGGVVTKVLHRP---SGLIMARKLI--HLEIKPAIRNQIIRELKVL-----HECN 57
Query: 220 --NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
+V F+ A+ + + ME +GG L D++L + G+ E+ IL ++
Sbjct: 58 SPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEN--------ILGKISIAV 108
Query: 278 LQG---------VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
L+G ++HRD+KP N L ++ E +K DFG+S + D N VG+ Y
Sbjct: 109 LRGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 164
Query: 329 VAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESG---IFRAVLKADPSFD--- 381
++PE L + Y+ ++D+WS+G+ + G P +F + + +
Sbjct: 165 MSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHR 224
Query: 382 -----------------------EAPWPSL-----SSEARDFVKRLLNKDPRKRLTAAQA 413
P P L S E +DFV + L K+P++R +
Sbjct: 225 PVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKEL 284
Query: 414 LSHPWIKNSNDVKVPLDVIIFKLM 437
HP+IK + +V + M
Sbjct: 285 TKHPFIKRAELEEVDFAGWVCSTM 308
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 7e-17
Identities = 79/273 (28%), Positives = 121/273 (44%), Gaps = 29/273 (10%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIED--VRREVKIL 212
N G+ +G G FG A L +KV K TA + E + E+KI+
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYG--LSKSDAVMKVAVKMLKPTAHSSEREALMSELKIM 92
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILN 271
L H N+V A + V+ E C G+LL+ + + + T +D + Q+
Sbjct: 93 SHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV-GSAY--- 327
+AF + +HRDL N L T ++K DFGL+ + D N +V G+A
Sbjct: 153 GMAFLASKNCIHRDLAARNVLLT---HGKIVKICDFGLARDIMNDS--NYVVKGNARLPV 207
Query: 328 -YVAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK-----ADPS 379
++APE + + Y+ E+DVWS G++ + I GS P+ F ++K A P
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE 267
Query: 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQ 412
AP +E D +K + DP KR T Q
Sbjct: 268 H--AP-----AEIYDIMKTCWDADPLKRPTFKQ 293
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 67/261 (25%), Positives = 116/261 (44%), Gaps = 16/261 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG CA + K G+ A K + K ++ + E +IL + +V
Sbjct: 1 LGKGGFGEVCAVQVKN---TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPF-IV 56
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTE-DDAKAVMIQILNVVAFCHLQGV 281
A+E ++ +VM L GG+L I + G + E + QI + H +
Sbjct: 57 NLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDI 116
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYST 340
V+RD+KPEN L D+ + D GL+ ++ + + G+ Y+APE+L YS
Sbjct: 117 VYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSY 173
Query: 341 EADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSFDEAPWPSLSSEARDFV 396
D +++G Y ++ G PF E + R L+ + F+ + + E++D
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQ---NFTEESKDIC 230
Query: 397 KRLLNKDPRKRLTAAQALSHP 417
+ L K P RL + + P
Sbjct: 231 RLFLAKKPEDRLGSREKNDDP 251
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 1e-16
Identities = 78/311 (25%), Positives = 135/311 (43%), Gaps = 61/311 (19%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI--PKHKMTTAIAIEDVRREVKILR 213
+Y+ + +G G G CAA + + VA+K + P T A + RE+ +++
Sbjct: 18 RYQNLKPIGSGAQGIVCAAY---DAVLDRNVAIKKLSRPFQNQTHA---KRAYRELVLMK 71
Query: 214 ALTGHNNLVKFFDAY------EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
+ H N++ + + E+ +VY+VMEL + L +++ + + ++
Sbjct: 72 CVN-HKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQM--ELDHERMSYLLY 126
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY 327
Q+L + H G++HRDLKP N + + + LK +DFGL+ + V + Y
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 183
Query: 328 YVAPEV-LHRSYSTEADVWSIGVIA------YILLCGSR----------------PFWAR 364
Y APEV L Y D+WS+G I IL G P + +
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243
Query: 365 TESGIFRAVLKADPSFDEAPWPSL----------------SSEARDFVKRLLNKDPRKRL 408
R ++ P + +P L +S+ARD + ++L DP KR+
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303
Query: 409 TAAQALSHPWI 419
+ +AL HP+I
Sbjct: 304 SVDEALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 61/231 (26%), Positives = 99/231 (42%), Gaps = 30/231 (12%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+++G G FG ++ K VAVK + K++ + +D +E I+ +L H N
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIM--DDFLKEAAIMHSLD-HEN 57
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRI-LSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
L++ + T + +V EL G LLDR+ G + +QI N + + +
Sbjct: 58 LIRLYGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV---------- 329
+HRDL N L + D+ +K DFGL L +YV
Sbjct: 117 RFIHRDLAARNILLASDDK---VKIGDFGLM------RALPQ--NEDHYVMEEHLKVPFA 165
Query: 330 --APEVL-HRSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKA 376
APE L R++S +DVW GV + + G P+ + S I + + K
Sbjct: 166 WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE 216
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 71/272 (26%), Positives = 120/272 (44%), Gaps = 19/272 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG A + + G+ A K + K ++ E E +IL A +V
Sbjct: 1 LGKGGFGEVSACQMRA---TGKLYACKKLNKKRLKKRKGYEGAMVEKRIL-AKVHSRFIV 56
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQ 279
A++ ++ +VM + GG+L I + + E A QI++ + H +
Sbjct: 57 SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLH-RS 337
+++RDLKPEN L D + ++ D GL+ + + G+ ++APE+L
Sbjct: 117 RIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEE 173
Query: 338 YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP-SLSSEARDFV 396
Y D +++GV Y ++ PF AR E + LK D +P S ++ F
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRILNDSVTYPDKFSPASKSFC 232
Query: 397 KRLLNKDPRKRL-----TAAQALSHPWIKNSN 423
+ LL KDP KRL +HP ++ N
Sbjct: 233 EALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 4e-16
Identities = 69/251 (27%), Positives = 109/251 (43%), Gaps = 54/251 (21%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRR----EVKILRAL 215
E++G+G+FG KG LKG +VAVK + T D++R E +IL+
Sbjct: 1 EKIGKGNFG-----DVYKGVLKGNTEVAVKTC---RSTL---PPDLKRKFLQEAEILKQY 49
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N+VK +Y+VMEL GG LL + + + T + + + +
Sbjct: 50 D-HPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEY 108
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY------YV 329
+ +HRDL N L EN+VLK DFG+S R +E V +
Sbjct: 109 LESKNCIHRDLAARNCLV---GENNVLKISDFGMS---REEEGGIYTVSDGLKQIPIKWT 162
Query: 330 APEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388
APE L+ Y++E+DVWS G++ + F S + P+P +
Sbjct: 163 APEALNYGRYTSESDVWSYGILLW---------------ETF--------SLGDTPYPGM 199
Query: 389 S-SEARDFVKR 398
S + R+ ++
Sbjct: 200 SNQQTRERIES 210
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 5e-16
Identities = 66/215 (30%), Positives = 102/215 (47%), Gaps = 17/215 (7%)
Query: 149 FSKHFANKYELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVIPKHKMTTAIAIEDVRR 207
F K F + ++G GHFG ++ +G+ G+QVAVK + IA D+++
Sbjct: 1 FEKRFLKRIR---DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA--DLKK 55
Query: 208 EVKILRALTGHNNLVKFFD-AYEDTDN-VYVVMELCEGGELLDRILSRGGKYTEDDAKAV 265
E++ILR L H N+VK+ ED N + ++ME G L + + K
Sbjct: 56 EIEILRNLY-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKY 114
Query: 266 MIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL----ND 321
+QI + + + VHRDL N L + E+ V K DFGL+ + D+ +D
Sbjct: 115 AVQICKGMDYLGSRQYVHRDLAARNVL--VESEHQV-KIGDFGLTKAIETDKEYYTVKDD 171
Query: 322 IVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILL 355
+ ++ APE L + +DVWS GV Y LL
Sbjct: 172 LDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 7e-16
Identities = 78/311 (25%), Positives = 135/311 (43%), Gaps = 61/311 (19%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI--PKHKMTTAIAIEDVRREVKILR 213
+Y+ + +G G G CAA E + VA+K + P T A + RE+ +++
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILE---RNVAIKKLSRPFQNQTHA---KRAYRELVLMK 78
Query: 214 ALTGHNNLVKFFDAY------EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
+ H N++ + + E+ +VY+VMEL + L +++ + + ++
Sbjct: 79 CVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQM--ELDHERMSYLLY 133
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY 327
Q+L + H G++HRDLKP N + + + LK +DFGL+ + V + Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 328 YVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL------------ 374
Y APEV L Y D+WS+G I ++ G F + V+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250
Query: 375 KADPS-------------------FDEAPWPSLS-------SEARDFVKRLLNKDPRKRL 408
K P+ F + +P+ S S+ARD + ++L D KR+
Sbjct: 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310
Query: 409 TAAQALSHPWI 419
+ +AL HP+I
Sbjct: 311 SVDEALQHPYI 321
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 62/247 (25%), Positives = 110/247 (44%), Gaps = 29/247 (11%)
Query: 184 QQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEG 243
Q++ V+ I K K AI E + + + + N +K + + ++M+ +
Sbjct: 41 QKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKD 93
Query: 244 GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303
G+L D +L + GK +E + K ++ Q++ + H ++H D+K EN L+ + L
Sbjct: 94 GDLFD-LLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYL- 151
Query: 304 AIDFGLSDFVRPDERLNDIVG--SAY-----YVAPE-VLHRSYSTEADVWSIGVIAYILL 355
D+GL I+G S Y Y +PE + +Y D W++GV+ Y LL
Sbjct: 152 -CDYGLC----------KIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELL 200
Query: 356 CGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTA-AQAL 414
G PF + + L ++S A DFV+ +L + RLT + +
Sbjct: 201 TGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEII 260
Query: 415 SHPWIKN 421
HP++K
Sbjct: 261 KHPFLKI 267
|
Length = 267 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 74/257 (28%), Positives = 129/257 (50%), Gaps = 27/257 (10%)
Query: 163 VGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+GRG FG Y C +K + G+ A+K + K ++ E + +I+ +L +
Sbjct: 2 IGRGGFGEVYGC----RKAD-TGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGD 55
Query: 221 ---LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
+V A+ D + +++L GG+L LS+ G ++E + + +I+ + H
Sbjct: 56 CPFIVCMTYAFHTPDKLCFILDLMNGGDL-HYHLSQHGVFSEKEMRFYATEIILGLEHMH 114
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR 336
+ VV+RDLKP N L DE+ ++ D GL+ DF + ++ + VG+ Y+APEVL +
Sbjct: 115 NRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQK 169
Query: 337 --SYSTEADVWSIGVIAYILLCGSRPFW---ARTESGIFRAVLKADPSFDEAPWPSLSSE 391
+Y + AD +S+G + + LL G PF + + I R L + + S S E
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPD----SFSPE 225
Query: 392 ARDFVKRLLNKDPRKRL 408
+ ++ LL +D KRL
Sbjct: 226 LKSLLEGLLQRDVSKRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 68/261 (26%), Positives = 115/261 (44%), Gaps = 50/261 (19%)
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
RE+++L +V F+ A+ + + ME +GG L D++L + G+ E V
Sbjct: 52 RELQVLHECNS-PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVS 109
Query: 267 IQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGS 325
I ++ + + + ++HRD+KP N L ++ E +K DFG+S + D N VG+
Sbjct: 110 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGT 165
Query: 326 AYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFW---ARTESGIFRAVLKADPSFD 381
Y++PE L + YS ++D+WS+G+ + G P A+ +F ++ DP+
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAES 225
Query: 382 EA----------------------------------PWPSLSS-----EARDFVKRLLNK 402
E P P L S E +DFV + L K
Sbjct: 226 ETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIK 285
Query: 403 DPRKRLTAAQALSHPWIKNSN 423
+P +R Q + H +IK S
Sbjct: 286 NPAERADLKQLMVHAFIKRSE 306
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 68/273 (24%), Positives = 125/273 (45%), Gaps = 27/273 (9%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR---EVKILRALTG 217
EE+GRG +G + G +AVK ++ + ++ +R ++ I
Sbjct: 7 EELGRGAYGVVDKMRHVP---TGTIMAVK-----RIRATVNSQEQKRLLMDLDISMRSVD 58
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGG--ELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
V F+ A +V++ ME+ + + ++ +G ED + + I+ + +
Sbjct: 59 CPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEY 118
Query: 276 CHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL 334
H + V+HRD+KP N L + N +K DFG+S ++ G Y+APE +
Sbjct: 119 LHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERI 175
Query: 335 -----HRSYSTEADVWSIGVIAYILLCGSRPF--WARTESGIFRAVLKADPSFDEAPWPS 387
+ Y ++DVWS+G+ L G P+ W +T + V++ +PS + P
Sbjct: 176 NPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW-KTPFQQLKQVVE-EPS-PQLPAEK 232
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
S E +DFV + L K+ ++R + L HP+ +
Sbjct: 233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 7e-15
Identities = 76/277 (27%), Positives = 118/277 (42%), Gaps = 50/277 (18%)
Query: 163 VGRGHFG--YTCAAKFKKGELKG-QQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG-- 217
+G G FG Y A G G +VAVK + K A + ++E L
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG------ATDQEKKEFLKEAHLMSNF 56
Query: 218 -HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV----MIQI-LN 271
H N+VK + Y++MEL EGG+LL + R + + ++ I L+
Sbjct: 57 NHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYL--RDARVERFGPPLLTLKELLDICLD 114
Query: 272 VVAFCH-LQGV--VHRDLKPENFLFTTKDENS--VLKAIDFGLSDFVRPDERLNDIVGSA 326
V C L+ + +HRDL N L + K ++ V+K DFGL+ DI S
Sbjct: 115 VAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA---------RDIYKSD 165
Query: 327 YY------------VAPEVLHRS-YSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRA 372
YY +APE L ++T++DVWS GV+ + IL G +P+ A + +
Sbjct: 166 YYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH 225
Query: 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT 409
V A + P + + + +DP +R T
Sbjct: 226 V-TAGGRL-QKP-ENCPDKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 60/230 (26%), Positives = 100/230 (43%), Gaps = 35/230 (15%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+ +G G FG C + K K VA+K + ++ D E I+ H N
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL--KAGSSDKQRLDFLTEASIMGQFD-HPN 66
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
+++ + V ++ E E G L D+ L E+D K + Q++ + L+G
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSL-DKFLR------ENDGKFTVGQLVGM-----LRG 114
Query: 281 V------------VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVG---S 325
+ VHRDL N L + N V K DFGLS + E G
Sbjct: 115 IASGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLEDSEATYTTKGGKIP 171
Query: 326 AYYVAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
+ APE + +R +++ +DVWS G++ + ++ G RP+W + + +AV
Sbjct: 172 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV 221
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 29/202 (14%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+E+G G+FG + K +VAVK + + + ++ RE ++ L H
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK--KEFLREASVMAQLD-HPC 57
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
+V+ + + + +VMEL G LL + R + D K + Q+ +A+ +
Sbjct: 58 IVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKH 115
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY------------ 328
VHRDL N L + + K DFG+S + GS YY
Sbjct: 116 FVHRDLAARNVLLVNRHQ---AKISDFGMSRALGA--------GSDYYRATTAGRWPLKW 164
Query: 329 VAPEVLH-RSYSTEADVWSIGV 349
APE ++ +S+++DVWS GV
Sbjct: 165 YAPECINYGKFSSKSDVWSYGV 186
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 67/265 (25%), Positives = 115/265 (43%), Gaps = 48/265 (18%)
Query: 181 LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN--LVKFFDAYEDTDNVYVVM 238
L + +AVKVIP I +E ++ + L L ++ ++ F+ A+ + + +
Sbjct: 24 LTRRILAVKVIP-----LDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78
Query: 239 ELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG--------VVHRDLKPEN 290
E +GG L D + + +L +A ++G ++HRD+KP N
Sbjct: 79 EFMDGGSL-------------DVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSN 125
Query: 291 FLFTTKDENSVLKAIDFGLSDFVRPDERLNDI----VGSAYYVAPE-VLHRSYSTEADVW 345
L T+ + +K DFG+S + +N I VG+ Y+APE + Y +DVW
Sbjct: 126 MLVNTRGQ---VKLCDFGVST-----QLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVW 177
Query: 346 SIGVIAYILLCGSRPF-WARTESGIFRAVLKADPSFDEAPWPSL-----SSEARDFVKRL 399
S+G+ L G P+ + G + DE P P L S + F+ +
Sbjct: 178 SLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP-PVLPVGQFSEKFVHFITQC 236
Query: 400 LNKDPRKRLTAAQALSHPWIKNSND 424
+ K P++R + HP+I ND
Sbjct: 237 MRKQPKERPAPENLMDHPFIVQYND 261
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-14
Identities = 80/372 (21%), Positives = 156/372 (41%), Gaps = 68/372 (18%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI---PKHKMTTAIAIEDVRREVKILR 213
Y+LG +G G FG A ++VA+K + P++K RE+ I++
Sbjct: 68 YKLGNIIGNGSFGVVYEAICID---TSEKVAIKKVLQDPQYK----------NRELLIMK 114
Query: 214 ALTGHNNLVKFFDAY------EDTDNVY--VVMELCEGGELLDRILSRGGKYTEDDAKAV 265
L H N++ D Y ++ N++ VVME + + + + K+ + A+
Sbjct: 115 NLN-HINIIFLKDYYYTECFKKNEKNIFLNVVMEF------IPQTVHKYMKHYARNNHAL 167
Query: 266 MI--------QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE 317
+ Q+ +A+ H + + HRDLKP+N L LK DFG + + +
Sbjct: 168 PLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPN--THTLKLCDFGSAKNLLAGQ 225
Query: 318 RLNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK 375
R + S +Y APE++ +Y+T D+WS+G I ++ G F ++ +++
Sbjct: 226 RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ 285
Query: 376 A------------DPSFDEAPWPSLSS-------------EARDFVKRLLNKDPRKRLTA 410
+P++ + +P + +A +F+ + L +P KRL
Sbjct: 286 VLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNP 345
Query: 411 AQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALRALSKTLTVDELFYLKEQY 470
+AL+ P+ + D + L I KL + + K A + + + +++
Sbjct: 346 IEALADPFFDDLRDPCIKLPKYIDKLPDLFNFCDAEIKEMSDACRRKIIPKCTYEAYKEF 405
Query: 471 ALLEPNKNGTIS 482
+ + N I+
Sbjct: 406 LMSDENDANIIA 417
|
Length = 440 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 4e-14
Identities = 74/258 (28%), Positives = 116/258 (44%), Gaps = 55/258 (21%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
K LGE +G G FG GE GQ+VAVK I K +T +E+ K+
Sbjct: 7 KLTLGEIIGEGEFGAVLQ-----GEYTGQKVAVKNI-KCDVTAQAFLEETAVMTKL---- 56
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV--- 272
H NLV+ + +Y+VMEL G L++ + +RG A +IQ+L
Sbjct: 57 -HHKNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRG------RALVSVIQLLQFSLD 108
Query: 273 ----VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
+ + + +VHRDL N L + E+ V K DFGL+ +++ +
Sbjct: 109 VAEGMEYLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGS--MGVDNSKLPVKW 163
Query: 329 VAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
APE L H+ +S+++DVWS GV+ W +F S+ AP+P
Sbjct: 164 TAPEALKHKKFSSKSDVWSYGVL----------LWE-----VF--------SYGRAPYPK 200
Query: 388 LS-SEARDFVKRLLNKDP 404
+S E ++ V++ +P
Sbjct: 201 MSLKEVKECVEKGYRMEP 218
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-14
Identities = 85/322 (26%), Positives = 138/322 (42%), Gaps = 67/322 (20%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+YE G +VGRG +G+ AK K G+ + A+K I ++ + RE+ +LR L
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKRKDGK-DDRDYALKQIEGTGISMSAC-----REIALLREL 55
Query: 216 TGHN--NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDA-------KAVM 266
N +L K F ++ D V+++ + E R K + K+++
Sbjct: 56 KHPNVISLQKVFLSHADR-KVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 114
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAIDFGLSDF----VRPDERLND 321
QIL+ + + H V+HRDLKP N L + E +K D G + ++P L+
Sbjct: 115 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174
Query: 322 IVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTE------------- 366
+V + +Y APE+L R Y+ D+W+IG I LL F R E
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 234
Query: 367 SGIFRAV-LKADPSFDE-APWPSLSSEARDF----------------------------V 396
IF + AD +++ P S+ +DF +
Sbjct: 235 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLL 294
Query: 397 KRLLNKDPRKRLTAAQALSHPW 418
++LL DP KR+T+ QA+ P+
Sbjct: 295 QKLLTMDPIKRITSEQAMQDPY 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 85/323 (26%), Positives = 140/323 (43%), Gaps = 69/323 (21%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+YE G +VGRG +G+ AK K G+ ++ A+K I ++ + RE+ +LR L
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKRKDGK-DEKEYALKQIEGTGISMSAC-----REIALLREL 55
Query: 216 TGHNNLV---KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDD-------AKAV 265
H N++ K F ++ D V+++ + E R K + K++
Sbjct: 56 K-HPNVIALQKVFLSHSDR-KVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSL 113
Query: 266 MIQILNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAIDFGLSDF----VRPDERLN 320
+ QIL+ + + H V+HRDLKP N L + E +K D G + ++P L+
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 321 DIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTE------------ 366
+V + +Y APE+L R Y+ D+W+IG I LL F R E
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQ 233
Query: 367 -SGIFRAV-LKADPSFDE----APWPSLSSEARD-------------------------F 395
IF + AD +++ +P+L + R
Sbjct: 234 LDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLL 293
Query: 396 VKRLLNKDPRKRLTAAQALSHPW 418
+++LL DP KR+T+ QAL P+
Sbjct: 294 LQKLLTMDPTKRITSEQALQDPY 316
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
LG +G G FG + E + VAVK K+ + ++ E +E I+R
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC-KNCTSPSVR-EKFLQEAYIMRQFD- 65
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM--IQILNVVAF 275
H ++VK + + V++VMEL GEL R + KY+ D A ++ Q+ +A+
Sbjct: 66 HPHIVKLIGVITE-NPVWIVMELAPLGEL--RSYLQVNKYSLDLASLILYSYQLSTALAY 122
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGS--AYYVAPEV 333
+ VHRD+ N L ++ D +K DFGLS ++ + G ++APE
Sbjct: 123 LESKRFVHRDIAARNVLVSSPD---CVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPES 179
Query: 334 LH-RSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKAD--PSFDEAPWPSLS 389
++ R +++ +DVW GV + IL+ G +PF + + + + P P P+L
Sbjct: 180 INFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCP-PTLY 238
Query: 390 SEARDFVKRLLNKDPRKR 407
S + + DP KR
Sbjct: 239 S----LMTKCWAYDPSKR 252
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 19/198 (9%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+L + +G+G FG G+ +G +VAVK I K+ T + E ++ L
Sbjct: 9 KLLQTIGKGEFG-----DVMLGDYRGNKVAVKCI-KNDATAQAFLA----EASVMTQLR- 57
Query: 218 HNNLVKFFDA-YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAK-AVMIQILNVVAF 275
H+NLV+ E+ +Y+V E G L+D + SRG D + + + +
Sbjct: 58 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL- 334
VHRDL N L + E++V K DFGL+ + + + APE L
Sbjct: 118 LEANNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALR 172
Query: 335 HRSYSTEADVWSIGVIAY 352
+ +ST++DVWS G++ +
Sbjct: 173 EKKFSTKSDVWSFGILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 69/262 (26%), Positives = 115/262 (43%), Gaps = 37/262 (14%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
E +GRG+FG + G L+ V V + +E +IL+ + H N
Sbjct: 1 ERIGRGNFGEVFS-----GRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYS-HPN 54
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
+V+ +Y+VMEL +GG+ L + + G + + ++ + + +
Sbjct: 55 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH 114
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---------YVAP 331
+HRDL N L T E +VLK DFG+S R +E D V ++ + AP
Sbjct: 115 CIHRDLAARNCLVT---EKNVLKISDFGMS---REEE---DGVYASTGGMKQIPVKWTAP 165
Query: 332 EVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
E L + YS+E+DVWS G++ + G+ P+ + A+ + P P L
Sbjct: 166 EALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG----VRLPCPELC 221
Query: 390 SEARDFVKRLLNK----DPRKR 407
+A V RL+ + DP +R
Sbjct: 222 PDA---VYRLMERCWEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 5e-13
Identities = 61/198 (30%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQ-VAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN 219
E +G+G+FG + KG LK + VAVK K + + I+ + E +IL+ H
Sbjct: 1 ELLGKGNFG-----EVFKGTLKDKTPVAVKTC-KEDLPQELKIKFLS-EARILKQYD-HP 52
Query: 220 NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
N+VK +Y+VMEL GG+ L + + + + +A+ +
Sbjct: 53 NIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK 112
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLS----DFVRPDERLNDIVGSAYYVAPEVL- 334
+HRDL N L EN+VLK DFG+S D + L I + APE L
Sbjct: 113 NCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALN 167
Query: 335 HRSYSTEADVWSIGVIAY 352
+ YS+E+DVWS G++ +
Sbjct: 168 YGRYSSESDVWSYGILLW 185
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 66/292 (22%), Positives = 112/292 (38%), Gaps = 55/292 (18%)
Query: 155 NKYELGEEVGRGHFGYT---CAAKFKKGELKGQQVAVK-VIPKHKMTTAIAIEDVRREVK 210
K L E+G+G FG A KGE + + VA+K V M I E
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETR-VAIKTVNENASMRERIEF---LNEAS 61
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR---------GGKYTEDD 261
+++ H+ +V+ VVMEL G+L + SR G T
Sbjct: 62 VMKEFNCHH-VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQK 120
Query: 262 AKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND 321
+ +I + +A+ + VHRDL N + E+ +K DFG++ D
Sbjct: 121 FIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA---EDLTVKIGDFGMT---------RD 168
Query: 322 IVGSAYY------------VAPEVLHRS-YSTEADVWSIGVIAY-ILLCGSRPFWARTES 367
I + YY +APE L ++T++DVWS GV+ + + +P+ +
Sbjct: 169 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE 228
Query: 368 GIFRAVLKAD----PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ + V+ P + ++ +P+ R T + +S
Sbjct: 229 EVLKFVIDGGHLDLPENCPDKL-------LELMRMCWQYNPKMRPTFLEIVS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 65/260 (25%), Positives = 117/260 (45%), Gaps = 26/260 (10%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+L +++G G FG + +VAVK + M+ +E E +++ L
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNNS----TKVAVKTLKPGTMSVQAFLE----EANLMKTLQ- 59
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILS-RGGKYTEDDAKAVMIQILNVVAFC 276
H+ LV+ + + +Y++ E G LLD + S GGK QI +A+
Sbjct: 60 HDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPEV 333
+ +HRDL+ N L + E+ + K DFGL+ + +E G+ + + APE
Sbjct: 120 ERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEA 175
Query: 334 LHR-SYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKA--DPSFDEAPWPSLS 389
++ S++ ++DVWS G++ Y I+ G P+ + S + A+ + P + P
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCP----- 230
Query: 390 SEARDFVKRLLNKDPRKRLT 409
E D +K + +R T
Sbjct: 231 DELYDIMKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 29/231 (12%)
Query: 155 NKYELGEEVGRGHFGYTCAAKF----KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
+K LG+ +G G FG A+ K + VAVK++ T + D+ E++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEME 72
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR---GGKYTED------- 260
+++ + H N++ A +YV++E G L + + +R G +Y+ D
Sbjct: 73 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDE 132
Query: 261 -----DAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
D + Q+ + + Q +HRDL N L T EN+V+K DFGL+ V
Sbjct: 133 QMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDVNN 189
Query: 316 DERLNDIVGS---AYYVAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPF 361
+ ++APE L R Y+ ++DVWS GV+ + I G P+
Sbjct: 190 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 9e-13
Identities = 50/182 (27%), Positives = 88/182 (48%), Gaps = 15/182 (8%)
Query: 186 VAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGE 245
VAVK + M +D E +I++ L H L++ + + +Y+V EL + G
Sbjct: 33 VAVKTLKPGTM----DPKDFLAEAQIMKKLR-HPKLIQLYAVCTLEEPIYIVTELMKYGS 87
Query: 246 LLDRILSRGGKYTE-DDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304
LL+ + G+ + + Q+ + +A+ Q +HRDL N L EN++ K
Sbjct: 88 LLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV---GENNICKV 144
Query: 305 IDFGLSDFVRPDERLNDIVGSAY---YVAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSR 359
DFGL+ ++ D G+ + + APE L+ +S ++DVWS G++ I+ G
Sbjct: 145 ADFGLARVIKEDI-YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRM 203
Query: 360 PF 361
P+
Sbjct: 204 PY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 30/226 (13%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG---HN 219
+G G FG C+ + K + VA+K + A E RR+ ++ G H
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTL------KAGYTEKQRRDFLSEASIMGQFDHP 65
Query: 220 NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
N++ + V +V E E G L + G++T ++ I + + +
Sbjct: 66 NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM 125
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY----------YV 329
G VHRDL N L + N V K DFGLS + D +AY +
Sbjct: 126 GYVHRDLAARNILVNS---NLVCKVSDFGLSRVLEDDPE------AAYTTRGGKIPIRWT 176
Query: 330 APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
APE + +R +++ +DVWS G++ + ++ G RP+W + + +A+
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI 222
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 48/156 (30%), Positives = 82/156 (52%), Gaps = 8/156 (5%)
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
RE+++L +V F+ A+ + + ME +GG L D++L + E+ V
Sbjct: 52 RELQVLHECNS-PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEAKRIPEEILGKVS 109
Query: 267 IQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGS 325
I +L +A+ + ++HRD+KP N L ++ E +K DFG+S + D N VG+
Sbjct: 110 IAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGT 165
Query: 326 AYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRP 360
Y++PE L + YS ++D+WS+G+ L G P
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 69/242 (28%), Positives = 108/242 (44%), Gaps = 60/242 (24%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
K+ELGE G FG A+ E VAVK + K + A +D +RE ++L
Sbjct: 10 KWELGE----GAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLT 62
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV-------- 265
L H ++V+F+ + + +V E G+L +R L G DAK +
Sbjct: 63 VLQ-HQHIVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGP----DAKILAGGEDVAP 116
Query: 266 -------MIQILNVVA--FCHLQGV--VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314
M+ I + +A +L + VHRDL N L + V+K DFG+S
Sbjct: 117 GQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV---GQGLVVKIGDFGMS---- 169
Query: 315 PDERLNDIVGSAYY------------VAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRP 360
DI + YY + PE +L+R ++TE+D+WS GV+ + I G +P
Sbjct: 170 -----RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
Query: 361 FW 362
++
Sbjct: 225 WY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 22/225 (9%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG--- 217
E +G G FG C + K + VA+K + K T E RR+ ++ G
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYT-----EKQRRDFLSEASIMGQFD 63
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H N++ + V ++ E E G L + G++T ++ I + +
Sbjct: 64 HPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS 123
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY-------YVA 330
VHRDL N L + N V K DFGLS F+ D+ + S+ + A
Sbjct: 124 EMNYVHRDLAARNILVNS---NLVCKVSDFGLSRFLE-DDTSDPTYTSSLGGKIPIRWTA 179
Query: 331 PE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
PE + +R +++ +DVWS G++ + ++ G RP+W + + A+
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 66/249 (26%), Positives = 114/249 (45%), Gaps = 47/249 (18%)
Query: 159 LGEEVGRGHFGYTCAAK-FKKGELKGQQ-VAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
L E+G G FG A+ + K + VAVK + K T A +D +RE ++L L
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLTNLQ 65
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG--------GKYTEDDAKAVMIQ 268
H ++VKF+ D D + +V E + G+L + + G G+ + + + Q
Sbjct: 66 -HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 269 ILNV-------VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND 321
+L++ + + Q VHRDL N L N ++K DFG+S D
Sbjct: 125 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGA---NLLVKIGDFGMS---------RD 172
Query: 322 IVGSAYY------------VAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPFWARTES 367
+ + YY + PE +++R ++TE+DVWS GVI + I G +P++ + +
Sbjct: 173 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232
Query: 368 GIFRAVLKA 376
+ + +
Sbjct: 233 EVIECITQG 241
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 5e-12
Identities = 79/298 (26%), Positives = 123/298 (41%), Gaps = 56/298 (18%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+Y++ +G+G G A ++VA+K I + + + RE KI L
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVC---SRRVALKKIREDLSENPLLKKRFLREAKIAADL 59
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRIL-------SRGGKYTEDDAKAVMIQ 268
H +V + D D VY M EG L +L S + E + +
Sbjct: 60 I-HPGIVPVYSICSDGDPVYYTMPYIEG-YTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117
Query: 269 ILN----VVAFCHLQGVVHRDLKPENFLF---------------TTKDENSVLKAIDFGL 309
I + + + H +GV+HRDLKP+N L K E L ID
Sbjct: 118 IFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177
Query: 310 -----SDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEA-DVWSIGVIAYILLCGSRPFWA 363
S P + IVG+ Y+APE L ++E+ D++++GVI Y +L S P+
Sbjct: 178 RNICYSSMTIPGK----IVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY-- 231
Query: 364 RTESG---IFRAVLKADPSFDEAPW----PSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
R + G +R V+ P + AP+ P LS + L DP +R ++ Q L
Sbjct: 232 RRKKGRKISYRDVI-LSPI-EVAPYREIPPFLSQ----IAMKALAVDPAERYSSVQEL 283
|
Length = 932 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 66/246 (26%), Positives = 111/246 (45%), Gaps = 44/246 (17%)
Query: 159 LGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
L E+G G FG A+ E VAVK + K + A +D RE ++L L
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL---KDASDNARKDFHREAELLTNLQ 65
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGEL--------LDRILSRGGKYTEDDAKAVMIQ 268
H ++VKF+ + D + +V E + G+L D +L G + ++ M+
Sbjct: 66 -HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 269 ILNVVA----FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVG 324
I +A + Q VHRDL N L EN ++K DFG+S D+
Sbjct: 125 IAQQIAAGMVYLASQHFVHRDLATRNCLV---GENLLVKIGDFGMS---------RDVYS 172
Query: 325 SAYY------------VAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIF 370
+ YY + PE +++R ++TE+DVWS+GV+ + I G +P++ + + +
Sbjct: 173 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 232
Query: 371 RAVLKA 376
+ +
Sbjct: 233 ECITQG 238
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 20/222 (9%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+L +++G G FG A + K +VAVK + M+ + E +++ L
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKH----TKVAVKTMKPGSMSVEAFLA----EANVMKTLQ- 59
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILS-RGGKYTEDDAKAVMIQILNVVAFC 276
H+ LVK A + +Y++ E G LLD + S G K QI +AF
Sbjct: 60 HDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 118
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPEV 333
+ +HRDL+ N L + V K DFGL+ + +E G+ + + APE
Sbjct: 119 EQRNYIHRDLRAANILVSAS---LVCKIADFGLARVIEDNEYTAR-EGAKFPIKWTAPEA 174
Query: 334 L-HRSYSTEADVWSIGV-IAYILLCGSRPFWARTESGIFRAV 373
+ S++ ++DVWS G+ + I+ G P+ + + RA+
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 216
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 60/231 (25%), Positives = 92/231 (39%), Gaps = 36/231 (15%)
Query: 158 ELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
L +G G FG Y + + G+ QVAVK +P+ + D E I+
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPE--SCSEQDESDFLMEALIMSKF 66
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN---- 271
H N+V+ + ++++EL GG+L L E + M +L
Sbjct: 67 N-HQNIVRLIGVSFERLPRFILLELMAGGDLKS-FLRENRPRPERPSSLTMKDLLFCARD 124
Query: 272 VVAFCHL---QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
V C +HRD+ N L T K V K DFG++ DI ++YY
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA---------RDIYRASYY 175
Query: 329 ------------VAPEV-LHRSYSTEADVWSIGVIAY-ILLCGSRPFWART 365
+ PE L ++++ DVWS GV+ + I G P+ RT
Sbjct: 176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 62/235 (26%), Positives = 100/235 (42%), Gaps = 41/235 (17%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIE----DVRREVKI 211
+ LG+ +G G FG A+ + + V V KM A E D+ E+++
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAV----KMLKDDATEKDLSDLVSEMEM 68
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR---------------GGK 256
++ + H N++ +YVV+E G L D + +R
Sbjct: 69 MKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEET 128
Query: 257 YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS------ 310
T+ D + Q+ + F + +HRDL N L T E+ V+K DFGL+
Sbjct: 129 LTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT---EDHVMKIADFGLARDIHHI 185
Query: 311 DFVRP--DERLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPF 361
D+ R + RL ++APE L R Y+ ++DVWS GV+ + I G P+
Sbjct: 186 DYYRKTTNGRL-----PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 79/285 (27%), Positives = 124/285 (43%), Gaps = 48/285 (16%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR--REVKILRALTGH 218
E+GRG FG K G +AVK I +T E R ++ ++ +
Sbjct: 10 GEIGRGAFGTVNKMLHKP---SGTIMAVKRI----RSTVDEKEQKRLLMDLDVVMRSSDC 62
Query: 219 NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI-QILNVVAFC- 276
+VKF+ A + ++ MEL +D L + KY + K+V+ +IL +A
Sbjct: 63 PYIVKFYGALFREGDCWICMEL------MDISLDKFYKYVYEVLKSVIPEEILGKIAVAT 116
Query: 277 -----HLQ---GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI-----V 323
+L+ ++HRD+KP N L D N +K DFG+S + ++ I
Sbjct: 117 VKALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQL-----VDSIAKTRDA 168
Query: 324 GSAYYVAPEVLHRS----YSTEADVWSIGVIAYILLCGSRPFWARTESGIF---RAVLKA 376
G Y+APE + S Y +DVWS+G+ Y + G P+ + +F V+K
Sbjct: 169 GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY--PKWNSVFDQLTQVVKG 226
Query: 377 D-PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
D P + S +F+ L KD KR + L HP+IK
Sbjct: 227 DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
++G G +G +KK VAVK + + M +E+ +E +++ + H NL
Sbjct: 13 KLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNL 64
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM---IQILNVVAFCHL 278
V+ Y++ E G LLD + R E +A ++ QI + + +
Sbjct: 65 VQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEK 122
Query: 279 QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPEVL- 334
+ +HRDL N L EN ++K DFGLS + + G+ + + APE L
Sbjct: 123 KNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA 178
Query: 335 HRSYSTEADVWSIGVIAY-ILLCGSRPF 361
+ +S ++DVW+ GV+ + I G P+
Sbjct: 179 YNKFSIKSDVWAFGVLLWEIATYGMSPY 206
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 68/250 (27%), Positives = 110/250 (44%), Gaps = 22/250 (8%)
Query: 168 FGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFD 226
G C + G G +VA+K + M ++ E +I++ L H+ LV +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQ----EAQIMKKLR-HDKLVPLY- 67
Query: 227 AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI-QILNVVAFCHLQGVVHRD 285
A + +Y+V E G LLD + GKY + M QI + +A+ +HRD
Sbjct: 68 AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 286 LKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPE-VLHRSYSTE 341
L+ N L +N V K DFGL+ + D G+ + + APE L+ ++ +
Sbjct: 128 LRAANILVG---DNLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 342 ADVWSIGVIAYILLCGSR-PFWARTESGIFRAVLKADPSFDEAPWPSLSSEA-RDFVKRL 399
+DVWS G++ L+ R P+ + R VL+ P P E+ + +K
Sbjct: 184 SDVWSFGILLTELVTKGRVPY----PGMVNREVLEQVERGYRMPCPQGCPESLHELMKLC 239
Query: 400 LNKDPRKRLT 409
KDP +R T
Sbjct: 240 WKKDPDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 5e-11
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 33/222 (14%)
Query: 149 FSKHFANKYELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVI-----PKHKMTTAIAI 202
F K + K +G GHFG + + G+ VAVK + ++
Sbjct: 1 FHKRYLKKIR---VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNT------- 50
Query: 203 EDVRREVKILRALTGHNNLVKFFDAYEDTDN--VYVVMELCEGGELLDRILSRGGKYTED 260
++E+ IL+ L H N+VK+ + + ++ME G L D + K+ +
Sbjct: 51 SGWKKEINILKTLY-HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLN 105
Query: 261 DAKAVMI--QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER 318
A+ ++ QI +A+ H Q +HRDL N L D + ++K DFGL+ V
Sbjct: 106 LAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHE 162
Query: 319 L----NDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILL 355
D ++ A E L +S +DVWS GV Y LL
Sbjct: 163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 29/231 (12%)
Query: 155 NKYELGEEVGRGHFGYTCAAKF----KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
+ LG+ +G G FG A+ K K VAVK++ T + D+ E++
Sbjct: 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEME 69
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR---GGKYTEDDAK---- 263
+++ + H N++ A +YV++E G L + + +R G Y+ D K
Sbjct: 70 MMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEE 129
Query: 264 --------AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
+ Q+ + + Q +HRDL N L T E++V+K DFGL+ V
Sbjct: 130 QLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT---EDNVMKIADFGLARDVHN 186
Query: 316 DERLNDIVGS---AYYVAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPF 361
+ ++APE L R Y+ ++DVWS GV+ + I G P+
Sbjct: 187 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 41/215 (19%)
Query: 161 EEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN 219
+++G+G+FG ++ + G+ VAVK K + +TA + D RE++IL++L H+
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVK---KLQHSTAEHLRDFEREIEILKSLQ-HD 65
Query: 220 NLVKF----FDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI---QILNV 272
N+VK+ + A N+ +VME G L D + + D + +++ QI
Sbjct: 66 NIVKYKGVCYSA--GRRNLRLVMEYLPYGSLRDYLQKHRERL---DHRKLLLYASQICKG 120
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV--- 329
+ + + VHRDL N L + EN V K DFGL+ + D+ YY
Sbjct: 121 MEYLGSKRYVHRDLATRNIL--VESENRV-KIGDFGLTKVLPQDKE--------YYKVRE 169
Query: 330 ---------APEVLHRS-YSTEADVWSIGVIAYIL 354
APE L S +S +DVWS GV+ Y L
Sbjct: 170 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 8e-11
Identities = 61/210 (29%), Positives = 89/210 (42%), Gaps = 30/210 (14%)
Query: 220 NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
N+V D+V++V++ EGG+L I E+ K +++ + H +
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL-NIPEECVKRWAAEMVVALDALHRE 104
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYS 339
G+V RDL P N L D+ ++ F V + V Y APEV S
Sbjct: 105 GIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVED-SCDGEAV-ENMYCAPEVGGISEE 159
Query: 340 TEA-DVWSIGVIAYILLCG-----SRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393
TEA D WS+G I + LL G P SGI P + +S EAR
Sbjct: 160 TEACDWWSLGAILFELLTGKTLVECHP------SGINTHTTLNIPEW-------VSEEAR 206
Query: 394 DFVKRLLNKDPRKRLTAAQA-----LSHPW 418
+++LL +P +RL A A SHP+
Sbjct: 207 SLLQQLLQFNPTERLGAGVAGVEDIKSHPF 236
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 158 ELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
E + +G G FG + +GE VA+KV+ + T+ A +++ E ++ A
Sbjct: 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE--TSPKANKEILDEAYVM-ASV 66
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H ++V+ + V ++ +L G LLD + + +QI +++
Sbjct: 67 DHPHVVRLL-GICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL 125
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPE- 332
+ +VHRDL N L T +K DFGL+ + DE+ G ++A E
Sbjct: 126 EEKRLVHRDLAARNVLVKTP---QHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 333 VLHRSYSTEADVWSIGVIAYILLC-GSRPF 361
+LHR Y+ ++DVWS GV + L+ G++P+
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQ--VAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+GRG FG AK K E +G + V VK + K K + + RRE+ + R L+ H N
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQS--EFRRELDMFRKLS-HKN 69
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH--L 278
+V+ + + Y+++E + G+L + + K ++ K + VA C
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSK--DEKLKPPPLSTKQKVALCTQIA 127
Query: 279 QGV--------VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYY 328
G+ VHRDL N L ++ + V K LS V E +L + + +
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSS--QREV-KVSLLSLSKDVYNSEYYKLRNALIPLRW 184
Query: 329 VAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPF 361
+APE V +ST++DVWS GV+ + + G PF
Sbjct: 185 LAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF 219
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 63/223 (28%), Positives = 101/223 (45%), Gaps = 29/223 (13%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G G+FG A+ KK L+ A+K + ++ + D E+++L L H N++
Sbjct: 3 IGEGNFGQVLKARIKKDGLR-MDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNII 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLD-----RILSRGGKYTEDDAKAVMI---QIL---- 270
A E +Y+ +E G LLD R+L + ++ A + Q+L
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 271 ---NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGS- 325
+ + + +HRDL N L EN V K DFGLS R E + +G
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLS---RGQEVYVKKTMGRL 173
Query: 326 -AYYVAPEVLHRS-YSTEADVWSIGVIAY-ILLCGSRPFWART 365
++A E L+ S Y+T +DVWS GV+ + I+ G P+ T
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 69/250 (27%), Positives = 108/250 (43%), Gaps = 22/250 (8%)
Query: 168 FGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFD 226
G C + G G +VA+K + M+ E +E ++++ L H LV+ +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLR-HEKLVQLY- 67
Query: 227 AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI-QILNVVAFCHLQGVVHRD 285
A + +Y+V E G LLD + GKY M QI + +A+ VHRD
Sbjct: 68 AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 286 LKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPE-VLHRSYSTE 341
L+ N L EN V K DFGL+ + D G+ + + APE L+ ++ +
Sbjct: 128 LRAANILV---GENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 342 ADVWSIGVIAYILLCGSR-PFWARTESGIFRAVLKADPSFDEAPWPSLSSEA-RDFVKRL 399
+DVWS G++ L R P+ + R VL P P E+ D + +
Sbjct: 184 SDVWSFGILLTELTTKGRVPY----PGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 239
Query: 400 LNKDPRKRLT 409
K+P +R T
Sbjct: 240 WRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 3e-10
Identities = 45/148 (30%), Positives = 74/148 (50%), Gaps = 8/148 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+ RG FG + K + AVKV+ K M + V+ E L AL+ +V
Sbjct: 12 ISRGAFGKVYLGRKKN---NSKLYAVKVVKKADMINKNMVHQVQAERDAL-ALSKSPFIV 67
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ + + +NVY+VME GG++ +L G + E+ A + ++ + + H G++
Sbjct: 68 HLYYSLQSANNVYLVMEYLIGGDV-KSLLHIYGYFDEEMAVKYISEVALALDYLHRHGII 126
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLS 310
HRDLKP+N L + + +K DFGLS
Sbjct: 127 HRDLKPDNMLISNEGH---IKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 54/220 (24%), Positives = 102/220 (46%), Gaps = 20/220 (9%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+L +++G G FG + +VA+K + + M+ + E +++ L
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNGH----TKVAIKSLKQGSMSPEAFLA----EANLMKQLQ- 59
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRI-LSRGGKYTEDDAKAVMIQILNVVAFC 276
H LV+ + A + +Y++ E E G L+D + G K T + + QI +AF
Sbjct: 60 HPRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI 118
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPEV 333
+ +HRDL+ N L + E K DFGL+ + +E G+ + + APE
Sbjct: 119 ERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEA 174
Query: 334 L-HRSYSTEADVWSIGV-IAYILLCGSRPFWARTESGIFR 371
+ + +++ ++DVWS G+ + I+ G P+ T + +
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ 214
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 29/227 (12%)
Query: 159 LGEEVGRGHFGYTCAAKF----KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
LG+ +G G FG A+ K+ + +VAVK++ T + D+ E+++++
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKM 79
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR---GGKYTED----------- 260
+ H N++ A +YV++E G L + + +R G +Y +
Sbjct: 80 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139
Query: 261 -DAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDER 318
D + Q+ + + + +HRDL N L T E++V+K DFGL+ D D
Sbjct: 140 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY 196
Query: 319 LNDIVGS--AYYVAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPF 361
G ++APE L R Y+ ++DVWS GV+ + I G P+
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 29/223 (13%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G G+FG A KK LK A+K++ + + D E+++L L H N++
Sbjct: 10 IGEGNFGQVIRAMIKKDGLK-MNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNII 66
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLD-----RILSRGGKYTEDDAKAVMI---QIL---- 270
A E+ +Y+ +E G LLD R+L + ++ A + Q+L
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 271 ---NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGS- 325
+ + + +HRDL N L EN K DFGLS R +E + +G
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLV---GENLASKIADFGLS---RGEEVYVKKTMGRL 180
Query: 326 -AYYVAPEVLHRS-YSTEADVWSIGVIAY-ILLCGSRPFWART 365
++A E L+ S Y+T++DVWS GV+ + I+ G P+ T
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 73/283 (25%), Positives = 122/283 (43%), Gaps = 38/283 (13%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR---EVKI 211
N + + +G G+FG A+ KK L+ A+K +M + +D R E+++
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLR-MDAAIK-----RMKEYASKDDHRDFAGELEV 60
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD-----RILSRGGKYTEDDAKAVM 266
L L H N++ A E +Y+ +E G LLD R+L + ++ A
Sbjct: 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120
Query: 267 IQILNVVAFC----------HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316
+ ++ F + +HRDL N L EN V K DFGLS R
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLS---RGQ 174
Query: 317 E-RLNDIVGS--AYYVAPEVLHRS-YSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFR 371
E + +G ++A E L+ S Y+T +DVWS GV+ + I+ G P+ T + ++
Sbjct: 175 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 234
Query: 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
K + + E D +++ + P +R + AQ L
Sbjct: 235 ---KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 9e-10
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 25/202 (12%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQ----VAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
E+G G+FG KKG K ++ VAVK++ A+ +++ RE +++ L
Sbjct: 2 ELGSGNFG-----TVKKGMYKMKKSEKTVAVKILKNDNNDPALK-DELLREANVMQQL-- 53
Query: 218 HNN--LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
+N +V+ E ++ +VMEL E G L ++ L + TE + ++ Q+ + +
Sbjct: 54 -DNPYIVRMIGICE-AESWMLVMELAELGPL-NKFLQKNKHVTEKNITELVHQVSMGMKY 110
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY----VAP 331
VHRDL N L T+ K DFGLS + DE + AP
Sbjct: 111 LEETNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAP 167
Query: 332 EVL-HRSYSTEADVWSIGVIAY 352
E + + +S+++DVWS GV+ +
Sbjct: 168 ECMNYYKFSSKSDVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 52/218 (23%), Positives = 100/218 (45%), Gaps = 32/218 (14%)
Query: 170 YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229
+ C K G+ + ++V VK + K RE+ IL+ ++ H ++ AY
Sbjct: 109 FVCT---KHGDEQRKKVIVKAVTGGK--------TPGREIDILKTIS-HRAIINLIHAYR 156
Query: 230 DTDNVYVVMEL--CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLK 287
V +VM C+ +DR G + A + ++L +A+ H +G++HRD+K
Sbjct: 157 WKSTVCMVMPKYKCDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVK 212
Query: 288 PENFLFTTKDENSVLKAIDFGLSDFVRPDERLND-----IVGSAYYVAPEVLH-RSYSTE 341
EN +F + EN+VL DFG + + D + G+ +PE+L Y +
Sbjct: 213 TEN-IFLDEPENAVLG--DFGAA--CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAK 267
Query: 342 ADVWSIGVIAYILLCGSRPFWAR---TESGIFRAVLKA 376
D+WS G++ + + + + + + S R++++
Sbjct: 268 TDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC 305
|
Length = 392 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 33/104 (31%), Positives = 51/104 (49%), Gaps = 4/104 (3%)
Query: 253 RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312
R D A + QIL + + H Q ++HRD+K EN D + V D G + F
Sbjct: 150 RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI--NDVDQVCIG-DLGAAQF 206
Query: 313 VRPDERLNDIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILL 355
+ G+ APEVL R Y+++AD+WS G++ + +L
Sbjct: 207 PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 58/227 (25%), Positives = 101/227 (44%), Gaps = 29/227 (12%)
Query: 159 LGEEVGRGHFGYTCAAKF----KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
LG+ +G G FG A+ K + VAVK++ + +A D+ E+++++
Sbjct: 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLA--DLISEMELMKL 73
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR---GGKYTED----------- 260
+ H N++ +YV++E G L + + +R G YT D
Sbjct: 74 IGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 261 -DAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL 319
D + Q+ + + + +HRDL N L T E++V+K DFGL+ V +
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT---EDNVMKIADFGLARGVHDIDYY 190
Query: 320 NDIVGS---AYYVAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPF 361
++APE L R Y+ ++DVWS G++ + I G P+
Sbjct: 191 KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 52/217 (23%), Positives = 91/217 (41%), Gaps = 12/217 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G G FG K K VA+K + T +D E I+ + H+N++
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTEKQRQDFLSEASIMGQFS-HHNII 69
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ ++ E E G L + G+++ ++ I + + V
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYV 129
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLNDIVGSAY---YVAPEVL-HRS 337
HRDL N L + N K DFGLS + D E G + APE + +R
Sbjct: 130 HRDLAARNILV---NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 338 YSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
+++ +DVWS G++ + ++ G RP+W + + +A+
Sbjct: 187 FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI 223
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+L +++G G FG + G G +VAVK + M+ +E E +I++ L
Sbjct: 9 QLIKKLGNGQFG-----EVWMGTWNGNTKVAVKTLKPGTMSPESFLE----EAQIMKKLR 59
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI-QILNVVAF 275
H+ LV+ + A + +Y+V E G LLD + G+ + M Q+ +A+
Sbjct: 60 -HDKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAY 117
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPE 332
+HRDL+ N L + V K DFGL+ + D G+ + + APE
Sbjct: 118 IERMNYIHRDLRSANILV---GDGLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPE 173
Query: 333 V-LHRSYSTEADVWSIGVIAYILLCGSR 359
L+ ++ ++DVWS G++ L+ R
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 60/246 (24%), Positives = 95/246 (38%), Gaps = 66/246 (26%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAI------------EDV 205
EE+G G FG K KGEL G + T++AI ++
Sbjct: 8 RFLEELGEGAFG-----KVYKGELTGPN-------ERLSATSVAIKTLKENAEPKVQQEF 55
Query: 206 RREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG-----GKYTED 260
R+E + L + H N+V ++ E G+L + ++ G + D
Sbjct: 56 RQEAE-LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGD 114
Query: 261 DAKA----------VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310
+ + IQI + + VHRDL N L E +K DFGLS
Sbjct: 115 ETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV---GEGLTVKISDFGLS 171
Query: 311 DFVRPDERLNDIVGSAYY------------VAPE-VLHRSYSTEADVWSIGVIAY-ILLC 356
DI + YY + PE +L+ ++TE+D+WS GV+ + I
Sbjct: 172 ---------RDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSY 222
Query: 357 GSRPFW 362
G +P++
Sbjct: 223 GLQPYY 228
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 61/239 (25%), Positives = 105/239 (43%), Gaps = 42/239 (17%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQ----QVAVKVIPKHKMTTAIAIEDVRREVKI 211
LG+ +G G FG K LKG+ VAVK++ ++ ++ + D+ E +
Sbjct: 1 NLVLGKTLGEGEFGKV--VKATAFRLKGRAGYTTVAVKMLKEN--ASSSELRDLLSEFNL 56
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGEL--------------LDRILSRGGKY 257
L+ + H +++K + A + +++E + G L L +R Y
Sbjct: 57 LKQVN-HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 258 TE-DDAKAVMIQILNVVAFCHLQG--------VVHRDLKPENFLFTTKDENSVLKAIDFG 308
+ D +A+ + L A+ +G +VHRDL N L E +K DFG
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA---EGRKMKISDFG 172
Query: 309 LSDFVRPDE----RLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPF 361
LS V ++ R + ++A E L Y+T++DVWS GV+ + I+ G P+
Sbjct: 173 LSRDVYEEDSYVKRSKGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 67/292 (22%), Positives = 111/292 (38%), Gaps = 51/292 (17%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQ---VAVKVIPKHKMTTAIAIEDVRREVKI 211
N E ++G+G FG A+ G L + VAVK++ + A D +RE +
Sbjct: 5 NNIEYVRDIGQGAFGRVFQAR-APGLLPYEPFTMVAVKMLKEEASADMQA--DFQREAAL 61
Query: 212 LRALTGHNNLVKF---------------FDAYEDTDNV------YVVMELCEGGELLDRI 250
+ H N+VK + AY D + L +
Sbjct: 62 MAEFD-HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 251 LSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310
+ + + Q+ +A+ + VHRDL N L EN V+K DFGLS
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLS 177
Query: 311 ------DFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAY-ILLCGSRPFWA 363
D+ + E ND + + + + Y+TE+DVW+ GV+ + I G +P++
Sbjct: 178 RNIYSADYYKASE--NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235
Query: 364 RTESGIFRAVLKAD----PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAA 411
+ V + P D P E + ++ +K P R + A
Sbjct: 236 MAHEEVIYYVRDGNVLSCP--DNCP-----LELYNLMRLCWSKLPSDRPSFA 280
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-08
Identities = 34/135 (25%), Positives = 56/135 (41%), Gaps = 20/135 (14%)
Query: 180 ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV-KFFDAYEDTDNVYVVM 238
K + +K+ P + D REV IL+ L V K + E Y++M
Sbjct: 18 GTKDEDYVLKINP-----SREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLM 72
Query: 239 ELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH---LQGVVHRDLKPENFLFTT 295
E EG L + +E++ + + Q+ ++A H L + H DL P N L
Sbjct: 73 EWIEGETL--------DEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILV-- 122
Query: 296 KDENSVLKAIDFGLS 310
D+ +L ID+ +
Sbjct: 123 -DDGKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 40/219 (18%)
Query: 162 EVGRGHFGYTCAAKFKKG--ELKGQQ--VAVKVIPKHKMTTAIAIED-VRREVKILRALT 216
E+G G+FG C KKG +++ +Q VA+KV+ K ++ D + RE +I+ L
Sbjct: 2 ELGSGNFG--CV---KKGVYKMRKKQIDVAIKVL---KNENEKSVRDEMMREAEIMHQLD 53
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
+ +V+ E + + +VME+ GG L + + + T + +M Q+ + +
Sbjct: 54 -NPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYL 111
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY-------- 328
+ VHRDL N L + K DFGLS + D+ +YY
Sbjct: 112 EGKNFVHRDLAARNVLLVNQ---HYAKISDFGLSKALGADD--------SYYKARSAGKW 160
Query: 329 ----VAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPF 361
APE ++ R +S+ +DVWS G+ + G +P+
Sbjct: 161 PLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 43/136 (31%), Positives = 66/136 (48%), Gaps = 8/136 (5%)
Query: 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290
T V +V +L G LLD + + D +QI +++ +VHRDL N
Sbjct: 80 TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARN 139
Query: 291 FLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPE-VLHRSYSTEADVWS 346
L K N V K DFGL+ + DE G ++A E +LHR ++ ++DVWS
Sbjct: 140 VL--VKSPNHV-KITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWS 196
Query: 347 IGVIAYILLC-GSRPF 361
GV + L+ G++P+
Sbjct: 197 YGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 8e-08
Identities = 71/327 (21%), Positives = 126/327 (38%), Gaps = 71/327 (21%)
Query: 158 ELGEEVGRGHFGYTCA--AKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR---EVKIL 212
EL +G+ AK K VAVK I + ED++ E+
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKP---TNTLVAVKKINLDSCSK----EDLKLLQQEIITS 53
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGG---ELLDRILSRGGKYTEDDAKAVMIQ- 268
R L H N++ + ++ +YVV L G +LL G A A +++
Sbjct: 54 RQLQ-HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPEL---AIAFILKD 109
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSA-- 326
+LN + + H +G +HR +K + L + D VL + + +S ++ +R +
Sbjct: 110 VLNALDYIHSKGFIHRSVKASHILLSG-DGKVVLSGLRYSVS-MIKHGKRQRVVHDFPKS 167
Query: 327 -----YYVAPEVLHRS---YSTEADVWSIGVIAYILLCGSRPFW---------------- 362
+++PEVL ++ Y+ ++D++S+G+ A L G PF
Sbjct: 168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTV 227
Query: 363 ----------------ARTESGIFRAVLKADPSFDEAPWPSLSSEA-RDFVKRLLNKDPR 405
+++ S + P+ SE FV+ L +DP
Sbjct: 228 PCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVD---HPYTRTFSEHFHQFVELCLQRDPE 284
Query: 406 KRLTAAQALSHPW---IKNSNDVKVPL 429
R +A+Q L+H + K N + L
Sbjct: 285 SRPSASQLLNHSFFKQCKRRNTSLLDL 311
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 8e-08
Identities = 32/131 (24%), Positives = 63/131 (48%), Gaps = 8/131 (6%)
Query: 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT 295
+V +L G LLD + +QI + + +VHR+L N L +
Sbjct: 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKS 144
Query: 296 KDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIA 351
+S+++ DFG++D + PD++ ++ ++A E + Y+ ++DVWS GV
Sbjct: 145 ---DSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTV 201
Query: 352 YILLC-GSRPF 361
+ ++ G+ P+
Sbjct: 202 WEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 33/101 (32%), Positives = 50/101 (49%), Gaps = 10/101 (9%)
Query: 322 IVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 380
I+G+ Y+APE+L + + D W++GV + L G PF T +F+ +L D
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRD--- 596
Query: 381 DEAPWP----SLSSEARDFVKRLLNKDPRKRLTAAQALSHP 417
PWP LS A++ ++ LL DP KR + HP
Sbjct: 597 --IPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHP 635
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 54/193 (27%), Positives = 82/193 (42%), Gaps = 41/193 (21%)
Query: 249 RILSRGGKYTEDDAKAVMI-----------------QILNVVAFCHLQGVVHRDLKPENF 291
R R G Y + D + ++ Q+ ++F + +HRDL N
Sbjct: 186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNI 245
Query: 292 LFTTKDENSVLKAIDFGLSDFVRPDERLNDIV-GSAY----YVAPE-VLHRSYSTEADVW 345
L T + K DFGL+ +R D N +V G+A ++APE + + Y+ E+DVW
Sbjct: 246 LLT---HGRITKICDFGLARDIRNDS--NYVVKGNARLPVKWMAPESIFNCVYTFESDVW 300
Query: 346 SIGVIAY-ILLCGSRPFWARTESGIFRAVLKA-----DPSFDEAPWPSLSSEARDFVKRL 399
S G++ + I GS P+ F ++K P AP SE D +K
Sbjct: 301 SYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPEC--AP-----SEMYDIMKSC 353
Query: 400 LNKDPRKRLTAAQ 412
+ DP KR T Q
Sbjct: 354 WDADPLKRPTFKQ 366
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 53/216 (24%), Positives = 94/216 (43%), Gaps = 32/216 (14%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+GHFG + + AVK + +++T +E +E I++ + H N++
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSL--NRITDLEEVEQFLKEGIIMKDFS-HPNVL 59
Query: 223 KFFDAYEDTDNV-YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
++ VV+ + G+L + I S T D +Q+ + + +
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKF 119
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY------------- 328
VHRDL N + DE+ +K DFGL+ DI YY
Sbjct: 120 VHRDLAARNCML---DESFTVKVADFGLA---------RDIYDKEYYSVHNHTGAKLPVK 167
Query: 329 -VAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPF 361
+A E L + ++T++DVWS GV+ + L+ G+ P+
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 41/136 (30%), Positives = 64/136 (47%), Gaps = 8/136 (5%)
Query: 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290
T V ++ +L G LLD + +QI + + + +VHRDL N
Sbjct: 80 TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARN 139
Query: 291 FLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPE-VLHRSYSTEADVWS 346
L T +K DFGL+ + DE+ G ++A E +LHR Y+ ++DVWS
Sbjct: 140 VLVKTPQH---VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWS 196
Query: 347 IGVIAYILLC-GSRPF 361
GV + L+ GS+P+
Sbjct: 197 YGVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 38/114 (33%), Positives = 58/114 (50%), Gaps = 18/114 (15%)
Query: 258 TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS------- 310
T +D Q+ + F + +HRDL N L + EN+V+K DFGL+
Sbjct: 177 TLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDP 233
Query: 311 DFVRP-DERLNDIVGSAYYVAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPF 361
D+VR D RL ++APE + R Y+ ++DVWS GV+ + I G+ P+
Sbjct: 234 DYVRKGDARL-----PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 34/90 (37%), Positives = 51/90 (56%), Gaps = 18/90 (20%)
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLS-------DFVRP-DERLNDIVGSAYYVAPE- 332
+HRDL N L + EN+V+K DFGL+ D+VR D RL ++APE
Sbjct: 195 IHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARL-----PLKWMAPES 246
Query: 333 VLHRSYSTEADVWSIGVIAY-ILLCGSRPF 361
+ + Y+T++DVWS GV+ + I G+ P+
Sbjct: 247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 6e-07
Identities = 59/237 (24%), Positives = 99/237 (41%), Gaps = 38/237 (16%)
Query: 155 NKYELGEEVGRGHFG--YTCAAK-------FKKGELKGQQVAVKVIPKHKMTTAIAIEDV 205
+ L E++G G FG + C A+ E GQ V V V T A D
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64
Query: 206 RREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTE------ 259
+E+KI+ L + N+++ D + ++ E E G+L ++ LS+ +
Sbjct: 65 LKEIKIMSRLK-NPNIIRLLGVCVSDDPLCMITEYMENGDL-NQFLSQREIESTFTHANN 122
Query: 260 ------DDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS--- 310
+ + +QI + + + VHRDL N L + +K DFG+S
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV---GNHYTIKIADFGMSRNL 179
Query: 311 ---DFVRPDERLNDIVGSAYYVAPE-VLHRSYSTEADVWSIGVIAY--ILLCGSRPF 361
D+ R R V ++A E +L ++T +DVW+ GV + LC +P+
Sbjct: 180 YSGDYYRIQGR---AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY 233
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 59/247 (23%), Positives = 99/247 (40%), Gaps = 24/247 (9%)
Query: 122 GSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFG--YTCAAKFKKG 179
S + A P+ + P P A F + + +++ G FG + CA +
Sbjct: 117 ASHLDFDEAPPDAAGPVPLA--QAKLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTE 174
Query: 180 EL---KGQQVAVKVIPKHKMTTAIAIEDVRR-------EVKILRALTGHNNLVKFFDAYE 229
E +G + PK + A ++ R E+ L L H N++K +
Sbjct: 175 EAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN-HENILKIEEILR 233
Query: 230 DTDNVYVVMELCE---GGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDL 286
N Y++ + + + D + +A+M Q+L V + H + ++HRD+
Sbjct: 234 SEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDI 293
Query: 287 KPENFLFTTKDENSVLKAIDFG-LSDFVRPDE-RLNDIVGSAYYVAPEVLHR-SYSTEAD 343
K EN +F D VL DFG F + E VG+ +PE+L Y D
Sbjct: 294 KLEN-IFLNCDGKIVLG--DFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITD 350
Query: 344 VWSIGVI 350
+WS G+I
Sbjct: 351 IWSCGLI 357
|
Length = 501 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 68/275 (24%), Positives = 120/275 (43%), Gaps = 40/275 (14%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ LG +G+G FG A+ K + Q+VAVK++ K + ++ IE+ RE ++
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59
Query: 217 GHNNLVKFFD------AYEDTDNVYVVMELCEGGELLDRIL-SRGGK----YTEDDAKAV 265
H N++K A V++ + G+L +L SR G+
Sbjct: 60 -HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118
Query: 266 MIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS------DFVRPDERL 319
MI I + + + + +HRDL N + +EN + DFGLS D+ R
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVADFGLSKKIYSGDYYRQ---- 171
Query: 320 NDIVGSAY-----YVAPEVLHRS-YSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRA 372
G A ++A E L + Y+T +DVW+ GV + I+ G P+ S I+
Sbjct: 172 ----GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNY 227
Query: 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKR 407
++K + + P P + + + + + +P+ R
Sbjct: 228 LIKGNRL--KQP-PDCLEDVYELMCQCWSPEPKCR 259
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 38/117 (32%), Positives = 59/117 (50%), Gaps = 24/117 (20%)
Query: 258 TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS------- 310
T +D Q+ + F + +HRDL N L + EN+V+K DFGL+
Sbjct: 172 TMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDP 228
Query: 311 DFVRPDERLNDIVGSAY----YVAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPF 361
D+VR GSA ++APE + + Y+T++DVWS GV+ + I G+ P+
Sbjct: 229 DYVRK--------GSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 32/93 (34%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLN--- 320
AV Q+L+ + + H +G++HRD+K EN L E+ L DFG + F R
Sbjct: 264 AVARQLLSAIDYIHGEGIIHRDIKTENVLVNGP-EDICLG--DFGAACFARGSWSTPFHY 320
Query: 321 DIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAY 352
I G+ APEVL Y+ D+WS G++ +
Sbjct: 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 35/127 (27%), Positives = 59/127 (46%), Gaps = 12/127 (9%)
Query: 242 EGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301
D +++ + D Q+ N + F + VHRDL N L E +
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC---EGKL 277
Query: 302 LKAIDFGLS-DFVRPDERLNDIVGSAY----YVAPE-VLHRSYSTEADVWSIGVIAY-IL 354
+K DFGL+ D +R ++ GS + ++APE + + Y+T +DVWS G++ + I
Sbjct: 278 VKICDFGLARDIMRDSNYISK--GSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIF 335
Query: 355 LCGSRPF 361
G P+
Sbjct: 336 TLGGTPY 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 52/213 (24%), Positives = 85/213 (39%), Gaps = 61/213 (28%)
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR------PDER 318
+M QIL + H G+VHRD+KP+N +F+ + + K ID G + +R P E
Sbjct: 260 IMRQILFALDGLHSTGIVHRDVKPQNIIFS--EGSGSFKIIDLGAAADLRVGINYIPKEF 317
Query: 319 LNDIVGSAYYVAPEVLHRSYST-EA----------------------DVWSIGVIAYILL 355
L D Y APE S T A D++S G+I ++ +
Sbjct: 318 LLD----PRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI-FLQM 372
Query: 356 CGSRPFWARTESGI--FRAVLKADPSFDEAPW-----PSLSSEAR--------------D 394
R++S + F LK +D W P S + R +
Sbjct: 373 AFPN---LRSDSNLIQFNRQLK-RNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWE 428
Query: 395 FVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKV 427
+K ++ R+R++A AL+HP+ + +
Sbjct: 429 LLKSMMRFKGRQRISAKAALAHPYFDREGLLGL 461
|
Length = 566 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 6e-06
Identities = 41/152 (26%), Positives = 65/152 (42%), Gaps = 21/152 (13%)
Query: 174 AKFKKGELKGQQVAVKV-IPK----HKMTTAIAIEDVRREVKIL-RALTGHNN--LVKFF 225
A+ G+ G + +K IPK ++ I E RRE +I+ RA N V F
Sbjct: 10 AEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV 69
Query: 226 DAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRD 285
D +VME EG L D +++ G + ++ + V H G++H D
Sbjct: 70 DPENFI----IVMEYIEGEPLKD-LINSNGMEELELSREIGRL----VGKLHSAGIIHGD 120
Query: 286 LKPENFLFTTKDENSVLKAIDFGLSDFVRPDE 317
L N + + + IDFGL++F + E
Sbjct: 121 LTTSNMILSGGK----IYLIDFGLAEFSKDLE 148
|
Length = 211 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 58/239 (24%), Positives = 102/239 (42%), Gaps = 26/239 (10%)
Query: 156 KYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR--REVKI 211
K + E+G+G FG Y AK + +VA+K + + A E + E +
Sbjct: 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNE----AASMRERIEFLNEASV 62
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV-----M 266
++ H+ +V+ V+MEL G+L + S + + +A M
Sbjct: 63 MKEFNCHH-VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 267 IQ----ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLND 321
IQ I + +A+ + VHRDL N + E+ +K DFG++ D D
Sbjct: 122 IQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 322 IVG--SAYYVAPEVLHRS-YSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKA 376
G +++PE L ++T +DVWS GV+ + I +P+ + + R V++
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG 237
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 7e-06
Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 35/223 (15%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR--REVKILRALTGH 218
+E+G G FG K GE+ +V+ K +A E ++ E + R+L H
Sbjct: 1 KEIGNGWFG-----KVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQ-H 54
Query: 219 NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILS-RGGKYTEDDAKAVM---IQILNVVA 274
+NL++ + +VME C G+L + S R + D + +I +
Sbjct: 55 SNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLL 114
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD-------FVRPDERLNDIVGSAY 327
H +H DL N L T + +K D+GLS +V PD+ +
Sbjct: 115 HLHKNNFIHSDLALRNCLLTA---DLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL----R 167
Query: 328 YVAPEVLHRSY--------STEADVWSIGVIAYILL-CGSRPF 361
++APE++ + + E++VWS+GV + L GS+P+
Sbjct: 168 WIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 49/218 (22%), Positives = 90/218 (41%), Gaps = 29/218 (13%)
Query: 178 KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVK----FFDAYEDTDN 233
KG ++V ++ K + I+ E+K LR + NN++K D +D
Sbjct: 38 KGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPR 96
Query: 234 VYVVMELCEGGELLDRILSRGGKYTEDD---AKAVMIQI---LNVVAFCHLQGVVHRDLK 287
+ +++E C G L R E D + + I + +++L
Sbjct: 97 LSLILEYCTRGYL------REVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLT 150
Query: 288 PENFLFTTKDENSVLKAIDFGLSDF--VRPDERLNDIVGSAYYVAPEVLH---RSYSTEA 342
+FL T EN LK I GL P + +N +V Y + ++L+ Y+ +
Sbjct: 151 SVSFLVT---ENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLNDIFSEYTIKD 203
Query: 343 DVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 380
D++S+GV+ + + G PF T I+ ++ + S
Sbjct: 204 DIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL 241
|
Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 62/239 (25%), Positives = 95/239 (39%), Gaps = 45/239 (18%)
Query: 161 EEVGRGHFG--YTCAA---------KFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
E++G G FG + C +F KG+ + V V A D +EV
Sbjct: 11 EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEV 70
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGEL--------LDRILSRGGKYTEDD 261
KIL L N+++ D D + ++ E E G+L LD G
Sbjct: 71 KILSRLK-DPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPA 129
Query: 262 AK----------AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS- 310
V +QI + + + VHRDL N L EN +K DFG+S
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLV---GENLTIKIADFGMSR 186
Query: 311 -----DFVRPDERLNDIVGSAYYVAPE-VLHRSYSTEADVWSIGVIAY--ILLCGSRPF 361
D+ R R V ++A E +L ++T +DVW+ GV + ++LC +P+
Sbjct: 187 NLYAGDYYRIQGR---AVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 42/150 (28%), Positives = 59/150 (39%), Gaps = 20/150 (13%)
Query: 174 AKFKKGELKGQQVAVKV-IPK---HK-MTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228
A + G VK IPK H + + E RRE +IL V Y
Sbjct: 10 AIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKA--REAGVPVPIVY 67
Query: 229 E-DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLK 287
+ D DN +VME EG L D E+ ++ ++ +V H G+VH DL
Sbjct: 68 DVDPDNGLIVMEYIEGELLKD--------ALEEARPDLLREVGRLVGKLHKAGIVHGDLT 119
Query: 288 PENFLFTTKDENSVLKAIDFGLSDFVRPDE 317
N + + + IDFGL +F E
Sbjct: 120 TSNIILS----GGRIYFIDFGLGEFSDEVE 145
|
Length = 204 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSA 326
+QI + + + +VHRDL N L K N V K DFGL+ + DE+ + G
Sbjct: 116 VQIAKGMMYLEERRLVHRDLAARNVL--VKSPNHV-KITDFGLARLLEGDEKEYNADGGK 172
Query: 327 Y---YVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPF 361
++A E +H R ++ ++DVWS GV + L+ G +P+
Sbjct: 173 MPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 63/247 (25%), Positives = 97/247 (39%), Gaps = 57/247 (23%)
Query: 155 NKYELGEEVGRGHFG------------YTCAAKFKKGELKGQ--QVAVKVIPKHKMTTAI 200
E++G G FG ++ A F + + VAVKV+ A
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKA-FAENDNADAPVLVAVKVLRPDASDNAR 63
Query: 201 AIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTED 260
ED +EVKIL L+ N+ + + ++ME E G+L ++ L + T
Sbjct: 64 --EDFLKEVKILSRLS-DPNIARLLGVCTVDPPLCMIMEYMENGDL-NQFLQKHVAETSG 119
Query: 261 DAKAV----------MI-QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309
A M QI + + + VHRDL N L +N +K DFG+
Sbjct: 120 LACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV---GKNYTIKIADFGM 176
Query: 310 SDFVRPDERLNDIVGSAYY------VAP-------EVLHRSYSTEADVWSIGVIAY-IL- 354
S ++ S YY P VL ++T++DVW+ GV + IL
Sbjct: 177 S---------RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
Query: 355 LCGSRPF 361
LC +P+
Sbjct: 228 LCREQPY 234
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 58/242 (23%), Positives = 95/242 (39%), Gaps = 59/242 (24%)
Query: 161 EEVGRGHFG--YTCAA----KFKKGELKGQQVAVKVIPKHKMTTAI----------AIED 204
E++G G FG + C A KF + ++ V + A+ A D
Sbjct: 11 EKLGEGQFGEVHLCEAEGMEKFMDKDF-----SLDVSGNQPVLVAVKMLREDANKNARND 65
Query: 205 VRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGEL---LDRILSRGGKYTED- 260
+E+KI+ L N+++ +D + ++ E E G+L L R + D
Sbjct: 66 FLKEIKIMSRLK-DPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 261 ------DAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS---- 310
+ QI + + + VHRDL N L +N +K DFG+S
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV---GKNYTIKIADFGMSRNLY 181
Query: 311 --DFVRPDERLNDIVGSAYYVAP-------EVLHRSYSTEADVWSIGVIAY--ILLCGSR 359
D+ R I G A V P +L ++T +DVW+ GV + + LC +
Sbjct: 182 SGDYYR-------IQGRA--VLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQ 232
Query: 360 PF 361
P+
Sbjct: 233 PY 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 7e-05
Identities = 44/185 (23%), Positives = 70/185 (37%), Gaps = 22/185 (11%)
Query: 244 GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303
L D + RG E++ AV +Q L + H + T D +LK
Sbjct: 1 VSLADILEVRGRPLNEEEIWAVCLQCLGALRELH-------RQAKSGNILLTWD--GLLK 51
Query: 304 AIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRP-F 361
G F Y++APEV+ SY+ +AD++S+G+ Y L P
Sbjct: 52 L--DGSVAFK---TPEQSRPDP-YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYN 105
Query: 362 WARTESGIFRAVLKADPSFDEAPWPSLSS-----EARDFVKRLLNKDPRKRLTAAQALSH 416
R S I +L P+ D +L DF++ ++ P++R A L+H
Sbjct: 106 EERELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAH 165
Query: 417 PWIKN 421
Sbjct: 166 CRALF 170
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 7e-05
Identities = 58/251 (23%), Positives = 97/251 (38%), Gaps = 56/251 (22%)
Query: 161 EEVGRGHFGYTCAAKFKKGEL------KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
EE+G FG K KG L Q VA+K + + + ++E ++
Sbjct: 11 EELGECAFG-----KIYKGHLYLPGMDHAQLVAIKTL--KDINNPQQWGEFQQEASLMAE 63
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR------GGKYTED-------- 260
L H N+V V ++ E G+L + ++ R G ED
Sbjct: 64 LH-HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLD 122
Query: 261 --DAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER 318
D + IQI + + VH+DL N L E +K D GLS
Sbjct: 123 HGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---GEQLHVKISDLGLS-------- 171
Query: 319 LNDIVGSAYY------------VAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPFWAR 364
+I + YY + PE +++ +S+++D+WS GV+ + I G +P++
Sbjct: 172 -REIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF 230
Query: 365 TESGIFRAVLK 375
+ + V K
Sbjct: 231 SNQEVIEMVRK 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 7e-05
Identities = 59/233 (25%), Positives = 104/233 (44%), Gaps = 32/233 (13%)
Query: 159 LGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
LG+ +G G FG + + + LK VAVK + K + T +ED E ++
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILK---VAVKTM-KIAICTRSEMEDFLSEAVCMKEFD 58
Query: 217 GHNNLVKFFDA-YEDTDN-----VYVVMELCEGGELLDRIL-SRGGKYTEDDAKAVMIQI 269
H N+++ + ++ V++ + G+L +L SR G + ++++
Sbjct: 59 -HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKF 117
Query: 270 LNVVA----FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS------DFVRPDERL 319
+ +A + + +HRDL N + +EN + DFGLS D+ R R+
Sbjct: 118 MTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVADFGLSKKIYNGDYYR-QGRI 173
Query: 320 NDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIF 370
+ ++A E L R Y+T++DVWS GV + I G P+ S I+
Sbjct: 174 AKM--PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY 224
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 62/247 (25%), Positives = 106/247 (42%), Gaps = 46/247 (18%)
Query: 156 KYELGEEVGRGHFG--YTCAAK-FKKGELKGQQVAVKVIPKHKMTTAIAIEDVR--REVK 210
K L E+G+G FG Y A+ KGE + +VAVK + + +A E + E
Sbjct: 7 KITLLRELGQGSFGMVYEGNARDIIKGEAE-TRVAVKTVNE----SASLRERIEFLNEAS 61
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV----- 265
+++ T H+ +V+ VVMEL G+L + S + + +
Sbjct: 62 VMKGFTCHH-VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 120
Query: 266 MIQ----ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND 321
MIQ I + +A+ + + VHRDL N + + +K DFG++ D
Sbjct: 121 MIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMT---------RD 168
Query: 322 IVGSAYY------------VAPEVLHR-SYSTEADVWSIGVIAY-ILLCGSRPFWARTES 367
I + YY +APE L ++T +D+WS GV+ + I +P+ +
Sbjct: 169 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 228
Query: 368 GIFRAVL 374
+ + V+
Sbjct: 229 QVLKFVM 235
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 18/171 (10%)
Query: 247 LDRILSRGGK--YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304
+ +LS G T D + Q+ + F + VHRDL N L + ++K
Sbjct: 222 VKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA---QGKIVKI 278
Query: 305 IDFGLSDFVRPDERLNDIV--GSAY----YVAPE-VLHRSYSTEADVWSIGVIAY-ILLC 356
DFGL+ + D ++ V GS + ++APE + Y+T +DVWS G++ + I
Sbjct: 279 CDFGLARDIMHD---SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSL 335
Query: 357 GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKR 407
G P+ F +K+ + A + E D + + N +P KR
Sbjct: 336 GGTPYPGMIVDSTFYNKIKS--GYRMAKPDHATQEVYDIMVKCWNSEPEKR 384
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 102/471 (21%), Positives = 168/471 (35%), Gaps = 123/471 (26%)
Query: 24 NTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAVIEGKKSPFFPFYSPSPAHYFFSK 83
+ P N +P N+ S +T + + A G K + +
Sbjct: 19 TSGAPVNALSGNSPKANNSAS---TGQTTSRSTNSARRSGSKRDR----ETATSTDSGRT 71
Query: 84 KSSPARSSANSTPNRFFKRPFPPPSPAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGL 143
KS ++ P P K K A + S + + G + + +
Sbjct: 72 KSHEGAATTKQATTTPTTNVEVAPPPKKK-KVTYALPNQSREEGHFYVVLGEDIDVSTQ- 129
Query: 144 NKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI---PKHKMTTAI 200
++++ +G G FG A +K + + AVK++ PK+ I
Sbjct: 130 ------------RFKILSLLGEGTFGKVVEAWDRK---RKEYCAVKIVRNVPKYTRDAKI 174
Query: 201 AI---EDVRRE--------VKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDR 249
I E VR+ +KI R +F +T ++ +VM G LLD
Sbjct: 175 EIQFMEKVRQADPADRFPLMKIQR----------YFQ--NETGHMCIVMPK-YGPCLLDW 221
Query: 250 ILSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFG 308
I+ + G ++ ++ Q + + H + ++H DLKPEN L T D +D
Sbjct: 222 IM-KHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSD-----TVVDPV 275
Query: 309 LSDFVRPDE---RLND-------------IVGSAYYVAPEV---LHRSYSTEADVWSIGV 349
+ + PD R+ D IV + +Y +PEV L YST D+WS+G
Sbjct: 276 TNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYST--DMWSMGC 333
Query: 350 IAYILLCGSRPF----------------------WAR---TESG--IFRAVLKADPSFDE 382
I Y L G + WA TE ++ + + P D
Sbjct: 334 IIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDP 393
Query: 383 APWPSLSSEAR--------------DFVKRLLNKDPRKRLTAAQALSHPWI 419
L+ AR D + LL+ D +KRL A Q +HP++
Sbjct: 394 K---HLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYV 441
|
Length = 467 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 49/225 (21%), Positives = 89/225 (39%), Gaps = 30/225 (13%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT----GH 218
+G G FG C K + VA+ T D +R + ALT H
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIH-------TLRAGCSDKQRRGFLAEALTLGQFDH 65
Query: 219 NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCH 277
+N+V+ + + +V E G LD L + G+ ++ + + + +
Sbjct: 66 SNIVRLEGVITRGNTMMIVTEYMSNG-ALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS 124
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGS------AYYVAP 331
G VH+ L L + + V K F +++ I + + AP
Sbjct: 125 EMGYVHKGLAAHKVLVNS---DLVCKISGFRRL----QEDKSEAIYTTMSGKSPVLWAAP 177
Query: 332 EVL--HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
E + H +S+ +DVWS G++ + ++ G RP+W + + +AV
Sbjct: 178 EAIQYHH-FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV 221
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 52/233 (22%), Positives = 90/233 (38%), Gaps = 49/233 (21%)
Query: 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH 218
LG+ +G G FG + + + +VAVK + K + T IE+ E ++ H
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFD-H 60
Query: 219 NNLVKFF------DAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
N++K + + V++ + G+L +L + + +Q L
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLY---SRLGGLPEKLPLQTL-- 115
Query: 273 VAF-----CHLQ-----GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI 322
+ F ++ +HRDL N + E+ + DFGLS I
Sbjct: 116 LKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADFGLS---------KKI 163
Query: 323 VGSAYY------------VAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPF 361
YY +A E L R Y++++DVW+ GV + I G P+
Sbjct: 164 YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 55/237 (23%), Positives = 95/237 (40%), Gaps = 56/237 (23%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKG-------QQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
EE+G FG K KG L G Q VA+K + K K + E+ + E ++R
Sbjct: 11 EELGEDRFG-----KVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLR-EEFKHEA-MMR 62
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY----TEDDAKA----- 264
+ H N+V + ++ C +L + ++ R T+DD
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 265 ------VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER 318
++ QI + F VVH+DL N L K +K D GL
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN---VKISDLGL--------- 170
Query: 319 LNDIVGSAYY------------VAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPF 361
++ + YY ++PE +++ +S ++D+WS GV+ + + G +P+
Sbjct: 171 FREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|185504 PTZ00184, PTZ00184, calmodulin; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 3e-04
Identities = 41/150 (27%), Positives = 75/150 (50%), Gaps = 16/150 (10%)
Query: 458 LTVDELFYLKEQYALLEPNKNGTIS---LENVKSALMKNATDAMKDSRIPDFLSSLNSLQ 514
LT +++ KE ++L + + +GTI+ L V +L +N T+A I + + N
Sbjct: 5 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGT- 63
Query: 515 YRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASEL-GLGPAV 573
+DF EF L +++ D E+ + A+++F++DGN I EL + LG +
Sbjct: 64 ---IDFPEFLT--LMARKMKDTDS-EEEIKEAFKVFDRDGNGFISAAELRHVMTNLGEKL 117
Query: 574 PVHAVLHDWIRHTD----GKLSFLGFVKLL 599
V + IR D G++++ FVK++
Sbjct: 118 TDEEV-DEMIREADVDGDGQINYEEFVKMM 146
|
Length = 149 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 28/89 (31%), Positives = 45/89 (50%), Gaps = 11/89 (12%)
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSA 326
IQI +++ H +GV+H+D+ N + DE +K D LS + P + +G
Sbjct: 124 IQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKITDNALSRDLFPMDY--HCLGDN 178
Query: 327 YY-----VAPEVL-HRSYSTEADVWSIGV 349
+A E L ++ YS+ +DVWS GV
Sbjct: 179 ENRPVKWMALESLVNKEYSSASDVWSFGV 207
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 5e-04
Identities = 41/152 (26%), Positives = 58/152 (38%), Gaps = 24/152 (15%)
Query: 174 AKFKKGELKGQQVAVKV-IPK---H-KMTTAIAIEDVRREVKILRAL--TGHNN-LVKFF 225
A G+ G + +K +PK H ++ I E R E ++L G N +V
Sbjct: 8 AIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV 67
Query: 226 DAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRD 285
D T +VME EG L D I + + + V H G+VH D
Sbjct: 68 DPDNKT----IVMEYIEGKPLKDVIEEGNDELLREIGRLV--------GKLHKAGIVHGD 115
Query: 286 LKPENFLFTTKDENSVLKAIDFGLSDFVRPDE 317
L N + D+ L IDFGL + E
Sbjct: 116 LTTSNIIVR--DDKLYL--IDFGLGKYSDEIE 143
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 5e-04
Identities = 22/46 (47%), Positives = 28/46 (60%), Gaps = 3/46 (6%)
Query: 263 KAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308
K VM Q+L + H G+VHRD+KPEN L T + +K IDFG
Sbjct: 312 KGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ---VKIIDFG 354
|
Length = 507 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 53/217 (24%), Positives = 86/217 (39%), Gaps = 28/217 (12%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+ RG G + K K + Q VK I + I D+ + L+ H N+V
Sbjct: 698 ISRGKKGASYKGKSIKNGM---QFVVKEINDVNSIPSSEIADMGK----LQ----HPNIV 746
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ--- 279
K Y++ E EG L + + + + + + + I I + F H +
Sbjct: 747 KLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSP 802
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYS 339
VV +L PE + KDE + L + D S+ YVAPE
Sbjct: 803 AVVVGNLSPEKIIIDGKDEPHLR----LSLPGLLCTD---TKCFISSAYVAPETRETKDI 855
Query: 340 TE-ADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK 375
TE +D++ G+I LL G P A E G+ ++++
Sbjct: 856 TEKSDIYGFGLILIELLTGKSP--ADAEFGVHGSIVE 890
|
Length = 968 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 12/101 (11%)
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV-GSA 326
Q+ + F + +HRD+ N L T V K DFGL+ + D N +V G+A
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDG---RVAKICDFGLARDIMNDS--NYVVKGNA 274
Query: 327 Y----YVAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPF 361
++APE + Y+ ++DVWS G++ + I G P+
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY 315
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 611 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.98 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.88 | |
| COG5126 | 160 | FRQ1 Ca2+-binding protein (EF-Hand superfamily) [S | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG0027 | 151 | consensus Calmodulin and related proteins (EF-Hand | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| KOG0028 | 172 | consensus Ca2+-binding protein (centrin/caltractin | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.76 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.74 | |
| PTZ00184 | 149 | calmodulin; Provisional | 99.73 | |
| PTZ00183 | 158 | centrin; Provisional | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.7 | |
| KOG0031 | 171 | consensus Myosin regulatory light chain, EF-Hand p | 99.68 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| KOG0034 | 187 | consensus Ca2+/calmodulin-dependent protein phosph | 99.64 | |
| KOG0030 | 152 | consensus Myosin essential light chain, EF-Hand pr | 99.63 | |
| KOG0037 | 221 | consensus Ca2+-binding protein, EF-Hand protein su | 99.62 | |
| KOG0044 | 193 | consensus Ca2+ sensor (EF-Hand superfamily) [Signa | 99.62 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.6 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.48 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.47 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.43 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.43 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.43 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.38 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.37 | |
| KOG0036 | 463 | consensus Predicted mitochondrial carrier protein | 99.37 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.36 | |
| KOG4223 | 325 | consensus Reticulocalbin, calumenin, DNA supercoil | 99.26 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.25 | |
| KOG4223 | 325 | consensus Reticulocalbin, calumenin, DNA supercoil | 99.21 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.16 | |
| PLN02964 | 644 | phosphatidylserine decarboxylase | 99.13 | |
| COG5126 | 160 | FRQ1 Ca2+-binding protein (EF-Hand superfamily) [S | 99.08 | |
| KOG0038 | 189 | consensus Ca2+-binding kinase interacting protein | 99.08 | |
| KOG0027 | 151 | consensus Calmodulin and related proteins (EF-Hand | 99.07 | |
| KOG0044 | 193 | consensus Ca2+ sensor (EF-Hand superfamily) [Signa | 99.05 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.03 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.03 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.99 | |
| PF13499 | 66 | EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A | 98.99 | |
| KOG0377 | 631 | consensus Protein serine/threonine phosphatase RDG | 98.99 | |
| cd05022 | 89 | S-100A13 S-100A13: S-100A13 domain found in protei | 98.97 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.96 | |
| PTZ00183 | 158 | centrin; Provisional | 98.94 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.9 | |
| cd05022 | 89 | S-100A13 S-100A13: S-100A13 domain found in protei | 98.88 | |
| KOG0037 | 221 | consensus Ca2+-binding protein, EF-Hand protein su | 98.84 | |
| PF13499 | 66 | EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A | 98.83 | |
| cd05027 | 88 | S-100B S-100B: S-100B domain found in proteins sim | 98.81 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.81 | |
| PTZ00184 | 149 | calmodulin; Provisional | 98.77 | |
| cd05027 | 88 | S-100B S-100B: S-100B domain found in proteins sim | 98.75 | |
| KOG0028 | 172 | consensus Ca2+-binding protein (centrin/caltractin | 98.75 | |
| cd05026 | 93 | S-100Z S-100Z: S-100Z domain found in proteins sim | 98.74 | |
| cd05029 | 88 | S-100A6 S-100A6: S-100A6 domain found in proteins | 98.74 | |
| smart00027 | 96 | EH Eps15 homology domain. Pair of EF hand motifs t | 98.73 | |
| cd00252 | 116 | SPARC_EC SPARC_EC; extracellular Ca2+ binding doma | 98.66 | |
| cd05026 | 93 | S-100Z S-100Z: S-100Z domain found in proteins sim | 98.65 | |
| cd05025 | 92 | S-100A1 S-100A1: S-100A1 domain found in proteins | 98.64 | |
| KOG0034 | 187 | consensus Ca2+/calmodulin-dependent protein phosph | 98.63 | |
| cd05031 | 94 | S-100A10_like S-100A10_like: S-100A10 domain found | 98.63 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.63 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.62 | |
| cd00213 | 88 | S-100 S-100: S-100 domain, which represents the la | 98.62 | |
| KOG2643 | 489 | consensus Ca2+ binding protein, contains EF-hand m | 98.58 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.57 | |
| cd05029 | 88 | S-100A6 S-100A6: S-100A6 domain found in proteins | 98.56 | |
| KOG0036 | 463 | consensus Predicted mitochondrial carrier protein | 98.55 | |
| cd05025 | 92 | S-100A1 S-100A1: S-100A1 domain found in proteins | 98.53 | |
| cd05023 | 89 | S-100A11 S-100A11: S-100A11 domain found in protei | 98.53 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.52 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-60 Score=465.27 Aligned_cols=268 Identities=37% Similarity=0.676 Sum_probs=242.0
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCH----HHHHHHHHHHHHHHHhcCCCCeeEEEE
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA----IAIEDVRREVKILRALTGHNNLVKFFD 226 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~----~~~~~~~~E~~~l~~l~~h~~iv~l~~ 226 (611)
+.+.+.|.+.+.||+|+||.|-+|..+. +|+.||||++.+...... .....+.+|++||++|+ |||||++++
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~---tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~IV~~~d 243 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKK---TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNIVRIKD 243 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcc---cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCEEEEee
Confidence 4467889999999999999999999877 799999999986644331 12344679999999998 999999999
Q ss_pred EEeeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEee
Q 007253 227 AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (611)
Q Consensus 227 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D 306 (611)
+|+..+..||||||++||+|.+.+..+ +.+.+...+.+++||+.||.|||++||+||||||+|||+..+.+...+||+|
T Consensus 244 ~f~~~ds~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 244 FFEVPDSSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred eeecCCceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecc
Confidence 999999999999999999999998766 5689999999999999999999999999999999999998877889999999
Q ss_pred cccccccCCCCcccccccCCCcCcchhhcC----CCCCcchhhHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCCC
Q 007253 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLHR----SYSTEADVWSIGVIAYILLCGSRPFWARTESG-IFRAVLKADPSFD 381 (611)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~-~~~~i~~~~~~~~ 381 (611)
||+|++......+.+.||||.|.|||++.. .+..++|||||||+||-+++|.+||.+..... ..+.|.++...+.
T Consensus 323 FGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~ 402 (475)
T KOG0615|consen 323 FGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFG 402 (475)
T ss_pred cchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccccc
Confidence 999999988888999999999999999962 24558999999999999999999997765555 8899999999998
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 382 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
...|..++++..+||++||..||+.|||+.++|+||||+...
T Consensus 403 p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 403 PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 899999999999999999999999999999999999999643
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-57 Score=465.11 Aligned_cols=263 Identities=35% Similarity=0.641 Sum_probs=243.2
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
.+|..++.||+|||+.||.++... +|+.||+|++++..+......+.+.+||+|++.|+ |||||+++++|+|.+++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~---tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~FEDs~nV 93 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLD---TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFFEDSNNV 93 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcC---CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEeecCCce
Confidence 579999999999999999999766 69999999999888888888899999999999998 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
|||+|+|+.|+|..+++ +.+.++|.+++.+++||+.||.|||+++|||||||..|+|| +++.+|||+|||||..+.
T Consensus 94 YivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 94 YIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL---NENMNVKIGDFGLATQLE 169 (592)
T ss_pred EEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee---cCcCcEEecccceeeeec
Confidence 99999999999988776 66789999999999999999999999999999999999999 688899999999999887
Q ss_pred CC-CcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 315 PD-ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 315 ~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
.+ ++..+.||||.|.|||++. ..++..+||||+|||+|-|++|++||......+++..|...+..+|. .++.++
T Consensus 170 ~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A 245 (592)
T KOG0575|consen 170 YDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEA 245 (592)
T ss_pred CcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHH
Confidence 44 7889999999999999997 56999999999999999999999999999999999999999888875 689999
Q ss_pred HHHHHHhcccCccCCCCHHHHHcCccc-CCCCCCCCch
Q 007253 393 RDFVKRLLNKDPRKRLTAAQALSHPWI-KNSNDVKVPL 429 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rpt~~~ll~hp~~-~~~~~~~~~~ 429 (611)
++||.+||++||.+|||++++|.|+|| ++.....++.
T Consensus 246 ~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp~ 283 (592)
T KOG0575|consen 246 KDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARLPS 283 (592)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCCCc
Confidence 999999999999999999999999999 4444444444
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-55 Score=431.70 Aligned_cols=263 Identities=30% Similarity=0.485 Sum_probs=230.8
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC-
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD- 232 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~- 232 (611)
..+.+.++.||+|..|+||+++++. +++.+|+|++.-. .+....+++.+|++++++.+ |||||.+||+|..++
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~---t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~-spyIV~~ygaF~~~~~ 151 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKP---TGKIYALKVILLN--IDPALQKQILRELEILRSCQ-SPYIVGFYGAFYSNGE 151 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcC---CCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCC-CCCeeeEeEEEEeCCc
Confidence 4568889999999999999999987 7999999999432 45667789999999999996 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
.++|+||||+||+|.+++... ++++|..+..|+.++++||.|||+ ++||||||||+|||+ ...|.|||||||.++
T Consensus 152 ~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~ 227 (364)
T KOG0581|consen 152 EISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV---NSKGEVKICDFGVSG 227 (364)
T ss_pred eEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee---ccCCCEEeccccccH
Confidence 499999999999998877655 779999999999999999999996 899999999999999 567889999999999
Q ss_pred ccCCCCcccccccCCCcCcchhhcC-CCCCcchhhHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHhcC-CCCCCCC
Q 007253 312 FVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWAR-----TESGIFRAVLKAD-PSFDEAP 384 (611)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~el~~g~~Pf~~~-----~~~~~~~~i~~~~-~~~~~~~ 384 (611)
.+... ..++.+||..|||||.+.+ .|+.++||||||++++|+++|+.||... ...+.+..|.... |.++.
T Consensus 228 ~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~-- 304 (364)
T KOG0581|consen 228 ILVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE-- 304 (364)
T ss_pred Hhhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc--
Confidence 88655 5678899999999999985 6999999999999999999999999764 4456667776643 33333
Q ss_pred CCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCCCCchh
Q 007253 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLD 430 (611)
Q Consensus 385 ~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~~~~~~ 430 (611)
..+|+++++||..||++||.+||++.||++|||++......+.+.
T Consensus 305 -~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~vd~~ 349 (364)
T KOG0581|consen 305 -GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNVDMA 349 (364)
T ss_pred -ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccccccHH
Confidence 258999999999999999999999999999999998876666654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-55 Score=428.34 Aligned_cols=259 Identities=32% Similarity=0.640 Sum_probs=235.7
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|+++++||+|+||.||.++.++ +++.||+|+++|.........+.+..|..||.+++ ||.||+++-.|++.+.
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~d---t~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ysFQt~~k 99 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKD---TGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIYSFQTEEK 99 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcc---cCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEecccCCe
Confidence 5789999999999999999999885 79999999999887777667788999999999987 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|||+||+.||.|..+|.+. +.++|..++.++.+|+.||.|||++|||||||||+|||| |+.|+|+|+|||+|+..
T Consensus 100 LylVld~~~GGeLf~hL~~e-g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQRE-GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEEEEeccCCccHHHHHHhc-CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhc
Confidence 99999999999999887544 679999999999999999999999999999999999999 78999999999999954
Q ss_pred -CCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 314 -RPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 314 -~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
..+..+.+.|||+.|||||++. ..|+..+|+|||||++|||++|.+||.+.+...++++|.+.....+. ..++.+
T Consensus 176 ~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p---~~ls~~ 252 (357)
T KOG0598|consen 176 LKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP---GYLSEE 252 (357)
T ss_pred ccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC---ccCCHH
Confidence 4445677889999999999886 67999999999999999999999999999999999999988733332 247999
Q ss_pred HHHHHHHhcccCccCCC----CHHHHHcCcccCCCC
Q 007253 392 ARDFVKRLLNKDPRKRL----TAAQALSHPWIKNSN 423 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rp----t~~~ll~hp~~~~~~ 423 (611)
+++||+++|.+||++|. .+.++.+||||...+
T Consensus 253 ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in 288 (357)
T KOG0598|consen 253 ARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN 288 (357)
T ss_pred HHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence 99999999999999996 789999999999754
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-53 Score=438.68 Aligned_cols=321 Identities=53% Similarity=0.918 Sum_probs=289.6
Q ss_pred ccccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe
Q 007253 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (611)
Q Consensus 150 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 229 (611)
...+...|++++.||+|.||.||+++.+. +|+.+|+|++.+.........+.+.+|+.+|++|.+|||||.++++|+
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~---tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e 106 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKS---TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFE 106 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecC---CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 34567889999999999999999999887 599999999988777666667889999999999988999999999999
Q ss_pred eCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCC-CceEEEeecc
Q 007253 230 DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE-NSVLKAIDFG 308 (611)
Q Consensus 230 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~-~~~vkl~DfG 308 (611)
+...+++|||+|.||.|++.|... .+++..+..++.||+.++.|||+.||+||||||+|+|+...+. ++.+|++|||
T Consensus 107 ~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 107 DPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred cCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999999999887 3999999999999999999999999999999999999986544 4589999999
Q ss_pred cccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 007253 309 LSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (611)
Q Consensus 309 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (611)
++.....+......+||+.|+|||++. ..|+..+||||+||++|.|++|..||++.+..+.+..|...+..+...+|+.
T Consensus 185 la~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~ 264 (382)
T KOG0032|consen 185 LAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDD 264 (382)
T ss_pred CceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccc
Confidence 999998877888999999999999998 7899999999999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC-CCCCchhHHHHHHHHHHhhcchHHHHHHHhhhhcchhhHHHHH
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN-DVKVPLDVIIFKLMKAYMRSSSLRKAALRALSKTLTVDELFYL 466 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~l~~~e~~~l 466 (611)
++..+++||++||..||.+|+|+.++|+|||++... ....+........++++...+.+++..++...+.++ +..+
T Consensus 265 is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 341 (382)
T KOG0032|consen 265 ISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEATNIPLDISVLSRSKQFLSMSKLKKLALRVLAESLS---ISGL 341 (382)
T ss_pred cCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcccccccccchhhhhHHHHHHHHHHHHHHHHHHhhhhh---HHHH
Confidence 999999999999999999999999999999999863 334455555566677777777777777777777666 7889
Q ss_pred HHHhhhcCCCCC
Q 007253 467 KEQYALLEPNKN 478 (611)
Q Consensus 467 ~~~F~~~D~d~~ 478 (611)
+..|..+|.+++
T Consensus 342 ~~~~~~~~~~~~ 353 (382)
T KOG0032|consen 342 KEMFKLMDTDNN 353 (382)
T ss_pred HHHHHhhccccc
Confidence 999999998776
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-53 Score=420.46 Aligned_cols=264 Identities=37% Similarity=0.685 Sum_probs=237.1
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
...+|.+.++||+|+||+||+|++++ ++..||||.+.+... .....+.+..|+++|+.|+ |||||+|++++.+++
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~---~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~~~ 82 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKK---SGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELK-HPNIVRLLDCIEDDD 82 (429)
T ss_pred ccccceehhhccCcceEEEEEeEecc---CCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcC-CcceeeEEEEEecCC
Confidence 35789999999999999999999998 679999999977654 5567788999999999998 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCC---ceEEEeeccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN---SVLKAIDFGL 309 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~---~~vkl~DfG~ 309 (611)
.+|||||||.||+|.++|+.+ +.+++.+++.++.||+.||++||+++||||||||+||||+....+ ..+||+|||+
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 999999999999999999877 479999999999999999999999999999999999999865333 6899999999
Q ss_pred ccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 310 SDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 310 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
|+.+.++.-..+.||+|.|||||++. +.|+.|+|+||+|+|||+|++|+.||...+..+.+..+.+.....+..+ ..+
T Consensus 162 AR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~-~~~ 240 (429)
T KOG0595|consen 162 ARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP-AEL 240 (429)
T ss_pred hhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh-hhc
Confidence 99999888888999999999999995 8899999999999999999999999999999998887776654443322 245
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
+....+++...|+.++.+|.+..+-+.|+++....
T Consensus 241 s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 241 SNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred cCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 67778999999999999999999999999998765
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-53 Score=430.75 Aligned_cols=260 Identities=34% Similarity=0.657 Sum_probs=237.9
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
-..+|.+++.||.|+|++|++|+.+. +++.||||++.+.....+...+-+..|-.+|.+|.+||.|++|+-.|+|+.
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~---t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~ 147 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKA---TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE 147 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecC---CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc
Confidence 35689999999999999999999887 799999999987766666666677899999999988999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.+|+|+||+++|+|+++|.+. +.+++..++.++.+|+.||+|||++|||||||||+|||| +.++++||+|||.|+.
T Consensus 148 sLYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKI 223 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeecccccc
Confidence 999999999999999999766 689999999999999999999999999999999999999 7999999999999998
Q ss_pred cCCCCc--------------ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC
Q 007253 313 VRPDER--------------LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 377 (611)
Q Consensus 313 ~~~~~~--------------~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~ 377 (611)
+.+... ..+.|||..|.+||++. +..++.+|||+||||||+|+.|.+||.+.++.-+++.|+..+
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~ 303 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD 303 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc
Confidence 754321 14589999999999997 567899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 378 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
..|++ .+++.+.+||+++|..||++|+|+.+|.+||||.+.+
T Consensus 304 y~fp~----~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd 345 (604)
T KOG0592|consen 304 YEFPE----GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD 345 (604)
T ss_pred ccCCC----CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence 88885 6889999999999999999999999999999998754
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-53 Score=401.39 Aligned_cols=255 Identities=33% Similarity=0.632 Sum_probs=237.6
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++++.||.|+||.|.+++.+. +|..||+|++.+...-.....+...+|..+|+.+. ||.++++++.|.+.+.
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~---~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~d~~~ 118 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKH---SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFKDNSN 118 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEcc---CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeeccCCe
Confidence 4679999999999999999999887 69999999998887777777888999999999998 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|+||||++||.|..++++. +++++..++.++.||+.||+|||+++||+|||||+|||| |.+|++||+|||+|+.+
T Consensus 119 lymvmeyv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v 194 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRV 194 (355)
T ss_pred EEEEEeccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEe
Confidence 99999999999999987654 689999999999999999999999999999999999999 79999999999999987
Q ss_pred CCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 314 RPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
. .++.+.||||.|+|||++. +.|+.++|+|||||++|||+.|.+||.+.....++++|+..+..+|. .+++++
T Consensus 195 ~--~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----~fs~~~ 268 (355)
T KOG0616|consen 195 S--GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----YFSSDA 268 (355)
T ss_pred c--CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----ccCHHH
Confidence 5 3478899999999999886 78999999999999999999999999999999999999999988885 689999
Q ss_pred HHHHHHhcccCccCCC-----CHHHHHcCcccCCC
Q 007253 393 RDFVKRLLNKDPRKRL-----TAAQALSHPWIKNS 422 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rp-----t~~~ll~hp~~~~~ 422 (611)
++||+++|++|-.+|. ...++.+||||++.
T Consensus 269 kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 269 KDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred HHHHHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence 9999999999999993 67899999999864
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-54 Score=399.42 Aligned_cols=299 Identities=34% Similarity=0.680 Sum_probs=264.8
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+.++|++.++||+|.|+.|+++.+.. +|+.+|+|++........ ..+.+.+|+.|.+.|+ |||||+|.+.+..+
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~---tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~Lq-HP~IvrL~~ti~~~ 82 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQ-HPNIVRLHDSIQEE 82 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhcc---chHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcC-CCcEeehhhhhccc
Confidence 457889999999999999999987665 799999999976554443 5678999999999998 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+..|||+|+|+|++|..-|-.+ .-++|..+-.+++||+.+|.|||.+||||||+||.|+|+...+...-|||+|||+|.
T Consensus 83 ~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 83 SFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred ceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEE
Confidence 9999999999999998777665 458999999999999999999999999999999999999887777889999999999
Q ss_pred ccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 312 FVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
.+..+......+|||.|||||+++ ..|+..+|||+.|||||-|+.|.+||++.+...+++.|+.....++...|+++++
T Consensus 162 ~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~ 241 (355)
T KOG0033|consen 162 EVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTP 241 (355)
T ss_pred EeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCH
Confidence 988666777889999999999997 5699999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCCCCchh-HHHHHHHHHHhhcchHHHHHHHhhhh
Q 007253 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLD-VIIFKLMKAYMRSSSLRKAALRALSK 456 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~l~~~~~ 456 (611)
++++||++||..||.+|+|+.|.|+|||+++.......+- .-....+++|....+|+-.+|..+..
T Consensus 242 ~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkfNarRKLKgavLtav~s 308 (355)
T KOG0033|consen 242 EAKSLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTVIA 308 (355)
T ss_pred HHHHHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHhhHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999999987542221111 12466778888888888888877744
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-52 Score=423.77 Aligned_cols=263 Identities=33% Similarity=0.563 Sum_probs=234.2
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.-.++|++++.||+|+||.||+|+-+. +|..||+|++++..+.....++.++.|-.+|... ++|+||+||-.|++.
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~---Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~ 213 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKD---TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDK 213 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEcc---CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCC
Confidence 346889999999999999999999777 7999999999999888888889999999999995 499999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+++||||||++||++...|... +.|++..++.++.+++.|++.||+.|+|||||||+|+|| |..|++||+|||||.
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLST 289 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeeccccccc
Confidence 9999999999999998877655 679999999999999999999999999999999999999 899999999999984
Q ss_pred ccCC-----------------------CCc-------------------------ccccccCCCcCcchhhc-CCCCCcc
Q 007253 312 FVRP-----------------------DER-------------------------LNDIVGSAYYVAPEVLH-RSYSTEA 342 (611)
Q Consensus 312 ~~~~-----------------------~~~-------------------------~~~~~gt~~y~aPE~~~-~~~~~~~ 342 (611)
-+.. +.. ....+|||.|||||++. ..|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 3210 000 02358999999999986 5699999
Q ss_pred hhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCC---HHHHHcCccc
Q 007253 343 DVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT---AAQALSHPWI 419 (611)
Q Consensus 343 DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~~ll~hp~~ 419 (611)
|+||||||+|||+.|.+||.+.+..+.+++|......+....-..++.+++|||.+||+ ||.+|.. ++||..||||
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF 448 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFF 448 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcc
Confidence 99999999999999999999999999999999887555544445788999999999999 9999985 9999999999
Q ss_pred CCCC
Q 007253 420 KNSN 423 (611)
Q Consensus 420 ~~~~ 423 (611)
++..
T Consensus 449 ~~v~ 452 (550)
T KOG0605|consen 449 KGVD 452 (550)
T ss_pred ccCC
Confidence 9753
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-52 Score=395.27 Aligned_cols=258 Identities=30% Similarity=0.578 Sum_probs=225.6
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|+.+.++|+|+||.||+++++. +|+.||||.+..+. .+....+-..+||++|+.|+ |+|+|.|+++|.....+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~---TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLk-H~NLVnLiEVFrrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKD---TGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLK-HENLVNLIEVFRRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCC---cccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcc-cchHHHHHHHHHhccee
Confidence 468999999999999999999888 79999999986543 33444555689999999998 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
+||+|||+. ++++.+......++...++.++.|++.|+.|||++++|||||||+|||| ..++++||||||+|+.+.
T Consensus 77 hLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi---t~~gvvKLCDFGFAR~L~ 152 (396)
T KOG0593|consen 77 HLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI---TQNGVVKLCDFGFARTLS 152 (396)
T ss_pred EEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE---ecCCcEEeccchhhHhhc
Confidence 999999987 7777787777789999999999999999999999999999999999999 578899999999999887
Q ss_pred -CCCcccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHh--------------cC
Q 007253 315 -PDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK--------------AD 377 (611)
Q Consensus 315 -~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~--------------~~ 377 (611)
++...+..+.|.||.|||.+-+ +|+..+||||+||++.||++|.+.|.+.++-+.+..|.. .+
T Consensus 153 ~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 153 APGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred CCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 6677888999999999998865 699999999999999999999999999888776555533 22
Q ss_pred CCCCC-------------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCC
Q 007253 378 PSFDE-------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 378 ~~~~~-------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
+.|.. ..++.++..+.+|++.||+.||.+|++.+++|.|+||.+
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 22221 124567888999999999999999999999999999954
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-51 Score=417.89 Aligned_cols=258 Identities=31% Similarity=0.543 Sum_probs=223.8
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
......|....+||+|+-|.||.|+... +++.||||.+..... ...+.+.+|+.+|+.++ |+|||++++.|..
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~---~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~~-H~NiVnfl~Sylv 341 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKIS---TKQEVAIKRMDLRKQ---PKKELLLNEILVMRDLH-HPNIVNFLDSYLV 341 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeecc---CCceEEEEEEEeccC---CchhhhHHHHHHHHhcc-chHHHHHHHHhcc
Confidence 4456779999999999999999999776 688999999965433 34467899999999998 9999999999999
Q ss_pred CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 231 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
.+.+|+|||||+||+|.|.+... .++|.++..|+++++.||+|||.+||||||||.+|||+ +.++.|||+|||+|
T Consensus 342 ~deLWVVMEym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL---~~~g~vKltDFGFc 416 (550)
T KOG0578|consen 342 GDELWVVMEYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL---TMDGSVKLTDFGFC 416 (550)
T ss_pred cceeEEEEeecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe---ccCCcEEEeeeeee
Confidence 99999999999999999988543 59999999999999999999999999999999999999 56777999999999
Q ss_pred cccCCCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHH-hcCCCCCCCCCCC
Q 007253 311 DFVRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL-KADPSFDEAPWPS 387 (611)
Q Consensus 311 ~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~~~ 387 (611)
..+.... ...+++|||+|||||++. +.|++++||||||++++||+-|++||.......-+..|. ++.+.+ ..+..
T Consensus 417 aqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~l--k~~~k 494 (550)
T KOG0578|consen 417 AQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKL--KNPEK 494 (550)
T ss_pred eccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCc--CCccc
Confidence 8876655 567889999999999986 679999999999999999999999998665554444443 333333 33457
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
+|+.+++|+.+||+.|+.+|+++.+||+||||+..
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 99999999999999999999999999999999543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-51 Score=423.56 Aligned_cols=259 Identities=41% Similarity=0.772 Sum_probs=233.6
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcC-C-HHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-T-AIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~-~-~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
..+.|++++.||+|+||.|+.|+... +|..||+|++.+.... . ....+.+.+|+.+++++..||||+++++++..
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~---t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t 91 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRL---TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT 91 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeecc---CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence 45789999999999999999999876 6899999988764222 1 23456778999999999889999999999999
Q ss_pred CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCC-ceEEEeeccc
Q 007253 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN-SVLKAIDFGL 309 (611)
Q Consensus 231 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~-~~vkl~DfG~ 309 (611)
...+|+|||||.||+|++++.+ .+++.|..++.+|+||+.|++|||++||+||||||+|||+ +.+ +++||+|||+
T Consensus 92 ~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENill---d~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 92 PTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILL---DGNEGNLKLSDFGL 167 (370)
T ss_pred CCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEe---cCCCCCEEEecccc
Confidence 9999999999999999999988 6789999999999999999999999999999999999999 555 8999999999
Q ss_pred cccc-CCCCcccccccCCCcCcchhhcC-C-C-CCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 007253 310 SDFV-RPDERLNDIVGSAYYVAPEVLHR-S-Y-STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (611)
Q Consensus 310 a~~~-~~~~~~~~~~gt~~y~aPE~~~~-~-~-~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (611)
+... ..+....+.+||+.|+|||++.+ . | +.++||||+||+||.|++|+.||.......++..|.+....++..
T Consensus 168 s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~-- 245 (370)
T KOG0583|consen 168 SAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSY-- 245 (370)
T ss_pred ccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCC--
Confidence 9988 56678889999999999999974 3 5 578999999999999999999999999899999988888777653
Q ss_pred CCC-CHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 386 PSL-SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 386 ~~~-s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
+ +.++.+||.+||..||.+|+|+.++++||||+..
T Consensus 246 --~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 246 --LLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred --cCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 4 9999999999999999999999999999999973
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-53 Score=396.19 Aligned_cols=254 Identities=28% Similarity=0.571 Sum_probs=220.2
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEE-EEeeC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFD-AYEDT 231 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~-~~~~~ 231 (611)
...+|++.++||+|.||.||++.... +|..||.|.+... ..+....+.+..|+.+|+.|+ |||||++++ .|.++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~---~g~l~a~K~i~f~-~md~k~rq~~v~Ei~lLkQL~-HpNIVqYy~~~f~~~ 91 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLL---DGKLVALKKIQFG-MMDAKARQDCVKEISLLKQLN-HPNIVQYYAHSFIED 91 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeecc---Ccchhhhhhcchh-hccHHHHHHHHHHHHHHHhcC-CchHHHHHHHhhhcc
Confidence 35679999999999999999999776 7999999999743 345666778889999999998 999999998 55555
Q ss_pred Ce-eEEEeeecCCCChHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH--cC--CeeecCCCCceEEeccCCCceEE
Q 007253 232 DN-VYVVMELCEGGELLDRIL---SRGGKYTEDDAKAVMIQILNVVAFCHL--QG--VVHRDLKPENFLFTTKDENSVLK 303 (611)
Q Consensus 232 ~~-~~lv~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~qi~~~L~~LH~--~~--iiHrDlkp~NIll~~~~~~~~vk 303 (611)
+. ++||||||.+|+|...|. +..+.++|..+|+++.|++.||.+||+ .. |+||||||.||+| +.+|+||
T Consensus 92 ~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvK 168 (375)
T KOG0591|consen 92 NEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL---TANGVVK 168 (375)
T ss_pred chhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE---cCCCcee
Confidence 55 999999999999988775 345679999999999999999999999 44 9999999999999 6899999
Q ss_pred EeecccccccCCCCc-ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Q 007253 304 AIDFGLSDFVRPDER-LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381 (611)
Q Consensus 304 l~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~ 381 (611)
|+|||+++++..... ..+.+|||+||+||+++ ..|+.++||||+||++|||+.-+.||+++.-.+...+|.+.+..
T Consensus 169 LGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~-- 246 (375)
T KOG0591|consen 169 LGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYP-- 246 (375)
T ss_pred eccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCC--
Confidence 999999999876653 45689999999999987 67999999999999999999999999999988888888887532
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCC
Q 007253 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 382 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
..+-..+|.++..+|..|+.+||++||+. +|+++.
T Consensus 247 ~~p~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~d 281 (375)
T KOG0591|consen 247 PLPDEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQD 281 (375)
T ss_pred CCcHHHhhhHHHHHHHHHccCCcccCCCc-----chHHHH
Confidence 22223689999999999999999999987 555554
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-51 Score=426.72 Aligned_cols=260 Identities=30% Similarity=0.543 Sum_probs=240.1
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.-.++|.+.++||+|+||+|+++..+. +++.||||+++|...-....++....|.+|+....+||.+++|+..|+..
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~---~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~ 441 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKG---TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK 441 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcC---CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccC
Confidence 346789999999999999999999887 68999999999998888888999999999999888899999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+++|+||||+.||++..+ .+.+.+++..++.|+..|+.||.|||++||||||||.+|||| |..|++||+|||+++
T Consensus 442 ~~l~fvmey~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCK 516 (694)
T ss_pred CeEEEEEEecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEeccccccc
Confidence 999999999999995432 344679999999999999999999999999999999999999 789999999999998
Q ss_pred ccC-CCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 312 FVR-PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 312 ~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
..- .+..+.+.||||.|||||++. ..|+..+|+|||||+||||+.|+.||.+.++.+++..|+..++.+|. .++
T Consensus 517 e~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~----~ls 592 (694)
T KOG0694|consen 517 EGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLS 592 (694)
T ss_pred ccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----ccc
Confidence 654 566888999999999999997 67999999999999999999999999999999999999999988886 589
Q ss_pred HHHHHHHHHhcccCccCCCC-----HHHHHcCcccCCCC
Q 007253 390 SEARDFVKRLLNKDPRKRLT-----AAQALSHPWIKNSN 423 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt-----~~~ll~hp~~~~~~ 423 (611)
.++.++++++|.++|++|.. +.+|..||||+..+
T Consensus 593 ~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~ 631 (694)
T KOG0694|consen 593 KEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID 631 (694)
T ss_pred HHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence 99999999999999999996 57899999999864
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-52 Score=414.67 Aligned_cols=262 Identities=36% Similarity=0.553 Sum_probs=231.5
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
+-++|.++++||.|.||.||+|+.+. +|..||||.+++.... ...-.-.+|++.|++|..|||||+|.+++.+.+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~---~~~~VAIK~MK~Kf~s--~ee~~nLREvksL~kln~hpniikL~Evi~d~~ 82 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKE---TGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNPHPNIIKLKEVIRDND 82 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecC---CCceeeHHHHHhhhcc--HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence 45789999999999999999999877 7899999999765433 222234689999999988999999999999988
Q ss_pred -eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 233 -NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 233 -~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
.+|+|||||+. +|++.++.+++.+++..++.|+.||++||+|+|.+|+.||||||+|||+. .+..|||+|||+|+
T Consensus 83 ~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~---~~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 83 RILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS---GNDVIKIADFGLAR 158 (538)
T ss_pred ceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec---ccceeEeccccccc
Confidence 99999999965 99999999988999999999999999999999999999999999999994 47789999999999
Q ss_pred ccCCCCcccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCC----
Q 007253 312 FVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW---- 385 (611)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~---- 385 (611)
.+......+.++.|.||+|||++- +.|+.++||||+|||++|+.+-++.|.+.++-+.+.+|+.--.......|
T Consensus 159 ev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 159 EVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred ccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 999888899999999999999874 66999999999999999999999999999998888887664433322222
Q ss_pred ----------------------CCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 386 ----------------------PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 386 ----------------------~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
+..++++.++|.+||.+||.+||||.++|+||||+...
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 44689999999999999999999999999999998554
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-51 Score=411.84 Aligned_cols=265 Identities=34% Similarity=0.521 Sum_probs=235.0
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
...+.|+.+++||+|.||.||+|+... +|+.||+|.+...... .....-..+||.||++|. ||||++|.+...+.
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~---tgkivALKKvr~d~~~-~~~~~t~~REI~ILr~l~-HpNIikL~eivt~~ 188 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLE---TGKIVALKKVRFDNEK-EGFPITAIREIKILRRLD-HPNIIKLEEIVTSK 188 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecc---cCcEEEEEEeecccCC-CcchHHHHHHHHHHHhcC-CCcccceeeEEEec
Confidence 346779999999999999999999877 7999999999765432 334455679999999998 99999999998876
Q ss_pred --CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccc
Q 007253 232 --DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (611)
Q Consensus 232 --~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~ 309 (611)
..+|||+|||+. +|..++....-+|++.+++.+++||+.||+|||++||+|||||.+|||| |++|++||+||||
T Consensus 189 ~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi---dn~G~LKiaDFGL 264 (560)
T KOG0600|consen 189 LSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI---DNNGVLKIADFGL 264 (560)
T ss_pred CCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---cCCCCEEeccccc
Confidence 689999999987 8988887777789999999999999999999999999999999999999 7999999999999
Q ss_pred ccccCCCC--cccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 007253 310 SDFVRPDE--RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (611)
Q Consensus 310 a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (611)
|+++.... ..+..+-|.||.|||++.+ .|+.++|+||.||||.||++|++.|.+.++.+.+..|.+......+..|
T Consensus 265 Ar~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W 344 (560)
T KOG0600|consen 265 ARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW 344 (560)
T ss_pred eeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence 99887655 4677899999999999864 5999999999999999999999999999999999999888776666666
Q ss_pred C-------------------------CCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCC
Q 007253 386 P-------------------------SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (611)
Q Consensus 386 ~-------------------------~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~ 425 (611)
+ .++....+|+..||+.||.+|.|+.++|+|+||......
T Consensus 345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~ 409 (560)
T KOG0600|consen 345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLP 409 (560)
T ss_pred ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCC
Confidence 4 247788999999999999999999999999999654433
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-51 Score=421.43 Aligned_cols=259 Identities=34% Similarity=0.635 Sum_probs=239.0
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.+-|++++-||.|+-|.|-+|++.. +|+.+|||++.+...........+.+||-+|+-|. ||||+++|++|++..+
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~---TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVwe~~~~ 86 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAE---TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVWENKQH 86 (786)
T ss_pred ccceeccccccCCCCceehhhhccc---ccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeeeeccCce
Confidence 4569999999999999999999887 79999999998875555556678999999999998 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|+|.||++||.|++++..+ +++++..+.+++.||+.|+.|||..+|+||||||+|+|| |..+++||+|||+|..-
T Consensus 87 lylvlEyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL---d~~~nIKIADFGMAsLe 162 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL---DVKNNIKIADFGMASLE 162 (786)
T ss_pred EEEEEEecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh---hcccCEeeeccceeecc
Confidence 99999999999999999877 579999999999999999999999999999999999999 67777999999999998
Q ss_pred CCCCcccccccCCCcCcchhhcCC--CCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 314 RPDERLNDIVGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
.++.-..+.||+|.|.|||++.+. .+.++||||.|||||.|++|+.||.+++...++.++.++....+ ..++.+
T Consensus 163 ~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP----s~Is~e 238 (786)
T KOG0588|consen 163 VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP----SNISSE 238 (786)
T ss_pred cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC----CcCCHH
Confidence 888889999999999999999753 47899999999999999999999999999999999999887776 478999
Q ss_pred HHHHHHHhcccCccCCCCHHHHHcCcccCCCCC
Q 007253 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~ 424 (611)
+++||++||.+||++|+|.+||++|||+.+...
T Consensus 239 aQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 239 AQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred HHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence 999999999999999999999999999987654
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=412.48 Aligned_cols=255 Identities=33% Similarity=0.621 Sum_probs=231.5
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|.+.+.||+|.||.||+|+.+. +.+.||+|.+.|... ....++.+++|++|+++|+ |||||.++++|+...++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~---t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lk-Hpniv~m~esfEt~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKY---TIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLK-HPNIVEMLESFETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeeccccc---ceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcC-CcchhhHHHhhcccceE
Confidence 578999999999999999999776 689999999988764 4456788999999999998 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
|+|+|||.| +|..++ +.++.++|+.++.++.+++.||.|||+++|+|||+||.|||+ +..+++|+||||+|+.+.
T Consensus 77 ~vVte~a~g-~L~~il-~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~ 151 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTIL-EQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMS 151 (808)
T ss_pred EEEehhhhh-hHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcc
Confidence 999999976 988866 455789999999999999999999999999999999999999 788999999999999887
Q ss_pred CCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 315 PDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
.+. ....+.|||.|||||++. +.|+..+|+||||||+|||++|++||......+....|+.+...++. +.+..+
T Consensus 152 ~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~----~~S~~f 227 (808)
T KOG0597|consen 152 TNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS----TASSSF 227 (808)
T ss_pred cCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc----cccHHH
Confidence 654 345678999999999987 66999999999999999999999999999999999999888766654 789999
Q ss_pred HHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.+|++.+|.+||.+|.|+.+++.|||.++..
T Consensus 228 ~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 228 VNFLQGLLIKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred HHHHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence 9999999999999999999999999998543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=372.10 Aligned_cols=265 Identities=32% Similarity=0.541 Sum_probs=232.2
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
.+|...++||+|.||.||+|+... +|+.||||.+......+... ....+||+.|+.++ |+||+.++++|...+.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~---t~~~VAIKKIkl~~~kdGi~-~talREIK~Lqel~-h~nIi~LiD~F~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTE---TGKRVAIKKIKLGNAKDGIN-RTALREIKLLQELK-HPNIIELIDVFPHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecC---CCcEEEEEEeeccccccCcc-HHHHHHHHHHHHcc-CcchhhhhhhccCCCce
Confidence 478899999999999999999777 79999999997664443333 34668999999998 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
.||+|||+. +|...|+.....++..+++.++.++++||+|||++.|+||||||.|+|+ +.+|.+||+|||+++.+.
T Consensus 77 ~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLi---s~~g~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 77 SLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLI---SSDGQLKIADFGLARFFG 152 (318)
T ss_pred EEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEE---cCCCcEEeecccchhccC
Confidence 999999976 9999998888889999999999999999999999999999999999999 688899999999999876
Q ss_pred CCC-cccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC----
Q 007253 315 PDE-RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS---- 387 (611)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~---- 387 (611)
+.. .....+-|.||.|||.+- +.|+..+||||.|||+.||+.|.+-|.+.++-+.+..|++.-....+..|++
T Consensus 153 ~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 153 SPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred CCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 544 333448999999999886 5699999999999999999999999999999998888888765555555543
Q ss_pred --------------------CCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCCCCc
Q 007253 388 --------------------LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVP 428 (611)
Q Consensus 388 --------------------~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~~~~ 428 (611)
.++++.+|+.+||..||.+|+|+.|+|+|+||+.......+
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~ 293 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPP 293 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCCh
Confidence 36788999999999999999999999999999976644443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-50 Score=401.11 Aligned_cols=263 Identities=33% Similarity=0.659 Sum_probs=226.1
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCH-----------HHHHHHHHHHHHHHHhcCCCC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA-----------IAIEDVRREVKILRALTGHNN 220 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~~h~~ 220 (611)
...++|++++.||+|.||.|-+|+... .++.||||++++...... ..++.+++||.||++|+ |||
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~---~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-H~n 169 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEV---DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-HPN 169 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecC---CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-CcC
Confidence 456889999999999999999998665 799999999976532211 12468899999999998 999
Q ss_pred eeEEEEEEeeC--CeeEEEeeecCCCChHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccC
Q 007253 221 LVKFFDAYEDT--DNVYVVMELCEGGELLDRILSRGGK-YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD 297 (611)
Q Consensus 221 iv~l~~~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~ 297 (611)
||+|+++..+. +.+|||+|||..|.+.. ...... +++.+++.|+++++.||+|||.+|||||||||+|+|| +
T Consensus 170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w--~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl---~ 244 (576)
T KOG0585|consen 170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKW--CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLL---S 244 (576)
T ss_pred eeEEEEeecCcccCceEEEEEeccCCcccc--CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEE---c
Confidence 99999999874 57999999999998654 223344 8999999999999999999999999999999999999 5
Q ss_pred CCceEEEeecccccccCC------CCcccccccCCCcCcchhhcCC-----CCCcchhhHHHHHHHHHHhCCCCCCCCCh
Q 007253 298 ENSVLKAIDFGLSDFVRP------DERLNDIVGSAYYVAPEVLHRS-----YSTEADVWSIGVIAYILLCGSRPFWARTE 366 (611)
Q Consensus 298 ~~~~vkl~DfG~a~~~~~------~~~~~~~~gt~~y~aPE~~~~~-----~~~~~DiwSlGvil~el~~g~~Pf~~~~~ 366 (611)
++|+|||+|||.+..... +......+|||.|||||.+.+. .+.+.||||+||+||+|+.|+.||.+...
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 779999999999986622 2234457999999999988642 36789999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCC
Q 007253 367 SGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (611)
Q Consensus 367 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~ 425 (611)
.+.+.+|.+....++.. +.+.+++++||++||++||.+|+++.++..|||.....+.
T Consensus 325 ~~l~~KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~ 381 (576)
T KOG0585|consen 325 LELFDKIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDS 381 (576)
T ss_pred HHHHHHHhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCC
Confidence 99999999998888775 4688999999999999999999999999999999866433
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=378.39 Aligned_cols=263 Identities=37% Similarity=0.670 Sum_probs=241.0
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCC-----cCCHHHHHHHHHHHHHHHHhcCCCCeeEEEE
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHK-----MTTAIAIEDVRREVKILRALTGHNNLVKFFD 226 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~ 226 (611)
.+-..|+-.+.||+|..+.|-++.++. +|+.+|+|++.... -......+.-++|+.||+++.+||+|+++.+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~---t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D 90 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKE---TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD 90 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcc---cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence 345678899999999999999888777 68899999885221 1123455667899999999999999999999
Q ss_pred EEeeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEee
Q 007253 227 AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (611)
Q Consensus 227 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D 306 (611)
+|+.+..+++|+|.|+.|.|.|++.+. -.+++...+.|++||+.|+.|||.++||||||||+|||+ +++.++||+|
T Consensus 91 ~yes~sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~isD 166 (411)
T KOG0599|consen 91 VYESDAFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKISD 166 (411)
T ss_pred eccCcchhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEEec
Confidence 999999999999999999999998665 569999999999999999999999999999999999999 7899999999
Q ss_pred cccccccCCCCcccccccCCCcCcchhhc-------CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC
Q 007253 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 379 (611)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~ 379 (611)
||+++.+.++.+....||||+|+|||.+. ..|+..+|+|++|||+|-|+.|.+|||+....-+++.|.+++..
T Consensus 167 FGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq 246 (411)
T KOG0599|consen 167 FGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ 246 (411)
T ss_pred cceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc
Confidence 99999999999999999999999999873 45899999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCC
Q 007253 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 380 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
|....|.+++...++||.+||+.||.+|.|++++|.||||+.
T Consensus 247 F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 247 FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 999999999999999999999999999999999999999953
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=397.90 Aligned_cols=258 Identities=34% Similarity=0.571 Sum_probs=215.6
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC-
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD- 232 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~- 232 (611)
..+|..++.||+|+||.||++...+ +|...|||.+.... ....+.+.+|+.+|.+|+ |||||+++|......
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~---~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~ 88 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKK---TGELMAVKSVELED---SPTSESLEREIRILSRLN-HPNIVQYYGSSSSREN 88 (313)
T ss_pred cchhhhhccccCccceEEEEEEecC---CCcceeeeeeeccc---chhHHHHHHHHHHHHhCC-CCCEEeeCCccccccC
Confidence 3458899999999999999999877 48999999986542 122677899999999999 999999999754444
Q ss_pred -eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCC-CceEEEeecccc
Q 007253 233 -NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE-NSVLKAIDFGLS 310 (611)
Q Consensus 233 -~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~-~~~vkl~DfG~a 310 (611)
.++|+|||+++|+|.+++...++++++..++.+.+||++||.|||++|||||||||+|||+ +. ++.+||+|||++
T Consensus 89 ~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl---~~~~~~~KlaDFG~a 165 (313)
T KOG0198|consen 89 DEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILL---DPSNGDVKLADFGLA 165 (313)
T ss_pred eeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEE---eCCCCeEEeccCccc
Confidence 6999999999999999998876689999999999999999999999999999999999999 45 688999999999
Q ss_pred cccCC----CCcccccccCCCcCcchhhcCCC--CCcchhhHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhcCCCCCCC
Q 007253 311 DFVRP----DERLNDIVGSAYYVAPEVLHRSY--STEADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLKADPSFDEA 383 (611)
Q Consensus 311 ~~~~~----~~~~~~~~gt~~y~aPE~~~~~~--~~~~DiwSlGvil~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~ 383 (611)
+.... ........||+.|||||++.... ..++|||||||+++||+||+.||.. ......+..+.... ..+ .
T Consensus 166 ~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-~~P-~ 243 (313)
T KOG0198|consen 166 KKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-SLP-E 243 (313)
T ss_pred cccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-CCC-C
Confidence 87763 12244578999999999998443 3499999999999999999999987 33334344444443 122 2
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 384 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
....++.++++||.+||.+||++|||+.++|+|||++...
T Consensus 244 ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 244 IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 2246899999999999999999999999999999998753
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-50 Score=370.84 Aligned_cols=259 Identities=32% Similarity=0.617 Sum_probs=238.1
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
...++|++++.||+|-||.||+|+.++ ++-.||+|++.+..........++++|++|...|+ ||||+++|++|.+.
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekk---s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~fhd~ 94 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKK---SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGYFHDS 94 (281)
T ss_pred cchhhccccccccCCccccEeEeeecc---CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhheecc
Confidence 346789999999999999999999888 68899999998877666667788999999999998 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 232 DNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
..+||++||...|+|+..+... ..++++...+.++.|++.||.|||..+||||||||+|+|+ +..+.+||+|||.+
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLl---g~~~~lkiAdfGws 171 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLL---GSAGELKIADFGWS 171 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhcc---CCCCCeeccCCCce
Confidence 9999999999999999988743 4569999999999999999999999999999999999999 67778999999998
Q ss_pred cccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 311 DFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
.... ..+..+.|||..|.+||+.. ..++..+|+|++|++.||++.|.+||...+..+.+..|.+.+..++ ..++
T Consensus 172 V~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p----~~is 246 (281)
T KOG0580|consen 172 VHAP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP----STIS 246 (281)
T ss_pred eecC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC----cccC
Confidence 7655 56667899999999999997 5699999999999999999999999999999999999999988877 4799
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
.++.++|.+||.++|.+|.+..|++.|||+...
T Consensus 247 ~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 247 GGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred hhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 999999999999999999999999999999754
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=388.13 Aligned_cols=261 Identities=31% Similarity=0.528 Sum_probs=228.2
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.+.|++.++||.|.-++||+|+... .+..||||++.-+..... .+.+++|+..|+.++ ||||++++..|..+..
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p---~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~-HPNIv~~~~sFvv~~~ 98 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIP---TNEVVAIKIINLEKCNND--LDALRKEVQTMSLID-HPNIVTYHCSFVVDSE 98 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecc---cCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcC-CCCcceEEEEEEecce
Confidence 5789999999999999999999887 689999999976654443 688999999999987 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 234 VYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
+|+||.||.+|++++.+...- ..++|..+..|++++++||.|||.+|.||||||+.|||| +.+|.|||+|||.+..
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVSAS 175 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceeeee
Confidence 999999999999999987653 349999999999999999999999999999999999999 7899999999998765
Q ss_pred cCCCC-----cccccccCCCcCcchhhc---CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-----
Q 007253 313 VRPDE-----RLNDIVGSAYYVAPEVLH---RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS----- 379 (611)
Q Consensus 313 ~~~~~-----~~~~~~gt~~y~aPE~~~---~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~----- 379 (611)
+.... +.++.+||++|||||++. ..|+.|+||||||++.+||++|..||.......++..-++..+.
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~ 255 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTS 255 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccc
Confidence 54322 235679999999999954 56999999999999999999999999888887777666666653
Q ss_pred -CCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 380 -FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 380 -~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
++......++..++.+|..||.+||.+|||+.++|+|+||+...
T Consensus 256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 23333456788999999999999999999999999999998654
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=386.98 Aligned_cols=261 Identities=30% Similarity=0.539 Sum_probs=235.1
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.+.|++++.||+|.-|.||+++.+. ++..+|+|++.+........+.++..|.+||..+. ||.+++||..|+.++.
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~---t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lD-HPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRG---TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLD-HPFLPTLYASFETDKY 151 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecC---CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcC-CCccchhhheeeccce
Confidence 4569999999999999999999887 57999999999888877778888999999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 234 VYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.|+|||||+||+|....+++. +.+++..++.++.+++.||+|||-.|||+|||||+|||| .++|+|-|+||.|+..
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLR 228 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeecccccc
Confidence 999999999999988776654 469999999999999999999999999999999999999 5888999999998632
Q ss_pred cC----------------------------------C-C----------------------CcccccccCCCcCcchhhc
Q 007253 313 VR----------------------------------P-D----------------------ERLNDIVGSAYYVAPEVLH 335 (611)
Q Consensus 313 ~~----------------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~ 335 (611)
.. . . .+.+..+||-.|+|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 10 0 0 0123468999999999998
Q ss_pred C-CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCC----H
Q 007253 336 R-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT----A 410 (611)
Q Consensus 336 ~-~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt----~ 410 (611)
+ ..+.++|||+|||++|||+.|..||.+.+..+.+.+|+.....+++.+ .++..++|||+++|.+||.+|.. +
T Consensus 309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA 386 (459)
T KOG0610|consen 309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGA 386 (459)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccch
Confidence 5 589999999999999999999999999999999999999999998874 78899999999999999999998 9
Q ss_pred HHHHcCcccCCCC
Q 007253 411 AQALSHPWIKNSN 423 (611)
Q Consensus 411 ~~ll~hp~~~~~~ 423 (611)
.||.+||||++.+
T Consensus 387 ~eIK~HpFF~gVn 399 (459)
T KOG0610|consen 387 AEIKRHPFFEGVN 399 (459)
T ss_pred HHhhcCccccCCC
Confidence 9999999999864
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=373.77 Aligned_cols=268 Identities=30% Similarity=0.466 Sum_probs=229.3
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee--C
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--T 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~--~ 231 (611)
.+.|+.++.|++|.||.||+|+++. +++.||+|.++-......--+ .-.+||.+|.+++ |||||.+-.+..- -
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~---t~eIVALKr~kmekek~GFPI-tsLREIniLl~~~-H~NIV~vkEVVvG~~~ 149 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKK---TDEIVALKRLKMEKEKEGFPI-TSLREINILLKAR-HPNIVEVKEVVVGSNM 149 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCC---cceeEEeeecccccccCCCcc-hhHHHHHHHHhcC-CCCeeeeEEEEecccc
Confidence 4679999999999999999999887 799999999864432222111 2468999999998 9999999988764 3
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+.+|||||||+. +|...+....+++...+++.++.|+++||+|||.+.|+|||||++|+|+ .+.|.+||+|||+|+
T Consensus 150 d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm---~~~G~lKiaDFGLAR 225 (419)
T KOG0663|consen 150 DKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL---SHKGILKIADFGLAR 225 (419)
T ss_pred ceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee---ccCCcEEecccchhh
Confidence 579999999987 8999888888899999999999999999999999999999999999999 578889999999999
Q ss_pred ccCCC-CcccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC-
Q 007253 312 FVRPD-ERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS- 387 (611)
Q Consensus 312 ~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~- 387 (611)
.+... ...+..+-|.||.|||++- ..|+.++|+||+|||+.||+++++.|.+..+.+.+..|.+.-....+..|+.
T Consensus 226 ~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 226 EYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred hhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 88644 3567789999999999886 5699999999999999999999999999999998888887654444444432
Q ss_pred ---------------------------CCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCCCCchh
Q 007253 388 ---------------------------LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLD 430 (611)
Q Consensus 388 ---------------------------~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~~~~~~ 430 (611)
+++...+|+..+|..||.+|.|+.+.|+|.||.......-|-.
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~ 375 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSM 375 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhh
Confidence 3577889999999999999999999999999998765554443
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-49 Score=385.55 Aligned_cols=259 Identities=34% Similarity=0.641 Sum_probs=239.5
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
+...-+|++.+.||+|.||.|-+|.... .|+.||||.|.+....+.+.+-.+++||+||..|+ ||||+++|++|+.
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~---sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLN-HPhII~IyEVFEN 124 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHK---SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLN-HPHIIQIYEVFEN 124 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhcc---CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcC-CCceeehhhhhcC
Confidence 3456689999999999999999998655 69999999999999999999999999999999998 9999999999999
Q ss_pred CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 231 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
.+.+.|||||..+|.|+|||.++ +.|++..++.+|+||++|+.|||.++|+|||||.+|||| |.++++||+|||++
T Consensus 125 kdKIvivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGLS 200 (668)
T KOG0611|consen 125 KDKIVIVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGLS 200 (668)
T ss_pred CceEEEEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccchh
Confidence 99999999999999999999766 679999999999999999999999999999999999999 89999999999999
Q ss_pred cccCCCCcccccccCCCcCcchhhcCC--CCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 311 DFVRPDERLNDIVGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
..+..+.-..++||+|-|.+||++++. -++.+|.|||||+||-|+.|..||.+.+...+.+.|.++...-+. -
T Consensus 201 Nly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-----~ 275 (668)
T KOG0611|consen 201 NLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-----T 275 (668)
T ss_pred hhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-----C
Confidence 999888888999999999999999864 478999999999999999999999999999999999887655443 4
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
+..+.-||+.||-+||++|.|+.++-.|.|++.-
T Consensus 276 PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNwg 309 (668)
T KOG0611|consen 276 PSDASGLIRWMLMVNPERRATIEDIASHWWVNWG 309 (668)
T ss_pred CchHHHHHHHHHhcCcccchhHHHHhhhheeecc
Confidence 6788999999999999999999999999999754
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=370.00 Aligned_cols=262 Identities=37% Similarity=0.676 Sum_probs=236.8
Q ss_pred ccCCceeEeC-eeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 152 HFANKYELGE-EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 152 ~~~~~y~~~~-~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
.++++|.+.. +||-|--|.|..+..+. +|+.+|+|++... ...++|+++.-...+|||||.++++|..
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~---T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKR---TQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEecc---chhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence 3578888865 69999999999998777 7999999998432 3467899999888899999999999864
Q ss_pred ----CCeeEEEeeecCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 231 ----TDNVYVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 231 ----~~~~~lv~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
...+.+|||.|+||.|+..|..++. .++|.++..|++||+.|+.|||+.+|.||||||+|+|.+....+..+||+
T Consensus 127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence 4578999999999999999988754 59999999999999999999999999999999999999988889999999
Q ss_pred ecccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhcCCCC
Q 007253 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART----ESGIFRAVLKADPSF 380 (611)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~----~~~~~~~i~~~~~~~ 380 (611)
|||+|+.........+.|.||+|.|||++. ..|+..+|+||+||++|-|++|.+||+... ..++...|..+...|
T Consensus 207 DfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F 286 (400)
T KOG0604|consen 207 DFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF 286 (400)
T ss_pred ccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence 999999887677788899999999999996 669999999999999999999999998653 357889999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCC
Q 007253 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (611)
Q Consensus 381 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~ 424 (611)
+...|..+|++.+++|+.+|..+|++|.|++++++|||+.....
T Consensus 287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence 99999999999999999999999999999999999999987653
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=392.30 Aligned_cols=247 Identities=28% Similarity=0.456 Sum_probs=213.7
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcE-EEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC-e
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQ-VAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD-N 233 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~-~ 233 (611)
...+.+.||+|+||+||+|.+. |+. ||+|++......... .+.|.+|+.+|.+|+ |||||+|+|++.+.. .
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~-----g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~-HpNIV~f~G~~~~~~~~ 114 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWR-----GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLR-HPNIVQFYGACTSPPGS 114 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeC-----CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCc
Confidence 4556677999999999999864 566 999999776544444 789999999999998 999999999999988 7
Q ss_pred eEEEeeecCCCChHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcC-CeeecCCCCceEEeccCCCc-eEEEeecccc
Q 007253 234 VYVVMELCEGGELLDRILS-RGGKYTEDDAKAVMIQILNVVAFCHLQG-VVHRDLKPENFLFTTKDENS-VLKAIDFGLS 310 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~-iiHrDlkp~NIll~~~~~~~-~vkl~DfG~a 310 (611)
++|||||+++|+|.+++.. ....+++..+..|+.||++||.|||+++ ||||||||+|||| +.++ ++||+|||++
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv---~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV---DLKGKTLKIADFGLS 191 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE---cCCCCEEEECCCccc
Confidence 9999999999999999988 4678999999999999999999999999 9999999999999 5675 9999999999
Q ss_pred cccCCC-CcccccccCCCcCcchhhcC---CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 007253 311 DFVRPD-ERLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 311 ~~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (611)
+..... .......||+.|||||++.+ .|+.++|||||||++|||+||+.||......+....+.......... .
T Consensus 192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p--~ 269 (362)
T KOG0192|consen 192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP--K 269 (362)
T ss_pred eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--c
Confidence 887654 34444789999999999985 39999999999999999999999999988877666666544333322 2
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHH
Q 007253 387 SLSSEARDFVKRLLNKDPRKRLTAAQAL 414 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rpt~~~ll 414 (611)
..++.+..+|.+||..||.+||+..+++
T Consensus 270 ~~~~~l~~l~~~CW~~dp~~RP~f~ei~ 297 (362)
T KOG0192|consen 270 ECPPHLSSLMERCWLVDPSRRPSFLEIV 297 (362)
T ss_pred cCCHHHHHHHHHhCCCCCCcCCCHHHHH
Confidence 3889999999999999999999998875
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-47 Score=385.52 Aligned_cols=260 Identities=28% Similarity=0.454 Sum_probs=218.5
Q ss_pred eeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEE
Q 007253 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (611)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 236 (611)
|++.+.||+|+||.||+|.... +|+.||+|++.+...........+.+|+.+++++. |+||+++++++.+++.+++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~iv~~~~~~~~~~~~~l 77 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN-SRFVVSLAYAYETKDALCL 77 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEec---CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC-CCcEEEEEEEEccCCeEEE
Confidence 7889999999999999999876 68999999987654443344456789999999997 9999999999999999999
Q ss_pred EeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC
Q 007253 237 VMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (611)
Q Consensus 237 v~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~ 315 (611)
|||||++|+|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.....
T Consensus 78 v~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 78 VLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred EEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCC
Confidence 999999999988776543 468999999999999999999999999999999999999 5778899999999987654
Q ss_pred CCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 007253 316 DERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARD 394 (611)
Q Consensus 316 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 394 (611)
.......+||+.|+|||++. ..++.++|||||||++|+|++|+.||...........+..............++.++.+
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 234 (285)
T cd05631 155 GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKS 234 (285)
T ss_pred CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHH
Confidence 44455668999999999886 56899999999999999999999999876543332222222222222233468999999
Q ss_pred HHHHhcccCccCCCC-----HHHHHcCcccCCCC
Q 007253 395 FVKRLLNKDPRKRLT-----AAQALSHPWIKNSN 423 (611)
Q Consensus 395 li~~~L~~dP~~Rpt-----~~~ll~hp~~~~~~ 423 (611)
||++||+.||.+||+ ++++++||||++.+
T Consensus 235 li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 235 ICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred HHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 999999999999997 89999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-47 Score=393.08 Aligned_cols=255 Identities=31% Similarity=0.589 Sum_probs=223.9
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++.+.||+|+||.||+|+... +|+.||+|++.+.........+.+.+|+.++++++ ||||+++++++.+++.
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~ 92 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVNMMCSFQDENR 92 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEcCCE
Confidence 4679999999999999999999776 68999999997544333445567889999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~ 168 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKV 168 (329)
T ss_pred EEEEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---CCCCCEEEeeccCceEc
Confidence 99999999999999988654 578999999999999999999999999999999999999 67788999999999876
Q ss_pred CCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 314 RPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
... ....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+......+..+......++. .++..+
T Consensus 169 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~ 242 (329)
T PTZ00263 169 PDR--TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN----WFDGRA 242 (329)
T ss_pred CCC--cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCC----CCCHHH
Confidence 432 33468999999999986 55889999999999999999999999988887778888776554432 478999
Q ss_pred HHHHHHhcccCccCCCC-----HHHHHcCcccCCC
Q 007253 393 RDFVKRLLNKDPRKRLT-----AAQALSHPWIKNS 422 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rpt-----~~~ll~hp~~~~~ 422 (611)
.+||++||+.||.+|++ +.++++||||++.
T Consensus 243 ~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 243 RDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 99999999999999997 7999999999863
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-47 Score=386.35 Aligned_cols=254 Identities=28% Similarity=0.529 Sum_probs=223.1
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++.+.||+|+||.||+|.... +|+.||+|++...........+.+.+|+.+++++. ||||+++++++.+++.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~ 76 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRI---SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTEHDQRFL 76 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcC---CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhhccCCeE
Confidence 369999999999999999999776 58999999986543333345567889999999998 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
|+||||+++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 77 YMLMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred EEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEEecCcchhcc
Confidence 9999999999999988654 579999999999999999999999999999999999999 567889999999998764
Q ss_pred CCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 007253 315 PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (611)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 393 (611)
.. ....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+.+..+......++. .++..+.
T Consensus 153 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~ 226 (291)
T cd05612 153 DR--TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAK 226 (291)
T ss_pred CC--cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc----cCCHHHH
Confidence 32 33467999999999886 45889999999999999999999999998888888888877655543 4689999
Q ss_pred HHHHHhcccCccCCCC-----HHHHHcCcccCCC
Q 007253 394 DFVKRLLNKDPRKRLT-----AAQALSHPWIKNS 422 (611)
Q Consensus 394 ~li~~~L~~dP~~Rpt-----~~~ll~hp~~~~~ 422 (611)
+||++||+.||.+|++ +.++++||||+..
T Consensus 227 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 227 DLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred HHHHHHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence 9999999999999995 9999999999864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=395.65 Aligned_cols=259 Identities=27% Similarity=0.484 Sum_probs=219.4
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++.+.||+|+||.||+|+... +++.||||++.+...........+.+|+.++.++. |+||+++++++.+...+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~-~~~iv~~~~~~~~~~~~ 76 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKD---TGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD-SLWVVKMFYSFQDKLNL 76 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECC---CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCeE
Confidence 469999999999999999998766 68999999997644334445567889999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
|||||||+||+|.+++... +.+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+++.+.
T Consensus 77 ~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi---~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 77 YLIMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL---DSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCCEEEeeccCccccc
Confidence 9999999999999988654 579999999999999999999999999999999999999 577889999999987543
Q ss_pred CCC------------------------------------cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhC
Q 007253 315 PDE------------------------------------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCG 357 (611)
Q Consensus 315 ~~~------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g 357 (611)
... .....+||+.|+|||++. ..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence 211 012458999999999986 5689999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcc---CCCCHHHHHcCcccCCC
Q 007253 358 SRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPR---KRLTAAQALSHPWIKNS 422 (611)
Q Consensus 358 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~---~Rpt~~~ll~hp~~~~~ 422 (611)
+.||.+....+.+..+..............+++++++||.+|+. +|. .||++.++++||||++.
T Consensus 233 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 233 YPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 99999888888888887644333323334578999999999875 444 45899999999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=390.94 Aligned_cols=250 Identities=29% Similarity=0.545 Sum_probs=218.0
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeee
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~ 240 (611)
+.||+|+||.||+|+... +|+.||||++.+...........+.+|+.++++++ ||||+++++++...+.+||||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~ 76 (323)
T cd05571 1 KLLGKGTFGKVILVREKA---TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQTHDRLCFVMEY 76 (323)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEcCCEEEEEEeC
Confidence 479999999999998766 68999999997644334445567789999999997 99999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC-CCcc
Q 007253 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERL 319 (611)
Q Consensus 241 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~-~~~~ 319 (611)
+++|+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+++.... ....
T Consensus 77 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~ 152 (323)
T cd05571 77 ANGGELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGATM 152 (323)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCCcc
Confidence 9999998887654 579999999999999999999999999999999999999 5778899999999875432 2334
Q ss_pred cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 007253 320 NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398 (611)
Q Consensus 320 ~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 398 (611)
...+||+.|+|||++. ..++.++|||||||++|||++|+.||...........+......++ ..++.++.+||++
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~ 228 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLAG 228 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Confidence 5568999999999986 5689999999999999999999999998888777777776655544 3689999999999
Q ss_pred hcccCccCCC-----CHHHHHcCcccCCC
Q 007253 399 LLNKDPRKRL-----TAAQALSHPWIKNS 422 (611)
Q Consensus 399 ~L~~dP~~Rp-----t~~~ll~hp~~~~~ 422 (611)
||+.||++|| ++.++++||||+..
T Consensus 229 ~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 229 LLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred HccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999 89999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=378.75 Aligned_cols=262 Identities=35% Similarity=0.682 Sum_probs=239.8
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+.+-|.+.+.||+|.|..|-+|++.- +|..||||++.+..+... ....+.+|++.|+-++ |||||+||++....
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVF---TGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQ-HpNiVRLYEViDTQ 89 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVF---TGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQ-HPNIVRLYEVIDTQ 89 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhc---ccceeEEEEecccccchh-hhhHHHHHHHHHHHhc-CcCeeeeeehhccc
Confidence 456679999999999999999998765 799999999988776543 4466789999999998 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
-.+|||+|+-++|+|+|||.++...++|..++++|.||+.|+.|||+..||||||||+||.+. ..-|.|||+|||++.
T Consensus 90 TKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSN 167 (864)
T KOG4717|consen 90 TKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSN 167 (864)
T ss_pred ceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeeccccc
Confidence 999999999999999999999988999999999999999999999999999999999999886 567899999999999
Q ss_pred ccCCCCcccccccCCCcCcchhhcC-CCC-CcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 312 FVRPDERLNDIVGSAYYVAPEVLHR-SYS-TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~-~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
.+.++....+.||+..|.|||++.+ .|+ +++||||||||||-|+||+.||...++.+.+..|+......+. .++
T Consensus 168 kf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs----hvS 243 (864)
T KOG4717|consen 168 KFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS----HVS 243 (864)
T ss_pred cCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch----hhh
Confidence 9999999999999999999999875 464 6899999999999999999999999999999999887766664 689
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCC
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~ 424 (611)
.++++||..||..||.+|.+.++|..|+|++....
T Consensus 244 ~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 244 KECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred HHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 99999999999999999999999999999997653
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=393.92 Aligned_cols=259 Identities=30% Similarity=0.549 Sum_probs=222.1
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++.+.||+|+||.||+|+... +|+.||||++.+...........+.+|+.+++.++ ||||+++++++.+++.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~ 76 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKD---TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQDENYL 76 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCeE
Confidence 369999999999999999999776 68999999997543333445567889999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
|||||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+.
T Consensus 77 ~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 77 YLIMEYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred EEEECCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEeecccceecc
Confidence 9999999999999988664 469999999999999999999999999999999999999 678889999999987543
Q ss_pred CCC---------------------------------------cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHH
Q 007253 315 PDE---------------------------------------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYIL 354 (611)
Q Consensus 315 ~~~---------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el 354 (611)
... .....+||+.|+|||++. ..++.++|||||||++|+|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 232 (364)
T cd05599 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232 (364)
T ss_pred ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence 211 011347999999999886 5689999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCC---HHHHHcCcccCCC
Q 007253 355 LCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT---AAQALSHPWIKNS 422 (611)
Q Consensus 355 ~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~~ll~hp~~~~~ 422 (611)
++|..||......+.+..+......+.......+++++.+||++||. +|.+|++ +.++++||||+..
T Consensus 233 ~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 233 LVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred hcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 99999999888877777777655444333334679999999999997 9999998 9999999999874
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-47 Score=370.07 Aligned_cols=262 Identities=34% Similarity=0.608 Sum_probs=219.9
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee-
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED- 230 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~- 230 (611)
.....|...+.||+|+||.|+.|..+. +|+.||||.+.. ........++..+|+++|+.++ |+||+.+++.+..
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~---t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p~ 93 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKR---TGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRPP 93 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcC---CCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhc-CCCcceEEeecccc
Confidence 445667778999999999999999887 689999999853 2355667788899999999998 9999999999876
Q ss_pred ----CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEee
Q 007253 231 ----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (611)
Q Consensus 231 ----~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D 306 (611)
-+.+|+|+|+|+ -+|.+.++ .+..+++..+..+++||+.||+|+|+.+|+||||||.|+|++ .+..+||||
T Consensus 94 ~~~~f~DvYiV~elMe-tDL~~iik-~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n---~~c~lKI~D 168 (359)
T KOG0660|consen 94 SRDKFNDVYLVFELME-TDLHQIIK-SQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLN---ADCDLKICD 168 (359)
T ss_pred cccccceeEEehhHHh-hHHHHHHH-cCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeec---cCCCEEecc
Confidence 356999999994 47777664 445699999999999999999999999999999999999994 666699999
Q ss_pred cccccccCC---CCcccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-----
Q 007253 307 FGLSDFVRP---DERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA----- 376 (611)
Q Consensus 307 fG~a~~~~~---~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~----- 376 (611)
||+|+.... +...+..+.|.||.|||++. ..|+..+||||.|||+.||++|++.|.+......+..|...
T Consensus 169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~ 248 (359)
T KOG0660|consen 169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS 248 (359)
T ss_pred ccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence 999998864 44557789999999999874 67999999999999999999999999887665554444332
Q ss_pred ------------------CCCCCCCC----CCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 377 ------------------DPSFDEAP----WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 377 ------------------~~~~~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.+..+..+ +++.++.+.+|+.+||..||.+|+|++|+|.||||...-
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 22223222 467899999999999999999999999999999997554
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=385.53 Aligned_cols=262 Identities=28% Similarity=0.507 Sum_probs=223.4
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
..|...+.||+|.||.||+|.+.. +++.||+|++.-.. ....++.+.+|+.++..+. ++||.++|+.|..+..+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~---t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~-~~~it~yygsyl~g~~L 86 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNK---TKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCD-SPNITEYYGSYLKGTKL 86 (467)
T ss_pred cccccchhccccccceeeeeeecc---ccceEEEEEechhh--cchhhHHHHHHHHHHHhcC-cchHHhhhhheeecccH
Confidence 457888999999999999999877 79999999996553 3445688999999999998 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
+++||||.||++.+.+. .+..+.+..+..++++++.||.|||..+.||||||+.|||+. ..|.|||+|||.+..+.
T Consensus 87 wiiMey~~gGsv~~lL~-~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s---~~g~vkl~DfgVa~ql~ 162 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLK-SGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS---ESGDVKLADFGVAGQLT 162 (467)
T ss_pred HHHHHHhcCcchhhhhc-cCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe---ccCcEEEEecceeeeee
Confidence 99999999999999763 445569999999999999999999999999999999999995 56889999999998776
Q ss_pred CCC-cccccccCCCcCcchhhcC-CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 315 PDE-RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
... +..+.+|||.|||||++.+ .|+.++||||||++++||++|.+||........+..|-+..|..-. ..+++.+
T Consensus 163 ~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~---~~~S~~~ 239 (467)
T KOG0201|consen 163 NTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLD---GDFSPPF 239 (467)
T ss_pred chhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccc---cccCHHH
Confidence 544 3478999999999999985 7999999999999999999999999776664444444333322222 3689999
Q ss_pred HHHHHHhcccCccCCCCHHHHHcCcccCCCCCCCCch
Q 007253 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPL 429 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~~~~~ 429 (611)
++||..||++||+.||+|.+||+|.|++..++.....
T Consensus 240 kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~k~s~L~ 276 (467)
T KOG0201|consen 240 KEFVEACLDKNPEFRPSAKELLKHKFIKRAKKTSELK 276 (467)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhhHHHHhcCCchHHH
Confidence 9999999999999999999999999999854443333
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=393.25 Aligned_cols=259 Identities=29% Similarity=0.479 Sum_probs=217.8
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
.|++++.||+|+||.||+|+... +++.||||++.+...........+.+|+.++++++ |+||+++++++.+.+.+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~ 77 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVD---THALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLY 77 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEEecCCEEE
Confidence 58999999999999999998766 68999999997655445556678899999999997 999999999999999999
Q ss_pred EEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC
Q 007253 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~ 315 (611)
+|||||+||+|.+++... ..+++..++.++.||+.||.|||+.|||||||||+|||+ +.++.+||+|||++.....
T Consensus 78 lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 78 FVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred EEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE---CCCCCEEEeeCcCCccccc
Confidence 999999999999988654 568999999999999999999999999999999999999 5778899999999754311
Q ss_pred CC------------------------------------------------cccccccCCCcCcchhhc-CCCCCcchhhH
Q 007253 316 DE------------------------------------------------RLNDIVGSAYYVAPEVLH-RSYSTEADVWS 346 (611)
Q Consensus 316 ~~------------------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwS 346 (611)
.. .....+||+.|+|||++. ..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence 00 012357999999999986 56899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcc--cCccCCCCHHHHHcCcccCCC
Q 007253 347 IGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLN--KDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 347 lGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~--~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
|||++|||++|+.||...........+...........+..++.++.+||.+|+. .++..|+++.++++||||+..
T Consensus 234 lG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 9999999999999998877766666665443333333345689999999999664 455559999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=388.38 Aligned_cols=256 Identities=29% Similarity=0.535 Sum_probs=223.2
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++.+.||+|+||.||+|.+... .+..||+|++.+.........+.+.+|+.+++.++ ||||+++++++.+++.
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNE--DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGSFKDESY 105 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECC--CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEEEEeCCE
Confidence 46799999999999999999987652 24789999986544334445567889999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|+|||||++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEecCCCCeec
Confidence 99999999999999988654 569999999999999999999999999999999999999 57788999999999876
Q ss_pred CCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 314 RPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
.. .....+||+.|||||++. ..++.++|||||||++|||++|..||.+......+..+......++ ..++..+
T Consensus 182 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~ 255 (340)
T PTZ00426 182 DT--RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP----KFLDNNC 255 (340)
T ss_pred CC--CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHH
Confidence 43 234568999999999986 4588999999999999999999999998888777888877655444 3578999
Q ss_pred HHHHHHhcccCccCCC-----CHHHHHcCcccCCC
Q 007253 393 RDFVKRLLNKDPRKRL-----TAAQALSHPWIKNS 422 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rp-----t~~~ll~hp~~~~~ 422 (611)
.++|++||+.||.+|+ +++++++||||++.
T Consensus 256 ~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 256 KHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred HHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999999995 89999999999874
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=387.17 Aligned_cols=258 Identities=33% Similarity=0.542 Sum_probs=222.6
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++.+.||+|+||.||+|+... +++.||||++.+...........+.+|+.++..+. ||||+++++++.+.+.+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~ 76 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKD---TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQDDEYL 76 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEEcCCEE
Confidence 369999999999999999999776 58899999997554333345567889999999998 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
|||||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 77 YLAMEYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIV 152 (333)
T ss_pred EEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEEEeCcCCcccc
Confidence 9999999999999988654 568999999999999999999999999999999999999 577889999999997654
Q ss_pred CCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCC----CCCC
Q 007253 315 PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW----PSLS 389 (611)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----~~~s 389 (611)
. .....+||+.|+|||++. ..++.++|||||||++|||++|..||......+.+..+......+....+ ..++
T Consensus 153 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s 230 (333)
T cd05600 153 T--YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLS 230 (333)
T ss_pred c--ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccC
Confidence 3 344568999999999986 56899999999999999999999999988877777776654332222221 2578
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
.++.+||.+||..+|.+||++.++++||||+..
T Consensus 231 ~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 231 DEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-46 Score=377.70 Aligned_cols=256 Identities=27% Similarity=0.439 Sum_probs=213.6
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++.++||.|+||.||+|+... +++.||+|++...... .....+.+|+.+++++. ||||+++++++.+++.
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 77 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKL---TENLVALKEIRLEHEE--GAPCTAIREVSLLKNLK-HANIVTLHDIIHTERC 77 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECC---CCCEEEEEEecccccC--CcchhHHHHHHHHHhCC-CCCEeeEEEEEcCCCe
Confidence 3579999999999999999998765 6899999998644221 22345778999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
.++||||+++ +|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 78 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~DfG~~~~~ 153 (288)
T cd07871 78 LTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI---NEKGELKLADFGLARAK 153 (288)
T ss_pred EEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEECcCcceeec
Confidence 9999999975 9999887776678999999999999999999999999999999999999 56788999999998765
Q ss_pred CCC-CcccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-------
Q 007253 314 RPD-ERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA------- 383 (611)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~------- 383 (611)
... .......|++.|+|||++. ..++.++|||||||++|+|++|+.||.+....+.+..+.......+..
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 154 SVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred cCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence 422 2334567899999999885 358999999999999999999999998877766555554322111100
Q ss_pred -------------------CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 384 -------------------PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 384 -------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
..+.++.++.+||++||+.||.+|||++|+|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 113468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=392.26 Aligned_cols=260 Identities=28% Similarity=0.486 Sum_probs=223.8
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++.+.||+|+||.||+|+... +++.||+|++.+.........+.+.+|+.+++.++ ||||+++++++.+++.
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKS---SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN-SEWIVQLHYAFQDDKY 117 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCE
Confidence 5689999999999999999999776 68999999996543333344456788999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|+|||||+||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---cCCCCEEEEeccceeec
Confidence 9999999999999998754 358999999999999999999999999999999999999 67888999999999876
Q ss_pred CCCC--cccccccCCCcCcchhhcC-----CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 007253 314 RPDE--RLNDIVGSAYYVAPEVLHR-----SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 314 ~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (611)
.... .....+||+.|+|||++.. .++.++|||||||++|||++|+.||.+......+..+.............
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 272 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI 272 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcC
Confidence 5332 2345689999999998852 37889999999999999999999999988888888887655444333344
Q ss_pred CCCHHHHHHHHHhcccCccC--CCCHHHHHcCcccCCC
Q 007253 387 SLSSEARDFVKRLLNKDPRK--RLTAAQALSHPWIKNS 422 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~--Rpt~~~ll~hp~~~~~ 422 (611)
.++.++.+||++||+.+|.+ |+|+.++++||||+..
T Consensus 273 ~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred CCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 68999999999999999988 9999999999999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-46 Score=392.92 Aligned_cols=258 Identities=31% Similarity=0.536 Sum_probs=219.9
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
.|+++++||+|+||.||+|+... +++.||||++.+...........+.+|+.+++++. |+||+++++++.+++.+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~-h~~iv~~~~~~~~~~~~~ 77 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVD---TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLY 77 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECC---CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC-CCcCCeEEEEEEeCCEEE
Confidence 58999999999999999999766 68999999996544334445677889999999997 999999999999999999
Q ss_pred EEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC
Q 007253 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~ 315 (611)
+|||||++|+|.+++... +.+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||++.....
T Consensus 78 lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl---~~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 78 FVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEeECCCCccccc
Confidence 999999999999988654 568999999999999999999999999999999999999 6778899999999753210
Q ss_pred C------------------------------------------------CcccccccCCCcCcchhhc-CCCCCcchhhH
Q 007253 316 D------------------------------------------------ERLNDIVGSAYYVAPEVLH-RSYSTEADVWS 346 (611)
Q Consensus 316 ~------------------------------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwS 346 (611)
. ......+||+.|+|||++. ..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (382)
T cd05625 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence 0 0012357999999999886 56999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCC---HHHHHcCcccCCC
Q 007253 347 IGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT---AAQALSHPWIKNS 422 (611)
Q Consensus 347 lGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~~ll~hp~~~~~ 422 (611)
|||++|||++|+.||.+....+....+..............+++++.++|.+|+ .+|.+|++ +.++++||||+..
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred chHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 999999999999999988877777777665544444444578999999999986 59999997 9999999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-46 Score=392.60 Aligned_cols=259 Identities=27% Similarity=0.492 Sum_probs=217.2
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++++.||+|+||.||+|+... +|+.||||++.+.........+.+.+|+++++.+. ||||+++++++.+.+.+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~ 76 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKD---TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD-SPWVVSLYYSFQDAQYL 76 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCee
Confidence 369999999999999999998776 68999999986543333445677889999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
|||||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 77 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll---~~~~~~kl~DfGla~~~~ 152 (377)
T cd05629 77 YLIMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFH 152 (377)
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEEeecccccccc
Confidence 9999999999999988654 579999999999999999999999999999999999999 577889999999986321
Q ss_pred CCC------------------------------------------------cccccccCCCcCcchhhc-CCCCCcchhh
Q 007253 315 PDE------------------------------------------------RLNDIVGSAYYVAPEVLH-RSYSTEADVW 345 (611)
Q Consensus 315 ~~~------------------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Diw 345 (611)
... .....+||+.|+|||++. ..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 232 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence 100 001247999999999886 5689999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCC---CCHHHHHcCcccCCC
Q 007253 346 SIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKR---LTAAQALSHPWIKNS 422 (611)
Q Consensus 346 SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R---pt~~~ll~hp~~~~~ 422 (611)
||||++|||++|..||.+....+.+..+......+.......++.++.+||.+||. +|.+| +++.++++||||++.
T Consensus 233 SlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 233 SLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred ecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 99999999999999998888777777776543333222233578999999999998 77765 599999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=383.53 Aligned_cols=250 Identities=29% Similarity=0.543 Sum_probs=217.1
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeee
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~ 240 (611)
+.||+|+||.||+++... +|+.||+|++.+...........+.+|+.+++.+. ||||+++++++..++.+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~Ey 76 (328)
T cd05593 1 KLLGKGTFGKVILVREKA---SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSFQTKDRLCFVMEY 76 (328)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCEEEEEEeC
Confidence 479999999999999766 68999999997654444445667889999999997 99999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC-CCcc
Q 007253 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERL 319 (611)
Q Consensus 241 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~-~~~~ 319 (611)
+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ....
T Consensus 77 ~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~ 152 (328)
T cd05593 77 VNGGELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAATM 152 (328)
T ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE---CCCCcEEEecCcCCccCCCccccc
Confidence 9999998877544 579999999999999999999999999999999999999 5778899999999876432 2234
Q ss_pred cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 007253 320 NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398 (611)
Q Consensus 320 ~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 398 (611)
...+||+.|+|||++. ..++.++|||||||++|+|++|+.||...........+......++ ..++.++.+||++
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~ 228 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP----RTLSADAKSLLSG 228 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCC----CCCCHHHHHHHHH
Confidence 4568999999999986 5689999999999999999999999998887777777766555444 3679999999999
Q ss_pred hcccCccCCC-----CHHHHHcCcccCCC
Q 007253 399 LLNKDPRKRL-----TAAQALSHPWIKNS 422 (611)
Q Consensus 399 ~L~~dP~~Rp-----t~~~ll~hp~~~~~ 422 (611)
||.+||.+|+ ++.++++||||...
T Consensus 229 ~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 229 LLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred HcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999997 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=381.47 Aligned_cols=248 Identities=27% Similarity=0.541 Sum_probs=216.3
Q ss_pred eeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeeecC
Q 007253 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCE 242 (611)
Q Consensus 163 LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~~~ 242 (611)
||+|+||.||+|+... +++.||+|++.+...........+.+|+.++++++ ||||+++++++.+.+.+|+|||||+
T Consensus 1 lg~G~~g~Vy~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~ 76 (312)
T cd05585 1 IGKGSFGKVMQVRKRD---TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLKFSFQSPEKLYLVLAFIN 76 (312)
T ss_pred CCcCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCcEeceeeEEecCCeEEEEEcCCC
Confidence 7999999999999766 68899999997544334445567889999999997 9999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC-CCcccc
Q 007253 243 GGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERLND 321 (611)
Q Consensus 243 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~-~~~~~~ 321 (611)
+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ......
T Consensus 77 ~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~ 152 (312)
T cd05585 77 GGELFHHLQRE-GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNT 152 (312)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCCcccc
Confidence 99999988654 579999999999999999999999999999999999999 6778899999999986432 223445
Q ss_pred cccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhc
Q 007253 322 IVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400 (611)
Q Consensus 322 ~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 400 (611)
.+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+.+..+......++ ..+++++.+||.+||
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L 228 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLL 228 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHc
Confidence 68999999999886 5689999999999999999999999998888888888777655444 368899999999999
Q ss_pred ccCccCCC---CHHHHHcCcccCCC
Q 007253 401 NKDPRKRL---TAAQALSHPWIKNS 422 (611)
Q Consensus 401 ~~dP~~Rp---t~~~ll~hp~~~~~ 422 (611)
..||.+|| ++.++|+||||...
T Consensus 229 ~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 229 SRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 99999997 58999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=392.74 Aligned_cols=259 Identities=30% Similarity=0.508 Sum_probs=219.1
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
.+|++++.||+|+||.||+|+... +++.||||++.+...........+.+|+.+++++. |+||+++++.+.+++.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~ 76 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVD---TNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYSFQDKDNL 76 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC---CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCEE
Confidence 369999999999999999999776 58999999986543333334567889999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
|||||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|..+.
T Consensus 77 ~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~ikL~DFG~a~~~~ 152 (376)
T cd05598 77 YFVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFR 152 (376)
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE---CCCCCEEEEeCCCCcccc
Confidence 9999999999999988654 568999999999999999999999999999999999999 577889999999975321
Q ss_pred CC--------------------------------------------CcccccccCCCcCcchhhc-CCCCCcchhhHHHH
Q 007253 315 PD--------------------------------------------ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGV 349 (611)
Q Consensus 315 ~~--------------------------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGv 349 (611)
.. ......+||+.|||||++. ..++.++|||||||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 232 (376)
T cd05598 153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 232 (376)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccc
Confidence 00 0012357999999999986 56899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCC---CHHHHHcCcccCCC
Q 007253 350 IAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL---TAAQALSHPWIKNS 422 (611)
Q Consensus 350 il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~~ll~hp~~~~~ 422 (611)
++|+|++|+.||.+....+....+...........+..++.++.+||.+|+ .+|.+|+ ++.++++||||+..
T Consensus 233 ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 233 ILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred eeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 999999999999988877766666655444444444578999999999977 5999999 99999999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-46 Score=363.32 Aligned_cols=261 Identities=32% Similarity=0.511 Sum_probs=223.6
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCC-eeEEEEEEeeCC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN-LVKFFDAYEDTD 232 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~-iv~l~~~~~~~~ 232 (611)
...|+.+++||+|+||.||+|+.+. +|+.||+|.+.-.... +-.-....+|+.+++.|+ |+| ||+|++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~---~g~~VALKkirl~~~~-EG~P~taiREisllk~L~-~~~~iv~L~dv~~~~~ 84 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKR---TGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLS-HANHIVRLHDVIHTSN 84 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEec---CCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhC-CCcceEEEEeeeeecc
Confidence 3568889999999999999999887 6899999998644321 112344679999999998 999 999999999877
Q ss_pred ------eeEEEeeecCCCChHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEE
Q 007253 233 ------NVYVVMELCEGGELLDRILSRG---GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303 (611)
Q Consensus 233 ------~~~lv~E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vk 303 (611)
.+++|+||++- +|.+++.... ..++...++.+++||+.||+|||+++|+||||||+|||| ++.|.+|
T Consensus 85 ~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi---~~~G~lK 160 (323)
T KOG0594|consen 85 NHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI---SSSGVLK 160 (323)
T ss_pred cccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE---CCCCcEe
Confidence 89999999965 9999987765 358889999999999999999999999999999999999 5688999
Q ss_pred EeecccccccC-CCCcccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC
Q 007253 304 AIDFGLSDFVR-PDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 380 (611)
Q Consensus 304 l~DfG~a~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~ 380 (611)
|+|||+|+... +.......++|.+|.|||++-+ .|+..+||||+|||++||++++..|.+.++.+.+..|.+.-...
T Consensus 161 laDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 161 LADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTP 240 (323)
T ss_pred eeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCC
Confidence 99999999776 4445667799999999999864 59999999999999999999999999999988888887765444
Q ss_pred CCCCCCC--------------------------CCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 381 DEAPWPS--------------------------LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 381 ~~~~~~~--------------------------~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.+..|+. .+....+++.+||+.+|.+|.|+..+|+||||....
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 4444432 235788999999999999999999999999999764
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=389.33 Aligned_cols=259 Identities=34% Similarity=0.605 Sum_probs=223.8
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++.+.||+|+||.||+|+... +|+.||||++.+...........+.+|+.++..++ |+||+++++++.+++.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~ 76 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKD---TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSFQDEEHL 76 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECC---CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhheecCCeE
Confidence 469999999999999999999776 68999999997654333345567889999999998 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 77 YLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMN 152 (350)
T ss_pred EEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEeecCCCCccCc
Confidence 9999999999999988765 679999999999999999999999999999999999999 677889999999998664
Q ss_pred CCC------------------------------cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCC
Q 007253 315 PDE------------------------------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWA 363 (611)
Q Consensus 315 ~~~------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~ 363 (611)
... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 332 233457999999999986 5689999999999999999999999998
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCC-HHHHHcCcccCCC
Q 007253 364 RTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT-AAQALSHPWIKNS 422 (611)
Q Consensus 364 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-~~~ll~hp~~~~~ 422 (611)
.........+......+.......+++++.+||.+||. ||.+|++ +.++++||||+..
T Consensus 233 ~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 233 DTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred CCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 88777777777633333333334579999999999997 9999999 9999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=382.29 Aligned_cols=250 Identities=29% Similarity=0.547 Sum_probs=216.5
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeee
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~ 240 (611)
+.||+|+||.||+++... +|+.||+|++.+...........+.+|+.+++.++ ||||+++++++...+.+||||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~E~ 76 (323)
T cd05595 1 KLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFVMEY 76 (323)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCEEEEEEeC
Confidence 479999999999998765 68999999997543333445567788999999997 99999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC-CCcc
Q 007253 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERL 319 (611)
Q Consensus 241 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~-~~~~ 319 (611)
+++|+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ....
T Consensus 77 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~ 152 (323)
T cd05595 77 ANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATM 152 (323)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---cCCCCEEecccHHhccccCCCCcc
Confidence 9999998877544 579999999999999999999999999999999999999 5778899999999876432 2233
Q ss_pred cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 007253 320 NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398 (611)
Q Consensus 320 ~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 398 (611)
...+||+.|+|||++. +.++.++|||||||++|+|++|+.||...........+......++ ..+++++.+||.+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~ 228 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAG 228 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHH
Confidence 4568999999999886 5689999999999999999999999998887777777766655444 3679999999999
Q ss_pred hcccCccCCC-----CHHHHHcCcccCCC
Q 007253 399 LLNKDPRKRL-----TAAQALSHPWIKNS 422 (611)
Q Consensus 399 ~L~~dP~~Rp-----t~~~ll~hp~~~~~ 422 (611)
||+.||.+|+ ++.++++|+||...
T Consensus 229 ~L~~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 229 LLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred HccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 9999999998 89999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-46 Score=385.63 Aligned_cols=260 Identities=30% Similarity=0.500 Sum_probs=223.9
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++.+.||+|+||.||+|+... +|+.||+|++.+.........+.+.+|+.+++.++ |+||+++++++.+.+.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-~~~i~~~~~~~~~~~~~ 76 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKA---TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN-SPWIPQLQYAFQDKDNL 76 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCeE
Confidence 469999999999999999998776 68999999997654434445667889999999987 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
||||||+++|+|.+++......+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++..+.
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 77 YLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLT 153 (330)
T ss_pred EEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE---CCCCCEEeccCCCCeECC
Confidence 99999999999999987776789999999999999999999999999999999999999 677889999999998765
Q ss_pred CCCc--ccccccCCCcCcchhhc-------CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 007253 315 PDER--LNDIVGSAYYVAPEVLH-------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (611)
Q Consensus 315 ~~~~--~~~~~gt~~y~aPE~~~-------~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (611)
.... .....||+.|+|||++. ..++.++|||||||++|+|++|+.||........+..+............
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (330)
T cd05601 154 ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPED 233 (330)
T ss_pred CCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCC
Confidence 4332 23357999999999884 34788999999999999999999999888877777777665433322223
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
+.++.++.+||.+||+ +|.+|||+.++++||||+..
T Consensus 234 ~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 234 PKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred CCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 4689999999999998 99999999999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=380.56 Aligned_cols=256 Identities=28% Similarity=0.488 Sum_probs=221.2
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
+|++.+.||+|+||.||+|+... +++.||||++.+.........+.+..|+.++..+.+|++|+++++++.+.+.+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 77 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEE
Confidence 48999999999999999998766 588999999976543344455678889999999975667999999999999999
Q ss_pred EEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC-
Q 007253 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR- 314 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~- 314 (611)
+|||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 78 lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 78 FVMEYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DAEGHIKIADFGMCKENIF 153 (324)
T ss_pred EEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---cCCCCEEEeecCcceecCC
Confidence 999999999999887654 568999999999999999999999999999999999999 567889999999987532
Q ss_pred CCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 007253 315 PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (611)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 393 (611)
........+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+.+..+......++ ..++.++.
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~ 229 (324)
T cd05587 154 GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAV 229 (324)
T ss_pred CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHH
Confidence 223344568999999999986 5689999999999999999999999998888888888877655444 35799999
Q ss_pred HHHHHhcccCccCCCCH-----HHHHcCcccCCC
Q 007253 394 DFVKRLLNKDPRKRLTA-----AQALSHPWIKNS 422 (611)
Q Consensus 394 ~li~~~L~~dP~~Rpt~-----~~ll~hp~~~~~ 422 (611)
++|++||.+||.+|++. .++++||||+..
T Consensus 230 ~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 230 SICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred HHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 99999999999999986 899999999874
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=388.40 Aligned_cols=261 Identities=28% Similarity=0.479 Sum_probs=221.6
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|++.+.||+|+||.||+|+... +++.||+|++.+...........+.+|+.+++.+. ||||+++++++.+++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~ 116 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKS---SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFCAFQDDK 116 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCC
Confidence 35789999999999999999999876 68899999996543333344556789999999987 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.+|+|||||+||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl---~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEEeccccee
Confidence 99999999999999998854 358999999999999999999999999999999999999 6778899999999987
Q ss_pred cCCCC--cccccccCCCcCcchhhcC-----CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 007253 313 VRPDE--RLNDIVGSAYYVAPEVLHR-----SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (611)
Q Consensus 313 ~~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (611)
..... .....+||+.|||||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+......+.....
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 271 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPED 271 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCc
Confidence 64332 2345689999999999853 2788999999999999999999999988888888877765433333333
Q ss_pred CCCCHHHHHHHHHhcccCccC--CCCHHHHHcCcccCCC
Q 007253 386 PSLSSEARDFVKRLLNKDPRK--RLTAAQALSHPWIKNS 422 (611)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~--Rpt~~~ll~hp~~~~~ 422 (611)
..++..++++|.+||..++.+ |+++.++++||||+..
T Consensus 272 ~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 272 VEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred ccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 467999999999999866544 8999999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=381.63 Aligned_cols=251 Identities=31% Similarity=0.560 Sum_probs=217.2
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeee
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~ 240 (611)
+.||+|+||.||+|+.+. +++.||||++.+.........+.+..|+.++..+.+||||+++++++.+.+.+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLKE---SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEcC---CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcC
Confidence 479999999999999776 68999999987543333344567788999998876699999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC-CCcc
Q 007253 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERL 319 (611)
Q Consensus 241 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~-~~~~ 319 (611)
|++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ....
T Consensus 78 ~~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~~~ 153 (320)
T cd05590 78 VNGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTT 153 (320)
T ss_pred CCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCCcc
Confidence 9999999877654 579999999999999999999999999999999999999 5778899999999875432 2334
Q ss_pred cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 007253 320 NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398 (611)
Q Consensus 320 ~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 398 (611)
...+||+.|+|||++. ..++.++|||||||++|+|++|+.||......+++..+......++. .++.++.+||++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~ 229 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLSQDAVDILKA 229 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHH
Confidence 4568999999999986 56899999999999999999999999998888888888776554432 478999999999
Q ss_pred hcccCccCCCCH------HHHHcCcccCCC
Q 007253 399 LLNKDPRKRLTA------AQALSHPWIKNS 422 (611)
Q Consensus 399 ~L~~dP~~Rpt~------~~ll~hp~~~~~ 422 (611)
||+.||.+|+++ +++++||||+..
T Consensus 230 ~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 230 FMTKNPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred HcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 999999999998 999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=384.23 Aligned_cols=256 Identities=29% Similarity=0.430 Sum_probs=208.6
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
..+|+++++||+|+||.||+|+... +|+.||||++... ........+.+|+.+++.++ |+||+++++++.+++.
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 146 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRP---TGRLYALKVIYGN--HEDTVRRQICREIEILRDVN-HPNVVKCHDMFDHNGE 146 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECC---CCCEEEEEEEecC--CcHHHHHHHHHHHHHHHhCC-CCCcceeeeEeccCCe
Confidence 4678999999999999999998765 5899999998543 23445567899999999998 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+++|||||++|+|.+. ....+..+..++.||+.||.|||++|||||||||+|||+ +.++.+||+|||++..+
T Consensus 147 ~~lv~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~ 218 (353)
T PLN00034 147 IQVLLEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI---NSAKNVKIADFGVSRIL 218 (353)
T ss_pred EEEEEecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEcccccceec
Confidence 9999999999998542 346788899999999999999999999999999999999 56788999999999876
Q ss_pred CCCC-cccccccCCCcCcchhhcC------CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 007253 314 RPDE-RLNDIVGSAYYVAPEVLHR------SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (611)
.... .....+||..|+|||++.. ..+.++|||||||++|||++|+.||...........+.............
T Consensus 219 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (353)
T PLN00034 219 AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPA 298 (353)
T ss_pred ccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCC
Confidence 4332 2345689999999998742 23568999999999999999999997433322222211111111122224
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.++.++.+||.+||+.||++|||+.++|+||||....
T Consensus 299 ~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 299 TASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 6789999999999999999999999999999998764
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=383.04 Aligned_cols=259 Identities=31% Similarity=0.556 Sum_probs=217.0
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCc-CCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-TTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
+|++++.||+|+||.||+++...+...++.||+|++.+... ......+.+.+|+.+++.+.+|+||+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 48999999999999999998765555789999999865322 12234466789999999997799999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++|||||++|+|.+++..+ ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili---~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE---CCCCCEEEeeCcCCcccc
Confidence 9999999999999988654 569999999999999999999999999999999999999 567789999999998653
Q ss_pred CCC--cccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHhcCCCCCCCCCC
Q 007253 315 PDE--RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWAR----TESGIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 315 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~~ 386 (611)
... .....+||+.|||||++.+ .++.++|||||||++|+|++|+.||... ....+...+....+.++ .
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~ 232 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP----S 232 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCC----C
Confidence 322 2345689999999999864 4788999999999999999999999643 22334444554444333 3
Q ss_pred CCCHHHHHHHHHhcccCccCCC-----CHHHHHcCcccCCC
Q 007253 387 SLSSEARDFVKRLLNKDPRKRL-----TAAQALSHPWIKNS 422 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rp-----t~~~ll~hp~~~~~ 422 (611)
.++..+.+||.+||+.||++|| ++.++++||||+..
T Consensus 233 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 233 FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 5799999999999999999999 88999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=375.21 Aligned_cols=259 Identities=28% Similarity=0.451 Sum_probs=210.2
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++.+.||+|+||.||+|+... +++.||||++...... .....+.+|+.+++.+. ||||+++++++.+++.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 77 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKV---NGKLVALKVIRLQEEE--GTPFTAIREASLLKGLK-HANIVLLHDIIHTKET 77 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECC---CCCEEEEEEecccccc--ccchhHHHHHHHHhhCC-CCCcCeEEEEEecCCe
Confidence 4689999999999999999999765 6889999998654322 22345678999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
.++||||+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~ 153 (303)
T cd07869 78 LTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI---SDTGELKLADFGLARAK 153 (303)
T ss_pred EEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECCCCcceec
Confidence 999999995 68888887776779999999999999999999999999999999999999 57788999999998754
Q ss_pred CCC-CcccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCCCCCC-----
Q 007253 314 RPD-ERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSFDEAP----- 384 (611)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~-~~~~~i~~~~~~~~~~~----- 384 (611)
... .......||+.|+|||++. ..++.++|||||||++|+|++|..||.+.... ..+..+...........
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 154 SVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred cCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence 322 2334567899999999885 34788999999999999999999999765432 22222221100000000
Q ss_pred ---------------------C--CCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 385 ---------------------W--PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 385 ---------------------~--~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
| ..++..+.+||.+||+.||++|||+.++|+||||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 0 1245788999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=378.86 Aligned_cols=256 Identities=27% Similarity=0.474 Sum_probs=222.3
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
+|++.+.||+|+||.||+|+... +++.||||++.+.........+.+..|..++..+..|++|+++++++.+.+.+|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLY 77 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEE
Confidence 48899999999999999998765 588999999976543344445667788899888876899999999999999999
Q ss_pred EEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC
Q 007253 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~ 315 (611)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 78 lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 78 FVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENMW 153 (323)
T ss_pred EEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE---CCCCcEEEccCCCceecCC
Confidence 999999999999887654 569999999999999999999999999999999999999 6778899999999875432
Q ss_pred -CCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 007253 316 -DERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (611)
Q Consensus 316 -~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 393 (611)
.......+||+.|+|||++. +.++.++|||||||++|||++|+.||.+......+..+......++ ..++.++.
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~ 229 (323)
T cd05616 154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAV 229 (323)
T ss_pred CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CcCCHHHH
Confidence 23344568999999999986 5689999999999999999999999999888888888877665544 35799999
Q ss_pred HHHHHhcccCccCCCC-----HHHHHcCcccCCC
Q 007253 394 DFVKRLLNKDPRKRLT-----AAQALSHPWIKNS 422 (611)
Q Consensus 394 ~li~~~L~~dP~~Rpt-----~~~ll~hp~~~~~ 422 (611)
++|.+||+.||.+|++ ..++++||||+..
T Consensus 230 ~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 230 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred HHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999999999998 4899999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=379.31 Aligned_cols=251 Identities=29% Similarity=0.503 Sum_probs=217.7
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeee
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~ 240 (611)
+.||+|+||.||+|+... +++.||||++.+.........+.+..|++++..+.+||||+++++++.+.+.+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELKG---TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEECC---CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeC
Confidence 479999999999998765 58899999997654334445566778999998876799999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC-CCcc
Q 007253 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERL 319 (611)
Q Consensus 241 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~-~~~~ 319 (611)
|++|+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (321)
T cd05591 78 VNGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVTT 153 (321)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeecccceecccCCccc
Confidence 9999999887654 569999999999999999999999999999999999999 6778899999999875432 2234
Q ss_pred cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 007253 320 NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398 (611)
Q Consensus 320 ~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 398 (611)
...+||+.|+|||++. ..++.++|||||||++|+|++|+.||......+.+..+......++. .++.++.+||++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~ll~~ 229 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV----WLSKEAVSILKA 229 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHH
Confidence 4567999999999986 56899999999999999999999999999888888888876654442 478999999999
Q ss_pred hcccCccCCC-------CHHHHHcCcccCCC
Q 007253 399 LLNKDPRKRL-------TAAQALSHPWIKNS 422 (611)
Q Consensus 399 ~L~~dP~~Rp-------t~~~ll~hp~~~~~ 422 (611)
||+.||++|+ ++.++++||||...
T Consensus 230 ~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 230 FMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred HhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 9999999999 99999999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=378.60 Aligned_cols=250 Identities=29% Similarity=0.534 Sum_probs=211.1
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeee
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~ 240 (611)
+.||+|+||.||+|+... +++.||||++.+...........+.+|+.++..+.+||||+++++++.+.+.+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKK---TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeC
Confidence 479999999999999776 68999999997654444555667889999999996799999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc-CCCCcc
Q 007253 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV-RPDERL 319 (611)
Q Consensus 241 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~-~~~~~~ 319 (611)
|+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++... ......
T Consensus 78 ~~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (329)
T cd05588 78 VSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTT 153 (329)
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEECcCccccccccCCCcc
Confidence 9999998877544 579999999999999999999999999999999999999 56788999999998753 233344
Q ss_pred cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCC---------hHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 320 NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART---------ESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 320 ~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~---------~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
...+||+.|+|||++. ..++.++|||||||++|+|++|+.||.... .......+......++ ..++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~ 229 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP----RSLS 229 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC----CCCC
Confidence 5678999999999986 568999999999999999999999995321 1123344444443333 3578
Q ss_pred HHHHHHHHHhcccCccCCCC------HHHHHcCcccCC
Q 007253 390 SEARDFVKRLLNKDPRKRLT------AAQALSHPWIKN 421 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt------~~~ll~hp~~~~ 421 (611)
.++.++|++||+.||.+|++ +.++++||||+.
T Consensus 230 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 99999999999999999987 789999999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=385.47 Aligned_cols=259 Identities=29% Similarity=0.529 Sum_probs=219.4
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++.+.||+|+||.||+|+... +++.||||++.+...........+.+|+.++..+. |+||+++++++.+++.+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~ 76 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKD---TGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD-GAWVVKMFYSFQDKRNL 76 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEE
Confidence 468999999999999999999876 68999999997543334445667889999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
|||||||+||+|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||++..+.
T Consensus 77 ~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli---~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 77 YLIMEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred EEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEeeccCCcccc
Confidence 9999999999999988654 569999999999999999999999999999999999999 577889999999987543
Q ss_pred CCC------------------------------------cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhC
Q 007253 315 PDE------------------------------------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCG 357 (611)
Q Consensus 315 ~~~------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g 357 (611)
... .....+||+.|+|||++. ..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence 211 012357999999999986 5689999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCC---CHHHHHcCcccCCC
Q 007253 358 SRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL---TAAQALSHPWIKNS 422 (611)
Q Consensus 358 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~~ll~hp~~~~~ 422 (611)
+.||........+..+..............++.++.+||.+|+ .||.+|+ ++.++++||||++.
T Consensus 233 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 233 YPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCC
Confidence 9999988888877777754333322222357899999999987 4999998 58999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=378.00 Aligned_cols=253 Identities=30% Similarity=0.548 Sum_probs=217.3
Q ss_pred eeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHH---HhcCCCCeeEEEEEEeeCCe
Q 007253 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR---ALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~---~l~~h~~iv~l~~~~~~~~~ 233 (611)
|++.+.||+|+||.||+|.... +|+.||||++.+.........+.+.+|++++. .+. ||||+++++++.+.+.
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~-hp~i~~~~~~~~~~~~ 76 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER-HPFLVNLFACFQTEDH 76 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccC-CCChhceeeEEEcCCE
Confidence 7889999999999999998766 68999999997543333344566777877664 444 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|+|||||+||+|...+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 77 ~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 77 VCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL---DTEGFVKIADFGLCKEG 151 (324)
T ss_pred EEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCcEEeCcccCCccC
Confidence 9999999999999887643 469999999999999999999999999999999999999 57788999999998754
Q ss_pred CC-CCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 314 RP-DERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 314 ~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
.. .......+|++.|||||++. ..++.++|||||||++|+|++|+.||.+....+....+......++ ..++..
T Consensus 152 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~ 227 (324)
T cd05589 152 MGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RFLSRE 227 (324)
T ss_pred CCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHH
Confidence 32 23345578999999999886 5689999999999999999999999998888888888877665544 357999
Q ss_pred HHHHHHHhcccCccCCC-----CHHHHHcCcccCCC
Q 007253 392 ARDFVKRLLNKDPRKRL-----TAAQALSHPWIKNS 422 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rp-----t~~~ll~hp~~~~~ 422 (611)
+.+||++||+.||.+|| ++.++++||||++.
T Consensus 228 ~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 228 AISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred HHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 99999999999999999 79999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=380.48 Aligned_cols=250 Identities=30% Similarity=0.547 Sum_probs=216.0
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeee
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~ 240 (611)
+.||+|+||.||+++... +|+.||+|++.+...........+.+|+++++.+. ||||+++++++...+.+||||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~~~~~~~~~lv~E~ 76 (325)
T cd05594 1 KLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCFVMEY 76 (325)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEEEEcCCEEEEEEeC
Confidence 479999999999998765 68999999997654444445567788999999997 99999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeecCCCCceEEeccCCCceEEEeecccccccCC-CCc
Q 007253 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DER 318 (611)
Q Consensus 241 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~-~~~ 318 (611)
+++|+|.+++... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++..... ...
T Consensus 77 ~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~ 152 (325)
T cd05594 77 ANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGAT 152 (325)
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCcc
Confidence 9999998877544 579999999999999999999997 799999999999999 5778899999999875432 233
Q ss_pred ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 007253 319 LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397 (611)
Q Consensus 319 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 397 (611)
....+||+.|+|||++. +.++.++|||||||++|+|++|+.||.+.........+......++ ..+++++.+||+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~ 228 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLS 228 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHH
Confidence 44567999999999986 5689999999999999999999999998887777777766655444 357899999999
Q ss_pred HhcccCccCCC-----CHHHHHcCcccCCC
Q 007253 398 RLLNKDPRKRL-----TAAQALSHPWIKNS 422 (611)
Q Consensus 398 ~~L~~dP~~Rp-----t~~~ll~hp~~~~~ 422 (611)
+||+.||.+|+ ++.++++||||.+.
T Consensus 229 ~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 229 GLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred HHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 99999999997 99999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=376.14 Aligned_cols=252 Identities=25% Similarity=0.419 Sum_probs=213.9
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
...++..++..||+|.||+||+|++.. .||||++.-.. ......+.|++||.++++-+ |.||+-|.|+|...
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG------dVAVK~Lnv~~-pt~~qlqaFKnEVa~lkkTR-H~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWHG------DVAVKLLNVDD-PTPEQLQAFKNEVAVLKKTR-HENILLFMGACMNP 460 (678)
T ss_pred cCHHHhhccceeccccccceeeccccc------ceEEEEEecCC-CCHHHHHHHHHHHHHHhhcc-hhhheeeehhhcCC
Confidence 345678899999999999999999765 49999997654 45568899999999999988 99999999999988
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
.. .||+.+|+|-+|+.+|+-...++.....+.|++||++|+.|||.++|||||||..|||| .+++.|||+|||++.
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDFGLAT 536 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEeccccee
Confidence 77 99999999999999998877889999999999999999999999999999999999999 566899999999986
Q ss_pred cc---CCCCcccccccCCCcCcchhhc----CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-C
Q 007253 312 FV---RPDERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE-A 383 (611)
Q Consensus 312 ~~---~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~ 383 (611)
.. ..+.......|...|||||+++ ..|+..+|||||||++|||++|..||......+++..+-++...... .
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~ 616 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSK 616 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchh
Confidence 43 2233455567889999999986 35899999999999999999999999877666666555554322221 1
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 384 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
.....++++++|+..||..++++||...+||.
T Consensus 617 ~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 617 IRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred hhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 22456789999999999999999999999886
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-46 Score=379.03 Aligned_cols=256 Identities=31% Similarity=0.524 Sum_probs=229.4
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.+.|+.++++|+|+||.+++++++. .++.|++|.+.-....... .....+|+.++++++ |||||.+.+.|..++.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~---~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~-hP~iv~y~ds~~~~~~ 77 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKS---DDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLL-HPNIVEYKDSFEEDGQ 77 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhcc---CCceEEEEEEeccccCchh-hHHHHHHHHHHHhcc-CCCeeeeccchhcCCc
Confidence 3679999999999999999999877 5779999999765544433 347789999999998 9999999999999988
Q ss_pred -eEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 234 -VYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 234 -~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
++|||+||+||+|.+.|.+.. ..++++.+..|+.||+.||.|||+++|+|||||+.|||++ .++.|||+|||+|+
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt---k~~~VkLgDfGlaK 154 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT---KDKKVKLGDFGLAK 154 (426)
T ss_pred eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc---ccCceeecchhhhh
Confidence 999999999999999998776 5699999999999999999999999999999999999996 55568999999999
Q ss_pred ccCCCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 312 FVRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 312 ~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
.+.+.. ...+.+||++||.||++. ..|+.++|||||||++|||++-+++|.+.+..+...+|.+....... ..++
T Consensus 155 ~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp---~~ys 231 (426)
T KOG0589|consen 155 ILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP---SMYS 231 (426)
T ss_pred hcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC---cccc
Confidence 998776 677899999999999997 67999999999999999999999999999999999999887722222 3689
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHcCcccC
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~ 420 (611)
.+++.+|+.||..+|..||++.+||.+|.++
T Consensus 232 ~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 232 SELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred HHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 9999999999999999999999999998886
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=369.11 Aligned_cols=260 Identities=29% Similarity=0.459 Sum_probs=217.5
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
.|++.+.||+|+||.||++.... +++.||+|++.............+.+|+.++++++ ||||+++++++.+++.++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 76 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALC 76 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcC---CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC-CCCEeeeeeeecCCCeEE
Confidence 38899999999999999998765 58899999986544333444456788999999997 999999999999999999
Q ss_pred EEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 236 VVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
+|||||++|+|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||++ ++++.++|+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIP 153 (285)
T ss_pred EEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE---CCCCCEEEeeCCCceecC
Confidence 9999999999998876543 469999999999999999999999999999999999999 577889999999998765
Q ss_pred CCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 007253 315 PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (611)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 393 (611)
........+|++.|+|||++. ..++.++||||+||++|+|++|+.||.+.........+..............++..+.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd05605 154 EGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAAR 233 (285)
T ss_pred CCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHH
Confidence 444445568999999999886 5688999999999999999999999987665433333322211112222246899999
Q ss_pred HHHHHhcccCccCCC-----CHHHHHcCcccCCC
Q 007253 394 DFVKRLLNKDPRKRL-----TAAQALSHPWIKNS 422 (611)
Q Consensus 394 ~li~~~L~~dP~~Rp-----t~~~ll~hp~~~~~ 422 (611)
+||.+||..||.+|| +++++++||||...
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 234 SICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred HHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 999999999999999 99999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=375.41 Aligned_cols=251 Identities=30% Similarity=0.567 Sum_probs=214.1
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeee
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~ 240 (611)
+.||+|+||.||+|+... +++.||||++.+.........+.+..|..++..+.+||||+++++++..++.+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELKG---TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 479999999999999766 68899999997543333334455667888887665699999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC-CCcc
Q 007253 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERL 319 (611)
Q Consensus 241 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~-~~~~ 319 (611)
++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ....
T Consensus 78 ~~gg~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~~ 153 (316)
T cd05592 78 LNGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKA 153 (316)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCCcc
Confidence 9999999887654 579999999999999999999999999999999999999 5778899999999976432 2334
Q ss_pred cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 007253 320 NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398 (611)
Q Consensus 320 ~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 398 (611)
...+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+++..+....+.++ ..++.++.+||.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ll~~ 229 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP----RWISKEAKDCLSK 229 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Confidence 5568999999999986 4589999999999999999999999999888888877776655444 3578999999999
Q ss_pred hcccCccCCCCH-HHHHcCcccCCC
Q 007253 399 LLNKDPRKRLTA-AQALSHPWIKNS 422 (611)
Q Consensus 399 ~L~~dP~~Rpt~-~~ll~hp~~~~~ 422 (611)
||+.||.+||++ .++++||||+..
T Consensus 230 ~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 230 LFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred HccCCHHHcCCChHHHHcCcccCCC
Confidence 999999999986 588899999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=376.60 Aligned_cols=254 Identities=31% Similarity=0.536 Sum_probs=217.2
Q ss_pred eCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCc-CCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEe
Q 007253 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-TTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVM 238 (611)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 238 (611)
++.||+|+||.||+++...+...++.||||++.+... ........+.+|+.+++.++ ||||+++++++..++.+|+||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEecCCeEEEEE
Confidence 3689999999999998765555789999999865322 12233456788999999998 999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC-CC
Q 007253 239 ELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DE 317 (611)
Q Consensus 239 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~-~~ 317 (611)
||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.... ..
T Consensus 80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 80 EYLSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred eCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEeeCcCCeecccCCC
Confidence 999999999987654 568999999999999999999999999999999999999 6778899999999875432 22
Q ss_pred cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 007253 318 RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFV 396 (611)
Q Consensus 318 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 396 (611)
.....+||+.|+|||++. ..++.++|||||||++|||++|+.||........+..+......++ +.++.++.+||
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li 231 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLL 231 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Confidence 344568999999999986 4588999999999999999999999998888777777776654443 35789999999
Q ss_pred HHhcccCccCCC-----CHHHHHcCcccCCC
Q 007253 397 KRLLNKDPRKRL-----TAAQALSHPWIKNS 422 (611)
Q Consensus 397 ~~~L~~dP~~Rp-----t~~~ll~hp~~~~~ 422 (611)
++||++||++|| ++.++++||||+..
T Consensus 232 ~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 232 KKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999999999 89999999999864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=375.28 Aligned_cols=251 Identities=28% Similarity=0.542 Sum_probs=214.3
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeee
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~ 240 (611)
+.||+|+||.||+|+.+. +|+.||+|++.+.........+.+..|..++..+.+||||+++++++.+.+.+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLAELKG---KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECC
Confidence 479999999999999776 68999999997543222234456778888888765699999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC-CCcc
Q 007253 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERL 319 (611)
Q Consensus 241 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~-~~~~ 319 (611)
|.||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..... ....
T Consensus 78 ~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05620 78 LNGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRA 153 (316)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEeCccCCCeecccCCCce
Confidence 9999999887654 568999999999999999999999999999999999999 5777899999999875322 2234
Q ss_pred cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 007253 320 NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398 (611)
Q Consensus 320 ~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 398 (611)
...+||+.|+|||++. ..++.++|||||||++|+|++|+.||...........+....+.++. .++.++.+||++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~ 229 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR----WITKESKDILEK 229 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHHHH
Confidence 5568999999999986 56899999999999999999999999988888877777666554443 478999999999
Q ss_pred hcccCccCCCCH-HHHHcCcccCCC
Q 007253 399 LLNKDPRKRLTA-AQALSHPWIKNS 422 (611)
Q Consensus 399 ~L~~dP~~Rpt~-~~ll~hp~~~~~ 422 (611)
||+.||++|+++ +++++||||+..
T Consensus 230 ~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 230 LFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred HccCCHHHcCCChHHHHcCCCcCCC
Confidence 999999999998 589999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-45 Score=383.13 Aligned_cols=260 Identities=28% Similarity=0.480 Sum_probs=221.2
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++.+.||+|+||.||+|+... +++.||+|++.+...........+.+|+.+++.++ ||||+++++++.+++.
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDRY 117 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECC---CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCE
Confidence 5789999999999999999999776 68999999986543333344456788999999987 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|+|||||+||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll---~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKM 192 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE---CCCCCEEEEeCCceeEc
Confidence 9999999999999998754 358999999999999999999999999999999999999 57788999999999876
Q ss_pred CCCC--cccccccCCCcCcchhhcC-----CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 007253 314 RPDE--RLNDIVGSAYYVAPEVLHR-----SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 314 ~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (611)
.... .....+||+.|||||++.+ .++.++|||||||++|||++|+.||.+......+..+......+......
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 272 (371)
T cd05622 193 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 272 (371)
T ss_pred CcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcC
Confidence 5332 2345689999999999853 27889999999999999999999999988888888887655444333345
Q ss_pred CCCHHHHHHHHHhcccCccC--CCCHHHHHcCcccCCC
Q 007253 387 SLSSEARDFVKRLLNKDPRK--RLTAAQALSHPWIKNS 422 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~--Rpt~~~ll~hp~~~~~ 422 (611)
.++.++++||.+||..++.+ |+++.++++|+||++.
T Consensus 273 ~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 273 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred CCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 78999999999999854443 7899999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=376.60 Aligned_cols=261 Identities=29% Similarity=0.518 Sum_probs=219.2
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++++.||+|+||.||+++... +++.||+|++.+.........+.+.+|+.++..++ |+||+++++++.+++.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~ 76 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKN---TGQVYAMKILNKWEMLKRAETACFREERDVLVNGD-RRWITNLHYAFQDENNL 76 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCceEEEEecCCeE
Confidence 469999999999999999998776 68899999996543333444566889999999987 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
|+||||++||+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+.
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLL 153 (331)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE---CCCCCEEEEECCceeecC
Confidence 99999999999999987766789999999999999999999999999999999999999 577889999999987654
Q ss_pred CCCc--ccccccCCCcCcchhhc------CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-CCC
Q 007253 315 PDER--LNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE-APW 385 (611)
Q Consensus 315 ~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~ 385 (611)
.... ....+||+.|||||++. +.++.++|||||||++|+|++|+.||.+....+.+..+......+.. ...
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 233 (331)
T cd05597 154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDV 233 (331)
T ss_pred CCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCcc
Confidence 3332 22357999999999985 34788999999999999999999999888777777777654432221 122
Q ss_pred CCCCHHHHHHHHHhcccCccC--CCCHHHHHcCcccCCC
Q 007253 386 PSLSSEARDFVKRLLNKDPRK--RLTAAQALSHPWIKNS 422 (611)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~--Rpt~~~ll~hp~~~~~ 422 (611)
..++.++++||++||+.++.+ |+++.++++||||...
T Consensus 234 ~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 234 TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred CCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 458999999999999765544 7899999999999763
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=369.16 Aligned_cols=256 Identities=29% Similarity=0.483 Sum_probs=210.7
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++.+.||+|+||.||+|+... +++.||+|++..... .....+.+.+|+.+++.++ ||||+++++++..++.+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKE---TKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLK-QENIVELKEAFRRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECC---CCcEEEEEEEecccc-cccchhhHHHHHHHHHhCC-CccccchhhhEecCCEE
Confidence 369999999999999999999776 688999999865432 2334567889999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
|+||||++++.+ +.+......+++..++.++.||+.||.|||+.||+||||||+||++ +.++.+||+|||++....
T Consensus 76 ~lv~e~~~~~~l-~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~ 151 (287)
T cd07848 76 YLVFEYVEKNML-ELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI---SHNDVLKLCDFGFARNLS 151 (287)
T ss_pred EEEEecCCCCHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccCccccc
Confidence 999999988654 4555555679999999999999999999999999999999999999 577889999999998764
Q ss_pred CCC--cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-------------
Q 007253 315 PDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP------------- 378 (611)
Q Consensus 315 ~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~------------- 378 (611)
... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+....+.....
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 152 EGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred ccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhcc
Confidence 332 233467999999999886 5689999999999999999999999987665544333322111
Q ss_pred -CCCCC--------------CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 379 -SFDEA--------------PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 379 -~~~~~--------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
.+... .+..++.++.+||++||++||++|||++++|+||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00000 012368889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=356.86 Aligned_cols=264 Identities=35% Similarity=0.631 Sum_probs=229.9
Q ss_pred CceeE-eCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 155 NKYEL-GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 155 ~~y~~-~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
+-|.+ .+.||+|+|+.|--+.... +|..||||++.+.. .....++.+|++++...++|+||++|+++|+++.+
T Consensus 77 d~YkLt~e~LGeGAyasVqtcv~i~---t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 77 DMYKLTSELLGEGAYASVQTCVSIQ---TGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred HHHHhHHHHhcCccceeeeeeeeec---cchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 44555 4679999999998887665 79999999997753 34567899999999999999999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|||||-|.||.|+..|.++ ..+++..+..+.++|+.||.|||.+||.||||||+|||-...+.-.-||||||.+..-.
T Consensus 151 FYLVfEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred EEEEEecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccc
Confidence 99999999999999999877 56999999999999999999999999999999999999987777777999999886432
Q ss_pred CC--------CCcccccccCCCcCcchhhc------CCCCCcchhhHHHHHHHHHHhCCCCCCCCCh-------------
Q 007253 314 RP--------DERLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTE------------- 366 (611)
Q Consensus 314 ~~--------~~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~------------- 366 (611)
.- .....+.+|+..|||||+.. -.|+.++|.||||||||.|+.|.+||.+...
T Consensus 230 k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~ 309 (463)
T KOG0607|consen 230 KLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRV 309 (463)
T ss_pred ccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHH
Confidence 11 11245678999999999863 2489999999999999999999999965322
Q ss_pred --HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCC
Q 007253 367 --SGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (611)
Q Consensus 367 --~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~ 425 (611)
...+..|..+...|++..|..+|.+.+++|+.+|..|+.+|.++.++++|||++.-...
T Consensus 310 CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 310 CQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 35788899999999999999999999999999999999999999999999999876533
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=391.11 Aligned_cols=257 Identities=26% Similarity=0.430 Sum_probs=208.3
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC--
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT-- 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~-- 231 (611)
..+|++++.||+|+||.||+|.... .++.||||++.... ....+|+.+++.++ ||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~---~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~-h~niv~l~~~~~~~~~ 133 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICID---TSEKVAIKKVLQDP-------QYKNRELLIMKNLN-HINIIFLKDYYYTECF 133 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECC---CCCEEEEEEEecCc-------chHHHHHHHHHhcC-CCCCcceeeeEeeccc
Confidence 4679999999999999999998765 68899999885432 12357999999997 99999999887532
Q ss_pred ------CeeEEEeeecCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceE
Q 007253 232 ------DNVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVL 302 (611)
Q Consensus 232 ------~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~v 302 (611)
..+++|||||++ +|.+++.. ....+++..++.++.||+.||.|||++|||||||||+||||+ ...+.+
T Consensus 134 ~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~--~~~~~v 210 (440)
T PTZ00036 134 KKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID--PNTHTL 210 (440)
T ss_pred ccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEc--CCCCce
Confidence 247799999975 77666643 346799999999999999999999999999999999999994 233479
Q ss_pred EEeecccccccCCCCcccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--
Q 007253 303 KAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP-- 378 (611)
Q Consensus 303 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~-- 378 (611)
||+|||+|+.+.........+||+.|+|||++.+ .|+.++|||||||++|||++|.+||.+....+.+..+.+...
T Consensus 211 kL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p 290 (440)
T PTZ00036 211 KLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP 290 (440)
T ss_pred eeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999999987765555556789999999998753 589999999999999999999999988877665555543211
Q ss_pred ----------CCCCCCC-------------CCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCC
Q 007253 379 ----------SFDEAPW-------------PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (611)
Q Consensus 379 ----------~~~~~~~-------------~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~ 424 (611)
.+....+ ...+.++.+||.+||+.||.+|||+.++|+||||+....
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 1110000 135789999999999999999999999999999986543
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=367.66 Aligned_cols=258 Identities=30% Similarity=0.439 Sum_probs=210.6
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhc--CCCCeeEEEEEEe---
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT--GHNNLVKFFDAYE--- 229 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~iv~l~~~~~--- 229 (611)
.+|++.+.||+|+||.||+|+.... .|+.||+|++....... .....+.+|+.+++.+. .||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~ 77 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 77 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCC--CCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEeccc
Confidence 3699999999999999999987542 46889999986543222 22234567888887764 4999999999985
Q ss_pred --eCCeeEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEee
Q 007253 230 --DTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (611)
Q Consensus 230 --~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D 306 (611)
....+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 78 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~---~~~~~~kl~D 153 (290)
T cd07862 78 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLAD 153 (290)
T ss_pred CCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---cCCCCEEEcc
Confidence 2456999999996 58988886543 458999999999999999999999999999999999999 5677899999
Q ss_pred cccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---
Q 007253 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE--- 382 (611)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--- 382 (611)
||++.............||+.|+|||++. ..++.++|||||||++|||++|+.||.+....+.+..+.........
T Consensus 154 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 154 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred ccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence 99998766554455678999999999885 56899999999999999999999999988877776666543211110
Q ss_pred --------------------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 383 --------------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 383 --------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
...+.++..+.+||.+||+.||++|||+.++|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0123578889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=375.16 Aligned_cols=251 Identities=28% Similarity=0.525 Sum_probs=211.1
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeee
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~ 240 (611)
+.||+|+||.||+|+... +++.||+|++.+...........+.+|+.++.++.+||||+++++++.+.+.+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKK---TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeC
Confidence 479999999999999776 68899999997655445555667889999998886699999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC-CCCcc
Q 007253 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERL 319 (611)
Q Consensus 241 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~-~~~~~ 319 (611)
|++|+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~~~ 153 (329)
T cd05618 78 VNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTT 153 (329)
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCCcc
Confidence 9999998877544 579999999999999999999999999999999999999 677889999999987542 23334
Q ss_pred cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCC---------ChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 320 NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWAR---------TESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 320 ~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
...+||+.|+|||++. ..++.++|||||||++|+|++|+.||... ........+......++ ..++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~~ 229 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLS 229 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----CCCC
Confidence 5568999999999986 56889999999999999999999999521 11223344444444333 3578
Q ss_pred HHHHHHHHHhcccCccCCCC------HHHHHcCcccCCC
Q 007253 390 SEARDFVKRLLNKDPRKRLT------AAQALSHPWIKNS 422 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt------~~~ll~hp~~~~~ 422 (611)
.++.+||++||+.||.+||+ +.++++||||+..
T Consensus 230 ~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 230 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 99999999999999999998 5899999999763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=374.42 Aligned_cols=251 Identities=29% Similarity=0.539 Sum_probs=217.2
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeee
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~ 240 (611)
+.||+|+||.||+|+... +++.||||++.+...........+.+|+.++..+.+||||+++++++.+.+.+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 479999999999999766 58899999997654333445566788999999886799999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC-CCCcc
Q 007253 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERL 319 (611)
Q Consensus 241 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~-~~~~~ 319 (611)
++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (318)
T cd05570 78 VNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGVTT 153 (318)
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE---CCCCcEEecccCCCeecCcCCCcc
Confidence 9999998887654 579999999999999999999999999999999999999 577889999999987532 22334
Q ss_pred cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 007253 320 NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398 (611)
Q Consensus 320 ~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 398 (611)
...+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.........+......++ ..++.++.+||++
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~ 229 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP----RWLSKEAKSILKS 229 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHH
Confidence 4567999999999986 5689999999999999999999999998888877777776655443 3578999999999
Q ss_pred hcccCccCCCCH-----HHHHcCcccCCC
Q 007253 399 LLNKDPRKRLTA-----AQALSHPWIKNS 422 (611)
Q Consensus 399 ~L~~dP~~Rpt~-----~~ll~hp~~~~~ 422 (611)
||..||.+||++ .++++||||+..
T Consensus 230 ~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 230 FLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred HccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999999999 999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=408.75 Aligned_cols=260 Identities=30% Similarity=0.501 Sum_probs=230.5
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
-.++|+++++||+|+||.|.+++.+. +++.||+|++.+..+........|..|-.+|..-. .+.|++++-+|.|+.
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~---t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n-s~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKS---TEKVYAMKILNKWEMLKRAETACFREERDIMVFGN-SEWIVQLHYAFQDER 148 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeec---cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC-cHHHHHHHHHhcCcc
Confidence 36789999999999999999999887 79999999998765554445567888999987654 899999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
++|+|||||+||+|...+.+.. ++++..++.|+..|+.||.-||+.|+|||||||+|||| |..|++||+|||.|-.
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsClk 224 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLK 224 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHHh
Confidence 9999999999999999876665 89999999999999999999999999999999999999 7899999999999988
Q ss_pred cCCCC--cccccccCCCcCcchhhc------CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CCCCC
Q 007253 313 VRPDE--RLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD--PSFDE 382 (611)
Q Consensus 313 ~~~~~--~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~--~~~~~ 382 (611)
+..++ .....+|||.|.+||++. +.|++.+|+||+||++|||++|..||+..+.-+.+.+|..-. ..||
T Consensus 225 m~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP- 303 (1317)
T KOG0612|consen 225 MDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP- 303 (1317)
T ss_pred cCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC-
Confidence 87555 356679999999999984 459999999999999999999999999999999999998774 4444
Q ss_pred CCCCCCCHHHHHHHHHhcccCccCCCC---HHHHHcCcccCCCC
Q 007253 383 APWPSLSSEARDFVKRLLNKDPRKRLT---AAQALSHPWIKNSN 423 (611)
Q Consensus 383 ~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~~ll~hp~~~~~~ 423 (611)
.-..+|+++++||.++++ +|+.|.. ++++..||||.+..
T Consensus 304 -~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~ 345 (1317)
T KOG0612|consen 304 -DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGID 345 (1317)
T ss_pred -cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCC
Confidence 234699999999999996 6889998 99999999998643
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=359.95 Aligned_cols=258 Identities=30% Similarity=0.526 Sum_probs=217.5
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC--
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT-- 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~-- 231 (611)
.-.|+..+++|+|+||.||.|.... +++.||||.+-.+... --+|+.+|+.+. |||||+|+-+|...
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e---~~~~vAIKKv~~d~r~-------knrEl~im~~l~-HpNIV~L~~~f~~~~~ 91 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRE---TEEEVAIKKVLQDKRY-------KNRELQIMRKLD-HPNIVRLLYFFSSSTE 91 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcC---CCceeEEEEecCCCCc-------CcHHHHHHHhcC-CcCeeeEEEEEEecCC
Confidence 4468999999999999999999887 4899999987544321 236999999887 99999999888642
Q ss_pred C---eeEEEeeecCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 232 D---NVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 232 ~---~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
. .+.+|||||+. +|..+++. .+.+++.-.++-+..||++||.|||+.||+||||||.|+|++ .+.+.+|||
T Consensus 92 ~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD--~~tg~LKic 168 (364)
T KOG0658|consen 92 SDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD--PDTGVLKIC 168 (364)
T ss_pred CchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc--CCCCeEEec
Confidence 2 46799999976 99888864 356799999999999999999999999999999999999996 466999999
Q ss_pred ecccccccCCCCcccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-------
Q 007253 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA------- 376 (611)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~------- 376 (611)
|||.|+.+..++...+...|.+|+|||.+- ..|+.+.||||.|||+.||+-|++.|.+.+....+..|.+.
T Consensus 169 DFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e 248 (364)
T KOG0658|consen 169 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRE 248 (364)
T ss_pred cCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHH
Confidence 999999999888888889999999999886 56999999999999999999999999998887766655442
Q ss_pred -----CCCCCC--------CC-----CCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCC
Q 007253 377 -----DPSFDE--------AP-----WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (611)
Q Consensus 377 -----~~~~~~--------~~-----~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~ 425 (611)
++...+ .. ....++++.+|+.++|..+|.+|.++.++|.||||....+.
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 222111 11 23468999999999999999999999999999999865543
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=369.50 Aligned_cols=262 Identities=28% Similarity=0.461 Sum_probs=211.2
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
..-...|+++++||+||.+.||++...+ .+.||+|.+.... .+...+.-+.+|+.+|.+|++|.+||+||+|-..
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~----~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~ 431 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSD----KQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT 431 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCC----CcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc
Confidence 4456789999999999999999998543 4677877664432 4667788899999999999999999999999999
Q ss_pred CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 231 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
++.+|+||||-+ .+|-.+|.....-++.-.++.+..|++.++.++|+.||||.||||.|+|+. .|.+||+|||+|
T Consensus 432 d~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV----kG~LKLIDFGIA 506 (677)
T KOG0596|consen 432 DGYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV----KGRLKLIDFGIA 506 (677)
T ss_pred CceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE----eeeEEeeeechh
Confidence 999999999974 488887776665555459999999999999999999999999999999994 678999999999
Q ss_pred cccCCCCc---ccccccCCCcCcchhhc-C-----------CCCCcchhhHHHHHHHHHHhCCCCCCCCC-hHHHHHHHH
Q 007253 311 DFVRPDER---LNDIVGSAYYVAPEVLH-R-----------SYSTEADVWSIGVIAYILLCGSRPFWART-ESGIFRAVL 374 (611)
Q Consensus 311 ~~~~~~~~---~~~~~gt~~y~aPE~~~-~-----------~~~~~~DiwSlGvil~el~~g~~Pf~~~~-~~~~~~~i~ 374 (611)
..+..+.. ..+.+||+.||+||.+. . ..++++||||||||||+|+.|+.||..-. ....+..|.
T Consensus 507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~ 586 (677)
T KOG0596|consen 507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAIT 586 (677)
T ss_pred cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhc
Confidence 98876653 35679999999999873 1 15789999999999999999999995432 222233333
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 375 KADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 375 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
..+..++....+. ..++.++++.||.+||++||++.+||+|||++...
T Consensus 587 ~P~~~Iefp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~ 634 (677)
T KOG0596|consen 587 DPNHEIEFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQP 634 (677)
T ss_pred CCCccccccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcCccccccc
Confidence 3322222221121 23499999999999999999999999999998754
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=354.63 Aligned_cols=261 Identities=29% Similarity=0.555 Sum_probs=236.9
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
+...++|..+++||+|.||.|.+++.+. +|+.||||++++...-.......-..|-++|+..+ ||.+..|--.|+.
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKa---t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsFQt 239 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKA---TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSFQT 239 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecc---cCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhhcc
Confidence 3345789999999999999999999776 79999999999887776666677788999999987 9999999889999
Q ss_pred CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 231 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
.+++|+||||..||.|.-++. +.+.+++...+.+-..|+.||.|||+++||+||||.+|.|+ |.+|++||+|||++
T Consensus 240 ~drlCFVMeyanGGeLf~HLs-rer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLC 315 (516)
T KOG0690|consen 240 QDRLCFVMEYANGGELFFHLS-RERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLC 315 (516)
T ss_pred CceEEEEEEEccCceEeeehh-hhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccc
Confidence 999999999999999987664 44679999999999999999999999999999999999999 78999999999999
Q ss_pred ccc-CCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 311 DFV-RPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 311 ~~~-~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
+.- ..+..+.+.||||.|+|||++. ..|+..+|+|.+||++|||+||+.||+.......+..|+..+..++. .+
T Consensus 316 KE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr----~l 391 (516)
T KOG0690|consen 316 KEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR----TL 391 (516)
T ss_pred hhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc----cC
Confidence 853 3455778899999999999997 67999999999999999999999999999999999999999988885 68
Q ss_pred CHHHHHHHHHhcccCccCCC-----CHHHHHcCcccCCCC
Q 007253 389 SSEARDFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rp-----t~~~ll~hp~~~~~~ 423 (611)
+++++.|+..+|.+||.+|. .+.++.+|+||...+
T Consensus 392 s~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~ 431 (516)
T KOG0690|consen 392 SPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD 431 (516)
T ss_pred CHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence 99999999999999999998 589999999998753
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=372.34 Aligned_cols=265 Identities=25% Similarity=0.401 Sum_probs=217.2
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++.+.||+|+||.||+++... +|..||+|++.... .....+.+.+|++++++++ ||||+++++++.+++.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 77 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKP---SGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGE 77 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECC---CCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCE
Confidence 4789999999999999999999776 68899999986532 3345577899999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
+++||||+++|+|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++..
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~ 153 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQ 153 (331)
T ss_pred EEEEeecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE---cCCCcEEEccCccccc
Confidence 99999999999999987654 4689999999999999999999986 69999999999999 5677899999999876
Q ss_pred cCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--------------
Q 007253 313 VRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD-------------- 377 (611)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~-------------- 377 (611)
... .......||+.|+|||++. ..++.++|||||||++|+|++|+.||......++...+....
T Consensus 154 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 154 LID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred ccc-cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcc
Confidence 643 2334567999999999987 458999999999999999999999997655443322111000
Q ss_pred ------------------------------CCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCCCC
Q 007253 378 ------------------------------PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKV 427 (611)
Q Consensus 378 ------------------------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~~~ 427 (611)
...+......++.++.+||.+||.+||++|||+.++|+||||+.......
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~~~ 312 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEVEEV 312 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcccccc
Confidence 00011112347889999999999999999999999999999987654433
Q ss_pred ch
Q 007253 428 PL 429 (611)
Q Consensus 428 ~~ 429 (611)
.+
T Consensus 313 ~~ 314 (331)
T cd06649 313 DF 314 (331)
T ss_pred cH
Confidence 33
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=373.36 Aligned_cols=256 Identities=28% Similarity=0.489 Sum_probs=220.9
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
+|+..+.||+|+||.||+|+... +|+.||||++.+.........+.+..|+.++..+.+|++|+++++++.+.+.+|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLY 77 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEE
Confidence 47889999999999999998766 689999999976433333445667889999998876788999999999999999
Q ss_pred EEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC
Q 007253 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~ 315 (611)
+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 78 lv~Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 78 FVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred EEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeccccccccCC
Confidence 999999999999887554 569999999999999999999999999999999999999 5778899999999875432
Q ss_pred C-CcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 007253 316 D-ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (611)
Q Consensus 316 ~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 393 (611)
. ......+||+.|+|||++. +.++.++|||||||++|+|++|+.||.+.........+......++ ..++.++.
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~ 229 (323)
T cd05615 154 DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAV 229 (323)
T ss_pred CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHH
Confidence 2 2344567999999999886 5689999999999999999999999999888888888877665444 35789999
Q ss_pred HHHHHhcccCccCCCC-----HHHHHcCcccCCC
Q 007253 394 DFVKRLLNKDPRKRLT-----AAQALSHPWIKNS 422 (611)
Q Consensus 394 ~li~~~L~~dP~~Rpt-----~~~ll~hp~~~~~ 422 (611)
+++.+||++||.+|++ ..++++||||+..
T Consensus 230 ~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 230 SICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred HHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 9999999999999997 5799999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=376.29 Aligned_cols=262 Identities=27% Similarity=0.466 Sum_probs=228.3
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
..|.-++.||+|+||.||.|++.. +.+.||||.+.-........-..+.+||.+|++|. |||++.+-|+|..+...
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~---n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkgCyLre~Ta 101 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYLREHTA 101 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccC---ccceeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccceeeccchH
Confidence 458889999999999999999877 68999999997665555555578999999999998 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
||||||| -|+-.|++.-+.+++.+..+..|+.+.+.||.|||+.+.||||||..|||| .+.|.|||+|||.|.++.
T Consensus 102 WLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL---se~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 102 WLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL---SEPGLVKLADFGSASIMA 177 (948)
T ss_pred HHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe---cCCCeeeeccccchhhcC
Confidence 9999999 458788887777889999999999999999999999999999999999999 588999999999998876
Q ss_pred CCCcccccccCCCcCcchhh----cCCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CCCCCCCCCCCC
Q 007253 315 PDERLNDIVGSAYYVAPEVL----HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD-PSFDEAPWPSLS 389 (611)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~----~~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~s 389 (611)
+ .++++|||+|||||++ .|.|+-++||||||++.+||...++|+...+....+..|.+.+ |.+. .+.|+
T Consensus 178 P---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLq---s~eWS 251 (948)
T KOG0577|consen 178 P---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ---SNEWS 251 (948)
T ss_pred c---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCC---CchhH
Confidence 4 4567999999999987 3789999999999999999999999987777666565565544 3333 35789
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCCCCchh
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLD 430 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~~~~~~ 430 (611)
..+..||..||++-|.+|||.+++|.|+|+.-.....+.++
T Consensus 252 ~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~tvi~d 292 (948)
T KOG0577|consen 252 DYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPPTVIMD 292 (948)
T ss_pred HHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCchHHHH
Confidence 99999999999999999999999999999987655555544
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=342.34 Aligned_cols=260 Identities=27% Similarity=0.446 Sum_probs=225.5
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++.+.+..||.|.-|.|++++++. +|..+|||.+.+.. .....++++..+.++..-+++|+||+.+|+|..+..+
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs---~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRS---TGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV 166 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcc---cceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence 456778889999999999999987 78999999997764 4455688999999998887899999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|.||.|.. -+...+..-.++++|..+-++...++.||.||-++ ||||||+||+|||+ |+.|++||||||++..+
T Consensus 167 ~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 167 FICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRL 242 (391)
T ss_pred HHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeeccccccee
Confidence 999999943 34444444566799999999999999999999875 89999999999999 89999999999999998
Q ss_pred CCCCcccccccCCCcCcchhhc----CCCCCcchhhHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 314 RPDERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
.+........|.+.|||||.+. ..|+.++||||||++++||.||+.||.+ .++-+++..+++..|..-... ..+
T Consensus 243 vdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~-~gF 321 (391)
T KOG0983|consen 243 VDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGH-MGF 321 (391)
T ss_pred ecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcc-cCc
Confidence 8888888889999999999985 4589999999999999999999999976 466688888888665332221 348
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCC
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~ 424 (611)
|+.+.+|+..||.+|+.+||...+||+|||++....
T Consensus 322 Sp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~ 357 (391)
T KOG0983|consen 322 SPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYET 357 (391)
T ss_pred CHHHHHHHHHHhhcCcccCcchHHHhcCcceeecch
Confidence 999999999999999999999999999999987643
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=365.74 Aligned_cols=253 Identities=26% Similarity=0.431 Sum_probs=207.7
Q ss_pred eeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeeecC
Q 007253 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCE 242 (611)
Q Consensus 163 LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~~~ 242 (611)
||+|+||.||++.... +|+.||+|++.+.........+.+..|+.+++.++ |+||+++++++..+..+++|||||+
T Consensus 1 lg~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~ 76 (280)
T cd05608 1 LGKGGFGEVSACQMRA---TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH-SRFIVSLAYAFQTKTDLCLVMTIMN 76 (280)
T ss_pred CCCCCceeEEEEEEcc---CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC-CCcEeeeeEEEcCCCeEEEEEeCCC
Confidence 7999999999998766 68999999987654444444567788999999997 9999999999999999999999999
Q ss_pred CCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCC-c
Q 007253 243 GGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-R 318 (611)
Q Consensus 243 ~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~-~ 318 (611)
+|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....... .
T Consensus 77 ~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~ 153 (280)
T cd05608 77 GGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSK 153 (280)
T ss_pred CCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCcc
Confidence 9999887743 33469999999999999999999999999999999999999 567889999999997664332 2
Q ss_pred ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 007253 319 LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397 (611)
Q Consensus 319 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 397 (611)
.....||+.|+|||++. +.++.++|||||||++|+|++|+.||...........+..............++..+.+|+.
T Consensus 154 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 233 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCE 233 (280)
T ss_pred ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHH
Confidence 34567999999999986 56889999999999999999999999765432211122111111111122468999999999
Q ss_pred HhcccCccCCC-----CHHHHHcCcccCCC
Q 007253 398 RLLNKDPRKRL-----TAAQALSHPWIKNS 422 (611)
Q Consensus 398 ~~L~~dP~~Rp-----t~~~ll~hp~~~~~ 422 (611)
+||+.||.+|| +++++++||||+..
T Consensus 234 ~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 234 ALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred HHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 99999999999 88999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=371.75 Aligned_cols=252 Identities=29% Similarity=0.530 Sum_probs=213.7
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeee
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~ 240 (611)
+.||+|+||.||+|+... +++.||||++.+.........+.+..|..++..+.+||||+++++++.+.+.+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKG---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeC
Confidence 479999999999999776 58899999997543222233455677888888765699999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC-CCcc
Q 007253 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERL 319 (611)
Q Consensus 241 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~-~~~~ 319 (611)
++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ....
T Consensus 78 ~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05619 78 LNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKT 153 (316)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEccCCcceECCCCCCce
Confidence 9999999888654 568999999999999999999999999999999999999 5677899999999875322 2234
Q ss_pred cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 007253 320 NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398 (611)
Q Consensus 320 ~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 398 (611)
...+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+.+..+....+.++. .++.++.+||.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~ 229 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR----WLTREAKDILVK 229 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHHHH
Confidence 4568999999999986 56899999999999999999999999988877777777665544432 478999999999
Q ss_pred hcccCccCCCCHH-HHHcCcccCCCC
Q 007253 399 LLNKDPRKRLTAA-QALSHPWIKNSN 423 (611)
Q Consensus 399 ~L~~dP~~Rpt~~-~ll~hp~~~~~~ 423 (611)
||+.||.+||++. ++++||||+...
T Consensus 230 ~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 230 LFVREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred HhccCHhhcCCChHHHHcCcccCCCC
Confidence 9999999999996 899999998743
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=382.69 Aligned_cols=261 Identities=31% Similarity=0.512 Sum_probs=227.3
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.+.|+|+..||-|+||.||+|..+. ++-..|.|+|. ......++.+.-||.||..+. ||+||+|++.|..++.
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nke---t~~lAAaKvIe---tkseEELEDylVEIeILa~Cd-HP~ivkLl~ayy~enk 103 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKE---TKLLAAAKVIE---TKSEEELEDYLVEIEILAECD-HPVIVKLLSAYYFENK 103 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhccc---chhhhhhhhhc---ccchhHHhhhhhhhhhhhcCC-ChHHHHHHHHHhccCc
Confidence 4569999999999999999999876 56677889883 345667888999999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+||+.|||.||-+..++.+-+..|.+.++..+++|++.||.|||+++|||||||..|||++ .+|.|+|+|||.+...
T Consensus 104 LwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T---ldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 104 LWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT---LDGDIRLADFGVSAKN 180 (1187)
T ss_pred eEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE---ecCcEeeecccccccc
Confidence 9999999999999999989888999999999999999999999999999999999999996 5667999999987654
Q ss_pred C-CCCcccccccCCCcCcchhhc------CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 007253 314 R-PDERLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 314 ~-~~~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (611)
. .-....+++|||+|||||++. ..|++++||||||++|+||..+.+|-...+...++-+|.+..|.--.. ..
T Consensus 181 ~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlq-PS 259 (1187)
T KOG0579|consen 181 KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQ-PS 259 (1187)
T ss_pred hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccC-cc
Confidence 3 223456789999999999862 569999999999999999999999998888777777776665433222 24
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCC
Q 007253 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~ 425 (611)
.|+..+.+|+++||.+||..||++.+||+||||++....
T Consensus 260 ~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 260 HWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN 298 (1187)
T ss_pred hhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence 689999999999999999999999999999999976544
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=373.96 Aligned_cols=261 Identities=27% Similarity=0.490 Sum_probs=219.7
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++.++||+|+||.||+++... .++.||+|++.+...........+.+|+.++..++ |+||+++++++.+.+.+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~ 76 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-NQWITTLHYAFQDENNL 76 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC---CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCEE
Confidence 469999999999999999999776 57899999986533333334456788999999987 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
|+||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLM 153 (332)
T ss_pred EEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEeecchheecc
Confidence 99999999999999997766779999999999999999999999999999999999999 577889999999987654
Q ss_pred CCCc--ccccccCCCcCcchhhc------CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-CCC
Q 007253 315 PDER--LNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE-APW 385 (611)
Q Consensus 315 ~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~ 385 (611)
.... ....+||+.|+|||++. +.++.++|||||||++|||++|+.||......+.+..+......+.. ...
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 233 (332)
T cd05623 154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQV 233 (332)
T ss_pred cCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCcc
Confidence 3322 23457999999999874 35788999999999999999999999988887877777665433221 122
Q ss_pred CCCCHHHHHHHHHhcccCccC--CCCHHHHHcCcccCCC
Q 007253 386 PSLSSEARDFVKRLLNKDPRK--RLTAAQALSHPWIKNS 422 (611)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~--Rpt~~~ll~hp~~~~~ 422 (611)
..++.++.+||++||+.++.+ |+++.++++||||++.
T Consensus 234 ~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 234 TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 467999999999999765554 6899999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=375.07 Aligned_cols=259 Identities=31% Similarity=0.507 Sum_probs=208.5
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC----
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT---- 231 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~---- 231 (611)
+|++.+.||+|+||.||+|+... +|+.||||++.... ........+.+|+.++++++ ||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~ 75 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTH---TGEKVAIKKINDVF-EHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRRE 75 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECC---CCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCC
Confidence 58999999999999999999766 68999999986432 22233456889999999998 99999999988643
Q ss_pred -CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 232 -DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 232 -~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
..+|+|||||. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 76 ~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~ 150 (338)
T cd07859 76 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLA 150 (338)
T ss_pred CceEEEEEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEccCccc
Confidence 35899999995 6888877544 569999999999999999999999999999999999999 67888999999999
Q ss_pred cccCCCC----cccccccCCCcCcchhhc---CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHh--------
Q 007253 311 DFVRPDE----RLNDIVGSAYYVAPEVLH---RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK-------- 375 (611)
Q Consensus 311 ~~~~~~~----~~~~~~gt~~y~aPE~~~---~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~-------- 375 (611)
+...... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.........+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 230 (338)
T cd07859 151 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230 (338)
T ss_pred cccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 7643221 123467999999999875 4688999999999999999999999977654332221111
Q ss_pred -------------------cCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCC
Q 007253 376 -------------------ADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (611)
Q Consensus 376 -------------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~ 424 (611)
..+......++.+++.+.++|.+||+.||++|||+.++|+||||+....
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 0111111123467889999999999999999999999999999987554
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=379.09 Aligned_cols=263 Identities=32% Similarity=0.493 Sum_probs=219.8
Q ss_pred ccccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCC-----CCeeEE
Q 007253 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH-----NNLVKF 224 (611)
Q Consensus 150 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-----~~iv~l 224 (611)
.+++..+|++.+.||+|+||.|.+|...+ +++.||||+++.. .....+...|+.+|..|+.| -|||++
T Consensus 181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~---T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm 253 (586)
T KOG0667|consen 181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHK---TGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRM 253 (586)
T ss_pred cceeEEEEEEEEEecccccceeEEEEecC---CCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEe
Confidence 34566689999999999999999999877 7999999999654 23445667899999999844 389999
Q ss_pred EEEEeeCCeeEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEE
Q 007253 225 FDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303 (611)
Q Consensus 225 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vk 303 (611)
+++|...+++|||+|.++ -+|+++++.+. ..++...++.++.||+.||.+||+.||||+||||+||||...+.. .||
T Consensus 254 ~d~F~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~-~vK 331 (586)
T KOG0667|consen 254 LDYFYFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRS-RIK 331 (586)
T ss_pred eeccccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcC-cee
Confidence 999999999999999995 59999998664 459999999999999999999999999999999999999865444 899
Q ss_pred EeecccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-
Q 007253 304 AIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD- 381 (611)
Q Consensus 304 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~- 381 (611)
|+|||+|.+.. ....+.+.+..|+|||++- ..|+.+.||||||||++||++|.+.|.+.++.+.+..|.......+
T Consensus 332 VIDFGSSc~~~--q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~ 409 (586)
T KOG0667|consen 332 VIDFGSSCFES--QRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPP 409 (586)
T ss_pred EEecccccccC--CcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCH
Confidence 99999998874 3344788999999999886 5799999999999999999999999999888877766643221110
Q ss_pred --------------C-CC-------------------------------CC------------CCCHHHHHHHHHhcccC
Q 007253 382 --------------E-AP-------------------------------WP------------SLSSEARDFVKRLLNKD 403 (611)
Q Consensus 382 --------------~-~~-------------------------------~~------------~~s~~~~~li~~~L~~d 403 (611)
. .. .+ .-...+.+||++||.+|
T Consensus 410 ~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~d 489 (586)
T KOG0667|consen 410 KMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWD 489 (586)
T ss_pred HHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccC
Confidence 0 00 01 11356789999999999
Q ss_pred ccCCCCHHHHHcCcccCCCC
Q 007253 404 PRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 404 P~~Rpt~~~ll~hp~~~~~~ 423 (611)
|.+|+|+.++|+||||....
T Consensus 490 P~~R~tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 490 PAERITPAQALNHPFLTGTS 509 (586)
T ss_pred chhcCCHHHHhcCccccccc
Confidence 99999999999999998543
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=372.67 Aligned_cols=261 Identities=27% Similarity=0.476 Sum_probs=219.6
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++.+.||+|+||.||+++... +++.||+|++.+...........+.+|+.++..+. |+||+++++++.+++.+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~l~~~~~~~~~~ 76 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKH---TERIYAMKILNKWEMLKRAETACFREERNVLVNGD-CQWITTLHYAFQDENYL 76 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEE
Confidence 479999999999999999998776 68899999986533233334456788999999987 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
|+||||++||+|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMN 153 (331)
T ss_pred EEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE---cCCCCEEEEeccceeecc
Confidence 99999999999999997766789999999999999999999999999999999999999 577789999999997665
Q ss_pred CCCc--ccccccCCCcCcchhhc------CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-CCC
Q 007253 315 PDER--LNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE-APW 385 (611)
Q Consensus 315 ~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~ 385 (611)
.... ....+||+.|+|||++. +.++.++|||||||++|+|++|+.||......+.+..+......+.. ..+
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 233 (331)
T cd05624 154 QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI 233 (331)
T ss_pred CCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCcc
Confidence 4332 23357999999999885 35788999999999999999999999988877777777654433221 123
Q ss_pred CCCCHHHHHHHHHhcccCccC--CCCHHHHHcCcccCCC
Q 007253 386 PSLSSEARDFVKRLLNKDPRK--RLTAAQALSHPWIKNS 422 (611)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~--Rpt~~~ll~hp~~~~~ 422 (611)
..++.++.+||.+||+.++.+ |++++++++|+||+..
T Consensus 234 ~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 234 TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 457899999999999876655 5699999999999863
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=381.11 Aligned_cols=260 Identities=24% Similarity=0.371 Sum_probs=203.8
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhc-----CCCCeeEEEEE
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT-----GHNNLVKFFDA 227 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~l~~~ 227 (611)
..++|++.++||+|+||.||+|.... .++.||||++.... .....+..|+.+++.+. +|.+|++++++
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~---~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRK---RKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcC---CCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 35789999999999999999998766 58899999985421 22345667888888775 24468999999
Q ss_pred EeeC-CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeecCCCCceEEeccCC-------
Q 007253 228 YEDT-DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDE------- 298 (611)
Q Consensus 228 ~~~~-~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NIll~~~~~------- 298 (611)
|..+ +++|||||++ |++|.+++... +.+++..++.|+.||+.||.|||+ .|||||||||+|||+...+.
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccc
Confidence 8765 5799999998 77999888655 579999999999999999999998 59999999999999964321
Q ss_pred ------CceEEEeecccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHH
Q 007253 299 ------NSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFR 371 (611)
Q Consensus 299 ------~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~ 371 (611)
...+||+|||.+.... ......+||+.|||||++. ..|+.++|||||||++|||++|+.||.+....+.+.
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred cccCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 2259999999886432 2334578999999999986 569999999999999999999999998776655444
Q ss_pred HHHhcCCCCCCC------------------------------------CC--CCCCHHHHHHHHHhcccCccCCCCHHHH
Q 007253 372 AVLKADPSFDEA------------------------------------PW--PSLSSEARDFVKRLLNKDPRKRLTAAQA 413 (611)
Q Consensus 372 ~i~~~~~~~~~~------------------------------------~~--~~~s~~~~~li~~~L~~dP~~Rpt~~~l 413 (611)
.+......++.. .+ ...+..+.+||.+||++||.+|||++|+
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 333221111100 00 0014567899999999999999999999
Q ss_pred HcCcccCCCC
Q 007253 414 LSHPWIKNSN 423 (611)
Q Consensus 414 l~hp~~~~~~ 423 (611)
|+||||+...
T Consensus 436 L~Hp~~~~~~ 445 (467)
T PTZ00284 436 TTHPYVLKYY 445 (467)
T ss_pred hcCccccccC
Confidence 9999998753
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=370.26 Aligned_cols=251 Identities=28% Similarity=0.508 Sum_probs=210.9
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeee
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~ 240 (611)
+.||+|+||.||+|+... .++.||+|++.+.........+.+.+|+.++.++.+||||+++++++.+.+.+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKK---NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeC
Confidence 479999999999999776 58899999997654444555677889999999997799999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC-CCCcc
Q 007253 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERL 319 (611)
Q Consensus 241 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~-~~~~~ 319 (611)
|+||+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (327)
T cd05617 78 VNGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTT 153 (327)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---eCCCCEEEeccccceeccCCCCce
Confidence 9999998877544 579999999999999999999999999999999999999 567789999999987532 23344
Q ss_pred cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 320 NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART-------ESGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 320 ~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
...+||+.|+|||++. ..++.++|||||||++|+|++|+.||.... .......+......++ ..++..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~ 229 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP----RFLSVK 229 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC----CCCCHH
Confidence 5678999999999886 568999999999999999999999995321 1223344443333332 357899
Q ss_pred HHHHHHHhcccCccCCCC------HHHHHcCcccCCC
Q 007253 392 ARDFVKRLLNKDPRKRLT------AAQALSHPWIKNS 422 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rpt------~~~ll~hp~~~~~ 422 (611)
+.++|++||..||.+|++ +.++++||||+..
T Consensus 230 ~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 230 ASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 999999999999999998 5799999999874
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=373.25 Aligned_cols=253 Identities=30% Similarity=0.522 Sum_probs=217.2
Q ss_pred eCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEee
Q 007253 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVME 239 (611)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E 239 (611)
++.||+|+||.||+++...+...|+.||+|++.+.... ......+.+|++++++++ ||||+++++++.+++.+|+|||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 78 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVN-HPFIVKLHYAFQTEGKLYLILD 78 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCEEEEEEc
Confidence 36799999999999987654457899999999654322 223345678999999997 9999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCC-Cc
Q 007253 240 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ER 318 (611)
Q Consensus 240 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~-~~ 318 (611)
||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...... ..
T Consensus 79 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 79 FLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCCc
Confidence 99999999988554 569999999999999999999999999999999999999 57778999999999865443 23
Q ss_pred ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 007253 319 LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397 (611)
Q Consensus 319 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 397 (611)
....+||+.|+|||++. ..++.++|||||||++|+|++|+.||...........+......++ ..++.++.+||+
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~ 230 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQSLLR 230 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence 44568999999999986 5688999999999999999999999998888777777776655443 357899999999
Q ss_pred HhcccCccCCCC-----HHHHHcCcccCCC
Q 007253 398 RLLNKDPRKRLT-----AAQALSHPWIKNS 422 (611)
Q Consensus 398 ~~L~~dP~~Rpt-----~~~ll~hp~~~~~ 422 (611)
+||+.||.+||+ +.+++.||||+..
T Consensus 231 ~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 231 ALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred HHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 999999999999 7889999999864
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=371.49 Aligned_cols=250 Identities=29% Similarity=0.536 Sum_probs=211.6
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHH-HHHhcCCCCeeEEEEEEeeCCeeEEEee
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKI-LRALTGHNNLVKFFDAYEDTDNVYVVME 239 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~~h~~iv~l~~~~~~~~~~~lv~E 239 (611)
+.||+|+||.||+|+... +|+.||||++.+...........+..|..+ ++.++ ||||+++++++.+.+.+|+|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~-hp~iv~~~~~~~~~~~~~lv~e 76 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKA---DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTADKLYFVLD 76 (323)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCC-CCCCCCeeEEEEeCCEEEEEEc
Confidence 479999999999999776 689999999965433333333455566554 56676 9999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC-CCc
Q 007253 240 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DER 318 (611)
Q Consensus 240 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~-~~~ 318 (611)
|+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ...
T Consensus 77 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~ 152 (323)
T cd05575 77 YVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSKT 152 (323)
T ss_pred CCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeccCCCcccccCCCc
Confidence 99999998887654 579999999999999999999999999999999999999 6778899999999875432 233
Q ss_pred ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 007253 319 LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397 (611)
Q Consensus 319 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 397 (611)
....+||+.|+|||++. ..++.++|||||||++|+|++|..||......+++..+........ +.++..+.++|+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~ 228 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLE 228 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence 44568999999999886 5689999999999999999999999998888888888776654433 467999999999
Q ss_pred HhcccCccCCCCH----HHHHcCcccCCC
Q 007253 398 RLLNKDPRKRLTA----AQALSHPWIKNS 422 (611)
Q Consensus 398 ~~L~~dP~~Rpt~----~~ll~hp~~~~~ 422 (611)
+||+.||.+||++ .++++||||...
T Consensus 229 ~~l~~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 229 GLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred HHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999987 699999999763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=367.47 Aligned_cols=260 Identities=27% Similarity=0.439 Sum_probs=214.9
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|.+.+.||+|+||.||+|+... +++.||+|++...... .....+.+|+.++++++ ||||+++++++..++.
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 78 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKL---TENLVALKEIRLEHEE--GAPCTAIREVSLLKDLK-HANIVTLHDIVHTDKS 78 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecC---CCCeEEEEEeeccccC--CcchhHHHHHHHHHhCC-CCCcceEEEEEeeCCe
Confidence 3679999999999999999998765 5789999998654322 22345678999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
.++||||+++ +|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~ 154 (309)
T cd07872 79 LTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAK 154 (309)
T ss_pred EEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECccccceec
Confidence 9999999975 8888887776678999999999999999999999999999999999999 56778999999998765
Q ss_pred CCCC-cccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------
Q 007253 314 RPDE-RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF---------- 380 (611)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~---------- 380 (611)
.... ......+|+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+....+.......
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 155 SVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred CCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence 3322 233457899999999885 357899999999999999999999998776655544443321110
Q ss_pred ---------CC-------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 381 ---------DE-------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 381 ---------~~-------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
+. ...+.++.++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 00 11235788999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=369.34 Aligned_cols=246 Identities=28% Similarity=0.473 Sum_probs=211.1
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.+.+.+++.||+|.||.||.|.+.. ...||+|.+....+.. +.|.+|+++|++|+ |+|||+|+++|..++.
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~----~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~-H~~lV~l~gV~~~~~p 275 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNG----STKVAVKTIKEGSMSP----EAFLREAQIMKKLR-HEKLVKLYGVCTKQEP 275 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcC----CCcccceEEeccccCh----hHHHHHHHHHHhCc-ccCeEEEEEEEecCCc
Confidence 3456778999999999999998764 3479999986553332 56779999999998 9999999999999899
Q ss_pred eEEEeeecCCCChHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 234 VYVVMELCEGGELLDRILS-RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
+|||||||+.|+|+++|.. .+..+...+...++.|||+|++||+++++|||||-+.|||| +++..|||+|||||+.
T Consensus 276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV---~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV---DEDLVVKISDFGLARL 352 (468)
T ss_pred eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee---ccCceEEEcccccccc
Confidence 9999999999999999987 45679999999999999999999999999999999999999 7888999999999996
Q ss_pred cCCCCccccc--ccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 313 VRPDERLNDI--VGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 313 ~~~~~~~~~~--~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
..++...... --...|.|||.++ +.|+.+||||||||+||||+| |+.||.+.+..+.++.+.++.. .+.+ ..+
T Consensus 353 ~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyR-lp~P--~~C 429 (468)
T KOG0197|consen 353 IGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYR-LPRP--EGC 429 (468)
T ss_pred cCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCc-CCCC--CCC
Confidence 5544332221 2235799999987 789999999999999999997 9999999999998888877643 2222 478
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHH
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQAL 414 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll 414 (611)
|.++.+++..||+.+|++|||.+.+.
T Consensus 430 P~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 430 PDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 99999999999999999999998654
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=361.27 Aligned_cols=257 Identities=30% Similarity=0.487 Sum_probs=215.2
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
.|++.+.||+|+||.||++.... +++.||+|.+.+...........+.+|+.++++++ |++|+++++.+.+.+.++
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~ 76 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN-SRFVVSLAYAYETKDALC 76 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcC---CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC-CCCeeeeeEEEecCCEEE
Confidence 37888999999999999999876 68999999987654444444566788999999997 999999999999999999
Q ss_pred EEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 236 VVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
+||||++||+|.+++.... ..+++..+..++.|++.||.|||+.+|+||||||+||++ +.++.++|+|||++....
T Consensus 77 lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05630 77 LVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVP 153 (285)
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeccceeecC
Confidence 9999999999998885543 359999999999999999999999999999999999999 567789999999997765
Q ss_pred CCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHH---HHHHHHhcCCCCCCCCCCCCCH
Q 007253 315 PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESG---IFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
.........|+..|+|||++. +.++.++|||||||++|+|++|+.||....... ....+... ........++.
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 230 (285)
T cd05630 154 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE---VQEEYSEKFSP 230 (285)
T ss_pred CCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh---hhhhcCccCCH
Confidence 444445568999999999986 568999999999999999999999997654321 12222111 11122346789
Q ss_pred HHHHHHHHhcccCccCCCC-----HHHHHcCcccCCC
Q 007253 391 EARDFVKRLLNKDPRKRLT-----AAQALSHPWIKNS 422 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt-----~~~ll~hp~~~~~ 422 (611)
++.+||.+||+.||.+||| +.++++||||+..
T Consensus 231 ~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 231 DARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred HHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 9999999999999999999 9999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=373.92 Aligned_cols=250 Identities=31% Similarity=0.562 Sum_probs=212.1
Q ss_pred eeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhc--CCCCeeEEEEEEeeCCeeEEEeee
Q 007253 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT--GHNNLVKFFDAYEDTDNVYVVMEL 240 (611)
Q Consensus 163 LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~iv~l~~~~~~~~~~~lv~E~ 240 (611)
||+|+||.||+|+... +|+.||||++.+..............|..++.++. +||||+++++++.+.+.+|+||||
T Consensus 1 lG~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKD---TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECC---CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcC
Confidence 7999999999998766 68999999986543333333445566777777654 699999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC-CCcc
Q 007253 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERL 319 (611)
Q Consensus 241 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~-~~~~ 319 (611)
+++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ....
T Consensus 78 ~~~g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~ 153 (330)
T cd05586 78 MSGGELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL---DATGHIALCDFGLSKANLTDNKTT 153 (330)
T ss_pred CCCChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCCCc
Confidence 9999999887654 579999999999999999999999999999999999999 5677899999999875432 2334
Q ss_pred cccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 007253 320 NDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397 (611)
Q Consensus 320 ~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 397 (611)
...+||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+.+..+......++. ..++.++.+||+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~ 230 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVLSDEGRQFVK 230 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC---ccCCHHHHHHHH
Confidence 56789999999998853 4789999999999999999999999988888887777766555443 357899999999
Q ss_pred HhcccCccCCC----CHHHHHcCcccCCC
Q 007253 398 RLLNKDPRKRL----TAAQALSHPWIKNS 422 (611)
Q Consensus 398 ~~L~~dP~~Rp----t~~~ll~hp~~~~~ 422 (611)
+||+.||.+|| ++.++++||||+..
T Consensus 231 ~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 231 GLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred HHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 99999999998 79999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=370.38 Aligned_cols=250 Identities=29% Similarity=0.523 Sum_probs=211.5
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHH-HHHhcCCCCeeEEEEEEeeCCeeEEEee
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKI-LRALTGHNNLVKFFDAYEDTDNVYVVME 239 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~~h~~iv~l~~~~~~~~~~~lv~E 239 (611)
+.||+|+||.||+|+... +|+.||+|++.+...........+..|..+ ++.+. ||||+++++++..++.+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-hp~iv~~~~~~~~~~~~~lv~e 76 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKL---DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTTEKLYFVLD 76 (325)
T ss_pred CceeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCC-CCCCccEEEEEecCCEEEEEEc
Confidence 479999999999999766 689999999965433333344556666665 55565 9999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC-CCc
Q 007253 240 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DER 318 (611)
Q Consensus 240 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~-~~~ 318 (611)
|++||+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ...
T Consensus 77 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~~ 152 (325)
T cd05604 77 FVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSDT 152 (325)
T ss_pred CCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEeecCCcccCCCCCCC
Confidence 9999999887754 4579999999999999999999999999999999999999 6778899999999875432 233
Q ss_pred ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 007253 319 LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397 (611)
Q Consensus 319 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 397 (611)
....+||+.|+|||++. ..++.++|||||||++|+|++|..||......+++..+........ +..+..+.++|+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ll~ 228 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILE 228 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC----CCCCHHHHHHHH
Confidence 44568999999999986 5689999999999999999999999999888888887776543332 467899999999
Q ss_pred HhcccCccCCCCH----HHHHcCcccCCC
Q 007253 398 RLLNKDPRKRLTA----AQALSHPWIKNS 422 (611)
Q Consensus 398 ~~L~~dP~~Rpt~----~~ll~hp~~~~~ 422 (611)
+||+.||.+||++ .++++||||+..
T Consensus 229 ~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 229 ELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred HHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 9999999999976 599999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=363.16 Aligned_cols=259 Identities=30% Similarity=0.523 Sum_probs=229.5
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.+.|..-++||+||||.||-++.+. +|+.||+|.+.+.............+|-.+|.+++ .+.||.+--+|+..+.
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvra---TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRA---TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLAYAFETKDA 259 (591)
T ss_pred ccceeeeEEEecccccceeEEEEec---chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEeeeecCCCc
Confidence 4568889999999999999999887 79999999998776666666677889999999998 8999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
+|+||..|.||+|.-+|.+.+. .+++..++.++.+|+.||++||+.+||+|||||+|||| |+.|+|+|+|+|+|..
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLAVE 336 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceEEe
Confidence 9999999999999888877653 59999999999999999999999999999999999999 8999999999999999
Q ss_pred cCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChH----HHHHHHHhcCCCCCCCCCCC
Q 007253 313 VRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES----GIFRAVLKADPSFDEAPWPS 387 (611)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~ 387 (611)
+..+......+||.+|||||+++ +.|+...|+|||||+||||+.|+.||....+. ++-+.++.....++ ..
T Consensus 337 i~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~----~k 412 (591)
T KOG0986|consen 337 IPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS----DK 412 (591)
T ss_pred cCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc----cc
Confidence 98888888889999999999997 56999999999999999999999999766554 33344444443333 57
Q ss_pred CCHHHHHHHHHhcccCccCCC-----CHHHHHcCcccCCCC
Q 007253 388 LSSEARDFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rp-----t~~~ll~hp~~~~~~ 423 (611)
+|++++++.+.+|++||++|. ++.++.+||||++.+
T Consensus 413 FS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ln 453 (591)
T KOG0986|consen 413 FSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLN 453 (591)
T ss_pred cCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCC
Confidence 899999999999999999998 577999999999854
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=358.13 Aligned_cols=261 Identities=30% Similarity=0.488 Sum_probs=219.6
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
.|+..+.||+|+||.||+|.... +++.||+|++.............+.+|+.+++.++ |+||+.+++++.+++.++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~ 76 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRA---TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN-SQFVVNLAYAYETKDALC 76 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECC---CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CcCceeEEEEEecCCEEE
Confidence 37788999999999999998776 68999999986654444444556788999999997 999999999999999999
Q ss_pred EEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 236 VVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
+||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||++ +.++.+||+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili---~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 77 LVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIP 153 (285)
T ss_pred EEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---CCCCCEEEecCCcceecC
Confidence 9999999999988876543 469999999999999999999999999999999999999 567789999999997665
Q ss_pred CCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 007253 315 PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (611)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 393 (611)
.........|+..|+|||++. ..++.++|||||||++|+|++|..||...........+..............++.++.
T Consensus 154 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd05632 154 EGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAK 233 (285)
T ss_pred CCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHH
Confidence 444445568999999999886 5689999999999999999999999987766544444433322222233356889999
Q ss_pred HHHHHhcccCccCCCC-----HHHHHcCcccCCCC
Q 007253 394 DFVKRLLNKDPRKRLT-----AAQALSHPWIKNSN 423 (611)
Q Consensus 394 ~li~~~L~~dP~~Rpt-----~~~ll~hp~~~~~~ 423 (611)
+|+.+||+.||.+||+ +.++++|+||+...
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 234 SICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN 268 (285)
T ss_pred HHHHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence 9999999999999999 89999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=353.18 Aligned_cols=255 Identities=27% Similarity=0.531 Sum_probs=219.5
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.+-|.++++||+|+||.||+|.++. +|+.+|||.++. ...++++.+|+.||.++. .|+||++||.|.....
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~E---sG~v~AIK~VPV-----~sDLQEIIKEISIMQQC~-S~yVVKYYGSYFK~sD 102 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRE---SGHVLAIKKVPV-----DTDLQEIIKEISIMQQCK-SKYVVKYYGSYFKHSD 102 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhc---cCcEEEEEecCc-----cchHHHHHHHHHHHHHcC-CchhhhhhhhhccCCc
Confidence 3458999999999999999999888 799999998843 345678999999999987 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|||||||..|++.+.++.+++.|++..+..+++..+.||+|||...-||||||..|||| ..+|+.||+|||.+..+
T Consensus 103 LWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL---NT~G~AKLADFGVAGQL 179 (502)
T KOG0574|consen 103 LWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL---NTDGIAKLADFGVAGQL 179 (502)
T ss_pred eEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE---cccchhhhhhccccchh
Confidence 999999999999999999999999999999999999999999999999999999999999 56788999999999877
Q ss_pred CCCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CCCCCCCCCCCCC
Q 007253 314 RPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA--DPSFDEAPWPSLS 389 (611)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s 389 (611)
.+.. ..++++|||.|||||++. -.|+.++||||||++..||..|++||..-.. ++.|.-- ++.........++
T Consensus 180 TDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP---MRAIFMIPT~PPPTF~KPE~WS 256 (502)
T KOG0574|consen 180 TDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP---MRAIFMIPTKPPPTFKKPEEWS 256 (502)
T ss_pred hhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc---cceeEeccCCCCCCCCChHhhh
Confidence 6543 457789999999999997 4699999999999999999999999965433 2222211 1111111113478
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.++.+||++||-+.|++|-|+.+|++|+|+++..
T Consensus 257 ~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 257 SEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred hHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 9999999999999999999999999999998753
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=359.50 Aligned_cols=256 Identities=28% Similarity=0.435 Sum_probs=208.5
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhc--CCCCeeEEEEEEee---
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT--GHNNLVKFFDAYED--- 230 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~iv~l~~~~~~--- 230 (611)
+|++.+.||+|+||.||+|+... +|+.||+|.+....... .....+.+|+.+++.+. +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~---~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~ 76 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPH---SGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRT 76 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECC---CCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccC
Confidence 58999999999999999999876 68999999986542221 12234567888887764 49999999998865
Q ss_pred --CCeeEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeec
Q 007253 231 --TDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (611)
Q Consensus 231 --~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~Df 307 (611)
...+++||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+||
T Consensus 77 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~kl~df 152 (288)
T cd07863 77 DRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGQVKLADF 152 (288)
T ss_pred CCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECcc
Confidence 3458999999974 8888876543 358999999999999999999999999999999999999 56778999999
Q ss_pred ccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----
Q 007253 308 GLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD----- 381 (611)
Q Consensus 308 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----- 381 (611)
|++.............||..|+|||++. ..++.++|||||||++|+|++|++||........+..+........
T Consensus 153 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 153 GLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred CccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 9998776554455668899999999885 5689999999999999999999999988776665555543211000
Q ss_pred ------------------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 382 ------------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 382 ------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
....+.++.++.+||.+||+.||.+|||+.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 01124578889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=367.10 Aligned_cols=259 Identities=36% Similarity=0.645 Sum_probs=233.9
Q ss_pred ceeE--eCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 156 KYEL--GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 156 ~y~~--~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
-|++ .+.||.|.||.||-|++++ +|+.||||+|.+....... ..++++|+.||..++ ||.||.|.-.|+..+.
T Consensus 563 vYQif~devLGSGQFG~VYgg~hRk---tGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~-HPGiV~le~M~ET~er 637 (888)
T KOG4236|consen 563 VYQIFADEVLGSGQFGTVYGGKHRK---TGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLH-HPGIVNLECMFETPER 637 (888)
T ss_pred HHHhhhHhhccCCcceeeecceecc---cCceeeeeeeecccCCCch-HHHHHHHHHHHHhcC-CCCeeEEEEeecCCce
Confidence 3555 5789999999999999988 7999999999887765543 478999999999998 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 234 VYVVMELCEGGELLDRILS-RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
+++|||-+. |+.++.|++ ..+++++...+.++.||+.||.|||-++|+|+||||+|||+..-+.-..|||||||+|++
T Consensus 638 vFVVMEKl~-GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARi 716 (888)
T KOG4236|consen 638 VFVVMEKLH-GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARI 716 (888)
T ss_pred EEEEehhhc-chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceee
Confidence 999999995 577776664 467899999999999999999999999999999999999998766667899999999999
Q ss_pred cCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 313 VRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
+....-..+++|||.|+|||+++ +.|+..-|+||.|||+|--+.|..||... .++...|.+....++..+|..++.+
T Consensus 717 IgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~~ 794 (888)
T KOG4236|consen 717 IGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISPE 794 (888)
T ss_pred cchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCHH
Confidence 98777778899999999999996 78999999999999999999999999654 3566778888889999999999999
Q ss_pred HHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
+.+||..+|+..-++|.++++.|.|||+|+.
T Consensus 795 AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 795 AIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 9999999999999999999999999999975
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=356.93 Aligned_cols=250 Identities=27% Similarity=0.456 Sum_probs=207.4
Q ss_pred eeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeeecC
Q 007253 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCE 242 (611)
Q Consensus 163 LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~~~ 242 (611)
||+|+||.||+++.+. +|+.||+|++.............+..|+++++++. ||||+++++++.++..+++||||++
T Consensus 1 lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~ 76 (277)
T cd05607 1 LGKGGFGEVCAVQVKN---TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN-SPFIVNLAYAFESKTHLCLVMSLMN 76 (277)
T ss_pred CCCCCceEEEEEEEcc---CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC-CCcEEEEEEEEecCCeEEEEEecCC
Confidence 7999999999999876 68999999986544333333445667999999997 9999999999999999999999999
Q ss_pred CCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCCcccc
Q 007253 243 GGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND 321 (611)
Q Consensus 243 ~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~ 321 (611)
||+|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++...........
T Consensus 77 g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~~~~ 153 (277)
T cd05607 77 GGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQ 153 (277)
T ss_pred CCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE---cCCCCEEEeeceeeeecCCCceeec
Confidence 999988876543 358999999999999999999999999999999999999 5677899999999987654444445
Q ss_pred cccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 007253 322 IVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSFDEAPWPSLSSEARDFV 396 (611)
Q Consensus 322 ~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 396 (611)
..|+..|+|||++. ..++.++|||||||++|+|++|+.||..... ..+........... ....++.++.+||
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li 230 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF---EHQNFTEESKDIC 230 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc---ccccCCHHHHHHH
Confidence 67999999999886 5689999999999999999999999975433 22333333322222 1236899999999
Q ss_pred HHhcccCccCCCCH----HHHHcCcccCCC
Q 007253 397 KRLLNKDPRKRLTA----AQALSHPWIKNS 422 (611)
Q Consensus 397 ~~~L~~dP~~Rpt~----~~ll~hp~~~~~ 422 (611)
++||+.||.+||++ .+++.|+||+..
T Consensus 231 ~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 231 RLFLAKKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred HHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence 99999999999999 778899999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=366.97 Aligned_cols=250 Identities=29% Similarity=0.523 Sum_probs=209.5
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHH-HHHhcCCCCeeEEEEEEeeCCeeEEEee
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKI-LRALTGHNNLVKFFDAYEDTDNVYVVME 239 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~~h~~iv~l~~~~~~~~~~~lv~E 239 (611)
+.||+|+||.||+|+... .++.||+|++.+...........+..|... ++.+. ||||+++++++...+.+|+|||
T Consensus 1 ~~lg~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~Iv~~~~~~~~~~~~~lv~e 76 (325)
T cd05602 1 KVIGKGSFGKVLLARHKA---EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTADKLYFVLD 76 (325)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCC-CCCCCceeEEEEcCCeEEEEEe
Confidence 479999999999998766 578999999965432222233445555554 56665 9999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC-CCCc
Q 007253 240 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDER 318 (611)
Q Consensus 240 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~-~~~~ 318 (611)
||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.... ....
T Consensus 77 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili---~~~~~~kl~DfG~a~~~~~~~~~ 152 (325)
T cd05602 77 YINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNGT 152 (325)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEEccCCCCcccccCCCC
Confidence 99999999887654 568999999999999999999999999999999999999 567789999999987543 2233
Q ss_pred ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 007253 319 LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397 (611)
Q Consensus 319 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 397 (611)
....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+.+..+......+ .+.++..+.++|.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~ 228 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL----KPNITNSARHLLE 228 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCC----CCCCCHHHHHHHH
Confidence 45668999999999886 568899999999999999999999999888888877776654333 2468999999999
Q ss_pred HhcccCccCCCCHH----HHHcCcccCCC
Q 007253 398 RLLNKDPRKRLTAA----QALSHPWIKNS 422 (611)
Q Consensus 398 ~~L~~dP~~Rpt~~----~ll~hp~~~~~ 422 (611)
+||+.||.+|+++. ++++|+||...
T Consensus 229 ~~l~~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 229 GLLQKDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred HHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence 99999999999876 89999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=373.30 Aligned_cols=253 Identities=18% Similarity=0.325 Sum_probs=204.4
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
..+|++.+.||+|+||.||+|.... +++.||+|.... ..+.+|+.++++|+ ||||++++++|..+..
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~---~~~~vaiK~~~~---------~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~ 157 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNK---TCEHVVIKAGQR---------GGTATEAHILRAIN-HPSIIQLKGTFTYNKF 157 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECC---CCCEEEEechhh---------hhhHHHHHHHHhCC-CCCCCCEeEEEEECCe
Confidence 4579999999999999999999776 689999997521 24678999999998 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
.++|||++. ++|..++... ..+++..++.++.||+.||.|||++|||||||||+|||+ +..+.+||+|||++...
T Consensus 158 ~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll---~~~~~vkL~DFG~a~~~ 232 (391)
T PHA03212 158 TCLILPRYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI---NHPGDVCLGDFGAACFP 232 (391)
T ss_pred eEEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE---cCCCCEEEEeCCccccc
Confidence 999999995 6888887654 568999999999999999999999999999999999999 56778999999999754
Q ss_pred CCC--CcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHhcCC-----
Q 007253 314 RPD--ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART-------ESGIFRAVLKADP----- 378 (611)
Q Consensus 314 ~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~-------~~~~~~~i~~~~~----- 378 (611)
... ......+||+.|+|||++. ..++.++|||||||++|||++|..||.... ....+..+.....
T Consensus 233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~ 312 (391)
T PHA03212 233 VDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE 312 (391)
T ss_pred ccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence 322 2334568999999999986 568999999999999999999998875422 1111111111100
Q ss_pred ---------------------CCC--CCCC---CCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCC
Q 007253 379 ---------------------SFD--EAPW---PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (611)
Q Consensus 379 ---------------------~~~--~~~~---~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~ 424 (611)
..+ ...| ..++.++.+||.+||+.||.+|||+.++|+||||+....
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 384 (391)
T PHA03212 313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPD 384 (391)
T ss_pred cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCC
Confidence 000 0001 134678999999999999999999999999999987543
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=365.84 Aligned_cols=250 Identities=29% Similarity=0.515 Sum_probs=209.9
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHH-HHHHhcCCCCeeEEEEEEeeCCeeEEEee
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK-ILRALTGHNNLVKFFDAYEDTDNVYVVME 239 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~iv~l~~~~~~~~~~~lv~E 239 (611)
+.||+|+||.||+|+... .|+.||+|++.+...........+..|+. +++.++ ||||+++++++.+.+.+|+|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~e 76 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKS---DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK-HPFLVGLHYSFQTAEKLYFVLD 76 (321)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCEEEEEEc
Confidence 479999999999999766 68999999996543333333445556655 566776 9999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC-CCCc
Q 007253 240 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDER 318 (611)
Q Consensus 240 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~-~~~~ 318 (611)
||+||+|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.... ....
T Consensus 77 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~ 152 (321)
T cd05603 77 YVNGGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEET 152 (321)
T ss_pred CCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEccCCCCccCCCCCCc
Confidence 9999999887754 3568999999999999999999999999999999999999 577889999999987532 2233
Q ss_pred ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 007253 319 LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397 (611)
Q Consensus 319 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 397 (611)
....+||+.|+|||++. ..++.++|||||||++|+|++|..||...+....+..+......++ +..+..+.++|.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~ 228 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLV 228 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHH
Confidence 44568999999999986 5689999999999999999999999998887777777776544333 357889999999
Q ss_pred HhcccCccCCCCH----HHHHcCcccCCC
Q 007253 398 RLLNKDPRKRLTA----AQALSHPWIKNS 422 (611)
Q Consensus 398 ~~L~~dP~~Rpt~----~~ll~hp~~~~~ 422 (611)
+||+.||.+|+++ .++++|+||...
T Consensus 229 ~~l~~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 229 GLLHKDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred HHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 9999999999875 599999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=370.17 Aligned_cols=257 Identities=29% Similarity=0.505 Sum_probs=208.4
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|++.+.||+|+||.||++.... .|+.||+|++.... ........+.+|+.+++.++ ||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 93 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTV---LGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVN-HKNIISLLNVFTPQK 93 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcC---CCceeEEEEecccc-cchhHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCC
Confidence 46789999999999999999998765 68999999986543 23344567789999999997 999999999987543
Q ss_pred ------eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEee
Q 007253 233 ------NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (611)
Q Consensus 233 ------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D 306 (611)
.+|+||||+++ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~---~~~~~~kl~D 166 (359)
T cd07876 94 SLEEFQDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILD 166 (359)
T ss_pred CccccceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEec
Confidence 57999999965 6766653 348999999999999999999999999999999999999 5778899999
Q ss_pred cccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHh----------
Q 007253 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK---------- 375 (611)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~---------- 375 (611)
||++.............||+.|+|||++. ..++.++|||||||++|+|++|+.||.+......+..+..
T Consensus 167 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 167 FGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred CCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 99998765444455668999999999986 5689999999999999999999999987655433222211
Q ss_pred ------------cCCCCCCCC----------------CCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCC
Q 007253 376 ------------ADPSFDEAP----------------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 376 ------------~~~~~~~~~----------------~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
..+..+... ....++++.+||.+||+.||++|||+.|+|+||||+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 111111100 0124678999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=379.21 Aligned_cols=255 Identities=29% Similarity=0.430 Sum_probs=217.9
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
..|.+.+.||+|+||.||+|..... .++.||+|.+.. ........+.+|+.+++.+. |||||++++++..++.+
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~--~~~~vv~K~~~~---~~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~ 140 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSD--PKEKVVAKFVML---NDERQAAYARSELHCLAACD-HFGIVKHFDDFKSDDKL 140 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCC--CCeEEEEEEccc---CCHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEEECCEE
Confidence 3499999999999999999986552 267889997743 23344566788999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 235 YVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
|||||||+||+|.+++... ...+++..+..++.||+.||.|||+++||||||||+|||+ +.++.+||+|||++.
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~ 217 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL---MPTGIIKLGDFGFSK 217 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE---CCCCcEEEEeCcCce
Confidence 9999999999999887542 3468999999999999999999999999999999999999 567889999999998
Q ss_pred ccCCCC---cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 007253 312 FVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (611)
Q Consensus 312 ~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (611)
.+.... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+++..+........ ...
T Consensus 218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~ 294 (478)
T PTZ00267 218 QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF---PCP 294 (478)
T ss_pred ecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---Ccc
Confidence 764332 234567999999999986 5689999999999999999999999998888777777776543211 135
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHcCcccCC
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
++.++.+||.+||..||++||++.+++.|+|++.
T Consensus 295 ~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 295 VSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 7899999999999999999999999999999965
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=357.82 Aligned_cols=260 Identities=27% Similarity=0.442 Sum_probs=214.5
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++.+.||+|+||.||+|+... +++.||+|.+...... .....+.+|+.++++|+ ||||+++++++..++.
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~ 78 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKL---TDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKS 78 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcC---CCcEEEEEEEeccccc--CchhHHHHHHHHHHhcC-CCCcceEEEEEecCCe
Confidence 4679999999999999999998765 6889999998644322 22345678999999998 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+++||||++ ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~ 154 (301)
T cd07873 79 LTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAK 154 (301)
T ss_pred EEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE---CCCCcEEECcCcchhcc
Confidence 999999996 59999887776779999999999999999999999999999999999999 56778999999998765
Q ss_pred CCCC-cccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------
Q 007253 314 RPDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF---------- 380 (611)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~---------- 380 (611)
.... ......+++.|+|||++.+ .++.++|||||||++|+|++|+.||...+..+....+.......
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 155 SIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred CCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence 3222 2334567899999998853 47889999999999999999999998777655544433321110
Q ss_pred ---------CC-------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 381 ---------DE-------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 381 ---------~~-------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
+. ...+.+++++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 00 01235788999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=362.16 Aligned_cols=257 Identities=26% Similarity=0.425 Sum_probs=211.8
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++.++||+|+||.||++.... +|..+|+|++.... .....+.+.+|+++++.++ |+||++++++|.+++.
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~---~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 77 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKP---SGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGE 77 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECC---CCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCcccceeEEEEECCE
Confidence 4689999999999999999998765 58899999986542 3344567899999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
+++||||+++|+|.+++... +.+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++..
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~ 153 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQ 153 (333)
T ss_pred EEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE---cCCCCEEEeeCCcchh
Confidence 99999999999999988654 5689999999999999999999985 79999999999999 5677899999999876
Q ss_pred cCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHH------------------
Q 007253 313 VRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAV------------------ 373 (611)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i------------------ 373 (611)
... .......|+..|+|||++. ..++.++|||||||++|+|++|+.||...........+
T Consensus 154 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (333)
T cd06650 154 LID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR 232 (333)
T ss_pred hhh-hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccC
Confidence 532 2234457999999999986 45889999999999999999999999765443321111
Q ss_pred --------------------------HhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 374 --------------------------LKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 374 --------------------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.... .+......++.++.+||.+||++||++|||+.+++.||||+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEP--PPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred CccchhhhhcccccccccHHHHHHHHhcCC--CccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 0000 00011123678899999999999999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=380.08 Aligned_cols=260 Identities=30% Similarity=0.471 Sum_probs=220.1
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
...++|++.+.||+|+||.||+|+... +|+.||||++..... .......+.+|+.++..+. |+||+++++.+...
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~---~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~-h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVS---DGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCD-FFSIVKCHEDFAKK 103 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcC---CCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCC-CCcEEEeecceecc
Confidence 345789999999999999999998766 689999999976543 3445567889999999997 99999998877543
Q ss_pred C--------eeEEEeeecCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCc
Q 007253 232 D--------NVYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS 300 (611)
Q Consensus 232 ~--------~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~ 300 (611)
+ .+++||||+++|+|.+++..+ ...+++..++.++.||+.||.|||+.+||||||||+|||+ +.++
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl---~~~~ 180 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL---CSNG 180 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---eCCC
Confidence 2 378999999999999988653 3468999999999999999999999999999999999999 5678
Q ss_pred eEEEeecccccccCCC---CcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 007253 301 VLKAIDFGLSDFVRPD---ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 376 (611)
Q Consensus 301 ~vkl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~ 376 (611)
.+||+|||+++.+... ......+||+.|+|||++. ..++.++|||||||++|||++|+.||.+....+.+..++..
T Consensus 181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~ 260 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG 260 (496)
T ss_pred CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence 8999999999865432 2234568999999999987 56899999999999999999999999988877777777654
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 377 DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 377 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
.... ..+.+++++.+||.+||+.||.+||++.++++|||++..
T Consensus 261 ~~~~---~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 261 RYDP---LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred CCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 4321 124689999999999999999999999999999998753
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=389.94 Aligned_cols=265 Identities=31% Similarity=0.546 Sum_probs=219.6
Q ss_pred ccccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe
Q 007253 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (611)
Q Consensus 150 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 229 (611)
......+|++++.||+|+||.||+|+... .+..||+|++..... .......+..|+.+++.|. |||||+++++|.
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~---tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~-HPNIVrl~d~f~ 82 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKR---TQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELK-HKNIVRYIDRFL 82 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECC---CCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEE
Confidence 44556789999999999999999999876 688999999865433 3344567889999999998 999999999986
Q ss_pred eC--CeeEEEeeecCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc-------CCeeecCCCCceEEecc-
Q 007253 230 DT--DNVYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQ-------GVVHRDLKPENFLFTTK- 296 (611)
Q Consensus 230 ~~--~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~-------~iiHrDlkp~NIll~~~- 296 (611)
+. ..+|||||||++|+|.++|... ...+++..++.|+.||+.||.|||+. +||||||||+||||...
T Consensus 83 de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~ 162 (1021)
T PTZ00266 83 NKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI 162 (1021)
T ss_pred ecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence 54 5699999999999999988653 35699999999999999999999995 49999999999999632
Q ss_pred -------------CCCceEEEeecccccccCCCCcccccccCCCcCcchhhc---CCCCCcchhhHHHHHHHHHHhCCCC
Q 007253 297 -------------DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH---RSYSTEADVWSIGVIAYILLCGSRP 360 (611)
Q Consensus 297 -------------~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwSlGvil~el~~g~~P 360 (611)
+....+||+|||++..+.........+||+.|+|||++. ..++.++||||||||||+|++|..|
T Consensus 163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred cccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 224469999999998775544455668999999999884 3488999999999999999999999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 361 FWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 361 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
|........+...+...+.++ ...++.++.+||..||..+|.+||++.++|.|+|++..
T Consensus 243 F~~~~~~~qli~~lk~~p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 243 FHKANNFSQLISELKRGPDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCcCCcHHHHHHHHhcCCCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 976655444444444433332 34678999999999999999999999999999999754
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=352.87 Aligned_cols=254 Identities=41% Similarity=0.726 Sum_probs=210.1
Q ss_pred eeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEE
Q 007253 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (611)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 236 (611)
|++++.||+|+||.||+++... .++.||+|++........ ......+|+.+++++. ||||+++++++.+....++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~---~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKK---NGQKVAVKIIDKSEIEEE-EREENIREIKILRRLR-HPNIVQILDVFQDDNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETT---TTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHHT-BTTBCHEEEEEEESSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECC---CCeEEEEEEecccccccc-ccchhhhhhhcccccc-ccccccccccccccccccc
Confidence 8899999999999999999877 688999999976543222 2233456999999996 9999999999999999999
Q ss_pred EeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc-CC
Q 007253 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV-RP 315 (611)
Q Consensus 237 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~-~~ 315 (611)
||||+.+++|.+++. ....+++..++.++.||+.||.|||++||+|+||||+||++ +.++.++|+|||.+... ..
T Consensus 76 v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~ 151 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL---DENGEVKLIDFGSSVKLSEN 151 (260)
T ss_dssp EEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE---STTSEEEESSGTTTEESTST
T ss_pred ccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccc
Confidence 999999999999887 34578999999999999999999999999999999999999 67888999999999764 22
Q ss_pred CCcccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 316 DERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWART---ESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 316 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
........++..|+|||++. ..++.++||||||+++|+|++|..||.... ....+..................+.
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSE 231 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHH
Confidence 34455678999999999987 568999999999999999999999998773 2233333332211111111112348
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 391 EARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
++.++|.+||+.||++||++.++++||||
T Consensus 232 ~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 232 ELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=364.53 Aligned_cols=251 Identities=24% Similarity=0.367 Sum_probs=204.1
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
...|.+.+.||+|+||.||+|.+.. .++.||||.... ..+.+|++++++|+ |+|||++++++..++.
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~---~~~~vavK~~~~---------~~~~~E~~iL~~L~-HpnIv~l~~~~~~~~~ 234 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPD---YPQRVVVKAGWY---------ASSVHEARLLRRLS-HPAVLALLDVRVVGGL 234 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECC---CCCEEEEecccc---------cCHHHHHHHHHHCC-CCCCCcEEEEEEECCE
Confidence 4579999999999999999998776 588999996421 23568999999998 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
.++|||++. ++|.+++......+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+++..
T Consensus 235 ~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl---~~~~~vkL~DFGla~~~ 310 (461)
T PHA03211 235 TCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV---NGPEDICLGDFGAACFA 310 (461)
T ss_pred EEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE---CCCCCEEEcccCCceec
Confidence 999999995 69999887766679999999999999999999999999999999999999 56778999999999876
Q ss_pred CCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHhcCCC--
Q 007253 314 RPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART--------ESGIFRAVLKADPS-- 379 (611)
Q Consensus 314 ~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~--------~~~~~~~i~~~~~~-- 379 (611)
..... ....+||+.|||||++. ..++.++|||||||++|||++|..|+.... ...+...+......
T Consensus 311 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~ 390 (461)
T PHA03211 311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD 390 (461)
T ss_pred ccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence 43321 23457999999999986 558999999999999999999887653321 12233322222110
Q ss_pred -C------------------------CCCCCC---CCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCC
Q 007253 380 -F------------------------DEAPWP---SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 380 -~------------------------~~~~~~---~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
+ ....|. .++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 1 011121 35668999999999999999999999999999975
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=362.49 Aligned_cols=255 Identities=26% Similarity=0.407 Sum_probs=204.1
Q ss_pred CCceeEeCeeeeccceEEEEEEEec--CCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~--~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.++|+++++||+|+||.||+|.... ....+..||||++.... .......+.+|+.++.++.+||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 4689999999999999999998642 12246789999986432 2334567889999999995599999999998765
Q ss_pred -CeeEEEeeecCCCChHHHHHhcC--------------------------------------------------------
Q 007253 232 -DNVYVVMELCEGGELLDRILSRG-------------------------------------------------------- 254 (611)
Q Consensus 232 -~~~~lv~E~~~~gsL~~~l~~~~-------------------------------------------------------- 254 (611)
+.+++|||||++|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 46899999999999999886531
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCC---cccccccCC
Q 007253 255 -----GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE---RLNDIVGSA 326 (611)
Q Consensus 255 -----~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~ 326 (611)
..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...... ......+++
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 247888999999999999999999999999999999999 567889999999998654322 122345678
Q ss_pred CcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCc
Q 007253 327 YYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDP 404 (611)
Q Consensus 327 ~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 404 (611)
.|+|||++. ..++.++|||||||++|||++ |..||.+......+...+....... ....++..+.+||.+||+.||
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp 318 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR--APENATPEIYRIMLACWQGDP 318 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHccCCh
Confidence 899999885 568999999999999999996 9999987654443333333222211 123578999999999999999
Q ss_pred cCCCCHHHHHc
Q 007253 405 RKRLTAAQALS 415 (611)
Q Consensus 405 ~~Rpt~~~ll~ 415 (611)
.+|||+.++++
T Consensus 319 ~~RPs~~el~~ 329 (338)
T cd05102 319 KERPTFSALVE 329 (338)
T ss_pred hhCcCHHHHHH
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=364.81 Aligned_cols=258 Identities=27% Similarity=0.484 Sum_probs=209.0
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC-
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~- 231 (611)
..++|++.+.||+|+||.||++.... .++.||||++.... ........+.+|+.+++.++ ||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 89 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQK 89 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecC---CCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhC-CCchhceeeeeeccc
Confidence 45789999999999999999998655 68899999986543 23344567789999999997 99999999988654
Q ss_pred -----CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEee
Q 007253 232 -----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (611)
Q Consensus 232 -----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D 306 (611)
..+|+||||+++ +|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 90 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill---~~~~~~kl~D 162 (355)
T cd07874 90 SLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILD 162 (355)
T ss_pred cccccceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---CCCCCEEEee
Confidence 357999999965 67766642 48999999999999999999999999999999999999 5678899999
Q ss_pred cccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---------
Q 007253 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA--------- 376 (611)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~--------- 376 (611)
||+++............||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+.+..+...
T Consensus 163 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 163 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred CcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99998765544455678999999999886 46899999999999999999999999877654433332221
Q ss_pred -------------CCCCC----------------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 377 -------------DPSFD----------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 377 -------------~~~~~----------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
.+... .......+.++.+||.+||..||++|||+.++|+||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 11100 00112245788999999999999999999999999999744
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=365.39 Aligned_cols=257 Identities=26% Similarity=0.471 Sum_probs=210.2
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC-
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~- 231 (611)
..++|++.+.||+|+||.||+|.... .++.||||++.... ........+.+|+.+++.++ ||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~~ 96 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQK 96 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECC---CCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcC-CCCccccceeecccc
Confidence 45789999999999999999998765 68899999986543 22334466789999999997 99999999987643
Q ss_pred -----CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEee
Q 007253 232 -----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (611)
Q Consensus 232 -----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D 306 (611)
..+|+||||+++ +|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 97 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~D 169 (364)
T cd07875 97 SLEEFQDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILD 169 (364)
T ss_pred cccccCeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE---CCCCcEEEEe
Confidence 357999999965 77776642 48899999999999999999999999999999999999 5678899999
Q ss_pred cccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-------
Q 007253 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP------- 378 (611)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~------- 378 (611)
||+++............||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+.+..++....
T Consensus 170 fG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 170 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred CCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 99998765544455668999999999886 5689999999999999999999999988776665555543211
Q ss_pred ---------------CCCC----------------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCC
Q 007253 379 ---------------SFDE----------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 379 ---------------~~~~----------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
.+.. ......+.++++||.+||+.||.+|||+.++|+||||..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 1000 001123567899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=368.00 Aligned_cols=257 Identities=32% Similarity=0.517 Sum_probs=211.3
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC---
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD--- 232 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~--- 232 (611)
+|++++.||+|+||.||+|.... +|+.||||++.... ........+.+|+.+++.++ |+||+++++++...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 75 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPR---DGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDP 75 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECC---CCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCccc
Confidence 47899999999999999998765 68999999986432 23344567889999999998 999999999998776
Q ss_pred --eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 233 --NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 233 --~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
.+|+||||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 76 ~~~~~lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a 150 (372)
T cd07853 76 FEEIYVVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV---NSNCVLKICDFGLA 150 (372)
T ss_pred cceEEEEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE---CCCCCEEeccccce
Confidence 7999999996 5888877543 579999999999999999999999999999999999999 57788999999999
Q ss_pred cccCCCC--cccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC---------
Q 007253 311 DFVRPDE--RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD--------- 377 (611)
Q Consensus 311 ~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~--------- 377 (611)
....... .....++|+.|+|||++.+ .++.++|||||||++|||++|+.||.+......+..+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 151 RVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR 230 (372)
T ss_pred eecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 8654332 2334578999999998864 47899999999999999999999998877665554443211
Q ss_pred --------------CCCCC-----CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 378 --------------PSFDE-----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 378 --------------~~~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
...+. ......++++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 00000 1123468899999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=370.42 Aligned_cols=251 Identities=29% Similarity=0.503 Sum_probs=214.2
Q ss_pred eeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeeec
Q 007253 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELC 241 (611)
Q Consensus 162 ~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~~ 241 (611)
+||+|.||+||.|++.. +...+|||.++.. .....+-+..||.+.+.|+ |.|||+++|.+..++.+-|.||-+
T Consensus 582 VLGKGTYG~VYA~RD~~---tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~Lr-HkNIVrYLGs~senGf~kIFMEqV 654 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMD---TQVRIAIKEIPEK---DSREVQPLHEEIALHSTLR-HKNIVRYLGSVSENGFFKIFMEQV 654 (1226)
T ss_pred EeecCceeEEEeecccc---ceeEEEeeecccc---cchhhccHHHHHHHHHHHh-hHhHHHHhhccCCCCeEEEEeecC
Confidence 69999999999999877 5778999999643 3334466789999999998 999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC-CCc
Q 007253 242 EGGELLDRILSRGGKY--TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DER 318 (611)
Q Consensus 242 ~~gsL~~~l~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~-~~~ 318 (611)
+||+|.+.+...-+++ +|.++..+.+||+.||.|||++.|||||||-+||||+ .-.|++||+|||-++.+.. +.-
T Consensus 655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCCcc
Confidence 9999999999888888 8999999999999999999999999999999999998 4578999999999886643 234
Q ss_pred ccccccCCCcCcchhhc---CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHH-HHHHH--HhcCCCCCCCCCCCCCHHH
Q 007253 319 LNDIVGSAYYVAPEVLH---RSYSTEADVWSIGVIAYILLCGSRPFWARTESG-IFRAV--LKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 319 ~~~~~gt~~y~aPE~~~---~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~-~~~~i--~~~~~~~~~~~~~~~s~~~ 392 (611)
+.+.-||..|||||++. +.|+.++|||||||++.||.||++||......+ .+.++ .+..|.+++ .++.++
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPe----elsaea 808 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPE----ELSAEA 808 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcH----HHHHHH
Confidence 56778999999999995 459999999999999999999999997543332 12222 223344443 578999
Q ss_pred HHHHHHhcccCccCCCCHHHHHcCcccCCCCCC
Q 007253 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~ 425 (611)
+.||.+|+.+||.+||++.++|++||++..++.
T Consensus 809 k~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk 841 (1226)
T KOG4279|consen 809 KNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKK 841 (1226)
T ss_pred HHHHHHHcCCCcccCccHHHhccCcccccCCCC
Confidence 999999999999999999999999999987543
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=362.74 Aligned_cols=251 Identities=21% Similarity=0.320 Sum_probs=202.8
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
...|++++.||+|+||.||+|+... .++.||+|+..+. ....|+.++++++ |+||+++++++...+.
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~valK~~~~~---------~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 131 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPG---QPDPVVLKIGQKG---------TTLIEAMLLQNVN-HPSVIRMKDTLVSGAI 131 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECC---CCceEEEEeCCcc---------ccHHHHHHHHhCC-CCCCcChhheEEeCCe
Confidence 3469999999999999999999765 5789999985432 1346999999998 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
.++||||+. |+|.+++......+++..++.|+.||+.||.|||++|||||||||+|||+ +..+.+||+|||++...
T Consensus 132 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 132 TCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFP 207 (357)
T ss_pred eEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEecCcccccc
Confidence 999999995 68999888777789999999999999999999999999999999999999 57778999999999865
Q ss_pred CCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCCh-H---------HHHHHHHhcC----C
Q 007253 314 RPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE-S---------GIFRAVLKAD----P 378 (611)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~-~---------~~~~~i~~~~----~ 378 (611)
..........||+.|+|||++. ..++.++|||||||++|||+++..|+..... . ..+..+.... .
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 287 (357)
T PHA03209 208 VVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE 287 (357)
T ss_pred ccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence 4444445668999999999886 5689999999999999999986555432211 0 1111111110 0
Q ss_pred CCCC--------------------------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCC
Q 007253 379 SFDE--------------------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 379 ~~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
.++. .....++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 0110 001245677888999999999999999999999999985
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=358.96 Aligned_cols=252 Identities=29% Similarity=0.458 Sum_probs=195.7
Q ss_pred eCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee--CCeeEEE
Q 007253 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--TDNVYVV 237 (611)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~--~~~~~lv 237 (611)
+++||+|+||.||+|+.+.+ ..++.||+|.+..... ...+.+|+.+++++. ||||+++++++.. +..+|+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~-~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDG-KDDRDYALKQIEGTGI-----SMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccC-CCCceEEEEEECCCCC-----cHHHHHHHHHHHhcC-CCCCcceeeeEecCCCcEEEEE
Confidence 57899999999999987542 2578999999864322 234678999999997 9999999999865 4568999
Q ss_pred eeecCCCChHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEecc-CCCceEEEeecc
Q 007253 238 MELCEGGELLDRILSR--------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK-DENSVLKAIDFG 308 (611)
Q Consensus 238 ~E~~~~gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~-~~~~~vkl~DfG 308 (611)
|||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+... +..+.+||+|||
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 79 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 99995 5888876532 1258999999999999999999999999999999999999543 356789999999
Q ss_pred cccccCCCC----cccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChH---------HHHHHH
Q 007253 309 LSDFVRPDE----RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTES---------GIFRAV 373 (611)
Q Consensus 309 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~---------~~~~~i 373 (611)
++....... .....+||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... ..+..+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 998764332 2345688999999998863 4889999999999999999999999643321 112222
Q ss_pred HhcCCCCC----------------------------------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 374 LKADPSFD----------------------------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 374 ~~~~~~~~----------------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
........ .......+.++.+||++||+.||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 11100000 00001235678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=350.11 Aligned_cols=254 Identities=31% Similarity=0.622 Sum_probs=221.5
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++.+.||+|+||.||++.... .++.||+|++.+.........+.+.+|+++++++. ||||+++++++.+++.+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 76 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQDDSNL 76 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCeE
Confidence 369999999999999999999876 58999999987654444455677889999999998 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+.||+||||+|+|||+ +.++.+||+|||++....
T Consensus 77 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 77 YLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVK 152 (290)
T ss_pred EEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEeeCCCccccC
Confidence 9999999999999988665 579999999999999999999999999999999999999 567789999999998765
Q ss_pred CCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 007253 315 PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (611)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 393 (611)
.. .....|++.|+|||.+. +.++.++||||||+++|+|++|+.||...........+......++ ..++..+.
T Consensus 153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~ 226 (290)
T cd05580 153 GR--TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFP----SFFSPDAK 226 (290)
T ss_pred CC--CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCC----ccCCHHHH
Confidence 43 34557899999999875 5678899999999999999999999988776666666665554443 24689999
Q ss_pred HHHHHhcccCccCCC-----CHHHHHcCcccCCC
Q 007253 394 DFVKRLLNKDPRKRL-----TAAQALSHPWIKNS 422 (611)
Q Consensus 394 ~li~~~L~~dP~~Rp-----t~~~ll~hp~~~~~ 422 (611)
++|.+||..||.+|+ +++++++||||+..
T Consensus 227 ~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 227 DLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred HHHHHHccCCHHHccCcccCCHHHHHcCcccccC
Confidence 999999999999999 99999999999763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=346.34 Aligned_cols=258 Identities=29% Similarity=0.496 Sum_probs=232.1
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
..+|..+.+||+|+||.|.+|..+. +.+.||||++++...-.....+.-..|-++|.-...-|.+++++..|+.-++
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkg---tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKG---TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ecccceEEEeccCccceeeeecccC---cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 5679999999999999999998665 6789999999988776666667777888888766667899999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|+||||+.||+|.-.|..- +++-|..+..++.+|+-||-+||++|||+||||.+|||| +..|++||+|||+++.-
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKEN 500 (683)
T ss_pred eeeEEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeeccccccc
Confidence 99999999999998877554 679999999999999999999999999999999999999 78899999999999853
Q ss_pred -CCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 314 -RPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 314 -~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
-.+..+.+.||||.|+|||++. +.|+..+|+||+||+||||+.|++||.+.++.+.+++|...+-.++. .+|.+
T Consensus 501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPK----slSkE 576 (683)
T KOG0696|consen 501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPK----SLSKE 576 (683)
T ss_pred ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcc----cccHH
Confidence 3455678899999999999875 88999999999999999999999999999999999999998887775 68999
Q ss_pred HHHHHHHhcccCccCCCC-----HHHHHcCcccCCC
Q 007253 392 ARDFVKRLLNKDPRKRLT-----AAQALSHPWIKNS 422 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rpt-----~~~ll~hp~~~~~ 422 (611)
+.++++.+|.+.|.+|.. -.++.+||||+..
T Consensus 577 Av~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 577 AVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred HHHHHHHHhhcCCccccCCCCccccchhhCcchhhc
Confidence 999999999999999984 4689999999864
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=363.99 Aligned_cols=256 Identities=21% Similarity=0.380 Sum_probs=206.8
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
...+|++++.||+|+||.||++.... ...+..||+|.+... ....+|+++++.|+ ||||+++++++...+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~-~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~-h~~iv~~~~~~~~~~ 159 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHG-DEQRKKVIVKAVTGG--------KTPGREIDILKTIS-HRAIINLIHAYRWKS 159 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcC-CccceeEEEEecccc--------ccHHHHHHHHHhcC-CCCccceeeeEeeCC
Confidence 45689999999999999999997543 235788999988543 13458999999998 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.+|+|||++. ++|.+++ .....+++..++.++.||+.||.|||++|||||||||+|||+ +..+.+||+|||++..
T Consensus 160 ~~~lv~e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill---~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 160 TVCMVMPKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL---DEPENAVLGDFGAACK 234 (392)
T ss_pred EEEEEehhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEccCccccc
Confidence 9999999995 6888887 444679999999999999999999999999999999999999 5777899999999976
Q ss_pred cCCCC---cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCC----CCC
Q 007253 313 VRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE---SGIFRAVLKADP----SFD 381 (611)
Q Consensus 313 ~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~---~~~~~~i~~~~~----~~~ 381 (611)
+.... .....+||+.|+|||++. ..++.++|||||||++|||++|+.||.+... ...+..+.+... .++
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 54332 223467999999999987 5689999999999999999999999976432 122222222110 000
Q ss_pred C--------------------CC------CCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 382 E--------------------AP------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 382 ~--------------------~~------~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
. .. ...++.++.+||++||..||.+|||+.++|.||||+...
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence 0 00 013467889999999999999999999999999998643
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=347.96 Aligned_cols=259 Identities=31% Similarity=0.524 Sum_probs=219.7
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++.+.||.|+||.||+|.... ++..||+|++.. ......+.+.+|+.++++++ |+||+++++++..+..
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~---~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 76 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKE---TGLFAAAKIIQI---ESEEELEDFMVEIDILSECK-HPNIVGLYEAYFYENK 76 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcC---CCcEEEEEEEee---CCHHHHHHHHHHHHHHHhCC-CCceeEEEEEEecCCe
Confidence 4679999999999999999998765 588999999853 34445577889999999998 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~ 153 (280)
T cd06611 77 LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL---TLDGDVKLADFGVSAKN 153 (280)
T ss_pred EEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---CCCCCEEEccCccchhh
Confidence 999999999999999887766779999999999999999999999999999999999999 57788999999998765
Q ss_pred CCCC-cccccccCCCcCcchhhc------CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 007253 314 RPDE-RLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (611)
.... ......|++.|+|||++. ..++.++|||||||++|+|++|+.||...........+........ ....
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~ 232 (280)
T cd06611 154 KSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTL-DQPS 232 (280)
T ss_pred cccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCc-CCcc
Confidence 4322 234457899999999874 3367799999999999999999999988776665555544332111 1123
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.++.++.++|.+||+.+|.+||++.++++||||....
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (280)
T cd06611 233 KWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS 269 (280)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence 5789999999999999999999999999999998763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=347.14 Aligned_cols=255 Identities=31% Similarity=0.463 Sum_probs=208.2
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
+|++.+.||+|+||.||+|+... +++.||||++..... .......+.+|+.+++.+. ||||+++++++.+++.+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKK---TGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQ-HPNIVCLQDVLMQESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECC---CCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcC-CCCEeeeEEEEeeCCeEE
Confidence 48899999999999999998765 588999999865332 2223456788999999997 999999999999999999
Q ss_pred EEeeecCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 236 VVMELCEGGELLDRILSRG--GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+||||++ ++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++...
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~ 151 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAF 151 (285)
T ss_pred EEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---cCCCcEEECcccceeec
Confidence 9999997 58888876533 568999999999999999999999999999999999999 57788999999998765
Q ss_pred CCCC-cccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------
Q 007253 314 RPDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF---------- 380 (611)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~---------- 380 (611)
.... ......+++.|+|||++.+ .++.++|||||||++|+|++|+.||.+.........+.......
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 152 GIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred CCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence 4322 2233467899999998853 47889999999999999999999998766544333332211100
Q ss_pred ---------------CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 381 ---------------DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 381 ---------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
....+..++.++.+||++||+.||.+|||+.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 011124578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=361.54 Aligned_cols=259 Identities=27% Similarity=0.524 Sum_probs=209.6
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC-
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~- 231 (611)
+.++|++.+.||+|+||.||+|.... +++.||||++.+.. ........+.+|+.++++++ ||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 87 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTR---LRQKVAVKKLSRPF-QSLIHARRTYRELRLLKHMK-HENVIGLLDVFTPAT 87 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECC---CCCEEEEEEeCchh-hhhHHHHHHHHHHHHHHhcC-CCchhhhhhhhcccc
Confidence 45789999999999999999998765 58899999986532 22234456778999999998 99999999988643
Q ss_pred -----CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEee
Q 007253 232 -----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (611)
Q Consensus 232 -----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D 306 (611)
..+|++||++ +++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 88 ~~~~~~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~---~~~~~~kl~D 161 (343)
T cd07878 88 SIENFNEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILD 161 (343)
T ss_pred cccccCcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE---CCCCCEEEcC
Confidence 3579999998 778887663 3469999999999999999999999999999999999999 5778899999
Q ss_pred cccccccCCCCcccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC------
Q 007253 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP------ 378 (611)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~------ 378 (611)
||++..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+..+.....
T Consensus 162 fg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 162 FGLARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV 239 (343)
T ss_pred CccceecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999987543 2345689999999998864 588999999999999999999999977655444433322110
Q ss_pred -----------------CCCCC----CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCC
Q 007253 379 -----------------SFDEA----PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (611)
Q Consensus 379 -----------------~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~ 424 (611)
..+.. .+...++.+.+||.+||..||.+|||+.++|+||||.....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~ 306 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence 01100 12245677899999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=364.89 Aligned_cols=254 Identities=25% Similarity=0.448 Sum_probs=218.6
Q ss_pred eEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCC-CcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe--e
Q 007253 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKH-KMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN--V 234 (611)
Q Consensus 158 ~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~-~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~--~ 234 (611)
+...+||+|+|-+||+|-+.. .|..||--.++.. .......++++..|+.+|+.|+ ||||+++|.+|.+..+ +
T Consensus 43 k~~evLGrGafKtVYka~De~---~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEE---EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred ehhhhcccccceeeeeccccc---cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecCCCcee
Confidence 456789999999999998754 6878875544322 2235566789999999999998 9999999999998765 8
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.+|+|++..|+|..|+++. ++++...++.|++||++||.|||++. |||||||.+||+|+ +..|.|||+|+|||..
T Consensus 119 n~iTEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATL 195 (632)
T ss_pred eeeeecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHHH
Confidence 8999999999999998766 67999999999999999999999995 99999999999998 7889999999999999
Q ss_pred cCCCCcccccccCCCcCcchhhcCCCCCcchhhHHHHHHHHHHhCCCCCC-CCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 313 VRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFW-ARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~el~~g~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
++.... ...+|||.|||||+....|+..+||||||++++||+|+..||. .....++++++..+...-... .--.++
T Consensus 196 ~r~s~a-ksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~--kV~dPe 272 (632)
T KOG0584|consen 196 LRKSHA-KSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALS--KVKDPE 272 (632)
T ss_pred hhcccc-ceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhh--ccCCHH
Confidence 875544 3489999999999999999999999999999999999999995 466678888888775432222 223789
Q ss_pred HHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
.++||.+||.. .+.|+|+.|||.||||...
T Consensus 273 vr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 273 VREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 99999999999 9999999999999999976
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=346.48 Aligned_cols=261 Identities=30% Similarity=0.495 Sum_probs=218.1
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.+.|+++++||+|+||.||+|+... .++.||+|++... .....+.+.+|+.+++.+. |+||+++++++..++.
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~---~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 83 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKE---TGALAAAKVIETK---SEEELEDYMVEIEILATCN-HPYIVKLLGAFYWDGK 83 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECC---CCceEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCcEeeeEEEEEeCCe
Confidence 4679999999999999999998766 6889999998543 4445677889999999998 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+++||||+++++|..++.+....+++..++.++.||+.||.|||+.||+||||||+||++ +.++.+||+|||++...
T Consensus 84 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 84 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL---TLDGDIKLADFGVSAKN 160 (292)
T ss_pred EEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE---cCCCCEEEccCccceec
Confidence 999999999999988887666779999999999999999999999999999999999999 56778999999998654
Q ss_pred CCC-CcccccccCCCcCcchhhc------CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 007253 314 RPD-ERLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (611)
... .......+++.|+|||++. ..++.++|||||||++|+|++|..||........+..+...... ......
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~ 239 (292)
T cd06644 161 VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-TLSQPS 239 (292)
T ss_pred cccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCc-cCCCCc
Confidence 322 2234457889999999873 33678999999999999999999999876655555444433221 111124
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCC
Q 007253 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~ 425 (611)
.++.++.+||.+||..||++||++.++++||||......
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 278 (292)
T cd06644 240 KWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN 278 (292)
T ss_pred ccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence 578899999999999999999999999999999875433
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=351.73 Aligned_cols=260 Identities=33% Similarity=0.593 Sum_probs=222.3
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++.+.||+|+||.||+|.... .++.||+|.+.+.........+.+.+|+++++.+. |+||+++++.+.+....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 76 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKG---TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQTETYL 76 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcC---CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeeeecCCEE
Confidence 369999999999999999998766 68999999997665444456677899999999998 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 235 YVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
|+||||+.|++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+||++ +.++.++|+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~ 153 (316)
T cd05574 77 CLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL---HESGHIMLSDFDLSKQS 153 (316)
T ss_pred EEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE---cCCCCEEEeecchhhcc
Confidence 9999999999999988654 3569999999999999999999999999999999999999 56778999999998754
Q ss_pred CCCC------------------------------cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCC
Q 007253 314 RPDE------------------------------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFW 362 (611)
Q Consensus 314 ~~~~------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~ 362 (611)
.... .....+||..|+|||++. ..++.++|||||||++|+|++|..||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 154 DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 3221 112347899999999886 458889999999999999999999998
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCC----HHHHHcCcccCCCC
Q 007253 363 ARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT----AAQALSHPWIKNSN 423 (611)
Q Consensus 363 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt----~~~ll~hp~~~~~~ 423 (611)
+......+..+......++.. ..++.++.++|.+||..||.+||| +.++|+||||++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 234 GSNRDETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred CCchHHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence 888777777776555444332 237899999999999999999999 99999999998643
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=344.49 Aligned_cols=258 Identities=32% Similarity=0.522 Sum_probs=216.9
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
+.|++.+.||+|+||.||+|.... .+..+|+|.+... .....+.+.+|+.+++.+. |+||+++++++..++..
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~---~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~ 77 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKE---TGVLAAAKVIDTK---SEEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNL 77 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECC---CCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCC-CCCeeeEEEEEeeCCEE
Confidence 347889999999999999998765 5788999998543 3445677889999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++||||+++|+|..++......+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++....
T Consensus 78 ~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 78 WILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNT 154 (282)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---ccCCCEEEcccccccccc
Confidence 99999999999988877666679999999999999999999999999999999999999 567789999999987653
Q ss_pred CC-CcccccccCCCcCcchhhc------CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 007253 315 PD-ERLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (611)
Q Consensus 315 ~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (611)
.. .......|++.|+|||++. ..++.++|||||||++|+|++|+.||......+....+........ .....
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 233 (282)
T cd06643 155 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-AQPSR 233 (282)
T ss_pred ccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC-CCccc
Confidence 22 2234457899999999873 3477899999999999999999999987776665555554432211 11235
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
++.++.+||.+||+.||.+||++.++++||||+...
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 234 WSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 789999999999999999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=374.25 Aligned_cols=251 Identities=27% Similarity=0.468 Sum_probs=211.0
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEE-Eee--
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDA-YED-- 230 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~-~~~-- 230 (611)
.-++++.+.|.+|||+.||+|+... .|..||+|++- ..+...++.+.+||.+|+.|.+|+|||.|++. ...
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~---~~~~~AlKrm~---~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVK---GGKKYALKRMY---VNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecC---CCceeeeeeee---cCCHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence 3468899999999999999999876 35899999983 34778889999999999999999999999993 221
Q ss_pred ----CCeeEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcC--CeeecCCCCceEEeccCCCceEE
Q 007253 231 ----TDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSVLK 303 (611)
Q Consensus 231 ----~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NIll~~~~~~~~vk 303 (611)
...++|.||||+||+|.|++..+- .+|++.++++|+.|+++|+.+||... |||||||-+|||| ..+++.|
T Consensus 110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl---s~~g~~K 186 (738)
T KOG1989|consen 110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL---SADGNYK 186 (738)
T ss_pred CCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE---cCCCCEE
Confidence 135889999999999999997552 35999999999999999999999998 9999999999999 5778899
Q ss_pred EeecccccccCCCC-ccc---------ccccCCCcCcchhhc----CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHH
Q 007253 304 AIDFGLSDFVRPDE-RLN---------DIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGI 369 (611)
Q Consensus 304 l~DfG~a~~~~~~~-~~~---------~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~ 369 (611)
|||||.+.-..... ... ....|+.|+|||++. ...+.|+|||+|||+||-|+....||+....
T Consensus 187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--- 263 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--- 263 (738)
T ss_pred eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc---
Confidence 99999986432111 110 134689999999984 4589999999999999999999999987654
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 370 FRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 370 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
.+|+.....++.. +.++..+.+||+.||+.||.+||++.+++.+-+.
T Consensus 264 -laIlng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 264 -LAILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred -eeEEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 3566666666653 6899999999999999999999999999987544
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=343.39 Aligned_cols=255 Identities=29% Similarity=0.512 Sum_probs=210.8
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC-
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~- 231 (611)
..+.|++.+.||+|+||.||+|.... .++.||+|++.... .....+.+|+.+++++.+|+||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 76 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcC---CCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence 35679999999999999999998766 58899999986432 12356789999999996699999999998753
Q ss_pred -----CeeEEEeeecCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 232 -----DNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 232 -----~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
..+|+||||+.+|+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+||++ +.++.+||+
T Consensus 77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili---~~~~~~~l~ 153 (272)
T cd06637 77 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLV 153 (272)
T ss_pred CCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE---CCCCCEEEc
Confidence 4689999999999999988764 3468999999999999999999999999999999999999 577789999
Q ss_pred ecccccccCCC-CcccccccCCCcCcchhhc------CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Q 007253 306 DFGLSDFVRPD-ERLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (611)
Q Consensus 306 DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~ 378 (611)
|||++...... .......|++.|+|||++. ..++.++|||||||++|+|++|..||...........+....
T Consensus 154 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~- 232 (272)
T cd06637 154 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP- 232 (272)
T ss_pred cCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC-
Confidence 99998765432 2334567999999999874 247889999999999999999999997665544333333221
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 379 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
........++.++.+||.+||..||.+|||+.+++.||||
T Consensus 233 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 233 -APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred -CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 1222234678999999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=340.00 Aligned_cols=255 Identities=26% Similarity=0.468 Sum_probs=212.6
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcC--CHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT--TAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
+.|++.+.||+|+||.||.|.... +++.||+|++...... .......+.+|+.+++++. ||||+++++++.+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~---~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVD---TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIVQYYGCLRDDE 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEcC---CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEccCC
Confidence 468999999999999999998765 5889999998654322 1223457889999999997 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.+++||||+++++|.+.+... ..+++..+..++.||+.||.|||+.||+||||||+||++ +.++.+||+|||++..
T Consensus 78 ~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv---~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 78 TLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKR 153 (263)
T ss_pred eEEEEEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeeccccee
Confidence 999999999999999987654 568999999999999999999999999999999999999 5677899999999876
Q ss_pred cCCCCc----ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 007253 313 VRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (611)
Q Consensus 313 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (611)
...... .....|+..|+|||++. ..++.++|||||||++|+|++|+.||...........+....... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~ 231 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP--QLPSH 231 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCC--CCCcc
Confidence 543221 13456889999999886 458899999999999999999999997765554444443332211 12236
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
++..+.++|++||..+|.+|||+.++++|+||
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 232 VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred CCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 78999999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=360.42 Aligned_cols=257 Identities=34% Similarity=0.602 Sum_probs=233.7
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
...|.+.+.||+|.|+.|.+|++.. +|..||||++.+...... ....+.+|+++|+.|. |||||+++.+.+....
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~---t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l~-HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHIL---TGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSLN-HPNIVKLFSVIETEAT 129 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecC---CCceEEEEEehhcccChH-HHHHHHHHHHHHHhcC-Ccceeeeeeeeeecce
Confidence 4569999999999999999999776 699999999988765443 4455889999999998 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|+||||+.+|.+.+++.++ +++.+..++.++.|++++++|||+++|||||||++|||| +.+.++||+|||++.++
T Consensus 130 lylV~eya~~ge~~~yl~~~-gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKH-GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTFF 205 (596)
T ss_pred eEEEEEeccCchhHHHHHhc-ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---ccccceeeeccccceee
Confidence 99999999999999999777 467779999999999999999999999999999999999 78888999999999999
Q ss_pred CCCCcccccccCCCcCcchhhcCC--CCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 314 RPDERLNDIVGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
..+....+.||++.|.|||++.+. -++.+|+||+|+++|-|+.|.+||.+....+.-..++.....++. .++.+
T Consensus 206 ~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~----~ms~d 281 (596)
T KOG0586|consen 206 DYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF----YMSCD 281 (596)
T ss_pred cccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc----eeech
Confidence 988888999999999999999743 578999999999999999999999999888888888887777665 47889
Q ss_pred HHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
+.++|+++|.++|.+|++.++++.|.|.....
T Consensus 282 ce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 282 CEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred hHHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence 99999999999999999999999999997554
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=340.69 Aligned_cols=256 Identities=31% Similarity=0.524 Sum_probs=216.8
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++++.||.|+||.||+|.... .+..+|+|++....... ....+.+|+.+++.+. |+||+++++.+..++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 74 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLP---NNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCN-HPNVVKYYTSFVVGDEL 74 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcC---CCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcC-CCCEEEEEEEEeeCCEE
Confidence 469999999999999999998765 58899999986543222 5677899999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 235 YVVMELCEGGELLDRILSRG--GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||++ ++++.+||+|||++..
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~ 151 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSAS 151 (267)
T ss_pred EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccchHHH
Confidence 99999999999999987642 468999999999999999999999999999999999999 5677899999999876
Q ss_pred cCCCCcc-----cccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC--
Q 007253 313 VRPDERL-----NDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA-- 383 (611)
Q Consensus 313 ~~~~~~~-----~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-- 383 (611)
+...... ...+|+..|+|||++.. .++.++|+|||||++|+|++|+.||........+..+....+.....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (267)
T cd06610 152 LADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGA 231 (267)
T ss_pred hccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcc
Confidence 6543221 34578999999998863 58899999999999999999999998776666555555543322111
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 384 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
.+..++.++.++|.+||..||.+||++.++++||||
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 232 DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 124678999999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=342.09 Aligned_cols=252 Identities=24% Similarity=0.404 Sum_probs=209.0
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++.+.||+|+||.||+|.... +++.||+|++.... .......+.+|+++++++. ||||+++++++...+..
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 74 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLL---TRRILAVKVIPLDI--TVELQKQIMSELEILYKCD-SPYIIGFYGAFFVENRI 74 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcC---CCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEECCEE
Confidence 368899999999999999998765 68899999986542 3344567889999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++||||+++|+|..+ ..+++..+..++.||+.||.|||+.||+|+||||+|||+ +.++.+||+|||++....
T Consensus 75 ~lv~e~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~ 146 (279)
T cd06619 75 SICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLV 146 (279)
T ss_pred EEEEecCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE---CCCCCEEEeeCCcceecc
Confidence 999999999988543 357899999999999999999999999999999999999 567889999999997654
Q ss_pred CCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhcCCCCCCCCCC
Q 007253 315 PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE-------SGIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~ 386 (611)
.. .....+||..|+|||++. ..++.++|||||||++|+|++|+.||..... ......+.... .......
T Consensus 147 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 223 (279)
T cd06619 147 NS-IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--PPVLPVG 223 (279)
T ss_pred cc-cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--CCCCCCC
Confidence 32 334568999999999886 5689999999999999999999999964321 12222222221 1222234
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.++.++.+||.+||+.||.+||+++++++||||+..+
T Consensus 224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 224 QFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred cCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 5789999999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=349.01 Aligned_cols=255 Identities=31% Similarity=0.529 Sum_probs=207.5
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
+|++.+.||+|+||.||+|+... +|+.||+|++..... .......+.+|+.++++++ |+||+++++++.+.+.++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~---~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLYDVLHSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECC---CCcEEEEEEeecccc-cccCccchhHHHHHHHhcC-CCCeeeHHHHhccCCceE
Confidence 48899999999999999999776 688999999865432 2223356778999999997 999999999999999999
Q ss_pred EEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC
Q 007253 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~ 315 (611)
+|+||++ ++|.+++......+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.....
T Consensus 76 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 76 LVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGI 151 (284)
T ss_pred EEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---cCCCcEEECccchhhccCC
Confidence 9999996 58888887766789999999999999999999999999999999999999 5677899999999986543
Q ss_pred CC-cccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhcCC-------------
Q 007253 316 DE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLKADP------------- 378 (611)
Q Consensus 316 ~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~-~~~~~~~~~i~~~~~------------- 378 (611)
.. ......+++.|+|||++.+ .++.++|||||||++|+|++|..||.. .+....+..+.....
T Consensus 152 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 152 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred CCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 32 2334578899999998864 478999999999999999999988643 333333333322110
Q ss_pred -CC---CC--------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 379 -SF---DE--------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 379 -~~---~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
.. +. ...+.++.++.+||++||+.||.+|||+.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 00 00 1123578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=341.91 Aligned_cols=258 Identities=30% Similarity=0.530 Sum_probs=218.3
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++.+.||.|+||.||+|+... +++.||+|++.... .......+.+|+.+++.++ |+||+++++++.++..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 74 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKR---TNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCR-SPYITKYYGSFLKGSKL 74 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECC---CCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcC-CCCeeeeeEEEEECCeE
Confidence 368999999999999999998765 68999999986542 2334466889999999998 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++|+||+++++|.+++... .+++..++.++.||+.||.|||+.+|+||||+|+||++ ++++.++|+|||++....
T Consensus 75 ~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~ 149 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---SEEGDVKLADFGVSGQLT 149 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEcccccceeec
Confidence 9999999999999988654 78999999999999999999999999999999999999 567889999999998765
Q ss_pred CC-CcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 315 PD-ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 315 ~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
.. .......|++.|+|||++. ..++.++|||||||++|+|++|..||...........+........ ....++.++
T Consensus 150 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 227 (274)
T cd06609 150 STMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSL--EGNKFSKPF 227 (274)
T ss_pred ccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCC--cccccCHHH
Confidence 43 2334557889999999886 4589999999999999999999999987665555544444322211 112278999
Q ss_pred HHHHHHhcccCccCCCCHHHHHcCcccCCCCCC
Q 007253 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~ 425 (611)
.++|.+||..+|++|||+.++++||||+...+.
T Consensus 228 ~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 228 KDFVSLCLNKDPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred HHHHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence 999999999999999999999999999986544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=336.87 Aligned_cols=253 Identities=27% Similarity=0.483 Sum_probs=216.9
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
+|.+.+.||+|+||.||+|.... +|+.|++|.+..... .......+.+|+.++++++ ||||+++++++.+.+..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKA---DKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLD-SSYIIRYYESFLDKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcC---CCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcC-CCCeehheeeeccCCEEE
Confidence 48889999999999999998776 589999999865433 3445677889999999997 999999999999999999
Q ss_pred EEeeecCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 236 VVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
+||||+++++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+||++ +.++.+||+|||++....
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili---~~~~~~~l~df~~~~~~~ 152 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLS 152 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---eCCCCEEEcccccceecc
Confidence 999999999999998765 4579999999999999999999999999999999999999 466789999999988765
Q ss_pred CCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 315 PDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
... ......|++.|+|||++. +.++.++|||||||++|+|++|+.||...........+......... ..++..+
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 229 (256)
T cd08529 153 DNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS---QMYSQQL 229 (256)
T ss_pred CccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHH
Confidence 433 233457899999999886 55889999999999999999999999888776666666554322111 2578999
Q ss_pred HHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 393 RDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
.++|.+||+.+|++||++.++++|||+
T Consensus 230 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 230 AQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=347.28 Aligned_cols=258 Identities=25% Similarity=0.434 Sum_probs=211.1
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++.+.||+|+||.||++.... +|..||+|.+.... .......+.+|++++++++ ||||+++++++.+++.+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~---~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 74 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRP---SGLIMARKLIHLEI--KPAIRNQIIRELKVLHECN-SPYIVGFYGAFYSDGEI 74 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcC---CCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCEE
Confidence 369999999999999999998766 57889999986432 3345567889999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+ .+++||||||+|||+ +.++.+||+|||++...
T Consensus 75 ~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~ 150 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQL 150 (308)
T ss_pred EEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE---ecCCcEEEccCCCcccc
Confidence 9999999999999988655 678999999999999999999998 599999999999999 56778999999998765
Q ss_pred CCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-------------
Q 007253 314 RPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS------------- 379 (611)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~------------- 379 (611)
... .....+|+..|+|||++. ..++.++|||||||++|+|++|+.||...........+......
T Consensus 151 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 151 IDS-MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred ccc-ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence 422 234567899999999886 45888999999999999999999999755433322111110000
Q ss_pred ---------------------CCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 380 ---------------------FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 380 ---------------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.+..+...++.++.+||.+||..||++|||+.++++||||....
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 294 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE 294 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence 01111123678899999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=343.77 Aligned_cols=241 Identities=20% Similarity=0.274 Sum_probs=206.4
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee----CCeeEE
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED----TDNVYV 236 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~----~~~~~l 236 (611)
..||+|++|.||+|.+ +|+.||||++.+.........+.+.+|+.+|++++ ||||+++++++.+ ...+++
T Consensus 26 ~~i~~g~~~~v~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~~~~~~~~~l 99 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-----NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPRLSL 99 (283)
T ss_pred eEEeeCCceEEEEEEE-----CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEecccCCCceEE
Confidence 5799999999999985 47899999997655445455678889999999998 9999999999877 347899
Q ss_pred EeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeecCCCCceEEeccCCCceEEEeecccccccCC
Q 007253 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (611)
Q Consensus 237 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~ 315 (611)
|||||++|+|.+++.+. ..+++.....++.|++.||.|||+. +++||||||+|||+ +.++.+||+|||+++.+..
T Consensus 100 v~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 100 ILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSS 175 (283)
T ss_pred EEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE---CCCCcEEEcccchHhhhcc
Confidence 99999999999988654 5789999999999999999999985 99999999999999 5778899999999986543
Q ss_pred CCcccccccCCCcCcchhhc---CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 316 DERLNDIVGSAYYVAPEVLH---RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 316 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
. ....+|+..|+|||++. +.++.++|||||||++|||++|+.||.+....+++..+......+... ...+.++
T Consensus 176 ~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l 251 (283)
T PHA02988 176 P--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--LDCPLEI 251 (283)
T ss_pred c--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCcHHH
Confidence 2 23457899999999985 468999999999999999999999999888888777776554433321 2578999
Q ss_pred HHHHHHhcccCccCCCCHHHHHc
Q 007253 393 RDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
.+||.+||+.||.+|||+.++++
T Consensus 252 ~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 252 KCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHHHHHhcCCcccCcCHHHHHH
Confidence 99999999999999999999974
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=344.69 Aligned_cols=265 Identities=27% Similarity=0.448 Sum_probs=215.7
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++++.||+|+||.||+|.... .|..||+|.+... ........+.+|+.+++++. |+||+++++++...+.+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~---~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~ 74 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRP---TGVTMAMKEIRLE--LDESKFNQIIMELDILHKAV-SPYIVDFYGAFFIEGAV 74 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcC---CCcEEEEEEeecc--cCHHHHHHHHHHHHHHHhcC-CCcHHhhhhheecCCeE
Confidence 468999999999999999998765 5899999988543 23334567889999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 235 YVVMELCEGGELLDRILSR--GGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
++||||+++++|..++... ...+++..+..++.||+.||.|||+ .+|+||||||+||++ +.++.+||+|||++.
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~ 151 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLV---NGNGQVKLCDFGVSG 151 (286)
T ss_pred EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEE---CCCCCEEEeecCCcc
Confidence 9999999999998877653 2368999999999999999999997 599999999999999 467789999999987
Q ss_pred ccCCCCcccccccCCCcCcchhhcC-------CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 007253 312 FVRPDERLNDIVGSAYYVAPEVLHR-------SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384 (611)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 384 (611)
.+.. .......|++.|+|||++.+ .++.++|||||||++|+|++|+.||...........+.......+...
T Consensus 152 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd06622 152 NLVA-SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTL 230 (286)
T ss_pred cccC-CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCC
Confidence 6542 23344578899999998742 257899999999999999999999976555444333222111111222
Q ss_pred CCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCCCCch
Q 007253 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPL 429 (611)
Q Consensus 385 ~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~~~~~ 429 (611)
.+.++.++.+||.+||..+|.+||++.++++||||.........+
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~~~~~ 275 (286)
T cd06622 231 PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVDM 275 (286)
T ss_pred CcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCCccch
Confidence 345899999999999999999999999999999998776554443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=352.52 Aligned_cols=256 Identities=21% Similarity=0.329 Sum_probs=204.4
Q ss_pred EeCeeeec--cceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEE
Q 007253 159 LGEEVGRG--HFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (611)
Q Consensus 159 ~~~~LG~G--~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 236 (611)
++++||+| +||+||++..+. +|+.||+|++..... .....+.+.+|+.+++.++ ||||++++++|..++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKP---TGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecc---cCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCEEEE
Confidence 56889999 678999998776 689999999865432 2344567888999999997 9999999999999999999
Q ss_pred EeeecCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC
Q 007253 237 VMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (611)
Q Consensus 237 v~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~ 315 (611)
|||||++|+|.+++..+ ...+++..++.++.||+.||.|||+++||||||||+|||+ +.++.++++|||.+.....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~---~~~~~~~l~~~~~~~~~~~ 153 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMIN 153 (327)
T ss_pred EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE---ecCCcEEEcccchhhcccc
Confidence 99999999999988654 3458999999999999999999999999999999999999 5677899999986543321
Q ss_pred CC-c-------ccccccCCCcCcchhhcC---CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---
Q 007253 316 DE-R-------LNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD--- 381 (611)
Q Consensus 316 ~~-~-------~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~--- 381 (611)
.. . .....++..|+|||++.+ .++.++|||||||++|+|++|+.||....................
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (327)
T cd08227 154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 233 (327)
T ss_pred ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccc
Confidence 11 0 122356788999999863 488999999999999999999999976554443333222110000
Q ss_pred ---------------------------------------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 382 ---------------------------------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 382 ---------------------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
......+++.+.+||.+||+.||++|||+.++++||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 00112357789999999999999999999999999999763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=345.08 Aligned_cols=260 Identities=29% Similarity=0.495 Sum_probs=219.7
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++.+.||+|+||.||++.... .++.||+|.+.+...........+.+|+.+++.++ ||||+++++.+..++.+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~ 76 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKE---TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE-NPFVVSMFCSFETKRHL 76 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECC---CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEecCCEE
Confidence 368999999999999999998766 58899999987654333445567889999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++||||++|++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||+++...
T Consensus 77 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll---~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 77 CMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE---CCCCCEEEeeCCCccccC
Confidence 9999999999999988654 569999999999999999999999999999999999999 577889999999986421
Q ss_pred CCC----------------cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC
Q 007253 315 PDE----------------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 377 (611)
Q Consensus 315 ~~~----------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~ 377 (611)
... ......|+..|+|||.+. ..++.++|||||||++|+|++|..||.+....+....+....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~ 232 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 232 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence 110 011246788999999875 568999999999999999999999999888777777776655
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCccCCCC---HHHHHcCcccCCCC
Q 007253 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT---AAQALSHPWIKNSN 423 (611)
Q Consensus 378 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~~ll~hp~~~~~~ 423 (611)
...+... ..++.++.++|.+||+.||.+||+ +.++|+||||....
T Consensus 233 ~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~ 280 (305)
T cd05609 233 IEWPEGD-EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280 (305)
T ss_pred cCCCCcc-ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence 4444332 257899999999999999999998 79999999997643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=344.09 Aligned_cols=256 Identities=33% Similarity=0.534 Sum_probs=214.8
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
+|++.+.||+|+||.||+|.... .|+.||+|++...... ......+.+|+.+++++. ||||+++++++.++..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRE---TGETVALKKVALRRLE-GGIPNQALREIKALQACQ-HPYVVKLLDVFPHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECC---CCceEEEEEEEccccc-chhhHHHHHHHHHHHhCC-CCCCcceeeEEecCCeeE
Confidence 58999999999999999999766 5899999998764322 234567889999999998 999999999999999999
Q ss_pred EEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC
Q 007253 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~ 315 (611)
+||||+ +++|.+++......+++..++.++.||+.||.|||+.||+|+||||+||++ +.++.++|+|||++.....
T Consensus 76 ~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~---~~~~~~~l~dfg~~~~~~~ 151 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSE 151 (286)
T ss_pred EEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE---cCCCcEEEeeeeecccccC
Confidence 999999 999999987766779999999999999999999999999999999999999 5678899999999887654
Q ss_pred CC--cccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------
Q 007253 316 DE--RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF----------- 380 (611)
Q Consensus 316 ~~--~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~----------- 380 (611)
.. ......|+..|+|||++. ..++.++|||||||++|+|++|.+||.+......+..+.......
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 152 EEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCc
Confidence 33 234457899999999875 346899999999999999999998887776655555444321110
Q ss_pred --------CC-------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccC
Q 007253 381 --------DE-------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420 (611)
Q Consensus 381 --------~~-------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~ 420 (611)
+. ..++..+.++.+||.+||..||.+|||++++|+||||.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 00 01235678999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=342.72 Aligned_cols=253 Identities=30% Similarity=0.499 Sum_probs=208.8
Q ss_pred eeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC--Cee
Q 007253 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT--DNV 234 (611)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~--~~~ 234 (611)
|++.++||+|+||.||+|.... +++.||+|++.+...... .....+|+.++.++.+|+||+++++++.+. +.+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~---~~~~~aik~~~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRK---TGKYYAIKCMKKHFKSLE--QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRL 75 (282)
T ss_pred CceEeeccccccceEEEEEEcC---CCcEEEEEEehhccCCch--hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcE
Confidence 6789999999999999998765 688999999865432221 223457999999997799999999999987 889
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++||||++ |+|.+.+......+++..++.++.||+.||.|||+.||+||||||+||+++ . +.+||+|||++....
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~---~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 76 ALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK---D-DILKLADFGSCRGIY 150 (282)
T ss_pred EEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc---C-CCeEEEecccccccc
Confidence 99999996 588888877666799999999999999999999999999999999999994 4 889999999998775
Q ss_pred CCCcccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-------------
Q 007253 315 PDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS------------- 379 (611)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~------------- 379 (611)
.........++..|+|||++. +.++.++|||||||++|||++|..||.+.+..+.+..+......
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 151 SKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred cCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 544445567899999999764 44788999999999999999999999877665554444321111
Q ss_pred -----CCCC-------CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 380 -----FDEA-------PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 380 -----~~~~-------~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
++.. ..+.++.++.+||.+||.++|.+|||+.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0000 013568999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=335.23 Aligned_cols=253 Identities=24% Similarity=0.510 Sum_probs=212.9
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee-CCee
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-TDNV 234 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~-~~~~ 234 (611)
.|++.+.||+|++|.||+++... .++.||+|.+..... .....+.+.+|+.++++++ |+||+++++.+.. +..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRT---DGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLK-HPNIVAYRESWEGEDGLL 75 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcC---CCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeecCCCCEE
Confidence 48999999999999999999766 578999999865332 2334567889999999997 9999999998864 4468
Q ss_pred EEEeeecCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 235 YVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.++|+|||++...
T Consensus 76 ~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~ 152 (257)
T cd08223 76 YIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVL 152 (257)
T ss_pred EEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE---ecCCcEEEecccceEEe
Confidence 9999999999999988764 3458999999999999999999999999999999999999 56778999999999876
Q ss_pred CCCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 314 RPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
.... ......|++.|+|||++. ..++.++|||||||++|+|++|+.||...........+....... ....++.+
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 229 (257)
T cd08223 153 ENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP---MPKDYSPE 229 (257)
T ss_pred cccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC---CccccCHH
Confidence 4332 234457899999999886 568899999999999999999999998777666655555443211 12357899
Q ss_pred HHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 392 ARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
+.+||.+||+.||.+|||+.++++||||
T Consensus 230 ~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 230 LGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=341.42 Aligned_cols=254 Identities=28% Similarity=0.494 Sum_probs=209.3
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++.+.||+|+||.||+|+... +++.||+|++.... ......+.+|+.+++.+. ||||+++++++...+.
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~-h~~ii~~~~~~~~~~~ 80 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVN---TGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCK-HSNIVAYFGSYLRRDK 80 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcC---CCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCE
Confidence 4579999999999999999998765 58899999986442 223356788999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|+||||+++++|.+++... +.+++..++.++.||+.||.|||++||+|+||||+||++ +.++.+||+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~ 156 (267)
T cd06645 81 LWICMEFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL---TDNGHVKLADFGVSAQI 156 (267)
T ss_pred EEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECcceeeeEc
Confidence 99999999999999987654 579999999999999999999999999999999999999 56778999999998765
Q ss_pred CCCC-cccccccCCCcCcchhhc----CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-CCCC
Q 007253 314 RPDE-RLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA-PWPS 387 (611)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~ 387 (611)
.... ......|+..|+|||++. +.++.++|||||||++|+|++|..||...................+.. ....
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06645 157 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMK 236 (267)
T ss_pred cCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCC
Confidence 4322 234457999999999873 458889999999999999999999997655443333332222111111 1124
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHcCcc
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~ 418 (611)
++..+.+||.+||..+|++|||+.++++|||
T Consensus 237 ~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 237 WSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 7889999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=338.89 Aligned_cols=253 Identities=18% Similarity=0.304 Sum_probs=211.5
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
..+|++.+.||+|+||.||+|.++.....+..||+|.+.... .......+.+|+.+++++. ||||+++++++...+.
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFD-HSNIVRLEGVITRGNT 80 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEecCCC
Confidence 356999999999999999999876544467899999986542 2334567889999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
.++||||+++|+|.+++......+++..++.++.||+.||.|||++|++||||||+|||+ +.++.+|++|||.+...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili---~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV---NSDLVCKISGFRRLQED 157 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE---cCCCcEEECCCcccccc
Confidence 999999999999999887766679999999999999999999999999999999999999 56788999999987654
Q ss_pred CCCCccc--ccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 314 RPDERLN--DIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 314 ~~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
....... ...++..|+|||++. +.++.++|||||||++||+++ |..||+.....+....+..... .+ ....++
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~ 234 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR-LP--APRNCP 234 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-CC--CCCCCC
Confidence 3222111 234567899999875 678999999999999999774 9999998887777666654322 11 224678
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
..+.+++.+||+.+|.+||++.++++
T Consensus 235 ~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 235 NLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 99999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=353.46 Aligned_cols=239 Identities=26% Similarity=0.396 Sum_probs=205.1
Q ss_pred EeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEe
Q 007253 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVM 238 (611)
Q Consensus 159 ~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~ 238 (611)
.++-||.|+-|.||+|+++ ++.||||.+.. .-..+|+-|++|. |+||+.|.|+|.....+||||
T Consensus 128 ELeWlGSGaQGAVF~Grl~-----netVAVKKV~e----------lkETdIKHLRkLk-H~NII~FkGVCtqsPcyCIiM 191 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-----NETVAVKKVRE----------LKETDIKHLRKLK-HPNIITFKGVCTQSPCYCIIM 191 (904)
T ss_pred hhhhhccCcccceeeeecc-----CceehhHHHhh----------hhhhhHHHHHhcc-CcceeeEeeeecCCceeEEee
Confidence 4677999999999999864 68899997632 2345889999998 999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCCc
Q 007253 239 ELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER 318 (611)
Q Consensus 239 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~ 318 (611)
|||..|.|..+|+.. +.+.......|..+|+.|+.|||.+.|||||||.-||||+ .+..|||+|||-++.......
T Consensus 192 EfCa~GqL~~VLka~-~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs---~~d~VKIsDFGTS~e~~~~ST 267 (904)
T KOG4721|consen 192 EFCAQGQLYEVLKAG-RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS---YDDVVKISDFGTSKELSDKST 267 (904)
T ss_pred eccccccHHHHHhcc-CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee---ccceEEeccccchHhhhhhhh
Confidence 999999999987654 6799999999999999999999999999999999999996 455699999999998876666
Q ss_pred ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 007253 319 LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397 (611)
Q Consensus 319 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 397 (611)
...++||..|||||+++ ...+.|+|||||||+||||+||..||.......++..+-.....++.. ...++.++=||+
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvP--stcP~GfklL~K 345 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVP--STCPDGFKLLLK 345 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCc--ccCchHHHHHHH
Confidence 67789999999999997 568999999999999999999999998776655544443333333322 467899999999
Q ss_pred HhcccCccCCCCHHHHHcCccc
Q 007253 398 RLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 398 ~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
+||+-.|..||++.++|.|-=+
T Consensus 346 qcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 346 QCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred HHHhcCCCCCccHHHHHHHHhh
Confidence 9999999999999999999533
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=353.33 Aligned_cols=254 Identities=24% Similarity=0.374 Sum_probs=204.6
Q ss_pred ccccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe
Q 007253 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (611)
Q Consensus 150 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 229 (611)
....++.|...+.||+|+||.||+|.... |..||||++....... ..+|.+|+.++.+++ |||||+|+|||.
T Consensus 70 l~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~----~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~-H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 70 LRKATNNFSESNLIGEGGFGTVYKGVLSD----GTVVAVKRLSSNSGQG---EREFLNEVEILSRLR-HPNLVKLLGYCL 141 (361)
T ss_pred HHHHHhCCchhcceecCCCeEEEEEEECC----CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCC-CcCcccEEEEEe
Confidence 34567889999999999999999999775 5899999886543221 345999999999999 999999999999
Q ss_pred eCC-eeEEEeeecCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcC---CeeecCCCCceEEeccCCCceEEE
Q 007253 230 DTD-NVYVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQG---VVHRDLKPENFLFTTKDENSVLKA 304 (611)
Q Consensus 230 ~~~-~~~lv~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NIll~~~~~~~~vkl 304 (611)
+.+ +.+||+|||++|+|.+++..... .++|..+.+|+.++|+||+|||+.. |||||||++|||| |+++++||
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL---D~~~~aKl 218 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL---DEDFNAKL 218 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE---CCCCCEEc
Confidence 998 59999999999999999988766 8999999999999999999999964 9999999999999 79999999
Q ss_pred eecccccccCC-CCccccc-ccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHh
Q 007253 305 IDFGLSDFVRP-DERLNDI-VGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART------ESGIFRAVLK 375 (611)
Q Consensus 305 ~DfG~a~~~~~-~~~~~~~-~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~------~~~~~~~i~~ 375 (611)
+|||+|+.... .....+. .||.+|+|||++. +..+.++|||||||+|+||++|+.+..... ..+.....+.
T Consensus 219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred cCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 99999976654 3333334 8999999999886 789999999999999999999998886432 1122122222
Q ss_pred cC--CCCCCCCC--CCCC-----HHHHHHHHHhcccCccCCCCHHHHH
Q 007253 376 AD--PSFDEAPW--PSLS-----SEARDFVKRLLNKDPRKRLTAAQAL 414 (611)
Q Consensus 376 ~~--~~~~~~~~--~~~s-----~~~~~li~~~L~~dP~~Rpt~~~ll 414 (611)
.. ..+..... ..++ ..+..+..+|++.+|..||++.+++
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv 346 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVV 346 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHH
Confidence 21 11111111 2233 2356788899999999999999864
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=341.75 Aligned_cols=256 Identities=29% Similarity=0.526 Sum_probs=209.6
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++.+.||+|+||.||+|+... .|+.||+|++..... .....+.+.+|+.+++++. |+||+++++++.....+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRE---TGQIVAIKKFVESED-DPVIKKIALREIRMLKQLK-HPNLVNLIEVFRRKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECC---CCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCC-CCCEeeeeeEEeeCCEE
Confidence 469999999999999999998765 589999999865432 2223356789999999998 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++||||++++.|..++ .....+++..++.++.||+.||.|||+.||+||||||+||++ +.++.+||+|||++....
T Consensus 76 ~~v~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07847 76 HLVFEYCDHTVLNELE-KNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFARILT 151 (286)
T ss_pred EEEEeccCccHHHHHH-hCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE---cCCCcEEECccccceecC
Confidence 9999999887766544 444579999999999999999999999999999999999999 567789999999998765
Q ss_pred CCC-cccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC------------
Q 007253 315 PDE-RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS------------ 379 (611)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~------------ 379 (611)
... ......++..|+|||++. ..++.++|||||||++|+|++|+.||.+....+....+......
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 152 GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred CCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 433 334456889999999875 34788999999999999999999999877655444333221100
Q ss_pred -------CCC--------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 380 -------FDE--------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 380 -------~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
.+. ..++.++..+.+||.+||+.||++|||+.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 0124578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=348.53 Aligned_cols=252 Identities=29% Similarity=0.479 Sum_probs=194.2
Q ss_pred eCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee--CCeeEEE
Q 007253 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--TDNVYVV 237 (611)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~--~~~~~lv 237 (611)
+.+||+|+||.||+|+...+ ..+..||+|.+..... ...+.+|+.++++++ ||||+++++++.. +..+++|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~-~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDG-KDEKEYALKQIEGTGI-----SMSACREIALLRELK-HPNVIALQKVFLSHSDRKVWLL 78 (317)
T ss_pred ceEeccCCCeeEEEEEecCC-CccceEEEEEecCCCC-----cHHHHHHHHHHHhCC-CCCeeeEEEEEeccCCCeEEEE
Confidence 46899999999999986543 2568899999864321 235678999999998 9999999999854 5678999
Q ss_pred eeecCCCChHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEecc-CCCceEEEeecc
Q 007253 238 MELCEGGELLDRILSR--------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK-DENSVLKAIDFG 308 (611)
Q Consensus 238 ~E~~~~gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~-~~~~~vkl~DfG 308 (611)
|||+. ++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||+... +.++.+||+|||
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 79 FDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 99996 4788776532 1248999999999999999999999999999999999999533 356789999999
Q ss_pred cccccCCCC----cccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChH---------HHHHHH
Q 007253 309 LSDFVRPDE----RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTES---------GIFRAV 373 (611)
Q Consensus 309 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~---------~~~~~i 373 (611)
+++...... .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||...... ..+..+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 998764332 2345678999999998863 4789999999999999999999999654321 111111
Q ss_pred HhcC--------------CCCC--------------------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 374 LKAD--------------PSFD--------------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 374 ~~~~--------------~~~~--------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
.... +.++ .......+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 1100 0000 00011235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=343.14 Aligned_cols=259 Identities=31% Similarity=0.473 Sum_probs=209.2
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe-
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN- 233 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~- 233 (611)
++|++.+.||+|+||.||+|.... +|+.||||++..... .......+.+|+.+++++.+|+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~---~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 76 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKN---TGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKN 76 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECC---CCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCC
Confidence 369999999999999999999765 688999999865322 222335678899999999768999999999987665
Q ss_pred ----eEEEeeecCCCChHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 234 ----VYVVMELCEGGELLDRILSRG----GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 234 ----~~lv~E~~~~gsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
.|+||||+++ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++ ..++.+||+
T Consensus 77 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~--~~~~~~kl~ 153 (295)
T cd07837 77 GKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIA 153 (295)
T ss_pred CCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEe--cCCCeEEEe
Confidence 8999999975 8888876542 3589999999999999999999999999999999999994 227789999
Q ss_pred ecccccccCCC-CcccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-
Q 007253 306 DFGLSDFVRPD-ERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD- 381 (611)
Q Consensus 306 DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~- 381 (611)
|||++...... .......+++.|+|||++. ..++.++|||||||++|+|++|..||.+.+.......+........
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (295)
T cd07837 154 DLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE 233 (295)
T ss_pred ecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 99998765322 2223346788999999875 3478999999999999999999999988776655544433211000
Q ss_pred -----------------------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccC
Q 007253 382 -----------------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420 (611)
Q Consensus 382 -----------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~ 420 (611)
....+.++.++.+||.+||..||.+||++.+++.||||+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 011245789999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=344.52 Aligned_cols=262 Identities=31% Similarity=0.491 Sum_probs=215.0
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcC--CHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT--TAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
+|++.+.||+|+||.||+|.... +|+.||||.+...... .......+.+|+.++++++ |+||+++++++.+.+.
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~ 76 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKE---TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFGHKSN 76 (298)
T ss_pred CceeeeeeeeccccEEEEEEECC---CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheeecCCE
Confidence 48899999999999999999766 5889999999755433 1223456778999999998 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
.++||||+ +|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 77 ~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 77 INLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSF 152 (298)
T ss_pred EEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE---cCCCCEEEccceeeeec
Confidence 99999999 889999886654479999999999999999999999999999999999999 56788999999999876
Q ss_pred CCCC-cccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--------
Q 007253 314 RPDE-RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE-------- 382 (611)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~-------- 382 (611)
.... ......+++.|+|||++. ..++.++|||||||++|+|++|.+||.+....+.+..+.........
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 153 GSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred cCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc
Confidence 5432 333446788999999885 35788999999999999999998888776665555444432111100
Q ss_pred ----------------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCC
Q 007253 383 ----------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (611)
Q Consensus 383 ----------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~ 425 (611)
..+...+.++.+||.+||..||++|||+.++++|+||++....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~ 291 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAP 291 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCC
Confidence 0113457889999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=343.11 Aligned_cols=255 Identities=23% Similarity=0.308 Sum_probs=205.1
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCC-------------ccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGE-------------LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~-------------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~ 220 (611)
.++|++.++||+|+||.||+|.+.... ..+..||+|++.... .......+.+|+.++.+++ |||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~n 80 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLK-DPN 80 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcC-CCC
Confidence 467999999999999999999864321 134579999986542 3445667899999999997 999
Q ss_pred eeEEEEEEeeCCeeEEEeeecCCCChHHHHHhcC------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 007253 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG------------------GKYTEDDAKAVMIQILNVVAFCHLQGVV 282 (611)
Q Consensus 221 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~------------------~~l~~~~~~~i~~qi~~~L~~LH~~~ii 282 (611)
|+++++++.+.+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999886432 2368889999999999999999999999
Q ss_pred eecCCCCceEEeccCCCceEEEeecccccccCCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh--
Q 007253 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-- 356 (611)
Q Consensus 283 HrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-- 356 (611)
||||||+|||+ +.++.+||+|||++..+..... .....++..|||||++. +.++.++|||||||++|+|++
T Consensus 161 H~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 161 HRDLATRNCLV---GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred ccCcchhheEE---cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 99999999999 5678899999999986543321 22345678899999875 678999999999999999986
Q ss_pred CCCCCCCCChHHHHHHHHhcC----CCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHH
Q 007253 357 GSRPFWARTESGIFRAVLKAD----PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414 (611)
Q Consensus 357 g~~Pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll 414 (611)
+..||......+....+.... ........+.++..+.+||.+||..||.+|||+.++.
T Consensus 238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 678888766665554443211 1111111245789999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=333.55 Aligned_cols=254 Identities=28% Similarity=0.500 Sum_probs=217.5
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
+|++.+.||+|+||.||+|.... +++.+|+|++...... ......+.+|+.++++++ ||||+++++.+..++..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKA---DQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLS-HPNIIEYYENFLEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcC---CCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCC-CCchhheeeeEecCCEEE
Confidence 58999999999999999998765 6899999998765433 334577899999999997 999999999999999999
Q ss_pred EEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 236 VVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++ +.++.+||+|||++....
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~~~ 153 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILS 153 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccCCCceecC
Confidence 9999999999999987653 4589999999999999999999999999999999999995 345578999999998776
Q ss_pred CCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 007253 315 PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (611)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 393 (611)
.........|+..|+|||++. ..++.++||||||+++|+|++|+.||...........+....... ....++.++.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~ 230 (256)
T cd08220 154 SKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP---ISDRYSPDLR 230 (256)
T ss_pred CCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCC---CCCCcCHHHH
Confidence 554445567899999999986 457889999999999999999999998877666665555443221 1135789999
Q ss_pred HHHHHhcccCccCCCCHHHHHcCccc
Q 007253 394 DFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 394 ~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
++|.+||..||.+|||+.+++.||||
T Consensus 231 ~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 231 QLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHHccCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=355.41 Aligned_cols=255 Identities=25% Similarity=0.359 Sum_probs=206.0
Q ss_pred CCceeEeCeeeeccceEEEEEEEecC--CccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.++|++++.||+|+||.||+|+.... ...+..||||++.... .....+.+.+|+.+++.+.+|+|||+++++|...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 46799999999999999999986431 1245689999996543 2334567889999999995599999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcC---------------------------------------------------------
Q 007253 232 DNVYVVMELCEGGELLDRILSRG--------------------------------------------------------- 254 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~--------------------------------------------------------- 254 (611)
+.+++|||||++|+|.+++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 99999999999999999885421
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCCc---c
Q 007253 255 ------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER---L 319 (611)
Q Consensus 255 ------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~---~ 319 (611)
.++++..++.++.||+.||.|||++||+||||||+|||+ ++++.+||+|||++..+..... .
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~---~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL---TDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE---eCCCeEEEeeceeeeeccCCcceeec
Confidence 247888999999999999999999999999999999999 5678899999999976543321 1
Q ss_pred cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 007253 320 NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397 (611)
Q Consensus 320 ~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 397 (611)
....++..|||||++. ..++.++|||||||++|+|++ |+.||........+..+......... ...++.++.++|.
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~ 349 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSR--PDFAPPEIYSIMK 349 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccC--CCCCCHHHHHHHH
Confidence 1233566899999875 678999999999999999997 99999876554444444443322221 1246899999999
Q ss_pred HhcccCccCCCCHHHHHc
Q 007253 398 RLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 398 ~~L~~dP~~Rpt~~~ll~ 415 (611)
+||+.||.+|||+.++++
T Consensus 350 ~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 350 MCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=341.09 Aligned_cols=259 Identities=29% Similarity=0.494 Sum_probs=215.3
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
...+|++.+.||+|+||.||+|.... .++.||+|.+...... ..+.+.+|+.+++.+. |+||+++++.+....
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~-h~~v~~~~~~~~~~~ 90 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQP---KKELIINEILVMRENK-NPNIVNYLDSYLVGD 90 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECC---CCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCC-CCCEeeEEEEEEeCC
Confidence 34689999999999999999998655 5889999998654322 3466889999999987 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
..|+||||+++++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++..
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill---~~~~~~kl~dfg~~~~ 165 (296)
T cd06654 91 ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQ 165 (296)
T ss_pred EEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEECccccchh
Confidence 99999999999999998754 358999999999999999999999999999999999999 5677899999999876
Q ss_pred cCCCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 313 VRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 313 ~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
..... ......|++.|+|||.+. ..++.++|||||||++|+|++|+.||...........+.... .........++.
T Consensus 166 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 244 (296)
T cd06654 166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSA 244 (296)
T ss_pred ccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCC-CCCCCCccccCH
Confidence 54332 223457899999999886 457899999999999999999999998776544433333221 111112245789
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHcCcccCCCCC
Q 007253 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~ 424 (611)
.+.++|.+||..||.+|||+.++++||||.....
T Consensus 245 ~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 278 (296)
T cd06654 245 IFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278 (296)
T ss_pred HHHHHHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence 9999999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=335.87 Aligned_cols=252 Identities=30% Similarity=0.561 Sum_probs=213.2
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++.+.||.|+||.||+|.... .++.||+|.+.... ..+.+.+|+++++++. |+||+++++++.++..+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~ 73 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKE---TGQVVAIKVVPVEE-----DLQEIIKEISILKQCD-SPYIVKYYGSYFKNTDL 73 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcC---CCcEEEEEEeecHH-----HHHHHHHHHHHHHhCC-CCcEeeeeeeeecCCcE
Confidence 579999999999999999999776 57899999985431 2578999999999996 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
|+++||+++++|.+++......+++..++.++.||+.||.|||+.+|+||||+|+||++ +.++.+||+|||++....
T Consensus 74 ~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~---~~~~~~~l~dfg~~~~~~ 150 (256)
T cd06612 74 WIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQLT 150 (256)
T ss_pred EEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---CCCCcEEEcccccchhcc
Confidence 99999999999999987767789999999999999999999999999999999999999 567789999999998765
Q ss_pred CCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 315 PDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
... ......|+..|+|||++. ..++.++|||||||++|+|++|+.||...........+....... ......++.++
T Consensus 151 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 229 (256)
T cd06612 151 DTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPT-LSDPEKWSPEF 229 (256)
T ss_pred cCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCC-CCchhhcCHHH
Confidence 433 233456889999999986 458889999999999999999999997765544333332221111 11123567899
Q ss_pred HHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 393 RDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
.++|.+||+.||.+|||+.++|.||||
T Consensus 230 ~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 230 NDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=335.71 Aligned_cols=252 Identities=33% Similarity=0.512 Sum_probs=211.1
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeee
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~ 240 (611)
+.||+|+||.||+|.... .|+.||+|++.+...........+..|..++....+|+||+++++++..++.+|+||||
T Consensus 2 ~~l~~g~~~~v~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKRS---TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEecC---CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEec
Confidence 579999999999998765 58899999986554333333445566766665555699999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCCccc
Q 007253 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLN 320 (611)
Q Consensus 241 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~ 320 (611)
+++++|.+++... ..+++..+..++.||+.||.|||+.+|+||||+|+||++ +.++.+||+|||++..... ..
T Consensus 79 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~---~~ 151 (260)
T cd05611 79 LNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI---DQTGHLKLTDFGLSRNGLE---NK 151 (260)
T ss_pred cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEeecccceeccc---cc
Confidence 9999999887554 568999999999999999999999999999999999999 5677899999999876432 23
Q ss_pred ccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHh
Q 007253 321 DIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399 (611)
Q Consensus 321 ~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 399 (611)
...|+..|+|||.+. ..++.++||||||+++|+|++|..||........+..+......++......++.++.++|.+|
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 231 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRL 231 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHH
Confidence 456889999999886 4478999999999999999999999988887777777766555554444456899999999999
Q ss_pred cccCccCCC---CHHHHHcCcccCCC
Q 007253 400 LNKDPRKRL---TAAQALSHPWIKNS 422 (611)
Q Consensus 400 L~~dP~~Rp---t~~~ll~hp~~~~~ 422 (611)
|+.||++|| ++.|+|.||||+..
T Consensus 232 l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 232 LCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred ccCCHHHccCCCcHHHHHcChHhhcC
Confidence 999999999 55799999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=345.71 Aligned_cols=261 Identities=28% Similarity=0.442 Sum_probs=214.1
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC--
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT-- 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~-- 231 (611)
.++|++.+.||+|+||.||+|.... +|+.||+|++....... .....+.+|+.++++++ |+||+++++++...
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~---~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 80 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTT---SGEIVALKKVRMDNERD-GIPISSLREITLLLNLR-HPNIVELKEVVVGKHL 80 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECC---CCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCC-CCCCcceEEEEecCCC
Confidence 4679999999999999999999765 68999999986443222 12234568999999998 99999999998765
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+.+++||||+.+ +|.+++......+++..++.++.||+.||.|||+.||+||||||+||++ +.++.+||+|||++.
T Consensus 81 ~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~kL~dfg~~~ 156 (309)
T cd07845 81 DSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLAR 156 (309)
T ss_pred CeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccceee
Confidence 568999999964 8888887666679999999999999999999999999999999999999 567789999999998
Q ss_pred ccCCCC-cccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC----
Q 007253 312 FVRPDE-RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP---- 384 (611)
Q Consensus 312 ~~~~~~-~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~---- 384 (611)
...... ......+++.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+.+..+...........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 157 TYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred ecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 765432 223345688999999885 3578999999999999999999999998887777666655321111000
Q ss_pred ----------------------CCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 385 ----------------------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 385 ----------------------~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
...+++++.+||.+||+.||++|||+.+++.||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 123588899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=341.11 Aligned_cols=258 Identities=26% Similarity=0.438 Sum_probs=216.9
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
....|++.+.||+|+||.||+|.... .|+.||+|++.............+.+|+.+++.++ ||||+++++++.+++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~ 88 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVR---TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYLREH 88 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcC---CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEEeCC
Confidence 34669999999999999999998765 58899999986554444555567889999999997 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
..++||||+. |+|.+.+......+++..+..++.||+.||.|||+.||+||||+|+||++ +.++.+||+|||++..
T Consensus 89 ~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~---~~~~~~kL~dfg~~~~ 164 (307)
T cd06607 89 TAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL---TEPGTVKLADFGSASL 164 (307)
T ss_pred eEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE---CCCCCEEEeecCccee
Confidence 9999999996 58888777666679999999999999999999999999999999999999 5678899999999876
Q ss_pred cCCCCcccccccCCCcCcchhhc----CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 313 VRPDERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
.... ....|++.|+|||++. +.++.++||||||+++|+|++|..||...........+..... +......+
T Consensus 165 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~ 239 (307)
T cd06607 165 VSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLSSNDW 239 (307)
T ss_pred cCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC--CCCCchhh
Confidence 5432 3457889999999873 4588899999999999999999999987766554444433221 11112346
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
+..+.++|.+||..||.+||++.+++.||||....
T Consensus 240 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 240 SDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 88999999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=342.08 Aligned_cols=257 Identities=30% Similarity=0.511 Sum_probs=215.8
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
..+|++.+.||.|+||.||+|.... +|+.||+|.+..... ...+.+.+|+.+++.++ ||||+++++++...+.
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 90 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVA---TGQEVAIKQINLQKQ---PKKELIINEILVMKELK-NPNIVNFLDSFLVGDE 90 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcC---CCcEEEEEEEecccC---chHHHHHHHHHHHHhcC-CCceeeeeeeEecCce
Confidence 3569999999999999999998655 689999999865322 23467889999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+++|+||+++++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+||++ +.++.+||+|||++...
T Consensus 91 ~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili---~~~~~~kl~dfg~~~~~ 165 (296)
T cd06655 91 LFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL---GMDGSVKLTDFGFCAQI 165 (296)
T ss_pred EEEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccchhc
Confidence 9999999999999987754 358999999999999999999999999999999999999 56778999999998766
Q ss_pred CCCCc-ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 314 RPDER-LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 314 ~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
..... .....|+..|+|||.+. +.++.++|||||||++|+|++|+.||...........+..... ........++..
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 244 (296)
T cd06655 166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSPI 244 (296)
T ss_pred ccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-cccCCcccCCHH
Confidence 54332 33457899999999886 5588999999999999999999999988766554444433221 111123467899
Q ss_pred HHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
+.+||++||..||.+|||+.+++.||||+...
T Consensus 245 ~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 245 FRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred HHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 99999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=332.10 Aligned_cols=253 Identities=27% Similarity=0.507 Sum_probs=217.6
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
+|++.+.||.|+||.||.++... .++.+++|.+..... .......+.+|+.++++++ |+||+++++++.+.+.++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~---~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTE---DDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQ-HPNIIAYYNHFMDDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcC---CCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCC-CCCeeEEEeEEecCCeEE
Confidence 48999999999999999998765 688999999865432 2344567889999999997 999999999999999999
Q ss_pred EEeeecCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 236 VVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++||||++|+|.+++... ...+++..+..++.|++.||.|||+.|++||||||+||++ +.++.+||+|||++....
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~---~~~~~~kl~d~~~~~~~~ 152 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILG 152 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEE---eCCCCEEECcCcceEEcc
Confidence 999999999999988765 4568999999999999999999999999999999999999 466789999999988664
Q ss_pred CCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 315 PDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
... ......|++.|+|||++. ..++.++||||||+++|+|++|..||......+....+........ ...++.++
T Consensus 153 ~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 229 (256)
T cd08221 153 SEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPV---VSVYSSEL 229 (256)
T ss_pred cccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC---ccccCHHH
Confidence 333 334567899999999886 4578899999999999999999999988877777777765443222 14678999
Q ss_pred HHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 393 RDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
.++|.+||..+|.+||++.++|+|+|+
T Consensus 230 ~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 230 ISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=355.12 Aligned_cols=256 Identities=26% Similarity=0.377 Sum_probs=205.8
Q ss_pred CCceeEeCeeeeccceEEEEEEEecC--CccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.++|++++.||+|+||.||+|..... ...+..||||++.... .....+.+.+|+.+++.+..||||++++++|.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 45799999999999999999975421 2246789999986432 2234467889999999995599999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcC---------------------------------------------------------
Q 007253 232 DNVYVVMELCEGGELLDRILSRG--------------------------------------------------------- 254 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~--------------------------------------------------------- 254 (611)
+..++|||||++|+|.+++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999999886532
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCC
Q 007253 255 -----------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE 317 (611)
Q Consensus 255 -----------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~ 317 (611)
..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEE---ECCCcEEEecCccceeccCcc
Confidence 247888999999999999999999999999999999999 467789999999998664332
Q ss_pred c---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 318 R---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 318 ~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
. .....++..|+|||++. ..++.++|||||||++|||++ |..||........+...+....... .....+.++
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 346 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML--SPECAPSEM 346 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC--CCCCCCHHH
Confidence 2 12234566799999886 568999999999999999997 8999977655444444443322111 113468899
Q ss_pred HHHHHHhcccCccCCCCHHHHHcC
Q 007253 393 RDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
.+||.+||+.||++|||+.++++.
T Consensus 347 ~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 347 YDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHHccCChhHCcCHHHHHHH
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=338.80 Aligned_cols=252 Identities=33% Similarity=0.600 Sum_probs=216.0
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
+|++.+.||.|+||.||+|+... +++.||+|++.+.........+.+.+|++++++++ ||||+++++.+...+.++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 76 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRD---TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNLWYSFQDEENMY 76 (258)
T ss_pred CceEEEEeccCCCceEEEEEEcc---CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCC-CCChHHHHHhhcCCCeEE
Confidence 48999999999999999998765 68899999997655445456778999999999997 999999999999999999
Q ss_pred EEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC
Q 007253 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~ 315 (611)
+|+||+.|++|.+++... ..+++..+..++.||+.||.|||+++|+|+||||+||++ ++++.++|+|||++.....
T Consensus 77 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 77 LVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTP 152 (258)
T ss_pred EEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---cCCCCEEEeecccccccCC
Confidence 999999999999988655 579999999999999999999999999999999999999 5778899999999987765
Q ss_pred CCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 316 DERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE---SGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 316 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
........|+..|+|||++. ..++.++|+||||+++|+|++|..||..... ..............+ ..++.+
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 228 (258)
T cd05578 153 DTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYP----ATWSTE 228 (258)
T ss_pred CccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCc----ccCcHH
Confidence 54445567899999999886 4578999999999999999999999987663 222222222222222 357899
Q ss_pred HHHHHHHhcccCccCCCCH--HHHHcCccc
Q 007253 392 ARDFVKRLLNKDPRKRLTA--AQALSHPWI 419 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rpt~--~~ll~hp~~ 419 (611)
+.++|.+||..||.+||+. .++++||||
T Consensus 229 ~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 229 AIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 9999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=340.13 Aligned_cols=254 Identities=31% Similarity=0.490 Sum_probs=209.0
Q ss_pred eeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeeecC
Q 007253 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCE 242 (611)
Q Consensus 163 LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~~~ 242 (611)
||+|+||.||+|.... +|+.||+|++.+...........+.+|+.+++.++ ||||+++++++...+.+|+||||++
T Consensus 1 lg~g~~g~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~ 76 (277)
T cd05577 1 LGKGGFGEVCACQVKA---TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFETKDDLCLVMTLMN 76 (277)
T ss_pred CCCCCceeEEEEEEcC---CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEecCCeEEEEEecCC
Confidence 6999999999998665 68999999987544333344556678999999998 9999999999999999999999999
Q ss_pred CCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCCcccc
Q 007253 243 GGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND 321 (611)
Q Consensus 243 ~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~ 321 (611)
+++|.+++.... ..+++..++.++.||+.||.|||+.||+||||+|+||++ +.++.+||+|||++...........
T Consensus 77 ~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~ 153 (277)
T cd05577 77 GGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKG 153 (277)
T ss_pred CCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEccCcchhhhccCCcccc
Confidence 999999887654 369999999999999999999999999999999999999 5777899999999877654444445
Q ss_pred cccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhc
Q 007253 322 IVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400 (611)
Q Consensus 322 ~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 400 (611)
..++..|+|||++. +.++.++|||||||++|+|++|+.||...........+..............+++.+.++|.+||
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 233 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALL 233 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHc
Confidence 67889999999885 45888999999999999999999999765442222222222111222223467999999999999
Q ss_pred ccCccCCC-----CHHHHHcCcccCCCC
Q 007253 401 NKDPRKRL-----TAAQALSHPWIKNSN 423 (611)
Q Consensus 401 ~~dP~~Rp-----t~~~ll~hp~~~~~~ 423 (611)
+.||.+|| ++.++++||||+..+
T Consensus 234 ~~~p~~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 234 QKDPEKRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred cCChhHccCCCcccHHHHHhChhhhcCC
Confidence 99999999 999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=338.00 Aligned_cols=254 Identities=28% Similarity=0.474 Sum_probs=207.8
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++++.||+|+||.||+|+... .++.||+|++.... ......+.+|+.+++++. ||||+++++++..++.
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~-h~~ii~~~~~~~~~~~ 80 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLH---TGELAAVKIIKLEP---GDDFSLIQQEIFMVKECK-HCNIVAYFGSYLSREK 80 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECC---CCeEEEEEEEecCc---cchHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCCE
Confidence 4679999999999999999998765 58899999985432 223356789999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+++||||+++++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||++ +.++.+||+|||++...
T Consensus 81 ~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~ 156 (267)
T cd06646 81 LWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL---TDNGDVKLADFGVAAKI 156 (267)
T ss_pred EEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEECcCccceee
Confidence 99999999999999887644 578999999999999999999999999999999999999 56778999999999866
Q ss_pred CCCC-cccccccCCCcCcchhhc----CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-CCCC
Q 007253 314 RPDE-RLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA-PWPS 387 (611)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~ 387 (611)
.... ......|+..|+|||.+. ..++.++|||||||++|+|++|+.||...........+.......+.. ....
T Consensus 157 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06646 157 TATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTK 236 (267)
T ss_pred cccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccc
Confidence 4322 234457899999999873 347889999999999999999999996554332222221211111111 1135
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHcCcc
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~ 418 (611)
++..+.+||++||+.||.+|||++++++|+|
T Consensus 237 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 237 WSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 7899999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=334.96 Aligned_cols=254 Identities=28% Similarity=0.462 Sum_probs=210.2
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcC---CHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT---TAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
+|.+++.||+|+||.||+|... +|+.+|+|.+...... .......+.+|+.+++++. |+||+++++++.+.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~----~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 75 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN----QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCLDDN 75 (265)
T ss_pred CccccceEeccCCeEEEEEEEc----CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEeecCC
Confidence 4889999999999999999753 4789999988643221 2234466889999999997 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.+++||||+++++|.+++.+. ..+++..++.++.||+.||.|||+.+|+|+||||+||++ +.++.+||+|||++..
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~ 151 (265)
T cd06631 76 TISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML---MPNGIIKLIDFGCARR 151 (265)
T ss_pred eEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE---CCCCeEEeccchhhHh
Confidence 999999999999999988654 468999999999999999999999999999999999999 5778899999999875
Q ss_pred cCCC-------CcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 007253 313 VRPD-------ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384 (611)
Q Consensus 313 ~~~~-------~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 384 (611)
.... .......|+..|+|||++. ..++.++|||||||++|+|++|..||...........+.......+. .
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~ 230 (265)
T cd06631 152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR-L 230 (265)
T ss_pred hhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCC-C
Confidence 4211 1123456899999999986 45789999999999999999999999876554444333333222222 2
Q ss_pred CCCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 385 ~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
...++.++.+||++||..+|.+||++.++++||||
T Consensus 231 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 231 PDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 24678999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=334.51 Aligned_cols=253 Identities=29% Similarity=0.524 Sum_probs=210.9
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCC------HHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT------AIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 229 (611)
+|.+++.||+|+||.||+|.... .++.||+|.+....... ....+.+.+|+.++++++ ||||+++++++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 76 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNAS---SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSSL 76 (267)
T ss_pred CccccceeecCCCeEEEEEEecC---CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEE
Confidence 47888999999999999998765 57899999886443221 234467889999999997 999999999999
Q ss_pred eCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccc
Q 007253 230 DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (611)
Q Consensus 230 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~ 309 (611)
..+..++||||+++++|.+++... +.+++..+..++.||+.||.|||++|++||||||+||++ +.++.+||+|||+
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~---~~~~~~~l~dfg~ 152 (267)
T cd06628 77 DADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV---DNKGGIKISDFGI 152 (267)
T ss_pred eCCccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE---cCCCCEEecccCC
Confidence 999999999999999999988654 568999999999999999999999999999999999999 5778899999999
Q ss_pred ccccCCCC-------cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Q 007253 310 SDFVRPDE-------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381 (611)
Q Consensus 310 a~~~~~~~-------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~ 381 (611)
+....... ......|+..|+|||.+. ..++.++|||||||++|+|++|+.||........+..+.... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~ 229 (267)
T cd06628 153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA---S 229 (267)
T ss_pred CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC---C
Confidence 88664221 112346889999999886 568889999999999999999999998766554444443321 1
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 382 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
......++..+.++|++||+.||.+||++.++++||||
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 230 PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 11123578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=338.51 Aligned_cols=259 Identities=25% Similarity=0.419 Sum_probs=208.0
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++.+.||+|+||.||+|+... +|+.||+|++....... ....+..|+.++.+..+||||+++++++..++.+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVP---TGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcC---CCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcE
Confidence 468999999999999999999776 68999999986543222 2345666777655555699999999999999999
Q ss_pred EEEeeecCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 235 YVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
|+||||++ |+|.+++.. ....+++..++.++.||+.||.|||++ +++||||||+|||+ +.++.+||+|||++
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~---~~~~~~kl~dfg~~ 151 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGIS 151 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecccc
Confidence 99999996 588777654 234689999999999999999999998 99999999999999 57788999999999
Q ss_pred cccCCCCcccccccCCCcCcchhhc-----CCCCCcchhhHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhc-CCCCCCC
Q 007253 311 DFVRPDERLNDIVGSAYYVAPEVLH-----RSYSTEADVWSIGVIAYILLCGSRPFWART-ESGIFRAVLKA-DPSFDEA 383 (611)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DiwSlGvil~el~~g~~Pf~~~~-~~~~~~~i~~~-~~~~~~~ 383 (611)
.............|+..|+|||++. ..++.++|+|||||++|+|++|+.||.... ..+.+..+... .+.++
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 229 (283)
T cd06617 152 GYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLP-- 229 (283)
T ss_pred cccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCC--
Confidence 8764333334457899999999874 346889999999999999999999996432 22333333322 12222
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCC
Q 007253 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (611)
Q Consensus 384 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~ 425 (611)
...++.++.+||.+||..+|.+||++.++++||||+.....
T Consensus 230 -~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 270 (283)
T cd06617 230 -AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK 270 (283)
T ss_pred -ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence 23578999999999999999999999999999999986533
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=339.50 Aligned_cols=258 Identities=31% Similarity=0.515 Sum_probs=208.2
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe-
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE- 229 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~- 229 (611)
....++|++.+.||+|+||.||+|.... .++.||+|++.... .....+.+|+.+++++.+|+||+++++++.
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~---~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKK---NGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECC---CCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 3457889999999999999999998766 58899999875421 123567889999999966999999999884
Q ss_pred ----eCCeeEEEeeecCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceE
Q 007253 230 ----DTDNVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVL 302 (611)
Q Consensus 230 ----~~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~v 302 (611)
.++.+++||||++||+|.+++.. ....+++..++.++.||+.||.|||+.+|+||||||+||++ +.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILL---TTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEE---CCCCCE
Confidence 34579999999999999887753 33568999999999999999999999999999999999999 566779
Q ss_pred EEeecccccccCCCC-cccccccCCCcCcchhhc------CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 007253 303 KAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK 375 (611)
Q Consensus 303 kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~ 375 (611)
||+|||++....... ......|++.|+|||++. ..++.++|||||||++|+|++|+.||........+..+..
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~ 243 (286)
T cd06638 164 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR 243 (286)
T ss_pred EEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc
Confidence 999999987654322 234457999999999874 3478899999999999999999999987655433332222
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 376 ADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 376 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
... ........++.++.+||.+||+.||.+|||+.++++|+||
T Consensus 244 ~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 244 NPP-PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cCC-CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 111 1111112357899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=334.11 Aligned_cols=255 Identities=31% Similarity=0.518 Sum_probs=214.6
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++.+.||.|+||.||+|.... +++.+|+|++.... ....+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~ 74 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIA---TGELVAIKVIKLEP---GDDFEIIQQEISMLKECR-HPNIVAYFGSYLRRDK 74 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecC---CCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCC-CCChhceEEEEEeCCE
Confidence 3679999999999999999998766 57889999986542 224577889999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|++|||+++++|.+++......+++..++.++.||+.||.|||+++|+|+||||+||++ +.++.+||+|||++...
T Consensus 75 ~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~ 151 (262)
T cd06613 75 LWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVSAQL 151 (262)
T ss_pred EEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE---CCCCCEEECccccchhh
Confidence 999999999999999887765789999999999999999999999999999999999999 56778999999998766
Q ss_pred CCCC-cccccccCCCcCcchhhc-C---CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-CCCCC
Q 007253 314 RPDE-RLNDIVGSAYYVAPEVLH-R---SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE-APWPS 387 (611)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~-~---~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~ 387 (611)
.... ......++..|+|||++. . .++.++|||||||++|+|++|+.||...........+......... .....
T Consensus 152 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (262)
T cd06613 152 TATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEK 231 (262)
T ss_pred hhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhh
Confidence 4332 334457899999999875 3 5888999999999999999999999877655544444433211111 11234
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHcCcc
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~ 418 (611)
++.++.+||.+||..+|.+|||+.+++.|+|
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 232 WSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 6788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=339.09 Aligned_cols=254 Identities=30% Similarity=0.512 Sum_probs=209.4
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee---
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--- 230 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~--- 230 (611)
.+.|++.+.||.|+||.||+|+... .++.||+|++... ......+..|+.+++++.+|+||+++++++..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVK---TGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcC---CCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 4679999999999999999999876 5889999998543 22345688899999999679999999999853
Q ss_pred ---CCeeEEEeeecCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEee
Q 007253 231 ---TDNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (611)
Q Consensus 231 ---~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D 306 (611)
.+.+|++|||+.+|+|.+++... ...+++..++.++.||+.||.|||+.||+||||||+||++ +.++.+||+|
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili---~~~~~~~l~d 164 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL---TENAEVKLVD 164 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEee
Confidence 45789999999999999988654 3458999999999999999999999999999999999999 5677899999
Q ss_pred cccccccCCC-CcccccccCCCcCcchhhc------CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC
Q 007253 307 FGLSDFVRPD-ERLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 379 (611)
Q Consensus 307 fG~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~ 379 (611)
||++...... .......|++.|+|||++. ..++.++|||||||++|+|++|..||...........+....
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-- 242 (282)
T cd06636 165 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-- 242 (282)
T ss_pred CcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC--
Confidence 9998765422 2334567999999999874 347889999999999999999999997665544333333221
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 380 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
........++.++.+||.+||..||.+|||+.+||+||||
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 243 PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 1112224578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=334.84 Aligned_cols=251 Identities=30% Similarity=0.590 Sum_probs=213.3
Q ss_pred eeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeeecC
Q 007253 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCE 242 (611)
Q Consensus 163 LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~~~ 242 (611)
||.|+||.||+|+... .++.||+|++.+.........+.+.+|+.+++.+. ||||+++++++.++..+++||||++
T Consensus 1 lg~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (262)
T cd05572 1 LGVGGFGRVELVKVKS---KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLYRTFKDKKYIYMLMEYCL 76 (262)
T ss_pred CCCCCceEEEEEEECC---CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC-CCCEeeeeeeEEcCCccEEEEecCC
Confidence 7999999999999765 58899999997665544455678999999999997 9999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCCccccc
Q 007253 243 GGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI 322 (611)
Q Consensus 243 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~ 322 (611)
+++|.+++... ..+++..+..++.||+.||.|||+.+++|+||||+||++ +.++.+||+|||++............
T Consensus 77 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~~~~~ 152 (262)
T cd05572 77 GGELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTF 152 (262)
T ss_pred CCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---cCCCCEEEeeCCcccccCcccccccc
Confidence 99999988654 468999999999999999999999999999999999999 56778999999999877654444456
Q ss_pred ccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHh
Q 007253 323 VGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART--ESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399 (611)
Q Consensus 323 ~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 399 (611)
.|++.|+|||++. ..++.++|+||||+++|+|++|..||.... ....+..+.......... ...+.++.++|.+|
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~ 230 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFP--NYIDKAAKDLIKQL 230 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCC--cccCHHHHHHHHHH
Confidence 7899999999875 568899999999999999999999998776 445555555322111111 23488999999999
Q ss_pred cccCccCCCC-----HHHHHcCcccCCCC
Q 007253 400 LNKDPRKRLT-----AAQALSHPWIKNSN 423 (611)
Q Consensus 400 L~~dP~~Rpt-----~~~ll~hp~~~~~~ 423 (611)
|+.||.+||+ ++|+++||||++.+
T Consensus 231 l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 231 LRRNPEERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred ccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence 9999999999 99999999998753
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=337.47 Aligned_cols=257 Identities=28% Similarity=0.485 Sum_probs=211.2
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC-
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~- 231 (611)
..++|++.+.||+|+||.||+|.... .++.+|+|++.... .....+.+|+.+++++.+||||+++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~---~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKK---DGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECC---CCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 46789999999999999999998765 58899999985432 22356788999999996699999999998753
Q ss_pred ----CeeEEEeeecCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEE
Q 007253 232 ----DNVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304 (611)
Q Consensus 232 ----~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl 304 (611)
+.+++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+.||+||||||+||++ +.++.+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili---~~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL---TTEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEE
Confidence 368999999999999987753 34578999999999999999999999999999999999999 56677999
Q ss_pred eecccccccCCCC-cccccccCCCcCcchhhcC------CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC
Q 007253 305 IDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLHR------SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 377 (611)
Q Consensus 305 ~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~ 377 (611)
+|||++....... ......|+..|+|||++.. .++.++|||||||++|+|++|+.||........+..+....
T Consensus 170 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 249 (291)
T cd06639 170 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP 249 (291)
T ss_pred eecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC
Confidence 9999988654332 2334578999999998752 26789999999999999999999998776655554444332
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccC
Q 007253 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420 (611)
Q Consensus 378 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~ 420 (611)
.... .....++..+.+||.+||+.+|.+||++.++++||||+
T Consensus 250 ~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 250 PPTL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 2111 11134678899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=341.12 Aligned_cols=260 Identities=29% Similarity=0.492 Sum_probs=214.9
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
...+|.+.+.||+|+||.||+|.... .++.||+|.+..... ...+.+.+|+.+++.+. |+||+++++++..++
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~ 89 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIA---TGQEVAIKQMNLQQQ---PKKELIINEILVMRENK-NPNIVNYLDSYLVGD 89 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECC---CCCEEEEEEEecCcc---chHHHHHHHHHHHHhCC-CCCEeeEEEEEecCC
Confidence 45789999999999999999998665 588999999865432 23466889999999997 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
..++||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||+ +.++.+||+|||++..
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili---~~~~~~~l~Dfg~~~~ 164 (297)
T cd06656 90 ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQ 164 (297)
T ss_pred EEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEECcCccceE
Confidence 99999999999999998754 458999999999999999999999999999999999999 5678899999999876
Q ss_pred cCCCCc-ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 313 VRPDER-LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 313 ~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
...... .....+++.|+|||.+. ..++.++|||||||++|+|++|..||...........+.... .........++.
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 243 (297)
T cd06656 165 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPERLSA 243 (297)
T ss_pred ccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC-CCCCCCccccCH
Confidence 654332 23457899999999886 558899999999999999999999997765433322222211 111112235788
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCC
Q 007253 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~ 425 (611)
.+.+||.+||..+|.+||++.++++||||+.....
T Consensus 244 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 278 (297)
T cd06656 244 VFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPL 278 (297)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCchhcccccc
Confidence 99999999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=337.91 Aligned_cols=253 Identities=26% Similarity=0.408 Sum_probs=200.2
Q ss_pred eeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHh--cCCCCeeEEEEEEeeCCeeEEEee
Q 007253 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL--TGHNNLVKFFDAYEDTDNVYVVME 239 (611)
Q Consensus 162 ~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~~h~~iv~l~~~~~~~~~~~lv~E 239 (611)
.||+|+||.||++.... +++.||+|++.+.............+|..+++.+ .+||||+.+++++..++..++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECC---CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEe
Confidence 48999999999998765 6899999998765443333333444555444433 249999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCCcc
Q 007253 240 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL 319 (611)
Q Consensus 240 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~ 319 (611)
|+++|+|.+++... +.+++..+..++.||+.||.|||+.+|+||||||+|||+ +.++.+||+|||++...... ..
T Consensus 78 ~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~---~~~~~~~l~dfg~~~~~~~~-~~ 152 (279)
T cd05633 78 LMNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKK-KP 152 (279)
T ss_pred cCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE---CCCCCEEEccCCcceecccc-Cc
Confidence 99999998887654 569999999999999999999999999999999999999 57788999999998755432 22
Q ss_pred cccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 007253 320 NDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397 (611)
Q Consensus 320 ~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 397 (611)
....|++.|+|||++. ..++.++|||||||++|+|++|..||......... .+..............++.++.++|+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~ 231 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTVNVELPDSFSPELKSLLE 231 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhhcCCcCCccccCHHHHHHHH
Confidence 3457999999999885 34789999999999999999999999754322111 11111111122223467899999999
Q ss_pred HhcccCccCCC-----CHHHHHcCcccCCCC
Q 007253 398 RLLNKDPRKRL-----TAAQALSHPWIKNSN 423 (611)
Q Consensus 398 ~~L~~dP~~Rp-----t~~~ll~hp~~~~~~ 423 (611)
+||..||.+|+ ++.++++||||++..
T Consensus 232 ~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 232 GLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred HHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 99999999999 699999999999854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=300.90 Aligned_cols=259 Identities=31% Similarity=0.528 Sum_probs=223.3
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
.|...++||+|.||+|++|+.+. +++.||+|++.-.... +..-....+|+-+++.|. |.|||+++++...++.+.
T Consensus 3 ~ydkmekigegtygtvfkarn~~---t~eivalkrvrldddd-egvpssalreicllkelk-hknivrl~dvlhsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRE---THEIVALKRVRLDDDD-EGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCC---ccceEEEEEEeccCCC-CCCcHHHHHHHHHHHHhh-hcceeehhhhhccCceeE
Confidence 47778999999999999999877 7999999998654322 223345779999999998 999999999999999999
Q ss_pred EEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC
Q 007253 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~ 315 (611)
+|+|||.. +|..+..+-++.++.+.++.++.|+++||.|+|+++++||||||.|.|| ..+|.+||+|||+++.+.-
T Consensus 78 lvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli---n~ngelkladfglarafgi 153 (292)
T KOG0662|consen 78 LVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI---NRNGELKLADFGLARAFGI 153 (292)
T ss_pred EeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe---ccCCcEEecccchhhhcCC
Confidence 99999965 8999998889999999999999999999999999999999999999999 5788899999999987653
Q ss_pred CC-cccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC----
Q 007253 316 DE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS---- 387 (611)
Q Consensus 316 ~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~---- 387 (611)
.- -....+-|.+|.+|.++-+ -|+...|+||.|||+.|+.. |++.|.+.+..+.+..|...-....+..|+.
T Consensus 154 pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence 32 2345578999999999864 49999999999999999985 7888889888888888887666555555543
Q ss_pred ---------------------CCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 388 ---------------------LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 388 ---------------------~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
++..-+++++++|.-+|.+|++++..|+||||.+..
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence 344568999999999999999999999999998754
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=342.45 Aligned_cols=256 Identities=32% Similarity=0.492 Sum_probs=211.5
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC--C
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT--D 232 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~--~ 232 (611)
+.|++.+.||+|+||.||+|.... +++.||+|.+...... ......+.+|+.+++++. ||||+++++++... +
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~ 79 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKK---TGEIVALKKLKMEKEK-EGFPITSLREINILLKLQ-HPNIVTVKEVVVGSNLD 79 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECC---CCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcC-CCCEEEEEEEEEecCCC
Confidence 579999999999999999998765 5889999998654332 223345678999999998 99999999999887 8
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
..|+||||+++ +|.+++......+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++..
T Consensus 80 ~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~~l~d~g~~~~ 155 (293)
T cd07843 80 KIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL---NNRGILKICDFGLARE 155 (293)
T ss_pred cEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCcEEEeecCceee
Confidence 89999999974 8988887666679999999999999999999999999999999999999 5778899999999887
Q ss_pred cCCC-CcccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--------
Q 007253 313 VRPD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD-------- 381 (611)
Q Consensus 313 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~-------- 381 (611)
.... .......+++.|+|||++.+ .++.++|||||||++|+|++|..||........+..+........
T Consensus 156 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 156 YGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred ccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 6543 23344568899999998863 368899999999999999999999988776665555433211000
Q ss_pred ------------------CCCCCC--CCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 382 ------------------EAPWPS--LSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 382 ------------------~~~~~~--~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
...++. +++.+.++|++||+.||++|||+.|+|+||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 011122 48889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=331.23 Aligned_cols=253 Identities=27% Similarity=0.547 Sum_probs=216.0
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
+|++.+.||+|+||.||+++... .|+.||+|.+...... ......+.+|+.++++++ |+||+++++++...+..+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKE---DGKQYVIKEINISKMS-PKEREESRKEVAVLSNMK-HPNIVQYQESFEENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcC---CCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCC-CCCeeeeEeeecCCCeEE
Confidence 58999999999999999998766 5889999998654322 334467899999999998 999999999999999999
Q ss_pred EEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 236 VVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
+||||+.+++|.+++.... ..+++..+..++.||+.||.|||++|++|+||+|+|||+ +.++.++|+|||++....
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~ 152 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLN 152 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEEeeccceeecC
Confidence 9999999999999887643 358999999999999999999999999999999999999 567789999999997664
Q ss_pred CCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 315 PDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
... ......|++.|+|||++. +.++.++|+|||||++|+|++|+.||......+....+........ ...++.++
T Consensus 153 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 229 (256)
T cd08218 153 STVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV---SSHYSYDL 229 (256)
T ss_pred cchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC---cccCCHHH
Confidence 332 223456889999999886 5578899999999999999999999988777777766665442211 13578999
Q ss_pred HHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 393 RDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
.++|.+||+.+|.+||++.++++||||
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 230 RNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=335.75 Aligned_cols=255 Identities=31% Similarity=0.544 Sum_probs=210.2
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC-
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD- 232 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~- 232 (611)
.++|++.+.||+|+||.||+|.... .++.||+|++.... ...+.+.+|+.+++++.+|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKK---TGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP 77 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECC---CCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence 5789999999999999999999765 57899999986542 234678899999999966999999999997644
Q ss_pred -----eeEEEeeecCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEE
Q 007253 233 -----NVYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304 (611)
Q Consensus 233 -----~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl 304 (611)
.+++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+++|+||+|+||++ +.++.+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~---~~~~~~~l 154 (275)
T cd06608 78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL---TKNAEVKL 154 (275)
T ss_pred CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---ccCCeEEE
Confidence 489999999999998887643 3579999999999999999999999999999999999999 56788999
Q ss_pred eecccccccCCCC-cccccccCCCcCcchhhc------CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC
Q 007253 305 IDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 377 (611)
Q Consensus 305 ~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~ 377 (611)
+|||++....... ......|+..|+|||++. ..++.++|||||||++|+|++|..||...........+....
T Consensus 155 ~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 234 (275)
T cd06608 155 VDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP 234 (275)
T ss_pred CCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC
Confidence 9999987654322 234457899999999874 236789999999999999999999997665544444444332
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 378 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
... ......++.++.+||.+||..||.+|||+.++++|||+
T Consensus 235 ~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 235 PPT-LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCC-CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 211 11112378899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=326.80 Aligned_cols=274 Identities=30% Similarity=0.470 Sum_probs=217.0
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCc-cCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee-C
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGEL-KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-T 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~-~ 231 (611)
...|++++.||+|.||.||+|.-+++.. ..+.+|||.+......+... ....+|+.+++.|+ ||||+.|..+|.. +
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS-~SAcREiaL~REl~-h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGIS-MSACREIALLRELK-HPNVISLVKVFLSHD 100 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcC-HHHHHHHHHHHHhc-CCcchhHHHHHhccC
Confidence 3569999999999999999996554321 24579999986553322222 34668999999998 9999999999988 7
Q ss_pred CeeEEEeeecCCCChHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEecc-CCCceEEEee
Q 007253 232 DNVYVVMELCEGGELLDRILSRG----GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK-DENSVLKAID 306 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~-~~~~~vkl~D 306 (611)
..+++++||.+. +|+..|+-+. ..++...++.|+.||+.|+.|||++-|+||||||.|||+..+ .+.|.|||+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 899999999987 8998887442 358999999999999999999999999999999999999743 3458999999
Q ss_pred cccccccCCCC----cccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChH---------HHHH
Q 007253 307 FGLSDFVRPDE----RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTES---------GIFR 371 (611)
Q Consensus 307 fG~a~~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~---------~~~~ 371 (611)
||+++++...- ....++-|.||.|||.+- +.|+.++|||++|||+.||++.++.|.+.... ..+.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99999875332 345678899999999886 56999999999999999999999999654331 3344
Q ss_pred HHHhcCCCCCCCCCCC---------------------------------CCHHHHHHHHHhcccCccCCCCHHHHHcCcc
Q 007253 372 AVLKADPSFDEAPWPS---------------------------------LSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418 (611)
Q Consensus 372 ~i~~~~~~~~~~~~~~---------------------------------~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~ 418 (611)
.|++.-.......|+. -++...+|+.+||+.||.+|+|+++.|+|+|
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 5544333333333321 1444789999999999999999999999999
Q ss_pred cCCCCCCCCchh
Q 007253 419 IKNSNDVKVPLD 430 (611)
Q Consensus 419 ~~~~~~~~~~~~ 430 (611)
|........|.+
T Consensus 340 F~~d~lpp~pt~ 351 (438)
T KOG0666|consen 340 FTEDPLPPLPTS 351 (438)
T ss_pred cccCCCCCCccc
Confidence 998765544443
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=338.16 Aligned_cols=256 Identities=28% Similarity=0.488 Sum_probs=205.2
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++.+.||+|+||.||+|.... .++.||||.+....... ....+.+|+.+++.++ |+||+++++++.+++.
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~---~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 77 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKL---TGQLVALKEIRLEHEEG--APFTAIREASLLKDLK-HANIVTLHDIIHTKKT 77 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcC---CCcEEEEEEEecccccC--CchhHHHHHHHHhhCC-CcceeeEEEEEecCCe
Confidence 4679999999999999999998765 58899999986543221 2234678999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
.++||||+.+ +|.+++......+++..++.++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||++...
T Consensus 78 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 78 LTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI---SERGELKLADFGLARAK 153 (291)
T ss_pred EEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE---cCCCCEEECcccccccc
Confidence 9999999975 9999887766678999999999999999999999999999999999999 57788999999998754
Q ss_pred CCCC-cccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhcCCCC---------
Q 007253 314 RPDE-RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSF--------- 380 (611)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~-~~~~~~i~~~~~~~--------- 380 (611)
.... ......++..|+|||++. ..++.++|||||||++|+|++|+.||..... .+....+.......
T Consensus 154 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 154 SVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred CCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence 3221 222345788999999885 3478899999999999999999999976552 22222221110000
Q ss_pred -----C------------CCCCCCCC--HHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 381 -----D------------EAPWPSLS--SEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 381 -----~------------~~~~~~~s--~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
. ...++.++ .++.++|.+||+.+|++|||+.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 00012334 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=350.85 Aligned_cols=256 Identities=26% Similarity=0.387 Sum_probs=217.0
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCc-cCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGEL-KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
.++..+.++||+|+||.||+|+++.... ....||+|............+.++.+|.++|+.|+ |||||++||+..++.
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~-H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN-HPNVVRFYGVAVLEE 234 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCC
Confidence 4556678999999999999999987533 11228999986544456778889999999999998 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.++||||+|.||+|.+++.+....++..+...++.+.+.||+|||++++|||||-..|||+ ..++.+||+|||+++.
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~---~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLY---SKKGVVKISDFGLSRA 311 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhee---cCCCeEEeCccccccC
Confidence 9999999999999999998887789999999999999999999999999999999999999 5667799999999876
Q ss_pred cCCCCccc-ccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 313 VRPDERLN-DIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 313 ~~~~~~~~-~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
-..-.... ...-...|+|||.+. +.|+.++|||||||++||+++ |..||.+....++...|.......+.. ...+
T Consensus 312 ~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~--~~~p 389 (474)
T KOG0194|consen 312 GSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP--SKTP 389 (474)
T ss_pred CcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC--CCCH
Confidence 54111111 112346899999987 679999999999999999998 889999999999999886655443332 3668
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
.++..++.+|+..||++||++.++.+
T Consensus 390 ~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 390 KELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHHHHhccCChhhccCHHHHHH
Confidence 89999999999999999999988753
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=363.86 Aligned_cols=253 Identities=25% Similarity=0.410 Sum_probs=218.7
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCC--ccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
.+.+.+..+.||+|+||.||+|+...-. .....||||.++.. .+.+..++|++|++++..|+ |||||+|+|+|..
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla~l~-H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--AENQARQDFRREAELLAELQ-HPNIVRLLGVCRE 560 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--ccHHHHHHHHHHHHHHHhcc-CCCeEEEEEEEcc
Confidence 3566788999999999999999876533 24578999998654 45567889999999999998 9999999999999
Q ss_pred CCeeEEEeeecCCCChHHHHHhcC---------CC----CCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccC
Q 007253 231 TDNVYVVMELCEGGELLDRILSRG---------GK----YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD 297 (611)
Q Consensus 231 ~~~~~lv~E~~~~gsL~~~l~~~~---------~~----l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~ 297 (611)
++.+|+|+|||..|||.++|+.+. .. |+..+...|+.||+.|+.||-++.+|||||-..|+|| +
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV---g 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV---G 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee---c
Confidence 999999999999999999998542 22 8889999999999999999999999999999999999 7
Q ss_pred CCceEEEeecccccccCCCCccc---ccccCCCcCcchhh-cCCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 007253 298 ENSVLKAIDFGLSDFVRPDERLN---DIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRA 372 (611)
Q Consensus 298 ~~~~vkl~DfG~a~~~~~~~~~~---~~~gt~~y~aPE~~-~~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~ 372 (611)
++.+|||+|||+++.+...+... ...-..+|||||.+ .+.|+.+|||||+||+|||+++ |+.||++.+..++++.
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~ 717 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC 717 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence 89999999999998765433221 22335689999965 5899999999999999999995 9999999999999999
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHH
Q 007253 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414 (611)
Q Consensus 373 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll 414 (611)
|..... ++.. .+.+.++.+|+..||+.+|.+||+++||-
T Consensus 718 i~~g~l-L~~P--e~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 718 IRAGQL-LSCP--ENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HHcCCc-ccCC--CCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 988765 4333 47899999999999999999999999873
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=319.31 Aligned_cols=252 Identities=24% Similarity=0.386 Sum_probs=205.9
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC-
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~- 231 (611)
-.++|++.++||+|||+.||+++... ++..||+|.+... ....++..++|++..++++ ||||++++++...+
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s---~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~-s~~vl~l~dh~l~~~ 91 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLS---TGHLYALKKILCH---SQEDIEEALREIDNHRKFN-SPNVLRLVDHQLREE 91 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccC---cccchhhheeecc---chHHHHHHHHHHHHHHhhC-CcchHHHHHHHHHhh
Confidence 46789999999999999999998554 7899999998554 3556788999999999998 99999999876543
Q ss_pred ----CeeEEEeeecCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeecCCCCceEEeccCCCceE
Q 007253 232 ----DNVYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSVL 302 (611)
Q Consensus 232 ----~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NIll~~~~~~~~v 302 (611)
...||++.|...|+|.+.+... +..+++.++..|+.+|++||++||+.. +.||||||.|||++ +.+.+
T Consensus 92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls---~~~~~ 168 (302)
T KOG2345|consen 92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS---DSGLP 168 (302)
T ss_pred ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec---CCCce
Confidence 3499999999999999998654 336999999999999999999999998 99999999999994 57789
Q ss_pred EEeecccccccCCCCc----------ccccccCCCcCcchhhc----CCCCCcchhhHHHHHHHHHHhCCCCCCCCChH-
Q 007253 303 KAIDFGLSDFVRPDER----------LNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTES- 367 (611)
Q Consensus 303 kl~DfG~a~~~~~~~~----------~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~- 367 (611)
+|+|||.+....-.-. ...-..|..|.|||.++ ...+.++|||||||+||.|+.|..||+..-..
T Consensus 169 vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G 248 (302)
T KOG2345|consen 169 VLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG 248 (302)
T ss_pred EEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC
Confidence 9999999876532111 11234688999999986 23688999999999999999999999532111
Q ss_pred -HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 368 -GIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 368 -~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
.+..++......++... .+|+.+.+||+.||++||.+||++.+++.+
T Consensus 249 gSlaLAv~n~q~s~P~~~--~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 249 GSLALAVQNAQISIPNSS--RYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CeEEEeeeccccccCCCC--CccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 12233444445555543 489999999999999999999999999864
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=339.76 Aligned_cols=260 Identities=25% Similarity=0.384 Sum_probs=208.6
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|+..+.||+|+||.||++.... .|+.||+|.+...... .....+.+|+.++.++.+|+||+++++++..++..
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~---~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~ 78 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKP---SGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDC 78 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECC---CCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcE
Confidence 457788899999999999998766 6899999998654322 44567889999999997799999999999999999
Q ss_pred EEEeeecCCCChHHHH---Hh-cCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeecCCCCceEEeccCCCceEEEeeccc
Q 007253 235 YVVMELCEGGELLDRI---LS-RGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l---~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DfG~ 309 (611)
+++|||+.+ ++.+.. .. ....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+
T Consensus 79 ~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~ 154 (288)
T cd06616 79 WICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGI 154 (288)
T ss_pred EEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE---ccCCcEEEeecch
Confidence 999999954 554433 22 235799999999999999999999985 99999999999999 5677899999999
Q ss_pred ccccCCCCcccccccCCCcCcchhhcC----CCCCcchhhHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhcC-CCCCCC
Q 007253 310 SDFVRPDERLNDIVGSAYYVAPEVLHR----SYSTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKAD-PSFDEA 383 (611)
Q Consensus 310 a~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwSlGvil~el~~g~~Pf~~~~~-~~~~~~i~~~~-~~~~~~ 383 (611)
+.............|+..|+|||++.+ .++.++|||||||++|+|++|+.||..... .+....+.... +.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd06616 155 SGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNS 234 (288)
T ss_pred hHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCc
Confidence 976654443444578999999999863 488999999999999999999999965432 12222222211 222222
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 384 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.+..++.++.+||.+||+.||.+|||+.+++.||||+...
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 235 EEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 2345889999999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=339.91 Aligned_cols=256 Identities=29% Similarity=0.516 Sum_probs=210.0
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++.+.||+|+||.||+|.... .++.||+|++.+..... ...+.+.+|+++++.+. ||||+++++++.+++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~---~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKE---TGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLR-HENLVNLIEVFRRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECC---CCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcC-CcchhhHHHhcccCCeE
Confidence 469999999999999999998765 58899999986543332 34567889999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++||||+++++|..+.. ....+++..++.++.||+.||.|||+.||+||||+|+||++ ++++.+||+|||++....
T Consensus 76 ~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07846 76 YLVFEFVDHTVLDDLEK-YPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLA 151 (286)
T ss_pred EEEEecCCccHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCcEEEEeeeeeeecc
Confidence 99999999887766543 44569999999999999999999999999999999999999 577889999999987654
Q ss_pred CCC-cccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------
Q 007253 315 PDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF----------- 380 (611)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~----------- 380 (611)
... ......++..|+|||++.+ .++.++|||||||++|+|++|+.||......+....+......+
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 152 APGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred CCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 332 2334578899999998863 47889999999999999999999997666544433333211110
Q ss_pred --------CC--------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 381 --------DE--------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 381 --------~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
+. ..++.++..+.+|+.+||..+|.+||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 00 1134678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=330.46 Aligned_cols=253 Identities=35% Similarity=0.556 Sum_probs=214.6
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee--CCe
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--TDN 233 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~--~~~ 233 (611)
+|++.+.||.|+||.||+|.... .|+.||+|++..... .....+.+.+|+.++++++ |+||+++++++.. ...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKS---DGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQT 75 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecC---CCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcC-CCccceeeeeeecCCCCE
Confidence 48899999999999999998766 588999999865443 3445577889999999998 9999999998864 456
Q ss_pred eEEEeeecCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH-----HcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 234 VYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCH-----LQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH-----~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
.+++|||+++++|.+++... ...+++..++.++.||+.||.||| +.+|+|+||||+||++ +.++.+||+
T Consensus 76 ~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili---~~~~~~kl~ 152 (265)
T cd08217 76 LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLG 152 (265)
T ss_pred EEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEE---ecCCCEEEe
Confidence 89999999999999988654 467999999999999999999999 8899999999999999 567889999
Q ss_pred ecccccccCCCCc-ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 007253 306 DFGLSDFVRPDER-LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA 383 (611)
Q Consensus 306 DfG~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 383 (611)
|||++........ .....|++.|+|||++. ..++.++|+||||+++|+|++|..||.......+...+.......
T Consensus 153 d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--- 229 (265)
T cd08217 153 DFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR--- 229 (265)
T ss_pred cccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCC---
Confidence 9999987754443 44567899999999986 557889999999999999999999998877666555555443211
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 384 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
....++..+.+++.+||..+|.+||++.++++|||+
T Consensus 230 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 230 IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 123678999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=340.48 Aligned_cols=257 Identities=30% Similarity=0.464 Sum_probs=204.8
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC-
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD- 232 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~- 232 (611)
.++|++.+.||+|+||.||+|.... +++.||||++...... ......+.+|+.+++++. ||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 85 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKK---TKQIVALKKVLMENEK-EGFPITALREIKILQLLK-HENVVNLIEICRTKAT 85 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECC---CCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCC-CCCccceEEEEecccc
Confidence 4579999999999999999998765 6899999988643222 222234568999999997 999999999987654
Q ss_pred -------eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 233 -------NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 233 -------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
..++||||+. ++|.+.+......+++..++.++.||+.||.|||++||+|+||||+||++ +.++.+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~ 161 (310)
T cd07865 86 PYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKLA 161 (310)
T ss_pred cccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---CCCCcEEEC
Confidence 4599999996 58888887666679999999999999999999999999999999999999 577889999
Q ss_pred ecccccccCCCCc-----ccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Q 007253 306 DFGLSDFVRPDER-----LNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (611)
Q Consensus 306 DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~ 378 (611)
|||++........ .....++..|+|||++.+ .++.++||||||+++|+|++|+.||.+.........+.....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T cd07865 162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG 241 (310)
T ss_pred cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999976543221 234467889999998753 378899999999999999999999987665544333332211
Q ss_pred CCCCCCC----------------------------CCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 379 SFDEAPW----------------------------PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 379 ~~~~~~~----------------------------~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
.++...+ ...+..+.+||.+||..||.+|||++++|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 1111100 0125678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=335.55 Aligned_cols=256 Identities=27% Similarity=0.479 Sum_probs=213.3
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++.+.||.|+||.||+|.... .++.||+|++..... ......+.+|+.+++++. ||||+++++++..++.+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~ 74 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRP---TGKIMAVKTIRLEIN--EAIQKQILRELDILHKCN-SPYIVGFYGAFYNNGDI 74 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcC---CCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCC-CCchhhhheeeecCCEE
Confidence 368889999999999999999876 689999999866432 345567889999999998 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
++|+||+++++|.+++......+++..++.++.||+.||.|||+ .|++||||||+||++ +.++.+||+|||.+...
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~---~~~~~~~l~d~g~~~~~ 151 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV---NSRGQIKLCDFGVSGQL 151 (265)
T ss_pred EEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE---CCCCCEEEeecccchhh
Confidence 99999999999999887665789999999999999999999999 999999999999999 56778999999998765
Q ss_pred CCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHhcCCCCCCCCCCC
Q 007253 314 RPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART-----ESGIFRAVLKADPSFDEAPWPS 387 (611)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~ 387 (611)
..... ....++..|+|||++. ..++.++|||||||++|+|++|..||.... .......+..... +......
T Consensus 152 ~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 228 (265)
T cd06605 152 VNSLA-KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP--PRLPSGK 228 (265)
T ss_pred HHHHh-hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC--CCCChhh
Confidence 43222 2267889999999886 558899999999999999999999996542 2223333332221 1111122
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
++.++.++|.+||..||.+|||+.+++.||||+..
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 229 FSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred cCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 78999999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=329.38 Aligned_cols=246 Identities=26% Similarity=0.452 Sum_probs=207.5
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++.+.||+|+||.||++..+. +..+|+|.+..... ..+.+.+|+.++++++ ||||+++++++...+..
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 74 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA----QIKVAIKAINEGAM----SEEDFIEEAKVMMKLS-HPKLVQLYGVCTQQKPL 74 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc----CceEEEEecccCCc----cHHHHHHHHHHHHHCC-CCCceeEEEEEccCCCE
Confidence 468999999999999999998654 56799998754332 2356889999999998 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 75 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05114 75 YIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV---SSTGVVKVSDFGMTRYVL 151 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE---cCCCeEEECCCCCccccC
Confidence 99999999999999987665679999999999999999999999999999999999999 567889999999987654
Q ss_pred CCCcc--cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 315 PDERL--NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 315 ~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
..... ....++..|+|||++. ..++.++||||||+++|+|++ |+.||......+....+......... ...+.
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~ 228 (256)
T cd05114 152 DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP---KLASM 228 (256)
T ss_pred CCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC---CCCCH
Confidence 32221 2234566899999886 568899999999999999999 99999888877777777654322211 24678
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHc
Q 007253 391 EARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
.+.+++.+||+.+|.+||++.++++
T Consensus 229 ~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 229 TVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHH
Confidence 8999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=333.16 Aligned_cols=250 Identities=23% Similarity=0.420 Sum_probs=199.3
Q ss_pred CCceeEeCee--eeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 154 ANKYELGEEV--GRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 154 ~~~y~~~~~L--G~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+.|++.+.+ |+|+||.||++..+. ++..+|+|++....... .|+.+...+.+|+||+++++++...
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKP---TQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcC---CCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 3567777766 999999999998766 58899999986532211 1333333334599999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCc-eEEEeecccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS-VLKAIDFGLS 310 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~-~vkl~DfG~a 310 (611)
+.+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||+.|++||||||+||++. .++ .++|+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~~l~dfg~~ 157 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD---RAKDRIYLCDYGLC 157 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe---CCCCeEEEecCccc
Confidence 9999999999999999988665 4799999999999999999999999999999999999995 444 8999999998
Q ss_pred cccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 311 DFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
...... ....|+..|+|||++. ..++.++|||||||++|+|++|+.||.......................++.++
T Consensus 158 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T PHA03390 158 KIIGTP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVS 234 (267)
T ss_pred eecCCC---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccC
Confidence 765432 2346889999999986 568899999999999999999999997554333211111111122223334689
Q ss_pred HHHHHHHHHhcccCccCCCC-HHHHHcCcccCC
Q 007253 390 SEARDFVKRLLNKDPRKRLT-AAQALSHPWIKN 421 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt-~~~ll~hp~~~~ 421 (611)
..+.+||.+||+.||.+|++ ++++|+||||++
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 235 KNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 99999999999999999996 699999999974
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=348.79 Aligned_cols=258 Identities=30% Similarity=0.521 Sum_probs=224.1
Q ss_pred eeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEE
Q 007253 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (611)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 236 (611)
|..++.||-|+||.|++++-.+ +...||+|.+.+..+-.......++.|-.||..-. .+.||+||-.|.|++++|+
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvD---T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD-n~WVVrLyySFQDkdnLYF 706 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVD---TRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLYF 706 (1034)
T ss_pred eEEEeeecccccceeEEEeecc---hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC-CcceEEEEEEeccCCceEE
Confidence 8899999999999999998665 57889999998877777777788899999999875 8999999999999999999
Q ss_pred EeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC--
Q 007253 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-- 314 (611)
Q Consensus 237 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~-- 314 (611)
||+|++||++..+|.+. +-+.|..++.++.++..|+++.|..|+|||||||+|||| |.+|++||+|||||.-++
T Consensus 707 VMdYIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred EEeccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeeccccccceec
Confidence 99999999999988766 569999999999999999999999999999999999999 789999999999985332
Q ss_pred -------CCCc----------------------------------ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHH
Q 007253 315 -------PDER----------------------------------LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAY 352 (611)
Q Consensus 315 -------~~~~----------------------------------~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ 352 (611)
.+.. ....+||+.|+|||++. ..|+..+|+||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 0000 01358999999999886 67999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCC---CHHHHHcCcccCCCC
Q 007253 353 ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL---TAAQALSHPWIKNSN 423 (611)
Q Consensus 353 el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~~ll~hp~~~~~~ 423 (611)
||+.|+.||...+..+.-.+|++....+....-.+++.++.++|.++++ +++.|. .++++..||||+...
T Consensus 863 em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgID 935 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGID 935 (1034)
T ss_pred HHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccc
Confidence 9999999999988888777777776666666667899999999999764 678887 477899999999853
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=333.35 Aligned_cols=258 Identities=24% Similarity=0.426 Sum_probs=208.9
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCC---HHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT---AIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
.|+.++.||+|+||.||++.... +++.||+|++....... ....+.+.+|++++++++ |+||+++++++.+.+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~---~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVK---TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATCEDS 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcC---CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhceeccCC
Confidence 47889999999999999998765 68899999986543221 234577899999999998 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.+++||||+++++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||++. .....+||+|||++..
T Consensus 77 ~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~--~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 77 HFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLID--STGQRLRIADFGAAAR 153 (268)
T ss_pred eEEEEEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEcccccccc
Confidence 999999999999999887654 5789999999999999999999999999999999999994 2234699999999876
Q ss_pred cCCCC-----cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCCCC
Q 007253 313 VRPDE-----RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP-SFDEAPW 385 (611)
Q Consensus 313 ~~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~ 385 (611)
..... ......|+..|+|||++. ..++.++|||||||++|+|++|..||...........+..... .......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIP 233 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCc
Confidence 64321 122356889999999886 5688999999999999999999999965443322222222111 1111112
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccC
Q 007253 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420 (611)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~ 420 (611)
..+++++.+++.+||..+|.+|||+.++++||||+
T Consensus 234 ~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 234 EHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred hhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 35789999999999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=336.69 Aligned_cols=261 Identities=29% Similarity=0.464 Sum_probs=212.1
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++.+.||+|++|.||+|.... +|+.||+|.+..... .....+.+.+|+++++++. |+||+++++++.+.+..
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRV---TNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecC---CCcEEEEEehhhccc-cccchHHHHHHHHHHHhcc-CCCEeeEEEEEecCCeE
Confidence 579999999999999999998765 588999999865432 2233456788999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 235 YVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
|+||||++ ++|.+++..... .+++..++.++.||+.||.|||+++|+||||||+||+++. .++.+||+|||++...
T Consensus 77 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~--~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR--RTNALKLADFGLARAF 153 (294)
T ss_pred EEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC--CCCEEEEccccccccc
Confidence 99999995 588887765433 3688999999999999999999999999999999999952 3457999999999765
Q ss_pred CCCC-cccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-------
Q 007253 314 RPDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA------- 383 (611)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~------- 383 (611)
.... ......+++.|+|||++.+ .++.++|||||||++|+|++|+.||......+.+..+..........
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 4322 2234567899999998853 47889999999999999999999998776665555544321111110
Q ss_pred ------------------CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 384 ------------------PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 384 ------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
..+.++.++.++|.+||+.+|++||++.++++||||++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 1245788999999999999999999999999999998753
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=330.94 Aligned_cols=254 Identities=26% Similarity=0.454 Sum_probs=206.7
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCc--CCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee--C
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--TTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--T 231 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~--~ 231 (611)
.|++.+.||+|+||.||+|.... ++..||+|++..... ........+.+|+.++++++ ||||+++++++.+ .
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 78 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVD---TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRDRAE 78 (266)
T ss_pred CccccceecCCCCEEEEEEEEcC---CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEcCCC
Confidence 58999999999999999998765 588999998864432 22334567889999999997 9999999998876 3
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
..++++|||+++++|.+++... ..+++..++.++.||+.||.|||+.+|+||||||+||++ +.++.+||+|||++.
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~---~~~~~~~l~dfg~~~ 154 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASK 154 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCCCcc
Confidence 5789999999999999988654 468999999999999999999999999999999999999 567789999999987
Q ss_pred ccCCC----CcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 007253 312 FVRPD----ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 312 ~~~~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (611)
.+... .......++..|+|||++. ..++.++|||||||++|+|++|+.||...........+..... .+. ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~-~~~ 232 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPT-NPQ-LPS 232 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCC-CCC-Cch
Confidence 65321 1223356889999999886 5588999999999999999999999987655544443332211 111 112
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHcCcccC
Q 007253 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~ 420 (611)
.+++.+.++| +||..+|.+||+++++++||||+
T Consensus 233 ~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 233 HISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred hcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 4678899999 67778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=335.85 Aligned_cols=253 Identities=20% Similarity=0.351 Sum_probs=212.1
Q ss_pred CceeEeCeeeeccceEEEEEEEecCC--ccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
.+|++.+.||+|+||.||+|...... .....||+|.+... ........+.+|+.++++++ ||||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~--~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN--AEPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCTKEQ 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC--CCHHHHHHHHHHHHHHHhcC-CcccceEEEEEcCCC
Confidence 57999999999999999999876522 23478999998643 23445567899999999997 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccC
Q 007253 233 NVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD 297 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~ 297 (611)
..+++|||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||++ +
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~---~ 158 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV---G 158 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE---c
Confidence 9999999999999999887542 458899999999999999999999999999999999999 5
Q ss_pred CCceEEEeecccccccCCCC---cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 007253 298 ENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRA 372 (611)
Q Consensus 298 ~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~ 372 (611)
+++.+||+|||++....... ......+++.|+|||++. +.++.++|||||||++|||++ |..||.+....+....
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 67789999999987653322 123446788999999875 678999999999999999997 9999998887777776
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 373 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
+....... ....++.++.+|+.+||+.||.+||++.+++++
T Consensus 239 i~~~~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 239 IRSRQLLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHcCCcCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 66543221 124688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=333.27 Aligned_cols=257 Identities=28% Similarity=0.541 Sum_probs=213.4
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhc--CCCCeeEEEEEEeeCCe
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT--GHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~iv~l~~~~~~~~~ 233 (611)
.|++.+.||+|+||.||+|.... .++.||+|++.... .....+.+.+|+.+++++. .||||+++++++.++..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~---~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVP---TGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcC---CCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCE
Confidence 47889999999999999999765 58899999986532 2334567889999999986 59999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
.++||||+++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||+|+||++ +..+.++|+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV---TNTGNVKLCDFGVAALL 151 (277)
T ss_pred EEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE---cCCCCEEEccCCceeec
Confidence 9999999999999988744 379999999999999999999999999999999999999 56788999999999876
Q ss_pred CCCC-cccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 314 RPDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
.... ......|+..|+|||++.+ .++.++|+|||||++|+|++|..||...........+... ..+......++.
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 229 (277)
T cd06917 152 NQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPRLEDNGYSK 229 (277)
T ss_pred CCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCCCCCcccCCH
Confidence 5433 2344578999999998863 4688999999999999999999999776554433332222 112222224788
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHcCcccCCCCC
Q 007253 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~ 424 (611)
++.+++.+||..||.+||++.+++.|+||+....
T Consensus 230 ~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~ 263 (277)
T cd06917 230 LLREFVAACLDEEPKERLSAEELLKSKWIKAHSK 263 (277)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhhChHhhcccc
Confidence 9999999999999999999999999999987543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=332.07 Aligned_cols=256 Identities=28% Similarity=0.492 Sum_probs=211.0
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcC-------CHHHHHHHHHHHHHHHHhcCCCCeeEEEEEE
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-------TAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~ 228 (611)
+|.+.+.||.|+||.||+|.... +|+.||+|.+...... .....+.+.+|+.+++.+. |+||+++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~ 77 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVT---TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGFE 77 (272)
T ss_pred ceeecceecccCceEEEEEeecC---CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEEEe
Confidence 58899999999999999998665 5889999987532111 1123456789999999997 99999999999
Q ss_pred eeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecc
Q 007253 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (611)
Q Consensus 229 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG 308 (611)
...+.+++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++++||||||+||++ +.++.+||+|||
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~---~~~~~~~l~d~~ 153 (272)
T cd06629 78 TTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV---DADGICKISDFG 153 (272)
T ss_pred ccCCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE---cCCCeEEEeecc
Confidence 9999999999999999999988665 579999999999999999999999999999999999999 577889999999
Q ss_pred cccccCCCC---cccccccCCCcCcchhhcC---CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CCCC
Q 007253 309 LSDFVRPDE---RLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA--DPSF 380 (611)
Q Consensus 309 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~ 380 (611)
++....... ......|+..|+|||++.. .++.++|+||||+++|+|++|..||......+....+... ...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPI 233 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcC
Confidence 987653221 1234568899999998852 3788999999999999999999999765554433333222 2233
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 381 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
+....+.++.++.++|.+||..+|.+|||+.++|+||||
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 234 PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 333345678999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=333.36 Aligned_cols=265 Identities=29% Similarity=0.506 Sum_probs=212.9
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC--C
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT--D 232 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~--~ 232 (611)
++|+..+.||.|++|.||+|.... .++.||+|++.... .......+.+|++++++++ ||||++++++|.+. +
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 74 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKN---TGMIFALKTITTDP--NPDLQKQILRELEINKSCK-SPYIVKYYGAFLDESSS 74 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECC---CCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEccCCC
Confidence 368999999999999999999876 58999999986542 2244567889999999997 99999999998654 4
Q ss_pred eeEEEeeecCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccc
Q 007253 233 NVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~ 309 (611)
.+++||||+++++|.+++.. ....+++..+..++.||+.||.|||+.|++|+||+|+||++ +.++.+||+|||+
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~ 151 (287)
T cd06621 75 SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGV 151 (287)
T ss_pred eEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---ecCCeEEEeeccc
Confidence 78999999999999887643 34568999999999999999999999999999999999999 5677899999999
Q ss_pred ccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHhcC-CCCCC
Q 007253 310 SDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART-----ESGIFRAVLKAD-PSFDE 382 (611)
Q Consensus 310 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~-----~~~~~~~i~~~~-~~~~~ 382 (611)
+....... .....++..|+|||.+. ..++.++|||||||++|+|++|..||.... ..+....+.... +....
T Consensus 152 ~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd06621 152 SGELVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKD 230 (287)
T ss_pred cccccccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhcc
Confidence 87654322 22456788999999886 568999999999999999999999997652 223333333211 11111
Q ss_pred CCC--CCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCCCCch
Q 007253 383 APW--PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPL 429 (611)
Q Consensus 383 ~~~--~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~~~~~ 429 (611)
... ..+++.+.+||.+||..+|.+|||+.|++.||||+........+
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~~~~ 279 (287)
T cd06621 231 EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKVNM 279 (287)
T ss_pred CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccchhhH
Confidence 111 23578899999999999999999999999999998776554443
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=329.01 Aligned_cols=254 Identities=32% Similarity=0.555 Sum_probs=211.5
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
+|.+.+.||+|+||.||+|.... .++.||+|++...... ....+.+.+|+.++++++ |+||+++++++...+.++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLD---TGELMAVKEIRIQDND-PKTIKEIADEMKVLELLK-HPNLVKYYGVEVHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECC---CCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCC-CCChhheeeeEecCCEEE
Confidence 58999999999999999998765 5889999998765433 456678999999999997 999999999999999999
Q ss_pred EEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC
Q 007253 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~ 315 (611)
+|+||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||+|+||++ +.++.+||+|||++.....
T Consensus 76 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~kl~d~g~~~~~~~ 151 (264)
T cd06626 76 IFMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKN 151 (264)
T ss_pred EEEecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEcccccccccCC
Confidence 999999999999987654 458999999999999999999999999999999999999 5678899999999887654
Q ss_pred CCc-----ccccccCCCcCcchhhcC-C---CCCcchhhHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCCCCCCC
Q 007253 316 DER-----LNDIVGSAYYVAPEVLHR-S---YSTEADVWSIGVIAYILLCGSRPFWARTESG-IFRAVLKADPSFDEAPW 385 (611)
Q Consensus 316 ~~~-----~~~~~gt~~y~aPE~~~~-~---~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~ 385 (611)
... .....++..|+|||++.+ . ++.++||||||+++|+|++|+.||....... ....+.. ........+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~ 230 (264)
T cd06626 152 NTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPIPDS 230 (264)
T ss_pred CCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCCCCcc
Confidence 332 223568899999999863 3 7889999999999999999999997653332 2222222 222222223
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
..++..+.+||.+||+.+|.+|||+.+++.|||+
T Consensus 231 ~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 231 LQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 4568999999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=340.40 Aligned_cols=260 Identities=30% Similarity=0.544 Sum_probs=215.7
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.+.|.....||+|+||.||++.... .+..||||.+... .....+.+.+|+.+++.++ |+||+++++.+...+.
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~ 93 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKH---TGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYH-HENVVDMYNSYLVGDE 93 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECC---CCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCC-CCcHHHHHHheecCCe
Confidence 4556667889999999999998765 5889999998542 2344567889999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
.++||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 94 ~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kL~dfg~~~~~ 168 (292)
T cd06658 94 LWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL---TSDGRIKLSDFGFCAQV 168 (292)
T ss_pred EEEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEccCcchhhc
Confidence 9999999999999887643 468999999999999999999999999999999999999 56778999999998755
Q ss_pred CCCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 314 RPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
.... ......|+..|+|||++. ..++.++|||||||++|||++|..||........+..+....+.... ....++..
T Consensus 169 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 247 (292)
T cd06658 169 SKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVK-DSHKVSSV 247 (292)
T ss_pred ccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccc-cccccCHH
Confidence 3222 234457899999999886 46889999999999999999999999887766655555443222111 12357889
Q ss_pred HHHHHHHhcccCccCCCCHHHHHcCcccCCCCCCC
Q 007253 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVK 426 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~~ 426 (611)
+.++|.+||..||.+|||+.++++||||+......
T Consensus 248 ~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~ 282 (292)
T cd06658 248 LRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS 282 (292)
T ss_pred HHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence 99999999999999999999999999999765444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=337.57 Aligned_cols=255 Identities=30% Similarity=0.496 Sum_probs=208.5
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
.|++.+.||.|+||.||+|+... +|+.||||.+..... .......+.+|++++++++ ||||+++++++.+++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKL---TGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECC---CCCEEEEEEcccccc-ccccchHHHHHHHHHHhcC-CCCCcchhhhcccCCcEE
Confidence 48899999999999999998765 688999999864432 2223356889999999997 999999999999999999
Q ss_pred EEeeecCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 236 VVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
+||||+. ++|.+++... ...+++..++.++.||+.||+|||+.+++||||+|+||++ +.++.+||+|||++....
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill---~~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 76 LVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFG 151 (284)
T ss_pred EEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEeeccchhhcc
Confidence 9999996 5888887653 3568999999999999999999999999999999999999 577789999999987654
Q ss_pred CCC-cccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----------
Q 007253 315 PDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD---------- 381 (611)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~---------- 381 (611)
... ......+++.|+|||++.+ .++.++|||||||++|+|++|+.||...........+........
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence 332 2334467889999998763 368899999999999999999999987766544444332211110
Q ss_pred --------C-------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 382 --------E-------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 382 --------~-------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
. ...+.++.++.++|.+||+.||.+|||+.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0 0123578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=330.54 Aligned_cols=252 Identities=25% Similarity=0.503 Sum_probs=209.4
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++.+.||+|+||.||+|+... +++.||||.+.............+.+|+.+++.++ ||||+++++++.+.+..
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 77 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLL---DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIEDNEL 77 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeC---CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEEECCeE
Confidence 579999999999999999999776 58999999886654455566677889999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 235 YVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+||++ +.++.++|+|||++.
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~---~~~~~~~l~d~g~~~ 154 (267)
T cd08228 78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE---cCCCCEEECccccce
Confidence 999999999999887753 23458999999999999999999999999999999999999 567789999999988
Q ss_pred ccCCCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhcCCCCCCCCCCC
Q 007253 312 FVRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE--SGIFRAVLKADPSFDEAPWPS 387 (611)
Q Consensus 312 ~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~ 387 (611)
...... ......|++.|+|||.+. ..++.++||||||+++|+|++|+.||..... ......+... ..+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 232 (267)
T cd08228 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC--DYPPLPTEH 232 (267)
T ss_pred eccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcC--CCCCCChhh
Confidence 765332 223457889999999886 5688899999999999999999999965432 2333333221 222222335
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
++..+.++|.+||+.+|.+||++.++++
T Consensus 233 ~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 233 YSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred cCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 7889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=335.50 Aligned_cols=256 Identities=28% Similarity=0.449 Sum_probs=204.8
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.+.|.+.+.||+|+||.||+|.... .|+.||+|++....... ....+.+|+.+++.+. |+||+++++++.+++.
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~ 77 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRI---NGQLVALKVISMKTEEG--VPFTAIREASLLKGLK-HANIVLLHDIIHTKET 77 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcC---CCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcC-CCCEeEEEEEEecCCe
Confidence 4679999999999999999998766 58899999986543222 2235678999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
.|+||||+. ++|.+.+......+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++...
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI---SYLGELKLADFGLARAK 153 (291)
T ss_pred EEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---cCCCcEEEecccccccc
Confidence 999999995 68888777666678999999999999999999999999999999999999 56778999999998764
Q ss_pred CCC-CcccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcC------------
Q 007253 314 RPD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKAD------------ 377 (611)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~-~~~~~i~~~~------------ 377 (611)
... .......+++.|+|||++.+ .++.++|||||||++|+|++|..||...... +.+..+....
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 322 22344567899999998853 4788999999999999999999999765432 2222211100
Q ss_pred --CCCCCC------------CCC--CCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 378 --PSFDEA------------PWP--SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 378 --~~~~~~------------~~~--~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
+.+... .+. ..+..+.+++.+||..||++|||+.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 000000 001 125788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=333.55 Aligned_cols=256 Identities=28% Similarity=0.504 Sum_probs=214.8
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
..|+..+.||.|+||.||.|.... .+..||+|++.... .......+.+|+.+++++. |+||+++++++.+++.+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 77 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNR---TQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKGTKL 77 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEcc---CCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEE
Confidence 458889999999999999998765 57899999986542 2344577899999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++||||++||+|.+++.. ..+++..+..++.||+.||.|||+.+++|+||+|+||++ +.++.++|+|||++....
T Consensus 78 ~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~---~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06640 78 WIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL---SEQGDVKLADFGVAGQLT 152 (277)
T ss_pred EEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE---cCCCCEEEcccccceecc
Confidence 999999999999998753 468999999999999999999999999999999999999 567789999999997654
Q ss_pred CCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 315 PDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
... ......++..|+|||++. ..++.++|+|||||++|+|++|..||...........+....+ ......++..+
T Consensus 153 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 229 (277)
T cd06640 153 DTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP---PTLTGEFSKPF 229 (277)
T ss_pred CCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCC---CCCchhhhHHH
Confidence 333 223456888999999886 4588999999999999999999999987766554444332221 11223567889
Q ss_pred HHHHHHhcccCccCCCCHHHHHcCcccCCCCC
Q 007253 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~ 424 (611)
.++|.+||+.+|.+||++.+++.|+||.....
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 230 KEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred HHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=335.12 Aligned_cols=254 Identities=28% Similarity=0.514 Sum_probs=209.3
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
+|++.+.||.|++|.||+|+... +|..||||++...... ...+.+.+|+.++++++ |+||+++++++.+.+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 74 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRT---TGEIVALKEIHLDAEE--GTPSTAIREISLMKELK-HENIVRLHDVIHTENKLM 74 (284)
T ss_pred CceEeeeeccCCceEEEEEEECC---CCeEEEEEEecccccc--cchHHHHHHHHHHHhhc-CCCEeeeeeeEeeCCcEE
Confidence 48999999999999999999765 5889999998654322 23356778999999997 999999999999999999
Q ss_pred EEeeecCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 236 VVMELCEGGELLDRILSRG--GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+||||+++ +|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||++ ++++.+||+|||++...
T Consensus 75 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~ 150 (284)
T cd07836 75 LVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI---NKRGELKLADFGLARAF 150 (284)
T ss_pred EEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCcEEEeecchhhhh
Confidence 99999975 8888886654 468999999999999999999999999999999999999 56778999999999765
Q ss_pred CCCC-cccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--------
Q 007253 314 RPDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE-------- 382 (611)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~-------- 382 (611)
.... ......++..|+|||++.+ .++.++|||||||++|+|++|+.||.+....+....+.........
T Consensus 151 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 151 GIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred cCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 4332 2234567899999998853 4788999999999999999999999877766555544332110000
Q ss_pred -----------------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 383 -----------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 383 -----------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
...+.++.++.++|.+||+.||.+||++.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0012457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=334.89 Aligned_cols=262 Identities=27% Similarity=0.426 Sum_probs=218.4
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.+.|...+.||+|+||.||+|+... .|+.||+|++.............+.+|+.+++.++ |||++++++++.+...
T Consensus 20 ~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 95 (313)
T cd06633 20 EEIFVGLHEIGHGSFGAVYFATNSH---TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYLKEHT 95 (313)
T ss_pred HHHhhcceeeccCCCeEEEEEEECC---CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCE
Confidence 3447778889999999999998655 68999999987654444555567889999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
.|+||||+. |+|.+.+......+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 96 ~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili---~~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 96 AWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASKS 171 (313)
T ss_pred EEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE---CCCCCEEEeecCCCccc
Confidence 999999995 58888887766789999999999999999999999999999999999999 56778999999998653
Q ss_pred CCCCcccccccCCCcCcchhhc----CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 314 RPDERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
. ......|+..|+|||++. +.++.++|||||||++|+|++|..||...........+..... +......++
T Consensus 172 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 246 (313)
T cd06633 172 S---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLQSNEWT 246 (313)
T ss_pred C---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCCccccC
Confidence 2 233567899999999873 4588899999999999999999999987765555554443322 222234577
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCCCCc
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVP 428 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~~~~ 428 (611)
..+.+||.+||+.+|.+||++.+++.||||+.....++.
T Consensus 247 ~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~~~~ 285 (313)
T cd06633 247 DSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARVL 285 (313)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCcccCCCchhHHH
Confidence 889999999999999999999999999999976544433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=347.11 Aligned_cols=256 Identities=28% Similarity=0.510 Sum_probs=207.6
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC-
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~- 231 (611)
+.++|++.+.||+|+||.||+|.... +|+.||||++.+... .......+.+|+.+++++. |+||++++++|...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 88 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTV---TGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQK 88 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECC---CCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcC-CCCCcceeeeeccCC
Confidence 46789999999999999999998766 689999999865332 3334456778999999997 99999999998644
Q ss_pred -----CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEee
Q 007253 232 -----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (611)
Q Consensus 232 -----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D 306 (611)
...|+|||||. ++|.+.+... +++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 89 ~~~~~~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~---~~~~~~kL~D 161 (353)
T cd07850 89 SLEEFQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILD 161 (353)
T ss_pred CccccCcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEcc
Confidence 35799999995 5888877433 8999999999999999999999999999999999999 5778899999
Q ss_pred cccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--------
Q 007253 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD-------- 377 (611)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~-------- 377 (611)
||++.............+++.|+|||++. ..++.++|||||||++|+|++|+.||........+..+....
T Consensus 162 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 162 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred CccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 99998765444444567899999999886 568999999999999999999999998766544433332211
Q ss_pred --------------CCCC---------CCC--------CCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccC
Q 007253 378 --------------PSFD---------EAP--------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420 (611)
Q Consensus 378 --------------~~~~---------~~~--------~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~ 420 (611)
+... ... ....+..+.+||.+||+.||++|||+.++|+||||+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence 0000 000 113466789999999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=328.39 Aligned_cols=255 Identities=27% Similarity=0.487 Sum_probs=208.3
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCC--cCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC-
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHK--MTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~- 231 (611)
..|++++.||+|+||.||.|.... +|..||||++.... .......+.+.+|+.+++++. ||||+++++++.+.
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 77 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDAD---TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLRDPM 77 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcC---CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEeccCC
Confidence 469999999999999999998765 68899999885332 122344567889999999997 99999999998764
Q ss_pred -CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 232 -DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 232 -~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
..+++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+|+|+||||+||++ +.++.+||+|||++
T Consensus 78 ~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~Dfg~~ 153 (265)
T cd06652 78 ERTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR---DSVGNVKLGDFGAS 153 (265)
T ss_pred CceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe---cCCCCEEECcCccc
Confidence 4688999999999999988655 468999999999999999999999999999999999999 56778999999998
Q ss_pred cccCCC----CcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 007253 311 DFVRPD----ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (611)
Q Consensus 311 ~~~~~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (611)
...... .......|+..|+|||++. ..++.++|||||||++|+|++|+.||...........+... +..+. ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~-~~ 231 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ-PTNPV-LP 231 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcC-CCCCC-Cc
Confidence 765321 1223456889999999885 56889999999999999999999999776554444333322 11111 12
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccC
Q 007253 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420 (611)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~ 420 (611)
..++..+.++|.+|+. +|.+||+++++++|||++
T Consensus 232 ~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 232 PHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred hhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 3577889999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=327.12 Aligned_cols=254 Identities=31% Similarity=0.511 Sum_probs=213.0
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCc--CCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--TTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
+|+..+.||+|+||.||+|.... ++..||+|++..... ......+.+.+|+.+++++. |+||+++++++.++..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~ 76 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLD---DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQYLGTEREEDN 76 (258)
T ss_pred CccccceeeecCCceEEEEEEcC---CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC-CCCchheeeeEecCCe
Confidence 47888999999999999998765 588999999865332 22345577899999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+++||||+++++|.+++... ..+++..+..++.||+.||.|||+.||+|+||+|+||++ +.++.+||+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 77 LYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccceec
Confidence 99999999999999988654 468999999999999999999999999999999999999 56788999999998876
Q ss_pred CCCCcccccccCCCcCcchhhc-CC-CCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 314 RPDERLNDIVGSAYYVAPEVLH-RS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~-~~-~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
..........|+..|+|||.+. .. ++.++|+|||||++|+|++|+.||...........+.... ..+ .....++..
T Consensus 153 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~ 230 (258)
T cd06632 153 VEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK-ELP-PIPDHLSDE 230 (258)
T ss_pred cccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc-cCC-CcCCCcCHH
Confidence 5444345567899999999875 34 7899999999999999999999997766544444433311 111 122457899
Q ss_pred HHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 392 ARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
+.+||.+||+.+|.+||++.+++.|||+
T Consensus 231 ~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 231 AKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 9999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=332.41 Aligned_cols=250 Identities=28% Similarity=0.435 Sum_probs=200.2
Q ss_pred eeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHh--cCCCCeeEEEEEEeeCCeeEEEee
Q 007253 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL--TGHNNLVKFFDAYEDTDNVYVVME 239 (611)
Q Consensus 162 ~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~~h~~iv~l~~~~~~~~~~~lv~E 239 (611)
.||+|+||.||+|.... +++.||+|++.+...........+..|..+++.+ .+||+|+.+++++.+.+.+++|||
T Consensus 1 ~ig~g~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 77 (278)
T ss_pred CcccCCCeEEEEEEEec---CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEe
Confidence 48999999999998765 6889999998765433333233344454444333 249999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCCcc
Q 007253 240 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL 319 (611)
Q Consensus 240 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~ 319 (611)
|+.||+|.+++.. ...+++..++.++.|++.||.|||+.+|+||||||+||++ +.++.+||+|||++...... ..
T Consensus 78 ~~~g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili---~~~~~~kl~dfg~~~~~~~~-~~ 152 (278)
T cd05606 78 LMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKK-KP 152 (278)
T ss_pred cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE---CCCCCEEEccCcCccccCcc-CC
Confidence 9999999887754 4579999999999999999999999999999999999999 56778999999998765432 23
Q ss_pred cccccCCCcCcchhhc-C-CCCCcchhhHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 007253 320 NDIVGSAYYVAPEVLH-R-SYSTEADVWSIGVIAYILLCGSRPFWART---ESGIFRAVLKADPSFDEAPWPSLSSEARD 394 (611)
Q Consensus 320 ~~~~gt~~y~aPE~~~-~-~~~~~~DiwSlGvil~el~~g~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 394 (611)
....|+..|+|||++. + .++.++||||+||++|+|++|+.||.... .......+......+ ...++.++.+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~s~~~~~ 228 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL----PDSFSPELRS 228 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCC----CCcCCHHHHH
Confidence 3457999999999986 3 48899999999999999999999997652 222222222222222 2356899999
Q ss_pred HHHHhcccCccCCC-----CHHHHHcCcccCCCC
Q 007253 395 FVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423 (611)
Q Consensus 395 li~~~L~~dP~~Rp-----t~~~ll~hp~~~~~~ 423 (611)
+|.+||..+|.+|| ++.++++||||+...
T Consensus 229 li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 229 LLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred HHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 99999999999999 999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=326.94 Aligned_cols=249 Identities=31% Similarity=0.534 Sum_probs=211.6
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
+|++.+.||+|+||.||+++... +++.||+|.+.... .....+.+.+|+.+++.++ |+||+++++++.+++.+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~---~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 74 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVN---SDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMK-HPNIVAFKESFEADGHLY 74 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcC---CCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEE
Confidence 58999999999999999998765 68999999985432 2334567889999999997 999999999999999999
Q ss_pred EEeeecCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 236 VVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
+||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||++ +.++.++|+|||++....
T Consensus 75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~ 151 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLT 151 (255)
T ss_pred EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---CCCCcEEEcccCcceeec
Confidence 999999999999988653 3458999999999999999999999999999999999999 567789999999997664
Q ss_pred CCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 315 PDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
... ......|++.|+|||++. ..++.++|+||||+++|+|++|..||...........+........ ...++..+
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 228 (255)
T cd08219 152 SPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPL---PSHYSYEL 228 (255)
T ss_pred ccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCC---CcccCHHH
Confidence 332 233467899999999986 5588999999999999999999999988776666666654432211 13578899
Q ss_pred HHHHHHhcccCccCCCCHHHHHcC
Q 007253 393 RDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
.+||.+||+.||.+|||+.+++.-
T Consensus 229 ~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 229 RSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHHhCCcccCCCHHHHhhc
Confidence 999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=329.06 Aligned_cols=253 Identities=25% Similarity=0.395 Sum_probs=212.3
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++.+.||+|+||.||+|...........||||++.... .......+.+|+.++++++ ||||+++++++...+..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFD-HPNIIRLEGVVTKSRPV 80 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCcceEeEEEecCCce
Confidence 57999999999999999999987543345689999986542 3344567889999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++||||+++++|.+++......+++..++.++.|++.||.|||+++|+||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCCEEECccchhhccc
Confidence 99999999999999988776789999999999999999999999999999999999999 567789999999998764
Q ss_pred CC-Cc--ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 315 PD-ER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 315 ~~-~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
.. .. .....++..|+|||.+. ..++.++||||||+++|+|++ |..||...........+...... + ....++
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~ 234 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL-P--PPMDCP 234 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-C--CCCCCC
Confidence 21 11 11234567899999886 568999999999999999997 99999887777666666543221 1 123578
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
..+.+|+.+||+.+|++||++.+++++
T Consensus 235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 235 SALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=360.48 Aligned_cols=267 Identities=20% Similarity=0.297 Sum_probs=199.5
Q ss_pred ccccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEE--------------EecCCCcCCHHHHHHHHHHHHHHHHh
Q 007253 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVK--------------VIPKHKMTTAIAIEDVRREVKILRAL 215 (611)
Q Consensus 150 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK--------------~~~~~~~~~~~~~~~~~~E~~~l~~l 215 (611)
...+.++|+++++||+|+||.||++..+.. .+..+++| ++.+...........+.+|+.++++|
T Consensus 143 ~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l 220 (501)
T PHA03210 143 DDEFLAHFRVIDDLPAGAFGKIFICALRAS--TEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL 220 (501)
T ss_pred chhhhhccEEEeEecCCCCcceEEEEEecc--chhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC
Confidence 344668899999999999999999876542 12222222 11111112233456688999999999
Q ss_pred cCCCCeeEEEEEEeeCCeeEEEeeecCCCChHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCce
Q 007253 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG----GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENF 291 (611)
Q Consensus 216 ~~h~~iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NI 291 (611)
+ |||||++++++.+.+..|+|+|++. ++|.+++.... .......++.|+.||+.||.|||++|||||||||+||
T Consensus 221 ~-HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NI 298 (501)
T PHA03210 221 N-HENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENI 298 (501)
T ss_pred C-CCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 7 9999999999999999999999995 58888775432 2344667889999999999999999999999999999
Q ss_pred EEeccCCCceEEEeecccccccCCCC--cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCC---
Q 007253 292 LFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART--- 365 (611)
Q Consensus 292 ll~~~~~~~~vkl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~--- 365 (611)
|+ +.++.+||+|||++..+.... .....+||+.|+|||++. ..++.++|||||||++|||++|..++....
T Consensus 299 Ll---~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~ 375 (501)
T PHA03210 299 FL---NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK 375 (501)
T ss_pred EE---CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC
Confidence 99 567889999999998765432 223468999999999986 568999999999999999999886543321
Q ss_pred hHHHHHHHHhcCC----CCCC----------------C--------CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCc
Q 007253 366 ESGIFRAVLKADP----SFDE----------------A--------PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHP 417 (611)
Q Consensus 366 ~~~~~~~i~~~~~----~~~~----------------~--------~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp 417 (611)
....+..++.... .++. . ....++.++.++|.+||+.||.+|||+.|+|.||
T Consensus 376 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 376 PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 1122222221110 0000 0 0013567788899999999999999999999999
Q ss_pred ccCCCC
Q 007253 418 WIKNSN 423 (611)
Q Consensus 418 ~~~~~~ 423 (611)
||....
T Consensus 456 ~f~~~~ 461 (501)
T PHA03210 456 LFSAEE 461 (501)
T ss_pred hhhcCC
Confidence 998754
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=347.41 Aligned_cols=255 Identities=24% Similarity=0.366 Sum_probs=205.6
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCC--ccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.++|+++++||+|+||.||+|...... ..+..||||++.... .....+.+.+|+++++++..||||++++++|.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 568999999999999999999865321 234679999986532 2334567899999999996699999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcC---------------------------------------------------------
Q 007253 232 DNVYVVMELCEGGELLDRILSRG--------------------------------------------------------- 254 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~--------------------------------------------------------- 254 (611)
+.+|||||||++|+|.+++....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 99999999999999998876421
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEecc
Q 007253 255 --------------------------------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296 (611)
Q Consensus 255 --------------------------------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~ 296 (611)
..+++..+..++.||+.||.|||+.+|+||||||+|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill--- 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL--- 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE---
Confidence 247888899999999999999999999999999999999
Q ss_pred CCCceEEEeecccccccCCCC---cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 007253 297 DENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFR 371 (611)
Q Consensus 297 ~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~ 371 (611)
+.++.+||+|||++....... ......+++.|+|||++. ..++.++|||||||++|+|++ |..||........+.
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 567789999999998654322 123345778899999886 568999999999999999997 999997755443333
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 372 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
.......... ....++.++.++|.+||+.||++|||+.++.+
T Consensus 351 ~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 351 NKIKSGYRMA--KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHhcCCCCC--CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 3333322221 12467899999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=344.01 Aligned_cols=259 Identities=31% Similarity=0.555 Sum_probs=207.0
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC-
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~- 231 (611)
++++|++.++||+|+||.||+|.... +|+.||||++... ........+.+|+.++++++ |+||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 76 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKP---TGVKVAIKKISPF--EHQTFCQRTLREIKILRRFK-HENIIGILDIIRPPS 76 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcC---CCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCC-CCCcCchhheeeccc
Confidence 46789999999999999999998765 6899999998542 22334466788999999998 99999999987654
Q ss_pred ----CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeec
Q 007253 232 ----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (611)
Q Consensus 232 ----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~Df 307 (611)
..+|+|+||+. ++|.+.+. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+||
T Consensus 77 ~~~~~~~~lv~e~~~-~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill---~~~~~~kl~df 150 (336)
T cd07849 77 FESFNDVYIVQELME-TDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDF 150 (336)
T ss_pred ccccceEEEEehhcc-cCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEECcc
Confidence 35899999996 48887763 3469999999999999999999999999999999999999 57788999999
Q ss_pred ccccccCCCC----cccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC----
Q 007253 308 GLSDFVRPDE----RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD---- 377 (611)
Q Consensus 308 G~a~~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~---- 377 (611)
|++....... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.........+....
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~ 230 (336)
T cd07849 151 GLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPS 230 (336)
T ss_pred cceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 9987654322 123357899999999864 458899999999999999999999997655433222221100
Q ss_pred -------------------CCCCCC----CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 378 -------------------PSFDEA----PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 378 -------------------~~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
+..... ..+.++.++.+||.+||+.||++|||+.++++||||+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 000000 1235688899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=328.41 Aligned_cols=250 Identities=29% Similarity=0.465 Sum_probs=203.7
Q ss_pred eeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEE
Q 007253 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (611)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 236 (611)
+.....||+|+||.||+|.... ++..||+|.+... .....+.+.+|+.++++++ |+||+++++++..++..++
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~---~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLS---TQVRIAIKEIPER---DSRYVQPLHEEIALHSYLK-HRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred CCceEEEecCCceEEEEeEecC---CCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcC-CCCeeeeeeeeccCCEEEE
Confidence 3344589999999999998765 5789999988543 2334567889999999997 9999999999999999999
Q ss_pred EeeecCCCChHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 237 VMELCEGGELLDRILSRGGKY--TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 237 v~E~~~~gsL~~~l~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
|+||+++++|.+++......+ ++..+..++.||+.||.|||++||+||||||+||+++ ...+.+||+|||++....
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~--~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN--TYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc--CCCCeEEEecchhheecc
Confidence 999999999999987654555 8899999999999999999999999999999999994 235689999999987654
Q ss_pred CCC-cccccccCCCcCcchhhcC---CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHH-HHHH--HhcCCCCCCCCCCC
Q 007253 315 PDE-RLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFWARTESGI-FRAV--LKADPSFDEAPWPS 387 (611)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~-~~~i--~~~~~~~~~~~~~~ 387 (611)
... ......|++.|+|||++.+ .++.++||||||+++|+|++|+.||........ ...+ ....+.+ ...
T Consensus 161 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~ 236 (268)
T cd06624 161 GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEI----PES 236 (268)
T ss_pred cCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCC----Ccc
Confidence 322 2334468899999998852 378899999999999999999999975433221 1111 1111112 235
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
++.++.+|+.+||+.+|.+|||+.+++.||||
T Consensus 237 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 237 LSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred cCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 78899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=333.12 Aligned_cols=260 Identities=26% Similarity=0.427 Sum_probs=218.9
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
...|...+.||+|+||.||+|+... .|..||+|++.............+.+|+.++++++ |+|++++++++.+++.
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~---~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 99 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVR---TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYLREHT 99 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcC---CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCe
Confidence 3558899999999999999998765 58899999987654445555677899999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
.++||||+. |+|.+.+......+++..+..++.||+.||.|||++||+||||+|+||++ +.++.+||+|||++...
T Consensus 100 ~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~ 175 (317)
T cd06635 100 AWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASIA 175 (317)
T ss_pred EEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE---CCCCCEEEecCCCcccc
Confidence 999999996 58888877666779999999999999999999999999999999999999 56778999999998765
Q ss_pred CCCCcccccccCCCcCcchhhc----CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 314 RPDERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
.. .....|++.|+|||++. +.++.++|||||||++|+|++|..||...........+....... .....++
T Consensus 176 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 250 (317)
T cd06635 176 SP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--LQSNEWS 250 (317)
T ss_pred CC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC--CCCcccc
Confidence 42 23457889999999873 458889999999999999999999998776666555555443221 1223578
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCCC
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVK 426 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~~ 426 (611)
..+.+||.+||+.+|.+||++.++++|+|+.......
T Consensus 251 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~ 287 (317)
T cd06635 251 DYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET 287 (317)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence 8999999999999999999999999999997654333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=332.73 Aligned_cols=253 Identities=26% Similarity=0.417 Sum_probs=212.3
Q ss_pred CCceeEeCeeeeccceEEEEEEEecC--CccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.++|.+.+.||+|+||.||+|..... ...+..||||++... ......+.+.+|+++++++. |+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET--ASNDARKDFEREAELLTNFQ-HENIVKFYGVCTEG 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc--CCHHHHHHHHHHHHHHHhcC-CCCchheeeEEecC
Confidence 35689999999999999999987653 235688999998654 22334578899999999997 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCC
Q 007253 232 DNVYVVMELCEGGELLDRILSRG-------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE 298 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~ 298 (611)
...++||||+++|+|.+++...+ ..+++..+..++.||+.||.|||++|++||||||+||++ +.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili---~~ 157 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GY 157 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE---cC
Confidence 99999999999999999987542 347899999999999999999999999999999999999 56
Q ss_pred CceEEEeecccccccCCCC---cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 007253 299 NSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAV 373 (611)
Q Consensus 299 ~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i 373 (611)
++.+||+|||++....... ......+++.|+|||++. +.++.++|||||||++|+|++ |..||......+....+
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237 (280)
T ss_pred CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 7889999999987653222 122335678899999886 668999999999999999998 99999888777777776
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 374 LKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
........ ...++..+.++|.+||+.||.+||++.++++
T Consensus 238 ~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 238 TQGRLLQR---PRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HcCCcCCC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 65433222 2467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=334.47 Aligned_cols=256 Identities=35% Similarity=0.592 Sum_probs=209.3
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++.+.||+|+||.||+|.... +++.||+|++..... .....+.+.+|+++++++. |+||+++++++..++.+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~---~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKA---TGEIVAIKKFKESED-DEDVKKTALREVKVLRQLR-HENIVNLKEAFRRKGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCC---CCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcC-CCCeeehhheEEECCEE
Confidence 369999999999999999998776 588999999865332 2334567899999999998 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++||||++++.+ +.+......+++..++.++.||+.||.|||+.+|+||||+|+||++ ++++.+||+|||++....
T Consensus 76 ~iv~e~~~~~~l-~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~ 151 (288)
T cd07833 76 YLVFEYVERTLL-ELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALR 151 (288)
T ss_pred EEEEecCCCCHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEEeeecccccC
Confidence 999999987554 4455555669999999999999999999999999999999999999 568889999999988765
Q ss_pred CCC--cccccccCCCcCcchhhc-C-CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-----------
Q 007253 315 PDE--RLNDIVGSAYYVAPEVLH-R-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS----------- 379 (611)
Q Consensus 315 ~~~--~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~----------- 379 (611)
... ......++..|+|||++. . .++.++||||||+++|+|++|+.||.+....+....+......
T Consensus 152 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 152 ARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred CCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhccc
Confidence 443 334567889999999886 4 5788999999999999999999999876554433332221100
Q ss_pred ---CC-----CC--------CCC-CCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 380 ---FD-----EA--------PWP-SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 380 ---~~-----~~--------~~~-~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
+. .. .++ .++.++.+||++||..+|++|||+.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00 00 011 248899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=367.52 Aligned_cols=254 Identities=27% Similarity=0.410 Sum_probs=206.3
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|+++++||+|+||.||+|.... +|+.||||++...........+++.+|+.++++++ ||||+++++++.+++..
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~---tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~d~~~l 77 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPV---CSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICSDGDPV 77 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECC---CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEeeCCEE
Confidence 579999999999999999998765 68999999997654444556678999999999998 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEE
Q 007253 235 YVVMELCEGGELLDRILSR----------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~----------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl 304 (611)
|+||||++||+|.+++... ...+++..+..++.||+.||.|||++|||||||||+|||+ +.++.+||
T Consensus 78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKL 154 (932)
T PRK13184 78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL---GLFGEVVI 154 (932)
T ss_pred EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE---cCCCCEEE
Confidence 9999999999999988642 1235677889999999999999999999999999999999 57778999
Q ss_pred eecccccccCCCC-------------------cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCC
Q 007253 305 IDFGLSDFVRPDE-------------------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWAR 364 (611)
Q Consensus 305 ~DfG~a~~~~~~~-------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~ 364 (611)
+|||++....... .....+||+.|||||++. ..++.++|||||||++|||++|+.||...
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 9999997652110 112357999999999886 56899999999999999999999999775
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 365 TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 365 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
....+........+ ....++..++..+.+++.+||..||++|++..+.+.+
T Consensus 235 ~~~ki~~~~~i~~P-~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 235 KGRKISYRDVILSP-IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred chhhhhhhhhccCh-hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 54433222111111 1112235688999999999999999999876665543
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=338.47 Aligned_cols=253 Identities=21% Similarity=0.308 Sum_probs=207.3
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCC-ccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..+|++.+.||+|+||.||+|++.... .....||+|++... ......+.+.+|+.+++.+. ||||+++++++...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~niv~~~g~~~~~- 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NPHVCRLLGICLTS- 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEcCC-
Confidence 356999999999999999999876422 12345999998543 23445567889999999997 99999999998764
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
..++|+||+++|+|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill---~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV---KTPQHVKITDFGLAKL 158 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe---cCCCcEEEcccccccc
Confidence 5789999999999999998776779999999999999999999999999999999999999 5677899999999987
Q ss_pred cCCCCcc---cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 007253 313 VRPDERL---NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (611)
Q Consensus 313 ~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (611)
+...... ....++..|+|||++. ..++.++|||||||++|||++ |..||.+....++. .+.......+.. +.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~--~~ 235 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQP--PI 235 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCCCCCC--CC
Confidence 6543322 2223467899999886 668999999999999999997 99999877665543 344433333322 35
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
++.++.+++.+||..||.+||++.+++.+
T Consensus 236 ~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 236 CTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 68899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=326.97 Aligned_cols=255 Identities=31% Similarity=0.504 Sum_probs=215.8
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
+|++.+.||+|++|.||+|.... +++.||+|++...... .....+.+|+.++.+++ |+||+++++++...+..+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~---~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKP---TGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCE-SPYVVKCYGAFYKEGEIS 75 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcC---CCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcC-CCCeeeEEEEEccCCeEE
Confidence 68999999999999999998776 6899999998654322 44577899999999998 999999999999999999
Q ss_pred EEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+ .+++||||+|+||++ +.++.++|+|||++....
T Consensus 76 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~ 151 (264)
T cd06623 76 IVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI---NSKGEVKIADFGISKVLE 151 (264)
T ss_pred EEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE---CCCCCEEEccCccceecc
Confidence 999999999999988665 679999999999999999999999 999999999999999 567889999999998765
Q ss_pred CCCcc-cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 315 PDERL-NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART---ESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 315 ~~~~~-~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
..... ....++..|+|||++. ..++.++||||||+++|+|++|..||.... ..+....+..... +......++
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 229 (264)
T cd06623 152 NTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP--PSLPAEEFS 229 (264)
T ss_pred cCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC--CCCCcccCC
Confidence 43332 3567889999999886 557889999999999999999999997763 3344444443221 111111278
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
..+.++|.+||..+|++||++.++++||||+..
T Consensus 230 ~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 230 PEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 999999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=333.53 Aligned_cols=260 Identities=31% Similarity=0.551 Sum_probs=214.2
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcC-CHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-TAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
.|++.+.||.|+||.||+|+...+..+|..||+|++...... .....+.+.+|+++++++.+|+||+++++++..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 388999999999999999987654457899999998653221 2233466789999999997799999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---CCCCCEEEeeCccceecc
Confidence 9999999999999988655 568999999999999999999999999999999999999 567889999999997764
Q ss_pred CCC--cccccccCCCcCcchhhc---CCCCCcchhhHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhcCCCCCCCCC
Q 007253 315 PDE--RLNDIVGSAYYVAPEVLH---RSYSTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSFDEAPW 385 (611)
Q Consensus 315 ~~~--~~~~~~gt~~y~aPE~~~---~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~ 385 (611)
... ......|+..|+|||++. ..++.++||||||+++|+|++|..||..... ..+...+....+.++
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 232 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP---- 232 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCC----
Confidence 332 223457899999999885 3467899999999999999999999964322 233333333333322
Q ss_pred CCCCHHHHHHHHHhcccCccCCC-----CHHHHHcCcccCCCC
Q 007253 386 PSLSSEARDFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423 (611)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rp-----t~~~ll~hp~~~~~~ 423 (611)
..++..+.+|+.+||..||.+|| ++.+++.||||+..+
T Consensus 233 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 233 QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 35789999999999999999997 899999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=332.88 Aligned_cols=257 Identities=24% Similarity=0.415 Sum_probs=212.6
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++.+.||+|+||.||++.... .|+.||+|++.... .....+.+.+|+++++.++ ||||+++++++...+.
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~---~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 77 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIP---TGTVMAKKVVHIGA--KSSVRKQILRELQIMHECR-SPYIVSFYGAFLNENN 77 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcC---CCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcC-CCCcceEeeeEecCCE
Confidence 3579999999999999999998766 58899999986542 2345578899999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
+++||||+++++|.+++... +.+++..+..++.+++.||.|||+ .+++||||||+||++ +.++.++|+|||++..
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~ 153 (284)
T cd06620 78 ICMCMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV---NSRGQIKLCDFGVSGE 153 (284)
T ss_pred EEEEEecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE---CCCCcEEEccCCcccc
Confidence 99999999999998877554 568999999999999999999997 589999999999999 5677899999999875
Q ss_pred cCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChH-----------HHHHHHHhcCCCC
Q 007253 313 VRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES-----------GIFRAVLKADPSF 380 (611)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~-----------~~~~~i~~~~~~~ 380 (611)
... ......+|+..|+|||++. +.++.++|||||||++|+|++|+.||...... +....+.....
T Consensus 154 ~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 230 (284)
T cd06620 154 LIN-SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP-- 230 (284)
T ss_pred hhh-hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC--
Confidence 532 2233457999999999875 66889999999999999999999999754431 22233332221
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 381 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
+......++.++.+||.+||+.||.+|||+.++++|+||....
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 231 PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 1111224788999999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=328.62 Aligned_cols=254 Identities=28% Similarity=0.505 Sum_probs=212.7
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
+-|++.+.||.|+||.||+|.... .+..||||++.... .......+.+|+.+++++. ||||+++++++.+++.+
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~---~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 77 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNR---TQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKL 77 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECC---CCcEEEEEEecccc--chHHHHHHHHHHHHHHhcC-CCCEeEEEEEEEeCCeE
Confidence 347889999999999999998665 58899999985432 2334567889999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++||||+++++|.+++.. ..+++..+..++.||+.||.|||+.|++|+||||+||++ +.++.++|+|||++..+.
T Consensus 78 ~lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06641 78 WIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLT 152 (277)
T ss_pred EEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE---CCCCCEEEeecccceecc
Confidence 999999999999988743 468999999999999999999999999999999999999 567789999999987654
Q ss_pred CCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 315 PDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
... ......|+..|+|||++. ..++.++|+|||||++|+|++|..||...........+...... .....++.++
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 229 (277)
T cd06641 153 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPP---TLEGNYSKPL 229 (277)
T ss_pred cchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCC---CCCcccCHHH
Confidence 332 223457889999999886 55788999999999999999999999876655555444332211 1123578999
Q ss_pred HHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
.++|.+||+.+|.+||++.++++||||+..
T Consensus 230 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 230 KEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 999999999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=328.94 Aligned_cols=257 Identities=21% Similarity=0.345 Sum_probs=210.2
Q ss_pred CCceeEeCeeeeccceEEEEEEEecC--CccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+.|.+.+.||+|+||.||+|.+... ...+..||+|.+... ........+.+|+.+++++. |+||+++++++.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES--CSEQDESDFLMEALIMSKFN-HQNIVRLIGVSFER 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEccC
Confidence 46799999999999999999987642 124678999987543 23344567889999999997 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 232 DNVYVVMELCEGGELLDRILSRG------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
+..++||||++||+|.+++.... ..+++..+..++.||+.||.|||+++++||||||+|||+...+....+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999999887653 258999999999999999999999999999999999999754445679999
Q ss_pred ecccccccCCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCC
Q 007253 306 DFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSF 380 (611)
Q Consensus 306 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~ 380 (611)
|||++..+..... ......+..|+|||++. +.++.++|||||||++|+|++ |..||...........+..... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-~ 240 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGR-L 240 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-C
Confidence 9999987632221 11223456799999885 669999999999999999996 9999988777666555543321 1
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 381 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
. ....++..+.+++.+||+.+|++|||+.++++|
T Consensus 241 ~--~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 241 D--PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred C--CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1 124678999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=333.21 Aligned_cols=260 Identities=27% Similarity=0.430 Sum_probs=212.0
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++.+.||+|+||.||+|.... +++.||||++.+... ......+..|+.++.++.+|+||+++++++.++..
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKK---TGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECC---CCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 4679999999999999999999765 588999999865432 22345667788888887779999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
+|+||||+. ++|.+.+......+++..+..++.||+.||.|||+ .||+||||+|+||++ ++++.+||+|||++..
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill---~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGR 164 (296)
T ss_pred EEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE---cCCCCEEECccccchh
Confidence 999999995 57777776656689999999999999999999997 599999999999999 5778899999999987
Q ss_pred cCCCCcccccccCCCcCcchhhcC-----CCCCcchhhHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhcCCCCCCCCCC
Q 007253 313 VRPDERLNDIVGSAYYVAPEVLHR-----SYSTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwSlGvil~el~~g~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~ 386 (611)
+..........++..|+|||++.+ .++.++||||||+++|+|++|+.||..... .+.+..+........ ....
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~ 243 (296)
T cd06618 165 LVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL-PPNE 243 (296)
T ss_pred ccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC-CCCC
Confidence 654444444568889999998853 378899999999999999999999965322 334444444332111 1112
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.++.++.+||.+||..||.+||++.++++|+||+...
T Consensus 244 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 244 GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 4789999999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=330.06 Aligned_cols=257 Identities=32% Similarity=0.570 Sum_probs=214.9
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
..|...+.||+|++|.||++.... .++.||+|++... .....+.+.+|+.+++.+. |+||+++++++...+..
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~-h~~vv~~~~~~~~~~~~ 91 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKS---TGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQ-HPNIVEMYSSYLVGDEL 91 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECC---CCCEEEEEEEecc---chhHHHHHHHHHHHHHHcC-CCChheEEEEEEcCCeE
Confidence 345666799999999999998665 5789999988532 2233456889999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++|+||+++++|.+++.. .++++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++....
T Consensus 92 ~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~ 166 (285)
T cd06648 92 WVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVS 166 (285)
T ss_pred EEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE---cCCCcEEEcccccchhhc
Confidence 999999999999998765 568999999999999999999999999999999999999 567889999999887554
Q ss_pred CCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 315 PDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
... ......|++.|+|||++. ..++.++|||||||++|+|++|+.||...........+....+.... ....++..+
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l 245 (285)
T cd06648 167 KEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLK-NLHKVSPRL 245 (285)
T ss_pred cCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCc-ccccCCHHH
Confidence 322 223457899999999886 45889999999999999999999999887766666655554322221 123478999
Q ss_pred HHHHHHhcccCccCCCCHHHHHcCcccCCCCC
Q 007253 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~ 424 (611)
.+||.+||+.+|.+|||+.++++|+||+...+
T Consensus 246 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 246 RSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred HHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 99999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=331.98 Aligned_cols=254 Identities=31% Similarity=0.510 Sum_probs=211.4
Q ss_pred eeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC--Cee
Q 007253 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT--DNV 234 (611)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~--~~~ 234 (611)
|++.+.||.|+||.||+|.... .|+.||+|++.... ........+.+|+.+++++. |+||+++++++.+. +..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~---~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~ 75 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKK---TGELVALKKIRMEN-EKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGSI 75 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECC---CCeEEEEEEEeccc-ccccchHHHHHHHHHHHhcc-CCCeeeheeeEecCCCCcE
Confidence 6789999999999999998776 58899999997653 22333456789999999998 99999999999988 899
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++||||+++ +|.+++......+++..++.++.||+.||.|||+.|++|+||||+||++ ++++.+||+|||++....
T Consensus 76 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~ 151 (287)
T cd07840 76 YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYT 151 (287)
T ss_pred EEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---cCCCCEEEccccceeecc
Confidence 999999975 8888887665679999999999999999999999999999999999999 578889999999998765
Q ss_pred CCC--cccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCC-----
Q 007253 315 PDE--RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW----- 385 (611)
Q Consensus 315 ~~~--~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----- 385 (611)
... ......++..|+|||.+. ..++.++||||||+++|+|++|+.||........+..+...........|
T Consensus 152 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 152 KRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred CCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccccc
Confidence 433 234456788999999775 34789999999999999999999999887766655555443221111111
Q ss_pred ---------------------CC-CCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 386 ---------------------PS-LSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 386 ---------------------~~-~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
.. ++..+.++|++||+.+|.+||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 12 27889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=341.39 Aligned_cols=256 Identities=27% Similarity=0.408 Sum_probs=204.8
Q ss_pred CCceeEeCeeeeccceEEEEEEEec--CCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~--~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.++|++.+.||+|+||.||+|.... ...+++.||+|++.... .....+.+.+|+.++.++.+|+||++++++|...
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 4689999999999999999997543 22356899999985432 2334466788999999995599999999988654
Q ss_pred -CeeEEEeeecCCCChHHHHHhcC--------------------------------------------------------
Q 007253 232 -DNVYVVMELCEGGELLDRILSRG-------------------------------------------------------- 254 (611)
Q Consensus 232 -~~~~lv~E~~~~gsL~~~l~~~~-------------------------------------------------------- 254 (611)
..++++|||+++|+|.+++....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 57899999999999999886431
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCC---cccccccCCC
Q 007253 255 ----GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAY 327 (611)
Q Consensus 255 ----~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~ 327 (611)
..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+.... ......++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill---~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---eCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 258999999999999999999999999999999999999 567789999999998764322 1233456778
Q ss_pred cCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCcc
Q 007253 328 YVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPR 405 (611)
Q Consensus 328 y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 405 (611)
|+|||++. ..++.++|||||||++|||++ |..||.+....+.+...+........ ...++.++.+++.+||+.+|.
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~cl~~~p~ 318 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA--PEYATPEIYSIMLDCWHNNPE 318 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCC--CccCCHHHHHHHHHHccCChh
Confidence 99999875 669999999999999999997 99999775544444333333221111 135688999999999999999
Q ss_pred CCCCHHHHHcC
Q 007253 406 KRLTAAQALSH 416 (611)
Q Consensus 406 ~Rpt~~~ll~h 416 (611)
+||++.++++|
T Consensus 319 ~RPs~~ell~~ 329 (337)
T cd05054 319 DRPTFSELVEI 329 (337)
T ss_pred hCcCHHHHHHH
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=335.05 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=203.9
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCc--EEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQ--QVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
++|++.+.||+|+||.||+|.... ++. .+|+|.+... ........+.+|+.++.++.+|+||+++++++.+++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~---~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKK---DGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEcc---CCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 579999999999999999998765 343 4677776432 234455678899999999955999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccC
Q 007253 233 NVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD 297 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~ 297 (611)
.+|+||||+++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili---~ 158 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---G 158 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe---c
Confidence 9999999999999999886542 258899999999999999999999999999999999999 5
Q ss_pred CCceEEEeecccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 007253 298 ENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLK 375 (611)
Q Consensus 298 ~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~ 375 (611)
.++.+||+|||++.............++..|+|||++. ..++.++|||||||++|+|++ |..||......+....+..
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 238 (303)
T cd05088 159 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 238 (303)
T ss_pred CCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence 67789999999986432111112223456799999886 457899999999999999998 9999987776666555533
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 376 ADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 376 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
.. .......++.++.+||.+||+.+|.+||++.+++.+
T Consensus 239 ~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 239 GY---RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CC---cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 21 111123578899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=328.89 Aligned_cols=249 Identities=29% Similarity=0.504 Sum_probs=203.7
Q ss_pred eEeCeeeeccceEEEEEEEe-cCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEE
Q 007253 158 ELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (611)
Q Consensus 158 ~~~~~LG~G~fg~V~~~~~~-~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 236 (611)
.+.+.||.|.||.||+|.+. .....+..|+||++... ......+.+.+|++++++++ ||||++++|++...+..++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~-h~ni~~~~g~~~~~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLR-HPNIVKLYGFCIENEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHS-BTTBE-EEEEEESSSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccc-ccccccccccccccccccc
Confidence 56789999999999999998 44446789999999442 34445788999999999996 9999999999998888999
Q ss_pred EeeecCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC
Q 007253 237 VMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (611)
Q Consensus 237 v~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~ 315 (611)
|||||++|+|.+++... ...+++..++.|+.||+.||.|||+++|+|+||+++|||+ +.++.+||+|||++.....
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill---~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILL---DSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE---ETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccc
Confidence 99999999999999887 5679999999999999999999999999999999999999 5678999999999987632
Q ss_pred CCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 316 DER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 316 ~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
... .....+...|+|||.+. ..++.++||||||+++|||++ |+.||.......+...+..... .. ....++.
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~ 232 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR-LP--IPDNCPK 232 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE-TT--SBTTSBH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ce--eccchhH
Confidence 221 23345677899999986 558999999999999999999 7899988877777777744432 21 1235799
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHc
Q 007253 391 EARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
.+.++|.+||..||.+|||+.++++
T Consensus 233 ~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 233 DIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHh
Confidence 9999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=329.80 Aligned_cols=260 Identities=20% Similarity=0.327 Sum_probs=210.8
Q ss_pred CCceeEeCeeeeccceEEEEEEEecC--CccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.++|++.+.||+|+||.||+|..+.. ...+..||+|.+.... .......+.+|+.+++++. |+||+++++++.+.
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 81 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFT-CHHVVRLLGVVSKG 81 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcCC
Confidence 57899999999999999999976531 1245689999886432 2233456788999999997 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceE
Q 007253 232 DNVYVVMELCEGGELLDRILSRG---------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVL 302 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~v 302 (611)
+..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili---~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV---AHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEE---cCCCcE
Confidence 99999999999999999986532 235677889999999999999999999999999999999 567889
Q ss_pred EEeecccccccCCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcC
Q 007253 303 KAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKAD 377 (611)
Q Consensus 303 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~ 377 (611)
||+|||+++....... .....++..|+|||.+. +.++.++|||||||++|||++ |..||.+....+....+....
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 238 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 238 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999876533221 12234567899999886 568999999999999999998 789998877766665554432
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc------CcccCCC
Q 007253 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS------HPWIKNS 422 (611)
Q Consensus 378 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~------hp~~~~~ 422 (611)
.. .. ....+..+.+++.+||+.||.+|||+.++++ ||||++.
T Consensus 239 ~~--~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 239 YL--DQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred CC--CC-CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 11 11 1246789999999999999999999999987 9999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=345.42 Aligned_cols=260 Identities=27% Similarity=0.521 Sum_probs=235.6
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
..+++++..||-||||.|-+++.... ...+|+|++++...-+....+.+..|-+||..++ .|.||+||..|.+.+.
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~---~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQ---KATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRDSKY 494 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEeccc---chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhccchh
Confidence 44577788899999999999987652 3358999998877777777889999999999998 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|++||-|-||.|...+..+ +.+.+.+++.++..++.|++|||++|||+|||||+|+|| +.+|.+||.|||+|+.+
T Consensus 495 vYmLmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKI 570 (732)
T ss_pred hhhhHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHh
Confidence 99999999999999877655 679999999999999999999999999999999999999 78999999999999999
Q ss_pred CCCCcccccccCCCcCcchhh-cCCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 314 RPDERLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
..+.++.+.||||.|.|||++ ++.++.++|.||||+++|||++|.+||.+.+....+..|+++.-.+..+ ..++..+
T Consensus 571 ~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--r~I~k~a 648 (732)
T KOG0614|consen 571 GSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--RRITKTA 648 (732)
T ss_pred ccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc--cccchhH
Confidence 999999999999999999965 6889999999999999999999999999999999999999876444333 4688999
Q ss_pred HHHHHHhcccCccCCCC-----HHHHHcCcccCCCC
Q 007253 393 RDFVKRLLNKDPRKRLT-----AAQALSHPWIKNSN 423 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rpt-----~~~ll~hp~~~~~~ 423 (611)
.+||+++...+|.+|.. +.+|.+|.||.+.+
T Consensus 649 ~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd 684 (732)
T KOG0614|consen 649 TDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFD 684 (732)
T ss_pred HHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence 99999999999999985 89999999998765
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=328.70 Aligned_cols=255 Identities=19% Similarity=0.300 Sum_probs=207.7
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecC--CccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
..++|++.+.||+|+||.||+|..... ...+..||+|++.... .......+.+|+.+++.++ |+||+++++++.+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~ 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQ 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcC
Confidence 457899999999999999999986531 2246789999985432 2233456889999999997 9999999999999
Q ss_pred CCeeEEEeeecCCCChHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCce
Q 007253 231 TDNVYVVMELCEGGELLDRILSRG---------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301 (611)
Q Consensus 231 ~~~~~lv~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~ 301 (611)
....++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.|++||||||+|||+ ++++.
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~---~~~~~ 157 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFT 157 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE---cCCCC
Confidence 999999999999999999886532 235778899999999999999999999999999999999 56788
Q ss_pred EEEeecccccccCCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q 007253 302 LKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKA 376 (611)
Q Consensus 302 vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~ 376 (611)
+||+|||++........ .....+++.|||||++. +.++.++|||||||++|||++ |..||.+.........+...
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 237 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG 237 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999875533221 11234577899999886 568999999999999999998 78999887776666655544
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 377 DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 377 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
..... ....+..+.++|.+||+.||++|||+.+++++
T Consensus 238 ~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 238 GLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CcCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 32111 13578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=335.21 Aligned_cols=253 Identities=28% Similarity=0.501 Sum_probs=211.0
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
+.|+..+.||+|+||.||+|.... .+..||+|++.... .....+.+.+|+.+++++. ||||+++++++..++.+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 77 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNR---TKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYITRYYGSYLKGTKL 77 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcC---CCeEEEEEEecccc--chHHHHHHHHHHHHHHcCC-CCccHhhhcccccCCce
Confidence 458888999999999999998765 57899999986442 2334567899999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++||||+++++|.+++.. ..+++..++.++.||+.||.|||++|++|+||+|+||++ +.++.+||+|||++..+.
T Consensus 78 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i---~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06642 78 WIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL---SEQGDVKLADFGVAGQLT 152 (277)
T ss_pred EEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEE---eCCCCEEEcccccccccc
Confidence 999999999999987743 568999999999999999999999999999999999999 567789999999997765
Q ss_pred CCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 315 PDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
... ......|+..|+|||++. ..++.++|||||||++|+|++|+.||...........+...... .....++.++
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 229 (277)
T cd06642 153 DTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPP---TLEGQYSKPF 229 (277)
T ss_pred CcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCC---CCCcccCHHH
Confidence 332 223346889999999986 45888999999999999999999999766554444333222211 1113568899
Q ss_pred HHHHHHhcccCccCCCCHHHHHcCcccCC
Q 007253 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
.++|.+||..+|.+||++.++++||||+.
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 230 KEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred HHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 99999999999999999999999999865
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=332.38 Aligned_cols=254 Identities=33% Similarity=0.659 Sum_probs=218.9
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|.+.+.||+|+||.||+|.... +|+.||+|++.+...........+.+|+.+++++.+|+||+++++++.+++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 77 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKE---TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENL 77 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcC---CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceE
Confidence 369999999999999999999776 68999999997654444455577889999999997799999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++||||+++++|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+||++ +.++.++|+|||++....
T Consensus 78 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 78 YFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEecCCccccccC
Confidence 9999999999999988655 479999999999999999999999999999999999999 567789999999987654
Q ss_pred CCC---------------------cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 007253 315 PDE---------------------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRA 372 (611)
Q Consensus 315 ~~~---------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~ 372 (611)
... ......|+..|+|||++. ..++.++||||||++++++++|+.||........+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 322 122346789999999876 5588899999999999999999999988877666666
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCH----HHHHcCccc
Q 007253 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTA----AQALSHPWI 419 (611)
Q Consensus 373 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~----~~ll~hp~~ 419 (611)
+......++ ..+++.+.+||.+||+.+|.+||++ .++++||||
T Consensus 234 ~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILKLEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHhcCCCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 665443333 3568999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=325.92 Aligned_cols=254 Identities=28% Similarity=0.549 Sum_probs=212.6
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
+|++.+.||+|+||.||+|.... .|..||+|.+....... ...+.+.+|+.+++.++ |+||+++++.+.+....+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~-h~~i~~~~~~~~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKS---DSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMK-HPNIVTFFASFQENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcC---CCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCC-CCChhhhhheeccCCeEE
Confidence 48899999999999999999776 58889999986543222 23456789999999997 999999999999999999
Q ss_pred EEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 236 VVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
+|+||+++++|.+++.... ..+++..+..++.||+.||.|||+.+|+|+||||+||+++ +....+||+|||.+....
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~--~~~~~~~l~d~~~~~~~~ 153 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLS--KNGMVAKLGDFGIARQLN 153 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEc--CCCCeEEecccccchhcc
Confidence 9999999999999886643 3589999999999999999999999999999999999995 233467999999988765
Q ss_pred CCCc-ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 315 PDER-LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 315 ~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
.... .....|++.|+|||++. ..++.++|+|||||++|+|++|..||...........+...... ...+.++.++
T Consensus 154 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 230 (257)
T cd08225 154 DSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA---PISPNFSRDL 230 (257)
T ss_pred CCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC---CCCCCCCHHH
Confidence 4332 23346899999999886 56889999999999999999999999877666655555443221 1124578899
Q ss_pred HHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 393 RDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
.++|.+||..+|++|||+.+++.||||
T Consensus 231 ~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 231 RSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=320.90 Aligned_cols=258 Identities=28% Similarity=0.519 Sum_probs=229.3
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
..+|.++++||+|+|..|.++++++ +.+.||+|++++.-..+...+..+..|-.+...-.+||.+|-|..+|..+.+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~---t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKK---TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred cccceeeeeecCcchhhhhheehcc---cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 4679999999999999999999988 6899999999988877888888899999999988899999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc-
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF- 312 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~- 312 (611)
+++|.||++||+|.-.+. +.++++++.++.+..+|+.||.|||++|||+||||.+|||+ |..|++||+|+|+++.
T Consensus 326 lffvieyv~ggdlmfhmq-rqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~ 401 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEEEecCcceeeehh-hhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcC
Confidence 999999999999976554 34679999999999999999999999999999999999999 7889999999999985
Q ss_pred cCCCCcccccccCCCcCcchhhcC-CCCCcchhhHHHHHHHHHHhCCCCCCC--------CChHHHHHHHHhcCCCCCCC
Q 007253 313 VRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWA--------RTESGIFRAVLKADPSFDEA 383 (611)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~el~~g~~Pf~~--------~~~~~~~~~i~~~~~~~~~~ 383 (611)
+.++..+.+.||||.|.|||++++ .|+..+|+|+|||+++||+.|+.||.- .++.-.++.|+.....++.
T Consensus 402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr- 480 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR- 480 (593)
T ss_pred CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc-
Confidence 466678889999999999999985 599999999999999999999999942 2333456677777666664
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCC------CHHHHHcCcccCCC
Q 007253 384 PWPSLSSEARDFVKRLLNKDPRKRL------TAAQALSHPWIKNS 422 (611)
Q Consensus 384 ~~~~~s~~~~~li~~~L~~dP~~Rp------t~~~ll~hp~~~~~ 422 (611)
.+|-.+..+++..|++||.+|. ...++..|+||+..
T Consensus 481 ---slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i 522 (593)
T KOG0695|consen 481 ---SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI 522 (593)
T ss_pred ---eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence 5677888999999999999997 47899999999853
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=328.30 Aligned_cols=250 Identities=36% Similarity=0.586 Sum_probs=213.6
Q ss_pred eeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeeecC
Q 007253 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCE 242 (611)
Q Consensus 163 LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~~~ 242 (611)
||.|+||.||+++... +|+.||+|++...........+.+.+|+.+++++. |+||+++++.+..++..|+||||++
T Consensus 1 lg~g~~~~vy~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (265)
T cd05579 1 ISKGAYGRVFLAKKKS---TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQGKKNLYLVMEYLP 76 (265)
T ss_pred CCCCCceEEEEEEECC---CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHheecCcEEEEEEecCC
Confidence 6899999999998765 58999999997654444456678899999999998 9999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCC-----
Q 007253 243 GGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE----- 317 (611)
Q Consensus 243 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~----- 317 (611)
+++|.+++.... .+++..++.++.||+.||.|||+.|++||||+|+||++ +.++.+||+|||++.......
T Consensus 77 ~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 77 GGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE---cCCCCEEEEecccchhcccCcccccc
Confidence 999999886654 79999999999999999999999999999999999999 567789999999987654321
Q ss_pred ----cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 318 ----RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 318 ----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
......++..|+|||++. ..++.++||||||+++|+|++|..||......+....+......++.. ..++..+
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 230 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEA 230 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc--ccCCHHH
Confidence 223456889999999875 458889999999999999999999998888777777766644333322 2358999
Q ss_pred HHHHHHhcccCccCCCCH---HHHHcCcccCCC
Q 007253 393 RDFVKRLLNKDPRKRLTA---AQALSHPWIKNS 422 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rpt~---~~ll~hp~~~~~ 422 (611)
.+||.+||+.+|.+|||+ .++|+||||++.
T Consensus 231 ~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 231 IDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred HHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 999999999999999999 999999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=324.82 Aligned_cols=247 Identities=25% Similarity=0.411 Sum_probs=207.4
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|.+++.||+|+||.||+|+... +..||+|.+..... ..+.+.+|+.++++++ ||||+++++++.+.+.+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 74 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG----QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLS-HEKLVQLYGVCTKQRPI 74 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC----CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCC-CCCeeeEEEEEccCCCc
Confidence 569999999999999999997643 45699998864322 2356889999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++||||+.+|+|.+++......+++..++.++.||+.||.|||+.||+|+||||+|||+ +.++.+||+|||++....
T Consensus 75 ~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05113 75 YIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVL 151 (256)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCCEEECCCccceecC
Confidence 99999999999999987765679999999999999999999999999999999999999 567789999999987654
Q ss_pred CCCcc--cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 315 PDERL--NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 315 ~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
..... ....++..|+|||++. ..++.++|||||||++|+|++ |..||...........+......... ...+.
T Consensus 152 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 228 (256)
T cd05113 152 DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP---HLASE 228 (256)
T ss_pred CCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC---CCCCH
Confidence 33211 1224567899999986 568899999999999999998 99999887777776766655432221 24689
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 391 EARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
.+.+++.+||..||.+||++.+++.+
T Consensus 229 ~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 229 KVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=328.60 Aligned_cols=252 Identities=26% Similarity=0.520 Sum_probs=208.4
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++.+.||+|+||.||+|.... +|+.||||.+.............+.+|+.+++.+. |+||+++++++.+++..
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~ 77 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLL---DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNEL 77 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecC---CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc-CCchhhhhheeEeCCeE
Confidence 468999999999999999999766 58899999886544444455678889999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 235 YVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+++|||+++++|.+++.. ....+++..++.++.||+.||.|||++|++|+||||+||++ +.++.++|+|||++.
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~ 154 (267)
T cd08229 78 NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEECcchhhh
Confidence 999999999999988753 23468999999999999999999999999999999999999 567789999999987
Q ss_pred ccCCCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhcCCCCCCCCCCC
Q 007253 312 FVRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES--GIFRAVLKADPSFDEAPWPS 387 (611)
Q Consensus 312 ~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~ 387 (611)
...... ......|+..|+|||++. ..++.++||||||+++|+|++|..||...... .....+... ..+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 232 (267)
T cd08229 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDH 232 (267)
T ss_pred ccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC--CCCCCCccc
Confidence 664332 223457899999999886 56888999999999999999999999754432 222222221 222223345
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
++.++.++|.+||..||.+|||+.++++
T Consensus 233 ~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 233 YSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 7899999999999999999999997764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=334.60 Aligned_cols=257 Identities=30% Similarity=0.572 Sum_probs=213.8
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
..|+....||+|+||.||+|.... .++.||+|++..... ...+.+.+|+.+++.+. ||||+++++++..++..
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~ 93 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKH---SGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQ-HQNVVEMYKSYLVGEEL 93 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcC---CCCEEEEEEEEeccc---chHHHHHHHHHHHHhCC-CCchhhhhhheeeCCeE
Confidence 345566689999999999998765 588999999854322 23456889999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 94 ~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill---~~~~~~kL~dfg~~~~~~ 168 (297)
T cd06659 94 WVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQIS 168 (297)
T ss_pred EEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE---ccCCcEEEeechhHhhcc
Confidence 999999999999886643 468999999999999999999999999999999999999 577889999999987554
Q ss_pred CCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 315 PDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
... ......|+..|+|||++. ..++.++|||||||++|+|++|+.||......+....+...... ....+..++..+
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 247 (297)
T cd06659 169 KDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP-KLKNAHKISPVL 247 (297)
T ss_pred cccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC-CccccCCCCHHH
Confidence 332 234467899999999986 46889999999999999999999999877666655544433222 222234678999
Q ss_pred HHHHHHhcccCccCCCCHHHHHcCcccCCCCC
Q 007253 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~ 424 (611)
.++|.+||+.+|.+||++.++++||||.....
T Consensus 248 ~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 248 RDFLERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred HHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 99999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=337.15 Aligned_cols=261 Identities=32% Similarity=0.525 Sum_probs=204.1
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC--Ce
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT--DN 233 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~--~~ 233 (611)
+|++.+.||+|+||.||+|..... ..++.||+|++...........+.+.+|+.+++.+. ||||+++++++.+. +.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~-~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 78 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG-KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLEHADKS 78 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC-CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEeCCCCce
Confidence 488999999999999999997652 147899999997643222333456788999999997 99999999999988 78
Q ss_pred eEEEeeecCCCChHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEec-cCCCceEEEeecc
Q 007253 234 VYVVMELCEGGELLDRILSRG----GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT-KDENSVLKAIDFG 308 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~-~~~~~~vkl~DfG 308 (611)
+++||||+++ +|.+.+.... ..+++..++.++.||+.||.|||+.+|+||||||+|||++. .+.++.+||+|||
T Consensus 79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 79 VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999999965 7777665332 36899999999999999999999999999999999999953 1127889999999
Q ss_pred cccccCCCCc----ccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHH---------HHHHH
Q 007253 309 LSDFVRPDER----LNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESG---------IFRAV 373 (611)
Q Consensus 309 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~---------~~~~i 373 (611)
++........ .....++..|+|||++.+ .++.++|||||||++|+|++|+.||.+..... .+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9887643221 234578899999998753 47899999999999999999999997544321 11111
Q ss_pred HhcC--------------C-------CCCCCCCC------------CCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 374 LKAD--------------P-------SFDEAPWP------------SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 374 ~~~~--------------~-------~~~~~~~~------------~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
...- + ......++ ..+.++.++|.+||+.||++|||+.++++||||
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 1100 0 00001111 467789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=322.95 Aligned_cols=243 Identities=24% Similarity=0.387 Sum_probs=200.6
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeee
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~ 240 (611)
+.||+|+||.||+|.... +++.||+|.+... ........+.+|+++++.+. ||||+++++++...+.+++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~---~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~ 74 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRA---DNTPVAVKSCRET--LPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMEL 74 (252)
T ss_pred CccCcccCccEEEEEEec---CCceEEEEecCcc--CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEcCCCCeEEEEee
Confidence 479999999999999876 5889999987543 23445567899999999997 99999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCCcc-
Q 007253 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL- 319 (611)
Q Consensus 241 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~- 319 (611)
+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.........
T Consensus 75 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~ 151 (252)
T cd05084 75 VQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYAS 151 (252)
T ss_pred ccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE---cCCCcEEECccccCcccccccccc
Confidence 99999999987666679999999999999999999999999999999999999 56778999999998765422111
Q ss_pred --cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 007253 320 --NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395 (611)
Q Consensus 320 --~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 395 (611)
....++..|+|||.+. +.++.++|||||||++|+|++ |..||...........+...... .....++..+.+|
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l 228 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL---PCPELCPDAVYRL 228 (252)
T ss_pred cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC---CCcccCCHHHHHH
Confidence 1112345699999886 568999999999999999997 99999776665555544432211 1223578999999
Q ss_pred HHHhcccCccCCCCHHHHHc
Q 007253 396 VKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 396 i~~~L~~dP~~Rpt~~~ll~ 415 (611)
+.+||+.+|.+|||+.++++
T Consensus 229 i~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 229 MERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=378.25 Aligned_cols=260 Identities=33% Similarity=0.570 Sum_probs=222.0
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
+..-++..+..||.|.||.||.|.... +|...|+|.+...... ......+.+|..++..|. |||+|++||+-.+.
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~---tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~ln-HpNlV~YyGVEvHR 1306 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLD---TGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLN-HPNLVRYYGVEVHR 1306 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCC---ccchhhhhhhhcCccc-cccCcchHHHHHHHHhcc-CccccccCceeecH
Confidence 345568889999999999999999776 7999999998755443 455677899999999998 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+.++|.||||+||+|.+.+ ++++-.++...+.+..|++.||.|||++|||||||||.|||| +.+|.+|++|||.|.
T Consensus 1307 ekv~IFMEyC~~GsLa~ll-~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L---d~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLL-EHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL---DFNGLIKYGDFGSAV 1382 (1509)
T ss_pred HHHHHHHHHhccCcHHHHH-HhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee---ecCCcEEeeccccee
Confidence 9999999999999998865 555667888888999999999999999999999999999999 688899999999998
Q ss_pred ccCCCC-----cccccccCCCcCcchhhcC----CCCCcchhhHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhc-CCCC
Q 007253 312 FVRPDE-----RLNDIVGSAYYVAPEVLHR----SYSTEADVWSIGVIAYILLCGSRPFWART-ESGIFRAVLKA-DPSF 380 (611)
Q Consensus 312 ~~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~~~~DiwSlGvil~el~~g~~Pf~~~~-~~~~~~~i~~~-~~~~ 380 (611)
.+.... .....+||+.|||||++.+ +...+.|||||||+++||+||+.||...+ +-+++..+..+ .|.+
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~ 1462 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQI 1462 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCC
Confidence 775442 3456799999999999953 46779999999999999999999996543 33555555443 4566
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCC
Q 007253 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (611)
Q Consensus 381 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~ 424 (611)
|+ .++++..+||.+||..||++|+++.|||+|.|-+...+
T Consensus 1463 P~----~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d 1502 (1509)
T KOG4645|consen 1463 PE----RLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTD 1502 (1509)
T ss_pred ch----hhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccc
Confidence 55 38999999999999999999999999999999876543
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=328.93 Aligned_cols=251 Identities=26% Similarity=0.411 Sum_probs=209.0
Q ss_pred CCceeEeCeeeeccceEEEEEEEecC--CccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
..+|.+.+.||+|+||.||++..... ...+..||+|.+... .......+.+|+.+++++. ||||+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 79 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEG 79 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecC
Confidence 35699999999999999999986442 224567999988543 3445567899999999997 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCC
Q 007253 232 DNVYVVMELCEGGELLDRILSRG------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN 299 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~ 299 (611)
+.+++||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili---~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---ccC
Confidence 99999999999999999987543 248999999999999999999999999999999999999 577
Q ss_pred ceEEEeecccccccCCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 007253 300 SVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVL 374 (611)
Q Consensus 300 ~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~ 374 (611)
+.+||+|||++........ .....++..|+|||++. ..++.++|||||||++|+|++ |..||...........+.
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~ 236 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 8899999999986543221 12334577899999886 568999999999999999998 999998887777777776
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHH
Q 007253 375 KADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414 (611)
Q Consensus 375 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll 414 (611)
....... ...++.++.+|+.+||+.||.+|||+.+++
T Consensus 237 ~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~ 273 (288)
T cd05093 237 QGRVLQR---PRTCPKEVYDLMLGCWQREPHMRLNIKEIH 273 (288)
T ss_pred cCCcCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 5542211 135789999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=349.50 Aligned_cols=281 Identities=28% Similarity=0.495 Sum_probs=230.6
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee-
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED- 230 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~- 230 (611)
...+.|++.+.||.|.+|.||+++.++ .|+..|+|++.... ...+++..|.++++.+.+|||++.+|++|.-
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~---~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVK---TGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeee---cCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 346779999999999999999999887 68899999985432 2346788899999999999999999999863
Q ss_pred ----CCeeEEEeeecCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 231 ----TDNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 231 ----~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
++.+|||||||.|||.-|.++.- +.++.|..+..|++.++.||.+||.+.+||||||-.|||++ .++.|||+
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT---~e~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLT---ENAEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEe---ccCcEEEe
Confidence 56899999999999999988653 56799999999999999999999999999999999999995 66779999
Q ss_pred ecccccccCCC-CcccccccCCCcCcchhhc------CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Q 007253 306 DFGLSDFVRPD-ERLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (611)
Q Consensus 306 DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~ 378 (611)
|||++..++.. .+.++.+|||+|||||++. ..|+..+|+||||++..||.-|.+|+.+.-....+..|-+ +|
T Consensus 166 DFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR-NP 244 (953)
T KOG0587|consen 166 DFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-NP 244 (953)
T ss_pred eeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC-CC
Confidence 99999877644 3567889999999999984 2377899999999999999999999977655433322222 22
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCCCCchhHHHHHHHHHHhhcchHHH
Q 007253 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRK 448 (611)
Q Consensus 379 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 448 (611)
......+..+++++.+||..||.+|-.+||+..++|+|||++.. +.+.++-..++.....++-.+
T Consensus 245 PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~-----~~e~qir~~ik~~~~~~r~~k 309 (953)
T KOG0587|consen 245 PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ-----PNERQVRIQIKDHIDRSRKKR 309 (953)
T ss_pred CccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc-----ccHHHHHHHHHHHHhhccchh
Confidence 22223356789999999999999999999999999999999932 266666666666555555333
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=331.38 Aligned_cols=254 Identities=30% Similarity=0.479 Sum_probs=207.9
Q ss_pred eeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEE
Q 007253 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (611)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 236 (611)
|++.+.||.|++|.||+|.... +|..||+|++...... ....+.+.+|+.+++.++ ||||+++++++.+++..|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKL---TGEIVALKKIRLETED-EGVPSTAIREISLLKELN-HPNIVRLLDVVHSENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcC---CCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcC-CCCccCHhheeccCCeEEE
Confidence 6788999999999999998766 5899999998654322 223356788999999998 9999999999999999999
Q ss_pred EeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC
Q 007253 237 VMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (611)
Q Consensus 237 v~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~ 315 (611)
||||+. ++|.+++.... ..+++..++.++.||+.||.|||+++++||||+|+||++ +.++.+||+|||++.....
T Consensus 76 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~ 151 (283)
T cd07835 76 VFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI---DREGALKLADFGLARAFGV 151 (283)
T ss_pred EEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCcEEEeecccccccCC
Confidence 999995 68998886654 368999999999999999999999999999999999999 5678899999999976543
Q ss_pred CC-cccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-------------
Q 007253 316 DE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS------------- 379 (611)
Q Consensus 316 ~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~------------- 379 (611)
.. ......+++.|+|||++.+ .++.++|||||||++|+|++|+.||...........+.+....
T Consensus 152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence 22 2233467899999998753 4788999999999999999999999877665444443332100
Q ss_pred ------------CCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 380 ------------FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 380 ------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
......+.++..+.++|.+||+.||.+|||+.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0011134678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=319.06 Aligned_cols=252 Identities=35% Similarity=0.607 Sum_probs=213.2
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
+|++.+.||+|++|.||++.... .++.|++|++..... .....+.+|+.+++++. |+||+++++.+..+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 73 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKR---TGKEVAIKVIKLESK---EKKEKIINEIQILKKCK-HPNIVKYYGSYLKKDELW 73 (253)
T ss_pred CceeeeeeccCCceEEEEEEECC---CCcEEEEEEecccch---hHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEE
Confidence 48899999999999999999775 588999999865432 35577899999999998 999999999999999999
Q ss_pred EEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC
Q 007253 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~ 315 (611)
+++||+++++|.+++......+++..++.++.||+.||.|||+.|++||||+|+||++ +.++.+||+|||.+.....
T Consensus 74 l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~ 150 (253)
T cd05122 74 IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL---TSDGEVKLIDFGLSAQLSD 150 (253)
T ss_pred EEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEE---ccCCeEEEeeccccccccc
Confidence 9999999999999887765679999999999999999999999999999999999999 5678899999999987765
Q ss_pred CCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 007253 316 DERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARD 394 (611)
Q Consensus 316 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 394 (611)
........|+..|+|||++. ..++.++||||||+++|+|++|+.||...........+........ .....++..+.+
T Consensus 151 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 229 (253)
T cd05122 151 TKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGL-RNPEKWSDEFKD 229 (253)
T ss_pred cccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCc-CcccccCHHHHH
Confidence 44345567899999999886 4578899999999999999999999987755444444333221111 111234899999
Q ss_pred HHHHhcccCccCCCCHHHHHcCcc
Q 007253 395 FVKRLLNKDPRKRLTAAQALSHPW 418 (611)
Q Consensus 395 li~~~L~~dP~~Rpt~~~ll~hp~ 418 (611)
+|.+||+.||.+|||+.++++|||
T Consensus 230 ~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 230 FLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHHccCChhhCCCHHHHhcCCC
Confidence 999999999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=324.25 Aligned_cols=247 Identities=24% Similarity=0.434 Sum_probs=207.5
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++.++||+|+||.||+|.... +..||+|.+.... ...+.+.+|+.+++.++ |+||+++++++.+.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~----~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 75 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNN----STKVAVKTLKPGT----MSVQAFLEEANLMKTLQ-HDKLVRLYAVVTKEEP 75 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecC----CceEEEEEccCCc----hhHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCC
Confidence 4679999999999999999998543 5679999875432 23467889999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 234 VYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.++||||+++|+|.+++... ...+++..+..++.||+.||.|||+.+++||||||+||++ +.++.+||+|||++..
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~ 152 (261)
T cd05072 76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLARV 152 (261)
T ss_pred cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe---cCCCcEEECCCcccee
Confidence 99999999999999988754 3568999999999999999999999999999999999999 5678899999999987
Q ss_pred cCCCCc--ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 313 VRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 313 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
...... .....++..|+|||++. +.++.++|||||||++|+|++ |..||...........+..... . .....+
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~ 229 (261)
T cd05072 153 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR-M--PRMENC 229 (261)
T ss_pred cCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC-C--CCCCCC
Confidence 643321 12234567899999886 568889999999999999998 9999988777766666654422 1 223467
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
+.++.+++.+||..+|++||++.++++
T Consensus 230 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 230 PDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=327.27 Aligned_cols=253 Identities=20% Similarity=0.338 Sum_probs=208.5
Q ss_pred CceeEeCeeeeccceEEEEEEEec-CCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
++|++.+.||+|+||.||+|.... +...+..||+|.+... ........+.+|+.++++++ ||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--NNPQQWGEFQQEASLMAELH-HPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCc
Confidence 568999999999999999998643 2225688999998643 23445567889999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccC
Q 007253 234 VYVVMELCEGGELLDRILSRG----------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD 297 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~ 297 (611)
.|+||||+++|+|.+++..+. ..+++..+..++.||+.||.|||++||+||||||+|||+ +
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili---~ 158 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---G 158 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE---c
Confidence 999999999999999885331 247889999999999999999999999999999999999 5
Q ss_pred CCceEEEeecccccccCCCC---cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 007253 298 ENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRA 372 (611)
Q Consensus 298 ~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~ 372 (611)
.++.+||+|||++....... ......++..|+|||++. +.++.++|||||||++|||++ |..||.+.....+...
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 67789999999998654332 223345677899999886 568999999999999999998 9999988776655555
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 373 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
+..... .+ ....++..+.+++.+||+.||.+||++.+++++
T Consensus 239 ~~~~~~-~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 239 VRKRQL-LP--CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHcCCc-CC--CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 544332 21 224678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=321.05 Aligned_cols=253 Identities=32% Similarity=0.589 Sum_probs=217.3
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
+|++.+.||.|+||.||++.... +++.||+|++..... .......+.+|+++++.++ |+|++++++.+...+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKS---DGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLN-HPNIIKYYESFEEKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcC---CCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcC-CCChhheEEEEecCCEEE
Confidence 58899999999999999999765 588999999865432 2345567889999999998 999999999999999999
Q ss_pred EEeeecCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 236 VVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
+|+||+++++|.+++... +..+++..+..++.+|+.||.|||+.|++|+||+|+||++ +.++.+||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~ 152 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKV 152 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEE---cCCCcEEECCccceee
Confidence 999999999999988765 3679999999999999999999999999999999999999 5678899999999987
Q ss_pred cCCCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 313 VRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 313 ~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
..... ......|++.|+|||.+. ..++.++|+||+|+++|+|++|..||.................... ...++.
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 229 (258)
T cd08215 153 LSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPI---PSQYSS 229 (258)
T ss_pred cccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCC---CCCCCH
Confidence 65443 234457899999999875 5588999999999999999999999988776666666554432211 126789
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 391 EARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
++.++|.+||..+|.+|||+.++|+||||
T Consensus 230 ~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 230 ELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=325.23 Aligned_cols=252 Identities=21% Similarity=0.329 Sum_probs=207.0
Q ss_pred eeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe---
Q 007253 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN--- 233 (611)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~--- 233 (611)
|.+++.||+|+||.||.|....+...+..||+|++.... ........+.+|+.+++.+. |+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI-HTYSEIEEFLSEAACMKDFD-HPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc-CCHHHHHHHHHHHHHHHhCC-CCCeeeEEeeeccCCcccc
Confidence 578899999999999999887644456889999986543 23445567899999999997 9999999998876554
Q ss_pred ---eEEEeeecCCCChHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 234 ---VYVVMELCEGGELLDRILSR-----GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 234 ---~~lv~E~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
.++||||+++|+|..++... ...+++..++.++.||+.||.|||+++|+||||||+||++ ++++.+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE---CCCCeEEEC
Confidence 79999999999999887543 2358999999999999999999999999999999999999 567889999
Q ss_pred ecccccccCCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCC
Q 007253 306 DFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSF 380 (611)
Q Consensus 306 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~ 380 (611)
|||+++.+..... .....++..|+|||++. ..++.++|||||||++|||++ |..||.+....+.+..+......
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~- 234 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL- 234 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-
Confidence 9999986643321 11223567899999886 568999999999999999999 99999887777776666544321
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 381 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
. ....++..+.+++.+||+.||.+|||+.+++++
T Consensus 235 ~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 235 K--QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred C--CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 123678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=332.84 Aligned_cols=258 Identities=29% Similarity=0.482 Sum_probs=210.8
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|++.+.||+|+||.||+|.... .|+.||+|++...... ......+.+|+.++++++ ||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~ 79 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKD---TGELVALKKVRLDNEK-EGFPITAIREIKILRQLN-HRNIVNLKEIVTDKQ 79 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECC---CCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCC-CCCeeeeeheecCcc
Confidence 45789999999999999999999876 5889999998654321 223346778999999997 999999999987655
Q ss_pred ----------eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceE
Q 007253 233 ----------NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVL 302 (611)
Q Consensus 233 ----------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~v 302 (611)
.+++|+||+++ +|.+.+......+++..++.++.||+.||.|||+.||+||||||+||++ ++++.+
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~ 155 (302)
T cd07864 80 DALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---NNKGQI 155 (302)
T ss_pred hhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCcE
Confidence 79999999976 7888777665679999999999999999999999999999999999999 677889
Q ss_pred EEeecccccccCCCC--cccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Q 007253 303 KAIDFGLSDFVRPDE--RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (611)
Q Consensus 303 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~ 378 (611)
||+|||++....... ......++..|+|||++.+ .++.++|||||||++|+|++|+.||......+.+..+.....
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~ 235 (302)
T cd07864 156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG 235 (302)
T ss_pred EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 999999998764333 1223456888999998753 478899999999999999999999987766655555444211
Q ss_pred CCCC--------------------------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 379 SFDE--------------------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 379 ~~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
.... ..+..++..+.++|.+||..||.+|||+.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 1100 0123468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=330.33 Aligned_cols=253 Identities=23% Similarity=0.343 Sum_probs=205.0
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++.+.||+|+||.||+|...... ....+++|.+... ......+.+.+|+.++.++.+||||+++++++...+.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDG-LKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCC-CcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence 57999999999999999999876531 1235788887532 23344567889999999996699999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCC
Q 007253 235 YVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN 299 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~ 299 (611)
++||||+++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~ 155 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV---GEN 155 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE---CCC
Confidence 99999999999999986532 248899999999999999999999999999999999999 567
Q ss_pred ceEEEeecccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcC
Q 007253 300 SVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKAD 377 (611)
Q Consensus 300 ~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~ 377 (611)
+.+||+|||++..............+..|+|||++. ..++.++|||||||++|||++ |..||...........+....
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 156 LASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred CeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 789999999986432211111222345799999886 568999999999999999997 999998887777666665432
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 378 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
. ......++..+.+||.+||..+|.+|||+.++++.
T Consensus 236 ~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 R---MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred C---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 11123578999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=339.94 Aligned_cols=261 Identities=31% Similarity=0.515 Sum_probs=209.5
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC-
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~- 231 (611)
+..+|.+.+.||+|+||.||+|+... +++.||||.+..... .......+.+|+.+++.++ |+||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~ 77 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSE---TNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLD-HENVIAIKDIMPPPH 77 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecC---CCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcC-CCCccchHHheeccc
Confidence 35689999999999999999998765 689999999865322 2233456778999999997 99999999988654
Q ss_pred ----CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeec
Q 007253 232 ----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (611)
Q Consensus 232 ----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~Df 307 (611)
..+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+++++||||||+||++ +.++.+||+||
T Consensus 78 ~~~~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~---~~~~~~kL~Df 152 (337)
T cd07858 78 REAFNDVYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDF 152 (337)
T ss_pred ccccCcEEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcC
Confidence 35899999995 6888877544 579999999999999999999999999999999999999 56778999999
Q ss_pred ccccccCCC-CcccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-------
Q 007253 308 GLSDFVRPD-ERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD------- 377 (611)
Q Consensus 308 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~------- 377 (611)
|++...... .......++..|+|||++. ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 153 GLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED 232 (337)
T ss_pred ccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence 999866433 2234457889999999875 458899999999999999999999997665433222221110
Q ss_pred ----------------CCCC----CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 378 ----------------PSFD----EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 378 ----------------~~~~----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
+... ...++.++.++.+||++||+.+|++|||+.++++||||....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 0000 011346789999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=328.44 Aligned_cols=261 Identities=29% Similarity=0.506 Sum_probs=219.3
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
...+.|++.+.||+|+||.||+|.... .+..||+|++..... ..+.+.+|+.+++.++ |+||+++++++...
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 87 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRA---TGKEVAIKKMRLRKQ----NKELIINEILIMKDCK-HPNIVDYYDSYLVG 87 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEcc---CCcEEEEEEEecCch----hHHHHHHHHHHHHHCC-CCCeeEEEEEEEEC
Confidence 456779999999999999999998775 578999999865422 4567889999999997 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+..|+|+||+++++|.+++......+++..+..++.||+.||.|||+.||+|+||||+||++ +.++.+||+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i---~~~~~~~l~d~~~~~ 164 (286)
T cd06614 88 DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL---SKDGSVKLADFGFAA 164 (286)
T ss_pred CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE---cCCCCEEECccchhh
Confidence 99999999999999999987765579999999999999999999999999999999999999 567789999999987
Q ss_pred ccCCCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 312 FVRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 312 ~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
...... ......++..|+|||++. ..++.++|||||||++|+|++|..||...........+...... .......++
T Consensus 165 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 243 (286)
T cd06614 165 QLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP-PLKNPEKWS 243 (286)
T ss_pred hhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCcchhhCC
Confidence 654322 223456889999999876 55889999999999999999999999876655544444332221 111123478
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCC
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~ 424 (611)
.++.+||.+||+.+|.+|||+.++++|+||+..+.
T Consensus 244 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 278 (286)
T cd06614 244 PEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP 278 (286)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence 99999999999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=323.22 Aligned_cols=248 Identities=22% Similarity=0.375 Sum_probs=208.0
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
..+|.+.+.||+|+||.||+|.... .++.||+|++... ......+.+|+++++++. |+||+++++++..++.
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~---~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 76 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKED----TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPP 76 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEec---CCceEEEEEecCC----chHHHHHHHHHHHHHhCC-CCChhheEEEEcCCCC
Confidence 3569999999999999999999876 5889999998543 223467889999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 234 VYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
+++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||+ ++++.+||+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~df~~~~~ 153 (263)
T cd05052 77 FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRL 153 (263)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCcEEeCCCccccc
Confidence 999999999999999886543 458999999999999999999999999999999999999 5778899999999987
Q ss_pred cCCCCcc--cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 313 VRPDERL--NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 313 ~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
....... ....++..|+|||++. ..++.++|||||||++|+|++ |..||.+....+....+..... ......+
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~ 230 (263)
T cd05052 154 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR---MERPEGC 230 (263)
T ss_pred cccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC---CCCCCCC
Confidence 6543221 1223456799999876 568899999999999999998 9999988777666666554321 1222467
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
+.++.++|.+||+.||++|||+.++++
T Consensus 231 ~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 231 PPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=331.14 Aligned_cols=257 Identities=30% Similarity=0.512 Sum_probs=212.4
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++.+.||+|+||.||++.... .+..||+|.+... .....+.+.+|+.++++++ ||||+++++++...+.
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~ 90 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVA---TGQEVAIKQMNLQ---QQPKKELIINEILVMRENK-HPNIVNYLDSYLVGDE 90 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcC---CCCEEEEEEeccc---cchHHHHHHHHHHHHhhcC-CCCeeehhheeeeCCc
Confidence 4689999999999999999998655 5788999998543 2223467889999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
.|+|+||+++++|.+++.+ ..+++..+..++.||+.||.|||++|++||||||+||++ +.++.+||+|||++...
T Consensus 91 ~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili---~~~~~~kL~dfg~~~~~ 165 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQI 165 (293)
T ss_pred EEEEEecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE---cCCCCEEEccCcceecc
Confidence 9999999999999998754 358899999999999999999999999999999999999 56778999999998765
Q ss_pred CCCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 314 RPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
.... ......|++.|+|||++. +.++.++|||||||++|++++|+.||...........+.... ......+..++..
T Consensus 166 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 244 (293)
T cd06647 166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAI 244 (293)
T ss_pred cccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC-CCCCCCccccCHH
Confidence 4333 233457889999999875 568899999999999999999999997665443332222211 1111123356889
Q ss_pred HHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
+.++|.+||..+|.+||++.+++.|+||+...
T Consensus 245 l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 245 FRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 99999999999999999999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=323.36 Aligned_cols=247 Identities=25% Similarity=0.434 Sum_probs=206.0
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
.+|++.+.||+|+||.||+|+... +..+|+|++.+.... ...+.+|+.+++.++ |+||+++++++...+..
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~----~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 74 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG----KIDVAIKMIREGAMS----EDDFIEEAKVMMKLS-HPNLVQLYGVCTKQRPI 74 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC----CccEEEEEeccCCCC----HHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCce
Confidence 468999999999999999997643 567999998654322 245778999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++||||++|++|.+++......+++..++.++.||+.||.|||+.||+||||||+||++ +.++.+||+|||+++...
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~ 151 (256)
T cd05059 75 FIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVL 151 (256)
T ss_pred EEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE---CCCCcEEECCcccceecc
Confidence 99999999999999987766679999999999999999999999999999999999999 577889999999987654
Q ss_pred CCCcc--cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 315 PDERL--NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 315 ~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
..... ....++..|+|||++. ..++.++|||||||++|+|++ |..||......+....+..... . .....++.
T Consensus 152 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~ 228 (256)
T cd05059 152 DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR-L--YRPKLAPT 228 (256)
T ss_pred cccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc-C--CCCCCCCH
Confidence 32211 1122345799999886 568999999999999999998 8999987777666666554321 1 11235799
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 391 EARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
++.+++.+||..+|.+|||+.++++.
T Consensus 229 ~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 229 EVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=321.97 Aligned_cols=247 Identities=26% Similarity=0.433 Sum_probs=210.2
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeee
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~ 240 (611)
+.||+|+||.||+|........+..||+|++....... ..+.+.+|+.+++.+. |+||+++++++.+...+++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLG-HPNVVRLLGVCTEEEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcC-CCChheeeeeecCCCceEEEEEe
Confidence 47999999999999987632347889999986553322 4678899999999998 99999999999999999999999
Q ss_pred cCCCChHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 241 CEGGELLDRILSR--------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 241 ~~~gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||.+..
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRD 154 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE---CCCCcEEEcccccccc
Confidence 9999999998776 4679999999999999999999999999999999999999 5678899999999987
Q ss_pred cCCCC---cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 007253 313 VRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (611)
Q Consensus 313 ~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (611)
..... ......++..|+|||.+. ..++.++|||||||++|+|++ |..||...........+..... . .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~ 231 (262)
T cd00192 155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR-L--PKPEY 231 (262)
T ss_pred cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-C--CCCcc
Confidence 65432 233456788999999886 568999999999999999998 6999988877777776665321 1 11235
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
++.++.+++.+||+.+|.+|||+.+++++
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 232 CPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 68999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=322.56 Aligned_cols=252 Identities=27% Similarity=0.540 Sum_probs=208.6
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++.+.||+|+||.||+|.... +|+.||+|.+...........+.+.+|+++++++. |+||+++++++.+++..
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~-~~~i~~~~~~~~~~~~~ 77 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLL---DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HPNVIKYLASFIENNEL 77 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcC---CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCeeeeeeeeecCCeE
Confidence 579999999999999999999775 68999999987544444555678899999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 235 YVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+.||+||||||+||++ +.++.++|+|||++.
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~ 154 (267)
T cd08224 78 NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI---TATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE---CCCCcEEEeccceee
Confidence 999999999999988754 23458999999999999999999999999999999999999 567789999999987
Q ss_pred ccCCCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhcCCCCCCCCCCC
Q 007253 312 FVRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES--GIFRAVLKADPSFDEAPWPS 387 (611)
Q Consensus 312 ~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~ 387 (611)
...... ......|+..|+|||++. ..++.++|||||||++|+|++|+.||...... .....+... ..+..+...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 232 (267)
T cd08224 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC--DYPPLPADH 232 (267)
T ss_pred eccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC--CCCCCChhh
Confidence 654332 223457889999999886 55889999999999999999999999654322 222222222 122222336
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
++..+.++|.+||..+|.+|||+.++++
T Consensus 233 ~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 233 YSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 7889999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=323.54 Aligned_cols=252 Identities=24% Similarity=0.401 Sum_probs=210.0
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
.+|++++.||+|+||.||+|........+..||+|.+.... .....+.+.+|+.++++++ ||||+++++++..++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcc
Confidence 57999999999999999999876543345589999986432 2334567899999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++||||+++++|.+++......+++..+..++.||+.||.|||+++++||||||+|||+ +.++.+||+|||++..+.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE---CCCCeEEeCCCCcccccc
Confidence 99999999999999988776779999999999999999999999999999999999999 567889999999998765
Q ss_pred CCCc----ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 315 PDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 315 ~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
.... .....++..|+|||++. +.++.++|+|||||++|++++ |..||......+....+.... ..+ ....+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~ 234 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY-RLP--APMDC 234 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC-cCC--CCCCC
Confidence 3321 11122356899999986 578999999999999999886 999998877766666655432 222 12357
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
+..+.+++.+||+.+|.+||++.++++
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 235 PAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=340.58 Aligned_cols=261 Identities=33% Similarity=0.558 Sum_probs=209.8
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee---
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--- 230 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~--- 230 (611)
.++|++.+.||+|+||.||+|.... +|+.||+|++..... .......+.+|+.+++++. ||||+++++++..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~---~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTR---SGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGA 78 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcC---CCCEEEEEEeccccc-cccchHHHHHHHHHHHhcC-CCCccCHHHhccccCC
Confidence 4789999999999999999998776 689999999865432 2234566788999999998 9999999998763
Q ss_pred -CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccc
Q 007253 231 -TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (611)
Q Consensus 231 -~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~ 309 (611)
...+++||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~ 153 (334)
T cd07855 79 DFKDVYVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGM 153 (334)
T ss_pred CCceEEEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEeccccc
Confidence 356899999995 6888877544 569999999999999999999999999999999999999 5778899999999
Q ss_pred ccccCCCC-----cccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc------
Q 007253 310 SDFVRPDE-----RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA------ 376 (611)
Q Consensus 310 a~~~~~~~-----~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~------ 376 (611)
+....... .....+|+..|+|||++. ..++.++|||||||++|+|++|+.||.+......+..+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~ 233 (334)
T cd07855 154 ARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE 233 (334)
T ss_pred ceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChh
Confidence 87654322 123457899999999875 35889999999999999999999999776544333222211
Q ss_pred -----------------CCCCCCCC----CCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCC
Q 007253 377 -----------------DPSFDEAP----WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (611)
Q Consensus 377 -----------------~~~~~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~ 424 (611)
.+...... .+.++.++.++|++||+.+|.+|||+.+++.||||+....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence 11111111 2457899999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=328.32 Aligned_cols=255 Identities=24% Similarity=0.414 Sum_probs=210.1
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCC--ccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.++|++.+.||+|+||.||++...... .....||+|.+.... .......+.+|+.+++++.+|+||+++++++..+
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 467999999999999999999876532 245789999986542 2334567889999999995599999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEecc
Q 007253 232 DNVYVVMELCEGGELLDRILSR---------------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~ 296 (611)
+.+++||||+++|+|.+++..+ ...+++..+..++.||+.||.|||+++|+||||||+|||+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~--- 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV--- 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE---
Confidence 9999999999999999988643 3468999999999999999999999999999999999999
Q ss_pred CCCceEEEeecccccccCCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 007253 297 DENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFR 371 (611)
Q Consensus 297 ~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~ 371 (611)
+.++.+||+|||++..+..... .....++..|+|||++. ..++.++|||||||++|+|++ |..||.+....+...
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 5678899999999987643321 12223557899999875 568999999999999999997 999998877766666
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 372 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
.+.... ... .....+..+.+|+.+||..||.+|||+.+++++
T Consensus 246 ~~~~~~-~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 246 LLKEGY-RME--KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHcCC-cCC--CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 554432 111 123568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=326.60 Aligned_cols=255 Identities=29% Similarity=0.454 Sum_probs=209.1
Q ss_pred eeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhc--CCCCeeEEEEEEeeCCe-
Q 007253 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT--GHNNLVKFFDAYEDTDN- 233 (611)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~iv~l~~~~~~~~~- 233 (611)
|++.+.||+|+||.||+|+... +++.||+|++..... .......+.+|+.+++++. .|+||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~---~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 76 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLN---TGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTD 76 (287)
T ss_pred CeEEEEecccCceEEEEEEECC---CCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCC
Confidence 6889999999999999999865 588999999864432 2222345667888888774 49999999999998776
Q ss_pred ----eEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecc
Q 007253 234 ----VYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (611)
Q Consensus 234 ----~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG 308 (611)
++++|||+.+ +|.+++.... ..+++..++.++.||+.||.|||+.+++|+||+|+||++ +.++.+||+|||
T Consensus 77 ~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili---~~~~~~~l~dfg 152 (287)
T cd07838 77 RELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV---TSDGQVKIADFG 152 (287)
T ss_pred CCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE---ccCCCEEEeccC
Confidence 9999999964 8888776543 358999999999999999999999999999999999999 566889999999
Q ss_pred cccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------
Q 007253 309 LSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF------- 380 (611)
Q Consensus 309 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~------- 380 (611)
++.............++..|+|||++. ..++.++|||||||++|+|++|..||......+.+..+.......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 153 LARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred cceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence 998775554445557889999999886 568899999999999999999999998877766666554421100
Q ss_pred ---------CC-------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 381 ---------DE-------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 381 ---------~~-------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
+. ...+.++..+.++|.+||+.||.+||++.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00 0012456788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=329.30 Aligned_cols=260 Identities=26% Similarity=0.425 Sum_probs=216.3
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
....|...+.||+|+||.||+|+... .++.||+|.+.............+.+|+.+++.++ |+|++++++++...+
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 88 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREH 88 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcC---CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEEcCC
Confidence 34568889999999999999999765 58899999986543344445567889999999997 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
..++||||+. |+|.+.+......+++..+..++.||+.||.|||+.+++||||||+||++ +.++.+||+|||++..
T Consensus 89 ~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~ 164 (308)
T cd06634 89 TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASI 164 (308)
T ss_pred eeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE---CCCCcEEECCccccee
Confidence 9999999996 68888877666679999999999999999999999999999999999999 5677899999999876
Q ss_pred cCCCCcccccccCCCcCcchhhc----CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 313 VRPDERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
.... ....|++.|+|||++. +.++.++|||||||++|+|++|..||...........+..... +......+
T Consensus 165 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~ 239 (308)
T cd06634 165 MAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PALQSGHW 239 (308)
T ss_pred ecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC--CCcCcccc
Confidence 5432 3456889999999873 4578899999999999999999999977655444444443321 11112357
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCC
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~ 425 (611)
+..+.+||++||..+|.+||++.++++|+|+......
T Consensus 240 ~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~ 276 (308)
T cd06634 240 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276 (308)
T ss_pred cHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCCh
Confidence 8899999999999999999999999999999875433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=328.10 Aligned_cols=256 Identities=21% Similarity=0.277 Sum_probs=209.0
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCc-------------cCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGEL-------------KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~-------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~ 220 (611)
..+|++++.||+|+||.||+|....... .+..||+|++.... .....+.+.+|++++++++ |||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~ 80 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLS-DPN 80 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcC-CCC
Confidence 4679999999999999999998754211 23568999986542 2345678899999999997 999
Q ss_pred eeEEEEEEeeCCeeEEEeeecCCCChHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCc
Q 007253 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG----------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290 (611)
Q Consensus 221 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~N 290 (611)
|+++++++..++..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999886543 268999999999999999999999999999999999
Q ss_pred eEEeccCCCceEEEeecccccccCCCC---cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh--CCCCCCCC
Q 007253 291 FLFTTKDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC--GSRPFWAR 364 (611)
Q Consensus 291 Ill~~~~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~--g~~Pf~~~ 364 (611)
|++ +.++.++|+|||++....... ......+++.|+|||++. +.++.++|||||||++|||++ |..||...
T Consensus 161 ili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 161 CLV---GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred eee---cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 999 566889999999987654332 123445678899999876 578999999999999999998 78899877
Q ss_pred ChHHHHHHHHhc----CCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 365 TESGIFRAVLKA----DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 365 ~~~~~~~~i~~~----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
.....+..+... ...........++.++.++|.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 766666655443 111111112356789999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=361.43 Aligned_cols=254 Identities=33% Similarity=0.554 Sum_probs=200.8
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe---
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE--- 229 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~--- 229 (611)
...+|+.++.||+||||.||+++.+- +|+.||||.|+-.. +......+.+|+.++.+|+ |||||+|+..|.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKl---DGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLn-HpNVVRYysAWVEs~ 550 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKL---DGREYAIKKIPLKA--SDKLYSKILREVKLLARLN-HPNVVRYYSAWVEST 550 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecc---cchhhhhhhccCch--HHHHHHHHHHHHHHHhhcC-CcceeeeehhhhccC
Confidence 45779999999999999999999887 69999999996543 4555677899999999998 999999995331
Q ss_pred --------------------------------------------------------e-----------------------
Q 007253 230 --------------------------------------------------------D----------------------- 230 (611)
Q Consensus 230 --------------------------------------------------------~----------------------- 230 (611)
.
T Consensus 551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~ 630 (1351)
T KOG1035|consen 551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL 630 (1351)
T ss_pred CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence 0
Q ss_pred -----------------------------C--------CeeEEEeeecCCCChHHHHHhcCCCC-CHHHHHHHHHHHHHH
Q 007253 231 -----------------------------T--------DNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNV 272 (611)
Q Consensus 231 -----------------------------~--------~~~~lv~E~~~~gsL~~~l~~~~~~l-~~~~~~~i~~qi~~~ 272 (611)
+ ..+||.||||+..+|.+++ .++... .....|++|++|+.|
T Consensus 631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI-~~N~~~~~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDII-RRNHFNSQRDEAWRLFREILEG 709 (1351)
T ss_pred ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHH-HhcccchhhHHHHHHHHHHHHH
Confidence 0 2368999999885555554 443333 478899999999999
Q ss_pred HHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC-------------------CCCcccccccCCCcCcchh
Q 007253 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-------------------PDERLNDIVGSAYYVAPEV 333 (611)
Q Consensus 273 L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~-------------------~~~~~~~~~gt~~y~aPE~ 333 (611)
|.|+|++|||||||||.||+| ++...|||+|||+|.... .+...+..+||.-|+|||+
T Consensus 710 LaYIH~~giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 710 LAYIHDQGIIHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHHHhCceeeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 999999999999999999999 677789999999998721 0113456799999999999
Q ss_pred hc--C--CCCCcchhhHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCCCCC--CCCCCCHHHHHHHHHhcccCccC
Q 007253 334 LH--R--SYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSFDEA--PWPSLSSEARDFVKRLLNKDPRK 406 (611)
Q Consensus 334 ~~--~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~-~~~~~i~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dP~~ 406 (611)
+. . .|+.|+||||||||++||+ .||....+. .++.++. .+.++.. .+..--+.-..+|++||+.||++
T Consensus 787 l~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR--~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~k 861 (1351)
T KOG1035|consen 787 LSDTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLR--KGSIPEPADFFDPEHPEEASLIRWLLSHDPSK 861 (1351)
T ss_pred hcccccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcc--cCCCCCCcccccccchHHHHHHHHHhcCCCcc
Confidence 85 3 5999999999999999998 467554443 3344444 3333333 22233456678999999999999
Q ss_pred CCCHHHHHcCcccCC
Q 007253 407 RLTAAQALSHPWIKN 421 (611)
Q Consensus 407 Rpt~~~ll~hp~~~~ 421 (611)
||||.|||++.||..
T Consensus 862 RPtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 862 RPTATELLNSELLPP 876 (1351)
T ss_pred CCCHHHHhhccCCCc
Confidence 999999999999985
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=336.85 Aligned_cols=260 Identities=28% Similarity=0.527 Sum_probs=212.6
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+.++|.+.+.||+|+||.||+|.... +|..||||++.+.. ........+.+|+.+++++. ||||+++++++..+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 86 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRR---TGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMK-HENVIGLLDVFTPD 86 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECC---CCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCccceeeeecCC
Confidence 357889999999999999999998765 68999999986432 23344567889999999997 99999999998765
Q ss_pred C------eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 232 D------NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 232 ~------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
. .+++||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||++ +.++.+||+
T Consensus 87 ~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill---~~~~~~kl~ 160 (343)
T cd07880 87 LSLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAV---NEDCELKIL 160 (343)
T ss_pred ccccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEe
Confidence 4 468999999 7788877643 469999999999999999999999999999999999999 567789999
Q ss_pred ecccccccCCCCcccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--
Q 007253 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD-- 381 (611)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~-- 381 (611)
|||++..... ......+++.|+|||++.+ .++.++|+|||||++|+|++|+.||........+..+.......+
T Consensus 161 dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 161 DFGLARQTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred eccccccccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9999876542 2234567899999998863 478899999999999999999999987766555444433221110
Q ss_pred -------------------------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCC
Q 007253 382 -------------------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (611)
Q Consensus 382 -------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~ 424 (611)
...++.++.++.++|.+||+.||.+|||+.+++.||||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 0112457888999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=341.01 Aligned_cols=246 Identities=37% Similarity=0.580 Sum_probs=210.3
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+...|++...+|.|+|+.|-.+.... +++..++|++.+... +..+|+.++....+||||+++.+++.+.
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~---t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~ 388 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSP---TDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDG 388 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccc---cccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCC
Confidence 467889999999999999998888766 689999999976521 2346887888888899999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
.+.|+|||++.||.|++.+... +.....+..|+.+|+.++.|||++|||||||||+|||+. +..++++|+|||.++
T Consensus 389 ~~~~~v~e~l~g~ell~ri~~~--~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 389 KEIYLVMELLDGGELLRRIRSK--PEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWS 464 (612)
T ss_pred ceeeeeehhccccHHHHHHHhc--chhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhh
Confidence 9999999999999999988654 333378888999999999999999999999999999995 477889999999998
Q ss_pred ccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCCCCCCCCCCC
Q 007253 312 FVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s 389 (611)
..+.+ ..+.+-|..|.|||++. ..|+.++||||||++||+|++|+.||...... +++..+.... +. ..+|
T Consensus 465 ~~~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~--~s----~~vS 536 (612)
T KOG0603|consen 465 ELERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPK--FS----ECVS 536 (612)
T ss_pred hCchh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCc--cc----cccC
Confidence 87654 44567889999999987 67999999999999999999999999877666 3333333222 11 4689
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
.++++||++||+.||.+|+++.+++.||||
T Consensus 537 ~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 537 DEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 999999999999999999999999999999
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=328.28 Aligned_cols=255 Identities=26% Similarity=0.386 Sum_probs=208.3
Q ss_pred CCceeEeCeeeeccceEEEEEEEecC--CccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.++|++.+.||+|+||.||++..... ...+..||+|++.... .....+.+.+|+.+++++.+|+||+++++++...
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 46799999999999999999986431 2246689999986542 2334567899999999995599999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
+.+++||||+.+|+|.+++..... .+++..+..++.||+.||.|||+++|+|+||||+|||+ +.++.+||+|||++
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~dfg~~ 188 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL---THGKIVKICDFGLA 188 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE---cCCCeEEECCCccc
Confidence 999999999999999999875433 48999999999999999999999999999999999999 56778999999999
Q ss_pred cccCCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 007253 311 DFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPW 385 (611)
Q Consensus 311 ~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (611)
........ .....++..|+|||++. +.++.++|||||||++|+|++ |..||........+........... ..
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~ 266 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA--QP 266 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC--CC
Confidence 86543321 12234677899999876 568999999999999999998 9999987666554444443322221 22
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
...+.++.+|+.+||..+|.+|||+.++++
T Consensus 267 ~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 267 EHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 356899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=326.77 Aligned_cols=252 Identities=26% Similarity=0.406 Sum_probs=208.2
Q ss_pred CCceeEeCeeeeccceEEEEEEEecC--CccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
..+|.+.+.||+|+||.||+|+.... ...+..+++|.+.. ......+.+.+|+.++++++ |+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~---~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 79 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD---PTLAARKDFQREAELLTNLQ-HEHIVKFYGVCGDG 79 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC---ccHHHHHHHHHHHHHHhcCC-CCCcceEEEEEccC
Confidence 35699999999999999999986532 22456799998743 23344567889999999997 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEecc
Q 007253 232 DNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~ 296 (611)
+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~--- 156 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV--- 156 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---
Confidence 99999999999999999986542 348999999999999999999999999999999999999
Q ss_pred CCCceEEEeecccccccCCCC---cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 007253 297 DENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFR 371 (611)
Q Consensus 297 ~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~ 371 (611)
+.++.+||+|||++....... ......++..|+|||++. ..++.++|||||||++|+|++ |..||..........
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 577889999999997654322 123345788999999876 568899999999999999998 999998877766666
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 372 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
.+....... .....+..+.+++.+||+.||++|||+.++++
T Consensus 237 ~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 237 CITQGRVLE---RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHhCCCCCC---CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 554433221 12356889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=329.91 Aligned_cols=255 Identities=23% Similarity=0.398 Sum_probs=207.8
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCC----ccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGE----LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 229 (611)
.++|.+++.||+|+||.||+|+..... ..+..||+|.+.... .......+.+|+.+++++.+|+||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 468999999999999999999864321 134679999986542 23345678899999999966999999999999
Q ss_pred eCCeeEEEeeecCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEe
Q 007253 230 DTDNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294 (611)
Q Consensus 230 ~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~ 294 (611)
..+.+|+||||+++|+|.+++..+. ..+++..+..++.||+.||+|||++|++||||||+|||+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill- 173 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV- 173 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE-
Confidence 9999999999999999999997642 248899999999999999999999999999999999999
Q ss_pred ccCCCceEEEeecccccccCCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHH
Q 007253 295 TKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGI 369 (611)
Q Consensus 295 ~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~ 369 (611)
+.++.+||+|||++........ .....+++.|+|||++. ..++.++|||||||++|+|++ |..||.+....++
T Consensus 174 --~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~ 251 (307)
T cd05098 174 --TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251 (307)
T ss_pred --cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 5677899999999876542221 11223456899999886 558899999999999999998 8999987776666
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 370 FRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 370 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
...+..... . .....++.++.+||.+||..+|.+|||+.+++++
T Consensus 252 ~~~~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 252 FKLLKEGHR-M--DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHcCCC-C--CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 655544321 1 1123578999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=333.01 Aligned_cols=257 Identities=31% Similarity=0.489 Sum_probs=207.3
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC--
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT-- 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~-- 231 (611)
.++|++.+.||.|+||.||+|.... +++.||||++....... .....+.+|++++++++ |+||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 81 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIK---TGRVVALKKILMHNEKD-GFPITALREIKILKKLK-HPNVVPLIDMAVERPD 81 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECC---CCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcC-CCCccchhhheecccc
Confidence 5789999999999999999999766 58899999986543222 12235678999999997 99999999987543
Q ss_pred ------CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 232 ------DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 232 ------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
..+++||||+.+ +|...+......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 82 ~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~---~~~~~~~l~ 157 (311)
T cd07866 82 KSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIA 157 (311)
T ss_pred cccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEC
Confidence 347999999964 7888776666679999999999999999999999999999999999999 677889999
Q ss_pred ecccccccCCCCc------------ccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHH
Q 007253 306 DFGLSDFVRPDER------------LNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFR 371 (611)
Q Consensus 306 DfG~a~~~~~~~~------------~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~ 371 (611)
|||++........ .....|++.|+|||++. ..++.++|||||||++|+|++|+.||.+........
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~ 237 (311)
T cd07866 158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH 237 (311)
T ss_pred cCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999976543221 12346788999999875 347899999999999999999999998777665555
Q ss_pred HHHhcCCCCCCC--------------------------CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 372 AVLKADPSFDEA--------------------------PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 372 ~i~~~~~~~~~~--------------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
.+.......... .+..+++.+.+||.+||..||.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 544322111100 112455788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=322.28 Aligned_cols=252 Identities=24% Similarity=0.412 Sum_probs=209.7
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
..|++.+.||+|+||.||+|........+..||||++... ........+..|+.+++.+. ||||+++++++.++...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSRPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCC-CcCcceEEEEECCCCce
Confidence 4689999999999999999998764333457999998643 23445678999999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++||||+++|+|.+++....+.+++..++.++.|++.||.|||++|++||||||+||++ +.++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE---cCCCcEEECCCccccccc
Confidence 99999999999999887766779999999999999999999999999999999999999 567789999999987654
Q ss_pred CCCcc---cccc---cCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 007253 315 PDERL---NDIV---GSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 315 ~~~~~---~~~~---gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (611)
..... .... .+..|+|||++. +.++.++|||||||++|||++ |..||+..........+.... .. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~-~~--~~~~ 234 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY-RL--PPPM 234 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-cC--CCcc
Confidence 33211 1111 235799999886 568999999999999999886 999998887777666664332 11 2224
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 387 SLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
.++..+.+++.+||..+|.+||++.+++.
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 235 DCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 67889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=324.31 Aligned_cols=252 Identities=21% Similarity=0.290 Sum_probs=204.7
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCc-cCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGEL-KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..+|++.+.||+|+||.||+|++..... ....||+|++... ......+.+.+|+.++..+. |+||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~-~ 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN--TSPKANKEILDEAYVMAGVG-SPYVCRLLGICLT-S 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC--CCHHHHHHHHHHHHHHHhcC-CCCCceEEEEEcC-C
Confidence 4679999999999999999998765211 2235899998643 23444567889999999997 9999999999875 4
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
..+++|||+++|+|.+++......+++..+..++.||+.||.|||+++|+||||||+|||+ ++++.+||+|||+++.
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~---~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV---KSPNHVKITDFGLARL 158 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE---cCCCcEEECCCCceee
Confidence 5789999999999999988766779999999999999999999999999999999999999 4667799999999987
Q ss_pred cCCCCcc---cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 007253 313 VRPDERL---NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (611)
Q Consensus 313 ~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (611)
+...... ....+++.|+|||++. ..++.++|||||||++|||++ |..||...........+.... ..+. ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~ 235 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE-RLPQ--PPI 235 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-cCCC--Ccc
Confidence 6533221 1223467899999885 568999999999999999998 999997766555444333322 2221 246
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
++.++.++|.+||..||.+||++.++++
T Consensus 236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 236 CTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7899999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=338.35 Aligned_cols=258 Identities=31% Similarity=0.519 Sum_probs=207.9
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC-
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~- 231 (611)
+..+|++.+.||.|+||.||+|.... +|+.||+|.+..... ...+.+.+|+.++++++ ||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~---~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~ 75 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSD---CDKRVAVKKIVLTDP---QSVKHALREIKIIRRLD-HDNIVKVYEVLGPSG 75 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECC---CCcEEEEEEEecCCC---chHHHHHHHHHHHHhcC-CCcchhhHhhhcccc
Confidence 35789999999999999999998766 689999999855432 34467889999999997 99999999876653
Q ss_pred -------------CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCC
Q 007253 232 -------------DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE 298 (611)
Q Consensus 232 -------------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~ 298 (611)
...|+||||++ ++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++ ..
T Consensus 76 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~--~~ 150 (342)
T cd07854 76 SDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN--TE 150 (342)
T ss_pred cccccccccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc--CC
Confidence 35799999996 588877643 4689999999999999999999999999999999999995 24
Q ss_pred CceEEEeecccccccCCCC----cccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 007253 299 NSVLKAIDFGLSDFVRPDE----RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRA 372 (611)
Q Consensus 299 ~~~vkl~DfG~a~~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~ 372 (611)
++.+||+|||++..+.... ......|+..|+|||++. ..++.++|||||||++|+|++|+.||...........
T Consensus 151 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~ 230 (342)
T cd07854 151 DLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL 230 (342)
T ss_pred CceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 5679999999997654321 112346788999999874 3578899999999999999999999987766555544
Q ss_pred HHhcCCCCC----------------------C----CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 373 VLKADPSFD----------------------E----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 373 i~~~~~~~~----------------------~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
++...+... . ...+.++.++.+||.+||+.||.+|||+.+++.||||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 231 ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 433221100 0 0123578899999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=334.57 Aligned_cols=264 Identities=28% Similarity=0.450 Sum_probs=211.4
Q ss_pred cCCceeE-eCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHH-----------HHHHHHHHHHHHHHhcCCCC
Q 007253 153 FANKYEL-GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAI-----------AIEDVRREVKILRALTGHNN 220 (611)
Q Consensus 153 ~~~~y~~-~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~~h~~ 220 (611)
+.++|.. .+.||.|+||.||+|.... .++.||||++......... ....+.+|+.+++.++ |+|
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~ 81 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTL---TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HEN 81 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECC---CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-Ccc
Confidence 4567765 5779999999999998765 6899999998644322100 1124678999999998 999
Q ss_pred eeEEEEEEeeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCc
Q 007253 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS 300 (611)
Q Consensus 221 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~ 300 (611)
|+++++++..++..++||||+. |+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||++ +.++
T Consensus 82 iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill---~~~~ 156 (335)
T PTZ00024 82 IMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI---NSKG 156 (335)
T ss_pred eeeeeEEEecCCcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE---CCCC
Confidence 9999999999999999999996 5898887543 569999999999999999999999999999999999999 5677
Q ss_pred eEEEeecccccccCCC---------------CcccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCC
Q 007253 301 VLKAIDFGLSDFVRPD---------------ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWA 363 (611)
Q Consensus 301 ~vkl~DfG~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~ 363 (611)
.+||+|||++...... .......+++.|+|||++.+ .++.++|||||||++|+|++|..||.+
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 8999999998765411 11223457889999998863 478899999999999999999999988
Q ss_pred CChHHHHHHHHhcCCCCCCC------------------------CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 364 RTESGIFRAVLKADPSFDEA------------------------PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 364 ~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
....+.+..+.......... ..+..+.++.++|.+||+.+|.+|||+.++|.||||
T Consensus 237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~ 316 (335)
T PTZ00024 237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316 (335)
T ss_pred CCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence 77766555554322111110 013457889999999999999999999999999999
Q ss_pred CCCCCC
Q 007253 420 KNSNDV 425 (611)
Q Consensus 420 ~~~~~~ 425 (611)
+.....
T Consensus 317 ~~~~~~ 322 (335)
T PTZ00024 317 KSDPLP 322 (335)
T ss_pred CCCCCC
Confidence 976533
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=323.10 Aligned_cols=253 Identities=21% Similarity=0.347 Sum_probs=209.3
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCC--ccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.++|++.+.||+|+||.||+|..+... ..+..||+|.+.... .......+.+|+.+++.+. |+||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~ 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSTG 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEcCC
Confidence 467999999999999999999876532 245889999985432 3334467889999999997 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceE
Q 007253 232 DNVYVVMELCEGGELLDRILSRG---------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVL 302 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~v 302 (611)
...++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+|+||||||+|||+ +.++.+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill---~~~~~~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV---AEDLTV 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE---cCCCCE
Confidence 99999999999999999886532 247889999999999999999999999999999999999 577889
Q ss_pred EEeecccccccCCCC---cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcC
Q 007253 303 KAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKAD 377 (611)
Q Consensus 303 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~ 377 (611)
||+|||+++.+.... ......++..|+|||++. +.++.++|||||||++|+|++ |..||...........+....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG 238 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC
Confidence 999999987654332 123345678999999885 668999999999999999998 999998877777666665332
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 378 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
. . .. ...++.++.++|.+||+.+|++|||+.++++
T Consensus 239 ~-~-~~-~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 239 H-L-DL-PENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred C-C-CC-CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1 1 11 1346899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=314.62 Aligned_cols=267 Identities=29% Similarity=0.497 Sum_probs=222.0
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee---
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--- 230 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~--- 230 (611)
...|+...+||+|.||.||+|+.+. +|+.||+|.+--.. .....-....+|+++|..|. |+|++.+++.|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n---~~kkvalkkvlmen-eKeGfpitalreikiL~~lk-Henv~nliEic~tk~T 90 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKN---TGKKVALKKVLMEN-EKEGFPITALREIKILQLLK-HENVVNLIEICRTKAT 90 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcC---ccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhc-chhHHHHHHHHhhccC
Confidence 4568899999999999999999887 68889998653211 11112234568999999998 9999999987753
Q ss_pred -----CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 231 -----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 231 -----~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
...+|+||.+|+. +|...+.....+++..++++++.++..||.|+|++.|+|||+|+.|+|| +.++.+||+
T Consensus 91 p~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI---t~dgilklA 166 (376)
T KOG0669|consen 91 PTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI---TKDGILKLA 166 (376)
T ss_pred CcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE---cCCceEEee
Confidence 2359999999987 8888887777889999999999999999999999999999999999999 678999999
Q ss_pred ecccccccCCCC-----cccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Q 007253 306 DFGLSDFVRPDE-----RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (611)
Q Consensus 306 DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~ 378 (611)
|||+++.+.... +....+-|.+|.+||.+- +.|+++.|||..|||+.||+++.+.+.+.++...+..|.....
T Consensus 167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG 246 (376)
T KOG0669|consen 167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG 246 (376)
T ss_pred ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence 999997654322 345567899999999875 5699999999999999999999999999999988888877776
Q ss_pred CCCCCCCCCC-------------------------------CHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCCCC
Q 007253 379 SFDEAPWPSL-------------------------------SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKV 427 (611)
Q Consensus 379 ~~~~~~~~~~-------------------------------s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~~~ 427 (611)
.+....||++ ++++.+|+.++|..||.+|+++.++|+|.||....-...
T Consensus 247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~pqa 326 (376)
T KOG0669|consen 247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMPQA 326 (376)
T ss_pred cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcchh
Confidence 6666666543 346789999999999999999999999999987654433
Q ss_pred ch
Q 007253 428 PL 429 (611)
Q Consensus 428 ~~ 429 (611)
++
T Consensus 327 nl 328 (376)
T KOG0669|consen 327 NL 328 (376)
T ss_pred hH
Confidence 33
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=326.90 Aligned_cols=253 Identities=19% Similarity=0.300 Sum_probs=209.7
Q ss_pred CceeEeCeeeeccceEEEEEEEecCC--ccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
.+|++.+.||+|+||.||+|...... ..++.||||++.... .....+.+.+|+.++..++ ||||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~ 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQ-HPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcCCC
Confidence 45889999999999999999876421 246789999986432 2334567889999999997 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccC
Q 007253 233 NVYVVMELCEGGELLDRILSR---------------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD 297 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~ 297 (611)
..++++||+.+++|.+++..+ ...+++..++.++.||+.||.|||++||+||||||+|||+ +
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~---~ 158 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV---F 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe---c
Confidence 999999999999999988532 2348889999999999999999999999999999999999 4
Q ss_pred CCceEEEeecccccccCCCC---cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 007253 298 ENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRA 372 (611)
Q Consensus 298 ~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~ 372 (611)
+++.+||+|||+++...... ......+++.|+|||++. +.++.++|||||||++|||++ |..||.+....+....
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 66779999999988654322 123345678999999875 678999999999999999998 8899988877777777
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 373 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
+........ ...++.++.+|+.+||+.+|.+||++.+++..
T Consensus 239 i~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 239 IRNRQVLPC---PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHcCCcCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 666543221 13678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=317.07 Aligned_cols=253 Identities=32% Similarity=0.543 Sum_probs=212.4
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC--Ce
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT--DN 233 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~--~~ 233 (611)
+|.+.+.||+|++|.||+|.... +++.|++|++...... ....+.+.+|+.+++++. |+||+++++.+.+. ..
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKD---TGELMAVKSVELSGDS-EEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNT 75 (260)
T ss_pred CceeeeEeeecCceEEEEEEECC---CCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCCe
Confidence 47889999999999999998775 5889999998654322 445678899999999998 99999999999988 89
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+++|+||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||++ +.++.+||+|||.+...
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~ 151 (260)
T cd06606 76 LNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILV---DSDGVVKLADFGCAKRL 151 (260)
T ss_pred EEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEcccccEEec
Confidence 999999999999999887654 89999999999999999999999999999999999999 45778999999999877
Q ss_pred CCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhcCCCCCCCCCCCC
Q 007253 314 RPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 314 ~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
..... .....++..|+|||.+. ..++.++||||||+++|+|++|..||..... ......+.... .. ......+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~-~~~~~~~ 229 (260)
T cd06606 152 GDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSG-EP-PEIPEHL 229 (260)
T ss_pred ccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccC-CC-cCCCccc
Confidence 65443 44567899999999886 4489999999999999999999999977652 22222222111 11 1112356
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
+..+.+||.+||..||.+||++.++++||||
T Consensus 230 ~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 230 SEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred CHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 8999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=319.16 Aligned_cols=254 Identities=27% Similarity=0.487 Sum_probs=209.0
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCC--cCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC-
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHK--MTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~- 231 (611)
.+|++.+.||+|+||.||+|.... +|+.||+|++.... .........+.+|+.++++++ |+||+++++++.+.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~ 77 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDAD---TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRDPE 77 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcC---CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEcCC
Confidence 469999999999999999998765 68999999875321 122345567889999999997 99999999998764
Q ss_pred -CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 232 -DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 232 -~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
+.++++|||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||++ +.++.++|+|||++
T Consensus 78 ~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~ 153 (264)
T cd06653 78 EKKLSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGAS 153 (264)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECccccc
Confidence 4689999999999999988654 458999999999999999999999999999999999999 56778999999999
Q ss_pred cccCCC----CcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 007253 311 DFVRPD----ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (611)
Q Consensus 311 ~~~~~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (611)
...... .......|+..|+|||++. ..++.++|||||||++|+|++|+.||...........+.... ......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~p 231 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQP--TKPMLP 231 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCC--CCCCCC
Confidence 765321 1223456899999999886 458899999999999999999999998766555444443322 111223
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
..++.++.++|.+||. +|..||++.++++|||.
T Consensus 232 ~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 232 DGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred cccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 4688999999999999 57999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=327.88 Aligned_cols=255 Identities=25% Similarity=0.404 Sum_probs=210.1
Q ss_pred CCceeEeCeeeeccceEEEEEEEec----CCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKK----GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~----~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 229 (611)
..+|.+++.||+|+||.||+|+... ....+..||+|.+... ........+.+|+.+++.+.+||||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc--cchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 5789999999999999999998642 1224568999998543 223445678899999999955999999999999
Q ss_pred eCCeeEEEeeecCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEe
Q 007253 230 DTDNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294 (611)
Q Consensus 230 ~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~ 294 (611)
..+..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili- 170 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV- 170 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE-
Confidence 9999999999999999999987642 247888999999999999999999999999999999999
Q ss_pred ccCCCceEEEeecccccccCCCC---cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHH
Q 007253 295 TKDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGI 369 (611)
Q Consensus 295 ~~~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~ 369 (611)
+.++.+||+|||++....... ......+++.|+|||++. ..++.++|||||||++|+|++ |..||.+....++
T Consensus 171 --~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 171 --TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred --cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 567789999999998664322 122334567899999886 558999999999999999998 8899988877777
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 370 FRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 370 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
...+....... ....++.++.+||.+||..+|.+|||+.++++.
T Consensus 249 ~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 249 FKLLKEGHRMD---KPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHcCCcCC---CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 76665443211 123678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=335.88 Aligned_cols=256 Identities=27% Similarity=0.408 Sum_probs=202.9
Q ss_pred CCceeEeCeeeeccceEEEEEEEec--CCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~--~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.++|++++.||+|+||.||+|.... ....++.||||++.... .......+.+|+.++.++.+|+||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 4689999999999999999998643 22367899999986432 2334467889999999996699999999988654
Q ss_pred -CeeEEEeeecCCCChHHHHHhcC--------------------------------------------------------
Q 007253 232 -DNVYVVMELCEGGELLDRILSRG-------------------------------------------------------- 254 (611)
Q Consensus 232 -~~~~lv~E~~~~gsL~~~l~~~~-------------------------------------------------------- 254 (611)
..+++|||||++|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 56899999999999999886532
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCCc---ccc
Q 007253 255 ----------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER---LND 321 (611)
Q Consensus 255 ----------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~---~~~ 321 (611)
..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........ ...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE---cCCCcEEEEecccccccccCcchhhcCC
Confidence 236788889999999999999999999999999999999 5677899999999876533221 222
Q ss_pred cccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHh
Q 007253 322 IVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399 (611)
Q Consensus 322 ~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 399 (611)
..++..|+|||++. ..++.++|||||||++|+|++ |..||...................... ..+++++.+++.+|
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~c 318 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDC 318 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCC--CCCCHHHHHHHHHH
Confidence 34567899999875 568999999999999999996 999997654433333333322222211 23678999999999
Q ss_pred cccCccCCCCHHHHHcC
Q 007253 400 LNKDPRKRLTAAQALSH 416 (611)
Q Consensus 400 L~~dP~~Rpt~~~ll~h 416 (611)
|+.||.+|||+.++++|
T Consensus 319 l~~~p~~Rps~~eil~~ 335 (343)
T cd05103 319 WHGEPSQRPTFSELVEH 335 (343)
T ss_pred ccCChhhCcCHHHHHHH
Confidence 99999999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=320.80 Aligned_cols=253 Identities=21% Similarity=0.351 Sum_probs=209.5
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
...|+..+.||+|+||.||+|...........+|+|.+.... .....+.+.+|+.+++++. |+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFS-HHNIIRLEGVVTKFKP 80 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEccCCC
Confidence 356889999999999999999987643334589999985432 2334567889999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
.++||||+++++|.+++......+++..+..++.|++.||.|||+.|++||||||+||++ +.++.+||+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVL 157 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE---cCCCcEEECCCccceec
Confidence 999999999999999987766789999999999999999999999999999999999999 56778999999998765
Q ss_pred CCCCcc----cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 007253 314 RPDERL----NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (611)
Q Consensus 314 ~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (611)
...... .....+..|+|||++. +.++.++|||||||++|||++ |..||+.....+....+..... .+ ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~-~~--~~~~ 234 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR-LP--APMD 234 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCC-CC--CCCC
Confidence 432211 1112345799999886 568999999999999999997 9999988877776666654321 11 1235
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
++..+.+++.+||..+|.+||++.++++
T Consensus 235 ~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 235 CPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 7899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=323.57 Aligned_cols=251 Identities=18% Similarity=0.306 Sum_probs=202.0
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCc-cCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGEL-KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
++|++.+.||+|+||.||+|....... ....|++|.+... ........+..|+.+++++. ||||+++++++. ...
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~-h~~iv~~~~~~~-~~~ 82 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLD-HAYIVRLLGICP-GAS 82 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCC-CCCcceEEEEEC-CCc
Confidence 579999999999999999998765211 1225788877432 22334467788998999997 999999999875 456
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
.++++||+++|+|.+++......+++..+..++.||+.||.|||+++++||||||+|||+ ++++.+||+|||+++..
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili---~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL---KSDSIVQIADFGVADLL 159 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEEcCCccceec
Confidence 789999999999999998777789999999999999999999999999999999999999 57788999999999876
Q ss_pred CCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 314 RPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 314 ~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
..... .....++..|+|||++. +.++.++|||||||++|||++ |..||.+.........+ ........ ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~--~~~~ 236 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-EKGERLAQ--PQIC 236 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcCCC--CCCC
Confidence 43321 23345778899999886 678999999999999999998 99999877655544333 32222221 1245
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
+..+.+++.+||..||.+|||+.++++
T Consensus 237 ~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 237 TIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 788999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=339.08 Aligned_cols=256 Identities=24% Similarity=0.363 Sum_probs=206.9
Q ss_pred CCceeEeCeeeeccceEEEEEEEec--CCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~--~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.++|.+++.||+|+||.||+|++.. ....+..||+|++.... .....+.+.+|+.++.++..|||||++++++...
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 4578999999999999999998753 12246789999996542 2233456889999999997799999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcC---------------------------------------------------------
Q 007253 232 DNVYVVMELCEGGELLDRILSRG--------------------------------------------------------- 254 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~--------------------------------------------------------- 254 (611)
+.+++|||||++|+|.+++....
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 99999999999999999986432
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEe
Q 007253 255 ----------------------------------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294 (611)
Q Consensus 255 ----------------------------------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~ 294 (611)
..+++..++.++.||+.||.|||+.+|+||||||+|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl- 272 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI- 272 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE-
Confidence 136777889999999999999999999999999999999
Q ss_pred ccCCCceEEEeecccccccCCCC---cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHH
Q 007253 295 TKDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGI 369 (611)
Q Consensus 295 ~~~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~ 369 (611)
++.+.+||+|||+++...... ......++..|||||++. ..++.++|||||||++|||++ |..||......+.
T Consensus 273 --~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 273 --CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred --eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 467789999999998653222 122346788999999886 558899999999999999998 8999977655554
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 370 FRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 370 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
............ ....++.++.+||.+||..+|.+||++.+|++.
T Consensus 351 ~~~~~~~~~~~~--~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 351 FYNAIKRGYRMA--KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHcCCCCC--CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 444443332221 123578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=327.28 Aligned_cols=254 Identities=35% Similarity=0.532 Sum_probs=209.4
Q ss_pred eeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEE
Q 007253 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (611)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 236 (611)
|++.+.||+|+||.||+|.... .++.||||++...... .......+|+..++++.+|+||+++++++.+++..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKE---TGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECC---CCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEE
Confidence 6789999999999999999765 5789999998654322 1223445799999999779999999999999999999
Q ss_pred EeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC
Q 007253 237 VMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (611)
Q Consensus 237 v~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~ 315 (611)
||||+ +|+|.+++.... ..+++..+..++.||+.+|.|||++|++|+||+|+||++ +.++.++|+|||++.....
T Consensus 76 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAREIRS 151 (283)
T ss_pred EEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCCEEEeecccceeccC
Confidence 99999 789999887654 468999999999999999999999999999999999999 5678899999999987765
Q ss_pred CCcccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----------
Q 007253 316 DERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE----------- 382 (611)
Q Consensus 316 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~----------- 382 (611)
........++..|+|||++. ..++.++|+||||+++++|++|+.||......+.+..+.........
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 44445567899999999874 44789999999999999999999999777665544443322111100
Q ss_pred ---------------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 383 ---------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 383 ---------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
...+..+..+.+||++||+.||.+|||+.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0012346889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=328.22 Aligned_cols=254 Identities=22% Similarity=0.390 Sum_probs=207.5
Q ss_pred CCceeEeCeeeeccceEEEEEEEecC----CccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKG----ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~----~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 229 (611)
.++|.+++.||+|+||.||+|+.... ......||+|++... ........+.+|+.+++.+.+||||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN--ATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC--CChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 46899999999999999999986421 123567999998643 233445678899999999966999999999999
Q ss_pred eCCeeEEEeeecCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEe
Q 007253 230 DTDNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294 (611)
Q Consensus 230 ~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~ 294 (611)
+.+.+++||||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill- 167 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV- 167 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE-
Confidence 9999999999999999999987532 348899999999999999999999999999999999999
Q ss_pred ccCCCceEEEeecccccccCCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHH
Q 007253 295 TKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGI 369 (611)
Q Consensus 295 ~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~ 369 (611)
+.++.+||+|||+++....... .....++..|||||++. +.++.++|||||||++|+|++ |..||.+....+.
T Consensus 168 --~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 245 (314)
T cd05099 168 --TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245 (314)
T ss_pred --cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 5677899999999986543211 11223456799999886 568999999999999999998 8999988777666
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 370 FRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 370 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
+..+..... . .....++.++.++|.+||..||.+|||+.++++
T Consensus 246 ~~~~~~~~~-~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 246 FKLLREGHR-M--DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHcCCC-C--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 665544321 1 112467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=328.93 Aligned_cols=255 Identities=22% Similarity=0.337 Sum_probs=213.7
Q ss_pred ccccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe
Q 007253 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (611)
Q Consensus 150 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 229 (611)
.+.......++++||+|-||.|.++.... +..||+|.++... .......|.+|+++|.+|+ |||||.|+|+|.
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg----~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~ 605 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEG----PLKVAVKILRPDA--TKNARNDFLKEIKILSRLK-HPNIVELLGVCV 605 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecC----ceEEEEeecCccc--chhHHHHHHHHHHHHhccC-CCCeeEEEeeee
Confidence 34456778999999999999999998654 6899999997653 3445688999999999997 999999999999
Q ss_pred eCCeeEEEeeecCCCChHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecc
Q 007253 230 DTDNVYVVMELCEGGELLDRILSRGGK-YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (611)
Q Consensus 230 ~~~~~~lv~E~~~~gsL~~~l~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG 308 (611)
.++.+++|+|||++|+|.++|.++..+ +......+|+.||+.||+||.+.++|||||.+.|||+ |.++++||+|||
T Consensus 606 ~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadfg 682 (807)
T KOG1094|consen 606 QDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADFG 682 (807)
T ss_pred cCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCcc
Confidence 999999999999999999999887544 3556777899999999999999999999999999999 799999999999
Q ss_pred cccccCCCCcc---cccccCCCcCcchhh-cCCCCCcchhhHHHHHHHHHH--hCCCCCCCCChHHHHHHHHhcCCCCCC
Q 007253 309 LSDFVRPDERL---NDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILL--CGSRPFWARTESGIFRAVLKADPSFDE 382 (611)
Q Consensus 309 ~a~~~~~~~~~---~~~~gt~~y~aPE~~-~~~~~~~~DiwSlGvil~el~--~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 382 (611)
+++.+..+... ...+-..+|||||.+ .+.++.++|+|+||+++||++ +...||...++.++.++.......-..
T Consensus 683 msR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~ 762 (807)
T KOG1094|consen 683 MSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGR 762 (807)
T ss_pred cccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCc
Confidence 99976544432 233556899999955 699999999999999999986 688999988888877766543222211
Q ss_pred C----CCCCCCHHHHHHHHHhcccCccCCCCHHHHH
Q 007253 383 A----PWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414 (611)
Q Consensus 383 ~----~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll 414 (611)
. ..+-++..+.++|-+|+..|.++||+.+++.
T Consensus 763 ~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh 798 (807)
T KOG1094|consen 763 QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLH 798 (807)
T ss_pred ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence 1 1235688999999999999999999999984
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=318.54 Aligned_cols=243 Identities=23% Similarity=0.347 Sum_probs=199.6
Q ss_pred eeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeeec
Q 007253 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELC 241 (611)
Q Consensus 162 ~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~~ 241 (611)
.||+|+||.||+|.+... ..+..||+|++... ......+.+.+|+.++++++ |+||+++++++. .+..++||||+
T Consensus 2 ~ig~G~~g~v~~~~~~~~-~~~~~vavk~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~-~~~~~lv~e~~ 76 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMR-KKQIDVAIKVLKNE--NEKSVRDEMMREAEIMHQLD-NPYIVRMIGVCE-AEALMLVMEMA 76 (257)
T ss_pred ccCCCCcccEEEEEEecC-CCceeEEEEEcccc--cChHHHHHHHHHHHHHHhcC-CCCeEEEEEEEc-CCCeEEEEEeC
Confidence 489999999999987532 14667999998644 23445567899999999997 999999999885 45789999999
Q ss_pred CCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCCcc--
Q 007253 242 EGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL-- 319 (611)
Q Consensus 242 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~-- 319 (611)
++|+|.+++......+++..++.++.||+.||.|||++|++||||||+|||+ +.++.+||+|||++.........
T Consensus 77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE---cCCCcEEeccCCccccccCCcccee
Confidence 9999999987766789999999999999999999999999999999999999 56778999999999765433221
Q ss_pred --cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 007253 320 --NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395 (611)
Q Consensus 320 --~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 395 (611)
....++..|+|||++. +.++.++|||||||++|+|++ |..||......+....+....... .....++++.++
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l 230 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLD---CPAECPPEMYAL 230 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC---CCCCCCHHHHHH
Confidence 1122357899999886 568899999999999999996 999998887777666555443211 113568999999
Q ss_pred HHHhcccCccCCCCHHHHHc
Q 007253 396 VKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 396 i~~~L~~dP~~Rpt~~~ll~ 415 (611)
|.+||..+|++||++.++++
T Consensus 231 i~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 231 MKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=359.86 Aligned_cols=150 Identities=28% Similarity=0.486 Sum_probs=135.2
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|.++++||+|+||.||+|.... .++.||||++.+...........+..|+.+++.+. |+||+++++++...+.
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~ 78 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKN---NSKLYAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYSLQSANN 78 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEEEECCE
Confidence 3679999999999999999999776 58999999997665555666678899999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+||||||+.|++|.+++... +.+++..++.|+.||+.||.|||+++||||||||+|||| +.++.+||+|||+++
T Consensus 79 ~~lVmEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl---~~~g~vkL~DFGls~ 152 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI---SNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE---cCCCCEEEEeCCCCc
Confidence 99999999999999988654 568999999999999999999999999999999999999 567789999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=334.94 Aligned_cols=255 Identities=20% Similarity=0.326 Sum_probs=201.4
Q ss_pred eCeeeec--cceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEE
Q 007253 160 GEEVGRG--HFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVV 237 (611)
Q Consensus 160 ~~~LG~G--~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 237 (611)
...||+| +||.||+++... .|+.||+|++..... .....+.+.+|+.+++.++ ||||++++++|..++..++|
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~~v 77 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTP---TGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFR-HPNIMTSWTVFTTGSWLWVI 77 (328)
T ss_pred HHHhCCcccCceeEEEEEEcC---CCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCC-CCCcceEeeeEecCCceEEE
Confidence 3466766 899999998765 689999999865432 2344578899999999997 99999999999999999999
Q ss_pred eeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCC
Q 007253 238 MELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316 (611)
Q Consensus 238 ~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~ 316 (611)
|||+.+|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+|++|||.+......
T Consensus 78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill---~~~~~~~~~~~~~~~~~~~~ 154 (328)
T cd08226 78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILI---SGDGLVSLSGLSHLYSLVRN 154 (328)
T ss_pred EecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---eCCCcEEEechHHHhhhhcc
Confidence 99999999999876543 358999999999999999999999999999999999999 46678999999865433211
Q ss_pred Cc--------ccccccCCCcCcchhhcC---CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----
Q 007253 317 ER--------LNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD---- 381 (611)
Q Consensus 317 ~~--------~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~---- 381 (611)
.. .....++..|+|||++.+ .++.++|||||||++|+|++|+.||............+...+..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT 234 (328)
T ss_pred CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence 11 011234567999999864 378899999999999999999999987665544433332211100
Q ss_pred ---------------------------------------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 382 ---------------------------------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 382 ---------------------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
......++..+.+||++||+.||.+|||+.++|+||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 00012356789999999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=323.32 Aligned_cols=252 Identities=24% Similarity=0.399 Sum_probs=208.3
Q ss_pred CCceeEeCeeeeccceEEEEEEEec--CCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~--~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
..+|.+.++||+|+||.||++.... ....+..+|+|.+... .....+.+.+|+++++.++ |+||+++++++.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 79 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQ-HQHIVRFYGVCTEG 79 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCC-CCCCceEEEEEecC
Confidence 3578999999999999999997543 1224678999987543 3445578999999999997 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccC
Q 007253 232 DNVYVVMELCEGGELLDRILSRG--------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD 297 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~ 297 (611)
+..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|||+ +
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~---~ 156 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV---G 156 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE---c
Confidence 99999999999999999987643 248899999999999999999999999999999999999 5
Q ss_pred CCceEEEeecccccccCCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 007253 298 ENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRA 372 (611)
Q Consensus 298 ~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~ 372 (611)
+++.+||+|||++........ .....+++.|+|||++. ..++.++|||||||++|+|++ |..||...........
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 678899999999875543221 12234578899999876 568999999999999999998 9999988777766666
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 373 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
+....... ....+++.+.+||.+||+.||.+||++.++++
T Consensus 237 ~~~~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 237 ITQGRELE---RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHcCccCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 65443221 12367899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=319.41 Aligned_cols=247 Identities=24% Similarity=0.377 Sum_probs=205.4
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++.+.||+|+||.||+|.... ++.||+|.+..... ..+.+.+|+.++++++ |+||+++++++...+.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~----~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 75 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN----TTPVAVKTLKPGTM----DPKDFLAEAQIMKKLR-HPKLIQLYAVCTLEEP 75 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC----CeEEEEEeeCCCcc----cHHHHHHHHHHHHHCC-CCCccceeEEEecCCC
Confidence 4679999999999999999998543 57899999865432 2356889999999998 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 234 VYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~ 152 (261)
T cd05068 76 IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV---GENNICKVADFGLARV 152 (261)
T ss_pred eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE---cCCCCEEECCcceEEE
Confidence 999999999999999986653 468999999999999999999999999999999999999 5677899999999987
Q ss_pred cCCCCcc--cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 313 VRPDERL--NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 313 ~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
....... ....++..|+|||++. ..++.++|||||||++|+|++ |+.||.+.........+..... .+ ....+
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~ 229 (261)
T cd05068 153 IKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR-MP--CPPGC 229 (261)
T ss_pred ccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CC--CCCcC
Confidence 6532211 1122345799999876 568899999999999999999 9999988777666666554321 11 12357
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
+..+.+++.+||+.+|.+||++.++++
T Consensus 230 ~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 230 PKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=327.25 Aligned_cols=260 Identities=32% Similarity=0.569 Sum_probs=211.8
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcC-CHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-TAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
+|++.+.||+|+||.||+++.......+..||||++.+.... .....+.+.+|+.++.++.+||||+++++.+..+..+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 488999999999999999987654446889999998643221 2234456789999999997799999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++||||+.+|+|.+++... ..+++..++.++.|++.||.|||+.+++||||||+||++ +.++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEEECccccccc
Confidence 9999999999999988654 568999999999999999999999999999999999999 567789999999987654
Q ss_pred CCCc--ccccccCCCcCcchhhcCC---CCCcchhhHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhcCCCCCCCCC
Q 007253 315 PDER--LNDIVGSAYYVAPEVLHRS---YSTEADVWSIGVIAYILLCGSRPFWART----ESGIFRAVLKADPSFDEAPW 385 (611)
Q Consensus 315 ~~~~--~~~~~gt~~y~aPE~~~~~---~~~~~DiwSlGvil~el~~g~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~ 385 (611)
.... .....|+..|+|||.+.+. .+.++||||||+++|+|++|..||.... ..++...+....+..+
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 232 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFP---- 232 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCC----
Confidence 3322 2335689999999988532 6889999999999999999999995432 2233333333332222
Q ss_pred CCCCHHHHHHHHHhcccCccCCCC---HHHHHcCcccCCCC
Q 007253 386 PSLSSEARDFVKRLLNKDPRKRLT---AAQALSHPWIKNSN 423 (611)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rpt---~~~ll~hp~~~~~~ 423 (611)
..++..+.++|.+||+.||++||| +.++|+||||+...
T Consensus 233 ~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 233 KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 357889999999999999999998 57789999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=332.85 Aligned_cols=260 Identities=32% Similarity=0.524 Sum_probs=206.6
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC----
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT---- 231 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~---- 231 (611)
+|++.+.||+|+||.||+++.... ..+..||+|++.... ......+.+.+|+.+++++.+||||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~-~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 78 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAET-SEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF 78 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCC-CcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence 488999999999999999997652 127889999986432 22334466788999999997799999999875432
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
..+++++||+. ++|.+.+.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.
T Consensus 79 ~~~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili---~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 79 NELYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV---NADCELKICDFGLAR 153 (332)
T ss_pred CcEEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE---cCCCCEEeCcCCCce
Confidence 45889999995 688887754 4579999999999999999999999999999999999999 567789999999997
Q ss_pred ccCCCC-----cccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-----
Q 007253 312 FVRPDE-----RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS----- 379 (611)
Q Consensus 312 ~~~~~~-----~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~----- 379 (611)
...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||........+..+......
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 654322 123457899999999875 35889999999999999999999999876654444333321100
Q ss_pred ------------------CC----CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 380 ------------------FD----EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 380 ------------------~~----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
.+ ...++..+..+.+||.+||+.||.+|||+.+++.||||+.-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 00 11234568899999999999999999999999999999744
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=317.74 Aligned_cols=244 Identities=23% Similarity=0.348 Sum_probs=199.8
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeee
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~ 240 (611)
++||+|+||.||+|.+... ..+..||+|++.... ......+.+.+|+.+++.+. |+||+++++++. .+..++||||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~-~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~-~~~~~lv~e~ 76 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMK-KSEKTVAVKILKNDN-NDPALKDELLREANVMQQLD-NPYIVRMIGICE-AESWMLVMEL 76 (257)
T ss_pred CcCCCcCCcceEEeEEecC-CCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCC-CCCcceEEEEEc-CCCcEEEEec
Confidence 3699999999999976532 257889999986443 34455678899999999997 999999999875 4567899999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCCc--
Q 007253 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER-- 318 (611)
Q Consensus 241 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~-- 318 (611)
+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+.....
T Consensus 77 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 77 AELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL---VTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE---cCCCeEEECCCccccccCCCCCee
Confidence 9999999988654 569999999999999999999999999999999999999 5677899999999987643322
Q ss_pred --ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 007253 319 --LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARD 394 (611)
Q Consensus 319 --~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 394 (611)
.....++..|+|||++. ..++.++|||||||++|||++ |..||......+....+.+... .+ ....++.++.+
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~-~~--~~~~~~~~l~~ 229 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-ME--CPQRCPPEMYD 229 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-CC--CCCCCCHHHHH
Confidence 12223457899999886 568889999999999999997 9999988777666666554332 11 12357899999
Q ss_pred HHHHhcccCccCCCCHHHHHc
Q 007253 395 FVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 395 li~~~L~~dP~~Rpt~~~ll~ 415 (611)
+|.+||+.||.+||++.+|..
T Consensus 230 li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 230 LMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHHHhccCchhCcCHHHHHH
Confidence 999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=326.25 Aligned_cols=254 Identities=34% Similarity=0.562 Sum_probs=211.3
Q ss_pred eeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEE
Q 007253 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (611)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 236 (611)
|++.+.||.|++|.||+|.... +|+.+|+|.+..... .......+.+|+.+++++. |+||+++++++.+++.+++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKL---TGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELN-HPNIIKLLDVFRHKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCC---CCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhc-CCCcchHHHhhccCCCEEE
Confidence 6778899999999999998765 589999999865432 2234567889999999998 9999999999999999999
Q ss_pred EeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCC
Q 007253 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316 (611)
Q Consensus 237 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~ 316 (611)
||||+++ +|.+++......+++..+..++.||+.||.|||+.+|+|+||||+||++ +.++.+||+|||.+......
T Consensus 76 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 76 VFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred EEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE---CCCCcEEEeeeeeeEecCCC
Confidence 9999975 8888887766789999999999999999999999999999999999999 56788999999998776544
Q ss_pred C-cccccccCCCcCcchhhc-C-CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC------------
Q 007253 317 E-RLNDIVGSAYYVAPEVLH-R-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD------------ 381 (611)
Q Consensus 317 ~-~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~------------ 381 (611)
. ......++..|+|||++. . .++.++||||||+++|+|++|+.||......+.+..+........
T Consensus 152 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 152 VRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred cccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence 3 233456888999999875 3 588899999999999999999999987766555444433211100
Q ss_pred --------------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 382 --------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 382 --------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
...++.++.++.+||.+||.+||.+||++.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 01123468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=315.55 Aligned_cols=261 Identities=22% Similarity=0.337 Sum_probs=214.2
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.+..+-+..||.|+||.|++..++. .|+..|||.|..... .....+++.|.....+-.++||||++||++..++.
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~---sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd 137 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKP---SGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD 137 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCc---cCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence 3456778899999999999999887 799999999975543 34557888999988887889999999999999999
Q ss_pred eEEEeeecCCCChHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeecCCCCceEEeccCCCceEEEeecc
Q 007253 234 VYVVMELCEGGELLDRIL----SRGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DfG 308 (611)
.||.||+|+- ||..+.+ -....++|..+..|....+.||.||-+. .|||||+||+|||| +..|.|||||||
T Consensus 138 cWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFG 213 (361)
T KOG1006|consen 138 CWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFG 213 (361)
T ss_pred eeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeeccc
Confidence 9999999964 6544332 1245699999999999999999999765 89999999999999 788889999999
Q ss_pred cccccCCCCcccccccCCCcCcchhhc---CCCCCcchhhHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcCCCCCCCC
Q 007253 309 LSDFVRPDERLNDIVGSAYYVAPEVLH---RSYSTEADVWSIGVIAYILLCGSRPFWART-ESGIFRAVLKADPSFDEAP 384 (611)
Q Consensus 309 ~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwSlGvil~el~~g~~Pf~~~~-~~~~~~~i~~~~~~~~~~~ 384 (611)
++..+..+-..+.-+|...|||||.+. ..|+.++||||||++|||+.||+.||..-. ..+.+..+..+++..-...
T Consensus 214 IcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~ 293 (361)
T KOG1006|consen 214 ICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFD 293 (361)
T ss_pred chHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCc
Confidence 998876665566668999999999985 459999999999999999999999995422 2233444444443332211
Q ss_pred --CCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 385 --WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 385 --~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
--.++..+..||.-||.+|-+.||...+|+.+||++...
T Consensus 294 ~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 294 KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred ccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 124789999999999999999999999999999998654
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=315.05 Aligned_cols=252 Identities=33% Similarity=0.608 Sum_probs=213.5
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
+|++.+.||+|++|.||++.... .++.||+|.+...... ....+.+.+|+++++++. |+||+++++++.+.+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLE---TGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLK-HPNIVKYIGSIETSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcC---CCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEE
Confidence 48899999999999999998765 5789999999765432 345578999999999997 999999999999999999
Q ss_pred EEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC
Q 007253 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~ 315 (611)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.....
T Consensus 76 ~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~ 151 (254)
T cd06627 76 IILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT---TKDGVVKLADFGVATKLND 151 (254)
T ss_pred EEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---CCCCCEEEeccccceecCC
Confidence 999999999999988655 679999999999999999999999999999999999999 4577899999999987654
Q ss_pred CCc-ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 007253 316 DER-LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (611)
Q Consensus 316 ~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 393 (611)
... .....++..|+|||.+. ..++.++||||||+++|+|++|..||...........+.... . ......++..+.
T Consensus 152 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~ 228 (254)
T cd06627 152 VSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD--H-PPLPEGISPELK 228 (254)
T ss_pred CcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC--C-CCCCCCCCHHHH
Confidence 332 23457889999999886 447889999999999999999999998766544444433221 1 112246789999
Q ss_pred HHHHHhcccCccCCCCHHHHHcCccc
Q 007253 394 DFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 394 ~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
++|.+||..+|++|||+.+++.||||
T Consensus 229 ~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 229 DFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=336.11 Aligned_cols=258 Identities=36% Similarity=0.582 Sum_probs=214.8
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC---
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD--- 232 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~--- 232 (611)
+|++.+.||.|+||.||+|+... .|+.||||++.... ......+.+.+|+.+++.++ |+||+++++++.+.+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~---~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKR---TGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPED 75 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCC---CCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCccc
Confidence 58999999999999999999765 58899999986542 22344567889999999998 999999999998775
Q ss_pred --eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 233 --NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 233 --~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++
T Consensus 76 ~~~~~lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili---~~~~~~~L~dfg~~ 150 (330)
T cd07834 76 FNDVYIVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLA 150 (330)
T ss_pred ccceEEEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccCce
Confidence 7999999997 4888877544 479999999999999999999999999999999999999 56788999999999
Q ss_pred cccCCCC----cccccccCCCcCcchhhc-C-CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-
Q 007253 311 DFVRPDE----RLNDIVGSAYYVAPEVLH-R-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA- 383 (611)
Q Consensus 311 ~~~~~~~----~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~- 383 (611)
....... ......+++.|+|||++. . .++.++|||||||++|+|++|+.||.+....+.+..+..........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 151 RGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230 (330)
T ss_pred EeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhH
Confidence 8765443 234557899999999886 3 58899999999999999999999998887766666555432211110
Q ss_pred --------------------------CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 384 --------------------------PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 384 --------------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
..+.++.++.+||.+||+++|.+|||+.+++.||||+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 0234688999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=317.69 Aligned_cols=246 Identities=25% Similarity=0.411 Sum_probs=206.4
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeee
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~ 240 (611)
++||+|++|.||+|.+.........||||++...... ...+.+.+|+.++++++ ||||+++++++.+ ...++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLD-HENLIRLYGVVLT-HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcC-CCCccceeEEEcC-CeEEEEEEe
Confidence 4789999999999998664323457999999765433 56678999999999998 9999999999988 889999999
Q ss_pred cCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCCc-
Q 007253 241 CEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER- 318 (611)
Q Consensus 241 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~- 318 (611)
+++|+|.+++.... ..+++..++.++.||+.||.|||++|++||||||+||++ +.++.+||+|||++..+.....
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL---ASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEE---ecCCEEEeccccccccccccccc
Confidence 99999999987765 568999999999999999999999999999999999999 5668899999999987644221
Q ss_pred ---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 007253 319 ---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (611)
Q Consensus 319 ---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 393 (611)
.....++..|+|||++. ..++.++|||||||++|+|++ |..||......++...+......... ...++..+.
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 231 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLER--PEACPQDIY 231 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCC--CccCCHHHH
Confidence 12245778899999886 568999999999999999998 99999887777776666653322221 135689999
Q ss_pred HHHHHhcccCccCCCCHHHHHc
Q 007253 394 DFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 394 ~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
+++.+||+.+|++|||+.++++
T Consensus 232 ~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 232 NVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHCCCCcccCCCHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=325.51 Aligned_cols=254 Identities=31% Similarity=0.567 Sum_probs=211.4
Q ss_pred eeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEE
Q 007253 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (611)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 236 (611)
|....+||+|+||.||++.... +|+.||||.+... .......+.+|+.+++.+. |+||+++++++...+..++
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 94 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKS---SGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWV 94 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcC---CCeEEEEEEeccc---chhHHHHHHHHHHHHHhcC-CcchhheeeEEEeCCEEEE
Confidence 4445789999999999998766 6899999987432 2334567889999999997 9999999999999999999
Q ss_pred EeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCC
Q 007253 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316 (611)
Q Consensus 237 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~ 316 (611)
||||+++++|.+++.. ..+++..++.++.||+.||.|||+.|++||||||+||++ +.++.++|+|||++......
T Consensus 95 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~ 169 (292)
T cd06657 95 VMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKE 169 (292)
T ss_pred EEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEcccccceecccc
Confidence 9999999999886633 468999999999999999999999999999999999999 56778999999998765433
Q ss_pred C-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 007253 317 E-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARD 394 (611)
Q Consensus 317 ~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 394 (611)
. ......|++.|+|||++. ..++.++|+|||||++|+|++|..||.+.........+....+.. ......++..+.+
T Consensus 170 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~ 248 (292)
T cd06657 170 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPK-LKNLHKVSPSLKG 248 (292)
T ss_pred cccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcc-cCCcccCCHHHHH
Confidence 2 233457899999999885 567899999999999999999999998776655554444332221 1123467899999
Q ss_pred HHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 395 FVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 395 li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
+|.+||+.||.+||++.++++||||....
T Consensus 249 li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 249 FLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred HHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 99999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=333.65 Aligned_cols=260 Identities=30% Similarity=0.540 Sum_probs=208.8
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+.++|++.+.||+|+||.||+|.... +|+.||+|++.+.. ......+.+.+|+.++++++ ||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~~ 88 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPA 88 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcC---CCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHcC-CCcccceeeeeeec
Confidence 356889999999999999999998765 68899999986532 22333466788999999997 99999999988643
Q ss_pred ------CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 232 ------DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 232 ------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
...|++++++ +++|.+.+.. ..+++..++.++.||+.||.|||+.||+||||||+||++ +.++.+||+
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~ 162 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKIL 162 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---cCCCCEEEe
Confidence 3478899987 7798876643 469999999999999999999999999999999999999 567789999
Q ss_pred ecccccccCCCCcccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-----
Q 007253 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP----- 378 (611)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~----- 378 (611)
|||++..... ......|+..|+|||++.+ .++.++|||||||++|+|++|+.||........+..+.....
T Consensus 163 dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T cd07877 163 DFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 240 (345)
T ss_pred cccccccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999876532 3344578999999998753 578899999999999999999999977655444333322111
Q ss_pred ------------------CCCCC----CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCC
Q 007253 379 ------------------SFDEA----PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (611)
Q Consensus 379 ------------------~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~ 424 (611)
..+.. .+...++++.+||.+||+.||.+||++.++++||||+....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 241 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred HHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 11110 11245788999999999999999999999999999986553
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=320.60 Aligned_cols=251 Identities=22% Similarity=0.326 Sum_probs=202.1
Q ss_pred eeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC-----
Q 007253 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT----- 231 (611)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~----- 231 (611)
|.+++.||+|+||.||+|+..... ....||+|.+.... ......+.+.+|+.+++.++ |+||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~-~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 77 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDD-SILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFD-HPNVMRLIGVCLQTVESEG 77 (272)
T ss_pred CccccccCcccCceEEEeEEccCC-CeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEccCCcccC
Confidence 357889999999999999876521 12369999886543 33445678889999999997 99999999987532
Q ss_pred -CeeEEEeeecCCCChHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 232 -DNVYVVMELCEGGELLDRILSR-----GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 232 -~~~~lv~E~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
...++||||+++|+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+
T Consensus 78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~ 154 (272)
T cd05075 78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVA 154 (272)
T ss_pred CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE---cCCCCEEEC
Confidence 2478999999999998887532 2348999999999999999999999999999999999999 567889999
Q ss_pred ecccccccCCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCC
Q 007253 306 DFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSF 380 (611)
Q Consensus 306 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~ 380 (611)
|||++..+..... .....+++.|+|||++. ..++.++|||||||++|+|++ |+.||...........+......
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~- 233 (272)
T cd05075 155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL- 233 (272)
T ss_pred CCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC-
Confidence 9999987643321 12234567899999886 568999999999999999999 89999887777666666554321
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 381 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
. ..+.++..+.++|.+||+.||.+|||+.+++++
T Consensus 234 ~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 234 K--QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred C--CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1 124678899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=321.32 Aligned_cols=248 Identities=25% Similarity=0.419 Sum_probs=209.0
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
..+|+++++||.|+||.||+|.... +..+|+|++.... ......+.+|+.+++.++ |+||+++++++.+.+.
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~----~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 76 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN----RVRVAIKILKSDD---LLKQQDFQKEVQALKRLR-HKHLISLFAVCSVGEP 76 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC----CCcEEEEeccccc---hhhHHHHHHHHHHHhcCC-CcchhheeeeEecCCC
Confidence 4579999999999999999998764 6789999986542 223457889999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 234 VYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.++||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||++ ++++.+||+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv---~~~~~~kl~d~g~~~~ 153 (261)
T cd05148 77 VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARL 153 (261)
T ss_pred eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE---cCCceEEEccccchhh
Confidence 99999999999999998764 3468999999999999999999999999999999999999 5677899999999976
Q ss_pred cCCCCc-ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 313 VRPDER-LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 313 ~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
...... .....++..|+|||++. +.++.++||||||+++|+|++ |+.||......+.+..+..... . .....++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~ 230 (261)
T cd05148 154 IKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR-M--PCPAKCP 230 (261)
T ss_pred cCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc-C--CCCCCCC
Confidence 643321 22334567899999886 568899999999999999998 8999988777777776664321 1 1124678
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
..+.++|.+||+.||.+|||+.++++
T Consensus 231 ~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 231 QEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=316.85 Aligned_cols=244 Identities=23% Similarity=0.345 Sum_probs=200.5
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeee
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~ 240 (611)
++||+|+||.||+|.+......+..||+|.+...... ...+.+.+|+.+++.+. |+||+++++++. .+.+++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLD-HPCIVRLIGVCK-GEPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcC-CCCeeeEEEEEc-CCceEEEEEe
Confidence 4799999999999987664434589999998755432 44567889999999997 999999999876 4568999999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCCcc-
Q 007253 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL- 319 (611)
Q Consensus 241 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~- 319 (611)
+++|+|.+++.... .+++..+..++.||+.||.|||+.+++||||||+|||+ +.++.+||+|||++.........
T Consensus 77 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 77 APLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE---cCCCcEEeccccccceeecCCccc
Confidence 99999999887653 78999999999999999999999999999999999999 56778999999999866433321
Q ss_pred ---cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 007253 320 ---NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARD 394 (611)
Q Consensus 320 ---~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 394 (611)
....++..|+|||.+. ..++.++|||||||++|+|++ |..||......+....+...... .....++..+.+
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~ 229 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL---PRPEECPQEIYS 229 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC---CCCCCCCHHHHH
Confidence 1112346799999886 568999999999999999997 99999877766665555443321 222467899999
Q ss_pred HHHHhcccCccCCCCHHHHHc
Q 007253 395 FVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 395 li~~~L~~dP~~Rpt~~~ll~ 415 (611)
+|.+||..+|++||++.++++
T Consensus 230 li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 230 IMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=335.77 Aligned_cols=261 Identities=30% Similarity=0.569 Sum_probs=213.7
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+.++|++.+.||+|+||.||+|+... +++.||+|++.... ........+.+|+.+++++. |+||+++++++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~---~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 86 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTK---TGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMD-HENVIGLLDVFTPA 86 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECC---CCcEEEEEeccccc-chhhHHHHHHHHHHHHHhcc-CCCHHHHHHHhhcc
Confidence 356789999999999999999999876 58899999986532 22334466778999999997 99999999888765
Q ss_pred Ce------eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 232 DN------VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 232 ~~------~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
+. +++|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||++ +.++.+||+
T Consensus 87 ~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill---~~~~~~kL~ 160 (343)
T cd07851 87 SSLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKIL 160 (343)
T ss_pred ccccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEc
Confidence 54 89999999 6799887754 469999999999999999999999999999999999999 567789999
Q ss_pred ecccccccCCCCcccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--
Q 007253 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD-- 381 (611)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~-- 381 (611)
|||++...... .....++..|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+.......+
T Consensus 161 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 161 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred ccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 99999765432 345578899999998753 578899999999999999999999987776665555544321110
Q ss_pred ---------------------C----CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCC
Q 007253 382 ---------------------E----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (611)
Q Consensus 382 ---------------------~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~ 425 (611)
. ..+..++.++.+||.+||+.||.+|||+.++++||||+.....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 0 0112468899999999999999999999999999999865533
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=334.46 Aligned_cols=261 Identities=31% Similarity=0.501 Sum_probs=210.4
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+.++|++.+.||+|+||.||+|.... +|+.||+|++.+.. ........+.+|+.+++++.+|+||+++++++...
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~ 79 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRR---TKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE 79 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcC---CCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC
Confidence 456789999999999999999998765 58899999885432 22233456778999999994499999999998654
Q ss_pred --CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccc
Q 007253 232 --DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (611)
Q Consensus 232 --~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~ 309 (611)
..+|+||||+. ++|.+++... .+++..++.++.||+.||.|||+.||+||||||+||++ +.++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill---~~~~~~kl~d~g~ 153 (337)
T cd07852 80 NDKDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGL 153 (337)
T ss_pred CCceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccc
Confidence 36899999996 5898877543 78999999999999999999999999999999999999 6788999999999
Q ss_pred ccccCCCC------cccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--
Q 007253 310 SDFVRPDE------RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS-- 379 (611)
Q Consensus 310 a~~~~~~~------~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~-- 379 (611)
+....... ......|+..|+|||++. ..++.++|||||||++|+|++|+.||.+.........+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07852 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS 233 (337)
T ss_pred hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 87654322 223457899999999874 45788999999999999999999999776554443333222111
Q ss_pred -------------------------CCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 380 -------------------------FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 380 -------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
......+.++.++.+||.+||+.||.+|||+.++++||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0111124478999999999999999999999999999999765
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=324.32 Aligned_cols=256 Identities=21% Similarity=0.300 Sum_probs=204.3
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCC-----------ccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCee
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGE-----------LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~-----------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv 222 (611)
..+|++.++||+|+||.||+++..... .....||+|.+... ........+.+|+++++++. |+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~ei~~l~~l~-h~~i~ 80 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD--VTKTARNDFLKEIKIMSRLK-NPNII 80 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC--CCHHHHHHHHHHHHHHHhCC-CCCcC
Confidence 357999999999999999998764311 12346899998653 23445567899999999998 99999
Q ss_pred EEEEEEeeCCeeEEEeeecCCCChHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCce
Q 007253 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRG-----------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENF 291 (611)
Q Consensus 223 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-----------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NI 291 (611)
++++++...+..++||||+++++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 99999999999999999999999999886432 1368899999999999999999999999999999999
Q ss_pred EEeccCCCceEEEeecccccccCCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh--CCCCCCCCC
Q 007253 292 LFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC--GSRPFWART 365 (611)
Q Consensus 292 ll~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~--g~~Pf~~~~ 365 (611)
++ +.++.+||+|||++..+..... .....++..|+|||++. +.++.++|||||||++|+|++ |..||....
T Consensus 161 ll---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 161 LV---GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EE---cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 99 5667899999999976543321 22334577899999875 668999999999999999988 678988776
Q ss_pred hHHHHHHHHhcC----CCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 366 ESGIFRAVLKAD----PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 366 ~~~~~~~i~~~~----~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
.......+.... ........+.++..+.+||.+||..||.+||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 665555443211 11111122457899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=321.35 Aligned_cols=251 Identities=25% Similarity=0.352 Sum_probs=197.0
Q ss_pred Cce-eEeCeeeeccceEEEEEEEecC-CccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC-
Q 007253 155 NKY-ELGEEVGRGHFGYTCAAKFKKG-ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (611)
Q Consensus 155 ~~y-~~~~~LG~G~fg~V~~~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~- 231 (611)
++| .+.+.||+|+||.||++..... ...+..||+|++.... .......+.+|+.+++++. ||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 79 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLY-HENIVKYKGCCSEQG 79 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCC
Confidence 455 8999999999999998875432 2257899999986542 2234567889999999997 99999999988653
Q ss_pred -CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 232 -DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 232 -~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
..+++||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~ 154 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLA 154 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE---cCCCcEEEeecccc
Confidence 4689999999999999988553 59999999999999999999999999999999999999 56778999999999
Q ss_pred cccCCCCc----ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChH--H------------HHH
Q 007253 311 DFVRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES--G------------IFR 371 (611)
Q Consensus 311 ~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~--~------------~~~ 371 (611)
........ .....++..|+|||++. ..++.++|||||||++|+|++|..||...... . ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI 234 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence 87653322 12234567799999886 56899999999999999999999998543221 0 001
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 372 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
.........+ ....++.++.+++.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 235 ELLERGMRLP--CPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1111111111 11356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=317.35 Aligned_cols=245 Identities=36% Similarity=0.658 Sum_probs=212.0
Q ss_pred eeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeeecC
Q 007253 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCE 242 (611)
Q Consensus 163 LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~~~ 242 (611)
||+|+||.||++.... .++.||+|++.+...........+..|+.+++++. |+||+++++.+..++.+++||||++
T Consensus 1 lg~G~~~~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~ 76 (250)
T cd05123 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQTEEKLYLVLEYAP 76 (250)
T ss_pred CCCCCceEEEEEEECC---CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHeecCCeeEEEEecCC
Confidence 7999999999998765 58899999997765555556778899999999998 9999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCC-Ccccc
Q 007253 243 GGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLND 321 (611)
Q Consensus 243 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~-~~~~~ 321 (611)
+++|.+++... ..+++..++.++.||+.||.|||+.+++|+||||+||++ +.++.++|+|||++...... .....
T Consensus 77 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (250)
T cd05123 77 GGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL---DADGHIKLTDFGLAKELSSEGSRTNT 152 (250)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE---cCCCcEEEeecCcceecccCCCcccC
Confidence 99999988655 468999999999999999999999999999999999999 56778999999998776443 23445
Q ss_pred cccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhc
Q 007253 322 IVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400 (611)
Q Consensus 322 ~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 400 (611)
..++..|+|||.+. ..++.++|+||||+++|+|++|..||...........+......++ ..++..+.++|++||
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~~i~~~l 228 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP----EFLSPEARDLISGLL 228 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHh
Confidence 67889999999886 4578899999999999999999999987777666666665433333 245899999999999
Q ss_pred ccCccCCCCH---HHHHcCccc
Q 007253 401 NKDPRKRLTA---AQALSHPWI 419 (611)
Q Consensus 401 ~~dP~~Rpt~---~~ll~hp~~ 419 (611)
..||.+||++ +++++||||
T Consensus 229 ~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 229 QKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred cCCHhhCCCcccHHHHHhCCCC
Confidence 9999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=322.57 Aligned_cols=251 Identities=24% Similarity=0.356 Sum_probs=204.0
Q ss_pred ceeEeCeeeeccceEEEEEEEecCC--ccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
+|++.+.||+|+||.||+|...... .....+|+|.+.... .......+.+|+.+++.+. ||||+++++.+..++.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVN-HPHVIKLYGACSQDGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCC
Confidence 4789999999999999999865311 134679999886442 2334567889999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCc
Q 007253 234 VYVVMELCEGGELLDRILSR-----------------------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~-----------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~N 290 (611)
.++||||+.+|+|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 99999999999999987642 1347899999999999999999999999999999999
Q ss_pred eEEeccCCCceEEEeecccccccCCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCC
Q 007253 291 FLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWART 365 (611)
Q Consensus 291 Ill~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~ 365 (611)
||+ ++++.+||+|||++........ .....++..|+|||++. ..++.++|||||||++|+|++ |..||.+..
T Consensus 158 ill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 158 VLV---AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred EEE---cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 999 5677899999999976533221 12234567899999875 558999999999999999998 999998777
Q ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 366 ESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 366 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
...+...+.... ..+ ....++.++.+|+.+||+.+|.+||++.++++
T Consensus 235 ~~~~~~~~~~~~-~~~--~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 235 PERLFNLLKTGY-RME--RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHHHhCCC-CCC--CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 666555444322 111 12357899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=356.18 Aligned_cols=253 Identities=23% Similarity=0.397 Sum_probs=217.0
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCcc--CcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELK--GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
....++.+.||+|+||.||.|.+...... -..||||.+.+. .+......|.+|..+|+++. |||||+++|++.+.
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~-HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFD-HPNIVSLIGVCLDS 767 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCC-CcceeeEEEeecCC
Confidence 45678899999999999999998764322 345888888654 56677889999999999998 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 232 DNVYVVMELCEGGELLDRILSR------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
...+|++|||+||+|+.+|++. ...++...+..++.||++|+.||+++++|||||-..|+|| +....|||+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL---~~~r~VKIa 844 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLL---DERRVVKIA 844 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheee---cccCcEEEc
Confidence 9999999999999999999876 5669999999999999999999999999999999999999 577999999
Q ss_pred ecccccccC-CCCccc-cc-ccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCC
Q 007253 306 DFGLSDFVR-PDERLN-DI-VGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSF 380 (611)
Q Consensus 306 DfG~a~~~~-~~~~~~-~~-~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~ 380 (611)
|||+|+.+. .+.... .. .-...|||||.+. +.|+.++|||||||++||+++ |..||.+....+++..++... .+
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL 923 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RL 923 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-cc
Confidence 999999443 222111 11 2235899999987 889999999999999999997 899999999988888777665 44
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 381 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
+.. ..++..+.++|.+||+.+|++||+...|++
T Consensus 924 ~~P--~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 924 DPP--SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCC--CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 332 478999999999999999999999999987
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=324.73 Aligned_cols=254 Identities=33% Similarity=0.560 Sum_probs=211.4
Q ss_pred eeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEE
Q 007253 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (611)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 236 (611)
|++.+.||+|+||.||+|+... +++.||+|++.... ......+.+.+|+.+++++. |+||+++++++.+.+.+++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~---~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKK---TGEIVALKKIRLDN-EEEGIPSTALREISLLKELK-HPNIVKLLDVIHTERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecC---CCcEEEEEEecccc-ccccccHHHHHHHHHHHhcC-CCCHHHHHhhhhcCCceEE
Confidence 6778899999999999999776 58999999987653 22333466788999999998 9999999999999999999
Q ss_pred EeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCC
Q 007253 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316 (611)
Q Consensus 237 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~ 316 (611)
||||++ ++|.+++......+++..++.++.||+.||.|||++||+||||+|+||++ ++++.+||+|||++......
T Consensus 76 v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~ 151 (282)
T cd07829 76 VFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIP 151 (282)
T ss_pred EecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE---cCCCCEEEecCCcccccCCC
Confidence 999997 59999987765679999999999999999999999999999999999999 56788999999999876543
Q ss_pred C-cccccccCCCcCcchhhc-C-CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--------------
Q 007253 317 E-RLNDIVGSAYYVAPEVLH-R-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS-------------- 379 (611)
Q Consensus 317 ~-~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~-------------- 379 (611)
. ......++..|+|||++. . .++.++|||||||++|+|++|+.||......+.+..+......
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 152 LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred ccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 3 333446678899999875 3 6889999999999999999999999887766555444332110
Q ss_pred ----CCC-------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 380 ----FDE-------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 380 ----~~~-------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
++. ..++.++..+.++|++||..||++||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 000 1123467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=318.36 Aligned_cols=246 Identities=24% Similarity=0.379 Sum_probs=202.9
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
..+|++.++||+|+||.||+|+... +..||+|++..... ..+.+.+|+.++++++ |+||+++++++. .+.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~----~~~valK~~~~~~~----~~~~~~~E~~~l~~l~-~~~i~~~~~~~~-~~~ 74 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVS-EEP 74 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecC----CceEEEEecccCcc----CHHHHHHHHHHHHhCC-CCCcceEEEEEC-CCC
Confidence 4679999999999999999997654 34699999865332 2356889999999997 999999999875 456
Q ss_pred eEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 234 VYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+|+||||||+||++ +.++.+||+|||.+..
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill---~~~~~~~L~dfg~~~~ 151 (262)
T cd05071 75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARL 151 (262)
T ss_pred cEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE---cCCCcEEeccCCceee
Confidence 899999999999999987643 458999999999999999999999999999999999999 5677899999999976
Q ss_pred cCCCCc--ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 313 VRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 313 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
+..... .....++..|+|||++. +.++.++|||||||++|+|++ |..||.+....+....+..... .+ ....+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~ 228 (262)
T cd05071 152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-MP--CPPEC 228 (262)
T ss_pred ccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC-CC--Ccccc
Confidence 643322 12334667899999875 668999999999999999999 8999988777666665544321 11 12467
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
+..+.++|.+||++||.+||++.++++
T Consensus 229 ~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 229 PESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=313.16 Aligned_cols=242 Identities=25% Similarity=0.363 Sum_probs=200.7
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeee
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~ 240 (611)
++||+|+||.||+|... .++.||+|++.... .......+.+|+.+++++. ||||+++++++...+..++||||
T Consensus 1 ~~ig~g~~g~vy~~~~~----~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~ 73 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK----DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYD-HPNIVKLIGVCTQRQPIYIVMEL 73 (250)
T ss_pred CccCCCCCceEEEEEec----CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCC-CCCcCeEEEEEecCCccEEEEEC
Confidence 47999999999999753 37789999986432 2334456889999999997 99999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCCc--
Q 007253 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER-- 318 (611)
Q Consensus 241 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~-- 318 (611)
+++|+|.+++......+++..+..++.||+.||.|||++|++||||||+||++ +.++.+||+|||++........
T Consensus 74 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~ 150 (250)
T cd05085 74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSS 150 (250)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE---cCCCeEEECCCccceecccccccc
Confidence 99999999887666678999999999999999999999999999999999999 5677899999999875432221
Q ss_pred ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 007253 319 LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFV 396 (611)
Q Consensus 319 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 396 (611)
.....++..|+|||++. +.++.++|||||||++|+|++ |..||...........+..... ......++..+.+++
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li 227 (250)
T cd05085 151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR---MSCPQKCPDDVYKVM 227 (250)
T ss_pred CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCHHHHHHH
Confidence 11223456799999886 568889999999999999998 9999987776666555544321 112235789999999
Q ss_pred HHhcccCccCCCCHHHHHc
Q 007253 397 KRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 397 ~~~L~~dP~~Rpt~~~ll~ 415 (611)
.+||..+|.+||++.++++
T Consensus 228 ~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 228 QRCWDYKPENRPKFSELQK 246 (250)
T ss_pred HHHcccCcccCCCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=317.96 Aligned_cols=246 Identities=24% Similarity=0.366 Sum_probs=197.9
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeee
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~ 240 (611)
+.||+|+||.||+|+...+. ....+|+|.+... ......+.+.+|+.++.++.+||||+++++++...+.+++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 77 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 77 (270)
T ss_pred CcCCCCCCceEEEEEEcCCC-CeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEe
Confidence 46899999999999886621 1235788887532 23344567889999999996699999999999999999999999
Q ss_pred cCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 241 CEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 241 ~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
+++|+|.+++.... ..+++..++.++.||+.||+|||++|++||||||+|||+ +.++.+||+
T Consensus 78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~ 154 (270)
T cd05047 78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIA 154 (270)
T ss_pred CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEEC
Confidence 99999999986532 247899999999999999999999999999999999999 577889999
Q ss_pred ecccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC
Q 007253 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEA 383 (611)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 383 (611)
|||++..............+..|+|||++. ..++.++|||||||++|||++ |..||.+....+....+.... .. .
T Consensus 155 dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~~--~ 231 (270)
T cd05047 155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RL--E 231 (270)
T ss_pred CCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC-CC--C
Confidence 999986432111111223356799999885 568899999999999999996 999998877666665554432 11 1
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 384 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
....++.++.+++.+||..||.+|||+.+++.
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 232 KPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 22357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=329.15 Aligned_cols=257 Identities=21% Similarity=0.317 Sum_probs=199.3
Q ss_pred eeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEE
Q 007253 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (611)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 236 (611)
|.+++.+|.|+++.||.+ .. +++.||||++.... ......+.+.+|+.+++.++ |+||+++++++.+.+..++
T Consensus 4 ~~i~~~~~~~~~v~~~~~--~~---~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~ 76 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKH--KP---TNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQ-HPNILPYVTSFIVDSELYV 76 (314)
T ss_pred hhhhHhhcCCceEEEEEe--cC---CCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcC-CcchhhhhheeecCCeEEE
Confidence 344455555555544444 33 58999999987643 23345678999999999998 9999999999999999999
Q ss_pred EeeecCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC
Q 007253 237 VMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (611)
Q Consensus 237 v~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~ 315 (611)
+|||+++|+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+||++ +.++.+||+|||.+..+..
T Consensus 77 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili---~~~~~~kl~d~~~~~~~~~ 153 (314)
T cd08216 77 VSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILL---SGDGKVVLSGLRYSVSMIK 153 (314)
T ss_pred EEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEE---ecCCceEEecCccceeecc
Confidence 99999999999988754 3468999999999999999999999999999999999999 5667899999998865432
Q ss_pred CC--------cccccccCCCcCcchhhcC---CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-----
Q 007253 316 DE--------RLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS----- 379 (611)
Q Consensus 316 ~~--------~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~----- 379 (611)
.. ......++..|+|||++.. .++.++|||||||++|+|++|..||..................
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (314)
T cd08216 154 HGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDK 233 (314)
T ss_pred ccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCcccccc
Confidence 21 1233457788999999853 4888999999999999999999999876544433222211100
Q ss_pred --CC-----------------------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 380 --FD-----------------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 380 --~~-----------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.+ ......++.++.+||.+||..||++|||+.++|+||||+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 00 000012356789999999999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=322.42 Aligned_cols=256 Identities=18% Similarity=0.275 Sum_probs=203.6
Q ss_pred CCceeEeCeeeeccceEEEEEEEecC-------------CccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKG-------------ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~-------------~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~ 220 (611)
.++|++.+.||+|+||.||++..... ...+..||+|++... ........+.+|+.++++++ |+|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~~E~~~l~~l~-~~~ 80 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED--ANKNARNDFLKEIKIMSRLK-DPN 80 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc--CCHHHHHHHHHHHHHHHhCC-CCC
Confidence 46799999999999999999864321 113457999998643 23445577899999999997 999
Q ss_pred eeEEEEEEeeCCeeEEEeeecCCCChHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCc
Q 007253 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG----------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290 (611)
Q Consensus 221 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~N 290 (611)
|+++++++..++..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 9999999999999999999999999999887542 247788999999999999999999999999999999
Q ss_pred eEEeccCCCceEEEeecccccccCCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh--CCCCCCCC
Q 007253 291 FLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC--GSRPFWAR 364 (611)
Q Consensus 291 Ill~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~--g~~Pf~~~ 364 (611)
||+ +.++.+||+|||++..+..... .....++..|+|||+.. +.++.++|||||||++|||++ |..||...
T Consensus 161 ili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 161 CLV---GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEE---cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 999 4677899999999976543321 12234467899999764 678999999999999999998 78999877
Q ss_pred ChHHHHHHHHhc---C-CCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 365 TESGIFRAVLKA---D-PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 365 ~~~~~~~~i~~~---~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
...+........ . ..........++..+.+|+.+||+.||.+||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 666554433221 0 00111112356789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=315.98 Aligned_cols=245 Identities=23% Similarity=0.388 Sum_probs=202.4
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++.++||+|+||.||+|.... +..||+|.+..... ..+.+.+|+.+++++. |+||+++++++. ...
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~----~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~-~~~i~~~~~~~~-~~~ 74 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNG----NTKVAVKTLKPGTM----SPESFLEEAQIMKKLR-HDKLVQLYAVVS-EEP 74 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecC----CceeEEEEecCCCC----CHHHHHHHHHHHHhcC-CCceEEEEeEEC-CCC
Confidence 4679999999999999999997543 56799999865432 2356889999999997 999999999875 456
Q ss_pred eEEEeeecCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 234 VYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.+++|||+++++|.+++... ...+++..++.++.||+.||.|||+++|+||||||+||++ ++++.+||+|||++..
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili---~~~~~~~l~dfg~~~~ 151 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV---GDGLVCKIADFGLARL 151 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---eCCceEEeCCceeeee
Confidence 89999999999999988764 3458999999999999999999999999999999999999 5677899999999976
Q ss_pred cCCCCc--ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 313 VRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 313 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
+..... .....++..|+|||++. ..++.++||||||+++|+|++ |..||.+....+....+..... . ......
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~ 228 (260)
T cd05070 152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR-M--PCPQDC 228 (260)
T ss_pred ccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-C--CCCCcC
Confidence 643321 12234566899999875 568899999999999999999 9999988777666666554321 1 112357
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHH
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQAL 414 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll 414 (611)
+..+.+|+.+||..+|.+|||+.+++
T Consensus 229 ~~~~~~li~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 229 PISLHELMLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred CHHHHHHHHHHcccCcccCcCHHHHH
Confidence 89999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=316.30 Aligned_cols=247 Identities=23% Similarity=0.399 Sum_probs=204.5
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|+++++||+|+||.||+|.... ++.||+|.+..... ..+.+.+|+.++++++ |+||+++++++. .+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~----~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~ 73 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNG----HTKVAIKSLKQGSM----SPEAFLAEANLMKQLQ-HPRLVRLYAVVT-QE 73 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCC----CceEEEEEecCCCC----cHHHHHHHHHHHHhcC-CcCeeeEEEEEc-cC
Confidence 35679999999999999999998543 67899999865432 2356889999999998 999999999874 45
Q ss_pred eeEEEeeecCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 233 NVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
..++||||+.+|+|.+++... +..+++..+..++.||+.||.|||+.|++||||||+||++ +.++.++|+|||++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~ 150 (260)
T cd05067 74 PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV---SETLCCKIADFGLAR 150 (260)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE---cCCCCEEEccCccee
Confidence 689999999999999988654 3468999999999999999999999999999999999999 567789999999997
Q ss_pred ccCCCCc--ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 007253 312 FVRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (611)
Q Consensus 312 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (611)
....... .....++..|+|||++. ..++.++|||||||++|+|++ |+.||.+....+....+.... .. .....
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~ 227 (260)
T cd05067 151 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY-RM--PRPDN 227 (260)
T ss_pred ecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC-CC--CCCCC
Confidence 6652221 22334667899999886 568899999999999999998 999998877766665554332 11 12235
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
++.++.++|.+||..+|++|||++++++
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 228 CPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 7889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=331.89 Aligned_cols=257 Identities=30% Similarity=0.582 Sum_probs=207.6
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC-
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~- 231 (611)
+..+|.+.+.||+|+||.||+|.... +|+.||||++.+... .......+.+|+.+++.+. |+||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 87 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKR---TGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQ-HENVIGLLDVFTSAV 87 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCC---CCcEEEEEEecCccc-cccchhHHHHHHHHHHhcC-CCCccchhheecccc
Confidence 45789999999999999999998765 589999999865432 2233456789999999997 99999999998754
Q ss_pred -----CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEee
Q 007253 232 -----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (611)
Q Consensus 232 -----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D 306 (611)
..+++|+||+.. +|..++ +..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 88 ~~~~~~~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll---~~~~~~kL~d 160 (342)
T cd07879 88 SGDEFQDFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV---NEDCELKILD 160 (342)
T ss_pred cCCCCceEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEee
Confidence 346999999964 666543 2468999999999999999999999999999999999999 5678899999
Q ss_pred cccccccCCCCcccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-------
Q 007253 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD------- 377 (611)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~------- 377 (611)
||++..... ......+++.|+|||++.+ .++.++|||||||++|||++|+.||.+......+..+....
T Consensus 161 fg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 161 FGLARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238 (342)
T ss_pred CCCCcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 999876532 2334578899999998853 47889999999999999999999998776555444443311
Q ss_pred ----------------CCCCCC----CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 378 ----------------PSFDEA----PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 378 ----------------~~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
+..+.. .++..+.++.+||.+||+.||.+||++.+++.||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 111111 1245678899999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=328.24 Aligned_cols=255 Identities=25% Similarity=0.402 Sum_probs=207.8
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCC----ccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGE----LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 229 (611)
..+|++++.||+|+||.||+|+..... ..+..||+|++... ......+.+.+|+.+++++.+||||+++++++.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 357999999999999999999864321 12347999988643 233455778899999999955999999999999
Q ss_pred eCCeeEEEeeecCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEe
Q 007253 230 DTDNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294 (611)
Q Consensus 230 ~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~ 294 (611)
.++.++++|||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill- 167 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV- 167 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE-
Confidence 9999999999999999999987532 247889999999999999999999999999999999999
Q ss_pred ccCCCceEEEeecccccccCCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHH
Q 007253 295 TKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGI 369 (611)
Q Consensus 295 ~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~ 369 (611)
+.++.+||+|||+++....... .....++..|+|||++. ..++.++|||||||++|||++ |..||.+....+.
T Consensus 168 --~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 245 (334)
T cd05100 168 --TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245 (334)
T ss_pred --cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 5677899999999876543221 12223456799999886 568999999999999999998 8999988877776
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 370 FRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 370 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
...+...... . ....++.++.+||.+||+.+|.+|||+.+++++
T Consensus 246 ~~~~~~~~~~-~--~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 246 FKLLKEGHRM-D--KPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHcCCCC-C--CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 6666543221 1 123578899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=315.84 Aligned_cols=246 Identities=23% Similarity=0.334 Sum_probs=197.8
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe-eCCeeEEEee
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE-DTDNVYVVME 239 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~-~~~~~~lv~E 239 (611)
+.||+|+||.||+|........+..||+|.+... ......+.+.+|+.+++.++ ||||+++++++. .++..++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFS-HPNVLSLLGICLPSEGSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCC-CCCcceEEEEeecCCCCcEEEEe
Confidence 4789999999999987654334578999987532 23345577889999999997 999999999876 4556899999
Q ss_pred ecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCC--
Q 007253 240 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-- 317 (611)
Q Consensus 240 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~-- 317 (611)
|+.+|+|.+++......+++..+..++.||+.||.|||+.+|+||||||+|||+ +.++.+||+|||++..+....
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCccccccccCCcce
Confidence 999999999987766667888899999999999999999999999999999999 567789999999987654321
Q ss_pred ---cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 318 ---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 318 ---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
......++..|+|||++. ..++.++|||||||++|||++ |.+||...........+........ ...++..+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 231 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ---PEYCPDPL 231 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCHHH
Confidence 112334677899999875 668899999999999999999 4667766665555555544322111 12468899
Q ss_pred HHHHHHhcccCccCCCCHHHHHc
Q 007253 393 RDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
.+++.+||..+|++||++.++++
T Consensus 232 ~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 232 YEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHHH
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=315.49 Aligned_cols=252 Identities=28% Similarity=0.501 Sum_probs=213.9
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
+|++.+.||+|+||.||+++... +++.+|+|.+...... ......+.+|+.+++.++ |+||+++++++.+....+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLS---DNQFYALKEVDLGSMS-QKEREDAVNEIRILASVN-HPNIISYKEAFLDGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECC---CCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCC-CCCchhhhhhhccCCEEE
Confidence 48999999999999999998765 5889999998654432 334567788999999998 999999999999999999
Q ss_pred EEeeecCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 236 VVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
+||||+++++|.+++... ...+++..++.++.||+.||.|||+.|++||||+|+||+++ .++.+||+|||++..
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~---~~~~~kl~d~g~~~~ 152 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV---ANDLVKIGDLGISKV 152 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe---cCCcEEEeeccchhh
Confidence 999999999999887652 34689999999999999999999999999999999999995 567799999999987
Q ss_pred cCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 313 VRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
.... ......|++.|+|||.+. ..++.++|+||||+++|+|++|+.||...+.......+.... ++... ..++.+
T Consensus 153 ~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~-~~~~~~ 228 (256)
T cd08530 153 LKKN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK--YPPIP-PIYSQD 228 (256)
T ss_pred hccC-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCCc-hhhCHH
Confidence 7544 334457889999999886 557889999999999999999999998877666555554433 22211 257899
Q ss_pred HHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 392 ARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
+.++|.+||..+|.+|||+.++++||++
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 229 LQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=320.64 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=208.0
Q ss_pred CCceeEeCeeeeccceEEEEEEEecC--CccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.++|++.+.||+|+||.||+|..... ...+..||+|++... ........+.+|+.+++++. ||||+++++++.++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~ei~~l~~l~-h~~iv~~~~~~~~~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFD-HPNIVKLLGVCAVG 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC--cCHHHHHHHHHHHHHHHhcC-CCchheEEEEEcCC
Confidence 46799999999999999999986431 124688999998643 23345567889999999997 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCc
Q 007253 232 DNVYVVMELCEGGELLDRILSRG---------------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~---------------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~N 290 (611)
+.+++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999986432 247888999999999999999999999999999999
Q ss_pred eEEeccCCCceEEEeecccccccCCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCC
Q 007253 291 FLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWART 365 (611)
Q Consensus 291 Ill~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~ 365 (611)
||+ +.++.+||+|||++..+..... .....++..|+|||++. +.++.++|||||||++|+|++ |..||.+..
T Consensus 161 il~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 161 CLV---GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred eEe---cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999 5678899999999876543221 12234566799999876 668999999999999999997 889998877
Q ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 366 ESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 366 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
..+....+....... ....++.++.+||.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 238 HEEVIYYVRDGNVLS---CPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 777766665443211 11357899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=317.18 Aligned_cols=244 Identities=20% Similarity=0.242 Sum_probs=193.3
Q ss_pred CeeeeccceEEEEEEEecCC---------ccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 161 EEVGRGHFGYTCAAKFKKGE---------LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~---------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
+.||+|+||.||+|...... .....||+|++... .......+.+|+.+++.+. ||||+++++++..+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVS-HKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence 47999999999999864311 12346899987543 2334457888999999997 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccC----CCceEEEeec
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD----ENSVLKAIDF 307 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~----~~~~vkl~Df 307 (611)
...++||||+++|+|..++......+++..++.++.||+.||.|||+++|+||||||+|||+...+ ....+|++||
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999999999888776667799999999999999999999999999999999999995322 1124899999
Q ss_pred ccccccCCCCcccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHH-hCCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 007253 308 GLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILL-CGSRPFWARTESGIFRAVLKADPSFDEAP 384 (611)
Q Consensus 308 G~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~-~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 384 (611)
|++..... .....++..|+|||++. ..++.++|||||||++|+|+ +|..||......+... ........
T Consensus 157 g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~~---- 228 (262)
T cd05077 157 GIPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCML---- 228 (262)
T ss_pred CCCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCccC----
Confidence 99875532 23346788999999885 45889999999999999998 5889987655443322 22221111
Q ss_pred CCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 385 ~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
....+.++.+||.+||+.||.+||++.+|+++
T Consensus 229 ~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 229 VTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 12346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=326.75 Aligned_cols=259 Identities=34% Similarity=0.554 Sum_probs=208.3
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee-
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED- 230 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~- 230 (611)
.+.++|++.+.||.|+||.||+|.... +|+.||+|++.+... .....+.+.+|+.+++.+. ||||++++++|..
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 81 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQL---TGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLR-HENIISLSDIFISP 81 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECC---CCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcC-CCCeeeEeeeEecC
Confidence 357889999999999999999998765 689999998865432 2234466789999999997 9999999999876
Q ss_pred CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 231 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
....++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||++
T Consensus 82 ~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili---~~~~~~~l~dfg~~ 155 (328)
T cd07856 82 LEDIYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLA 155 (328)
T ss_pred CCcEEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE---CCCCCEEeCccccc
Confidence 56789999999 5688876643 468899999999999999999999999999999999999 57788999999998
Q ss_pred cccCCCCcccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-----------
Q 007253 311 DFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD----------- 377 (611)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~----------- 377 (611)
..... ......+++.|+|||++.+ .++.++|||||||++|+|++|+.||...........+....
T Consensus 156 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 156 RIQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred cccCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 76532 2344578899999998753 58899999999999999999999997665432221111100
Q ss_pred ----------------CCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 378 ----------------PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 378 ----------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
+.......+.++..+.++|.+||+.+|++|||+.+++.||||....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 0000011235788999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=316.72 Aligned_cols=253 Identities=23% Similarity=0.368 Sum_probs=206.9
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
..+|.+.+.||+|+||.||+|...........||||.+... ......+.+.+|+.+++++. ||||+++++++.+ +.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREKFLQEAYIMRQFD-HPHIVKLIGVITE-NP 80 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc--CCHHHHHHHHHHHHHHHhCC-CCchhceeEEEcC-CC
Confidence 45689999999999999999987653223457999987543 22445568899999999997 9999999998875 45
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
.++||||+++|+|.+++......+++..++.++.||+.||.|||+.|++||||||+|||+ +.++.+||+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV---SSPDCVKLGDFGLSRYL 157 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEE---ecCCCeEEccCceeeec
Confidence 789999999999999987766679999999999999999999999999999999999999 46778999999998766
Q ss_pred CCCCcc--cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 314 RPDERL--NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 314 ~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
...... ....++..|+|||.+. ..++.++|||||||++|+|++ |..||......+....+...... .....++
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~ 234 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL---PMPPNCP 234 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC---CCCCCCC
Confidence 433221 1223456899999876 568899999999999999986 99999887776666555543322 1224678
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
..+.++|.+||..+|.+|||+.+++..
T Consensus 235 ~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 235 PTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=316.16 Aligned_cols=247 Identities=20% Similarity=0.338 Sum_probs=196.4
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeee
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~ 240 (611)
++||+|+||.||+|....+ .....+|+|.+... ........+.+|+.+++.+. |+||+++++++.....+++||||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~-~~~~~~~~k~~~~~--~~~~~~~~~~~e~~~~~~l~-h~nii~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRG-MSKARVVVKELRAS--ATPDEQLLFLQEVQPYRELN-HPNVLQCLGQCIESIPYLLVLEF 76 (269)
T ss_pred CcCCccCCceEEEEEEecC-CCCeEEEEeecCcc--CChHHHHHHHHHHHHHHhCC-CCCcceEEEEECCCCceEEEEEe
Confidence 4699999999999976543 34567899987543 23344567889999999997 99999999999999999999999
Q ss_pred cCCCChHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCC
Q 007253 241 CEGGELLDRILSRGG----KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316 (611)
Q Consensus 241 ~~~gsL~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~ 316 (611)
+++|+|.+++..... ..++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPE 153 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe---cCCCcEEEeccccccccccc
Confidence 999999999876432 35678899999999999999999999999999999999 56788999999998654322
Q ss_pred Cc---ccccccCCCcCcchhhc--------CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcC-CCCCCC
Q 007253 317 ER---LNDIVGSAYYVAPEVLH--------RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKAD-PSFDEA 383 (611)
Q Consensus 317 ~~---~~~~~gt~~y~aPE~~~--------~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~ 383 (611)
.. .....++..|+|||++. ..++.++|||||||++|||++ |..||......+.+..+.... ..++..
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP 233 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC
Confidence 21 22335677899999874 246789999999999999998 888998777666555554432 222222
Q ss_pred C-CCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 384 P-WPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 384 ~-~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
. ...++..+.+++..|+ .||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 234 QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred cccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 1 2357888999999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=317.29 Aligned_cols=252 Identities=21% Similarity=0.313 Sum_probs=207.7
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCc-cCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGEL-KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..+|++.+.||+|+||.||+|....... ....||+|.+.... .......+.+|+.+++++. |+||+++++++.. .
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~ 81 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVD-HPHVVRLLGICLS-S 81 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEec-C
Confidence 4679999999999999999998765211 23468999886543 2445577889999999997 9999999999887 7
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
..++||||+++|+|.+++......+++..+..++.||+.||+|||+.||+||||||+|||+ +.++.+||+|||++..
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFGLAKL 158 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE---cCCCeEEECCCccccc
Confidence 8999999999999999998776779999999999999999999999999999999999999 5677899999999987
Q ss_pred cCCCCccc---ccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 007253 313 VRPDERLN---DIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (611)
Q Consensus 313 ~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (611)
........ ...++..|+|||.+. ..++.++|||||||++||+++ |+.||.+....++...+..... .+.. ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~--~~ 235 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER-LPQP--PI 235 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC-CCCC--CC
Confidence 65333211 122356799999875 678999999999999999998 9999988777776665554322 2211 24
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
.+..+.+++.+||..||.+||++.++++
T Consensus 236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 236 CTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 6789999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=314.64 Aligned_cols=242 Identities=25% Similarity=0.408 Sum_probs=201.6
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe-eCCe
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE-DTDN 233 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~-~~~~ 233 (611)
.+|++.+.||+|+||.||++.. .|..||+|.+... ...+.+.+|+.+++++. |+||+++++++. .++.
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-----~~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 74 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-----RGNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGG 74 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-----cCCcEEEEEeCCC-----chHHHHHHHHHHHHhCC-CCCeeeEEEEEEcCCCc
Confidence 5799999999999999999864 3678999998532 12456889999999997 999999999765 4567
Q ss_pred eEEEeeecCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.++||||+++|+|.+++..... .+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~ 151 (256)
T cd05082 75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV---SEDNVAKVSDFGLTKE 151 (256)
T ss_pred eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE---cCCCcEEecCCcccee
Confidence 9999999999999999876544 48999999999999999999999999999999999999 5778899999999876
Q ss_pred cCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 313 VRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
..... ....++..|+|||++. ..++.++|||||||++|+|++ |+.||......+....+..... ......++.
T Consensus 152 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 226 (256)
T cd05082 152 ASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPP 226 (256)
T ss_pred ccccC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCCH
Confidence 53222 2334567899999886 568899999999999999997 9999987776666665554322 122246789
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHc
Q 007253 391 EARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
.+.++|.+||+.+|++|||+.++++
T Consensus 227 ~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 227 VVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=345.69 Aligned_cols=346 Identities=19% Similarity=0.246 Sum_probs=221.0
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecC-CccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEE----
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKG-ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDA---- 227 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~---- 227 (611)
..++|++.++||+|+||.||+|+...+ ...+..||+|.+..... .+....| . ++... +.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e-~-l~~~~-~~~~~~~~~~~~~~ 201 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE-R-VRRAC-PNSCADFVYGFLEP 201 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH-H-HHhhc-hhhHHHHHHhhhcc
Confidence 357899999999999999999998762 11278999998754221 1111111 1 11111 2222222221
Q ss_pred --EeeCCeeEEEeeecCCCChHHHHHhcCCC-------------------CCHHHHHHHHHHHHHHHHHHHHcCCeeecC
Q 007253 228 --YEDTDNVYVVMELCEGGELLDRILSRGGK-------------------YTEDDAKAVMIQILNVVAFCHLQGVVHRDL 286 (611)
Q Consensus 228 --~~~~~~~~lv~E~~~~gsL~~~l~~~~~~-------------------l~~~~~~~i~~qi~~~L~~LH~~~iiHrDl 286 (611)
...+..++|||||+.+++|.+++...... ..+..+..++.||+.||.|||+++||||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 24566899999999999999988654211 123456789999999999999999999999
Q ss_pred CCCceEEeccCCCceEEEeecccccccCCCC--cccccccCCCcCcchhhc-C----------------------CCCCc
Q 007253 287 KPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAPEVLH-R----------------------SYSTE 341 (611)
Q Consensus 287 kp~NIll~~~~~~~~vkl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~----------------------~~~~~ 341 (611)
||+|||++ +.++.+||+|||+|+.+.... .....+||+.|||||++. . .++.+
T Consensus 282 KP~NILl~--~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 282 KPQNIIFS--EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred CHHHEEEe--CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999995 245789999999998664332 335668999999999652 1 23446
Q ss_pred chhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-CCCC-------CCCC----------CCCCCHHHHHHHHHhcccC
Q 007253 342 ADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA-DPSF-------DEAP----------WPSLSSEARDFVKRLLNKD 403 (611)
Q Consensus 342 ~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~-~~~~-------~~~~----------~~~~s~~~~~li~~~L~~d 403 (611)
+|||||||+||||+++..++.. ....+..++.. .... .... +.......++||++||+.|
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 7999999999999998776532 22122222111 1000 0000 0112345669999999999
Q ss_pred ccCCCCHHHHHcCcccCCCCCCCCch-hHHHHHHHHHHhhcchHHHHHHHhhhhcchhhHHHHHHHHhhhcCCCCCCccc
Q 007253 404 PRKRLTAAQALSHPWIKNSNDVKVPL-DVIIFKLMKAYMRSSSLRKAALRALSKTLTVDELFYLKEQYALLEPNKNGTIS 482 (611)
Q Consensus 404 P~~Rpt~~~ll~hp~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~l~~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is 482 (611)
|++|||+.++|+||||+......... +.+....... ... .-.+-...+...+..-..+.+|..+
T Consensus 438 P~kR~ta~e~L~Hpff~~~~~~~~~~~~~~~~~~~~~--------------~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (566)
T PLN03225 438 GRQRISAKAALAHPYFDREGLLGLSVMQNLRLQLFRA--------------TQQ-DYGEAAAWVVFLMAKSGTEKEGGFT 502 (566)
T ss_pred cccCCCHHHHhCCcCcCCCCccccccccccccccchh--------------hHH-HHHHHHHHHHHHHHhcCCCCCCCcc
Confidence 99999999999999998765432221 1111111000 000 0011123455555566667778888
Q ss_pred HHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHH
Q 007253 483 LENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAA 526 (611)
Q Consensus 483 ~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~ 526 (611)
-.+++.+. ..+.+......=..|...++-+..|..++.+++.-
T Consensus 503 e~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (566)
T PLN03225 503 EAQLQELR-EKEPKKKGSAQRNALASALRLQRKGVKTVARTVDE 545 (566)
T ss_pred HHHHHHhh-hhcCcchhhhhhhhHHHHHhhhhhhhhhhhhhhhc
Confidence 88888854 33332221211124667778888888888888763
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=320.15 Aligned_cols=253 Identities=26% Similarity=0.414 Sum_probs=201.5
Q ss_pred ceeEeCeeeeccceEEEEEEEec-CCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC--C
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT--D 232 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~--~ 232 (611)
-|++.+.||+|+||.||++++.. +...+..||+|.+... ........+.+|+.+++++. ||||+++++++.+. .
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc--ccHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCCC
Confidence 47899999999999999998642 2336889999998643 23444567899999999997 99999999998875 5
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
..++||||++|++|.+++.+....+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~---~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKA 158 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE---cCCCCEEECCCccccc
Confidence 6899999999999999887665678999999999999999999999999999999999999 5677899999999987
Q ss_pred cCCCCc----ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCCh--------------HHHHHHH
Q 007253 313 VRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE--------------SGIFRAV 373 (611)
Q Consensus 313 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~--------------~~~~~~i 373 (611)
...... .....++..|+|||++. ..++.++|||||||++|+|++++.|+..... .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 643322 22345677899999875 5688999999999999999998876532111 0011111
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 374 LKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
....... ..+..++..+.+||.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 239 LEEGKRL--PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHcCccC--CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1111111 1234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=312.82 Aligned_cols=250 Identities=28% Similarity=0.441 Sum_probs=209.1
Q ss_pred eeEeCeeeeccceEEEEEEEecCC-ccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 157 YELGEEVGRGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
+++.+.||+|+||.||+++..... ..+..||+|++.... .....+.+.+|+.+++.+. |+||+++++++.+.+..+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLD-HPNIVKLLGVCTEEEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcC-CCchheEEEEEcCCCeeE
Confidence 457889999999999999987531 134889999985542 2225578899999999996 999999999999999999
Q ss_pred EEeeecCCCChHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 236 VVMELCEGGELLDRILSRGGK-YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++|||+++++|.+++...... +++..+..++.||+.||.|||+.+++||||||+||++ +.++.++|+|||++....
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLY 154 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE---ccCCeEEEcccCCceecc
Confidence 999999999999988765444 9999999999999999999999999999999999999 567789999999998765
Q ss_pred CCCccc--ccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 315 PDERLN--DIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 315 ~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
...... ...+++.|+|||.+. ..++.++|||||||++|+|++ |..||...........+........ ...++.
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 231 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPK---PENCPP 231 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCH
Confidence 432221 123678999999885 568999999999999999998 8999988777777777665543221 234789
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHc
Q 007253 391 EARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
++.+++.+||..||.+|||+.++++
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 232 EIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHHCcCChhhCcCHHHHHh
Confidence 9999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=313.08 Aligned_cols=244 Identities=27% Similarity=0.427 Sum_probs=205.6
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++.+.||.|+||.||+|.. .|+.||+|.+..... ..+++.+|+.+++++. |+||+++++++.+.+.
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-----~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 74 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-----RGQKVAVKCLKDDST----AAQAFLAEASVMTTLR-HPNLVQLLGVVLQGNP 74 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-----cCcEEEEEEeccchh----HHHHHHHHHHHHHhcC-CcceeeeEEEEcCCCC
Confidence 45799999999999999999974 378899999864422 4577889999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||.+..
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili---~~~~~~~l~d~g~~~~ 151 (256)
T cd05039 75 LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAKE 151 (256)
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE---eCCCCEEEcccccccc
Confidence 9999999999999998876543 68999999999999999999999999999999999999 5778899999999987
Q ss_pred cCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 313 VRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
...... ...++..|+|||++. +.++.++||||||+++|+|++ |..||...........+..... . .....+++
T Consensus 152 ~~~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~ 226 (256)
T cd05039 152 ASQGQD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR-M--EAPEGCPP 226 (256)
T ss_pred cccccc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-C--CCccCCCH
Confidence 632222 334566899999876 568889999999999999997 9999987776665555543321 1 11235789
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHc
Q 007253 391 EARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
.+.++|.+||..+|.+|||+.++++
T Consensus 227 ~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 227 EVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=312.89 Aligned_cols=247 Identities=26% Similarity=0.471 Sum_probs=206.4
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
.+|++.+.||+|+||.||++.... +..+|+|++...... ...+.+|+++++++. ||||+++++++......
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~----~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 74 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE----KRKVAIKTIREGAMS----EEDFIEEAQVMMKLS-HPKLVQLYGVCTERSPI 74 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC----CCeEEEEECCCCCCC----HHHHHHHHHHHHhCC-CCCeeeEEEEEccCCce
Confidence 468999999999999999997653 568999998654332 246788999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++||||+++++|.+++......+++..++.++.|++.||.|||+.+++||||||+||++ +.++.+||+|||++....
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~ 151 (256)
T cd05112 75 CLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV---GENQVVKVSDFGMTRFVL 151 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE---cCCCeEEECCCcceeecc
Confidence 99999999999999887766678999999999999999999999999999999999999 567789999999987553
Q ss_pred CCCc--ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 315 PDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 315 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
.... .....++..|+|||++. +.++.++|||||||++|+|++ |..||.......+...+......... ...+.
T Consensus 152 ~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 228 (256)
T cd05112 152 DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP---RLASQ 228 (256)
T ss_pred cCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC---CCCCH
Confidence 2221 12234567899999886 668889999999999999998 99999887777666665543222211 23688
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 391 EARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
.+.+|+.+||+.+|.+|||+.+++++
T Consensus 229 ~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 229 SVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHHHHcccChhhCCCHHHHHHh
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=313.55 Aligned_cols=246 Identities=24% Similarity=0.381 Sum_probs=202.7
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++.+.||+|+||.||+|.... +..+|+|++..... ..+.+.+|+.+++++. |+||+++++++. .+.
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~----~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~~ 74 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNG----TTKVAIKTLKPGTM----MPEAFLQEAQIMKKLR-HDKLVPLYAVVS-EEP 74 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcC----CceEEEEEcccCCc----cHHHHHHHHHHHHhCC-CCCeeeEEEEEc-CCC
Confidence 3679999999999999999998654 34699998754322 2356889999999997 999999999875 456
Q ss_pred eEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 234 VYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.++||||+.+|+|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||++ ++++.+||+|||++..
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill---~~~~~~~l~dfg~~~~ 151 (260)
T cd05069 75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV---GDNLVCKIADFGLARL 151 (260)
T ss_pred cEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCeEEECCCccceE
Confidence 899999999999999987643 358999999999999999999999999999999999999 6778899999999976
Q ss_pred cCCCCc--ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 313 VRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 313 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
...... .....++..|+|||.+. +.++.++|||||||++|+|++ |..||.+....+....+..... . .....+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~ 228 (260)
T cd05069 152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR-M--PCPQGC 228 (260)
T ss_pred ccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-C--CCCccc
Confidence 543321 12234667899999886 568899999999999999999 9999988777776666554321 1 112467
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
+..+.+++++||.+||.+||++.++++
T Consensus 229 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 229 PESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=318.50 Aligned_cols=243 Identities=19% Similarity=0.235 Sum_probs=194.0
Q ss_pred eeeeccceEEEEEEEecCC---------------------ccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCC
Q 007253 162 EVGRGHFGYTCAAKFKKGE---------------------LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220 (611)
Q Consensus 162 ~LG~G~fg~V~~~~~~~~~---------------------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~ 220 (611)
+||+|+||.||+|...... .....||+|++... .......+.+|+.+++.++ |||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~-h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVS-HIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCC-CCC
Confidence 6999999999999864211 12346899988542 2233456788999999998 999
Q ss_pred eeEEEEEEeeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEecc----
Q 007253 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK---- 296 (611)
Q Consensus 221 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~---- 296 (611)
|+++++++.+....++|||||++|+|..++....+.+++..+..++.||+.||.|||+++|+||||||+|||++..
T Consensus 78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 9999999999999999999999999988887666789999999999999999999999999999999999999642
Q ss_pred CCCceEEEeecccccccCCCCcccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHH-hCCCCCCCCChHHHHHHH
Q 007253 297 DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILL-CGSRPFWARTESGIFRAV 373 (611)
Q Consensus 297 ~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~-~g~~Pf~~~~~~~~~~~i 373 (611)
+....+||+|||++...... ....++..|+|||.+. ..++.++|||||||++|||+ +|..||......+... .
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~ 233 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-F 233 (274)
T ss_pred CccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-H
Confidence 12345899999987644221 2346788899999885 35889999999999999985 7999998766554433 2
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 374 LKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
.......+. ..+..+.++|.+||+.+|.+|||+.+++++
T Consensus 234 ~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 234 YEKKHRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHhccCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 222222222 346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=318.82 Aligned_cols=244 Identities=19% Similarity=0.263 Sum_probs=195.2
Q ss_pred CeeeeccceEEEEEEEecCC----ccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEE
Q 007253 161 EEVGRGHFGYTCAAKFKKGE----LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 236 (611)
+.||+|+||.||+|...... .....||+|.+... .....+.+.+|+.+++.+. ||||+++++++..++..++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLS-HKHLVLNYGVCVCGDESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCC-CCChhheeeEEEeCCCcEE
Confidence 47999999999999875421 12445888887432 2344567888999999997 9999999999999999999
Q ss_pred EeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCC-----CceEEEeeccccc
Q 007253 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE-----NSVLKAIDFGLSD 311 (611)
Q Consensus 237 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~-----~~~vkl~DfG~a~ 311 (611)
||||+++|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++. .+.+|++|||++.
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999999998776667999999999999999999999999999999999999964322 1348999999987
Q ss_pred ccCCCCcccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCC-CCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 312 FVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGS-RPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~-~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
.... .....++..|+|||++.+ .++.++|||||||++|+|++|. .||........ ..+......++. ..
T Consensus 157 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~----~~ 228 (258)
T cd05078 157 TVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQFYEDRHQLPA----PK 228 (258)
T ss_pred ccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHHHHccccCCC----CC
Confidence 6542 233568889999999864 4788999999999999999985 66655444332 223333333332 35
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
+.++.+||.+||+.||.+|||++++++.
T Consensus 229 ~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 229 WTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 6889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=319.42 Aligned_cols=266 Identities=29% Similarity=0.484 Sum_probs=215.3
Q ss_pred CcccccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCC-C----Cee
Q 007253 148 GFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH-N----NLV 222 (611)
Q Consensus 148 ~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~----~iv 222 (611)
...+.+..+|.+...||+|.||.|..+.+.. .+..||||+++. .....+..+-|++++.++..+ | -+|
T Consensus 82 ~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~---~~~~vAlKIik~----V~kYreAa~iEi~vLqki~~~DP~g~~rcv 154 (415)
T KOG0671|consen 82 QVGDILTNRYEIVDLLGEGTFGKVVECWDRE---TKEHVALKIIKN----VDKYREAALIEIEVLQKINESDPNGKFRCV 154 (415)
T ss_pred EeccccccceehhhhhcCCcccceEEEeecC---CCceehHHHHHH----HHHHhhHHHHHHHHHHHHHhcCCCCceEEE
Confidence 3456678999999999999999999998776 489999999843 234456677899999999533 2 478
Q ss_pred EEEEEEeeCCeeEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccC----
Q 007253 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD---- 297 (611)
Q Consensus 223 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~---- 297 (611)
++.++|...+++|||+|.+ |-|+.+++.+++ .+++..+++.++.||+.+++|||+++++|-||||+|||+...+
T Consensus 155 ~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 155 QMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred eeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEE
Confidence 8999999999999999999 679999997754 4699999999999999999999999999999999999997431
Q ss_pred -------------CCceEEEeecccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCC
Q 007253 298 -------------ENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWA 363 (611)
Q Consensus 298 -------------~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~ 363 (611)
.+..|||+|||.|.+... ...+++.|..|.|||++. -+++.++||||+||||+|+.+|...|+.
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e--~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHE--HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceecc--CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 245699999999988643 347889999999999886 5799999999999999999999999987
Q ss_pred CChHH---HHHHHHhcCCCC-------------CCCCCCC--------------------------CCHHHHHHHHHhcc
Q 007253 364 RTESG---IFRAVLKADPSF-------------DEAPWPS--------------------------LSSEARDFVKRLLN 401 (611)
Q Consensus 364 ~~~~~---~~~~i~~~~~~~-------------~~~~~~~--------------------------~s~~~~~li~~~L~ 401 (611)
.+..+ +++.|+...|.- ....|++ -..++.+||++||.
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 66554 555554321110 0001111 12357899999999
Q ss_pred cCccCCCCHHHHHcCcccCCCC
Q 007253 402 KDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 402 ~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.||.+|+|+.|+|.||||+...
T Consensus 392 fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 392 FDPARRITLREALSHPFFARLT 413 (415)
T ss_pred cCccccccHHHHhcCHHhhcCC
Confidence 9999999999999999998653
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=316.32 Aligned_cols=254 Identities=24% Similarity=0.360 Sum_probs=210.0
Q ss_pred CceeEeCeeeeccceEEEEEEEecCC--ccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
++|++...||+|+||.||+|+.+... ...+.||+|.+... ......+.+.+|++++++++ |+||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT--KDENLQSEFRRELDMFRKLS-HKNVVRLLGLCREAE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc--cchHHHHHHHHHHHHHHhcC-CcceeeeEEEECCCC
Confidence 57999999999999999999976432 24578999988543 23335577899999999997 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEE
Q 007253 233 NVYVVMELCEGGELLDRILSRG--------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~--------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl 304 (611)
..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+|+||||||+|||+ +.++.++|
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l 158 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV---SSQREVKV 158 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEE---eCCCcEEE
Confidence 9999999999999999886543 158999999999999999999999999999999999999 56778999
Q ss_pred eecccccccCCCC--cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCC
Q 007253 305 IDFGLSDFVRPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSF 380 (611)
Q Consensus 305 ~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~ 380 (611)
+|||++....... ......++..|+|||.+. +.++.++|||||||++|+|++ |..||...........+......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL 238 (275)
T ss_pred cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence 9999987543222 233446678899999875 567889999999999999998 889998776666666655443332
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 381 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
.. ...++..+.++|.+||+.+|.+|||+.+++..
T Consensus 239 ~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 239 PV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 22 23578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=313.22 Aligned_cols=247 Identities=27% Similarity=0.423 Sum_probs=206.7
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++.+.||+|+||.||+|.... ++.||||.+..... ..+.+.+|+.+++++. |+||+++++++.....
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~----~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 75 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNG----TTKVAVKTLKPGTM----SPEAFLQEAQIMKKLR-HDKLVQLYAVCSEEEP 75 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcC----CceEEEEEecCCcc----CHHHHHHHHHHHhhCC-CCCEeeeeeeeecCCc
Confidence 5789999999999999999998643 57799999865432 2356889999999998 9999999999999899
Q ss_pred eEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 234 VYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||++ +.++.+||+|||++..
T Consensus 76 ~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~ 152 (261)
T cd05034 76 IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV---GENLVCKIADFGLARL 152 (261)
T ss_pred eEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE---cCCCCEEECcccccee
Confidence 999999999999999987654 468999999999999999999999999999999999999 5678899999999876
Q ss_pred cCCCCc--ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 313 VRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 313 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
...... .....++..|+|||.+. +.++.++|||||||++|+|++ |+.||.+......+..+...... ......
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~ 229 (261)
T cd05034 153 IEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM---PRPPNC 229 (261)
T ss_pred ccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCC
Confidence 643221 11223456899999886 568889999999999999998 99999887777777666543211 111346
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
+.++.+++.+||+.+|.+||+++++++
T Consensus 230 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 230 PEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=314.02 Aligned_cols=247 Identities=21% Similarity=0.326 Sum_probs=194.8
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeee
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~ 240 (611)
+.||+|+||.||+|.... ...+..+|+|.+.... .......+.+|+.++++++ ||||+++++++.+...+++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~-~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05087 1 KEIGNGWFGKVILGEVNS-GYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCTEVTPYLLVMEF 76 (269)
T ss_pred CcccccCCceEEEEEEcC-CCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCCcEEEEEC
Confidence 469999999999998754 2356789999885543 2334457889999999997 99999999999999999999999
Q ss_pred cCCCChHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCC
Q 007253 241 CEGGELLDRILSRG----GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316 (611)
Q Consensus 241 ~~~gsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~ 316 (611)
+++|+|.+++.... ...++..+..++.||+.||.|||+.+++||||||+||++ +.++.+||+|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLL---TADLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEECCccccccccCc
Confidence 99999999886532 246778888999999999999999999999999999999 56778999999998754332
Q ss_pred Cc---ccccccCCCcCcchhhcC--------CCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHh-cCCCCCCC
Q 007253 317 ER---LNDIVGSAYYVAPEVLHR--------SYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLK-ADPSFDEA 383 (611)
Q Consensus 317 ~~---~~~~~gt~~y~aPE~~~~--------~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~-~~~~~~~~ 383 (611)
.. .....|+..|+|||++.+ .++.++|||||||++|||++ |+.||......+....... ........
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP 233 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCC
Confidence 21 223467888999998852 25789999999999999996 9999977665554333222 22222222
Q ss_pred CC-CCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 384 PW-PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 384 ~~-~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
.. ...+..+.+++.+|+ .+|.+|||+.+|+.
T Consensus 234 ~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 234 RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 11 246788999999998 68999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=316.44 Aligned_cols=253 Identities=28% Similarity=0.511 Sum_probs=205.0
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcC--CHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT--TAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
+|.+.+.||+|+||.||+++... .+..+++|++...... .......+..|+.++++++ ||||+++++++.+...
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 76 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKK---AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFLERDA 76 (260)
T ss_pred CceeeeeecCCCCceEEEEEecC---CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHHhcCCc
Confidence 58999999999999999998765 3444555555432211 1122345678999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 234 VYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
.++||||+++++|.+.+.. ....+++..++.++.||+.||.|||++|++|+||||+||++. ++.+||+|||++
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~~~~~l~d~g~~ 152 (260)
T cd08222 77 FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVS 152 (260)
T ss_pred eEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----cCCEeecccCce
Confidence 9999999999999888754 345699999999999999999999999999999999999994 345999999998
Q ss_pred cccCCCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 311 DFVRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 311 ~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
....... ......|++.|+|||.+. ..++.++|+||||+++|+|++|..||...........+....... ....+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 229 (260)
T cd08222 153 RLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPS---LPETY 229 (260)
T ss_pred eecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC---Ccchh
Confidence 7664332 233456889999999876 557889999999999999999999998766655555554432111 11357
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
+.++.++|.+||..||.+||++.++++||||
T Consensus 230 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 230 SRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred cHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 8899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=311.01 Aligned_cols=247 Identities=26% Similarity=0.423 Sum_probs=204.4
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|++.++||+|+||.||++.... +..+|+|.+... ....+.+.+|+.++++++ |+||+++++++.+ .
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~----~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-~ 73 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNK----HTKVAVKTMKPG----SMSVEAFLAEANVMKTLQ-HDKLVKLHAVVTK-E 73 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecC----CccEEEEecCCC----hhHHHHHHHHHHHHHhcC-CCCcceEEEEEcC-C
Confidence 35789999999999999999997543 567999987543 223467889999999997 9999999999887 7
Q ss_pred eeEEEeeecCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 233 NVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
..+++|||+++|+|.+++... ...+++..+..++.||+.||.|||+.|++||||||+||++ +..+.+||+|||++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~ 150 (260)
T cd05073 74 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLAR 150 (260)
T ss_pred CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCCccee
Confidence 789999999999999998764 3458899999999999999999999999999999999999 567889999999987
Q ss_pred ccCCCCc--ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 007253 312 FVRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (611)
Q Consensus 312 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (611)
....... .....++..|+|||++. +.++.++|||||||++|++++ |..||...........+..... . .....
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~ 227 (260)
T cd05073 151 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR-M--PRPEN 227 (260)
T ss_pred eccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC-C--CCccc
Confidence 6543221 12234567799999886 568889999999999999998 9999988777666665554321 1 22246
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
++.++.+++.+||+.+|++||++.+++.
T Consensus 228 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 228 CPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred CCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 7899999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=314.39 Aligned_cols=252 Identities=26% Similarity=0.397 Sum_probs=199.2
Q ss_pred CceeEeCeeeeccceEEEEEEEec-CCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee--C
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--T 231 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~--~ 231 (611)
.+|++.+.||+|+||.||++.... ....+..||+|.+... .....+.+.+|+++++++. ||||+++++++.. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGR 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEccCCC
Confidence 468999999999999999998642 2236889999998543 3445577899999999997 9999999998754 3
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
..+++||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~ 156 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTK 156 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE---CCCCeEEECCCcccc
Confidence 46899999999999999987666679999999999999999999999999999999999999 567789999999998
Q ss_pred ccCCCCcc----cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHH---------------HHH
Q 007253 312 FVRPDERL----NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESG---------------IFR 371 (611)
Q Consensus 312 ~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~---------------~~~ 371 (611)
........ ....++..|+|||++. ..++.++|||||||++|||++|..++......- .+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 76433221 1122345699999886 568899999999999999999887764322110 011
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 372 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
.+......++ ....++.++.+||.+||..+|++|||+.++++
T Consensus 237 ~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 237 ELLKNNGRLP--APPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHhcCCcCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1222221111 12457899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=313.74 Aligned_cols=253 Identities=21% Similarity=0.295 Sum_probs=206.8
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCC-ccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee-C
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-T 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~-~ 231 (611)
.++|++.+.||+|+||.||+|...... ..+..|++|++... ......+.+.+|+.+++++. |+||+++++++.. .
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~ 81 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLS-HQNILPILHVCIEDG 81 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCC
Confidence 568999999999999999999977522 13688999988543 34455677899999999997 9999999998776 4
Q ss_pred CeeEEEeeecCCCChHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEE
Q 007253 232 DNVYVVMELCEGGELLDRILSRG-------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl 304 (611)
...++++||+.+|+|.+++.... ..+++..++.++.||+.||.|||+++++||||||+||++ +.++.+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEE---cCCCcEEE
Confidence 67899999999999999886532 358999999999999999999999999999999999999 56688999
Q ss_pred eecccccccCCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCC
Q 007253 305 IDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPS 379 (611)
Q Consensus 305 ~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~ 379 (611)
+|||+++.+..... .....++..|+|||++. ..++.++|||||||++|++++ |+.||......++...+... ..
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~ 237 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-YR 237 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC-CC
Confidence 99999986543321 12234567899999886 558899999999999999998 99999877666655444432 22
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 380 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
+. ....++.++.+++.+||..||++|||+.++++
T Consensus 238 ~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 238 LA--QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CC--CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 22 12357899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=308.45 Aligned_cols=242 Identities=24% Similarity=0.366 Sum_probs=200.7
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeee
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~ 240 (611)
++||+|+||.||++.... ++.||+|.+..... ....+.+.+|+++++++. |+||+++++++.+....++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~----~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG----NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYD-HPNIVKLIGVCVQKQPIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEeC----CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCCeEEEEEc
Confidence 479999999999998643 78899999865432 245567899999999997 99999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCCcc-
Q 007253 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL- 319 (611)
Q Consensus 241 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~- 319 (611)
+.+++|.+++......+++..+..++.+++.||.|||+++++||||||+|||+ +.++.+||+|||++.........
T Consensus 74 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~ 150 (251)
T cd05041 74 VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTV 150 (251)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE---cCCCcEEEeeccccccccCCccee
Confidence 99999999987766678999999999999999999999999999999999999 56778999999998765422111
Q ss_pred --cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 007253 320 --NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395 (611)
Q Consensus 320 --~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 395 (611)
....++..|+|||++. +.++.++|||||||++|+|++ |..||...........+.... ... ....++.++.++
T Consensus 151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~l 227 (251)
T cd05041 151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-RMP--APQLCPEEIYRL 227 (251)
T ss_pred ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC-CCC--CCccCCHHHHHH
Confidence 1223456799999876 568999999999999999998 899998777655555544322 111 123578999999
Q ss_pred HHHhcccCccCCCCHHHHHc
Q 007253 396 VKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 396 i~~~L~~dP~~Rpt~~~ll~ 415 (611)
|.+||..+|.+|||+.++++
T Consensus 228 i~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 228 MLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHHhccChhhCcCHHHHHH
Confidence 99999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=317.53 Aligned_cols=253 Identities=21% Similarity=0.308 Sum_probs=203.3
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCc-cCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGEL-KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..+|+..+.||+|+||.||+|....... ....||+|++.... .......+.+|+.+++++. ||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMD-HPHLVRLLGVCLSP- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCcccEEEEEcCC-
Confidence 4578999999999999999998765211 12357999885432 2333456889999999997 99999999998754
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
..++++||+++|+|.+++......+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||++..
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill---~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV---KSPNHVKITDFGLARL 158 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee---cCCCceEEcccccccc
Confidence 4779999999999999988776679999999999999999999999999999999999999 5667899999999987
Q ss_pred cCCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 007253 313 VRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (611)
Q Consensus 313 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (611)
...... .....++..|+|||++. ..++.++|||||||++|||++ |..||.+........ +......++. .+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~--~~~ 235 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD-LLEKGERLPQ--PPI 235 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHCCCCCCC--CCC
Confidence 643322 22334577899999886 568899999999999999997 999997765544433 3333322222 245
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
.+..+.+++.+||..+|++||++.++++.
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 236 CTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 68899999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=336.03 Aligned_cols=248 Identities=30% Similarity=0.515 Sum_probs=200.7
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC--
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD-- 232 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~-- 232 (611)
.-|...+.||+||||.||+++++. +|+.||||.+.+.. .....+...+|+++|++|. |+|||+++++-++..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnke---tG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~ 86 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKE---TGRLVAVKTFNKES--SLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLG 86 (732)
T ss_pred cceeehhhhcCCccceeeeecccc---cccchhHHhhhhhc--ccchHHHHHHHHHHHHHcC-chhhhhhcccCCccccC
Confidence 347788999999999999999887 79999999987643 3344577889999999998 999999998765543
Q ss_pred ----eeEEEeeecCCCChHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccC-CCceEEEe
Q 007253 233 ----NVYVVMELCEGGELLDRILSR--GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAI 305 (611)
Q Consensus 233 ----~~~lv~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~-~~~~vkl~ 305 (611)
...+|||||.||||..++.+. ...|++..+..++.+++.||.|||++|||||||||.||++.... ....-||+
T Consensus 87 ~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 87 LVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred cccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeee
Confidence 467999999999999988643 34599999999999999999999999999999999999997543 45578999
Q ss_pred ecccccccCCCCcccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhcCCC
Q 007253 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWART----ESGIFRAVLKADPS 379 (611)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~----~~~~~~~i~~~~~~ 379 (611)
|||.|+.+..+....+.+||+.|++||+.. +.|+..+|.|||||++|+.+||..||.... ..++...++...+.
T Consensus 167 DfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 167 DFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS 246 (732)
T ss_pred cccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence 999999999888899999999999999986 678999999999999999999999995322 22344444333221
Q ss_pred CC----------CCCC-----------CCCCHHHHHHHHHhcccCccCCC
Q 007253 380 FD----------EAPW-----------PSLSSEARDFVKRLLNKDPRKRL 408 (611)
Q Consensus 380 ~~----------~~~~-----------~~~s~~~~~li~~~L~~dP~~Rp 408 (611)
-. ...| +.+-..+..++..+|..+|++|.
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 10 0001 11223455788889999999999
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=310.95 Aligned_cols=254 Identities=27% Similarity=0.517 Sum_probs=208.9
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCC-------cCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEE
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHK-------MTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~-------~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~ 228 (611)
.|++.+.||+|+||.||+|....+ .++.+|+|.+.... .........+.+|+.++.+..+|+||+++++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~--~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 78 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNN--GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF 78 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCC--CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE
Confidence 378899999999999999997652 46889999885321 123344566778999888644599999999999
Q ss_pred eeCCeeEEEeeecCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeecCCCCceEEeccCCCceEEE
Q 007253 229 EDTDNVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKA 304 (611)
Q Consensus 229 ~~~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NIll~~~~~~~~vkl 304 (611)
.+++..++||||++|++|.+++.. ....+++..++.++.||+.||.|||+ .+|+|+||||+|||+ +.++.+||
T Consensus 79 ~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~---~~~~~~~l 155 (269)
T cd08528 79 LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML---GEDDKVTI 155 (269)
T ss_pred ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE---CCCCcEEE
Confidence 999999999999999999887743 44569999999999999999999996 689999999999999 56778999
Q ss_pred eecccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 007253 305 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA 383 (611)
Q Consensus 305 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 383 (611)
+|||++.............|+..|+|||++. +.++.++||||||+++|+|++|+.||...........+....... .
T Consensus 156 ~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~ 233 (269)
T cd08528 156 TDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP--L 233 (269)
T ss_pred ecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc--C
Confidence 9999998765544445667899999999886 558899999999999999999999998776666555554433221 1
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 384 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
....++..+.++|.+||+.||++||++.++..+
T Consensus 234 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 123578999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=318.24 Aligned_cols=265 Identities=31% Similarity=0.497 Sum_probs=215.6
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCC----HHHHHHHHHHHHHHHHhcCCCCeeEEEEE
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT----AIAIEDVRREVKILRALTGHNNLVKFFDA 227 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~----~~~~~~~~~E~~~l~~l~~h~~iv~l~~~ 227 (611)
.+.++|-++.+||+|||+.||+|-+.. ..+.||||+-.-+.... ....+...+|.+|.+.|. ||.||++|++
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~---EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLD-HpRIVKlYDy 535 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLT---EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELD-HPRIVKLYDY 535 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccc---hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccC-cceeeeeeee
Confidence 356789999999999999999997654 57899999864332222 234456679999999997 9999999999
Q ss_pred Ee-eCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeecCCCCceEEeccCCCceEEE
Q 007253 228 YE-DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSVLKA 304 (611)
Q Consensus 228 ~~-~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NIll~~~~~~~~vkl 304 (611)
|. +.+.+|-|+|||+|.+|.-|+ +..+.+++..++.|+.||+.||.||.+.. |||-||||.||||......|.+||
T Consensus 536 fslDtdsFCTVLEYceGNDLDFYL-KQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 536 FSLDTDSFCTVLEYCEGNDLDFYL-KQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred eeeccccceeeeeecCCCchhHHH-HhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEe
Confidence 97 456799999999998865554 55578999999999999999999999874 999999999999998888899999
Q ss_pred eecccccccCCCCc--------ccccccCCCcCcchhhc-C----CCCCcchhhHHHHHHHHHHhCCCCCCCCChH-HHH
Q 007253 305 IDFGLSDFVRPDER--------LNDIVGSAYYVAPEVLH-R----SYSTEADVWSIGVIAYILLCGSRPFWARTES-GIF 370 (611)
Q Consensus 305 ~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~-~----~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~-~~~ 370 (611)
+|||+++++..+.. +....||.||++||.+- + ..+.++||||+|||+|..+.|+.||...-.. .++
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdIL 694 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDIL 694 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHH
Confidence 99999999875432 34468999999999773 2 3788999999999999999999999654332 222
Q ss_pred --HHHHhc-CCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 371 --RAVLKA-DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 371 --~~i~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
..|++. ...|+. -|.+++++++||++||+.--++|..+.+|-.||||..-.
T Consensus 695 qeNTIlkAtEVqFP~--KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~ 748 (775)
T KOG1151|consen 695 QENTILKATEVQFPP--KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHI 748 (775)
T ss_pred hhhchhcceeccCCC--CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchh
Confidence 122222 233443 357999999999999999999999999999999997543
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=309.50 Aligned_cols=247 Identities=19% Similarity=0.289 Sum_probs=195.2
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeee
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~ 240 (611)
++||+|+||.||+++...+. ....+++|.+.... .....+.+.+|+.+++.++ ||||+++++.+.+...+|+||||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~lv~e~ 76 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDT-GVARVVVKELKANA--SSKEQNEFLQQGDPYRILQ-HPNILQCLGQCVEAIPYLLVFEY 76 (268)
T ss_pred CcCCCCcCceEEEEEEEcCC-CcceEEEEEecCCC--ChHHHHHHHHHHHHHhccC-CcchhheEEEecCCCccEEEEec
Confidence 36999999999999765421 34456777765432 2344578899999999997 99999999999999999999999
Q ss_pred cCCCChHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCC
Q 007253 241 CEGGELLDRILSRG---GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE 317 (611)
Q Consensus 241 ~~~gsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~ 317 (611)
+++|+|.+++.... ..+++..++.++.||+.||.|||+.+|+||||||+|||+ +.++.+||+|||++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKED 153 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE---cCCccEEecccccccccCcch
Confidence 99999999887542 346777889999999999999999999999999999999 567889999999986432221
Q ss_pred ---cccccccCCCcCcchhhcC--------CCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCC-CCCCCC
Q 007253 318 ---RLNDIVGSAYYVAPEVLHR--------SYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADP-SFDEAP 384 (611)
Q Consensus 318 ---~~~~~~gt~~y~aPE~~~~--------~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~ 384 (611)
.....+|+..|+|||++.. .++.++|||||||++|||++ |..||......+.+..+..... ......
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd05086 154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQ 233 (268)
T ss_pred hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCc
Confidence 1234578899999998742 35778999999999999996 5778887777776666654432 222111
Q ss_pred -CCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 385 -WPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 385 -~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
...++..+.+++..|+ .+|.+||+++++++
T Consensus 234 ~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 234 LELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 2347889999999999 68999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=309.01 Aligned_cols=241 Identities=26% Similarity=0.435 Sum_probs=200.3
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++.+.||+|+||.||++.. .++.||+|.+.... ..+.+.+|+.++++++ ||||+++++++..+ ..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-----~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~-~~ 73 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-----TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLH-HKNLVRLLGVILHN-GL 73 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-----CCCceEEEeecCcc-----hHHHHHHHHHHHHhCC-CCCcCeEEEEEcCC-Cc
Confidence 5699999999999999998853 47889999985421 2356889999999997 99999999998754 47
Q ss_pred EEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 235 YVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.|++||||||+||++ +.++.+||+|||++...
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~ 150 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV---SEDGVAKVSDFGLARVG 150 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCcEEECCCccceec
Confidence 99999999999999987654 358999999999999999999999999999999999999 56778999999998764
Q ss_pred CCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 314 RPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
... ......+..|+|||++. +.++.++|||||||++|+|++ |+.||......+....+..... ......++..
T Consensus 151 ~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 225 (254)
T cd05083 151 SMG--VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR---MEPPEGCPAD 225 (254)
T ss_pred ccc--CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC---CCCCCcCCHH
Confidence 322 22234457899999886 668999999999999999997 9999988777666655544321 1122467899
Q ss_pred HHHHHHHhcccCccCCCCHHHHHc
Q 007253 392 ARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
+.+++.+||+.+|.+||++.++++
T Consensus 226 ~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 226 VYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=311.35 Aligned_cols=252 Identities=23% Similarity=0.371 Sum_probs=204.2
Q ss_pred eeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC----
Q 007253 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD---- 232 (611)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~---- 232 (611)
|.+.+.||+|+||.||+|.......+++.||||++.... ......+.+.+|+++++++. ||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCCc
Confidence 677899999999999999987655578999999986543 33445677889999999997 999999999886542
Q ss_pred --eeEEEeeecCCCChHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 233 --NVYVVMELCEGGELLDRILSRG-----GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 233 --~~~lv~E~~~~gsL~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
..++++||+.+|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||++ +.++.+||+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE---cCCCCEEEC
Confidence 2478999999999988775321 247899999999999999999999999999999999999 567789999
Q ss_pred ecccccccCCCC---cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCC
Q 007253 306 DFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSF 380 (611)
Q Consensus 306 DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~ 380 (611)
|||++....... ......+++.|++||.+. +.++.++|||||||++|+|++ |+.||.+.........+......
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~- 234 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRL- 234 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcC-
Confidence 999988654322 122334567899999886 558889999999999999998 89999877766665555543221
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 381 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
. ..+..+..+.+++.+||..+|.+||++.+++.+
T Consensus 235 ~--~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 235 K--QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred C--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 113578899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=312.12 Aligned_cols=249 Identities=23% Similarity=0.366 Sum_probs=199.9
Q ss_pred CeeeeccceEEEEEEEecCC---ccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEE
Q 007253 161 EEVGRGHFGYTCAAKFKKGE---LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVV 237 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv 237 (611)
+.||+|+||.||+|+..... ..++.||+|.+.+.. .......+.+|+.+++.+. ||||+++++++.+.+..++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFN-HPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcC-CCCeeeEeeeecCCCCeEEE
Confidence 46999999999999876421 134689999885432 2234567889999999997 99999999999999999999
Q ss_pred eeecCCCChHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccC--CCceEEEeeccc
Q 007253 238 MELCEGGELLDRILSR------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD--ENSVLKAIDFGL 309 (611)
Q Consensus 238 ~E~~~~gsL~~~l~~~------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~--~~~~vkl~DfG~ 309 (611)
|||+++|+|.+++... ...+++..+..++.||+.||.|||+.+++|+||||+||+++..+ ....+||+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999998753 23478999999999999999999999999999999999996432 223799999999
Q ss_pred ccccCCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 007253 310 SDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAP 384 (611)
Q Consensus 310 a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 384 (611)
+........ .....++..|+|||++. +.++.++|||||||++|+|++ |..||......+....+.... .+ ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~--~~ 234 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG-RL--QK 234 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC-cc--CC
Confidence 876543221 22335678899999886 668999999999999999998 999998776666555543322 11 12
Q ss_pred CCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 385 ~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
...++..+.+||.+||..+|.+||++.++++
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2467899999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=309.59 Aligned_cols=241 Identities=20% Similarity=0.235 Sum_probs=190.8
Q ss_pred CeeeeccceEEEEEEEecCC-------ccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 161 EEVGRGHFGYTCAAKFKKGE-------LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~-------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
+.||+|+||.||+|...... .....|++|++.... . ....+.+|+.+++.+. ||||+++++++.. +.
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---R-DSLAFFETASLMSQLS-HKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---h-hHHHHHHHHHHHHcCC-CcchhheeeEEec-CC
Confidence 47999999999999987632 011357888764332 1 1567889999999997 9999999999988 77
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccC----CCceEEEeeccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD----ENSVLKAIDFGL 309 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~----~~~~vkl~DfG~ 309 (611)
.++||||+++|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++ ....+||+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 8999999999999998877655799999999999999999999999999999999999995332 112799999999
Q ss_pred ccccCCCCcccccccCCCcCcchhhcC---CCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 007253 310 SDFVRPDERLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPW 385 (611)
Q Consensus 310 a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (611)
+..... .....++..|+|||++.+ .++.++|||||||++|+|++ |..||............. .....+.
T Consensus 155 a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~--- 227 (259)
T cd05037 155 PITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPM--- 227 (259)
T ss_pred cccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCC---
Confidence 886543 223457788999999864 58899999999999999999 688887665433322222 1111111
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
.....+.++|.+||..+|.+|||+.++++
T Consensus 228 -~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 228 -PDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 12378999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=312.41 Aligned_cols=253 Identities=26% Similarity=0.405 Sum_probs=203.9
Q ss_pred CceeEeCeeeeccceEEEEEEEecC-CccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee--C
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKG-ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--T 231 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~--~ 231 (611)
+.|.+.+.||+|+||.||+|+.... ...+..||+|++...... ...+.+.+|+++++.+. |+||+++++++.. .
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLD-HENIVKYKGVCEKPGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCC-CCChheEEeeeecCCC
Confidence 5688899999999999999987532 235789999998654322 45678999999999997 9999999999887 5
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
...++||||+++++|.+++......+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~ 157 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAK 157 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEccccccc
Confidence 57999999999999999997766679999999999999999999999999999999999999 567889999999998
Q ss_pred ccCCCCcc----cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHH--------------HHHH
Q 007253 312 FVRPDERL----NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESG--------------IFRA 372 (611)
Q Consensus 312 ~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~--------------~~~~ 372 (611)
........ ....++..|+|||.+. ..++.++|||||||++|+|++|..||....... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 76532211 1234556799999876 568899999999999999999999986532211 1122
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 373 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
.+......+. ...++.++.+|+.+||..+|.+|||+.++++
T Consensus 238 ~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 238 LLKEGERLPR--PPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHcCCcCCC--CccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 2222222221 2356789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=290.95 Aligned_cols=254 Identities=29% Similarity=0.590 Sum_probs=210.4
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC-
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~- 231 (611)
..++|++.+++|+|-++.|+.|.... +.+.++||+++. ...+.+.+|++||..|.+||||++|++...+.
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~---~~eK~ViKiLKP------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~ 106 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINIT---NNEKCVIKILKP------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPE 106 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccC---CCceEEEeeech------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCcc
Confidence 35789999999999999999998665 578899999843 34467999999999999999999999998875
Q ss_pred -CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 232 -DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 232 -~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
....||+||+++-+..... ..++.-.++.++.+|+.||.|||++||+|||+||.|++|+ .....++|+|||+|
T Consensus 107 SktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 107 SKTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLA 180 (338)
T ss_pred ccCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec--hhhceeeeeecchH
Confidence 4578999999987755433 4688999999999999999999999999999999999996 34567999999999
Q ss_pred cccCCCCcccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCC-CChHHHHHHHHh------------
Q 007253 311 DFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLK------------ 375 (611)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~-~~~~~~~~~i~~------------ 375 (611)
.+..++...+-.+.+.+|.-||.+- +.|+..-|+|||||++..|+..+.||.. .+..+.+.+|.+
T Consensus 181 EFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 181 EFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred hhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 9999888888889999999999885 6799999999999999999999999843 333333322211
Q ss_pred -----cCCCC-------CCCCCC---------CCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCC
Q 007253 376 -----ADPSF-------DEAPWP---------SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 376 -----~~~~~-------~~~~~~---------~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
.++.+ ...+|. -+++++.+|+.++|..|..+|+|+.|++.||||..
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 11111 111221 24789999999999999999999999999999975
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=334.02 Aligned_cols=251 Identities=24% Similarity=0.429 Sum_probs=221.1
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
...|.++||.|.||.||.|+++........||||.++.. ..+.....|+.|..||-++. ||||++|.|+.....-++
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFd-HPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFD-HPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCC-CCcEEEEEEEEecCceeE
Confidence 356788999999999999999876556688999999654 45566788999999999997 999999999999999999
Q ss_pred EEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC
Q 007253 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~ 315 (611)
||+|||++|+|..+|+.+.+.++..++..+++.|+.|++||-++++|||||-..|||+ +.+.++|++|||+++.+.+
T Consensus 707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV---NsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee---ccceEEEeccccceeeccc
Confidence 9999999999999999999999999999999999999999999999999999999999 6899999999999998865
Q ss_pred CC--ccccccc--CCCcCcchhhc-CCCCCcchhhHHHHHHHHHH-hCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 316 DE--RLNDIVG--SAYYVAPEVLH-RSYSTEADVWSIGVIAYILL-CGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 316 ~~--~~~~~~g--t~~y~aPE~~~-~~~~~~~DiwSlGvil~el~-~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
+. ...+..| ..+|.|||.+. +.++.++||||+||++||.+ .|+.|||..+.++++..|.++.. ++ +....+
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyR-LP--pPmDCP 860 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYR-LP--PPMDCP 860 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccC-CC--CCCCCc
Confidence 54 2223333 35899999885 89999999999999999877 69999999999999988876542 22 225789
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
..+.+|+..||++|-.+||...||+.
T Consensus 861 ~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 861 AALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred HHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 99999999999999999999998864
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=322.13 Aligned_cols=250 Identities=24% Similarity=0.400 Sum_probs=209.6
Q ss_pred CceeEeCeeeeccceEEEEEEEecCC-ccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
+...+.+.||.|.||.||.|.+..-+ ...-.||||..+.+. +....+.|..|..+|+.+. ||||++|+|+|.+. .
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfd-HphIikLIGv~~e~-P 464 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFD-HPHIIKLIGVCVEQ-P 464 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCC-Ccchhheeeeeecc-c
Confidence 34455778999999999999886532 123458889876543 3445788999999999997 99999999999754 5
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
.|||||+++.|.|..++..+...++...+..++.||+.+|.|||+.++|||||-..|||+. ....|||+|||+++.+
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs---Sp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS---SPQCVKLADFGLSRYL 541 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec---Ccceeeecccchhhhc
Confidence 8999999999999999998888899999999999999999999999999999999999994 5667999999999998
Q ss_pred CCCCccccccc--CCCcCcchhhc-CCCCCcchhhHHHHHHHHHH-hCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 314 RPDERLNDIVG--SAYYVAPEVLH-RSYSTEADVWSIGVIAYILL-CGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 314 ~~~~~~~~~~g--t~~y~aPE~~~-~~~~~~~DiwSlGvil~el~-~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
..+.......| ..-|||||-++ +.++.++|||-|||++||++ .|..||.+....+++-.+.++. .++.. ++++
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGe-RlP~P--~nCP 618 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGE-RLPCP--PNCP 618 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCC-CCCCC--CCCC
Confidence 86654444344 35799999887 88999999999999999988 5999999988877665555443 22222 5789
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHH
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQAL 414 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll 414 (611)
+.+..|+.+||..||.+||+..++.
T Consensus 619 p~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 619 PALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred hHHHHHHHHHhccCcccCCcHHHHH
Confidence 9999999999999999999887764
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=326.72 Aligned_cols=257 Identities=24% Similarity=0.376 Sum_probs=218.0
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++..+.++||+|+||.|++|.+.....+.-.||||++....... ....|++|+.+|.+|+ |+|+++|||+..+ ..
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~-H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQ-HPHLIRLYGVVLD-QP 184 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhcc-CcceeEEeeeecc-ch
Confidence 356778899999999999999988744345678999996554322 5678999999999998 9999999999987 77
Q ss_pred eEEEeeecCCCChHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 234 VYVVMELCEGGELLDRILS-RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
+.+|||++++|+|++.|.+ ....|....+..++.||+.||.||.++++|||||-..|+||- ....|||||||+++.
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNllla---sprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLA---SPRTVKICDFGLMRA 261 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheec---ccceeeeecccceec
Confidence 8899999999999999987 445688999999999999999999999999999999999995 466799999999998
Q ss_pred cCCCCccccccc----CCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 007253 313 VRPDERLNDIVG----SAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 313 ~~~~~~~~~~~g----t~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (611)
+..++....+.+ ...|+|||.++ +.|+.++|||++||+||||++ |+.||.+....+++.+|- ....++.. +
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRP--k 338 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRP--K 338 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCC--C
Confidence 876654443322 34799999996 889999999999999999996 899999999999888887 33333332 4
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHcCcccC
Q 007253 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~ 420 (611)
.+++++.+++++||..+|.+|||+..|.+.-+++
T Consensus 339 ~csedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 339 YCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred CChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 6799999999999999999999999997666554
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=309.95 Aligned_cols=253 Identities=15% Similarity=0.203 Sum_probs=186.5
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHH--------HHHHHHHHHHHHhcCCCCeeE
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAI--------EDVRREVKILRALTGHNNLVK 223 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~--------~~~~~E~~~l~~l~~h~~iv~ 223 (611)
...++|++.++||+|+||.||+|....+...+..+|+|+............ .....+...+..+. |+||++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~-h~~i~~ 87 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNID-HLGIPK 87 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCC-CCCCCc
Confidence 445789999999999999999999776433366778886532221110000 01112333344455 999999
Q ss_pred EEEEEeeCC----eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCC
Q 007253 224 FFDAYEDTD----NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN 299 (611)
Q Consensus 224 l~~~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~ 299 (611)
+++++.... ..++++|++. .++.+.+.. ....++..++.++.||+.||.|||+.+|+||||||+|||+ +.+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill---~~~ 162 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV---DGN 162 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhc-cCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCC
Confidence 999776543 3578888874 466665533 3446889999999999999999999999999999999999 567
Q ss_pred ceEEEeecccccccCCCC--------cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChH-HH
Q 007253 300 SVLKAIDFGLSDFVRPDE--------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES-GI 369 (611)
Q Consensus 300 ~~vkl~DfG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~-~~ 369 (611)
+.+||+|||+|+.+.... ......||+.|+|||++. ..++.++|||||||++|||++|+.||.+.... ..
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 789999999998654221 112346999999999886 55899999999999999999999999776332 21
Q ss_pred H--------HHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 370 F--------RAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 370 ~--------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
. ..+.... ...+..+.++.++++.|+..+|.+||++.++++
T Consensus 243 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 243 IHAAKCDFIKRLHEGK-----IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHhHHHHHHHhhhhh-----hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1 1222211 122456899999999999999999999999875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=303.25 Aligned_cols=228 Identities=25% Similarity=0.344 Sum_probs=185.8
Q ss_pred ccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeeecCCCC
Q 007253 166 GHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGE 245 (611)
Q Consensus 166 G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~~~~gs 245 (611)
|.||.||+++... +++.||+|++.+.. ...+|...+.... ||||+++++++.+.+..++||||++||+
T Consensus 4 g~~~~v~~~~~~~---~~~~~~~K~i~~~~--------~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 71 (237)
T cd05576 4 GVIDKVLLVMDTR---TQQTFILKGLRKSS--------EYSRERLTIIPHC-VPNMVCLHKYIVSEDSVFLVLQHAEGGK 71 (237)
T ss_pred cccceEEEEEEcc---CCcEEEEEeecchh--------hhhhHHHHHHhcC-CCceeehhhheecCCeEEEEEecCCCCC
Confidence 8999999999776 68999999986542 1234444455554 9999999999999999999999999999
Q ss_pred hHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCCcccccccC
Q 007253 246 LLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGS 325 (611)
Q Consensus 246 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt 325 (611)
|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||++ +.++.++|+|||.+...... .....++
T Consensus 72 L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~df~~~~~~~~~--~~~~~~~ 145 (237)
T cd05576 72 LWSHISKF-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDS--CDGEAVE 145 (237)
T ss_pred HHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEecccchhccccc--cccCCcC
Confidence 99988665 459999999999999999999999999999999999999 56778999999987665432 2334567
Q ss_pred CCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCc
Q 007253 326 AYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDP 404 (611)
Q Consensus 326 ~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 404 (611)
..|+|||++. +.++.++||||+||++|+|++|+.||...... + .....+. ....++..+.+||.+||+.||
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-~~~~~~~--~~~~~~~~~~~li~~~l~~dp 217 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I-NTHTTLN--IPEWVSEEARSLLQQLLQFNP 217 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-ccccccC--CcccCCHHHHHHHHHHccCCH
Confidence 8899999886 56889999999999999999999987543211 0 0001111 113578999999999999999
Q ss_pred cCCCCH-----HHHHcCccc
Q 007253 405 RKRLTA-----AQALSHPWI 419 (611)
Q Consensus 405 ~~Rpt~-----~~ll~hp~~ 419 (611)
.+||++ .++++||||
T Consensus 218 ~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 218 TERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred HHhcCCCccchHHHHcCCCC
Confidence 999985 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=319.86 Aligned_cols=265 Identities=27% Similarity=0.497 Sum_probs=220.3
Q ss_pred CcCcccccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcC-----CCC
Q 007253 146 SFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG-----HNN 220 (611)
Q Consensus 146 ~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-----h~~ 220 (611)
.+.+++.+-.+|++....|+|-|+.|..|.... .|+.||||+|..+. .+.+.=+.|+.||++|++ --|
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~---r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk~H 495 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQA---RGQEVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDKFH 495 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccC---CCCeeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhhhH
Confidence 344556677889999999999999999998766 68899999996543 334455689999999983 348
Q ss_pred eeEEEEEEeeCCeeEEEeeecCCCChHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCC
Q 007253 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGG--KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE 298 (611)
Q Consensus 221 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~ 298 (611)
+++|+..|...+++|||+|-+ ..+|.+++.+-+. .|....++.++.|++.||..|-..||+|.||||+|||++ ..
T Consensus 496 clrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN--E~ 572 (752)
T KOG0670|consen 496 CLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN--ES 572 (752)
T ss_pred HHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec--cC
Confidence 999999999999999999999 4599998877654 478889999999999999999999999999999999997 46
Q ss_pred CceEEEeecccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC
Q 007253 299 NSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 377 (611)
Q Consensus 299 ~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~ 377 (611)
...+||||||.|.+...+. .+.+.-+..|.|||++- -.|+...|+||.||+||||.||+..|.+.+...++.-.....
T Consensus 573 k~iLKLCDfGSA~~~~ene-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K 651 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK 651 (752)
T ss_pred cceeeeccCcccccccccc-ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence 6789999999998876544 33445567899999886 469999999999999999999999999999998887766555
Q ss_pred CCCCCCCC-------------------------------------C------------CC-------CHHHHHHHHHhcc
Q 007253 378 PSFDEAPW-------------------------------------P------------SL-------SSEARDFVKRLLN 401 (611)
Q Consensus 378 ~~~~~~~~-------------------------------------~------------~~-------s~~~~~li~~~L~ 401 (611)
..++...+ | .+ -..+.+|+.+||.
T Consensus 652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~ 731 (752)
T KOG0670|consen 652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI 731 (752)
T ss_pred CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence 44443211 0 01 1357899999999
Q ss_pred cCccCCCCHHHHHcCcccCC
Q 007253 402 KDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 402 ~dP~~Rpt~~~ll~hp~~~~ 421 (611)
.||.+|.|+.++|.||||+.
T Consensus 732 LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 732 LDPEKRITVNQALKHPFITE 751 (752)
T ss_pred cChhhcCCHHHHhcCCcccC
Confidence 99999999999999999975
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=315.04 Aligned_cols=246 Identities=23% Similarity=0.388 Sum_probs=208.6
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
.+.....+||-|.||.||.|.+++ ..-.||||.++... ..+++|+.|..+|+.++ |||+|+|+|+|..+..+
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKk---yslTvAVKtLKEDt----MeveEFLkEAAvMKeik-HpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeec---cceeeehhhhhhcc----hhHHHHHHHHHHHHhhc-CccHHHHhhhhccCCCe
Confidence 345567899999999999999988 46779999986543 34578999999999998 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 235 YVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
|||+|||..|+|++|+.+.++ .++.-.+..++.||..|++||..+++|||||-..|+|+ +++..|||+|||+++++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV---gEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc---cccceEEeeccchhhhh
Confidence 999999999999999987654 37777888999999999999999999999999999999 78999999999999998
Q ss_pred CCCCcc--cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 314 RPDERL--NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 314 ~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
..+..+ ...--...|.|||-+. ..++.++|||+|||+|||+.| |-.||.+-+..+++..+.+ ..... ....++
T Consensus 416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk-gyRM~--~PeGCP 492 (1157)
T KOG4278|consen 416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK-GYRMD--GPEGCP 492 (1157)
T ss_pred cCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc-ccccc--CCCCCC
Confidence 755422 1122345799999775 789999999999999999996 8899988877776654443 32222 234789
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHH
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQAL 414 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll 414 (611)
+...+|++.||++.|.+||+..++-
T Consensus 493 pkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 493 PKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred HHHHHHHHHHhcCCcccCccHHHHH
Confidence 9999999999999999999998874
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=319.84 Aligned_cols=264 Identities=23% Similarity=0.310 Sum_probs=191.4
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEec-------------CCccCcEEEEEEecCCCcCCHH-----------HHHHHHH
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKK-------------GELKGQQVAVKVIPKHKMTTAI-----------AIEDVRR 207 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~-------------~~~~g~~vavK~~~~~~~~~~~-----------~~~~~~~ 207 (611)
...++|++.++||+|+||.||+|.... ....++.||||.+......... ..+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 346789999999999999999996421 1124678999998533211000 1122345
Q ss_pred HHHHHHHhcCCCC-----eeEEEEEEee--------CCeeEEEeeecCCCChHHHHHhcC--------------------
Q 007253 208 EVKILRALTGHNN-----LVKFFDAYED--------TDNVYVVMELCEGGELLDRILSRG-------------------- 254 (611)
Q Consensus 208 E~~~l~~l~~h~~-----iv~l~~~~~~--------~~~~~lv~E~~~~gsL~~~l~~~~-------------------- 254 (611)
|+.++.+++ |.+ +++++++|.. .+..+|||||+++|+|.+++....
T Consensus 222 E~~~l~~l~-~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 222 EAYMCAKIK-RNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHhh-cccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 777788886 544 4677777753 356899999999999999886431
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCCccccc--ccCCCcC
Q 007253 255 ---GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI--VGSAYYV 329 (611)
Q Consensus 255 ---~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~--~gt~~y~ 329 (611)
..+++..++.++.||+.||.|||+.+|+||||||+|||+ +.++.+||+|||++............ .+|+.|+
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~ 377 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYS 377 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCccCccccCCCccee
Confidence 124677899999999999999999999999999999999 56678999999999766443332222 3478999
Q ss_pred cchhhcCC---------------------CC--CcchhhHHHHHHHHHHhCCC-CCCCCChH-----------HHHHHHH
Q 007253 330 APEVLHRS---------------------YS--TEADVWSIGVIAYILLCGSR-PFWARTES-----------GIFRAVL 374 (611)
Q Consensus 330 aPE~~~~~---------------------~~--~~~DiwSlGvil~el~~g~~-Pf~~~~~~-----------~~~~~i~ 374 (611)
|||++... |+ .+.||||+||++|+|++|.. ||...... ...+.+.
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~ 457 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK 457 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc
Confidence 99987421 12 24799999999999999986 77432111 1111111
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhcccCc---cCCCCHHHHHcCcccCC
Q 007253 375 KADPSFDEAPWPSLSSEARDFVKRLLNKDP---RKRLTAAQALSHPWIKN 421 (611)
Q Consensus 375 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP---~~Rpt~~~ll~hp~~~~ 421 (611)
... +....+...++..++|+.+||..+| .+|+|+.|+|+||||..
T Consensus 458 ~~~--~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 458 GQK--YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred ccC--CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 222 2233456789999999999999866 78999999999999964
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=274.32 Aligned_cols=215 Identities=26% Similarity=0.420 Sum_probs=180.9
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..+....+..||+|++|.|-+.++.. +|+..|+|.+.... ..+..++..+|+.+..+..++|.+|.|||.+.++.
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~---sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQ---SGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeecc---CCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 35667778999999999998888877 79999999996543 23455778899999998888999999999999999
Q ss_pred eeEEEeeecCCCChHHHH---HhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeecCCCCceEEeccCCCceEEEeecc
Q 007253 233 NVYVVMELCEGGELLDRI---LSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l---~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DfG 308 (611)
.+||.||.|.. ||..+. ..+++.++|..+-+|+..++.||.|||++ .|||||+||+|||| +..|.||+||||
T Consensus 119 dvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFG 194 (282)
T KOG0984|consen 119 DVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI---NYDGQVKICDFG 194 (282)
T ss_pred cEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE---ccCCcEEEcccc
Confidence 99999999964 665443 35678899999999999999999999997 89999999999999 678889999999
Q ss_pred cccccCCCCcccccccCCCcCcchhhc-----CCCCCcchhhHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhc
Q 007253 309 LSDFVRPDERLNDIVGSAYYVAPEVLH-----RSYSTEADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLKA 376 (611)
Q Consensus 309 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DiwSlGvil~el~~g~~Pf~~-~~~~~~~~~i~~~ 376 (611)
.+..+.++-..+...|...|||||.+. ..|+.++||||||++++||.+++.||.. .+.-+.+..+...
T Consensus 195 IsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 195 ISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred cceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 999887665555567889999999985 3689999999999999999999999954 3444445555443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=298.65 Aligned_cols=270 Identities=28% Similarity=0.492 Sum_probs=207.9
Q ss_pred CcCcccccC-CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCC------
Q 007253 146 SFGFSKHFA-NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH------ 218 (611)
Q Consensus 146 ~~~~~~~~~-~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h------ 218 (611)
.+..++.|. .+|.+.++||.|.|++||+|.+.. ..+.||+|+.+. .....+....||++|++++.+
T Consensus 68 pV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq---~~r~VAlKVvKS----AqhYtEaAlDEIklL~~v~~~Dp~~~~ 140 (590)
T KOG1290|consen 68 PVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQ---NKRYVALKVVKS----AQHYTEAALDEIKLLQQVREGDPNDPG 140 (590)
T ss_pred eeeccccccCceEEEEEeccccccceeEEEeecc---CCeEEEEEEEeh----hhHHHHHHHHHHHHHHHHHhcCCCCCC
Confidence 444566676 899999999999999999999776 578999999843 345667788999999998743
Q ss_pred -CCeeEEEEEEee----CCeeEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHc-CCeeecCCCCce
Q 007253 219 -NNLVKFFDAYED----TDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENF 291 (611)
Q Consensus 219 -~~iv~l~~~~~~----~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NI 291 (611)
.+||+|++.|.. +.++|+|+|++ |.+|+.+|...+ +.++...++.|++||+.||.|||+. ||||-||||+||
T Consensus 141 ~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENv 219 (590)
T KOG1290|consen 141 KKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENV 219 (590)
T ss_pred CceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCccee
Confidence 379999999975 45899999999 779999987654 4599999999999999999999986 899999999999
Q ss_pred EEeccC--------------------------------------------------------------------------
Q 007253 292 LFTTKD-------------------------------------------------------------------------- 297 (611)
Q Consensus 292 ll~~~~-------------------------------------------------------------------------- 297 (611)
|+...+
T Consensus 220 Ll~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~ 299 (590)
T KOG1290|consen 220 LLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPN 299 (590)
T ss_pred eeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccc
Confidence 994320
Q ss_pred --------------------------------------C-----------------------------------------
Q 007253 298 --------------------------------------E----------------------------------------- 298 (611)
Q Consensus 298 --------------------------------------~----------------------------------------- 298 (611)
.
T Consensus 300 ~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~ 379 (590)
T KOG1290|consen 300 QESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPL 379 (590)
T ss_pred ccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccc
Confidence 0
Q ss_pred ----------CceEEEeecccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCC--
Q 007253 299 ----------NSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART-- 365 (611)
Q Consensus 299 ----------~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~-- 365 (611)
...|||+|||.|..+. ..++.-+.|..|+|||++- ..|+..+||||++|+++||+||-..|.-..
T Consensus 380 v~p~~~~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~ 457 (590)
T KOG1290|consen 380 VNPDIPLPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGE 457 (590)
T ss_pred cCCCCCCCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCC
Confidence 0126777888777653 3345567889999999886 569999999999999999999999994221
Q ss_pred ----hHHHHHHHHhcCCCCCC-------------------------CCCC---------CC----CHHHHHHHHHhcccC
Q 007253 366 ----ESGIFRAVLKADPSFDE-------------------------APWP---------SL----SSEARDFVKRLLNKD 403 (611)
Q Consensus 366 ----~~~~~~~i~~~~~~~~~-------------------------~~~~---------~~----s~~~~~li~~~L~~d 403 (611)
+.+.+..|......+|. .+|+ .+ ..++.+||.-||+.+
T Consensus 458 ~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~ 537 (590)
T KOG1290|consen 458 NYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFD 537 (590)
T ss_pred CCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcC
Confidence 11222222221111110 1121 12 346789999999999
Q ss_pred ccCCCCHHHHHcCcccCCCCCC
Q 007253 404 PRKRLTAAQALSHPWIKNSNDV 425 (611)
Q Consensus 404 P~~Rpt~~~ll~hp~~~~~~~~ 425 (611)
|++||||.++|+|||+......
T Consensus 538 PeKR~tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 538 PEKRPTAAQCLKHPWLNPVAGP 559 (590)
T ss_pred ccccccHHHHhcCccccCCCCC
Confidence 9999999999999999966543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=288.43 Aligned_cols=242 Identities=45% Similarity=0.787 Sum_probs=203.1
Q ss_pred cceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeeecCCCCh
Q 007253 167 HFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGEL 246 (611)
Q Consensus 167 ~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~~~~gsL 246 (611)
+||.||+|.... +|+.+|+|++........ .+.+.+|++.+++++ |+||+++++.+......+++|||+++++|
T Consensus 1 ~~g~v~~~~~~~---~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKK---TGKLVAIKVIKKEKIKKK--RERILREISILKKLK-HPNIVRLYDVFEDEDKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECC---CCcEEEEEEecccccccH--HHHHHHHHHHHHhCC-CCcHHHHHhheeeCCEEEEEEeCCCCCCH
Confidence 589999998775 588999999865433221 578899999999996 99999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCCcccccccCC
Q 007253 247 LDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSA 326 (611)
Q Consensus 247 ~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~ 326 (611)
.+++.... .+++..++.++.+++.+|.|||+.+|+|+||+|+||++ +.++.++|+|||.+.............++.
T Consensus 75 ~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 150 (244)
T smart00220 75 FDLLKKRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL---DEDGHVKLADFGLARQLDPGGLLTTFVGTP 150 (244)
T ss_pred HHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE---CCCCcEEEccccceeeeccccccccccCCc
Confidence 99886543 38999999999999999999999999999999999999 456789999999998876554555677899
Q ss_pred CcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCc
Q 007253 327 YYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDP 404 (611)
Q Consensus 327 ~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 404 (611)
.|+|||.+. ..++.++||||||+++++|++|..||.. .....+...+....... ...+..++.++.+++.+||..+|
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p 229 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF-PPPEWKISPEAKDLIRKLLVKDP 229 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC-ccccccCCHHHHHHHHHHccCCc
Confidence 999999886 6688899999999999999999999987 44444444333333222 22222278999999999999999
Q ss_pred cCCCCHHHHHcCccc
Q 007253 405 RKRLTAAQALSHPWI 419 (611)
Q Consensus 405 ~~Rpt~~~ll~hp~~ 419 (611)
++||++.++++||||
T Consensus 230 ~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 230 EKRLTAEEALQHPFF 244 (244)
T ss_pred hhccCHHHHhhCCCC
Confidence 999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=323.23 Aligned_cols=251 Identities=31% Similarity=0.498 Sum_probs=199.2
Q ss_pred eeEeCeeeeccce-EEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 157 YELGEEVGRGHFG-YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 157 y~~~~~LG~G~fg-~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
|.-.+.+|.|+-| .||+|.+ .|+.||||++-. .....+.+||..|+.-..|||||++|+.-.+.+.+|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-----e~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~Y 579 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-----EGREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLY 579 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-----CCceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEE
Confidence 4445679999998 6888875 478999998732 223457899999999888999999999988999999
Q ss_pred EEeeecCCCChHHHHHhcCC--C-CCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccC--CCceEEEeecccc
Q 007253 236 VVMELCEGGELLDRILSRGG--K-YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD--ENSVLKAIDFGLS 310 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~~~--~-l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~--~~~~vkl~DfG~a 310 (611)
|+.|.|. .+|.+++..... . ......+.+..|+++||++||+.+||||||||.||||...+ ....++|+|||++
T Consensus 580 IalELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 580 IALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred EEehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccc
Confidence 9999995 599999976411 1 12245688999999999999999999999999999998642 3457999999999
Q ss_pred cccCCCC----cccccccCCCcCcchhhcC-CCCCcchhhHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhcCCCCCCCC
Q 007253 311 DFVRPDE----RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCG-SRPFWARTESGIFRAVLKADPSFDEAP 384 (611)
Q Consensus 311 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~el~~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 384 (611)
+.+..+. +..+..||-+|+|||++.. .-..++|||||||++|+.++| ..||...... -.+|+..........
T Consensus 659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~ 736 (903)
T KOG1027|consen 659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLE 736 (903)
T ss_pred cccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeec
Confidence 9987554 3456789999999999974 456789999999999988886 9999654433 235555554433221
Q ss_pred CCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 385 ~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
+....++.+||.+||++||..||++.++|.||||=..
T Consensus 737 -~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 737 -PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred -cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 1112289999999999999999999999999999654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=282.99 Aligned_cols=263 Identities=29% Similarity=0.546 Sum_probs=208.2
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC-
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~- 231 (611)
...+|.-+..+|.|+- .|..+-+. ..++.||+|.+... .......++..+|..++..+. |+||++++.+|.-.
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~---v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~-~~nii~l~n~ftP~~ 88 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQ---VLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVN-HKNIISLLNVFTPQK 88 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchh---hccCceehhhhcCc-cccCccchhhhhhhhhhhhhc-ccceeeeeeccCccc
Confidence 3467888888999987 56555533 36899999987554 233334466789999999998 99999999999743
Q ss_pred -----CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEee
Q 007253 232 -----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (611)
Q Consensus 232 -----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D 306 (611)
...|+|||||.. +|.+.++. .++-..+..|+.|++.|++|||+.||+||||||+||++ ..+..+||.|
T Consensus 89 ~l~~~~e~y~v~e~m~~-nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv---~~~~~lKi~d 161 (369)
T KOG0665|consen 89 TLEEFQEVYLVMELMDA-NLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV---NSDCTLKILD 161 (369)
T ss_pred cHHHHHhHHHHHHhhhh-HHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee---cchhheeecc
Confidence 358999999964 89888873 47889999999999999999999999999999999999 5777899999
Q ss_pred cccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--------
Q 007253 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD-------- 377 (611)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~-------- 377 (611)
||+++....+-..+..+.|.+|.|||++- -.|...+||||+||++.||++|...|.+...-+.+.++...-
T Consensus 162 fg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 162 FGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred chhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence 99999887776778889999999999875 349999999999999999999999998766544433332111
Q ss_pred --------------C---------CCCCCCCC-------CCCHHHHHHHHHhcccCccCCCCHHHHHcCcccC---CCCC
Q 007253 378 --------------P---------SFDEAPWP-------SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK---NSND 424 (611)
Q Consensus 378 --------------~---------~~~~~~~~-------~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~---~~~~ 424 (611)
+ .++...|+ .-+..+++++.+||..||++|.+++++|+||||+ ...+
T Consensus 242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~e 321 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDE 321 (369)
T ss_pred HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeeccccc
Confidence 0 11111121 1245688999999999999999999999999998 4444
Q ss_pred CCCc
Q 007253 425 VKVP 428 (611)
Q Consensus 425 ~~~~ 428 (611)
...|
T Consensus 322 v~ap 325 (369)
T KOG0665|consen 322 VEAP 325 (369)
T ss_pred ccCC
Confidence 4333
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=281.77 Aligned_cols=256 Identities=30% Similarity=0.511 Sum_probs=205.6
Q ss_pred eeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC-----
Q 007253 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT----- 231 (611)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~----- 231 (611)
.+-.+.||.|+||.||.+.+.. +|+.||+|.+.. .......-+++.+|+++|.-++ |.|++..++...-.
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPR---dgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph~dfF 129 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPR---SGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPANPSFF 129 (449)
T ss_pred CCCCCcccccceeEEEeccCCC---CccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCCchHH
Confidence 3456789999999999998665 699999998753 2234455678899999999998 99999998877644
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
..+|+|+|+|.. +|.+.|.+. +.++...++-+++||++||+|||+.+|+||||||.|.|+ +.+-++||||||+++
T Consensus 130 qEiYV~TELmQS-DLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---NSNCvLKICDFGLAR 204 (449)
T KOG0664|consen 130 QELYVLTELMQS-DLHKIIVSP-QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---NSNCILKICDFGLAR 204 (449)
T ss_pred HHHHHHHHHHHh-hhhheeccC-CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---ccCceEEeccccccc
Confidence 358899999954 787766544 679999999999999999999999999999999999999 688899999999999
Q ss_pred ccCCCC--cccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHh------------
Q 007253 312 FVRPDE--RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK------------ 375 (611)
Q Consensus 312 ~~~~~~--~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~------------ 375 (611)
....+. ..+..+-|.+|.|||++. +.|+.++||||.|||+.||+..+..|.....-+.++.|..
T Consensus 205 vee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 205 TWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred ccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 876554 344557899999999987 4699999999999999999999999987766554444322
Q ss_pred -----------cCCCCCCCC-------CCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 376 -----------ADPSFDEAP-------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 376 -----------~~~~~~~~~-------~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
..+..+... ...-..+...++.++|..||++|.+.++.+.|+++...
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 111111111 01224577899999999999999999999999998653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=309.88 Aligned_cols=260 Identities=29% Similarity=0.491 Sum_probs=217.5
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
...++|++...+|.|.+|.||+++++. +++..|+|+++-.. .....-+.+|+-+++..+ |||||.|++.+...
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~---s~elaavkvVkLep---~dd~~~iqqei~~~~dc~-h~nivay~gsylr~ 84 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKR---SGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCR-HPNIVAYFGSYLRR 84 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccc---cCchhhheeeeccC---CccccccccceeeeecCC-CcChHHHHhhhhhh
Confidence 346789999999999999999999887 78999999996543 233456778999999987 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+.+||+||||.||+|.+..+ -.+.+++.++...++..+.||+|||+.|-+|||||-.|||+ .+.+.||+.|||.+.
T Consensus 85 dklwicMEycgggslQdiy~-~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanill---td~gDvklaDfgvsa 160 (829)
T KOG0576|consen 85 DKLWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILL---TDEGDVKLADFGVSA 160 (829)
T ss_pred cCcEEEEEecCCCcccceee-ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceee---cccCceeecccCchh
Confidence 99999999999999988654 34679999999999999999999999999999999999999 467789999999986
Q ss_pred ccCCC-CcccccccCCCcCcchhh----cCCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC-C
Q 007253 312 FVRPD-ERLNDIVGSAYYVAPEVL----HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP-W 385 (611)
Q Consensus 312 ~~~~~-~~~~~~~gt~~y~aPE~~----~~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~ 385 (611)
.+... .+.....||++|||||+. .+.|...+|||++|++..|+..-++|.........+...-+..+..+... -
T Consensus 161 qitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk 240 (829)
T KOG0576|consen 161 QITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDK 240 (829)
T ss_pred hhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCC
Confidence 55432 244677999999999986 37799999999999999999999988766555444433333333322211 2
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
..+++.+.+|++.+|.++|++||+++.+|.|||....
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 3578999999999999999999999999999999865
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=308.61 Aligned_cols=253 Identities=26% Similarity=0.447 Sum_probs=207.0
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCcc----CcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELK----GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 229 (611)
.+...+.+.||+|+||.|++|........ ...||||.++..... ...+.+..|+++|+.+..|+||+.++|+|.
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 34456777999999999999987643322 567999998655432 566889999999999999999999999999
Q ss_pred eCCeeEEEeeecCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEe
Q 007253 230 DTDNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294 (611)
Q Consensus 230 ~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~ 294 (611)
..+.+++|+|||+.|+|++++.... ..++...+..++.||+.|++||++..+|||||-..|||+
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi- 451 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLI- 451 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEe-
Confidence 9999999999999999999998765 348999999999999999999999999999999999999
Q ss_pred ccCCCceEEEeecccccccCCCCcc--ccccc--CCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCC-hH
Q 007253 295 TKDENSVLKAIDFGLSDFVRPDERL--NDIVG--SAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWART-ES 367 (611)
Q Consensus 295 ~~~~~~~vkl~DfG~a~~~~~~~~~--~~~~g--t~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~-~~ 367 (611)
..+..+||+|||+|+........ ....| ...|||||.+. ..|+.++|||||||+|||+++ |..||.+-. ..
T Consensus 452 --~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~ 529 (609)
T KOG0200|consen 452 --TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE 529 (609)
T ss_pred --cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence 57789999999999865443322 22222 23599999887 579999999999999999997 899998754 45
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHH
Q 007253 368 GIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414 (611)
Q Consensus 368 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll 414 (611)
+++..+..+. ..... ...+.++.++++.||+.+|.+||+..++.
T Consensus 530 ~l~~~l~~G~-r~~~P--~~c~~eiY~iM~~CW~~~p~~RP~F~~~~ 573 (609)
T KOG0200|consen 530 ELLEFLKEGN-RMEQP--EHCSDEIYDLMKSCWNADPEDRPTFSECV 573 (609)
T ss_pred HHHHHHhcCC-CCCCC--CCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence 5554333332 22221 35699999999999999999999998875
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=301.12 Aligned_cols=250 Identities=24% Similarity=0.345 Sum_probs=209.5
Q ss_pred ceeEeCeeeeccceEEEEEEEec-CCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
..+..++||.|+||.||+|.+.- ++.-.-+||+|++... .....-.++..|+-+|.+|. |||+++|++++.... +
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~--t~~~~s~e~LdeAl~masld-Hpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF--TSPKASIELLDEALRMASLD-HPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc--CCchhhHHHHHHHHHHhcCC-CchHHHHhhhcccch-H
Confidence 35667899999999999998764 2223467999998654 34445578899999999997 999999999998776 8
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
.||++||++|.|+|+++.+...+.......|..||++||.|||++++|||||-..||||. .-.+|||.|||+++.+.
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVk---sP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVK---SPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeec---CCCeEEEEecchhhccC
Confidence 899999999999999999988999999999999999999999999999999999999995 55679999999999987
Q ss_pred CCCcccc-c--ccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 315 PDERLND-I--VGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 315 ~~~~~~~-~--~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
.+..... . .-.+.|||-|.++ +.|+.++|||||||++||++| |..||.+....++-..+...+ .+... +..+
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge-RLsqP--piCt 926 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE-RLSQP--PICT 926 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc-cCCCC--CCcc
Confidence 6653322 2 2346799999876 779999999999999999997 999998888777655444443 34433 5688
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
-++.-++-+||..|+..||+++++..
T Consensus 927 iDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 927 IDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHHHHhccCcccCccHHHHHH
Confidence 99999999999999999999988754
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=280.64 Aligned_cols=241 Identities=25% Similarity=0.384 Sum_probs=187.9
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeeCC-
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT-GHNNLVKFFDAYEDTD- 232 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-~h~~iv~l~~~~~~~~- 232 (611)
....+.++||+|.||.||+|++ .++.||||+++. ...+.+.+|-+|+.-.. .|+||++|+++-....
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL-----~~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~ 278 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL-----DNRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA 278 (534)
T ss_pred CchhhHHHhhcCccceeehhhc-----cCceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence 4567889999999999999986 468999999843 33466778888876432 3999999998866544
Q ss_pred ---eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---------CCeeecCCCCceEEeccCCCc
Q 007253 233 ---NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ---------GVVHRDLKPENFLFTTKDENS 300 (611)
Q Consensus 233 ---~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---------~iiHrDlkp~NIll~~~~~~~ 300 (611)
.++||+||.+.|+|.+++..+ .++|....+++..+++||+|||+. .|+|||||+.|||| .+++
T Consensus 279 ~~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~Dl 353 (534)
T KOG3653|consen 279 DRMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDL 353 (534)
T ss_pred cccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCC
Confidence 799999999999999999665 689999999999999999999974 49999999999999 6788
Q ss_pred eEEEeecccccccCCCCc---ccccccCCCcCcchhhcCCCC-------CcchhhHHHHHHHHHHhCCC-----------
Q 007253 301 VLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLHRSYS-------TEADVWSIGVIAYILLCGSR----------- 359 (611)
Q Consensus 301 ~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~-------~~~DiwSlGvil~el~~g~~----------- 359 (611)
...|+|||+|..+.++.. .-..+||.+|||||++.+..+ .+.||||+|.+||||++...
T Consensus 354 TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yq 433 (534)
T KOG3653|consen 354 TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQ 433 (534)
T ss_pred cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCccc
Confidence 899999999998876542 334799999999999976533 25899999999999997532
Q ss_pred -CCC-----CCChHHHHHHHHh--cCCCCCCCCCCC-CCHHHHHHHHHhcccCccCCCCHH
Q 007253 360 -PFW-----ARTESGIFRAVLK--ADPSFDEAPWPS-LSSEARDFVKRLLNKDPRKRLTAA 411 (611)
Q Consensus 360 -Pf~-----~~~~~~~~~~i~~--~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~Rpt~~ 411 (611)
||. +.+..++...+.+ ..|.++..+... .-..+.+.+..||+.|++.|.|+.
T Consensus 434 lpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 434 LPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred CchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 332 1222334333333 334444322211 235678999999999999999975
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=278.17 Aligned_cols=245 Identities=26% Similarity=0.452 Sum_probs=189.0
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHH--hcCCCCeeEEEEEE
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA--LTGHNNLVKFFDAY 228 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~~h~~iv~l~~~~ 228 (611)
..+..+..+.+.||+|-||.||+|++ .|+.||||++.... ...+.+|.+|+.. |+ |+||+.|++.-
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~w-----rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLR-HENILgFIaaD 274 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRW-----RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLR-HENILGFIAAD 274 (513)
T ss_pred HhhhheeEEEEEecCccccceeeccc-----cCCceEEEEecccc------hhhhhhHHHHHHHHHhc-cchhhhhhhcc
Confidence 45678899999999999999999985 57899999995321 2456678777764 55 99999999875
Q ss_pred eeCC----eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeeecCCCCceEEecc
Q 007253 229 EDTD----NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ--------GVVHRDLKPENFLFTTK 296 (611)
Q Consensus 229 ~~~~----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------~iiHrDlkp~NIll~~~ 296 (611)
..+. ++|||++|.+.|||+|+|.. ..++.....+++..++.||+|||-. .|.|||||+.|||+
T Consensus 275 ~~~~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV--- 349 (513)
T KOG2052|consen 275 NKDNGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--- 349 (513)
T ss_pred ccCCCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE---
Confidence 5432 59999999999999999965 5799999999999999999999963 39999999999999
Q ss_pred CCCceEEEeecccccccCCCC-----cccccccCCCcCcchhhcCCCC-------CcchhhHHHHHHHHHHhC-------
Q 007253 297 DENSVLKAIDFGLSDFVRPDE-----RLNDIVGSAYYVAPEVLHRSYS-------TEADVWSIGVIAYILLCG------- 357 (611)
Q Consensus 297 ~~~~~vkl~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-------~~~DiwSlGvil~el~~g------- 357 (611)
..++.+-|+|+|||-....+. ..+..+||.+|||||++..... ..+||||||+|+||++..
T Consensus 350 Kkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ 429 (513)
T KOG2052|consen 350 KKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIV 429 (513)
T ss_pred ccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEe
Confidence 688899999999997655432 3567899999999999964432 358999999999999853
Q ss_pred ---CCCCCCC-----ChHHHHHHHHhc--CCCCCCCCCCCCC--HHHHHHHHHhcccCccCCCCHHHH
Q 007253 358 ---SRPFWAR-----TESGIFRAVLKA--DPSFDEAPWPSLS--SEARDFVKRLLNKDPRKRLTAAQA 413 (611)
Q Consensus 358 ---~~Pf~~~-----~~~~~~~~i~~~--~~~~~~~~~~~~s--~~~~~li~~~L~~dP~~Rpt~~~l 413 (611)
++||++. ...++..-+.-. .|.++. .|...+ ..+..+++.||..+|.-|.|+-.+
T Consensus 430 eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipn-rW~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 430 EEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPN-RWKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred hhhcCCcccCCCCCCCHHHHhcceeecccCCCCCc-ccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 5788643 222333322222 222222 233222 245678999999999999998543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=329.97 Aligned_cols=240 Identities=24% Similarity=0.329 Sum_probs=183.4
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
..|...+.||+|+||.||+|+... .|..||||.+...... ...|++++++++ |||||+++++|.+.+..
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-------~~~~~~~l~~l~-HpnIv~~~~~~~~~~~~ 758 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIK---NGMQFVVKEINDVNSI-------PSSEIADMGKLQ-HPNIVKLIGLCRSEKGA 758 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECC---CCcEEEEEEccCCccc-------cHHHHHHHhhCC-CCCcceEEEEEEcCCCC
Confidence 456778899999999999998765 5889999998543211 134688899997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH---LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
|+|||||++|+|.+++. .+++..+..++.||+.||+||| +.+|+||||||+||++ +.++.+++. ||...
T Consensus 759 ~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~---~~~~~~~~~-~~~~~ 830 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII---DGKDEPHLR-LSLPG 830 (968)
T ss_pred EEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE---CCCCceEEE-ecccc
Confidence 99999999999999884 3899999999999999999999 6699999999999999 455556664 66654
Q ss_pred ccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCCh--HHHHH---HHHhc-------CC
Q 007253 312 FVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE--SGIFR---AVLKA-------DP 378 (611)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~--~~~~~---~i~~~-------~~ 378 (611)
..... ....||+.|||||++. +.++.++|||||||++|||++|+.||..... ..+.. ..... ++
T Consensus 831 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (968)
T PLN00113 831 LLCTD---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDP 907 (968)
T ss_pred ccccC---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCc
Confidence 43222 2347899999999886 5699999999999999999999999853211 11111 10000 01
Q ss_pred CCCCCC--CCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 379 SFDEAP--WPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 379 ~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
...... ......++.+++.+||+.||++|||+.++++.
T Consensus 908 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred cccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 110000 00112356789999999999999999998754
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=279.89 Aligned_cols=261 Identities=26% Similarity=0.451 Sum_probs=203.6
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+...|.++++||.|.|+.||++.........+.||+|.+.... .-.++.+|+++|..+.++.||+++.+++..+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 44577999999999999999999877644467899999885432 2246889999999999999999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+.+.+||||++..+..+++ ..++...++.+++.++.||.++|.+|||||||||.|+|.+. ..+.-.|+|||+|.
T Consensus 108 d~v~ivlp~~~H~~f~~l~----~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~--~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLY----RSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNR--RTQRGVLVDFGLAQ 181 (418)
T ss_pred CeeEEEecccCccCHHHHH----hcCCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccc--ccCCceEEechhHH
Confidence 9999999999998887766 34779999999999999999999999999999999999974 45556789999986
Q ss_pred ccC-----------------C--CC--------------------------cccccccCCCcCcchhhc--CCCCCcchh
Q 007253 312 FVR-----------------P--DE--------------------------RLNDIVGSAYYVAPEVLH--RSYSTEADV 344 (611)
Q Consensus 312 ~~~-----------------~--~~--------------------------~~~~~~gt~~y~aPE~~~--~~~~~~~Di 344 (611)
... + +. ......||++|.|||++. +.-++++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 210 0 00 001247999999999986 557889999
Q ss_pred hHHHHHHHHHHhCCCCCCCCChH--------------HHHHHHHh-cC---------------------------CC---
Q 007253 345 WSIGVIAYILLCGSRPFWARTES--------------GIFRAVLK-AD---------------------------PS--- 379 (611)
Q Consensus 345 wSlGvil~el~~g~~Pf~~~~~~--------------~~~~~i~~-~~---------------------------~~--- 379 (611)
||.|||++.+++++.||....+. ++.....- +. ..
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 99999999999999999432211 00000000 00 00
Q ss_pred ---CCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 380 ---FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 380 ---~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
..+.....++..+.+|+.+||..||.+|.|++++|.||||....
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD 388 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence 00111123466899999999999999999999999999998543
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=282.46 Aligned_cols=201 Identities=31% Similarity=0.577 Sum_probs=175.2
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHH-----HHHHHHHHHHHhc--CCCCeeEEEEE
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIE-----DVRREVKILRALT--GHNNLVKFFDA 227 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~-----~~~~E~~~l~~l~--~h~~iv~l~~~ 227 (611)
.+|...+.||.|+||.|++|.++. +...|+||.|.|+..-.....+ .+-.||+||..|. .|+||++++++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~---n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKE---NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred ccceeeeeccccccceEEEeeecc---cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 459999999999999999999988 5789999999876544333222 2457999999986 48999999999
Q ss_pred EeeCCeeEEEeeecC-CCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEee
Q 007253 228 YEDTDNVYVVMELCE-GGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (611)
Q Consensus 228 ~~~~~~~~lv~E~~~-~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D 306 (611)
|++++++||+||--. |.+|.++|..+ ..++|..++.|++|++.|+++||+.||||||||-+||.+ +.+|-+||+|
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv---d~~g~~klid 713 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV---DSNGFVKLID 713 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccCceecccccccEEE---ecCCeEEEee
Confidence 999999999999863 44899988544 579999999999999999999999999999999999999 7899999999
Q ss_pred cccccccCCCCcccccccCCCcCcchhhcCC--CCCcchhhHHHHHHHHHHhCCCCCCC
Q 007253 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWA 363 (611)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlGvil~el~~g~~Pf~~ 363 (611)
||.+.... .......+||..|.|||++.+. .+..-|||+||++||-++..+.||+.
T Consensus 714 fgsaa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 714 FGSAAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ccchhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99987665 5567888999999999999854 57889999999999999999999864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=251.94 Aligned_cols=254 Identities=24% Similarity=0.442 Sum_probs=196.8
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEE-EEeeC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFD-AYEDT 231 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~-~~~~~ 231 (611)
+.+.|.+.+.||+|.||.+.+++++. +.+.+++|.+++.. ..+.+|.+|...--.|..|.||+.-|+ .|+..
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~---s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~ 94 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQ---SKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS 94 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccC---CceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcC
Confidence 56789999999999999999999887 68899999986542 345778899988888888999998776 47778
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+.+++++||++.|+|..-+.. ..+.|...+.++.|+++|+.|+|++++||||||.+||||-..| ...|||||||+.+
T Consensus 95 d~YvF~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~d-f~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 95 DAYVFVQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDAD-FYRVKLCDFGLTR 171 (378)
T ss_pred ceEEEeeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCC-ccEEEeeeccccc
Confidence 889999999999999886633 4588999999999999999999999999999999999997543 3489999999987
Q ss_pred ccCCCCcccccccCCCcCcchhhc----CC--CCCcchhhHHHHHHHHHHhCCCCCCCCChH-H---HHHHH-HhcCCCC
Q 007253 312 FVRPDERLNDIVGSAYYVAPEVLH----RS--YSTEADVWSIGVIAYILLCGSRPFWARTES-G---IFRAV-LKADPSF 380 (611)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~----~~--~~~~~DiwSlGvil~el~~g~~Pf~~~~~~-~---~~~~i-~~~~~~~ 380 (611)
.... .....-.+..|.+||+.. +. ..+.+|||.||+++|..++|.+||...... . .+..- ....+..
T Consensus 172 k~g~--tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~ 249 (378)
T KOG1345|consen 172 KVGT--TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPAL 249 (378)
T ss_pred ccCc--eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccC
Confidence 6532 222334556799999763 22 467899999999999999999999632211 1 11111 2222323
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCC---CCHHHHHcCccc
Q 007253 381 DEAPWPSLSSEARDFVKRLLNKDPRKR---LTAAQALSHPWI 419 (611)
Q Consensus 381 ~~~~~~~~s~~~~~li~~~L~~dP~~R---pt~~~ll~hp~~ 419 (611)
|. .+.-+++.+..+.++-|..++++| .++++.....|.
T Consensus 250 P~-~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 250 PK-KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred ch-hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 32 234679999999999999999999 444444444444
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=243.21 Aligned_cols=211 Identities=44% Similarity=0.801 Sum_probs=183.5
Q ss_pred eeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeeecC
Q 007253 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCE 242 (611)
Q Consensus 163 LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~~~ 242 (611)
||.|++|.||++.... .|+.+++|++....... ..+.+.+|+.+++.+. |++|+++++++......+++|||+.
T Consensus 1 l~~g~~~~v~~~~~~~---~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDKK---TGKKVAIKIIKKEDSSS--LLEELLREIEILKKLN-HPNIVKLYGVFEDENHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEecC---CCcEEEEEEeccccchh--HHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeEEEEEecCC
Confidence 6899999999998765 58899999986543221 3567899999999998 9999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCC-CceEEEeecccccccCCCC-ccc
Q 007253 243 GGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE-NSVLKAIDFGLSDFVRPDE-RLN 320 (611)
Q Consensus 243 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~-~~~vkl~DfG~a~~~~~~~-~~~ 320 (611)
|++|.+++......+++..++.++.+++.+|.+||+.|++|+||+|.||++. . .+.++|+|||.+....... ...
T Consensus 75 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~---~~~~~~~l~d~~~~~~~~~~~~~~~ 151 (215)
T cd00180 75 GGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD---SDNGKVKLADFGLSKLLTSDKSLLK 151 (215)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEe---CCCCcEEEecCCceEEccCCcchhh
Confidence 8999998866545689999999999999999999999999999999999994 4 6789999999998765332 133
Q ss_pred ccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 007253 321 DIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398 (611)
Q Consensus 321 ~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 398 (611)
...+...|++||.+.. .++.++|+|++|+++++| ..+.+++.+
T Consensus 152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~ 196 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRK 196 (215)
T ss_pred cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHH
Confidence 4567889999999874 788899999999999999 567999999
Q ss_pred hcccCccCCCCHHHHHcCc
Q 007253 399 LLNKDPRKRLTAAQALSHP 417 (611)
Q Consensus 399 ~L~~dP~~Rpt~~~ll~hp 417 (611)
|++.||.+||++.++++|+
T Consensus 197 ~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 197 MLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HhhCCcccCcCHHHHhhCC
Confidence 9999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=303.43 Aligned_cols=198 Identities=18% Similarity=0.258 Sum_probs=149.2
Q ss_pred CCeeEEEEEE-------eeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCce
Q 007253 219 NNLVKFFDAY-------EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENF 291 (611)
Q Consensus 219 ~~iv~l~~~~-------~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NI 291 (611)
.||++++++| .....++++|||+ +++|.+++......+++..++.+++||+.||.|||++|||||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 5888888877 2334688889988 5699999876556799999999999999999999999999999999999
Q ss_pred EEecc----------------CCCceEEEeecccccccCCCC-----------------cccccccCCCcCcchhhc-CC
Q 007253 292 LFTTK----------------DENSVLKAIDFGLSDFVRPDE-----------------RLNDIVGSAYYVAPEVLH-RS 337 (611)
Q Consensus 292 ll~~~----------------~~~~~vkl~DfG~a~~~~~~~-----------------~~~~~~gt~~y~aPE~~~-~~ 337 (611)
||... +.++.+||+|||+++...... .....+||++|||||++. ..
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 191 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS 191 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence 99531 234567788888876432100 011246899999999876 56
Q ss_pred CCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCc
Q 007253 338 YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHP 417 (611)
Q Consensus 338 ~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp 417 (611)
|+.++|||||||+||||++|..|+..... .+..+.... .+... ........+++.+||++||.+||++.++|+||
T Consensus 192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 192 SNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRV--LPPQI-LLNWPKEASFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred CCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhh--cChhh-hhcCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence 99999999999999999999998754221 122221111 11111 11245567899999999999999999999999
Q ss_pred ccCCC
Q 007253 418 WIKNS 422 (611)
Q Consensus 418 ~~~~~ 422 (611)
||...
T Consensus 267 ~~~~~ 271 (793)
T PLN00181 267 FINEP 271 (793)
T ss_pred hhhhh
Confidence 99864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-29 Score=243.27 Aligned_cols=212 Identities=42% Similarity=0.747 Sum_probs=178.6
Q ss_pred eeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEE
Q 007253 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (611)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 236 (611)
|.+.+.||.|++|.||++.... .++.+|+|.+...... ...+.+.+|+..++++. |+|++++++++......++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~ 74 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKG---TGELVAVKVLKKEKTE--KQREEFLREIRILKKLK-HPNIVKLYGVFEDPEPLYL 74 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcC---CCcEEEEEeeccccch--HHHHHHHHHHHHHHhCC-CCChhhheeeeecCCceEE
Confidence 5778999999999999998775 5789999998654322 25678899999999997 9999999999999999999
Q ss_pred EeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCC
Q 007253 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316 (611)
Q Consensus 237 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~ 316 (611)
++||+++++|.+++......+++..++.++.+++.+|.+||+.+++|+||+|.||++ +.++.++|+|||++......
T Consensus 75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v---~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 75 VMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL---GMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred EEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeeCceeeEecCc
Confidence 999999999999887654338999999999999999999999999999999999999 45688999999998876544
Q ss_pred C--cccccccCCCcCcchhh-c-CCCCCcchhhHHHHHHHHHHhCCCCCCC-CCh-HHHHHHHHhcC
Q 007253 317 E--RLNDIVGSAYYVAPEVL-H-RSYSTEADVWSIGVIAYILLCGSRPFWA-RTE-SGIFRAVLKAD 377 (611)
Q Consensus 317 ~--~~~~~~gt~~y~aPE~~-~-~~~~~~~DiwSlGvil~el~~g~~Pf~~-~~~-~~~~~~i~~~~ 377 (611)
. ......++..|++||++ . ..++.++|||+||+++++|++|+.||.. ... ..+.+.+....
T Consensus 152 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 152 LAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred ccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 3 33456788899999987 3 4577799999999999999999999977 333 35555555544
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=244.36 Aligned_cols=254 Identities=19% Similarity=0.266 Sum_probs=206.2
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCc--cCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGEL--KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
...+++..-++-+|.||.||.|.+.+.+. +.+.|-+|.++.. .+......+..|-..+..+. |||+.++.+++..
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~s-H~nll~V~~V~ie 358 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGAS-HPNLLSVLGVSIE 358 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCc-CCCccceeEEEee
Confidence 35668889999999999999998775432 3466778877544 45667788899999999998 9999999999876
Q ss_pred C-CeeEEEeeecCCCChHHHHHh-----c--CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceE
Q 007253 231 T-DNVYVVMELCEGGELLDRILS-----R--GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVL 302 (611)
Q Consensus 231 ~-~~~~lv~E~~~~gsL~~~l~~-----~--~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~v 302 (611)
+ ...++++.++.-|+|..++.. . .+.++..++..++.||+.|++|||++||||.||-..|++| ++...|
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI---dd~LqV 435 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI---DDQLQV 435 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee---hhheeE
Confidence 5 568899999988999998872 1 2347888899999999999999999999999999999999 788999
Q ss_pred EEeecccccccCCCCcc---cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcC
Q 007253 303 KAIDFGLSDFVRPDERL---NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKAD 377 (611)
Q Consensus 303 kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~ 377 (611)
||+|=.+++.+-+.... ..--....||+||.+. ..|+.++|+|||||++|||+| |+.||..-+..++..-++.+
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG- 514 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG- 514 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc-
Confidence 99999999876544321 1112345799999885 779999999999999999997 89999887777765555443
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 378 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
..+... .+++.++..++..||..+|++||+..|+..
T Consensus 515 yRlaQP--~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 515 YRLAQP--FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ceecCC--CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 333322 378999999999999999999999998753
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=225.00 Aligned_cols=162 Identities=29% Similarity=0.412 Sum_probs=129.8
Q ss_pred CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCCcccccc
Q 007253 244 GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323 (611)
Q Consensus 244 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~ 323 (611)
|+|.+++..++..+++..++.|+.||+.||.|||+++ ||+|||+ +.++.+|+ ||++....... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~~----~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPEQ----SR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeecccc----CC
Confidence 6899999877777999999999999999999999998 9999999 57788998 99998765322 26
Q ss_pred cCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCCCC---CCCCCCCH--HHHHHH
Q 007253 324 GSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSFDE---APWPSLSS--EARDFV 396 (611)
Q Consensus 324 gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~-~~~~~i~~~~~~~~~---~~~~~~s~--~~~~li 396 (611)
||+.|||||++. +.++.++|||||||++|||++|+.||...... ..+..+......... .....++. ++.++|
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 899999999986 56899999999999999999999999765432 333333332221111 01112333 699999
Q ss_pred HHhcccCccCCCCHHHHHcCcccC
Q 007253 397 KRLLNKDPRKRLTAAQALSHPWIK 420 (611)
Q Consensus 397 ~~~L~~dP~~Rpt~~~ll~hp~~~ 420 (611)
.+||..||.+||++.++++|+|+.
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHH
Confidence 999999999999999999999985
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-27 Score=216.09 Aligned_cols=249 Identities=22% Similarity=0.291 Sum_probs=203.4
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
...+|.++++||.|+||.+|+|.... .|..||||+-+.... . .++..|.++++.|++...|..+..+..+..
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~---~ge~VAiK~Es~~a~-h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ 84 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISIT---SGEEVAIKLESSKAK-H----PQLLYESKVYRILQGGVGIPHIRHYGTEKD 84 (341)
T ss_pred eccceEEEEeecCCchhheeeeeecc---CCceEEEEeecccCC-C----cchhHHHHHHHHhccCCCCchhhhhccccc
Confidence 35789999999999999999999776 799999999755432 2 246789999999998889999998888899
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.-.+||+.+ |-+|.+.+.-..+.++..++..++-|++.-++|+|.+++|||||||+|+|++-......+.|+|||+|+.
T Consensus 85 ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 85 YNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred cceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhh
Confidence 999999999 8899998876667899999999999999999999999999999999999998777778899999999987
Q ss_pred cCCCC--------cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCC
Q 007253 313 VRPDE--------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE---SGIFRAVLKADPSF 380 (611)
Q Consensus 313 ~~~~~--------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~---~~~~~~i~~~~~~~ 380 (611)
+.+-. .-....||..|.+-.... -..+.+.|+=|+|.+|..+.-|..||.+... .+.++.|.+.....
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~ 243 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST 243 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence 65332 124568999999877655 3468889999999999999999999987544 34566666655443
Q ss_pred CCCC-CCCCCHHHHHHHHHhcccCccCCCCH
Q 007253 381 DEAP-WPSLSSEARDFVKRLLNKDPRKRLTA 410 (611)
Q Consensus 381 ~~~~-~~~~s~~~~~li~~~L~~dP~~Rpt~ 410 (611)
+... -..++.++.-.+..|-..--++-|..
T Consensus 244 ~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy 274 (341)
T KOG1163|consen 244 PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDY 274 (341)
T ss_pred CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence 3221 24678888888888877666666654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=232.79 Aligned_cols=255 Identities=23% Similarity=0.292 Sum_probs=195.9
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhc---CCCCeeEEEEEE-eeC
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT---GHNNLVKFFDAY-EDT 231 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---~h~~iv~l~~~~-~~~ 231 (611)
+|.+.++||+|+||.||.|...... ...+|+|+......... ..+..|+.++..+. +..++..+++.. ..+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~--~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~ 93 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK--NKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE 93 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC--CeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence 8999999999999999999976632 46899998865422221 14678999999987 246999999999 577
Q ss_pred CeeEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCC--ceEEEeecc
Q 007253 232 DNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN--SVLKAIDFG 308 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~--~~vkl~DfG 308 (611)
...||||+.+ |.+|.++..... +.++..++..|+.|++.+|++||+.|+|||||||+|++++..... ..+.|.|||
T Consensus 94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 8899999999 889999776555 789999999999999999999999999999999999999754312 579999999
Q ss_pred cccccC---CCC-------c-ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 007253 309 LSDFVR---PDE-------R-LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 376 (611)
Q Consensus 309 ~a~~~~---~~~-------~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~ 376 (611)
+++... ... . .....||..|.++.+.. ...+++.|+||++.++.++..|..||...........+...
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998322 111 1 12345999999999886 56899999999999999999999999765543323333222
Q ss_pred CCCCCCC-CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 377 DPSFDEA-PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 377 ~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
....... .....+.++..+...+-..+...+|....+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 253 PRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 2111111 123356788888888888888899988776544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-25 Score=226.35 Aligned_cols=257 Identities=36% Similarity=0.637 Sum_probs=208.0
Q ss_pred eeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCC-CeeEEEEEEeeCCeeE
Q 007253 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN-NLVKFFDAYEDTDNVY 235 (611)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-~iv~l~~~~~~~~~~~ 235 (611)
|.+.+.||.|+||.||.+... ..+++|.+.............+.+|+.++..+. |+ +|+++++.+......+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~~~~~~~ 74 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR------KLVALKVLAKKLESKSKEVERFLREIQILASLN-HPPNIVKLYDFFQDEGSLY 74 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec------cEEEEEeechhhccchhHHHHHHHHHHHHHHcc-CCcceeeEEEEEecCCEEE
Confidence 788999999999999999865 678999997665544445678999999999998 66 8999999998777889
Q ss_pred EEeeecCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCc-eEEEeecccccc
Q 007253 236 VVMELCEGGELLDRILSRG--GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS-VLKAIDFGLSDF 312 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~-~vkl~DfG~a~~ 312 (611)
++++|+.++++.+.+.... ..+.......++.|++.++.|+|+.+++||||||+||++ +..+ .++++|||++..
T Consensus 75 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~---~~~~~~~~l~dfg~~~~ 151 (384)
T COG0515 75 LVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILL---DRDGRVVKLIDFGLAKL 151 (384)
T ss_pred EEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee---cCCCCeEEEeccCccee
Confidence 9999999999996665443 269999999999999999999999999999999999999 4555 699999999986
Q ss_pred cCCCC-------cccccccCCCcCcchhhcC----CCCCcchhhHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhcC
Q 007253 313 VRPDE-------RLNDIVGSAYYVAPEVLHR----SYSTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKAD 377 (611)
Q Consensus 313 ~~~~~-------~~~~~~gt~~y~aPE~~~~----~~~~~~DiwSlGvil~el~~g~~Pf~~~~~----~~~~~~i~~~~ 377 (611)
..... .....+||..|+|||.+.+ .+....|+||+|++++++++|..||..... ......+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 231 (384)
T COG0515 152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231 (384)
T ss_pred cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence 54433 2466789999999998864 678899999999999999999999876653 34444444433
Q ss_pred CC-CCCCCCCCC----CHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 378 PS-FDEAPWPSL----SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 378 ~~-~~~~~~~~~----s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.. ......... ...+.+++.+++..+|..|.+..+...++|.....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~ 282 (384)
T COG0515 232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK 282 (384)
T ss_pred CcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence 22 222211122 25789999999999999999999999987766543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-28 Score=253.57 Aligned_cols=245 Identities=27% Similarity=0.466 Sum_probs=212.0
Q ss_pred eeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeeec
Q 007253 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELC 241 (611)
Q Consensus 162 ~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~~ 241 (611)
.+|+|+||.|++++-..+...|..+|+|+..+......... ....|-.++...+.||.+|++.-.+..+..++++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 47999999999998777666899999999876554433322 55678888888888999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCCcccc
Q 007253 242 EGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND 321 (611)
Q Consensus 242 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~ 321 (611)
.||+|...+... ..+.+.....+...++.+++++|+.+|+|||+|++||++ +.+|++|+.|||+++........
T Consensus 80 rgg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKE-VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred ccchhhhccccC-CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhhhc--
Confidence 999988776444 457888899999999999999999999999999999999 78999999999999876544332
Q ss_pred cccCCCcCcchhhcCCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcc
Q 007253 322 IVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLN 401 (611)
Q Consensus 322 ~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 401 (611)
|||..|||||+++ .+...+|+||||++++||++|..||.. ++...|++.....+. .++..+++++..++.
T Consensus 154 -cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~----~l~~~a~~~~~~l~~ 223 (612)
T KOG0603|consen 154 -CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR----ELSAEARSLFRQLFK 223 (612)
T ss_pred -ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch----hhhHHHHHHHHHHHh
Confidence 9999999999998 678899999999999999999999977 677888887777765 578899999999999
Q ss_pred cCccCCCC-----HHHHHcCcccCCCC
Q 007253 402 KDPRKRLT-----AAQALSHPWIKNSN 423 (611)
Q Consensus 402 ~dP~~Rpt-----~~~ll~hp~~~~~~ 423 (611)
.+|..|.. +.++++|+||+..+
T Consensus 224 r~p~nrLg~~~~~~~eik~h~f~~~i~ 250 (612)
T KOG0603|consen 224 RNPENRLGAGPDGVDEIKQHEFFQSID 250 (612)
T ss_pred hCHHHHhccCcchhHHHhccchheeee
Confidence 99999985 57899999998765
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.3e-26 Score=232.82 Aligned_cols=166 Identities=21% Similarity=0.251 Sum_probs=129.7
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCc--CCHHHHHHHHHHHHHHHHhcCCCCeeE-EEEEE
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--TTAIAIEDVRREVKILRALTGHNNLVK-FFDAY 228 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~-l~~~~ 228 (611)
.+.++|.+.+.||+|+||.||+|++... .++.||||++..... ......+.+.+|+++|++|. |+||+. +++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~~l~~-- 89 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGD--PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVPQLLA-- 89 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCC--CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCcEEEE--
Confidence 3467899999999999999999987642 467789998753211 13345567899999999998 999885 543
Q ss_pred eeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecC-CCCceEEeccCCCceEEEeec
Q 007253 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDL-KPENFLFTTKDENSVLKAIDF 307 (611)
Q Consensus 229 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDl-kp~NIll~~~~~~~~vkl~Df 307 (611)
.+..|||||||+|++|.. + .. .. ...++.|++.+|.|||++||||||| ||+|||+ +.++.+||+||
T Consensus 90 --~~~~~LVmE~~~G~~L~~-~-~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv---~~~~~ikLiDF 156 (365)
T PRK09188 90 --TGKDGLVRGWTEGVPLHL-A-RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLM---GPDGEAAVIDF 156 (365)
T ss_pred --cCCcEEEEEccCCCCHHH-h-Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE---cCCCCEEEEEC
Confidence 246899999999998862 2 11 11 1467899999999999999999999 9999999 45678999999
Q ss_pred ccccccCCCCc---------ccccccCCCcCcchhhc
Q 007253 308 GLSDFVRPDER---------LNDIVGSAYYVAPEVLH 335 (611)
Q Consensus 308 G~a~~~~~~~~---------~~~~~gt~~y~aPE~~~ 335 (611)
|+|+.+..... .....+++.|+|||++.
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 99987654331 13567899999999985
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-27 Score=260.74 Aligned_cols=260 Identities=31% Similarity=0.477 Sum_probs=193.5
Q ss_pred Cce-eEeCeeeeccceEEEEEEEecCCccCcEEEEEEecC---CCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 155 NKY-ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPK---HKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 155 ~~y-~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~---~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
+.| ...+.+|.|++|.|+.+.... ..+.++.|.+.. ...........+..|+-+-..|. |+|++..+..+.+
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~---~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~-h~~~~e~l~~~~~ 392 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRS---DLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS-HPNIIETLDIVQE 392 (601)
T ss_pred cccCCccceeeecccCceEEEEecC---CCccchhhhhhcccCCcccHHHHhhhhhhheeeccccc-CCchhhhHHHHhh
Confidence 345 457789999999777776544 233344443321 11122233333667888888887 9999888777777
Q ss_pred CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 231 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
....+-+||||++ +|...+... ..+....+-.++.||+.||.|||+.||.|||||++|+++ ..++.+||+|||.+
T Consensus 393 ~~~~~~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~---~~~g~lki~Dfg~~ 467 (601)
T KOG0590|consen 393 IDGILQSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLV---TENGILKIIDFGAA 467 (601)
T ss_pred cccchhhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEE---ecCCceEEeecCcc
Confidence 6666666999999 999987554 578999999999999999999999999999999999999 57779999999998
Q ss_pred cccCCCC-----cccccccCCCcCcchhhc-CCCCC-cchhhHHHHHHHHHHhCCCCCCCCChHHHH--HHHHhcCCCC-
Q 007253 311 DFVRPDE-----RLNDIVGSAYYVAPEVLH-RSYST-EADVWSIGVIAYILLCGSRPFWARTESGIF--RAVLKADPSF- 380 (611)
Q Consensus 311 ~~~~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~-~~DiwSlGvil~el~~g~~Pf~~~~~~~~~--~~i~~~~~~~- 380 (611)
....... .....+|+..|+|||++. ..|.+ ..||||.|++++.|++|+.||......+.. ...-......
T Consensus 468 ~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~ 547 (601)
T KOG0590|consen 468 SVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIF 547 (601)
T ss_pred eeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccc
Confidence 8765332 235678999999999986 45665 689999999999999999999543332111 1110011111
Q ss_pred --CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 381 --DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 381 --~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
+...+..++...+.+|.+||++||.+|.|+++|++.+||+...
T Consensus 548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 1122345788889999999999999999999999999998653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-24 Score=210.54 Aligned_cols=250 Identities=20% Similarity=0.343 Sum_probs=193.7
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
..+-.|+++++||+|+||.++.|+..- +++.||||.-+... . .-+++.|.+.++.|.+.++|...|-+...+
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~---nne~VAIKfEPrkS-~----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG 96 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLY---NNEPVAIKFEPRKS-E----APQLRDEYRTYKLLGGTEGIPQVYYFGQEG 96 (449)
T ss_pred EecccceeccccccCcceeeecccccc---cCceEEEEeccccC-C----cchHHHHHHHHHHHcCCCCCCceeeecccc
Confidence 345679999999999999999998655 79999999875432 1 135778999999999999999999777777
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccC--CCceEEEeeccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD--ENSVLKAIDFGL 309 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~--~~~~vkl~DfG~ 309 (611)
.+-.||+|++ |-||.|.+.-.+++++..++..++.|++.-++|+|++.+|+|||||+|+||+..+ ....|.|+|||+
T Consensus 97 ~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 97 KYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred chhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccc
Confidence 8889999999 8899998877778899999999999999999999999999999999999997543 345799999999
Q ss_pred ccccCCCCc--------ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhcC
Q 007253 310 SDFVRPDER--------LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART---ESGIFRAVLKAD 377 (611)
Q Consensus 310 a~~~~~~~~--------~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~---~~~~~~~i~~~~ 377 (611)
|+.+.+... .....||.+||+-.... +.-+++.|+=|||=++.+++-|.+||.+.. ..+.+++|-...
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K 255 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK 255 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence 998764432 35568999999987654 567899999999999999999999998653 344555554333
Q ss_pred CCCCCC-CCCCCCHHHHHHHHHhcccCccCCCCH
Q 007253 378 PSFDEA-PWPSLSSEARDFVKRLLNKDPRKRLTA 410 (611)
Q Consensus 378 ~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt~ 410 (611)
...+.. .-..++.++..-++..-..+-.+-|..
T Consensus 256 r~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDY 289 (449)
T KOG1165|consen 256 RSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDY 289 (449)
T ss_pred ccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCH
Confidence 222111 112355566555555544444444443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.3e-24 Score=233.01 Aligned_cols=223 Identities=30% Similarity=0.499 Sum_probs=175.0
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
..+|+.++.|..|++|.||+++++. +.+.+|+|+ .+.. .+.+- ++.. .+.|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~---trqrfa~ki-Nkq~--------lilRn--ilt~-a~npfvv----------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKE---TRQRFAMKI-NKQN--------LILRN--ILTF-AGNPFVV----------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccc---cccchhhcc-cccc--------hhhhc--cccc-cCCccee-----------
Confidence 4679999999999999999999886 567899954 2221 11111 2211 2244444
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
|+-...++ .-+.++... +.+++|||+-||+|||+||+|.+|+ .-|++|++|||+++..
T Consensus 136 ----------gDc~tllk-~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT---~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 ----------GDCATLLK-NIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLIT---SMGHIKLTDFGLSKKG 193 (1205)
T ss_pred ----------chhhhhcc-cCCCCcchh--------hHHhHhhccCCeecCCCCCCcceee---ecccccccchhhhhhh
Confidence 34344332 224455443 8899999999999999999999995 6778999999998753
Q ss_pred CCCC----------------cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 007253 314 RPDE----------------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 376 (611)
Q Consensus 314 ~~~~----------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~ 376 (611)
-... .-...+|||.|.|||++. +.|+..+|||+||+|+||++.|..||.+.+..+.+..++..
T Consensus 194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd 273 (1205)
T KOG0606|consen 194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD 273 (1205)
T ss_pred hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh
Confidence 2111 113569999999999875 77999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCccCCC---CHHHHHcCcccCCCCCC
Q 007253 377 DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL---TAAQALSHPWIKNSNDV 425 (611)
Q Consensus 377 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~~ll~hp~~~~~~~~ 425 (611)
...+++.. ..++++++++|.++|+.+|..|. .+-++.+|+||+...-.
T Consensus 274 ~i~wpE~d-ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 274 DIEWPEED-EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred hccccccC-cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 98888874 46889999999999999999996 57789999999987644
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.1e-23 Score=198.45 Aligned_cols=175 Identities=17% Similarity=0.167 Sum_probs=135.0
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHH------HHHHHHHHHHhcCCCCeeEEE
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIED------VRREVKILRALTGHNNLVKFF 225 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l~~h~~iv~l~ 225 (611)
.+..+|++.+.||.|+||.||++.. .+..+|||++...........+. +.+|+..+.+|. |++|....
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-----~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~~~ 101 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-----DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR-SEGLASLN 101 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-----CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCcce
Confidence 4578899999999999999998643 25679999997655455555444 579999999997 99999999
Q ss_pred EEEeeC--------CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccC
Q 007253 226 DAYEDT--------DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD 297 (611)
Q Consensus 226 ~~~~~~--------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~ 297 (611)
+++.+. ...+|||||++|.+|.+.. .+++ ....+|+.+|..||+.|++||||||+||+++
T Consensus 102 d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~--- 169 (232)
T PRK10359 102 DFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS--- 169 (232)
T ss_pred EeeeecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe---
Confidence 886643 3588999999999987752 2333 2456999999999999999999999999995
Q ss_pred CCceEEEeecccccccCCCCcccccccCCCcCcchhhcCCCCCcchhhHHHHHHHHHH
Q 007253 298 ENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILL 355 (611)
Q Consensus 298 ~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~el~ 355 (611)
.++ ++|+|||............. =++...|+.++|+||||+++..+.
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a~d~----------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKAKDR----------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhhHHH----------HHHHhHhcccccccceeEeehHHH
Confidence 445 99999998865532221111 022356778999999999987654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=191.17 Aligned_cols=189 Identities=20% Similarity=0.212 Sum_probs=143.0
Q ss_pred eEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCC-HHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEE
Q 007253 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT-AIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (611)
Q Consensus 158 ~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 236 (611)
.+...|++|+||+||++.. .+..++.+.+....... ..+...+.+|+++|++|.+|++|++++++ +..++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-----~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~l 75 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-----GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHL 75 (218)
T ss_pred ccceeecCCCcceEEEeec-----CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEE
Confidence 4577899999999997653 46777777664332211 11223578999999999867899999986 45799
Q ss_pred EeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecC-CCCceEEeccCCCceEEEeecccccccCC
Q 007253 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDL-KPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (611)
Q Consensus 237 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDl-kp~NIll~~~~~~~~vkl~DfG~a~~~~~ 315 (611)
+|||+.|.+|...+. .. ...++.|++.+|.+||++||||||| ||+|||+ +.++.++|+|||++.....
T Consensus 76 vmeyI~G~~L~~~~~-------~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv---~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 76 DRSYLAGAAMYQRPP-------RG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLV---QEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred EEeeecCccHHhhhh-------hh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEE---cCCCCEEEEECCCceecCC
Confidence 999999988865331 11 2357889999999999999999999 7999999 4567799999999986554
Q ss_pred CCcc--------------cccccCCCcCcchhhc--CCCC-CcchhhHHHHHHHHHHhCCCCCCCCCh
Q 007253 316 DERL--------------NDIVGSAYYVAPEVLH--RSYS-TEADVWSIGVIAYILLCGSRPFWARTE 366 (611)
Q Consensus 316 ~~~~--------------~~~~gt~~y~aPE~~~--~~~~-~~~DiwSlGvil~el~~g~~Pf~~~~~ 366 (611)
.... .-..+++.|++|+... ...+ ...++++.|+-+|.++|+..+++++.+
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 3321 0123688899998643 3344 678999999999999999999987654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=199.36 Aligned_cols=254 Identities=28% Similarity=0.451 Sum_probs=175.3
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCc----c----------------------------CcEEEEEEecCCCc--
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGEL----K----------------------------GQQVAVKVIPKHKM-- 196 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~----~----------------------------g~~vavK~~~~~~~-- 196 (611)
+...++|++++.||+|+-..||.|+...... + .-+.|||.+-.-..
T Consensus 153 kFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s 232 (598)
T KOG4158|consen 153 KFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDS 232 (598)
T ss_pred ccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCC
Confidence 4456789999999999999999998764110 0 01245555422111
Q ss_pred CCHHHHHHHHHHHHH--------------HH-------HhcCCCCeeEEEEEEee-------------------------
Q 007253 197 TTAIAIEDVRREVKI--------------LR-------ALTGHNNLVKFFDAYED------------------------- 230 (611)
Q Consensus 197 ~~~~~~~~~~~E~~~--------------l~-------~l~~h~~iv~l~~~~~~------------------------- 230 (611)
.+...++.+-+|+-- .+ .|..|||||++.++|.+
T Consensus 233 ~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~ 312 (598)
T KOG4158|consen 233 GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGA 312 (598)
T ss_pred chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccccc
Confidence 112222333333210 01 12369999999987752
Q ss_pred --CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEecc-CCCceEEEeec
Q 007253 231 --TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK-DENSVLKAIDF 307 (611)
Q Consensus 231 --~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~-~~~~~vkl~Df 307 (611)
...+|+||..++. +|.+++..+ ..+.....-++.|+++|+.|||.+||.|||+|++||||.-+ |+...++|+||
T Consensus 313 g~~~tlylvMkrY~~-tLr~yl~~~--~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDF 389 (598)
T KOG4158|consen 313 GEPKTLYLVMKRYRQ-TLREYLWTR--HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADF 389 (598)
T ss_pred CCCceEEEehhcchh-hHHHHHhcC--CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccc
Confidence 2358999999965 999988654 46778888899999999999999999999999999999754 44567999999
Q ss_pred ccccccCCC-------CcccccccCCCcCcchhhcC---C----CCCcchhhHHHHHHHHHHhCCCCCCCCChHHH-HHH
Q 007253 308 GLSDFVRPD-------ERLNDIVGSAYYVAPEVLHR---S----YSTEADVWSIGVIAYILLCGSRPFWARTESGI-FRA 372 (611)
Q Consensus 308 G~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~---~----~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~-~~~ 372 (611)
|++-.-... ...-...|.-.-||||+... . --.++|.|+.|.+.||+++...||+...+... .+.
T Consensus 390 GCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~ 469 (598)
T KOG4158|consen 390 GCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT 469 (598)
T ss_pred ceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh
Confidence 987432211 11123457888999999852 2 12479999999999999999999987443211 111
Q ss_pred HHhc-CCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHH
Q 007253 373 VLKA-DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAA 411 (611)
Q Consensus 373 i~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 411 (611)
..+. -|..+ ..+++.+++++..+|+.||++|++..
T Consensus 470 Yqe~qLPalp----~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 470 YQESQLPALP----SRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred hhhhhCCCCc----ccCChHHHHHHHHHhcCCccccCCcc
Confidence 1111 11111 35788999999999999999999853
|
|
| >COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-22 Score=178.00 Aligned_cols=145 Identities=24% Similarity=0.377 Sum_probs=128.7
Q ss_pred hhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhh
Q 007253 453 ALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQ 532 (611)
Q Consensus 453 ~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~ 532 (611)
....+|+.+++++|+++|..+|.|++|.|+..+|..+|+.++ .+.++.++.+|++.+|. +.+.|+|.+|+.++.....
T Consensus 9 ~~~~~~t~~qi~~lkeaF~l~D~d~~G~I~~~el~~ilr~lg-~~~s~~ei~~l~~~~d~-~~~~idf~~Fl~~ms~~~~ 86 (160)
T COG5126 9 LTFTQLTEEQIQELKEAFQLFDRDSDGLIDRNELGKILRSLG-FNPSEAEINKLFEEIDA-GNETVDFPEFLTVMSVKLK 86 (160)
T ss_pred hhcccCCHHHHHHHHHHHHHhCcCCCCCCcHHHHHHHHHHcC-CCCcHHHHHHHHHhccC-CCCccCHHHHHHHHHHHhc
Confidence 344678999999999999999999999999999999987555 47899999999999999 9999999999999987654
Q ss_pred HHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 533 LEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 533 ~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
.... ++++++||+.||+|++|+|+..||++++. +|...+ ++.+|+.+|.|+||.|+|++|++.+.+-
T Consensus 87 ~~~~---~Eel~~aF~~fD~d~dG~Is~~eL~~vl~~lge~~~deev~~ll~~~d~d~dG~i~~~eF~~~~~~~ 157 (160)
T COG5126 87 RGDK---EEELREAFKLFDKDHDGYISIGELRRVLKSLGERLSDEEVEKLLKEYDEDGDGEIDYEEFKKLIKDS 157 (160)
T ss_pred cCCc---HHHHHHHHHHhCCCCCceecHHHHHHHHHhhcccCCHHHHHHHHHhcCCCCCceEeHHHHHHHHhcc
Confidence 3332 77899999999999999999999999995 776665 8999999999999999999999987653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=190.22 Aligned_cols=143 Identities=17% Similarity=0.180 Sum_probs=108.8
Q ss_pred eCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHH-----------------------HHHHHHHHHHHHHHhc
Q 007253 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAI-----------------------AIEDVRREVKILRALT 216 (611)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~ 216 (611)
.+.||+|+||.||+|... +|+.||||++......... ......+|++++.+|.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 77 (190)
T cd05147 2 NGCISTGKEANVYHATTA----NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV 77 (190)
T ss_pred CCccccccceEEEEEECC----CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 468999999999999864 4899999999654221110 0123346999999997
Q ss_pred CCCCeeEEEEEEeeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHcCCeeecCCCCceEEec
Q 007253 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC-HLQGVVHRDLKPENFLFTT 295 (611)
Q Consensus 217 ~h~~iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~iiHrDlkp~NIll~~ 295 (611)
++++.....+.. ...+|||||++|+++...+.. ...+++..+..++.||+.+|.|| |+.|||||||||+|||++
T Consensus 78 -~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~- 152 (190)
T cd05147 78 -TAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH- 152 (190)
T ss_pred -HCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence 776643332222 223899999988776654433 35789999999999999999999 799999999999999995
Q ss_pred cCCCceEEEeecccccccC
Q 007253 296 KDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 296 ~~~~~~vkl~DfG~a~~~~ 314 (611)
++.++|+|||+|....
T Consensus 153 ---~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 ---DGKLYIIDVSQSVEHD 168 (190)
T ss_pred ---CCcEEEEEccccccCC
Confidence 3569999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.6e-22 Score=197.64 Aligned_cols=236 Identities=25% Similarity=0.386 Sum_probs=151.5
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcC---------CCCeeEEE
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG---------HNNLVKFF 225 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~---------h~~iv~l~ 225 (611)
..+..++.||.|+|+.||.+.+.. +|+.+|||++...........+.+++|.-....+.+ |-.++--+
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~---t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~ 88 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVE---TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL 88 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S
T ss_pred eEEEEccccccCCceEEEEEEEcc---CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee
Confidence 356788999999999999999877 799999999865444444556777777655544331 21222222
Q ss_pred EEE---------eeC---C-----eeEEEeeecCCCChHHHHH---hcCCC---CCHHHHHHHHHHHHHHHHHHHHcCCe
Q 007253 226 DAY---------EDT---D-----NVYVVMELCEGGELLDRIL---SRGGK---YTEDDAKAVMIQILNVVAFCHLQGVV 282 (611)
Q Consensus 226 ~~~---------~~~---~-----~~~lv~E~~~~gsL~~~l~---~~~~~---l~~~~~~~i~~qi~~~L~~LH~~~ii 282 (611)
+.. ... . +.+++|+-+. ++|.+.+. ..... +.......+..|+++.+++||..|||
T Consensus 89 d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlV 167 (288)
T PF14531_consen 89 DLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLV 167 (288)
T ss_dssp EEEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceE
Confidence 221 111 1 2467888884 58877654 22222 22233445668999999999999999
Q ss_pred eecCCCCceEEeccCCCceEEEeecccccccCCCCcccccccCCCcCcchhhcC---------CCCCcchhhHHHHHHHH
Q 007253 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR---------SYSTEADVWSIGVIAYI 353 (611)
Q Consensus 283 HrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~DiwSlGvil~e 353 (611)
|+||||+|+|+ +.+|.++|+||+....... .......+..|.+||.... .++.+.|.|+||+++|.
T Consensus 168 Hgdi~~~nfll---~~~G~v~Lg~F~~~~r~g~--~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 168 HGDIKPENFLL---DQDGGVFLGDFSSLVRAGT--RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EST-SGGGEEE----TTS-EEE--GGGEEETTE--EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred ecccceeeEEE---cCCCCEEEcChHHHeecCc--eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 99999999999 6789999999987655432 2222345578999997632 26778999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCC
Q 007253 354 LLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKR 407 (611)
Q Consensus 354 l~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 407 (611)
|+||+.||........... .+.. - .++++..+.||+.+|++||.+|
T Consensus 243 lWC~~lPf~~~~~~~~~~~------~f~~-C-~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEADPEW------DFSR-C-RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGSTSGG------GGTT-S-S---HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCccccccc------cchh-c-CCcCHHHHHHHHHHccCCcccC
Confidence 9999999975433211110 1111 1 2678999999999999999988
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-22 Score=189.43 Aligned_cols=243 Identities=18% Similarity=0.267 Sum_probs=184.8
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
.+..+.-+|.+...|..|+|++. |..+++|++.-...... ....|..|.-.|+-+. ||||+.++++|....++
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwq-----gndivakil~vr~~t~r-isrdfneefp~lrifs-hpnilpvlgacnsppnl 262 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQ-----GNDIVAKILNVREVTAR-ISRDFNEEFPALRIFS-HPNILPVLGACNSPPNL 262 (448)
T ss_pred hhhhhhhhhccCCCccccccccc-----Ccchhhhhhhhhhcchh-hcchhhhhCcceeeec-CCchhhhhhhccCCCCc
Confidence 44567778899999999988754 55677788754433322 2356778888888887 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcC--CeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 235 YVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
.++..||+.|+|+..+++... ..+..++.+++.+|++|+.|||+.. |.---|.+..|++ |++.+.+|+ .+-.+
T Consensus 263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi---dedltaris-mad~k 338 (448)
T KOG0195|consen 263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI---DEDLTARIS-MADTK 338 (448)
T ss_pred eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe---cchhhhhee-cccce
Confidence 999999999999999976643 3778899999999999999999985 4445688899999 666666653 22222
Q ss_pred ccCCCCcccccccCCCcCcchhhcCC----CCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 007253 312 FVRPDERLNDIVGSAYYVAPEVLHRS----YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (611)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (611)
+. -........|.||+||.+++. .-..+|+|||++++|||.|.+.||......+.-.+|.-+..... ..+.
T Consensus 339 fs---fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~--ippg 413 (448)
T KOG0195|consen 339 FS---FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVH--IPPG 413 (448)
T ss_pred ee---eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccccc--CCCC
Confidence 21 112234567899999998743 23479999999999999999999988776655444433332222 2257
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHH
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQA 413 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~l 413 (611)
++..+..|++-|+..||.+||..+.+
T Consensus 414 is~hm~klm~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 414 ISRHMNKLMNICMNEDPGKRPKFDMI 439 (448)
T ss_pred ccHHHHHHHHHHhcCCCCcCCCccee
Confidence 89999999999999999999988654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.6e-21 Score=182.69 Aligned_cols=144 Identities=17% Similarity=0.184 Sum_probs=111.4
Q ss_pred EeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCC-----------------------HHHHHHHHHHHHHHHHh
Q 007253 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT-----------------------AIAIEDVRREVKILRAL 215 (611)
Q Consensus 159 ~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~~l 215 (611)
+.+.||+|+||.||+|... +|+.||||++....... ......+.+|...+.++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~----~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 76 (190)
T cd05145 1 INGCISTGKEANVYHARTG----DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL 76 (190)
T ss_pred CCceeecCCCcEEEEEEcC----CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence 3578999999999999854 48999999987642110 00122346899999999
Q ss_pred cCCCCeeEEEEEEeeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeecCCCCceEEe
Q 007253 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFT 294 (611)
Q Consensus 216 ~~h~~iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NIll~ 294 (611)
. |++|.....+.... .+|||||++|+++...+... ..++...+..++.|++.+|.+||+ .||+||||||+|||++
T Consensus 77 ~-~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~-~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~ 152 (190)
T cd05145 77 Y-EAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD-VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH 152 (190)
T ss_pred H-hCCCCCceEEEecC--CEEEEEEecCCCchhhhhhh-ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE
Confidence 8 88875444333332 48999999988655443333 468889999999999999999999 9999999999999994
Q ss_pred ccCCCceEEEeecccccccC
Q 007253 295 TKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 295 ~~~~~~~vkl~DfG~a~~~~ 314 (611)
++.++|+|||++..+.
T Consensus 153 ----~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 ----DGKPYIIDVSQAVELD 168 (190)
T ss_pred ----CCCEEEEEcccceecC
Confidence 5679999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.6e-21 Score=175.90 Aligned_cols=144 Identities=24% Similarity=0.422 Sum_probs=125.9
Q ss_pred chhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhH
Q 007253 458 LTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALD 537 (611)
Q Consensus 458 l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~ 537 (611)
++..+..+++++|..||.+++|+|+..||..++..++. .+++.++..++..+|.+++|.|++.||+.++..........
T Consensus 2 ~~~~~~~el~~~F~~fD~d~~G~i~~~el~~~lr~lg~-~~t~~el~~~~~~~D~dg~g~I~~~eF~~l~~~~~~~~~~~ 80 (151)
T KOG0027|consen 2 LSEEQILELKEAFQLFDKDGDGKISVEELGAVLRSLGQ-NPTEEELRDLIKEIDLDGDGTIDFEEFLDLMEKLGEEKTDE 80 (151)
T ss_pred CCHHHHHHHHHHHHHHCCCCCCcccHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHhhhcccccc
Confidence 45677889999999999999999999999999988876 68899999999999999999999999999887665433221
Q ss_pred -HHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 538 -RWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 538 -~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
...++++.+|+.||+|++|+||.+||+++|. +|...+ ++.+++.+|.|+||.|+|+||+++|...
T Consensus 81 ~~~~~el~eaF~~fD~d~~G~Is~~el~~~l~~lg~~~~~~e~~~mi~~~d~d~dg~i~f~ef~~~m~~~ 150 (151)
T KOG0027|consen 81 EASSEELKEAFRVFDKDGDGFISASELKKVLTSLGEKLTDEECKEMIREVDVDGDGKVNFEEFVKMMSGK 150 (151)
T ss_pred cccHHHHHHHHHHHccCCCCcCcHHHHHHHHHHhCCcCCHHHHHHHHHhcCCCCCCeEeHHHHHHHHhcC
Confidence 1245899999999999999999999999994 776665 8899999999999999999999998753
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.8e-22 Score=218.65 Aligned_cols=245 Identities=24% Similarity=0.329 Sum_probs=174.9
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCC-cCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHK-MTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
.|...+.||.+.|=.|++|++.+ |. |+||++-+.. .-......+...|++ .. +..|||++++.-+...+...
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e----G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~-l~~~pn~lPfqk~~~t~kAA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE----GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FA-LMKAPNCLPFQKVLVTDKAA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC----ce-EEEEEEeccCCCCCchHHHHHHHHHH-HH-hhcCCcccchHHHHHhhHHH
Confidence 68889999999999999998776 44 8999986543 222223333445555 23 33499999999888888889
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc-
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV- 313 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~- 313 (611)
|||=+|... +|+|.+..+ .-+...+.+.|+.||+.||.-+|..||+|||||.+||||+ .-.=+.|+||..-+-.
T Consensus 97 ylvRqyvkh-nLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT---SWNW~~LtDFAsFKPtY 171 (1431)
T KOG1240|consen 97 YLVRQYVKH-NLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT---SWNWLYLTDFASFKPTY 171 (1431)
T ss_pred HHHHHHHhh-hhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe---eechhhhhcccccCCcc
Confidence 999999966 999988554 3477788889999999999999999999999999999995 4555889999876432
Q ss_pred -CCCCc--c----cccccCCCcCcchhhcC-----------C-CCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 007253 314 -RPDER--L----NDIVGSAYYVAPEVLHR-----------S-YSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAV 373 (611)
Q Consensus 314 -~~~~~--~----~~~~gt~~y~aPE~~~~-----------~-~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i 373 (611)
..+.. . .+...-.+|.|||.+.. . .+++-||||+||+++||++ |++||.- ..+-+.
T Consensus 172 LPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aY 247 (1431)
T KOG1240|consen 172 LPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAY 247 (1431)
T ss_pred CCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhH
Confidence 11211 1 11222347999998732 1 4668899999999999997 6888831 001111
Q ss_pred HhcCCCCCCCCCCC-CCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 374 LKADPSFDEAPWPS-LSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 374 ~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
.......++..... -+..++.+|..|++.||++|.++++.|+.
T Consensus 248 r~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 248 RSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 11110000000000 13367999999999999999999999986
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=180.52 Aligned_cols=139 Identities=20% Similarity=0.280 Sum_probs=106.9
Q ss_pred EeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhc----CCCCeeEEEEEEeeCC--
Q 007253 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT----GHNNLVKFFDAYEDTD-- 232 (611)
Q Consensus 159 ~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~iv~l~~~~~~~~-- 232 (611)
-.+.||+|+||.||. +.. .+.. +||++.... ....+.+.+|+.+++.|. .||||+++++++.++.
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~---~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~ 76 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPE---DAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT 76 (210)
T ss_pred CcceecCCCceEEEE--CCC---CcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCC
Confidence 357899999999995 333 3333 799885532 223467899999999994 3899999999999874
Q ss_pred -eeE-EEeee--cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHHHHcCCeeecCCCCceEEeccC-CCceEEEee
Q 007253 233 -NVY-VVMEL--CEGGELLDRILSRGGKYTEDDAKAVMIQILNVV-AFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAID 306 (611)
Q Consensus 233 -~~~-lv~E~--~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L-~~LH~~~iiHrDlkp~NIll~~~~-~~~~vkl~D 306 (611)
.++ +|||| +.+|+|.+++.+ ..+++. ..++.|++.++ +|||+++||||||||+|||++..+ .+..++|+|
T Consensus 77 g~v~~~I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 77 GYVYDVIADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred eEEEEEEecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 434 78999 557999999854 346666 36688888888 999999999999999999997533 345899999
Q ss_pred cccc
Q 007253 307 FGLS 310 (611)
Q Consensus 307 fG~a 310 (611)
|+-+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-19 Score=203.02 Aligned_cols=197 Identities=22% Similarity=0.314 Sum_probs=155.8
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhc--CCCCeeEEEEEEe
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT--GHNNLVKFFDAYE 229 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~iv~l~~~~~ 229 (611)
.-...|.|.+.||+|+||.||+|.... |+.||||+-....... |.--.+++.+|. --+.|..+..++.
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~----~~~~alK~e~P~~~WE------fYI~~q~~~RLk~~~~~~~~~~~~a~~ 764 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN----GKLVALKVEKPPNPWE------FYICLQVMERLKPQMLPSIMHISSAHV 764 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC----CcEEEEEeecCCCcee------eeehHHHHHhhchhhhcchHHHHHHHc
Confidence 346789999999999999999998654 8999999975543322 111222333332 0134455555555
Q ss_pred eCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEec----cCCCceEEEe
Q 007253 230 DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT----KDENSVLKAI 305 (611)
Q Consensus 230 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~----~~~~~~vkl~ 305 (611)
-.+.-+||+||.+.|+|++++. ..+.++|..+..++.|++..+++||..+|||+||||+|+||.. +.+...++|+
T Consensus 765 ~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 765 FQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred cCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEE
Confidence 5667789999999999999886 5567999999999999999999999999999999999999964 2335569999
Q ss_pred eccccccc---CCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCC
Q 007253 306 DFGLSDFV---RPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSR 359 (611)
Q Consensus 306 DfG~a~~~---~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~ 359 (611)
|||.+-.+ .++..+...++|-.+--+|+.. +.+++.+|.|.|+.+++.|+.|+.
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99998644 3344677889999999999987 569999999999999999999873
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.7e-19 Score=187.03 Aligned_cols=226 Identities=30% Similarity=0.392 Sum_probs=172.8
Q ss_pred HHhcCCCCeeEEEEEEeeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCC-eeecCCCCce
Q 007253 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV-VHRDLKPENF 291 (611)
Q Consensus 213 ~~l~~h~~iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i-iHrDlkp~NI 291 (611)
+.+. |.|+.+|+|.+.++...++|.+||.-|+|.|.+......+++-....++++|+.||.|||...| .|+.+++.|+
T Consensus 2 ~~l~-h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 2 RQLD-HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred cccc-hhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4566 9999999999999999999999999999999998888889999999999999999999999866 9999999999
Q ss_pred EEeccCCCceEEEeecccccccCCC---CcccccccCCCcCcchhhcCC--------CCCcchhhHHHHHHHHHHhCCCC
Q 007253 292 LFTTKDENSVLKAIDFGLSDFVRPD---ERLNDIVGSAYYVAPEVLHRS--------YSTEADVWSIGVIAYILLCGSRP 360 (611)
Q Consensus 292 ll~~~~~~~~vkl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~--------~~~~~DiwSlGvil~el~~g~~P 360 (611)
++ +....+||+|||+..+.... .......-..-|.|||.++.. .+.+.||||||++++|+++.+.|
T Consensus 81 lv---d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 81 LV---DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ee---eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99 78999999999998776421 111122234579999998642 46679999999999999999999
Q ss_pred CCCC----ChHHHHHHHHh-cCCCCCCCCC--CCCCHHHHHHHHHhcccCccCCCCHHHHHcC--cccCCCCCCCCchhH
Q 007253 361 FWAR----TESGIFRAVLK-ADPSFDEAPW--PSLSSEARDFVKRLLNKDPRKRLTAAQALSH--PWIKNSNDVKVPLDV 431 (611)
Q Consensus 361 f~~~----~~~~~~~~i~~-~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h--p~~~~~~~~~~~~~~ 431 (611)
|... ...++...+.. ....+....+ ....+++..++++||..+|.+||+++++-.. ..++.. ..+-++.-
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~-~~~~nl~D 236 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG-SSKGNLMD 236 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc-cccchhHH
Confidence 9652 22345555555 2211211111 1456679999999999999999999987642 222221 12235555
Q ss_pred HHHHHHHHHhhc
Q 007253 432 IIFKLMKAYMRS 443 (611)
Q Consensus 432 ~~~~~~~~~~~~ 443 (611)
..++.+.+|..+
T Consensus 237 ~m~~~le~Y~~n 248 (484)
T KOG1023|consen 237 SLFRMLESYADN 248 (484)
T ss_pred HHHHHHHHHHhh
Confidence 667777777665
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.5e-20 Score=193.66 Aligned_cols=248 Identities=24% Similarity=0.362 Sum_probs=164.8
Q ss_pred eeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEE-------EEe
Q 007253 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFD-------AYE 229 (611)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~-------~~~ 229 (611)
+.+.+-.+.+++|.+...+...+......++.+... ...........+++-.+.-...|+..+ +.+ .+.
T Consensus 246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~---~d~~~~~~~~~r~~~~l~~~~~~~~s~-~~d~~~s~~~~~~ 321 (516)
T KOG1033|consen 246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRAD---VDSLCACKYTFRQLGVLVDSSHSNRSI-LEDLRPSLFESSK 321 (516)
T ss_pred ccccccccccccCCchhhhhcccchhhhhccchhhh---ccchhhhhhhhhhhhheeccccCCccc-ccCCCCchhhhcc
Confidence 445555666666655554433321112223333321 122122333445555555554244333 222 111
Q ss_pred -----eCCeeEEEeeecCCCChHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceE
Q 007253 230 -----DTDNVYVVMELCEGGELLDRILSR--GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVL 302 (611)
Q Consensus 230 -----~~~~~~lv~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~v 302 (611)
...++||.|++|...+|.++|..+ ....++..++.++.||+.|++| +|.+|||+||.||+.. .+..+
T Consensus 322 ~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~---~d~q~ 395 (516)
T KOG1033|consen 322 RNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS---DDDQL 395 (516)
T ss_pred ccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc---cchhh
Confidence 123589999999999999998643 2357888999999999999999 9999999999999995 45579
Q ss_pred EEeecccccccCCCC-------cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 007253 303 KAIDFGLSDFVRPDE-------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAV 373 (611)
Q Consensus 303 kl~DfG~a~~~~~~~-------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i 373 (611)
||.|||+........ .....+||.+||+||.+. ..|+.++||||||+||+|++. =...|+.. ..+..+
T Consensus 396 kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~ 472 (516)
T KOG1033|consen 396 KIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI---ATLTDI 472 (516)
T ss_pred hhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH---Hhhhhh
Confidence 999999987766554 556779999999999998 569999999999999999996 33333211 111111
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccC
Q 007253 374 LKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~ 420 (611)
- +..++...+.++ ++-..|+.+||.+.|.+||++.+.--|.|.+
T Consensus 473 r--~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 473 R--DGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred h--cCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 1 122332233333 3446899999999999999888877777753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.7e-21 Score=211.57 Aligned_cols=261 Identities=27% Similarity=0.487 Sum_probs=212.0
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
..|.+.+.||+|+|+.|-++....+ ....+|+|.+.... ......+.+..|..+-+.+.+|.|++.+++...+.+..
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~--~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~ 96 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRD--PESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY 96 (601)
T ss_pred ccccccccccccccchhhhhhhcCC--CcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccc
Confidence 4577888899999999877765442 34567777765433 33445567778999988888899999999999999999
Q ss_pred EEEeeecCCCChHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHH-HcCCeeecCCCCceEEeccCCCc-eEEEeeccccc
Q 007253 235 YVVMELCEGGELLDRI-LSRGGKYTEDDAKAVMIQILNVVAFCH-LQGVVHRDLKPENFLFTTKDENS-VLKAIDFGLSD 311 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l-~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~iiHrDlkp~NIll~~~~~~~-~vkl~DfG~a~ 311 (611)
+++++|..|+++.+.+ .......+...+..++.|+..+|.|+| ..++.||||||+|.++ +..+ .+|+.|||+|.
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l---~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLL---DESGSALKIADFGLAT 173 (601)
T ss_pred ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchh---ccCCCcccCCCchhhc
Confidence 9999999999998877 443336788899999999999999999 9999999999999999 4566 89999999998
Q ss_pred ccCC-CC---ccccccc-CCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhcCCCCCCC
Q 007253 312 FVRP-DE---RLNDIVG-SAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGI-FRAVLKADPSFDEA 383 (611)
Q Consensus 312 ~~~~-~~---~~~~~~g-t~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~-~~~i~~~~~~~~~~ 383 (611)
.+.. .. .....+| ++.|+|||...+ ......|+||.|+++..+++|..||........ +.........+...
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQL 253 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccC
Confidence 7765 33 2345688 999999998865 467789999999999999999999965443322 22222222344566
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCC
Q 007253 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 384 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
.|..++....+++.+++..+|..|.+.+++..++|+..
T Consensus 254 ~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 254 PWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 78889999999999999999999999999999999988
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.3e-19 Score=173.22 Aligned_cols=147 Identities=21% Similarity=0.189 Sum_probs=112.2
Q ss_pred CceeEeCeeeeccceEEEEEE-EecCCccCcEEEEEEecCCCcCC---------------------HHHHHHHHHHHHHH
Q 007253 155 NKYELGEEVGRGHFGYTCAAK-FKKGELKGQQVAVKVIPKHKMTT---------------------AIAIEDVRREVKIL 212 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~-~~~~~~~g~~vavK~~~~~~~~~---------------------~~~~~~~~~E~~~l 212 (611)
.-|.+.+.||+|+||.||+|. ... +|+.||||++....... ......+.+|+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~---~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L 104 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDG---SGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL 104 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCC---CCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence 358899999999999999997 333 58999999986532110 00123467899999
Q ss_pred HHhcCCC--CeeEEEEEEeeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC-CeeecCCCC
Q 007253 213 RALTGHN--NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG-VVHRDLKPE 289 (611)
Q Consensus 213 ~~l~~h~--~iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-iiHrDlkp~ 289 (611)
.++. +. .+.+++++ ...+|||||++|++|....... ..+....+..++.||+.+|.+||+.| |+||||||+
T Consensus 105 ~~L~-~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~ 178 (237)
T smart00090 105 QRLY-EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEY 178 (237)
T ss_pred HHHH-hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChh
Confidence 9997 43 34445442 2358999999988876644332 34666778899999999999999999 999999999
Q ss_pred ceEEeccCCCceEEEeecccccccC
Q 007253 290 NFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 290 NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
||++. ++.++|+|||.+....
T Consensus 179 NIli~----~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 179 NILVH----DGKVVIIDVSQSVELD 199 (237)
T ss_pred hEEEE----CCCEEEEEChhhhccC
Confidence 99994 5679999999987644
|
|
| >KOG0028 consensus Ca2+-binding protein (centrin/caltractin), EF-Hand superfamily protein [Cytoskeleton; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-18 Score=150.15 Aligned_cols=144 Identities=20% Similarity=0.329 Sum_probs=128.0
Q ss_pred hhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHH
Q 007253 455 SKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLE 534 (611)
Q Consensus 455 ~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~ 534 (611)
...+.+++.+++++.|..||.+++|+|+.+||+.++..++. .+.+.++.+++..+|+++.|+|+|++|...+.......
T Consensus 24 ~~~l~~~q~q~i~e~f~lfd~~~~g~iD~~EL~vAmralGF-E~~k~ei~kll~d~dk~~~g~i~fe~f~~~mt~k~~e~ 102 (172)
T KOG0028|consen 24 KSELTEEQKQEIKEAFELFDPDMAGKIDVEELKVAMRALGF-EPKKEEILKLLADVDKEGSGKITFEDFRRVMTVKLGER 102 (172)
T ss_pred CccccHHHHhhHHHHHHhhccCCCCcccHHHHHHHHHHcCC-CcchHHHHHHHHhhhhccCceechHHHHHHHHHHHhcc
Confidence 34578888899999999999999999999999999888887 58888999999999999999999999999877654333
Q ss_pred hhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 535 ALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 535 ~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
. ..+++..+|+.+|-|++|.|+..+|+.+.. +|++++ +.+||.++|+|+||.|+-+||..+|.+.
T Consensus 103 d---t~eEi~~afrl~D~D~~Gkis~~~lkrvakeLgenltD~El~eMIeEAd~d~dgevneeEF~~imk~t 171 (172)
T KOG0028|consen 103 D---TKEEIKKAFRLFDDDKTGKISQRNLKRVAKELGENLTDEELMEMIEEADRDGDGEVNEEEFIRIMKKT 171 (172)
T ss_pred C---cHHHHHHHHHcccccCCCCcCHHHHHHHHHHhCccccHHHHHHHHHHhcccccccccHHHHHHHHhcC
Confidence 2 277899999999999999999999999994 888766 8899999999999999999999998763
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.4e-18 Score=165.07 Aligned_cols=137 Identities=26% Similarity=0.361 Sum_probs=112.2
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCH-----HHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA-----IAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
+.||+|++|.||+|.. .|..|++|+......... .....+.+|+.++..+. |++|.....++.+....+
T Consensus 2 ~~l~~G~~~~vy~~~~-----~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~ 75 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-----LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYFVDPENFI 75 (211)
T ss_pred cccccCceEEEEEEee-----CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEEEeCCCCE
Confidence 6799999999999975 367799998653322221 12345788999999998 888887777777778899
Q ss_pred EEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
+||||++|++|.+.+... .. ....++.+|+.+|.+||+.|++|||++|.|||+. .+.++|+|||++..
T Consensus 76 lv~e~~~G~~L~~~~~~~----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~~ 143 (211)
T PRK14879 76 IVMEYIEGEPLKDLINSN----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEEeCCcCHHHHHHhc----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCcccC
Confidence 999999999999887543 22 8889999999999999999999999999999994 56799999999865
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.9e-18 Score=162.13 Aligned_cols=134 Identities=26% Similarity=0.337 Sum_probs=105.8
Q ss_pred eeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCC-----HHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEE
Q 007253 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT-----AIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (611)
Q Consensus 162 ~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~l 236 (611)
.||+|+||.||+|.. .|..|++|+........ .....++.+|++++..+. |+++.....++...+..++
T Consensus 1 ~ig~G~~~~vy~~~~-----~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~l 74 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-----LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYDVDPDNKTI 74 (199)
T ss_pred CCCCCceEEEEEeec-----CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEEEECCCCEE
Confidence 489999999999983 46789999864432221 122366789999999998 7765554445556777899
Q ss_pred EeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 237 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
||||++|++|.+.+..... .++.+|+.+|.+||+.|++|||++|.||++. ++.++++|||++...
T Consensus 75 v~e~~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~----~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 75 VMEYIEGKPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKYS 139 (199)
T ss_pred EEEEECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE----CCcEEEEECCCCcCC
Confidence 9999999999887643211 8899999999999999999999999999994 567999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.9e-18 Score=186.30 Aligned_cols=141 Identities=21% Similarity=0.299 Sum_probs=112.1
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcC-----CHHHHHHHHHHHHHHHHhcCCCCeeEEEEEE
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-----TAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~ 228 (611)
...|...++||+|+||.||++.+.. ..+++|+....... .....+.+.+|+++++.++ |++|+..+.++
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~-----~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~ 405 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLG-----RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGVPTPVIYD 405 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecC-----ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCCCeeEEEE
Confidence 4456778999999999999987543 33444443211111 1123456889999999998 99999888788
Q ss_pred eeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecc
Q 007253 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (611)
Q Consensus 229 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG 308 (611)
.+....++||||++|++|.+++. ....++.+|+.+|.|||+.||+||||||+|||+ .++.++|+|||
T Consensus 406 ~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl----~~~~~~liDFG 472 (535)
T PRK09605 406 VDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV----RDDRLYLIDFG 472 (535)
T ss_pred EeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE----ECCcEEEEeCc
Confidence 77778899999999999988774 356799999999999999999999999999999 24569999999
Q ss_pred ccccc
Q 007253 309 LSDFV 313 (611)
Q Consensus 309 ~a~~~ 313 (611)
+++..
T Consensus 473 la~~~ 477 (535)
T PRK09605 473 LGKYS 477 (535)
T ss_pred ccccC
Confidence 99764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.2e-18 Score=161.52 Aligned_cols=141 Identities=25% Similarity=0.283 Sum_probs=108.2
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCH-------------------HHHHHHHHHHHHHHHhc
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA-------------------IAIEDVRREVKILRALT 216 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~-------------------~~~~~~~~E~~~l~~l~ 216 (611)
.|.+.+.||+|+||.||++... +|+.||||++........ ........|+.++..+.
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 91 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP----DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY 91 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC----CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence 4888899999999999999753 489999999764321100 01123678999999997
Q ss_pred CCC--CeeEEEEEEeeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEe
Q 007253 217 GHN--NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294 (611)
Q Consensus 217 ~h~--~iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~ 294 (611)
|+ .+...++ ....++||||++|++|..... ......++.+|+.++.++|+.||+||||||+||++
T Consensus 92 -~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill- 158 (198)
T cd05144 92 -EEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV- 158 (198)
T ss_pred -HcCCCCCceee----cCCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE-
Confidence 66 4455543 345689999999998865321 13456789999999999999999999999999999
Q ss_pred ccCCCceEEEeecccccccCC
Q 007253 295 TKDENSVLKAIDFGLSDFVRP 315 (611)
Q Consensus 295 ~~~~~~~vkl~DfG~a~~~~~ 315 (611)
+.++.++|+|||++.....
T Consensus 159 --~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 159 --DDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred --cCCCcEEEEECCccccCCC
Confidence 5677899999999976553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.5e-18 Score=179.67 Aligned_cols=261 Identities=22% Similarity=0.278 Sum_probs=204.1
Q ss_pred ccCCceeEeCeeee--ccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe
Q 007253 152 HFANKYELGEEVGR--GHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (611)
Q Consensus 152 ~~~~~y~~~~~LG~--G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 229 (611)
.+...+.+...+|. |.+|.||.+.... ...+..+|+|.-+. ..........-.+|+...+++..|+|.++.+..|.
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~-~~s~~~~a~k~s~~-p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTN-SESPHKFAVKKSKI-PFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCc-ccCCcccccccccC-CCCCccccccccchhhcccccCccccccccCcccc
Confidence 34556788899999 9999999998722 12688899997322 11222222334578888888888999999999999
Q ss_pred eCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHH----HHHHHHHcCCeeecCCCCceEEeccCCC-ceEEE
Q 007253 230 DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN----VVAFCHLQGVVHRDLKPENFLFTTKDEN-SVLKA 304 (611)
Q Consensus 230 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~----~L~~LH~~~iiHrDlkp~NIll~~~~~~-~~vkl 304 (611)
..+..++-+|+| +.+|..+.......++...++.++.+... ||.++|+.+++|-|+||+||++. .+ ...++
T Consensus 189 ~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~---~~~~s~~~ 264 (524)
T KOG0601|consen 189 GSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTT---SDWTSCKL 264 (524)
T ss_pred cCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecc---cccceeec
Confidence 999999999999 57999988888777999999999999999 99999999999999999999995 44 78999
Q ss_pred eecccccccCCCCc------ccccccCCCcCcchhhcCCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Q 007253 305 IDFGLSDFVRPDER------LNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (611)
Q Consensus 305 ~DfG~a~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~ 378 (611)
+|||+...+....- .....|...|++||..++-++...||||||.++.+..++..+........+.+.- + .
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r-~--~ 341 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR-Q--G 341 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc-c--c
Confidence 99999887765431 1223678889999999999999999999999999999988776444222211100 0 0
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCC
Q 007253 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 379 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
.++.......+..+...+..|++.+|..|++...+++|+++..
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 1222222345777788999999999999999999999999984
|
|
| >PTZ00184 calmodulin; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.5e-17 Score=150.34 Aligned_cols=141 Identities=21% Similarity=0.402 Sum_probs=119.0
Q ss_pred hcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHh
Q 007253 456 KTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEA 535 (611)
Q Consensus 456 ~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~ 535 (611)
..+++.+.+++++.|..+|.+++|.|+.+||..++..++. ......+..+++.+|.+++|.|+|+||+.++........
T Consensus 3 ~~~~~~~~~~~~~~F~~~D~~~~G~i~~~e~~~~l~~~~~-~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~l~~~~~~~~ 81 (149)
T PTZ00184 3 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQ-NPTEAELQDMINEVDADGNGTIDFPEFLTLMARKMKDTD 81 (149)
T ss_pred CccCHHHHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCC-CCCHHHHHHHHHhcCcCCCCcCcHHHHHHHHHHhccCCc
Confidence 4577888999999999999999999999999999877654 455667899999999999999999999988765432211
Q ss_pred hHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007253 536 LDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLH 600 (611)
Q Consensus 536 ~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~ 600 (611)
.+..++.+|+.+|.+++|+|+.+||+.++. ++...+ +..++..+|.+++|.|+|+||+.++.
T Consensus 82 ---~~~~~~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~ 147 (149)
T PTZ00184 82 ---SEEEIKEAFKVFDRDGNGFISAAELRHVMTNLGEKLTDEEVDEMIREADVDGDGQINYEEFVKMMM 147 (149)
T ss_pred ---HHHHHHHHHHhhCCCCCCeEeHHHHHHHHHHHCCCCCHHHHHHHHHhcCCCCCCcCcHHHHHHHHh
Confidence 145788999999999999999999999984 443333 88899999999999999999999875
|
|
| >PTZ00183 centrin; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.4e-17 Score=149.33 Aligned_cols=144 Identities=21% Similarity=0.322 Sum_probs=120.9
Q ss_pred hhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHH
Q 007253 455 SKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLE 534 (611)
Q Consensus 455 ~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~ 534 (611)
...+++.+..++..+|..+|.+++|.|+.+||..++...+. ......+..++..+|.+++|.|+|+||+.++.......
T Consensus 8 ~~~~~~~~~~~~~~~F~~~D~~~~G~i~~~e~~~~l~~~g~-~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~ 86 (158)
T PTZ00183 8 RPGLTEDQKKEIREAFDLFDTDGSGTIDPKELKVAMRSLGF-EPKKEEIKQMIADVDKDGSGKIDFEEFLDIMTKKLGER 86 (158)
T ss_pred cCCCCHHHHHHHHHHHHHhCCCCCCcccHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHHhcCC
Confidence 34578889999999999999999999999999999977654 45666789999999999999999999998765432111
Q ss_pred hhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 535 ALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 535 ~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
. .++.++.+|+.+|.+++|+|+.+||..++. .+..++ +..+|..+|.|++|.|+|+||..++.+.
T Consensus 87 ~---~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~l~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~ 155 (158)
T PTZ00183 87 D---PREEILKAFRLFDDDKTGKISLKNLKRVAKELGETITDEELQEMIDEADRNGDGEISEEEFYRIMKKT 155 (158)
T ss_pred C---cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHhcc
Confidence 1 155788999999999999999999999984 444333 8889999999999999999999998763
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.5e-17 Score=152.58 Aligned_cols=141 Identities=23% Similarity=0.222 Sum_probs=100.1
Q ss_pred eCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHH---------------------HHHHHHHHHHHhcCC
Q 007253 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIE---------------------DVRREVKILRALTGH 218 (611)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~---------------------~~~~E~~~l~~l~~h 218 (611)
++.||+|+||.||+|... .|+.||||++............ ....|...+.++..+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~----~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~ 77 (187)
T cd05119 2 GGPIGTGKEADVYLALDG----DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEA 77 (187)
T ss_pred CcccccccceeEEEEECC----CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHc
Confidence 578999999999999754 4889999998654322111111 114677777777622
Q ss_pred -CCeeEEEEEEeeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeecCCCCceEEecc
Q 007253 219 -NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTK 296 (611)
Q Consensus 219 -~~iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NIll~~~ 296 (611)
-.+.+.++. ...++||||++|+.+......... . ...++.++.+++.++.++|. .+|+||||||+||+++
T Consensus 78 ~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-- 149 (187)
T cd05119 78 GVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-- 149 (187)
T ss_pred CCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE--
Confidence 234555543 246899999998654322111111 1 16788999999999999999 9999999999999994
Q ss_pred CCCceEEEeecccccccC
Q 007253 297 DENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 297 ~~~~~vkl~DfG~a~~~~ 314 (611)
++.++|+|||.+....
T Consensus 150 --~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 --DGKVYIIDVPQAVEID 165 (187)
T ss_pred --CCcEEEEECccccccc
Confidence 6679999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0031 consensus Myosin regulatory light chain, EF-Hand protein superfamily [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.5e-16 Score=135.50 Aligned_cols=140 Identities=16% Similarity=0.260 Sum_probs=123.5
Q ss_pred hhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhh
Q 007253 453 ALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQ 532 (611)
Q Consensus 453 ~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~ 532 (611)
.+-..|++.++++++++|..+|.|+||.|..++++..|..++. ..++++++.|+.. ..|.|+|.-|+.++.....
T Consensus 21 nvFamf~q~QIqEfKEAF~~mDqnrDG~IdkeDL~d~~aSlGk-~~~d~elDaM~~E----a~gPINft~FLTmfGekL~ 95 (171)
T KOG0031|consen 21 NVFAMFDQSQIQEFKEAFNLMDQNRDGFIDKEDLRDMLASLGK-IASDEELDAMMKE----APGPINFTVFLTMFGEKLN 95 (171)
T ss_pred hHHHHhhHHHHHHHHHHHHHHhccCCCcccHHHHHHHHHHcCC-CCCHHHHHHHHHh----CCCCeeHHHHHHHHHHHhc
Confidence 3445689999999999999999999999999999999877775 5889999999988 5689999999998876654
Q ss_pred HHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHh-cCCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007253 533 LEALDRWEQHARCAYELFEKDGNRAIVIEELASEL-GLGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLH 600 (611)
Q Consensus 533 ~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l-~~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~ 600 (611)
... .++.+..||+.||.+++|.|..+.|+++| .+|..++ |++|++.+-.|..|.|+|.+|+.++.
T Consensus 96 gtd---pe~~I~~AF~~FD~~~~G~I~~d~lre~Ltt~gDr~~~eEV~~m~r~~p~d~~G~~dy~~~~~~it 164 (171)
T KOG0031|consen 96 GTD---PEEVILNAFKTFDDEGSGKIDEDYLRELLTTMGDRFTDEEVDEMYREAPIDKKGNFDYKAFTYIIT 164 (171)
T ss_pred CCC---HHHHHHHHHHhcCccCCCccCHHHHHHHHHHhcccCCHHHHHHHHHhCCcccCCceeHHHHHHHHH
Confidence 433 27889999999999999999999999999 4776666 99999999999999999999999886
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.67 E-value=7.3e-16 Score=151.79 Aligned_cols=139 Identities=21% Similarity=0.246 Sum_probs=103.2
Q ss_pred eCeee-eccceEEEEEEEecCCccCcEEEEEEecCCCc----------CCHHHHHHHHHHHHHHHHhcCCCCe--eEEEE
Q 007253 160 GEEVG-RGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM----------TTAIAIEDVRREVKILRALTGHNNL--VKFFD 226 (611)
Q Consensus 160 ~~~LG-~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~~h~~i--v~l~~ 226 (611)
+..|| .||.|+||.+... +..++||.+..... ........+.+|+.++.+|. |++| +..++
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-----~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl~ 109 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-----GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPIA 109 (239)
T ss_pred CceeecCCCCccEEEEEeC-----CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeEe
Confidence 45677 8888888888643 67789998853211 11123456789999999998 7774 67777
Q ss_pred EEeeCC-e---eEEEeeecCC-CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCce
Q 007253 227 AYEDTD-N---VYVVMELCEG-GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301 (611)
Q Consensus 227 ~~~~~~-~---~~lv~E~~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~ 301 (611)
+..... . .++||||++| .+|.+++.. ..+++.. +.+|+.+|.+||+.||+||||||.|||++ .++.
T Consensus 110 ~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~---~~~~ 180 (239)
T PRK01723 110 ARVVRHGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLD---PDGK 180 (239)
T ss_pred eeeeecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEc---CCCC
Confidence 654332 2 3599999997 588777643 3455543 57899999999999999999999999994 4567
Q ss_pred EEEeeccccccc
Q 007253 302 LKAIDFGLSDFV 313 (611)
Q Consensus 302 vkl~DfG~a~~~ 313 (611)
++|+|||.+...
T Consensus 181 v~LIDfg~~~~~ 192 (239)
T PRK01723 181 FWLIDFDRGELR 192 (239)
T ss_pred EEEEECCCcccC
Confidence 999999998764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.8e-16 Score=141.49 Aligned_cols=134 Identities=24% Similarity=0.309 Sum_probs=111.3
Q ss_pred EeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCC-CCeeEEEEEEeeCCeeEEE
Q 007253 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH-NNLVKFFDAYEDTDNVYVV 237 (611)
Q Consensus 159 ~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~~iv~l~~~~~~~~~~~lv 237 (611)
+.+.||+|.++.||++... +..+++|+...... ...+.+|+.+++.++.+ .++++++.++...+..+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-----~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v 71 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-----DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLL 71 (155)
T ss_pred cceecccccccceEEEEec-----CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEE
Confidence 4578999999999999853 36799999855422 35688999999999833 6899999988888899999
Q ss_pred eeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 238 MELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ---GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 238 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
|||++|+.+... +......++.+++.+|.+||.. +++|+||+|+||+++ ..+.++++|||.+...
T Consensus 72 ~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~---~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 72 MEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD---DGKILGIIDWEYAGYG 139 (155)
T ss_pred EEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE---CCcEEEEEecccccCC
Confidence 999988776542 5667788899999999999985 699999999999995 4678999999998653
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0034 consensus Ca2+/calmodulin-dependent protein phosphatase (calcineurin subunit B), EF-Hand superfamily protein [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.7e-15 Score=140.42 Aligned_cols=138 Identities=22% Similarity=0.315 Sum_probs=115.0
Q ss_pred cchhhHHHHHHHHhhhcCCC-CCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCc-ccHHHHHHHHcchhhHH
Q 007253 457 TLTVDELFYLKEQYALLEPN-KNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRR-MDFEEFCAAALSVHQLE 534 (611)
Q Consensus 457 ~l~~~e~~~l~~~F~~~D~d-~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~-i~~~eF~~~~~~~~~~~ 534 (611)
.++..|+..|...|.++|.+ ++|.|+.+||..+..... ..-...++..+|.+++|. |+|++|+..+.......
T Consensus 26 ~fs~~EI~~L~~rF~kl~~~~~~g~lt~eef~~i~~~~~-----Np~~~rI~~~f~~~~~~~~v~F~~Fv~~ls~f~~~~ 100 (187)
T KOG0034|consen 26 QFSANEIERLYERFKKLDRNNGDGYLTKEEFLSIPELAL-----NPLADRIIDRFDTDGNGDPVDFEEFVRLLSVFSPKA 100 (187)
T ss_pred ccCHHHHHHHHHHHHHhccccccCccCHHHHHHHHHHhc-----CcHHHHHHHHHhccCCCCccCHHHHHHHHhhhcCCc
Confidence 48899999999999999999 999999999999862221 223567899999888888 99999999888766444
Q ss_pred hhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc--CC--CC--cc-----HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 535 ALDRWEQHARCAYELFEKDGNRAIVIEELASELG--LG--PA--VP-----VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 535 ~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~--~~--~~--~~-----~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
.. ++.++-||++||.+++|+|+.+||.+++. .+ .. .. ++.+|.++|.|+||+|+|+||.+++.+.
T Consensus 101 ~~---~~Kl~faF~vYD~~~~G~I~reel~~iv~~~~~~~~~~~~e~~~~i~d~t~~e~D~d~DG~IsfeEf~~~v~~~ 176 (187)
T KOG0034|consen 101 SK---REKLRFAFRVYDLDGDGFISREELKQILRMMVGENDDMSDEQLEDIVDKTFEEADTDGDGKISFEEFCKVVEKQ 176 (187)
T ss_pred cH---HHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHccCCcchHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHcC
Confidence 42 45899999999999999999999999994 12 22 11 6888999999999999999999998775
|
|
| >KOG0030 consensus Myosin essential light chain, EF-Hand protein superfamily [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.63 E-value=7.6e-16 Score=130.32 Aligned_cols=140 Identities=24% Similarity=0.338 Sum_probs=117.5
Q ss_pred chhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCC--CCCcccHHHHHHHHcchhhHHh
Q 007253 458 LTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSL--QYRRMDFEEFCAAALSVHQLEA 535 (611)
Q Consensus 458 l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~--~~g~i~~~eF~~~~~~~~~~~~ 535 (611)
++.+++.+++++|..||..+||+|+..+...+|+.++. ++++.++.+.+...+.+ +-.+|+|++|+-++....+...
T Consensus 5 ~~~d~~~e~ke~F~lfD~~gD~ki~~~q~gdvlRalG~-nPT~aeV~k~l~~~~~~~~~~~rl~FE~fLpm~q~vaknk~ 83 (152)
T KOG0030|consen 5 FTPDQMEEFKEAFLLFDRTGDGKISGSQVGDVLRALGQ-NPTNAEVLKVLGQPKRREMNVKRLDFEEFLPMYQQVAKNKD 83 (152)
T ss_pred cCcchHHHHHHHHHHHhccCcccccHHHHHHHHHHhcC-CCcHHHHHHHHcCcccchhhhhhhhHHHHHHHHHHHHhccc
Confidence 45677789999999999999999999999999988776 79999999999998876 5578999999998877655533
Q ss_pred hHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007253 536 LDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLH 600 (611)
Q Consensus 536 ~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~ 600 (611)
.. +.+.+...+++||++++|.|...|||++|. +|..++ ++.++...- |.+|.|.|++|++.+.
T Consensus 84 q~-t~edfvegLrvFDkeg~G~i~~aeLRhvLttlGekl~eeEVe~Llag~e-D~nG~i~YE~fVk~i~ 150 (152)
T KOG0030|consen 84 QG-TYEDFVEGLRVFDKEGNGTIMGAELRHVLTTLGEKLTEEEVEELLAGQE-DSNGCINYEAFVKHIM 150 (152)
T ss_pred cC-cHHHHHHHHHhhcccCCcceeHHHHHHHHHHHHhhccHHHHHHHHcccc-ccCCcCcHHHHHHHHh
Confidence 22 255677799999999999999999999994 777766 666666543 8999999999999765
|
|
| >KOG0037 consensus Ca2+-binding protein, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.2e-15 Score=138.38 Aligned_cols=132 Identities=17% Similarity=0.274 Sum_probs=117.3
Q ss_pred HHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHH
Q 007253 463 LFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQH 542 (611)
Q Consensus 463 ~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~ 542 (611)
...+...|...|.|+.|.|+-+|++.+|..........+.++.|+.++|.+.+|+|+|+||..+|..+.++
T Consensus 56 ~~~~~~~f~~vD~d~sg~i~~~eLq~aLsn~~~~~Fs~~TcrlmI~mfd~~~~G~i~f~EF~~Lw~~i~~W--------- 126 (221)
T KOG0037|consen 56 FPQLAGWFQSVDRDRSGRILAKELQQALSNGTWSPFSIETCRLMISMFDRDNSGTIGFKEFKALWKYINQW--------- 126 (221)
T ss_pred cHHHHHHHHhhCccccccccHHHHHHHhhcCCCCCCCHHHHHHHHHHhcCCCCCccCHHHHHHHHHHHHHH---------
Confidence 34688999999999999999999999997667777888899999999999999999999999999776644
Q ss_pred HHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhcch
Q 007253 543 ARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGVSS 604 (611)
Q Consensus 543 ~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~~~ 604 (611)
+.+|+.||+|++|.|+..||+++|. +|..++ .+.+++++|.-++|.|.|++|+.++..+.-
T Consensus 127 -r~vF~~~D~D~SG~I~~sEL~~Al~~~Gy~Lspq~~~~lv~kyd~~~~g~i~FD~FI~ccv~L~~ 191 (221)
T KOG0037|consen 127 -RNVFRTYDRDRSGTIDSSELRQALTQLGYRLSPQFYNLLVRKYDRFGGGRIDFDDFIQCCVVLQR 191 (221)
T ss_pred -HHHHHhcccCCCCcccHHHHHHHHHHcCcCCCHHHHHHHHHHhccccCCceeHHHHHHHHHHHHH
Confidence 4599999999999999999999994 777666 788999999888999999999999887743
|
|
| >KOG0044 consensus Ca2+ sensor (EF-Hand superfamily) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2e-15 Score=139.86 Aligned_cols=141 Identities=18% Similarity=0.242 Sum_probs=116.0
Q ss_pred hcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHh
Q 007253 456 KTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEA 535 (611)
Q Consensus 456 ~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~ 535 (611)
..++.+|+.++.+-|..-- .+|.++.++|+.++..++...-.+.-...+|+.+|.|++|.|+|.||+.++....+...
T Consensus 21 t~f~~~ei~~~Yr~Fk~~c--P~G~~~~~~F~~i~~~~fp~gd~~~y~~~vF~~fD~~~dg~i~F~Efi~als~~~rGt~ 98 (193)
T KOG0044|consen 21 TKFSKKEIQQWYRGFKNEC--PSGRLTLEEFREIYASFFPDGDASKYAELVFRTFDKNKDGTIDFLEFICALSLTSRGTL 98 (193)
T ss_pred cCCCHHHHHHHHHHhcccC--CCCccCHHHHHHHHHHHCCCCCHHHHHHHHHHHhcccCCCCcCHHHHHHHHHHHcCCcH
Confidence 4578888888888887733 57999999999999888763223334567999999999999999999998887776665
Q ss_pred hHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-----CCC----C--cc----HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007253 536 LDRWEQHARCAYELFEKDGNRAIVIEELASELG-----LGP----A--VP----VHAVLHDWIRHTDGKLSFLGFVKLLH 600 (611)
Q Consensus 536 ~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-----~~~----~--~~----~~~~~~~~D~~~dG~is~~eF~~~l~ 600 (611)
++.++++|++||.|++|+|+.+|+..++. .+. . .+ ++.+|+.+|.|+||.||++||+..+.
T Consensus 99 ----eekl~w~F~lyD~dgdG~It~~Eml~iv~~i~~m~~~~~~~~~~~~~~~~v~~if~k~D~n~Dg~lT~eef~~~~~ 174 (193)
T KOG0044|consen 99 ----EEKLKWAFRLYDLDGDGYITKEEMLKIVQAIYQMTGSKALPEDEETPEERVDKIFSKMDKNKDGKLTLEEFIEGCK 174 (193)
T ss_pred ----HHHhhhhheeecCCCCceEcHHHHHHHHHHHHHHcccccCCcccccHHHHHHHHHHHcCCCCCCcccHHHHHHHhh
Confidence 77899999999999999999999999882 221 1 11 89999999999999999999999876
Q ss_pred hc
Q 007253 601 GV 602 (611)
Q Consensus 601 ~~ 602 (611)
..
T Consensus 175 ~d 176 (193)
T KOG0044|consen 175 AD 176 (193)
T ss_pred hC
Confidence 54
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.8e-16 Score=174.47 Aligned_cols=263 Identities=27% Similarity=0.407 Sum_probs=202.2
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
-+.+.+.+-+-.|.||.++.++-.. .|...++|+......-.....+.++.+-.++-..+ +|-++...-.+.....
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~---sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~-~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAG---SGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPR-SPAVVRSFPSFPCRSP 878 (1205)
T ss_pred CccceecccccCCCCcccccCCccc---cccccchhhhccchhhccccccccCCccCccccCC-CCceecccCCCCCCCC
Confidence 4668888899999999988876443 45555666543332222222333444444433222 5777766555566778
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
.+|+++|+.+++|...++.- +..+++-.+.++..+..+++|||...++|||++|.|+|+ ...++.++.|||.....
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~---~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI---AYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred cchhhHHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccccchhhcccccccchhh---cccCCcccCcccccccc
Confidence 99999999999998877655 357888888999999999999999999999999999999 57788999999843221
Q ss_pred CC---------------------C-----------CcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCC
Q 007253 314 RP---------------------D-----------ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRP 360 (611)
Q Consensus 314 ~~---------------------~-----------~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~P 360 (611)
.. . ......+||+.|.+||.+. ......+|+|++|++++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 00 0 0012357999999999876 5688899999999999999999999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHH---HHHcCcccCCCCCC
Q 007253 361 FWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAA---QALSHPWIKNSNDV 425 (611)
Q Consensus 361 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~---~ll~hp~~~~~~~~ 425 (611)
|.....+.+++++......++... ...+.++++++.++|..+|.+|..+. ++..|+||+..+-.
T Consensus 1035 ~na~tpq~~f~ni~~~~~~~p~g~-~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~ 1101 (1205)
T KOG0606|consen 1035 FNAETPQQIFENILNRDIPWPEGP-EEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWE 1101 (1205)
T ss_pred CCCcchhhhhhccccCCCCCCCCc-cccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcc
Confidence 999999999999999887776654 25688999999999999999999888 99999999986533
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.3e-14 Score=137.46 Aligned_cols=197 Identities=19% Similarity=0.240 Sum_probs=141.0
Q ss_pred HHhcCCCCeeEEEEEEeeCC-----eeEEEeeecCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC--Ce
Q 007253 213 RALTGHNNLVKFFDAYEDTD-----NVYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQG--VV 282 (611)
Q Consensus 213 ~~l~~h~~iv~l~~~~~~~~-----~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~--ii 282 (611)
..+- |-|||+++.||.+.+ +..++.|||..|+|..+|++. ...+......+|+-||+.||.|||+.. ||
T Consensus 122 lqlv-HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 122 LQLV-HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHH-HHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 3444 899999999997654 588999999999999988753 345888999999999999999999985 99
Q ss_pred eecCCCCceEEeccCCCceEEEeecccccccCCCC------cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHH
Q 007253 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILL 355 (611)
Q Consensus 283 HrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~ 355 (611)
|+++..+-|++ ..++.+|+. -+.-......- ....-.+-++|.|||.-. -..+-++|||+||.+.++|.
T Consensus 201 hgnlTc~tifi---q~ngLIkig-~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 201 HGNLTCDTIFI---QHNGLIKIG-SVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred cCCcchhheee---cCCceEEec-ccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 99999999999 577888873 33211111110 011124568899999654 44566899999999999999
Q ss_pred hCCCCC-CCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCC
Q 007253 356 CGSRPF-WARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 356 ~g~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
.+..-- .+.+....-..+.+...... ...-++++.+||+..|..||++.+++.||-+-.
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~i~~le-------n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANVIIGLE-------NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred HheeccCCCcceeehhhhhhhheeecc-------CccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 887542 22221111222222211111 112357999999999999999999999998754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.8e-13 Score=146.37 Aligned_cols=143 Identities=23% Similarity=0.317 Sum_probs=96.7
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCH---------------------------HHH----H------
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA---------------------------IAI----E------ 203 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~---------------------------~~~----~------ 203 (611)
+.||.|++|.||+|+.+. |+.||||+........- ... .
T Consensus 123 ~plasaSigQVh~A~l~~----G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~El 198 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVD----GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRREL 198 (437)
T ss_pred cceeeeehhheEEEEecC----CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHH
Confidence 579999999999998764 88999999854321100 000 0
Q ss_pred HHHHHHHHHHHhc----CCCCeeEEEEEE-eeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHH-HHHHHH
Q 007253 204 DVRREVKILRALT----GHNNLVKFFDAY-EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN-VVAFCH 277 (611)
Q Consensus 204 ~~~~E~~~l~~l~----~h~~iv~l~~~~-~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~-~L~~LH 277 (611)
.+.+|...+.++. ++++|. +-.++ ......+|||||++|++|.+........+ ....++..++. .+..+|
T Consensus 199 df~~Ea~n~~~~~~~~~~~~~v~-vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 199 DLRREAANASELGENFKNDPGVY-VPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred CHHHHHHHHHHHHHhcCCCCCEE-eCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHH
Confidence 2345565555553 344432 22222 22345799999999999887654322222 23456666665 478899
Q ss_pred HcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 278 ~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
..|++|+|+||.||++ ..++.++|+|||++..+.
T Consensus 275 ~~g~~H~D~hPgNilv---~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 275 RDGFFHADLHPGNIFV---LKDGKIIALDFGIVGRLS 308 (437)
T ss_pred hCCceeCCCCcccEEE---CCCCcEEEEeCCCeeECC
Confidence 9999999999999999 566789999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.47 E-value=4.4e-11 Score=123.58 Aligned_cols=315 Identities=14% Similarity=0.170 Sum_probs=212.7
Q ss_pred eEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee----CCeeEEEeeecCCC
Q 007253 169 GYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED----TDNVYVVMELCEGG 244 (611)
Q Consensus 169 g~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~----~~~~~lv~E~~~~g 244 (611)
.+.|++.... +|..|++|++.-...... ...-.-+++++++. |+|||+|.++|.. +..+++|++|.++.
T Consensus 290 ~Ttyk~~s~~---DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~-h~NvV~frevf~t~tF~D~SlvlvYDYyP~s 362 (655)
T KOG3741|consen 290 ITTYKATSNV---DGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLC-HTNVVPFREVFLTYTFGDLSLVLVYDYYPSS 362 (655)
T ss_pred ceeEeeeecc---CCceeeeeeeccccccCc---ccchHHHHHHHHhc-cCceeehhhhhhhhccCcceEEEEEecCCCC
Confidence 3778887655 699999999943221111 12234577889998 9999999999873 45799999999864
Q ss_pred -ChHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccc
Q 007253 245 -ELLDRILS--------------RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (611)
Q Consensus 245 -sL~~~l~~--------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~ 309 (611)
+|+++... .+.+.+|..+|.++.||..||.++|+.|+.-+-|.+.+||++ .+..++|+-.|.
T Consensus 363 ~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~---G~~RIriS~C~i 439 (655)
T KOG3741|consen 363 PTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT---GKMRIRISGCGI 439 (655)
T ss_pred chHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee---CcceEEEecccc
Confidence 77776542 234578999999999999999999999999999999999994 555799988888
Q ss_pred ccccCCCCcccccccCCCcCcchhhcCCCCCcchhhHHHHHHHHHHhCCCCCCCCC-hHHH-HHHHHhcCCCCCCCCCCC
Q 007253 310 SDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWART-ESGI-FRAVLKADPSFDEAPWPS 387 (611)
Q Consensus 310 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~el~~g~~Pf~~~~-~~~~-~~~i~~~~~~~~~~~~~~ 387 (611)
...+..+.. +| +. --.+-|.=.||.+++.|.||..--+..+ ..+. +..|. +.
T Consensus 440 ~Dvl~~d~~-----------~~--le--~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-----------~~ 493 (655)
T KOG3741|consen 440 MDVLQEDPT-----------EP--LE--SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-----------TT 493 (655)
T ss_pred eeeecCCCC-----------cc--hh--HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-----------hh
Confidence 877665431 01 10 1235688899999999999965422221 1111 12121 36
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHcC---cccCCCCCCCCchhHHHHHHHHHHhhcchHHHHHHHhhh--hc----c
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALSH---PWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALRALS--KT----L 458 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~h---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~--~~----l 458 (611)
++.+++++|.-+...++++ -++.+++.+ .||... +..+...-.....+.+-+.+.+|.+.+++... .+ .
T Consensus 494 yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff~vm-es~q~~~d~mE~~Ls~emENGRLfRll~Kln~I~dR~e~~~ 571 (655)
T KOG3741|consen 494 YSTDLRNVVEYLESLNFRE-KSIQDLLPMIGSRFFTVM-ESVQLKTDVMETELSREMENGRLFRLLLKLNFIDDRPEYVD 571 (655)
T ss_pred hhHHHHHHHHHHHhcCccc-ccHHHHHHHHHHHHHHHH-HhHHHHHHHHHHHHHHHHhcchHHHHHHHHhhhccCccccc
Confidence 7899999999999999987 788888865 466543 22222233344555666778888887766441 11 1
Q ss_pred --hhh------HHHHHHH-HhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCC--cccHHHHHHHH
Q 007253 459 --TVD------ELFYLKE-QYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYR--RMDFEEFCAAA 527 (611)
Q Consensus 459 --~~~------e~~~l~~-~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g--~i~~~eF~~~~ 527 (611)
+.. -+..+|+ +|...|.||..-|+...+.+||.++.. - +.+-+..+..|+.. -|+|.|...++
T Consensus 572 D~~WSesG~~fmi~LFRDYlFHqvtedg~p~lDlaHvl~CLNKLDA--G----~~EkI~LvSrDE~t~IIvSY~ELK~~l 645 (655)
T KOG3741|consen 572 DPDWSESGDRFMIKLFRDYLFHQVTEDGKPWLDLAHVLQCLNKLDA--G----IQEKILLVSRDELTCIIVSYKELKTIL 645 (655)
T ss_pred CCcchhccceehHHHHHHhhheEeccCCChhhhHHHHHHHhhhccc--c----chhheeEeccCCCcEEEEEHHHHHHHH
Confidence 111 1234444 899999998888999999888866543 1 22233334333333 47777776644
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=7.8e-14 Score=147.09 Aligned_cols=252 Identities=21% Similarity=0.198 Sum_probs=185.2
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
...+|..+..||.|.|+.|+.+... ...+..|++|...+........ ..-..|+.+...|.-|.+++.++..|....
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r--~~~~~~Y~~ke~~~~l~~~~~d-i~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKR--PEGDCIYAAKELLNGLATFASD-IFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ecCCcceeEEccCCccccceeeeec--CCCCceEeChhhhccccchHhh-hcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 3467889999999999999988733 2368899999886654333222 223468888888877999999999999988
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
+.||-.|||+++++...+. -...+.+...+.+..|++.++.++|+..++|+|+||+||++..++ +..++.|||...-
T Consensus 340 ~~~ip~e~~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~--~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG--FFSKLGDFGCWTR 416 (524)
T ss_pred cccCchhhhcCcchhhhhH-HHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch--hhhhccccccccc
Confidence 8999999999998765552 224588889999999999999999999999999999999996432 7899999998753
Q ss_pred cCCCCcccccccCCCcC-cchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 313 VRPDERLNDIVGSAYYV-APEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 313 ~~~~~~~~~~~gt~~y~-aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
+. -......+.-+++ ..|++. ..+..+.|+||||+.+.+.+++..--+.... ...+.... .+ ..+...
T Consensus 417 ~~--~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~--~p--~~~~~~ 487 (524)
T KOG0601|consen 417 LA--FSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGD--TP--NLPGLK 487 (524)
T ss_pred cc--eecccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeeccc--cc--CCCchH
Confidence 21 1111222334455 356554 4577899999999999999988764332221 11122211 11 113445
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
.++..+.+.++..++..|+.+.++..|.=|
T Consensus 488 ~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 488 LQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred HhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 788999999999999999999999887654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.43 E-value=4.2e-13 Score=145.21 Aligned_cols=149 Identities=20% Similarity=0.338 Sum_probs=94.0
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcC--------------------------C-H----HHHH
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT--------------------------T-A----IAIE 203 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~--------------------------~-~----~~~~ 203 (611)
..|+. +.||.|++|.||+|+.+. +|+.||||++.+.... . . +..+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~---~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~ 195 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKD---NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK 195 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECC---CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence 34666 789999999999999876 5899999999654210 0 0 1122
Q ss_pred HHHH------HHHHHHHhc---CCCCeeEEEEEEee-CCeeEEEeeecCCCChHHH--HHhcCC---CCCHHHHHHHHHH
Q 007253 204 DVRR------EVKILRALT---GHNNLVKFFDAYED-TDNVYVVMELCEGGELLDR--ILSRGG---KYTEDDAKAVMIQ 268 (611)
Q Consensus 204 ~~~~------E~~~l~~l~---~h~~iv~l~~~~~~-~~~~~lv~E~~~~gsL~~~--l~~~~~---~l~~~~~~~i~~q 268 (611)
.+.+ |+..+.++. .+.+.+.+-.++.+ ....+||||||+|+.+.+. +...+. .+.+..+..++.|
T Consensus 196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 2333 444444433 12222322222222 3456899999999998764 222221 2444445555555
Q ss_pred HHHHHHHHHHcCCeeecCCCCceEEeccC-CCceEEEeecccccccC
Q 007253 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 269 i~~~L~~LH~~~iiHrDlkp~NIll~~~~-~~~~vkl~DfG~a~~~~ 314 (611)
|+ ..|++|+|+||.||++..++ ..+.++++|||++..+.
T Consensus 276 if-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 276 VF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 44 58999999999999995321 22389999999987664
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.6e-12 Score=116.04 Aligned_cols=149 Identities=21% Similarity=0.251 Sum_probs=113.3
Q ss_pred EeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCC-----HHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT-----AIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 159 ~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
....|-+|+-+.|+++.+ .|+.++||.-....... .....+..+|++++.++. --.|.--.=++.|...
T Consensus 11 ~l~likQGAEArv~~~~~-----~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~D~~~ 84 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-----SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFIDTYG 84 (229)
T ss_pred cceeeeccceeeEeeecc-----CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEEecCC
Confidence 567888999999888864 57888888543222222 223456779999999987 3444433335667777
Q ss_pred eEEEeeecCC-CChHHHHHhcCCCCCHHHH-HHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 234 VYVVMELCEG-GELLDRILSRGGKYTEDDA-KAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 234 ~~lv~E~~~~-gsL~~~l~~~~~~l~~~~~-~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
-.|+|||++| .++.+++.+....-.++.. ..+++.|-..+.-||.++|||+||..+||+|..++....+.++|||++.
T Consensus 85 ~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 85 GQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred CeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 8899999977 3778888876554444444 7899999999999999999999999999999987777778999999986
Q ss_pred cc
Q 007253 312 FV 313 (611)
Q Consensus 312 ~~ 313 (611)
.-
T Consensus 165 ~s 166 (229)
T KOG3087|consen 165 VS 166 (229)
T ss_pred cc
Confidence 53
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.1e-12 Score=120.45 Aligned_cols=129 Identities=17% Similarity=0.206 Sum_probs=94.9
Q ss_pred eCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEee
Q 007253 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVME 239 (611)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E 239 (611)
.+.|+.|.++.||+++. .+..|++|+...... ....+.+|+.+++.+.+...+.+++.+. ....++|||
T Consensus 3 ~~~l~~G~~~~vy~~~~-----~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e 71 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-----ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITE 71 (170)
T ss_pred eeecCCcccCceEEEEE-----CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEE
Confidence 46789999999999874 367899999754321 1124578999999987333344555543 334589999
Q ss_pred ecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCC-----eeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 240 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV-----VHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 240 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i-----iHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
|++|.++.+. ......++.+++.+|..||+.++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 72 ~i~G~~l~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liDf~~a~~ 136 (170)
T cd05151 72 FIEGSELLTE---------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLIDWEYAGM 136 (170)
T ss_pred ecCCCccccc---------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEecccccC
Confidence 9999877542 11123467899999999999985 9999999999994 34689999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.37 E-value=7.7e-12 Score=117.96 Aligned_cols=146 Identities=16% Similarity=0.134 Sum_probs=102.2
Q ss_pred eCeeeeccceEEEEEEEecC---CccCcEEEEEEecCCCc---------------C----CHHHHHH----HHHHHHHHH
Q 007253 160 GEEVGRGHFGYTCAAKFKKG---ELKGQQVAVKVIPKHKM---------------T----TAIAIED----VRREVKILR 213 (611)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~---~~~g~~vavK~~~~~~~---------------~----~~~~~~~----~~~E~~~l~ 213 (611)
...||.|--+.||.|....+ ...+..+|||+...... . ....... ..+|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 45789999999999974321 11357899998842210 0 0111222 348999999
Q ss_pred HhcCC-CCeeEEEEEEeeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHcCCeeecCCCCce
Q 007253 214 ALTGH-NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC-HLQGVVHRDLKPENF 291 (611)
Q Consensus 214 ~l~~h-~~iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~iiHrDlkp~NI 291 (611)
++... -++.+.+++ ...+|||||+.++.+....... ..+++..+..+..+++.+|..| |+.||||+||++.||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 99743 466667654 4578999999765442222222 2456667788899999999999 899999999999999
Q ss_pred EEeccCCCceEEEeecccccccC
Q 007253 292 LFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 292 ll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
|+. ++.++|+|||.+-...
T Consensus 157 L~~----~~~v~iIDF~qav~~~ 175 (197)
T cd05146 157 LWH----DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEE----CCcEEEEECCCceeCC
Confidence 994 3569999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0036 consensus Predicted mitochondrial carrier protein [Nucleotide transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.37 E-value=3.9e-12 Score=126.80 Aligned_cols=134 Identities=13% Similarity=0.166 Sum_probs=114.6
Q ss_pred chhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhH
Q 007253 458 LTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALD 537 (611)
Q Consensus 458 l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~ 537 (611)
..++...+++.+|+.||.+++|.++..++...+.++...+....-...+|..+|.|.||.+||+||...+...
T Consensus 8 ~~~er~~r~~~lf~~lD~~~~g~~d~~~l~k~~~~l~~~~~~~~~~~~l~~~~d~~~dg~vDy~eF~~Y~~~~------- 80 (463)
T KOG0036|consen 8 TDEERDIRIRCLFKELDSKNDGQVDLDQLEKGLEKLDHPKPNYEAAKMLFSAMDANRDGRVDYSEFKRYLDNK------- 80 (463)
T ss_pred CcHHHHHHHHHHHHHhccCCCCceeHHHHHHHHHhcCCCCCchHHHHHHHHhcccCcCCcccHHHHHHHHHHh-------
Confidence 3455566899999999999999999999999998887654555566789999999999999999998866432
Q ss_pred HHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007253 538 RWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLH 600 (611)
Q Consensus 538 ~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~ 600 (611)
|.++...|...|.+.||.|..+|+.+.|. +|.+++ ++.+++.+|+++++.|+++||.+++.
T Consensus 81 --E~~l~~~F~~iD~~hdG~i~~~Ei~~~l~~~gi~l~de~~~k~~e~~d~~g~~~I~~~e~rd~~l 145 (463)
T KOG0036|consen 81 --ELELYRIFQSIDLEHDGKIDPNEIWRYLKDLGIQLSDEKAAKFFEHMDKDGKATIDLEEWRDHLL 145 (463)
T ss_pred --HHHHHHHHhhhccccCCccCHHHHHHHHHHhCCccCHHHHHHHHHHhccCCCeeeccHHHHhhhh
Confidence 55678899999999999999999999995 665555 78899999999999999999999764
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.1e-11 Score=112.79 Aligned_cols=135 Identities=26% Similarity=0.331 Sum_probs=100.1
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHH-----HHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAI-----AIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
..+++|+-+.+|.+.+ .|..+++|.=.+.....+. ..++..+|+.++.++. --.|..-+=+..+.+...
T Consensus 2 ~~i~~GAEa~i~~~~~-----~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~-~~GV~~P~v~dvD~~~~~ 75 (204)
T COG3642 2 DLIKQGAEAIIYLTDF-----LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAR-EAGVPVPIVYDVDPDNGL 75 (204)
T ss_pred chhhCCcceeEEeeec-----cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHH-HcCCCCCeEEEEcCCCCE
Confidence 4678999999998854 3555777753332333332 3345678999999987 445554444566778889
Q ss_pred EEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
|+|||++|-.|.+.+... ...+++.+-.-+.-||..||||+||.++||++. .+.+.++|||++.+-
T Consensus 76 I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~----~~~i~~IDfGLg~~s 141 (204)
T COG3642 76 IVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS----GGRIYFIDFGLGEFS 141 (204)
T ss_pred EEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe----CCcEEEEECCccccc
Confidence 999999887777777544 256788888889999999999999999999995 334999999998764
|
|
| >KOG4223 consensus Reticulocalbin, calumenin, DNA supercoiling factor, and related Ca2+-binding proteins of the CREC family (EF-Hand protein superfamily) [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.26 E-value=8.8e-12 Score=121.34 Aligned_cols=135 Identities=20% Similarity=0.266 Sum_probs=104.3
Q ss_pred HHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHH-H
Q 007253 463 LFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWE-Q 541 (611)
Q Consensus 463 ~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~-~ 541 (611)
+.+-++.|+.-|.|+||.++++||..+|+---...|..--+.+-+..+|+|+||+|+++||+.-+...........|. -
T Consensus 162 ~~rDe~rFk~AD~d~dg~lt~EEF~aFLHPEe~p~M~~iVi~Etl~d~Dkn~DG~I~~eEfigd~~~~~~~~~epeWv~~ 241 (325)
T KOG4223|consen 162 IARDEERFKAADQDGDGSLTLEEFTAFLHPEEHPHMKDIVIAETLEDIDKNGDGKISLEEFIGDLYSHEGNEEEPEWVLT 241 (325)
T ss_pred HHHHHHHHhhcccCCCCcccHHHHHhccChhhcchHHHHHHHHHHhhcccCCCCceeHHHHHhHHhhccCCCCCcccccc
Confidence 445568999999999999999999998865554455555567788899999999999999998766544322222222 2
Q ss_pred HHHHHHhHHhcCCCCcccHHHHHHHhcCCC----CccHHHHHHHHhcCCCCceeHHHHHH
Q 007253 542 HARCAYELFEKDGNRAIVIEELASELGLGP----AVPVHAVLHDWIRHTDGKLSFLGFVK 597 (611)
Q Consensus 542 ~~~~~F~~~D~d~~G~It~eEl~~~l~~~~----~~~~~~~~~~~D~~~dG~is~~eF~~ 597 (611)
+-.+.|..+|+|+||+++.+|+++.+-... +..+..++.+.|.|+||+||++|-+.
T Consensus 242 Ere~F~~~~DknkDG~L~~dEl~~WI~P~~~d~A~~EA~hL~~eaD~dkD~kLs~eEIl~ 301 (325)
T KOG4223|consen 242 EREQFFEFRDKNKDGKLDGDELLDWILPSEQDHAKAEARHLLHEADEDKDGKLSKEEILE 301 (325)
T ss_pred cHHHHHHHhhcCCCCccCHHHHhcccCCCCccHHHHHHHHHhhhhccCccccccHHHHhh
Confidence 334667888999999999999999884322 12278899999999999999999776
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.3e-10 Score=124.15 Aligned_cols=163 Identities=22% Similarity=0.306 Sum_probs=121.9
Q ss_pred cCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeeecCCCChHHHHHhcCCCCCHHH
Q 007253 182 KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDD 261 (611)
Q Consensus 182 ~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~ 261 (611)
.+.+|.|.+++.... ...+.+.+-++.|+.|+ ||||++|++.++.++.+|||+|.+. -|..++.+. ....
T Consensus 36 ~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlR-HP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l----~~~~ 105 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLR-HPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL----GKEE 105 (690)
T ss_pred cCCceEEEEEeCCCc---hhhHHHHHHHHHhhhcc-CchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh----HHHH
Confidence 578888888754432 44566788899999998 9999999999999999999999985 456666443 3677
Q ss_pred HHHHHHHHHHHHHHHHH-cCCeeecCCCCceEEeccCCCceEEEeecccccccCCCCc-ccccccCCCcCcchhhcCCCC
Q 007253 262 AKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER-LNDIVGSAYYVAPEVLHRSYS 339 (611)
Q Consensus 262 ~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~ 339 (611)
+...+.||+.||.|||+ .+++|++|.-+.|+| ...|..||++|.++........ .....---.|..|+.+... .
T Consensus 106 v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s-~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV---NESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS-E 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE---cCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc-c
Confidence 77789999999999984 589999999999999 5777899999998765432221 1111111235555544211 1
Q ss_pred CcchhhHHHHHHHHHHhCC
Q 007253 340 TEADVWSIGVIAYILLCGS 358 (611)
Q Consensus 340 ~~~DiwSlGvil~el~~g~ 358 (611)
-..|.|-|||+++|++.|.
T Consensus 182 ~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cchhhhhHHHHHHHHhCcc
Confidence 3469999999999999883
|
|
| >KOG4223 consensus Reticulocalbin, calumenin, DNA supercoiling factor, and related Ca2+-binding proteins of the CREC family (EF-Hand protein superfamily) [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.21 E-value=8.2e-11 Score=114.66 Aligned_cols=142 Identities=14% Similarity=0.204 Sum_probs=108.1
Q ss_pred hhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchh-------
Q 007253 459 TVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVH------- 531 (611)
Q Consensus 459 ~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~------- 531 (611)
..+-.++|..+|.++|.+++|.|+..|++.++..... ..-..++.+-+...|.|.+|.|+|+|++.......
T Consensus 72 ~ee~~~rl~~l~~~iD~~~Dgfv~~~El~~wi~~s~k-~~v~~~~~~~~~~~d~~~Dg~i~~eey~~~~~~~~~~~~~~~ 150 (325)
T KOG4223|consen 72 PEESQERLGKLVPKIDSDSDGFVTESELKAWIMQSQK-KYVVEEAARRWDEYDKNKDGFITWEEYLPQTYGRVDLPDEFP 150 (325)
T ss_pred cchhHHHHHHHHhhhcCCCCCceeHHHHHHHHHHHHH-HHHHHHHHHHHHHhccCccceeeHHHhhhhhhhcccCccccc
Confidence 3445668999999999999999999999999766553 34455667788889999999999999988665321
Q ss_pred hHHhhH---HHHHHHHHHHhHHhcCCCCcccHHHHHHHhcCCC-----CccHHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 532 QLEALD---RWEQHARCAYELFEKDGNRAIVIEELASELGLGP-----AVPVHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 532 ~~~~~~---~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~~~~-----~~~~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
...... .....-+.-|+.-|.|+||.+|.+||..+|+.-. .+-+.+.|...|+|+||+|+++||+.-|..
T Consensus 151 d~e~~~~~~km~~rDe~rFk~AD~d~dg~lt~EEF~aFLHPEe~p~M~~iVi~Etl~d~Dkn~DG~I~~eEfigd~~~ 228 (325)
T KOG4223|consen 151 DEEDNEEYKKMIARDEERFKAADQDGDGSLTLEEFTAFLHPEEHPHMKDIVIAETLEDIDKNGDGKISLEEFIGDLYS 228 (325)
T ss_pred cchhcHHHHHHHHHHHHHHhhcccCCCCcccHHHHHhccChhhcchHHHHHHHHHHhhcccCCCCceeHHHHHhHHhh
Confidence 000000 0111234569999999999999999999996321 222788999999999999999999986643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.6e-10 Score=112.62 Aligned_cols=143 Identities=27% Similarity=0.433 Sum_probs=104.7
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCC-CCeeEEEEEEeeC---CeeEE
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH-NNLVKFFDAYEDT---DNVYV 236 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~~iv~l~~~~~~~---~~~~l 236 (611)
+.||.|..+.||++.... |+.+++|+....... .....+.+|+.+++.+..+ ..+.+++.+.... +..++
T Consensus 4 ~~l~~G~~n~~~~v~~~~----g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~ 77 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG----GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFY 77 (223)
T ss_pred eecCCCccceEEEEEecC----CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceE
Confidence 568999999999997643 578999997543321 1234678999999999732 3456777776553 36789
Q ss_pred EeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 007253 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-------------------------------------- 278 (611)
Q Consensus 237 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~-------------------------------------- 278 (611)
||||++|+++.+.+.. ..+++.....++.+++.+|.+||+
T Consensus 78 v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 78 VMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred EEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 9999999887664421 346777777788888888888873
Q ss_pred ------------------cCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 279 ------------------QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 279 ------------------~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
..+||+|+++.||+++.. ..+.+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~ 206 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEecccccc
Confidence 236999999999999531 146789999998765
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PLN02964 phosphatidylserine decarboxylase | Back alignment and domain information |
|---|
Probab=99.13 E-value=9.7e-11 Score=127.77 Aligned_cols=104 Identities=18% Similarity=0.280 Sum_probs=87.5
Q ss_pred hcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCC---hhHHHhhcCCCCCCcccHHHHHHHHcchhh
Q 007253 456 KTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSR---IPDFLSSLNSLQYRRMDFEEFCAAALSVHQ 532 (611)
Q Consensus 456 ~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~---~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~ 532 (611)
..++.+|+++++++|..+|+|++|+| +..++..++...+++.+ +..+|+.+|.|++|.|+|+||+.++.....
T Consensus 135 t~f~~kqi~elkeaF~lfD~dgdG~i----Lg~ilrslG~~~pte~e~~fi~~mf~~~D~DgdG~IdfdEFl~lL~~lg~ 210 (644)
T PLN02964 135 FDFVTQEPESACESFDLLDPSSSNKV----VGSIFVSCSIEDPVETERSFARRILAIVDYDEDGQLSFSEFSDLIKAFGN 210 (644)
T ss_pred hhccHHHHHHHHHHHHHHCCCCCCcC----HHHHHHHhCCCCCCHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhcc
Confidence 35777888999999999999999997 77777776622455554 789999999999999999999998875443
Q ss_pred HHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHh
Q 007253 533 LEALDRWEQHARCAYELFEKDGNRAIVIEELASEL 567 (611)
Q Consensus 533 ~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l 567 (611)
... +++++.+|+.||+|++|+|+.+||+++|
T Consensus 211 ~~s----eEEL~eaFk~fDkDgdG~Is~dEL~~vL 241 (644)
T PLN02964 211 LVA----ANKKEELFKAADLNGDGVVTIDELAALL 241 (644)
T ss_pred CCC----HHHHHHHHHHhCCCCCCcCCHHHHHHHH
Confidence 222 6689999999999999999999999988
|
|
| >COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=4.8e-10 Score=100.50 Aligned_cols=111 Identities=13% Similarity=0.201 Sum_probs=94.3
Q ss_pred HHHhhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcc
Q 007253 450 ALRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALS 529 (611)
Q Consensus 450 ~l~~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~ 529 (611)
+++++....+..+ +.++|..+|. +.|.|++.+|..+|........+.+++.+.|..+|.|++|+|+..|+..++..
T Consensus 45 ilr~lg~~~s~~e---i~~l~~~~d~-~~~~idf~~Fl~~ms~~~~~~~~~Eel~~aF~~fD~d~dG~Is~~eL~~vl~~ 120 (160)
T COG5126 45 ILRSLGFNPSEAE---INKLFEEIDA-GNETVDFPEFLTVMSVKLKRGDKEEELREAFKLFDKDHDGYISIGELRRVLKS 120 (160)
T ss_pred HHHHcCCCCcHHH---HHHHHHhccC-CCCccCHHHHHHHHHHHhccCCcHHHHHHHHHHhCCCCCceecHHHHHHHHHh
Confidence 3446677777777 6677888888 99999999999999887754556778999999999999999999999999987
Q ss_pred hhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 530 VHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 530 ~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
...... ++++...++.+|.|++|+|+.+||.+.+.
T Consensus 121 lge~~~----deev~~ll~~~d~d~dG~i~~~eF~~~~~ 155 (160)
T COG5126 121 LGERLS----DEEVEKLLKEYDEDGDGEIDYEEFKKLIK 155 (160)
T ss_pred hcccCC----HHHHHHHHHhcCCCCCceEeHHHHHHHHh
Confidence 766555 77899999999999999999999998763
|
|
| >KOG0038 consensus Ca2+-binding kinase interacting protein (KIP) (EF-Hand protein superfamily) [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=4.5e-10 Score=95.90 Aligned_cols=137 Identities=18% Similarity=0.355 Sum_probs=98.3
Q ss_pred chhhHHHHHHHHhhhcCCCCC-----C------cccHHHHHHHHHhhcccccccCCh-hHHHhhcCCCCCCcccHHHHHH
Q 007253 458 LTVDELFYLKEQYALLEPNKN-----G------TISLENVKSALMKNATDAMKDSRI-PDFLSSLNSLQYRRMDFEEFCA 525 (611)
Q Consensus 458 l~~~e~~~l~~~F~~~D~d~~-----G------~Is~~e~~~~l~~~~~~~~~~~~~-~~~~~~~D~~~~g~i~~~eF~~ 525 (611)
++.+++-+|...|..+.++.- | ++..+.+.. +-. +.+.-. +++-..+..||.|.++|++|+.
T Consensus 22 FtrKdIlrl~~Rf~~L~P~lVP~~~~~~~~~~v~vp~e~i~k-MPE-----Lkenpfk~ri~e~FSeDG~GnlsfddFlD 95 (189)
T KOG0038|consen 22 FTRKDILRLHKRFYELAPHLVPTDMTGNRPPIVKVPFELIEK-MPE-----LKENPFKRRICEVFSEDGRGNLSFDDFLD 95 (189)
T ss_pred ccHHHHHHHHHHHHHhCcccccccccCCCCCceeecHHHHhh-Chh-----hhcChHHHHHHHHhccCCCCcccHHHHHH
Confidence 466677777777777766421 1 233333322 211 111112 3566777889999999999999
Q ss_pred HHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CC-CCcc-------HHHHHHHHhcCCCCceeHHHHH
Q 007253 526 AALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LG-PAVP-------VHAVLHDWIRHTDGKLSFLGFV 596 (611)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~-~~~~-------~~~~~~~~D~~~dG~is~~eF~ 596 (611)
+++........ +-.+..||+.||-|+|++|..++|.+.+. +. ..++ ++.++.+.|.|+||+|+|.||.
T Consensus 96 mfSV~sE~APr---dlK~~YAFkIYDfd~D~~i~~~DL~~~l~~lTr~eLs~eEv~~i~ekvieEAD~DgDgkl~~~eFe 172 (189)
T KOG0038|consen 96 MFSVFSEMAPR---DLKAKYAFKIYDFDGDEFIGHDDLEKTLTSLTRDELSDEEVELICEKVIEEADLDGDGKLSFAEFE 172 (189)
T ss_pred HHHHHHhhChH---HhhhhheeEEeecCCCCcccHHHHHHHHHHHhhccCCHHHHHHHHHHHHHHhcCCCCCcccHHHHH
Confidence 99877766554 34678899999999999999999999883 21 1122 6889999999999999999999
Q ss_pred HHHhhcc
Q 007253 597 KLLHGVS 603 (611)
Q Consensus 597 ~~l~~~~ 603 (611)
+++.+..
T Consensus 173 ~~i~raP 179 (189)
T KOG0038|consen 173 HVILRAP 179 (189)
T ss_pred HHHHhCc
Confidence 9987753
|
|
| >KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=5.8e-10 Score=101.86 Aligned_cols=112 Identities=15% Similarity=0.237 Sum_probs=92.8
Q ss_pred HHHhhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhccccccc----CChhHHHhhcCCCCCCcccHHHHHH
Q 007253 450 ALRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKD----SRIPDFLSSLNSLQYRRMDFEEFCA 525 (611)
Q Consensus 450 ~l~~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~----~~~~~~~~~~D~~~~g~i~~~eF~~ 525 (611)
.+..++...++.+ +..++..+|.+++|.|++++|..++.......... .++.++|+.+|.|++|.|+..|+..
T Consensus 33 ~lr~lg~~~t~~e---l~~~~~~~D~dg~g~I~~~eF~~l~~~~~~~~~~~~~~~~el~eaF~~fD~d~~G~Is~~el~~ 109 (151)
T KOG0027|consen 33 VLRSLGQNPTEEE---LRDLIKEIDLDGDGTIDFEEFLDLMEKLGEEKTDEEASSEELKEAFRVFDKDGDGFISASELKK 109 (151)
T ss_pred HHHHcCCCCCHHH---HHHHHHHhCCCCCCeEcHHHHHHHHHhhhcccccccccHHHHHHHHHHHccCCCCcCcHHHHHH
Confidence 3444445555555 88999999999999999999999887776532322 3789999999999999999999999
Q ss_pred HHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 526 AALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
++........ .+++...++.+|.|+||.|+.+|+.+++.
T Consensus 110 ~l~~lg~~~~----~~e~~~mi~~~d~d~dg~i~f~ef~~~m~ 148 (151)
T KOG0027|consen 110 VLTSLGEKLT----DEECKEMIREVDVDGDGKVNFEEFVKMMS 148 (151)
T ss_pred HHHHhCCcCC----HHHHHHHHHhcCCCCCCeEeHHHHHHHHh
Confidence 9988776665 66888999999999999999999998874
|
|
| >KOG0044 consensus Ca2+ sensor (EF-Hand superfamily) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=6.7e-10 Score=103.20 Aligned_cols=112 Identities=15% Similarity=0.174 Sum_probs=91.4
Q ss_pred hhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHh---
Q 007253 459 TVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEA--- 535 (611)
Q Consensus 459 ~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~--- 535 (611)
..+...+...+|..+|.|+||.|++.||..+|..... ...++.+...|+.+|.|++|.|+++|++.++...+.+..
T Consensus 59 ~gd~~~y~~~vF~~fD~~~dg~i~F~Efi~als~~~r-Gt~eekl~w~F~lyD~dgdG~It~~Eml~iv~~i~~m~~~~~ 137 (193)
T KOG0044|consen 59 DGDASKYAELVFRTFDKNKDGTIDFLEFICALSLTSR-GTLEEKLKWAFRLYDLDGDGYITKEEMLKIVQAIYQMTGSKA 137 (193)
T ss_pred CCCHHHHHHHHHHHhcccCCCCcCHHHHHHHHHHHcC-CcHHHHhhhhheeecCCCCceEcHHHHHHHHHHHHHHccccc
Confidence 3566678889999999999999999999998866553 345667888999999999999999999987776544322
Q ss_pred ----hHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhcCCC
Q 007253 536 ----LDRWEQHARCAYELFEKDGNRAIVIEELASELGLGP 571 (611)
Q Consensus 536 ----~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~~~~ 571 (611)
....++.+..+|+.+|.|+||.||.+|+.+.+...+
T Consensus 138 ~~~~~~~~~~~v~~if~k~D~n~Dg~lT~eef~~~~~~d~ 177 (193)
T KOG0044|consen 138 LPEDEETPEERVDKIFSKMDKNKDGKLTLEEFIEGCKADP 177 (193)
T ss_pred CCcccccHHHHHHHHHHHcCCCCCCcccHHHHHHHhhhCH
Confidence 222477899999999999999999999999885433
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.3e-09 Score=107.23 Aligned_cols=239 Identities=17% Similarity=0.140 Sum_probs=156.8
Q ss_pred eEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEE------eeC
Q 007253 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAY------EDT 231 (611)
Q Consensus 158 ~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~------~~~ 231 (611)
..++.||+|+-+.+|-.-.. +.. +.|++.+-.... .. +.+..|.+.-.||-+-.=+.+- -+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e~-----~d~-VAKIYh~Pppa~---~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~ 81 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV-----RDQ-VAKIYHAPPPAA---QA---QKVAELAATPDAPLLNYRVAWPQATLHGGRR 81 (637)
T ss_pred CCCccccCCccceeeecchh-----hch-hheeecCCCchH---HH---HHHHHhccCCCCcchhhhhcccHHHhhCCCc
Confidence 45788999999998865422 222 448875543221 11 2333344444566443312111 122
Q ss_pred -CeeEEEeeecCCCCh-HHHHH-----hcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEE
Q 007253 232 -DNVYVVMELCEGGEL-LDRIL-----SRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304 (611)
Q Consensus 232 -~~~~lv~E~~~~gsL-~~~l~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl 304 (611)
..+.+.|..+.|..= .+++. .......|..+.+.++.|+.+.+-||..|.+-+|++++|+|+ ++.+.|.|
T Consensus 82 ~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lV---sd~~~V~L 158 (637)
T COG4248 82 GKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLV---SDDSKVVL 158 (637)
T ss_pred cceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceee---ecCceEEE
Confidence 237788998877522 22221 112347899999999999999999999999999999999999 56777999
Q ss_pred eecccccccCCCCcccccccCCCcCcchhhc-CC-----CCCcchhhHHHHHHHHHHhC-CCCCCCCCh----HHHHH-H
Q 007253 305 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RS-----YSTEADVWSIGVIAYILLCG-SRPFWARTE----SGIFR-A 372 (611)
Q Consensus 305 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~-----~~~~~DiwSlGvil~el~~g-~~Pf~~~~~----~~~~~-~ 372 (611)
+|-..-.+-..+......+|.+.|.+||.-+ +. -+..+|.|.|||++++++.| +.||.+-.. ..-++ .
T Consensus 159 VdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 159 VDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred EcccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 9866544444445556678999999999765 33 35679999999999999987 999954211 00111 1
Q ss_pred HHh--------c----CCCCCCCCCCCCCHHHHHHHHHhccc--CccCCCCHH
Q 007253 373 VLK--------A----DPSFDEAPWPSLSSEARDFVKRLLNK--DPRKRLTAA 411 (611)
Q Consensus 373 i~~--------~----~~~~~~~~~~~~s~~~~~li~~~L~~--dP~~Rpt~~ 411 (611)
|.. . .+.....+|.-+++.+..|+.+|+.. ++.-|||++
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 111 1 12223344566889999999999875 356899865
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.03 E-value=8.8e-09 Score=102.75 Aligned_cols=130 Identities=17% Similarity=0.160 Sum_probs=90.9
Q ss_pred cCcEEEEEEecCCCcCC--------HHHHHHHHHHHHHHHHhcCCCC--eeEEEEEEee-----CCeeEEEeeecCCC-C
Q 007253 182 KGQQVAVKVIPKHKMTT--------AIAIEDVRREVKILRALTGHNN--LVKFFDAYED-----TDNVYVVMELCEGG-E 245 (611)
Q Consensus 182 ~g~~vavK~~~~~~~~~--------~~~~~~~~~E~~~l~~l~~h~~--iv~l~~~~~~-----~~~~~lv~E~~~~g-s 245 (611)
.|+.|.||......... ......+.+|...+.+|. .-+ +...+++... ...-+||||++++. +
T Consensus 44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~s 122 (268)
T PRK15123 44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLH-EVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTIS 122 (268)
T ss_pred CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHH-HcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCcc
Confidence 46778888763221100 000113678999998885 222 2334444433 23578999999876 7
Q ss_pred hHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEecc----CCCceEEEeecccccc
Q 007253 246 LLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK----DENSVLKAIDFGLSDF 312 (611)
Q Consensus 246 L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~----~~~~~vkl~DfG~a~~ 312 (611)
|.+++... ....+......++.+++..+.-||+.||+|+|+++.|||+... ++...+.|+||+.+..
T Consensus 123 L~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 123 LEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 88876532 2346677888999999999999999999999999999999641 3457899999998854
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1e-09 Score=117.83 Aligned_cols=154 Identities=24% Similarity=0.275 Sum_probs=111.1
Q ss_pred HHHHHHHHHHHc-CCeeecCCCCceEEeccCCCceEEEeecccccccCCCCcc----------cccccCCCcCcchhhcC
Q 007253 268 QILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL----------NDIVGSAYYVAPEVLHR 336 (611)
Q Consensus 268 qi~~~L~~LH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~----------~~~~gt~~y~aPE~~~~ 336 (611)
+.+.||.|+|.. ++||++|.|++|.+ +.++.+||+-|+.+......... .-..-...|.|||++..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred cccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 344999999987 89999999999999 57888999999987655432111 11234567999998864
Q ss_pred -CCCCcchhhHHHHHHHHHH-hCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHH
Q 007253 337 -SYSTEADVWSIGVIAYILL-CGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414 (611)
Q Consensus 337 -~~~~~~DiwSlGvil~el~-~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll 414 (611)
.-+.++|+||+||++|-+. .|+.-+........+.........-....-.++++++++-|.++|..++..||++..++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 4677999999999999888 55555544332222211111110000111147899999999999999999999999999
Q ss_pred cCcccCCCCC
Q 007253 415 SHPWIKNSND 424 (611)
Q Consensus 415 ~hp~~~~~~~ 424 (611)
..+||.+..-
T Consensus 264 ~~~ff~D~~~ 273 (700)
T KOG2137|consen 264 SIPFFSDPGL 273 (700)
T ss_pred cccccCCchh
Confidence 9999997663
|
|
| >PF13499 EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A 1TN4_A 1A2X_A 2CT9_B 2OTG_B 2OS8_B 1SNL_A 3O4Y_A 3J04_E | Back alignment and domain information |
|---|
Probab=98.99 E-value=9.1e-10 Score=85.28 Aligned_cols=57 Identities=30% Similarity=0.581 Sum_probs=48.8
Q ss_pred HHHHHhHHhcCCCCcccHHHHHHHhc-CCCCc---c----HHHHHHHHhcCCCCceeHHHHHHHH
Q 007253 543 ARCAYELFEKDGNRAIVIEELASELG-LGPAV---P----VHAVLHDWIRHTDGKLSFLGFVKLL 599 (611)
Q Consensus 543 ~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~---~----~~~~~~~~D~~~dG~is~~eF~~~l 599 (611)
++.+|+.+|+|++|+|+.+||+.++. ++... . ++.+|+.+|.|+||.|+|+||.+++
T Consensus 2 l~~~F~~~D~d~~G~i~~~el~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~i~~~Ef~~~~ 66 (66)
T PF13499_consen 2 LKEAFKKFDKDGDGYISKEELRRALKHLGRDMSDEESDEMIDQIFREFDTDGDGRISFDEFLNFM 66 (66)
T ss_dssp HHHHHHHHSTTSSSEEEHHHHHHHHHHTTSHSTHHHHHHHHHHHHHHHTTTSSSSEEHHHHHHHH
T ss_pred HHHHHHHHcCCccCCCCHHHHHHHHHHhcccccHHHHHHHHHHHHHHhCCCCcCCCcHHHHhccC
Confidence 57899999999999999999999994 44321 1 6777999999999999999999875
|
... |
| >KOG0377 consensus Protein serine/threonine phosphatase RDGC/PPEF, contains STphosphatase and EF-hand domains [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=5.5e-09 Score=104.87 Aligned_cols=158 Identities=15% Similarity=0.251 Sum_probs=111.2
Q ss_pred HHHHHHHhhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHH
Q 007253 446 LRKAALRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCA 525 (611)
Q Consensus 446 l~~~~l~~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~ 525 (611)
.....++.+...+.. ...+|.+.|+++|.++.|+|+..++..+++...+-+++...+..-+. ..+.+|.+.|.+.+.
T Consensus 447 vEeSAlk~Lrerl~s-~~sdL~~eF~~~D~~ksG~lsis~Wa~~mE~i~~L~LPWr~L~~kla--~~s~d~~v~Y~~~~~ 523 (631)
T KOG0377|consen 447 VEESALKELRERLRS-HRSDLEDEFRKYDPKKSGKLSISHWAKCMENITGLNLPWRLLRPKLA--NGSDDGKVEYKSTLD 523 (631)
T ss_pred HHHHHHHHHHHHHHh-hhhHHHHHHHhcChhhcCeeeHHHHHHHHHHHhcCCCcHHHhhhhcc--CCCcCcceehHhHHH
Confidence 344455555444322 23468899999999999999999999999887765555443332222 344678999998876
Q ss_pred HHcchhh--------HHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-----CCCCcc---HHHHHHHHhcCCCCc
Q 007253 526 AALSVHQ--------LEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-----LGPAVP---VHAVLHDWIRHTDGK 589 (611)
Q Consensus 526 ~~~~~~~--------~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-----~~~~~~---~~~~~~~~D~~~dG~ 589 (611)
.+....- .+...+....++.+|+.+|.|++|.|+.+||+.+.. +...++ +.++-+-+|.|+||+
T Consensus 524 ~l~~e~~~~ea~~slvetLYr~ks~LetiF~~iD~D~SG~isldEF~~a~~l~~sh~~~~i~~~~i~~la~~mD~NkDG~ 603 (631)
T KOG0377|consen 524 NLDTEVILEEAGSSLVETLYRNKSSLETIFNIIDADNSGEISLDEFRTAWKLLSSHMNGAISDDEILELARSMDLNKDGK 603 (631)
T ss_pred HhhhhhHHHHHHhHHHHHHHhchhhHHHHHHHhccCCCCceeHHHHHHHHHHHHhhcCCCcCHHHHHHHHHhhccCCCCc
Confidence 5432110 112223355688899999999999999999999872 333333 677788899999999
Q ss_pred eeHHHHHHHHhhcchhh
Q 007253 590 LSFLGFVKLLHGVSSRA 606 (611)
Q Consensus 590 is~~eF~~~l~~~~~~~ 606 (611)
|++.||.++++=+.-+.
T Consensus 604 IDlNEfLeAFrlvdr~~ 620 (631)
T KOG0377|consen 604 IDLNEFLEAFRLVDRRR 620 (631)
T ss_pred ccHHHHHHHHhhhcchh
Confidence 99999999987655433
|
|
| >cd05022 S-100A13 S-100A13: S-100A13 domain found in proteins similar to S100A13 | Back alignment and domain information |
|---|
Probab=98.97 E-value=9.7e-10 Score=89.62 Aligned_cols=65 Identities=17% Similarity=0.209 Sum_probs=56.6
Q ss_pred HHHHHHHHhHHhc-CCCCcccHHHHHHHhc--CCCC----ccHHHHHHHHhcCCCCceeHHHHHHHHhhcch
Q 007253 540 EQHARCAYELFEK-DGNRAIVIEELASELG--LGPA----VPVHAVLHDWIRHTDGKLSFLGFVKLLHGVSS 604 (611)
Q Consensus 540 ~~~~~~~F~~~D~-d~~G~It~eEl~~~l~--~~~~----~~~~~~~~~~D~~~dG~is~~eF~~~l~~~~~ 604 (611)
-..++.+|+.||+ +++|+|+.+||+.+|. ++.. ..++.+|+.+|.|+||.|+|+||+.+|.++..
T Consensus 7 i~~l~~~F~~fd~~~~~g~i~~~ELk~ll~~elg~~ls~~~~v~~mi~~~D~d~DG~I~F~EF~~l~~~l~~ 78 (89)
T cd05022 7 IETLVSNFHKASVKGGKESLTASEFQELLTQQLPHLLKDVEGLEEKMKNLDVNQDSKLSFEEFWELIGELAK 78 (89)
T ss_pred HHHHHHHHHHHhCCCCCCeECHHHHHHHHHHHhhhhccCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHHH
Confidence 4468889999999 9999999999999993 4432 33899999999999999999999999988754
|
S100A13 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A13 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100A13 is involved in the cellular export of interleukin-1 (IL-1) and of fibroblast growth factor-1 (FGF-1), which plays an important role in angiogenesis and tissue regeneration. Export is based on the CuII-dependent formation of multiprotein complexes containing the S100A13 protein. Assembly of these complexes occurs near the inner surface of the plasma membrane. Binding of two Ca(II) ions per monomer triggers key conformational changes leading to the creation of two identical and symmetrical Cu(II)-binding sites on the surface of the protein, close to the interface between the two monomers. These Cu |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.96 E-value=4e-09 Score=99.23 Aligned_cols=130 Identities=25% Similarity=0.288 Sum_probs=81.3
Q ss_pred EEEEEEEecCCccCcEEEEEEecCCCc-----------------------CCHHHHHHHHHHHHHHHHhcCC-CCeeEEE
Q 007253 170 YTCAAKFKKGELKGQQVAVKVIPKHKM-----------------------TTAIAIEDVRREVKILRALTGH-NNLVKFF 225 (611)
Q Consensus 170 ~V~~~~~~~~~~~g~~vavK~~~~~~~-----------------------~~~~~~~~~~~E~~~l~~l~~h-~~iv~l~ 225 (611)
.||.|... .|..+|||+...... ..........+|.+.|.++... -++.+.+
T Consensus 1 ~Vy~~~~~----~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~ 76 (188)
T PF01163_consen 1 DVYHAIDP----DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPY 76 (188)
T ss_dssp EEEEEEEC----TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EE
T ss_pred CEEEEECC----CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEE
Confidence 37888754 377999998743210 1112334567999999999832 2566666
Q ss_pred EEEeeCCeeEEEeeecC--CCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHH-HHHcCCeeecCCCCceEEeccCCCceE
Q 007253 226 DAYEDTDNVYVVMELCE--GGELLDRILSRGGKYTEDDAKAVMIQILNVVAF-CHLQGVVHRDLKPENFLFTTKDENSVL 302 (611)
Q Consensus 226 ~~~~~~~~~~lv~E~~~--~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~-LH~~~iiHrDlkp~NIll~~~~~~~~v 302 (611)
++. ..+|||||++ |..+ ..+... .++......++.+++..+.. +|..||||+||.+.|||+.. +.+
T Consensus 77 ~~~----~~~ivME~I~~~G~~~-~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~----~~~ 145 (188)
T PF01163_consen 77 DYN----RNVIVMEYIGEDGVPL-PRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDD----GKV 145 (188)
T ss_dssp EEE----TTEEEEE--EETTEEG-GCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEET----TCE
T ss_pred EEe----CCEEEEEecCCCccch-hhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeec----ceE
Confidence 442 3479999998 5444 333322 12245667788888886665 57999999999999999952 269
Q ss_pred EEeecccccccC
Q 007253 303 KAIDFGLSDFVR 314 (611)
Q Consensus 303 kl~DfG~a~~~~ 314 (611)
.|+|||.+....
T Consensus 146 ~iIDf~qav~~~ 157 (188)
T PF01163_consen 146 YIIDFGQAVDSS 157 (188)
T ss_dssp EE--GTTEEETT
T ss_pred EEEecCcceecC
Confidence 999999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PTZ00183 centrin; Provisional | Back alignment and domain information |
|---|
Probab=98.94 E-value=3.5e-09 Score=97.47 Aligned_cols=100 Identities=12% Similarity=0.176 Sum_probs=83.0
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHH
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHAR 544 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~ 544 (611)
.+..+|..+|.+++|.|+++||..++.........+..+..+|..+|.+++|.|+.+||..++........ ..++.
T Consensus 54 ~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~l~----~~~~~ 129 (158)
T PTZ00183 54 EIKQMIADVDKDGSGKIDFEEFLDIMTKKLGERDPREEILKAFRLFDDDKTGKISLKNLKRVAKELGETIT----DEELQ 129 (158)
T ss_pred HHHHHHHHhCCCCCCcEeHHHHHHHHHHHhcCCCcHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCC----HHHHH
Confidence 47789999999999999999999987554332344566889999999999999999999988865433333 55788
Q ss_pred HHHhHHhcCCCCcccHHHHHHHhc
Q 007253 545 CAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 545 ~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
.+|..+|.|++|.|+.+||..++.
T Consensus 130 ~~~~~~d~~~~g~i~~~ef~~~~~ 153 (158)
T PTZ00183 130 EMIDEADRNGDGEISEEEFYRIMK 153 (158)
T ss_pred HHHHHhCCCCCCcCcHHHHHHHHh
Confidence 899999999999999999999885
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.90 E-value=2e-08 Score=96.88 Aligned_cols=141 Identities=18% Similarity=0.206 Sum_probs=97.3
Q ss_pred EEEEEEecCCccCcEEEEEEecCCCcCC----HHHHHHHHHHHHHHHHhcCCC--CeeEEEEEEeeC----CeeEEEeee
Q 007253 171 TCAAKFKKGELKGQQVAVKVIPKHKMTT----AIAIEDVRREVKILRALTGHN--NLVKFFDAYEDT----DNVYVVMEL 240 (611)
Q Consensus 171 V~~~~~~~~~~~g~~vavK~~~~~~~~~----~~~~~~~~~E~~~l~~l~~h~--~iv~l~~~~~~~----~~~~lv~E~ 240 (611)
++.+........++.|-+|........+ ........+|...+.+|. .- .+...+++.... ...+||+|+
T Consensus 20 ~~~~~~~~~~~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~-~~Gi~tP~pva~~~~r~~~~~~s~lite~ 98 (206)
T PF06293_consen 20 GWFGVQRVVDLVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLR-EAGIPTPEPVAYGERRKGGGYRSYLITEA 98 (206)
T ss_pred EEEEEEccccccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHH-HcCCCCCcEEEEEEEcCCCceeEEEEEEe
Confidence 3443333333456666777543211111 122345778888888876 22 244555555542 245899999
Q ss_pred cCCC-ChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 241 CEGG-ELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 241 ~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+++. +|.+++..... ++......++.+++..+.-||+.||+|+|+++.|||+...+....+.|+||+-++..
T Consensus 99 l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 99 LPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred CCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9885 77777755333 677888999999999999999999999999999999976555568999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >cd05022 S-100A13 S-100A13: S-100A13 domain found in proteins similar to S100A13 | Back alignment and domain information |
|---|
Probab=98.88 E-value=3.1e-09 Score=86.64 Aligned_cols=72 Identities=14% Similarity=0.214 Sum_probs=62.0
Q ss_pred hhHHHHHHHHhhhcCC-CCCCcccHHHHHHHHHhhccccccc-CChhHHHhhcCCCCCCcccHHHHHHHHcchh
Q 007253 460 VDELFYLKEQYALLEP-NKNGTISLENVKSALMKNATDAMKD-SRIPDFLSSLNSLQYRRMDFEEFCAAALSVH 531 (611)
Q Consensus 460 ~~e~~~l~~~F~~~D~-d~~G~Is~~e~~~~l~~~~~~~~~~-~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~ 531 (611)
+.-+..|+++|+.||. +++|+|+..||+.+|....+..+++ .++++||+.+|.|+||.|+|+||+.++....
T Consensus 4 E~ai~~l~~~F~~fd~~~~~g~i~~~ELk~ll~~elg~~ls~~~~v~~mi~~~D~d~DG~I~F~EF~~l~~~l~ 77 (89)
T cd05022 4 EKAIETLVSNFHKASVKGGKESLTASEFQELLTQQLPHLLKDVEGLEEKMKNLDVNQDSKLSFEEFWELIGELA 77 (89)
T ss_pred HHHHHHHHHHHHHHhCCCCCCeECHHHHHHHHHHHhhhhccCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHH
Confidence 3456789999999999 9999999999999998833344677 7899999999999999999999998876543
|
S100A13 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A13 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100A13 is involved in the cellular export of interleukin-1 (IL-1) and of fibroblast growth factor-1 (FGF-1), which plays an important role in angiogenesis and tissue regeneration. Export is based on the CuII-dependent formation of multiprotein complexes containing the S100A13 protein. Assembly of these complexes occurs near the inner surface of the plasma membrane. Binding of two Ca(II) ions per monomer triggers key conformational changes leading to the creation of two identical and symmetrical Cu(II)-binding sites on the surface of the protein, close to the interface between the two monomers. These Cu |
| >KOG0037 consensus Ca2+-binding protein, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.7e-08 Score=93.32 Aligned_cols=120 Identities=12% Similarity=0.174 Sum_probs=57.2
Q ss_pred HHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHHHH
Q 007253 467 KEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCA 546 (611)
Q Consensus 467 ~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~ 546 (611)
+-+..+||.+++|+|.+.||+++. +... ....+|..+|.|++|+|+..|+..++....-... .+....+
T Consensus 97 rlmI~mfd~~~~G~i~f~EF~~Lw-~~i~------~Wr~vF~~~D~D~SG~I~~sEL~~Al~~~Gy~Ls----pq~~~~l 165 (221)
T KOG0037|consen 97 RLMISMFDRDNSGTIGFKEFKALW-KYIN------QWRNVFRTYDRDRSGTIDSSELRQALTQLGYRLS----PQFYNLL 165 (221)
T ss_pred HHHHHHhcCCCCCccCHHHHHHHH-HHHH------HHHHHHHhcccCCCCcccHHHHHHHHHHcCcCCC----HHHHHHH
Confidence 334444555555555555555532 1111 1344555555555555555555555544332222 3334445
Q ss_pred HhHHhcCCCCcccHHHHHHHhcCCCCccHHHHHHHHhcCCCCc--eeHHHHHHHH
Q 007253 547 YELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGK--LSFLGFVKLL 599 (611)
Q Consensus 547 F~~~D~d~~G~It~eEl~~~l~~~~~~~~~~~~~~~D~~~dG~--is~~eF~~~l 599 (611)
++.||..++|.|..+++.+.+-.... +-+.|+..|.+.+|. |+|++|+.+.
T Consensus 166 v~kyd~~~~g~i~FD~FI~ccv~L~~--lt~~Fr~~D~~q~G~i~~~y~dfl~~t 218 (221)
T KOG0037|consen 166 VRKYDRFGGGRIDFDDFIQCCVVLQR--LTEAFRRRDTAQQGSITISYDDFLQMT 218 (221)
T ss_pred HHHhccccCCceeHHHHHHHHHHHHH--HHHHHHHhccccceeEEEeHHHHHHHh
Confidence 55555554555555555555421111 234455555555554 3555555543
|
|
| >PF13499 EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A 1TN4_A 1A2X_A 2CT9_B 2OTG_B 2OS8_B 1SNL_A 3O4Y_A 3J04_E | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.7e-09 Score=81.87 Aligned_cols=62 Identities=26% Similarity=0.395 Sum_probs=41.6
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhccc---ccccCChhHHHhhcCCCCCCcccHHHHHHH
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNATD---AMKDSRIPDFLSSLNSLQYRRMDFEEFCAA 526 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~---~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~ 526 (611)
+|+++|..+|.|++|+|+.+||..++...+.. ...+..+..+|+.+|.|++|.|+|+||+.+
T Consensus 1 ~l~~~F~~~D~d~~G~i~~~el~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~i~~~Ef~~~ 65 (66)
T PF13499_consen 1 RLKEAFKKFDKDGDGYISKEELRRALKHLGRDMSDEESDEMIDQIFREFDTDGDGRISFDEFLNF 65 (66)
T ss_dssp HHHHHHHHHSTTSSSEEEHHHHHHHHHHTTSHSTHHHHHHHHHHHHHHHTTTSSSSEEHHHHHHH
T ss_pred CHHHHHHHHcCCccCCCCHHHHHHHHHHhcccccHHHHHHHHHHHHHHhCCCCcCCCcHHHHhcc
Confidence 47889999999999999999999988777642 112223344455566666666666666543
|
... |
| >cd05027 S-100B S-100B: S-100B domain found in proteins similar to S100B | Back alignment and domain information |
|---|
Probab=98.81 E-value=8.5e-09 Score=84.25 Aligned_cols=65 Identities=17% Similarity=0.290 Sum_probs=55.7
Q ss_pred HHHHHHHHhHHh-cCCCC-cccHHHHHHHhc------CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhcch
Q 007253 540 EQHARCAYELFE-KDGNR-AIVIEELASELG------LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGVSS 604 (611)
Q Consensus 540 ~~~~~~~F~~~D-~d~~G-~It~eEl~~~l~------~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~~~ 604 (611)
-..++.+|+.|| +|++| +|+.+||+.+|. ++...+ ++.+|+.+|.|+||.|+|+||+.++.++..
T Consensus 7 ~~~l~~aF~~fD~~dgdG~~I~~~eL~~ll~~~~~~~lg~~~~~~~v~~~i~~~D~n~dG~v~f~eF~~li~~~~~ 82 (88)
T cd05027 7 MVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGECDFQEFMAFVAMVTT 82 (88)
T ss_pred HHHHHHHHHHhcccCCCcCEECHHHHHHHHHHHhHHHhcCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHH
Confidence 346888999998 89999 599999999994 454433 899999999999999999999999987653
|
S100B is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100B group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100B is most abundant in glial cells of the central nervous system, predominately in astrocytes. S100B is involved in signal transduction via the inhibition of protein phoshorylation, regulation of enzyme activity and by affecting the calcium homeostasis. Upon calcium binding the S100B homodimer changes conformation to expose a hydrophobic cleft, which represents the interaction site of S100B with its more than 20 known target proteins. These target proteins include several cellular architecture proteins such as tubulin and GFAP; S100B can inhibit polymerization of these oligomeric molecules. Furthermore, S100B i |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.8e-08 Score=96.08 Aligned_cols=139 Identities=26% Similarity=0.271 Sum_probs=100.4
Q ss_pred eeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCC----------------c-C--CHHHHHHHHHHHHHHHHhcC
Q 007253 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHK----------------M-T--TAIAIEDVRREVKILRALTG 217 (611)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~----------------~-~--~~~~~~~~~~E~~~l~~l~~ 217 (611)
+.++.+||-|--+.||.|... .|..+|||.=.-.. . . -........+|.++|.+|..
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~----~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~ 168 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP----KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYP 168 (304)
T ss_pred HhhccccccCccceEEEEECC----CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhh
Confidence 567899999999999999865 48899999642110 0 0 01123446789999999974
Q ss_pred C-CCeeEEEEEEeeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEecc
Q 007253 218 H-NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296 (611)
Q Consensus 218 h-~~iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~ 296 (611)
+ -.|.+-++ .+...+||||++|-.|... ++.......++..|+.-+.-+-..||||+|+.+-||++
T Consensus 169 ~G~~VP~P~~----~nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV--- 235 (304)
T COG0478 169 EGVKVPKPIA----WNRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV--- 235 (304)
T ss_pred cCCCCCCccc----cccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE---
Confidence 3 24555443 4678899999998655431 23455666677777777777778999999999999999
Q ss_pred CCCceEEEeecccccc
Q 007253 297 DENSVLKAIDFGLSDF 312 (611)
Q Consensus 297 ~~~~~vkl~DfG~a~~ 312 (611)
+++|.++++||--+..
T Consensus 236 ~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 236 TEDGDIVVIDWPQAVP 251 (304)
T ss_pred ecCCCEEEEeCccccc
Confidence 5677799999976543
|
|
| >PTZ00184 calmodulin; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=2.7e-08 Score=90.36 Aligned_cols=101 Identities=13% Similarity=0.161 Sum_probs=81.3
Q ss_pred HHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHH
Q 007253 464 FYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHA 543 (611)
Q Consensus 464 ~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~ 543 (611)
..+..+|..+|.+++|.|++++|..++............+..+|..+|.+++|.|+.+||..++........ .+.+
T Consensus 47 ~~~~~~~~~~d~~~~g~i~~~ef~~~l~~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~----~~~~ 122 (149)
T PTZ00184 47 AELQDMINEVDADGNGTIDFPEFLTLMARKMKDTDSEEEIKEAFKVFDRDGNGFISAAELRHVMTNLGEKLT----DEEV 122 (149)
T ss_pred HHHHHHHHhcCcCCCCcCcHHHHHHHHHHhccCCcHHHHHHHHHHhhCCCCCCeEeHHHHHHHHHHHCCCCC----HHHH
Confidence 357899999999999999999999987654322233445788999999999999999999887755432222 5567
Q ss_pred HHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 544 RCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 544 ~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
..+|+.+|.+++|.|+.+||..++.
T Consensus 123 ~~~~~~~d~~~~g~i~~~ef~~~~~ 147 (149)
T PTZ00184 123 DEMIREADVDGDGQINYEEFVKMMM 147 (149)
T ss_pred HHHHHhcCCCCCCcCcHHHHHHHHh
Confidence 8899999999999999999998763
|
|
| >cd05027 S-100B S-100B: S-100B domain found in proteins similar to S100B | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.4e-08 Score=82.89 Aligned_cols=72 Identities=14% Similarity=0.185 Sum_probs=60.6
Q ss_pred hhHHHHHHHHhhhcC-CCCCC-cccHHHHHHHHHh----hcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchh
Q 007253 460 VDELFYLKEQYALLE-PNKNG-TISLENVKSALMK----NATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVH 531 (611)
Q Consensus 460 ~~e~~~l~~~F~~~D-~d~~G-~Is~~e~~~~l~~----~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~ 531 (611)
+.-+..|+++|+.|| .+++| +|+.+||+.+|.. +.+...++++++++++.+|.|++|+|+|+||+.++....
T Consensus 4 e~~~~~l~~aF~~fD~~dgdG~~I~~~eL~~ll~~~~~~~lg~~~~~~~v~~~i~~~D~n~dG~v~f~eF~~li~~~~ 81 (88)
T cd05027 4 EKAMVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGECDFQEFMAFVAMVT 81 (88)
T ss_pred HHHHHHHHHHHHHhcccCCCcCEECHHHHHHHHHHHhHHHhcCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHH
Confidence 345678999999998 79999 5999999999977 233456777899999999999999999999998776543
|
S100B is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100B group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100B is most abundant in glial cells of the central nervous system, predominately in astrocytes. S100B is involved in signal transduction via the inhibition of protein phoshorylation, regulation of enzyme activity and by affecting the calcium homeostasis. Upon calcium binding the S100B homodimer changes conformation to expose a hydrophobic cleft, which represents the interaction site of S100B with its more than 20 known target proteins. These target proteins include several cellular architecture proteins such as tubulin and GFAP; S100B can inhibit polymerization of these oligomeric molecules. Furthermore, S100B i |
| >KOG0028 consensus Ca2+-binding protein (centrin/caltractin), EF-Hand superfamily protein [Cytoskeleton; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.75 E-value=4.3e-08 Score=85.82 Aligned_cols=101 Identities=11% Similarity=0.131 Sum_probs=88.2
Q ss_pred HHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHH
Q 007253 464 FYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHA 543 (611)
Q Consensus 464 ~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~ 543 (611)
+++..+..-+|.++.|+|++++|...+....+..-+..++..+|+.+|.|++|+|++.+|+.++..+....+ .+++
T Consensus 69 ~ei~kll~d~dk~~~g~i~fe~f~~~mt~k~~e~dt~eEi~~afrl~D~D~~Gkis~~~lkrvakeLgenlt----D~El 144 (172)
T KOG0028|consen 69 EEILKLLADVDKEGSGKITFEDFRRVMTVKLGERDTKEEIKKAFRLFDDDKTGKISQRNLKRVAKELGENLT----DEEL 144 (172)
T ss_pred HHHHHHHHhhhhccCceechHHHHHHHHHHHhccCcHHHHHHHHHcccccCCCCcCHHHHHHHHHHhCcccc----HHHH
Confidence 457778888999999999999999987776654457788999999999999999999999999888877666 6688
Q ss_pred HHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 544 RCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 544 ~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
....+.+|.|++|-|+.+||.+++.
T Consensus 145 ~eMIeEAd~d~dgevneeEF~~imk 169 (172)
T KOG0028|consen 145 MEMIEEADRDGDGEVNEEEFIRIMK 169 (172)
T ss_pred HHHHHHhcccccccccHHHHHHHHh
Confidence 8899999999999999999998874
|
|
| >cd05026 S-100Z S-100Z: S-100Z domain found in proteins similar to S100Z | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.8e-08 Score=83.47 Aligned_cols=65 Identities=22% Similarity=0.340 Sum_probs=54.2
Q ss_pred HHHHHHHHhHHh-cCCCC-cccHHHHHHHhc--C----CCCc---cHHHHHHHHhcCCCCceeHHHHHHHHhhcch
Q 007253 540 EQHARCAYELFE-KDGNR-AIVIEELASELG--L----GPAV---PVHAVLHDWIRHTDGKLSFLGFVKLLHGVSS 604 (611)
Q Consensus 540 ~~~~~~~F~~~D-~d~~G-~It~eEl~~~l~--~----~~~~---~~~~~~~~~D~~~dG~is~~eF~~~l~~~~~ 604 (611)
-..++.+|..|| +|++| +|+.+||+.++. . .... .++++|+.+|.|+||.|+|+||+.+|..+..
T Consensus 9 ~~~~~~~F~~~dd~dgdg~~Is~~EL~~ll~~~~~~~~~~~~~~~~v~~i~~elD~n~dG~Idf~EF~~l~~~l~~ 84 (93)
T cd05026 9 MDTLIRIFHNYSGKEGDRYKLSKGELKELLQRELTDFLSSQKDPMLVDKIMNDLDSNKDNEVDFNEFVVLVAALTV 84 (93)
T ss_pred HHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHhHHhcccccCHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHH
Confidence 346778899998 89998 599999999993 2 2222 2999999999999999999999999988754
|
S100Z is a member of the S100 domain family within the EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100Z group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately.S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control. S100Z is normally expressed in various tissues, with its highest level of expression being in spleen and leukocytes. The function of S100Z remains unclear. Preliminary structural data suggests that S100Z is homodimer, however a heterodimer with S100P has been reported. S100Z is capable of binding calcium ions. When calcium binds to S110Z, the protein experiences a conformational change, which exposes hydrophobic surfac |
| >cd05029 S-100A6 S-100A6: S-100A6 domain found in proteins similar to S100A6 | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.5e-08 Score=81.51 Aligned_cols=64 Identities=16% Similarity=0.367 Sum_probs=55.9
Q ss_pred HHHHHHHhHHhc-CC-CCcccHHHHHHHhc----CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhcch
Q 007253 541 QHARCAYELFEK-DG-NRAIVIEELASELG----LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGVSS 604 (611)
Q Consensus 541 ~~~~~~F~~~D~-d~-~G~It~eEl~~~l~----~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~~~ 604 (611)
..+..+|..||. || +|+|+.+||+++|. +|...+ ++++|+.+|.|+||+|+|+||+.+|.++..
T Consensus 10 ~~~i~~F~~y~~~~~~~g~Is~~EL~~~l~~~~~lg~k~t~~ev~~m~~~~D~d~dG~Idf~EFv~lm~~l~~ 82 (88)
T cd05029 10 GLLVAIFHKYSGREGDKNTLSKKELKELIQKELTIGSKLQDAEIAKLMEDLDRNKDQEVNFQEYVTFLGALAL 82 (88)
T ss_pred HHHHHHHHHHHccCCCCCEECHHHHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCCCcHHHHHHHHHHHHH
Confidence 456779999998 77 89999999999993 566555 899999999999999999999999988753
|
S100A6 is a member of the S100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A6 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100A6 is normally expressed in the G1 phase of the cell cycle in neuronal cells. The function of S100A6 remains unclear, but evidence suggests that it is involved in cell cycle regulation and exocytosis. S100A6 may also be involved in tumorigenesis; the protein is overexpressed in several tumors. Ca2+ binding to S100A6 leads to a conformational change in the protein, which exposes a hydrophobic surface for interact |
| >smart00027 EH Eps15 homology domain | Back alignment and domain information |
|---|
Probab=98.73 E-value=2e-08 Score=83.97 Aligned_cols=73 Identities=15% Similarity=0.253 Sum_probs=64.3
Q ss_pred chhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhH
Q 007253 458 LTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQL 533 (611)
Q Consensus 458 l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~ 533 (611)
++.+++.+++++|..+|.+++|.|+.+|++.+|...+ ++++++..++..+|.+++|.|+|+||+.++....+.
T Consensus 4 ls~~~~~~l~~~F~~~D~d~~G~Is~~el~~~l~~~~---~~~~ev~~i~~~~d~~~~g~I~~~eF~~~~~~~~~~ 76 (96)
T smart00027 4 ISPEDKAKYEQIFRSLDKNQDGTVTGAQAKPILLKSG---LPQTLLAKIWNLADIDNDGELDKDEFALAMHLIYRK 76 (96)
T ss_pred CCHHHHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHcC---CCHHHHHHHHHHhcCCCCCCcCHHHHHHHHHHHHHH
Confidence 5778899999999999999999999999999987753 566789999999999999999999999888765544
|
Pair of EF hand motifs that recognise proteins containing Asn-Pro-Phe (NPF) sequences. |
| >cd00252 SPARC_EC SPARC_EC; extracellular Ca2+ binding domain (containing 2 EF-hand motifs) of SPARC and related proteins (QR1, SC1/hevin, testican and tsc-36/FRP) | Back alignment and domain information |
|---|
Probab=98.66 E-value=5.2e-08 Score=83.56 Aligned_cols=61 Identities=13% Similarity=0.177 Sum_probs=52.8
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhcCCCCcc-HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELGLGPAVP-VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~~~~~~~-~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
...+..+|..+|.|+||+|+.+||..++ +++... +..+|..+|.|+||.||++||..++..
T Consensus 47 ~~~l~w~F~~lD~d~DG~Ls~~EL~~~~-l~~~e~~~~~f~~~~D~n~Dg~IS~~Ef~~cl~~ 108 (116)
T cd00252 47 KDPVGWMFNQLDGNYDGKLSHHELAPIR-LDPNEHCIKPFFESCDLDKDGSISLDEWCYCFIK 108 (116)
T ss_pred HHHHHHHHHHHCCCCCCcCCHHHHHHHH-ccchHHHHHHHHHHHCCCCCCCCCHHHHHHHHhC
Confidence 6688999999999999999999999887 333222 788999999999999999999998843
|
SPARC (BM-40) is a multifunctional glycoprotein, a matricellular protein, that functions to regulate cell-matrix interactions; binds to such proteins as collagen and vitronectin and binds to endothelial cells thus inhibiting cellular proliferation. The EC domain interacts with a follistatin-like (FS) domain which appears to stabilize Ca2+ binding. The two EF-hands interact canonically but their conserved disulfide bonds confer a tight association between the EF-hand pair and an acid/amphiphilic N-terminal helix. Proposed active form involves a Ca2+ dependent symmetric homodimerization of EC-FS modules. |
| >cd05026 S-100Z S-100Z: S-100Z domain found in proteins similar to S100Z | Back alignment and domain information |
|---|
Probab=98.65 E-value=4.9e-08 Score=80.94 Aligned_cols=71 Identities=17% Similarity=0.242 Sum_probs=58.3
Q ss_pred hHHHHHHHHhhhcC-CCCCC-cccHHHHHHHHHhhccc----ccccCChhHHHhhcCCCCCCcccHHHHHHHHcchh
Q 007253 461 DELFYLKEQYALLE-PNKNG-TISLENVKSALMKNATD----AMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVH 531 (611)
Q Consensus 461 ~e~~~l~~~F~~~D-~d~~G-~Is~~e~~~~l~~~~~~----~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~ 531 (611)
.-+..+.++|+.|| .|++| +|+..||+.+|....+. ..++.++..+++.+|.|++|.|+|+||+.++....
T Consensus 7 ~a~~~~~~~F~~~dd~dgdg~~Is~~EL~~ll~~~~~~~~~~~~~~~~v~~i~~elD~n~dG~Idf~EF~~l~~~l~ 83 (93)
T cd05026 7 GAMDTLIRIFHNYSGKEGDRYKLSKGELKELLQRELTDFLSSQKDPMLVDKIMNDLDSNKDNEVDFNEFVVLVAALT 83 (93)
T ss_pred HHHHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHhHHhcccccCHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Confidence 44678999999999 78998 59999999998764321 23445799999999999999999999999886654
|
S100Z is a member of the S100 domain family within the EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100Z group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately.S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control. S100Z is normally expressed in various tissues, with its highest level of expression being in spleen and leukocytes. The function of S100Z remains unclear. Preliminary structural data suggests that S100Z is homodimer, however a heterodimer with S100P has been reported. S100Z is capable of binding calcium ions. When calcium binds to S110Z, the protein experiences a conformational change, which exposes hydrophobic surfac |
| >cd05025 S-100A1 S-100A1: S-100A1 domain found in proteins similar to S100A1 | Back alignment and domain information |
|---|
Probab=98.64 E-value=8.8e-08 Score=79.42 Aligned_cols=65 Identities=22% Similarity=0.363 Sum_probs=55.5
Q ss_pred HHHHHHHHhHHh-cCCCCc-ccHHHHHHHhc--CCC-------CccHHHHHHHHhcCCCCceeHHHHHHHHhhcch
Q 007253 540 EQHARCAYELFE-KDGNRA-IVIEELASELG--LGP-------AVPVHAVLHDWIRHTDGKLSFLGFVKLLHGVSS 604 (611)
Q Consensus 540 ~~~~~~~F~~~D-~d~~G~-It~eEl~~~l~--~~~-------~~~~~~~~~~~D~~~dG~is~~eF~~~l~~~~~ 604 (611)
++.++.+|+.|| +|++|+ |+.+||+.+|. ++. ...++.+|..+|.|++|.|+|+||+.++..+..
T Consensus 8 ~~~l~~~F~~fDd~dg~G~~Is~~El~~~l~~~lg~~~~~~~s~~~v~~i~~~~D~d~~G~I~f~eF~~l~~~~~~ 83 (92)
T cd05025 8 METLINVFHAHSGKEGDKYKLSKKELKDLLQTELSDFLDAQKDADAVDKIMKELDENGDGEVDFQEFVVLVAALTV 83 (92)
T ss_pred HHHHHHHHHHHhcccCCCCeECHHHHHHHHHHHHHHHccCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHHH
Confidence 567899999997 999995 99999999994 332 122899999999999999999999999987654
|
S100A1 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. As is the case with many other members of S100 protein family, S100A1 is implicated in intracellular and extracellular regulatory activities, including interaction with myosin-associated twitchin kinase, actin-capping protein CapZ, sinapsin I, and tubulin. Structural data suggests that S100A1 proteins exist within cells as antiparallel homodimers, while heterodimers with S100A4 and S100B also has been reported. Upon binding calcium S100A1 changes conformation to expose a hydrophobic cleft which is the interaction site of S100A1 with its more that 20 known target proteins. |
| >KOG0034 consensus Ca2+/calmodulin-dependent protein phosphatase (calcineurin subunit B), EF-Hand superfamily protein [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=9.4e-08 Score=88.98 Aligned_cols=105 Identities=14% Similarity=0.111 Sum_probs=85.1
Q ss_pred HHHHhhhcCCCCCCc-ccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHH---hhHHHHH
Q 007253 466 LKEQYALLEPNKNGT-ISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLE---ALDRWEQ 541 (611)
Q Consensus 466 l~~~F~~~D~d~~G~-Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~---~~~~~~~ 541 (611)
..++++.+|.+++|. |++++|...+..+......+..+.-.|+.+|.+++|.|+.+|+..++....... ..+..++
T Consensus 68 ~~rI~~~f~~~~~~~~v~F~~Fv~~ls~f~~~~~~~~Kl~faF~vYD~~~~G~I~reel~~iv~~~~~~~~~~~~e~~~~ 147 (187)
T KOG0034|consen 68 ADRIIDRFDTDGNGDPVDFEEFVRLLSVFSPKASKREKLRFAFRVYDLDGDGFISREELKQILRMMVGENDDMSDEQLED 147 (187)
T ss_pred HHHHHHHHhccCCCCccCHHHHHHHHhhhcCCccHHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHccCCcchHHHHHH
Confidence 346888999999988 999999999877776555555677789999999999999999987776543311 1233477
Q ss_pred HHHHHHhHHhcCCCCcccHHHHHHHhcCC
Q 007253 542 HARCAYELFEKDGNRAIVIEELASELGLG 570 (611)
Q Consensus 542 ~~~~~F~~~D~d~~G~It~eEl~~~l~~~ 570 (611)
.+...|..+|.|+||.|+.+|+..++.--
T Consensus 148 i~d~t~~e~D~d~DG~IsfeEf~~~v~~~ 176 (187)
T KOG0034|consen 148 IVDKTFEEADTDGDGKISFEEFCKVVEKQ 176 (187)
T ss_pred HHHHHHHHhCCCCCCcCcHHHHHHHHHcC
Confidence 88999999999999999999999998533
|
|
| >cd05031 S-100A10_like S-100A10_like: S-100A10 domain found in proteins similar to S100A10 | Back alignment and domain information |
|---|
Probab=98.63 E-value=7.9e-08 Score=80.03 Aligned_cols=65 Identities=25% Similarity=0.408 Sum_probs=54.8
Q ss_pred HHHHHHHHhHHhc-CC-CCcccHHHHHHHhc------CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhcch
Q 007253 540 EQHARCAYELFEK-DG-NRAIVIEELASELG------LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGVSS 604 (611)
Q Consensus 540 ~~~~~~~F~~~D~-d~-~G~It~eEl~~~l~------~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~~~ 604 (611)
...++.+|..||. |+ +|+|+.+||+.+|. ++...+ ++.+|..+|.|+||.|+|+||+.++.+.+.
T Consensus 7 ~~~l~~~F~~~D~~dg~dG~Is~~El~~~l~~~~g~~lg~~~s~~ei~~~~~~~D~~~dg~I~f~eF~~l~~~~~~ 82 (94)
T cd05031 7 MESLILTFHRYAGKDGDKNTLSRKELKKLMEKELSEFLKNQKDPMAVDKIMKDLDQNRDGKVNFEEFVSLVAGLSI 82 (94)
T ss_pred HHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHhHHHhhccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHH
Confidence 4578899999997 97 69999999999884 232323 899999999999999999999999987654
|
S100A10 is a member of the S100 family of EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1_like group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. A unique feature of S100A10 is that it contains mutation in both of the calcium binding sites, making it calcium insensitive. S100A10 has been detected in brain, heart, gastrointestinal tract, kidney, liver, lung, spleen, testes, epidermis, aorta, and thymus. Structural data supports the homo- and hetero-dimeric as well as hetero-tetrameric nature of the protein. S100A10 has multiple binding partners in its calcium free state and is therefore involved in many diverse biological functions. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.63 E-value=5.3e-07 Score=85.46 Aligned_cols=143 Identities=15% Similarity=0.129 Sum_probs=99.7
Q ss_pred eeeccceEEEEEEEecCCccCcEEEEEEecCCCcCC---HHHHHHHHHHHHHHHHhcCC-CCeeEEEEEEe-e----CCe
Q 007253 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT---AIAIEDVRREVKILRALTGH-NNLVKFFDAYE-D----TDN 233 (611)
Q Consensus 163 LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~h-~~iv~l~~~~~-~----~~~ 233 (611)
-|+||-+.|+...+. |+.+-+|.-......+ +.....|.+|+..+.+|... -.+.+.+ ++. . .-.
T Consensus 26 ~~rgG~SgV~r~~~~-----g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~r 99 (216)
T PRK09902 26 YRRNGMSGVQCVERN-----GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWR 99 (216)
T ss_pred cCCCCcceEEEEEeC-----CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceE
Confidence 466888888886543 4467888753221111 33456789999999998721 1244444 332 1 124
Q ss_pred eEEEeeecCCC-ChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 234 VYVVMELCEGG-ELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 234 ~~lv~E~~~~g-sL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
-+||+|-+.|- +|.+++.+.. .+.+......++.+|+..+.-||+.|+.|+|+.+.|||+...+ ...|+++||.-++
T Consensus 100 A~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g-~~~v~lIDlEk~r 178 (216)
T PRK09902 100 ALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG-KAEAGFLDLEKSR 178 (216)
T ss_pred EEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC-CeeEEEEEhhccc
Confidence 78999988643 7776664432 3567888899999999999999999999999999999995322 3459999998765
Q ss_pred c
Q 007253 312 F 312 (611)
Q Consensus 312 ~ 312 (611)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 4
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=2.1e-09 Score=114.00 Aligned_cols=246 Identities=17% Similarity=0.168 Sum_probs=169.2
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCC-eeEEEEEEeeC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN-LVKFFDAYEDT 231 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~-iv~l~~~~~~~ 231 (611)
-...|.....+++|+++.+++.+-.. -+....+.+... ....-++++|.+++ ||| .+..++-+..+
T Consensus 240 k~kws~~fh~fvK~altknpKkRpta----eklL~h~fvs~~--------l~~rl~~eLLdK~n-~P~~~v~~~~d~~~E 306 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTA----EKLLQHPFVSQT--------LSRRLAIELLDKVN-NPNPVVRYLEDYDGE 306 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCCh----hhheeceeeccc--------hhhHHHHHHHHHcc-CCCCcccccccCCcc
Confidence 34567778889999999998876443 233345655322 34567899999998 999 77888888888
Q ss_pred CeeEEEeeecCCC-ChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 232 DNVYVVMELCEGG-ELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 232 ~~~~lv~E~~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
+..++++++|.+| +...........+.+-+...+.+.-+++|++||+.-=+||| ||+. .++.+|..||+..
T Consensus 307 ~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~----s~~~~~~~~~~v~ 378 (829)
T KOG0576|consen 307 DYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILG----SEEEVKLLDFAVP 378 (829)
T ss_pred cccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccc----cccccccccccCC
Confidence 8999999999887 22211111111244445566777788899999998878999 8887 3466899999998
Q ss_pred cccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 311 DFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
.-+......++..+|+.|+|||+.. ..+....|+|++|+-..+|.-|-+|-.... .....+-.....+.......++
T Consensus 379 ~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~~g~~p~s~~L~~~~aw~ 456 (829)
T KOG0576|consen 379 PQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPMIGNGPNSPMLTDKSAWS 456 (829)
T ss_pred cccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCc--cccCCCCCCCCccccchhhhcC
Confidence 8777666677889999999999775 668999999999998888888877753210 0000000000000000000111
Q ss_pred HHHH-HHHHHhcccCccCCCCHHHHHcCcccCC
Q 007253 390 SEAR-DFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 390 ~~~~-~li~~~L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
.... ++...|+..-|..|+....++-|-+|..
T Consensus 457 ~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 457 PVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred cccccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence 1122 4788899999999999999999988864
|
|
| >cd00213 S-100 S-100: S-100 domain, which represents the largest family within the superfamily of proteins carrying the Ca-binding EF-hand motif | Back alignment and domain information |
|---|
Probab=98.62 E-value=6.2e-08 Score=79.67 Aligned_cols=72 Identities=13% Similarity=0.207 Sum_probs=61.0
Q ss_pred hhHHHHHHHHhhhcCC--CCCCcccHHHHHHHHHhhccccc----ccCChhHHHhhcCCCCCCcccHHHHHHHHcchh
Q 007253 460 VDELFYLKEQYALLEP--NKNGTISLENVKSALMKNATDAM----KDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVH 531 (611)
Q Consensus 460 ~~e~~~l~~~F~~~D~--d~~G~Is~~e~~~~l~~~~~~~~----~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~ 531 (611)
+++++.++++|..+|. +++|.|+.+||..++....+..+ +++++..++..+|.+++|.|+|++|+.++....
T Consensus 4 ~~~~~~l~~~F~~~D~~~~~~G~Is~~el~~~l~~~~g~~~~~~~~~~ei~~i~~~~d~~~~g~I~f~eF~~~~~~~~ 81 (88)
T cd00213 4 EKAIETIIDVFHKYSGKEGDKDTLSKKELKELLETELPNFLKNQKDPEAVDKIMKDLDVNKDGKVDFQEFLVLIGKLA 81 (88)
T ss_pred HHHHHHHHHHHHHHhhccCCCCcCcHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHhccCCCCcCcHHHHHHHHHHHH
Confidence 5678889999999999 89999999999999876433233 467899999999999999999999999876543
|
Note that this S-100 hierarchy contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. Intracellularly, S100 proteins act as Ca-signaling or Ca-buffering proteins. The most unusual characteristic of certain S100 proteins is their occurrence in extracellular space, where they act in a cytokine-like manner through RAGE, the receptor for advanced glycation products. Structural data suggest that many S100 members exist within cells as homo- or heterodimers and even oligomers; oligomerization contributes to their functional diversification. Upon binding calcium, most S100 proteins change conformation to a more open structure exposing a hydrophobic cleft. This hydrophobic surface represents th |
| >KOG2643 consensus Ca2+ binding protein, contains EF-hand motifs [Inorganic ion transport and metabolism] | Back alignment and domain information |
|---|
Probab=98.58 E-value=8.7e-08 Score=96.84 Aligned_cols=95 Identities=15% Similarity=0.248 Sum_probs=65.6
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhccc---cc------c-----cCChhH--HHhhcCCCCCCcccHHHHHHHHc
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNATD---AM------K-----DSRIPD--FLSSLNSLQYRRMDFEEFCAAAL 528 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~---~~------~-----~~~~~~--~~~~~D~~~~g~i~~~eF~~~~~ 528 (611)
.++-+|.+||.||||-|+.+||..+..-...+ .+ + ..++.. ....+..+++++++++||+.++.
T Consensus 234 ~F~IAFKMFD~dgnG~IdkeEF~~v~~li~sQ~~~g~~hrd~~tt~~s~~~~~nsaL~~yFFG~rg~~kLs~deF~~F~e 313 (489)
T KOG2643|consen 234 NFRIAFKMFDLDGNGEIDKEEFETVQQLIRSQTSVGVRHRDHFTTGNSFKVEVNSALLTYFFGKRGNGKLSIDEFLKFQE 313 (489)
T ss_pred cceeeeeeeecCCCCcccHHHHHHHHHHHHhccccceecccCccccceehhhhhhhHHHHhhccCCCccccHHHHHHHHH
Confidence 47779999999999999999999864111100 00 0 011111 33456888999999999988775
Q ss_pred chhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHh
Q 007253 529 SVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASEL 567 (611)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l 567 (611)
... ++.++--|..+|+..+|.|+..+|.++|
T Consensus 314 ~Lq--------~Eil~lEF~~~~~~~~g~Ise~DFA~~l 344 (489)
T KOG2643|consen 314 NLQ--------EEILELEFERFDKGDSGAISEVDFAELL 344 (489)
T ss_pred HHH--------HHHHHHHHHHhCcccccccCHHHHHHHH
Confidence 443 4456666888888888888888887766
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.57 E-value=1e-06 Score=83.84 Aligned_cols=142 Identities=21% Similarity=0.278 Sum_probs=91.6
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHH------HHHHHHHHHHhc--CCCCeeEE
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIED------VRREVKILRALT--GHNNLVKF 224 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l~--~h~~iv~l 224 (611)
...+|.+.+++-......|.+-.. .|+.+++|+.............. ..+++..+.++. +...+..+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-----~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~ 103 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-----DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADP 103 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-----CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccc
Confidence 456788888888777777766543 57889999875432221111111 234444444443 23344443
Q ss_pred EEEEee-----CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCC
Q 007253 225 FDAYED-----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN 299 (611)
Q Consensus 225 ~~~~~~-----~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~ 299 (611)
+-+.+. ....+|||||++|..|.+.. .+++ .+...|..++.-||+.|++|+|++|.|++++ +
T Consensus 104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~-----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~----~ 170 (229)
T PF06176_consen 104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIE-----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS----N 170 (229)
T ss_pred eeeeeeeeccceeEEEEEEEEecCeecccch-----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE----C
Confidence 333322 23467999999998776532 1333 2456677889999999999999999999995 3
Q ss_pred ceEEEeecccccc
Q 007253 300 SVLKAIDFGLSDF 312 (611)
Q Consensus 300 ~~vkl~DfG~a~~ 312 (611)
+.++++||+..+.
T Consensus 171 ~~i~iID~~~k~~ 183 (229)
T PF06176_consen 171 NGIRIIDTQGKRM 183 (229)
T ss_pred CcEEEEECccccc
Confidence 3499999986543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05029 S-100A6 S-100A6: S-100A6 domain found in proteins similar to S100A6 | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.1e-07 Score=77.79 Aligned_cols=72 Identities=14% Similarity=0.251 Sum_probs=60.8
Q ss_pred hhHHHHHHHHhhhcCC-CC-CCcccHHHHHHHHHhh--cccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchh
Q 007253 460 VDELFYLKEQYALLEP-NK-NGTISLENVKSALMKN--ATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVH 531 (611)
Q Consensus 460 ~~e~~~l~~~F~~~D~-d~-~G~Is~~e~~~~l~~~--~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~ 531 (611)
++.+..|-++|+.+|. ++ +|+|+.+||+.+|.+. .+...+++++.++++.+|.|++|+|+|+||+.++....
T Consensus 6 e~~~~~~i~~F~~y~~~~~~~g~Is~~EL~~~l~~~~~lg~k~t~~ev~~m~~~~D~d~dG~Idf~EFv~lm~~l~ 81 (88)
T cd05029 6 DQAIGLLVAIFHKYSGREGDKNTLSKKELKELIQKELTIGSKLQDAEIAKLMEDLDRNKDQEVNFQEYVTFLGALA 81 (88)
T ss_pred HHHHHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCCCcHHHHHHHHHHHH
Confidence 4556788899999998 67 8999999999999642 34567888999999999999999999999998776543
|
S100A6 is a member of the S100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A6 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100A6 is normally expressed in the G1 phase of the cell cycle in neuronal cells. The function of S100A6 remains unclear, but evidence suggests that it is involved in cell cycle regulation and exocytosis. S100A6 may also be involved in tumorigenesis; the protein is overexpressed in several tumors. Ca2+ binding to S100A6 leads to a conformational change in the protein, which exposes a hydrophobic surface for interact |
| >KOG0036 consensus Predicted mitochondrial carrier protein [Nucleotide transport and metabolism] | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.5e-07 Score=92.95 Aligned_cols=127 Identities=20% Similarity=0.248 Sum_probs=102.6
Q ss_pred HHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHH
Q 007253 462 ELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQ 541 (611)
Q Consensus 462 e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~ 541 (611)
..+....+|..+|.|.||.++++||+..+ ...+.++..+|..+|.+.||.|+.+|.-..+........ .+
T Consensus 49 ~~~~~~~l~~~~d~~~dg~vDy~eF~~Y~------~~~E~~l~~~F~~iD~~hdG~i~~~Ei~~~l~~~gi~l~----de 118 (463)
T KOG0036|consen 49 NYEAAKMLFSAMDANRDGRVDYSEFKRYL------DNKELELYRIFQSIDLEHDGKIDPNEIWRYLKDLGIQLS----DE 118 (463)
T ss_pred chHHHHHHHHhcccCcCCcccHHHHHHHH------HHhHHHHHHHHhhhccccCCccCHHHHHHHHHHhCCccC----HH
Confidence 34567889999999999999999999987 344567889999999999999999999877766554444 56
Q ss_pred HHHHHHhHHhcCCCCcccHHHHHHHhcCCCCccHHHHHHHH------hcCCCCceeHHHHHHHH
Q 007253 542 HARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDW------IRHTDGKLSFLGFVKLL 599 (611)
Q Consensus 542 ~~~~~F~~~D~d~~G~It~eEl~~~l~~~~~~~~~~~~~~~------D~~~dG~is~~eF~~~l 599 (611)
++...|+..|+++++.|+.+|+++.+.+-+...++.+...| |...|..|. ++|....
T Consensus 119 ~~~k~~e~~d~~g~~~I~~~e~rd~~ll~p~s~i~di~~~W~h~~~idigE~~~iP-dg~s~~e 181 (463)
T KOG0036|consen 119 KAAKFFEHMDKDGKATIDLEEWRDHLLLYPESDLEDIYDFWRHVLLIDIGEDAVLP-DGDSKLE 181 (463)
T ss_pred HHHHHHHHhccCCCeeeccHHHHhhhhcCChhHHHHHHHhhhhheEEEccccccCC-cchHHHH
Confidence 77889999999999999999999999776655577765554 567777777 6666543
|
|
| >cd05025 S-100A1 S-100A1: S-100A1 domain found in proteins similar to S100A1 | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.5e-07 Score=78.12 Aligned_cols=71 Identities=14% Similarity=0.231 Sum_probs=58.8
Q ss_pred hHHHHHHHHhhhcC-CCCCC-cccHHHHHHHHHhhccc----ccccCChhHHHhhcCCCCCCcccHHHHHHHHcchh
Q 007253 461 DELFYLKEQYALLE-PNKNG-TISLENVKSALMKNATD----AMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVH 531 (611)
Q Consensus 461 ~e~~~l~~~F~~~D-~d~~G-~Is~~e~~~~l~~~~~~----~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~ 531 (611)
.-++.|+++|+.|| .+++| +|+..||+.+|....+. .+++.+++.+|..+|.|++|.|+|+||+.++....
T Consensus 6 ~~~~~l~~~F~~fDd~dg~G~~Is~~El~~~l~~~lg~~~~~~~s~~~v~~i~~~~D~d~~G~I~f~eF~~l~~~~~ 82 (92)
T cd05025 6 TAMETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSDFLDAQKDADAVDKIMKELDENGDGEVDFQEFVVLVAALT 82 (92)
T ss_pred HHHHHHHHHHHHHhcccCCCCeECHHHHHHHHHHHHHHHccCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHH
Confidence 34567999999997 99999 59999999999763221 24667899999999999999999999998876554
|
S100A1 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. As is the case with many other members of S100 protein family, S100A1 is implicated in intracellular and extracellular regulatory activities, including interaction with myosin-associated twitchin kinase, actin-capping protein CapZ, sinapsin I, and tubulin. Structural data suggests that S100A1 proteins exist within cells as antiparallel homodimers, while heterodimers with S100A4 and S100B also has been reported. Upon binding calcium S100A1 changes conformation to expose a hydrophobic cleft which is the interaction site of S100A1 with its more that 20 known target proteins. |
| >cd05023 S-100A11 S-100A11: S-100A11 domain found in proteins similar to S100A11 | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.7e-07 Score=76.77 Aligned_cols=65 Identities=18% Similarity=0.297 Sum_probs=53.8
Q ss_pred HHHHHHHHhH-HhcCCCC-cccHHHHHHHhc-C-----CCC---ccHHHHHHHHhcCCCCceeHHHHHHHHhhcch
Q 007253 540 EQHARCAYEL-FEKDGNR-AIVIEELASELG-L-----GPA---VPVHAVLHDWIRHTDGKLSFLGFVKLLHGVSS 604 (611)
Q Consensus 540 ~~~~~~~F~~-~D~d~~G-~It~eEl~~~l~-~-----~~~---~~~~~~~~~~D~~~dG~is~~eF~~~l~~~~~ 604 (611)
...+..+|+. +|+||+| +|+.+||+.++. . +.. ..++++|+.+|.|+||.|+|+||+.+|..+..
T Consensus 8 i~~l~~~F~~y~~~dg~~~~Ls~~Elk~ll~~e~~~~~~~~~~~~~~~~ll~~~D~d~DG~I~f~EF~~l~~~l~~ 83 (89)
T cd05023 8 IESLIAVFQKYAGKDGDSYQLSKTEFLSFMNTELASFTKNQKDPGVLDRMMKKLDLNSDGQLDFQEFLNLIGGLAV 83 (89)
T ss_pred HHHHHHHHHHHhccCCCcCeECHHHHHHHHHHhhhHhhcCCCCHHHHHHHHHHcCCCCCCcCcHHHHHHHHHHHHH
Confidence 4567889988 7888976 999999999994 1 212 22899999999999999999999999988753
|
S100A11 is a member of the S-100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A11 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100 proteins have also been associated with a variety of pathological events, including neoplastic transformation and neurodegenerative diseases such as Alzheimer's, usually via over expression of the protein. S100A11 is expressed in smooth muscle and other tissues and involves in calcium-dependent membrane aggregation, which is important for cell vesiculation . As is the case for many other S100 proteins, S |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.2e-06 Score=99.45 Aligned_cols=250 Identities=20% Similarity=0.222 Sum_probs=161.9
Q ss_pred eeeccceEEEEEEEecCCc-cCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC----eeEEE
Q 007253 163 VGRGHFGYTCAAKFKKGEL-KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD----NVYVV 237 (611)
Q Consensus 163 LG~G~fg~V~~~~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~----~~~lv 237 (611)
|..-.+|.+++.++..... .-+.+-++.-..........+.....|+..+.++. |+|++.++.|-.... .+.+.
T Consensus 186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~l~k~~-~~n~~~~~~~~le~~~~g~~~~v~ 264 (1351)
T KOG1035|consen 186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELESLSKIA-HDNLGGYFVYGLERLFRGIVLDVL 264 (1351)
T ss_pred eccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHHHHhhc-cccccceeEEeehhhcchHHHHHH
Confidence 5566777777776543111 11122222111000011122233456777777887 999999998876543 24466
Q ss_pred eeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe--ecccccccCC
Q 007253 238 MELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI--DFGLSDFVRP 315 (611)
Q Consensus 238 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~--DfG~a~~~~~ 315 (611)
.|+|.+-++...+.. -+.++....+.+..+++.||.|+|+....|.-|..+-..-...+..+.+.++ ||+.+..+..
T Consensus 265 ~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d 343 (1351)
T KOG1035|consen 265 QEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD 343 (1351)
T ss_pred HhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCC
Confidence 788888888776644 4678999999999999999999999976666665553332222556677777 8888877654
Q ss_pred CCcccccccCCCcCcchhhcCC---CCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 316 DERLNDIVGSAYYVAPEVLHRS---YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 316 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
........-+..|.++|..... .....|+|.+|..+..+..|..+-.-. .....++.. ....+.
T Consensus 344 ~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~---~~~~~~l~~----------~~~~~~ 410 (1351)
T KOG1035|consen 344 NEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKS---AVPVSLLDV----------LSTSEL 410 (1351)
T ss_pred cccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccc---cchhhhhcc----------ccchhh
Confidence 4444444556678888877533 344579999999999998876542111 001111100 112267
Q ss_pred HHHHHHhcccCccCCCCHHHHHcCcccCCCCCCCC
Q 007253 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKV 427 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~~~ 427 (611)
.+++.+|+..++++|+++.+++.|+|.+...+...
T Consensus 411 ~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~~~ 445 (1351)
T KOG1035|consen 411 LDALPKCLDEDSEERLSALELLTHPFLRFPTDNES 445 (1351)
T ss_pred hhhhhhhcchhhhhccchhhhhhchhccccccccc
Confidence 89999999999999999999999999987665433
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 611 | ||||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-65 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-64 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-62 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 9e-62 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-61 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-61 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-59 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-57 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-57 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-56 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-54 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-54 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-54 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-54 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-54 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-54 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-54 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-53 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-53 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-53 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-48 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-48 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-48 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-48 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-48 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-46 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-45 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-45 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-45 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-45 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-45 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-45 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-44 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-44 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-44 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-44 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-44 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-44 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-44 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-44 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-44 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-44 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-44 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-44 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-44 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-44 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-44 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-44 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-44 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-44 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-43 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-43 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-43 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-43 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-43 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-42 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-42 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-42 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-41 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-41 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-41 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-40 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-40 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-40 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-40 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-40 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-40 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-39 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-39 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-39 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-39 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-39 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-39 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-39 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-39 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-39 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-39 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-39 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-39 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-38 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-38 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-38 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-37 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-37 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-37 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-37 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-37 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-37 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-37 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-37 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-37 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-37 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-37 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-37 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-37 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-36 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-36 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-36 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-36 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-35 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-35 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-35 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-35 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-35 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-35 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-35 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-34 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-34 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-34 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-34 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-34 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-34 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-34 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-34 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-34 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-34 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-34 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-34 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-34 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-34 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-34 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-34 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-34 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-33 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-33 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-33 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-33 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-33 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-33 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-33 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-33 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-33 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-33 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-33 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-33 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-33 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-33 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-33 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-33 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-33 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-33 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-33 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-33 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-33 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-33 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-33 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-33 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-33 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-32 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-32 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-32 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-32 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-32 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-32 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-32 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-32 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-31 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-31 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-31 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-31 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-30 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-30 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-29 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-28 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-28 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-28 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-28 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-28 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-28 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-28 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-28 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-28 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-28 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-28 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-28 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-28 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-28 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-28 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-28 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-28 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-28 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-28 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-28 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-28 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-28 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-28 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-28 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 9e-28 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-27 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-27 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-27 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-27 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-27 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-27 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-27 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-27 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-27 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-27 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-27 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-27 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-27 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-27 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-27 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-27 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-27 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-27 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-27 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-27 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-27 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-27 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-27 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-27 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-27 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-27 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-27 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-27 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-27 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-27 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-27 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-27 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-27 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-27 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-27 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-27 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-27 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-27 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-27 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-27 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-27 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-27 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-26 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-26 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-26 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-26 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-26 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-26 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-26 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-26 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-26 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-26 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-26 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-26 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-26 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-26 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-26 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-26 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-26 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-26 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-26 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-26 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-26 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-26 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-26 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-26 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-26 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-26 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-26 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-26 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-26 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-26 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-26 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-26 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-26 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-26 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-26 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-26 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-26 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-26 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-26 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-26 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-26 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-26 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-26 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-26 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-26 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-26 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 9e-26 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-25 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-25 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-25 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-25 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-25 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-25 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-25 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-25 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-25 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-25 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-25 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-25 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-25 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-25 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-25 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-25 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-25 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-24 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-24 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-24 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-24 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-24 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-24 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-24 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-24 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-24 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-24 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-24 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-24 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-24 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-24 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-24 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-24 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-24 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-24 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-24 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-24 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-24 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-23 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-23 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-23 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-23 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-23 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-23 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-23 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-23 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-23 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-23 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-23 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-23 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-23 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-23 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-23 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-23 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-23 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-23 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-23 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-23 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-23 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-23 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-23 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-23 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-23 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-23 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-23 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-23 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-23 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-23 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-23 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-23 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-23 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-23 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-23 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-23 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-23 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-23 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-23 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-23 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-23 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-23 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-23 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-23 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-23 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-22 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-22 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-22 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-22 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-22 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-22 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-22 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-22 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-22 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-22 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-22 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-22 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-22 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-22 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-22 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-22 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-22 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-22 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-22 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-22 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-22 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-22 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-22 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-22 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-22 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-22 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-22 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-22 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-22 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-22 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-22 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-22 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-22 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-22 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-22 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-22 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-22 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-22 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-22 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-22 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-22 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-22 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-22 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-22 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-22 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-22 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-22 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-21 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-21 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-21 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-21 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-21 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-21 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-21 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-21 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-21 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-21 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-21 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-21 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-21 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-21 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-21 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-21 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-21 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-21 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-21 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-21 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-21 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-21 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-21 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-21 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-21 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-21 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-21 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-21 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-21 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-21 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-21 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-21 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-21 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-21 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-21 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-21 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-21 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-21 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-21 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-21 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-21 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-21 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-21 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-21 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-21 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-21 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-21 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-21 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-21 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-21 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-21 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-21 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-21 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-21 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-21 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-21 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-21 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-21 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-21 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-21 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-21 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-21 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-21 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-21 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-21 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-21 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-21 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-21 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-21 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-21 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-21 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-21 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-20 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-20 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-20 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-20 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-20 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-20 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-20 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-20 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-20 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-20 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-20 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-20 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-20 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-20 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-20 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-20 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-20 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-20 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-20 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-20 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-20 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-20 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-20 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-20 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 8e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-20 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-20 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-20 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-20 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-20 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-19 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-19 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-19 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-19 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-19 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-19 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-19 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-19 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-19 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-19 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-19 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-19 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-19 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-19 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-19 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-19 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-19 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-19 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-19 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-19 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-18 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-18 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-18 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-18 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-18 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-18 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-18 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-18 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-18 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-18 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-18 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-18 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-18 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-18 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-18 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 6e-18 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-18 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 7e-18 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 7e-18 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 7e-18 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 7e-18 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 7e-18 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 7e-18 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 7e-18 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 7e-18 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-18 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 7e-18 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-18 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 8e-18 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 8e-18 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 8e-18 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-18 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 8e-18 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-18 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-18 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-17 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-17 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-17 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-17 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-17 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-17 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-17 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-17 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-17 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-17 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-17 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-17 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-17 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-17 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-17 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-17 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-17 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-17 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-17 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-17 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-17 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-17 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-17 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-17 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-17 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-17 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-17 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 4e-17 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 4e-17 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-17 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 4e-17 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 5e-17 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 5e-17 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-17 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-17 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 7e-17 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-17 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 9e-17 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-17 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-16 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-16 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-16 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-16 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-16 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-16 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-16 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-16 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-16 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-16 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-16 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-16 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-16 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-16 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-16 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-16 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-16 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-16 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-16 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-16 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-16 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-16 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-16 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-16 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-16 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-16 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-16 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-16 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-16 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-15 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-15 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-15 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-15 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-15 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-15 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-15 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-15 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-15 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-15 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 5e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-15 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-15 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 9e-15 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-15 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-14 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-14 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-14 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-14 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 7e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-14 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-13 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-13 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-13 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 9e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-12 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-12 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-12 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 5e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-12 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 6e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-12 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 8e-12 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 9e-12 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-11 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-11 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-11 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-11 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-11 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-11 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-11 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-11 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-11 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-11 | ||
| 2aao_A | 166 | Regulatory Apparatus Of Calcium Dependent Protein K | 5e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 8e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-10 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 5e-10 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 5e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-10 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 5e-10 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 5e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-09 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 8e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-09 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 9e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-08 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-08 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 7e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 9e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-07 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-07 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-07 | ||
| 1s6i_A | 188 | Ca2+-Regulatory Region (Cld) From Soybean Calcium-D | 5e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-06 |
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2AAO|A Chain A, Regulatory Apparatus Of Calcium Dependent Protein Kinase From Arabidopsis Thaliana Length = 166 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1S6I|A Chain A, Ca2+-Regulatory Region (Cld) From Soybean Calcium-Dependent Protein Kinase-Alpha (Cdpk) In The Presence Of Ca2+ And The Junction Domain (Jd) Length = 188 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 602 bits (1554), Expect = 0.0
Identities = 152/509 (29%), Positives = 241/509 (47%), Gaps = 36/509 (7%)
Query: 121 HGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGE 180
H E +G P + K G Y ++G G +G K K G
Sbjct: 5 HHHSSGRENLYFQGIAINPGMYVRKKEG---KIGESYFKVRKLGSGAYGEVLLCKEKNG- 60
Query: 181 LKGQQVAVKVIPKHKMTTAIAI----------EDVRREVKILRALTGHNNLVKFFDAYED 230
+ A+KVI K + E++ E+ +L++L H N++K FD +ED
Sbjct: 61 --HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLFDVFED 117
Query: 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290
Y+V E EGGEL ++I++R K+ E DA +M QIL+ + + H +VHRD+KPEN
Sbjct: 118 KKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLHKHNIVHRDIKPEN 176
Query: 291 FLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVI 350
L K+ +K +DFGLS F D +L D +G+AYY+APEVL + Y+ + DVWS GVI
Sbjct: 177 ILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVI 236
Query: 351 AYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTA 410
YILLCG PF + + I + V K FD W ++S EA++ +K +L D KR TA
Sbjct: 237 MYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTA 296
Query: 411 AQALSHPWIK----NSNDVKVPLDVIIFKLMKAYMRSSSLRKAALRALSKTL-TVDELFY 465
+AL+ WIK N N M+ + S L +AA+ + L T++E
Sbjct: 297 EEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGSKLTTLEERKE 356
Query: 466 LKEQYALLEPNKNGTISLENVKSALMKNATDAMK-------DSRIPDFLSSLNSLQYRRM 518
L + + L+ N +G + + + + + + + L ++ + +
Sbjct: 357 LTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEVDFDKNGYI 416
Query: 519 DFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELGLG--PAVPVH 576
++ EF + + L E+ R A+ LF+ D + I EELA+ GL +
Sbjct: 417 EYSEFISVCMDKQILF----SEERLRRAFNLFDTDKSGKITKEELANLFGLTSISEKTWN 472
Query: 577 AVLHDWIRHTDGKLSFLGFVKLLHGVSSR 605
VL + ++ D + F FV ++H +
Sbjct: 473 DVLGEADQNKDNMIDFDEFVSMMHKICDH 501
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 598 bits (1544), Expect = 0.0
Identities = 143/482 (29%), Positives = 246/482 (51%), Gaps = 33/482 (6%)
Query: 142 GLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIA 201
++ F FA +Y + +G+G FG K + Q+ AVKVI K
Sbjct: 9 SGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAKNK-D 64
Query: 202 IEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDD 261
+ REV++L+ L H N++K F+ ED+ + Y+V EL GGEL D I+ R +++E D
Sbjct: 65 TSTILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHD 122
Query: 262 AKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND 321
A ++ Q+ + + + H +VHRDLKPEN L +K+++ +K IDFGLS + + ++ D
Sbjct: 123 AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182
Query: 322 IVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381
+G+AYY+APEVL +Y + DVWS GVI YILL G+ PF+ + E I + V +FD
Sbjct: 183 RIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD 242
Query: 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVK-----VPLDVIIFKL 436
W ++S +A+D ++++L P R+TA Q L HPWI+ + +P
Sbjct: 243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTN 302
Query: 437 MKAYMRSSSLRKAALRALSKTL-TVDELFYLKEQYALLEPNKNGTISLENVKSALMK--- 492
++ + L +AAL ++ L T+DE L E + L+ N +G + + + +
Sbjct: 303 IRQFQAEKKLAQAALLYMASKLTTLDETKQLTEIFRKLDTNNDGMLDRDELVRGYHEFMR 362
Query: 493 ----------NATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQH 542
+ + +I + L+ +++ EF A+A+ L + +R E+
Sbjct: 363 LKGVDSNSLIQNEGSTIEDQIDSLMPLLDMDGSGSIEYSEFIASAIDRTILLSRERMER- 421
Query: 543 ARCAYELFEKDGNRAIVIEELASELGLGPA----VPVHAVLHDWIRHTDGKLSFLGFVKL 598
A+++F+KDG+ I +EL + + +++ + DG++ F FV++
Sbjct: 422 ---AFKMFDKDGSGKISTKELFKLFSQADSSIQMEELESIIEQVDNNKDGEVDFNEFVEM 478
Query: 599 LH 600
L
Sbjct: 479 LQ 480
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 592 bits (1528), Expect = 0.0
Identities = 140/472 (29%), Positives = 241/472 (51%), Gaps = 26/472 (5%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
+ F+++Y+ +G+G FG K K GQ+ AVKVI K ++ E + REV
Sbjct: 21 TAIFSDRYKGQRVLGKGSFGEVILCKDKI---TGQECAVKVISKRQVKQKTDKESLLREV 77
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
++L+ L H N++K ++ +ED Y+V E+ GGEL D I+SR +++E DA ++ Q+
Sbjct: 78 QLLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQV 135
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
L+ + + H +VHRDLKPEN L +K +++ ++ IDFGLS +++ D +G+AYY+
Sbjct: 136 LSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYI 195
Query: 330 APEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
APEVLH +Y + DVWS GVI YILL G PF E I + V K +F+ W +S
Sbjct: 196 APEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVS 255
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND----VKVPLDVIIFKLMKAYMRSSS 445
A+D ++++L P R++A AL H WI+ V VP ++ + +
Sbjct: 256 ESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQK 315
Query: 446 LRKAALRALSKTL-TVDELFYLKEQYALLEPNKNGTISLENVKSALMK----------NA 494
L +AAL + L + DE L + ++ N +G + + +
Sbjct: 316 LAQAALLYMGSKLTSQDETKELTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASML 375
Query: 495 TDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDG 554
+ + + L +++ + +++ EF A+ L + +R E+ A+ +F+ D
Sbjct: 376 DASAVEHEVDQVLDAVDFDKNGYIEYSEFVTVAMDRKTLLSRERLER----AFRMFDSDN 431
Query: 555 NRAIVIEELASELGLGPA--VPVHAVLHDWIRHTDGKLSFLGFVKLLHGVSS 604
+ I ELA+ G+ +VL + ++ DG++ F F ++L +
Sbjct: 432 SGKISSTELATIFGVSDVDSETWKSVLSEVDKNNDGEVDFDEFQQMLLKLCG 483
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 592 bits (1529), Expect = 0.0
Identities = 146/471 (30%), Positives = 255/471 (54%), Gaps = 25/471 (5%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
H + Y+ +++G G +G + K + A+K+I K ++T+ + + EV
Sbjct: 32 KGHLSEMYQRVKKLGSGAYGEVLLCRDKVT---HVERAIKIIRKTSVSTS-SNSKLLEEV 87
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
+L+ L H N++K +D +ED N Y+VME +GGEL D I+ R K+ E DA ++ Q+
Sbjct: 88 AVLKLL-DHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM-KFNEVDAAVIIKQV 145
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
L+ V + H +VHRDLKPEN L +K++++++K +DFGLS +++ + +G+AYY+
Sbjct: 146 LSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYI 205
Query: 330 APEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
APEVL + Y + DVWSIGVI +ILL G PF +T+ I R V K +FD W ++S
Sbjct: 206 APEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVS 265
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKN-----SNDVKVPLDVIIFKLMKAYMRSS 444
A+D +K++L D ++R++A QAL HPWIK + +++P + M+ + S
Sbjct: 266 EGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQ 325
Query: 445 SLRKAALRALSKTL-TVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMK---- 499
L +AAL ++ L + +E L + + ++ N +G + + + K + + +
Sbjct: 326 KLAQAALLYMASKLTSQEETKELTDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDL 385
Query: 500 ---DSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNR 556
+S + L + + + +D+ EF A+ L + D+ E A++ F++DGN
Sbjct: 386 PQIESEVDAILGAADFDRNGYIDYSEFVTVAMDRKSLLSKDKLES----AFQKFDQDGNG 441
Query: 557 AIVIEELASELGLG--PAVPVHAVLHDWIRHTDGKLSFLGFVKLLHGVSSR 605
I ++ELAS GL + ++ + DG + F F K++ + S
Sbjct: 442 KISVDELASVFGLDHLESKTWKEMISGIDSNNDGDVDFEEFCKMIQKLCSN 492
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 484 bits (1248), Expect = e-168
Identities = 121/450 (26%), Positives = 196/450 (43%), Gaps = 28/450 (6%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
F +Y+L EE+G+G F GQ+ A +I K++ + + RE
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVL---AGQEYAAMIINTKKLSA-RDHQKLEREA 61
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
+I R L H N+V+ D+ + + Y++ +L GGEL + I++R Y+E DA + QI
Sbjct: 62 RICRLL-KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE-YYSEADASHCIQQI 119
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERLNDIVGSAYY 328
L V CH GVVHR+LKPEN L +K + + +K DFGL+ V + G+ Y
Sbjct: 120 LEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY 179
Query: 329 VAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
++PEVL + Y D+W+ GVI YILL G PFW + +++ + F W +
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDT 239
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV-KVPLDVIIFKLMKAYMRSSSL 446
++ EA+D + ++L +P KR+TAA+AL HPWI + + V +K + L
Sbjct: 240 VTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKL 299
Query: 447 RKAALR--ALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIP 504
+ A L ++ +V + +K L+E NG + + A + +
Sbjct: 300 KGAILTVMLATRNFSVRKQEIIKVTEQLIEAISNGDFESY---TKMCDPGMTAFEPEALG 356
Query: 505 DFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELA 564
+ + +DF F L + + D + I +
Sbjct: 357 NLVEG--------LDFHRFYFENLWSRNSK---PVHTTILNPHIHLMGDESACIAYIRIT 405
Query: 565 SEL-GLGPAVPVHAVLHD-WIRHTDGKLSF 592
L G + W R DGK
Sbjct: 406 QYLDAGGIPRTAQSEETRVWHRR-DGKWQI 434
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 471 bits (1215), Expect = e-164
Identities = 110/368 (29%), Positives = 168/368 (45%), Gaps = 26/368 (7%)
Query: 71 FYSPSPAHYFFSKKSSPARSSANSTPN------RFFKRPFPPPSPAKHIKAVLARRHGSV 124
+ S F+K+ AR PN R F R A++
Sbjct: 5 HHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDA 64
Query: 125 KPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQ 184
+P P L + +K F KY+ + +GRG + G
Sbjct: 65 QPKGTENLYFQSMGPEDEL-PDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA---TGH 120
Query: 185 QVAVKVIPKHKMTTAI-----AIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVME 239
+ AVK++ + E RRE ILR + GH +++ D+YE + +++V +
Sbjct: 121 EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFD 180
Query: 240 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN 299
L GEL D + + +E + +++M +L V+F H +VHRDLKPEN L D+N
Sbjct: 181 LMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDN 236
Query: 300 SVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-------HRSYSTEADVWSIGVIAY 352
++ DFG S + P E+L ++ G+ Y+APE+L H Y E D+W+ GVI +
Sbjct: 237 MQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILF 296
Query: 353 ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQ 412
LL GS PFW R + + R +++ F W SS +D + RLL DP RLTA Q
Sbjct: 297 TLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQ 356
Query: 413 ALSHPWIK 420
AL HP+ +
Sbjct: 357 ALQHPFFE 364
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 457 bits (1178), Expect = e-159
Identities = 106/286 (37%), Positives = 166/286 (58%), Gaps = 6/286 (2%)
Query: 139 PAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT 198
+ ++ F FA +Y + +G+G FG K + Q+ AVKVI K
Sbjct: 6 HHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAKN 62
Query: 199 AIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYT 258
+ REV++L+ L H N++K F+ ED+ + Y+V EL GGEL D I+ R +++
Sbjct: 63 K-DTSTILREVELLKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFS 119
Query: 259 EDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER 318
E DA ++ Q+ + + + H +VHRDLKPEN L +K+++ +K IDFGLS + + +
Sbjct: 120 EHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179
Query: 319 LNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378
+ D +G+AYY+APEVL +Y + DVWS GVI YILL G+ PF+ + E I + V
Sbjct: 180 MKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY 239
Query: 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424
+FD W ++S +A+D ++++L P R+TA Q L HPWI+ +
Sbjct: 240 AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 458 bits (1181), Expect = e-159
Identities = 86/328 (26%), Positives = 155/328 (47%), Gaps = 13/328 (3%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
K KY + E++GRG FG + K + V++E+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETS---SKKTYMAKFVKVKGTD----QVLVKKEIS 53
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQIL 270
IL H N++ +++E + + ++ E G ++ +RI + + E + + + Q+
Sbjct: 54 ILNIA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC 112
Query: 271 NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVA 330
+ F H + H D++PEN ++ T+ +S +K I+FG + ++P + + + Y A
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171
Query: 331 PEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
PEV H ST D+WS+G + Y+LL G PF A T I ++ A+ +FDE + +S
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS 231
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKA 449
EA DFV RLL K+ + R+TA++AL HPW+K + + + + +K +L K
Sbjct: 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE---RVSTKVIRTLKHRRYYHTLIKK 288
Query: 450 ALRALSKTLTVDELFYLKEQYALLEPNK 477
L + + ++ Q +
Sbjct: 289 DLNMVVSAARISCGGAIRSQKGVSVAKV 316
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 452 bits (1165), Expect = e-157
Identities = 99/287 (34%), Positives = 160/287 (55%), Gaps = 10/287 (3%)
Query: 139 PAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT 198
+ ++ F + + ++G G FG + + G + +K I K +
Sbjct: 6 HHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERS---SGLERVIKTINKDRS-- 60
Query: 199 AIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR---GG 255
+ +E + E+++L++L H N++K F+ +ED N+Y+VME CEGGELL+RI+S G
Sbjct: 61 QVPMEQIEAEIEVLKSL-DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGK 119
Query: 256 KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
+E +M Q++N +A+ H Q VVH+DLKPEN LF +S +K IDFGL++ +
Sbjct: 120 ALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179
Query: 316 DERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK 375
DE + G+A Y+APEV R + + D+WS GV+ Y LL G PF + + +
Sbjct: 180 DEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY 239
Query: 376 ADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422
+P++ P L+ +A D +K++L KDP +R +AAQ L H W K +
Sbjct: 240 KEPNYAVECRP-LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 450 bits (1159), Expect = e-157
Identities = 105/280 (37%), Positives = 165/280 (58%), Gaps = 9/280 (3%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
Y L +GRG +G A K + A K IPK+ + ++ ++E++I+
Sbjct: 7 INQYYTLENTIGRGSWGEVKIAVQKGT---RIRRAAKKIPKYFVE---DVDRFKQEIEIM 60
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
++L H N+++ ++ +ED ++Y+VMELC GGEL +R++ + + E DA +M +L+
Sbjct: 61 KSLD-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR-VFRESDAARIMKDVLSA 118
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPE 332
VA+CH V HRDLKPENFLF T +S LK IDFGL+ +P + + VG+ YYV+P+
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ 178
Query: 333 VLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392
VL Y E D WS GV+ Y+LLCG PF A T+S + + + +F E W ++S +A
Sbjct: 179 VLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQA 238
Query: 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVI 432
++RLL K P++R+T+ QAL H W + P +++
Sbjct: 239 ESLIRRLLTKSPKQRITSLQALEHEWFEK-QLSSSPRNLL 277
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 444 bits (1144), Expect = e-153
Identities = 97/328 (29%), Positives = 160/328 (48%), Gaps = 13/328 (3%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT--AIAIEDVRR 207
F + YEL E +G+G F ++ GQQ AVK++ K T+ ++ ED++R
Sbjct: 19 DVLFEDVYELCEVIGKGPFSVVRRCINRE---TGQQFAVKIVDVAKFTSSPGLSTEDLKR 75
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG---GKYTEDDAKA 264
E I L H ++V+ + Y +Y+V E +G +L I+ R Y+E A
Sbjct: 76 EASICHML-KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 134
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIV 323
M QIL + +CH ++HRD+KP L +K+ ++ +K FG++ V
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194
Query: 324 GSAYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 382
G+ +++APEV+ R Y DVW GVI +ILL G PF+ T+ +F ++K +
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNP 253
Query: 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV-KVPLDVIIFKLMKAYM 441
W +S A+D V+R+L DP +R+T +AL+HPW+K + + ++ +
Sbjct: 254 RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFN 313
Query: 442 RSSSLRKAALRALSKTLTVDELFYLKEQ 469
L+ A L A+S E+
Sbjct: 314 ARRKLKGAVLAAVSSHKFNSFYGDPPEE 341
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 444 bits (1143), Expect = e-153
Identities = 110/365 (30%), Positives = 180/365 (49%), Gaps = 13/365 (3%)
Query: 126 PNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQ 185
P+ A++ G + + + S F++ Y++ EE+G+G F K G +
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNA--STKFSDNYDVKEELGKGAFSVVRRCVHKTT---GLE 56
Query: 186 VAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGE 245
A K+I K++ A + + RE +I R L H N+V+ D+ ++ Y+V +L GGE
Sbjct: 57 FAAKIINTKKLS-ARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGE 114
Query: 246 LLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305
L + I++R Y+E DA + QIL +A+CH G+VHR+LKPEN L +K + + +K
Sbjct: 115 LFEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 173
Query: 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWAR 364
DFGL+ V E + G+ Y++PEVL + YS D+W+ GVI YILL G PFW
Sbjct: 174 DFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 233
Query: 365 TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424
+ ++ + + W +++ EA+ + +L +P+KR+TA QAL PWI N
Sbjct: 234 DQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 293
Query: 425 V-KVPLDVIIFKLMKAYMRSSSLRKAALRALSKTLTVDELFYLKEQYALLEPNKNGTISL 483
V +K + L+ A L + T + L + +
Sbjct: 294 VASAIHRQDTVDCLKKFNARRKLKGAILTTMIATRNLSN---LGRNLLNKKEQGPPSTIK 350
Query: 484 ENVKS 488
E+ +S
Sbjct: 351 ESSES 355
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 430 bits (1109), Expect = e-149
Identities = 98/273 (35%), Positives = 153/273 (56%), Gaps = 7/273 (2%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
S F++ Y++ EE+G+G F K G + A K+I K++ A + + RE
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTT---GLEFAAKIINTKKLS-ARDFQKLEREA 56
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
+I R L H N+V+ D+ ++ Y+V +L GGEL + I++R Y+E DA + QI
Sbjct: 57 RICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQI 114
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
L +A+CH G+VHR+LKPEN L +K + + +K DFGL+ V E + G+ Y+
Sbjct: 115 LESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYL 174
Query: 330 APEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388
+PEVL + YS D+W+ GVI YILL G PFW + ++ + + W ++
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV 234
Query: 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
+ EA+ + +L +P+KR+TA QAL PWI N
Sbjct: 235 TPEAKSLIDSMLTVNPKKRITADQALKVPWICN 267
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 423 bits (1091), Expect = e-146
Identities = 87/305 (28%), Positives = 150/305 (49%), Gaps = 9/305 (2%)
Query: 151 KHFANKYEL-GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
++F N Y L +E+GRG F K GQ+ A K + K + ++ E+
Sbjct: 24 ENFNNFYILTSKELGRGKFAVVRQCISKST---GQEYAAKFLKKRRRG-QDCRAEILHEI 79
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQ 268
+L ++ + YE+T + +++E GGE+ L +E+D ++ Q
Sbjct: 80 AVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQ 139
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
IL V + H +VH DLKP+N L ++ +K +DFG+S + L +I+G+ Y
Sbjct: 140 ILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEY 199
Query: 329 VAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
+APE+L+ +T D+W+IG+IAY+LL + PF + + + + + E + S
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSS 259
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKV--PLDVIIFKLMKAYMRSSS 445
+S A DF++ LL K+P KR TA LSH W++ + + P + + + SS
Sbjct: 260 VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDHSVRSS 319
Query: 446 LRKAA 450
K +
Sbjct: 320 EDKTS 324
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 422 bits (1086), Expect = e-145
Identities = 96/292 (32%), Positives = 145/292 (49%), Gaps = 20/292 (6%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAI------E 203
+ F YE E +GRG K ++ AVK+I + A E
Sbjct: 12 THGFYENYEPKEILGRGVSSVVRRCIHKPT---CKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 204 DVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAK 263
+EV ILR ++GH N+++ D YE ++V +L + GEL D + + +E + +
Sbjct: 69 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETR 127
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323
+M +L V+ H +VHRDLKPEN L D++ +K DFG S + P E+L ++
Sbjct: 128 KIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVC 184
Query: 324 GSAYYVAPEVL-------HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 376
G+ Y+APE++ H Y E D+WS GVI Y LL GS PFW R + + R ++
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244
Query: 377 DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVP 428
+ F W S +D V R L P+KR TA +AL+HP+ + +V
Sbjct: 245 NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVR 296
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 425 bits (1094), Expect = e-145
Identities = 109/401 (27%), Positives = 174/401 (43%), Gaps = 36/401 (8%)
Query: 90 SSANSTPNRFFKRPFPPPSPAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGF 149
+S +P F P PPP P L P + + K+
Sbjct: 4 NSQGQSPPVPFPAPAPPPQPPTP---ALPHPPAQPPPPPPQQFPQFHVKSGLQIKKN--- 57
Query: 150 SKHFANKYEL-GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRRE 208
+ Y++ + +G G G K+ ++ A+K++ RRE
Sbjct: 58 --AIIDDYKVTSQVLGLGINGKVLQIFNKRT---QEKFALKMLQD--------CPKARRE 104
Query: 209 VKILRALTGHNNLVKFFDAYEDT----DNVYVVMELCEGGELLDRILSRGGK-YTEDDAK 263
V++ + ++V+ D YE+ + +VME +GGEL RI RG + +TE +A
Sbjct: 105 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 164
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323
+M I + + H + HRD+KPEN L+T+K N++LK DFG + L
Sbjct: 165 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 224
Query: 324 GSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWA----RTESGIFRAVLKADP 378
+ YYVAPEVL Y D+WS+GVI YILLCG PF++ G+ +
Sbjct: 225 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 284
Query: 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV-KVPLDVIIFKLM 437
F W +S E + ++ LL +P +R+T + ++HPWI S V + PL L
Sbjct: 285 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSR-VLK 343
Query: 438 KAYMRSSSLRKAALRALSKTLTVDELFYLKEQYALLEPNKN 478
+ R +++ AL+ E +K+ +E N
Sbjct: 344 EDKERWEDVKEEMTSALATMRVDYEQIKIKK----IEDASN 380
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 425 bits (1095), Expect = e-143
Identities = 102/374 (27%), Positives = 160/374 (42%), Gaps = 11/374 (2%)
Query: 85 SSPARSSANSTPNRFFKRPFPPPSPAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGLN 144
+ S P P + + K ++ + +
Sbjct: 85 ENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYY 144
Query: 145 KSFGFSK--HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAI 202
K H + Y++ EE+G G FG + G A K + +
Sbjct: 145 PQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTPHESD---K 198
Query: 203 EDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDA 262
E VR+E++ + L H LV DA+ED + + ++ E GGEL +++ K +ED+A
Sbjct: 199 ETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA 257
Query: 263 KAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI 322
M Q+ + H VH DLKPEN +FTTK N LK IDFGL+ + P + +
Sbjct: 258 VEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVT 316
Query: 323 VGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381
G+A + APEV + D+WS+GV++YILL G PF + R V D + D
Sbjct: 317 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD 376
Query: 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYM 441
++ + +S + +DF+++LL DP R+T QAL HPW+ N + + K
Sbjct: 377 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRD 436
Query: 442 RSSSLRKAALRALS 455
+ A L
Sbjct: 437 SIKTKYDAWPEPLP 450
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 417 bits (1073), Expect = e-143
Identities = 115/350 (32%), Positives = 170/350 (48%), Gaps = 16/350 (4%)
Query: 105 PPPSPAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVG 164
S L + S AA S + ++ +E+ E+G
Sbjct: 6 HHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRD---ALSDFFEVESELG 62
Query: 165 RGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKF 224
RG K K + A+KV+ K + VR E+ +L L+ H N++K
Sbjct: 63 RGATSIVYRCKQKG---TQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKL 113
Query: 225 FDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHR 284
+ +E + +V+EL GGEL DRI+ +G Y+E DA + QIL VA+ H G+VHR
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLHENGIVHR 172
Query: 285 DLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEAD 343
DLKPEN L+ T ++ LK DFGLS V + + G+ Y APE+L +Y E D
Sbjct: 173 DLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVD 232
Query: 344 VWSIGVIAYILLCGSRPFWART-ESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNK 402
+WS+G+I YILLCG PF+ + +FR +L + F W +S A+D V++L+
Sbjct: 233 MWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVL 292
Query: 403 DPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALR 452
DP+KRLT QAL HPW+ V +D K ++ + L+ A
Sbjct: 293 DPKKRLTTFQALQHPWVTGKAANFVHMDTAQ-KKLQEFNARRKLKAAVKA 341
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 413 bits (1063), Expect = e-142
Identities = 102/284 (35%), Positives = 160/284 (56%), Gaps = 10/284 (3%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT---AIAIEDVRREV 209
+ YE+GEE+G G F + K G++ A K I K ++++ ++ E++ REV
Sbjct: 3 VEDHYEMGEELGSGQFAIVRKCRQKG---TGKEYAAKFIKKRRLSSSRRGVSREEIEREV 59
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
ILR + H N++ D +E+ +V +++EL GGEL D + + TED+A + QI
Sbjct: 60 NILREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQI 117
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
L+ V + H + + H DLKPEN + K+ N +K IDFG++ + +I G+ +
Sbjct: 118 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEF 177
Query: 329 VAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
VAPE+++ EAD+WSIGVI YILL G+ PF T+ + + FDE + +
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSN 237
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDV 431
S A+DF++RLL KDP++R+T AQ+L H WIK V +
Sbjct: 238 TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGED 281
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 408 bits (1050), Expect = e-139
Identities = 105/333 (31%), Positives = 169/333 (50%), Gaps = 19/333 (5%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT---AIAIEDVRR 207
++ + Y+ GEE+G G F + K G Q A K I K + + ++ ED+ R
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKST---GLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
EV IL+ + H N++ + YE+ +V +++EL GGEL D + + TE++A +
Sbjct: 64 EVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLK 121
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAIDFGLSDFVRPDERLNDIVGSA 326
QILN V + H + H DLKPEN + ++ +K IDFGL+ + +I G+
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181
Query: 327 YYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385
+VAPE+++ EAD+WSIGVI YILL G+ PF T+ V + F++ +
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241
Query: 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSS 445
+ S+ A+DF++RLL KDP+KR+T +L HPWIK + + M+
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNME------K 295
Query: 446 LRKAALRALSKTLTVDELFYLKEQYALLEPNKN 478
+K A R S + L + + + +
Sbjct: 296 FKKFAARKKSNNGSGGG---LNDIFEAQKIEWH 325
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 400 bits (1029), Expect = e-136
Identities = 102/320 (31%), Positives = 162/320 (50%), Gaps = 24/320 (7%)
Query: 150 SKHFANKYELG---EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR 206
F Y+L + +G G F KK Q AVK+I K + +
Sbjct: 3 DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKK---SNQAFAVKIISKRME------ANTQ 53
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
+E+ L+ GH N+VK + + D + ++VMEL GGEL +RI + ++E +A +M
Sbjct: 54 KEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK-HFSETEASYIM 112
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLNDIVGS 325
++++ V+ H GVVHRDLKPEN LFT +++N +K IDFG + PD + L +
Sbjct: 113 RKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFT 172
Query: 326 AYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTES-------GIFRAVLKAD 377
+Y APE+L+++ Y D+WS+GVI Y +L G PF + S I + + K D
Sbjct: 173 LHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232
Query: 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV-KVPLDVIIFKL 436
SF+ W ++S EA+D ++ LL DP KRL + + W+++ + + PL
Sbjct: 233 FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILG 292
Query: 437 MKAYMRSSSLRKAALRALSK 456
+ + KA A +K
Sbjct: 293 SSGAAVHTCV-KATFHAFNK 311
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 400 bits (1031), Expect = e-136
Identities = 101/367 (27%), Positives = 170/367 (46%), Gaps = 20/367 (5%)
Query: 85 SSPARSSANSTPNRFFKRPFPPPSPAKHIKAVLARRHGSVKPNEAAIPEGSE------PE 138
SS + + K S + H +A + + + + P
Sbjct: 9 SSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPA 68
Query: 139 PAAGLNKSFGFSKH--FANKYELG--EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKH 194
P A + +K + Y + E +G G FG + G ++A K+I
Sbjct: 69 PPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETAT---GLKLAAKIIKTR 125
Query: 195 KMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG 254
M E+V+ E+ ++ L H NL++ +DA+E +++ +VME +GGEL DRI+
Sbjct: 126 GMKD---KEEVKNEISVMNQL-DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDES 181
Query: 255 GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314
TE D M QI + H ++H DLKPEN L +D +K IDFGL+ +
Sbjct: 182 YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQ-IKIIDFGLARRYK 240
Query: 315 PDERLNDIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAV 373
P E+L G+ ++APEV++ S D+WS+GVIAY+LL G PF ++ +
Sbjct: 241 PREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI 300
Query: 374 LKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN-DVKVPLDVI 432
L ++ + +S EA++F+ +LL K+ R++A++AL HPW+ + ++
Sbjct: 301 LACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKK 360
Query: 433 IFKLMKA 439
+ A
Sbjct: 361 KNRGSDA 367
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 401 bits (1032), Expect = e-136
Identities = 97/320 (30%), Positives = 155/320 (48%), Gaps = 14/320 (4%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
+ Y++ EE+G G FG K G+ K I V+ E+
Sbjct: 46 QGSVYDYYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTPYPLD---KYTVKNEI 99
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
I+ L H L+ DA+ED + +++E GGEL DRI + K +E + M Q
Sbjct: 100 SIMNQLH-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQA 158
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
+ H +VH D+KPEN + TK +S +K IDFGL+ + PDE + +A +
Sbjct: 159 CEGLKHMHEHSIVHLDIKPENIMCETKKASS-VKIIDFGLATKLNPDEIVKVTTATAEFA 217
Query: 330 APEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388
APE++ R D+W+IGV+ Y+LL G PF + + V + D FDE + S+
Sbjct: 218 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 277
Query: 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND-VKVPLDVIIFKLMKAYMR----S 443
S EA+DF+K LL K+PRKRLT AL HPW+K + + + + ++ ++
Sbjct: 278 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYAD 337
Query: 444 SSLRKAALRALSKTLTVDEL 463
+ A+ ++ ++ +
Sbjct: 338 WPAPQPAIGRIANFSSLRKH 357
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 399 bits (1027), Expect = e-136
Identities = 95/328 (28%), Positives = 150/328 (45%), Gaps = 54/328 (16%)
Query: 146 SFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--TTAIAIE 203
G KY L +G+G +G A + A+K++ K+K+ +E
Sbjct: 17 QGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQT---RAIRAIKIMNKNKIRQINPKDVE 73
Query: 204 DVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGK------- 256
++ EV++++ L H N+ + ++ YED + +VMELC GG LLD++
Sbjct: 74 RIKTEVRLMKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAM 132
Query: 257 --------------------------------YTEDDAKAVMIQILNVVAFCHLQGVVHR 284
E +M QI + + + H QG+ HR
Sbjct: 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHR 192
Query: 285 DLKPENFLFTTKDENSVLKAIDFGLSDFVRP-----DERLNDIVGSAYYVAPEVLH---R 336
D+KPENFLF+T +++ +K +DFGLS + G+ Y+VAPEVL+
Sbjct: 193 DIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE 251
Query: 337 SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFV 396
SY + D WS GV+ ++LL G+ PF ++ VL F+ + LS ARD +
Sbjct: 252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLL 311
Query: 397 KRLLNKDPRKRLTAAQALSHPWIKNSND 424
LLN++ +R A +AL HPWI +D
Sbjct: 312 SNLLNRNVDERFDAMRALQHPWISQFSD 339
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 396 bits (1020), Expect = e-135
Identities = 100/312 (32%), Positives = 165/312 (52%), Gaps = 12/312 (3%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT---AIAIEDVRR 207
+ + Y++GEE+G G F + K G + A K I K + ++ E++ R
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKST---GLEYAAKFIKKRQSRASRRGVSREEIER 64
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
EV ILR + H+N++ D YE+ +V +++EL GGEL D + + +E++A + +
Sbjct: 65 EVSILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIK 122
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDEN-SVLKAIDFGLSDFVRPDERLNDIVGSA 326
QIL+ V + H + + H DLKPEN + K+ +K IDFGL+ + +I G+
Sbjct: 123 QILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP 182
Query: 327 YYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385
+VAPE+++ EAD+WSIGVI YILL G+ PF T+ + FDE +
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFF 242
Query: 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSS 445
S A+DF+++LL K+ RKRLT +AL HPWI ++ + + ++ + +
Sbjct: 243 SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYV 302
Query: 446 LRK--AALRALS 455
R+ + +S
Sbjct: 303 RRRWKLSFSIVS 314
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 397 bits (1021), Expect = e-135
Identities = 110/359 (30%), Positives = 172/359 (47%), Gaps = 39/359 (10%)
Query: 117 LARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEV-GRGHFGYTCAAK 175
+A H + +G EP+ + Y+L ++V G G G
Sbjct: 1 MAHHHHHHSSGLEVLFQGPEPK-----------KYAVTDDYQLSKQVLGLGVNGKVLECF 49
Query: 176 FKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN-- 233
++ GQ+ A+K++ R+EV +G ++V D YE+ +
Sbjct: 50 HRR---TGQKCALKLLYDSP--------KARQEVDHHWQASGGPHIVCILDVYENMHHGK 98
Query: 234 --VYVVMELCEGGELLDRILSRGGK-YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290
+ ++ME EGGEL RI RG + +TE +A +M I + F H + HRD+KPEN
Sbjct: 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPEN 158
Query: 291 FLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGV 349
L+T+K++++VLK DFG + + L + YYVAPEVL Y D+WS+GV
Sbjct: 159 LLYTSKEKDAVLKLTDFGFAKETTQNA-LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 217
Query: 350 IAYILLCGSRPFWARTES----GIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPR 405
I YILLCG PF++ T G+ R + F W +S +A+ ++ LL DP
Sbjct: 218 IMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPT 277
Query: 406 KRLTAAQALSHPWIKNSNDV-KVPLD-VIIFKLMKAYMRSSSLRKAALRALSKTLTVDE 462
+RLT Q ++HPWI S V + PL + + K + +++ AL+ T+ VD
Sbjct: 278 ERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHWD--EVKEEMTSALA-TMRVDY 333
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 395 bits (1018), Expect = e-134
Identities = 103/350 (29%), Positives = 169/350 (48%), Gaps = 15/350 (4%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT---AIAIEDVRR 207
+ + Y++GEE+G G F + K G + A K I K + + E++ R
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKST---GLEYAAKFIKKRQSRASRRGVCREEIER 64
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
EV ILR + H N++ D YE+ +V +++EL GGEL D + + +E++A + +
Sbjct: 65 EVSILRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIK 122
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAIDFGLSDFVRPDERLNDIVGSA 326
QIL+ V + H + + H DLKPEN + K+ +K IDFGL+ + +I G+
Sbjct: 123 QILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP 182
Query: 327 YYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385
+VAPE+++ EAD+WSIGVI YILL G+ PF T+ + FDE +
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF 242
Query: 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSS 445
S A+DF+++LL K+ RKRLT +AL HPWI + + + ++ + +
Sbjct: 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYV 302
Query: 446 LRK-----AALRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSAL 490
R+ + + + L ++ T + AL
Sbjct: 303 RRRWKLSFSIVSLCNHLTRSLMKKVHLRTSEDLRNCESDTEENIARRKAL 352
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 392 bits (1010), Expect = e-133
Identities = 96/312 (30%), Positives = 148/312 (47%), Gaps = 38/312 (12%)
Query: 149 FSKHFANKYELGEEV-GRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR 207
FS F + Y+L E+V G G Q+ AVK+I K V R
Sbjct: 6 FSGRFEDVYQLQEDVLGEGAHARVQTCINLI---TSQEYAVKIIEKQPGHI---RSRVFR 59
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
EV++L GH N+++ + +E+ D Y+V E GG +L I R + E +A V+
Sbjct: 60 EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR-HFNELEASVVVQ 118
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI----- 322
+ + + F H +G+ HRDLKPEN L ++ S +K DF L ++ + + I
Sbjct: 119 DVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178
Query: 323 ---VGSAYYVAPEVL------HRSYSTEADVWSIGVIAYILLCGSRPFWAR--------- 364
GSA Y+APEV+ Y D+WS+GVI YILL G PF R
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR 238
Query: 365 ------TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
++ +F ++ + F + W +S A+D + +LL +D ++RL+AAQ L HPW
Sbjct: 239 GEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPW 298
Query: 419 IKNSNDVKVPLD 430
++ + L
Sbjct: 299 VQGCAP-ENTLP 309
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 385 bits (992), Expect = e-131
Identities = 89/333 (26%), Positives = 145/333 (43%), Gaps = 48/333 (14%)
Query: 134 GSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPK 193
G + + K+ + + +G G G K+ ++ A+K++
Sbjct: 1 GPHVKSGLQIKKNAIIDDY----KVTSQVLGLGINGKVLQIFNKRT---QEKFALKMLQD 53
Query: 194 HKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT----DNVYVVMELCEGGELLDR 249
RREV++ + ++V+ D YE+ + +VME +GGEL R
Sbjct: 54 --------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSR 105
Query: 250 ILSRGGK-YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308
I RG + +TE +A +M I + + H + HRD+KPEN L+T+K N++LK DFG
Sbjct: 106 IQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 165
Query: 309 LSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWA----R 364
A E Y D+WS+GVI YILLCG PF++
Sbjct: 166 F--------------------AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 205
Query: 365 TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424
G+ + F W +S E + ++ LL +P +R+T + ++HPWI S
Sbjct: 206 ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265
Query: 425 V-KVPLD-VIIFKLMKAYMRSSSLRKAALRALS 455
V + PL + K K R +++ AL+
Sbjct: 266 VPQTPLHTSRVLKEDKE--RWEDVKEEMTSALA 296
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 384 bits (988), Expect = e-130
Identities = 97/324 (29%), Positives = 164/324 (50%), Gaps = 21/324 (6%)
Query: 149 FSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT-----AIAIE 203
+ K ++Y + + +G G G A +K ++VA+K+I K K A
Sbjct: 4 YPKALRDEYIMSKTLGSGACGEVKLAFERKT---CKKVAIKIISKRKFAIGSAREADPAL 60
Query: 204 DVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAK 263
+V E++IL+ L H ++K + ++ ++ Y+V+EL EGGEL D+++ + E K
Sbjct: 61 NVETEIEILKKL-NHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNK-RLKEATCK 117
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323
Q+L V + H G++HRDLKPEN L ++++E+ ++K DFG S + + +
Sbjct: 118 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 177
Query: 324 GSAYYVAPEVL----HRSYSTEADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLKADP 378
G+ Y+APEVL Y+ D WS+GVI +I L G PF RT+ + +
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 237
Query: 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMK 438
+F W +S +A D VK+LL DP+ R T +AL HPW+++ + + D L+
Sbjct: 238 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQD-----LLS 292
Query: 439 AYMRSSSLRKAALRALSKTLTVDE 462
S++L + + + E
Sbjct: 293 EENESTALPQVLAQPSTSRKRPRE 316
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 384 bits (988), Expect = e-130
Identities = 108/322 (33%), Positives = 160/322 (49%), Gaps = 24/322 (7%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
S F + YE+ E++G G + K + AVK+I K K D E+
Sbjct: 17 SIQFTDGYEVKEDIGVGSYSVCKRCIHKA---TNMEFAVKIIDKSK-------RDPTEEI 66
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
+IL H N++ D Y+D VYVV EL +GGELLD+IL + ++E +A AV+ I
Sbjct: 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK-FFSEREASAVLFTI 125
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDEN-SVLKAIDFGLSDFVRPDER-LNDIVGSAY 327
V + H QGVVHRDLKP N L+ + N ++ DFG + +R + L +A
Sbjct: 126 TKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTAN 185
Query: 328 YVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWAR---TESGIFRAVLKADPSFDEA 383
+VAPEVL R Y D+WS+GV+ Y +L G PF T I + S
Sbjct: 186 FVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGG 245
Query: 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV-KVPLD-VIIFKLMKAYM 441
W S+S A+D V ++L+ DP +RLTAA L HPWI + + + + L+ L+K M
Sbjct: 246 YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLVKGAM 305
Query: 442 RSS-----SLRKAALRALSKTL 458
++ + L + ++
Sbjct: 306 AATYSALNRNQSPVLEPVGRST 327
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 375 bits (964), Expect = e-125
Identities = 92/294 (31%), Positives = 156/294 (53%), Gaps = 16/294 (5%)
Query: 149 FSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT-----AIAIE 203
+ K ++Y + + +G G G A +K ++VA+++I K K A
Sbjct: 129 YPKALRDEYIMSKTLGSGACGEVKLAFERKT---CKKVAIRIISKRKFAIGSAREADPAL 185
Query: 204 DVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAK 263
+V E++IL+ L H ++K + ++ ++ Y+V+EL EGGEL D+++ + E K
Sbjct: 186 NVETEIEILKKLN-HPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNK-RLKEATCK 242
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323
Q+L V + H G++HRDLKPEN L ++++E+ ++K DFG S + + +
Sbjct: 243 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 302
Query: 324 GSAYYVAPEVL----HRSYSTEADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLKADP 378
G+ Y+APEVL Y+ D WS+GVI +I L G PF RT+ + +
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 362
Query: 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVI 432
+F W +S +A D VK+LL DP+ R T +AL HPW+++ + + D++
Sbjct: 363 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLL 416
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 337 bits (866), Expect = e-110
Identities = 85/424 (20%), Positives = 167/424 (39%), Gaps = 32/424 (7%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+ + +G G G +G + VAVK I REV++LR
Sbjct: 25 SFCPKDVLGHGAEGTIV----YRGMFDNRDVAVKRILPECF------SFADREVQLLRES 74
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N++++F +D Y+ +ELC L + + + + + ++ Q + +A
Sbjct: 75 DEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAH 133
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAI--DFGLSDFVRPDE----RLNDIVGSAYYV 329
H +VHRDLKP N L + + + +KA+ DFGL + R + + G+ ++
Sbjct: 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 330 APEVL----HRSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFD-EA 383
APE+L + + D++S G + Y ++ GS PF + +L S D
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN--ILLGACSLDCLH 251
Query: 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRS 443
P AR+ +++++ DP+KR +A L HP+ + ++ + ++
Sbjct: 252 PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK-QLQFFQDVSDRIEKESLD 310
Query: 444 SSLRKAALRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSAL--MKNATDAMKDS 501
+ K R + +D + + K T +V+ L M+N ++
Sbjct: 311 GPIVKQLERGGRAVVKMDWRENITVPL-QTDLRKFRTYKGGSVRDLLRAMRNKKHHYREL 369
Query: 502 RIPDFLSSLNSLQYRRMDF--EEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIV 559
+ +L +L + + F ++ L E+ + Y + +
Sbjct: 370 P-AEVRETLGTLPDDFVCYFTSRFPHLLAHTYRAMELCSHERLFQPYYFHEPPEPQPPVT 428
Query: 560 IEEL 563
+ L
Sbjct: 429 PDAL 432
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 331 bits (851), Expect = e-108
Identities = 79/308 (25%), Positives = 133/308 (43%), Gaps = 44/308 (14%)
Query: 149 FSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRRE 208
F + N + +G G G +G +G+ VAVK + + E
Sbjct: 9 FEQSLKNLVVSEKILGYGSSGTVV----FQGSFQGRPVAVKRMLIDFC------DIALME 58
Query: 209 VKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG------GKYTEDDA 262
+K+L H N+++++ + +Y+ +ELC L D + S+ E +
Sbjct: 59 IKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNP 117
Query: 263 KAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD----------ENSVLKAIDFGLSDF 312
+++ QI + VA H ++HRDLKP+N L +T EN + DFGL
Sbjct: 118 ISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 313 VRPDE-----RLNDIVGSAYYVAPEVL--------HRSYSTEADVWSIGVIAYILLC-GS 358
+ + LN+ G++ + APE+L R + D++S+G + Y +L G
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237
Query: 359 RPFWAR--TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416
PF + ES I R + D SL +EA D + ++++ DP KR TA + L H
Sbjct: 238 HPFGDKYSRESNIIRGIFSLDE-MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296
Query: 417 PWIKNSND 424
P +
Sbjct: 297 PLFWPKSK 304
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 283 bits (727), Expect = 2e-91
Identities = 74/313 (23%), Positives = 134/313 (42%), Gaps = 43/313 (13%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
S +A+ +E +G+G FG A+ + A+K I + + + EV
Sbjct: 1 SLRYASDFEEIAVLGQGAFGQVVKARNALD---SRYYAIKKIRHTEE----KLSTILSEV 53
Query: 210 KILRALTGHNNLVKFFDAYEDTDN-------------VYVVMELCEGGELLDRILSRGGK 256
+L +L H +V+++ A+ + N +++ ME CE G L D I S
Sbjct: 54 MLLASLN-HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN 112
Query: 257 YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS------ 310
D+ + QIL +++ H QG++HRDLKP N DE+ +K DFGL+
Sbjct: 113 QQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRS 169
Query: 311 ---------DFVRPDERLNDIVGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSR 359
+ + L +G+A YVA EVL + Y+ + D++S+G+I + ++
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-- 227
Query: 360 PFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
I + + F + + ++ L++ DP KR A L+ W+
Sbjct: 228 FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287
Query: 420 KNSNDVKVPLDVI 432
+ +V + +
Sbjct: 288 PVKHQDEVIKEAL 300
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 281 bits (720), Expect = 2e-90
Identities = 70/315 (22%), Positives = 117/315 (37%), Gaps = 50/315 (15%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELK--GQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
+ + L + +G+G +G K G A+KV + + RE ++L
Sbjct: 9 HLWLLSDILGQGATA-----NVFRGRHKKTGDLFAIKVFNNISFLRPV--DVQMREFEVL 61
Query: 213 RALTGHNNLVKFFDAYED--TDNVYVVMELCEGGELLDRILSRG--GKYTEDDAKAVMIQ 268
+ L H N+VK F E+ T + ++ME C G L + E + V+
Sbjct: 62 KKLN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 269 ILNVVAFCHLQGVVHRDLKPENFL-FTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY 327
++ + G+VHR++KP N + +D SV K DFG + + DE+ + G+
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180
Query: 328 YVAPEVL---------HRSYSTEADVWSIGVIAYILLCGSRPFWA----RTESGIFRAVL 374
Y+ P++ + Y D+WSIGV Y GS PF R + ++
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240
Query: 375 KADP-----------------SFDEAPWPSLSSEARD----FVKRLLNKDPRKRLTAAQA 413
P S D SLS + + +L D K Q
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
Query: 414 LSHPW-IKNSNDVKV 427
+ I + +
Sbjct: 301 FAETSDILHRGNSHH 315
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 4e-87
Identities = 70/284 (24%), Positives = 126/284 (44%), Gaps = 30/284 (10%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKG-ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
Y + +++G G K + K Q A+K + + ++ R E+ L
Sbjct: 28 RIYSILKQIGSGGSS-----KVFQVLNEKKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLN 81
Query: 214 ALTGHN-NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
L H+ +++ +D +Y+VME C +L + + + K+ +L
Sbjct: 82 KLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEA 139
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYV 329
V H G+VH DLKP NFL + +LK IDFG+++ ++PD + VG+ Y+
Sbjct: 140 VHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 330 APEVLHRS------------YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 377
PE + S ++DVWS+G I Y + G PF I + D
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISKLHAIID 254
Query: 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
P+ + + +D +K L +DP++R++ + L+HP+++
Sbjct: 255 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 270 bits (694), Expect = 1e-86
Identities = 85/270 (31%), Positives = 130/270 (48%), Gaps = 18/270 (6%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELK--GQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+Y G +G+G F AK + + A K++PK + E + E+ I R
Sbjct: 16 RYVRGRFLGKGGF-----AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
+L H ++V F +ED D V+VV+ELC LL+ R TE +A+ + QI+
Sbjct: 71 SLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGC 128
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV-RPDERLNDIVGSAYYVAPE 332
+ H V+HRDLK N +E+ +K DFGL+ V ER + G+ Y+APE
Sbjct: 129 QYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE 185
Query: 333 VL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391
VL + +S E DVWSIG I Y LL G PF + + K + S P ++
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI---P-KHINPV 241
Query: 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
A ++++L DP R T + L+ + +
Sbjct: 242 AASLIQKMLQTDPTARPTINELLNDEFFTS 271
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 269 bits (691), Expect = 1e-86
Identities = 85/269 (31%), Positives = 146/269 (54%), Gaps = 13/269 (4%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+++G +G+G F A+ G +VA+K+I K M A ++ V+ EVKI
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIH---TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L H ++++ ++ +ED++ VY+V+E+C GE+ + +R ++E++A+ M QI+ +
Sbjct: 68 LK-HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV-RPDERLNDIVGSAYYVAPEV 333
+ H G++HRDL N L N +K DFGL+ + P E+ + G+ Y++PE+
Sbjct: 127 YLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEI 183
Query: 334 L-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392
++ E+DVWS+G + Y LL G PF T V+ AD P LS EA
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM---P-SFLSIEA 239
Query: 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
+D + +LL ++P RL+ + L HP++
Sbjct: 240 KDLIHQLLRRNPADRLSLSSVLDHPFMSR 268
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 269 bits (691), Expect = 9e-86
Identities = 90/307 (29%), Positives = 134/307 (43%), Gaps = 18/307 (5%)
Query: 118 ARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFK 177
G A P P A +Y G +G+G F AK
Sbjct: 4 PADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGF-----AKCF 58
Query: 178 KGELK--GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235
+ + A K++PK + E + E+ I R+L H ++V F +ED D V+
Sbjct: 59 EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVF 117
Query: 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT 295
VV+ELC LL+ R TE +A+ + QI+ + H V+HRDLK N
Sbjct: 118 VVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL-- 174
Query: 296 KDENSVLKAIDFGLSDFV-RPDERLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYI 353
+E+ +K DFGL+ V ER + G+ Y+APEVL + +S E DVWSIG I Y
Sbjct: 175 -NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYT 233
Query: 354 LLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQA 413
LL G PF + + K + S P ++ A ++++L DP R T +
Sbjct: 234 LLVGKPPFETSCLKETYLRIKKNEYSI---P-KHINPVAASLIQKMLQTDPTARPTINEL 289
Query: 414 LSHPWIK 420
L+ +
Sbjct: 290 LNDEFFT 296
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 269 bits (689), Expect = 2e-85
Identities = 70/284 (24%), Positives = 126/284 (44%), Gaps = 30/284 (10%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
Y + +++G G K + K Q A+K + + ++ R E+ L
Sbjct: 9 RIYSILKQIGSGGSS-----KVFQVLNEKKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLN 62
Query: 214 ALTGHN-NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
L H+ +++ +D +Y+VME C +L + + + K+ +L
Sbjct: 63 KLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEA 120
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYV 329
V H G+VH DLKP NFL + +LK IDFG+++ ++PD + VG+ Y+
Sbjct: 121 VHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 330 APEVLHRS------------YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 377
PE + S ++DVWS+G I Y + G PF I + D
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISKLHAIID 235
Query: 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
P+ + + +D +K L +DP++R++ + L+HP+++
Sbjct: 236 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 269 bits (690), Expect = 7e-85
Identities = 77/367 (20%), Positives = 134/367 (36%), Gaps = 52/367 (14%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELK--GQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
+ + L + +G+G +G K G A+KV + + RE ++L
Sbjct: 9 HLWLLSDILGQGATA-----NVFRGRHKKTGDLFAIKVFNNISFLRPV--DVQMREFEVL 61
Query: 213 RALTGHNNLVKFFDAYED--TDNVYVVMELCEGGELLDRILSRG--GKYTEDDAKAVMIQ 268
+ L H N+VK F E+ T + ++ME C G L + E + V+
Sbjct: 62 KKLN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 269 ILNVVAFCHLQGVVHRDLKPENFL-FTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY 327
++ + G+VHR++KP N + +D SV K DFG + + DE+ + G+
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180
Query: 328 YVAPEVL---------HRSYSTEADVWSIGVIAYILLCGSRPFWA----RTESGIFRAVL 374
Y+ P++ + Y D+WSIGV Y GS PF R + ++
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240
Query: 375 KADP-----------------SFDEAPWPSLSSEARD----FVKRLLNKDPRKRLTAAQA 413
P S D SLS + + +L D K Q
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
Query: 414 LSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALRALS---KTLTVDELFYLKEQY 470
+ V + K Y+ S + + K ++ ++ + +
Sbjct: 301 FAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRR 360
Query: 471 ALLEPNK 477
+LEP +
Sbjct: 361 LVLEPGR 367
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 2e-83
Identities = 75/334 (22%), Positives = 136/334 (40%), Gaps = 36/334 (10%)
Query: 105 PPPSPAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVG 164
P S K A + P+ + + + Y + +++G
Sbjct: 12 PRGSGMKETAA------AKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIG 65
Query: 165 RGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN-NLV 222
G K + K Q A+K + + ++ R E+ L L H+ ++
Sbjct: 66 SGGSS-----KVFQVLNEKKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQHSDKII 119
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ +D +Y+VME C +L + + + K+ +L V H G+V
Sbjct: 120 RLYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIV 177
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLHRS-- 337
H DLKP NFL + +LK IDFG+++ ++PD + VG+ Y+ PE +
Sbjct: 178 HSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 338 ----------YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
S ++DVWS+G I Y + G PF I + DP+ +
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISKLHAIIDPNHEIEFPDI 292
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
+ +D +K L +DP++R++ + L+HP+++
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 256 bits (657), Expect = 2e-81
Identities = 82/268 (30%), Positives = 137/268 (51%), Gaps = 14/268 (5%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+E+G +G+G FG A+ K+ +A+KV+ K ++ A +RREV+I
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 65
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L H N+++ + + D VY+++E G + L + K+ E + ++ N ++
Sbjct: 66 LR-HPNILRLYGYFHDATRVYLILEYAPLGTVYRE-LQKLSKFDEQRTATYITELANALS 123
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL 334
+CH + V+HRD+KPEN L LK DFG S P R D+ G+ Y+ PE++
Sbjct: 124 YCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMI 179
Query: 335 -HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393
R + + D+WS+GV+ Y L G PF A T ++ + + + +F P ++ AR
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF---P-DFVTEGAR 235
Query: 394 DFVKRLLNKDPRKRLTAAQALSHPWIKN 421
D + RLL +P +R + L HPWI
Sbjct: 236 DLISRLLKHNPSQRPMLREVLEHPWITA 263
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 2e-81
Identities = 89/269 (33%), Positives = 146/269 (54%), Gaps = 19/269 (7%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
Y L + +G+G+F K K L G++VA+K+I K ++ +++ + REV+I++
Sbjct: 16 NYRLLKTIGKGNFA-----KVKLARHILTGREVAIKIIDKTQLNPT-SLQKLFREVRIMK 69
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
L H N+VK F+ E +Y++ME GGE+ D +++ G + E +A++ QI++ V
Sbjct: 70 ILN-HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAV 127
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV 333
+CH + +VHRDLK EN L D + +K DFG S+ +L+ G+ Y APE+
Sbjct: 128 QYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPEL 184
Query: 334 LH-RSYS-TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391
+ Y E DVWS+GVI Y L+ GS PF + + VL+ + + +S++
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK--YRIPFY--MSTD 240
Query: 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
+ +KR L +P KR T Q + WI
Sbjct: 241 CENLLKRFLVLNPIKRGTLEQIMKDRWIN 269
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 3e-80
Identities = 96/269 (35%), Positives = 137/269 (50%), Gaps = 18/269 (6%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
Y LG+ +G G FG K K GE L G +VAVK++ + K+ + + ++RE++ L+
Sbjct: 12 HYVLGDTLGVGTFG-----KVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK 66
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
H +++K + + ++VME GGEL D I G + E +A+ + QIL+ V
Sbjct: 67 LFR-HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAV 124
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV 333
+CH VVHRDLKPEN L D + K DFGLS+ + E L GS Y APEV
Sbjct: 125 DYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV 181
Query: 334 L-HRSYS-TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391
+ R Y+ E D+WS GVI Y LLCG+ PF +F+ + F + L+
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV--FYIPEY--LNRS 237
Query: 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
+ +L DP KR T H W K
Sbjct: 238 VATLLMHMLQVDPLKRATIKDIREHEWFK 266
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 4e-80
Identities = 80/278 (28%), Positives = 142/278 (51%), Gaps = 15/278 (5%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ +++G +G+G FG A+ K+ +A+KV+ K ++ +RRE++I
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQ---NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSH 70
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L H N+++ ++ + D +Y+++E GEL L + G++ E + M ++ + +
Sbjct: 71 LR-HPNILRMYNYFHDRKRIYLMLEFAPRGELYKE-LQKHGRFDEQRSATFMEELADALH 128
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL 334
+CH + V+HRD+KPEN L LK DFG S P R + G+ Y+ PE++
Sbjct: 129 YCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVHA-PSLRRRTMCGTLDYLPPEMI 184
Query: 335 -HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393
+++ + D+W GV+ Y L G PF + + + R ++ D F P P LS ++
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF---P-PFLSDGSK 240
Query: 394 DFVKRLLNKDPRKRLTAAQALSHPWI-KNSNDVKVPLD 430
D + +LL P +RL + HPW+ NS V P+
Sbjct: 241 DLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVY 278
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 255 bits (652), Expect = 1e-79
Identities = 48/304 (15%), Positives = 85/304 (27%), Gaps = 46/304 (15%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
K +L E + G + + + A+KV + +E + L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVER---LEDFALKVFTMGAENSRSELERLHEATFAAARL 119
Query: 216 TGHN-----------------------NLVKFFDAYEDTD--NVYVVMELCEG-----GE 245
G + + +D N ++M
Sbjct: 120 LGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFS 179
Query: 246 LLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305
LD + G + Q++ + A +G+VH P+N + L
Sbjct: 180 TLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI---MPDGRLMLG 236
Query: 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS---YSTEADVWSIGVIAYILLCGSRPFW 362
D + R Y E L+ S ++ + W +G+ Y + C PF
Sbjct: 237 DVSAL--WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294
Query: 363 ARTESGIFRAVLKAD-----PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHP 417
T + S L + + R LN D R+RL +A+ P
Sbjct: 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP 354
Query: 418 WIKN 421
Sbjct: 355 EFLQ 358
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 1e-78
Identities = 78/271 (28%), Positives = 128/271 (47%), Gaps = 18/271 (6%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
++L + +G G +G + + + VAVK++ + E++++E+ I + L
Sbjct: 8 DWDLVQTLGEGAYG---EVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKML 62
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N+VKF+ + + Y+ +E C GGEL DRI E DA+ Q++ V +
Sbjct: 63 N-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVY 120
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP---DERLNDIVGSAYYVAPE 332
H G+ HRD+KPEN L DE LK DFGL+ R + LN + G+ YVAPE
Sbjct: 121 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 333 VL-HRSYS-TEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSFDEAPWPSLS 389
+L R + DVWS G++ +L G P+ ++S + + PW +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--TYLNPWKKID 235
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
S + ++L ++P R+T W
Sbjct: 236 SAPLALLHKILVENPSARITIPDIKKDRWYN 266
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 249 bits (639), Expect = 1e-78
Identities = 80/296 (27%), Positives = 137/296 (46%), Gaps = 41/296 (13%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM------------------ 196
N+Y L +E+G+G +G K E A+KV+ K K+
Sbjct: 13 NQYTLKDEIGKGSYG---VVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPA 69
Query: 197 -----TTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--TDNVYVVMELCEGGELLDR 249
IE V +E+ IL+ L H N+VK + +D D++Y+V EL G +++
Sbjct: 70 PGGCIQPRGPIEQVYQEIAILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV 128
Query: 250 ILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309
+ED A+ ++ + + H Q ++HRD+KP N L E+ +K DFG+
Sbjct: 129 P--TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV---GEDGHIKIADFGV 183
Query: 310 S-DFVRPDERLNDIVGSAYYVAPEVL---HRSYS-TEADVWSIGVIAYILLCGSRPFWAR 364
S +F D L++ VG+ ++APE L + +S DVW++GV Y + G PF
Sbjct: 184 SNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243
Query: 365 TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
+ + F + P ++ + +D + R+L+K+P R+ + HPW+
Sbjct: 244 RIMCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 261 bits (668), Expect = 1e-78
Identities = 71/381 (18%), Positives = 146/381 (38%), Gaps = 46/381 (12%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELK--GQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+E+ E +G G FG + + G+QVA+K + E E++I++
Sbjct: 15 PWEMKERLGTGGFG-----YVLRWIHQDTGEQVAIKQCRQELSPKNR--ERWCLEIQIMK 67
Query: 214 ALTGHNNLVKFFDAYED------TDNVYVVMELCEGGELLDRILSRG--GKYTEDDAKAV 265
L H N+V + + D + ME CEGG+L + E + +
Sbjct: 68 KLN-HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126
Query: 266 MIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGS 325
+ I + + + H ++HRDLKPEN + + + K ID G + + E + VG+
Sbjct: 127 LSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGT 186
Query: 326 AYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384
Y+APE+L + Y+ D WS G +A+ + G RPF + + ++ +
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246
Query: 385 W--------------------PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424
+ L+ + +++ +L R+R T Q + + +
Sbjct: 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS 306
Query: 425 VKVPLDVIIFKLMKAYMRSSSLRK----AALRALSKTLT---VDELFYLKEQYALLEPNK 477
+ + + ++ + + + + L++ + T +E L+ L +
Sbjct: 307 ILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPEEEQELLQASGLALNSAQ 366
Query: 478 NGTISLENVKSALMKNATDAM 498
T + + + +
Sbjct: 367 PLTQYVIDCTVIDGRQGEGDL 387
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 3e-78
Identities = 77/292 (26%), Positives = 112/292 (38%), Gaps = 20/292 (6%)
Query: 132 PEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVK 189
E SE + G + S S F ++ +G G +G + K + G+ AVK
Sbjct: 35 GEASETLQSPGYDPSRPES-FFQQSFQRLSRLGHGSYGEVFKV---RSKED--GRLYAVK 88
Query: 190 VIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDR 249
EV + H V+ A+E+ +Y+ ELC G L
Sbjct: 89 RSMSPFRGPK-DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQH 146
Query: 250 ILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309
+ G E + L +A H QG+VH D+KP N K DFGL
Sbjct: 147 CEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFGL 203
Query: 310 SDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCG-SRPFWARTESG 368
+ G Y+APE+L SY T ADV+S+G+ + C P
Sbjct: 204 LVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQ 263
Query: 369 IFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
+ + L P F LSSE R + +L DP+ R TA L+ P ++
Sbjct: 264 LRQGYLP--PEF----TAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLR 309
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 2e-77
Identities = 78/271 (28%), Positives = 128/271 (47%), Gaps = 18/271 (6%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
++L + +G G +G + + + VAVK++ + E++++E+ I + L
Sbjct: 8 DWDLVQTLGEGAYG---EVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKML 62
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N+VKF+ + + Y+ +E C GGEL DRI E DA+ Q++ V +
Sbjct: 63 N-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVY 120
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP---DERLNDIVGSAYYVAPE 332
H G+ HRD+KPEN L DE LK DFGL+ R + LN + G+ YVAPE
Sbjct: 121 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 333 VL-HRSYS-TEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSFDEAPWPSLS 389
+L R + DVWS G++ +L G P+ ++S + + PW +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--TYLNPWKKID 235
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
S + ++L ++P R+T W
Sbjct: 236 SAPLALLHKILVENPSARITIPDIKKDRWYN 266
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 247 bits (634), Expect = 3e-77
Identities = 86/269 (31%), Positives = 135/269 (50%), Gaps = 19/269 (7%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
Y + E +G G FG K K Q+VA+K I + + + V RE+ L+
Sbjct: 10 PYIIRETLGEGSFG-----KVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLK 64
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
L H +++K +D ++ +V+E GGEL D I+ + + TED+ + QI+ +
Sbjct: 65 LLR-HPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAI 121
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV 333
+CH +VHRDLKPEN L D+N +K DFGLS+ + L GS Y APEV
Sbjct: 122 EYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 178
Query: 334 L-HRSYS-TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391
+ + Y+ E DVWS G++ Y++L G PF +F+ V + + LS
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV--YVMPDF--LSPG 234
Query: 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
A+ ++R++ DP +R+T + PW
Sbjct: 235 AQSLIRRMIVADPMQRITIQEIRRDPWFN 263
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 248 bits (634), Expect = 3e-77
Identities = 70/344 (20%), Positives = 131/344 (38%), Gaps = 51/344 (14%)
Query: 126 PNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQ 185
P + S LNK + N Y + + +G F K E +
Sbjct: 2 PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFN-----KIILCEKDNKF 56
Query: 186 VAVKVIPKH--------------KMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231
A+K K K++ +D + E++I+ + + + +
Sbjct: 57 YALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NEYCLTCEGIITNY 115
Query: 232 DNVYVVMELCEGGELLDRILSRG-------GKYTEDDAKAVMIQILNVVAFCHLQ-GVVH 283
D VY++ E E +L K ++ +LN ++ H + + H
Sbjct: 116 DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICH 175
Query: 284 RDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS---YST 340
RD+KP N L D+N +K DFG S+++ D+++ G+ ++ PE
Sbjct: 176 RDVKPSNILM---DKNGRVKLSDFGESEYM-VDKKIKGSRGTYEFMPPEFFSNESSYNGA 231
Query: 341 EADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLKADPSF---------------DEAP 384
+ D+WS+G+ Y++ PF + +F + + +
Sbjct: 232 KVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCS 291
Query: 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVP 428
LS+E DF+K L K+P +R+T+ AL H W+ ++N +
Sbjct: 292 NNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLR 335
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 5e-77
Identities = 83/306 (27%), Positives = 133/306 (43%), Gaps = 35/306 (11%)
Query: 126 PNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGE--LKG 183
P G+ P G ++ + F +Y LG +G+G FG G
Sbjct: 7 LQGPPAPPGTPTPPPGGKDR-----EAFEAEYRLGPLLGKGGFG-----TVFAGHRLTDR 56
Query: 184 QQVAVKVIPKHKMTTAIAIED---VRREVKILRAL---TGHNNLVKFFDAYEDTDNVYVV 237
QVA+KVIP++++ + D EV +L + GH +++ D +E + +V
Sbjct: 57 LQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLV 116
Query: 238 MEL-CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296
+E +L D I +G E ++ Q++ + CH +GVVHRD+K EN L +
Sbjct: 117 LERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLR 175
Query: 297 DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYS-TEADVWSIGVIAYIL 354
K IDFG + DE D G+ Y PE + Y A VWS+G++ Y +
Sbjct: 176 RGC--AKLIDFGSGALL-HDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDM 232
Query: 355 LCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
+CG PF + I A L P+ +S + ++R L P R + + L
Sbjct: 233 VCGDIPF--ERDQEILEAELH-FPAH-------VSPDCCALIRRCLAPKPSSRPSLEEIL 282
Query: 415 SHPWIK 420
PW++
Sbjct: 283 LDPWMQ 288
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 6e-77
Identities = 96/269 (35%), Positives = 139/269 (51%), Gaps = 18/269 (6%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
Y LG+ +G G FG K K G+ L G +VAVK++ + K+ + + +RRE++ L+
Sbjct: 17 HYILGDTLGVGTFG-----KVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLK 71
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
H +++K + ++++VME GGEL D I G + E +++ + QIL+ V
Sbjct: 72 LFR-HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGV 129
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV 333
+CH VVHRDLKPEN L D + K DFGLS+ + E L GS Y APEV
Sbjct: 130 DYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV 186
Query: 334 L-HRSYS-TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391
+ R Y+ E D+WS GVI Y LLCG+ PF +F+ + F + L+
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI--FYTPQY--LNPS 242
Query: 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
+K +L DP KR T H W K
Sbjct: 243 VISLLKHMLQVDPMKRATIKDIREHEWFK 271
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 2e-76
Identities = 83/320 (25%), Positives = 140/320 (43%), Gaps = 32/320 (10%)
Query: 117 LARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKH----FANKYELGEEVGRGHFGYTC 172
+ H + +P GS P L+ + ++Y++G +G G FG
Sbjct: 1 MGSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFG--- 57
Query: 173 AAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIED---VRREVKILRALT-GHNNLVKFFD 226
G VA+K + K +++ + + V EV +L+ ++ G + +++ D
Sbjct: 58 --SVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115
Query: 227 AYEDTDNVYVVMELCEG-GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRD 285
+E D+ +++E E +L D I RG E+ A++ Q+L V CH GV+HRD
Sbjct: 116 WFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCGVLHRD 174
Query: 286 LKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYS-TEAD 343
+K EN L LK IDFG + D D G+ Y PE + + Y A
Sbjct: 175 IKDENILIDLNRGE--LKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAA 231
Query: 344 VWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKD 403
VWS+G++ Y ++CG PF + I R + +SSE + ++ L
Sbjct: 232 VWSLGILLYDMVCGDIPF--EHDEEIIRGQVF-FRQR-------VSSECQHLIRWCLALR 281
Query: 404 PRKRLTAAQALSHPWIKNSN 423
P R T + +HPW+++
Sbjct: 282 PSDRPTFEEIQNHPWMQDVL 301
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 5e-76
Identities = 81/302 (26%), Positives = 125/302 (41%), Gaps = 34/302 (11%)
Query: 136 EPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPK 193
EP A L ++ KY +G G FG K ++V VK I K
Sbjct: 5 EPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFG-----FVWTAVDKEKNKEVVVKFIKK 59
Query: 194 HKMTTAIAIED-----VRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL-CEGGELL 247
K+ IED V E+ IL + H N++K D +E+ +VME G +L
Sbjct: 60 EKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLDIFENQGFFQLVMEKHGSGLDLF 118
Query: 248 DRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307
I + E A + Q+++ V + L+ ++HRD+K EN + E+ +K IDF
Sbjct: 119 AFIDRHP-RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDF 174
Query: 308 GLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYS-TEADVWSIGVIAYILLCGSRPF--WA 363
G + ++ + G+ Y APEVL Y E ++WS+GV Y L+ PF
Sbjct: 175 GSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE 234
Query: 364 RTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423
T P +S E V LL P +R T + ++ PW+
Sbjct: 235 ETVEAAIH-----PPYL-------VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282
Query: 424 DV 425
++
Sbjct: 283 NL 284
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 6e-76
Identities = 87/273 (31%), Positives = 139/273 (50%), Gaps = 22/273 (8%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+Y+ +++G G+FG A+ + +L + VAVK I + E+V+RE+ R+L
Sbjct: 21 RYDFVKDIGSGNFG---VARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSL 73
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N+V+F + ++ ++ME GGEL +RI + G +++ED+A+ Q+L+ V++
Sbjct: 74 R-HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSY 131
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSV--LKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV 333
CH + HRDLK EN L D + LK DFG S + VG+ Y+APEV
Sbjct: 132 CHSMQICHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 188
Query: 334 L-HRSYS-TEADVWSIGVIAYILLCGSRPFWARTESGIFR----AVLKADPSFDEAPWPS 387
L + Y ADVWS GV Y++L G+ PF E +R +L S +
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR-- 246
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
+S E + R+ DP R++ + +H W
Sbjct: 247 ISPECCHLISRIFVADPATRISIPEIKTHSWFL 279
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 4e-75
Identities = 80/280 (28%), Positives = 128/280 (45%), Gaps = 25/280 (8%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
YE+ +G G +G + K G+ + K + MT A + + EV +LR
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSD---GKILVWKELDYGSMTEA-EKQMLVSEVNLLRE 61
Query: 215 LTGHNNLVKFFDAYEDTDN--VYVVMELCEGGELLDRI--LSRGGKY-TEDDAKAVMIQI 269
L H N+V+++D D N +Y+VME CEGG+L I ++ +Y E+ VM Q+
Sbjct: 62 LK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 270 LNVVAFCH-----LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL-NDIV 323
+ CH V+HRDLKP N +K DFGL+ + D V
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDFGLARILNHDTSFAKTFV 177
Query: 324 GSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 382
G+ YY++PE + SY+ ++D+WS+G + Y L PF A ++ + + +
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR--- 234
Query: 383 APWPSL-SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
P S E + + R+LN R + + L +P I
Sbjct: 235 -RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 1e-73
Identities = 74/271 (27%), Positives = 136/271 (50%), Gaps = 16/271 (5%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
KY +++G G FG K + G+Q +K I +M++ E+ RREV +L
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTED---GRQYVIKEINISRMSSK-EREESRREVAVLAN 79
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVV 273
+ H N+V++ +++E+ ++Y+VM+ CEGG+L RI ++ G ED +QI +
Sbjct: 80 MK-HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLAL 138
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPE 332
H + ++HRD+K +N +F TKD ++ DFG++ E +G+ YY++PE
Sbjct: 139 KHVHDRKILHRDIKSQN-IFLTKDGT--VQLGDFGIARVLNSTVELARACIGTPYYLSPE 195
Query: 333 VL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS-LSS 390
+ ++ Y+ ++D+W++G + Y L F A + + ++ P S
Sbjct: 196 ICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF----PPVSLHYSY 251
Query: 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
+ R V +L ++PR R + L +I
Sbjct: 252 DLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 8e-73
Identities = 47/309 (15%), Positives = 93/309 (30%), Gaps = 60/309 (19%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
G +G+ A ++ G+ V V + + AI+ ++ EV LR L
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQET---GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 130
Query: 216 ------------------------TGHNNLVKFFDAYEDTD--NVYVVMELCEG-----G 244
+++ D + + + + G
Sbjct: 131 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 190
Query: 245 ELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304
E+L S + +Q++ ++A H G+VH L+P + + D+ +
Sbjct: 191 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFL 247
Query: 305 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS------------YSTEADVWSIGVIAY 352
F D S + PE+ R + D W++G++ Y
Sbjct: 248 TGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304
Query: 353 ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQ 412
+ C P G + + ++ R ++ L RL Q
Sbjct: 305 WIWCADLPITKDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQ 356
Query: 413 ALSHPWIKN 421
A+ P +
Sbjct: 357 AMETPEYEQ 365
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 2e-72
Identities = 73/278 (26%), Positives = 123/278 (44%), Gaps = 28/278 (10%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIED-VRREVKIL 212
KY +G+ +G G +G K K+ + AVK++ K K+ E V++E+++L
Sbjct: 6 KYLMGDLLGEGSYG-----KVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLL 60
Query: 213 RALTGHNNLVKFFD--AYEDTDNVYVVMELCEGG--ELLDRILSRGGKYTEDDAKAVMIQ 268
R L H N+++ D E+ +Y+VME C G E+LD + ++ A Q
Sbjct: 61 RRLR-HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE--KRFPVCQAHGYFCQ 117
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS---DFVRPDERLNDIVGS 325
+++ + + H QG+VH+D+KP N L LK G++ D+ GS
Sbjct: 118 LIDGLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAEALHPFAADDTCRTSQGS 174
Query: 326 AYYVAPEVL--HRSYS-TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 382
+ PE+ ++S + D+WS GV Y + G PF +F + K +
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS--YAI 232
Query: 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
D +K +L +P KR + Q H W +
Sbjct: 233 PGD--CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFR 268
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 8e-71
Identities = 66/289 (22%), Positives = 118/289 (40%), Gaps = 40/289 (13%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
K F ++ E +G G FG AK + G+ +K + + E REVK
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRI---DGKTYVIKRVKYNN-------EKAEREVK 56
Query: 211 ILRALTGHNNLVKFFDAYEDTD----------------NVYVVMELCEGGELLDRILSRG 254
L L H N+V + ++ D +++ ME C+ G L I R
Sbjct: 57 ALAKLD-HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 115
Query: 255 GKY-TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313
G+ + A + QI V + H + +++RDLKP N + +K DFGL +
Sbjct: 116 GEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSL 172
Query: 314 RPDERLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRA 372
+ D + G+ Y++PE + + Y E D++++G+I LL + ++ F
Sbjct: 173 KNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK--FFTD 230
Query: 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
+ S + + +++LL+K P R ++ L +
Sbjct: 231 LRDGIIS------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 5e-67
Identities = 71/305 (23%), Positives = 134/305 (43%), Gaps = 18/305 (5%)
Query: 125 KPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQ 184
+ P + +P L G++ + + +++GRG F A G
Sbjct: 4 QSQGMQGPPVPQFQPQKALRPDMGYNT--LANFRIEKKIGRGQFSEVYRAACLLD---GV 58
Query: 185 QVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGG 244
VA+K + + A A D +E+ +L+ L H N++K++ ++ + + + +V+EL + G
Sbjct: 59 PVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIVLELADAG 117
Query: 245 ELLDRI---LSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301
+L I + E +Q+ + + H + V+HRD+KP N +F T V
Sbjct: 118 DLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPAN-VFITAT--GV 174
Query: 302 LKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSR 359
+K D GL F + +VG+ YY++PE + Y+ ++D+WS+G + Y +
Sbjct: 175 VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 234
Query: 360 PFWARTES--GIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHP 417
PF+ + + + + + D + P S E R V +N DP KR
Sbjct: 235 PFYGDKMNLYSLCKKIEQCD--YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVA 292
Query: 418 WIKNS 422
++
Sbjct: 293 KRMHA 297
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 3e-65
Identities = 60/285 (21%), Positives = 100/285 (35%), Gaps = 32/285 (11%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
Y +++G G F Y + G A+K I H+ E+ +RE + R
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHD---GHFYALKRILCHEQQ---DREEAQREADMHRLF 83
Query: 216 TGHNNLVKFFDAYEDTDN----VYVVMELCEGGELLDRI---LSRGGKYTEDDAKAVMIQ 268
H N+++ ++++ + G L + I +G TED +++
Sbjct: 84 -NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD----------ER 318
I + H +G HRDLKP N L + +D G + +
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 319 LNDIVGSAYYVAPEVL----HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL 374
+ Y APE+ H DVWS+G + Y ++ G P+ + G A L
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA-L 258
Query: 375 KADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
P SS + ++ DP +R LS
Sbjct: 259 AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEA 303
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 1e-63
Identities = 78/299 (26%), Positives = 125/299 (41%), Gaps = 42/299 (14%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
+ +E + +GRG FG AK K A+K I A E V REVK L
Sbjct: 3 YLTDFEPIQCLGRGGFGVVFEAKNKVD---DCNYAIKRIRLPNRELAR--EKVMREVKAL 57
Query: 213 RALTGHNNLVKFFDAYEDTDN------------VYVVMELCEGGELLDRILSRGGKYT-- 258
L H +V++F+A+ + + +Y+ M+LC L D + R
Sbjct: 58 AKLE-HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
Query: 259 EDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-------- 310
+ +QI V F H +G++HRDLKP N FT + V+K DFGL
Sbjct: 117 RSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEE 173
Query: 311 -----DFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWAR 364
+ R VG+ Y++PE +H SYS + D++S+G+I + LL PF +
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ 230
Query: 365 TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423
E ++ + F V+ +L+ P +R A + + ++ +
Sbjct: 231 MERVRTLTDVR-NLKFPPLF-TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 1e-61
Identities = 61/299 (20%), Positives = 121/299 (40%), Gaps = 40/299 (13%)
Query: 148 GFSKHFANKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDV 205
G + ++ E++G G FG + C + L G A+K K + ++
Sbjct: 4 GMKSRYTTEFHELEKIGSGEFGSVFKCVKR-----LDGCIYAIKRSKKPLAGSVD-EQNA 57
Query: 206 RREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR---GGKYTEDDA 262
REV L H+++V++F A+ + D++ + E C GG L D I + E +
Sbjct: 58 LREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 117
Query: 263 KAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK----------------DENSVLKAID 306
K +++Q+ + + H +VH D+KP N + + K D
Sbjct: 118 KDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177
Query: 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWAR 364
G V G + ++A EVL ++ +AD++++ + G+ P
Sbjct: 178 LGH---VTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVV-CAAGAEPLPRN 233
Query: 365 TESGIFRAVLKADPSFDEAPWPS-LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422
+ + + + P LS E + +K +++ DP +R +A + H + ++
Sbjct: 234 GDQ--WHEIRQGRLP----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 2e-59
Identities = 62/319 (19%), Positives = 120/319 (37%), Gaps = 46/319 (14%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+ + + G F + A+ G++ A+K + ++ + +EV ++ L
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGS---GREYALKRLLSNEEE---KNRAIIQEVCFMKKL 82
Query: 216 TGHNNLVKFFDAY--------EDTDNVYVVMELCEGGELLDRILSR--GGKYTEDDAKAV 265
+GH N+V+F A ++ ELC+G L++ + G + D +
Sbjct: 83 SGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQ-LVEFLKKMESRGPLSCDTVLKI 141
Query: 266 MIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD------- 316
Q V H Q ++HRDLK EN L +K DFG + +
Sbjct: 142 FYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIKLCDFGSATTISHYPDYSWSA 198
Query: 317 ------ERLNDIVGSAYYVAPEVL----HRSYSTEADVWSIGVIAYILLCGSRPFWARTE 366
E + Y PE++ + + D+W++G I Y+L PF E
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF----E 254
Query: 367 SGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVK 426
G ++ + P + + ++ +L +P +RL+ A+ + + +
Sbjct: 255 DGAKLRIVNG--KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ-EIAAARN 311
Query: 427 VPLDVIIFKLMKAYMRSSS 445
V I +L++ S
Sbjct: 312 VNPKSPITELLEQNGGYGS 330
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 4e-58
Identities = 49/306 (16%), Positives = 93/306 (30%), Gaps = 57/306 (18%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
G +G+ A ++ G+ V V + + AI+ ++ EV LR L
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQET---GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 136
Query: 217 G---------------------HNNLVKFFDAYEDTD-----NVYVVMELCEG-----GE 245
G K D + + + + GE
Sbjct: 137 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 196
Query: 246 LLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305
+L S + +Q++ ++A H G+VH L+P + + D+ +
Sbjct: 197 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLT 253
Query: 306 DFGLSDFVRPDERLNDIVGSAY----YVAPEVLHRS------YSTEADVWSIGVIAYILL 355
F VR +G + A +L + D W++G+ Y +
Sbjct: 254 GFEHL--VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311
Query: 356 CGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
C P G + ++ ++ R ++ L RL QA+
Sbjct: 312 CADLPNTDDAALGGSEWIFRSC--------KNIPQPVRALLEGFLRYPKEDRLLPLQAME 363
Query: 416 HPWIKN 421
P +
Sbjct: 364 TPEYEQ 369
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 197 bits (501), Expect = 1e-57
Identities = 47/285 (16%), Positives = 96/285 (33%), Gaps = 30/285 (10%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
+ +G G F Y Q+ +KV + ++ L
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERL 121
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG----GKYTEDDAKAVMIQ 268
+ + +KF+ A+ + +V EL G LL+ I + + ++
Sbjct: 122 KPSM-QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTK--------DENSVLKAIDFGLSDFVR---PDE 317
+L ++ H ++H D+KP+NF+ D ++ L ID G S ++
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 318 RLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 376
++ + E+L ++ ++ + D + + Y +L G+ + E G +
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV-KNEGGECKPEGLF 299
Query: 377 DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
W +F +LN L + L K
Sbjct: 300 RRLPHLDMWN-------EFFHVMLNIPDCHHLPSLDLLRQKLKKV 337
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-54
Identities = 77/301 (25%), Positives = 126/301 (41%), Gaps = 31/301 (10%)
Query: 144 NKSFGFSKHFANKYEL-----GEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKM 196
+ S YE +G+G +G Y +A+K IP+
Sbjct: 6 EEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVY-AGRDLSNQVR----IAIKEIPERDS 60
Query: 197 TTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGK 256
+ + E+ + + L H N+V++ ++ + + + ME GG L + S+ G
Sbjct: 61 RY---SQPLHEEIALHKHLK-HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGP 116
Query: 257 --YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFV 313
E QIL + + H +VHRD+K +N L T + VLK DFG S
Sbjct: 117 LKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY--SGVLKISDFGTSKRLA 174
Query: 314 RPDERLNDIVGSAYYVAPEVLH---RSYSTEADVWSIGVIAYILLCGSRPFWARTE--SG 368
+ G+ Y+APE++ R Y AD+WS+G + G PF+ E +
Sbjct: 175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA 234
Query: 369 IFR-AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKV 427
+F+ + K P E S+S+EA+ F+ + DP KR A L ++K S+ K
Sbjct: 235 MFKVGMFKVHPEIPE----SMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKK 290
Query: 428 P 428
Sbjct: 291 T 291
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 3e-54
Identities = 65/274 (23%), Positives = 108/274 (39%), Gaps = 25/274 (9%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR-REVKILR 213
+ VGRG FG K K+ G Q AVK + +E R E+
Sbjct: 58 HWMTHQPRVGRGSFGEVHRMKDKQ---TGFQCAVKKVR---------LEVFRVEELVACA 105
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
L+ +V + A + V + MEL EGG L ++ + G ED A + Q L +
Sbjct: 106 GLS-SPRIVPLYGAVREGPWVNIFMELLEGGSLGQ-LIKQMGCLPEDRALYYLGQALEGL 163
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS------DFVRPDERLNDIVGSAY 327
+ H + ++H D+K +N L + D + DFG + + + I G+
Sbjct: 164 EYLHTRRILHGDVKADNVL-LSSDGSRA-ALCDFGHALCLQPDGLGKSLLTGDYIPGTET 221
Query: 328 YVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386
++APEV+ + D+WS + +L G P+ + + P E P P
Sbjct: 222 HMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP-P 280
Query: 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
S + ++ L K+P R +A +
Sbjct: 281 SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 5e-54
Identities = 81/302 (26%), Positives = 140/302 (46%), Gaps = 28/302 (9%)
Query: 133 EGSEPEPAAGLNKSFGFSKHFANK------YELGEEVGRGHFGYTCAAKFKKGELKGQQV 186
+G+ EP G + ++ G+ +G G F A+ ++
Sbjct: 2 DGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELAT---SREY 58
Query: 187 AVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGEL 246
A+K++ K + + V RE ++ L H VK + ++D + +Y + + GEL
Sbjct: 59 AIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGEL 117
Query: 247 LDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306
L + + G + E + +I++ + + H +G++HRDLKPEN L +E+ ++ D
Sbjct: 118 LKY-IRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITD 173
Query: 307 FGLS---DFVRPDERLNDIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFW 362
FG + R N VG+A YV+PE+L +D+W++G I Y L+ G PF
Sbjct: 174 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR 233
Query: 363 ARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQA------LSH 416
A E IF+ ++K + F P +ARD V++LL D KRL + +H
Sbjct: 234 AGNEYLIFQKIIKLEYDF---P-EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 289
Query: 417 PW 418
P+
Sbjct: 290 PF 291
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-52
Identities = 60/274 (21%), Positives = 113/274 (41%), Gaps = 22/274 (8%)
Query: 157 YELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ E+GRG F Y +VA + K+T + + + E ++L+
Sbjct: 28 LKFDIEIGRGSFKTVYKG---LDTET--TVEVAWCELQDRKLTKS-ERQRFKEEAEMLKG 81
Query: 215 LTGHNNLVKFFDAYEDT----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQIL 270
L H N+V+F+D++E T + +V EL G L L R ++ QIL
Sbjct: 82 LQ-HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT-YLKRFKVMKIKVLRSWCRQIL 139
Query: 271 NVVAFCHLQG--VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
+ F H + ++HRDLK +N T +K D GL+ R ++G+ +
Sbjct: 140 KGLQFLHTRTPPIIHRDLKCDNIFITGP--TGSVKIGDLGLATLKRASFA-KAVIGTPEF 196
Query: 329 VAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESG-IFRAVLKADPSFDEAPWPS 387
+APE+ Y DV++ G+ + P+ + I+R V +
Sbjct: 197 MAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKV 254
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
E ++ ++ + ++ +R + L+H + +
Sbjct: 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 6e-51
Identities = 68/269 (25%), Positives = 135/269 (50%), Gaps = 20/269 (7%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG C + + A+K + K K + +V +E++I++ L H LV
Sbjct: 23 IGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLV 78
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ +++D +++++V++L GG+L L + + E+ K + +++ + + Q ++
Sbjct: 79 NLWYSFQDEEDMFMVVDLLLGGDLRYH-LQQNVHFKEETVKLFICELVMALDYLQNQRII 137
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS----Y 338
HRD+KP+N L DE+ + DF ++ + + ++ + G+ Y+APE+ Y
Sbjct: 138 HRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGY 194
Query: 339 STEADVWSIGVIAYILLCGSRPFWARTESG---IFRAVLKADPSFDEAPWPSLSSEARDF 395
S D WS+GV AY LL G RP+ R+ + I ++ P + S E
Sbjct: 195 SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY---P-SAWSQEMVSL 250
Query: 396 VKRLLNKDPRKRLTAAQAL-SHPWIKNSN 423
+K+LL +P +R + + + P++ + N
Sbjct: 251 LKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 6e-50
Identities = 83/314 (26%), Positives = 134/314 (42%), Gaps = 59/314 (18%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVK---------VIPKHKMTTAIAIEDV 205
KYE ++G G +G + + GQ VA+K VI K A+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRD---TGQIVAIKKFLESEDDPVIKK----IAL----- 50
Query: 206 RREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV 265
RE+++L+ L H NLV + + +++V E C+ +L + E K++
Sbjct: 51 -REIRMLKQLK-HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSI 107
Query: 266 MIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVG 324
Q L V FCH +HRD+KPEN L ++SV+K DFG + P + +D V
Sbjct: 108 TWQTLQAVNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPSDYYDDEVA 164
Query: 325 SAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFW-ARTE----SGIFRAV---- 373
+ +Y +PE+L Y DVW+IG + LL G P W +++ I + +
Sbjct: 165 TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG-VPLWPGKSDVDQLYLIRKTLGDLI 223
Query: 374 ---------LKADPSFDEAPW----------PSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
+ P++S A +K L+ DP +RLT Q L
Sbjct: 224 PRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283
Query: 415 SHPWIKNSNDVKVP 428
HP+ +N +++
Sbjct: 284 HHPYFENIREIEDL 297
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 7e-49
Identities = 73/303 (24%), Positives = 123/303 (40%), Gaps = 55/303 (18%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ Y+L ++GRG + A ++V VK++ K RE+KIL
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITN---NEKVVVKILKPVKKKKIK------REIKILEN 86
Query: 215 LTGHNNLVKFFDAYEDTDN---VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
L G N++ D +D + V + ++ T+ D + M +IL
Sbjct: 87 LRGGPNIITLADIVKDPVSRTPALVFEHVNN--TDFKQLYQ---TLTDYDIRFYMYEILK 141
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAP 331
+ +CH G++HRD+KP N + E+ L+ ID+GL++F P + N V S Y+ P
Sbjct: 142 ALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 199
Query: 332 EVL--HRSYSTEADVWSIGVIAYILLCGSRPF-------------------------WAR 364
E+L ++ Y D+WS+G + ++ PF +
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259
Query: 365 TESGIFRAVLKADPSFDEAPW---------PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ W +S EA DF+ +LL D + RLTA +A+
Sbjct: 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319
Query: 416 HPW 418
HP+
Sbjct: 320 HPY 322
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-48
Identities = 80/300 (26%), Positives = 141/300 (47%), Gaps = 38/300 (12%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
A +EL E VG G +G + K GQ A+KV+ T E++++E+ +L+
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMD----VTGDEEEEIKQEINMLK 75
Query: 214 ALTGHNNLVKFFDAY------EDTDNVYVVMELCEGGELLDRI-LSRGGKYTEDDAKAVM 266
+ H N+ ++ A+ D +++VME C G + D I ++G E+ +
Sbjct: 76 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 135
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGS 325
+IL ++ H V+HRD+K +N L T EN+ +K +DFG+S R R N +G+
Sbjct: 136 REILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGT 192
Query: 326 AYYVAPEVLHR------SYSTEADVWSIGVIAYIL------LCGSRPFWARTESGIFRAV 373
Y++APEV+ +Y ++D+WS+G+ A + LC P A +F
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-----LFLIP 247
Query: 374 LKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVII 433
P W S + + F++ L K+ +R Q + HP+I++ + + +
Sbjct: 248 RNPAPRLKSKKW---SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLK 304
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-48
Identities = 84/296 (28%), Positives = 150/296 (50%), Gaps = 28/296 (9%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+ ++G G G C A+ K G+QVAVK++ + E + EV I+R
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKH---SGRQVAVKMMD---LRKQQRRELLFNEVVIMRDY 99
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N+V+ + +Y + ++V+ME +GG L D + + E+ V +L +A+
Sbjct: 100 Q-HFNVVEMYKSYLVGEELWVLMEFLQGGALTD--IVSQVRLNEEQIATVCEAVLQALAY 156
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAPEVL 334
H QGV+HRD+K ++ L T + +K DFG + D + +VG+ Y++APEV+
Sbjct: 157 LHAQGVIHRDIKSDSILLT---LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI 213
Query: 335 HRS-YSTEADVWSIGVIAYILLCGSRPFW----ARTESGIFRAVLKADPSFDEAPWPSLS 389
RS Y+TE D+WS+G++ ++ G P++ + + R P +S
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MKRLRDSPPPKLKN--SHKVS 268
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSS 445
RDF++R+L +DP++R TA + L HP++ + + + L++ Y + +S
Sbjct: 269 PVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPE-----CLVPLIQLYRKQTS 319
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 4e-48
Identities = 78/290 (26%), Positives = 133/290 (45%), Gaps = 32/290 (11%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+ YEL E +G G AA K ++VA+K I K T++ +++ +E++ +
Sbjct: 14 RDDYELQEVIGSGATAVVQAAYCAP---KKEKVAIKRINLEKCQTSM--DELLKEIQAMS 68
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD-------RILSRGGKYTEDDAKAVM 266
H N+V ++ ++ D +++VM+L GG +LD + + G E ++
Sbjct: 69 QCH-HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-------DFVRPDERL 319
++L + + H G +HRD+K N L E+ ++ DFG+S D R R
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRNKVR- 183
Query: 320 NDIVGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 377
VG+ ++APEV+ + Y +AD+WS G+ A L G+ P+ + L+ D
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND 243
Query: 378 P------SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
P D+ R + L KDP KR TAA+ L H + +
Sbjct: 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 4e-48
Identities = 83/288 (28%), Positives = 133/288 (46%), Gaps = 26/288 (9%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+E+ E+G G FG AK K+ G A KVI + +ED E++IL
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKE---TGALAAAKVIE---TKSEEELEDYIVEIEILATC 73
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H +VK AY +++++E C GG + +L TE + V Q+L + F
Sbjct: 74 D-HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNF 132
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAPEVL 334
H + ++HRDLK N L T ++ DFG+S ++ + +G+ Y++APEV+
Sbjct: 133 LHSKRIIHRDLKAGNVLMT---LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVV 189
Query: 335 HR------SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK----ADPSFDEAP 384
Y +AD+WS+G+ + P E R +LK P+
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH---ELNPMRVLLKIAKSDPPTLLT-- 244
Query: 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVI 432
S E RDF+K L+K+P R +AAQ L HP++ + K +++
Sbjct: 245 PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELV 292
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-47
Identities = 77/280 (27%), Positives = 132/280 (47%), Gaps = 17/280 (6%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
KY E++G+G G A GQ+VA++ + + E + E+ ++R
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMN---LQQQPKKELIINEILVMREN 74
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
+ N+V + D+Y D ++VVME GG L D + E AV + L + F
Sbjct: 75 K-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTD--VVTETCMDEGQIAAVCRECLQALEF 131
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVL 334
H V+HRD+K +N L + +K DFG + P++ + + +VG+ Y++APEV+
Sbjct: 132 LHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 335 HRS-YSTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDEAPWPSLSSEA 392
R Y + D+WS+G++A ++ G P+ ++ P LS+
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN--PEKLSAIF 246
Query: 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVI 432
RDF+ R L D KR +A + L H ++K + + +I
Sbjct: 247 RDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLI 286
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 1e-47
Identities = 78/273 (28%), Positives = 131/273 (47%), Gaps = 20/273 (7%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
++ + +G G FG K K+ G A+K++ K K+ IE E +IL+A+
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
LVK +++D N+Y+VME GGE+ L R G+++E A+ QI+ +
Sbjct: 100 -FPFLVKLEFSFKDNSNLYMVMEYVAGGEMF-SHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR 336
H +++RDLKPEN L D+ ++ DFG + V R + G+ +APE++
Sbjct: 158 HSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILS 212
Query: 337 S-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395
Y+ D W++GV+ Y + G PF+A I+ ++ F P SS+ +D
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF---P-SHFSSDLKDL 268
Query: 396 VKRLLNKDPRKRLTAAQA-----LSHPWIKNSN 423
++ LL D KR + +H W ++
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-47
Identities = 83/298 (27%), Positives = 125/298 (41%), Gaps = 47/298 (15%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI---PKHKMTTAIAIEDVRREVKI 211
KYE VG G +G + K G+ VA+K KM IA+ RE+K+
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKD---TGRIVAIKKFLESDDDKMVKKIAM----REIKL 77
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
L+ L H NLV + + Y+V E + +LD + + + QI+N
Sbjct: 78 LKQLR-HENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIIN 135
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVA 330
+ FCH ++HRD+KPEN L ++ V+K DFG + P E +D V + +Y A
Sbjct: 136 GIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRA 192
Query: 331 PEVL--HRSYSTEADVWSIGVIAYILLCGSRPFW-ARTE----SGIFRAV--LKAD--PS 379
PE+L Y DVW+IG + + G P + ++ I + L
Sbjct: 193 PELLVGDVKYGKAVDVWAIGCLVTEMFMG-EPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251
Query: 380 FDEAPW-------------------PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
F++ P P LS D K+ L+ DP KR A+ L H +
Sbjct: 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 6e-47
Identities = 77/283 (27%), Positives = 140/283 (49%), Gaps = 23/283 (8%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+++ E++G G +G A K+ GQ VA+K +P ++++ +E+ I++
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKE---TGQIVAIKQVPVES-----DLQEIIKEISIMQQC 81
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
++VK++ +Y ++++VME C G + D I R TED+ ++ L + +
Sbjct: 82 D-SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEY 140
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL 334
H +HRD+K N L K DFG++ + N ++G+ +++APEV+
Sbjct: 141 LHFMRKIHRDIKAGNILLN---TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 197
Query: 335 HRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL----KADPSFDEAPWPSLS 389
Y+ AD+WS+G+ A + G P+ + RA+ P+F + S
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPPYA---DIHPMRAIFMIPTNPPPTFRKPEL--WS 252
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVI 432
DFVK+ L K P +R TA Q L HP+++++ V + D+I
Sbjct: 253 DNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLI 295
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-46
Identities = 78/304 (25%), Positives = 141/304 (46%), Gaps = 23/304 (7%)
Query: 135 SEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKH 194
+ +GL + E++G+G FG + + VA+K+I
Sbjct: 2 AHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNR---TQKVVAIKIIDLE 58
Query: 195 KMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG 254
+ I ED+++E+ +L + K++ +Y ++++ME GG LD L
Sbjct: 59 EAEDEI--EDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLWIIMEYLGGGSALD--LLEP 113
Query: 255 GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFV 313
G E ++ +IL + + H + +HRD+K N L + E+ +K DFG++
Sbjct: 114 GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLT 170
Query: 314 RPDERLNDIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRA 372
+ N VG+ +++APEV+ +S Y ++AD+WS+G+ A L G P E +
Sbjct: 171 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS---ELHPMKV 227
Query: 373 VL---KADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI-KNSNDVKVP 428
+ K +P E + S ++FV+ LNK+P R TA + L H +I +N+
Sbjct: 228 LFLIPKNNPPTLEGNY---SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYL 284
Query: 429 LDVI 432
++I
Sbjct: 285 TELI 288
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-46
Identities = 73/285 (25%), Positives = 120/285 (42%), Gaps = 25/285 (8%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+ E+G G FG A+ + + VA+K + + +D+ +EV+ L+ L
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 111
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N +++ Y ++VME C G D + E + AV L +A+
Sbjct: 112 R-HPNTIQYRGCYLREHTAWLVMEYCLGS-ASDLLEVHKKPLQEVEIAAVTHGALQGLAY 169
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH 335
H ++HRD+K N L + E ++K DFG + + N VG+ Y++APEV+
Sbjct: 170 LHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIM---APANSFVGTPYWMAPEVIL 223
Query: 336 RS----YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL----KADPSFDEAPWPS 387
Y + DVWS+G+ L P + A+ P+ W
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYHIAQNESPALQSGHW-- 278
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVI 432
S R+FV L K P+ R T+ L H ++ V +D+I
Sbjct: 279 -SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI 322
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-46
Identities = 79/264 (29%), Positives = 129/264 (48%), Gaps = 14/264 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG A+FKK Q A+K + K + +E E ++L H L
Sbjct: 25 LGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
F ++ +N++ VME GG+L+ I K+ A +I+ + F H +G+V
Sbjct: 82 HMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQFLHSKGIV 140
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR-SYST 340
+RDLK +N L D++ +K DFG+ + + D + N G+ Y+APE+L Y+
Sbjct: 141 YRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNH 197
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D WS GV+ Y +L G PF + E +F ++ +P + P L EA+D + +L
Sbjct: 198 SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY---P-RWLEKEAKDLLVKLF 253
Query: 401 NKDPRKRLTAAQAL-SHPWIKNSN 423
++P KRL + HP + N
Sbjct: 254 VREPEKRLGVRGDIRQHPLFREIN 277
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 4e-46
Identities = 71/273 (26%), Positives = 131/273 (47%), Gaps = 20/273 (7%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+++ +G G FG + + G+ A+KV+ K + +E E +L +T
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H +++ + ++D ++++M+ EGGEL L + ++ AK ++ + +
Sbjct: 65 -HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSL-LRKSQRFPNPVAKFYAAEVCLALEYL 122
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR 336
H + +++RDLKPEN L D+N +K DFG + +V + + G+ Y+APEV+
Sbjct: 123 HSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVVST 177
Query: 337 S-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395
Y+ D WS G++ Y +L G PF+ + +L A+ F P P + + +D
Sbjct: 178 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF---P-PFFNEDVKDL 233
Query: 396 VKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423
+ RL+ +D +RL +HPW K
Sbjct: 234 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 4e-46
Identities = 75/314 (23%), Positives = 125/314 (39%), Gaps = 36/314 (11%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIA-IEDVRREVKIL 212
N E E+G G G +F+K G +AVK + + + + ++ ++
Sbjct: 24 INDLENLGEMGSGTCGQVWKMRFRKT---GHVIAVKQMR---RSGNKEENKRILMDLDVV 77
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
+V+ F + +V++ MEL G E + + I+
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELMGTC-AEKLKKRMQGPIPERILGKMTVAIVKA 136
Query: 273 VAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAP 331
+ + + GV+HRD+KP N L + + +K DFG+S + D+ + G A Y+AP
Sbjct: 137 LYYLKEKHGVIHRDVKPSNILLDERGQ---IKLCDFGISGRLVDDKAKDRSAGCAAYMAP 193
Query: 332 EVL------HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFR---AVLKADPSFDE 382
E + Y ADVWS+G+ L G P+ + F VL+ +P
Sbjct: 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY--KNCKTDFEVLTKVLQEEP---- 247
Query: 383 APWPSL------SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKL 436
P L S + + FVK L KD RKR + L H +IK ++V + +
Sbjct: 248 ---PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDV 304
Query: 437 MKAYMRSSSLRKAA 450
M S +
Sbjct: 305 MAKTESPRSGPSSG 318
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 5e-46
Identities = 92/307 (29%), Positives = 141/307 (45%), Gaps = 58/307 (18%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--------TTAIAIEDVR 206
KY E++G G +G A+ GE A+K I ++ +T I
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGET----FALKKI---RLEKEDEGIPSTTI------ 48
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEG--GELLDRILSRGGKYTEDDAKA 264
RE+ IL+ L H+N+VK +D + +V E + +LLD G AK+
Sbjct: 49 REISILKELK-HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD---VCEGGLESVTAKS 104
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIV 323
++Q+LN +A+CH + V+HRDLKP+N L + LK DFGL+ F P + +
Sbjct: 105 FLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEI 161
Query: 324 GSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRA----- 372
+ +Y AP+VL + YST D+WS+G I ++ G+ F +E IFR
Sbjct: 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN 221
Query: 373 ------VLK---ADPSFDEAP-------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416
V + DP+F L D + ++L DP +R+TA QAL H
Sbjct: 222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281
Query: 417 PWIKNSN 423
+ K +N
Sbjct: 282 AYFKENN 288
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 6e-46
Identities = 57/276 (20%), Positives = 103/276 (37%), Gaps = 27/276 (9%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+ R + K E + +++ ++ +++ + + N V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS-TKNTV 124
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKA--VMIQILNVVAFCHLQG 280
+Y+ M+LC L D + R + + IQI V F H +G
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGLS-------------DFVRPDERLNDIVGSAY 327
++HRDLKP N F + V+K DFGL + VG+
Sbjct: 185 LMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 328 YVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDEAPW 385
Y++PE +H +YS + D++S+G+I + LL F + E I V +
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRNLKFPLL---F 295
Query: 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
+ V+ +L+ P +R A + + +N
Sbjct: 296 TQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 27/92 (29%), Positives = 41/92 (44%), Gaps = 6/92 (6%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
+ + +E + +GRG FG AK K + A+K I A E V REV
Sbjct: 1 ASRYLTDFEPIQCMGRGGFGVVFEAKNK---VDDCNYAIKRIRLPNREL--AREKVMREV 55
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELC 241
K L L H +V++F+A+ +T E+
Sbjct: 56 KALAKL-EHPGIVRYFNAWLETPPEKWQEEMD 86
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 9e-46
Identities = 70/301 (23%), Positives = 118/301 (39%), Gaps = 31/301 (10%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIA-IEDVRREVKIL 212
A + E+GRG +G K GQ +AVK I T + + ++ ++
Sbjct: 21 AEDLKDLGEIGRGAYGSVNKMVHKPS---GQIMAVKRIR---STVDEKEQKQLLMDLDVV 74
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILS-----RGGKYTEDDAKAVMI 267
+ +V+F+ A + ++ MEL D+ E+ + +
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITL 132
Query: 268 QILNVVAFCHLQG-VVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGS 325
+ + ++HRD+KP N L +K DFG+S V + D G
Sbjct: 133 ATVKALNHLKENLKIIHRDIKPSNILLDRSGN---IKLCDFGISGQLVDSIAKTRD-AGC 188
Query: 326 AYYVAPEVLH-----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRA---VLKAD 377
Y+APE + + Y +DVWS+G+ Y L G P+ + +F V+K D
Sbjct: 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY--PKWNSVFDQLTQVVKGD 246
Query: 378 -PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKL 436
P + S +FV L KD KR + L HP+I + V + + K+
Sbjct: 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKI 306
Query: 437 M 437
+
Sbjct: 307 L 307
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-45
Identities = 67/287 (23%), Positives = 121/287 (42%), Gaps = 27/287 (9%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIA-IEDVRREVKIL 212
A+ E E+GRG +G + GQ +AVK I T + + ++ I
Sbjct: 6 ADDLEPIMELGRGAYGVVEKMRHVPS---GQIMAVKRIR---ATVNSQEQKRLLMDLDIS 59
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGG--ELLDRILSRGGKYTEDDAKAVMIQIL 270
V F+ A +V++ MEL + + +++ +G ED + + I+
Sbjct: 60 MRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 271 NVVAFCHLQG-VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
+ H + V+HRD+KP N L + +K DFG+S ++ D + G Y+
Sbjct: 120 KALEHLHSKLSVIHRDVKPSNVLINALGQ---VKMCDFGISGYLVDDVAKDIDAGCKPYM 176
Query: 330 APEVLH-----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRA----VLKADPSF 380
APE ++ + YS ++D+WS+G+ L P+ + F+ V + P
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPY--DSWGTPFQQLKQVVEEPSPQL 234
Query: 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKV 427
+ S+E DF + L K+ ++R T + + HP+
Sbjct: 235 PADKF---SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGT 278
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 170 bits (431), Expect = 2e-45
Identities = 76/362 (20%), Positives = 139/362 (38%), Gaps = 19/362 (5%)
Query: 69 FPFYSPSPAHYFFSKKSSPARSSANSTPNRFFKRPFPPPSPAKHIKAVLARRHGSVKPNE 128
F + +F P PP + + +
Sbjct: 256 FMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGT 315
Query: 129 AAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAV 188
A PE + + + + + +G+G FG ++ K + AV
Sbjct: 316 KA-PEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKG---TDELYAV 371
Query: 189 KVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD 248
K++ K + +E E ++L L + ++ D +Y VME GG+L+
Sbjct: 372 KILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMY 431
Query: 249 RILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308
I + G++ E A +I + F +G+++RDLK +N + D +K DFG
Sbjct: 432 HI-QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFG 487
Query: 309 LS-DFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTE 366
+ + + G+ Y+APE++ Y D W+ GV+ Y +L G PF E
Sbjct: 488 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 547
Query: 367 SGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQA-----LSHPWIKN 421
+F+++++ + ++ P S+S EA K L+ K P KRL H + +
Sbjct: 548 DELFQSIMEHNVAY---P-KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603
Query: 422 SN 423
+
Sbjct: 604 ID 605
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-45
Identities = 75/271 (27%), Positives = 121/271 (44%), Gaps = 20/271 (7%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG FG + K + A+K++ K +M E I+ A +V
Sbjct: 77 IGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFANSPWVV 132
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ F A++D +Y+VME GG+L+ ++S E A+ +++ + H G +
Sbjct: 133 QLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFI 190
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAPEVL-----H 335
HRD+KP+N L D++ LK DFG + + R + VG+ Y++PEVL
Sbjct: 191 HRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 247
Query: 336 RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395
Y E D WS+GV Y +L G PF+A + G + ++ S +S EA++
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 307
Query: 396 VKRLLNKDPRKRLTAAQAL---SHPWIKNSN 423
+ L D RL H + KN
Sbjct: 308 ICAFL-TDREVRLGRNGVEEIKRHLFFKNDQ 337
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-45
Identities = 78/275 (28%), Positives = 125/275 (45%), Gaps = 22/275 (8%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG F K K+ GQ A+K++ K M + R E +L +
Sbjct: 69 IGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVL-VNGDRRWIT 124
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ A++D + +Y+VME GG+LL + G + + A+ + +I+ + H G V
Sbjct: 125 QLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYV 184
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAPEVLHR---- 336
HRD+KP+N L D ++ DFG +R D R VG+ Y++PE+L
Sbjct: 185 HRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGG 241
Query: 337 ----SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS-LSSE 391
SY E D W++GV AY + G PF+A + + + ++ + E
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEE 301
Query: 392 ARDFVKRLLNKDPRKRLTAAQAL---SHPWIKNSN 423
ARDF++RLL P RL A +HP+ +
Sbjct: 302 ARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLD 335
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 6e-45
Identities = 68/268 (25%), Positives = 121/268 (45%), Gaps = 18/268 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG ++ K + AVK++ K + +E E ++L L
Sbjct: 28 LGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ ++ D +Y VME GG+L+ I + G++ E A +I + F +G++
Sbjct: 85 QLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFYAAEIAIGLFFLQSKGII 143
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR-SYST 340
+RDLK +N + D +K DFG+ + + G+ Y+APE++ Y
Sbjct: 144 YRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGK 200
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W+ GV+ Y +L G PF E +F+++++ + ++ P S+S EA K L+
Sbjct: 201 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---P-KSMSKEAVAICKGLM 256
Query: 401 NKDPRKRLTAAQA-----LSHPWIKNSN 423
K P KRL H + + +
Sbjct: 257 TKHPGKRLGCGPEGERDIKEHAFFRYID 284
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 7e-45
Identities = 85/308 (27%), Positives = 138/308 (44%), Gaps = 58/308 (18%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--------TTAIAIEDVR 206
KYE E++G G +G AK ++ + VA+K + ++ ++A+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRET---HEIVALKRV---RLDDDDEGVPSSAL------ 49
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEG--GELLDRILSRGGKYTEDDAKA 264
RE+ +L+ L H N+V+ D + +V E C+ + D S G + K+
Sbjct: 50 REICLLKELK-HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFD---SCNGDLDPEIVKS 105
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIV 323
+ Q+L + FCH + V+HRDLKP+N L + N LK +FGL+ F P + V
Sbjct: 106 FLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEV 162
Query: 324 GSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRP-FWARTE----SGIFRAV--- 373
+ +Y P+VL + YST D+WS G I L RP F IFR +
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222
Query: 374 -------LKADPSFDEAP-----------WPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ P + P P L++ RD ++ LL +P +R++A +AL
Sbjct: 223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
Query: 416 HPWIKNSN 423
HP+ +
Sbjct: 283 HPYFSDFC 290
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 8e-45
Identities = 78/269 (28%), Positives = 127/269 (47%), Gaps = 19/269 (7%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG A+ K+ G AVKV+ K + +E E +IL H L
Sbjct: 31 LGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 87
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ F ++ D ++ VME GG+L+ I + ++ E A+ +I++ + F H +G++
Sbjct: 88 QLFCCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEARARFYAAEIISALMFLHDKGII 146
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR-SYST 340
+RDLK +N L D K DFG+ + + G+ Y+APE+L Y
Sbjct: 147 YRDLKLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGP 203
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W++GV+ Y +LCG PF A E +F A+L + + P L +A +K +
Sbjct: 204 AVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY---P-TWLHEDATGILKSFM 259
Query: 401 NKDPRKRL-----TAAQAL-SHPWIKNSN 423
K+P RL A+ HP+ K +
Sbjct: 260 TKNPTMRLGSLTQGGEHAILRHPFFKEID 288
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-44
Identities = 78/270 (28%), Positives = 130/270 (48%), Gaps = 21/270 (7%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDV--RREVKILRALTGHNN 220
+G+G FG K G Q A+KV+ K + + V + E IL H
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL---KVRDRVRTKMERDIL-VEVNHPF 87
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
+VK A++ +Y++++ GG+L R LS+ +TE+D K + ++ + H G
Sbjct: 88 IVKLHYAFQTEGKLYLILDFLRGGDLFTR-LSKEVMFTEEDVKFYLAELALALDHLHSLG 146
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHRS-Y 338
+++RDLKPEN L DE +K DFGLS + + +++ G+ Y+APEV++R +
Sbjct: 147 IIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH 203
Query: 339 STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398
+ AD WS GV+ + +L G+ PF + +LKA P LS EA+ ++
Sbjct: 204 TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM---P-QFLSPEAQSLLRM 259
Query: 399 LLNKDPRKRL-----TAAQALSHPWIKNSN 423
L ++P RL + H + +
Sbjct: 260 LFKRNPANRLGAGPDGVEEIKRHSFFSTID 289
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-44
Identities = 85/330 (25%), Positives = 138/330 (41%), Gaps = 62/330 (18%)
Query: 135 SEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKH 194
++ + ++ S S ++Y ++G G +G A + VA+K I
Sbjct: 14 AQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTV---TNETVAIKRI--- 67
Query: 195 KM--------TTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGEL 246
++ TAI REV +L+ L H N+++ ++++ E E
Sbjct: 68 RLEHEEEGVPGTAI------REVSLLKELQ-HRNIIELKSVIHHNHRLHLIFEYAEND-- 118
Query: 247 LDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS--VLKA 304
L + + + + K+ + Q++N V FCH + +HRDLKP+N L + D + VLK
Sbjct: 119 LKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKI 178
Query: 305 IDFGLS-DFVRPDERLNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPF 361
DFGL+ F P + + + +Y PE+L R YST D+WSI I +L + F
Sbjct: 179 GDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF 238
Query: 362 WARTE----SGIFRAVLKADPSFDEAPWP--------------------------SLSSE 391
+E IF VL P + WP L E
Sbjct: 239 PGDSEIDQLFKIFE-VLGL-PD--DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDE 294
Query: 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
D + +L DP KR++A AL HP+ +
Sbjct: 295 GLDLLTAMLEMDPVKRISAKNALEHPYFSH 324
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-44
Identities = 82/313 (26%), Positives = 131/313 (41%), Gaps = 57/313 (18%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-------TTAIAIEDVRR 207
Y +++G G + K K VA+K I ++ TAI R
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKL---TDNLVALKEI---RLEHEEGAPCTAI------R 49
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEG--GELLDRILSRGGKYTEDDAKAV 265
EV +L+ L H N+V D ++ +V E + + LD G + K
Sbjct: 50 EVSLLKDLK-HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLD---DCGNIINMHNVKLF 105
Query: 266 MIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVG 324
+ Q+L +A+CH Q V+HRDLKP+N L +E LK DFGL+ P + ++ V
Sbjct: 106 LFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYDNEVV 162
Query: 325 SAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAV----- 373
+ +Y P++L YST+ D+W +G I Y + G F T IFR +
Sbjct: 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTE 222
Query: 374 -----LKADPSFDEAP------------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416
+ ++ F P L S+ D + +LL + R R++A A+ H
Sbjct: 223 ETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282
Query: 417 PWIKNSNDVKVPL 429
P+ + + L
Sbjct: 283 PFFLSLGERIHKL 295
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-44
Identities = 70/273 (25%), Positives = 120/273 (43%), Gaps = 20/273 (7%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG FG K K + A+K++ K +M R E +L +
Sbjct: 82 IGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVL-VNGDSKWIT 137
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
A++D +N+Y+VM+ GG+LL + + E+ A+ + +++ + H V
Sbjct: 138 TLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYV 197
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAPEVL------ 334
HRD+KP+N L D N ++ DFG + D + + VG+ Y++PE+L
Sbjct: 198 HRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGG 254
Query: 335 HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS-LSSEAR 393
Y E D WS+GV Y +L G PF+A + + ++ F + +S A+
Sbjct: 255 KGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAK 314
Query: 394 DFVKRLLNKDPRKRLTAAQAL---SHPWIKNSN 423
D ++RL+ RL HP+ +
Sbjct: 315 DLIRRLICSRE-HRLGQNGIEDFKKHPFFSGID 346
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-44
Identities = 78/269 (28%), Positives = 129/269 (47%), Gaps = 17/269 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPK-HKMTTAIAIEDVRREVKILRALTGHNNL 221
+G+G +G + G G+ A+KV+ K + A + E IL H +
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL-EEVKHPFI 83
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
V A++ +Y+++E GGEL + L R G + ED A + +I + H +G+
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQ-LEREGIFMEDTACFYLAEISMALGHLHQKGI 142
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHRS-YS 339
++RDLKPEN + + +K DFGL + + + G+ Y+APE+L RS ++
Sbjct: 143 IYRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHN 199
Query: 340 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399
D WS+G + Y +L G+ PF +LK + P P L+ EARD +K+L
Sbjct: 200 RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL---P-PYLTQEARDLLKKL 255
Query: 400 LNKDPRKRLTAAQA-----LSHPWIKNSN 423
L ++ RL A +HP+ ++ N
Sbjct: 256 LKRNAASRLGAGPGDAGEVQAHPFFRHIN 284
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 6e-44
Identities = 87/314 (27%), Positives = 137/314 (43%), Gaps = 59/314 (18%)
Query: 149 FSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--------TTAI 200
+ + KY+ E+VG G +G AK +G + VA+K I ++ +TAI
Sbjct: 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRI----VALKRI---RLDAEDEGIPSTAI 67
Query: 201 AIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEG--GELLDRILSRGGKYT 258
RE+ +L+ L H N+V D + +V E E ++LD
Sbjct: 68 ------REISLLKELH-HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLD---ENKTGLQ 117
Query: 259 EDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDE 317
+ K + Q+L VA CH ++HRDLKP+N L + + LK DFGL+ F P
Sbjct: 118 DSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLARAFGIPVR 174
Query: 318 RLNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTE----SGIFR 371
V + +Y AP+VL + YST D+WSIG I ++ G F T+ IF
Sbjct: 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFS 234
Query: 372 AV----------LKADPSFDEAP------------WPSLSSEARDFVKRLLNKDPRKRLT 409
+ ++ P + + P E D + +L DP KR++
Sbjct: 235 ILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS 294
Query: 410 AAQALSHPWIKNSN 423
A A++HP+ K+ +
Sbjct: 295 ARDAMNHPYFKDLD 308
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-43
Identities = 78/268 (29%), Positives = 130/268 (48%), Gaps = 19/268 (7%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG + K G+ A+K++ K + + E ++L T H L
Sbjct: 13 LGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVL-QNTRHPFLT 68
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
A++ D + VME GGEL LSR +TE+ A+ +I++ + + H + VV
Sbjct: 69 ALKYAFQTHDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR-SYST 340
+RD+K EN + D++ +K DFGL + + + G+ Y+APEVL Y
Sbjct: 128 YRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W +GV+ Y ++CG PF+ + +F +L + F P +LS EA+ + LL
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF---P-RTLSPEAKSLLAGLL 240
Query: 401 NKDPRKRLTAAQA-----LSHPWIKNSN 423
KDP++RL + + H + + N
Sbjct: 241 KKDPKQRLGGGPSDAKEVMEHRFFLSIN 268
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 1e-43
Identities = 70/275 (25%), Positives = 124/275 (45%), Gaps = 25/275 (9%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG FG A + K G+ A K + K ++ + E KIL A +V
Sbjct: 193 LGRGGFGEVFACQMKA---TGKLYACKKLNKKRLKKRKGYQGAMVEKKIL-AKVHSRFIV 248
Query: 223 KFFDAYEDTDNVYVVMELCEGGEL---LDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
A+E ++ +VM + GG++ + + + E A QI++ + H +
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR-S 337
+++RDLKPEN L D++ ++ D GL+ + + G+ ++APE+L
Sbjct: 309 NIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 338 YSTEADVWSIGVIAYILLCGSRPFWARTESG----IFRAVLKADPSFDEAPWPSLSSEAR 393
Y D +++GV Y ++ PF AR E + + VL+ ++ S ++
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DKFSPASK 421
Query: 394 DFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423
DF + LL KDP KRL + +HP ++ +
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 165 bits (418), Expect = 2e-43
Identities = 80/360 (22%), Positives = 142/360 (39%), Gaps = 39/360 (10%)
Query: 91 SANSTPNRFFKRPFPPPSPAKHIKAVLARRHGS---VKPNEAAIPEGSEPEPAAGLNKS- 146
S +H++ L ++ +P I + + +S
Sbjct: 110 DTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESD 169
Query: 147 ----FGFSKHFANKYELGEE-------VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHK 195
F K+ L +GRG FG + G+ A+K + K +
Sbjct: 170 KFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKR 226
Query: 196 MTTAIAIEDVRREVKILRALTGHNN--LVKFFDAYEDTDNVYVVMELCEGGELLDRILSR 253
+ E +L ++ + +V A+ D + +++L GG+L LS+
Sbjct: 227 IKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYH-LSQ 285
Query: 254 GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313
G ++E D + +I+ + H + VV+RDLKP N L DE+ ++ D GL+
Sbjct: 286 HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDF 342
Query: 314 RPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESG--- 368
++ + VG+ Y+APEVL + +Y + AD +S+G + + LL G PF
Sbjct: 343 -SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 401
Query: 369 IFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423
I R L S S E R ++ LL +D +RL A + P+ ++ +
Sbjct: 402 IDRMTLTMAVELP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-43
Identities = 74/278 (26%), Positives = 131/278 (47%), Gaps = 28/278 (10%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG + + KK + A+KV+ K + I+ V+ E + + H LV
Sbjct: 17 IGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
++ ++ V+E GG+L+ + R K E+ A+ +I + + H +G++
Sbjct: 74 GLHSCFQTESRLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALNYLHERGII 132
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR-SYST 340
+RDLK +N L D +K D+G+ + +RP + + G+ Y+APE+L Y
Sbjct: 133 YRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 189
Query: 341 EADVWSIGVIAYILLCGSRPFW---------ARTESGIFRAVLKADPSFDEAPWPSLSSE 391
D W++GV+ + ++ G PF TE +F+ +L+ P SLS +
Sbjct: 190 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---P-RSLSVK 245
Query: 392 ARDFVKRLLNKDPRKRL-----TAAQAL-SHPWIKNSN 423
A +K LNKDP++RL T + HP+ +N +
Sbjct: 246 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 4e-43
Identities = 84/306 (27%), Positives = 127/306 (41%), Gaps = 55/306 (17%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT--------TAIAIEDV 205
A +YE + +G G F A+ K Q VA+K I + TA+
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKN---TNQIVAIKKIKLGHRSEAKDGINRTAL----- 60
Query: 206 RREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEG--GELLDRILSRGGKYTEDDAK 263
RE+K+L+ L+ H N++ DA+ N+ +V + E ++ T K
Sbjct: 61 -REIKLLQELS-HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK---DNSLVLTPSHIK 115
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDI 322
A M+ L + + H ++HRDLKP N L DEN VLK DFGL+ F P+
Sbjct: 116 AYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQ 172
Query: 323 VGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWA-RTE----SGIFRAV-- 373
V + +Y APE+L R Y D+W++G I LL PF ++ + IF +
Sbjct: 173 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR-VPFLPGDSDLDQLTRIFETLGT 231
Query: 374 --------------LKADPSFDEAPW----PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
SF P + + D ++ L +P R+TA QAL
Sbjct: 232 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291
Query: 416 HPWIKN 421
+ N
Sbjct: 292 MKYFSN 297
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 7e-43
Identities = 63/313 (20%), Positives = 111/313 (35%), Gaps = 54/313 (17%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIA-----IEDVR 206
+ Y + + G +G CA +G VA+K + +
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGI----PVAIKRVFNTVSDGRTVNILSDSFLCK 74
Query: 207 ---REVKILRALTGHNNLVKFFD-----AYEDTDNVYVVMELCEGGELLDRIL-SRGGKY 257
RE+++L H N++ D +Y+V EL L +++ +
Sbjct: 75 RVLREIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTELMRTD--LAQVIHDQRIVI 131
Query: 258 TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE 317
+ + M IL + H GVVHRDL P N L +N+ + DF L+ D
Sbjct: 132 SPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDITICDFNLAREDTADA 188
Query: 318 RLNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCG------------------ 357
V +Y APE++ + ++ D+WS G + +
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE 248
Query: 358 -----SRPFWARTESGIFRAVLKAD-PSFDEAPW----PSLSSEARDFVKRLLNKDPRKR 407
S R L+ + W P+ A D + ++L +P++R
Sbjct: 249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRR 308
Query: 408 LTAAQALSHPWIK 420
++ QAL HP+ +
Sbjct: 309 ISTEQALRHPYFE 321
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-42
Identities = 75/267 (28%), Positives = 123/267 (46%), Gaps = 17/267 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG A+ K + AVKV+ K + + + E +L H LV
Sbjct: 46 IGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+++ D +Y V++ GGEL L R + E A+ +I + + + H +V
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYH-LQRERCFLEPRARFYAAEIASALGYLHSLNIV 161
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHRS-YST 340
+RDLKPEN L D + DFGL + + + + G+ Y+APEVLH+ Y
Sbjct: 162 YRDLKPENILL---DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDR 218
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W +G + Y +L G PF++R + ++ +L P++++ AR ++ LL
Sbjct: 219 TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL---K-PNITNSARHLLEGLL 274
Query: 401 NKDPRKRL----TAAQALSHPWIKNSN 423
KD KRL + SH + N
Sbjct: 275 QKDRTKRLGAKDDFMEIKSHVFFSLIN 301
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-42
Identities = 85/311 (27%), Positives = 129/311 (41%), Gaps = 58/311 (18%)
Query: 148 GFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR 207
G + Y + +G G FG AK G+ VA+K + + K R
Sbjct: 47 GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQDKRFKN-------R 96
Query: 208 EVKILRALTGHNNLVK----FFDAYEDTDNVYV--VMELCEG--GELLDRILSRGGKYTE 259
E++I+R L H N+V+ F+ + E D VY+ V++ +
Sbjct: 97 ELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 155
Query: 260 DDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS-VLKAIDFGLSDFVRPDER 318
K M Q+ +A+ H G+ HRD+KP+N L D ++ VLK DFG + + E
Sbjct: 156 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLCDFGSAKQLVRGEP 212
Query: 319 LNDIVGSAYYVAPEVLHRS--YSTEADVWSIG-VIAYILLCGSRPFWARTESG------I 369
+ S YY APE++ + Y++ DVWS G V+A +LL +P + +SG I
Sbjct: 213 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG--QPIF-PGDSGVDQLVEI 269
Query: 370 FRAVL----KAD-------------PSFDEAPW-----PSLSSEARDFVKRLLNKDPRKR 407
+ VL + P PW P EA RLL P R
Sbjct: 270 IK-VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 328
Query: 408 LTAAQALSHPW 418
LT +A +H +
Sbjct: 329 LTPLEACAHSF 339
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 75/344 (21%), Positives = 131/344 (38%), Gaps = 61/344 (17%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+ +E E+G G+ G K G +A K+I + RE+++L
Sbjct: 32 DDDFEKISELGAGNGGVVFKVSHKPS---GLVMARKLIHLE--IKPAIRNQIIRELQVLH 86
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
+V F+ A+ + + ME +GG LD++L + G+ E V I ++ +
Sbjct: 87 ECN-SPYIVGFYGAFYSDGEISICMEHMDGG-SLDQVLKKAGRIPEQILGKVSIAVIKGL 144
Query: 274 AFCHLQG-VVHRDLKPENFLFTTKDENSVLKAIDFG----LSDFVRPDERLNDIVGSAYY 328
+ + ++HRD+KP N L ++ E +K DFG L D + N VG+ Y
Sbjct: 145 TYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-----NSFVGTRSY 196
Query: 329 VAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPF--------------------WARTES 367
++PE L + YS ++D+WS+G+ + G P
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256
Query: 368 GIFRAVLKADPSFDEAPWPSL--------------------SSEARDFVKRLLNKDPRKR 407
D P ++ S E +DFV + L K+P +R
Sbjct: 257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 316
Query: 408 LTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAAL 451
Q + H +IK S+ +V + + S+ A +
Sbjct: 317 ADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQPSTPTHAAGV 360
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-42
Identities = 88/402 (21%), Positives = 166/402 (41%), Gaps = 49/402 (12%)
Query: 35 PAPSPLNAESQSNNN--RTNVKGNDDAVIEGKKSPFFP---FYSPSPAHYFFSKKSSPAR 89
+PLN S + +T + +I + F+ +P ++
Sbjct: 47 QREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETP------EEREEWT 100
Query: 90 SSANSTPNRFFKRPFPPPSPAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGF 149
++ + + L ++ + + P + ++ +
Sbjct: 101 TAIQTVADG------------------LKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPK 142
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
+ N++E + +G+G FG K K G+ A+K++ K + + E
Sbjct: 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTEN 199
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
++L + H L +++ D + VME GGEL LSR ++ED A+ +I
Sbjct: 200 RVL-QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEI 257
Query: 270 LNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAY 327
++ + + H + VV+RDLK EN + D++ +K DFGL + ++ + G+
Sbjct: 258 VSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPE 314
Query: 328 YVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386
Y+APEVL + Y D W +GV+ Y ++CG PF+ + +F +L + F P
Sbjct: 315 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF---P-R 370
Query: 387 SLSSEARDFVKRLLNKDPRKRLTAAQA-----LSHPWIKNSN 423
+L EA+ + LL KDP++RL + H +
Sbjct: 371 TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV 412
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-42
Identities = 73/278 (26%), Positives = 131/278 (47%), Gaps = 28/278 (10%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG + + KK + A++V+ K + I+ V+ E + + H LV
Sbjct: 60 IGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
++ ++ V+E GG+L+ + R K E+ A+ +I + + H +G++
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALNYLHERGII 175
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR-SYST 340
+RDLK +N L D +K D+G+ + +RP + + G+ Y+APE+L Y
Sbjct: 176 YRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 232
Query: 341 EADVWSIGVIAYILLCGSRPFW---------ARTESGIFRAVLKADPSFDEAPWPSLSSE 391
D W++GV+ + ++ G PF TE +F+ +L+ P SLS +
Sbjct: 233 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---P-RSLSVK 288
Query: 392 ARDFVKRLLNKDPRKRL-----TAAQAL-SHPWIKNSN 423
A +K LNKDP++RL T + HP+ +N +
Sbjct: 289 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-42
Identities = 83/303 (27%), Positives = 126/303 (41%), Gaps = 57/303 (18%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
Y + +G G FG AK ++ +VA+K + + K RE++I+R
Sbjct: 40 IAYTNCKVIGNGSFGVVFQAK----LVESDEVAIKKVLQDK-------RFKNRELQIMRI 88
Query: 215 LTGHNNLVKFFDAY------EDTDNVYVVMELCEG--GELLDRILSRGGKYTEDDAKAVM 266
+ H N+V + +D + +V+E K M
Sbjct: 89 VK-HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYM 147
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS-VLKAIDFGLSDFVRPDERLNDIVGS 325
Q+L +A+ H G+ HRD+KP+N L D S VLK IDFG + + E + S
Sbjct: 148 YQLLRSLAYIHSIGICHRDIKPQNLLL---DPPSGVLKLIDFGSAKILIAGEPNVSYICS 204
Query: 326 AYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESG------IFRAVL--- 374
YY APE++ + Y+T D+WS G + L+ G +P + ESG I + VL
Sbjct: 205 RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG-QPLF-PGESGIDQLVEIIK-VLGTP 261
Query: 375 -----------KADPSF---DEAPW-----PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ F P+ P +A D + RLL P RLTA +AL
Sbjct: 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321
Query: 416 HPW 418
HP+
Sbjct: 322 HPF 324
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 3e-42
Identities = 80/309 (25%), Positives = 130/309 (42%), Gaps = 60/309 (19%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-------TTAIAIEDVR 206
+++++ E++G G + K G VA+K + K+ +TAI
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKT---TGVYVALKEV---KLDSEEGTPSTAI------ 51
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEG--GELLD--RILSRGGKYTEDDA 262
RE+ +++ L H N+V+ +D + + +V E + + +D + + +
Sbjct: 52 REISLMKELK-HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLV 110
Query: 263 KAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLND 321
K Q+L +AFCH ++HRDLKP+N L ++ LK DFGL+ F P +
Sbjct: 111 KYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLARAFGIPVNTFSS 167
Query: 322 IVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTE----SGIFR---- 371
V + +Y AP+VL R+YST D+WS G I ++ G F + IF
Sbjct: 168 EVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGT 227
Query: 372 ----------------AVLKADPS------FDEAPWPSLSSEARDFVKRLLNKDPRKRLT 409
++ P L DF+ LL +P RL+
Sbjct: 228 PNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS 287
Query: 410 AAQALSHPW 418
A QAL HPW
Sbjct: 288 AKQALHHPW 296
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 6e-42
Identities = 80/276 (28%), Positives = 137/276 (49%), Gaps = 23/276 (8%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHK-MTTAIAIEDVRREVKILRALTGHNNL 221
+G G +G + G G+ A+KV+ K + A E R E ++L + L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
V A++ ++++++ GGEL LS+ ++TE + + + +I+ + H G+
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTH-LSQRERFTEHEVQIYVGEIVLALEHLHKLGI 180
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLS--DFVRPDERLNDIVGSAYYVAPEVLHRS-- 337
++RD+K EN L D N + DFGLS ER D G+ Y+AP+++
Sbjct: 181 IYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDS 237
Query: 338 -YSTEADVWSIGVIAYILLCGSRPFWA----RTESGIFRAVLKADPSFDEAPWPSLSSEA 392
+ D WS+GV+ Y LL G+ PF +++ I R +LK++P + P +S+ A
Sbjct: 238 GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY---P-QEMSALA 293
Query: 393 RDFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423
+D ++RLL KDP+KRL A + H + + N
Sbjct: 294 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 6e-42
Identities = 76/272 (27%), Positives = 121/272 (44%), Gaps = 22/272 (8%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG CA + + G+ A K + K ++ E +IL +V
Sbjct: 192 LGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQIL-EKVNSRFVV 247
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGV 281
AYE D + +V+ L GG+L I G + E A +I + H + +
Sbjct: 248 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERI 307
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYST 340
V+RDLKPEN L D++ ++ D GL+ V + + VG+ Y+APEV+ Y+
Sbjct: 308 VYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTF 364
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESG----IFRAVLKADPSFDEAPWPSLSSEARDFV 396
D W++G + Y ++ G PF R + + R V + + S +AR
Sbjct: 365 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERFSPQARSLC 420
Query: 397 KRLLNKDPRKRL-----TAAQALSHPWIKNSN 423
+LL KDP +RL +A + HP K N
Sbjct: 421 SQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 8e-42
Identities = 82/318 (25%), Positives = 132/318 (41%), Gaps = 64/318 (20%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR--REV 209
++Y + +G G G +A ++VA+K I + RE+
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDND---CDKRVAIKKIVLTDPQSVK-----HALREI 59
Query: 210 KILRALTGHNNLVKFFD--------------AYEDTDNVYVVMELCEGGELLDRILSRGG 255
KI+R L H+N+VK F+ + + ++VY+V E E L +L G
Sbjct: 60 KIIRRL-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD--LANVL-EQG 115
Query: 256 KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
E+ A+ M Q+L + + H V+HRDLKP N T E+ VLK DFGL+ + P
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--EDLVLKIGDFGLARIMDP 173
Query: 316 DERLNDI----VGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCG------------ 357
+ + +Y +P +L +Y+ D+W+ G I +L G
Sbjct: 174 HYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ 233
Query: 358 -----------SRPFWARTESGIFRAVLKADPSFDEAPW----PSLSSEARDFVKRLLNK 402
S ++ D + P P +S EA DF++++L
Sbjct: 234 MQLILESIPVVHEEDRQELLSV-IPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTF 292
Query: 403 DPRKRLTAAQALSHPWIK 420
P RLTA +ALSHP++
Sbjct: 293 SPMDRLTAEEALSHPYMS 310
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 5e-41
Identities = 79/307 (25%), Positives = 136/307 (44%), Gaps = 54/307 (17%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPK--HKMTTAIAIEDVRREV 209
+Y+ VG G +G CAA K G +VAVK + + + A RE+
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRT---YREL 79
Query: 210 KILRALTGHNNLVKFFD------AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAK 263
++L+ + H N++ D + E+ ++VY+V L L+ I+ + K T+D +
Sbjct: 80 RLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--LNNIV-KCQKLTDDHVQ 135
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERLNDI 322
++ QIL + + H ++HRDLKP N +E+ LK +DFGL+ R + +
Sbjct: 136 FLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA---RHTADEMTGY 189
Query: 323 VGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCG----------------------- 357
V + +Y APE++ Y+ D+WS+G I LL G
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249
Query: 358 SRPFWARTESGIFRAVLKADPSFDEAPW----PSLSSEARDFVKRLLNKDPRKRLTAAQA 413
+ S R +++ + + + A D ++++L D KR+TAAQA
Sbjct: 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 309
Query: 414 LSHPWIK 420
L+H +
Sbjct: 310 LAHAYFA 316
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 6e-41
Identities = 62/365 (16%), Positives = 129/365 (35%), Gaps = 67/365 (18%)
Query: 154 ANKYELGEEVGRGH--FGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKI 211
YEL +G+G A++K G+ V V+ I + + + ++ E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKP---TGEYVTVRRINLEACSNEM-VTFLQGELHV 79
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRI-LSRGGKYTEDDAKAVMIQIL 270
+ H N+V + + + ++VV G D I E ++ +L
Sbjct: 80 SKLFN-HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL 138
Query: 271 NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLN-------DI 322
+ + H G VHR +K + L + + + + + +R
Sbjct: 139 KALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 323 VGSAYYVAPEVLHRS---YSTEADVWSIGVIAYILLCGSRPF------------------ 361
V +++PEVL ++ Y ++D++S+G+ A L G PF
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255
Query: 362 ------------------WARTESGIFRAVLKADPSFDEAPWPS------LSSEARDFVK 397
+ SG+ ++ + P PS S FV+
Sbjct: 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVE 315
Query: 398 RLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALRALSKT 457
+ L ++P R +A+ L+H + K +K + +L++ ++ + + S
Sbjct: 316 QCLQRNPDARPSASTLLNHSFFKQ---IKRRASEALPELLRPVTPITNFEGSQSQDHSGI 372
Query: 458 LTVDE 462
+
Sbjct: 373 FGLVT 377
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 81/304 (26%), Positives = 137/304 (45%), Gaps = 55/304 (18%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPK--HKMTTAIAIEDVRREVKIL 212
Y VG G +G C+A K+ G++VA+K + + A RE+ +L
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKR---SGEKVAIKKLSRPFQSEIFAKRA---YRELLLL 77
Query: 213 RALTGHNNLVKFFDA------YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
+ + H N++ D + + Y+VM + L +I+ K++E+ + ++
Sbjct: 78 KHMQ-HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGL--KFSEEKIQYLV 132
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERLNDIVGS 325
Q+L + + H GVVHRDLKP N +E+ LK +DFGL+ R D + V +
Sbjct: 133 YQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLA---RHADAEMTGYVVT 186
Query: 326 AYYVAPEVL--HRSYSTEADVWSIGVIAYILLCG-----------------------SRP 360
+Y APEV+ Y+ D+WS+G I +L G
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246
Query: 361 FWARTESGIFRAVLKADPSFDEAPW----PSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416
F + ++ +++ P + P S +A D ++++L D KRLTAAQAL+H
Sbjct: 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306
Query: 417 PWIK 420
P+ +
Sbjct: 307 PFFE 310
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 82/319 (25%), Positives = 131/319 (41%), Gaps = 61/319 (19%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKM--------TTAIAIED 204
+YE E+G G +G + K + + G+ VA+K + ++ + I
Sbjct: 11 QQYECVAEIGEGAYGKVF----KARDLKNGGRFVALKRV---RVQTGEEGMPLSTI---- 59
Query: 205 VRREVKILRAL--TGHNNLVKFFD-----AYEDTDNVYVVMELCEG--GELLDRILSRGG 255
REV +LR L H N+V+ FD + + +V E + LD++
Sbjct: 60 --REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV--PEP 115
Query: 256 KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
+ K +M Q+L + F H VVHRDLKP+N L + +K DFGL+
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSF 172
Query: 316 DERLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTE----SGIF 370
L +V + +Y APEVL SY+T D+WS+G I + F ++ I
Sbjct: 173 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 232
Query: 371 RAVLKAD----PSFDEAPW---------------PSLSSEARDFVKRLLNKDPRKRLTAA 411
+ P P + +D + + L +P KR++A
Sbjct: 233 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 292
Query: 412 QALSHPWIKNSNDVKVPLD 430
ALSHP+ ++ K LD
Sbjct: 293 SALSHPYFQDLERCKENLD 311
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 77/308 (25%), Positives = 118/308 (38%), Gaps = 55/308 (17%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT--------TAIAIEDVR 206
++YE E+G G +G A+ G VA+K + + +
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPH---SGHFVALKSVRVPNGGGGGGGLPISTV------ 59
Query: 207 REVKILRAL--TGHNNLVKFFD-----AYEDTDNVYVVMELCEG--GELLDRILSRGGKY 257
REV +LR L H N+V+ D + V +V E + LD+
Sbjct: 60 REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA--PPPGL 117
Query: 258 TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE 317
+ K +M Q L + F H +VHRDLKPEN L +K DFGL+
Sbjct: 118 PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTVKLADFGLARIYSYQM 174
Query: 318 RLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRA 372
L +V + +Y APEVL +Y+T D+WS+G I + F +E IF
Sbjct: 175 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234
Query: 373 VLKAD----PSFDEAPW---------------PSLSSEARDFVKRLLNKDPRKRLTAAQA 413
+ P P P + + +L +P KR++A +A
Sbjct: 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRA 294
Query: 414 LSHPWIKN 421
L H ++
Sbjct: 295 LQHSYLHK 302
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-40
Identities = 75/322 (23%), Positives = 124/322 (38%), Gaps = 65/322 (20%)
Query: 145 KSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIED 204
+ S+ +++++ G+G FG K K G VA+K + +
Sbjct: 13 AADERSRKEMDRFQVERMAGQGTFGTVQLGKEKS---TGMSVAIKKVIQDPRFR------ 63
Query: 205 VRREVKILRALT--GHNNLVKFFDAY-----EDTDNVY--VVMELCEGGELLDRILSRGG 255
RE++I++ L H N+V+ + D ++Y VVME + L R
Sbjct: 64 -NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP--DTLHRCCRNYY 120
Query: 256 KY----TEDDAKAVMIQILNVVAFCHLQ--GVVHRDLKPENFLFTTKDENSVLKAIDFGL 309
+ K + Q++ + HL V HRD+KP N L + LK DFG
Sbjct: 121 RRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE--ADGTLKLCDFGS 178
Query: 310 SDFVRPDERLNDIVGSAYYVAPEVL--HRSYSTEADVWSIG-VIAYILL-----CG---- 357
+ + P E + S YY APE++ ++ Y+T D+WS+G + A ++L G
Sbjct: 179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238
Query: 358 -------------SRPFWARTESGIFRAVLKADPSFDEAPW--------PSLSSEARDFV 396
SR + + PW + EA D +
Sbjct: 239 GQLHEIVRVLGCPSREVLRKLNPSHTD---VDLYNSKGIPWSNVFSDHSLKDAKEAYDLL 295
Query: 397 KRLLNKDPRKRLTAAQALSHPW 418
LL P +R+ +AL HP+
Sbjct: 296 SALLQYLPEERMKPYEALCHPY 317
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 4e-40
Identities = 80/327 (24%), Positives = 142/327 (43%), Gaps = 57/327 (17%)
Query: 135 SEPEPAAGLNKSFGFSK---HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI 191
S P PA +K Y + VG G +G C+A + G +VA+K +
Sbjct: 2 SSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKL 58
Query: 192 PK--HKMTTAIAIEDVRREVKILRALTGHNNLVKFFDA------YEDTDNVYVVMELCEG 243
+ A RE+++L+ + H N++ D +D + Y+VM
Sbjct: 59 YRPFQSELFAKRA---YRELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGT 114
Query: 244 GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303
L +++ + K ED + ++ Q+L + + H G++HRDLKP N +E+ LK
Sbjct: 115 D--LGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELK 168
Query: 304 AIDFGLSDFVRP-DERLNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCG--- 357
+DFGL+ R D + V + +Y APEV+ Y+ D+WS+G I ++ G
Sbjct: 169 ILDFGLA---RQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 225
Query: 358 --------------------SRPFWARTESGIFRAVLKADPSFDEAPW----PSLSSEAR 393
F R +S + +K P ++ + + S A
Sbjct: 226 FKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAV 285
Query: 394 DFVKRLLNKDPRKRLTAAQALSHPWIK 420
+ ++++L D +R+TA +AL+HP+ +
Sbjct: 286 NLLEKMLVLDAEQRVTAGEALAHPYFE 312
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 6e-40
Identities = 74/262 (28%), Positives = 116/262 (44%), Gaps = 30/262 (11%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ E+ E VGRG FG C K + + + VA+K I + E++ L
Sbjct: 8 KEIEVEEVVGRGAFGVVC-----KAKWRAKDVAIKQIESESE-----RKAFIVELRQLSR 57
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV--MIQILNV 272
+ H N+VK + A + V +VME EGG L + + A A+ +Q
Sbjct: 58 VN-HPNIVKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114
Query: 273 VAFCH---LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
VA+ H + ++HRDLKP N L +VLK DFG + + + + GSA ++
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLV--AGGTVLKICDFGTACDI--QTHMTNNKGSAAWM 170
Query: 330 APEVL-HRSYSTEADVWSIGVIAYILLCGSRPFW--ARTESGIFRAVLKAD-PSFDEAPW 385
APEV +YS + DV+S G+I + ++ +PF I AV P +
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLP 230
Query: 386 PSLSSEARDFVKRLLNKDPRKR 407
+ + R +KDP +R
Sbjct: 231 KPI----ESLMTRCWSKDPSQR 248
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-39
Identities = 66/214 (30%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-TAIAIEDVRREVKILRALT 216
L E +G G FG K + G +VAVK + IE+VR+E K+ L
Sbjct: 10 TLEEIIGIGGFG-----KVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N++ N+ +VME GG L + G + D +QI + +
Sbjct: 65 -HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYL 121
Query: 277 HLQG---VVHRDLKPENFLFTTKDE-----NSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
H + ++HRDLK N L K E N +LK DFGL+ +++ G+ +
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGAYAW 180
Query: 329 VAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPF 361
+APEV+ +S +DVWS GV+ + LL G PF
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 65/258 (25%), Positives = 110/258 (42%), Gaps = 22/258 (8%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+ E++G G FG + E G VAVK++ + + + REV I++ L
Sbjct: 40 NIKEKIGAGSFG-----TVHRAEWHGSDVAVKILMEQDFHAE-RVNEFLREVAIMKRLR- 92
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV--MIQILNVVAF 275
H N+V F A N+ +V E G L + G + D+ + + + + +
Sbjct: 93 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 276 CHLQG--VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER-LNDIVGSAYYVAPE 332
H + +VHR+LK N L D+ +K DFGLS G+ ++APE
Sbjct: 153 LHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE 209
Query: 333 VL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD--PSFDEAPWPSLS 389
VL + ++DV+S GVI + L +P+ + + AV E P +L+
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL---EIP-RNLN 265
Query: 390 SEARDFVKRLLNKDPRKR 407
+ ++ +P KR
Sbjct: 266 PQVAAIIEGCWTNEPWKR 283
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-39
Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKH----KMTTAIAIEDVRREVKILR 213
E +++G+G FG + K VA+K + + ++ +REV I+
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVK---DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
L H N+VK + + +VME G+L R+L + +M+ I +
Sbjct: 79 NLN-HPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 274 AFCHLQG--VVHRDLKPENFLFTTKDENS--VLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
+ Q +VHRDL+ N + DEN+ K DFGLS ++ ++G+ ++
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS--VHSVSGLLGNFQWM 193
Query: 330 APEVL---HRSYSTEADVWSIGVIAYILLCGSRPF 361
APE + SY+ +AD +S +I Y +L G PF
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-39
Identities = 58/267 (21%), Positives = 111/267 (41%), Gaps = 32/267 (11%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
E+GE +G+G FG + G G+ VA+++I + ++ +REV R
Sbjct: 36 EIGELIGKGRFG-----QVYHGRWHGE-VAIRLIDIERDNED-QLKAFKREVMAYRQTR- 87
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H N+V F A ++ ++ LC+G L + + + + +I+ + + H
Sbjct: 88 HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH 147
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS------DFVRPDERLNDIVGSAYYVAP 331
+G++H+DLK +N + +N + DFGL R +++L G ++AP
Sbjct: 148 AKGILHKDLKSKNVFY----DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
Query: 332 EVL----------HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK-ADPSF 380
E++ +S +DV+++G I Y L PF + I + P+
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL 263
Query: 381 DEAPWPSLSSEARDFVKRLLNKDPRKR 407
+ E D + + +R
Sbjct: 264 ---SQIGMGKEISDILLFCWAFEQEER 287
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 82/307 (26%), Positives = 129/307 (42%), Gaps = 56/307 (18%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI-PKHKMTTAIAIEDVR--REVKI 211
+Y +G G +G C+A +VA+K I P T R RE+KI
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNL---NKVRVAIKKISPFEHQTYCQ-----RTLREIKI 78
Query: 212 LRALTGHNNLVKFFD-----AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
L H N++ D E +VY+V +L E L ++L + + D +
Sbjct: 79 LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL-KTQHLSNDHICYFL 134
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI---- 322
QIL + + H V+HRDLKP N L + LK DFGL+ PD
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 323 VGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCG----------------------- 357
V + +Y APE++ + Y+ D+WS+G I +L
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251
Query: 358 SRPFWARTESGIFRAVLKADPSFDEAPW----PSLSSEARDFVKRLLNKDPRKRLTAAQA 413
S+ + R L + P ++ PW P+ S+A D + ++L +P KR+ QA
Sbjct: 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 311
Query: 414 LSHPWIK 420
L+HP+++
Sbjct: 312 LAHPYLE 318
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 90/319 (28%), Positives = 140/319 (43%), Gaps = 66/319 (20%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI-PKHKMTTAIAIEDVR--RE 208
+ ++ ++L +G G +G C+A K G+ VA+K I P K A+ R RE
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKP---TGEIVAIKKIEPFDKPLFAL-----RTLRE 59
Query: 209 VKILRALTGHNNLVKFFD-----AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAK 263
+KIL+ H N++ F+ ++E+ + VY++ EL + L R++ ++D +
Sbjct: 60 IKILKHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVI-STQMLSDDHIQ 115
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323
+ Q L V H V+HRDLKP N L + N LK DFGL+ + N
Sbjct: 116 YFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 324 GSA-----------YYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFW-------- 362
+Y APEV+ YS DVWS G I L RP +
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPIFPGRDYRHQ 231
Query: 363 -----------------ARTESGIFRAVLKADPSFDEAPW----PSLSSEARDFVKRLLN 401
ES R +K+ P + AP P ++ + D ++R+L
Sbjct: 232 LLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLV 291
Query: 402 KDPRKRLTAAQALSHPWIK 420
DP KR+TA +AL HP+++
Sbjct: 292 FDPAKRITAKEALEHPYLQ 310
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-38
Identities = 72/335 (21%), Positives = 125/335 (37%), Gaps = 50/335 (14%)
Query: 103 PFPPPSPAKHIKAVLA-------RRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHF-- 153
P P + A++ +R + + G G F
Sbjct: 14 RAPDIDPLE---ALMTNPVVPESKRFCWNCGRPVGRSDSETKGASEGWCPYCGSPYSFLP 70
Query: 154 --------ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDV 205
A +YE+ + G G+ A + + G+ V +K + A A
Sbjct: 71 QLNPGDIVAGQYEVKGCIAHGGLGWIYLALDRN--VNGRPVVLKGL--VHSGDAEAQAMA 126
Query: 206 RREVKILRALTGHNNLVKFFDAYEDTDN-----VYVVMELCEGGELLDRILSRGGKYTED 260
E + L + H ++V+ F+ E TD Y+VME G L G K
Sbjct: 127 MAERQFLAEVV-HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVA 182
Query: 261 DAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLN 320
+A A +++IL +++ H G+V+ DLKPEN + T E + K ID G V
Sbjct: 183 EAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT---EEQL-KLIDLGA---VSRINSFG 235
Query: 321 DIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 380
+ G+ + APE++ + D++++G L R + P
Sbjct: 236 YLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRY--------VDGLP-- 285
Query: 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
++ P ++R ++ DPR+R T A+ +S
Sbjct: 286 EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMS 320
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 62/262 (23%), Positives = 109/262 (41%), Gaps = 27/262 (10%)
Query: 158 ELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+G+ +G G FG Y KG+ G VAVK++ T ++ + EV +LR
Sbjct: 27 TVGQRIGSGSFGTVY-------KGKWHGD-VAVKMLNVTAPTPQ-QLQAFKNEVGVLRKT 77
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N++ F + +V + CEG L + + K+ + Q + +
Sbjct: 78 R-HVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY 135
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS---DFVRPDERLNDIVGSAYYVAPE 332
H + ++HRDLK N E++ +K DFGL+ + + GS ++APE
Sbjct: 136 LHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
Query: 333 VL----HRSYSTEADVWSIGVIAYILLCGSRPFWART-ESGIFRAVLKAD--PSFDEAPW 385
V+ YS ++DV++ G++ Y L+ G P+ I V + P +
Sbjct: 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR- 251
Query: 386 PSLSSEARDFVKRLLNKDPRKR 407
+ + + L K +R
Sbjct: 252 SNCPKRMKRLMAECLKKKRDER 273
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 73/316 (23%), Positives = 130/316 (41%), Gaps = 67/316 (21%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPK--HKMTTAIAIEDVR--REVK 210
+Y+ + +G G G CAA + VA+K + + T A R RE+
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSRPFQNQTHAK-----RAYRELV 76
Query: 211 ILRALTGHNNLVKFFDA------YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKA 264
+++ + H N++ + E+ +VY+VMEL + L +++ + +
Sbjct: 77 LMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQM--ELDHERMSY 131
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVG 324
++ Q+L + H G++HRDLKP N + + LK +DFGL+ + V
Sbjct: 132 LLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVV 188
Query: 325 SAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCG-----------------------SRP 360
+ YY APEV L Y D+WS+G I ++ G
Sbjct: 189 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE 248
Query: 361 FWARTESGIFRAVLKADPSFDEAPW----------------PSLSSEARDFVKRLLNKDP 404
F + + + R ++ P + + +S+ARD + ++L D
Sbjct: 249 FMKKLQPTV-RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 307
Query: 405 RKRLTAAQALSHPWIK 420
KR++ +AL HP+I
Sbjct: 308 SKRISVDEALQHPYIN 323
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 3e-38
Identities = 71/269 (26%), Positives = 117/269 (43%), Gaps = 14/269 (5%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
K +Y++ +++G G A+ + +VA+K I ++ REV
Sbjct: 7 KIINERYKIVDKLGGGGMSTVYLAE---DTILNIKVAIKAIFIPPREKEETLKRFEREVH 63
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQIL 270
L+ H N+V D E+ D Y+VME EG L + + G + D A QIL
Sbjct: 64 NSSQLS-HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSE-YIESHGPLSVDTAINFTNQIL 121
Query: 271 NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL---NDIVGSAY 327
+ + H +VHRD+KP+N L N LK DFG++ + + L N ++G+
Sbjct: 122 DGIKHAHDMRIVHRDIKPQNILID---SNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQ 177
Query: 328 YVAPEVLHRSYSTEA-DVWSIGVIAYILLCGSRPFWARTESGI-FRAVLKADPSFDEAPW 385
Y +PE + E D++SIG++ Y +L G PF T I + + + P+
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVR 237
Query: 386 PSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
+ + + R KD R Q +
Sbjct: 238 KDIPQSLSNVILRATEKDKANRYKTIQEM 266
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 7e-38
Identities = 75/315 (23%), Positives = 131/315 (41%), Gaps = 67/315 (21%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPK--HKMTTAIAIEDVR--REVKI 211
+Y+ + +G G G CAA + VA+K + + T A R RE+ +
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQNQTHAK-----RAYRELVL 114
Query: 212 LRALTGHNNLVKFFDA------YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV 265
++ + H N++ + E+ +VY+VMEL + L +++ + + +
Sbjct: 115 MKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQM--ELDHERMSYL 169
Query: 266 MIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGS 325
+ Q+L + H G++HRDLKP N + + LK +DFGL+ + V +
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVT 226
Query: 326 AYYVAPEV-LHRSYSTEADVWSIGVIAYILLCG-----------------------SRPF 361
YY APEV L Y D+WS+G I ++ F
Sbjct: 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 286
Query: 362 WARTESGIFRAVLKADPSFDEAPWPSL----------------SSEARDFVKRLLNKDPR 405
+ + + R ++ P + +P L +S+ARD + ++L DP
Sbjct: 287 MKKLQPTV-RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 345
Query: 406 KRLTAAQALSHPWIK 420
KR++ AL HP+I
Sbjct: 346 KRISVDDALQHPYIN 360
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 9e-37
Identities = 70/337 (20%), Positives = 125/337 (37%), Gaps = 90/337 (26%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+ KY LG+ +G G FG C + G++ A+K + + RE+ I++
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIE---SGKRFALKKVLQDPRYK-------NRELDIMK 55
Query: 214 ALTGHNNLVKFFDAY--------------------------------------EDTDNVY 235
L H N++K D + +
Sbjct: 56 VLD-HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN 114
Query: 236 VVMELCEGGELLDRILSRGGKY----TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENF 291
V+ME + L ++L + + + Q+ V F H G+ HRD+KP+N
Sbjct: 115 VIMEYVP--DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNL 172
Query: 292 LFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIG- 348
L + +++ LK DFG + + P E + S +Y APE++ Y+ D+WSIG
Sbjct: 173 LVNS--KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230
Query: 349 VIAYILL-----CG-----------------SRPFWARTESGIFRAVLKADPSFDEAPWP 386
V ++L G ++ R P+ W
Sbjct: 231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRF---PTLKAKDWR 287
Query: 387 SL-----SSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
+ S A D ++++L +P R+ +A++HP+
Sbjct: 288 KILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPF 324
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 79/335 (23%), Positives = 131/335 (39%), Gaps = 74/335 (22%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKI 211
+ +Y L ++G GHF AK VA+K++ K+ T A + E+K+
Sbjct: 16 YKDARYILVRKLGWGHFSTVWLAKDMV---NNTHVAMKIVRGDKVYTEAAED----EIKL 68
Query: 212 LRALT----------GHNNLVKFFDAYE----DTDNVYVVMELCEGGELLDRI-LSRGGK 256
L+ + G N+++K D + + +V +V E+ G LL I
Sbjct: 69 LQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRG 127
Query: 257 YTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDEN---SVLKAIDFGLSDF 312
K + Q+L + + H + G++H D+KPEN L D +K D G + +
Sbjct: 128 IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187
Query: 313 VRPDERLNDIVGSAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFR 371
DE + + + Y +PEV L + AD+WS + + L+ G F +
Sbjct: 188 Y--DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245
Query: 372 ---------AVLKADPS------------FDE----------APWP----------SLSS 390
+L PS F+ WP
Sbjct: 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD 305
Query: 391 EAR---DFVKRLLNKDPRKRLTAAQALSHPWIKNS 422
EA+ DF+ +L DPRKR A ++HPW+K++
Sbjct: 306 EAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 340
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 77/346 (22%), Positives = 130/346 (37%), Gaps = 95/346 (27%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR----- 206
H KYEL +++G+G +G + ++ G+ VAVK I A ++
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRR---TGEVVAVKKIFD-------AFQNSTDAQRT 55
Query: 207 -REVKILRALTGHNNLVKFFDAY--EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAK 263
RE+ IL L+GH N+V + ++ +VY+V + E L ++ R +
Sbjct: 56 FREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETD--LHAVI-RANILEPVHKQ 112
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323
V+ Q++ V+ + H G++HRD+KP N L + +K DFGLS R+ + +
Sbjct: 113 YVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 324 GSA----------------------YYVAPEVL--HRSYSTEADVWSIGVI--------- 350
+ +Y APE+L Y+ D+WS+G I
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229
Query: 351 -----------------------------------AYILLCGSRPFWARTESGIFRAVLK 375
I + +S K
Sbjct: 230 IFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKV--EIRQSNKRDIFTK 287
Query: 376 ADPSFDEA-PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
+ P + EA D + +LL +P KR++A AL HP++
Sbjct: 288 WKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVS 333
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 3e-36
Identities = 74/273 (27%), Positives = 118/273 (43%), Gaps = 17/273 (6%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
H +++YELGE +G G A+ + VAVKV+ RRE +
Sbjct: 8 SHLSDRYELGEILGFGGMSEVHLAR---DLRDHRDVAVKVLRADLARDPSFYLRFRREAQ 64
Query: 211 ILRALTGHNNLVKFFDAYEDTDN----VYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
AL H +V +D E Y+VME +G L D I+ G T A V+
Sbjct: 65 NAAALN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTPKRAIEVI 122
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL----SDFVRPDERLNDI 322
+ F H G++HRD+KP N + + + +K +DFG+ +D + +
Sbjct: 123 ADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 323 VGSAYYVAPEVLHRSYSTEA-DVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381
+G+A Y++PE DV+S+G + Y +L G PF + + ++ DP
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 239
Query: 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
A LS++ V + L K+P R A +
Sbjct: 240 SARHEGLSADLDAVVLKALAKNPENRYQTAAEM 272
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 9e-36
Identities = 82/330 (24%), Positives = 124/330 (37%), Gaps = 88/330 (26%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--------TTAIAIEDV 205
+KYE ++G+G FG A+ +K GQ+VA+K K M TA+
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRK---TGQKVALK---KVLMENEKEGFPITAL----- 64
Query: 206 RREVKILRALTGHNNLVKFFD--------AYEDTDNVYVVMELCEG--GELLDRILSRGG 255
RE+KIL+ L H N+V + ++Y+V + CE LL +
Sbjct: 65 -REIKILQLLK-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS---NVLV 119
Query: 256 KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
K+T + K VM +LN + + H ++HRD+K N L + VLK DFGL+
Sbjct: 120 KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSL 176
Query: 316 DERLNDIVGSAY--------YVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRP-FWAR 364
+ + Y Y PE+L R Y D+W G I + P
Sbjct: 177 AKNSQP---NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR-SPIMQGN 232
Query: 365 TESG----IFRAVLKADPSFDEAPWP----------------------------SLSSEA 392
TE I + S WP A
Sbjct: 233 TEQHQLALISQLC----GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYA 288
Query: 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422
D + +LL DP +R+ + AL+H + +
Sbjct: 289 LDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-35
Identities = 54/262 (20%), Positives = 96/262 (36%), Gaps = 31/262 (11%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
++ H G KG +G + VKV+ +T D E LR +
Sbjct: 13 NFLTKLNENHSGELW-----KGRWQGNDIVVKVLKVRDWSTRK-SRDFNEECPRLRIFS- 65
Query: 218 HNNLVKFFDAYED--TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV--MIQILNVV 273
H N++ A + + ++ G L + +L G + D ++AV + + +
Sbjct: 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYN-VLHEGTNFVVDQSQAVKFALDMARGM 124
Query: 274 AFCHLQG--VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAP 331
AF H + L + + DE+ + + + + + +VAP
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADVKFS----FQSPGRMYAPAWVAP 177
Query: 332 EVLHRS----YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD--PSFDEAPW 385
E L + AD+WS V+ + L+ PF + I V P+ P
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI---P- 233
Query: 386 PSLSSEARDFVKRLLNKDPRKR 407
P +S +K +N+DP KR
Sbjct: 234 PGISPHVSKLMKICMNEDPAKR 255
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-35
Identities = 78/330 (23%), Positives = 130/330 (39%), Gaps = 71/330 (21%)
Query: 154 ANKYE-LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-TTAIAIEDVRREVKI 211
+ +E G +VGRG +G+ AK K G+ + A+K I + +A RE+ +
Sbjct: 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGK-DDKDYALKQIEGTGISMSAC------REIAL 71
Query: 212 LRALTGHNNLVKFFDA-YEDTDN-VYVVMELCEG--GELLD-----RILSRGGKYTEDDA 262
LR L H N++ D V+++ + E ++ + + +
Sbjct: 72 LRELK-HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMV 130
Query: 263 KAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK-DENSVLKAIDFGL----SDFVRPDE 317
K+++ QIL+ + + H V+HRDLKP N L + E +K D G + ++P
Sbjct: 131 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 190
Query: 318 RLNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRP-FWARTESGIFRAVL 374
L+ +V + +Y APE+L R Y+ D+W+IG I LL P F R E
Sbjct: 191 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDIKTSNPY 249
Query: 375 KAD-----------------PSFDEAPW--------------------------PSLSSE 391
D + P S+
Sbjct: 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSK 309
Query: 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
A +++LL DP KR+T+ QA+ P+
Sbjct: 310 AFHLLQKLLTMDPIKRITSEQAMQDPYFLE 339
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 77/302 (25%), Positives = 124/302 (41%), Gaps = 26/302 (8%)
Query: 120 RHGSVKPNEAAIPEG---SEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKF 176
H + E G FG Y L VGRG G A+
Sbjct: 5 HHHHHHSSGLVPRGSHMDGTAESREG--TQFG-------PYRLRRLVGRGGMGDVYEAE- 54
Query: 177 KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236
++ + VA+K++ + + + ++RE + L ++V D E +YV
Sbjct: 55 --DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDGQLYV 111
Query: 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296
M L G +L +L R G A A++ QI + + H G HRD+KPEN L +
Sbjct: 112 DMRLINGVDL-AAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSAD 170
Query: 297 DENSVLKAIDFGLSDFVRPDERL---NDIVGSAYYVAPEVLHRSYSTE-ADVWSIGVIAY 352
D +DFG++ DE+L + VG+ YY+APE S++T AD++++ + Y
Sbjct: 171 D---FAYLVDFGIASAT-TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLY 226
Query: 353 ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQ 412
L GS P+ S + + +A P P + + R + K+P R
Sbjct: 227 ECLTGSPPYQGDQLSVMGAHINQAIPRPSTVR-PGIPVAFDAVIARGMAKNPEDRYVTCG 285
Query: 413 AL 414
L
Sbjct: 286 DL 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 4e-35
Identities = 51/220 (23%), Positives = 90/220 (40%), Gaps = 26/220 (11%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
GE +G+G FG K + + + + +EVK++R L
Sbjct: 13 IHGEVLGKGCFGQAI-----KVTHRETGEVMVMKELIRFDEE-TQRTFLKEVKVMRCLE- 65
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H N++KF + + E +GG L I S +Y + I + +A+ H
Sbjct: 66 HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND---------------I 322
++HRDL N L EN + DFGL+ + ++ + +
Sbjct: 126 SMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 323 VGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPF 361
VG+ Y++APE++ RSY + DV+S G++ ++
Sbjct: 183 VGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD 222
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-35
Identities = 75/359 (20%), Positives = 132/359 (36%), Gaps = 103/359 (28%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPK--HKMTTAIAIEDVR--R 207
H + Y + +GRG +GY A K + VA+K + + + R R
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKN---TEKNVAIKKVNRMFEDLIDCK-----RILR 74
Query: 208 EVKILRALTGHNNLVKFFD-----AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDA 262
E+ IL L + +++ +D D +Y+V+E+ + L ++ TE+
Sbjct: 75 EITILNRL-KSDYIIRLYDLIIPDDLLKFDELYIVLEIADSD--LKKLFKTPIFLTEEHI 131
Query: 263 KAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI 322
K ++ +L F H G++HRDLKP N L +++ +K DFGL+ + ++ N +
Sbjct: 132 KTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGLARTINSEKDTNIV 188
Query: 323 VGSA-----------------------YYVAPEVL--HRSYSTEADVWSIGVIAYILLCG 357
+Y APE++ +Y+ D+WS G I LL
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248
Query: 358 SRPFWARTESG--------------------------------IF--------------- 370
+ + IF
Sbjct: 249 LQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNIN 308
Query: 371 ----RAVLKADPSFDEAPW----PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
+K P PS+S + + ++ +L +P KR+T QAL HP++K+
Sbjct: 309 KPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 78/334 (23%), Positives = 122/334 (36%), Gaps = 76/334 (22%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI-PKHKMTTAIAIEDVRREVK 210
+ +YE+ + +G G FG K G+ VAVK++ + A E ++
Sbjct: 11 VLSARYEIVDTLGEGAFGKVVECIDHK--AGGRHVAVKIVKNVDRYCEAARSE-----IQ 63
Query: 211 ILRAL-----TGHNNLVKFFDAYEDTDNVYVVMELCEGG--ELLDRILSRGGKYTEDDAK 263
+L L V+ + +E ++ +V EL + + + D +
Sbjct: 64 VLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLP--FRLDHIR 121
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD----------------ENSVLKAIDF 307
+ QI V F H + H DLKPEN LF D N +K +DF
Sbjct: 122 KMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181
Query: 308 GLSDFVRPDERLNDIVGSAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPFWARTE 366
G + + DE + +V + +Y APEV L +S DVWSIG I G F
Sbjct: 182 GSATYD--DEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239
Query: 367 S----------GIF-RAVLKADPS-----FDEAPWPSLSSEAR----------------- 393
G + +++ D W SS R
Sbjct: 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQD 299
Query: 394 -------DFVKRLLNKDPRKRLTAAQALSHPWIK 420
D ++++L DP KR+T +AL HP+
Sbjct: 300 VEHERLFDLIQKMLEYDPAKRITLREALKHPFFD 333
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-34
Identities = 74/335 (22%), Positives = 116/335 (34%), Gaps = 76/335 (22%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI-PKHKMTTAIAIEDVRREVK 210
+YE+ +G G FG QVA+K+I K A +E +
Sbjct: 16 WLQERYEIVGNLGEGTFGKVVECLDHARG--KSQVALKIIRNVGKYREAARLE-----IN 68
Query: 211 ILRAL-----TGHNNLVKFFDAYEDTDNVYVVMELCEGG--ELLDRILSRGGKYTEDDAK 263
+L+ + V D + ++ + EL E L + Y +
Sbjct: 69 VLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQP--YPLPHVR 126
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD----------------ENSVLKAIDF 307
+ Q+ + + F H + H DLKPEN LF + +N+ ++ DF
Sbjct: 127 HMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 308 GLSDFVRPDERLNDIVGSAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPFWARTE 366
G + F E IV + +Y PEV L ++ DVWSIG I + G F
Sbjct: 187 GSATFD--HEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244
Query: 367 ---------------SGIFRAVLKADPSFDE-APWPSLSSEAR----------------- 393
S + K + W SS+ R
Sbjct: 245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDS 304
Query: 394 -------DFVKRLLNKDPRKRLTAAQALSHPWIKN 421
D ++R+L DP +R+T A+AL HP+
Sbjct: 305 LEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAG 339
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 72/342 (21%), Positives = 122/342 (35%), Gaps = 86/342 (25%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI-PKHKMTTAIAIEDVRREVK 210
N + + ++G G FG + + AVKV+ K T + IE
Sbjct: 32 LLNNAFLVIRKMGDGTFGRVLLCQHID---NKKYYAVKVVRNIKKYTRSAKIE-----AD 83
Query: 211 ILRAL----TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY---TEDDAK 263
IL+ + +NN+VK+ + D++ ++ E G L + + Y +D K
Sbjct: 84 ILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYE--IITRNNYNGFHIEDIK 140
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFT----------------------TKDENSV 301
I+IL + + + H DLKPEN L + +++
Sbjct: 141 LYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200
Query: 302 LKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRP 360
+K IDFG + F + I+ + Y APEV L+ + +D+WS G + L GS
Sbjct: 201 IKLIDFGCATFK--SDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL 258
Query: 361 FWARTE---------------SGIFRAVLKADPSF------DEAPWPSLSSEAR------ 393
F + K + S + WP +S
Sbjct: 259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVK 318
Query: 394 ---------------DFVKRLLNKDPRKRLTAAQALSHPWIK 420
DF+ +L DP R + A+ L H +++
Sbjct: 319 KCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-33
Identities = 82/402 (20%), Positives = 143/402 (35%), Gaps = 111/402 (27%)
Query: 118 ARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHF--ANKYELGEEVGRGHFGYTCAAK 175
+ +V ++ + + + + ++YE+ +G G +G+ C A
Sbjct: 14 SGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAY 73
Query: 176 FKKGELKGQQVAVKVIPK---HKMTTAIAIEDVRREVKILRALTGHNNLVKFFD-----A 227
K + + VA+K I + + + RE+ IL L H+++VK D
Sbjct: 74 DKL---EKRVVAIKKILRVFEDLIDCKRIL----REIAILNRL-NHDHVVKVLDIVIPKD 125
Query: 228 YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLK 287
E D +YVV+E+ + ++ TE K ++ +L V + H G++HRDLK
Sbjct: 126 VEKFDELYVVLEIADSD--FKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLK 183
Query: 288 PENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSA--------------------- 326
P N L +++ +K DFGL+ V E N + +
Sbjct: 184 PANCLV---NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQL 240
Query: 327 -------YYVAPEVL--HRSYSTEADVWSIGVI-AYILLC----------------GSRP 360
+Y APE++ +Y+ DVWSIG I A +L GS
Sbjct: 241 TGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSC 300
Query: 361 FWARTESGIFRAVLKADPSF--------------DEAPWPSLSSE-ARDFVKR------- 398
F + E +L E A+ +++
Sbjct: 301 FPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGT 360
Query: 399 ---------------LLNK----DPRKRLTAAQALSHPWIKN 421
LL + +P KR+T + L+HP+ K
Sbjct: 361 DLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-32
Identities = 77/333 (23%), Positives = 124/333 (37%), Gaps = 77/333 (23%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI-PKHKMTTAIAIEDVRREVK 210
H A +YE+ + +G+G FG A K Q VA+K++ + + A E ++
Sbjct: 94 HVAYRYEVLKVIGKGSFGQVVKAYDHK---VHQHVALKMVRNEKRFHRQAAEE-----IR 145
Query: 211 ILRAL-----TGHNNLVKFFDAYEDTDNVYVVMELCEGG--ELLDRILSRGGKYTEDDAK 263
IL L N++ + + +++ + EL EL+ + +G ++ +
Sbjct: 146 ILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG--FSLPLVR 203
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323
IL + H ++H DLKPEN L + S +K IDFG S + +R+ +
Sbjct: 204 KFAHSILQCLDALHKNRIIHCDLKPENILLKQQG-RSGIKVIDFGSSCYE--HQRVYTYI 260
Query: 324 GSAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPFWARTE---------------S 367
S +Y APEV L Y D+WS+G I LL G E
Sbjct: 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ 320
Query: 368 GIFRAVLKADPSFDEAPWP-------------------------SLSSEARDFVKRLLNK 402
+ A +A +P E+R++ L
Sbjct: 321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGC 380
Query: 403 D---------------PRKRLTAAQALSHPWIK 420
D P R+T QAL HPW++
Sbjct: 381 DDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR 413
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 38/291 (13%), Positives = 69/291 (23%), Gaps = 47/291 (16%)
Query: 126 PNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQ 185
+A P+ + P A + +Y L G A +Q
Sbjct: 11 RESSAPPDDVQLVPGARI---------ANGRYRLLIFHGGVPPLQFWQAL---DTALDRQ 58
Query: 186 VAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGE 245
VA+ + + +++ L + + + D VV E GG
Sbjct: 59 VALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVHTRAGGLVVAEWIRGGS 117
Query: 246 LLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305
L + + + A M + H GV P
Sbjct: 118 LQEVADTSP---SPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVR------------- 161
Query: 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWART 365
V D + ++ + + + D+ IG Y LL P
Sbjct: 162 -------VSIDGDV--VLAYPATMPDA------NPQDDIRGIGASLYALLVNRWPLPEAG 206
Query: 366 ESGIFRAVLKADPSFDEAPW---PSLSSEARDFVKRLLNKDPRKRLTAAQA 413
+ P + + R + D R +
Sbjct: 207 VRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-30
Identities = 68/315 (21%), Positives = 123/315 (39%), Gaps = 62/315 (19%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
L E +G+G FG +G+ +G++VAVK+ + + E+ L
Sbjct: 45 VLQESIGKGRFGEVW-----RGKWRGEEVAVKIFSSREERSWFR----EAEIYQTVMLR- 94
Query: 218 HNNLVKFFDAYEDTDNV----YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
H N++ F A + ++V + E G L D L+R T + + + + +
Sbjct: 95 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD-YLNR-YTVTVEGMIKLALSTASGL 152
Query: 274 AFCHLQ--------GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI--- 322
A H++ + HRDLK +N L +N D GL+ DI
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPN 209
Query: 323 --VGSAYYVAPEVL-------HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGI-FRA 372
VG+ Y+APEVL H AD++++G++ + + + + +
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269
Query: 373 VLKADPSFDEA-------------PWPSLSSEARDFVKRLL----NKDPRKRLTAAQA-- 413
++ +DPS +E P S EA + +++ + RLTA +
Sbjct: 270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
Query: 414 -LSHPWIKNSNDVKV 427
LS + +K+
Sbjct: 330 TLSQ--LSQQEGIKM 342
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 58/231 (25%), Positives = 95/231 (41%), Gaps = 25/231 (10%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
L E++G G FG ++ K VAVK + ++ A++D REV + +L
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD- 79
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H NL++ + T + +V EL G LLDR+ G + +Q+ + +
Sbjct: 80 HRNLIRLY-GVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV-------- 329
+ +HRDL N L ++K DFGL + ++ Y +
Sbjct: 139 SKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRALPQND-------DHYVMQEHRKVPF 188
Query: 330 ---APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
APE L R++S +D W GV + + G P+ S I + K
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-29
Identities = 61/301 (20%), Positives = 114/301 (37%), Gaps = 59/301 (19%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR-ALT 216
L E VG+G +G + +G +G+ VAVK+ + RE ++ +
Sbjct: 11 TLLECVGKGRYG-----EVWRGSWQGENVAVKIFSSRDE------KSWFRETELYNTVML 59
Query: 217 GHNNLVKFFDAYEDTDN----VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
H N++ F + + + ++++ E G L D + + +++ I +
Sbjct: 60 RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASG 117
Query: 273 VAFCHLQ--------GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI-- 322
+A H++ + HRDLK +N L +N D GL+ D+
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVGN 174
Query: 323 ---VGSAYYVAPEVL-------HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGI-FR 371
VG+ Y+APEVL D+W+ G++ + + + F
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234
Query: 372 AVLKADPSFDEA-----------PWPS--LSSEARDFVKRLL----NKDPRKRLTAAQAL 414
V+ DPSF++ P+ S + +L+ ++P RLTA +
Sbjct: 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294
Query: 415 S 415
Sbjct: 295 K 295
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-28
Identities = 59/232 (25%), Positives = 96/232 (41%), Gaps = 32/232 (13%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
LGE++GRG+FG + + + VAVK + +E +IL+ +
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADN---TLVAVKSCRETLPPDLK--AKFLQEARILKQYS- 170
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H N+V+ +Y+VMEL +GG+ L + + G + ++ + +
Sbjct: 171 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV-------- 329
+ +HRDL N L T E +VLK DFG+S Y
Sbjct: 231 SKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEADGV---------YAASGGLRQVP 278
Query: 330 ----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
APE L + YS+E+DVWS G++ + G+ P+ + V K
Sbjct: 279 VKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK 330
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 68/316 (21%), Positives = 124/316 (39%), Gaps = 64/316 (20%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR-ALT 216
++ +++G+G +G + G+ +G++VAVKV + RE +I + L
Sbjct: 40 QMVKQIGKGRYG-----EVWMGKWRGEKVAVKVFFTTEE------ASWFRETEIYQTVLM 88
Query: 217 GHNNLVKFFDA----YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
H N++ F A +Y++ + E G L D + + + ++
Sbjct: 89 RHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSG 146
Query: 273 VAFCHLQ--------GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI-- 322
+ H + + HRDLK +N L +N D GL+ D DI
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIPP 203
Query: 323 ---VGSAYYVAPEVL-------HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGI-FR 371
VG+ Y+ PEVL H AD++S G+I + + E + +
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263
Query: 372 AVLKADPSFDEA-------------PWPSLSSEARDFVKRLL----NKDPRKRLTAAQ-- 412
++ +DPS+++ P S E + +L+ +P RLTA +
Sbjct: 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323
Query: 413 -ALSHPWIKNSNDVKV 427
L+ + S D+K+
Sbjct: 324 KTLAK--MSESQDIKL 337
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 71/375 (18%), Positives = 127/375 (33%), Gaps = 118/375 (31%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIA--IEDVRREVK 210
F +Y + ++G GHF + + + VA+KV+ + E E++
Sbjct: 35 FNGRYHVIRKLGWGHFSTVWLSWDIQ---GKKFVAMKVV------KSAEHYTETALDEIR 85
Query: 211 ILRALT-------GHNNLVKFFDAYEDT----DNVYVVMELCEGGELLD-RILSRGGKYT 258
+L+++ +V+ D ++ + ++ +V E+ G LL I S
Sbjct: 86 LLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLP 144
Query: 259 EDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKD-------------------- 297
K ++ Q+L + + H + ++H D+KPEN L + +
Sbjct: 145 LPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPP 204
Query: 298 --------------------------ENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAP 331
E +K D G + + + + + Y +
Sbjct: 205 PSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA--CWVHKHFTEDIQTRQYRSL 262
Query: 332 EV-LHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFR---------AVLKADPS-- 379
EV + Y+T AD+WS +A+ L G F + R +L P
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322
Query: 380 ----------FDE----------APWPSLSS----------EAR---DFVKRLLNKDPRK 406
F + PW EA DF+ +L P K
Sbjct: 323 IVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEK 382
Query: 407 RLTAAQALSHPWIKN 421
R TAA+ L HPW+ +
Sbjct: 383 RATAAECLRHPWLNS 397
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-28
Identities = 55/225 (24%), Positives = 96/225 (42%), Gaps = 22/225 (9%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKI 211
+ ++YE+ +G+G FG A + + + VA+K+I K A + EV++
Sbjct: 51 KWMDRYEIDSLIGKGSFGQVVKAYDRV---EQEWVAIKIIKNKKAFLNQA----QIEVRL 103
Query: 212 LRAL-----TGHNNLVKFFDAYEDTDNVYVVMELCEGG--ELLDRILSRGGKYTEDDAKA 264
L + +V + +++ +V E+ +LL RG + + +
Sbjct: 104 LELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG--VSLNLTRK 161
Query: 265 VMIQILNVVAFCHLQ--GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI 322
Q+ + F ++H DLKPEN L S +K +DFG S + +R+
Sbjct: 162 FAQQMCTALLFLATPELSIIHCDLKPENILLCNPK-RSAIKIVDFGSSCQL--GQRIYQY 218
Query: 323 VGSAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPFWARTE 366
+ S +Y +PEV L Y D+WS+G I + G F E
Sbjct: 219 IQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 11/31 (35%), Positives = 18/31 (58%)
Query: 394 DFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424
D + R+L+ DP+ R+ AL H + K + D
Sbjct: 351 DLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 36/230 (15%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+G G FG G + +VA+K I + M+ ED E +++ L+
Sbjct: 11 TFVQEIGSGQFGLVH-----LGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLS 61
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H LV+ + + + +V E E G L D + ++ G + + + + + +A+
Sbjct: 62 -HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------- 329
V+HRDL N L EN V+K DFG++ FV D+ Y
Sbjct: 121 EEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ---------YTSSTGTKFP 168
Query: 330 ----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
+PEV YS+++DVWS GV+ + + G P+ R+ S + +
Sbjct: 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 36/229 (15%)
Query: 159 LGEEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
L +E+G G FG G+ KGQ VAVK+I + M+ ++ +E + + L+
Sbjct: 12 LLKELGSGQFGVVK-----LGKWKGQYDVAVKMIKEGSMSE----DEFFQEAQTMMKLS- 61
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H LVKF+ +Y+V E G LL+ + S G + + +AF
Sbjct: 62 HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV-------- 329
+HRDL N L D + +K DFG++ +V D+ Y
Sbjct: 122 SHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVLDDQ---------YVSSVGTKFPV 169
Query: 330 ---APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
APEV + YS+++DVW+ G++ + + G P+ T S + V
Sbjct: 170 KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV 218
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 51/230 (22%), Positives = 94/230 (40%), Gaps = 29/230 (12%)
Query: 158 ELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ + +G G FG + +GE VA+K + + T+ A +++ E ++ ++
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD 75
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
+ ++ + T V ++ +L G LLD + +QI + +
Sbjct: 76 -NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------- 329
+ +VHRDL N L +K DFGL+ + +E Y
Sbjct: 134 EDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEE--------KEYHAEGGKVP 182
Query: 330 ----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
A E + HR Y+ ++DVWS GV + ++ GS+P+ S I +
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 54/232 (23%), Positives = 99/232 (42%), Gaps = 36/232 (15%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+G G FG G+ +GQ VA+K+I + M+ ++ E K++ L+
Sbjct: 27 TFLKELGTGQFGVVK-----YGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLS 77
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H LV+ + ++++ E G LL+ + ++ + + + +
Sbjct: 78 -HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------- 329
+ +HRDL N L ++ V+K DFGLS +V DE Y
Sbjct: 137 ESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE---------YTSSVGSKFP 184
Query: 330 ----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
PEVL + +S+++D+W+ GV+ + I G P+ T S + +
Sbjct: 185 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 43/234 (18%), Positives = 78/234 (33%), Gaps = 31/234 (13%)
Query: 158 ELGEEVGRGHFGYTCAAKFK----KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
E +G+G F + G+L +V +KV+ K + E ++
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS---ESFFEAASMMS 67
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
L+ H +LV + D +V E + G L + V Q+ +
Sbjct: 68 KLS-HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAM 126
Query: 274 AFCHLQGVVHRDLKPENFLFTTKD-----ENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
F ++H ++ +N L ++ +K D G+S V P +
Sbjct: 127 HFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---------IL 177
Query: 329 ------VAPEVLH--RSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
V PE + ++ + D WS G + I G +P A +
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 58/229 (25%), Positives = 92/229 (40%), Gaps = 26/229 (11%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+ + +G G G C + + + VA+K + T D E I+
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL--KAGYTERQRRDFLSEASIMGQFD- 108
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H N+++ +V E E G L + + G++T ++ + + +
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS 168
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV-------- 329
G VHRDL N L D N V K DFGLS + D A Y
Sbjct: 169 DLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDP-------DAAYTTTGGKIPI 218
Query: 330 ---APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
APE + R++S+ +DVWS GV+ + +L G RP+W T + +V
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 57/242 (23%), Positives = 96/242 (39%), Gaps = 32/242 (13%)
Query: 158 ELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ ++G+G+FG ++ G+ G VAVK + + + D +RE++IL+AL
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQREIQILKAL- 81
Query: 217 GHNNLVKFFDAYEDT--DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
+ +VK+ ++ +VME G L D + + QI +
Sbjct: 82 HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME 141
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV----- 329
+ + VHRDL N L + +K DFGL+ + D+ YYV
Sbjct: 142 YLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAKLLPLDK--------DYYVVREPG 190
Query: 330 -------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADPSF 380
APE L +S ++DVWS GV+ Y + + E + P+
Sbjct: 191 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL 250
Query: 381 DE 382
Sbjct: 251 SR 252
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 6e-26
Identities = 56/229 (24%), Positives = 85/229 (37%), Gaps = 29/229 (12%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
L +G G FG + + + VAVK K T E E I++ L
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMKNLD- 71
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H ++VK + + +++MEL GEL + +QI +A+
Sbjct: 72 HPHIVKLI-GIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 130
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV-------- 329
VHRD+ N L +K DFGLS R I YY
Sbjct: 131 SINCVHRDIAVRNILV---ASPECVKLGDFGLS---R------YIEDEDYYKASVTRLPI 178
Query: 330 ---APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
+PE + R ++T +DVW V + IL G +PF+ + +
Sbjct: 179 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL 227
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 26/228 (11%)
Query: 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH 218
+ + VG G FG C+ + K K VA+K + T D E I+ H
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFD-H 105
Query: 219 NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL 278
N+++ + V +V E E G L + ++T ++ I + + +
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 279 QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV--------- 329
G VHRDL N L + N V K DFGL + D A Y
Sbjct: 166 MGYVHRDLAARNILI---NSNLVCKVSDFGLGRVLEDDP-------EAAYTTRGGKIPIR 215
Query: 330 --APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
+PE + +R +++ +DVWS G++ + ++ G RP+W + + +AV
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 59/229 (25%), Positives = 91/229 (39%), Gaps = 29/229 (12%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
ELG +G G FG + E VA+K + E +E +R
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQFD- 74
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H ++VK + V+++MELC GEL + R Q+ +A+
Sbjct: 75 HPHIVKLI-GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 133
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV-------- 329
+ VHRD+ N L + N +K DFGLS R + S YY
Sbjct: 134 SKRFVHRDIAARNVLVS---SNDCVKLGDFGLS---R------YMEDSTYYKASKGKLPI 181
Query: 330 ---APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
APE + R +++ +DVW GV + IL+ G +PF + + +
Sbjct: 182 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 59/229 (25%), Positives = 96/229 (41%), Gaps = 34/229 (14%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+L + +G+G FG G+ +G +VAVK I + E ++ L
Sbjct: 196 KLLQTIGKGEFGDVM-----LGDYRGNKVAVKCIKNDATA-----QAFLAEASVMTQLR- 244
Query: 218 HNNLVKFFDA-YEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVVAF 275
H+NLV+ E+ +Y+V E G L+D + SRG D + + + +
Sbjct: 245 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 304
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------ 329
VHRDL N L + E++V K DFGL+ + + +
Sbjct: 305 LEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLT---K------EASSTQDTGKLPVKW 352
Query: 330 -APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
APE L + +ST++DVWS G++ + I G P+ + V K
Sbjct: 353 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 401
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 51/232 (21%), Positives = 94/232 (40%), Gaps = 29/232 (12%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ + +G G FG + K + VA+K + + T+ A +++ E ++ ++
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD 75
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
+ ++ + T V ++ +L G LLD + +QI + +
Sbjct: 76 -NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------- 329
+ +VHRDL N L +K DFGL+ + +E Y
Sbjct: 134 EDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEE--------KEYHAEGGKVP 182
Query: 330 ----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
A E + HR Y+ ++DVWS GV + ++ GS+P+ S I + K
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 55/235 (23%), Positives = 96/235 (40%), Gaps = 32/235 (13%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
E +GRGHFG + K AVK + +++T + E I++ +
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFS- 84
Query: 218 HNNLVKFFDAYEDTDN-VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N++ ++ VV+ + G+L + I + T D +Q+ + +
Sbjct: 85 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 144
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------- 329
+ VHRDL N + DE +K DFGL+ R D+ YY
Sbjct: 145 ASKKFVHRDLAARNCML---DEKFTVKVADFGLA---R------DMYDKEYYSVHNKTGA 192
Query: 330 -------APEVLH-RSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
A E L + ++T++DVWS GV+ + ++ G+ P+ I +L+
Sbjct: 193 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 56/232 (24%), Positives = 95/232 (40%), Gaps = 34/232 (14%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+ ++G G +G +KK L VAVK + + M E+ +E +++ +
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTMEV----EEFLKEAAVMKEIK- 67
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVVAFC 276
H NLV+ Y++ E G LLD + + + + QI + + +
Sbjct: 68 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------- 329
+ +HRDL N L EN ++K DFGLS + D Y
Sbjct: 128 EKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDT---------YTAHAGAKFP 175
Query: 330 ----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
APE L + +S ++DVW+ GV+ + I G P+ S ++ + K
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 54/238 (22%), Positives = 94/238 (39%), Gaps = 34/238 (14%)
Query: 158 ELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
L +G G FG Y + QVAVK +P+ D E I+
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE--LDFLMEALIISKF 90
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV--MIQILNVV 273
H N+V+ + +++MEL GG+L + + ++ + A+ ++ + +
Sbjct: 91 N-HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 274 AF--CHL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
A +L +HRD+ N L T V K DFG++ R DI ++YY
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---R------DIYRASYYR 200
Query: 330 ------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
PE ++++ D WS GV+ + I G P+ +++ + V
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 58/227 (25%), Positives = 94/227 (41%), Gaps = 34/227 (14%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+L + +G+G FG G+ +G +VAVK I + E ++ L
Sbjct: 24 KLLQTIGKGEFGDVM-----LGDYRGNKVAVKCIKNDATA-----QAFLAEASVMTQLR- 72
Query: 218 HNNLVKFFDA-YEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVVAF 275
H+NLV+ E+ +Y+V E G L+D + SRG D + + + +
Sbjct: 73 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------ 329
VHRDL N L E++V K DFGL+ + + +
Sbjct: 133 LEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLT---K------EASSTQDTGKLPVKW 180
Query: 330 -APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
APE L + +ST++DVWS G++ + I G P+ + V
Sbjct: 181 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 227
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 53/223 (23%), Positives = 93/223 (41%), Gaps = 16/223 (7%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+ ++G G +G +KK VAVK + + M E+ +E +++ +
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDTMEV----EEFLKEAAVMKEIK- 274
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVVAFC 276
H NLV+ Y++ E G LLD + + + + QI + + +
Sbjct: 275 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 334
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY--VAPEVL 334
+ +HR+L N L EN ++K DFGLS + D APE L
Sbjct: 335 EKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 391
Query: 335 -HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
+ +S ++DVW+ GV+ + I G P+ S ++ + K
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 53/229 (23%), Positives = 93/229 (40%), Gaps = 27/229 (11%)
Query: 159 LGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+ +G G FG K K VA+K + T D E I+ +
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEAGIMGQFS- 104
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H+N+++ + ++ E E G L + + G+++ ++ I + +
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 164
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV-------- 329
VHRDL N L + N V K DFGLS + D A Y
Sbjct: 165 NMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDP-------EATYTTSGGKIPI 214
Query: 330 ---APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
APE + +R +++ +DVWS G++ + ++ G RP+W + + +A+
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 65/313 (20%), Positives = 110/313 (35%), Gaps = 74/313 (23%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
+ +L E +GRG +G Y KG L + VAVKV ++ E I
Sbjct: 13 DNLKLLELIGRGRYGAVY-------KGSLDERPVAVKVFSFANR------QNFINEKNIY 59
Query: 213 R-ALTGHNNLVKFFDA-----YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
R L H+N+ +F + +VME G L + + +
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLA 117
Query: 267 IQILNVVAFCHLQ---------GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE 317
+ +A+ H + + HRDL N L + DFGLS + +
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNR 174
Query: 318 RL---------NDIVGSAYYVAPEVL--------HRSYSTEADVWSIGVIAYILL---CG 357
+ VG+ Y+APEVL S + D++++G+I + +
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 358 SRPFWARTESGI-FRAVLKADPSFDE---------------APWPSLSSEARDFVKRLL- 400
P + E + F+ + P+F++ W S R + +
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 401 --NKDPRKRLTAA 411
++D RLTA
Sbjct: 295 CWDQDAEARLTAQ 307
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 56/233 (24%), Positives = 100/233 (42%), Gaps = 38/233 (16%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+L E +G G FG G G +VAVK + + M+ + E +++ L
Sbjct: 16 KLVERLGAGQFGEVW-----MGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQ 66
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVVAF 275
H LV+ + A + +Y++ E E G L+D + + G T + + QI +AF
Sbjct: 67 -HQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------ 329
+ +HRDL+ N L + K DFGL+ + +E Y
Sbjct: 125 IEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNE---------YTAREGAKF 172
Query: 330 -----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
APE + + +++ ++DVWS G++ I+ G P+ T + + + +
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-24
Identities = 53/241 (21%), Positives = 94/241 (39%), Gaps = 34/241 (14%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
L +G G FG Y + QVAVK +P+ + D E I+
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALII 128
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV--MIQIL 270
H N+V+ + ++++EL GG+L + + ++ + A+ ++ +
Sbjct: 129 SKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 271 NVVAF--CHL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSA 326
+A +L +HRD+ N L T V K DFG++ R DI +
Sbjct: 188 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---R------DIYRAG 238
Query: 327 YYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRA 372
YY PE ++++ D WS GV+ + I G P+ +++ +
Sbjct: 239 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF 298
Query: 373 V 373
V
Sbjct: 299 V 299
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 54/226 (23%), Positives = 96/226 (42%), Gaps = 30/226 (13%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
E+G G+FG ++ + K VA+KV+ + T E++ RE +I+ L + +
Sbjct: 17 ELGCGNFGSVRQGVYRMRK-KQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLD-NPYI 72
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
V+ + + +VME+ GG L ++ + + + ++ Q+ + + +
Sbjct: 73 VRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------------ 329
VHRDL N L K DFGLS + D+ +YY
Sbjct: 132 VHRDLAARNVLL---VNRHYAKISDFGLSKALGADD--------SYYTARSAGKWPLKWY 180
Query: 330 APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
APE + R +S+ +DVWS GV + L G +P+ + +
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 56/227 (24%), Positives = 93/227 (40%), Gaps = 31/227 (13%)
Query: 158 ELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ ++G GHFG ++ +G+ G+QVAVK + + I D+++E++ILR L
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--KPESGGNHIADLKKEIEILRNLY 81
Query: 217 GHNNLVKFFDA--YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
H N+VK+ + + + ++ME G L + + K +QI +
Sbjct: 82 -HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMD 140
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV----- 329
+ + VHRDL N L + +K DFGL+ + D+ YY
Sbjct: 141 YLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDK--------EYYTVKDDR 189
Query: 330 -------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTES 367
APE L + +DVWS GV + +L
Sbjct: 190 DSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALF 236
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 59/300 (19%), Positives = 102/300 (34%), Gaps = 57/300 (19%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+L E RG FG K +L + VAVK+ P EV L
Sbjct: 24 MPLQLLEVKARGRFGCVW-----KAQLLNEYVAVKIFP----IQDKQSWQNEYEVYSLPG 74
Query: 215 LTGHNNLVKFFDAYEDTDNVYV----VMELCEGGELLDRILSRGGKYTEDDAKAVMIQIL 270
+ H N+++F A + +V V + E G L D + + + ++ + +
Sbjct: 75 MK-HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETMA 131
Query: 271 NVVAFCHLQ----------GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLN 320
+A+ H + HRD+K +N L N DFGL+ +
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVL---LKNNLTACIADFGLALKFEAGKSAG 188
Query: 321 DI---VGSAYYVAPEVL------HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGI-- 369
D VG+ Y+APEVL R D++++G++ + L + +
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248
Query: 370 FRAVLKADPSFDEA-----------PWPS--LSSEARDFVKRLLNK----DPRKRLTAAQ 412
F + PS ++ + + + D RL+A
Sbjct: 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 31/211 (14%)
Query: 158 ELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ +++G+G+FG ++ + G+ VAVK + + +T + D RE++IL++L
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQ 100
Query: 217 GHNNLVKFFDA--YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
H+N+VK+ N+ ++ME G L D + + QI +
Sbjct: 101 -HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 159
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV----- 329
+ + +HRDL N L + + +K DFGL+ + D+ YY
Sbjct: 160 YLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDK--------EYYKVKEPG 208
Query: 330 -------APEVL-HRSYSTEADVWSIGVIAY 352
APE L +S +DVWS GV+ Y
Sbjct: 209 ESPIFWYAPESLTESKFSVASDVWSFGVVLY 239
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 52/211 (24%), Positives = 93/211 (44%), Gaps = 31/211 (14%)
Query: 158 ELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ +++G+G+FG ++ + G+ VAVK + + +T + D RE++IL++L
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQ 69
Query: 217 GHNNLVKFFDA--YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
H+N+VK+ N+ ++ME G L D + + QI +
Sbjct: 70 -HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 128
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV----- 329
+ + +HRDL N L + + +K DFGL+ + D+ ++
Sbjct: 129 YLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDK--------EFFKVKEPG 177
Query: 330 -------APEVL-HRSYSTEADVWSIGVIAY 352
APE L +S +DVWS GV+ Y
Sbjct: 178 ESPIFWYAPESLTESKFSVASDVWSFGVVLY 208
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 48/232 (20%), Positives = 91/232 (39%), Gaps = 29/232 (12%)
Query: 158 ELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ +G G FG + +GE V +KVI + + + V + + +L
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSGRQSFQAVTDHMLAIGSLD 73
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H ++V+ ++ +V + G LLD + G +QI + +
Sbjct: 74 -HAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL 131
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------- 329
G+VHR+L N L S ++ DFG++D + PD+ +
Sbjct: 132 EEHGMVHRNLAARNVLL---KSPSQVQVADFGVADLLPPDD--------KQLLYSEAKTP 180
Query: 330 ----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
A E + Y+ ++DVWS GV + ++ G+ P+ + + + K
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 232
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 55/243 (22%), Positives = 92/243 (37%), Gaps = 39/243 (16%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
LG +G+G FG A+ K+ + +VAVK++ K + + IE+ RE ++
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFD- 83
Query: 218 HNNLVKFF------DAYEDTDNVYVVMELCEGGELLD-----RILSRGGKYTEDDAKAVM 266
H ++ K A V++ + G+L RI M
Sbjct: 84 HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSA 326
+ I + + + +HRDL N + E+ + DFGLS R I
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCML---AEDMTVCVADFGLS---R------KIYSGD 191
Query: 327 YYV------------APEVLH-RSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRA 372
YY A E L Y+ +DVW+ GV + I+ G P+ + I+
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251
Query: 373 VLK 375
++
Sbjct: 252 LIG 254
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 57/235 (24%), Positives = 97/235 (41%), Gaps = 32/235 (13%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+G+GHFG ++ Q A+K + + T +E RE ++R L
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLN- 80
Query: 218 HNNLVKFFDAYEDTDNV-YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N++ + + +V++ G+LL I S T D + +Q+ + +
Sbjct: 81 HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------- 329
Q VHRDL N + DE+ +K DFGL+ R DI+ YY
Sbjct: 141 AEQKFVHRDLAARNCML---DESFTVKVADFGLA---R------DILDREYYSVQQHRHA 188
Query: 330 -------APEVLH-RSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
A E L ++T++DVWS GV+ + +L G+ P+ + + +
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 63/248 (25%), Positives = 104/248 (41%), Gaps = 47/248 (18%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
N + + +G G+FG A+ KK L+ A+K + ++ + D E+++L
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLR-MDAAIKRMKEY--ASKDDHRDFAGELEVLCK 81
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD-----RILSRGGKYTEDDAKAVMIQI 269
L H N++ A E +Y+ +E G LLD R+L + ++ A +
Sbjct: 82 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141
Query: 270 LNVVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL 319
++ F +L + +HRDL N L EN V K DFGLS R
Sbjct: 142 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS-------RG 191
Query: 320 NDIVGSAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWART 365
+ YV A E L + Y+T +DVWS GV+ + I+ G P+ T
Sbjct: 192 QE-----VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246
Query: 366 ESGIFRAV 373
+ ++ +
Sbjct: 247 CAELYEKL 254
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 62/235 (26%), Positives = 94/235 (40%), Gaps = 43/235 (18%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
N + G+ +G G FG A E +VAVK++ A E + E+KI+
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIM 103
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
L H N+V A V V+ E C G+LL+ + + D A A+ +
Sbjct: 104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 273 ---VAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL 319
+ F L + +HRD+ N L T V K DFGL+ R
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLA-------R- 212
Query: 320 NDIVGSAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRP 360
DI+ + Y+ APE + Y+ ++DVWS G++ + I G P
Sbjct: 213 -DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 54/235 (22%), Positives = 95/235 (40%), Gaps = 32/235 (13%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
E +GRGHFG + K AVK + +++T + E I++ +
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFS- 148
Query: 218 HNNLVKFFDAYEDTDN-VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N++ ++ VV+ + G+L + I + T D +Q+ + F
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 208
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------- 329
+ VHRDL N + DE +K DFGL+ R D+ +
Sbjct: 209 ASKKFVHRDLAARNCML---DEKFTVKVADFGLA---R------DMYDKEFDSVHNKTGA 256
Query: 330 -------APEVLH-RSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
A E L + ++T++DVWS GV+ + ++ G+ P+ I +L+
Sbjct: 257 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 311
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 57/233 (24%), Positives = 94/233 (40%), Gaps = 38/233 (16%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+L +++G G FG +VAVK + M+ E E +++ L
Sbjct: 191 KLEKKLGAGQFGEVW-----MATYNKHTKVAVKTMKPGSMSV----EAFLAEANVMKTLQ 241
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVVAF 275
H+ LVK + +Y++ E G LLD + S G QI +AF
Sbjct: 242 -HDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 299
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------ 329
+ +HRDL+ N L + V K DFGL+ + +E Y
Sbjct: 300 IEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNE---------YTAREGAKF 347
Query: 330 -----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
APE + S++ ++DVWS G++ I+ G P+ + + RA+ +
Sbjct: 348 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 51/245 (20%), Positives = 94/245 (38%), Gaps = 38/245 (15%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
N LG+ +G G FG K+ + +VAVK + K ++ IE+ E ++
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKD 92
Query: 215 LTGHNNLVKFF-----DAYEDTDNVYVVMELCEGGELLD-----RILSRGGKYTEDDAKA 264
+ H N+++ + + V++ + G+L R+ +
Sbjct: 93 FS-HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLK 151
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVG 324
M+ I + + + +HRDL N + ++ + DFGLS + I
Sbjct: 152 FMVDIALGMEYLSNRNFLHRDLAARNCML---RDDMTVCVADFGLS---K------KIYS 199
Query: 325 SAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIF 370
YY A E L R Y++++DVW+ GV + I G P+ ++
Sbjct: 200 GDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY 259
Query: 371 RAVLK 375
+L
Sbjct: 260 DYLLH 264
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 58/233 (24%), Positives = 96/233 (41%), Gaps = 38/233 (16%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
L ++G+G FG G G +VA+K + M+ E +E ++++ L
Sbjct: 187 RLEVKLGQGCFGEVW-----MGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLR 237
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVVAF 275
H LV+ + + + +Y+V E G LLD + GKY + QI + +A+
Sbjct: 238 -HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------ 329
VHRDL+ N L EN V K DFGL+ + +E Y
Sbjct: 296 VERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE---------YTARQGAKF 343
Query: 330 -----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
APE + ++ ++DVWS G++ + G P+ + V +
Sbjct: 344 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 3e-23
Identities = 70/363 (19%), Positives = 125/363 (34%), Gaps = 52/363 (14%)
Query: 29 ANGTPIPAPSPLNAESQSNNNRTNVKGNDDAVIEGKKSPFFPFYSPSPAHYFFSKKSSPA 88
GT L + + + + PAH P
Sbjct: 224 PEGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLT--HPQ 281
Query: 89 RSSANSTPNRFFKRPFPPPSPAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFG 148
R + + P SP K P + ++ E +P +K
Sbjct: 282 RRIDTLNSDGYTPEPARITSPDKP----------RPMPMDTSVFESPFSDPEELKDKKLF 331
Query: 149 FSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQ----QVAVKVIPKHKMTTAIAIED 204
+ N E+G G+FG +G + + VA+KV+ + T E+
Sbjct: 332 LKRD--NLLIADIELGCGNFGSVR-----QGVYRMRKKQIDVAIKVL--KQGTEKADTEE 382
Query: 205 VRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKA 264
+ RE +I+ L + +V+ + + +VME+ GG L ++ + + +
Sbjct: 383 MMREAQIMHQLD-NPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE 440
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVG 324
++ Q+ + + + VHR+L N L K DFGLS + D+
Sbjct: 441 LLHQVSMGMKYLEEKNFVHRNLAARNVLL---VNRHYAKISDFGLSKALGADD------- 490
Query: 325 SAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIF 370
+YY APE + R +S+ +DVWS GV + L G +P+ +
Sbjct: 491 -SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 549
Query: 371 RAV 373
+
Sbjct: 550 AFI 552
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 4e-23
Identities = 59/229 (25%), Positives = 92/229 (40%), Gaps = 29/229 (12%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
ELG +G G FG + E VA+K T+ E +E +R
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--KNCTSDSVREKFLQEALTMRQFD- 449
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H ++VK + + V+++MELC GEL + R Q+ +A+
Sbjct: 450 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV-------- 329
+ VHRD+ N L + N +K DFGLS + S YY
Sbjct: 509 SKRFVHRDIAARNVLVS---SNDCVKLGDFGLSR---------YMEDSTYYKASKGKLPI 556
Query: 330 ---APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
APE + R +++ +DVW GV + IL+ G +PF + + +
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 5e-23
Identities = 52/229 (22%), Positives = 98/229 (42%), Gaps = 30/229 (13%)
Query: 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH 218
+E+G G+FG ++ + + VAVK++ K++ +++ E +++ L +
Sbjct: 21 EDKELGSGNFGTVKKGYYQ-MKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLD-N 77
Query: 219 NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL 278
+V+ + ++ +VME+ E G L L + + + ++ Q+ + +
Sbjct: 78 PYIVRMI-GICEAESWMLVMEMAELGPLNKY-LQQNRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 279 QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV--------- 329
VHRDL N L K DFGLS +R DE YY
Sbjct: 136 SNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADE--------NYYKAQTHGKWPV 184
Query: 330 ---APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
APE + + +S+++DVWS GV+ + G +P+ S + +
Sbjct: 185 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 62/240 (25%), Positives = 100/240 (41%), Gaps = 46/240 (19%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
++ +LG+ +GRG FG A + VAVK++ + T + E+KIL
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKIL 84
Query: 213 RALTGHNNLVKFFDAYEDTDN-VYVVMELCEGGELLD-----RILSRGGKYTEDDAKAVM 266
+ H N+V A + V++E C+ G L R K +D
Sbjct: 85 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 267 IQILNVVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316
+ + +++ + L + +HRDL N L + E +V+K DFGL+
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLA------ 195
Query: 317 ERLNDIVGSAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFW 362
R DI YV APE + R Y+ ++DVWS GV+ + I G+ P+
Sbjct: 196 -R--DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 58/239 (24%), Positives = 91/239 (38%), Gaps = 47/239 (19%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
N+ G+ +G G FG A VAVK++ E + E+K+L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVL 80
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD-------RILSRGGKYTEDDAKAV 265
L H N+V A V+ E C G+LL+ + + +
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 266 MIQILNVVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
+ + ++++F L + +HRDL N L T + K DFGL+ R
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFGLA---R- 193
Query: 316 DERLNDIVGSAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRP 360
DI + YV APE + + Y+ E+DVWS G+ + + GS P
Sbjct: 194 -----DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 58/233 (24%), Positives = 96/233 (41%), Gaps = 38/233 (16%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
L ++G+G FG G G +VA+K + M+ E +E ++++ L
Sbjct: 270 RLEVKLGQGCFGEVW-----MGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLR 320
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVVAF 275
H LV+ + + + +Y+V E G LLD + GKY + QI + +A+
Sbjct: 321 -HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 378
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------ 329
VHRDL+ N L EN V K DFGL+ + +E Y
Sbjct: 379 VERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE---------YTARQGAKF 426
Query: 330 -----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
APE + ++ ++DVWS G++ + G P+ + V +
Sbjct: 427 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 54/246 (21%), Positives = 99/246 (40%), Gaps = 40/246 (16%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
K + E+G+G FG Y AK + +VA+K + + + + E ++
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVM 82
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKA-------- 264
+ +++V+ V+MEL G+L + S + A
Sbjct: 83 KEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 265 -VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323
+ +I + +A+ + VHRDL N + E+ +K DFG++ R DI
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT---R------DIY 189
Query: 324 GSAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGI 369
+ YY +PE L ++T +DVWS GV+ + I +P+ + +
Sbjct: 190 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 249
Query: 370 FRAVLK 375
R V++
Sbjct: 250 LRFVME 255
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 3e-22
Identities = 51/239 (21%), Positives = 84/239 (35%), Gaps = 46/239 (19%)
Query: 158 ELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
EE+G FG Y + Q VA+K + E+ R E + L
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK--AEGPLREEFRHEAMLRARL 69
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD--RILSRGGKYTEDDAKAVMIQILNVV 273
H N+V + ++ C G+L + + S D + L
Sbjct: 70 Q-HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 274 AFCHL-------------QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLN 320
F HL VVH+DL N L + +K D GL R
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY---DKLNVKISDLGLF-------R-- 176
Query: 321 DIVGSAYYV------------APE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPFWART 365
++ + YY APE +++ +S ++D+WS GV+ + + G +P+ +
Sbjct: 177 EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 235
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 55/234 (23%), Positives = 84/234 (35%), Gaps = 35/234 (14%)
Query: 158 ELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+ ++G GHFG + G+ VAVK + ++E+ ILR L
Sbjct: 34 KKIRDLGEGHFGKVSLYCYD-PTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTL 90
Query: 216 TGHNNLVKFFDA--YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
H +++K+ ++ +VME G L D + QI +
Sbjct: 91 Y-HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGM 147
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV---- 329
A+ H Q +HRDL N L + ++K DFGL+ V YY
Sbjct: 148 AYLHAQHYIHRDLAARNVLLD---NDRLVKIGDFGLAKAVPEGHE--------YYRVRED 196
Query: 330 --------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
APE L + +DVWS GV Y +L T+ +
Sbjct: 197 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A Length = 191 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-21
Identities = 40/209 (19%), Positives = 76/209 (36%), Gaps = 43/209 (20%)
Query: 414 LSHPWIKNSNDV-KVPLDVIIFKLMKAYMRSSSLRKAALRALSKTLTVDELFYLKEQYAL 472
+ H +S + + + K Y +K A+ +++ ++ LK + +
Sbjct: 1 MHHHHHHSSGRENLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLV 60
Query: 473 LEPNKNGTISLENVKSALMK-------------NATDAMKDSRIPDFLSSLNSLQYRRMD 519
L+ + G I+ E +K L K + D+ +I D
Sbjct: 61 LDEDGKGYITKEQLKKGLEKDGLKLPYNFDLLLDQIDSDGSGKI---------------D 105
Query: 520 FEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVPVHAV 578
+ EF AAAL QL ++ CA+ +F+ D + I ELA L +
Sbjct: 106 YTEFIAAALDRKQLS-----KKLIYCAFRVFDVDNDGEITTAELAHILYNGNKKGNITQR 160
Query: 579 LHDWIRHT--------DGKLSFLGFVKLL 599
+ ++ DGK+ F F +++
Sbjct: 161 DVNRVKRMIRDVDKNNDGKIDFHEFSEMM 189
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 60/232 (25%), Positives = 93/232 (40%), Gaps = 51/232 (21%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
E G+ +G G FG A QVAVK++ + + E + E+K++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSEREALMSELKMM 102
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD------------RILSRGGKYTED 260
L H N+V A + +Y++ E C G+LL+ I K E+
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 261 DAKAVMIQILNVVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310
+ ++ +++ F L + VHRDL N L T V+K DFGL+
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLA 219
Query: 311 DFVRPDERLNDIVGSAYYV------------APEVL-HRSYSTEADVWSIGV 349
R DI+ + YV APE L Y+ ++DVWS G+
Sbjct: 220 ---R------DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI 262
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-21
Identities = 63/256 (24%), Positives = 101/256 (39%), Gaps = 48/256 (18%)
Query: 142 GLNKSFGFSKHFA-NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTT 198
G S +H L E+G G FG + VAVK + +
Sbjct: 1 GAMHSGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA- 59
Query: 199 AIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD-----RILSR 253
A +D +RE ++L L H ++VKF+ D D + +V E + G+L +
Sbjct: 60 --ARKDFQREAELLTNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAM 116
Query: 254 GGKYTEDDAKAVMIQILNVVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLK 303
+ + + ++ +L Q VHRDL N L N ++K
Sbjct: 117 ILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---ANLLVK 173
Query: 304 AIDFGLSDFVRPDERLNDIVGSAYYV------------APEVL-HRSYSTEADVWSIGVI 350
DFG+S R D+ + YY PE + +R ++TE+DVWS GVI
Sbjct: 174 IGDFGMS-------R--DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVI 224
Query: 351 AY-ILLCGSRPFWART 365
+ I G +P++ +
Sbjct: 225 LWEIFTYGKQPWFQLS 240
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 60/227 (26%), Positives = 94/227 (41%), Gaps = 46/227 (20%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQ--QVAVKVIPKHKMTTAIAIEDVRREVK 210
+K LG+ +G G FG A + + VAVK++ T + D+ E++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEME 92
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD-----RILSRGGKYTEDDAKAV 265
+++ + H N++ A +YV++E G L + R Y +
Sbjct: 93 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 266 MIQILNVVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
+ ++V+ +L Q +HRDL N L T EN+V+K DFGL+ R
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLA---R- 205
Query: 316 DERLNDIVGSAYYV------------APEVL-HRSYSTEADVWSIGV 349
DI YY APE L R Y+ ++DVWS GV
Sbjct: 206 -----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 247
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 5e-21
Identities = 62/252 (24%), Positives = 104/252 (41%), Gaps = 47/252 (18%)
Query: 155 NKYELGEEVGRGHFG--YTCAAK--FKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
++ LG+ +G G FG A K + +VAVK++ T + D+ E++
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEME 126
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD-----RILSRGGKYTEDDAKAV 265
+++ + H N++ A +YV++E G L + R Y
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 266 MIQILNVVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
+ ++V+ +L + +HRDL N L T E++V+K DFGL+ R
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLA---R- 239
Query: 316 DERLNDIVGSAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPF 361
DI YY APE L R Y+ ++DVWS GV+ + I G P+
Sbjct: 240 -----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 294
Query: 362 WARTESGIFRAV 373
+F+ +
Sbjct: 295 PGVPVEELFKLL 306
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 7e-21
Identities = 60/227 (26%), Positives = 94/227 (41%), Gaps = 46/227 (20%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQ--QVAVKVIPKHKMTTAIAIEDVRREVK 210
+K LG+ +G G FG A + + VAVK++ T + D+ E++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEME 138
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD-----RILSRGGKYTEDDAKAV 265
+++ + H N++ A +YV++E G L + R Y +
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 266 MIQILNVVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
+ ++V+ +L Q +HRDL N L T EN+V+K DFGL+ R
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLA---R- 251
Query: 316 DERLNDIVGSAYYV------------APEVL-HRSYSTEADVWSIGV 349
DI YY APE L R Y+ ++DVWS GV
Sbjct: 252 -----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 293
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 58/258 (22%), Positives = 99/258 (38%), Gaps = 54/258 (20%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
LG+ +G G FG A KG VAVK++ ++ + + D+ E +L
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVL 80
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD-------------RILSRGGKYTE 259
+ + H +++K + A + +++E + G L +
Sbjct: 81 KQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 260 DDAKAVMIQILNVVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309
D + + ++++F +L +VHRDL N L E +K DFGL
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA---EGRKMKISDFGL 196
Query: 310 SDFVRPDERLNDIVGSAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILL 355
S R D+ YV A E L Y+T++DVWS GV+ + I+
Sbjct: 197 S---R------DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
Query: 356 CGSRPFWARTESGIFRAV 373
G P+ +F +
Sbjct: 248 LGGNPYPGIPPERLFNLL 265
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 60/238 (25%), Positives = 97/238 (40%), Gaps = 46/238 (19%)
Query: 158 ELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
L E+G G FG + E VAVK + + + A +D +RE ++L L
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES---ARQDFQREAELLTML 100
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD----RILSRGGKYTEDDAKAVMIQILN 271
H ++V+FF + + +V E G+L +D + +
Sbjct: 101 Q-HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159
Query: 272 VVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND 321
++A +L VHRDL N L + V+K DFG+S R D
Sbjct: 160 LLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QGLVVKIGDFGMS-------R--D 207
Query: 322 IVGSAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWART 365
I + YY PE + +R ++TE+DVWS GV+ + I G +P++ +
Sbjct: 208 IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} Length = 197 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 3e-20
Identities = 37/197 (18%), Positives = 79/197 (40%), Gaps = 15/197 (7%)
Query: 412 QALSHPWIKNSNDV--KVPLDVIIFKLMKAYMRSSSLRKAALRALSKTLTVDELFYLKEQ 469
H + + V L + K +K + + + L+K AL ++K L E+ L+
Sbjct: 3 HHHHHSSGRENLYFQGHVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRNI 62
Query: 470 YALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALS 529
+ L+ + +GT+S + + L K I L ++S ++ + +F AA +
Sbjct: 63 FIALDVDNSGTLSSQEILDGLKKIGYQ-KIPPDIHQVLRDIDSNASGQIHYTDFLAATID 121
Query: 530 VHQLEALDRWEQHARCAYELFEKDGNRAIVIEELA---SELGLGPAVPVHAVLHDWIRHT 586
++ ++ F+ DGN I +EEL + + + ++
Sbjct: 122 KQTYLK----KEVCLIPFKFFDIDGNGKISVEELKRIFGRDDIENPLI-DKAIDSLLQEV 176
Query: 587 D----GKLSFLGFVKLL 599
D G++ F F+ ++
Sbjct: 177 DLNGDGEIDFHEFMLMM 193
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 6e-19
Identities = 54/247 (21%), Positives = 89/247 (36%), Gaps = 54/247 (21%)
Query: 158 ELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
E ++G G FG + A VAVK++ + +A D +RE ++
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEF 107
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD-------------RILSRGGKYTEDDA 262
+ N+VK + ++ E G+L + +
Sbjct: 108 -DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 263 KAVMIQILNVVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312
+ + +L + VHRDL N L EN V+K DFGLS
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLS-- 221
Query: 313 VRPDERLNDIVGSAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGS 358
R +I + YY PE + + Y+TE+DVW+ GV+ + I G
Sbjct: 222 -R------NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274
Query: 359 RPFWART 365
+P++
Sbjct: 275 QPYYGMA 281
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 49/224 (21%), Positives = 98/224 (43%), Gaps = 27/224 (12%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKV-IPKHKMTTAIAIEDVRREVKI 211
+ +G+++G G+FG K + VA+K+ K + + E +
Sbjct: 7 VGPNFRVGKKIGCGNFGELRLGKNLY---TNEYVAIKLEPMKSRAPQ------LHLEYRF 57
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
+ L + + + + +V+EL G L D ++ + IQ+++
Sbjct: 58 YKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLIS 116
Query: 272 VVAFCHLQGVVHRDLKPENFLF---TTKDENSVLKAIDFGLS-DFVRPDERL-------N 320
+ + H + +++RD+KPENFL K + V+ IDF L+ +++ P+ +
Sbjct: 117 RMEYVHSKNLIYRDVKPENFLIGRPGNKTQQ-VIHIIDFALAKEYIDPETKKHIPYREHK 175
Query: 321 DIVGSAYYVAPEV-LHRSYSTEADVWSIG-VIAYILLCGSRPFW 362
+ G+A Y++ L + S D+ ++G + Y L GS P W
Sbjct: 176 SLTGTARYMSINTHLGKEQSRRDDLEALGHMFMY-FLRGSLP-W 217
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 23/221 (10%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKV-IPKHKMTTAIAIEDVRREVKI 211
N+Y LG ++G G FG G++VA+K+ K K + E KI
Sbjct: 7 VGNRYRLGRKIGSGSFGDIYLGTDIAA---GEEVAIKLECVKTKHPQ------LHIESKI 57
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
+ + G + + D +VMEL G L D K++ + Q+++
Sbjct: 58 YKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMIS 116
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR--------PDERLNDIV 323
+ + H + +HRD+KP+NFL + +++ IDFGL+ R P ++
Sbjct: 117 RIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 176
Query: 324 GSAYYVAPEV-LHRSYSTEADVWSIG-VIAYILLCGSRPFW 362
G+A Y + L S D+ S+G V+ Y GS P W
Sbjct: 177 GTARYASINTHLGIEQSRRDDLESLGYVLMY-FNLGSLP-W 215
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 25/223 (11%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIP-KHKMTTAIAIEDVRREVKI 211
Y++G +G G FG QQVA+K P + +R E +
Sbjct: 8 VGVHYKVGRRIGEGSFGVIFEGTNLLN---NQQVAIKFEPRRSDAPQ------LRDEYRT 58
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
+ L G + + ++ + +V++L G L D + G K++ Q+L
Sbjct: 59 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLA 117
Query: 272 VVAFCHLQGVVHRDLKPENFLF---TTKDENSVLKAIDFGLS-DFVRPDERL-------N 320
V H + +V+RD+KP+NFL +K+ N + +DFG+ + P +
Sbjct: 118 RVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIY-VVDFGMVKFYRDPVTKQHIPYREKK 176
Query: 321 DIVGSAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPFW 362
++ G+A Y++ L R S D+ ++G + L GS P W
Sbjct: 177 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP-W 218
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 50/239 (20%), Positives = 90/239 (37%), Gaps = 42/239 (17%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
N++ LG+++G G FG A K + VKV + + E+K
Sbjct: 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP-------LFSELKFY 87
Query: 213 RALTGHNNLVKFFD------------------AYEDTDNVYVVMELCEGGELLDRILSRG 254
+ + + + K+ + ++ ++VME G L +I +
Sbjct: 88 QRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQN 145
Query: 255 GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314
G + + + I++L+V+ + H VH D+K N L K+ + V D+GLS
Sbjct: 146 GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY-LADYGLSYRYC 204
Query: 315 PDERLNDI--------VGSAYYVAPEVLHRSY--STEADVWSIG-VIAYILLCGSRPFW 362
P+ G+ + H+ S +DV +G + LCG P W
Sbjct: 205 PNGNHKQYQENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILGYCMLR-WLCGKLP-W 260
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 42/244 (17%), Positives = 85/244 (34%), Gaps = 49/244 (20%)
Query: 153 FANKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIP-KHKMTTAIAIEDVRREV 209
A +++G +G+G FG Y + VKV P + + E+
Sbjct: 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG--------PLFTEL 84
Query: 210 KILRALTGHNNL----------------VKFFDAYEDTDNVY--VVMELCEGGELLDRIL 251
K + + ++ Y ++M+ G +L
Sbjct: 85 KFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYE 143
Query: 252 SRGGKYTEDDAKAVM---IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308
+ +++ K V+ ++IL+++ + H VH D+K N L K+ + V +D+G
Sbjct: 144 ANAKRFSR---KTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVY-LVDYG 199
Query: 309 LSDFVRPDERLNDI--------VGSAYYVAPEV-LHRSYSTEADVWSIG-VIAYILLCGS 358
L+ P+ G+ + + + + S D+ +G + L G
Sbjct: 200 LAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQ-WLTGH 258
Query: 359 RPFW 362
P W
Sbjct: 259 LP-W 261
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 81.2 bits (200), Expect = 2e-16
Identities = 60/219 (27%), Positives = 91/219 (41%), Gaps = 21/219 (9%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIP-KHKMTTAIAIEDVRREVKIL 212
NK+ LG ++G G FG + ++VA+K+ K K + E KI
Sbjct: 6 GNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTKHPQ------LLYESKIY 56
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
R L G + + D +VM+L G L D K + + Q++N
Sbjct: 57 RILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR--------PDERLNDIVG 324
V F H + +HRD+KP+NFL + + IDFGL+ R P ++ G
Sbjct: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
Query: 325 SAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPFW 362
+A Y + L S D+ S+G + L GS P W
Sbjct: 176 TARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-W 213
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} Length = 180 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 8e-16
Identities = 29/142 (20%), Positives = 61/142 (42%), Gaps = 10/142 (7%)
Query: 429 LDVIIFKLMKAYMRSSSLRKAALRALSKTLTV--DELFYLKEQYALLEPNKNGTISLENV 486
+ + MK+YM+ S++R + ++ L+V + + Y+ E + L+ N NG++S +
Sbjct: 2 ISPNVLNNMKSYMKHSNIRNIIINIMAHELSVINNHIKYINELFYKLDTNHNGSLSHREI 61
Query: 487 KSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCA 546
+ L +K I L +L+ + + EF A +E + A
Sbjct: 62 YTVLASV---GIKKWDINRILQALDINDRGNITYTEFMAGCYRWKNIE-----STFLKAA 113
Query: 547 YELFEKDGNRAIVIEELASELG 568
+ +KD + I ++ S +
Sbjct: 114 FNKIDKDEDGYISKSDIVSLVH 135
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 28/219 (12%), Positives = 68/219 (31%), Gaps = 18/219 (8%)
Query: 385 WPSLSSEARDFVKRL--LNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMR 442
++ + ++ +L ++ + A + D + L+K
Sbjct: 43 EAQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAARGD-AAAEKQRLASLLKDLED 101
Query: 443 SSSLRKAALRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSR 502
+S LR L+ ++ L++ + + +G S +++K + D + +
Sbjct: 102 DAS-GYNRLRPSKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQV-LAKYADTIPEGP 159
Query: 503 IPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEE 562
+ + + RM + A A + L A + + + N + +E
Sbjct: 160 LKKLFVMVENDTKGRMSYITLVAVANDLAALVA----------DFRKIDTNSNGTLSRKE 209
Query: 563 LA---SELGLGPAVPVHAVLHDWIRHTDGKLSFLGFVKL 598
LG A+ + F +V L
Sbjct: 210 FREHFVRLGFDKKSVQDALFRYADEDESDDVGFSEYVHL 248
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 21/142 (14%), Positives = 36/142 (25%), Gaps = 43/142 (30%)
Query: 476 NKNGTISLENVKSALMK-------------NATDAMKDSRIPDFLSSLNSLQYRRMDFEE 522
N NGT+S + + ++ D + + F E
Sbjct: 200 NSNGTLSRKEFREHFVRLGFDKKSVQDALFRYADEDESDDV---------------GFSE 244
Query: 523 FCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVPVHAVLHD 581
+ L + L Y + D + + EE+ L
Sbjct: 245 YVHLGLCLLVLRI----------LYAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEH 294
Query: 582 WIRHTD----GKLSFLGFVKLL 599
D LS+ FV L+
Sbjct: 295 QFSVVDVDDSKSLSYQEFVMLV 316
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 7e-15
Identities = 70/325 (21%), Positives = 107/325 (32%), Gaps = 84/325 (25%)
Query: 133 EGSEPEPAAGLNKSFGFS------KHFANKYELGEE--VGRGHFG--YTCAAKFKKGELK 182
E E + SF F +F + +G G FG Y KG +
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVY-------KGYVN 53
Query: 183 GQQVAVKVIPKHKMTTAIAIEDV------RREVKILRALTGHNNLVKFFDAYEDTDN--- 233
VAVK K+ + I +E+K++ H NLV+ + +
Sbjct: 54 NTTVAVK-----KLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELL-GFSSDGDDLC 106
Query: 234 -VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV---VAFCHLQGVVHRDLKPE 289
VY G LLDR+ G I + F H +HRD+K
Sbjct: 107 LVY---VYMPNGSLLDRLSCLDGTPPLSWHMRCKI-AQGAANGINFLHENHHIHRDIKSA 162
Query: 290 NFLFTTKDENSVLKAIDFGLSDFVRPDERLND----------IVGSAYYVAPEVLHRSYS 339
N L DE K DFGL+ R ++ IVG+ Y+APE L +
Sbjct: 163 NILL---DEAFTAKISDFGLA-------RASEKFAQTVMTSRIVGTTAYMAPEALRGEIT 212
Query: 340 TEADVWSIGVIAYILLCGSRPF-----------WAR---TESGIFRAVLKADPSFDEAPW 385
++D++S GV+ ++ G E D ++A
Sbjct: 213 PKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY--IDKKMNDAD- 269
Query: 386 PSLSSEARDFVK---RLLNKDPRKR 407
S+ + L++ KR
Sbjct: 270 ---STSVEAMYSVASQCLHEKKNKR 291
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 42/234 (17%), Positives = 77/234 (32%), Gaps = 33/234 (14%)
Query: 155 NKYELGEEVGRGHFG-----YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR-- 207
+++L R + G + + Q+ ++K+ K R
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 208 --EVKILRALTGHNNL----VKFFDAYEDTDNVYVVMELCEGGELLDRIL--SRGGKYTE 259
+V + L L F ++D ++V+ G L L S +E
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYR-FLVLPSL--GRSLQSALDVSPKHVLSE 158
Query: 260 DDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD--- 316
V ++L+ + F H VH ++ EN +D++ V +G + P
Sbjct: 159 RSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVT-LAGYGFAFRYCPSGKH 217
Query: 317 ----ERLND-IVGSAYYVAPEVLHRSY--STEADVWSIG-VIAYILLCGSRPFW 362
E G + LH+ S +D+ S+G + L G P W
Sbjct: 218 VAYVEGSRSPHEGDLEF-ISMDLHKGCGPSRRSDLQSLGYCMLK-WLYGFLP-W 268
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} Length = 191 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-14
Identities = 34/188 (18%), Positives = 67/188 (35%), Gaps = 23/188 (12%)
Query: 428 PLDVIIFKLMKAYMRSSSLRKAALRALSKTL-TVDELFYLKEQYALLEPNKNGTISLENV 486
MK + S L +AA+ + L T++E L + + L+ N +G + + +
Sbjct: 3 HALTGALGNMKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKEL 62
Query: 487 KSALMKNATDAMKDSRIPDFLSSLNSLQYRRM------------DFEEFCAAALSVHQLE 534
K D + + ++ EF + L
Sbjct: 63 IEGYRKLMQWKGDTVSDLDSSQIEAEVD--HILQSVDFDRNGYIEYSEFVTVCMDKQLLL 120
Query: 535 ALDRWEQHARCAYELFEKDGNRAIVIEEL---ASELGLGPAVPVHAVLHDWIRHTDGKLS 591
+ + A++ F+ DG+ I EEL + H VL + ++ DG++
Sbjct: 121 S----RERLLAAFQQFDSDGSGKITNEELGRLFGVTEVDDET-WHQVLQECDKNNDGEVD 175
Query: 592 FLGFVKLL 599
F FV+++
Sbjct: 176 FEEFVEMM 183
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} Length = 166 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 6e-14
Identities = 44/165 (26%), Positives = 87/165 (52%), Gaps = 17/165 (10%)
Query: 446 LRKAALRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPD 505
+K ALR ++++L+ +E+ LKE + +++ +K+G I+ E +K+ +K +K+S I D
Sbjct: 9 FKKMALRVIAESLSEEEIAGLKEMFNMIDADKSGQITFEELKAG-LKRVGANLKESEILD 67
Query: 506 FLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEEL-- 563
+ + + +D++EF AA L ++++E E H A+ F+KDG+ I +EL
Sbjct: 68 LMQAADVDNSGTIDYKEFIAATLHLNKIER----EDHLFAAFTYFDKDGSGYITPDELQQ 123
Query: 564 -ASELGLGPAVPVHAVLHDWIRHTD----GKLSFLGFVKLLHGVS 603
E G+ + + +R D G++ + FV ++ S
Sbjct: 124 ACEEFGVE-----DVRIEELMRDVDQDNDGRIDYNEFVAMMQKGS 163
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} Length = 219 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 4e-13
Identities = 27/173 (15%), Positives = 49/173 (28%), Gaps = 22/173 (12%)
Query: 443 SSSLRKAALR----ALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAM 498
+ RK A A+ + T + E + + N+ G + + V S ++
Sbjct: 23 KAKDRKEAWERIRQAIPREKTAEAKQRRIELFKKFDKNETGKLCYDEVYSGCLEVLKLDE 82
Query: 499 KDSRIPDFLSSLNSLQYRRM---------DFEEFCAAALSVHQLEALDRWEQHARCAYEL 549
SR+ D DF EF L + + ++
Sbjct: 83 FTSRVRDITKRAFDKSRTLGSKLENKGSEDFVEFLEFRLMLCYIYD----FFELTVMFDE 138
Query: 550 FEKDGNRAIVIEELASELG-LGPAVPVHAVLHDWIRHTD----GKLSFLGFVK 597
+ GN + EE + L + D G ++F F
Sbjct: 139 IDASGNMLVDEEEFKRAVPKLEAWGAKVEDPAALFKELDKNGTGSVTFDEFAA 191
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.5 bits (169), Expect = 5e-13
Identities = 49/318 (15%), Positives = 97/318 (30%), Gaps = 74/318 (23%)
Query: 149 FSKHFA-NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTA-----I 200
FS K + E++G G FG + + VA+K+I
Sbjct: 13 FSHCLPTEKLQRCEKIGEGVFGEVF-------QTIADHTPVAIKIIAIEGPDLVNGSHQK 65
Query: 201 AIEDVRREVKILRALTGHNN-------------------------LVKFFDAYEDT---- 231
E++ E+ I + L+ + L+K +D Y T
Sbjct: 66 TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125
Query: 232 ---------DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GV 281
D +++V+E GG L+++ ++ + AK+++ Q+ +A
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK--LSSLATAKSILHQLTASLAVAEASLRF 183
Query: 282 VHRDLKPENFLFTT--------KDENSVLKAIDFGLS----DFVRP-DERLNDIVGSAYY 328
HRDL N L GL D+ ER +V
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVS 243
Query: 329 VAPEVLHRSYSTEADVWSI-GVIAYILLCGSRP----FWARTESGIFRAVLKADPSFDEA 383
+ ++ + D++ + P W + + +
Sbjct: 244 MDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTP 303
Query: 384 PWPSLSSEARDFVKRLLN 401
+ + ++F + +LN
Sbjct: 304 AMKQIKRKIQEFHRTMLN 321
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 5e-11
Identities = 62/297 (20%), Positives = 106/297 (35%), Gaps = 73/297 (24%)
Query: 125 KPNEAAIPEGSEPEPAAGLNKSFGFS------KHFANKYELGEEVGRGHFG--YTCAAKF 176
K + S + +F +K+ +G G FG Y
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGH----GVFGKVY------ 56
Query: 177 KKGELK-GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235
KG L+ G +VA+K ++ IE+ E++ L H +LV ++ + +
Sbjct: 57 -KGVLRDGAKVALKRR---TPESSQGIEEFETEIETLSFCR-HPHLVSLIGFCDERNEMI 111
Query: 236 VVMELCEGGELLDRILSRGGKYTEDD-----------AKAVMIQILNVVAFCHLQGVVHR 284
++ + E G L + A+ + + H + ++HR
Sbjct: 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL--------HYLHTRAIIHR 163
Query: 285 DLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDE-----RLNDIVGSAYYVAPEVLHRSY 338
D+K N L DEN V K DFG+S D+ + G+ Y+ PE +
Sbjct: 164 DVKSINILL---DENFVPKITDFGISKKGTELDQTHLSTV---VKGTLGYIDPEYFIKGR 217
Query: 339 STE-ADVWSIGVIAYILLCGSRPF-------------WART--ESGIFRAVLKADPS 379
TE +DV+S GV+ + +LC WA +G + DP+
Sbjct: 218 LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI--VDPN 272
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 2e-10
Identities = 64/250 (25%), Positives = 98/250 (39%), Gaps = 37/250 (14%)
Query: 131 IPEGSEPEPAAGLNKSFGFS------KHFANKYELGEEVGRGHFG--YTCAAKFKKGELK 182
+P +PE G K F +F+NK LG G FG Y KG L
Sbjct: 4 VPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGR----GGFGKVY-------KGRLA 52
Query: 183 -GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELC 241
G VAVK + K + T ++ + EV+++ H NL++ +V
Sbjct: 53 DGTLVAVKRL-KEERTQGGELQ-FQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPYM 109
Query: 242 EGGELLDRILSRGGKYTEDDAKAVMIQILNV---VAFCHLQG---VVHRDLKPENFLFTT 295
G + + R D L +A+ H ++HRD+K N L
Sbjct: 110 ANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL-- 167
Query: 296 KDENSVLKAIDFGLSDFVRPDERLN---DIVGSAYYVAPEVLHRSYSTE-ADVWSIGVIA 351
DE DFGL+ + + + + G+ ++APE L S+E DV+ GV+
Sbjct: 168 -DEEFEAVVGDFGLAKLM-DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 225
Query: 352 YILLCGSRPF 361
L+ G R F
Sbjct: 226 LELITGQRAF 235
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* Length = 195 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 1e-09
Identities = 26/175 (14%), Positives = 51/175 (29%), Gaps = 26/175 (14%)
Query: 447 RKAALRALSKTLTVDELFYLKEQYALLEPNKNGTISLE----NVKSALMK----NATDA- 497
K A++ + + K + L+ N NG I+L+ +
Sbjct: 3 SKYAVKLKTDFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTK 62
Query: 498 MKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDR-------WEQHARCAYELF 550
+ F + + F +F + E + +++F
Sbjct: 63 RHQVCVEAFFRGCGMEYGKEIAFPQFLDGWKQLATSELKKWARNEPTLIREWGDAVFDIF 122
Query: 551 EKDGNRAIVIEEL---ASELGLGPAVPVHAVLHDWIRHTD----GKLSFLGFVKL 598
+KDG+ I ++E G+ P+ RH D G L +
Sbjct: 123 DKDGSGTITLDEWKAYGKISGISPSQ---EDCEATFRHCDLDNAGDLDVDEMTRQ 174
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 188 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 1e-08
Identities = 35/152 (23%), Positives = 78/152 (51%), Gaps = 17/152 (11%)
Query: 455 SKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQ 514
++ L+ +E+ LKE + +++ + +GTI+ + +K +K + +S I D + + + +
Sbjct: 1 AERLSEEEIGGLKELFKMIDTDNSGTITFDELKDG-LKRVGSELMESEIKDLMDAADIDK 59
Query: 515 YRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEEL---ASELGLGP 571
+D+ EF AA + +++LE E++ A+ F+KDG+ I ++E+ + GL
Sbjct: 60 SGTIDYGEFIAATVHLNKLER----EENLVSAFSYFDKDGSGYITLDEIQQACKDFGLD- 114
Query: 572 AVPVHAVLHDWIRHTD----GKLSFLGFVKLL 599
+ D I+ D G++ + F ++
Sbjct: 115 ----DIHIDDMIKEIDQDNDGQIDYGEFAAMM 142
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.2 bits (137), Expect = 1e-08
Identities = 59/488 (12%), Positives = 142/488 (29%), Gaps = 132/488 (27%)
Query: 188 VKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVV---M------ 238
+V K+ +V R L+ L E V+ +
Sbjct: 123 NQVFAKY---------NVSRLQPYLKL---RQAL------LELRPAKNVLIDGVLGSGKT 164
Query: 239 ----ELCEGGELLDRILSRG------GKYTEDDAKAVMIQIL------NVVAFC-HLQGV 281
++C ++ + + + M+Q L N + H +
Sbjct: 165 WVALDVCLSYKVQCK-MDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNI 223
Query: 282 VHR--DLKPE-NFLFTTKD-ENS-----------VLKAIDFGLSDFV--RPDERLNDIVG 324
R ++ E L +K EN A + + R +++ D +
Sbjct: 224 KLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTR-FKQVTDFLS 282
Query: 325 SAYYVAPEVLHRSYS-TEADVWSIGVIAYILLCGSR--PFWARTES----GIFRAVLKAD 377
+A + H S + T + ++ L C + P T + I ++
Sbjct: 283 AATTTHISLDHHSMTLTPDE--VKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDG 340
Query: 378 PS-FDEAPWPSLSSEA-----RDFVKRLLNKDPRKRLTAAQALS-HPWIKNSNDVKVPLD 430
+ +D W ++ + + L + RK LS P +P
Sbjct: 341 LATWD--NWKHVNCDKLTTIIESSLNVLEPAEYRKMF---DRLSVFP-----PSAHIPTI 390
Query: 431 VI-----------IFKLMKAYMRSSSLRKAALR--------ALSKTLTVDELFYLK---- 467
++ + ++ + S + K L + ++ + L
Sbjct: 391 LLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIV 450
Query: 468 EQYALLEPNKNGTISLENVKSAL-------MKNATDAMKDSRIPDFLSSLNSLQYR-RMD 519
+ Y + + + + + +KN + + L+ + R D
Sbjct: 451 DHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHD 510
Query: 520 FEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVL 579
+ A+ ++ L+ L ++ + + + D ++ + L P + + +
Sbjct: 511 STAWNASGSILNTLQQLKFYKPY------ICDNDPKYERLVNAILDFL---PKIEENLIC 561
Query: 580 HDWIRHTD 587
++TD
Sbjct: 562 S---KYTD 566
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 35/117 (29%), Positives = 51/117 (43%), Gaps = 26/117 (22%)
Query: 258 TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE 317
T + Q+ + F + +HRDL N L + E +V+K DFGL+
Sbjct: 191 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLA------- 240
Query: 318 RLNDIVGSAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRP 360
R DI YV APE + R Y+ ++DVWS GV+ + I G+ P
Sbjct: 241 R--DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 37/186 (19%), Positives = 68/186 (36%), Gaps = 20/186 (10%)
Query: 158 ELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+LG+ +GRG FG A + VAVK++ + T + E+KIL +
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHI 82
Query: 216 TGHNNLVKFFDAYEDTDN-VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
H N+V A + V++E C+ G L + S+ ++ +
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF-----VPYKTKGARFRQ 137
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER----------LNDIVG 324
G + DLK T+ ++ ++ V +E L ++
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLIC 197
Query: 325 SAYYVA 330
++ VA
Sbjct: 198 YSFQVA 203
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A Length = 220 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 7e-08
Identities = 21/188 (11%), Positives = 58/188 (30%), Gaps = 15/188 (7%)
Query: 416 HPWIKN-SNDVKVPLDVIIFKLMKAYMRSSSLRKAALRALSKTLTVDELFYLKEQYALLE 474
P + N P+ Y S+R L T+ +D+ + + + ++
Sbjct: 2 QPPVANFCLWNLQPIQGSWMGAACIYQMPPSVRNTWWFPLLNTIPLDQYTRIYQWFMGVD 61
Query: 475 PNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLE 534
+++GT+ + + + + ++ + F EF
Sbjct: 62 RDRSGTLEINELMMGQ-FPGGIRLSPQTALRMMRIFDTDFNGHISFYEFM---------- 110
Query: 535 ALDRWEQHARCAYELFEKDGNRAIVIEELAS---ELGLGPAVPVHAVLHDWIRHTDGKLS 591
A+ ++ + A + + + + + E+ +LG +LH
Sbjct: 111 AMYKFMELAYNLFVMNARARSGTLEPHEILPALQQLGFYINQRTSLLLHRLFARGMAFCD 170
Query: 592 FLGFVKLL 599
++ +
Sbjct: 171 LNCWIAIC 178
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A Length = 174 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-07
Identities = 25/149 (16%), Positives = 50/149 (33%), Gaps = 15/149 (10%)
Query: 466 LKEQYALLEPNKNGTISLENVKSALMKNATDA-MKDSRIPDFLSSLNSLQYR-------- 516
+K + ++ +K+G I+ + +S + A ++ MK + SL +
Sbjct: 8 MKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTGVWDNFLTAVAGG 67
Query: 517 -RMDFEEFCAAALSVHQLEALDRW-EQHARCAYELFEKDGNRAIVIEELA---SELGLGP 571
+D F + + + E + + + + I +E LGL
Sbjct: 68 KGIDETTFINSMKEMVKNPEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFFGMLGLDK 127
Query: 572 AVPVHAVLHDWIRHTDGKLSFLGFVKLLH 600
+ A + DG LS FV
Sbjct: 128 TM-APASFDAIDTNNDGLLSLEEFVIAGS 155
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} Length = 208 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 19/166 (11%), Positives = 48/166 (28%), Gaps = 27/166 (16%)
Query: 458 LTVDELFYLKEQYALLEPNKNGTISLENVKSALMK-NATDAMKDSRIPDFLSSLNSLQYR 516
L L L +++ + + +G + ++ V + D ++ ++
Sbjct: 30 LHPKMLSRLYKRFDTFDLDSDGKMEMDEVLYWPDRMRQLVNATDEQVEKMRDAVRVFFLH 89
Query: 517 -------RMDFEEFCAAA-------LSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEE 562
+ E++ A + + Y++ + DG+ + ++E
Sbjct: 90 KGVEPVNGLLREDWVEANRVFAEAERERERRGEPSLIALLSNSYYDVLDDDGDGTVDVDE 149
Query: 563 LA---SELGLGPAVPVHAVLHDWIRHTD----GKLSFLGFVKLLHG 601
L + + + D GKL V L
Sbjct: 150 LKTMMKAFDVP-----QEAAYTFFEKADTDKSGKLERTELVHLFRK 190
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A Length = 134 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 5e-07
Identities = 25/155 (16%), Positives = 54/155 (34%), Gaps = 44/155 (28%)
Query: 466 LKEQYALLEPNKNGTISLENVKSAL--------------MKNATDAMKDSRIPDFLSSLN 511
+ + ++ N +G +S E VK+ + + + DA + I
Sbjct: 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEI-------- 53
Query: 512 SLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELAS---ELG 568
D EF S+ + D + + Y+L + DG+ + EE+ S + G
Sbjct: 54 -------DQNEFAKFYGSIQGQDLSDD-KIGLKVLYKLMDVDGDGKLTKEEVTSFFKKHG 105
Query: 569 LGPAVPVHAVLHDWIRHTD----GKLSFLGFVKLL 599
+ + + + D G ++ F++
Sbjct: 106 I-------EKVAEQVMKADANGDGYITLEEFLEFS 133
|
| >3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A Length = 229 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 6e-07
Identities = 25/159 (15%), Positives = 56/159 (35%), Gaps = 12/159 (7%)
Query: 408 LTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALRALSKT--LTVDELFY 465
+ L ++ ++ L+ + ++ M + R AL L T EL
Sbjct: 11 VLIVIVLFVKLLEQFGLIEAGLEDSVEDELE--MATVRHRPEALELLEAQSKFTKKELQI 68
Query: 466 LKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFL-SSLNSLQYRRMDFEEFC 524
L + P+ G ++ E K + FL ++ ++ + FE+F
Sbjct: 69 LYRGFKNECPS--GVVNEETFKEIY-SQFFPQGDSTTYAHFLFNAFDTDHNGAVSFEDFI 125
Query: 525 AAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEEL 563
+ + ++ A+ L++ + + I EE+
Sbjct: 126 KGLSILLRGTV----QEKLNWAFNLYDINKDGYITKEEM 160
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A Length = 208 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 7e-07
Identities = 39/181 (21%), Positives = 70/181 (38%), Gaps = 30/181 (16%)
Query: 443 SSSLRKAALRALSKT--LTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKD 500
S+ LR L + K + ++ L ++ L+ +NGT+S E+ + + + A + + D
Sbjct: 6 STLLRDEELEEIKKETGFSHSQITRLYSRFTSLDKGENGTLSREDFQR-IPELAINPLGD 64
Query: 501 SRIPDFLSSLNSLQYRRMDFEEFCAA------------ALSVHQLEALDRWEQHARCAYE 548
I F S +++F F + V+ E L+ A+
Sbjct: 65 RIINAFFSEGE----DQVNFRGFMRTLAHFRPIEDNEKSKDVNGPEPLNSRSNKLHFAFR 120
Query: 549 LFEKDGNRAIVIEELASELG--LGPAVPVHAVLHDWIRHT--------DGKLSFLGFVKL 598
L++ D + I +EL L +G + L T D +SF FVK+
Sbjct: 121 LYDLDKDDKISRDELLQVLRMMVGVNIS-DEQLGSIADRTIQEADQDGDSAISFTEFVKV 179
Query: 599 L 599
L
Sbjct: 180 L 180
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} Length = 256 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 27/205 (13%), Positives = 58/205 (28%), Gaps = 24/205 (11%)
Query: 362 WARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
+L D P E+ + + + R WI +
Sbjct: 4 TKEAVKASDGNLL-----GDPGRIPLSKRESIKWQRPRFTRQALMR-----CCLIKWILS 53
Query: 422 SNDVKVPLDVIIFKLMKAYMRSSSLRKAALRALSKT--LTVDELFYLKEQYALLEPNKNG 479
S + + + + + L L T EL L + P G
Sbjct: 54 SAAPQGSDSS----DSELELSTVRHQPEGLDQLQAQTKFTKKELQSLYRGFKNECPT--G 107
Query: 480 TISLENVKSALMKNATDAMKDSRIPDFL-SSLNSLQYRRMDFEEFCAAALSVHQLEALDR 538
+ + K + FL ++ ++ + FE+F + +
Sbjct: 108 LVDEDTFKLIY-SQFFPQGDATTYAHFLFNAFDADGNGAIHFEDFVVGLSILLRGTV--- 163
Query: 539 WEQHARCAYELFEKDGNRAIVIEEL 563
+ + A+ L++ + + I EE+
Sbjct: 164 -HEKLKWAFNLYDINKDGCITKEEM 187
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A Length = 186 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 9e-07
Identities = 25/166 (15%), Positives = 56/166 (33%), Gaps = 17/166 (10%)
Query: 451 LRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSR-------- 502
+ ++++ L +K + ++ +G IS E+ + ++ A A +
Sbjct: 1 MPEITESERAYHLRKMKTRMQRVDVTGDGFISREDYELIAVRIAKIAKLSAEKAEETRQE 60
Query: 503 IPDFLSSLNSLQYRRMDFEEFCAAA---LSVHQLEALDRWEQHARCAYELFEKDGNRAIV 559
L R+ EE A L + E + Y+ + D + +
Sbjct: 61 FLRVADQLGLAPGVRISVEEAAVNATDSLLKMKGEEKAMAVIQSLIMYDCIDTDKDGYVS 120
Query: 560 IEELASELG-LGPAVPVHAVLHDWIRHTD----GKLSFLGFVKLLH 600
+ E + L +GP + D G++S F+ ++
Sbjct: 121 LPEFKAFLQAVGPDLT-DDKAITCFNTLDFNKNGQISRDEFLVTVN 165
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} Length = 204 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 25/166 (15%), Positives = 54/166 (32%), Gaps = 17/166 (10%)
Query: 451 LRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSL 510
LRA + + L + L+ + + ++ + + L K + +
Sbjct: 24 LRAQCLSRGASGIQGLARFFRQLDRDGSRSLDADEFRQGLAKLGLV-LDQAEAEGVCRKW 82
Query: 511 NSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELGLG 570
+ +D EEF A E A+ ++ G+ + +++L
Sbjct: 83 DRNGSGTLDLEEFLRALRPPMSQAR----EAVIAAAFAKLDRSGDGVVTVDDLRGVYSGR 138
Query: 571 PAVPVH-------AVLHDWIRHT-----DGKLSFLGFVKLLHGVSS 604
V VL ++ + DG+++ F GVS+
Sbjct: 139 AHPKVRSGEWTEDEVLRRFLDNFDSSEKDGQVTLAEFQDYYSGVSA 184
|
| >1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 Length = 193 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 26/125 (20%), Positives = 51/125 (40%), Gaps = 10/125 (8%)
Query: 442 RSSSLRKAALRALSKT--LTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMK 499
++S LR ++ L ++ T E+ + + L +G +S+E K + N
Sbjct: 4 QNSKLRPEVMQDLLESTDFTEHEIQEWYKGF--LRDCPSGHLSMEEFKK-IYGNFFPYGD 60
Query: 500 DSRIPDFLSSLNSLQY-RRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAI 558
S+ + + +DF EF A + + EQ + A+ +++ DGN I
Sbjct: 61 ASKFAEHVFRTFDANGDGTIDFREFIIALSVTSRGK----LEQKLKWAFSMYDLDGNGYI 116
Query: 559 VIEEL 563
E+
Sbjct: 117 SKAEM 121
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} PDB: 2gv5_A 2doq_A 3fwc_A Length = 161 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 2e-06
Identities = 27/132 (20%), Positives = 50/132 (37%), Gaps = 13/132 (9%)
Query: 443 SSSLRKAALRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKS---ALMKNATDAMK 499
S + L+ L ++ + E ++L + N +G + +K AL
Sbjct: 2 SKNRSSLQSGPLNSELLEEQKQEIYEAFSLFDMNNDGFLDYHELKVAMKALGFELPKRE- 60
Query: 500 DSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIV 559
I D + +S M +++F ++ D + A++LF+ D I
Sbjct: 61 ---ILDLIDEYDSEGRHLMKYDDFYIVM--GEKILKRDP-LDEIKRAFQLFDDDHTGKIS 114
Query: 560 IEEL---ASELG 568
I+ L A ELG
Sbjct: 115 IKNLRRVAKELG 126
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 Length = 176 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 19/160 (11%), Positives = 50/160 (31%), Gaps = 30/160 (18%)
Query: 466 LKEQYALLEPNKNGTIS---LENVKSALMKNATDAMKDSRIPDFLSSLNSLQYR------ 516
LK+++ + + NG + E + + + + ++ L
Sbjct: 9 LKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFDYLAKEAG 68
Query: 517 -----RMDFEEFCAAALSVHQLEALDRWEQH----ARCAYELFEKDGNRAIVIEELA--- 564
+ E+F ++ + + + + + +K+ + I +E A
Sbjct: 69 VGSDGSLTEEQFIRVTENLIFEQGEASFNRVLGPVVKGIVGMCDKNADGQINADEFAAWL 128
Query: 565 SELGLGPAVPVHAVLHDWIRHTD----GKLSFLGFVKLLH 600
+ LG+ A + D G+LS + +
Sbjct: 129 TALGMSK-----AEAAEAFNQVDTNGNGELSLDELLTAVR 163
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... Length = 162 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 2e-06
Identities = 30/168 (17%), Positives = 61/168 (36%), Gaps = 39/168 (23%)
Query: 456 KTLTVDELFYLKEQYALLEPNKNGTISLENVKSAL--------------MKNATDAMKDS 501
L+ + + K + + + + G IS + + + + + D
Sbjct: 12 AFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSG 71
Query: 502 RIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIE 561
I DFEEF + + +A + E+ + +F+K+ + I IE
Sbjct: 72 TI---------------DFEEFLVMMVRQMKEDAKGKSEEELANCFRIFDKNADGFIDIE 116
Query: 562 EL---ASELGLGPAVPVHAVLHDWIRHTD----GKLSFLGFVKLLHGV 602
EL G + D ++ +D G++ F F+K++ GV
Sbjct: 117 ELGEILRATGEHVT---EEDIEDLMKDSDKNNDGRIDFDEFLKMMEGV 161
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A Length = 226 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 4e-06
Identities = 31/130 (23%), Positives = 51/130 (39%), Gaps = 9/130 (6%)
Query: 437 MKAYMRSSSLRKAALRALSKTLTVDELFYLKEQYALLEPN--KNGTISLENVKSALMKNA 494
+ Y +S L L A +V E+ L E + + +G I+ E + AL K
Sbjct: 21 LDLYKQSGGLGDPELLARDTVFSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFKTN 80
Query: 495 TDAMKDSRIPDFLSSLNSL-QYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKD 553
K+S D + L + FEEF A ALSV + +++L++
Sbjct: 81 ---KKESLFADRVFDLFDTKHNGILGFEEF-ARALSVF-HPNAPI-DDKIHFSFQLYDLK 134
Query: 554 GNRAIVIEEL 563
I +E+
Sbjct: 135 QQGFIERQEV 144
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A Length = 169 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 6e-06
Identities = 30/149 (20%), Positives = 54/149 (36%), Gaps = 35/149 (23%)
Query: 437 MKAYMRSSSLRKAALRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSAL------ 490
M ++ + + LT ++ ++E + L + + +GTI + +K A+
Sbjct: 1 MSYKAKTVVSARRDQKKGRVGLTEEQKQEIREAFDLFDTDGSGTIDAKELKVAMRALGFE 60
Query: 491 --------MKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQH 542
M + D I DFEEF ++ D +
Sbjct: 61 PKKEEIKKMISEIDKDGSGTI---------------DFEEFLTMM--TAKMGERDS-REE 102
Query: 543 ARCAYELFEKDGNRAIVIEEL---ASELG 568
A+ LF+ D + I I++L A ELG
Sbjct: 103 ILKAFRLFDDDNSGTITIKDLRRVAKELG 131
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... Length = 148 | Back alignment and structure |
|---|
Score = 44.8 bits (107), Expect = 9e-06
Identities = 30/120 (25%), Positives = 64/120 (53%), Gaps = 13/120 (10%)
Query: 455 SKTLTVDELFYLKEQYALLEPNKNGTISLENVKS---ALMKNATDAMKDSRIPDFLSSLN 511
++ LT +++ KE +AL + + +GTI+ + + + +L +N T+A + D ++ ++
Sbjct: 1 AEQLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAE----LQDMINEVD 56
Query: 512 SLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEEL---ASELG 568
+ +DF EF + +++ D E+ A+++F++DGN I EL + LG
Sbjct: 57 ADGNGTIDFPEFLSLM--ARKMKEQDS-EEELIEAFKVFDRDGNGLISAAELRHVMTNLG 113
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* Length = 155 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 1e-05
Identities = 32/162 (19%), Positives = 64/162 (39%), Gaps = 37/162 (22%)
Query: 461 DELFYLKEQYALLEPNKNGTISLENVKSAL----------MKNATDAMKDSRIPDFLSSL 510
DE+ L +++ L+ + +G++S+E S + + D + +
Sbjct: 3 DEIKRLGKRFKKLDLDNSGSLSVEEFMSLPELQQNPLVQRVIDIFDTDGNGEV------- 55
Query: 511 NSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELGLG 570
DF+EF +S ++ D+ EQ R A+ +++ D + I EL L +
Sbjct: 56 --------DFKEFI-EGVSQFSVKG-DK-EQKLRFAFRIYDMDKDGYISNGELFQVLKMM 104
Query: 571 PAVPV-HAVLHDWIRHT--------DGKLSFLGFVKLLHGVS 603
+ L + T DG++SF F ++ G+
Sbjct: 105 VGNNLKDTQLQQIVDKTIINADKDGDGRISFEEFCAVVGGLD 146
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} Length = 202 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 35/185 (18%), Positives = 63/185 (34%), Gaps = 29/185 (15%)
Query: 443 SSSLRKAALRALSKT--LTVDELFYLKEQYALLEPNKNGTISLENVKS--ALMKNAT--- 495
S + ++ + + L L ++ L+ NK G +S +++ AL N
Sbjct: 6 SHAAVIPDGDSIRRETGFSQASLLRLHHRFRALDRNKKGYLSRMDLQQIGALAVNPLGDR 65
Query: 496 -----DAMKDSRI--PDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYE 548
R+ P F+ L E+ + E L+ A++
Sbjct: 66 IIESFFPDGSQRVDFPGFVRVLA----HFRPVEDEDTETQDPKKPEPLNSRRNKLHYAFQ 121
Query: 549 LFEKDGNRAIVIEELASELG--LGPAVPVHAVLHDWIRHT--------DGKLSFLGFVKL 598
L++ D + I E+ L +G V L + T DG +SF+ F K
Sbjct: 122 LYDLDRDGKISRHEMLQVLRLMVGVQVT-EEQLENIADRTVQEADEDGDGAVSFVEFTKS 180
Query: 599 LHGVS 603
L +
Sbjct: 181 LEKMD 185
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 1f54_A 1f55_A Length = 147 | Back alignment and structure |
|---|
Score = 44.8 bits (107), Expect = 1e-05
Identities = 30/131 (22%), Positives = 54/131 (41%), Gaps = 35/131 (26%)
Query: 455 SKTLTVDELFYLKEQYALLEPNKNGTISLENVKSAL--------------MKNATDAMKD 500
S+ LT +++ KE +AL + + +G+IS + + + + N D +
Sbjct: 2 SQNLTEEQIAEFKEAFALFDKDNSGSISASELATVMRSLGLSPSEAEVADLMNEIDVDGN 61
Query: 501 SRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVI 560
I +F EF A QL+ D EQ A+++F+K+G+ I
Sbjct: 62 HAI---------------EFSEFLALM--SRQLKCNDS-EQELLEAFKVFDKNGDGLISA 103
Query: 561 EEL---ASELG 568
EL + +G
Sbjct: 104 AELKHVLTSIG 114
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A Length = 263 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 25/168 (14%), Positives = 53/168 (31%), Gaps = 27/168 (16%)
Query: 455 SKTLTVDELFYLKEQYALLEPNKNGTIS---LENVKSALMKNATDAMKDSR--IPDFLSS 509
S +T + E + + + +G + L+N+ L++ A + + F+
Sbjct: 10 SSLITASQF---FEIWLHFDADGSGYLEGKELQNLIQELLQARKKAGLELSPEMKTFVDQ 66
Query: 510 LNSLQYRRMDFEEFCA------AALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEEL 563
++ E L + + + L + + ++ D + I EEL
Sbjct: 67 YGQRDDGKIGIVELAHVLPTEENFLLLFRCQQLKS-CEEFMKTWRKYDTDHSGFIETEEL 125
Query: 564 ---ASELGLGPAVPVHAVLHDW-----IRHTD----GKLSFLGFVKLL 599
+L V ++ D GKL +LL
Sbjct: 126 KNFLKDLLEKANKTVDDTKLAEYTDLMLKLFDSNNDGKLELTEMARLL 173
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A Length = 179 | Back alignment and structure |
|---|
Score = 44.8 bits (107), Expect = 1e-05
Identities = 31/120 (25%), Positives = 62/120 (51%), Gaps = 13/120 (10%)
Query: 455 SKTLTVDELFYLKEQYALLEPNKNGTISLENVKS---ALMKNATDAMKDSRIPDFLSSLN 511
+ LT +++ KE ++L + + +GTI+ + + + +L +N T+A + D ++ ++
Sbjct: 2 ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAE----LQDMINEVD 57
Query: 512 SLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEEL---ASELG 568
+ +DF EF +++ D E+ R A+ +F+KDGN I EL + LG
Sbjct: 58 ADGNGTIDFPEFLTMM--ARKMKDTDS-EEEIREAFRVFDKDGNGYISAAELRHVMTNLG 114
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A Length = 191 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 3e-05
Identities = 26/159 (16%), Positives = 46/159 (28%), Gaps = 26/159 (16%)
Query: 466 LKEQYALLEPNKNGTISLE--------NVKSALMKNATDA-MKDSRIPDFLSSLNSLQYR 516
K + L+ N NG ISL+ V + L A + F
Sbjct: 18 HKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHKDAVEAFFGGAGMKYGV 77
Query: 517 RMDFEEFCAAA-------LSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELAS---E 566
D+ + L + +++ +KD N AI ++E +
Sbjct: 78 ETDWPAYIEGWKKLATDELEKYAKNEPTLIRIWGDALFDIVDKDQNGAITLDEWKAYTKA 137
Query: 567 LGLGPAVPVHAVLHDWIRHTD----GKLSFLGFVKLLHG 601
G+ + + R D G+L + G
Sbjct: 138 AGIIQS---SEDCEETFRVCDIDESGQLDVDEMTRQHLG 173
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A Length = 166 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 3e-05
Identities = 20/159 (12%), Positives = 44/159 (27%), Gaps = 29/159 (18%)
Query: 466 LKEQYALLEPNKNGTIS-------LENVKSALMKNATDAMKDSRIPDFLSSLNSLQYR-- 516
+ ++ + + NG I + + + A + + L
Sbjct: 6 IAARFTTFDQDGNGHIDRSDFSGAAKAMLAEFGVAARSDRGQALYGGAEALWQGLAGIAD 65
Query: 517 -----RMDFEEFCAAALSVHQL---EALDRWEQHARCAYELFEKDGNRAIVIEELA---S 565
R+ EEF A+ + + A + + DG+ A+ + + A +
Sbjct: 66 RDGDQRITREEFVTGAVKRLRDKPDRFAEMARPFLHAALGVADTDGDGAVTVADTARALT 125
Query: 566 ELGLGPAVPVHAVLHDWIRHTD----GKLSFLGFVKLLH 600
G+ + D GK+ V
Sbjct: 126 AFGVPE-----DLARQAAAALDTDGDGKVGETEIVPAFA 159
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 142 | Back alignment and structure |
|---|
Score = 43.2 bits (103), Expect = 3e-05
Identities = 24/145 (16%), Positives = 53/145 (36%), Gaps = 23/145 (15%)
Query: 466 LKEQYALLEPNKNGTISLENVKS---ALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEE 522
KE + L + + G I+ E +++ A + + ++ ++ F E
Sbjct: 8 FKEAFELFDSERTGFITKEGLQTVLKQFGVRVEPAA----FNEMFNEADATGNGKIQFPE 63
Query: 523 FCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEEL---ASELG--LGPAVPVHA 577
F + +++ E R A+ F+ +G I L LG L P
Sbjct: 64 FLSMM--GRRMKQTTS-EDILRQAFRTFDPEGTGYIPKAALQDALLNLGDRLKP-----H 115
Query: 578 VLHDWIRHTD---GKLSFLGFVKLL 599
+++ T+ G++ + F+ +
Sbjct: 116 EFAEFLGITETEKGQIRYDNFINTM 140
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A Length = 143 | Back alignment and structure |
|---|
Score = 43.2 bits (103), Expect = 3e-05
Identities = 25/106 (23%), Positives = 48/106 (45%), Gaps = 7/106 (6%)
Query: 466 LKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCA 525
++E + L + + GTI ++ +K A M+ K I +S ++ +M+F +F
Sbjct: 8 IREAFDLFDADGTGTIDVKELKVA-MRALGFEPKKEEIKKMISEIDKEGTGKMNFGDFLT 66
Query: 526 AALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEEL---ASELG 568
++ D ++ A++LF+ D I + L A ELG
Sbjct: 67 VM--TQKMSEKDT-KEEILKAFKLFDDDETGKISFKNLKRVAKELG 109
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A Length = 158 | Back alignment and structure |
|---|
Score = 42.9 bits (102), Expect = 6e-05
Identities = 22/130 (16%), Positives = 44/130 (33%), Gaps = 34/130 (26%)
Query: 458 LTVDELFYLKEQYALL-EPNKNGTISLENVKSAL--------------MKNATDAMKDSR 502
L+ +++ L+ + P +G +S + + L + + D +
Sbjct: 7 LSSNQVKLLETAFRDFETPEGSGRVSTDQIGIILEVLGIQQTKSTIRQLIDEFDPFGNGD 66
Query: 503 IPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDR-WEQHARCAYELFEKDGNRAIVIE 561
I DF+ F E +Q R A+ L++K+GN I +
Sbjct: 67 I---------------DFDSFKIIGARFLGEEVNPEQMQQELREAFRLYDKEGNGYISTD 111
Query: 562 EL---ASELG 568
+ +EL
Sbjct: 112 VMREILAELD 121
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... Length = 161 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 7e-05
Identities = 25/159 (15%), Positives = 66/159 (41%), Gaps = 12/159 (7%)
Query: 452 RALSKTLTVDELFYLKEQYALLEPN-KNGTISLENVKSALMKNATDAMKDSRIPDFLSSL 510
+A + LT ++ K + + ++G+IS + + M+ + + + +
Sbjct: 6 KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKV-MRMLGQNPTPEELQEMIDEV 64
Query: 511 NSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEEL---ASEL 567
+ +DF+EF + + ++ + E+ + +F+K+ + I +EEL
Sbjct: 65 DEDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELSDLFRMFDKNADGYIDLEELKIMLQAT 124
Query: 568 GLGPAVPVHAVLHDWIRHTD----GKLSFLGFVKLLHGV 602
G + + ++ D G++ + F++ + GV
Sbjct: 125 GETIT---EDDIEELMKDGDKNNDGRIDYDEFLEFMKGV 160
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} Length = 190 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 9e-05
Identities = 22/124 (17%), Positives = 48/124 (38%), Gaps = 10/124 (8%)
Query: 443 SSSLRKAALRALSKT--LTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKD 500
S L + L+ L ++ EL + + P+ G ++ + K
Sbjct: 5 QSKLSQDQLQDLVRSTRFDKKELQQWYKGFFKDCPS--GHLNKSEFQKIY-KQFFPFGDP 61
Query: 501 SRIPDFL-SSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIV 559
S +++ + ++ + +DF+EF A + E A++L++ D N I
Sbjct: 62 SAFAEYVFNVFDADKNGYIDFKEFICALSVTSRGE----LNDKLIWAFQLYDLDNNGLIS 117
Query: 560 IEEL 563
+E+
Sbjct: 118 YDEM 121
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 43.5 bits (102), Expect = 9e-05
Identities = 32/176 (18%), Positives = 58/176 (32%), Gaps = 34/176 (19%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDV----------- 205
+G + G A K +AVK+ +++ T+ +
Sbjct: 49 TAMGGVISTGKEANVFYADGVFDG-KPVAMAVKI---YRIETSEFDKMDEYLYGDERFDM 104
Query: 206 ----RREVKILRALTGHNNLVKFFDA-------YEDTDNVYVVMELCEGGEL-LDRILSR 253
+E + NL + +A Y NV ++ME EL ++
Sbjct: 105 RRISPKEKVFIWTEKEFRNLERAKEAGVSVPQPYTYMKNV-LLMEFIGEDELPAPTLVEL 163
Query: 254 GGKYTEDDAKAVMIQILN-VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308
G + E D + + ++ V +VH DL N ++ K + ID G
Sbjct: 164 GRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYIDK-----VYFIDMG 214
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A Length = 153 | Back alignment and structure |
|---|
Score = 42.1 bits (100), Expect = 1e-04
Identities = 19/124 (15%), Positives = 43/124 (34%), Gaps = 30/124 (24%)
Query: 455 SKTLTVDELFYLKEQYALLEPNKNGTISLENVKSAL--------------MKNATDAMKD 500
++L +E+ L+E + + +K+G I+ ++ + + + +
Sbjct: 2 DRSLRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQINMNLG 61
Query: 501 SRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRW-EQHARCAYELFEKDGNRAIV 559
+ DF++F E D + R A+ F+ +G+ I
Sbjct: 62 GHV---------------DFDDFVELMGPKLLAETADMIGVKELRDAFREFDTNGDGEIS 106
Query: 560 IEEL 563
EL
Sbjct: 107 TSEL 110
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A Length = 207 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 1e-04
Identities = 34/180 (18%), Positives = 59/180 (32%), Gaps = 23/180 (12%)
Query: 437 MKAYMRSSSLRKAALRALSKT--LTVDELFYLKEQYALLEPN--KNGTISLENVKSALMK 492
K L+ TV+E+ L E + L + +G I E + AL +
Sbjct: 8 KKKKNAMRPPGYEDPELLASVTPFTVEEVEALYELFKKLSSSIIDDGLIHKEEFQLALFR 67
Query: 493 NATDAMKD-SRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFE 551
N RI D + ++F EF + L V A + + A++L++
Sbjct: 68 NRNRRNLFADRIFDVFDVKRN---GVIEFGEFVRS-LGVFHPSAPV--HEKVKFAFKLYD 121
Query: 552 KDGNRAIVIEEL----ASELGLGPAVPVHAVLHDWIRHT--------DGKLSFLGFVKLL 599
I EEL + L V ++ + DGK+ + +
Sbjct: 122 LRQTGFIEREELKEMVVALLHESELVLSEDMIEVMVDKAFVQADRKNDGKIDIDEWKDFV 181
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 37/147 (25%), Positives = 54/147 (36%), Gaps = 18/147 (12%)
Query: 163 VGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
C KF K G ++V K + +AI R E + L+ L G
Sbjct: 108 NCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---- 163
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
+ Y N V+MEL + EL ++ V+ IL VA + +G+
Sbjct: 164 LAVPKVYAWEGNA-VLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGI 214
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFG 308
VH DL N L + + IDF
Sbjct: 215 VHGDLSQYNVLVS----EEGIWIIDFP 237
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A Length = 272 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 26/177 (14%), Positives = 50/177 (28%), Gaps = 34/177 (19%)
Query: 452 RALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSAL---------MKNATDAMKDSR 502
A + L + + + + NG I + + TD
Sbjct: 3 SAFAN-LDAAGF---LQIWQHFDADDNGYIEGKELDDFFRHMLKKLQPKDKITDERVQQI 58
Query: 503 IPDFLSSLNSLQYRRMDFEEFCAAALS--------VHQLEALDRWEQHARCAYELFEKDG 554
F+S+ ++ R+ EE L + LD + ++ D
Sbjct: 59 KKSFMSAYDATFDGRLQIEELANMILPQEENFLLIFRREAPLDN-SVEFMKIWRKYDADS 117
Query: 555 NRAIVIEEL---ASELGLGPAVPVHAVLHDWI---------RHTDGKLSFLGFVKLL 599
+ I EL +L L + D ++ DG+L ++L
Sbjct: 118 SGYISAAELKNFLKDLFLQHKKKIPPNKLDEYTDAMMKIFDKNKDGRLDLNDLARIL 174
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C Length = 151 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 4e-04
Identities = 31/121 (25%), Positives = 50/121 (41%), Gaps = 17/121 (14%)
Query: 458 LTVDELFYLKEQYALLEPNKNGTISLENVKS---ALMKNATDA----MKDSRIPDFLSSL 510
D+L KE + L + +G I AL +N T+A + + D L S
Sbjct: 4 FNKDQLEEFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKSDELKS- 62
Query: 511 NSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEEL---ASEL 567
RR+DFE F +V + +E + +F+K+GN ++ EL + L
Sbjct: 63 -----RRVDFETFLPMLQAVAKNRGQGTYED-YLEGFRVFDKEGNGKVMGAELRHVLTTL 116
Query: 568 G 568
G
Sbjct: 117 G 117
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} Length = 211 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 5e-04
Identities = 23/116 (19%), Positives = 47/116 (40%), Gaps = 6/116 (5%)
Query: 448 KAALRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFL 507
++ K + E + + +G +L K+ L + + I
Sbjct: 6 GKSIAGDQKAVPTQETHVWYRTF--MMEYPSGLQTLHEFKTLLGLQGLNQKANKHIDQVY 63
Query: 508 SSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEEL 563
++ ++ + +DF EF AA + Q + EQ + ++L++ DGN +I EL
Sbjct: 64 NTFDTNKDGFVDFLEFIAAVNLIMQEKM----EQKLKWYFKLYDADGNGSIDKNEL 115
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} Length = 143 | Back alignment and structure |
|---|
Score = 39.8 bits (94), Expect = 5e-04
Identities = 22/117 (18%), Positives = 48/117 (41%), Gaps = 17/117 (14%)
Query: 458 LTVDELFYLKEQYALLEPNKNGTISLENVKS---ALMKNATDAMKDSRIPDFLSSLNSLQ 514
++ KE + +++ N++G I E++ ++ KN TD + +S
Sbjct: 1 FDQSQIQEFKEAFNMIDQNRDGFIDKEDLHDMLASMGKNPTDEY----LEGMMSEAPG-- 54
Query: 515 YRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEEL---ASELG 568
++F F + +L D E R A+ F+++ + I + L + +G
Sbjct: 55 --PINFTMFL--TMFGEKLNGTDP-EDVIRNAFACFDEEASGFIHEDHLRELLTTMG 106
|
| >2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 Length = 185 | Back alignment and structure |
|---|
Score = 40.3 bits (94), Expect = 6e-04
Identities = 19/147 (12%), Positives = 45/147 (30%), Gaps = 23/147 (15%)
Query: 476 NKNGTIS---LENVKSALMKNATDAMKDSRIPDFLSSLNSL-----------QYRRMDFE 521
N +G+I E++ + + ++ D+ +SL + + +E
Sbjct: 21 NHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASLEDEWRDLKGRADINKDDVVSWE 80
Query: 522 EFCAAALSVHQL-----EALDRWEQHARCAYELFEKDGNRAIVIEELA---SELGLGPAV 573
E+ A + + ++ + G+ + +EE L A
Sbjct: 81 EYLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQLQCAD 140
Query: 574 PVHAVLHDWIRHTDGKLSFLGFVKLLH 600
V AV + + +L +
Sbjct: 141 -VPAVYNVITDGGKVTFDLNRYKELYY 166
|
| >1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 87 | Back alignment and structure |
|---|
Score = 38.3 bits (90), Expect = 6e-04
Identities = 20/80 (25%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 452 RALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLN 511
+ +++ L+ +E+ LKE + +++ + +GTI+ + +K +K + +S I D + + +
Sbjct: 11 KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDG-LKRVGSELMESEIKDLMDAAD 69
Query: 512 SLQYRRMDFEEFCAAALSVH 531
+ +D+ EF AA +VH
Sbjct: 70 IDKSGTIDYGEFIAA--TVH 87
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... Length = 156 | Back alignment and structure |
|---|
Score = 39.8 bits (94), Expect = 6e-04
Identities = 23/128 (17%), Positives = 54/128 (42%), Gaps = 20/128 (15%)
Query: 450 ALRALSKT---LTVDELFYLKEQYALLEPNKNGTISLENVKSALM---KNATDAMKDSRI 503
A +A S L ++ +KE +++++ +++G +S E++K+ + D +
Sbjct: 1 ADKAASGVLTKLPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKE----L 56
Query: 504 PDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEEL 563
L ++F F + +L D E+ R A+ +F++ + + IE +
Sbjct: 57 TAMLKEAPG----PLNFTMFLSIF--SDKLSGTDS-EETIRNAFAMFDEQETKKLNIEYI 109
Query: 564 ---ASELG 568
+G
Sbjct: 110 KDLLENMG 117
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A Length = 172 | Back alignment and structure |
|---|
Score = 39.5 bits (93), Expect = 8e-04
Identities = 21/139 (15%), Positives = 49/139 (35%), Gaps = 16/139 (11%)
Query: 466 LKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCA 525
L + ++ +++G IS ++ AL + +S + ++F EF
Sbjct: 9 LWNVFQRVDKDRSGVISDTELQQALSNGTWTPFNPVTVRSIISMFDRENKAGVNFSEFTG 68
Query: 526 AALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEEL---ASELG--LGPAVPVHAVLH 580
+ + + +++D + I EL S G L ++
Sbjct: 69 VWKYITDW----------QNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQF-HDILIR 117
Query: 581 DWIRHTDGKLSFLGFVKLL 599
+ R G+++F F++
Sbjct: 118 KFDRQGRGQIAFDDFIQGC 136
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 611 | |||
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 3pm8_A | 197 | PFCDPK2, calcium-dependent protein kinase 2; malar | 99.93 | |
| 3k21_A | 191 | PFCDPK3, calcium-dependent protein kinase 3; calci | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 2lhi_A | 176 | Calmodulin, serine/threonine-protein phosphatase c | 99.89 | |
| 2lmt_A | 148 | Calmodulin-related protein 97A; spermatogenesis, m | 99.88 | |
| 3khe_A | 191 | Calmodulin-like domain protein kinase isoform 3; c | 99.87 | |
| 2obh_A | 143 | Centrin-2; DNA repair complex EF hand superfamily | 99.87 | |
| 3u0k_A | 440 | Rcamp; fluorescent protein, calcium binding, EF-ha | 99.87 | |
| 3mse_B | 180 | Calcium-dependent protein kinase, putative; CDPKS, | 99.86 | |
| 1exr_A | 148 | Calmodulin; high resolution, disorder, metal trans | 99.86 | |
| 3i5g_C | 159 | Myosin catalytic light chain LC-1, mantle muscle; | 99.85 | |
| 2aao_A | 166 | CDPK, calcium-dependent protein kinase, isoform AK | 99.85 | |
| 3i5g_B | 153 | Myosin regulatory light chain LC-2, mantle muscle; | 99.84 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4ds7_A | 147 | Calmodulin, CAM; protein binding, metal binding, s | 99.84 | |
| 1dtl_A | 161 | Cardiac troponin C; helix-turn-helix, structural p | 99.83 | |
| 3qrx_A | 169 | Centrin; calcium-binding, EF-hand, cell division, | 99.83 | |
| 1top_A | 162 | Troponin C; contractIle system protein; 1.78A {Gal | 99.83 | |
| 2f2o_A | 179 | Calmodulin fused with calmodulin-binding domain of | 99.83 | |
| 3fwb_A | 161 | Cell division control protein 31; gene gating, com | 99.82 | |
| 3ox6_A | 153 | Calcium-binding protein 1; EF-hand, calcium-sensor | 99.82 | |
| 2bl0_C | 142 | Myosin regulatory light chain; muscle protein, sli | 99.82 | |
| 2jnf_A | 158 | Troponin C; stretch activated muscle contraction, | 99.81 | |
| 3sjs_A | 220 | URE3-BP sequence specific DNA binding protein; EF- | 99.8 | |
| 2lvv_A | 226 | Flagellar calcium-binding protein TB-24; EF-hand, | 99.8 | |
| 1m45_A | 148 | MLC1P, myosin light chain; protein-peptide complex | 99.8 | |
| 1wdc_C | 156 | Scallop myosin; calcium binding protein, muscle pr | 99.8 | |
| 3j04_B | 143 | Myosin regulatory light chain 2, smooth muscle MA | 99.79 | |
| 2mys_C | 149 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 99.79 | |
| 2ovk_C | 159 | Myosin catalytic light chain LC-1, mantle muscle, | 99.79 | |
| 1s6i_A | 188 | CDPK, calcium-dependent protein kinase SK5; EF-han | 99.79 | |
| 1qv0_A | 195 | Obelin, OBL; photoprotein, bioluminescence, atomic | 99.79 | |
| 3e3r_A | 204 | Calcyphosin, calcyphosine; human calcyphosine, EF- | 99.79 | |
| 2mys_B | 166 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 99.78 | |
| 1w7j_B | 151 | Myosin light chain 1; motor protein, unconventiona | 99.78 | |
| 2bec_A | 202 | Calcineurin B homologous protein 2; calcineurin-ho | 99.78 | |
| 3ll8_B | 155 | Calcineurin subunit B type 1; protein-peptide dock | 99.78 | |
| 1nya_A | 176 | Calerythrin; EF-hand, metal binding protein; NMR { | 99.78 | |
| 3cs1_A | 219 | Flagellar calcium-binding protein; myristoylated, | 99.77 | |
| 2ccm_A | 191 | Calexcitin; EF hand, calcium, signaling protein; 1 | 99.77 | |
| 1wdc_B | 156 | Scallop myosin; calcium binding protein, muscle pr | 99.77 | |
| 1uhk_A | 191 | Aequorin 2, aequorin; EF-hand motif, complex, lumi | 99.77 | |
| 1jfj_A | 134 | Ehcabp, calcium-binding protein; EF-hand, helix-lo | 99.77 | |
| 2sas_A | 185 | Sarcoplasmic calcium-binding protein; 2.40A {Branc | 99.77 | |
| 2ovk_B | 153 | RLC, myosin regulatory light chain LC-2, mantle mu | 99.77 | |
| 2bl0_B | 145 | Myosin regulatory light chain; muscle protein, sli | 99.77 | |
| 3dtp_E | 196 | RLC, myosin regulatory light chain; muscle protein | 99.76 | |
| 1ij5_A | 323 | Plasmodial specific LAV1-2 protein; fourty kDa cal | 99.76 | |
| 2hpk_A | 208 | Photoprotein berovin; structural genomics, PSI, pr | 99.76 | |
| 3sg6_A | 450 | Gcamp2, myosin light chain kinase, green fluoresce | 99.75 | |
| 1q80_A | 174 | SCP, sarcoplasmic calcium-binding protein; all-alp | 99.75 | |
| 2ehb_A | 207 | Calcineurin B-like protein 4; protein complex, Ca( | 99.75 | |
| 2znd_A | 172 | Programmed cell death protein 6; penta-EF-hand pro | 99.75 | |
| 2zfd_A | 226 | Calcineurin B-like protein 2; calcium binding prot | 99.75 | |
| 3akb_A | 166 | Putative calcium binding protein; EF-hand, metal b | 99.74 | |
| 3dd4_A | 229 | KV channel-interacting protein 4; EF-hands protein | 99.74 | |
| 1y1x_A | 191 | Leishmania major homolog of programmed cell death | 99.74 | |
| 1s6c_A | 183 | KV4 potassium channel-interacting protein kchip1B; | 99.73 | |
| 2ct9_A | 208 | Calcium-binding protein P22; EF-hand, metal bindin | 99.73 | |
| 1ggw_A | 140 | Protein (CDC4P); light chain, cytokinesis, cell cy | 99.72 | |
| 2l2e_A | 190 | Calcium-binding protein NCS-1; NCS1P, myristoylate | 99.72 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 1alv_A | 173 | Calpain, S-camld; calcium binding, calmodulin like | 99.72 | |
| 1jba_A | 204 | GCAP-2, protein (guanylate cyclase activating prot | 99.72 | |
| 3a8r_A | 179 | Putative uncharacterized protein; EF-hand, membran | 99.72 | |
| 2r2i_A | 198 | Guanylyl cyclase-activating protein 1; EF hand, GC | 99.71 | |
| 1g8i_A | 190 | Frequenin, neuronal calcium sensor 1; calcium bind | 99.71 | |
| 1s1e_A | 224 | KV channel interacting protein 1; kchip, calcium-b | 99.71 | |
| 2qac_A | 146 | Myosin A tail domain interacting protein MTIP; mal | 99.7 | |
| 1bjf_A | 193 | Neurocalcin delta; calcium-binding, myristoylation | 99.7 | |
| 2hps_A | 186 | Coelenterazine-binding protein with bound coelent; | 99.7 | |
| 1fpw_A | 190 | Yeast frequenin, calcium-binding protein NCS-1; EF | 99.7 | |
| 2ggz_A | 211 | Guanylyl cyclase-activating protein 3; EF hand, gu | 99.69 | |
| 1dgu_A | 183 | Calcium-saturated CIB; helical, EF-hands, blood cl | 99.69 | |
| 1juo_A | 198 | Sorcin; calcium-binding proteins, penta-EF-hand, P | 99.69 | |
| 2l4h_A | 214 | Calcium and integrin-binding protein 1; metal bind | 99.68 | |
| 2d8n_A | 207 | Recoverin; structural genomics, NPPSFA, national p | 99.68 | |
| 1gjy_A | 167 | Sorcin, CP-22, V19; calcium binding, calcium-bindi | 99.68 | |
| 2i7a_A | 174 | Calpain 13; calcium-dependent cytoplasmic cysteine | 99.67 | |
| 1k94_A | 165 | Grancalcin; penta-EF-hand protein, calcium binding | 99.66 | |
| 2f33_A | 263 | Calbindin; EF-hand, Ca2+-binding, metal binding pr | 99.66 | |
| 2f33_A | 263 | Calbindin; EF-hand, Ca2+-binding, metal binding pr | 99.65 | |
| 1ij5_A | 323 | Plasmodial specific LAV1-2 protein; fourty kDa cal | 99.65 | |
| 2jul_A | 256 | Calsenilin; EF-hand, calcium, LXXLL, DNA binding p | 99.64 | |
| 2be4_A | 272 | Hypothetical protein LOC449832; DR.36843, BC083168 | 99.63 | |
| 3bow_A | 714 | Calpain-2 catalytic subunit; cysteine protease, in | 99.6 | |
| 2be4_A | 272 | Hypothetical protein LOC449832; DR.36843, BC083168 | 99.59 | |
| 1djx_A | 624 | PLC-D1, phosphoinositide-specific phospholipase C, | 99.53 | |
| 1sjj_A | 863 | Actinin; 3-helix bundle, calponin homology domain, | 99.53 | |
| 1y1x_A | 191 | Leishmania major homolog of programmed cell death | 99.52 | |
| 3h4s_E | 135 | KCBP interacting Ca2+-binding protein; kinesin, mo | 99.51 | |
| 5pal_A | 109 | Parvalbumin; calcium-binding protein; 1.54A {Triak | 99.5 | |
| 3fs7_A | 109 | Parvalbumin, thymic; calcium-binding protein, EF-h | 99.5 | |
| 2pvb_A | 108 | Protein (parvalbumin); calcium binding protein, me | 99.47 | |
| 2znd_A | 172 | Programmed cell death protein 6; penta-EF-hand pro | 99.47 | |
| 1rwy_A | 109 | Parvalbumin alpha; EF-hand, calcium-binding, calci | 99.46 | |
| 2i7a_A | 174 | Calpain 13; calcium-dependent cytoplasmic cysteine | 99.46 | |
| 1pva_A | 110 | Parvalbumin; calcium binding; 1.65A {Esox lucius} | 99.46 | |
| 1bu3_A | 109 | Calcium-binding protein; 1.65A {Merluccius bilinea | 99.45 | |
| 1rro_A | 108 | RAT oncomodulin; calcium-binding protein; 1.30A {R | 99.45 | |
| 3sjs_A | 220 | URE3-BP sequence specific DNA binding protein; EF- | 99.44 | |
| 1qxp_A | 900 | MU-like calpain; M-calpain, MU-calpain, catalytic | 99.42 | |
| 2d8n_A | 207 | Recoverin; structural genomics, NPPSFA, national p | 99.41 | |
| 1bjf_A | 193 | Neurocalcin delta; calcium-binding, myristoylation | 99.41 | |
| 2ggz_A | 211 | Guanylyl cyclase-activating protein 3; EF hand, gu | 99.39 | |
| 1alv_A | 173 | Calpain, S-camld; calcium binding, calmodulin like | 99.38 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.37 | |
| 2zkm_X | 799 | 1-phosphatidylinositol-4,5-bisphosphate phosphodie | 99.36 | |
| 1gjy_A | 167 | Sorcin, CP-22, V19; calcium binding, calcium-bindi | 99.33 | |
| 1k94_A | 165 | Grancalcin; penta-EF-hand protein, calcium binding | 99.33 | |
| 2kyc_A | 108 | Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand p | 99.32 | |
| 1juo_A | 198 | Sorcin; calcium-binding proteins, penta-EF-hand, P | 99.31 | |
| 1qxp_A | 900 | MU-like calpain; M-calpain, MU-calpain, catalytic | 99.29 | |
| 3a4u_B | 143 | Multiple coagulation factor deficiency protein 2; | 99.28 | |
| 2l2e_A | 190 | Calcium-binding protein NCS-1; NCS1P, myristoylate | 99.27 | |
| 1fpw_A | 190 | Yeast frequenin, calcium-binding protein NCS-1; EF | 99.27 | |
| 2lv7_A | 100 | Calcium-binding protein 7; metal binding protein; | 99.27 | |
| 2r2i_A | 198 | Guanylyl cyclase-activating protein 1; EF hand, GC | 99.24 | |
| 1s6c_A | 183 | KV4 potassium channel-interacting protein kchip1B; | 99.23 | |
| 1jba_A | 204 | GCAP-2, protein (guanylate cyclase activating prot | 99.23 | |
| 2obh_A | 143 | Centrin-2; DNA repair complex EF hand superfamily | 99.22 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 4drw_A | 121 | Protein S100-A10/annexin A2 chimeric protein; atyp | 99.21 | |
| 1nya_A | 176 | Calerythrin; EF-hand, metal binding protein; NMR { | 99.21 | |
| 3dd4_A | 229 | KV channel-interacting protein 4; EF-hands protein | 99.19 | |
| 2jul_A | 256 | Calsenilin; EF-hand, calcium, LXXLL, DNA binding p | 99.18 | |
| 1jfj_A | 134 | Ehcabp, calcium-binding protein; EF-hand, helix-lo | 99.18 | |
| 2jnf_A | 158 | Troponin C; stretch activated muscle contraction, | 99.17 | |
| 1eg3_A | 261 | Dystrophin; EF-hand like domain, WW domain, struct | 99.17 | |
| 3qrx_A | 169 | Centrin; calcium-binding, EF-hand, cell division, | 99.16 | |
| 1exr_A | 148 | Calmodulin; high resolution, disorder, metal trans | 99.16 | |
| 3h4s_E | 135 | KCBP interacting Ca2+-binding protein; kinesin, mo | 99.15 | |
| 3u0k_A | 440 | Rcamp; fluorescent protein, calcium binding, EF-ha | 99.14 | |
| 3fs7_A | 109 | Parvalbumin, thymic; calcium-binding protein, EF-h | 99.14 | |
| 2lmt_A | 148 | Calmodulin-related protein 97A; spermatogenesis, m | 99.14 | |
| 2sas_A | 185 | Sarcoplasmic calcium-binding protein; 2.40A {Branc | 99.14 | |
| 1s1e_A | 224 | KV channel interacting protein 1; kchip, calcium-b | 99.14 | |
| 3bow_A | 714 | Calpain-2 catalytic subunit; cysteine protease, in | 99.14 | |
| 2lv7_A | 100 | Calcium-binding protein 7; metal binding protein; | 99.14 | |
| 2ehb_A | 207 | Calcineurin B-like protein 4; protein complex, Ca( | 99.14 | |
| 1dtl_A | 161 | Cardiac troponin C; helix-turn-helix, structural p | 99.14 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.13 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.13 | |
| 3akb_A | 166 | Putative calcium binding protein; EF-hand, metal b | 99.13 | |
| 1g8i_A | 190 | Frequenin, neuronal calcium sensor 1; calcium bind | 99.13 | |
| 3fwb_A | 161 | Cell division control protein 31; gene gating, com | 99.13 | |
| 1wy9_A | 147 | Allograft inflammatory factor 1; EF-hand, calucium | 99.13 | |
| 2ccm_A | 191 | Calexcitin; EF hand, calcium, signaling protein; 1 | 99.13 | |
| 2bl0_C | 142 | Myosin regulatory light chain; muscle protein, sli | 99.12 | |
| 4ds7_A | 147 | Calmodulin, CAM; protein binding, metal binding, s | 99.12 | |
| 2f2o_A | 179 | Calmodulin fused with calmodulin-binding domain of | 99.12 | |
| 2jjz_A | 150 | Ionized calcium-binding adapter molecule 2; EF-han | 99.12 | |
| 2opo_A | 86 | Polcalcin CHE A 3; calcium-binding protein, dimer, | 99.11 | |
| 1m45_A | 148 | MLC1P, myosin light chain; protein-peptide complex | 99.11 | |
| 3nso_A | 101 | Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, meta | 99.11 | |
| 3ll8_B | 155 | Calcineurin subunit B type 1; protein-peptide dock | 99.1 | |
| 3ohm_B | 885 | 1-phosphatidylinositol-4,5-bisphosphate phosphodi | 99.1 | |
| 1top_A | 162 | Troponin C; contractIle system protein; 1.78A {Gal | 99.1 | |
| 2kld_A | 123 | Polycystin-2; PC2, PKD2, calcium binding domain, E | 99.09 | |
| 3a4u_B | 143 | Multiple coagulation factor deficiency protein 2; | 99.09 | |
| 3e3r_A | 204 | Calcyphosin, calcyphosine; human calcyphosine, EF- | 99.09 | |
| 2zfd_A | 226 | Calcineurin B-like protein 2; calcium binding prot | 99.07 | |
| 5pal_A | 109 | Parvalbumin; calcium-binding protein; 1.54A {Triak | 99.07 | |
| 1s6j_A | 87 | CDPK, calcium-dependent protein kinase SK5; EF-han | 99.07 | |
| 2lhi_A | 176 | Calmodulin, serine/threonine-protein phosphatase c | 99.06 | |
| 3pm8_A | 197 | PFCDPK2, calcium-dependent protein kinase 2; malar | 99.05 | |
| 1bu3_A | 109 | Calcium-binding protein; 1.65A {Merluccius bilinea | 99.05 | |
| 1rwy_A | 109 | Parvalbumin alpha; EF-hand, calcium-binding, calci | 99.05 | |
| 2pvb_A | 108 | Protein (parvalbumin); calcium binding protein, me | 99.05 | |
| 3ox6_A | 153 | Calcium-binding protein 1; EF-hand, calcium-sensor | 99.04 | |
| 1uhk_A | 191 | Aequorin 2, aequorin; EF-hand motif, complex, lumi | 99.04 | |
| 1pva_A | 110 | Parvalbumin; calcium binding; 1.65A {Esox lucius} | 99.03 | |
| 1rro_A | 108 | RAT oncomodulin; calcium-binding protein; 1.30A {R | 99.02 | |
| 1qv0_A | 195 | Obelin, OBL; photoprotein, bioluminescence, atomic | 99.02 | |
| 3khe_A | 191 | Calmodulin-like domain protein kinase isoform 3; c | 99.01 | |
| 2kn2_A | 92 | Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco | 99.01 | |
| 3n22_A | 98 | Protein S100-A2; EF-hand, calcium-binding, zinc-bi | 99.01 | |
| 3k21_A | 191 | PFCDPK3, calcium-dependent protein kinase 3; calci | 99.01 | |
| 1wdc_C | 156 | Scallop myosin; calcium binding protein, muscle pr | 99.0 | |
| 2bec_A | 202 | Calcineurin B homologous protein 2; calcineurin-ho | 99.0 | |
| 1s6i_A | 188 | CDPK, calcium-dependent protein kinase SK5; EF-han | 99.0 | |
| 2l4h_A | 214 | Calcium and integrin-binding protein 1; metal bind | 98.99 | |
| 1dgu_A | 183 | Calcium-saturated CIB; helical, EF-hands, blood cl | 98.98 | |
| 3zwh_A | 104 | Protein S100-A4; Ca-binding protein-motor protein | 98.98 | |
| 2ktg_A | 85 | Calmodulin, putative; ehcam, Ca-binding protein, p | 98.98 | |
| 4eto_A | 93 | Protein S100-A4; calcium-binding protein, EF-hand, | 98.98 | |
| 1w7j_B | 151 | Myosin light chain 1; motor protein, unconventiona | 98.97 | |
| 1avs_A | 90 | Troponin C; muscle contraction, calcium-activated, | 98.97 | |
| 2lnk_A | 113 | Protein S100-A4; EF-hand, calcium binding, all alp | 98.96 | |
| 2joj_A | 77 | Centrin protein; N-terminal domain, centrin soluti | 98.96 | |
| 2mys_C | 149 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 98.95 | |
| 1iq3_A | 110 | Ralbp1-interacting protein (partner of ralbp1); EF | 98.95 | |
| 1fi6_A | 92 | EH domain protein REPS1; EPS15 homology domain, EF | 98.94 | |
| 2aao_A | 166 | CDPK, calcium-dependent protein kinase, isoform AK | 98.93 | |
| 2jjz_A | 150 | Ionized calcium-binding adapter molecule 2; EF-han | 98.93 | |
| 4drw_A | 121 | Protein S100-A10/annexin A2 chimeric protein; atyp | 98.93 | |
| 2ovk_C | 159 | Myosin catalytic light chain LC-1, mantle muscle, | 98.93 | |
| 2hpk_A | 208 | Photoprotein berovin; structural genomics, PSI, pr | 98.93 | |
| 1tiz_A | 67 | Calmodulin-related protein, putative; helix-turn-h | 98.93 | |
| 2hps_A | 186 | Coelenterazine-binding protein with bound coelent; | 98.92 | |
| 3nso_A | 101 | Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, meta | 98.92 | |
| 2b1u_A | 71 | Calmodulin-like protein 5; CLSP, calmodulin-like S | 98.92 | |
| 2h2k_A | 106 | Protein S100-A13; calcium binding protein, metal b | 98.92 | |
| 3sg6_A | 450 | Gcamp2, myosin light chain kinase, green fluoresce | 98.92 | |
| 1c07_A | 95 | Protein (epidermal growth factor receptor pathway | 98.92 | |
| 3mse_B | 180 | Calcium-dependent protein kinase, putative; CDPKS, | 98.91 | |
| 1fi6_A | 92 | EH domain protein REPS1; EPS15 homology domain, EF | 98.91 | |
| 2lnk_A | 113 | Protein S100-A4; EF-hand, calcium binding, all alp | 98.91 | |
| 1xk4_C | 113 | Calgranulin B; S100 family, heterotetramer, metal | 98.91 | |
| 2pmy_A | 91 | RAS and EF-hand domain-containing protein; rasef, | 98.91 | |
| 1j7q_A | 86 | CAVP, calcium vector protein; EF-hand family, calc | 98.91 | |
| 2h2k_A | 106 | Protein S100-A13; calcium binding protein, metal b | 98.91 | |
| 3qr0_A | 816 | Phospholipase C-beta (PLC-beta); PH domain, EF han | 98.9 | |
| 2y5i_A | 99 | S100Z, S100 calcium binding protein Z; metal-bindi | 98.9 | |
| 1j55_A | 95 | S-100P protein; metal binding protein; 2.00A {Homo | 98.9 | |
| 2bl0_B | 145 | Myosin regulatory light chain; muscle protein, sli | 98.9 | |
| 2kz2_A | 94 | Calmodulin, CAM; TR2C, metal binding protein; NMR | 98.89 | |
| 2joj_A | 77 | Centrin protein; N-terminal domain, centrin soluti | 98.89 | |
| 3j04_B | 143 | Myosin regulatory light chain 2, smooth muscle MA | 98.89 | |
| 2kgr_A | 111 | Intersectin-1; structure, alternative splicing, ca | 98.89 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 98.89 | |
| 1c07_A | 95 | Protein (epidermal growth factor receptor pathway | 98.88 | |
| 4eto_A | 93 | Protein S100-A4; calcium-binding protein, EF-hand, | 98.88 | |
| 3zwh_A | 104 | Protein S100-A4; Ca-binding protein-motor protein | 98.88 | |
| 2ktg_A | 85 | Calmodulin, putative; ehcam, Ca-binding protein, p | 98.88 | |
| 3nxa_A | 100 | Protein S100-A16; S100 family, calcium binding pro | 98.88 | |
| 3n22_A | 98 | Protein S100-A2; EF-hand, calcium-binding, zinc-bi | 98.88 | |
| 3nxa_A | 100 | Protein S100-A16; S100 family, calcium binding pro | 98.88 | |
| 3i5g_C | 159 | Myosin catalytic light chain LC-1, mantle muscle; | 98.88 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.88 | |
| 2kyc_A | 108 | Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand p | 98.88 | |
| 1iq3_A | 110 | Ralbp1-interacting protein (partner of ralbp1); EF | 98.88 | |
| 1q80_A | 174 | SCP, sarcoplasmic calcium-binding protein; all-alp | 98.88 | |
| 1avs_A | 90 | Troponin C; muscle contraction, calcium-activated, | 98.87 | |
| 2kgr_A | 111 | Intersectin-1; structure, alternative splicing, ca | 98.87 | |
| 1wlz_A | 105 | DJBP, CAP-binding protein complex interacting prot | 98.87 | |
| 3rm1_A | 92 | Protein S100-B; alpha-helical, EF hand, metal bind | 98.87 | |
| 2ct9_A | 208 | Calcium-binding protein P22; EF-hand, metal bindin | 98.86 | |
| 1k9u_A | 78 | Polcalcin PHL P 7; pollen allergen, calcium-bindin | 98.86 | |
| 1j55_A | 95 | S-100P protein; metal binding protein; 2.00A {Homo | 98.86 | |
| 1qjt_A | 99 | EH1, epidermal growth factor receptor substrate su | 98.86 | |
| 2opo_A | 86 | Polcalcin CHE A 3; calcium-binding protein, dimer, | 98.86 | |
| 2mys_B | 166 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 98.85 | |
| 1eh2_A | 106 | EPS15; calcium binding, signaling domain, NPF bind | 98.85 | |
| 2kn2_A | 92 | Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco | 98.85 | |
| 1c7v_A | 81 | CAVP, calcium vector protein; EF-hand family, calc | 98.84 | |
| 2kax_A | 92 | Protein S100-A5; EF-hand, calcium binding protien, | 98.83 | |
| 1tiz_A | 67 | Calmodulin-related protein, putative; helix-turn-h | 98.83 |
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-74 Score=632.04 Aligned_cols=442 Identities=32% Similarity=0.590 Sum_probs=382.4
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+.++|++++.||+|+||.||+|+... ++..||||++.+..... .....+.+|+.+++.|. ||||++++++|.+.
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 108 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKV---THVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLD-HPNIMKLYDFFEDK 108 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETT---TCCEEEEEEEEC------CTTHHHHHHHHHHTTCC-CTTBCCEEEEEECS
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECC---CCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeC
Confidence 356789999999999999999999776 68999999997654222 22467889999999997 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+.+|+|||||+||+|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||+...+..+.+||+|||++.
T Consensus 109 ~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 109 RNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred CEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 9999999999999999988766 569999999999999999999999999999999999999765567789999999998
Q ss_pred ccCCCCcccccccCCCcCcchhhcCCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 312 FVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
...........+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+....+++..+......++...|..++++
T Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 267 (494)
T 3lij_A 188 VFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG 267 (494)
T ss_dssp ECBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHH
T ss_pred ECCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHH
Confidence 87766666778899999999999988999999999999999999999999999999999999998888887778899999
Q ss_pred HHHHHHHhcccCccCCCCHHHHHcCcccCCCCC-----CCCchhHHHHHHHHHHhhcchHHHHHHHhhhhcc-hhhHHHH
Q 007253 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND-----VKVPLDVIIFKLMKAYMRSSSLRKAALRALSKTL-TVDELFY 465 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~l-~~~e~~~ 465 (611)
+.+||++||+.||.+|||+.++|+||||+.... ...+........++++.....+++..+..+...+ +++++++
T Consensus 268 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~qa~l~~ia~~~~~~~~~~~ 347 (494)
T 3lij_A 268 AKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKLTSQEETKE 347 (494)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHHHHHHHHHHHSCCHHHHHH
T ss_pred HHHHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHHHHHHHHHHHHHhcccHHHHHH
Confidence 999999999999999999999999999986431 2233333456677888888999999999998877 8899999
Q ss_pred HHHHhhhcCCCCCCcccHHHHHHHHHhhccc-------ccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHH
Q 007253 466 LKEQYALLEPNKNGTISLENVKSALMKNATD-------AMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDR 538 (611)
Q Consensus 466 l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~-------~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~ 538 (611)
++++|..+|.|++|.|+.+||..+|..++.. ...+.++..+|..+|.|++|.|+|+||+.++........
T Consensus 348 l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~~G~I~~~EF~~~~~~~~~~~~--- 424 (494)
T 3lij_A 348 LTDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAADFDRNGYIDYSEFVTVAMDRKSLLS--- 424 (494)
T ss_dssp HHHHHHHHCTTCSSEECHHHHHHTTHHHHSSCCCCC--CHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHSCHHHHTC---
T ss_pred HHHHHHHhCcCCCCeEcHHHHHHHHHHhcccccccccccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhhhcccc---
Confidence 9999999999999999999999998887642 344667889999999999999999999998877644433
Q ss_pred HHHHHHHHHhHHhcCCCCcccHHHHHHHhcC--CCCccHHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 539 WEQHARCAYELFEKDGNRAIVIEELASELGL--GPAVPVHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 539 ~~~~~~~~F~~~D~d~~G~It~eEl~~~l~~--~~~~~~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
++.++.+|+.||+|++|+|+.+||++++.. .....++++|+.+|.|+||.|+|+||+++|.++.
T Consensus 425 -~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~~ 490 (494)
T 3lij_A 425 -KDKLESAFQKFDQDGNGKISVDELASVFGLDHLESKTWKEMISGIDSNNDGDVDFEEFCKMIQKLC 490 (494)
T ss_dssp -HHHHHHHHHHHCTTCSSEECHHHHHHHC-CCSCCCHHHHHHHHTTCSSSSSSEEHHHHHHHHHHHS
T ss_pred -HHHHHHHHHHHCCCCCCcCCHHHHHHHHHhcCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHhhc
Confidence 667899999999999999999999999963 1223389999999999999999999999998865
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-73 Score=626.23 Aligned_cols=445 Identities=32% Similarity=0.535 Sum_probs=383.0
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCH----------HHHHHHHHHHHHHHHhcCCCC
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA----------IAIEDVRREVKILRALTGHNN 220 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~~h~~ 220 (611)
..+.++|+++++||+|+||.||+|+... +++.||||++.+...... ...+.+.+|+.++++|. |||
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpn 107 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKN---GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPN 107 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETT---TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC-CTT
T ss_pred CCcccceEEEeEecccCCeEEEEEEECC---CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC-CCC
Confidence 3467889999999999999999999776 689999999976543211 23567889999999997 999
Q ss_pred eeEEEEEEeeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCc
Q 007253 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS 300 (611)
Q Consensus 221 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~ 300 (611)
|+++++++.+.+.+|||||||+||+|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||+...+...
T Consensus 108 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCS
T ss_pred CCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCc
Confidence 999999999999999999999999999988765 5699999999999999999999999999999999999997544445
Q ss_pred eEEEeecccccccCCCCcccccccCCCcCcchhhcCCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC
Q 007253 301 VLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 380 (611)
Q Consensus 301 ~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~ 380 (611)
.+||+|||++............+||+.|+|||++.+.++.++|||||||++|+|++|..||.+....+++..+......+
T Consensus 187 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 266 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF 266 (504)
T ss_dssp SEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred cEEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 79999999999887666667789999999999999889999999999999999999999999999999999999888777
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCCCCc----hhHHHHHHHHHHhhcchHHHHHHHhhhh
Q 007253 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVP----LDVIIFKLMKAYMRSSSLRKAALRALSK 456 (611)
Q Consensus 381 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~~~l~~~~~ 456 (611)
+...|..+++++.+||++||+.||.+|||+.++|+||||+........ .....+..++++....++++..+..+..
T Consensus 267 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~~a~l~~i~~ 346 (504)
T 3q5i_A 267 DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGS 346 (504)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCSHHHHHHHHHHHH
T ss_pred CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHHHHHHHHHHHhhc
Confidence 766677899999999999999999999999999999999876543321 2223456677777788999999999887
Q ss_pred cc-hhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcc-------cccccCChhHHHhhcCCCCCCcccHHHHHHHHc
Q 007253 457 TL-TVDELFYLKEQYALLEPNKNGTISLENVKSALMKNAT-------DAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAAL 528 (611)
Q Consensus 457 ~l-~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~-------~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~ 528 (611)
.+ +++++.+++++|..+|.|+||.|+.+||..+|..++. ...++.++..+|..+|.|++|.|+|+||+.++.
T Consensus 347 ~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~ 426 (504)
T 3q5i_A 347 KLTTLEERKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEVDFDKNGYIEYSEFISVCM 426 (504)
T ss_dssp HTSCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHC--CCSCCCHHHHHHHHHHHHCTTCSSSEEHHHHHHHHS
T ss_pred cCCcHHHHHHHHHHHHeeCCCCCCeEcHHHHHHHHHHhhhcccccccccccHHHHHHHHHHhCCCCCCcEeHHHHHHHHH
Confidence 76 8899999999999999999999999999999877632 235567889999999999999999999999887
Q ss_pred chhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhcC-CC-CccHHHHHHHHhcCCCCceeHHHHHHHHhhcch
Q 007253 529 SVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELGL-GP-AVPVHAVLHDWIRHTDGKLSFLGFVKLLHGVSS 604 (611)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~~-~~-~~~~~~~~~~~D~~~dG~is~~eF~~~l~~~~~ 604 (611)
....... ++.++.+|+.||+|++|+|+.+||+.++.. +. +..++++|..+|.|+||.|+|+||+++|.+...
T Consensus 427 ~~~~~~~----~~~~~~~F~~~D~d~dG~Is~~El~~~l~~~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~~~ 500 (504)
T 3q5i_A 427 DKQILFS----EERLRRAFNLFDTDKSGKITKEELANLFGLTSISEKTWNDVLGEADQNKDNMIDFDEFVSMMHKICD 500 (504)
T ss_dssp CHHHHTC----HHHHHHHHHHHCTTCCSEECHHHHHHHTTCSCCCHHHHHHHHHTTCSSCSSSEEHHHHHHHHHHHC-
T ss_pred hhhcccC----HHHHHHHHHHhcCCCCCcCcHHHHHHHHhhCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHhcc
Confidence 7644333 668899999999999999999999999963 21 222899999999999999999999999988753
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-74 Score=626.48 Aligned_cols=443 Identities=31% Similarity=0.559 Sum_probs=386.2
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+.++|++++.||+|+||.||+|+... +|+.||||++.+.........+.+.+|+.++++|. ||||+++++++.+.
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 98 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKI---TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFEDK 98 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC-CTTBCCEEEEEECS
T ss_pred cccCceEEeeEEecCCCEEEEEEEECC---CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeC
Confidence 456789999999999999999999775 68999999997665544445678999999999997 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+.+|+|||||.+|+|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||+...+.++.+||+|||++.
T Consensus 99 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 99 GYFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp SEEEEEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred CEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 9999999999999999988655 569999999999999999999999999999999999999765567889999999998
Q ss_pred ccCCCCcccccccCCCcCcchhhcCCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 312 FVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
...........+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+....+++..+......+....|..++++
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 257 (484)
T 3nyv_A 178 HFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES 257 (484)
T ss_dssp HBCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHH
T ss_pred EcccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHH
Confidence 87766666677899999999999989999999999999999999999999999999999999998877777777889999
Q ss_pred HHHHHHHhcccCccCCCCHHHHHcCcccCCCCCC----CCchhHHHHHHHHHHhhcchHHHHHHHhhhhcc-hhhHHHHH
Q 007253 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV----KVPLDVIIFKLMKAYMRSSSLRKAALRALSKTL-TVDELFYL 466 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~l-~~~e~~~l 466 (611)
+++||++||+.||.+|||+.++|+||||+..... ..+........++++.....+.+..+..+...+ ++++++++
T Consensus 258 ~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~qa~l~~i~~~~~~~~~~~~l 337 (484)
T 3nyv_A 258 AKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLTSQDETKEL 337 (484)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHHhhhhHHHHHHHHHHHhccCcHHHHHHH
Confidence 9999999999999999999999999999865432 334344556678888889999999999998776 88899999
Q ss_pred HHHhhhcCCCCCCcccHHHHHHHHHhhc---ccccc-------cCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhh
Q 007253 467 KEQYALLEPNKNGTISLENVKSALMKNA---TDAMK-------DSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEAL 536 (611)
Q Consensus 467 ~~~F~~~D~d~~G~Is~~e~~~~l~~~~---~~~~~-------~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~ 536 (611)
+++|..+|.|+||.|+.+||..++.... +...+ +.++..+|+.+|.|++|.|+|+||+.++........
T Consensus 338 ~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~D~d~~g~i~~~Ef~~~~~~~~~~~~- 416 (484)
T 3nyv_A 338 TAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLDASAVEHEVDQVLDAVDFDKNGYIEYSEFVTVAMDRKTLLS- 416 (484)
T ss_dssp HHHHHHHCTTCSSEEEHHHHHHHHHHHHC----CGGGCSHHHHHHHHHHHHHHHTCCTTSEEEHHHHHHHHHHHHHHHH-
T ss_pred HHHHHHhCcCCCceEeHHHHHHHHHHHhhhcccccccccccccHHHHHHHHHHhCCCCCCeEeHHHHHHHHHhccccCc-
Confidence 9999999999999999999976654432 22333 567889999999999999999999998766543333
Q ss_pred HHHHHHHHHHHhHHhcCCCCcccHHHHHHHhcC-C-CCccHHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 537 DRWEQHARCAYELFEKDGNRAIVIEELASELGL-G-PAVPVHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 537 ~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~~-~-~~~~~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
++.++.+|+.||+|++|+|+.+||+.++.. + ....++++|+.+|.|+||.|+|+||+++|.++.
T Consensus 417 ---~~~~~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~D~d~dG~i~~~Ef~~~~~~~~ 482 (484)
T 3nyv_A 417 ---RERLERAFRMFDSDNSGKISSTELATIFGVSDVDSETWKSVLSEVDKNNDGEVDFDEFQQMLLKLC 482 (484)
T ss_dssp ---HHHHHHHHHHHCTTCCSEEEHHHHHHHHHHTTCCHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHTT
T ss_pred ---HHHHHHHHHHHCCCCCCcCCHHHHHHHHHhcCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHhhh
Confidence 678999999999999999999999999952 2 222289999999999999999999999998763
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-73 Score=624.16 Aligned_cols=441 Identities=32% Similarity=0.589 Sum_probs=369.2
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+.++|++++.||+|+||.||+|+... +|+.||||++.+..... .....+.+|+.++++|. ||||+++++++.+.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 93 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAKN-KDTSTILREVELLKKLD-HPNIMKLFEILEDS 93 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETT---TCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECC---CCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCC-CCCcCeEEEEEEcC
Confidence 456889999999999999999999765 68999999986432211 22467889999999997 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+.+|+|||||.||+|.+.+... ..+++..++.++.||+.||.|||++|||||||||+|||+...+.++.+||+|||++.
T Consensus 94 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 94 SSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 9999999999999999988766 569999999999999999999999999999999999999766667789999999998
Q ss_pred ccCCCCcccccccCCCcCcchhhcCCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 312 FVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
...........+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+....+++..+......+....|..++++
T Consensus 173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 252 (486)
T 3mwu_A 173 CFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252 (486)
T ss_dssp TBCCC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHH
T ss_pred ECCCCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHH
Confidence 87766666777899999999999989999999999999999999999999999999999999988877777778889999
Q ss_pred HHHHHHHhcccCccCCCCHHHHHcCcccCCCCCCCC-----chhHHHHHHHHHHhhcchHHHHHHHhhhhcc-hhhHHHH
Q 007253 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKV-----PLDVIIFKLMKAYMRSSSLRKAALRALSKTL-TVDELFY 465 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~l-~~~e~~~ 465 (611)
+.+||++||+.||.+|||+.++|+||||+....... +........++++.....+++..+..+...+ +.+++++
T Consensus 253 ~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ia~~l~~~~~~~~ 332 (486)
T 3mwu_A 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALLYMASKLTTLDETKQ 332 (486)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCCHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccHHHHHH
Confidence 999999999999999999999999999987654321 2223346667888888999999999998876 8899999
Q ss_pred HHHHhhhcCCCCCCcccHHHHHHHHHhhc---ccccc----------cCChhHHHhhcCCCCCCcccHHHHHHHHcchhh
Q 007253 466 LKEQYALLEPNKNGTISLENVKSALMKNA---TDAMK----------DSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQ 532 (611)
Q Consensus 466 l~~~F~~~D~d~~G~Is~~e~~~~l~~~~---~~~~~----------~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~ 532 (611)
++++|..+|.|+||.|+.+||..++.... +...+ +.++..+|..+|.|++|.|+|+||+.++.....
T Consensus 333 l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~Ef~~~~~~~~~ 412 (486)
T 3mwu_A 333 LTEIFRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQNEGSTIEDQIDSLMPLLDMDGSGSIEYSEFIASAIDRTI 412 (486)
T ss_dssp HHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHTCCGGGHHHHTSSCHHHHHHHHHHHHCTTCCSSBCHHHHHHHHSCTTT
T ss_pred HHHHHHHhCCCCCceeeHHHHHHHHHHhhhhhcccchhcccccchhhHHHHHHHHHHhcCCCCCcCcHHHHHHHHHhhhc
Confidence 99999999999999999999977665442 11222 567889999999999999999999998876554
Q ss_pred HHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 533 LEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 533 ~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
... ++.++.+|+.||+|++|+|+.+||++++. +|...+ ++++|..+|.|+||.|+|+||+++|...
T Consensus 413 ~~~----~~~~~~~F~~~D~d~dG~Is~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~ 482 (486)
T 3mwu_A 413 LLS----RERMERAFKMFDKDGSGKISTKELFKLFSQADSSIQMEELESIIEQVDNNKDGEVDFNEFVEMLQNF 482 (486)
T ss_dssp TCC----HHHHHHHHHHHCSSCSSSBCSSCC--------------------CCCCSSCSSSBCHHHHHHHHHHH
T ss_pred cch----HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHh
Confidence 443 56789999999999999999999999995 443333 8899999999999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-62 Score=498.97 Aligned_cols=257 Identities=31% Similarity=0.597 Sum_probs=232.3
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++++.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|+++|++|+ |||||+++++|.+++.+
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~---~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~ 107 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKL 107 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred cccEEEEEEecccCeEEEEEEECC---CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEE
Confidence 579999999999999999999877 69999999997654333344678999999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
|||||||+||+|.+++.+. +.+++..++.|+.||+.||+|||++|||||||||+|||| +.++++||+|||+|+.+.
T Consensus 108 yivmEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl---~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE---cCCCCEEEEEcCCceecC
Confidence 9999999999999998765 579999999999999999999999999999999999999 678889999999999875
Q ss_pred CCC---cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 315 PDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 315 ~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
... ...+.+||+.|||||++. +.|+.++|||||||++|+|++|+.||.+.+..+++..|.+....++. .+++
T Consensus 184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~ 259 (311)
T 4aw0_A 184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE----KFFP 259 (311)
T ss_dssp TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TCCH
T ss_pred CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----ccCH
Confidence 432 456789999999999997 56999999999999999999999999999999999999998876653 6899
Q ss_pred HHHHHHHHhcccCccCCCCHHH------HHcCcccCCCC
Q 007253 391 EARDFVKRLLNKDPRKRLTAAQ------ALSHPWIKNSN 423 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~~------ll~hp~~~~~~ 423 (611)
++++||++||++||++|||+.| +++||||++.+
T Consensus 260 ~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id 298 (311)
T 4aw0_A 260 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 298 (311)
T ss_dssp HHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred HHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence 9999999999999999999987 68999999764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-61 Score=483.85 Aligned_cols=255 Identities=35% Similarity=0.633 Sum_probs=212.8
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++++.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|+.++++|+ |||||++++++.+++.+
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~ 88 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTT---TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVIKSKDEI 88 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTT---TCCEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEE
Confidence 579999999999999999999766 68999999998776666666778999999999998 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
||||||| +|+|.+++.++ +.+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+...
T Consensus 89 ~ivmEy~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 89 IMVIEYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp EEEEECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTCCEEECCSSCC----
T ss_pred EEEEeCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE---CCCCCEEEeecCCCeecC
Confidence 9999999 67999998765 579999999999999999999999999999999999999 677889999999999877
Q ss_pred CCCcccccccCCCcCcchhhcC-CC-CCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 315 PDERLNDIVGSAYYVAPEVLHR-SY-STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
......+.+||+.|||||++.+ .| +.++|||||||++|+|++|+.||.+.+...++..+......++ ..+|+++
T Consensus 164 ~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 239 (275)
T 3hyh_A 164 DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----KFLSPGA 239 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTSCHHH
T ss_pred CCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHH
Confidence 6666677899999999999974 34 6899999999999999999999999999899999988776654 3689999
Q ss_pred HHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
++||.+||++||++|||+.|+|+||||+..
T Consensus 240 ~~li~~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 240 AGLIKRMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred HHHHHHHccCChhHCcCHHHHHcCcccccC
Confidence 999999999999999999999999999753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-61 Score=495.29 Aligned_cols=258 Identities=30% Similarity=0.566 Sum_probs=228.5
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
...|+++++||+|+||.||+|+++. +|+.||||++....... .+.+.+|+.+|+.|+ |||||+++++|.+++.
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~---tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~ 145 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRS---SGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQ-HENVVEMYNSYLVGDE 145 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECC---CCCEEEEEEEecCchhH---HHHHHHHHHHHHhCC-CCCCCcEEEEEEECCE
Confidence 3569999999999999999999876 69999999997543322 345789999999998 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|||||||+||+|.+++.. +.+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+.+
T Consensus 146 ~~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~ 220 (346)
T 4fih_A 146 LWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQV 220 (346)
T ss_dssp EEEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE---CCCCCEEEecCcCceec
Confidence 9999999999999998854 469999999999999999999999999999999999999 67788999999999877
Q ss_pred CCC-CcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 314 RPD-ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
... ....+.+||+.|||||++. ..|+.++|||||||++|||++|+.||.+.+..+.+..+....+. ....+..++++
T Consensus 221 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-~~~~~~~~s~~ 299 (346)
T 4fih_A 221 SKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-RLKNLHKVSPS 299 (346)
T ss_dssp CSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC-CCSCGGGSCHH
T ss_pred CCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCCccccCCHH
Confidence 544 3556789999999999997 56999999999999999999999999999888888888765432 22334678999
Q ss_pred HHHHHHHhcccCccCCCCHHHHHcCcccCCCCC
Q 007253 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~ 424 (611)
+++||.+||++||++|||+.|+|+||||+....
T Consensus 300 ~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 300 LKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence 999999999999999999999999999987653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-61 Score=496.48 Aligned_cols=260 Identities=26% Similarity=0.518 Sum_probs=226.3
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|+++++||+|+||.||+|+++. +|+.||||++.+... .....+.+.+|+.+|++|+ |||||+++++|.+++.
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~ 97 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTE---DGRQYVIKEINISRM-SSKEREESRREVAVLANMK-HPNIVQYRESFEENGS 97 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETT---TCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred ccceEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCC-CCCCCcEEEEEEECCE
Confidence 3689999999999999999999876 689999999987654 3445678999999999998 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 234 VYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
+|||||||+||+|.++|..+. ..+++..++.|+.||+.||.|||++|||||||||+|||| +.++.|||+|||+|+.
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~ 174 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARV 174 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE---CTTCCEEECSTTEESC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCCEEEccccccee
Confidence 999999999999999997654 458999999999999999999999999999999999999 5778899999999998
Q ss_pred cCCCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 313 VRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 313 ~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
+.... ...+.+||+.|||||++. ..|+.++|||||||++|||++|+.||.+.+..+++..+....... .+..+++
T Consensus 175 ~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---~~~~~s~ 251 (350)
T 4b9d_A 175 LNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP---VSLHYSY 251 (350)
T ss_dssp CCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---CCTTSCH
T ss_pred ecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC---CCccCCH
Confidence 76433 345678999999999997 469999999999999999999999999999999999988876432 2357899
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHcCcccCCCCC
Q 007253 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~ 424 (611)
++.+||.+||++||++|||+.|+|+||||+...+
T Consensus 252 ~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~ 285 (350)
T 4b9d_A 252 DLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIE 285 (350)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTTGG
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCHHhhcCCC
Confidence 9999999999999999999999999999986543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-60 Score=499.22 Aligned_cols=259 Identities=30% Similarity=0.559 Sum_probs=229.7
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..+.|+++++||+|+||.||+|+++. +|+.||||++....... .+.+.+|+.+|+.|+ |||||+++++|.+++
T Consensus 149 p~~~y~~~~~iG~G~fG~V~~a~~~~---tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~ 221 (423)
T 4fie_A 149 PRSYLDNFIKIGEGSTGIVCIATVRS---SGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQ-HENVVEMYNSYLVGD 221 (423)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred hhHhcEeeeEeccCcCcEEEEEEECC---CCCEEEEEEEeccchhH---HHHHHHHHHHHHhCC-CCCCCceEEEEEECC
Confidence 34679999999999999999999876 69999999997654332 356889999999998 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.+|||||||+||+|.+++.. +.+++..++.|+.||+.||.|||++|||||||||+|||| +.++.|||+|||+|+.
T Consensus 222 ~~~iVmEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl---~~~g~vKl~DFGla~~ 296 (423)
T 4fie_A 222 ELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQ 296 (423)
T ss_dssp EEEEEEECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE---CTTCCEEECCCTTCEE
T ss_pred EEEEEEeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEecCccceE
Confidence 99999999999999998854 469999999999999999999999999999999999999 6778899999999987
Q ss_pred cCCC-CcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 313 VRPD-ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 313 ~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
+... ....+.+||++|||||++. ..|+.++|||||||++|||++|+.||.+....+.+..+....+. ....+..+++
T Consensus 297 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-~~~~~~~~s~ 375 (423)
T 4fie_A 297 VSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-RLKNLHKVSP 375 (423)
T ss_dssp CCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCSCTTSSCH
T ss_pred CCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCcccccCCH
Confidence 7544 3556789999999999987 56999999999999999999999999999988888888765432 2334567999
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHcCcccCCCCC
Q 007253 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~ 424 (611)
++++||.+||++||++|||+.|+|+||||+....
T Consensus 376 ~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~ 409 (423)
T 4fie_A 376 SLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 409 (423)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence 9999999999999999999999999999987643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-61 Score=485.27 Aligned_cols=259 Identities=29% Similarity=0.515 Sum_probs=223.8
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++++.||+|+||.||+|+...+..+++.||||++.+...... ....+.+|+.+|++|+ |||||+++++|.+++.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVN-HPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCC-CTTEECEEEEEEETTEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEE
Confidence 579999999999999999999876555789999999976533221 2235788999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
|||||||+||+|.+++.+. +.+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+...
T Consensus 102 ~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EEEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTSCEEEESSEEEEC--
T ss_pred EEEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE---cCCCCEEecccccceecc
Confidence 9999999999999998765 579999999999999999999999999999999999999 678889999999998654
Q ss_pred C-CCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 315 P-DERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 315 ~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
. .....+.+||+.|||||++. +.|+.++|||||||++|||++|+.||.+.+..+++..+.+....++ ..+|+++
T Consensus 178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 253 (304)
T 3ubd_A 178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP----QFLSPEA 253 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHH
T ss_pred CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CcCCHHH
Confidence 3 33456789999999999986 6699999999999999999999999999999999999998876654 3689999
Q ss_pred HHHHHHhcccCccCCCC-----HHHHHcCcccCCCC
Q 007253 393 RDFVKRLLNKDPRKRLT-----AAQALSHPWIKNSN 423 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rpt-----~~~ll~hp~~~~~~ 423 (611)
.+||++||++||++||| ++|+++||||++.+
T Consensus 254 ~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id 289 (304)
T 3ubd_A 254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID 289 (304)
T ss_dssp HHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence 99999999999999998 58999999998753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-60 Score=475.75 Aligned_cols=254 Identities=22% Similarity=0.383 Sum_probs=216.8
Q ss_pred eeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee----CC
Q 007253 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED----TD 232 (611)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~----~~ 232 (611)
|++.++||+|+||.||+|.+.. +++.||+|++.+... .....+.+.+|+.++++|+ |||||+++++|.+ ++
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~ 102 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEETTEE
T ss_pred EEeeeEEecCcCcEEEEEEECC---CCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEeeccCCCc
Confidence 4788899999999999999876 689999999976543 3445678999999999998 9999999999975 35
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
.+|||||||+||+|.+++.+. +.+++..++.|+.||+.||.|||++| ||||||||+||||+ +.++.+||+|||+|
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DFGla 179 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES--STTSCEEECCTTGG
T ss_pred EEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE--CCCCCEEEEeCcCC
Confidence 689999999999999998765 57999999999999999999999998 99999999999994 24678999999999
Q ss_pred cccCCCCcccccccCCCcCcchhhcCCCCCcchhhHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCCCCCCCCCCC
Q 007253 311 DFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESG-IFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s 389 (611)
+... .....+.+||+.|||||++.+.|+.++|||||||++|||+||+.||.+..... ++..+..... +......++
T Consensus 180 ~~~~-~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~ 256 (290)
T 3fpq_A 180 TLKR-ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAI 256 (290)
T ss_dssp GGCC-TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCC
T ss_pred EeCC-CCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC--CCCCCccCC
Confidence 8654 34456789999999999999889999999999999999999999997655444 4444433321 222234578
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHcCcccCC
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
+++.+||.+||++||++|||+.|+|+||||++
T Consensus 257 ~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 99999999999999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-58 Score=474.82 Aligned_cols=256 Identities=26% Similarity=0.368 Sum_probs=221.1
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
...|++.++||+|+||.||+|+++. +|+.||||++..... ..+|+.+++.|+ |||||+++++|.+++.
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~---~g~~vAiK~i~~~~~--------~~~E~~il~~l~-HpnIV~l~~~~~~~~~ 124 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQ---TGFQCAVKKVRLEVF--------RVEELVACAGLS-SPRIVPLYGAVREGPW 124 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTC--------CTHHHHTTTTCC-CTTBCCEEEEEEETTE
T ss_pred hhheEeCcEeccCCCeEEEEEEECC---CCCEEEEEEECHHHh--------HHHHHHHHHhCC-CCCCCcEEEEEEECCE
Confidence 3569999999999999999999876 699999999976432 246999999998 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCc-eEEEeecccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS-VLKAIDFGLSDF 312 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~-~vkl~DfG~a~~ 312 (611)
+|||||||+||+|.+++... +.+++..++.|+.||+.||.|||++|||||||||+|||| +.++ .+||+|||+|+.
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~~vKl~DFGla~~ 200 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL---SSDGSRAALCDFGHALC 200 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEE---CTTSCCEEECCCTTCEE
T ss_pred EEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE---eCCCCEEEEeeCCCCeE
Confidence 99999999999999998765 579999999999999999999999999999999999999 4555 599999999987
Q ss_pred cCCCCc------ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 007253 313 VRPDER------LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (611)
Q Consensus 313 ~~~~~~------~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (611)
+..+.. ....+||+.|||||++. +.|+.++|||||||++|||++|+.||.+....+++..+....+.+. ..+
T Consensus 201 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~ 279 (336)
T 4g3f_A 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR-EIP 279 (336)
T ss_dssp C------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG-GSC
T ss_pred ccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch-hcC
Confidence 754321 23468999999999987 5699999999999999999999999998887777888887665432 234
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHH-------------HcCcccCCCCCCC
Q 007253 386 PSLSSEARDFVKRLLNKDPRKRLTAAQA-------------LSHPWIKNSNDVK 426 (611)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rpt~~~l-------------l~hp~~~~~~~~~ 426 (611)
+.+++++.+||.+||++||.+|||+.|+ |+|||++...+++
T Consensus 280 ~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr 333 (336)
T 4g3f_A 280 PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR 333 (336)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence 6799999999999999999999999998 5799998765443
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-56 Score=472.62 Aligned_cols=262 Identities=30% Similarity=0.502 Sum_probs=223.5
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee-
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED- 230 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~- 230 (611)
.+.++|++++.||+|+||.||+|+++. +|+.||||++.+.. ......+.+.+|+++|+.|+ |||||++++++..
T Consensus 51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~---t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 125 (398)
T 4b99_A 51 DVGDEYEIIETIGNGAYGVVSSARRRL---TGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHFK-HDNIIAIKDILRPT 125 (398)
T ss_dssp CCCSSEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCS
T ss_pred CCCCCeEEEEEEecccCeEEEEEEECC---CCCEEEEEEECccc-cchHHHHHHHHHHHHHHhcC-CCCcceEeeeeecc
Confidence 346789999999999999999999876 69999999997653 34455677889999999998 9999999999764
Q ss_pred -----CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 231 -----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 231 -----~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
.+.+|||||||+ |+|.+++.. .+.+++..++.|+.||+.||.|||++|||||||||+|||+ +.++.+||+
T Consensus 126 ~~~~~~~~~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~---~~~~~~Ki~ 200 (398)
T 4b99_A 126 VPYGEFKSVYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIG 200 (398)
T ss_dssp SCTTTCCCEEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEEC
T ss_pred cccccCCEEEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc---CCCCCEEEe
Confidence 367999999995 689888754 4679999999999999999999999999999999999999 678889999
Q ss_pred ecccccccCCC-----CcccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Q 007253 306 DFGLSDFVRPD-----ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (611)
Q Consensus 306 DfG~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~ 378 (611)
|||+|+.+... ....+.+||++|||||++.+ .|+.++||||+|||+|||++|+.||.+.+..+.+..|.....
T Consensus 201 DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g 280 (398)
T 4b99_A 201 DFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLG 280 (398)
T ss_dssp CCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHC
T ss_pred ecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999876432 23456799999999998863 579999999999999999999999999998888888765433
Q ss_pred CCCCC---------------------------CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 379 SFDEA---------------------------PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 379 ~~~~~---------------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
..+.. .++.+++++.+||.+||.+||.+|||+.|+|+||||+...
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 22211 1245789999999999999999999999999999998754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-56 Score=462.72 Aligned_cols=260 Identities=26% Similarity=0.483 Sum_probs=213.1
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+.++|+++++||+|+||.||+|+.+....+++.||||++.+.. ...++.+|+++|+.+.+|||||+++++|.+.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 35678999999999999999999887544467899999985542 2346789999999997799999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+++|||||||+||+|.+++ +.+++..++.++.||+.||+|||++|||||||||+|||++ .+.+.+||+|||+|+
T Consensus 93 ~~~~lvmE~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~--~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN--RRLKKYALVDFGLAQ 166 (361)
T ss_dssp TEEEEEEECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCE
T ss_pred CEEEEEEeCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEe--CCCCeEEECcCCCCc
Confidence 9999999999999999987 3599999999999999999999999999999999999995 234789999999997
Q ss_pred ccCCCC-----------------------------cccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCC
Q 007253 312 FVRPDE-----------------------------RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRP 360 (611)
Q Consensus 312 ~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~P 360 (611)
...... ...+.+||++|||||++.+ .|+.++||||+|||+|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 543221 1234689999999999864 489999999999999999999999
Q ss_pred CCCCC-hHHHHHHHHhc--------------------------------------CC------------CCCCCCCCCCC
Q 007253 361 FWART-ESGIFRAVLKA--------------------------------------DP------------SFDEAPWPSLS 389 (611)
Q Consensus 361 f~~~~-~~~~~~~i~~~--------------------------------------~~------------~~~~~~~~~~s 389 (611)
|.... ..+.+..|... .. ......|..++
T Consensus 247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is 326 (361)
T 4f9c_A 247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP 326 (361)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence 96543 33333333210 00 01112356789
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
+++++||++||+.||++|+|++|+|+||||++.
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-55 Score=448.48 Aligned_cols=250 Identities=25% Similarity=0.409 Sum_probs=208.3
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++++++++||+|+||.||+|++. ..||||+++... ......+.|.+|+.++++|+ |||||++++++.+ +.
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~------~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~-~~ 105 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH------GDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTR-HVNILLFMGYMTK-DN 105 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS------SEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS-SS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC------CcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEC-Ce
Confidence 467899999999999999999743 359999986543 34566788999999999998 9999999998764 56
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|||||||+||+|.+++......+++..+..|+.||+.||.|||+++||||||||+|||| ++++++||+|||+|+..
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL---HEGLTVKIGDFGLATVK 182 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE---ETTEEEEECCCSSCBC-
T ss_pred EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE---CCCCcEEEeeccCceec
Confidence 899999999999999998877789999999999999999999999999999999999999 57889999999999876
Q ss_pred CCC---CcccccccCCCcCcchhhc----CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--CCC
Q 007253 314 RPD---ERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD--EAP 384 (611)
Q Consensus 314 ~~~---~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~--~~~ 384 (611)
... ......+||+.|||||++. +.|+.++|||||||++|||+||+.||.+......+..+.......+ ...
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 262 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKL 262 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTS
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Confidence 432 2345678999999999985 3489999999999999999999999988766655555544432222 223
Q ss_pred CCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 385 ~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
+..+++++.+||.+||+.||++|||+.++++
T Consensus 263 ~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 263 YKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 4578999999999999999999999998754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-56 Score=489.15 Aligned_cols=265 Identities=35% Similarity=0.646 Sum_probs=242.6
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
...++|++++.||+|+||.||+|+.+. +|+.||||++.+. .....+.+.+|+.+|+.|+ |||||+++++|.++
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~---tg~~~AiK~i~~~---~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~ 226 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTP---HESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDD 226 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC---SHHHHHHHHHHHHHHHHTC-CTTBCCEEEEEECS
T ss_pred cCccccEEEEEEeeccCeEEEEEEECC---CCCEEEEEEEecc---chhhHHHHHHHHHHHHhCC-CCCCCeEEEEEEEC
Confidence 456789999999999999999999876 6999999999654 3444577899999999998 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+.+|||||||+||+|.++|..+.+.+++..++.|+.||+.||.|||++|||||||||+|||++. +..+.+||+|||+|+
T Consensus 227 ~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~-~~~~~vKl~DFG~a~ 305 (573)
T 3uto_A 227 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTA 305 (573)
T ss_dssp SEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCSSCE
T ss_pred CEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC-CCCCCEEEeecccee
Confidence 9999999999999999999777778999999999999999999999999999999999999953 234789999999999
Q ss_pred ccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 312 FVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
.+.........+||+.|||||++. ..|+.++|||||||++|||++|+.||.+....+.+..+......++...+..+++
T Consensus 306 ~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 385 (573)
T 3uto_A 306 HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 385 (573)
T ss_dssp ECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCH
T ss_pred EccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 988777777889999999999987 5689999999999999999999999999999999999999888888888889999
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHcCcccCCCCC
Q 007253 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~ 424 (611)
++++||++||++||.+|||+.|+|+||||+..+.
T Consensus 386 ~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 386 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 9999999999999999999999999999997653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-56 Score=449.07 Aligned_cols=255 Identities=25% Similarity=0.403 Sum_probs=218.4
Q ss_pred CCceeEeCeeeeccceEEEEEEEecC--CccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.++|.+.++||+|+||.||+|++... ..++..||||++... .....+.|.+|+++|++|+ |||||+++++|.++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEG 87 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeC
Confidence 46799999999999999999987631 235789999999643 4556788999999999998 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCC
Q 007253 232 DNVYVVMELCEGGELLDRILSRG------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN 299 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~ 299 (611)
+.+|||||||++|+|.++|...+ ..+++..+..|+.||+.||.|||+++||||||||+|||| +.+
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl---~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE---CCC
Confidence 99999999999999999997642 469999999999999999999999999999999999999 678
Q ss_pred ceEEEeecccccccCCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 007253 300 SVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVL 374 (611)
Q Consensus 300 ~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~ 374 (611)
+++||+|||+|+....... ....+||+.|||||++. +.|+.++|||||||++|||+| |+.||.+.+..+++..+.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 8999999999987654332 23457999999999986 779999999999999999998 899999999988888888
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccC
Q 007253 375 KADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420 (611)
Q Consensus 375 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~ 420 (611)
...... ....+++++.+||.+||+.||++|||+.++ |+||+
T Consensus 245 ~~~~~~---~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~ 285 (299)
T 4asz_A 245 QGRVLQ---RPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQ 285 (299)
T ss_dssp HTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHH
T ss_pred cCCCCC---CCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHH
Confidence 765321 124689999999999999999999999998 45654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-56 Score=451.41 Aligned_cols=255 Identities=31% Similarity=0.512 Sum_probs=200.1
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC-
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD- 232 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~- 232 (611)
.++|++++.||+|+||.||+|+.+. +|+.||||++.... .....+.+.+|+.+|++|+ |||||+++++|.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~ 77 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKV---DDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNT 77 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETT---TCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC-
T ss_pred chhCEEeeEEecCCCeEEEEEEECC---CCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCc
Confidence 3569999999999999999999776 68999999996542 4455678999999999997 999999999997654
Q ss_pred -----------eeEEEeeecCCCChHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCC
Q 007253 233 -----------NVYVVMELCEGGELLDRILSRGG--KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN 299 (611)
Q Consensus 233 -----------~~~lv~E~~~~gsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~ 299 (611)
.+|||||||+||+|.+++..+.. ..++..++.|+.||+.||.|||++|||||||||+|||| +.+
T Consensus 78 ~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~ 154 (299)
T 4g31_A 78 TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMD 154 (299)
T ss_dssp ---------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTT
T ss_pred cccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE---CCC
Confidence 37999999999999999876532 25667899999999999999999999999999999999 577
Q ss_pred ceEEEeecccccccCCCC-------------cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCC
Q 007253 300 SVLKAIDFGLSDFVRPDE-------------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART 365 (611)
Q Consensus 300 ~~vkl~DfG~a~~~~~~~-------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~ 365 (611)
+++||+|||+|+.+..+. ...+.+||+.|||||++. ..|+.++|||||||++|||++ ||....
T Consensus 155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~ 231 (299)
T 4g31_A 155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM 231 (299)
T ss_dssp CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc
Confidence 889999999998765432 123468999999999987 569999999999999999996 886533
Q ss_pred hH-HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 366 ES-GIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 366 ~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.. ..+..+... .++. .+...++.+.+||++||++||.+|||+.|+|+||||++.+
T Consensus 232 ~~~~~~~~~~~~--~~p~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 232 ERVRTLTDVRNL--KFPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHHHHHHHTT--CCCH-HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHHHHHHHHhcC--CCCC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 22 222222222 2221 1234567788999999999999999999999999998753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-55 Score=446.11 Aligned_cols=254 Identities=20% Similarity=0.309 Sum_probs=216.9
Q ss_pred CCceeEeCeeeeccceEEEEEEEec--CCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~--~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
..++++.++||+|+||.||+|++.. ....++.||||++.... .....+.|.+|+.++++|+ |||||+++|+|.++
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQ-HPNVVCLLGVVTKD 101 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCC-CTTBCCEEEEECSS
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCC-CCCCCCcceEEEEC
Confidence 4568999999999999999998753 12357899999996542 3334578999999999998 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEecc
Q 007253 232 DNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~ 296 (611)
+.++||||||++|+|.++|..+. ..+++..+..|+.||+.||.|||+++||||||||+||||
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl--- 178 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV--- 178 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE---
Confidence 99999999999999999997542 358999999999999999999999999999999999999
Q ss_pred CCCceEEEeecccccccCCCC---cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 007253 297 DENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFR 371 (611)
Q Consensus 297 ~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~ 371 (611)
++++++||+|||+|+.+.... .....+||+.|||||++. +.|+.++|||||||++|||+| |+.||.+.+..++..
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 678899999999998764332 244568999999999886 779999999999999999998 899999999888888
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 372 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
.+...... + ....++.++.+||.+||+.||++|||+.+|+++
T Consensus 259 ~i~~~~~~-~--~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 259 MIRNRQVL-P--CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHTTCCC-C--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCC-C--CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 87765422 1 224689999999999999999999999999875
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-55 Score=449.97 Aligned_cols=253 Identities=24% Similarity=0.393 Sum_probs=211.6
Q ss_pred CCceeEeCeeeeccceEEEEEEEec--CCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~--~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.++|.+.++||+|+||.||+|+++. ...+++.||||++.. ......+.|.+|+++|++|+ |||||+++++|.+.
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~---~~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~ 115 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE---ASESARQDFQREAELLTMLQ-HQHIVRFFGVCTEG 115 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC---CSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc---CCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEEC
Confidence 4679999999999999999998763 223588999999964 34556788999999999998 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccC
Q 007253 232 DNVYVVMELCEGGELLDRILSRG--------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD 297 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~ 297 (611)
+.+|||||||++|+|.+++.... ..+++..+..|+.||+.||.|||+++||||||||+|||| +
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl---~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV---G 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---E
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE---C
Confidence 99999999999999999987542 359999999999999999999999999999999999999 5
Q ss_pred CCceEEEeecccccccCCCC---cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 007253 298 ENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRA 372 (611)
Q Consensus 298 ~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~ 372 (611)
.++++||+|||+|+.+.... .....+||+.|||||++. +.|+.++|||||||++|||+| |+.||.+....+++..
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 272 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 78899999999998764432 234568999999999987 569999999999999999998 8999999998888888
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 373 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
+...... + ....+++++.+||.+||+.||++|||+.||+++
T Consensus 273 i~~g~~~-~--~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 273 ITQGREL-E--RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHTCCC-C--CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHcCCCC-C--CcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 8775421 1 124689999999999999999999999999754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-55 Score=480.33 Aligned_cols=257 Identities=27% Similarity=0.440 Sum_probs=219.5
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHH---HHHHHHhcCCCCeeEEEEEEee
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRRE---VKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E---~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
.++|++++.||+|+||.||+|+.+. +|+.||||++.+...........+.+| +.+++.+. |||||+++++|.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~---tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~-HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHT 263 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEEEEC
T ss_pred hHHeEEEEEEecccCeEEEEEEECC---CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCC-CCCEeEEEEEEEE
Confidence 5789999999999999999999876 799999999975432222222334444 55555555 9999999999999
Q ss_pred CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 231 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
.+.+|||||||+||+|.++|... +.+++..++.|+.||+.||+|||++|||||||||+|||| +.+|+|||+|||+|
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA 339 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLA 339 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTSCEEECCCTTC
T ss_pred CCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---eCCCCEEeccccee
Confidence 99999999999999999998765 579999999999999999999999999999999999999 68889999999999
Q ss_pred cccCCCCcccccccCCCcCcchhhc-C-CCCCcchhhHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhcCCCCCCCCC
Q 007253 311 DFVRPDERLNDIVGSAYYVAPEVLH-R-SYSTEADVWSIGVIAYILLCGSRPFWAR---TESGIFRAVLKADPSFDEAPW 385 (611)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwSlGvil~el~~g~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~ 385 (611)
+.+.. ....+.+||+.|||||++. + .|+.++|||||||++|||++|+.||.+. ....+...+......++
T Consensus 340 ~~~~~-~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p---- 414 (689)
T 3v5w_A 340 CDFSK-KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP---- 414 (689)
T ss_dssp EECSS-CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC----
T ss_pred eecCC-CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC----
Confidence 87754 3456779999999999995 3 5999999999999999999999999753 33456666766665554
Q ss_pred CCCCHHHHHHHHHhcccCccCCCC-----HHHHHcCcccCCCC
Q 007253 386 PSLSSEARDFVKRLLNKDPRKRLT-----AAQALSHPWIKNSN 423 (611)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rpt-----~~~ll~hp~~~~~~ 423 (611)
..+|+++++||.+||++||.+|++ +.++++||||++.+
T Consensus 415 ~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id 457 (689)
T 3v5w_A 415 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457 (689)
T ss_dssp TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence 468999999999999999999998 79999999998754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-54 Score=444.16 Aligned_cols=256 Identities=26% Similarity=0.394 Sum_probs=215.6
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCC--ccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.++|+++++||+|+||.||+|++.... ..++.||||++.... .....+.+.+|+++|.+|.+|||||+++++|.+.
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 578999999999999999999987532 246789999996542 3445677999999999998569999999999765
Q ss_pred -CeeEEEeeecCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEec
Q 007253 232 -DNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT 295 (611)
Q Consensus 232 -~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~ 295 (611)
+.+|||||||++|+|.++|.... ..+++..+..|+.||+.||.|||+++||||||||+||||
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl-- 218 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL-- 218 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee--
Confidence 56999999999999999997532 348999999999999999999999999999999999999
Q ss_pred cCCCceEEEeecccccccCCCC---cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHH
Q 007253 296 KDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIF 370 (611)
Q Consensus 296 ~~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~ 370 (611)
++++++||+|||+|+.+..+. .....+||+.|||||++. +.|+.++|||||||++|||+| |+.||.+....+.+
T Consensus 219 -~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~ 297 (353)
T 4ase_A 219 -SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 297 (353)
T ss_dssp -CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred -CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 677899999999998765443 234568999999999886 679999999999999999998 99999887655544
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 371 RAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 371 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
..++......+. ...+++++.+||.+||+.||++|||+.+|++|
T Consensus 298 ~~~i~~g~~~~~--p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 298 CRRLKEGTRMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCCCC--CccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 444444332222 13679999999999999999999999999987
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=443.44 Aligned_cols=321 Identities=33% Similarity=0.608 Sum_probs=263.2
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+.++|++++.||+|+||.||+|.... +|+.||+|++..... .....+.+.+|+.+++.|+ ||||+++++++.++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~---~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~ 82 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVL---AGQEYAAMIINTKKL-SARDHQKLEREARICRLLK-HPNIVRLHDSISEE 82 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETT---TTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCC-BTTBCCEEEEEECS
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECC---CCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CcCCCeEEEEEEEC
Confidence 456789999999999999999998766 689999999976543 3344567899999999997 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+.+|+|||||+||+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++....++.+||+|||++.
T Consensus 83 ~~~~lv~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 83 GHHYLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp SEEEEEECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred CEEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 9999999999999999988765 569999999999999999999999999999999999999765567889999999998
Q ss_pred ccCCCC-cccccccCCCcCcchhhcC-CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 312 FVRPDE-RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 312 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+......+..+......++...|+.++
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 241 (444)
T 3soa_A 162 EVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVT 241 (444)
T ss_dssp CCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred EecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCC
Confidence 765443 3456789999999999874 69999999999999999999999999999999999999998888888888999
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCC-CCchhHHHHHHHHHHhhcchHHHHHHHhhhh--cc--hhhHHH
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV-KVPLDVIIFKLMKAYMRSSSLRKAALRALSK--TL--TVDELF 464 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~--~l--~~~e~~ 464 (611)
+++.+||.+||+.||.+|||+.++|+||||+..... ...........++.+...++++..++..+.. .+ ..+++.
T Consensus 242 ~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~klk~~~~~~~~~~~~~~~~~~e~~ 321 (444)
T 3soa_A 242 PEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTVMLATRNFSVRKQEII 321 (444)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHHHSCCCCCHHHHHHHHHHHHHHHHHTTCSCEECCCCSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCCCHHHHhcCccccCCccccccchhhHHHHHHHHHHHHHHHHHHHHHHHHHhhhcccchHHHH
Confidence 999999999999999999999999999999753211 1112223456667776666666666655522 22 234444
Q ss_pred HHHHHhhhcCCCCC
Q 007253 465 YLKEQYALLEPNKN 478 (611)
Q Consensus 465 ~l~~~F~~~D~d~~ 478 (611)
++.+.|.....++|
T Consensus 322 ~~~~~~l~~i~~gD 335 (444)
T 3soa_A 322 KVTEQLIEAISNGD 335 (444)
T ss_dssp HHHHHHHHHHHHTC
T ss_pred HHHHHHHhhhhcCC
Confidence 44444444443333
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=428.41 Aligned_cols=296 Identities=34% Similarity=0.664 Sum_probs=251.3
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+.++|++++.||+|+||.||+|.... +|+.||+|++..... .....+.+.+|+.++++|+ ||||+++++++.++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~ 100 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEE 100 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECC---CCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeC
Confidence 456789999999999999999998766 689999999976543 3445677899999999997 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+..|+|||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++..+..+.+||+|||++.
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 101 SFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp SEEEEEECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred CEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 9999999999999999988654 569999999999999999999999999999999999999765556779999999998
Q ss_pred ccCCCCcccccccCCCcCcchhhcC-CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 312 FVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
...........+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.....++..+......++...|..+++
T Consensus 180 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 259 (362)
T 2bdw_A 180 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 259 (362)
T ss_dssp CCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCH
T ss_pred EecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 8776655667799999999999874 699999999999999999999999999998889999988888887777788999
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCC-CCchhHHHHHHHHHHhhcchHHHHHHHh
Q 007253 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV-KVPLDVIIFKLMKAYMRSSSLRKAALRA 453 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~l~~ 453 (611)
++.+||.+||+.||.+|||+.++|+||||+..... ...........++++.....++..++..
T Consensus 260 ~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 323 (362)
T 2bdw_A 260 EAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTT 323 (362)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTHHHHSCCCCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCcccCCCcccccccchhhHHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999753211 1111122344555555555555554443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-51 Score=426.46 Aligned_cols=266 Identities=37% Similarity=0.662 Sum_probs=235.5
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCH---HHHHHHHHHHHHHHHhcCCCCeeEEEEEE
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA---IAIEDVRREVKILRALTGHNNLVKFFDAY 228 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~iv~l~~~~ 228 (611)
.+.++|++++.||+|+||.||+|+.+. +|+.||+|++.+...... ...+.+.+|+.+++.+. ||||+++++++
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~---~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~ 84 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKS---TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDVY 84 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEEE
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECC---CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEEE
Confidence 456789999999999999999999776 689999999976543221 23467899999999998 99999999999
Q ss_pred eeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCC-CceEEEeec
Q 007253 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE-NSVLKAIDF 307 (611)
Q Consensus 229 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~-~~~vkl~Df 307 (611)
.+.+.+|+|||||+||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+...+. ...+||+||
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 85 ENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EeCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999999998854 457999999999999999999999999999999999999953221 127999999
Q ss_pred ccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 007253 308 GLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 308 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (611)
|++............+||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+.+..+......++...|.
T Consensus 164 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (361)
T 2yab_A 164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS 243 (361)
T ss_dssp SSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred CCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhcc
Confidence 9998877666667789999999999987 569999999999999999999999999999999999998887777766677
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
.++.++++||.+||..||.+|||+.++|+||||+..
T Consensus 244 ~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred CCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 899999999999999999999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=416.42 Aligned_cols=258 Identities=34% Similarity=0.641 Sum_probs=232.0
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|++++.||+|+||.||+|++.. +|+.||||++.+... .....+.+.+|+++++.++ ||||+++++++.+.+
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~ 87 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHIL---TGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILN-HPNIVKLFEVIETEK 87 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECC
Confidence 45789999999999999999999766 689999999976443 4455678899999999998 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~ 163 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNE 163 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTCCGG
T ss_pred EEEEEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE---cCCCCEEEeeccCcee
Confidence 999999999999999998766 569999999999999999999999999999999999999 6778899999999988
Q ss_pred cCCCCcccccccCCCcCcchhhcC-CC-CCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 313 VRPDERLNDIVGSAYYVAPEVLHR-SY-STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
..........+||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||.+....+....+......++. .++.
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~ 239 (328)
T 3fe3_A 164 FTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMST 239 (328)
T ss_dssp GSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCH
T ss_pred cCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCH
Confidence 776666777899999999999864 34 47899999999999999999999999999988888887766553 5799
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
++.+||++||..||.+|||+.++++||||+...
T Consensus 240 ~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 240 DCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 999999999999999999999999999998654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-51 Score=424.65 Aligned_cols=258 Identities=30% Similarity=0.549 Sum_probs=225.3
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++++.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|+.+++.+.+||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcC---CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 5789999999999999999999876 6899999999754333334456788999999998679999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|||||||+||+|.+++... +.+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+|||+++..
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCS
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE---CCCCCEEEccccceeec
Confidence 99999999999999988665 569999999999999999999999999999999999999 67788999999999864
Q ss_pred CC-CCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 314 RP-DERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 314 ~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
.. .......+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+....+++..+......++. .++.+
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~ 250 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHED 250 (353)
T ss_dssp CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHH
T ss_pred ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHH
Confidence 32 33456678999999999986 56999999999999999999999999999999999999988776653 57999
Q ss_pred HHHHHHHhcccCccCCCCH------HHHHcCcccCCC
Q 007253 392 ARDFVKRLLNKDPRKRLTA------AQALSHPWIKNS 422 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rpt~------~~ll~hp~~~~~ 422 (611)
+.+||++||++||.+||++ .++++||||++.
T Consensus 251 ~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 251 ATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp HHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred HHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 9999999999999999998 899999999875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-51 Score=420.01 Aligned_cols=263 Identities=30% Similarity=0.586 Sum_probs=236.4
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+.++|++++.||+|+||.||+|.... +|+.||+|++... ......+.+|+.+++.++ ||||+++++++.+.
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~ 73 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETS---SKKTYMAKFVKVK----GTDQVLVKKEISILNIAR-HRNILHLHESFESM 73 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCC----THHHHHHHHHHHHHHHSC-CTTBCCEEEEEEET
T ss_pred chhhceEeeeEEecCCCeEEEEEEECC---CCcEEEEEEEecC----cccHHHHHHHHHHHHhCC-CCCCCeEeEEEecC
Confidence 356889999999999999999999766 6899999998543 234466889999999997 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+.+++|||||+||+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.. .++.+||+|||++.
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~-~~~~~kl~Dfg~a~ 152 (321)
T 1tki_A 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQAR 152 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC-CCCCEEEEECCCCe
Confidence 99999999999999999987666679999999999999999999999999999999999999531 26789999999999
Q ss_pred ccCCCCcccccccCCCcCcchhhcCC-CCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 312 FVRPDERLNDIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
...........+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+....+.+..+......++...|+.++.
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 232 (321)
T 1tki_A 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232 (321)
T ss_dssp ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCH
Confidence 88766666677899999999998754 78999999999999999999999999999999999998887777666778999
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
++.+||.+||..||.+|||+.++|+||||+...
T Consensus 233 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 999999999999999999999999999998653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-50 Score=417.98 Aligned_cols=293 Identities=37% Similarity=0.661 Sum_probs=231.8
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
..+.++|++.+.||+|+||.||+|+... +++.||||++.... ..+.+.+|+.++++|. ||||+++++++.+
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 119 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKG---TQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKEIFET 119 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEC---------------CHHHHHCC-CTTBCCEEEEEEC
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECC---CCcEEEEEEeccch-----hHHHHHHHHHHHHhCC-CCCCcceeeeEec
Confidence 3456789999999999999999999776 58899999996532 2356789999999998 9999999999999
Q ss_pred CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 231 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
.+.+++||||+++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++
T Consensus 120 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 120 PTEISLVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLS 198 (349)
T ss_dssp SSEEEEEECCCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred CCeEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence 99999999999999999988554 56999999999999999999999999999999999999975455888999999999
Q ss_pred cccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCCCCCCCCCC
Q 007253 311 DFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESG-IFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~ 388 (611)
............+||+.|+|||++. ..++.++|||||||++|+|++|..||....... .+..+......+....+..+
T Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 278 (349)
T 2w4o_A 199 KIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEV 278 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTS
T ss_pred cccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhC
Confidence 8776555556678999999999987 468999999999999999999999997765544 66777777666666667789
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCCCCchhHHHHHHHHHHhhcchHHHHHHHhh
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALRAL 454 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~ 454 (611)
+.++.+||++||+.||++|||+.++|+||||+........+. ...+.++++....++++......
T Consensus 279 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 343 (349)
T 2w4o_A 279 SLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMD-TAQKKLQEFNARRKLKAAVKAVV 343 (349)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCCCSCCH-HHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccchhhhc-chHHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999998876665554 44556666666666666554443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=428.79 Aligned_cols=260 Identities=33% Similarity=0.640 Sum_probs=216.0
Q ss_pred cCCceeEe-CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee-
Q 007253 153 FANKYELG-EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED- 230 (611)
Q Consensus 153 ~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~- 230 (611)
+.++|.+. +.||+|+||.||+|.... +|+.||||++... ..+.+|+.++.++.+||||++++++|..
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~---~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~ 127 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL 127 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECC---CCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeec
Confidence 45668776 789999999999999766 6899999998532 3467899998777679999999999876
Q ss_pred ---CCeeEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEee
Q 007253 231 ---TDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (611)
Q Consensus 231 ---~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D 306 (611)
.+.+|||||||+||+|.+++.... ..+++..++.|+.||+.||.|||++|||||||||+|||++..+.++.+||+|
T Consensus 128 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred ccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEe
Confidence 567999999999999999997653 3599999999999999999999999999999999999996544478999999
Q ss_pred cccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChH----HHHHHHHhcCCCCC
Q 007253 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES----GIFRAVLKADPSFD 381 (611)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~----~~~~~i~~~~~~~~ 381 (611)
||+++...........+||+.|+|||++. +.|+.++|||||||++|+|++|+.||.+.... .+...+......++
T Consensus 208 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~ 287 (400)
T 1nxk_A 208 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 287 (400)
T ss_dssp CTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC
T ss_pred cccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC
Confidence 99998776555566789999999999986 56999999999999999999999999765432 24566667777777
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 382 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
...|..++.++.+||++||+.||.+|||+.++|+||||....
T Consensus 288 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 288 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 777788999999999999999999999999999999998654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=416.46 Aligned_cols=257 Identities=29% Similarity=0.542 Sum_probs=227.8
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++++.||+|+||.||+|+.+. +|+.||||++.+...........+.+|+.+++.++ ||||+++++++.+.+.
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~ 79 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDR 79 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC-CCcCcceEEEEEeCCE
Confidence 4689999999999999999999765 68999999996542222234567889999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+++..
T Consensus 80 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~ 155 (337)
T 1o6l_A 80 LCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCS
T ss_pred EEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE---CCCCCEEEeeccchhhc
Confidence 99999999999999888654 579999999999999999999999999999999999999 67788999999999864
Q ss_pred C-CCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 314 R-PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 314 ~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
. ........+||+.|+|||++. ..++.++|||||||++|||++|+.||.+.....++..+......++. .++++
T Consensus 156 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~ 231 (337)
T 1o6l_A 156 ISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPE 231 (337)
T ss_dssp CCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHH
T ss_pred ccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHH
Confidence 3 334556779999999999986 56899999999999999999999999999888888888887766553 68999
Q ss_pred HHHHHHHhcccCccCCC-----CHHHHHcCcccCCC
Q 007253 392 ARDFVKRLLNKDPRKRL-----TAAQALSHPWIKNS 422 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rp-----t~~~ll~hp~~~~~ 422 (611)
+.+||.+||+.||.+|| ++.++++||||+..
T Consensus 232 ~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 99999999999999999 99999999999875
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-50 Score=422.43 Aligned_cols=258 Identities=28% Similarity=0.542 Sum_probs=223.7
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++++.||+|+||.||+|+.+. +++.||||++.+.........+.+.+|+.++.++.+|||||+++++|.+.+.
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~---~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 4679999999999999999999876 6899999999876555555556788999999988669999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc-
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF- 312 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~- 312 (611)
+|||||||+||+|..++... +.+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+|||+++.
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCC
T ss_pred EEEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---CCCCCEEEeecceeeec
Confidence 99999999999999988765 579999999999999999999999999999999999999 6788899999999986
Q ss_pred cCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCC---------ChHHHHHHHHhcCCCCCC
Q 007253 313 VRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWAR---------TESGIFRAVLKADPSFDE 382 (611)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~---------~~~~~~~~i~~~~~~~~~ 382 (611)
..........+||+.|+|||++. ..|+.++|||||||++|||++|+.||... ....+...+......++.
T Consensus 204 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~ 283 (396)
T 4dc2_A 204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 283 (396)
T ss_dssp CCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT
T ss_pred ccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC
Confidence 33445567789999999999987 56899999999999999999999999632 233456667776665553
Q ss_pred CCCCCCCHHHHHHHHHhcccCccCCCCH------HHHHcCcccCCC
Q 007253 383 APWPSLSSEARDFVKRLLNKDPRKRLTA------AQALSHPWIKNS 422 (611)
Q Consensus 383 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~------~~ll~hp~~~~~ 422 (611)
.++.++.+||++||++||.+||++ .++++||||++.
T Consensus 284 ----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 284 ----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp ----TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred ----cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 589999999999999999999985 799999999874
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=417.25 Aligned_cols=258 Identities=33% Similarity=0.570 Sum_probs=205.9
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++++.||+|+||.||+|+... +++.||||++.+..... +.+.+|+.+++.|+ ||||+++++++.+.+.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 90 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKL---TKELVAVKYIERGAAID----ENVQREIINHRSLR-HPNIVRFKEVILTPTH 90 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETT---TCCEEEEEEEESSTTSC----HHHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECC---CCcEEEEEEEecCcccc----HHHHHHHHHHHhCC-CCCCCcEEEEEeeCCE
Confidence 5789999999999999999999776 68999999997643322 45789999999998 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+++|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++. +..+.+||+|||+++..
T Consensus 91 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~-~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 91 LAIIMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSS 168 (361)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECS-SSSCCEEECCCCCC---
T ss_pred EEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC-CCCceEEEeecCccccc
Confidence 99999999999999988665 46999999999999999999999999999999999999942 12335999999999865
Q ss_pred CCCCcccccccCCCcCcchhhc-CCCCCc-chhhHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhcCCCCCCCCCCC
Q 007253 314 RPDERLNDIVGSAYYVAPEVLH-RSYSTE-ADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSFDEAPWPS 387 (611)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~-~DiwSlGvil~el~~g~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~ 387 (611)
.........+||+.|+|||++. ..+..+ +|||||||++|+|++|+.||.+... ...+..+......++. ...
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 246 (361)
T 3uc3_A 169 VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD--DIR 246 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCT--TSC
T ss_pred cccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCC--cCC
Confidence 5455556678999999999886 445544 8999999999999999999976443 3444555554444333 246
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
+++++.+||.+||+.||.+|||+.++++||||....
T Consensus 247 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 282 (361)
T 3uc3_A 247 ISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL 282 (361)
T ss_dssp CCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence 899999999999999999999999999999997654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=422.74 Aligned_cols=265 Identities=34% Similarity=0.656 Sum_probs=227.1
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCc--CCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--TTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
+.++|++.+.||+|+||.||+|.... +|+.||||++..... ......+.+.+|+.+++.|+ ||||+++++++.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~ 97 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRE---TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETYSS 97 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-CTTBCCEEEEEEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECC---CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC-CCCCCcEEEEEEe
Confidence 45789999999999999999998776 689999999853211 11113467899999999997 9999999999999
Q ss_pred CCeeEEEeeecCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeec
Q 007253 231 TDNVYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (611)
Q Consensus 231 ~~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~Df 307 (611)
++.+|+|||||+||+|.+.+... ...+++..++.++.||+.||.|||++|||||||||+|||++..+....+||+||
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecC
Confidence 99999999999999998888653 335899999999999999999999999999999999999976555667999999
Q ss_pred ccccccCCCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 007253 308 GLSDFVRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (611)
Q Consensus 308 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (611)
|++....... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+. ....+..+......+....|
T Consensus 178 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~ 256 (351)
T 3c0i_A 178 GVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQW 256 (351)
T ss_dssp TTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHH
T ss_pred cceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCcccc
Confidence 9998775443 245668999999999986 56899999999999999999999999874 45566777776665555556
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
..++.++.+||.+||..||.+|||+.++|+||||+..
T Consensus 257 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 7889999999999999999999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-50 Score=414.01 Aligned_cols=267 Identities=37% Similarity=0.679 Sum_probs=233.5
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCC---HHHHHHHHHHHHHHHHhcCCCCeeEEEEEE
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT---AIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~ 228 (611)
.+.++|++++.||+|+||.||+|.... +|+.||+|++.+..... ....+.+.+|+.++++|+ ||||+++++++
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~ 83 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVY 83 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred CcccceEeceEEeeCCCeEEEEEEECC---CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEE
Confidence 355789999999999999999999766 68999999997653321 123567899999999998 99999999999
Q ss_pred eeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccC-CCceEEEeec
Q 007253 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAIDF 307 (611)
Q Consensus 229 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~-~~~~vkl~Df 307 (611)
.+.+.+++|||||++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+...+ ....+||+||
T Consensus 84 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 84 ENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EeCCEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 999999999999999999998854 35799999999999999999999999999999999999995322 1237999999
Q ss_pred ccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 007253 308 GLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 308 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (611)
|++............+||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+.+..+......++...+.
T Consensus 163 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (326)
T 2y0a_A 163 GLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242 (326)
T ss_dssp TTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred CCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccc
Confidence 9998876555666778999999999987 568999999999999999999999999998888888888877666655566
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.++..+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 243 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 7899999999999999999999999999999998653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-50 Score=415.54 Aligned_cols=260 Identities=31% Similarity=0.531 Sum_probs=228.4
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|++.+.||+|+||.||+|+.+. +|+.||||++.+.........+.+..|..++..+.+||||+++++++.+.+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 35789999999999999999999876 689999999965422222334567889999998855999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+++.
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBC
T ss_pred EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE---CCCCCEEEeEChhhhh
Confidence 999999999999999988765 569999999999999999999999999999999999999 6778899999999986
Q ss_pred cCC-CCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 313 VRP-DERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 313 ~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
... .......+||+.|+|||++. ..++.++|||||||++|||++|+.||.+....+++..+....+.++. .++.
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~ 243 (345)
T 1xjd_A 168 NMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEK 243 (345)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCH
T ss_pred cccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc----ccCH
Confidence 432 33456779999999999986 56899999999999999999999999999999999999887766553 5899
Q ss_pred HHHHHHHHhcccCccCCCCHH-HHHcCcccCCCC
Q 007253 391 EARDFVKRLLNKDPRKRLTAA-QALSHPWIKNSN 423 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~-~ll~hp~~~~~~ 423 (611)
++.+||.+||+.||.+||++. ++++||||+..+
T Consensus 244 ~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 244 EAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp HHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred HHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence 999999999999999999998 999999998753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=410.74 Aligned_cols=258 Identities=28% Similarity=0.529 Sum_probs=226.1
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++++.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|+.+++++.+||||+++++++.+.+.
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhheEEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 4679999999999999999999876 6899999999876666666778889999999998569999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCGGGCBCS
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEEeccccccc
Confidence 99999999999999988665 569999999999999999999999999999999999999 67788999999999864
Q ss_pred C-CCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCC---------CChHHHHHHHHhcCCCCCC
Q 007253 314 R-PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWA---------RTESGIFRAVLKADPSFDE 382 (611)
Q Consensus 314 ~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~---------~~~~~~~~~i~~~~~~~~~ 382 (611)
. ........+||+.|+|||++. ..++.++|||||||++|||++|+.||.. .....+...+......++
T Consensus 161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p- 239 (345)
T 3a8x_A 161 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP- 239 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC-
T ss_pred cCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC-
Confidence 3 334556779999999999986 5689999999999999999999999965 233445666666665554
Q ss_pred CCCCCCCHHHHHHHHHhcccCccCCCCH------HHHHcCcccCCC
Q 007253 383 APWPSLSSEARDFVKRLLNKDPRKRLTA------AQALSHPWIKNS 422 (611)
Q Consensus 383 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~------~~ll~hp~~~~~ 422 (611)
..++.++.+||++||+.||.+||++ .++++||||++.
T Consensus 240 ---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 240 ---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp ---TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred ---CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 3689999999999999999999995 899999999864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=410.54 Aligned_cols=247 Identities=23% Similarity=0.316 Sum_probs=190.1
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC-
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD- 232 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~- 232 (611)
.++|.+.++||+|+||.||+|++ +|+.||||++.... ........|+..+.+|+ |||||++++++.+++
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~-----~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~-HpNIv~l~g~~~~~~~ 71 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLR-HENILGFIAADNKDNG 71 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE-----TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-----CCEEEEEEEECccc----hhhHHHHHHHHHHhcCC-CCCCCcEEEEEEecCC
Confidence 46799999999999999999975 47899999985421 12223345666667887 999999999998764
Q ss_pred ---eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeeecCCCCceEEeccCCCce
Q 007253 233 ---NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ--------GVVHRDLKPENFLFTTKDENSV 301 (611)
Q Consensus 233 ---~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------~iiHrDlkp~NIll~~~~~~~~ 301 (611)
.+|||||||+||+|.+++... .+++..+..++.||+.||.|||++ +||||||||+|||| +.+++
T Consensus 72 ~~~~~~lV~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~ 146 (303)
T 3hmm_A 72 TWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGT 146 (303)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSC
T ss_pred CceEEEEEecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCC
Confidence 589999999999999998654 689999999999999999999987 89999999999999 67889
Q ss_pred EEEeecccccccCCCCc-----ccccccCCCcCcchhhcCC-------CCCcchhhHHHHHHHHHHhCCCCCCCC-----
Q 007253 302 LKAIDFGLSDFVRPDER-----LNDIVGSAYYVAPEVLHRS-------YSTEADVWSIGVIAYILLCGSRPFWAR----- 364 (611)
Q Consensus 302 vkl~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~~DiwSlGvil~el~~g~~Pf~~~----- 364 (611)
+||+|||+|+....... ....+||+.|||||++.+. |+.++|||||||++|||+||..||...
T Consensus 147 ~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~ 226 (303)
T 3hmm_A 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp EEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred EEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc
Confidence 99999999987654322 2346899999999998643 567899999999999999997765321
Q ss_pred ----------ChHHHHHHHHhcC--CCCCCCC-CCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 365 ----------TESGIFRAVLKAD--PSFDEAP-WPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 365 ----------~~~~~~~~i~~~~--~~~~~~~-~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
....+...+.... +.++... ....+..+.+|+.+||+.||++|||+.++++
T Consensus 227 p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 1122333332222 1111110 0112357889999999999999999999875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=418.80 Aligned_cols=263 Identities=36% Similarity=0.617 Sum_probs=235.6
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
+.++|++++.||+|+||.||+|.... +|+.||+|++... .......+.+|+.+++.|+ ||||+++++++.+.+
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~---~~~~~a~K~~~~~---~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~ 121 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTP---YPLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKY 121 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSS
T ss_pred cccceEEEEEEecCCCEEEEEEEECC---CCCEEEEEEeccc---chhhHHHHHHHHHHHHhCC-CcCCCeEEEEEEeCC
Confidence 45789999999999999999998776 6899999999653 2334567889999999997 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.+++|||||+||+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++. +..+.+||+|||++..
T Consensus 122 ~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 122 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATK 200 (387)
T ss_dssp EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec-CCCCceEEEeccccee
Confidence 999999999999999988766667999999999999999999999999999999999999953 2356799999999998
Q ss_pred cCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 313 VRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
..........+||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+.+..+......++...+..++.+
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 280 (387)
T 1kob_A 201 LNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 280 (387)
T ss_dssp CCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred cCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHH
Confidence 77665556678999999999987 55899999999999999999999999999888888888888777777777889999
Q ss_pred HHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 281 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 281 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 99999999999999999999999999998754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=408.45 Aligned_cols=255 Identities=27% Similarity=0.590 Sum_probs=226.7
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++++.||+|+||.||+|+... +|+.||||++.+.........+.+.+|+.+++.+. ||||+++++++.+.+.
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~ 80 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQ 80 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC-CCCCceEeEEEEeCCE
Confidence 4679999999999999999999766 68999999996543222234567889999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|+|||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 81 ~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~Dfg~a~~~ 156 (318)
T 1fot_A 81 IFMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYV 156 (318)
T ss_dssp EEEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEEC
T ss_pred EEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE---cCCCCEEEeecCcceec
Confidence 99999999999999988654 579999999999999999999999999999999999999 67788999999999876
Q ss_pred CCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 314 RPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
.. .....+||+.|+|||++. ..++.++|||||||++|||++|+.||.+......+..+......++ +.++.++
T Consensus 157 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~ 230 (318)
T 1fot_A 157 PD--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDV 230 (318)
T ss_dssp SS--CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHH
T ss_pred CC--ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHH
Confidence 43 345678999999999986 5689999999999999999999999999998888999988776655 3689999
Q ss_pred HHHHHHhcccCccCCC-----CHHHHHcCcccCCC
Q 007253 393 RDFVKRLLNKDPRKRL-----TAAQALSHPWIKNS 422 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rp-----t~~~ll~hp~~~~~ 422 (611)
.+||++||..||.+|| +++++++||||++.
T Consensus 231 ~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 231 KDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp HHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 9999999999999999 99999999999864
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=414.98 Aligned_cols=258 Identities=26% Similarity=0.467 Sum_probs=228.2
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++++.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|..++..+.+||||+++++++.+.+.
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETT---EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 5789999999999999999999776 6889999999654322223456788999999988669999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+++..
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---cCCCcEEEEeCCccccc
Confidence 99999999999999988765 469999999999999999999999999999999999999 67888999999999864
Q ss_pred C-CCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 314 R-PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 314 ~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
. ........+||+.|+|||++. ..++.++|||||||++|||++|+.||.+....+++..+......++. .++.+
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~ 247 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKE 247 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHH
T ss_pred ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHH
Confidence 3 233456779999999999986 56899999999999999999999999999999999999988766653 68999
Q ss_pred HHHHHHHhcccCccCCC-----CHHHHHcCcccCCC
Q 007253 392 ARDFVKRLLNKDPRKRL-----TAAQALSHPWIKNS 422 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rp-----t~~~ll~hp~~~~~ 422 (611)
+.+||++||+.||.+|| ++.++++||||+..
T Consensus 248 ~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 248 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp HHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred HHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 99999999999999999 47999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-49 Score=396.50 Aligned_cols=267 Identities=36% Similarity=0.718 Sum_probs=239.9
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+.++|++.+.||+|+||.||+|.... +|+.||+|++..... .....+.+.+|+.++++++ ||||+++++++.+.
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 77 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEE 77 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcC---CCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEcC
Confidence 457899999999999999999998776 689999999965443 3445577889999999997 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+..++||||+++|+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++..+..+.+||+|||++.
T Consensus 78 ~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 78 SFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred CEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 9999999999999999988765 569999999999999999999999999999999999999765566679999999998
Q ss_pred ccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 312 FVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
............||+.|+|||++. ..++.++|||||||++|+|++|+.||...........+......++...+..+++
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T 3kk8_A 157 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 236 (284)
T ss_dssp ECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred EcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCH
Confidence 777666666778999999999986 5589999999999999999999999999999888888888887777777788999
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHcCcccCCCCC
Q 007253 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~ 424 (611)
++.+||.+||+.||.+|||+.++|+||||+....
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 237 EAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 9999999999999999999999999999987653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=404.79 Aligned_cols=265 Identities=29% Similarity=0.483 Sum_probs=220.4
Q ss_pred cccccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEE
Q 007253 149 FSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (611)
Q Consensus 149 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~ 228 (611)
..+.+.++|++++.||+|+||.||+|+.. .|+.||+|++.... ........+.+|+.++++++ ||||+++++++
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~ 88 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS----QGRIVALKRIRLDA-EDEGIPSTAIREISLLKELH-HPNIVSLIDVI 88 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEET----TSCEEEEEEEC-------CHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEEC----CCCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcC-CCCEeeeeeEE
Confidence 34567789999999999999999999864 38899999986543 22334567889999999997 99999999999
Q ss_pred eeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecc
Q 007253 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (611)
Q Consensus 229 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG 308 (611)
.+++.+++|||||++ +|.+.+......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 89 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg 164 (311)
T 3niz_A 89 HSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFG 164 (311)
T ss_dssp CCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCT
T ss_pred ccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE---CCCCCEEEccCc
Confidence 999999999999975 8999888777779999999999999999999999999999999999999 567789999999
Q ss_pred cccccCCC-CcccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC-
Q 007253 309 LSDFVRPD-ERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP- 384 (611)
Q Consensus 309 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~- 384 (611)
++...... ......+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+.+..+...........
T Consensus 165 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 244 (311)
T 3niz_A 165 LARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW 244 (311)
T ss_dssp TCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTS
T ss_pred CceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHh
Confidence 99876533 2344568999999999885 4589999999999999999999999988777666666554221111111
Q ss_pred -------------------------CCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 385 -------------------------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 385 -------------------------~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.+.+++++.+||++||+.||.+|||+.|+|+||||++.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp GGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred hhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 235788999999999999999999999999999999764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=426.48 Aligned_cols=262 Identities=28% Similarity=0.476 Sum_probs=225.8
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|++++.||+|+||.||+|+.+. +++.||||++.+.........+.+.+|+.+++.++ |||||+++++|.+++
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~---~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDR 142 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred CccccEEEEEEEcCCCEEEEEEEECC---CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEECC
Confidence 35789999999999999999999876 68999999986422111112234778999999997 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.+|||||||+||+|.+++.. ..+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+|||+++.
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMK 217 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEE
T ss_pred EEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE---CCCCCEEEeccceeEe
Confidence 99999999999999998854 369999999999999999999999999999999999999 6788999999999987
Q ss_pred cCCCC--cccccccCCCcCcchhhcC-C----CCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 007253 313 VRPDE--RLNDIVGSAYYVAPEVLHR-S----YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (611)
Q Consensus 313 ~~~~~--~~~~~~gt~~y~aPE~~~~-~----~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (611)
..... ...+.+||+.|+|||++.+ . |+.++|||||||++|||++|+.||.+....+.+..+......+....+
T Consensus 218 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 297 (410)
T 3v8s_A 218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 297 (410)
T ss_dssp CCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTT
T ss_pred eccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCc
Confidence 65443 3446789999999999863 2 788999999999999999999999999999888888875433333334
Q ss_pred CCCCHHHHHHHHHhcccCccC--CCCHHHHHcCcccCCCC
Q 007253 386 PSLSSEARDFVKRLLNKDPRK--RLTAAQALSHPWIKNSN 423 (611)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~--Rpt~~~ll~hp~~~~~~ 423 (611)
..++.++++||++||+.+|.+ |+++.++++||||++.+
T Consensus 298 ~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 298 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred ccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence 578999999999999999998 99999999999999754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=400.34 Aligned_cols=263 Identities=37% Similarity=0.701 Sum_probs=224.5
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+.++|++.+.||+|+||.||+|+... .+..||+|++..... ....+.+.+|++++++++ ||||+++++++.+.
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~ 92 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERS---SGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLD-HPNIIKIFEVFEDY 92 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECS
T ss_pred ChhhheeecceeccCCCeEEEEEEEcc---CCceEEEEEeecccc--chhHHHHHHHHHHHHhCC-CchHHhHHHheecC
Confidence 456789999999999999999999766 689999999865432 223467889999999997 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecc
Q 007253 232 DNVYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG 308 (611)
+..++|||||++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+...+.++.+||+|||
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg 172 (285)
T 3is5_A 93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFG 172 (285)
T ss_dssp SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence 9999999999999999988643 4679999999999999999999999999999999999999765567889999999
Q ss_pred cccccCCCCcccccccCCCcCcchhhcCCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 309 LSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 309 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
++.............||+.|+|||++.+.++.++|||||||++|+|++|+.||.+.........+....+.+.... ..+
T Consensus 173 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~ 251 (285)
T 3is5_A 173 LAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVEC-RPL 251 (285)
T ss_dssp CCCC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCC
T ss_pred cceecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccccc-CcC
Confidence 9988766655667789999999999998899999999999999999999999999888877777766665554332 357
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHcCcccCC
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 252 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 252 TPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 999999999999999999999999999999985
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-50 Score=428.71 Aligned_cols=263 Identities=26% Similarity=0.477 Sum_probs=226.8
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|+++++||+|+||.||+|+.+. +++.||||++.+...........+.+|+.++..++ ||||++++++|.+++
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~ 147 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYAFQDDN 147 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC-TTTBCCEEEEEECSS
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcC---CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCC
Confidence 45789999999999999999999876 68999999996432111122234788999999997 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.+|||||||+||+|.+++......+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+|||+++.
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---~~~g~vkL~DFGla~~ 224 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLK 224 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEE
T ss_pred EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE---cCCCCEEEcchhhhhh
Confidence 9999999999999999998766789999999999999999999999999999999999999 6788999999999977
Q ss_pred cCCCCc--ccccccCCCcCcchhhc------CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CCCCC
Q 007253 313 VRPDER--LNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD--PSFDE 382 (611)
Q Consensus 313 ~~~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~--~~~~~ 382 (611)
...... ....+||+.|+|||++. +.|+.++|||||||++|||++|+.||.+....+.+..+.... ..++.
T Consensus 225 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 304 (437)
T 4aw2_A 225 LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT 304 (437)
T ss_dssp CCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS
T ss_pred cccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCc
Confidence 654432 34468999999999885 458999999999999999999999999999888888887543 23332
Q ss_pred CCCCCCCHHHHHHHHHhcccCccC--CCCHHHHHcCcccCCCC
Q 007253 383 APWPSLSSEARDFVKRLLNKDPRK--RLTAAQALSHPWIKNSN 423 (611)
Q Consensus 383 ~~~~~~s~~~~~li~~~L~~dP~~--Rpt~~~ll~hp~~~~~~ 423 (611)
.+..+++++++||++||+.+|++ |++++++++||||++.+
T Consensus 305 -~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~ 346 (437)
T 4aw2_A 305 -QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID 346 (437)
T ss_dssp -SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred -ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence 23568999999999999999988 99999999999998754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=398.68 Aligned_cols=258 Identities=29% Similarity=0.490 Sum_probs=222.6
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|++.+.||+|+||.||+|.... +|+.||||++....... .+.+.+|+.+++.+. ||||+++++++.+.+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~ 90 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQPK---KELIINEILVMRENK-NPNIVNYLDSYLVGD 90 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTT---TCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred hhhceeeeeeeccCCCeEEEEEEECC---CCcEEEEEEeecccccH---HHHHHHHHHHHhcCC-CCCCCeEeEEEEECC
Confidence 45789999999999999999998655 68999999986543222 356889999999997 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.+++|||||+||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~ 165 (297)
T 3fxz_A 91 ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQ 165 (297)
T ss_dssp EEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEE
T ss_pred EEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE---CCCCCEEEeeCCCcee
Confidence 999999999999999988654 58999999999999999999999999999999999999 5677899999999987
Q ss_pred cCCCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 313 VRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 313 ~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
..... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.........+........ .....++.
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 244 (297)
T 3fxz_A 166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-QNPEKLSA 244 (297)
T ss_dssp CCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-SCGGGSCH
T ss_pred cCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-CCccccCH
Confidence 65443 345668999999999886 5689999999999999999999999988877766666554432211 12246899
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 245 ~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 245 IFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 999999999999999999999999999998653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=411.31 Aligned_cols=255 Identities=29% Similarity=0.564 Sum_probs=227.7
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++++.||+|+||.||+|+... +|+.||||++.+.........+.+.+|+.+++.+. ||||+++++++.+.+.
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~ 115 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSN 115 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECC---CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCE
Confidence 4689999999999999999999776 68999999996543222334567889999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred EEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE---CCCCCEEEcccccceec
Confidence 99999999999999988765 569999999999999999999999999999999999999 67788999999999876
Q ss_pred CCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 314 RPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
.. .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+++..+......++. .++.++
T Consensus 192 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~ 265 (350)
T 1rdq_E 192 KG--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDL 265 (350)
T ss_dssp SS--CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TCCHHH
T ss_pred cC--CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHH
Confidence 43 345678999999999886 56899999999999999999999999999998999999888766553 689999
Q ss_pred HHHHHHhcccCccCCCC-----HHHHHcCcccCCC
Q 007253 393 RDFVKRLLNKDPRKRLT-----AAQALSHPWIKNS 422 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rpt-----~~~ll~hp~~~~~ 422 (611)
.+||.+||+.||.+||+ +.++++||||+..
T Consensus 266 ~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 99999999999999998 9999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=422.49 Aligned_cols=262 Identities=30% Similarity=0.502 Sum_probs=225.3
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|++++.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|+.++..++ ||||++++++|.+.+
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~---~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLHFAFQDEN 134 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC-TTTBCCEEEEEECSS
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeCC
Confidence 45789999999999999999999876 68999999996532222223345789999999997 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.+|||||||+||+|.+++...+..+++..++.++.||+.||.|||++|||||||||+|||+ +.++++||+|||+++.
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---d~~g~vkL~DFGla~~ 211 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLK 211 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEE
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee---cCCCCEEEeechhhee
Confidence 9999999999999999998776689999999999999999999999999999999999999 6788999999999987
Q ss_pred cCCCCc--ccccccCCCcCcchhhc--------CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CCC
Q 007253 313 VRPDER--LNDIVGSAYYVAPEVLH--------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD--PSF 380 (611)
Q Consensus 313 ~~~~~~--~~~~~gt~~y~aPE~~~--------~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~--~~~ 380 (611)
...... ....+||+.|+|||++. +.|+.++|||||||++|||++|+.||.+....+.+..+.... ..+
T Consensus 212 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 291 (412)
T 2vd5_A 212 LRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL 291 (412)
T ss_dssp CCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred ccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCC
Confidence 754433 34568999999999985 358999999999999999999999999999888888887543 222
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCC---CCHHHHHcCcccCCCC
Q 007253 381 DEAPWPSLSSEARDFVKRLLNKDPRKR---LTAAQALSHPWIKNSN 423 (611)
Q Consensus 381 ~~~~~~~~s~~~~~li~~~L~~dP~~R---pt~~~ll~hp~~~~~~ 423 (611)
+. ....++.++++||++||+ +|.+| ++++++++||||++.+
T Consensus 292 p~-~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~ 335 (412)
T 2vd5_A 292 PL-VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLD 335 (412)
T ss_dssp C-----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCC
T ss_pred Cc-cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCC
Confidence 21 124689999999999999 99998 5999999999998764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=396.22 Aligned_cols=260 Identities=30% Similarity=0.498 Sum_probs=219.1
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++++.||+|+||.||+|+... +|+.||||++..... .......+.+|+.++++++ ||||+++++++.+++.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECC---CCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCC-CCCEeeEEeEEEeCCEE
Confidence 579999999999999999999776 689999999976543 3344567889999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++|||||++ +|.+.+....+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~ 152 (292)
T 3o0g_A 77 TLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFG 152 (292)
T ss_dssp EEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecC
Confidence 999999965 7888887777889999999999999999999999999999999999999 577889999999998765
Q ss_pred CC-CcccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCC-CCCChHHHHHHHHhcCCCCCCC-------
Q 007253 315 PD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPF-WARTESGIFRAVLKADPSFDEA------- 383 (611)
Q Consensus 315 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf-~~~~~~~~~~~i~~~~~~~~~~------- 383 (611)
.. ......+||+.|+|||++.+ .++.++|||||||++|+|++|..|| .+....+.+..+..........
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred CccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 33 23455689999999999863 3899999999999999999888875 5555556666655432211111
Q ss_pred ------------------CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 384 ------------------PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 384 ------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
..+.++.++.+||++||+.||.+|||+.|+|+||||++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 1235789999999999999999999999999999999754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-49 Score=413.30 Aligned_cols=259 Identities=34% Similarity=0.624 Sum_probs=227.0
Q ss_pred CceeE--eCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 155 NKYEL--GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 155 ~~y~~--~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..|.+ .+.||+|+||.||+|.... +|+.||+|++... .....+.+.+|+.++++|+ ||||+++++++.+.+
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~---~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 159 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETA---TGLKLAAKIIKTR---GMKDKEEVKNEISVMNQLD-HANLIQLYDAFESKN 159 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETT---TCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSS
T ss_pred cceeeecceEEecCcCEEEEEEEEcC---CCcEEEEEEEccc---ccccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECC
Confidence 44555 6789999999999998766 6899999999654 2345578899999999997 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.++||||||++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+.. +..+.+||+|||++..
T Consensus 160 ~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~ 238 (373)
T 2x4f_A 160 DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARR 238 (373)
T ss_dssp EEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCEE
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCcee
Confidence 999999999999999999877667999999999999999999999999999999999999954 3457899999999998
Q ss_pred cCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 313 VRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
..........+||+.|+|||++. +.++.++|||||||++|+|++|+.||.+....+.+..+......++...+..++++
T Consensus 239 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 318 (373)
T 2x4f_A 239 YKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEE 318 (373)
T ss_dssp CCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHH
T ss_pred cCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHH
Confidence 77666666678999999999986 56889999999999999999999999999998888999888777766667789999
Q ss_pred HHHHHHHhcccCccCCCCHHHHHcCcccCC
Q 007253 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 319 ~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 319 AKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 999999999999999999999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-49 Score=412.65 Aligned_cols=257 Identities=28% Similarity=0.517 Sum_probs=218.0
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHH-HHhcCCCCeeEEEEEEeeCC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL-RALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~~h~~iv~l~~~~~~~~ 232 (611)
.++|++++.||+|+||.||+|+.+. +++.||||++.+...........+.+|..++ +.+. ||||+++++++.+.+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~-hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTAD 112 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETT---TCCEEEEEEEEGGGBC-------------CCBCCCC-CTTBCCEEEEEECSS
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEeCC
Confidence 5689999999999999999999876 6899999999876554445556677788774 5565 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++|||||||||+|||+ +.++++||+|||+++.
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCBCGG
T ss_pred EEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEeeCccccc
Confidence 999999999999999988664 569999999999999999999999999999999999999 6778899999999986
Q ss_pred cC-CCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 313 VR-PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 313 ~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
.. ........+||+.|+|||++. ..++.++|||||||++|||++|..||.+....+++..+......++ +.++.
T Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~ 264 (373)
T 2r5t_A 189 NIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITN 264 (373)
T ss_dssp GBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC----SSSCH
T ss_pred cccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC----CCCCH
Confidence 43 334556779999999999986 5689999999999999999999999999999999999988765554 36899
Q ss_pred HHHHHHHHhcccCccCCCCH----HHHHcCcccCCC
Q 007253 391 EARDFVKRLLNKDPRKRLTA----AQALSHPWIKNS 422 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~----~~ll~hp~~~~~ 422 (611)
++.+||++||+.||.+||++ .++++||||+..
T Consensus 265 ~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 265 SARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp HHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 99999999999999999986 699999999874
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-49 Score=396.13 Aligned_cols=263 Identities=40% Similarity=0.775 Sum_probs=236.7
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+.++|++.+.||+|+||.||+|.... ++..||+|++.+..... .+.+.+|+.++++++ ||||+++++++.+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 78 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKG---TRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLD-HPNIIRLYETFEDN 78 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCC-CTTBCCEEEEEECS
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCC---CCcEEEEEeehhhccch---HHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence 356789999999999999999998766 58899999986543322 467889999999997 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+..++.++.+||+|||++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 79 TDIYLVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157 (277)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred CeEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence 9999999999999999988665 569999999999999999999999999999999999999766677889999999998
Q ss_pred ccCCCCcccccccCCCcCcchhhcCCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 312 FVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
............||+.|+|||++.+.++.++|||||||++|+|++|+.||......+....+......++...+..++++
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (277)
T 3f3z_A 158 RFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQ 237 (277)
T ss_dssp ECCTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHH
T ss_pred eccCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHH
Confidence 87766666777899999999999888999999999999999999999999999998888888888777766656678999
Q ss_pred HHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 238 ~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 238 AESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 9999999999999999999999999999753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-49 Score=413.75 Aligned_cols=258 Identities=26% Similarity=0.559 Sum_probs=224.3
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++++.||+|+||.||+|+... +++.||||++.+.........+.+.+|+.+++.++ |||||+++++|.+.+.
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~---~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVNLWYSFQDEED 89 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCE
Confidence 5789999999999999999999776 68999999986543223334567889999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|+|||||.||+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+|||++..+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAML 165 (384)
T ss_dssp EEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---CCCCCEEEeccceeeec
Confidence 9999999999999988765 4579999999999999999999999999999999999999 67888999999999988
Q ss_pred CCCCcccccccCCCcCcchhhc----CCCCCcchhhHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhcCCCCCCCCCC
Q 007253 314 RPDERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWAR---TESGIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~el~~g~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~~ 386 (611)
.........+||+.|+|||++. ..|+.++|||||||++|+|++|+.||... ....+...+......++ .
T Consensus 166 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p----~ 241 (384)
T 4fr4_A 166 PRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----S 241 (384)
T ss_dssp CTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC----T
T ss_pred cCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC----C
Confidence 7666777889999999999985 34889999999999999999999999743 33445555555554444 3
Q ss_pred CCCHHHHHHHHHhcccCccCCCC-HHHHHcCcccCCCC
Q 007253 387 SLSSEARDFVKRLLNKDPRKRLT-AAQALSHPWIKNSN 423 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rpt-~~~ll~hp~~~~~~ 423 (611)
.++.++.+||++||+.||.+||+ +.++++||||++.+
T Consensus 242 ~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~ 279 (384)
T 4fr4_A 242 AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279 (384)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred cCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence 68999999999999999999998 99999999998753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=409.44 Aligned_cols=259 Identities=39% Similarity=0.670 Sum_probs=226.6
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+.++|++++.||+|+||.||+|..+. +|+.||||++.+.... ..+|+.++.++.+||||+++++++.+.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~ 88 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKA---TNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDG 88 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcC
Confidence 356789999999999999999999776 6899999999765422 346889999986699999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccC-CCceEEEeecccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAIDFGLS 310 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~-~~~~vkl~DfG~a 310 (611)
+.+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+...+ ..+.+||+|||++
T Consensus 89 ~~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 89 KYVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp SEEEEEECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred CEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 9999999999999999988654 5699999999999999999999999999999999999985432 2356999999999
Q ss_pred cccCCC-CcccccccCCCcCcchhhcC-CCCCcchhhHHHHHHHHHHhCCCCCCC---CChHHHHHHHHhcCCCCCCCCC
Q 007253 311 DFVRPD-ERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWA---RTESGIFRAVLKADPSFDEAPW 385 (611)
Q Consensus 311 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~el~~g~~Pf~~---~~~~~~~~~i~~~~~~~~~~~~ 385 (611)
...... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ ....+++..+......+....|
T Consensus 168 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 247 (342)
T 2qr7_A 168 KQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW 247 (342)
T ss_dssp EECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT
T ss_pred ccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc
Confidence 876543 34556789999999999874 588999999999999999999999975 4556778888888877777778
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCC
Q 007253 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
..++.++.+||++||..||.+|||+.++|+||||+.
T Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 899999999999999999999999999999999965
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-50 Score=414.77 Aligned_cols=258 Identities=33% Similarity=0.607 Sum_probs=219.6
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
...++|++++.||+|+||.||+|.+.. +|+.||||++.+...........+.+|+.+++.++ ||||+++++++.+.
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~ 81 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYK---TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVITTP 81 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEECS
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeC
Confidence 446789999999999999999999766 68999999986432222223356889999999998 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+.+++||||+ +|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 82 ~~~~lv~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~DFG~s~ 156 (336)
T 3h4j_B 82 TDIVMVIEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSN 156 (336)
T ss_dssp SEEEEEECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE---CTTCCEEECCSSCTB
T ss_pred CEEEEEEECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE---cCCCCEEEEEeccce
Confidence 9999999999 78999988766 569999999999999999999999999999999999999 677889999999999
Q ss_pred ccCCCCcccccccCCCcCcchhhcCC-C-CCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 312 FVRPDERLNDIVGSAYYVAPEVLHRS-Y-STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
...........+||+.|+|||++.+. + +.++|||||||++|+|++|+.||.+.........+......+ ...++
T Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s 232 (336)
T 3h4j_B 157 IMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVM----PDFLS 232 (336)
T ss_dssp TTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCC----CTTSC
T ss_pred eccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC----cccCC
Confidence 88766667778999999999998754 3 789999999999999999999997765443332222222222 23579
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
+++.+||++||+.||.+|||+.++++||||+..
T Consensus 233 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 233 PGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 999999999999999999999999999999764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=400.45 Aligned_cols=261 Identities=29% Similarity=0.518 Sum_probs=218.1
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcC-CHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-TAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
..++|++++.||+|+||.||+|+...+...|+.||||++.+.... .......+.+|+.+++.++ ||||+++++++.+.
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYAFQTG 93 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEEEEECS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeEEEEcC
Confidence 357899999999999999999998654457999999999765322 2234456789999999998 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+.+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGLCK 169 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTSCEEECCCSCC-
T ss_pred CEEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE---CCCCcEEEEeCCccc
Confidence 9999999999999999988655 568999999999999999999999999999999999999 577889999999997
Q ss_pred ccCCC-CcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 312 FVRPD-ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 312 ~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
..... ......+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+......+..+......++ +.++
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~ 245 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLT 245 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC----TTSC
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----CCCC
Confidence 64332 3345678999999999986 5689999999999999999999999999988888888888766554 3689
Q ss_pred HHHHHHHHHhcccCccCCC-----CHHHHHcCcccCCC
Q 007253 390 SEARDFVKRLLNKDPRKRL-----TAAQALSHPWIKNS 422 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rp-----t~~~ll~hp~~~~~ 422 (611)
.++.+||.+||..||.+|| ++.++++||||+..
T Consensus 246 ~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 9999999999999999999 89999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=399.18 Aligned_cols=258 Identities=26% Similarity=0.344 Sum_probs=214.9
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
..+.++|++.++||+|+||.||+|+... +|+.||||++.... ...........|+..+.++..||||++++++|.+
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~ 128 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKE---DGRLYAVKRSMSPF-RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE 128 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETT---TSCEEEEEEESSSC-CSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred chhhhheeeeheeccCCCeEEEEEEECC---CCeEEEEEEecccc-cChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe
Confidence 4456789999999999999999999876 58999999986543 3334445566777777777569999999999999
Q ss_pred CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 231 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
++.++|||||| +|+|.+++......+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||++
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~DFG~a 204 (311)
T 3p1a_A 129 GGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFGLL 204 (311)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CGGGCEEECCCTTC
T ss_pred CCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEccceee
Confidence 99999999999 679999998887789999999999999999999999999999999999999 57788999999999
Q ss_pred cccCCCCcccccccCCCcCcchhhcCCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 311 DFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
.............||+.|+|||++.+.++.++|||||||++|||++|..|+..... ...+.... .+......+++
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~--~~~~~~~~~~~ 279 (311)
T 3p1a_A 205 VELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGY--LPPEFTAGLSS 279 (311)
T ss_dssp EECC------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTC--CCHHHHTTSCH
T ss_pred eecccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccC--CCcccccCCCH
Confidence 87765555566789999999999998999999999999999999999877755322 22222211 12222346899
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHcCcccCC
Q 007253 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
++.+||.+||+.||.+|||+.++|+||||+.
T Consensus 280 ~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 280 ELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 9999999999999999999999999999985
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=395.40 Aligned_cols=258 Identities=30% Similarity=0.494 Sum_probs=214.3
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++++.||+|+||.||+|+. . .|+.||+|++..... .....+.+.+|+.++++++ ||||+++++++.+.+.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~---~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-N---YGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-T---TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-C---CCCEEEEEEEecccc-ccccchhHHHHHHHHHhcC-CCCEeeeeeEEccCCeE
Confidence 5799999999999999999986 2 488999999865432 2223356789999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++||||+++ +|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 76 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~ 151 (288)
T 1ob3_A 76 VLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFG 151 (288)
T ss_dssp EEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHC
T ss_pred EEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEeECccccccC
Confidence 999999975 9999887776789999999999999999999999999999999999999 577889999999998664
Q ss_pred CC-CcccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---------
Q 007253 315 PD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE--------- 382 (611)
Q Consensus 315 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--------- 382 (611)
.. ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+.........
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence 32 23445689999999999863 5899999999999999999999999988877776666542111100
Q ss_pred ----------------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 383 ----------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 383 ----------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
.....+++++.+||.+||+.||++|||+.++|+||||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0123578999999999999999999999999999999874
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=403.16 Aligned_cols=276 Identities=30% Similarity=0.542 Sum_probs=236.1
Q ss_pred CcCcccccCCceeEe-CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEE
Q 007253 146 SFGFSKHFANKYELG-EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKF 224 (611)
Q Consensus 146 ~~~~~~~~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l 224 (611)
.+...+.+.++|.+. +.||+|+||.||+|.... +|+.||||++.+... .......+.+|+.+++.+.+||||+++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~ 94 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKS---TGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINL 94 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECC---CCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 344456678889998 899999999999999776 689999999975432 223456788999999999878999999
Q ss_pred EEEEeeCCeeEEEeeecCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEE
Q 007253 225 FDAYEDTDNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303 (611)
Q Consensus 225 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vk 303 (611)
++++.+.+.+++|||||++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.....+.+|
T Consensus 95 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 95 HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp EEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEE
T ss_pred EEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEE
Confidence 99999999999999999999999887543 35699999999999999999999999999999999999996433478899
Q ss_pred EeecccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC
Q 007253 304 AIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 382 (611)
Q Consensus 304 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 382 (611)
|+|||++............+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+....+......+..
T Consensus 175 L~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 254 (327)
T 3lm5_A 175 IVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE 254 (327)
T ss_dssp ECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred EeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc
Confidence 99999998876655566678999999999986 56899999999999999999999999999988888888888877777
Q ss_pred CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCC
Q 007253 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (611)
Q Consensus 383 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~ 425 (611)
..+..++..+.+||.+||+.||.+|||+.++|+||||+...-.
T Consensus 255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~ 297 (327)
T 3lm5_A 255 ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE 297 (327)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence 7778899999999999999999999999999999999976533
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=402.92 Aligned_cols=261 Identities=36% Similarity=0.671 Sum_probs=206.3
Q ss_pred CCceeEe---CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 154 ANKYELG---EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 154 ~~~y~~~---~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
.++|++. +.||+|+||.||+|.... +|+.||||++.+. ....+.+|+.+++.+.+||||+++++++.+
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~ 77 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKK---SNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHD 77 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETT---TCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred hhccccccCCCccccCCCeEEEEEEECC---CCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence 3567775 789999999999999876 6899999998542 235678999999999889999999999999
Q ss_pred CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 231 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
+...|+|||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++..+....+||+|||++
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a 156 (325)
T 3kn6_A 78 QLHTFLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFA 156 (325)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTC
T ss_pred CCEEEEEEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccc
Confidence 99999999999999999988765 57999999999999999999999999999999999999976555568999999999
Q ss_pred cccCCCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHhcCCCCC
Q 007253 311 DFVRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART-------ESGIFRAVLKADPSFD 381 (611)
Q Consensus 311 ~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~-------~~~~~~~i~~~~~~~~ 381 (611)
....... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.... ..+.+..+......++
T Consensus 157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~ 236 (325)
T 3kn6_A 157 RLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236 (325)
T ss_dssp EECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC
T ss_pred eecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC
Confidence 8665433 345668999999999986 568999999999999999999999997643 2456666766666666
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCC
Q 007253 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (611)
Q Consensus 382 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~ 424 (611)
...|..+++++.+||.+||+.||.+|||+.++++||||+....
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 5556678999999999999999999999999999999987643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=395.86 Aligned_cols=265 Identities=28% Similarity=0.439 Sum_probs=217.1
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcC--CHHHHHHHHHHHHHHHHhc--CCCCeeEEEEE
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT--TAIAIEDVRREVKILRALT--GHNNLVKFFDA 227 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~--~h~~iv~l~~~ 227 (611)
.+.++|++++.||+|+||.||+|+... +|+.||||++...... .......+.+|+.+++++. .||||++++++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~ 82 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPH---SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV 82 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTT---TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence 456889999999999999999998665 6899999998643211 1111234667888777765 49999999999
Q ss_pred EeeCC-----eeEEEeeecCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCce
Q 007253 228 YEDTD-----NVYVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301 (611)
Q Consensus 228 ~~~~~-----~~~lv~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~ 301 (611)
+.... .+++||||+. |+|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~---~~~~~ 158 (308)
T 3g33_A 83 CATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGT 158 (308)
T ss_dssp EEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE---CTTSC
T ss_pred eeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCC
Confidence 98765 5899999996 599998876543 39999999999999999999999999999999999999 57788
Q ss_pred EEEeecccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC
Q 007253 302 LKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 380 (611)
Q Consensus 302 vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~ 380 (611)
+||+|||++............+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+.+..+.......
T Consensus 159 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 159 VKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp EEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999999998877666667789999999999885 679999999999999999999999999998888877776543222
Q ss_pred CCCCC-----------------------CCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 381 DEAPW-----------------------PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 381 ~~~~~-----------------------~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
+...| +.+++++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 22222 35789999999999999999999999999999998753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=399.74 Aligned_cols=267 Identities=34% Similarity=0.611 Sum_probs=219.2
Q ss_pred ccccCCceeEe-CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEE
Q 007253 150 SKHFANKYELG-EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (611)
Q Consensus 150 ~~~~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~ 228 (611)
+..+.++|++. +.||+|+||.||+|+... +++.||||++..... ...+.+.+|+.++.++.+||||+++++++
T Consensus 7 ~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~ 80 (316)
T 2ac3_A 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLI---TSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFF 80 (316)
T ss_dssp CCCTTTSCEECCCCCCCCSSEEEEEEECSS---SCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CcccceeEEecCceecCCceEEEEEEEEcC---CCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 34567889995 789999999999998665 689999999976532 23467889999999976699999999999
Q ss_pred eeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecc
Q 007253 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (611)
Q Consensus 229 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG 308 (611)
.+++.+|+|||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++..+....+||+|||
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg 159 (316)
T 2ac3_A 81 EEEDRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFD 159 (316)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred eeCCEEEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence 9999999999999999999998765 569999999999999999999999999999999999999654444559999999
Q ss_pred cccccCCCC--------cccccccCCCcCcchhhc------CCCCCcchhhHHHHHHHHHHhCCCCCCCCCh--------
Q 007253 309 LSDFVRPDE--------RLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTE-------- 366 (611)
Q Consensus 309 ~a~~~~~~~--------~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~-------- 366 (611)
++....... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 239 (316)
T 2ac3_A 160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG 239 (316)
T ss_dssp CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence 987654221 223457999999999985 3488999999999999999999999976542
Q ss_pred -------HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 367 -------SGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 367 -------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
..+...+......++...+..++.++.+||.+||+.||.+|||+.++|+||||++..
T Consensus 240 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 240 EACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp -CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred ccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 345666666666655544567899999999999999999999999999999998754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-48 Score=393.63 Aligned_cols=264 Identities=42% Similarity=0.744 Sum_probs=231.2
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+.++|++.+.||+|+||.||+|+... +|+.||+|++..... ...+.+.+|+.++++++ ||||+++++++.+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 78 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRL---TGKLFALKCIKKSPA---FRDSSLENEIAVLKKIK-HENIVTLEDIYEST 78 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEECC---------HHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred chhccceeeeeccCCCCceEEEEEECC---CCCEEEEEEEecccc---cchHHHHHHHHHHHhCC-CCCeeehhhhcccC
Confidence 356789999999999999999999765 689999999975432 22356889999999997 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+.+++||||+++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~ 157 (304)
T 2jam_A 79 THYYLVMQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK 157 (304)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred CEEEEEEEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence 9999999999999999988765 469999999999999999999999999999999999999655677889999999997
Q ss_pred ccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 312 FVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
.... ......+||+.|+|||++. ..++.++|||||||++|+|++|+.||...........+......++...+..++.
T Consensus 158 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (304)
T 2jam_A 158 MEQN-GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISE 236 (304)
T ss_dssp CCCC-BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCH
T ss_pred ecCC-CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCH
Confidence 6543 2344567999999999986 5689999999999999999999999999888888888888877766666778999
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHcCcccCCCCC
Q 007253 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~ 424 (611)
++.+||.+||..||.+|||+.++|+||||+....
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (304)
T 2jam_A 237 SAKDFICHLLEKDPNERYTCEKALSHPWIDGNTA 270 (304)
T ss_dssp HHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence 9999999999999999999999999999987653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=420.72 Aligned_cols=258 Identities=29% Similarity=0.538 Sum_probs=218.4
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|++++.||+|+||.||+|+... +|+.||||++.+...........+.+|+.+++.++ ||||+++++++.+.+
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~ 221 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHD 221 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHC-------------CCCCCS-CTTSCCEEEEEEETT
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcC---CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEEEeeCC
Confidence 35789999999999999999999766 68999999997543333444566789999999997 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
.+|||||||+||+|.+++... ..+++..++.++.||+.||.|||+ .|||||||||+|||| +.++.+||+|||+++
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll---~~~~~~kl~DFG~a~ 297 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCK 297 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE---CSSSCEEECCCCCCC
T ss_pred EEEEEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE---CCCCCEEEccCCCce
Confidence 999999999999999888655 579999999999999999999998 899999999999999 577889999999998
Q ss_pred ccCC-CCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 312 FVRP-DERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 312 ~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
.... .......+||+.|+|||++. ..++.++|||||||++|||++|+.||.+.........+......++. .++
T Consensus 298 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~ 373 (446)
T 4ejn_A 298 EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLG 373 (446)
T ss_dssp TTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSC
T ss_pred eccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCC
Confidence 6433 33456678999999999986 66999999999999999999999999999998888888887766553 589
Q ss_pred HHHHHHHHHhcccCccCCC-----CHHHHHcCcccCCC
Q 007253 390 SEARDFVKRLLNKDPRKRL-----TAAQALSHPWIKNS 422 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rp-----t~~~ll~hp~~~~~ 422 (611)
+++.+||.+||+.||.+|| ++.++|+||||++.
T Consensus 374 ~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 374 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 9999999999999999999 99999999999875
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=398.72 Aligned_cols=263 Identities=37% Similarity=0.677 Sum_probs=231.1
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCH---HHHHHHHHHHHHHHHhcCCCCeeEEEEEE
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA---IAIEDVRREVKILRALTGHNNLVKFFDAY 228 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~iv~l~~~~ 228 (611)
.+.++|++++.||+|+||.||+|+... +|+.||+|++........ ...+.+.+|+.+++.+. ||||+++++++
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~ 84 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKS---TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVY 84 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECC---CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEEE
Confidence 356789999999999999999999776 689999999976543221 23567899999999998 99999999999
Q ss_pred eeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCc----eEEE
Q 007253 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS----VLKA 304 (611)
Q Consensus 229 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~----~vkl 304 (611)
.+.+.+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+. .++ .+||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~---~~~~~~~~~kl 160 (321)
T 2a2a_A 85 ENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL---DKNIPIPHIKL 160 (321)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES---CTTSSSCCEEE
T ss_pred ecCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEe---cCCCCcCCEEE
Confidence 999999999999999999998865 45799999999999999999999999999999999999995 344 7999
Q ss_pred eecccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 007253 305 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA 383 (611)
Q Consensus 305 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 383 (611)
+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+....+......++..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 240 (321)
T 2a2a_A 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEE 240 (321)
T ss_dssp CCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHH
T ss_pred ccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChh
Confidence 9999998876655566778999999999986 568999999999999999999999999988888888887776655544
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 384 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
.+..++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 241 ~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 241 FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 446789999999999999999999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=389.20 Aligned_cols=265 Identities=35% Similarity=0.633 Sum_probs=234.6
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcC------CHHHHHHHHHHHHHHHHhcCCCCeeEEE
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT------TAIAIEDVRREVKILRALTGHNNLVKFF 225 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~~h~~iv~l~ 225 (611)
.+.++|++.+.||+|+||.||+|.... +|+.||||++...... .....+.+.+|+.+++++.+||||++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKP---TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 90 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcC---cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeee
Confidence 356889999999999999999999766 6899999999654311 1234567889999999997799999999
Q ss_pred EEEeeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 226 DAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 226 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
+++.+.+..++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~ 166 (298)
T 1phk_A 91 DTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLT 166 (298)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEEC
T ss_pred eeeccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---cCCCcEEEe
Confidence 9999999999999999999999988765 569999999999999999999999999999999999999 577789999
Q ss_pred ecccccccCCCCcccccccCCCcCcchhhc-------CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Q 007253 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH-------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (611)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~ 378 (611)
|||++.............||+.|+|||++. ..++.++|||||||++|+|++|+.||...........+.....
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 246 (298)
T 1phk_A 167 DFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 246 (298)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred cccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCc
Confidence 999998877666666778999999999873 3578899999999999999999999999888888888888877
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 379 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.++...+..++..+.+||.+||+.||.+|||+.++|+||||++..
T Consensus 247 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 247 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 776666678999999999999999999999999999999999764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=394.56 Aligned_cols=256 Identities=30% Similarity=0.590 Sum_probs=215.1
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCC-----------------------HHHHHHHHHHHH
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT-----------------------AIAIEDVRREVK 210 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~ 210 (611)
.++|++.+.||+|+||.||+|+... +|+.||||++.+..... ....+.+.+|+.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 88 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNEN---DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA 88 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETT---TTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECC---CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence 4789999999999999999998765 68999999997543221 112456889999
Q ss_pred HHHHhcCCCCeeEEEEEEee--CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCC
Q 007253 211 ILRALTGHNNLVKFFDAYED--TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKP 288 (611)
Q Consensus 211 ~l~~l~~h~~iv~l~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp 288 (611)
++++|+ ||||+++++++.+ .+.+++||||+++|+|.+++ ....+++..++.++.||+.||.|||++||+||||||
T Consensus 89 ~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 165 (298)
T 2zv2_A 89 ILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKP 165 (298)
T ss_dssp HHHTCC-CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS--CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred HHHhCC-CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence 999997 9999999999987 56899999999999998754 345799999999999999999999999999999999
Q ss_pred CceEEeccCCCceEEEeecccccccCCCC-cccccccCCCcCcchhhcCC----CCCcchhhHHHHHHHHHHhCCCCCCC
Q 007253 289 ENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLHRS----YSTEADVWSIGVIAYILLCGSRPFWA 363 (611)
Q Consensus 289 ~NIll~~~~~~~~vkl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~DiwSlGvil~el~~g~~Pf~~ 363 (611)
+|||+ +.++.+||+|||++....... .....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||..
T Consensus 166 ~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 166 SNLLV---GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGEEE---CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHEEE---CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999 577889999999998765433 34456899999999998643 36789999999999999999999998
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccC
Q 007253 364 RTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420 (611)
Q Consensus 364 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~ 420 (611)
.........+......++. .+.+++++.+||.+||+.||.+|||+.++|+||||+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 243 ERIMCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp SSHHHHHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred ccHHHHHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 8877777777666544433 357899999999999999999999999999999995
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=398.12 Aligned_cols=260 Identities=28% Similarity=0.469 Sum_probs=206.1
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++++.||+|+||.||+|.... +|+.||||++..... ....+.+.+|+.++++++ ||||+++++++.+++.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~ 77 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKT---TGVYVALKEVKLDSE--EGTPSTAIREISLMKELK-HENIVRLYDVIHTENK 77 (317)
T ss_dssp ---------------CEEEEEECSS---SCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCC-BTTBCCEEEEECCTTE
T ss_pred ccceeEeeEECCCCCEEEEEEEECC---CCcEEEEEEeecccc--cccHHHHHHHHHHHHhcC-CCCcceEEEEEEECCe
Confidence 4679999999999999999998765 689999999965432 222356789999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecc
Q 007253 234 VYVVMELCEGGELLDRILSRG-----GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG 308 (611)
+++|||||+ |+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 78 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg 153 (317)
T 2pmi_A 78 LTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFG 153 (317)
T ss_dssp EEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCS
T ss_pred EEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE---cCCCCEEECcCc
Confidence 999999997 59999887542 358999999999999999999999999999999999999 577889999999
Q ss_pred cccccCCC-CcccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC--
Q 007253 309 LSDFVRPD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA-- 383 (611)
Q Consensus 309 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-- 383 (611)
++...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+..........
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 154 LARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp SCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTC
T ss_pred cceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHh
Confidence 99876533 23455689999999999863 58999999999999999999999999988877776665432111110
Q ss_pred ----------------------------CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 384 ----------------------------PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 384 ----------------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
....++.++.+||.+||+.||.+|||+.++|+||||++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 0125788999999999999999999999999999998754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=398.67 Aligned_cols=260 Identities=26% Similarity=0.423 Sum_probs=226.0
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..+.|++.+.||+|+||.||+|+... +|+.||||++...........+.+.+|+.++++++ ||||+++++++.+++
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 127 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREH 127 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred hhhheeeeeEEccCCCEEEEEEEEcc---CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECC
Confidence 34669999999999999999998765 68999999997665555556678999999999997 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
..+||||||. |+|.+.+......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 128 ~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~ 203 (348)
T 1u5q_A 128 TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASI 203 (348)
T ss_dssp EEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBS
T ss_pred eEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEeeccCcee
Confidence 9999999997 68999887777789999999999999999999999999999999999999 4678899999999987
Q ss_pred cCCCCcccccccCCCcCcchhhc----CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 313 VRPDERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
.... ...+||+.|+|||++. +.++.++|||||||++|||++|+.||...........+....... .....+
T Consensus 204 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~ 278 (348)
T 1u5q_A 204 MAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--LQSGHW 278 (348)
T ss_dssp SSSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--CCCTTS
T ss_pred cCCC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--CCCCCC
Confidence 6432 3568999999999873 568999999999999999999999998888777666666554222 223468
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCC
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~ 425 (611)
+..+.+||.+||+.||.+|||+.++++||||......
T Consensus 279 ~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~ 315 (348)
T 1u5q_A 279 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 315 (348)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCCc
Confidence 9999999999999999999999999999999876443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=403.52 Aligned_cols=263 Identities=36% Similarity=0.697 Sum_probs=231.5
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcC-----CHHHHHHHHHHHHHHHHhcCCCCeeEEE
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-----TAIAIEDVRREVKILRALTGHNNLVKFF 225 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~h~~iv~l~ 225 (611)
..+.++|++.+.||+|+||.||+|+... +|+.||||++...... .....+.+.+|+.+++++.+||||++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRA---TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECC---CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 3455789999999999999999999765 5899999998654321 1223466789999999995699999999
Q ss_pred EEEeeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 226 DAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 226 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
+++......|+|||||+||+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~---~~~~~ikl~ 242 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLS 242 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEEC
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEE
Confidence 9999999999999999999999988654 569999999999999999999999999999999999999 577889999
Q ss_pred ecccccccCCCCcccccccCCCcCcchhhc-------CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Q 007253 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH-------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (611)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~ 378 (611)
|||++..+.........+||+.|+|||++. ..++.++|||||||++|+|++|+.||...........+.....
T Consensus 243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 322 (365)
T 2y7j_A 243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY 322 (365)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence 999998877666667789999999999884 2478899999999999999999999999888888888887776
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccC
Q 007253 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420 (611)
Q Consensus 379 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~ 420 (611)
.+....|..++..+.+||.+||+.||.+|||+.++|+||||+
T Consensus 323 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 323 QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 665555667899999999999999999999999999999997
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=424.07 Aligned_cols=259 Identities=29% Similarity=0.494 Sum_probs=224.9
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|++.+.||+|+||.||+|+... +|+.||||++.+...........+.+|+.+++.++ |||||++++++.+.+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~---tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~ 257 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKD 257 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred cccceEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC-CCCEeeEEEEEeeCC
Confidence 35779999999999999999999876 68999999996543222233466889999999997 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
.+|||||||+||+|.+++.... ..+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+|||++.
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl---d~~g~vKL~DFGla~ 334 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAV 334 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE---eCCCCeEEEecccce
Confidence 9999999999999999887653 349999999999999999999999999999999999999 677899999999998
Q ss_pred ccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhcCCCCCCCCCC
Q 007253 312 FVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART----ESGIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~ 386 (611)
...........+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+.. ...+...+......++ .
T Consensus 335 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p----~ 410 (576)
T 2acx_A 335 HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----E 410 (576)
T ss_dssp ECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC----T
T ss_pred ecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC----c
Confidence 876666666779999999999987 468999999999999999999999998753 3445555655544443 4
Q ss_pred CCCHHHHHHHHHhcccCccCCC-----CHHHHHcCcccCCC
Q 007253 387 SLSSEARDFVKRLLNKDPRKRL-----TAAQALSHPWIKNS 422 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rp-----t~~~ll~hp~~~~~ 422 (611)
.++.++.+||++||+.||.+|| ++.++++||||+..
T Consensus 411 ~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 411 RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 6899999999999999999999 89999999999874
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=398.29 Aligned_cols=265 Identities=28% Similarity=0.454 Sum_probs=212.9
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
...++|++++.||+|+||.||+|+... +|+.||||++.... ......+.+.+|+.++++++ ||||+++++++.++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 105 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTV---TNETVAIKRIRLEH-EEEGVPGTAIREVSLLKELQ-HRNIIELKSVIHHN 105 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETT---TTEEEEEEECCCCC---------CHHHHHHGGGCC-CTTBCCEEEEEEET
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECC---CCceEEEEEEcccc-cccccchhHHHHHHHHHHcC-CCCcceEEEEEecC
Confidence 345789999999999999999998766 68999999996543 23334456789999999997 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEecc--CCCceEEEeeccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK--DENSVLKAIDFGL 309 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~--~~~~~vkl~DfG~ 309 (611)
+.++||||||++ +|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||+... +..+.+||+|||+
T Consensus 106 ~~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 106 HRLHLIFEYAEN-DLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp TEEEEEEECCSE-EHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred CEEEEEEecCCC-CHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999999999974 999988655 569999999999999999999999999999999999999643 2456799999999
Q ss_pred ccccCCC-CcccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 007253 310 SDFVRPD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 310 a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (611)
+...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+...........|+
T Consensus 184 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 184 ARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp HHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence 9876433 23455688999999999864 48999999999999999999999999988887777776543222222111
Q ss_pred --------------------------CCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 387 --------------------------SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 387 --------------------------~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.++.++.+||.+||+.||.+|||+.++|+||||++..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 1678999999999999999999999999999999754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=419.22 Aligned_cols=259 Identities=35% Similarity=0.616 Sum_probs=228.5
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
...++|.+++.||+|+||.||+|++.. +|+.||||++.+.........+.+.+|+.+++.++ ||||+++++++.+.
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~ 88 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHEL---TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVISTP 88 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETT---TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEEECS
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEEC
Confidence 345789999999999999999999765 68999999996543222234567899999999997 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+.+|+|||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 89 ~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll---~~~~~vkL~DFG~a~ 164 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSN 164 (476)
T ss_dssp SEEEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE---CTTCCEEECCCSSCE
T ss_pred CEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE---ecCCCeEEEeccchh
Confidence 999999999999999998754 4579999999999999999999999999999999999999 677889999999999
Q ss_pred ccCCCCcccccccCCCcCcchhhcCC--CCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 312 FVRPDERLNDIVGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
...........+||+.|+|||++.+. .+.++|||||||++|+|++|+.||.+......+..+.......+ ..++
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 240 (476)
T 2y94_A 165 MMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP----QYLN 240 (476)
T ss_dssp ECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC----TTCC
T ss_pred hccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC----ccCC
Confidence 87766666778999999999998754 36799999999999999999999999888888888877654443 3579
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
+++.+||++||+.||.+|||+.++++||||+..
T Consensus 241 ~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 241 PSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 999999999999999999999999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=435.57 Aligned_cols=260 Identities=26% Similarity=0.463 Sum_probs=230.8
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|++++.||+|+||.||+|+.+. +++.||||++.+.........+.+..|..++..+.+||+|+++++++.+.+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESS---SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred cccceEEEEEEccCCCEEEEEEEECC---CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence 45789999999999999999999876 689999999965432223344667889999998877999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.+|||||||+||+|.+++... +.+++..++.|+.||+.||.|||++|||||||||+|||| +.++++||+|||+++.
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl---~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE---CSSSCEEECCCTTCEE
T ss_pred EEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE---cCCCcEEEeecceeec
Confidence 999999999999999988765 569999999999999999999999999999999999999 6788999999999986
Q ss_pred cC-CCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 313 VR-PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 313 ~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
.. ........+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+.+..+++..|......++. .++.
T Consensus 492 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~ 567 (674)
T 3pfq_A 492 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSK 567 (674)
T ss_dssp CCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT----TSCH
T ss_pred cccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCH
Confidence 43 334566789999999999986 67999999999999999999999999999999999999988776654 6899
Q ss_pred HHHHHHHHhcccCccCCCCH-----HHHHcCcccCCCC
Q 007253 391 EARDFVKRLLNKDPRKRLTA-----AQALSHPWIKNSN 423 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~-----~~ll~hp~~~~~~ 423 (611)
++.+||++||++||.+||++ .+|++||||+..+
T Consensus 568 ~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~ 605 (674)
T 3pfq_A 568 EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 605 (674)
T ss_dssp HHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred HHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence 99999999999999999997 9999999998753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=408.54 Aligned_cols=263 Identities=30% Similarity=0.519 Sum_probs=211.1
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
..+.++|++++.||+|+||.||+|.+.. +|+.||||++.+.. ........+.+|+.+++.+.+||||+++++++..
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 80 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRR---TGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRA 80 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETT---TCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECC---CCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec
Confidence 3456889999999999999999998776 68999999986542 3455567788999999999889999999999986
Q ss_pred CC--eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecc
Q 007253 231 TD--NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (611)
Q Consensus 231 ~~--~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG 308 (611)
++ .+|+|||||+ |+|.+++.. ..+++..++.++.||+.||.|||+.|||||||||+|||+ +.++.+||+|||
T Consensus 81 ~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG 154 (388)
T 3oz6_A 81 DNDRDVYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFG 154 (388)
T ss_dssp TTSSCEEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCT
T ss_pred CCCCEEEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE---cCCCCEEecCCc
Confidence 54 7999999997 589888865 469999999999999999999999999999999999999 677889999999
Q ss_pred cccccCCC----------------------CcccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCC
Q 007253 309 LSDFVRPD----------------------ERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWAR 364 (611)
Q Consensus 309 ~a~~~~~~----------------------~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~ 364 (611)
+++.+... ......+||++|+|||++. ..|+.++|||||||++|||++|+.||.+.
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp TCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99865321 1234468999999999886 46899999999999999999999999998
Q ss_pred ChHHHHHHHHhcCCCCC--------------------------C-----------------CCCCCCCHHHHHHHHHhcc
Q 007253 365 TESGIFRAVLKADPSFD--------------------------E-----------------APWPSLSSEARDFVKRLLN 401 (611)
Q Consensus 365 ~~~~~~~~i~~~~~~~~--------------------------~-----------------~~~~~~s~~~~~li~~~L~ 401 (611)
.....+..+........ . .....+++++.+||++||+
T Consensus 235 ~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 314 (388)
T 3oz6_A 235 STMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ 314 (388)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred CHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence 88777766653211110 0 0112678999999999999
Q ss_pred cCccCCCCHHHHHcCcccCCCC
Q 007253 402 KDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 402 ~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.||.+|||+.++|+||||+...
T Consensus 315 ~dP~~R~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 315 FNPNKRISANDALKHPFVSIFH 336 (388)
T ss_dssp SSGGGSCCHHHHTTSTTTTTTC
T ss_pred cCcccCCCHHHHhCCHHHHHhc
Confidence 9999999999999999997543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=398.15 Aligned_cols=259 Identities=31% Similarity=0.560 Sum_probs=215.4
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
+.++|++++.||+|+||.||+|+... +++.||||++..... ....+.+.+|+.+++.++ ||||+++++++.+++
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 78 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGN 78 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC---------CHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred HhhhceeeeEEecCCCEEEEEEEECC---CCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCC-CCCCCeEEEEEecCC
Confidence 46789999999999999999998776 689999999865432 223456889999999997 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
..|+|||||+||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Dfg~a~~ 154 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATV 154 (323)
T ss_dssp EEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEE
T ss_pred eEEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE---eCCCCEEEEEeeccce
Confidence 99999999999999987743 3569999999999999999999999999999999999999 5777899999999986
Q ss_pred cCCCC---cccccccCCCcCcchhhcC-C-CCCcchhhHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhcCCCCCCCCCC
Q 007253 313 VRPDE---RLNDIVGSAYYVAPEVLHR-S-YSTEADVWSIGVIAYILLCGSRPFWARTESGI-FRAVLKADPSFDEAPWP 386 (611)
Q Consensus 313 ~~~~~---~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~ 386 (611)
+.... .....+||+.|+|||++.+ . ++.++|||||||++|+|++|+.||........ +....... .....+.
T Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~ 232 (323)
T 3tki_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--TYLNPWK 232 (323)
T ss_dssp CEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC--TTSTTGG
T ss_pred eccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc--ccCCccc
Confidence 54322 2346789999999999864 3 47789999999999999999999987655422 33333222 2223346
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.++.++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 233 ~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 233 KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 7899999999999999999999999999999998654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=398.70 Aligned_cols=261 Identities=29% Similarity=0.478 Sum_probs=214.4
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++++.||+|+||.||+|+... +++.||||++..... ......+.+|+.++++++ ||||+++++++.+++.+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 75 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKL---TDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSL 75 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECC--------CCCCCCCHHHHSCCC-CTTBCCEEEEEECSSCE
T ss_pred CceEEEEEEcCCCCEEEEEEEECC---CCcEEEEEEEecccc--cccchhHHHHHHHHHhcC-CCCCCeeeeEEeeCCEE
Confidence 579999999999999999999775 689999999854321 111123457999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++|||||+ |+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 76 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 76 TLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKS 151 (324)
T ss_dssp EEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE---CTTCCEEECSSSEEECC-
T ss_pred EEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE---CCCCCEEEccCccccccc
Confidence 99999997 59999998877789999999999999999999999999999999999999 567789999999998664
Q ss_pred CC-CcccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCC------
Q 007253 315 PD-ERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW------ 385 (611)
Q Consensus 315 ~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~------ 385 (611)
.. ......+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+....+...........|
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 33 2344568899999999886 35899999999999999999999999998888777776654332222222
Q ss_pred --------------------CCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCC
Q 007253 386 --------------------PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (611)
Q Consensus 386 --------------------~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~ 425 (611)
+.+++++.+||.+||+.||.+|||+.|+|+||||+.....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 3468999999999999999999999999999999876543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=394.08 Aligned_cols=259 Identities=32% Similarity=0.500 Sum_probs=229.5
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|.+++.||+|+||.||+++... +++.||+|++.+.........+.+.+|+.+++.+. ||||+++++++.+.+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 114 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDAD---TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDND 114 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCC
Confidence 45789999999999999999999766 68899999997765556667788999999999997 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.+|+|||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATK 190 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred eEEEEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE---cCCCCEEEeeccCcee
Confidence 999999999999999987654 579999999999999999999999999999999999999 5677899999999987
Q ss_pred cCCC-CcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 313 VRPD-ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 313 ~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
.... .......||+.|+|||++. ..++.++|||||||++|+|++|+.||......+.+..+......++ ..++.
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~ 266 (335)
T 2owb_A 191 VEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINP 266 (335)
T ss_dssp CCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSCH
T ss_pred cccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCC----ccCCH
Confidence 6533 3345568999999999986 5588999999999999999999999998888887777777665444 35789
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
++.+||++||+.||.+|||+.++|+||||+...
T Consensus 267 ~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 267 VAASLIQKMLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp HHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence 999999999999999999999999999998654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=388.61 Aligned_cols=265 Identities=40% Similarity=0.756 Sum_probs=234.8
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+.++|++++.||+|+||.||+|+... +++.||||++...... ....+.+.+|+.++++++ ||||+++++++.+.
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 93 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAK-NKDTSTILREVELLKKLD-HPNIMKLFEILEDS 93 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECS
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcC---CCcEEEEEEecccccc-hHHHHHHHHHHHHHHhcc-CCCccEEEEEEeCC
Confidence 456789999999999999999998765 6899999998654322 233567889999999997 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+.+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++..+..+.+||+|||++.
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 94 SSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred CeEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999999999988765 469999999999999999999999999999999999999755556689999999998
Q ss_pred ccCCCCcccccccCCCcCcchhhcCCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 312 FVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
............||+.|+|||++.+.++.++||||||+++|+|++|..||.+....+....+......++...+..++.+
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (287)
T 2wei_A 173 CFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252 (287)
T ss_dssp TBCCCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHH
T ss_pred eecCCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHH
Confidence 77655555666799999999999988999999999999999999999999998888888888887766665556788999
Q ss_pred HHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
+.+||.+||..||.+|||+.++|+||||+..
T Consensus 253 ~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 9999999999999999999999999999754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=397.06 Aligned_cols=264 Identities=29% Similarity=0.470 Sum_probs=223.6
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee---
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--- 230 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~--- 230 (611)
.++|++++.||+|+||.||+|+... +|+.||||++...... ......+.+|+.+++.++ ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 90 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMENEK-EGFPITALREIKILQLLK-HENVVNLIEICRTKAS 90 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETT---TCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC--
T ss_pred ccceeEEEEEecCCCcEEEEEEECC---CCCEEEEEEEeccccc-ccchHHHHHHHHHHHhcc-CCCcccHhheeecccc
Confidence 4689999999999999999999766 6899999998654332 223356779999999998 9999999999987
Q ss_pred -----CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 231 -----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 231 -----~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
.+.+++|||||++ +|.+.+......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 91 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~ 166 (351)
T 3mi9_A 91 PYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLA 166 (351)
T ss_dssp ------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEEC
T ss_pred ccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCCEEEc
Confidence 4568999999975 8888887777789999999999999999999999999999999999999 577889999
Q ss_pred ecccccccCCC-----CcccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Q 007253 306 DFGLSDFVRPD-----ERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (611)
Q Consensus 306 DfG~a~~~~~~-----~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~ 378 (611)
|||++..+... ......+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 246 (351)
T 3mi9_A 167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 246 (351)
T ss_dssp CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 99999866422 2334568999999999886 3589999999999999999999999999888888777776555
Q ss_pred CCCCCCCCCC----------------------------CHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCCC
Q 007253 379 SFDEAPWPSL----------------------------SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVK 426 (611)
Q Consensus 379 ~~~~~~~~~~----------------------------s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~~ 426 (611)
..+...|+.+ ++++.+||.+||+.||.+|||+.|+|+||||+......
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 322 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 322 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence 5544444332 67899999999999999999999999999998765433
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=403.68 Aligned_cols=262 Identities=21% Similarity=0.327 Sum_probs=216.4
Q ss_pred CCceeEeCeeeec--cceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 154 ANKYELGEEVGRG--HFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G--~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.++|++++.||+| +||.||+|+... +|+.||||++.... ......+.+.+|+.+++.++ |||||++++++.++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 98 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKP---TGEYVTVRRINLEA-CSNEMVTFLQGELHVSKLFN-HPNIVPYRATFIAD 98 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETT---TCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEET
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcC---CCCEEEEEEecccc-cChHHHHHHHHHHHHHHhCC-CCCCCcEeEEEEEC
Confidence 5689999999999 999999999876 68999999997643 33456678889999999998 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 232 DNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
+.+|+|||||++|+|.+++... ...+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll---~~~~~~kl~dfg~~ 175 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSN 175 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCGGGC
T ss_pred CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccccc
Confidence 9999999999999999998765 3569999999999999999999999999999999999999 57788999999988
Q ss_pred cccCCCC--------cccccccCCCcCcchhhcC---CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC
Q 007253 311 DFVRPDE--------RLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 379 (611)
Q Consensus 311 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~ 379 (611)
....... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+..+......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 255 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 6542211 1233579999999999864 5899999999999999999999999876655444333322110
Q ss_pred ------------------------------------------CCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCc
Q 007253 380 ------------------------------------------FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHP 417 (611)
Q Consensus 380 ------------------------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp 417 (611)
.....+..+++++.+||++||+.||.+|||+.++|+||
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence 00012345789999999999999999999999999999
Q ss_pred ccCCCC
Q 007253 418 WIKNSN 423 (611)
Q Consensus 418 ~~~~~~ 423 (611)
||+...
T Consensus 336 ~f~~~~ 341 (389)
T 3gni_B 336 FFKQIK 341 (389)
T ss_dssp GGGGC-
T ss_pred HHHHHh
Confidence 998764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=398.83 Aligned_cols=267 Identities=25% Similarity=0.408 Sum_probs=223.2
Q ss_pred CCCcCcccccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhc----CCC
Q 007253 144 NKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT----GHN 219 (611)
Q Consensus 144 ~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----~h~ 219 (611)
..++.....+.++|+++++||+|+||.||+|+... +++.||||++.. .......+..|+.+++.+. +||
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~h~ 96 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHID---NKKYYAVKVVRN----IKKYTRSAKIEADILKKIQNDDINNN 96 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECS----CHHHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECC---CCeEEEEEEecc----chhhhhhhHHHHHHHHHhcccCCCCC
Confidence 34455566778999999999999999999999766 689999999853 2344566788999999986 599
Q ss_pred CeeEEEEEEeeCCeeEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEecc--
Q 007253 220 NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK-- 296 (611)
Q Consensus 220 ~iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~-- 296 (611)
||+++++++...+.+++||||| +++|.+++.... ..+++..++.++.||+.||.|||++|||||||||+|||+...
T Consensus 97 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp GBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTC
T ss_pred CeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccc
Confidence 9999999999999999999999 899999987654 359999999999999999999999999999999999999531
Q ss_pred --------------------CCCceEEEeecccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHH
Q 007253 297 --------------------DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILL 355 (611)
Q Consensus 297 --------------------~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~ 355 (611)
...+.+||+|||++..... .....+||+.|+|||++. ..++.++|||||||++|+|+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 1267899999999986542 334568999999999886 56999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHhcCCCCCCC---------------------CCC---------------------CCCHHHH
Q 007253 356 CGSRPFWARTESGIFRAVLKADPSFDEA---------------------PWP---------------------SLSSEAR 393 (611)
Q Consensus 356 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---------------------~~~---------------------~~s~~~~ 393 (611)
+|+.||......+.+..+.......+.. .|+ ..++.+.
T Consensus 254 ~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 333 (360)
T 3llt_A 254 TGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFC 333 (360)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHH
T ss_pred HCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHH
Confidence 9999999888777766665543322210 011 1247788
Q ss_pred HHHHHhcccCccCCCCHHHHHcCcccC
Q 007253 394 DFVKRLLNKDPRKRLTAAQALSHPWIK 420 (611)
Q Consensus 394 ~li~~~L~~dP~~Rpt~~~ll~hp~~~ 420 (611)
+||.+||+.||.+|||+.++|+||||+
T Consensus 334 ~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 334 DFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 999999999999999999999999996
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=385.91 Aligned_cols=258 Identities=31% Similarity=0.611 Sum_probs=222.4
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|++++.||+|+||.||+|.... .++.||+|++.+...........+.+|+.++++++ ||||+++++++.+.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 82 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDAT 82 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSS
T ss_pred ecccEEEeeEEecCCCeEEEEEEEcc---CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheEecCC
Confidence 45789999999999999999998776 68899999986543223333567889999999998 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
..++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~Dfg~~~~ 158 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVH 158 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE---CTTSCEEECSCCEESC
T ss_pred EEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE---cCCCCEEEEecccccc
Confidence 999999999999999988665 569999999999999999999999999999999999999 5778899999999866
Q ss_pred cCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 313 VRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
.... ......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+......++. .++..
T Consensus 159 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~ 233 (279)
T 3fdn_A 159 APSS-RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEG 233 (279)
T ss_dssp C---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT----TSCHH
T ss_pred CCcc-cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCC----cCCHH
Confidence 5432 334568999999999987 45788999999999999999999999998888888888776655543 57899
Q ss_pred HHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 234 ~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 234 ARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred HHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 99999999999999999999999999998654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=411.37 Aligned_cols=261 Identities=31% Similarity=0.511 Sum_probs=199.1
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC-
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~- 231 (611)
+.++|++++.||+|+||.||+|+... +|+.||||++.+. .......+.+.+|+.++++|+ |||||++++++...
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 125 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKL---EKRVVAIKKILRV-FEDLIDCKRILREIAILNRLN-HDHVVKVLDIVIPKD 125 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC-----CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECC---CCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCC-CCCCCceEEEEecCC
Confidence 45789999999999999999999776 6899999998654 244556678999999999997 99999999999543
Q ss_pred ----CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeec
Q 007253 232 ----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (611)
Q Consensus 232 ----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~Df 307 (611)
..+|+||||+ +|+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+||
T Consensus 126 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl---~~~~~~kl~DF 200 (458)
T 3rp9_A 126 VEKFDELYVVLEIA-DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDF 200 (458)
T ss_dssp TTTCCCEEEEECCC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCC
T ss_pred cccCceEEEEEecc-ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE---CCCCCEeeccc
Confidence 5799999999 5689887754 4679999999999999999999999999999999999999 67788999999
Q ss_pred ccccccCCCC----------------------------cccccccCCCcCcchhh-c-CCCCCcchhhHHHHHHHHHHh-
Q 007253 308 GLSDFVRPDE----------------------------RLNDIVGSAYYVAPEVL-H-RSYSTEADVWSIGVIAYILLC- 356 (611)
Q Consensus 308 G~a~~~~~~~----------------------------~~~~~~gt~~y~aPE~~-~-~~~~~~~DiwSlGvil~el~~- 356 (611)
|+++...... .....+||++|+|||++ . ..|+.++||||||||+|||++
T Consensus 201 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 9998764221 23456899999999976 3 569999999999999999998
Q ss_pred ----------CCCCCCCCCh--------------------HHHHHHHHhc-----------------------CCCC---
Q 007253 357 ----------GSRPFWARTE--------------------SGIFRAVLKA-----------------------DPSF--- 380 (611)
Q Consensus 357 ----------g~~Pf~~~~~--------------------~~~~~~i~~~-----------------------~~~~--- 380 (611)
|+++|.+... ...+..+... .+..
T Consensus 281 ~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (458)
T 3rp9_A 281 IKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGT 360 (458)
T ss_dssp STTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCC
T ss_pred ccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCC
Confidence 6777755431 1112222111 0000
Q ss_pred -CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 381 -DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 381 -~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
....++.++.++.+||++||..||.+|||+.|+|+||||+...
T Consensus 361 ~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 361 DLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp CGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 0112456799999999999999999999999999999999764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=414.22 Aligned_cols=266 Identities=33% Similarity=0.639 Sum_probs=214.1
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcC-----CHHHHHHHHHHHHHHHHhcCCCCeeEEE
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-----TAIAIEDVRREVKILRALTGHNNLVKFF 225 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~h~~iv~l~ 225 (611)
..+.++|.+.+.||+|+||.||+|.... +++.||||++.+.... .......+.+|+.++++|+ ||||++++
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~ 206 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERK---TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIK 206 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC-CTTBCCCC
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECC---CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC-CCCEeeEE
Confidence 3456889999999999999999999776 6899999998654321 1222335789999999997 99999999
Q ss_pred EEEeeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 226 DAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 226 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
+++. .+.+|+|||||++|+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||++..+....+||+
T Consensus 207 ~~~~-~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 207 NFFD-AEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp EEEE-SSEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred EEEe-cCceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEe
Confidence 9975 4568999999999999887754 3579999999999999999999999999999999999999765566779999
Q ss_pred ecccccccCCCCcccccccCCCcCcchhhc----CCCCCcchhhHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCC
Q 007253 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSF 380 (611)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~-~~~~~i~~~~~~~ 380 (611)
|||+++...........+||+.|+|||++. ..++.++|||||||++|+|++|+.||...... .....+......+
T Consensus 285 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~ 364 (419)
T 3i6u_A 285 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 364 (419)
T ss_dssp CSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCC
T ss_pred ecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCC
Confidence 999999877666666789999999999884 45788999999999999999999999765433 3444555554444
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 381 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
....+..++..+.+||++||+.||.+|||+.++|+||||++.
T Consensus 365 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 365 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 444456789999999999999999999999999999999863
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=416.64 Aligned_cols=258 Identities=27% Similarity=0.455 Sum_probs=224.1
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++.+.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~---tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~ 259 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKA---TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLAYAFETKTD 259 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECC---CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC-CCCEeeEEEEEeeCCE
Confidence 4789999999999999999999866 68999999996543322234467889999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 234 VYVVMELCEGGELLDRILSRG---GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
+|+|||||+||+|.+++.... ..+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+|||++
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl---~~~g~vkL~DFGla 336 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLA 336 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE---eCCCCEEEeeccee
Confidence 999999999999999887643 469999999999999999999999999999999999999 67888999999999
Q ss_pred cccCCCCc-ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHhcCCCCCCCC
Q 007253 311 DFVRPDER-LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWAR----TESGIFRAVLKADPSFDEAP 384 (611)
Q Consensus 311 ~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~----~~~~~~~~i~~~~~~~~~~~ 384 (611)
..+..... ....+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+. ....+...+......++
T Consensus 337 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p--- 413 (543)
T 3c4z_A 337 VELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP--- 413 (543)
T ss_dssp EECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC---
T ss_pred eeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC---
Confidence 87754443 34569999999999987 46899999999999999999999999775 34566777777665554
Q ss_pred CCCCCHHHHHHHHHhcccCccCCCC-----HHHHHcCcccCCC
Q 007253 385 WPSLSSEARDFVKRLLNKDPRKRLT-----AAQALSHPWIKNS 422 (611)
Q Consensus 385 ~~~~s~~~~~li~~~L~~dP~~Rpt-----~~~ll~hp~~~~~ 422 (611)
..++.++.+||++||++||.+||+ +.++++||||+..
T Consensus 414 -~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 414 -DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp -TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred -cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 468999999999999999999996 5899999999874
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=401.93 Aligned_cols=269 Identities=35% Similarity=0.639 Sum_probs=226.1
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCc--CCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEE
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--TTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~ 228 (611)
..+.++|++++.||+|+||.||+|.... +++.||+|++.+... ......+.+.+|+.++++++ ||||+++++++
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~ 97 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQ---TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVY 97 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred hhhhhheeecceeeecCCeEEEEEEECC---CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeehhh
Confidence 3467889999999999999999998765 689999999864321 12334577899999999997 99999999999
Q ss_pred eeCCeeEEEeeecCCCChHHHHHhc---------------------------------------CCCCCHHHHHHHHHHH
Q 007253 229 EDTDNVYVVMELCEGGELLDRILSR---------------------------------------GGKYTEDDAKAVMIQI 269 (611)
Q Consensus 229 ~~~~~~~lv~E~~~~gsL~~~l~~~---------------------------------------~~~l~~~~~~~i~~qi 269 (611)
.+.+..++|||||+||+|.+++... ...+++..++.++.||
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 9999999999999999999887310 1124678899999999
Q ss_pred HHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCC-----cccccccCCCcCcchhhc---CCCCCc
Q 007253 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-----RLNDIVGSAYYVAPEVLH---RSYSTE 341 (611)
Q Consensus 270 ~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~---~~~~~~ 341 (611)
+.||.|||++||+||||||+|||++. +..+.+||+|||++..+.... ......||+.|+|||++. ..++.+
T Consensus 178 ~~~l~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 178 FSALHYLHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHHHTTEECCCCCGGGEEESC-SSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHHHCCccccCCChhhEEEec-CCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999999999999999999999953 123379999999998653221 234568999999999985 468899
Q ss_pred chhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCC
Q 007253 342 ADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 342 ~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
+|||||||++|+|++|+.||.+....+....+......+....+..+++++.+||.+||+.||.+|||+.++|+||||+.
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~ 336 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHT
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhcc
Confidence 99999999999999999999999998888888888777776666678999999999999999999999999999999987
Q ss_pred CCC
Q 007253 422 SND 424 (611)
Q Consensus 422 ~~~ 424 (611)
...
T Consensus 337 ~~~ 339 (345)
T 3hko_A 337 FSD 339 (345)
T ss_dssp TSS
T ss_pred ChH
Confidence 654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=415.54 Aligned_cols=259 Identities=27% Similarity=0.485 Sum_probs=210.4
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
...++|++++.||+|+||.||+|.... +|+.||||++.+.. ......+.+.+|+.+++.++ ||||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~ 133 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQ 133 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSC
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECC---CCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCC-CCCCCcEEEEEccC
Confidence 346889999999999999999998766 68999999997542 34555678899999999997 99999999999755
Q ss_pred ------CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 232 ------DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 232 ------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
..+|||||||++ +|.+.+. ..+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||+
T Consensus 134 ~~~~~~~~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll---~~~~~~kl~ 206 (464)
T 3ttj_A 134 KTLEEFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKIL 206 (464)
T ss_dssp CSTTTCCEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEEC
T ss_pred CccccCCeEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE---eCCCCEEEE
Confidence 457999999976 5666663 349999999999999999999999999999999999999 577889999
Q ss_pred ecccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-----
Q 007253 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS----- 379 (611)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~----- 379 (611)
|||+++...........+||++|+|||++. ..|+.++|||||||++|||++|+.||.+....+.+..+......
T Consensus 207 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~ 286 (464)
T 3ttj_A 207 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 286 (464)
T ss_dssp CCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred EEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 999999877665667789999999999886 56999999999999999999999999998877776666543211
Q ss_pred -----------------CCCCCC----CC------------CCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 380 -----------------FDEAPW----PS------------LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 380 -----------------~~~~~~----~~------------~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
.....+ +. .++++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 111100 00 15678999999999999999999999999999853
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=387.92 Aligned_cols=262 Identities=29% Similarity=0.515 Sum_probs=214.3
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++++.||+|+||.||+|+... +|+.||||++.... ......+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRD---TGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLK-HPNLVNLLEVFRRKRR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred cccceEeeEEeecCCeEEEEEEeCC---CCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCC-CCCccchhheeecCCe
Confidence 4689999999999999999999766 68999999986543 34455677889999999998 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
.++|||||++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 77 ~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~ 152 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDR-YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLL 152 (311)
T ss_dssp EEEEEECCSEEHHHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred EEEEEEeCCCchHHHHHh-hhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE---cCCCCEEEeeCCCchhc
Confidence 999999999988777654 44679999999999999999999999999999999999999 57788999999999876
Q ss_pred CCC-CcccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-----------
Q 007253 314 RPD-ERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS----------- 379 (611)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~----------- 379 (611)
... ......+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+....+......
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 153 TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp C------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred cCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 533 2345568999999999885 45899999999999999999999999988777665554432111
Q ss_pred --------CCCC--------CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCC
Q 007253 380 --------FDEA--------PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (611)
Q Consensus 380 --------~~~~--------~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~ 424 (611)
.+.. .++.++.++.+||++||+.||.+|||+.++|+||||++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 293 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence 0100 12468999999999999999999999999999999998653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=384.85 Aligned_cols=264 Identities=38% Similarity=0.719 Sum_probs=224.7
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCC---HHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT---AIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
.++|++++.||+|+||.||+|+... +|+.||+|++....... ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~ 79 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKG---TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFEN 79 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred hhhhhhHHhhcccCceEEEEEEEcC---CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhheecC
Confidence 4679999999999999999999776 68999999987654322 123567899999999998 9999999999999
Q ss_pred CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccC-CCceEEEeeccc
Q 007253 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAIDFGL 309 (611)
Q Consensus 231 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~-~~~~vkl~DfG~ 309 (611)
.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++...+ ....+||+|||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred CCeEEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999999988654 5699999999999999999999999999999999999995322 223799999999
Q ss_pred ccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 310 SDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 310 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
+.............||+.|+|||++. ..++.++||||||+++|+|++|..||.+....+....+......++...+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T 3bhy_A 159 AHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT 238 (283)
T ss_dssp CEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred ceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccC
Confidence 98776555556678999999999986 56899999999999999999999999998888888877776655554445678
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
+..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 239 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 9999999999999999999999999999999754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=388.27 Aligned_cols=255 Identities=31% Similarity=0.564 Sum_probs=220.2
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
.|...+.||+|+||.||+|+... +|+.||||++..... ...+.+.+|+.++++++ ||||+++++++...+..+
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~---~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 118 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKH---SGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEELW 118 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTC---CSHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEE
T ss_pred hhhccEEeccCCCeEEEEEEECC---CCcEEEEEEEeccch---hHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEE
Confidence 47888899999999999999765 689999999965432 23466889999999997 999999999999999999
Q ss_pred EEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC
Q 007253 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~ 315 (611)
+||||++||+|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 119 lv~e~~~~~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~ 193 (321)
T 2c30_A 119 VLMEFLQGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISK 193 (321)
T ss_dssp EEECCCCSCBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCS
T ss_pred EEEecCCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCcEEEeeeeeeeeccc
Confidence 9999999999999774 3469999999999999999999999999999999999999 5677899999999987654
Q ss_pred CC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 007253 316 DE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (611)
Q Consensus 316 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 393 (611)
.. .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||...........+........ .....+++++.
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~ 272 (321)
T 2c30_A 194 DVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL-KNSHKVSPVLR 272 (321)
T ss_dssp SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-TTGGGSCHHHH
T ss_pred CccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc-CccccCCHHHH
Confidence 33 345668999999999986 5689999999999999999999999998887777766665433221 12246789999
Q ss_pred HHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 394 DFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 394 ~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
+||.+||+.||.+|||+.++++||||+...
T Consensus 273 ~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 273 DFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred HHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 999999999999999999999999998654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=385.31 Aligned_cols=262 Identities=29% Similarity=0.615 Sum_probs=227.3
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++++.||+|+||.||+|+... +++.||||++.+.........+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQ---NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHDRKR 88 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred hhhceeeheecCCCCeEEEEEEEcC---CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC-CCCEeeEEEEEEcCCE
Confidence 5789999999999999999999765 58899999985432222223467889999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
.++||||+++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVHA 164 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---cCCCCEEEecccccccC
Confidence 99999999999999988765 469999999999999999999999999999999999999 56778999999998765
Q ss_pred CCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 314 RPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
.. .......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+......++ +.++.++
T Consensus 165 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 239 (284)
T 2vgo_A 165 PS-LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGS 239 (284)
T ss_dssp SS-SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHH
T ss_pred cc-cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC----CcCCHHH
Confidence 43 2334568999999999987 4589999999999999999999999998888888777777665444 3679999
Q ss_pred HHHHHHhcccCccCCCCHHHHHcCcccCCCCCCCCc
Q 007253 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVP 428 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~~~~ 428 (611)
.+||.+||+.||.+|||+.++++||||+......+|
T Consensus 240 ~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p 275 (284)
T 2vgo_A 240 KDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLP 275 (284)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCCC
T ss_pred HHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccccCC
Confidence 999999999999999999999999999876555444
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=394.54 Aligned_cols=263 Identities=29% Similarity=0.418 Sum_probs=216.3
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCC--HHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT--AIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
..++|++++.||+|+||.||+|+... +|+.||||++....... ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKN---TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGH 83 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSS---CCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECC---CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEEEee
Confidence 35789999999999999999998765 68999999986532221 112246789999999997 9999999999999
Q ss_pred CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 231 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
.+.+++|||||++ +|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 84 KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLA 159 (346)
T ss_dssp TTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGG
T ss_pred CCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE---cCCCCEEEEecccc
Confidence 9999999999976 8988887766679999999999999999999999999999999999999 57788999999999
Q ss_pred cccCCC-CcccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC---
Q 007253 311 DFVRPD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP--- 384 (611)
Q Consensus 311 ~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~--- 384 (611)
...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+...........
T Consensus 160 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 160 KSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp STTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred eeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence 876533 33456789999999999853 488999999999999999999999999888887777765422222111
Q ss_pred ---------------------CCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 385 ---------------------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 385 ---------------------~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
+..++.++.+||++||+.||.+|||+.|+|+||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 135678999999999999999999999999999998654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=385.43 Aligned_cols=259 Identities=32% Similarity=0.593 Sum_probs=197.6
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++++.||+|+||.||+|+... +|+.||||++...........+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 85 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIH---TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFEDSNY 85 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEEEECSSE
T ss_pred cccceeeeeecCCCceEEEEEEEcc---CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEEEccCCe
Confidence 4679999999999999999998765 68999999986432222223467889999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
.++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQL 162 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEEeecceeec
Confidence 999999999999999988776789999999999999999999999999999999999999 57788999999999876
Q ss_pred CCC-CcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 314 RPD-ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
... .......||+.|+|||++. ..++.++|||||||++|+|++|+.||...........+....... ...++.+
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 238 (278)
T 3cok_A 163 KMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM----PSFLSIE 238 (278)
T ss_dssp C----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCC----CTTSCHH
T ss_pred cCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCC----ccccCHH
Confidence 532 2334567999999999886 558899999999999999999999998766555444333322222 2357999
Q ss_pred HHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
+.+||.+||+.||.+|||+.++++||||+...
T Consensus 239 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 239 AKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 99999999999999999999999999998653
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=394.27 Aligned_cols=265 Identities=34% Similarity=0.640 Sum_probs=217.5
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcC-----CHHHHHHHHHHHHHHHHhcCCCCeeEEE
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-----TAIAIEDVRREVKILRALTGHNNLVKFF 225 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~h~~iv~l~ 225 (611)
..+.++|++.+.||+|+||.||+|+... +++.||||++...... .......+.+|+.+++++. ||||++++
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~ 81 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERK---TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIK 81 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECC---------------CHHHHHHHHHHCC-CTTBCCEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcC---CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC-CCCCceEe
Confidence 3456789999999999999999998766 6899999998654321 1223345789999999997 99999999
Q ss_pred EEEeeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 226 DAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 226 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
+++..++ .|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++..+....+||+
T Consensus 82 ~~~~~~~-~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 82 NFFDAED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp EEEESSS-EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred eEEcCCc-eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEc
Confidence 9987655 8999999999999998754 4579999999999999999999999999999999999999755555679999
Q ss_pred ecccccccCCCCcccccccCCCcCcchhhc----CCCCCcchhhHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCC
Q 007253 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSF 380 (611)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~-~~~~~i~~~~~~~ 380 (611)
|||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||...... .....+......+
T Consensus 160 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (322)
T 2ycf_A 160 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239 (322)
T ss_dssp CCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCC
T ss_pred cCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcccc
Confidence 999998776554445668999999999873 56889999999999999999999999765433 3344444444433
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCC
Q 007253 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 381 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
....+..++.++.+||.+||+.||.+|||+.++|+||||+.
T Consensus 240 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 33334578999999999999999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=394.25 Aligned_cols=263 Identities=28% Similarity=0.471 Sum_probs=222.4
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
..+.++|++++.||+|+||.||+|+... +++.||||++.............+.+|+.++++++ ||||+++++++..
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 83 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLR---DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEA 83 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC-CTTBCCEEEEEEE
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECC---CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCC-CCCcceEEEeeec
Confidence 4567899999999999999999999766 68999999998766566677788999999999997 9999999999887
Q ss_pred CCe----eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEee
Q 007253 231 TDN----VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (611)
Q Consensus 231 ~~~----~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D 306 (611)
... .|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~D 159 (311)
T 3ork_A 84 ETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMD 159 (311)
T ss_dssp EETTEEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---ETTSCEEECC
T ss_pred cCCCCcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEE---cCCCCEEEee
Confidence 543 49999999999999988765 569999999999999999999999999999999999999 4667899999
Q ss_pred cccccccCCCC----cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Q 007253 307 FGLSDFVRPDE----RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381 (611)
Q Consensus 307 fG~a~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~ 381 (611)
||++....... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.........+.......+
T Consensus 160 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (311)
T 3ork_A 160 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 239 (311)
T ss_dssp CSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH
T ss_pred ccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc
Confidence 99998765332 233467999999999886 5689999999999999999999999999888887777777665554
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCC
Q 007253 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 382 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
...+..++.++.+||.+||+.||.+||++.+++.|+|++.
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 240 SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 4445678999999999999999999999999999999974
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=381.50 Aligned_cols=259 Identities=34% Similarity=0.618 Sum_probs=216.4
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
...++|++++.||+|+||.||+|+... +|+.||||++...........+.+.+|+.+++.++ ||||+++++++.+.
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 83 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQL---TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVISTP 83 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECS
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECC---CCceEEEEEeccccccchhHHHHHHHHHHHHhcCC-CCCEeEEEEEEecC
Confidence 346789999999999999999999765 68999999986432222234567889999999997 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~ 159 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSN 159 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE---CTTSCEEECCCCGGG
T ss_pred CeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE---CCCCCEEEeeccccc
Confidence 9999999999999999988765 469999999999999999999999999999999999999 567789999999998
Q ss_pred ccCCCCcccccccCCCcCcchhhcCC-C-CCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 312 FVRPDERLNDIVGSAYYVAPEVLHRS-Y-STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
............||+.|+|||++.+. + +.++||||||+++|+|++|+.||...........+......++ ..++
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~ 235 (276)
T 2h6d_A 160 MMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLN 235 (276)
T ss_dssp CCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSC
T ss_pred ccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc----hhcC
Confidence 87655555567899999999998754 3 5799999999999999999999998888887777776654443 3578
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
..+.+||.+||+.||.+|||+.++++||||+..
T Consensus 236 ~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 236 RSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 999999999999999999999999999999865
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=380.46 Aligned_cols=259 Identities=32% Similarity=0.500 Sum_probs=228.7
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|.+++.||+|+||.||+|.... .++.||+|++.+.........+.+.+|+.+++.+. ||||+++++++.+.+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 88 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDAD---TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDND 88 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred cccceEEEEEEeecCCEEEEEEEECC---CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCC
Confidence 45789999999999999999999766 68899999997765556667788999999999997 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATK 164 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred EEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE---cCCCCEEEEeccCcee
Confidence 999999999999999987654 579999999999999999999999999999999999999 5778899999999987
Q ss_pred cCCC-CcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 313 VRPD-ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 313 ~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
.... .......||+.|+|||++. ..++.++||||||+++|+|++|+.||......+....+......++ ..++.
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~ 240 (294)
T 2rku_A 165 VEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINP 240 (294)
T ss_dssp CCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCH
T ss_pred cccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCc----cccCH
Confidence 6533 2344568999999999986 4588999999999999999999999998888877777776654443 36789
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.+.+||.+||+.||.+|||+.++++||||+...
T Consensus 241 ~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 241 VAASLIQKMLQTDPTARPTINELLNDEFFTSGY 273 (294)
T ss_dssp HHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred HHHHHHHHHcccChhhCcCHHHHhhChheecCC
Confidence 999999999999999999999999999998654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=394.72 Aligned_cols=259 Identities=27% Similarity=0.517 Sum_probs=214.6
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+.++|++.+.||+|+||.||+|.... +|+.||||++.... ......+.+.+|+.+++.++ ||||+++++++...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~ 96 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPD 96 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETT---TCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSC
T ss_pred eecceEEEeEEeeecCCeEEEEEEECC---CCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecC
Confidence 456889999999999999999998765 68999999986543 34555678899999999998 99999999999876
Q ss_pred C------eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 232 D------NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 232 ~------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
+ .+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~ 170 (367)
T 1cm8_A 97 ETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKIL 170 (367)
T ss_dssp SSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEEC
T ss_pred CccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE---cCCCCEEEE
Confidence 3 469999999 7899988765 469999999999999999999999999999999999999 577889999
Q ss_pred ecccccccCCCCcccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----
Q 007253 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS---- 379 (611)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~---- 379 (611)
|||+++.... .....+||++|+|||++. ..++.++|||||||++|+|++|+.||.+......+..+......
T Consensus 171 Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 248 (367)
T 1cm8_A 171 DFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 248 (367)
T ss_dssp CCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred eeeccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9999987643 345568999999999885 46899999999999999999999999988877766665442211
Q ss_pred -------------------CCC----CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 380 -------------------FDE----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 380 -------------------~~~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
... ..++.+++++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 249 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 111 12356799999999999999999999999999999998754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=396.53 Aligned_cols=258 Identities=26% Similarity=0.484 Sum_probs=213.6
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeeC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG-HNNLVKFFDAYEDT 231 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-h~~iv~l~~~~~~~ 231 (611)
...+|++++.||+|+||.||+|... .++.||||++..... .....+.+.+|+.++++|.+ ||||+++++++..+
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~----~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~ 128 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 128 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT----TCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred cCCceEEEEEEccCCCeEEEEEEcC----CCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC
Confidence 3467999999999999999999753 388999999976543 45566789999999999974 69999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+.+||||| +.+++|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||+. ++.+||+|||++.
T Consensus 129 ~~~~lv~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~----~~~~kl~DFG~a~ 202 (390)
T 2zmd_A 129 QYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIAN 202 (390)
T ss_dssp SEEEEEEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES----SSCEEECCCSSSC
T ss_pred CEEEEEEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE----CCeEEEEecCccc
Confidence 99999999 5578999988765 5789999999999999999999999999999999999993 4679999999998
Q ss_pred ccCCCC---cccccccCCCcCcchhhcC------------CCCCcchhhHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHh
Q 007253 312 FVRPDE---RLNDIVGSAYYVAPEVLHR------------SYSTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLK 375 (611)
Q Consensus 312 ~~~~~~---~~~~~~gt~~y~aPE~~~~------------~~~~~~DiwSlGvil~el~~g~~Pf~~~~~-~~~~~~i~~ 375 (611)
.+.... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||..... ...+..+..
T Consensus 203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~ 282 (390)
T 2zmd_A 203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282 (390)
T ss_dssp CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC
T ss_pred cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC
Confidence 775433 2345689999999999853 588899999999999999999999986543 344555554
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 376 ADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 376 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
........ ...+.++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 283 ~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 283 PNHEIEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp TTSCCCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred ccccCCCC--ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 43332222 24578999999999999999999999999999998653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=400.15 Aligned_cols=263 Identities=28% Similarity=0.525 Sum_probs=209.5
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+.++|++++.||+|+||.||+|+... +|+.||||++.+.. ......+.+.+|+.++++|+ ||||+++++++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 97 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKN---TEKNVAIKKVNRMF-EDLIDCKRILREITILNRLK-SDYIIRLYDLIIPD 97 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCS
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECC---CCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcC-CCCcceEEEEEecC
Confidence 356889999999999999999999776 68999999996542 44556678999999999998 99999999999876
Q ss_pred -----CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEee
Q 007253 232 -----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (611)
Q Consensus 232 -----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D 306 (611)
+.+|||||||. |+|.+++.. ...+++..++.++.||+.||.|||+.|||||||||+|||| +.++.+||+|
T Consensus 98 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~~kL~D 172 (432)
T 3n9x_A 98 DLLKFDELYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCD 172 (432)
T ss_dssp CTTTCCCEEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECC
T ss_pred CCCcCCeEEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE---CCCCCEEEcc
Confidence 57999999996 599988754 4579999999999999999999999999999999999999 5778899999
Q ss_pred cccccccCCCC-----------------------cccccccCCCcCcchhh-c-CCCCCcchhhHHHHHHHHHHhCCCC-
Q 007253 307 FGLSDFVRPDE-----------------------RLNDIVGSAYYVAPEVL-H-RSYSTEADVWSIGVIAYILLCGSRP- 360 (611)
Q Consensus 307 fG~a~~~~~~~-----------------------~~~~~~gt~~y~aPE~~-~-~~~~~~~DiwSlGvil~el~~g~~P- 360 (611)
||+++...... .....+||++|+|||++ . ..|+.++|||||||++|||++|..|
T Consensus 173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp CTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 99998765332 23567899999999986 3 5699999999999999999985443
Q ss_pred ----------CCCCCh-----------------HHHHHHHHh-----------------------cCCCCCCC----CCC
Q 007253 361 ----------FWARTE-----------------SGIFRAVLK-----------------------ADPSFDEA----PWP 386 (611)
Q Consensus 361 ----------f~~~~~-----------------~~~~~~i~~-----------------------~~~~~~~~----~~~ 386 (611)
|.+... ...+..+.. ..+..... .++
T Consensus 253 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (432)
T 3n9x_A 253 INDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYP 332 (432)
T ss_dssp CSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHST
T ss_pred ccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCC
Confidence 333220 111111111 11111110 125
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCC
Q 007253 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~ 424 (611)
.+++++.+||++||+.||.+|||+.|+|+||||+....
T Consensus 333 ~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 333 SISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred CCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence 68999999999999999999999999999999997653
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=377.80 Aligned_cols=259 Identities=20% Similarity=0.352 Sum_probs=216.4
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee---
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--- 230 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~--- 230 (611)
...|++.+.||+|+||.||+|.... ++..||+|++..... .....+.+.+|+.++++++ ||||+++++++..
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 99 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVK 99 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESS
T ss_pred ceeEEeeeeccCCCCeEEEEeEecC---CceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeeccccC
Confidence 4569999999999999999998766 688999999865433 3455678899999999997 9999999999875
Q ss_pred -CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeecCCCCceEEeccCCCceEEEeec
Q 007253 231 -TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSVLKAIDF 307 (611)
Q Consensus 231 -~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NIll~~~~~~~~vkl~Df 307 (611)
...+++||||+++|+|.+++... ..+++..++.++.||+.||.|||+.| |+||||||+|||++ +.++.+||+||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Df 176 (290)
T 1t4h_A 100 GKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDL 176 (290)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCT
T ss_pred CCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeC
Confidence 35689999999999999988665 56999999999999999999999999 99999999999994 26778999999
Q ss_pred ccccccCCCCcccccccCCCcCcchhhcCCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 007253 308 GLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (611)
Q Consensus 308 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (611)
|++..... .......||+.|+|||++.+.++.++|||||||++|+|++|+.||.................. +......
T Consensus 177 g~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~ 254 (290)
T 1t4h_A 177 GLATLKRA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-PASFDKV 254 (290)
T ss_dssp TGGGGCCT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-CGGGGGC
T ss_pred CCcccccc-cccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC-ccccCCC
Confidence 99976543 334456899999999999988999999999999999999999999875554433333332211 1112235
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
.++++.+||.+||+.||.+|||+.++|+||||++.
T Consensus 255 ~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 67899999999999999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=381.86 Aligned_cols=265 Identities=27% Similarity=0.408 Sum_probs=220.7
Q ss_pred ccccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe
Q 007253 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (611)
Q Consensus 150 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 229 (611)
++.+.++|++++.||+|+||.||+|+... .++.||+|++...........+.+.+|+.++++++ ||||+++++++.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~ 81 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTI---LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDVDE 81 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETT---TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-BTTBCCEEEEEE
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECC---CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC-CCCCceEEEeee
Confidence 34567899999999999999999998765 68999999997766666777788999999999997 999999999999
Q ss_pred eCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccc
Q 007253 230 DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (611)
Q Consensus 230 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~ 309 (611)
+++.+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 82 ~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~ 157 (294)
T 4eqm_A 82 EDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGI 157 (294)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCSS
T ss_pred eCCeEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEEeCCC
Confidence 999999999999999999988765 579999999999999999999999999999999999999 5778899999999
Q ss_pred ccccCCCC--cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCCCC
Q 007253 310 SDFVRPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP-SFDEAPW 385 (611)
Q Consensus 310 a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~ 385 (611)
+....... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+............... .......
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T 4eqm_A 158 AKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVR 237 (294)
T ss_dssp STTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSC
T ss_pred ccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcc
Confidence 98765432 234567999999999886 5588999999999999999999999998887766555554432 2212234
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
+.++..+.++|.+||+.||.+||+..+.+.+.|..-.
T Consensus 238 ~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 238 KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 5789999999999999999999977777777766543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=383.89 Aligned_cols=256 Identities=29% Similarity=0.527 Sum_probs=212.4
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee--
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-- 230 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~-- 230 (611)
..++|++++.||+|+||.||+|+... +++.||||++.... .+.+.+|+.++++|.+||||+++++++.+
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 104 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINIT---NNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPV 104 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred CCCceEEEEEecccCCeEEEEEEECC---CCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCC
Confidence 35789999999999999999998766 68999999985432 35688999999999889999999999998
Q ss_pred CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 231 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
....++||||+++++|.+++ ..+++..++.++.||+.||.|||++||+||||||+|||++ .+...+||+|||++
T Consensus 105 ~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~--~~~~~~kl~Dfg~a 178 (330)
T 3nsz_A 105 SRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLA 178 (330)
T ss_dssp TCCEEEEEECCCCCCHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCTTC
T ss_pred CCceEEEEeccCchhHHHHH----HhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEc--CCCCEEEEEeCCCc
Confidence 66799999999999998876 2489999999999999999999999999999999999995 23348999999999
Q ss_pred cccCCCCcccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCCh-HHHHHHH-------------H
Q 007253 311 DFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAV-------------L 374 (611)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~-~~~~~~i-------------~ 374 (611)
............+||+.|+|||++. ..++.++|||||||++|+|++|+.||..... ...+..+ .
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 179 EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp EECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred eEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence 8877666667778999999999886 4589999999999999999999999954332 2222211 1
Q ss_pred hcCCCCC--------------------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 375 KADPSFD--------------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 375 ~~~~~~~--------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
....... ......++.++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 1111110 011123799999999999999999999999999999999764
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=397.33 Aligned_cols=261 Identities=31% Similarity=0.543 Sum_probs=219.2
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcC-CHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-TAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
.++|++++.||+|+||.||+|+...+..+|+.||||++.+.... .....+.+.+|+.+++++.+||||+++++++.+++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46899999999999999999998655457999999998643211 11223456789999999966999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.++||||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCcEEEeeCCCCee
Confidence 999999999999999988765 469999999999999999999999999999999999999 6778899999999986
Q ss_pred cCCCC--cccccccCCCcCcchhhcC---CCCCcchhhHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHhcCCCCCCC
Q 007253 313 VRPDE--RLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFWAR----TESGIFRAVLKADPSFDEA 383 (611)
Q Consensus 313 ~~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlGvil~el~~g~~Pf~~~----~~~~~~~~i~~~~~~~~~~ 383 (611)
..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||... ....+...+....+.++
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 286 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP-- 286 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC--
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC--
Confidence 54332 3345689999999999863 3788999999999999999999999643 33445555555554443
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCC-----CHHHHHcCcccCCC
Q 007253 384 PWPSLSSEARDFVKRLLNKDPRKRL-----TAAQALSHPWIKNS 422 (611)
Q Consensus 384 ~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~~ll~hp~~~~~ 422 (611)
..++..+.+||.+||..||.+|| ++.++++||||+..
T Consensus 287 --~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 287 --QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred --cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 46899999999999999999999 99999999999865
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=402.52 Aligned_cols=259 Identities=29% Similarity=0.456 Sum_probs=211.8
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
.....+|++++.||+|+||.||+|+... +..||+|.+...... ..+|+.+++.++ ||||++++++|..
T Consensus 36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~----~~~~aikk~~~~~~~-------~~~E~~il~~l~-h~niv~l~~~~~~ 103 (394)
T 4e7w_A 36 EQREIAYTNCKVIGNGSFGVVFQAKLVE----SDEVAIKKVLQDKRF-------KNRELQIMRIVK-HPNVVDLKAFFYS 103 (394)
T ss_dssp CEEEEEEEEEEEEEEETTEEEEEEEETT----TEEEEEEEEECCTTS-------CCHHHHHHHTCC-CTTBCCEEEEEEE
T ss_pred CcccceEEEeEEEeeCCCeEEEEEEECC----CCeEEEEEEecCcch-------HHHHHHHHHhCC-CCCcceEEEEEEe
Confidence 3456789999999999999999998765 344888887543221 236999999997 9999999999965
Q ss_pred CC------eeEEEeeecCCCChHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCce
Q 007253 231 TD------NVYVVMELCEGGELLDRIL---SRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301 (611)
Q Consensus 231 ~~------~~~lv~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~ 301 (611)
.+ .+++|||||++ ++...+. .....+++..++.++.||+.||.|||++||+||||||+|||++ ..++.
T Consensus 104 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~--~~~~~ 180 (394)
T 4e7w_A 104 NGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--PPSGV 180 (394)
T ss_dssp ESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTE
T ss_pred cCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc--CCCCc
Confidence 43 38899999976 4444443 2356799999999999999999999999999999999999994 26788
Q ss_pred EEEeecccccccCCCCcccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--
Q 007253 302 LKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD-- 377 (611)
Q Consensus 302 vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~-- 377 (611)
+||+|||+++...........+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+....+.+..+.+..
T Consensus 181 ~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~ 260 (394)
T 4e7w_A 181 LKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGT 260 (394)
T ss_dssp EEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred EEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999999988766666667789999999998853 58999999999999999999999999888777666655421
Q ss_pred ----------C-----CCCC---C-----CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCC
Q 007253 378 ----------P-----SFDE---A-----PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (611)
Q Consensus 378 ----------~-----~~~~---~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~ 424 (611)
+ .++. . ..+.+++++.+||.+||+.||.+|||+.++|+||||+....
T Consensus 261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 261 PSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp CCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred CCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 0 1111 0 11347899999999999999999999999999999987653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=394.62 Aligned_cols=254 Identities=30% Similarity=0.523 Sum_probs=215.2
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCH-----HHHHHHHHHHHHHHHhcCCCCeeEEEE
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA-----IAIEDVRREVKILRALTGHNNLVKFFD 226 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~~iv~l~~ 226 (611)
.+.++|++++.||+|+||.||+|+... +|+.||||++.+...... ...+.+.+|+.++++++ ||||+++++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~ 96 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKE---KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLD 96 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETT---TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC-CTTBCCEEE
T ss_pred ccccceEEEeEEEecCCEEEEEEEECC---CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEE
Confidence 456789999999999999999998766 689999999976543221 12345678999999997 999999999
Q ss_pred EEeeCCeeEEEeeecCCC-ChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 227 AYEDTDNVYVVMELCEGG-ELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 227 ~~~~~~~~~lv~E~~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
++.+.+.+++||||+.+| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 97 ~~~~~~~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~ 172 (335)
T 3dls_A 97 IFENQGFFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLI 172 (335)
T ss_dssp EEECSSEEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEEC
T ss_pred EEeeCCEEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE---cCCCcEEEe
Confidence 999999999999999777 888877544 579999999999999999999999999999999999999 567889999
Q ss_pred ecccccccCCCCcccccccCCCcCcchhhcC-CC-CCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 007253 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SY-STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA 383 (611)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 383 (611)
|||++............+||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||..... ..... ..
T Consensus 173 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~----~~ 242 (335)
T 3dls_A 173 DFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAA----IH 242 (335)
T ss_dssp CCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTC----CC
T ss_pred ecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhc----cC
Confidence 9999988776666667789999999999864 34 7889999999999999999999975322 11111 11
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 384 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
....++.++.+||.+||+.||.+|||+.++++||||+...
T Consensus 243 ~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 243 PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 2235799999999999999999999999999999998753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=389.57 Aligned_cols=255 Identities=31% Similarity=0.501 Sum_probs=206.4
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
+.++|++++.||+|+||.||+|+... +|+.||||++.... .....+.+.+|+.++++|+ ||||++++++|.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 77 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKV---DDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLETP 77 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETT---TCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCC-CTTBCCEEEEEEECC
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcC---CCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEec
Confidence 45789999999999999999999775 68999999997543 2334577899999999997 999999999986643
Q ss_pred ---------------------------------------------------------eeEEEeeecCCCChHHHHHhcCC
Q 007253 233 ---------------------------------------------------------NVYVVMELCEGGELLDRILSRGG 255 (611)
Q Consensus 233 ---------------------------------------------------------~~~lv~E~~~~gsL~~~l~~~~~ 255 (611)
.+++|||||+||+|.+++.....
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 157 (332)
T 3qd2_B 78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157 (332)
T ss_dssp SCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS
T ss_pred cchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC
Confidence 38999999999999998876532
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCC-------------ccc
Q 007253 256 --KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-------------RLN 320 (611)
Q Consensus 256 --~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~-------------~~~ 320 (611)
..++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....... ...
T Consensus 158 ~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T 3qd2_B 158 LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234 (332)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECSCC--------------CCC
T ss_pred ccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCCCEEEeecCcccccccchhhcccccccccccccc
Confidence 35677899999999999999999999999999999999 567789999999998765432 223
Q ss_pred ccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHh
Q 007253 321 DIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399 (611)
Q Consensus 321 ~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 399 (611)
..+||+.|+|||++. ..++.++|||||||++|+|++|..|+.. .......+.... ++ ..+...++++.+||.+|
T Consensus 235 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~--~~-~~~~~~~~~~~~li~~~ 309 (332)
T 3qd2_B 235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLK--FP-LLFTQKYPQEHMMVQDM 309 (332)
T ss_dssp SCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTC--CC-HHHHHHCHHHHHHHHHH
T ss_pred ccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccC--CC-cccccCChhHHHHHHHH
Confidence 457999999999986 5689999999999999999998877521 111222222221 11 11234578889999999
Q ss_pred cccCccCCCCHHHHHcCcccCC
Q 007253 400 LNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 400 L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
|+.||.+|||+.++|+||||++
T Consensus 310 l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 310 LSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HCSSGGGSCCHHHHHHSTTCCC
T ss_pred ccCCCCcCCCHHHHhhchhhhc
Confidence 9999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=379.63 Aligned_cols=262 Identities=30% Similarity=0.497 Sum_probs=219.1
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
...++|++++.||+|+||.||+|+... +|+.||+|++.... ....+.+.+|+.+++.+. ||||+++++++.++
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 88 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKE---TGALAAAKVIETKS---EEELEDYIVEIEILATCD-HPYIVKLLGAYYHD 88 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETT---TCCEEEEEEEC-------CCHHHHHHHHHHHHHCC-CTTBCCEEEEEECC
T ss_pred CCccceeecceeccCCCeEEEEEEEcC---CCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCC-CCCEeeeeeeeeeC
Confidence 356789999999999999999999766 68999999986542 233567889999999997 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+.+++|||||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 89 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 89 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM---TLEGDIRLADFGVSA 165 (302)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTSCEEECCCHHHH
T ss_pred CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---CCCCCEEEEECCCCc
Confidence 99999999999999999888777789999999999999999999999999999999999999 567789999999875
Q ss_pred ccCCC-CcccccccCCCcCcchhh------cCCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 007253 312 FVRPD-ERLNDIVGSAYYVAPEVL------HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384 (611)
Q Consensus 312 ~~~~~-~~~~~~~gt~~y~aPE~~------~~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 384 (611)
..... .......||+.|+|||++ ...++.++|||||||++|+|++|..||...........+........ ..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~ 244 (302)
T 2j7t_A 166 KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL-LT 244 (302)
T ss_dssp HHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SS
T ss_pred cccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc-CC
Confidence 43211 123445799999999987 24588999999999999999999999998887777766666543221 11
Q ss_pred CCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCC
Q 007253 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (611)
Q Consensus 385 ~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~ 424 (611)
...++.++.+||.+||+.||.+|||+.++++||||+....
T Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 284 (302)
T 2j7t_A 245 PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS 284 (302)
T ss_dssp GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred ccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence 2467899999999999999999999999999999997643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=393.18 Aligned_cols=258 Identities=27% Similarity=0.475 Sum_probs=205.7
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|++++.||+|+||.||+|.... +|+.||||++.... ......+.+.+|+.+++.++ ||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 97 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQK 97 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSCC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECC---CCceEEEEEecccc-CChHHHHHHHHHHHHHHhcC-CCCccceEEeecccc
Confidence 46789999999999999999998765 68999999997543 34455677889999999997 999999999998765
Q ss_pred ------eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEee
Q 007253 233 ------NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (611)
Q Consensus 233 ------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D 306 (611)
.+|+|||||++ +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 98 ~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~D 170 (371)
T 2xrw_A 98 SLEEFQDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILD 170 (371)
T ss_dssp STTTCCEEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECC
T ss_pred ccccccceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEEE
Confidence 78999999975 7888774 358999999999999999999999999999999999999 5778899999
Q ss_pred cccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----
Q 007253 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF----- 380 (611)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~----- 380 (611)
||++............+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+.+..+.......
T Consensus 171 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 171 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp CCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred eecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99998776554556678999999999986 568999999999999999999999999888877766665432111
Q ss_pred -----------------CCCC---------CCC-------CCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 381 -----------------DEAP---------WPS-------LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 381 -----------------~~~~---------~~~-------~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
.... ++. .+.++.+||++||+.||.+|||+.++|+||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 0000 000 15678999999999999999999999999999753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=373.79 Aligned_cols=260 Identities=21% Similarity=0.349 Sum_probs=212.7
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
..+.++|++.+.||+|+||.||+|.... +++.||||++....... .....+.+|+.++..+.+||||+++++++.+
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~ 82 (289)
T 1x8b_A 7 SRYTTEFHELEKIGSGEFGSVFKCVKRL---DGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAE 82 (289)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE
T ss_pred ccccchhhhhhhhcCCCceEEEEEEEcC---CCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeec
Confidence 3456889999999999999999999765 68999999997654333 3456788999999999559999999999999
Q ss_pred CCeeEEEeeecCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccC----------
Q 007253 231 TDNVYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD---------- 297 (611)
Q Consensus 231 ~~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~---------- 297 (611)
.+.+++|||||++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++..+
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~ 162 (289)
T 1x8b_A 83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGD 162 (289)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------
T ss_pred CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccc
Confidence 99999999999999999998754 25699999999999999999999999999999999999996432
Q ss_pred ------CCceEEEeecccccccCCCCcccccccCCCcCcchhhcCC--CCCcchhhHHHHHHHHHHhCCCCCCCCChHHH
Q 007253 298 ------ENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGI 369 (611)
Q Consensus 298 ------~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~ 369 (611)
....+||+|||++...... ....||+.|+|||++.+. ++.++|||||||++|+|++|..|+.... .
T Consensus 163 ~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~ 236 (289)
T 1x8b_A 163 EDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---Q 236 (289)
T ss_dssp -------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---H
T ss_pred cccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---H
Confidence 4557999999999876533 234699999999998754 5579999999999999999998875443 2
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 370 FRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 370 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
...+...... .....++.++.+||.+||+.||.+|||+.++++||||+...
T Consensus 237 ~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 237 WHEIRQGRLP---RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp HHHHHTTCCC---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred HHHHHcCCCC---CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence 3334333221 11246899999999999999999999999999999998753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=385.19 Aligned_cols=260 Identities=25% Similarity=0.417 Sum_probs=215.7
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
...++|++++.||+|+||.||+|+... +|+.||||++...... ...+.+.+|+.++++++ ||||+++++++...
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 79 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKK---TGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLN-HKNIVKLFAIEEET 79 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCC-CTTBCCEEEEEECT
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECC---CCcEEEEEEecccccc--chHHHHHHHHHHHHhcC-CCCcceEEEEeecC
Confidence 456789999999999999999999776 6899999998653322 23466789999999998 99999999999876
Q ss_pred C--eeEEEeeecCCCChHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEec-cCCCceEEEee
Q 007253 232 D--NVYVVMELCEGGELLDRILSRGG--KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT-KDENSVLKAID 306 (611)
Q Consensus 232 ~--~~~lv~E~~~~gsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~-~~~~~~vkl~D 306 (611)
. .+++|||||++|+|.+++..... .+++..++.++.||+.||.|||++|||||||||+|||+.. .+..+.+||+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (319)
T 4euu_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (319)
T ss_dssp TTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred CCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEcc
Confidence 5 78999999999999999876433 3999999999999999999999999999999999999843 34667899999
Q ss_pred cccccccCCCCcccccccCCCcCcchhhc---------CCCCCcchhhHHHHHHHHHHhCCCCCCCC----ChHHHHHHH
Q 007253 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH---------RSYSTEADVWSIGVIAYILLCGSRPFWAR----TESGIFRAV 373 (611)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwSlGvil~el~~g~~Pf~~~----~~~~~~~~i 373 (611)
||++............+||+.|+|||++. ..++.++|||||||++|||++|+.||... ...+.+..+
T Consensus 160 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 239 (319)
T 4euu_A 160 FGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (319)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred CCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence 99999887666666778999999999874 56889999999999999999999999643 234556666
Q ss_pred HhcCCCC-------------------CC--CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCc
Q 007253 374 LKADPSF-------------------DE--APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHP 417 (611)
Q Consensus 374 ~~~~~~~-------------------~~--~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp 417 (611)
....+.. +. .....++..+.+||++||+.||++|||+.|+|+||
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 6554321 10 01123456889999999999999999999999987
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=398.10 Aligned_cols=260 Identities=27% Similarity=0.428 Sum_probs=215.9
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhc-----CCCCeeEEE
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT-----GHNNLVKFF 225 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~l~ 225 (611)
..+..+|++++.||+|+||.||+|.... +++.||||++... ......+.+|+.+++.+. +|+||++++
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~---~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~ 165 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHK---VHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHML 165 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETT---TTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECC---CCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence 4567889999999999999999998766 6899999998542 344567888999999885 377999999
Q ss_pred EEEeeCCeeEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCce--E
Q 007253 226 DAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV--L 302 (611)
Q Consensus 226 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~--v 302 (611)
+++...+.+++|||||. ++|.+++.... ..+++..++.++.||+.||.|||++|||||||||+||||+ .++. +
T Consensus 166 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~---~~~~~~v 241 (429)
T 3kvw_A 166 ENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLK---QQGRSGI 241 (429)
T ss_dssp EEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEES---STTSCCE
T ss_pred eecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc---cCCCcce
Confidence 99999999999999995 69999887654 3599999999999999999999999999999999999994 4544 9
Q ss_pred EEeecccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Q 007253 303 KAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381 (611)
Q Consensus 303 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~ 381 (611)
||+|||++.... ......+||+.|+|||++. ..++.++|||||||++|||++|..||.+....+.+..+.......+
T Consensus 242 kL~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~ 319 (429)
T 3kvw_A 242 KVIDFGSSCYEH--QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319 (429)
T ss_dssp EECCCTTCEETT--CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred EEeecccceecC--CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 999999997653 3345678999999999886 5699999999999999999999999998888777666553211100
Q ss_pred C--------------------------------------------------C-----CCCCCCHHHHHHHHHhcccCccC
Q 007253 382 E--------------------------------------------------A-----PWPSLSSEARDFVKRLLNKDPRK 406 (611)
Q Consensus 382 ~--------------------------------------------------~-----~~~~~s~~~~~li~~~L~~dP~~ 406 (611)
. . .....++++.+||++||+.||++
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~ 399 (429)
T 3kvw_A 320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAV 399 (429)
T ss_dssp HHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTT
T ss_pred HHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhh
Confidence 0 0 00123788999999999999999
Q ss_pred CCCHHHHHcCcccCCCC
Q 007253 407 RLTAAQALSHPWIKNSN 423 (611)
Q Consensus 407 Rpt~~~ll~hp~~~~~~ 423 (611)
|||+.|+|+||||+...
T Consensus 400 Rpta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 400 RMTPGQALRHPWLRRRL 416 (429)
T ss_dssp SCCHHHHHTSTTTC---
T ss_pred CCCHHHHhCChhhccCC
Confidence 99999999999998753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=386.89 Aligned_cols=260 Identities=29% Similarity=0.485 Sum_probs=214.3
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++++.||+|+||.||+|+... +|+.||||++.... ......+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 98 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKD---TGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLR-HENLVNLLEVCKKKKR 98 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETT---TCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred hhhheeeeEEeecCCEEEEEEEECC---CCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCC-CCCEeeEEEEeecCCE
Confidence 5789999999999999999999766 68999999986653 34455667889999999998 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
.++||||+++++|.+++ .....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 99 ~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLE-LFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTL 174 (331)
T ss_dssp EEEEEECCSEEHHHHHH-HSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCTTC---
T ss_pred EEEEEecCCcchHHHHH-hhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE---cCCCcEEEEeCCCceee
Confidence 99999999987776654 445679999999999999999999999999999999999999 57778999999999876
Q ss_pred CCC-CcccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-----------
Q 007253 314 RPD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS----------- 379 (611)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~----------- 379 (611)
... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+....+......
T Consensus 175 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 175 AAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred cCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 433 23455689999999999864 5899999999999999999999999988877665555432111
Q ss_pred ---CCCC-------------CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 380 ---FDEA-------------PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 380 ---~~~~-------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
+... .++.+++++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 0000 124679999999999999999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=384.16 Aligned_cols=258 Identities=26% Similarity=0.473 Sum_probs=209.8
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCC-CCeeEEEEEEeeC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH-NNLVKFFDAYEDT 231 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~~iv~l~~~~~~~ 231 (611)
..++|++++.||+|+||.||+|... .++.||||++.... ......+.+.+|+.++++|.+| +||+++++++.++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 81 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 81 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT----TSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC----CCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC
Confidence 3678999999999999999999763 48899999997654 3455667899999999999832 9999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+.++||||+ .+|+|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||+. ++.+||+|||++.
T Consensus 82 ~~~~lv~e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~----~~~~kl~DFG~a~ 155 (343)
T 3dbq_A 82 QYIYMVMEC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIAN 155 (343)
T ss_dssp SEEEEEECC-CSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSC
T ss_pred CEEEEEEeC-CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE----CCcEEEeeccccc
Confidence 999999995 578999988765 5799999999999999999999999999999999999994 4679999999998
Q ss_pred ccCCCCc---ccccccCCCcCcchhhc------------CCCCCcchhhHHHHHHHHHHhCCCCCCCCChH-HHHHHHHh
Q 007253 312 FVRPDER---LNDIVGSAYYVAPEVLH------------RSYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLK 375 (611)
Q Consensus 312 ~~~~~~~---~~~~~gt~~y~aPE~~~------------~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~-~~~~~i~~ 375 (611)
....... ....+||+.|+|||++. +.++.++|||||||++|+|++|+.||...... ..+..+..
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 235 (343)
T 3dbq_A 156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 235 (343)
T ss_dssp CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc
Confidence 7754332 34568999999999884 45788999999999999999999999765433 33333433
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 376 ADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 376 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
..... ......+.++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 236 ~~~~~--~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 236 PNHEI--EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp TTSCC--CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred CCccc--CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 22222 12235678999999999999999999999999999998643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=376.18 Aligned_cols=259 Identities=26% Similarity=0.385 Sum_probs=198.5
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|++++.||+|+||.||+|+... +|+.||||++.... ......+.+.++...++.+. ||||+++++++.+++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~-h~~iv~~~~~~~~~~ 79 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVP---SGQIMAVKRIRATV-NSQEQKRLLMDLDISMRTVD-CPFTVTFYGALFREG 79 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEC----CHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSS
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecC---CCeEEEEEEeeccc-CcHHHHHHHHHHHHHHHhCC-CCeEEEEeeeeeccC
Confidence 45789999999999999999999766 68999999986542 22222333444444456665 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeecCCCCceEEeccCCCceEEEeecc
Q 007253 233 NVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DfG 308 (611)
..++||||+++ +|.+++.. ....+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||
T Consensus 80 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg 155 (290)
T 3fme_A 80 DVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI---NALGQVKMCDFG 155 (290)
T ss_dssp SEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE---CTTCCEEBCCC-
T ss_pred CEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecC
Confidence 99999999974 88776654 456799999999999999999999998 99999999999999 567789999999
Q ss_pred cccccCCCCcccccccCCCcCcchhhc-----CCCCCcchhhHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhcCCCCCC
Q 007253 309 LSDFVRPDERLNDIVGSAYYVAPEVLH-----RSYSTEADVWSIGVIAYILLCGSRPFWAR-TESGIFRAVLKADPSFDE 382 (611)
Q Consensus 309 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DiwSlGvil~el~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~ 382 (611)
++.............||+.|+|||++. ..++.++|||||||++|+|++|+.||... .............. +.
T Consensus 156 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~ 233 (290)
T 3fme_A 156 ISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS--PQ 233 (290)
T ss_dssp --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC--CC
T ss_pred CcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC--CC
Confidence 998876655555668999999999962 45788999999999999999999999763 33333444433322 22
Q ss_pred CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 383 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
.....++.++.+||.+||+.||.+|||+.++++||||+..
T Consensus 234 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 234 LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 2234689999999999999999999999999999999754
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=395.45 Aligned_cols=256 Identities=28% Similarity=0.442 Sum_probs=211.5
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC--
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT-- 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~-- 231 (611)
..+|++++.||+|+||.||+|++.. +|+.||||++..... ...+|+++++.|+ |||||+++++|...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~---~~~~vaiK~~~~~~~-------~~~~E~~il~~l~-hpniv~l~~~~~~~~~ 121 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQDKR-------FKNRELQIMRKLD-HCNIVRLRYFFYSSGE 121 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEECCTT-------SCCHHHHHHHTCC-CTTBCCEEEEEEEEET
T ss_pred cceEEeeeEEeeCCCEEEEEEEECC---CCcEEEEEEecccch-------hHHHHHHHHHHcC-CCCccceeeEEeccCC
Confidence 4579999999999999999999876 689999999865422 1347999999997 99999999998542
Q ss_pred ----CeeEEEeeecCCCChHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEE
Q 007253 232 ----DNVYVVMELCEGGELLDRIL---SRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304 (611)
Q Consensus 232 ----~~~~lv~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl 304 (611)
..+++||||+++ +|.+.+. .....+++..++.++.||+.||.|||++|||||||||+||||+ .+.+.+||
T Consensus 122 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~--~~~~~~kl 198 (420)
T 1j1b_A 122 KKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKL 198 (420)
T ss_dssp TTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEE--TTTTEEEE
T ss_pred CCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEe--CCCCeEEe
Confidence 247799999975 6666554 3456799999999999999999999999999999999999995 24567999
Q ss_pred eecccccccCCCCcccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc------
Q 007253 305 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA------ 376 (611)
Q Consensus 305 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~------ 376 (611)
+|||+++.+.........+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+....+.+..+.+.
T Consensus 199 ~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~ 278 (420)
T 1j1b_A 199 CDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 278 (420)
T ss_dssp CCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred ccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999988765555666789999999998853 6899999999999999999999999988877666555442
Q ss_pred ------CCCCCCCC-------------CCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 377 ------DPSFDEAP-------------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 377 ------~~~~~~~~-------------~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.+.+.... .+.++.++.+||.+||..||.+|||+.++|+||||+...
T Consensus 279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 11111111 135689999999999999999999999999999997643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=390.91 Aligned_cols=267 Identities=25% Similarity=0.416 Sum_probs=220.9
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
....++|++.+.||+|+||.||+|+... +|+.||+|++... ......+.+.+|+.++++++ ||||+++++++.+
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~va~K~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 102 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKP---SGLVMARKLIHLE--IKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYS 102 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEECC--CCHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECC---CCcEEEEEEeccc--cCHHHHHHHHHHHHHHHHCC-CCCEEEEeEEEEE
Confidence 3446789999999999999999999775 6899999999764 24455678899999999997 9999999999999
Q ss_pred CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeecCCCCceEEeccCCCceEEEeeccc
Q 007253 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (611)
Q Consensus 231 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DfG~ 309 (611)
++.+++|||||+||+|.+++... ..+++..++.++.||+.||.|||+. ||+||||||+|||+ +.++.+||+|||+
T Consensus 103 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~ 178 (360)
T 3eqc_A 103 DGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGV 178 (360)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCC
T ss_pred CCEEEEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE---CCCCCEEEEECCC
Confidence 99999999999999999988665 4699999999999999999999996 99999999999999 5677899999999
Q ss_pred ccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHH----------------
Q 007253 310 SDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRA---------------- 372 (611)
Q Consensus 310 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~---------------- 372 (611)
+..... .......||+.|+|||++. ..++.++|||||||++|+|++|+.||...........
T Consensus 179 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3eqc_A 179 SGQLID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257 (360)
T ss_dssp CHHHHH-HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred Cccccc-ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence 875532 2334568999999999987 5689999999999999999999999977655433211
Q ss_pred --------------------------HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCCC
Q 007253 373 --------------------------VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVK 426 (611)
Q Consensus 373 --------------------------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~~ 426 (611)
+.... .+......++.++.+||.+||+.||.+|||+.++|+||||+......
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 335 (360)
T 3eqc_A 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 335 (360)
T ss_dssp ----------------CCCHHHHHHHHHHSC--CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSC
T ss_pred ccCCCcccccccCCCCcccchhhhhHHhccC--CCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhh
Confidence 11111 11122235789999999999999999999999999999998765555
Q ss_pred Cchh
Q 007253 427 VPLD 430 (611)
Q Consensus 427 ~~~~ 430 (611)
+...
T Consensus 336 ~~~~ 339 (360)
T 3eqc_A 336 VDFA 339 (360)
T ss_dssp CCHH
T ss_pred hhHH
Confidence 5443
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=377.89 Aligned_cols=260 Identities=27% Similarity=0.499 Sum_probs=214.6
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee-
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED- 230 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~- 230 (611)
...++|++++.||+|+||.||+|+... +|+.||||++..... ..+.+.+|+.+++++.+||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECC---CCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 456889999999999999999999765 689999999865432 235688999999999669999999999987
Q ss_pred -----CCeeEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEE
Q 007253 231 -----TDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304 (611)
Q Consensus 231 -----~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl 304 (611)
.+.+++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~---~~~~~~kl 170 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKL 170 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE---cCCCCEEE
Confidence 468999999999999999987643 469999999999999999999999999999999999999 56788999
Q ss_pred eecccccccCCCC-cccccccCCCcCcchhhc------CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC
Q 007253 305 IDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 377 (611)
Q Consensus 305 ~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~ 377 (611)
+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||...........+....
T Consensus 171 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 250 (326)
T 2x7f_A 171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 250 (326)
T ss_dssp CCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred eeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc
Confidence 9999998764332 334568999999999984 458899999999999999999999998877766665555443
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 378 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
. +......++..+.+||.+||..||.+|||+.++++||||+...
T Consensus 251 ~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 251 A--PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp C--CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred c--ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 2 2222356899999999999999999999999999999998753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=392.09 Aligned_cols=256 Identities=27% Similarity=0.488 Sum_probs=212.8
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee--
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-- 230 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~-- 230 (611)
..++|++++.||+|+||.||+|+... +|+.||||++...... ..+|+.+++.++ ||||++++++|..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~~~~~~~~-------~~~E~~il~~l~-hpnIv~l~~~~~~~~ 73 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIE---SGKRFALKKVLQDPRY-------KNRELDIMKVLD-HVNIIKLVDYFYTTG 73 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETT---TCCEEEEEEEECCTTS-------CCHHHHHHTTCC-CTTBCCEEEEEEEC-
T ss_pred ccceEEEEEEEEeccCEEEEEEEECC---CCCEEEEEEEecCcch-------HHHHHHHHHHcC-CCCccchhheeeecC
Confidence 45789999999999999999999766 6899999998654322 237999999997 9999999999854
Q ss_pred ------------------------------------CCeeEEEeeecCCCChHHHHH---hcCCCCCHHHHHHHHHHHHH
Q 007253 231 ------------------------------------TDNVYVVMELCEGGELLDRIL---SRGGKYTEDDAKAVMIQILN 271 (611)
Q Consensus 231 ------------------------------------~~~~~lv~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~qi~~ 271 (611)
...+++|||||+ |+|.+.+. .....+++..++.++.||+.
T Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~ 152 (383)
T 3eb0_A 74 DEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFR 152 (383)
T ss_dssp ------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence 334899999997 58777665 34567999999999999999
Q ss_pred HHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCCcccccccCCCcCcchhhcC--CCCCcchhhHHHH
Q 007253 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGV 349 (611)
Q Consensus 272 ~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGv 349 (611)
||.|||++||+||||||+|||++ ..++.+||+|||++............+||+.|+|||++.+ .++.++|||||||
T Consensus 153 aL~~LH~~gi~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 153 AVGFIHSLGICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHHHHHTTTEECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHHHHHCcCccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 99999999999999999999995 2567899999999998776666677789999999998863 4899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHhcC------------CCCCCCC-------------CCCCCHHHHHHHHHhcccCc
Q 007253 350 IAYILLCGSRPFWARTESGIFRAVLKAD------------PSFDEAP-------------WPSLSSEARDFVKRLLNKDP 404 (611)
Q Consensus 350 il~el~~g~~Pf~~~~~~~~~~~i~~~~------------~~~~~~~-------------~~~~s~~~~~li~~~L~~dP 404 (611)
++|+|++|+.||.+....+.+..+.... +.+.... ...++.++.+||.+||+.||
T Consensus 231 il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 9999999999999888877766665421 1111110 12478999999999999999
Q ss_pred cCCCCHHHHHcCcccCCC
Q 007253 405 RKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 405 ~~Rpt~~~ll~hp~~~~~ 422 (611)
.+|||+.|+|+||||+..
T Consensus 311 ~~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 311 DLRINPYEAMAHPFFDHL 328 (383)
T ss_dssp GGSCCHHHHHTSGGGHHH
T ss_pred hhCCCHHHHhcCHHHHHH
Confidence 999999999999999753
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=373.89 Aligned_cols=259 Identities=27% Similarity=0.486 Sum_probs=223.5
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..+.|++++.||+|+||.||+|.... +++.||||++...... ...+.+.+|+.+++.+. ||||+++++++.+++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 93 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNR---TQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDT 93 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECC---CCcEEEEEEecccccH--HHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCC
Confidence 35679999999999999999998765 6899999999765332 34577899999999997 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.+++||||+++++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 94 ~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~ 168 (303)
T 3a7i_A 94 KLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQ 168 (303)
T ss_dssp EEEEEEECCTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEE
T ss_pred eEEEEEEeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE---CCCCCEEEeeccccee
Confidence 9999999999999999874 3579999999999999999999999999999999999999 5778899999999987
Q ss_pred cCCCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 313 VRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 313 ~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
..... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||...........+....... ....++.
T Consensus 169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 245 (303)
T 3a7i_A 169 LTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT---LEGNYSK 245 (303)
T ss_dssp CBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC---CCSSCCH
T ss_pred cCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCC---CccccCH
Confidence 65433 344568999999999986 568899999999999999999999998887777666665544322 2246899
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCC
Q 007253 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~ 425 (611)
.+.+||.+||+.||.+|||+.++++||||......
T Consensus 246 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 280 (303)
T 3a7i_A 246 PLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKK 280 (303)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCCC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCCc
Confidence 99999999999999999999999999999765443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=399.13 Aligned_cols=263 Identities=28% Similarity=0.479 Sum_probs=198.6
Q ss_pred cCCceeE-eCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee-
Q 007253 153 FANKYEL-GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED- 230 (611)
Q Consensus 153 ~~~~y~~-~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~- 230 (611)
+.+.|++ +++||+|+||.||+|+.+.. ..++.||||++...... ..+.+|+.++++|+ ||||+++++++..
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~-~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDG-KDDKDYALKQIEGTGIS-----MSACREIALLRELK-HPNVISLQKVFLSH 90 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSS-SCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCC-CTTBCCCCEEEEET
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccC-CCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcC-CCCeeeEeeEEecC
Confidence 4566887 56899999999999987642 25789999999654322 35778999999998 9999999999965
Q ss_pred -CCeeEEEeeecCCCChHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEecc-CCCc
Q 007253 231 -TDNVYVVMELCEGGELLDRILSR--------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK-DENS 300 (611)
Q Consensus 231 -~~~~~lv~E~~~~gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~-~~~~ 300 (611)
+..+||||||+. |+|.+++... ...+++..++.|+.||+.||.|||++|||||||||+||||... +.++
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 91 ADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp TTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTT
T ss_pred CCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCC
Confidence 678999999996 5888877532 1249999999999999999999999999999999999999643 4567
Q ss_pred eEEEeecccccccCCC----CcccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChH-------
Q 007253 301 VLKAIDFGLSDFVRPD----ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTES------- 367 (611)
Q Consensus 301 ~vkl~DfG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~------- 367 (611)
.+||+|||++...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 8999999999876533 23345789999999998864 4899999999999999999999999765442
Q ss_pred --HHHHHHHhcCCCCCCCCCC----------------------------------CCCHHHHHHHHHhcccCccCCCCHH
Q 007253 368 --GIFRAVLKADPSFDEAPWP----------------------------------SLSSEARDFVKRLLNKDPRKRLTAA 411 (611)
Q Consensus 368 --~~~~~i~~~~~~~~~~~~~----------------------------------~~s~~~~~li~~~L~~dP~~Rpt~~ 411 (611)
+.+..+...........|. ..+..+.+||.+||+.||.+|||+.
T Consensus 250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~ 329 (405)
T 3rgf_A 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 329 (405)
T ss_dssp CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 3444444332222222222 1267889999999999999999999
Q ss_pred HHHcCcccCCCC
Q 007253 412 QALSHPWIKNSN 423 (611)
Q Consensus 412 ~ll~hp~~~~~~ 423 (611)
|+|+||||+...
T Consensus 330 e~L~hp~f~~~~ 341 (405)
T 3rgf_A 330 QAMQDPYFLEDP 341 (405)
T ss_dssp HHHTSGGGTSSS
T ss_pred HHhcChhhccCC
Confidence 999999998754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=385.93 Aligned_cols=259 Identities=37% Similarity=0.680 Sum_probs=190.0
Q ss_pred cCCceeEeC-eeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee-
Q 007253 153 FANKYELGE-EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED- 230 (611)
Q Consensus 153 ~~~~y~~~~-~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~- 230 (611)
+.++|++.+ .||+|+||.||+|+... +|+.||||++... . ...+|+..+.++.+||||+++++++..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~----~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 94 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRR---TGQKCALKLLYDS----P----KARQEVDHHWQASGGPHIVCILDVYENM 94 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEESS----H----HHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECC---CCCEEEEEEecCc----H----HHHHHHHHHHHhcCCCChHHHHHHHhhc
Confidence 467899965 69999999999999876 6899999998542 1 233444444444459999999999976
Q ss_pred ---CCeeEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEee
Q 007253 231 ---TDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (611)
Q Consensus 231 ---~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D 306 (611)
...++||||||+||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+..+.+||+|
T Consensus 95 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 95 HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp ETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred cCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEec
Confidence 456899999999999999997664 3699999999999999999999999999999999999997655677899999
Q ss_pred cccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHH----HHHHHhcCCCCC
Q 007253 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGI----FRAVLKADPSFD 381 (611)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~----~~~i~~~~~~~~ 381 (611)
||++..... ......+||+.|+|||++. ..++.++|||||||++|+|++|+.||........ ...+......++
T Consensus 175 fg~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 253 (336)
T 3fhr_A 175 FGFAKETTQ-NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFP 253 (336)
T ss_dssp CTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCC
T ss_pred cccceeccc-cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccC
Confidence 999986653 3345568899999999985 5588899999999999999999999976654433 233333444455
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 382 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
...+..++.++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 254 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 555678999999999999999999999999999999998653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=379.81 Aligned_cols=254 Identities=24% Similarity=0.363 Sum_probs=217.4
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|++.+.||+|+||.||+|++......+..||||++... ......+.+.+|+.++++|+ ||||+++++++.+.+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 123 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSEASIMGQFD-HPNIIRLEGVVTRGR 123 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT--CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECGGG
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC--CCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCC
Confidence 357899999999999999999998765445677999999654 24455678999999999997 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.+++|||||++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRV 200 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCSSCEE
T ss_pred ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---CCCCCEEECCCCcccc
Confidence 9999999999999999997777789999999999999999999999999999999999999 6778899999999987
Q ss_pred cCCCCc----ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 007253 313 VRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 313 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (611)
...... .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+....+....+....... ...
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~ 277 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP---APM 277 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---CCT
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC---CCC
Confidence 654321 22335678899999986 668999999999999999999 999999988888877776653221 224
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 387 SLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
.++.++.+||.+||..||.+|||+.++++
T Consensus 278 ~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 278 GCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 68999999999999999999999999875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=391.24 Aligned_cols=259 Identities=30% Similarity=0.533 Sum_probs=201.9
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+.++|++++.||+|+||.||+|.... +|+.||||++.... ......+.+.+|+.+++.++ ||||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~ 100 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPA 100 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETT---TTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSC
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECC---CCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecC
Confidence 456889999999999999999998765 68999999986543 34455678889999999998 99999999999754
Q ss_pred ------CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 232 ------DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 232 ------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
..+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 101 ~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kL~ 174 (367)
T 2fst_X 101 RSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKIL 174 (367)
T ss_dssp SSGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEEC
T ss_pred CccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE---CCCCCEEEe
Confidence 5689999999 7899888754 579999999999999999999999999999999999999 577889999
Q ss_pred ecccccccCCCCcccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-----
Q 007253 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP----- 378 (611)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~----- 378 (611)
|||+++.... .....+||++|+|||++. ..++.++|||||||++|+|++|+.||.+......+..+.....
T Consensus 175 DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~ 252 (367)
T 2fst_X 175 DFGLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252 (367)
T ss_dssp C-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred eccccccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999987543 244568999999999886 4689999999999999999999999998887776666554211
Q ss_pred ------------------CCCCC----CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 379 ------------------SFDEA----PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 379 ------------------~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
..+.. .++..++++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 11111 1245689999999999999999999999999999998754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=387.96 Aligned_cols=259 Identities=29% Similarity=0.502 Sum_probs=217.6
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC-
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~- 231 (611)
+..+|++++.||+|+||.||+|+... +++.||||++... ......+.+.+|++++++++ ||||+++++++...
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 98 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNL---NKVRVAIKKISPF--EHQTYCQRTLREIKILLRFR-HENIIGINDIIRAPT 98 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSS
T ss_pred ccccEEEEEEeecCCCeEEEEEEECC---CCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhcC-CCCCccceeEEecCC
Confidence 35789999999999999999998765 6899999999643 34455678899999999998 99999999999765
Q ss_pred ----CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeec
Q 007253 232 ----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (611)
Q Consensus 232 ----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~Df 307 (611)
...|+||||+. |+|.+++.. ..+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+||
T Consensus 99 ~~~~~~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Df 172 (364)
T 3qyz_A 99 IEQMKDVYIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDF 172 (364)
T ss_dssp TTTCCCEEEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCC
T ss_pred ccccceEEEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE---CCCCCEEEEeC
Confidence 46899999996 599998855 469999999999999999999999999999999999999 57778999999
Q ss_pred ccccccCCCCc----ccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Q 007253 308 GLSDFVRPDER----LNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381 (611)
Q Consensus 308 G~a~~~~~~~~----~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~ 381 (611)
|++........ ....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+.+..+........
T Consensus 173 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 252 (364)
T 3qyz_A 173 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252 (364)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCC
T ss_pred cceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99987654322 34568999999999864 4489999999999999999999999988877766666543211110
Q ss_pred -----------------------CC----CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 382 -----------------------EA----PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 382 -----------------------~~----~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.. .++.++.++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 00 1246789999999999999999999999999999998753
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=379.42 Aligned_cols=268 Identities=29% Similarity=0.423 Sum_probs=220.9
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhc--CCCCeeEEEEEEe-
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT--GHNNLVKFFDAYE- 229 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~iv~l~~~~~- 229 (611)
..++|++++.||+|+||.||+|+.... .|+.||||++....... .....+.+|+.+++.+. +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCC--CCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 357899999999999999999987532 57899999986432211 11234567888888773 4999999999987
Q ss_pred ----eCCeeEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEE
Q 007253 230 ----DTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304 (611)
Q Consensus 230 ----~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl 304 (611)
....+++||||++ |+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili---~~~~~~kl 161 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKL 161 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEE
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE---cCCCCEEE
Confidence 4567999999997 59999887654 349999999999999999999999999999999999999 56778999
Q ss_pred eecccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--
Q 007253 305 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD-- 381 (611)
Q Consensus 305 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~-- 381 (611)
+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|+.||.+......+..+........
T Consensus 162 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 162 ADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241 (326)
T ss_dssp CSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred ecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence 9999998776555556678999999999886 5689999999999999999999999998888777776664211100
Q ss_pred ---------------------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCCCC
Q 007253 382 ---------------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKV 427 (611)
Q Consensus 382 ---------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~~~ 427 (611)
...++.++..+.+||.+||+.||.+|||+.++|+||||+.......
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~ 308 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 308 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhhh
Confidence 0113468999999999999999999999999999999998764443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=388.09 Aligned_cols=265 Identities=24% Similarity=0.421 Sum_probs=217.8
Q ss_pred CcccccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCC-----ee
Q 007253 148 GFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN-----LV 222 (611)
Q Consensus 148 ~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~-----iv 222 (611)
.....+.++|++.+.||+|+||.||+|+... +++.||||++.. .......+.+|+.+++.+..|++ |+
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv 119 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRV---EQEWVAIKIIKN----KKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECS----SHHHHHHHHHHHHHHHHHHHCSSGGGGGBC
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcC---CCcEEEEEEEec----cHHHHHHHHHHHHHHHHHHhcccccceeEE
Confidence 3445677899999999999999999998765 689999999853 23445678889999999875664 99
Q ss_pred EEEEEEeeCCeeEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HcCCeeecCCCCceEEeccCCC
Q 007253 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCH--LQGVVHRDLKPENFLFTTKDEN 299 (611)
Q Consensus 223 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH--~~~iiHrDlkp~NIll~~~~~~ 299 (611)
++++++...+.++|||||+. |+|.+++.... ..+++..++.++.||+.||.||| +.|||||||||+||||.. +.+
T Consensus 120 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~~~ 197 (382)
T 2vx3_A 120 HLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKR 197 (382)
T ss_dssp CEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-TTS
T ss_pred EeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-CCC
Confidence 99999999999999999995 59999987764 46999999999999999999999 579999999999999953 246
Q ss_pred ceEEEeecccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Q 007253 300 SVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (611)
Q Consensus 300 ~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~ 378 (611)
+.+||+|||++..... .....+||+.|+|||++. ..++.++|||||||++|||++|+.||.+....+.+..+.....
T Consensus 198 ~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 275 (382)
T 2vx3_A 198 SAIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275 (382)
T ss_dssp CCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred CcEEEEeccCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 7899999999987643 345678999999999986 4689999999999999999999999999888777766654321
Q ss_pred CCC------------------CCCC-----------------CC-------------------------CCHHHHHHHHH
Q 007253 379 SFD------------------EAPW-----------------PS-------------------------LSSEARDFVKR 398 (611)
Q Consensus 379 ~~~------------------~~~~-----------------~~-------------------------~s~~~~~li~~ 398 (611)
..+ ...| .. .+.++.+||.+
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 355 (382)
T 2vx3_A 276 IPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR 355 (382)
T ss_dssp SCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHH
Confidence 110 0000 00 01478999999
Q ss_pred hcccCccCCCCHHHHHcCcccCCCC
Q 007253 399 LLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 399 ~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
||+.||++|||+.|+|+||||+...
T Consensus 356 mL~~dP~~Rpta~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 356 MLDYDPKTRIQPYYALQHSFFKKTA 380 (382)
T ss_dssp HTCSCTTTSCCHHHHTTSGGGCC--
T ss_pred hcCCChhhCCCHHHHhcCcccccCC
Confidence 9999999999999999999998753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=377.82 Aligned_cols=259 Identities=27% Similarity=0.519 Sum_probs=216.2
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
...++|++.+.||+|+||.||+|.... +|+.||||++.... ..+.+.+|+.+++++. ||||+++++++.+.
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 96 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKE---TGQIVAIKQVPVES-----DLQEIIKEISIMQQCD-SPHVVKYYGSYFKN 96 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETT---TCCEEEEEEEETTS-----CCHHHHHHHHHHHTCC-CTTBCCEEEEEEET
T ss_pred cchhhhhhheeeccCCCeEEEEEEECC---CCCEEEEEecCchH-----HHHHHHHHHHHHHhCC-CCCCccEEEEEEeC
Confidence 446789999999999999999998765 68999999996542 2356889999999997 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+.+++||||+++|+|.+++......+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.
T Consensus 97 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~ 173 (314)
T 3com_A 97 TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVAG 173 (314)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCE
T ss_pred CEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE---CCCCCEEEeecccch
Confidence 99999999999999999987677789999999999999999999999999999999999999 567789999999997
Q ss_pred ccCCCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 312 FVRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 312 ~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
...... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||...........+....... ......++
T Consensus 174 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 252 (314)
T 3com_A 174 QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPT-FRKPELWS 252 (314)
T ss_dssp ECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-CSSGGGSC
T ss_pred hhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcc-cCCcccCC
Confidence 765432 334568999999999986 568999999999999999999999998877666555544433221 11223578
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
..+.+||.+||..||.+|||+.++++||||+...
T Consensus 253 ~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 253 DNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 9999999999999999999999999999998764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=387.61 Aligned_cols=263 Identities=19% Similarity=0.263 Sum_probs=223.0
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEec--CCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~--~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 229 (611)
...++|++++.||+|+||.||+|++.. ....++.||||++... ........+.+|+.++++++ ||||+++++++.
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~ 144 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFN-HQNIVRCIGVSL 144 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCC-CCCCCeEEEEEe
Confidence 346789999999999999999999653 2236789999998643 34455567889999999997 999999999999
Q ss_pred eCCeeEEEeeecCCCChHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEE
Q 007253 230 DTDNVYVVMELCEGGELLDRILSRG------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303 (611)
Q Consensus 230 ~~~~~~lv~E~~~~gsL~~~l~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vk 303 (611)
+.+..++|||||+||+|.+++.... ..+++..++.++.||+.||.|||++|||||||||+|||++..+.+..+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 9999999999999999999997654 3599999999999999999999999999999999999996555666799
Q ss_pred EeecccccccCCC---CcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCC
Q 007253 304 AIDFGLSDFVRPD---ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADP 378 (611)
Q Consensus 304 l~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~ 378 (611)
|+|||+++..... .......||+.|+|||++. +.++.++|||||||++|||++ |..||......+....+.....
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~ 304 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 9999999754222 2234467899999999885 679999999999999999998 9999999888888877776543
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccC
Q 007253 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420 (611)
Q Consensus 379 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~ 420 (611)
... ...++..+.+||.+||+.||.+|||+.+++++.|+-
T Consensus 305 ~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 305 MDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 222 246899999999999999999999999999998764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=396.02 Aligned_cols=259 Identities=18% Similarity=0.197 Sum_probs=199.8
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhc-CCCCeeEEE-------
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT-GHNNLVKFF------- 225 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-~h~~iv~l~------- 225 (611)
..+|++++.||+|+||.||+|++.. +|+.||||++...........+.+.+|+.+++.|. .||||++++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~ 137 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVE---RLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPS 137 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCC
T ss_pred ceeeeeeeeccCCCCEEEEEEEECC---CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeee
Confidence 3459999999999999999999766 68999999998776556667778889977666665 499988866
Q ss_pred EEEeeC-----------------CeeEEEeeecCCCChHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHHHHcCCe
Q 007253 226 DAYEDT-----------------DNVYVVMELCEGGELLDRILSRGGKYTEDDA------KAVMIQILNVVAFCHLQGVV 282 (611)
Q Consensus 226 ~~~~~~-----------------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~------~~i~~qi~~~L~~LH~~~ii 282 (611)
+++... ..+|||||||+ |+|.+++...+..+.+..+ ..++.||+.||.|||++|||
T Consensus 138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~iv 216 (371)
T 3q60_A 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLV 216 (371)
T ss_dssp EEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCc
Confidence 455433 33899999998 8999999876555666666 77889999999999999999
Q ss_pred eecCCCCceEEeccCCCceEEEeecccccccCCCCcccccccCCCcCcchhhcC---CCCCcchhhHHHHHHHHHHhCCC
Q 007253 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSR 359 (611)
Q Consensus 283 HrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlGvil~el~~g~~ 359 (611)
||||||+|||| +.++.+||+|||+++.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.
T Consensus 217 HrDikp~NIll---~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 217 HGHFTPDNLFI---MPDGRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp ETTCSGGGEEE---CTTSCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCcCCHHHEEE---CCCCCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 99999999999 5778899999999987642 2224567799999999864 58999999999999999999999
Q ss_pred CCCCCChHHH--HHH---HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCC
Q 007253 360 PFWARTESGI--FRA---VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 360 Pf~~~~~~~~--~~~---i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
||........ +.. .......+....++.+++++.+||.+||+.||++|||+.++|+||||+.
T Consensus 292 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 292 PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp STTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred CCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 9976533210 000 0011112222334578999999999999999999999999999999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=372.41 Aligned_cols=260 Identities=31% Similarity=0.562 Sum_probs=217.7
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
+.++|++++.||+|+||.||+|.... +++.||||++..... ....+.+.+|+.+++.++ ||||+++++++.+.+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 78 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGN 78 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETT
T ss_pred eecceEEEEEeecCCCcEEEEEEECC---CCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcC-CCCceeeeeEEEcCC
Confidence 35689999999999999999998765 689999999864432 234577899999999997 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~ 154 (276)
T 2yex_A 79 IQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATV 154 (276)
T ss_dssp EEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEE
T ss_pred EEEEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE---ccCCCEEEeeCCCccc
Confidence 99999999999999987743 3569999999999999999999999999999999999999 5677899999999976
Q ss_pred cCCCC---cccccccCCCcCcchhhcC-C-CCCcchhhHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCCCCCCCC
Q 007253 313 VRPDE---RLNDIVGSAYYVAPEVLHR-S-YSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 313 ~~~~~---~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwSlGvil~el~~g~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~ 386 (611)
..... ......||+.|+|||++.+ . ++.++|||||||++|+|++|+.||...... ..+..+...... ...+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~ 232 (276)
T 2yex_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--LNPWK 232 (276)
T ss_dssp CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT--STTGG
T ss_pred cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc--cCchh
Confidence 54322 2345689999999999864 3 467899999999999999999999876543 233333332222 22345
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCC
Q 007253 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~ 424 (611)
.++..+.+||.+||+.||.+|||+.++++||||+....
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 233 KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred hcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence 78999999999999999999999999999999987643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=373.83 Aligned_cols=257 Identities=26% Similarity=0.417 Sum_probs=210.1
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
...+|++.+.||+|+||.||+|+. .|+.||||++..... .....+.+.+|+.++++++ ||||+++++++.+.+
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-----HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLR-HPNIVLFMGAVTQPP 107 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-----TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSTT
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-----CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECC
Confidence 357899999999999999999974 478899999876543 4455678899999999998 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcC--CeeecCCCCceEEeccCCCceEEEeecc
Q 007253 233 NVYVVMELCEGGELLDRILSRGG--KYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSVLKAIDFG 308 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NIll~~~~~~~~vkl~DfG 308 (611)
.+++|||||++|+|.+++..... .+++..++.++.||+.||.|||++| ||||||||+|||+ +.++.+||+|||
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll---~~~~~~kL~Dfg 184 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFG 184 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE---CTTCCEEECCCC
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE---eCCCcEEECCCC
Confidence 99999999999999998865432 3999999999999999999999999 9999999999999 577889999999
Q ss_pred cccccCCCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 007253 309 LSDFVRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 309 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (611)
++....... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||......+....+......... ..
T Consensus 185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--~~ 262 (309)
T 3p86_A 185 LSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEI--PR 262 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCC--CT
T ss_pred CCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--Cc
Confidence 998654332 234568999999999987 55899999999999999999999999988887777766544433322 24
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHc--CcccCC
Q 007253 387 SLSSEARDFVKRLLNKDPRKRLTAAQALS--HPWIKN 421 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rpt~~~ll~--hp~~~~ 421 (611)
.+++++.+||.+||+.||.+|||+.++++ ++|++.
T Consensus 263 ~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 263 NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 68999999999999999999999999987 566654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=384.21 Aligned_cols=255 Identities=24% Similarity=0.407 Sum_probs=216.7
Q ss_pred CCceeEeCeeeeccceEEEEEEEecC----CccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKG----ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~----~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 229 (611)
.++|++++.||+|+||.||+|+.... ...+..||||++... ......+.+.+|+.+++++.+||||+++++++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 57899999999999999999987531 124678999999654 345566789999999999955999999999999
Q ss_pred eCCeeEEEeeecCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEe
Q 007253 230 DTDNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294 (611)
Q Consensus 230 ~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~ 294 (611)
+.+.+|+|||||++|+|.+++.... ..+++..++.++.||+.||.|||++|||||||||+|||+
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll- 236 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV- 236 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE-
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE-
Confidence 9999999999999999999987653 348999999999999999999999999999999999999
Q ss_pred ccCCCceEEEeecccccccCCCC---cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHH
Q 007253 295 TKDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGI 369 (611)
Q Consensus 295 ~~~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~ 369 (611)
+.++.+||+|||+++...... ......||+.|+|||++. ..++.++|||||||++|||++ |..||.+....++
T Consensus 237 --~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~ 314 (370)
T 2psq_A 237 --TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314 (370)
T ss_dssp --CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred --CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 677889999999998664332 223456788999999886 568999999999999999999 9999998887777
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 370 FRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 370 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
+..+...... .....++.++.+||.+||+.||.+|||+.+++++
T Consensus 315 ~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 315 FKLLKEGHRM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHHTTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7666654321 1124689999999999999999999999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=378.58 Aligned_cols=261 Identities=30% Similarity=0.534 Sum_probs=199.4
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++++.||+|+||.||+|.... +++.||||++..... ....+.+.+|+.++++++ ||||+++++++...+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAP---KKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCH-HPNIVSYYTSFVVKDE 87 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC-------CEEEEECCC------------------CCCCCC-CTTBCCEEEEEESSSC
T ss_pred hhhhhhhheeccccceEEEEEEECC---CCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcC-CCCEeeEEEEEeecCC
Confidence 5789999999999999999998765 588999999864422 234567889999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEee
Q 007253 234 VYVVMELCEGGELLDRILS-------RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~-------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D 306 (611)
.++||||+++|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~d 164 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIAD 164 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECC
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE---cCCCCEEEEe
Confidence 9999999999999998864 24569999999999999999999999999999999999999 5678899999
Q ss_pred cccccccCCCC------cccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Q 007253 307 FGLSDFVRPDE------RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (611)
Q Consensus 307 fG~a~~~~~~~------~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~ 378 (611)
||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.................
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 244 (303)
T 2vwi_A 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP 244 (303)
T ss_dssp CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSC
T ss_pred ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCC
Confidence 99987654322 123457999999999986 4689999999999999999999999988777666555554432
Q ss_pred CCCC------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 379 SFDE------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 379 ~~~~------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.... .....++.++.+||.+||+.||.+|||+.++++||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 2211 22356889999999999999999999999999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=382.51 Aligned_cols=257 Identities=26% Similarity=0.390 Sum_probs=214.2
Q ss_pred cCCceeEeCeeeeccceEEEEEEEec--CCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~--~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
..++|++++.||+|+||.||+|++.. ...+++.||||++... ......+.+.+|++++.++.+||||+++++++.+
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc--CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 46789999999999999999998754 2346789999999654 3344567789999999999669999999999988
Q ss_pred CC-eeEEEeeecCCCChHHHHHhcCC------------------------------------------------------
Q 007253 231 TD-NVYVVMELCEGGELLDRILSRGG------------------------------------------------------ 255 (611)
Q Consensus 231 ~~-~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------------ 255 (611)
.+ .+++|||||++|+|.+++.....
T Consensus 98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 65 49999999999999999876532
Q ss_pred -----------CCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCC---cccc
Q 007253 256 -----------KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE---RLND 321 (611)
Q Consensus 256 -----------~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~---~~~~ 321 (611)
.+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||++....... ....
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 254 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGD 254 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTSCTTCEEC--
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCcEEEEeccceeeecccccchhccc
Confidence 18999999999999999999999999999999999999 567789999999998764332 2345
Q ss_pred cccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHh
Q 007253 322 IVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399 (611)
Q Consensus 322 ~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 399 (611)
..||+.|+|||++. ..++.++|||||||++|+|++ |..||.+................... ...+++++.++|.+|
T Consensus 255 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~ 332 (359)
T 3vhe_A 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA--PDYTTPEMYQTMLDC 332 (359)
T ss_dssp CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCC--CTTCCHHHHHHHHHH
T ss_pred cCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCC--CCCCCHHHHHHHHHH
Confidence 67899999999886 678999999999999999998 99999887655554444444332222 245899999999999
Q ss_pred cccCccCCCCHHHHHcC
Q 007253 400 LNKDPRKRLTAAQALSH 416 (611)
Q Consensus 400 L~~dP~~Rpt~~~ll~h 416 (611)
|+.||.+|||+.++++|
T Consensus 333 l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 333 WHGEPSQRPTFSELVEH 349 (359)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCChhhCCCHHHHHHH
Confidence 99999999999999876
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=385.78 Aligned_cols=264 Identities=24% Similarity=0.412 Sum_probs=211.1
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCc--------CCHHHHHHHHHHHHHHHHhcCCCCee
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--------TTAIAIEDVRREVKILRALTGHNNLV 222 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~~h~~iv 222 (611)
..+.++|++++.||+|+||.||+|... .|+.||||++..... ......+.+.+|+.++++++ ||||+
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv 92 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDS----EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPNIL 92 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECT----TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTTBC
T ss_pred HHhccceEEeEEeccCCCEEEEEEECC----CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcCcc
Confidence 345788999999999999999999854 388999999854321 22334578899999999998 99999
Q ss_pred EEEEEEee-----CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccC
Q 007253 223 KFFDAYED-----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD 297 (611)
Q Consensus 223 ~l~~~~~~-----~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~ 297 (611)
++++++.. ...+|+|||||. |+|.+.+......+++..++.++.||+.||.|||++||+||||||+|||+ +
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~ 168 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---A 168 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---C
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE---c
Confidence 99999854 336899999997 69999988777789999999999999999999999999999999999999 5
Q ss_pred CCceEEEeecccccccCCCCcccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 007253 298 ENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK 375 (611)
Q Consensus 298 ~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~ 375 (611)
.++.+||+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+....+..
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 248 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE 248 (362)
T ss_dssp TTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 67789999999998766555566678999999999886 4689999999999999999999999998887776666643
Q ss_pred cCCC------------------------CCCCC----CCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 376 ADPS------------------------FDEAP----WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 376 ~~~~------------------------~~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.... .+... .+.+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp HHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 2111 11111 235688999999999999999999999999999998753
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=389.45 Aligned_cols=266 Identities=24% Similarity=0.412 Sum_probs=211.4
Q ss_pred CcCcccccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhc-------CC
Q 007253 146 SFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT-------GH 218 (611)
Q Consensus 146 ~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-------~h 218 (611)
.+.....+.++|++.++||+|+||.||+|+... +++.||||++... ....+.+.+|+.+++.++ +|
T Consensus 28 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~ 100 (397)
T 1wak_A 28 LVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQ---GKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNR 100 (397)
T ss_dssp SSCTTCEETTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGG
T ss_pred EEehhhhcCCeEEEEEEeeecCCeeEEEEEecC---CCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCc
Confidence 344456678899999999999999999998766 6899999998532 445677889999999996 27
Q ss_pred CCeeEEEEEEe----eCCeeEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHc-CCeeecCCCCceE
Q 007253 219 NNLVKFFDAYE----DTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFL 292 (611)
Q Consensus 219 ~~iv~l~~~~~----~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NIl 292 (611)
+||+++++++. +...++|||||+ +|+|++.+.... ..+++..++.++.||+.||.|||++ |||||||||+|||
T Consensus 101 ~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIl 179 (397)
T 1wak_A 101 EMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENIL 179 (397)
T ss_dssp GGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEE
T ss_pred ceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHee
Confidence 88999999988 456899999999 668888777654 5699999999999999999999998 9999999999999
Q ss_pred EeccC----------------------------------------------CCceEEEeecccccccCCCCcccccccCC
Q 007253 293 FTTKD----------------------------------------------ENSVLKAIDFGLSDFVRPDERLNDIVGSA 326 (611)
Q Consensus 293 l~~~~----------------------------------------------~~~~vkl~DfG~a~~~~~~~~~~~~~gt~ 326 (611)
|+..+ ....+||+|||++..... .....+||+
T Consensus 180 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~ 257 (397)
T 1wak_A 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTR 257 (397)
T ss_dssp ECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCG
T ss_pred EeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCC
Confidence 95321 113799999999987643 344568999
Q ss_pred CcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcCCCCCC-----------------
Q 007253 327 YYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE------SGIFRAVLKADPSFDE----------------- 382 (611)
Q Consensus 327 ~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~~~----------------- 382 (611)
.|+|||++. ..++.++|||||||++|+|++|+.||..... ...+..+.......+.
T Consensus 258 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 337 (397)
T 1wak_A 258 QYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKG 337 (397)
T ss_dssp GGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTS
T ss_pred cccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcc
Confidence 999999886 5599999999999999999999999976442 2222222221111000
Q ss_pred --------C-------------CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCC
Q 007253 383 --------A-------------PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 383 --------~-------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
. .....+..+.+||.+||+.||.+|||+.++|+||||++
T Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 338 DLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp SBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred ccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0 00122467889999999999999999999999999974
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=385.79 Aligned_cols=258 Identities=31% Similarity=0.560 Sum_probs=214.4
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+.++|.+++.||+|+||.||+|.... +|+.||||++.... ......+.+.+|+.+++.++ ||||+++++++...
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 113 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKR---SGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPA 113 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSC
T ss_pred cccccEEEEeEEecCCCeEEEEEEECC---CCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcC-CCCchhhhhheecc
Confidence 356889999999999999999998776 68999999997543 34556678899999999998 99999999999887
Q ss_pred Cee------EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 232 DNV------YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 232 ~~~------~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
+.. ++||||+. |+|.+.+ ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 114 ~~~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~ 186 (371)
T 4exu_A 114 SSLRNFYDFYLVMPFMQ-TDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKIL 186 (371)
T ss_dssp SSSTTCCCCEEEEECCC-EEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEEC
T ss_pred CCcccceeEEEEEcccc-ccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE---CCCCCEEEE
Confidence 655 99999996 5887765 3459999999999999999999999999999999999999 577889999
Q ss_pred ecccccccCCCCcccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---
Q 007253 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF--- 380 (611)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~--- 380 (611)
|||++..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+.......
T Consensus 187 Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 187 DFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 264 (371)
T ss_dssp STTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ecCccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHH
Confidence 9999986543 3445689999999998864 68999999999999999999999999888777666665422111
Q ss_pred --------------------CCC----CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 381 --------------------DEA----PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 381 --------------------~~~----~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
... .++.+++++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 110 1245789999999999999999999999999999998653
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=372.53 Aligned_cols=256 Identities=29% Similarity=0.518 Sum_probs=211.3
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee--
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-- 230 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~-- 230 (611)
+.++|++++.||+|+||.||+|+... +|+.||||++.. .....+.+.+|+.++++++ ||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 75 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNAL---DSRYYAIKKIRH----TEEKLSTILSEVMLLASLN-HQYVVRYYAAWLERR 75 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEE----EHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEECC
T ss_pred ccccchhhheeccCCcEEEEEEEEcC---CCeEEEEEEEec----cHHHHHHHHHHHHHHHhcC-chHHHHHHHHHHhhc
Confidence 45789999999999999999999765 689999999853 3345677899999999997 9999999999865
Q ss_pred -----------CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCC
Q 007253 231 -----------TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN 299 (611)
Q Consensus 231 -----------~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~ 299 (611)
.+.+|+|||||++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.+
T Consensus 76 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~ 152 (303)
T 1zy4_A 76 NFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DES 152 (303)
T ss_dssp CCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTT
T ss_pred chhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE---cCC
Confidence 356899999999999999998776678999999999999999999999999999999999999 577
Q ss_pred ceEEEeecccccccCCC---------------CcccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCC
Q 007253 300 SVLKAIDFGLSDFVRPD---------------ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFW 362 (611)
Q Consensus 300 ~~vkl~DfG~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~ 362 (611)
+.+||+|||++...... .......||+.|+|||++.+ .++.++|||||||++|+|++ ||.
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~ 229 (303)
T 1zy4_A 153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFS 229 (303)
T ss_dssp SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccC
Confidence 88999999999876422 12345679999999999863 58999999999999999998 664
Q ss_pred CC-ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 363 AR-TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 363 ~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
.. ........+......++.......+..+.+||.+||+.||.+|||+.++++||||+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 230 TGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp SHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred CchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 32 2334455555555555555556778899999999999999999999999999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=365.09 Aligned_cols=248 Identities=25% Similarity=0.442 Sum_probs=216.1
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++.+.||+|+||.||+|+... ++.||+|++...... .+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLN----KDKVAIKTIREGAMS----EEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAP 79 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT----TEEEEEEEECTTSBC----HHHHHHHHHHHHTCC-CTTBCCEEEEECSSSS
T ss_pred hhhceeeheecCCCccEEEEEEecC----CCeEEEEEecccccC----HHHHHHHHHHHHhCC-CCCEeeEEEEEecCCc
Confidence 4689999999999999999998653 678999999754332 256889999999998 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
.++||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~ 156 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFV 156 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECCTTGGGGB
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE---cCCCCEEeccccccccc
Confidence 999999999999999998777789999999999999999999999999999999999999 56778999999999876
Q ss_pred CCCC--cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 314 RPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 314 ~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
.... ......||+.|+|||++. ..++.++|||||||++|+|++ |+.||......+....+........ ...++
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 233 (269)
T 4hcu_A 157 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLAS 233 (269)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSC
T ss_pred cccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC---CCcCC
Confidence 5432 233456788899999986 678999999999999999999 9999999888888777776533222 23579
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
..+.++|.+||+.||.+|||+.++++|
T Consensus 234 ~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 234 THVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 999999999999999999999999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=376.07 Aligned_cols=260 Identities=32% Similarity=0.523 Sum_probs=212.8
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe-
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE- 229 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~- 229 (611)
..+.++|++++.||+|+||.||+|.... +|+.||||++... .....+.+.+|+.++++++ ||||+++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 79 (320)
T 2i6l_A 7 FDLGSRYMDLKPLGCGGNGLVFSAVDND---CDKRVAIKKIVLT---DPQSVKHALREIKIIRRLD-HDNIVKVFEILGP 79 (320)
T ss_dssp EEETTTEEEEEECC-----CEEEEEETT---TTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECT
T ss_pred CccCCceeEEEEeccCCCeEEEEEEECC---CCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcC-CCCeeEEEEeccc
Confidence 3467899999999999999999999765 6899999998643 4556678899999999997 999999999874
Q ss_pred -------------eCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEecc
Q 007253 230 -------------DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296 (611)
Q Consensus 230 -------------~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~ 296 (611)
+.+..++||||++ |+|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~-- 154 (320)
T 2i6l_A 80 SGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN-- 154 (320)
T ss_dssp TSCBCCC----CCSCSEEEEEEECCS-EEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE--
T ss_pred cccccccccccccccCceeEEeeccC-CCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc--
Confidence 3467899999997 59998874 35799999999999999999999999999999999999995
Q ss_pred CCCceEEEeecccccccCCCC----cccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHH
Q 007253 297 DENSVLKAIDFGLSDFVRPDE----RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIF 370 (611)
Q Consensus 297 ~~~~~vkl~DfG~a~~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~ 370 (611)
..++.+||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+.+
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 234 (320)
T 2i6l_A 155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234 (320)
T ss_dssp TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 245789999999998764321 234457899999999875 56889999999999999999999999988887777
Q ss_pred HHHHhcCCCCCC--------------------------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 371 RAVLKADPSFDE--------------------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 371 ~~i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
..+....+.... ..++.++.++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 666654332110 0124689999999999999999999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=377.68 Aligned_cols=260 Identities=30% Similarity=0.531 Sum_probs=215.7
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+.++|++++.||+|+||.||+|+... +|+.||||++... ........+.+|+.++++++ ||||+++++++...
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 81 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKP---TGEIVAIKKIEPF--DKPLFALRTLREIKILKHFK-HENIITIFNIQRPD 81 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCS
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECC---CCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCc-CCCcCCeeeeeccc
Confidence 456889999999999999999998765 6899999999543 34455667889999999997 99999999988764
Q ss_pred -----CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEee
Q 007253 232 -----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (611)
Q Consensus 232 -----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D 306 (611)
...++||||+. |+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 82 ~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~D 155 (353)
T 2b9h_A 82 SFENFNEVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCD 155 (353)
T ss_dssp CSTTCCCEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECC
T ss_pred ccCccceEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---cCCCcEEEEe
Confidence 67999999996 589888765 469999999999999999999999999999999999999 5778899999
Q ss_pred cccccccCCCC-----------cccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 007253 307 FGLSDFVRPDE-----------RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAV 373 (611)
Q Consensus 307 fG~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i 373 (611)
||++....... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+......+..+
T Consensus 156 fg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 235 (353)
T 2b9h_A 156 FGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235 (353)
T ss_dssp CTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 99998764322 123357899999999874 56889999999999999999999999988776655444
Q ss_pred HhcCC------------------------CCCCC----CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 374 LKADP------------------------SFDEA----PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 374 ~~~~~------------------------~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
..... ..+.. .++.++.++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp HHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 32211 11111 1246899999999999999999999999999999998754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=398.44 Aligned_cols=250 Identities=18% Similarity=0.235 Sum_probs=201.4
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhc--CCCCeeEEE------
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT--GHNNLVKFF------ 225 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~iv~l~------ 225 (611)
.++|++++.||+|+||.||+|+... +|+.||||++.+.........+.+.+|+.+++.|. .|||||+++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQE---TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-C---CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred CceEEEcceeecCCCEEEEEEEECC---CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence 5789999999999999999999765 58999999997654455556688999995555443 499999998
Q ss_pred -EEEeeCCe-----------------eEEEeeecCCCChHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHcCC
Q 007253 226 -DAYEDTDN-----------------VYVVMELCEGGELLDRILSRGG------KYTEDDAKAVMIQILNVVAFCHLQGV 281 (611)
Q Consensus 226 -~~~~~~~~-----------------~~lv~E~~~~gsL~~~l~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~~i 281 (611)
+++.+.+. .||||||| +|+|.+++..... .+++..++.|+.||+.||.|||++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 227 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL 227 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence 77665542 88999999 6799999876421 13348888999999999999999999
Q ss_pred eeecCCCCceEEeccCCCceEEEeecccccccCCCCcccccccCCCcCcchhhc-C-----------CCCCcchhhHHHH
Q 007253 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-R-----------SYSTEADVWSIGV 349 (611)
Q Consensus 282 iHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~-----------~~~~~~DiwSlGv 349 (611)
|||||||+|||| +.++.+||+|||+++... ......+| +.|+|||++. . .++.++|||||||
T Consensus 228 vHrDikp~NIll---~~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVL---DQRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEE---CTTCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEE---cCCCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 999999999999 567889999999998643 34456678 9999999986 3 5899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCC
Q 007253 350 IAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 350 il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
++|||++|+.||.+.........+. ..+..+++++.+||.+||+.||.+|||+.++|+||||+.
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEWIF--------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHHHSSCCC------CCSGGGG--------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHHHCCCCCcccccccchhhhh--------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 9999999999997654332222221 122578999999999999999999999999999999975
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=366.66 Aligned_cols=253 Identities=23% Similarity=0.375 Sum_probs=205.4
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|++++.||+|+||.||+|.+......+..||+|++... ......+.+.+|+.++++++ ||||+++++++. ++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~ 88 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-EN 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-SS
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCC-CCccceEEEEEc-cC
Confidence 457899999999999999999998765445778999998653 34556678999999999997 999999999984 56
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
..++||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRY 165 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEEC---CCCCEEECccccccc
Confidence 78999999999999999987766799999999999999999999999999999999999994 567899999999987
Q ss_pred cCCCCc--ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 313 VRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 313 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
...... .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+....+....+....... ..+.+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~---~~~~~ 242 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPPNC 242 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCTTC
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCC---CCCCC
Confidence 654332 23345778999999986 678999999999999999996 999999888877777776553221 22478
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
++.+.+||.+||+.||.+|||+.++++
T Consensus 243 ~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 243 PPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999999999875
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=367.05 Aligned_cols=259 Identities=30% Similarity=0.494 Sum_probs=220.0
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee--C
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--T 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~--~ 231 (611)
.++|++++.||+|+||.||+|+... +|+.||+|++..... .....+.+.+|+.++++++ ||||+++++++.+ .
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 79 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKS---DGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTN 79 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEEGGG
T ss_pred hhheeeehhccCCCCcEEEEEEECC---CCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcC-CCCCCeEEEEEecCCC
Confidence 4689999999999999999998765 689999999976543 3455678899999999997 9999999998854 5
Q ss_pred CeeEEEeeecCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC-----CeeecCCCCceEEeccCCCceEE
Q 007253 232 DNVYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQG-----VVHRDLKPENFLFTTKDENSVLK 303 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~-----iiHrDlkp~NIll~~~~~~~~vk 303 (611)
+.+++||||+++|+|.+++... ...+++..++.++.||+.||.|||+.| |+||||||+|||+ +.++.+|
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~k 156 (279)
T 2w5a_A 80 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVK 156 (279)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE---CSSSCEE
T ss_pred ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE---cCCCCEE
Confidence 6899999999999999988753 335999999999999999999999999 9999999999999 5778899
Q ss_pred EeecccccccCCCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Q 007253 304 AIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381 (611)
Q Consensus 304 l~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~ 381 (611)
|+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.......+...+.......
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~- 235 (279)
T 2w5a_A 157 LGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR- 235 (279)
T ss_dssp ECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-
T ss_pred EecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc-
Confidence 99999998765432 233457999999999886 468899999999999999999999999888877777776654321
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 382 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
....++.++.+||.+||+.||.+|||+.++++|+|+....
T Consensus 236 --~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 236 --IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred --CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 1236899999999999999999999999999999998653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=362.23 Aligned_cols=249 Identities=27% Similarity=0.418 Sum_probs=215.7
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|++.+.||+|+||.||+|+... +..||+|++...... .+.+.+|+.++++++ ||||+++++++.+++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 76 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKG----QYDVAVKMIKEGSMS----EDEFFQEAQTMMKLS-HPKLVKFYGVCSKEY 76 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT----TEEEEEEEECBTTBC----HHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred chhheeeeeeeccCCCceEEEEEecC----ceeEEEEEeccCCCc----HHHHHHHHHHHHhCC-CCCEeeEEEEEccCC
Confidence 35789999999999999999997653 678999999654332 256889999999998 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
..++||||+++|+|.+++......+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++..
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~ 153 (268)
T 3sxs_A 77 PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRY 153 (268)
T ss_dssp SEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE---CTTCCEEECCTTCEEE
T ss_pred ceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE---CCCCCEEEccCcccee
Confidence 9999999999999999998876679999999999999999999999999999999999999 5778899999999987
Q ss_pred cCCCCc--ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 313 VRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 313 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
...... .....+|+.|+|||++. ..++.++||||||+++|+|++ |+.||...........+......... ..+
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 230 (268)
T 3sxs_A 154 VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---HLA 230 (268)
T ss_dssp CCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTS
T ss_pred cchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC---CcC
Confidence 654432 23345677899999986 468999999999999999998 99999988888777777665433322 357
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
++.+.++|.+||+.||.+|||+.+++++
T Consensus 231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 231 SDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8999999999999999999999999976
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=373.84 Aligned_cols=264 Identities=28% Similarity=0.460 Sum_probs=216.6
Q ss_pred cccccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCC------Cee
Q 007253 149 FSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN------NLV 222 (611)
Q Consensus 149 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~------~iv 222 (611)
....+.++|++++.||+|+||.||+|.... ..|+.||||++... ....+.+.+|+.+++.+. |+ +|+
T Consensus 8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~-~~~~~~~~~i~ 80 (339)
T 1z57_A 8 SGDVLSARYEIVDTLGEGAFGKVVECIDHK--AGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLN-TTDPNSTFRCV 80 (339)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETT--TTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHH-HHCTTCTTCBC
T ss_pred cCCCccCceEEEEEEecCCCeEEEEEEecC--CCCcEEEEEEEecC----CchhHHHHHHHHHHHHhh-hcCCCCceeeE
Confidence 345667899999999999999999998643 25889999998532 345577889999999987 54 599
Q ss_pred EEEEEEeeCCeeEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCC---
Q 007253 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE--- 298 (611)
Q Consensus 223 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~--- 298 (611)
++++++.+.+.+++||||| +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+...+.
T Consensus 81 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 159 (339)
T 1z57_A 81 QMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEA 159 (339)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEE
T ss_pred eeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccc
Confidence 9999999999999999999 889999987664 36899999999999999999999999999999999999954221
Q ss_pred -------------CceEEEeecccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCC
Q 007253 299 -------------NSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWAR 364 (611)
Q Consensus 299 -------------~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~ 364 (611)
++.+||+|||++..... .....+||+.|+|||++. ..++.++|||||||++|+|++|..||...
T Consensus 160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 160 YNPKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp EC----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCCccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 56799999999986542 334568999999999986 56899999999999999999999999887
Q ss_pred ChHHHHHHHHhcCCCCCC----------------CCC------------------------CCCCHHHHHHHHHhcccCc
Q 007253 365 TESGIFRAVLKADPSFDE----------------APW------------------------PSLSSEARDFVKRLLNKDP 404 (611)
Q Consensus 365 ~~~~~~~~i~~~~~~~~~----------------~~~------------------------~~~s~~~~~li~~~L~~dP 404 (611)
...+....+.......+. ..| ...++++.+||.+||+.||
T Consensus 238 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 317 (339)
T 1z57_A 238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317 (339)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred ChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence 776655444332211110 001 1224678899999999999
Q ss_pred cCCCCHHHHHcCcccCCC
Q 007253 405 RKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 405 ~~Rpt~~~ll~hp~~~~~ 422 (611)
.+|||+.++|+||||+..
T Consensus 318 ~~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 318 AKRITLREALKHPFFDLL 335 (339)
T ss_dssp TTSCCHHHHTTSGGGGGG
T ss_pred ccccCHHHHhcCHHHHHH
Confidence 999999999999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=378.42 Aligned_cols=260 Identities=25% Similarity=0.387 Sum_probs=203.9
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|++.+.||+|+||.||+|+... +|+.||||++....... ....+|++.+..++ ||||++++++|...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~-h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKS---TGMSVAIKKVIQDPRFR----NRELQIMQDLAVLH-HPNIVQLQSYFYTLG 92 (360)
T ss_dssp HHTTEEEC----------CEEEEETT---TCCEEEEEEEECCTTCC----CHHHHHHHHHHHHC-CTTBCCEEEEEEEEC
T ss_pred hccceEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEecCcccc----HHHHHHHHHHHhcC-CCCcccHHHhhhccc
Confidence 35789999999999999999999766 68999999986543222 34567888888887 999999999997644
Q ss_pred e-------eEEEeeecCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH--HcCCeeecCCCCceEEeccCCCc
Q 007253 233 N-------VYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCH--LQGVVHRDLKPENFLFTTKDENS 300 (611)
Q Consensus 233 ~-------~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH--~~~iiHrDlkp~NIll~~~~~~~ 300 (611)
. +++|||||++ +|.+.+.. ....+++..++.++.||+.||.||| ++||+||||||+|||++ ..++
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~--~~~~ 169 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN--EADG 169 (360)
T ss_dssp SSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEE--TTTT
T ss_pred cccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEe--CCCC
Confidence 3 8899999976 66555443 4567999999999999999999999 99999999999999995 2377
Q ss_pred eEEEeecccccccCCCCcccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Q 007253 301 VLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (611)
Q Consensus 301 ~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~ 378 (611)
.+||+|||++............+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+......+..+.....
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 249 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG 249 (360)
T ss_dssp EEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred cEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence 89999999999887666666778999999999885 3489999999999999999999999999888777766654211
Q ss_pred CCC--------------------C--------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 379 SFD--------------------E--------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 379 ~~~--------------------~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
... . ......+.++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 110 0 00122578999999999999999999999999999998654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=372.83 Aligned_cols=259 Identities=25% Similarity=0.483 Sum_probs=216.7
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcC-CHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe--
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-TAIAIEDVRREVKILRALTGHNNLVKFFDAYE-- 229 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~-- 229 (611)
+.++|++++.||+|+||.||+|.... +++.||+|++...... .....+.+.+|+.++++++ ||||+++++++.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 78 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSE---TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNE 78 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTT---TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECC
T ss_pred cccceeEeeEEecCCCeEEEEEEECC---CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEcC
Confidence 45789999999999999999998665 6899999998543211 1234567899999999997 999999999984
Q ss_pred eCCeeEEEeeecCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecc
Q 007253 230 DTDNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (611)
Q Consensus 230 ~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG 308 (611)
+.+.+++|||||+++ |.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 79 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~dfg 154 (305)
T 2wtk_C 79 EKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALG 154 (305)
T ss_dssp ---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCT
T ss_pred CCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---cCCCcEEeeccc
Confidence 456899999999876 77776653 4569999999999999999999999999999999999999 567889999999
Q ss_pred cccccCCC---CcccccccCCCcCcchhhcCC---CCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC
Q 007253 309 LSDFVRPD---ERLNDIVGSAYYVAPEVLHRS---YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 382 (611)
Q Consensus 309 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~---~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 382 (611)
++...... .......||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.........+......++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~- 233 (305)
T 2wtk_C 155 VAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP- 233 (305)
T ss_dssp TCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCC-
T ss_pred cccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCC-
Confidence 99876432 223456799999999998642 46799999999999999999999999888888888877655443
Q ss_pred CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 383 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
..++..+.+||.+||+.||.+|||+.++++||||+...
T Consensus 234 ---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 234 ---GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp ---SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred ---CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 36799999999999999999999999999999998654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=373.43 Aligned_cols=267 Identities=21% Similarity=0.343 Sum_probs=199.2
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|++++.||+|+||.||+|+..........||||++...... ....+.+.+|+.++++++ ||||+++++++.+..
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-SSDIEEFLREAACMKEFD-HPHVAKLVGVSLRSR 98 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCC-CTTBCCCCEEEECC-
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC-HHHHHHHHHHHHHHHHCC-CCceehhhceeeccc
Confidence 457899999999999999999987763222348999999654332 344678899999999997 999999999998876
Q ss_pred ee------EEEeeecCCCChHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCce
Q 007253 233 NV------YVVMELCEGGELLDRILSRG-----GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301 (611)
Q Consensus 233 ~~------~lv~E~~~~gsL~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~ 301 (611)
.. ++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli---~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML---AEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE---cCCCC
Confidence 55 99999999999999886542 259999999999999999999999999999999999999 56788
Q ss_pred EEEeecccccccCCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q 007253 302 LKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKA 376 (611)
Q Consensus 302 vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~ 376 (611)
+||+|||++........ .....+++.|+|||++. ..++.++|||||||++|+|++ |..||.+....+....+...
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~ 255 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG 255 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC
Confidence 99999999987654332 22345778999999886 568999999999999999999 99999988888877777665
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCccCCCC-------HHHHHcCcccCCCCCCCC
Q 007253 377 DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT-------AAQALSHPWIKNSNDVKV 427 (611)
Q Consensus 377 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-------~~~ll~hp~~~~~~~~~~ 427 (611)
.... ..+.++.++.+||.+||+.||.+||| ++++++|+|+.......+
T Consensus 256 ~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl 310 (323)
T 3qup_A 256 NRLK---QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPL 310 (323)
T ss_dssp CCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----------
T ss_pred CCCC---CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCC
Confidence 4222 22468999999999999999999999 888999999987654433
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=378.41 Aligned_cols=256 Identities=23% Similarity=0.395 Sum_probs=218.6
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCC----ccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEE
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGE----LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~ 228 (611)
..++|++++.||+|+||.||+|+..... ..+..||||++... ......+.+.+|+++++++.+||||+++++++
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 3578999999999999999999875421 24568999999654 34555678899999999995599999999999
Q ss_pred eeCCeeEEEeeecCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEE
Q 007253 229 EDTDNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLF 293 (611)
Q Consensus 229 ~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll 293 (611)
.+++.+++|||||++|+|.+++.... ..+++..++.++.||+.||.|||++|||||||||+||||
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence 99999999999999999999998754 359999999999999999999999999999999999999
Q ss_pred eccCCCceEEEeecccccccCCCC---cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHH
Q 007253 294 TTKDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESG 368 (611)
Q Consensus 294 ~~~~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~ 368 (611)
+.++.+||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++ |..||.+....+
T Consensus 225 ---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 225 ---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp ---CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred ---cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 567889999999998765432 233456788999999886 568999999999999999999 999999888887
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 369 IFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 369 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
+...+....... ....++.++.+||.+||+.||.+|||+.+++++
T Consensus 302 ~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 302 LFKLLKEGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHTTCCCC---CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCCC---CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 777766553222 124689999999999999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=367.99 Aligned_cols=260 Identities=27% Similarity=0.434 Sum_probs=207.7
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
+|.....||+|+||.||+|.... +++.||||++.... ....+.+.+|+.+++.+. ||||+++++++.+.+..+
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 95 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLS---NQVRIAIKEIPERD---SRYSQPLHEEIALHKHLK-HKNIVQYLGSFSENGFIK 95 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETT---TCCEEEEEEEECCC---C---HHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECC---CCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCC-CCCEeeEeeEEEeCCcEE
Confidence 34555699999999999999765 68999999986542 234567889999999997 999999999999999999
Q ss_pred EEeeecCCCChHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 236 VVMELCEGGELLDRILSRGG--KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+||||+++++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++. .++.+||+|||++...
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT--YSGVLKISDFGTSKRL 173 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTCCEEECCTTTCEES
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEEC--CCCCEEEeeccccccc
Confidence 99999999999999876543 4679999999999999999999999999999999999952 3678999999999876
Q ss_pred CCCC-cccccccCCCcCcchhhcC---CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhcCCCCCCCCCCCC
Q 007253 314 RPDE-RLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFWARTESGI-FRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~ 388 (611)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||........ ........ ........+
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~ 251 (295)
T 2clq_A 174 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK--VHPEIPESM 251 (295)
T ss_dssp CC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHC--CCCCCCTTS
T ss_pred CCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccc--ccccccccC
Confidence 5322 2345689999999999863 388999999999999999999999976443322 11111111 111122468
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCCC
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVK 426 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~~ 426 (611)
+.++.+||.+||+.||.+|||+.++|+||||+...+.+
T Consensus 252 ~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 289 (295)
T 2clq_A 252 SAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKK 289 (295)
T ss_dssp CHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-----
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccccC
Confidence 99999999999999999999999999999999765443
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=383.58 Aligned_cols=263 Identities=24% Similarity=0.464 Sum_probs=221.2
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCH--------------HHHHHHHHHHHHHHHhc
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA--------------IAIEDVRREVKILRALT 216 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~--------------~~~~~~~~E~~~l~~l~ 216 (611)
....++|++++.||+|+||.||+|+. +|+.||||++........ ...+.+.+|+.++++|+
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 101 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK-----DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK 101 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE-----TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc-----CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC
Confidence 34567899999999999999999986 489999999864322211 11267899999999998
Q ss_pred CCCCeeEEEEEEeeCCeeEEEeeecCCCChHHH------HHhc-CCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeecCCC
Q 007253 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDR------ILSR-GGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKP 288 (611)
Q Consensus 217 ~h~~iv~l~~~~~~~~~~~lv~E~~~~gsL~~~------l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp 288 (611)
||||+++++++.+.+.+++|||||++|+|.++ +... ...+++..++.++.||+.||.|||+ .||+||||||
T Consensus 102 -h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p 180 (348)
T 2pml_X 102 -NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKP 180 (348)
T ss_dssp -CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCG
T ss_pred -CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCCh
Confidence 99999999999999999999999999999887 4332 4679999999999999999999999 9999999999
Q ss_pred CceEEeccCCCceEEEeecccccccCCCCcccccccCCCcCcchhhcCC--CCC-cchhhHHHHHHHHHHhCCCCCCCCC
Q 007253 289 ENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS--YST-EADVWSIGVIAYILLCGSRPFWART 365 (611)
Q Consensus 289 ~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~-~~DiwSlGvil~el~~g~~Pf~~~~ 365 (611)
+|||+ +.++.+||+|||++...... ......||+.|+|||++.+. ++. ++|||||||++|+|++|+.||....
T Consensus 181 ~Nil~---~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 181 SNILM---DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp GGEEE---CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HhEEE---cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999 57778999999999876533 44556899999999998743 555 8999999999999999999998877
Q ss_pred h-HHHHHHHHhcCCCCCCCC---------------CCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 366 E-SGIFRAVLKADPSFDEAP---------------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 366 ~-~~~~~~i~~~~~~~~~~~---------------~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
. .+....+......++... ...++.++.+||.+||+.||.+|||+.++++||||+...
T Consensus 257 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 257 SLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp CSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred cHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 6 666666666554444211 146899999999999999999999999999999998753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=364.56 Aligned_cols=249 Identities=22% Similarity=0.384 Sum_probs=212.7
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|++++.||+|+||.||+|.... +..||||++...... .+.+.+|+.++++++ ||||+++++++.+.+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRG----QYDVAIKMIKEGSMS----EDEFIEEAKVMMNLS-HEKLVQLYGVCTKQR 92 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETT----TEEEEEEEECTTSBC----HHHHHHHHHHHHTCC-CTTBCCEEEEECSSS
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcC----CCeEEEEEecCCCCC----HHHHHHHHHHHhcCC-CCCEeeEEEEEecCC
Confidence 35789999999999999999997653 678999999754332 256889999999998 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.+++||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRY 169 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTSCEEECSTTGGGG
T ss_pred CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE---cCCCCEEEcccccccc
Confidence 9999999999999999998766779999999999999999999999999999999999999 5777899999999987
Q ss_pred cCCCC--cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 313 VRPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 313 ~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
..... ......+|+.|+|||++. ..++.++|||||||++|+|++ |+.||...........+......... ..+
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 246 (283)
T 3gen_A 170 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLA 246 (283)
T ss_dssp BCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTC
T ss_pred ccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCC---CcC
Confidence 65332 223345778899999986 678999999999999999998 99999988888877777665433222 357
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
++.+.+||.+||+.||.+|||+.++++|
T Consensus 247 ~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 247 SEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 8999999999999999999999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=370.33 Aligned_cols=264 Identities=28% Similarity=0.434 Sum_probs=199.0
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++++.||+|+||.||+|+... +|+.||||++..... .....+.+.++..+++.+. ||||+++++++.+.+.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~~~~~ 98 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRK---TGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHD-CPYIVQCFGTFITNTD 98 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETT---TCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTT-CTTBCCEEEEEECSSE
T ss_pred hccccccceeeecCCeeEEEEEEec---CCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCc
Confidence 5689999999999999999999876 689999999976532 2222333444445566665 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
+++||||+ ++.+..+.......+++..++.++.||+.||.|||+. ||+||||||+|||+ +.++.+||+|||++..
T Consensus 99 ~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFGISGR 174 (318)
T ss_dssp EEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE---CTTSCEEECCCTTC--
T ss_pred EEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE---CCCCCEEEEECCCchh
Confidence 99999999 5565555555567899999999999999999999995 99999999999999 5778899999999987
Q ss_pred cCCCCcccccccCCCcCcchhhc------CCCCCcchhhHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhcCCCCCCCCC
Q 007253 313 VRPDERLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWAR-TESGIFRAVLKADPSFDEAPW 385 (611)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~el~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~ 385 (611)
...........||+.|+|||++. ..++.++|||||||++|+|++|+.||... .....+..+......... ..
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~ 253 (318)
T 2dyl_A 175 LVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP-GH 253 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCC-SS
T ss_pred ccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCC-cc
Confidence 76555555668999999999983 45888999999999999999999999863 445556666655433221 22
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCCCC
Q 007253 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKV 427 (611)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~~~ 427 (611)
..++.++.+||.+||+.||.+|||+.++++||||+.......
T Consensus 254 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~ 295 (318)
T 2dyl_A 254 MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEV 295 (318)
T ss_dssp SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHHSCC
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcccccc
Confidence 468999999999999999999999999999999986543333
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=374.98 Aligned_cols=265 Identities=25% Similarity=0.422 Sum_probs=217.1
Q ss_pred cccccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCC------ee
Q 007253 149 FSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN------LV 222 (611)
Q Consensus 149 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~------iv 222 (611)
....+.++|++.+.||+|+||.||+|..... .++.||+|++... ....+.+.+|+.+++++. |++ ++
T Consensus 13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-~~~~~~~~~~~ 85 (355)
T 2eu9_A 13 IGDWLQERYEIVGNLGEGTFGKVVECLDHAR--GKSQVALKIIRNV----GKYREAARLEINVLKKIK-EKDKENKFLCV 85 (355)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEECSC----HHHHHHHHHHHHHHHHHH-HHCTTSCSCBC
T ss_pred cCceecccEEEEEEeeccCCeEEEEEEecCC--CceEEEEEEEccc----ccchhHHHHHHHHHHHHh-hcCCCCceeEE
Confidence 4456788999999999999999999987652 2478999998532 345567889999999997 555 99
Q ss_pred EEEEEEeeCCeeEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEecc-----
Q 007253 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK----- 296 (611)
Q Consensus 223 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~----- 296 (611)
.+++++...+.++|||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+...
T Consensus 86 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~ 164 (355)
T 2eu9_A 86 LMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETL 164 (355)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEE
T ss_pred EeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccc
Confidence 9999999999999999999 678888887654 469999999999999999999999999999999999999532
Q ss_pred -----------CCCceEEEeecccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCC
Q 007253 297 -----------DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWAR 364 (611)
Q Consensus 297 -----------~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~ 364 (611)
+.++.+||+|||++..... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||...
T Consensus 165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 165 YNEHKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp ECCC-CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 2467899999999986542 334568999999999986 56899999999999999999999999888
Q ss_pred ChHHHHHHHHhcCCCCCCC----------------CC------------------------CCCCHHHHHHHHHhcccCc
Q 007253 365 TESGIFRAVLKADPSFDEA----------------PW------------------------PSLSSEARDFVKRLLNKDP 404 (611)
Q Consensus 365 ~~~~~~~~i~~~~~~~~~~----------------~~------------------------~~~s~~~~~li~~~L~~dP 404 (611)
...+....+.......+.. .| ...+.++.+||++||+.||
T Consensus 243 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred CHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 7766555443322211110 01 1124578899999999999
Q ss_pred cCCCCHHHHHcCcccCCCC
Q 007253 405 RKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 405 ~~Rpt~~~ll~hp~~~~~~ 423 (611)
.+|||+.++|+||||+...
T Consensus 323 ~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 323 AQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp TTSCCHHHHTTSGGGGGCC
T ss_pred hhCcCHHHHhcChhhcCCC
Confidence 9999999999999999754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=375.19 Aligned_cols=257 Identities=31% Similarity=0.543 Sum_probs=212.8
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
+.++|.+.+.||+|+||.||+|.... +|+.||||++.... ......+.+.+|+.+++.++ ||||+++++++...+
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 96 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKR---SGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPAS 96 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCS
T ss_pred cCceEEEeeeEecCCCeEEEEEEECC---CCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCcccHhheEeccc
Confidence 45789999999999999999998766 68999999996543 34555678899999999998 999999999998765
Q ss_pred e------eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEee
Q 007253 233 N------VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (611)
Q Consensus 233 ~------~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D 306 (611)
. +|+||||+. |+|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 97 ~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~D 169 (353)
T 3coi_A 97 SLRNFYDFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILD 169 (353)
T ss_dssp SGGGCCCCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTCCEEECS
T ss_pred ccccceeEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE---CCCCcEEEee
Confidence 4 499999997 58877652 359999999999999999999999999999999999999 5778899999
Q ss_pred cccccccCCCCcccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC------
Q 007253 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP------ 378 (611)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~------ 378 (611)
||++..... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+.+..+.....
T Consensus 170 fg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 170 FGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247 (353)
T ss_dssp TTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHH
T ss_pred cccccCCCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999987543 234568999999999886 4689999999999999999999999998877666655543210
Q ss_pred -----------------CC----CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 379 -----------------SF----DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 379 -----------------~~----~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.. ....++.++.++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 00 0112346799999999999999999999999999999998653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=373.63 Aligned_cols=246 Identities=24% Similarity=0.386 Sum_probs=207.8
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++++.||+|+||.||+|.+.. +++.||+|++.. ......+.+.+|+.++++++ ||||+++++++.+++.
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~---~~~~va~K~~~~---~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~ 81 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRE---TGEVMVMKELIR---FDEETQRTFLKEVKVMRCLE-HPNVLKFIGVLYKDKR 81 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEESC---CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTE
T ss_pred hhHeeccceecCCCCEEEEEEEECC---CCcEEEEEEecc---CCHHHHHHHHHHHHHHHhCC-CcCcccEEEEEecCCe
Confidence 4789999999999999999999776 689999999844 34566778999999999998 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
.++|||||++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 82 LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLM 158 (310)
T ss_dssp EEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---CTTSCEEECCCTTCEEC
T ss_pred eEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE---CCCCCEEEeecccceec
Confidence 999999999999999998877889999999999999999999999999999999999999 57788999999999876
Q ss_pred CCCCcc---------------cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHH-----HHHH
Q 007253 314 RPDERL---------------NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESG-----IFRA 372 (611)
Q Consensus 314 ~~~~~~---------------~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~-----~~~~ 372 (611)
...... ...+||+.|+|||++. ..++.++|||||||++|+|++|..||....... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~ 238 (310)
T 3s95_A 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG 238 (310)
T ss_dssp C--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHH
T ss_pred ccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhc
Confidence 433211 1568999999999987 568999999999999999999999986432211 0111
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 373 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
..... . .+.+++.+.+||.+||+.||.+|||+.++++
T Consensus 239 ~~~~~--~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 239 FLDRY--C----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHHHT--C----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccc--C----CCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11111 1 1357888999999999999999999999975
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=372.88 Aligned_cols=255 Identities=22% Similarity=0.306 Sum_probs=217.2
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCC--ccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
..++|++++.||+|+||.||+|+..... .+++.||||++... ......+.+.+|+.++++++ ||||+++++++.+
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 121 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFD-NPNIVKLLGVCAV 121 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc--cCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEcc
Confidence 4578999999999999999999987421 24689999999654 24455678999999999997 9999999999999
Q ss_pred CCeeEEEeeecCCCChHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCC
Q 007253 231 TDNVYVVMELCEGGELLDRILSRG-----------------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLK 287 (611)
Q Consensus 231 ~~~~~lv~E~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlk 287 (611)
.+.+++|||||++|+|.+++.... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 201 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 201 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 999999999999999999987642 569999999999999999999999999999999
Q ss_pred CCceEEeccCCCceEEEeecccccccCCCC---cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCC
Q 007253 288 PENFLFTTKDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFW 362 (611)
Q Consensus 288 p~NIll~~~~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~ 362 (611)
|+|||+ +.++.+||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++ |..||.
T Consensus 202 p~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 202 TRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp GGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred cceEEE---CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 999999 567789999999997654332 223457899999999886 678999999999999999999 999999
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 363 ARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 363 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
+....+....+........ ...++.++.+||.+||+.||.+|||+.+++++
T Consensus 279 ~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 279 GMAHEEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp TSCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCChHHHHHHHhCCCcCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 9888887777766543221 24689999999999999999999999999753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=366.11 Aligned_cols=257 Identities=26% Similarity=0.374 Sum_probs=216.4
Q ss_pred cCCceeEeCeeeeccceEEEEEEEec--CCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~--~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
..++|++++.||+|+||.||+|+... ....++.||||++... ......+.+.+|+.++++|.+||||+++++++.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc--hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 35789999999999999999998643 2236789999999654 2344567889999999999559999999999999
Q ss_pred CCeeEEEeeecCCCChHHHHHhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEE
Q 007253 231 TDNVYVVMELCEGGELLDRILSRGG-----------------KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLF 293 (611)
Q Consensus 231 ~~~~~lv~E~~~~gsL~~~l~~~~~-----------------~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll 293 (611)
++..++|||||++|+|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 9999999999999999999976543 48999999999999999999999999999999999999
Q ss_pred eccCCCceEEEeecccccccCCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHH
Q 007253 294 TTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESG 368 (611)
Q Consensus 294 ~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~ 368 (611)
+.++.+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|++ |+.||.+.....
T Consensus 179 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 179 ---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp ---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred ---cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 4678899999999987654432 23456788999999875 678999999999999999998 999998876655
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 369 IFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 369 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
....+........ ....++.++.+||.+||+.||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 256 KFYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhccCCCCC--CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 5555554433222 224689999999999999999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=381.55 Aligned_cols=250 Identities=24% Similarity=0.379 Sum_probs=213.8
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++++.||+|+||.||+|+... +++.||||++... ......+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRA---DNTLVAVKSCRET--LPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQP 186 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred hHHeEEeeEeccCCCCeEEEEEEec---CCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEecCCC
Confidence 5689999999999999999999875 5889999998643 23445567889999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|||||||++|+|.+++...+..+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+++..
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV---TEKNVLKISDFGMSREE 263 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGGCEEC
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE---cCCCcEEECcCCCceec
Confidence 999999999999999998776779999999999999999999999999999999999999 57788999999999865
Q ss_pred CCCCcc---cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 314 RPDERL---NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 314 ~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
...... ....+++.|+|||++. +.++.++|||||||++|||++ |..||.+....+....+..... .+. ...+
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~ 340 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR-LPC--PELC 340 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC-CCC--CTTC
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCC--CCCC
Confidence 433211 1234577899999986 668999999999999999998 9999998887776666654432 221 2357
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
+.++.+||.+||+.||.+|||+.++++
T Consensus 341 ~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 341 PDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 899999999999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=373.54 Aligned_cols=250 Identities=18% Similarity=0.266 Sum_probs=206.6
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
+.++|++++.||+|+||.||+|+... +|+.||||++...... +.+.+|+.++++|.+||||+++++++.+.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 78 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLY---TNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGK 78 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETT---TTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETT
T ss_pred EcCCeEEEEEeeccCCceEEEEEECC---CCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCC
Confidence 46789999999999999999999765 6899999998654322 347799999999955999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCce-----EEEeec
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV-----LKAIDF 307 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~-----vkl~Df 307 (611)
..++||||+ +|+|.+++......+++..++.++.||+.||.|||++|||||||||+|||++ .++. +||+||
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~---~~~~~~~~~~kl~DF 154 (330)
T 2izr_A 79 YNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIG---RPGNKTQQVIHIIDF 154 (330)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---CGGGTCTTSEEECCC
T ss_pred ccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---cCCCCCCceEEEEEc
Confidence 999999999 9999999987667899999999999999999999999999999999999994 4554 999999
Q ss_pred ccccccCCCCc--------ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHh
Q 007253 308 GLSDFVRPDER--------LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART---ESGIFRAVLK 375 (611)
Q Consensus 308 G~a~~~~~~~~--------~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~---~~~~~~~i~~ 375 (611)
|++..+..... ....+||+.|+|||++. ..++.++|||||||++|||++|+.||.+.. ..+.+..+..
T Consensus 155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~ 234 (330)
T 2izr_A 155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234 (330)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence 99987643321 24678999999999987 558999999999999999999999998743 3344444433
Q ss_pred cCCCCCCCC-CCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 376 ADPSFDEAP-WPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 376 ~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
.....+... ...++ ++.+||.+||+.||.+||++.+|++
T Consensus 235 ~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 235 TKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 322222111 12344 9999999999999999999998875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=378.77 Aligned_cols=253 Identities=25% Similarity=0.397 Sum_probs=205.3
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
..+|++.+.||+|+||.||+|+.......+..||||++... ......+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 120 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKP 120 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT--CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc--cCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCc
Confidence 46799999999999999999987744345788999998654 24455678999999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+++|||||++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---cCCCCEEECcCcccccc
Confidence 999999999999999998777789999999999999999999999999999999999999 67788999999999876
Q ss_pred CCCCc----ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 007253 314 RPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (611)
Q Consensus 314 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (611)
..... .....+++.|+|||++. +.++.++|||||||++|||++ |+.||......++...+...... + ....
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~-~--~~~~ 274 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL-P--PPMD 274 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC-C--CCTT
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-C--CCcc
Confidence 54321 12234577899999886 678999999999999999997 99999988888777766554211 1 1236
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
++..+.+||.+||+.||.+||++.++++
T Consensus 275 ~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 275 CPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp CBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 7899999999999999999999999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=361.86 Aligned_cols=253 Identities=25% Similarity=0.416 Sum_probs=208.6
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHH----HHHHHHHHHHHHhcCCCCeeEEEEEE
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAI----EDVRREVKILRALTGHNNLVKFFDAY 228 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~----~~~~~E~~~l~~l~~h~~iv~l~~~~ 228 (611)
..++|++.+.||+|+||.||+|+... +++.||+|++........... +.+.+|+.++++++ ||||+++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~ 92 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVK---DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGLM 92 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETT---TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC-CTTBCCEEEEE
T ss_pred hhccceehhccccCCceeEEEEEEcC---CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC-CCCchhhheee
Confidence 35789999999999999999999876 689999999865443332221 67889999999997 99999999999
Q ss_pred eeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeecCCCCceEEeccCC--CceEEE
Q 007253 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDE--NSVLKA 304 (611)
Q Consensus 229 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NIll~~~~~--~~~vkl 304 (611)
.+.. ++||||+++|+|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++..+. ...+||
T Consensus 93 ~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 93 HNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp TTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred cCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 7665 7999999999999999888778999999999999999999999999 999999999999953221 223999
Q ss_pred eecccccccCCCCcccccccCCCcCcchhhc---CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhcCCC
Q 007253 305 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLH---RSYSTEADVWSIGVIAYILLCGSRPFWARTESGI--FRAVLKADPS 379 (611)
Q Consensus 305 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~--~~~i~~~~~~ 379 (611)
+|||++..... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||........ ...+.....
T Consensus 171 ~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~- 247 (287)
T 4f0f_A 171 ADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL- 247 (287)
T ss_dssp CCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC-
T ss_pred CCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC-
Confidence 99999975432 345568999999999983 3478899999999999999999999976654443 333333322
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 380 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
.......+++++.+||.+||+.||.+|||+.++++
T Consensus 248 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 248 -RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 22223578999999999999999999999999985
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=371.76 Aligned_cols=259 Identities=25% Similarity=0.362 Sum_probs=214.3
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecC--CccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
..++|++++.||+|+||.||+|..... ...+..||||++.... .....+.+.+|+.++++|.+||||+++++++.+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 357899999999999999999997532 1256789999996432 233446789999999999559999999999999
Q ss_pred CCeeEEEeeecCCCChHHHHHhcCC----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCC
Q 007253 231 TDNVYVVMELCEGGELLDRILSRGG----------------------KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKP 288 (611)
Q Consensus 231 ~~~~~lv~E~~~~gsL~~~l~~~~~----------------------~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp 288 (611)
.+.+++|||||++|+|.+++..... .+++..++.++.||+.||.|||++||+||||||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 200 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 9999999999999999999976543 379999999999999999999999999999999
Q ss_pred CceEEeccCCCceEEEeecccccccCCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCC
Q 007253 289 ENFLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWA 363 (611)
Q Consensus 289 ~NIll~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~ 363 (611)
+|||+ +.++.+||+|||++........ .....||+.|+|||++. +.++.++|||||||++|+|++ |..||.+
T Consensus 201 ~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 201 RNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp GGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred hhEEE---cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 99999 4678899999999987654332 23456788999999885 678999999999999999998 9999988
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcc
Q 007253 364 RTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418 (611)
Q Consensus 364 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~ 418 (611)
......+..+......... ...++.++.+||.+||+.||.+|||+.++++|-.
T Consensus 278 ~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 278 IPVDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp CCCSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCcHHHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 7766655555554433222 2467999999999999999999999999988653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=363.09 Aligned_cols=254 Identities=26% Similarity=0.507 Sum_probs=202.3
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|++.+.||+|+||.||+|.... +|+.||||++...........+.+.+|+.++++++ ||||+++++++.+.+
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 105 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLL---DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDN 105 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETT---TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETT
T ss_pred cccceEEEEeecCCCCceEEEEEEcC---CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCC
Confidence 35689999999999999999998765 58999999997655556667788999999999997 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccc
Q 007253 233 NVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~ 309 (611)
..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~ 182 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGL 182 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCC--
T ss_pred cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE---cCCCCEEEEeccc
Confidence 99999999999999998864 34569999999999999999999999999999999999999 5778899999999
Q ss_pred ccccCCCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhcCCCCCCCCC
Q 007253 310 SDFVRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE--SGIFRAVLKADPSFDEAPW 385 (611)
Q Consensus 310 a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~ 385 (611)
+....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+... ......+... .++....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~ 260 (310)
T 2wqm_A 183 GRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPS 260 (310)
T ss_dssp ----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT--CSCCCCT
T ss_pred eeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc--cCCCCcc
Confidence 98765432 234567999999999886 5688999999999999999999999976432 2333334332 2333334
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
..++.++.+||.+||..||.+|||+.++++
T Consensus 261 ~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 261 DHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 578999999999999999999999999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=364.71 Aligned_cols=260 Identities=25% Similarity=0.479 Sum_probs=210.3
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEe
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG-HNNLVKFFDAYE 229 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-h~~iv~l~~~~~ 229 (611)
....++|++++.||+|+||.||+|... .++.||||++.... ......+.+.+|+.+++++.+ |+||+++++++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 98 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 98 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT----TCCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC----CCcEEEEEEecccc-ccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence 345678999999999999999999863 38899999997543 344566789999999999974 699999999999
Q ss_pred eCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccc
Q 007253 230 DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (611)
Q Consensus 230 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~ 309 (611)
+++.+++||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+. ++.+||+|||+
T Consensus 99 ~~~~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~kL~Dfg~ 172 (313)
T 3cek_A 99 TDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGI 172 (313)
T ss_dssp CSSEEEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSS
T ss_pred cCCEEEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----CCeEEEeeccc
Confidence 9999999999 4578999988765 5799999999999999999999999999999999999994 37899999999
Q ss_pred ccccCCCCc---ccccccCCCcCcchhhcC------------CCCCcchhhHHHHHHHHHHhCCCCCCCCChH-HHHHHH
Q 007253 310 SDFVRPDER---LNDIVGSAYYVAPEVLHR------------SYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAV 373 (611)
Q Consensus 310 a~~~~~~~~---~~~~~gt~~y~aPE~~~~------------~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~-~~~~~i 373 (611)
+........ ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... ..+..+
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 252 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252 (313)
T ss_dssp SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH
Confidence 987654332 235579999999999853 5788999999999999999999999765433 333334
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 374 LKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
........ .....+.++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 253 ~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 253 IDPNHEIE--FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp HCTTSCCC--CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred HhcccccC--CcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 33322221 1234688999999999999999999999999999998754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=358.49 Aligned_cols=254 Identities=23% Similarity=0.340 Sum_probs=213.0
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|++.+.||+|+||.||+|........+..||+|++... ......+.+.+|+.++++++ ||||+++++++.+ +
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~ 85 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMKNLD-HPHIVKLIGIIEE-E 85 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT--SCHHHHHHHHHHHHHHHHHC-CTTBCCEEEEECS-S
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc--cCchHHHHHHHHHHHHHhCC-CCCcceEEEEEcC-C
Confidence 357899999999999999999998765445667999998654 24455678999999999997 9999999999865 4
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLSRY 162 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---ETTEEEECCCCGGGC
T ss_pred CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEC---CCCcEEeCccCCCcc
Confidence 57899999999999999988777799999999999999999999999999999999999994 567899999999987
Q ss_pred cCCCC--cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 313 VRPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 313 ~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
..... ......+|+.|+|||++. ..++.++|||||||++|+|++ |+.||...........+........ ...+
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~ 239 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK---PDLC 239 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC---CTTC
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC---CCCC
Confidence 65433 223446788999999986 678999999999999999998 9999988777776666655432211 2357
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
++.+.++|.+||..||.+|||+.+++++
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 240 PPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 9999999999999999999999999865
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=370.44 Aligned_cols=263 Identities=20% Similarity=0.275 Sum_probs=217.8
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEec--CCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~--~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 229 (611)
...++|++++.||+|+||.||+|++.. ....++.||||++... ........+.+|+.+++++. ||||+++++++.
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~ 103 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFN-HQNIVRCIGVSL 103 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCC-CCCCCeEEEEEc
Confidence 346789999999999999999998543 2236889999998643 34455667899999999997 999999999999
Q ss_pred eCCeeEEEeeecCCCChHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEE
Q 007253 230 DTDNVYVVMELCEGGELLDRILSRG------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303 (611)
Q Consensus 230 ~~~~~~lv~E~~~~gsL~~~l~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vk 303 (611)
+.+..|+|||||++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+....+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999999998654 3489999999999999999999999999999999999997555667899
Q ss_pred EeecccccccCCCC---cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCC
Q 007253 304 AIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADP 378 (611)
Q Consensus 304 l~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~ 378 (611)
|+|||++....... ......||+.|+|||++. +.++.++|||||||++|+|++ |..||...........+.....
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 263 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence 99999987543222 233457899999999885 678999999999999999998 9999988888777776665542
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccC
Q 007253 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420 (611)
Q Consensus 379 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~ 420 (611)
.. ....++..+.+||.+||+.||.+|||+.++++|.|+-
T Consensus 264 ~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 264 MD---PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 22 2246899999999999999999999999999998864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=370.87 Aligned_cols=264 Identities=25% Similarity=0.379 Sum_probs=192.6
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHH-HHHHhcCCCCeeEEEEEEeeCC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK-ILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
.++|++++.||+|+||.||+|.... +|+.||||++.... .......+..|+. +++.+ +||||+++++++.+++
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~-~h~niv~~~~~~~~~~ 94 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKP---SGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSS-DCPYIVQFYGALFREG 94 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETT---TTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSC-CCTTBCCEEEEEECSS
T ss_pred HHHhhehheeccCCCEEEEEEEEcC---CCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcC-CCCcEeeeeeEEEeCC
Confidence 5789999999999999999999765 68999999997542 3334456667777 44555 4999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeecCCCCceEEeccCCCceEEEeec
Q 007253 233 NVYVVMELCEGGELLDRILS----RGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDF 307 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NIll~~~~~~~~vkl~Df 307 (611)
..++||||+++ +|.+++.. ....+++..++.++.||+.||.|||+. ||+||||||+|||+ +.++.+||+||
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll---~~~~~~kl~Df 170 (327)
T 3aln_A 95 DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL---DRSGNIKLCDF 170 (327)
T ss_dssp EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEE---ETTTEEEECCC
T ss_pred ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEE---cCCCCEEEccC
Confidence 99999999975 88777653 246799999999999999999999999 99999999999999 56788999999
Q ss_pred ccccccCCCCcccccccCCCcCcchhhc-----CCCCCcchhhHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhc-CCCC
Q 007253 308 GLSDFVRPDERLNDIVGSAYYVAPEVLH-----RSYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKA-DPSF 380 (611)
Q Consensus 308 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~-~~~~~i~~~-~~~~ 380 (611)
|++.............||+.|+|||++. ..++.++|||||||++|+|++|+.||...... +.+..+... .+.+
T Consensus 171 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3aln_A 171 GISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL 250 (327)
T ss_dssp SSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCC
T ss_pred CCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence 9998776554445568999999999982 45889999999999999999999999764321 111111111 1222
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCCCC
Q 007253 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKV 427 (611)
Q Consensus 381 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~~~ 427 (611)
....+..++..+.+||.+||+.||.+|||+.++++||||........
T Consensus 251 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~ 297 (327)
T 3aln_A 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAV 297 (327)
T ss_dssp CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSCC
T ss_pred CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhhHH
Confidence 33333568999999999999999999999999999999986544333
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=365.04 Aligned_cols=255 Identities=23% Similarity=0.336 Sum_probs=216.4
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecC--CccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
..++|++++.||+|+||.||+|..... ...++.||||++... ......+.+.+|+.++++++ ||||+++++++.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVLKQVN-HPHVIKLYGACSQ 97 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCC-CCceeeEEEEEec
Confidence 357899999999999999999987532 235689999999654 34555678899999999997 9999999999999
Q ss_pred CCeeEEEeeecCCCChHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCC
Q 007253 231 TDNVYVVMELCEGGELLDRILSRG-----------------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLK 287 (611)
Q Consensus 231 ~~~~~lv~E~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlk 287 (611)
.+..++|||||++|+|.+++.... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik 177 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA 177 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence 999999999999999999987643 238999999999999999999999999999999
Q ss_pred CCceEEeccCCCceEEEeecccccccCCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCC
Q 007253 288 PENFLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFW 362 (611)
Q Consensus 288 p~NIll~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~ 362 (611)
|+|||+ +.++.+||+|||++........ .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.
T Consensus 178 p~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 178 ARNILV---AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp GGGEEE---ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred hheEEE---cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999 4677899999999987644332 23446788999999886 568999999999999999999 999998
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 363 ARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 363 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
+.........+...... .....+++++.+||.+||+.||.+|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 255 GIPPERLFNLLKTGHRM---ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp TCCGGGHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHhhcCCcC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 88877776666554321 1224689999999999999999999999999865
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=356.58 Aligned_cols=252 Identities=28% Similarity=0.411 Sum_probs=201.7
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCC-HHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT-AIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
.++|++.+.||+|+||.||+|.+ .|+.||||++....... ....+.+.+|+.+++.++ ||||+++++++.+++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 79 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-----IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGVCLKEP 79 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-----TTEEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEEECCC-
T ss_pred hhheeeeeeeccCCCeEEEEEEE-----cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEEEecCC
Confidence 46899999999999999999985 37889999986543222 234567889999999998 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CeeecCCCCceEEeccC-----CCceEEE
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG---VVHRDLKPENFLFTTKD-----ENSVLKA 304 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NIll~~~~-----~~~~vkl 304 (611)
..++||||+++++|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++... .++.+||
T Consensus 80 ~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp -CEEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred ceEEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 9999999999999988773 457999999999999999999999999 89999999999996422 2678999
Q ss_pred eecccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 007253 305 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA 383 (611)
Q Consensus 305 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 383 (611)
+|||++....... .....||+.|+|||++. ..++.++||||||+++|+|++|+.||.+.........+.......+.
T Consensus 158 ~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 235 (271)
T 3dtc_A 158 TDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI- 235 (271)
T ss_dssp CCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC-
T ss_pred ccCCccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC-
Confidence 9999998765333 33567999999999886 56899999999999999999999999988877776666655433332
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 384 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
...+++.+.+||.+||+.||.+|||+.+++++
T Consensus 236 -~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 236 -PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 24689999999999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=362.42 Aligned_cols=256 Identities=21% Similarity=0.317 Sum_probs=210.7
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
..+.++|++++.||+|+||.||+|.... +|+.||||++...... +.+.+|+.+++.+.+|+||+++++++.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 77 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLL---NNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQE 77 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECC---CCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecCC
Confidence 3457889999999999999999998765 6899999998654322 3477899999999779999999999999
Q ss_pred CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccC--CCceEEEeecc
Q 007253 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD--ENSVLKAIDFG 308 (611)
Q Consensus 231 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~--~~~~vkl~DfG 308 (611)
....++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++ ....+||+|||
T Consensus 78 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 78 GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred CceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 99999999999 9999999987777799999999999999999999999999999999999995331 23349999999
Q ss_pred cccccCCCC--------cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhc
Q 007253 309 LSDFVRPDE--------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWAR---TESGIFRAVLKA 376 (611)
Q Consensus 309 ~a~~~~~~~--------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~---~~~~~~~~i~~~ 376 (611)
++....... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+. .....+..+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 998765432 134567999999999986 56899999999999999999999999774 333334443332
Q ss_pred CCCCC-CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 377 DPSFD-EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 377 ~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
....+ ......+++++.+||.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 237 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 21111 1112468999999999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=362.69 Aligned_cols=253 Identities=17% Similarity=0.219 Sum_probs=207.5
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCc----cCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEE
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGEL----KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~ 228 (611)
..++|++.+.||+|+||.||+|+...... .+..||+|++... .....+.+.+|+.++++++ ||||+++++++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~ 81 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMSKLS-HKHLVLNYGVC 81 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG---GGGGHHHHHHHHHHHHTSC-CTTBCCEEEEE
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc---cHHHHHHHHHHHHHHHhCC-CCCEeEEEEEE
Confidence 46789999999999999999999876211 1357999998543 3344577899999999998 99999999999
Q ss_pred eeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCC-----CceEE
Q 007253 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE-----NSVLK 303 (611)
Q Consensus 229 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~-----~~~vk 303 (611)
.+++..++|||||++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++..+. .+.+|
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999999999877666999999999999999999999999999999999999964322 12299
Q ss_pred EeecccccccCCCCcccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Q 007253 304 AIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381 (611)
Q Consensus 304 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~ 381 (611)
|+|||++...... ....||+.|+|||++. ..++.++|||||||++|+|++|..|+...................+
T Consensus 162 l~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (289)
T 4fvq_A 162 LSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLP 238 (289)
T ss_dssp ECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred eccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCC
Confidence 9999998765432 3456899999999886 4589999999999999999996555544444444444444443333
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 382 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
. ..+.++.+||.+||+.||.+|||+.++++|
T Consensus 239 ~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 239 A----PKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp C----CSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred C----CCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 2 457788999999999999999999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=364.27 Aligned_cols=257 Identities=26% Similarity=0.390 Sum_probs=213.2
Q ss_pred cCCceeEeCeeeeccceEEEEEEEec--CCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~--~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
..++|++++.||+|+||.||+|+... ....++.||||++... ......+.+.+|+.+++++.+||||+++++++..
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 102 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 102 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC--CCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence 45789999999999999999998754 2236789999999654 2344556789999999999669999999999987
Q ss_pred CC-eeEEEeeecCCCChHHHHHhcCCC---------------CCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEe
Q 007253 231 TD-NVYVVMELCEGGELLDRILSRGGK---------------YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294 (611)
Q Consensus 231 ~~-~~~lv~E~~~~gsL~~~l~~~~~~---------------l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~ 294 (611)
.+ .+++|||||++|+|.+++...... +++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~- 181 (316)
T 2xir_A 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL- 181 (316)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE-
Confidence 65 599999999999999998765432 8999999999999999999999999999999999999
Q ss_pred ccCCCceEEEeecccccccCCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHH
Q 007253 295 TKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGI 369 (611)
Q Consensus 295 ~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~ 369 (611)
+.++.+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.+......
T Consensus 182 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~ 259 (316)
T 2xir_A 182 --SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259 (316)
T ss_dssp --CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred --CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence 5677899999999987654332 23457889999999886 668999999999999999998 9999987665444
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 370 FRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 370 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
+............ ...+++++.++|.+||+.||.+|||+.++++|
T Consensus 260 ~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 260 FCRRLKEGTRMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhccCccCCC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4443333322221 23579999999999999999999999999876
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=359.57 Aligned_cols=253 Identities=23% Similarity=0.416 Sum_probs=199.8
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
+...++|++++.||+|+||.||+|+. ...||+|++.... ......+.+.+|+.++++++ ||||+++++++ .
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~------~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~-~ 90 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKW------HGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTR-HVNILLFMGYS-T 90 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEES------SSEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE-C
T ss_pred ccCccceeeeeEecCCCCeEEEEEEE------cCceEEEEEeccC-CCHHHHHHHHHHHHHHHhCC-CCcEEEEEeec-c
Confidence 44567899999999999999999974 3359999986543 34556678999999999998 99999999965 5
Q ss_pred CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 231 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
....++|||||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~ 167 (289)
T 3og7_A 91 APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLA 167 (289)
T ss_dssp SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTTEEEECCCC--
T ss_pred CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE---CCCCCEEEccceec
Confidence 667899999999999999987777789999999999999999999999999999999999999 46778999999999
Q ss_pred cccCCC---CcccccccCCCcCcchhhc----CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CCCC-
Q 007253 311 DFVRPD---ERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD-PSFD- 381 (611)
Q Consensus 311 ~~~~~~---~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~-~~~~- 381 (611)
...... .......||+.|+|||++. ..++.++|||||||++|+|++|+.||...........+.... ....
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 247 (289)
T 3og7_A 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL 247 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCT
T ss_pred cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcch
Confidence 765432 2334567999999999884 457889999999999999999999998766555444444332 2211
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 382 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
......+++++.+||.+||+.||.+|||+.++++
T Consensus 248 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 2223568999999999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=369.00 Aligned_cols=253 Identities=20% Similarity=0.286 Sum_probs=206.6
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCC-ccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
.++|++.+.||+|+||.||+|++.... .....||+|.+.... .....+.+.+|+.++++++ ||||+++++++.+..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTST 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCC-BTTBCCEEEEEESSS
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCC
Confidence 467999999999999999999976521 122346888875432 2334577899999999998 999999999998755
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.++|+||+.+|+|.+++......+++..++.|+.||+.||.|||++|||||||||+|||+ +.++.+||+|||+++.
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKL 166 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTHHHH
T ss_pred -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEE---CCCCCEEEccCcceeE
Confidence 789999999999999998877889999999999999999999999999999999999999 4677899999999987
Q ss_pred cCCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 007253 313 VRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (611)
Q Consensus 313 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (611)
...... .....||+.|+|||++. +.++.++|||||||++|||++ |+.||.+.....+...+..... .+ ....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~ 243 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-LP--QPPI 243 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-CC--CCTT
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCC-CC--CCcc
Confidence 654332 23345688999999886 668999999999999999999 9999988877776655554432 22 1246
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
++.++.++|.+||+.||.+|||+.+++++
T Consensus 244 ~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 244 CTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp BCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 78999999999999999999999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=370.24 Aligned_cols=256 Identities=29% Similarity=0.529 Sum_probs=213.2
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCH---HHHHHHHHHHHHHHHhc-CCCCeeEEEE
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA---IAIEDVRREVKILRALT-GHNNLVKFFD 226 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~-~h~~iv~l~~ 226 (611)
..+.++|++++.||+|+||.||+|+... +|+.||||++........ ...+.+.+|+.+++++. +|+||+++++
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVS---DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETT---TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECC---CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 3456889999999999999999998766 689999999965432221 11234668999999997 3799999999
Q ss_pred EEeeCCeeEEEeeecCC-CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 227 AYEDTDNVYVVMELCEG-GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 227 ~~~~~~~~~lv~E~~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
++.+.+..++||||+.+ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ..++.+||+
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--~~~~~~kL~ 192 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLI 192 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEEC
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe--CCCCCEEEe
Confidence 99999999999999976 7999988765 5799999999999999999999999999999999999994 256789999
Q ss_pred ecccccccCCCCcccccccCCCcCcchhhc-CC-CCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 007253 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA 383 (611)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~-~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 383 (611)
|||++..... .......||+.|+|||++. .. ++.++|||||||++|+|++|+.||.... .+......++
T Consensus 193 Dfg~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~-- 263 (320)
T 3a99_A 193 DFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR-- 263 (320)
T ss_dssp CCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS--
T ss_pred eCcccccccc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccccccc--
Confidence 9999987653 3344567999999999886 33 4678999999999999999999996532 2333332222
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 384 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
..+++++.+||.+||+.||.+|||+.++++||||++..
T Consensus 264 --~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 264 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp --SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred --ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 46899999999999999999999999999999998753
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=361.91 Aligned_cols=253 Identities=23% Similarity=0.340 Sum_probs=203.8
Q ss_pred cCCceeEeCeeeeccceEEEEEEEec-CCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
..++|++++.||+|+||.||+|++.. ...+++.||||++... .....+.+.+|+.++++++ ||||+++++++...
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSA 83 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECHH
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence 46789999999999999999998642 2236899999998543 4555678999999999998 99999999998654
Q ss_pred --CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccc
Q 007253 232 --DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (611)
Q Consensus 232 --~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~ 309 (611)
..+++|||||++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~---~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGL 160 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCCS
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEc---CCCeEEEccCcc
Confidence 568999999999999999987766799999999999999999999999999999999999994 667899999999
Q ss_pred ccccCCCCc----ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChH----------------H
Q 007253 310 SDFVRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES----------------G 368 (611)
Q Consensus 310 a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~----------------~ 368 (611)
+........ .....++..|+|||++. ..++.++|||||||++|+|++|..||...... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 987654322 23345778899999886 67899999999999999999999998543211 1
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 369 IFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 369 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
....+ ......+ ....+++++.+||.+||+.||.+|||+.++++
T Consensus 241 ~~~~~-~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 241 LIELL-KNNGRLP--RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHH-HTTCCCC--CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHH-hccCcCC--CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 11112 2222222 23468999999999999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=354.06 Aligned_cols=248 Identities=25% Similarity=0.439 Sum_probs=214.7
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++.+.||+|+||.||+|.... ++.||+|++...... .+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 77 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLN----KDKVAIKTIREGAMS----EEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAP 77 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT----TEEEEEEEECTTTBC----HHHHHHHHHHHHTCC-CTTBCCEEEEECSSSS
T ss_pred hhheeeeeEecCCCceeEEEEEecC----CCeEEEEEccccCCC----HHHHHHHHHHHHhCC-CCCEeeEEEEEccCCC
Confidence 4679999999999999999998653 678999999754322 256889999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+++||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~ 154 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFV 154 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CGGGCEEECCTTGGGGB
T ss_pred eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---CCCCCEEEccccccccc
Confidence 999999999999999998877789999999999999999999999999999999999999 56778999999999876
Q ss_pred CCCC--cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 314 RPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 314 ~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
.... ......|++.|+|||++. ..++.++||||||+++|+|++ |+.||......+....+........ ...++
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~ 231 (267)
T 3t9t_A 155 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLAS 231 (267)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSC
T ss_pred ccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC---CccCc
Confidence 4322 223456788999999986 678999999999999999999 8999998888887777766533222 23578
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
..+.++|.+||+.||.+|||+.+++++
T Consensus 232 ~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 232 THVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=367.25 Aligned_cols=256 Identities=29% Similarity=0.566 Sum_probs=203.2
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCH---HHHHHHHHHHHHHHHhc---CCCCeeEE
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA---IAIEDVRREVKILRALT---GHNNLVKF 224 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~---~h~~iv~l 224 (611)
..+.++|++++.||+|+||.||+|+... +|+.||||++........ .....+.+|+.+++++. +||||+++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLT---DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTT---TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEcc---CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 3456889999999999999999998665 689999999965543221 12234568999999993 39999999
Q ss_pred EEEEeeCCeeEEEeee-cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEE
Q 007253 225 FDAYEDTDNVYVVMEL-CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303 (611)
Q Consensus 225 ~~~~~~~~~~~lv~E~-~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vk 303 (611)
++++.+.+..++|||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ..++.+|
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~k 180 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID--LRRGCAK 180 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE--TTTTEEE
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe--CCCCeEE
Confidence 9999999999999999 7899999988765 4699999999999999999999999999999999999995 2677899
Q ss_pred EeecccccccCCCCcccccccCCCcCcchhhc-CCC-CCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Q 007253 304 AIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSY-STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381 (611)
Q Consensus 304 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~-~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~ 381 (611)
|+|||++...... ......||+.|+|||++. ..+ +.++|||||||++|+|++|+.||.... .+......++
T Consensus 181 l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~ 253 (312)
T 2iwi_A 181 LIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFP 253 (312)
T ss_dssp ECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCC
T ss_pred EEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCc
Confidence 9999999877543 345567999999999886 333 458999999999999999999996532 2333333332
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 382 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
..++.++.+||.+||+.||++|||+.++++||||+...
T Consensus 254 ----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 254 ----AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp ----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred ----ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 46899999999999999999999999999999998754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=362.49 Aligned_cols=253 Identities=25% Similarity=0.392 Sum_probs=205.3
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++.+.||+|+||.||+|+... +++.||||++...........+.+.+|+.++++++ ||||+++++++.+++.
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~ 108 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTV---RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDGQ 108 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETT---TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcC---CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEeeCCe
Confidence 4689999999999999999998765 58999999997665555666788999999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV---SADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSCCC----
T ss_pred EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE---cCCCCEEEecCccCccc
Confidence 99999999999999988765 569999999999999999999999999999999999999 56778999999999876
Q ss_pred CCCC--cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 314 RPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 314 ~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
.... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.....+ ...............+.++.
T Consensus 185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 263 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM-GAHINQAIPRPSTVRPGIPV 263 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH-HHHHHSCCCCGGGTSTTCCT
T ss_pred cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH-HHHhccCCCCccccCCCCCH
Confidence 5432 234567999999999886 5688999999999999999999999987665543 33334333333334467899
Q ss_pred HHHHHHHHhcccCccCCC-CHHHHHc
Q 007253 391 EARDFVKRLLNKDPRKRL-TAAQALS 415 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rp-t~~~ll~ 415 (611)
++.+||.+||+.||.+|| +++++++
T Consensus 264 ~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 264 AFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 999999999999999999 7877764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=363.68 Aligned_cols=256 Identities=24% Similarity=0.395 Sum_probs=215.6
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecC----CccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEE
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKG----ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~----~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~ 228 (611)
..++|++++.||+|+||.||+|+.... ...+..||||++... ......+.+.+|+.+++++.+||||+++++++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC--CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 357899999999999999999987531 125788999998654 24455678899999999995599999999999
Q ss_pred eeCCeeEEEeeecCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEE
Q 007253 229 EDTDNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLF 293 (611)
Q Consensus 229 ~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll 293 (611)
.+.+.+++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 99999999999999999999987653 248999999999999999999999999999999999999
Q ss_pred eccCCCceEEEeecccccccCCCC---cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHH
Q 007253 294 TTKDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESG 368 (611)
Q Consensus 294 ~~~~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~ 368 (611)
+.++.+||+|||++....... ......+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+....+
T Consensus 191 ---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 191 ---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp ---CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred ---cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 577889999999998765432 223446788999999886 568999999999999999999 999999888877
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 369 IFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 369 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
+...+....... ....++.++.+||.+||+.||.+|||+.+++++
T Consensus 268 ~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 268 LFKLLKEGHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 777666654221 224689999999999999999999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=357.23 Aligned_cols=253 Identities=22% Similarity=0.342 Sum_probs=213.9
Q ss_pred CCceeEeC-eeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 154 ANKYELGE-EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 154 ~~~y~~~~-~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
.++|.+.+ .||+|+||.||+|.+... ..+..||||++... ......+.+.+|+.++++++ ||||+++++++ ..+
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLD-NPYIVRLIGVC-QAE 82 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC----CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE-ESS
T ss_pred HHHhhhhhccccccCceeEEEeEeccC-CCcceEEEEecCCc--cchhHHHHHHHHHHHHHhCC-CCCEeEEEEEe-cCC
Confidence 46677777 999999999999986532 25788999999654 34556678999999999997 99999999999 556
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
..++||||+++|+|.+++......+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKA 159 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTCEE
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEc---CCCCEEECcccceee
Confidence 79999999999999999877667799999999999999999999999999999999999994 667899999999987
Q ss_pred cCCCCc----ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 007253 313 VRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 313 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (611)
...... .....||+.|+|||++. ..++.++|||||||++|+|++ |+.||......+....+....... ..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~---~~~ 236 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME---CPP 236 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC---CCT
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCC---CCC
Confidence 654332 22345688999999986 668999999999999999998 999999888877777766643211 124
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHcCc
Q 007253 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHP 417 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp 417 (611)
.++.++.++|.+||..||.+||++.++++|.
T Consensus 237 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 7899999999999999999999999998764
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=373.93 Aligned_cols=261 Identities=26% Similarity=0.431 Sum_probs=208.3
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhc----------CCCCee
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT----------GHNNLV 222 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----------~h~~iv 222 (611)
..++|++++.||+|+||.||+|+... +|+.||||++.. .....+.+.+|+.+++++. +|+||+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~ 89 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMV---NNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL 89 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecC---CCcEEEEEEecC----CccchhhhhHHHHHHHHhhcccccchhccccchHH
Confidence 35789999999999999999998765 689999999853 2344567889999999886 278999
Q ss_pred EEEEEEeeCC----eeEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHc-CCeeecCCCCceEEecc
Q 007253 223 KFFDAYEDTD----NVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTK 296 (611)
Q Consensus 223 ~l~~~~~~~~----~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NIll~~~ 296 (611)
++++++...+ .+++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++ |||||||||+|||+...
T Consensus 90 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 90 KLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV 168 (373)
T ss_dssp CCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred HHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEecc
Confidence 9999998654 799999999 889999987643 4599999999999999999999998 99999999999999643
Q ss_pred ---CCCceEEEeecccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCC------h
Q 007253 297 ---DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART------E 366 (611)
Q Consensus 297 ---~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~------~ 366 (611)
+..+.+||+|||++..... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.... .
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CCCcCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 2445899999999987643 334568999999999986 558999999999999999999999997544 2
Q ss_pred HHHHHHHHhcCCCCCC--------------------------------------CCCCCCCHHHHHHHHHhcccCccCCC
Q 007253 367 SGIFRAVLKADPSFDE--------------------------------------APWPSLSSEARDFVKRLLNKDPRKRL 408 (611)
Q Consensus 367 ~~~~~~i~~~~~~~~~--------------------------------------~~~~~~s~~~~~li~~~L~~dP~~Rp 408 (611)
...+..+.......+. .....++.++.+||.+||+.||.+||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 2222222221111100 00012457889999999999999999
Q ss_pred CHHHHHcCcccCCCC
Q 007253 409 TAAQALSHPWIKNSN 423 (611)
Q Consensus 409 t~~~ll~hp~~~~~~ 423 (611)
|+.++|+||||++..
T Consensus 327 t~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 327 DAGGLVNHPWLKDTL 341 (373)
T ss_dssp CHHHHHTCGGGTTCT
T ss_pred CHHHHhhChhhhccc
Confidence 999999999999754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=361.42 Aligned_cols=256 Identities=19% Similarity=0.305 Sum_probs=217.3
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEec--CCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~--~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 229 (611)
...++|++.+.||+|+||.||+|.... ....++.||||++... ........+.+|+.+++.+. ||||+++++++.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~ 98 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFN-CHHVVRLLGVVS 98 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCC-CTTBCCEEEEEC
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc--cCHHHHHHHHHHHHHHHhcC-CCCEeeeEEEEc
Confidence 446789999999999999999998763 1225788999998644 33445567889999999997 999999999999
Q ss_pred eCCeeEEEeeecCCCChHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCc
Q 007253 230 DTDNVYVVMELCEGGELLDRILSRG---------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS 300 (611)
Q Consensus 230 ~~~~~~lv~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~ 300 (611)
+.+..++|||||++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli---~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE---cCCC
Confidence 9999999999999999999987532 457999999999999999999999999999999999999 5678
Q ss_pred eEEEeecccccccCCCC---cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 007253 301 VLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLK 375 (611)
Q Consensus 301 ~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~ 375 (611)
.+||+|||++....... ......||+.|+|||++. +.++.++|||||||++|+|++ |..||.+.........+..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 255 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence 89999999998664332 123446789999999986 668999999999999999999 8999998888777777766
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 376 ADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 376 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
..... ....++..+.+||.+||+.||.+|||+.++++|
T Consensus 256 ~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 256 GGLLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp TCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 54221 124689999999999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=366.60 Aligned_cols=252 Identities=24% Similarity=0.367 Sum_probs=209.5
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcE--EEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQ--VAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.++|++.+.||+|+||.||+|+... +|.. ||+|++... ......+.+.+|+.+++++.+||||+++++++.+.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 98 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKK---DGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 98 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEE---TTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred HHHccceeeeecCCCceEEEEEEcc---CCcccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC
Confidence 4689999999999999999999876 4654 499998643 22334567889999999995599999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEecc
Q 007253 232 DNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~ 296 (611)
+.+++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~--- 175 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV--- 175 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE---
Confidence 99999999999999999987553 469999999999999999999999999999999999999
Q ss_pred CCCceEEEeecccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 007253 297 DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVL 374 (611)
Q Consensus 297 ~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~ 374 (611)
+.++.+||+|||++.............+++.|+|||++. ..++.++|||||||++|+|++ |+.||.+.........+.
T Consensus 176 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 176 GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255 (327)
T ss_dssp CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred cCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence 567789999999997554333344456788999999986 558999999999999999998 999999888877766665
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 375 KADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 375 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
.... ......++.++.+||.+||+.||.+|||+.+++++
T Consensus 256 ~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 256 QGYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GTCC---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCC---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 4421 11224689999999999999999999999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=361.05 Aligned_cols=255 Identities=23% Similarity=0.383 Sum_probs=207.9
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++++.||+|+||.||+|++......+..||||++...........+.+.+|+.++++++ ||||+++++++.+..
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTPP- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS-
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEccCC-
Confidence 568999999999999999999876543334579999987655445566788999999999997 999999999998765
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
.++||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~---~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRAL 171 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEc---CCCCEEEccccccccc
Confidence 8999999999999999987767799999999999999999999999999999999999994 5678999999999876
Q ss_pred CCCCc----ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 007253 314 RPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (611)
Q Consensus 314 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (611)
..... .....+|+.|+|||++. ..++.++|||||||++|+|++ |+.||.+....+....+.......+. ...
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 249 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PED 249 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CTT
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCC--CcC
Confidence 54332 23446788999999986 558899999999999999999 99999998888888777766544332 246
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
++.++.++|.+||..||.+|||+.++++
T Consensus 250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 250 CPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 8999999999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=361.59 Aligned_cols=258 Identities=20% Similarity=0.301 Sum_probs=207.7
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
....++|.+++.||+|+||.||+|........+..||+|++.... ......+.+.+|+.++++++ ||||+++++++.+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 107 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN-SSQREIEEFLSEAACMKDFS-HPNVIRLLGVCIE 107 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C-CCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEC
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc-cchhHHHHHHHHHHHHhcCC-CCCeeeeeEEEee
Confidence 344678999999999999999999887655567799999986543 34455678899999999998 9999999999987
Q ss_pred CC-----eeEEEeeecCCCChHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCc
Q 007253 231 TD-----NVYVVMELCEGGELLDRILS-----RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS 300 (611)
Q Consensus 231 ~~-----~~~lv~E~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~ 300 (611)
.+ ..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML---RDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE---CTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCC
Confidence 55 35999999999999998853 23569999999999999999999999999999999999999 5778
Q ss_pred eEEEeecccccccCCCC---cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 007253 301 VLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLK 375 (611)
Q Consensus 301 ~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~ 375 (611)
.+||+|||++....... ......+++.|+|||++. ..++.++|||||||++|+|++ |..||...........+..
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 264 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc
Confidence 89999999998765432 123346788999999986 568999999999999999999 9999988888777777766
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 376 ADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 376 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
..... ....++.++.+||.+||..||.+|||+.+++++
T Consensus 265 ~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 265 GHRLK---QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp TCCCC---CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCC---CCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 54221 224689999999999999999999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=382.72 Aligned_cols=256 Identities=25% Similarity=0.398 Sum_probs=200.1
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
..+|.+.+.||+|+||.||.... .+|+.||||++...... .+.+|+.+++.+.+|||||++++++.+.+.
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~----~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 92 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGM----FDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQF 92 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEE----SSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTE
T ss_pred cEEEecCCeeecCcCEEEEEEEE----eCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCE
Confidence 35699999999999998764332 25899999998654322 256899999999569999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccC--CCceEEEeeccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD--ENSVLKAIDFGLSD 311 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~--~~~~vkl~DfG~a~ 311 (611)
+|||||||. |+|.+++......+.+..++.++.||+.||.|||++|||||||||+|||++..+ ....+||+|||+++
T Consensus 93 ~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 93 QYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred EEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 999999996 599999987766677777889999999999999999999999999999996432 23458899999998
Q ss_pred ccCCCC----cccccccCCCcCcchhhc----CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCC
Q 007253 312 FVRPDE----RLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDE 382 (611)
Q Consensus 312 ~~~~~~----~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~ 382 (611)
...... .....+||+.|+|||++. ..++.++|||||||++|+|++ |..||......... .+ ........
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~-~~~~~~~~ 249 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-IL-LGACSLDC 249 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HH-TTCCCCTT
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HH-hccCCccc
Confidence 765432 334568999999999985 346789999999999999999 99999655443322 22 22211111
Q ss_pred -CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 383 -APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 383 -~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
......+..+.+||.+||+.||.+|||+.++++||||...
T Consensus 250 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 1112345678999999999999999999999999999763
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=370.76 Aligned_cols=253 Identities=20% Similarity=0.301 Sum_probs=207.4
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCc-cCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGEL-KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
.++|++++.||+|+||.||+|++..... ....||+|++..... ......+.+|+.++++++ ||||+++++++. ++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLD-HAHIVRLLGLCP-GS 87 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCC-CTTBCCEEEEEC-BS
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCC-CCCcCeEEEEEc-CC
Confidence 4689999999999999999999765211 123478888754321 122345678999999997 999999999886 56
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
..++||||+.+|+|.+++......+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+++.
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADL 164 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE---SSSSCEEECSCSGGGG
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE---CCCCeEEECCCCcccc
Confidence 6899999999999999998766689999999999999999999999999999999999999 5778899999999987
Q ss_pred cCCCC---cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 007253 313 VRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (611)
Q Consensus 313 ~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (611)
..... ......||+.|+|||++. +.++.++|||||||++|+|++ |+.||.+.....+...+......... ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 241 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP---QI 241 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC---TT
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC---Cc
Confidence 75433 234457888999999986 679999999999999999999 99999988777777666654322211 24
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
++.++.+||.+||..||.+|||+.++++|
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 242 CTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp BCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 67788999999999999999999999876
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=374.43 Aligned_cols=261 Identities=16% Similarity=0.222 Sum_probs=198.3
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCc--cCcEEEEEEecCCCcCCHHH--------HHHHHHHHHHHHHhcCCCCe
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGEL--KGQQVAVKVIPKHKMTTAIA--------IEDVRREVKILRALTGHNNL 221 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~--~g~~vavK~~~~~~~~~~~~--------~~~~~~E~~~l~~l~~h~~i 221 (611)
...++|++++.||+|+||.||+|.+..+.. .++.||||++.......... ...+..|+..++.+. ||||
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~~i 110 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLK-YLGV 110 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCS-CCCS
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhcc-CCCC
Confidence 345689999999999999999998876421 46899999986542110000 011223444455555 9999
Q ss_pred eEEEEEEeeC----CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccC
Q 007253 222 VKFFDAYEDT----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD 297 (611)
Q Consensus 222 v~l~~~~~~~----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~ 297 (611)
+++++++... ...||||||| ||+|.+++......+++..++.|+.||+.||.|||++|||||||||+|||++. +
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~-~ 188 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-K 188 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES-S
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec-C
Confidence 9999998875 4589999999 99999999887778999999999999999999999999999999999999953 2
Q ss_pred CCceEEEeecccccccCCCCc--------ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHH
Q 007253 298 ENSVLKAIDFGLSDFVRPDER--------LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESG 368 (611)
Q Consensus 298 ~~~~vkl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~ 368 (611)
.++.+||+|||+++.+..... ....+||+.|+|||++. ..++.++|||||||++|||++|+.||.+.....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 567899999999987653321 13456999999999987 458999999999999999999999997543322
Q ss_pred HHHHHHhcC--CCCC-----CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 369 IFRAVLKAD--PSFD-----EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 369 ~~~~i~~~~--~~~~-----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
......... .... ......++.++.+||..||..||.+||++.+|++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 211111100 0000 0011367899999999999999999999998864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=362.40 Aligned_cols=254 Identities=22% Similarity=0.355 Sum_probs=209.9
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCC-ccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..+|.+.+.||+|+||.||+|...... ..+..||||++... ........+.+|+.+++++. ||||+++++++.+.+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYK 119 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC--CCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecCC
Confidence 568999999999999999999877532 13457999998654 23445567899999999997 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
..+||||||++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC---
T ss_pred CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE---CCCCcEEECCCCcchh
Confidence 9999999999999999998777789999999999999999999999999999999999999 5778899999999987
Q ss_pred cCCCCc----ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 007253 313 VRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 313 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (611)
...... .....+|+.|+|||++. ..++.++|||||||++|+|++ |+.||......+....+..... .+ ...
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~-~~--~~~ 273 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-LP--TPM 273 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-CC--CCT
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc-CC--Ccc
Confidence 653321 22335678999999986 568999999999999999998 9999998888877777665432 11 124
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
.++..+.++|.+||+.||.+||++.+++++
T Consensus 274 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 274 DCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp TCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 689999999999999999999999998764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=357.49 Aligned_cols=253 Identities=22% Similarity=0.316 Sum_probs=209.6
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe-eCC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE-DTD 232 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~-~~~ 232 (611)
..+|++.+.||+|+||.||+|...........||+|.+... ......+.+.+|+.++++++ ||||+++++++. .++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEG 100 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCC-CCCEeeeeeEEEcCCC
Confidence 35699999999999999999997664445567999998653 34556678999999999997 999999999865 456
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
..++||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARD 177 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSCGGGCC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---CCCCCEEECccccccc
Confidence 8899999999999999998777779999999999999999999999999999999999999 5778899999999987
Q ss_pred cCCCC-----cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 007253 313 VRPDE-----RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPW 385 (611)
Q Consensus 313 ~~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (611)
..... ......||+.|+|||++. ..++.++|||||||++|+|++ |.+||......+....+.........
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 254 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP--- 254 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC---
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC---
Confidence 65332 123456788999999886 668999999999999999999 66777776666666666655433322
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
..++..+.++|.+||+.||.+|||+.++++
T Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 357899999999999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=354.58 Aligned_cols=250 Identities=22% Similarity=0.366 Sum_probs=215.1
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
...++|++.+.||+|+||.||+|.+.. .+..||+|++.... ...+.+.+|+.++++++ ||||+++++++.++
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTRE 81 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGG---GTEEEEEEEECSCS----THHHHHHHHHHHHHHCC-CTTBCCEEEEECSS
T ss_pred ccccceeEEeecCCCCceeEEEeEecC---CCEEEEEEecCcCH----HHHHHHHHHHHHHHhCC-CCCEeeEEEEEccC
Confidence 346789999999999999999999876 58999999986432 24567889999999998 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
+.+++||||++||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~ 158 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLS 158 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE---CGGGCEEECCCCGG
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE---cCCCCEEEccCccc
Confidence 99999999999999999987643 459999999999999999999999999999999999999 56778999999999
Q ss_pred cccCCCC--cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 007253 311 DFVRPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 311 ~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (611)
....... ......+|+.|+|||++. ..++.++|||||||++|+|++ |..||...........+...... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~ 235 (288)
T 3kfa_A 159 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPE 235 (288)
T ss_dssp GTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---CCCT
T ss_pred eeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC---CCCC
Confidence 8765443 223456788999999886 678999999999999999999 99999888777766666554221 2224
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 387 SLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
.+++.+.+||.+||..||.+|||+.++++
T Consensus 236 ~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 236 GCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 68999999999999999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=363.56 Aligned_cols=256 Identities=24% Similarity=0.341 Sum_probs=214.1
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCC--ccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
..++|++++.||+|+||.||+|...... ..+..||+|++... ......+.+.+|+.++++|.+||||+++++++.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc--cChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 4578999999999999999999876521 13468999998654 2344567889999999999459999999999999
Q ss_pred CCeeEEEeeecCCCChHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccC
Q 007253 231 TDNVYVVMELCEGGELLDRILSR-------------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD 297 (611)
Q Consensus 231 ~~~~~lv~E~~~~gsL~~~l~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~ 297 (611)
.+.+++|||||++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL---T 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE---E
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE---C
Confidence 99999999999999999998754 3458999999999999999999999999999999999999 4
Q ss_pred CCceEEEeecccccccCCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 007253 298 ENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRA 372 (611)
Q Consensus 298 ~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~ 372 (611)
.++.+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.+.........
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 278 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence 677899999999986643322 23456788999999886 678999999999999999998 9999988766665555
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 373 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
+......... ...++..+.+||.+||+.||.+|||+.++++
T Consensus 279 ~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 279 LVKDGYQMAQ--PAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcCCCCCC--CCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 5554433222 2357899999999999999999999999976
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=379.63 Aligned_cols=258 Identities=26% Similarity=0.424 Sum_probs=211.9
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
...++|++++.||+|+||.||+|++.. +|+.||||++..... ....+.+.+|+.++++++ ||||+++++++.+.
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~ 79 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKK---TGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEET 79 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECT
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECC---CCcEEEEEEeccccc--cchHHHHHHHHHHHHhcC-CCCCCeEEEeeccC
Confidence 456789999999999999999999776 689999999965332 223466789999999998 99999999999876
Q ss_pred C--eeEEEeeecCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEec-cCCCceEEEee
Q 007253 232 D--NVYVVMELCEGGELLDRILSRG--GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT-KDENSVLKAID 306 (611)
Q Consensus 232 ~--~~~lv~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~-~~~~~~vkl~D 306 (611)
+ ..++|||||++|+|.+++.... ..+++..++.++.||+.||.|||++|||||||||+|||+.. .+.++.+||+|
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (396)
T 4eut_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (396)
T ss_dssp TTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred CCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEec
Confidence 5 7899999999999999886543 23999999999999999999999999999999999999843 24567899999
Q ss_pred cccccccCCCCcccccccCCCcCcchhhc---------CCCCCcchhhHHHHHHHHHHhCCCCCCC----CChHHHHHHH
Q 007253 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH---------RSYSTEADVWSIGVIAYILLCGSRPFWA----RTESGIFRAV 373 (611)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwSlGvil~el~~g~~Pf~~----~~~~~~~~~i 373 (611)
||++............+||+.|+|||++. ..++.++|||||||++|||++|+.||.. ....+.+..+
T Consensus 160 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 239 (396)
T 4eut_A 160 FGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (396)
T ss_dssp GGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred CCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence 99998877666666778999999999875 3577899999999999999999999964 3344566666
Q ss_pred HhcCCCCCC---------------------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 374 LKADPSFDE---------------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 374 ~~~~~~~~~---------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
....+.... .....++..+.+||++||+.||++|||+.++++
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 665432110 000124567889999999999999999998754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=381.73 Aligned_cols=249 Identities=22% Similarity=0.373 Sum_probs=214.2
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
...+|++.+.||+|+||.||+|.+.. .+..||||++..... ..+.+.+|+.+|++|+ |||||++++++.+.+
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~---~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLLGVCTREP 289 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGG---GTEEEEEEECCSSSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcC---CCeEEEEEEecCccc----chHHHHHHHHHHHhcC-CCCEeeEEEEEecCC
Confidence 45789999999999999999999876 588999999965432 2467899999999997 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
.++||||||++|+|.+++.... ..+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+++
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~ 366 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLSR 366 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEE
T ss_pred cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE---CCCCcEEEeecccce
Confidence 9999999999999999997643 459999999999999999999999999999999999999 567889999999998
Q ss_pred ccCCCC--cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 007253 312 FVRPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (611)
Q Consensus 312 ~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (611)
...... ......+++.|+|||++. +.++.++|||||||++|||++ |..||.+....++...+.... .. .....
T Consensus 367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~ 443 (495)
T 1opk_A 367 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-RM--ERPEG 443 (495)
T ss_dssp CCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-CC--CCCTT
T ss_pred eccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CC--CCCCC
Confidence 765432 223345678999999986 668999999999999999999 999999888777666655432 11 22246
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
++.++.+||.+||+.||.+|||+.++++
T Consensus 444 ~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 444 CPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 8999999999999999999999999975
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=354.30 Aligned_cols=252 Identities=23% Similarity=0.305 Sum_probs=209.8
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
-.|.+++.||+|+||.||+|.+......+..||+|++... ......+.+.+|+.++++++ ||||+++++++.+.+..
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 97 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLN-HPNVLALIGIMLPPEGL 97 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSSC
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEecCCCC
Confidence 4578889999999999999998765445568999998653 34556678899999999997 99999999999877655
Q ss_pred -EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 235 -YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 235 -~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
++||||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLARDI 174 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECCTTSSCTT
T ss_pred cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEEeCcCCCcccc
Confidence 99999999999999998777789999999999999999999999999999999999999 57778999999999865
Q ss_pred CCCC-----cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCC-CCCCChHHHHHHHHhcCCCCCCCCCC
Q 007253 314 RPDE-----RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRP-FWARTESGIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 314 ~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~P-f~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (611)
.... ......+|+.|+|||++. ..++.++|||||||++|+|++|..| |...........+...... + ...
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~--~~~ 251 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL-P--QPE 251 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC-C--CCT
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC-C--CCc
Confidence 4322 233457889999999987 4689999999999999999995554 5555555555555444322 1 124
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 387 SLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
.++..+.+||.+||+.||.+|||+.++++
T Consensus 252 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 252 YCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 67899999999999999999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=375.01 Aligned_cols=257 Identities=29% Similarity=0.443 Sum_probs=199.0
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+.+.|.+.+.||+|+||.||.+.. .+|+.||||++... ..+.+.+|+.+++++.+|||||++++++.++
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~~~----~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 81 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQGS----FQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTD 81 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEEEE----SSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred hhhheeeccCeEeeCCCeEEEEEEE----ECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 3456788889999999999986532 25899999998542 2345789999999885699999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCC------CCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEecc---------
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGK------YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK--------- 296 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~------l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~--------- 296 (611)
+.+|||||||. |+|.+++...... .++..++.++.||+.||.|||++|||||||||+|||++..
T Consensus 82 ~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~ 160 (434)
T 2rio_A 82 RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQT 160 (434)
T ss_dssp SEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTT
T ss_pred CeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccccc
Confidence 99999999995 6999988654321 1333467899999999999999999999999999999643
Q ss_pred -CCCceEEEeecccccccCCCCc-----ccccccCCCcCcchhhc--------CCCCCcchhhHHHHHHHHHHh-CCCCC
Q 007253 297 -DENSVLKAIDFGLSDFVRPDER-----LNDIVGSAYYVAPEVLH--------RSYSTEADVWSIGVIAYILLC-GSRPF 361 (611)
Q Consensus 297 -~~~~~vkl~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~--------~~~~~~~DiwSlGvil~el~~-g~~Pf 361 (611)
+.++.+||+|||++........ ....+||+.|+|||++. +.++.++|||||||++|||++ |+.||
T Consensus 161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf 240 (434)
T 2rio_A 161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240 (434)
T ss_dssp CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence 2456899999999987754331 23468999999999985 358899999999999999998 99999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCC---CCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCC
Q 007253 362 WARTESGIFRAVLKADPSFDEAP---WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 362 ~~~~~~~~~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
....... ..+.......+... ...++.++.+||.+||+.||.+|||+.++++||||..
T Consensus 241 ~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 241 GDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp CSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred CCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 7655443 34444443332221 1234688999999999999999999999999999975
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=355.22 Aligned_cols=254 Identities=24% Similarity=0.376 Sum_probs=205.9
Q ss_pred CCceeEeCeeeeccceEEEEEEEec-CCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC-
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~- 231 (611)
..+|++++.||+|+||.||+|++.. +...++.||||++.... .....+.+.+|+.++++++ ||||+++++++.+.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTEDG 96 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC--
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCeeeeeeEEecCC
Confidence 5679999999999999999998542 22368999999996543 2234567899999999998 99999999999876
Q ss_pred -CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 232 -DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 232 -~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
..+++||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLT 173 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTC
T ss_pred CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEc---CCCCEEECccccc
Confidence 678999999999999999977777899999999999999999999999999999999999994 5678999999999
Q ss_pred cccCCCC----cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCC--------------ChHHHHH
Q 007253 311 DFVRPDE----RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWAR--------------TESGIFR 371 (611)
Q Consensus 311 ~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~--------------~~~~~~~ 371 (611)
....... ......||..|+|||++. ..++.++|||||||++|+|++|..|+... .......
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 8775443 233457888999999886 56889999999999999999999886321 1111222
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 372 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
.........+ ....+++++.+||.+||+.||.+|||+.++++
T Consensus 254 ~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 254 NTLKEGKRLP--CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHTTCCCC--CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHhccCCCC--CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 2222222222 23578999999999999999999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=378.64 Aligned_cols=248 Identities=25% Similarity=0.409 Sum_probs=211.9
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
...++|++.+.||+|+||.||+|.... +..||||++..... ..+.+.+|+.++++|+ |||||++++++. .
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~iv~l~~~~~-~ 254 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNK----HTKVAVKTMKPGSM----SVEAFLAEANVMKTLQ-HDKLVKLHAVVT-K 254 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETT----TEEEEEEEECTTSB----CHHHHHHHHHHHTTCC-CTTBCCEEEEEC-S
T ss_pred echHHeEEEEEcccCCceEEEEEEECC----ccEEEEEEecCCCc----cHHHHHHHHHHHhhCC-CCCEeeEEEEEe-C
Confidence 346789999999999999999998753 67899999965432 3567899999999997 999999999986 6
Q ss_pred CeeEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
+.++||||||++|+|.+++.... ..+++..++.++.||+.||.|||+++||||||||+|||+ +.++.+||+|||++
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a 331 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLA 331 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTCCEEECSTTGG
T ss_pred CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE---CCCCcEEEeeCCCc
Confidence 67999999999999999987543 368999999999999999999999999999999999999 57788999999999
Q ss_pred cccCCCC--cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 007253 311 DFVRPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 311 ~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (611)
+...... ......+|+.|+|||++. +.++.++|||||||++|||++ |+.||.+....++...+..... .+ ...
T Consensus 332 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-~~--~~~ 408 (454)
T 1qcf_A 332 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR-MP--RPE 408 (454)
T ss_dssp GGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC-CC--CCT
T ss_pred eEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CC--CCC
Confidence 8765332 123345678899999986 779999999999999999999 9999999888888777766432 22 124
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 387 SLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
.+++++.+||.+||+.||.+|||+.++++
T Consensus 409 ~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 409 NCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 68999999999999999999999999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=363.09 Aligned_cols=252 Identities=20% Similarity=0.286 Sum_probs=203.7
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCc-cCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGEL-KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
.++|++++.||+|+||.||+|++..... ....||+|.+.... .....+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTST 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCC-BTTBCCCCEEEESSS
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEecCC
Confidence 5789999999999999999999765211 12245777765432 2234567889999999997 999999999998765
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.++|+||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKL 166 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTC---
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEE---cCCCCEEEccCcceeE
Confidence 889999999999999998887889999999999999999999999999999999999999 4667899999999987
Q ss_pred cCCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 007253 313 VRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (611)
Q Consensus 313 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (611)
...... .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.+.....+...+...... + ....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~ 243 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-P--QPPI 243 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-C--CCTT
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-C--CCcc
Confidence 654332 23345688999999886 668999999999999999999 99999888877766666554322 2 1246
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
++.++.+||.+||..||.+|||+.++++
T Consensus 244 ~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 244 CTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8999999999999999999999999876
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=349.22 Aligned_cols=246 Identities=18% Similarity=0.252 Sum_probs=210.3
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC--
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT-- 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~-- 231 (611)
.++|++.+.||+|+||.||+|++ .|+.||||++.... ......+.+.+|+.++++++ ||||+++++++.+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~avK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-----QGNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFS-HPNVLPVLGACQSPPA 81 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-----TTEEEEEEEECCTT-CCHHHHHHHHHHGGGGCCCS-CTTEECEEEEECTTTS
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-----CCeeEEEEEecccc-cCHHHHHHHHHHHHHHHhcC-CCchhheEEEEccCCC
Confidence 46799999999999999999986 37889999997643 34455677999999999997 99999999999887
Q ss_pred CeeEEEeeecCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcC--CeeecCCCCceEEeccCCCceEEEeecc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSVLKAIDFG 308 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NIll~~~~~~~~vkl~DfG 308 (611)
+..++||||+++|+|.+++..... .+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~ 158 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMAD 158 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGG
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE---cCCcceeEEecc
Confidence 789999999999999999876543 5899999999999999999999999 9999999999999 577889999998
Q ss_pred cccccCCCCcccccccCCCcCcchhhcCC-C---CCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 007253 309 LSDFVRPDERLNDIVGSAYYVAPEVLHRS-Y---STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384 (611)
Q Consensus 309 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~---~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 384 (611)
++.... .....||+.|+|||++.+. + +.++|||||||++|+|++|+.||...........+........ .
T Consensus 159 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~ 232 (271)
T 3kmu_A 159 VKFSFQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT--I 232 (271)
T ss_dssp SCCTTS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC--C
T ss_pred ceeeec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC--C
Confidence 875533 2345789999999998643 3 3379999999999999999999998888877777766543322 2
Q ss_pred CCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 385 ~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
...++.++.+||.+||+.||.+|||+.++++
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 3468999999999999999999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=372.07 Aligned_cols=253 Identities=22% Similarity=0.311 Sum_probs=203.5
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee-CCe
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-TDN 233 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~-~~~ 233 (611)
..|++.+.||+|+||.||+|........+..||+|.+... ......+.+.+|+.++++++ ||||+++++++.. ++.
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGS 165 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCC-CTTBCCCCEEECCCSSC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCCC
Confidence 4589999999999999999998764334567999998643 33455678999999999997 9999999998764 567
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
.++|||||++|+|.+++......+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+++..
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDM 242 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE---CCCCCEEEeeccccccc
Confidence 899999999999999998777779999999999999999999999999999999999999 57788999999999866
Q ss_pred CCCC-----cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 007253 314 RPDE-----RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 314 ~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (611)
.... ......+|+.|+|||++. +.++.++|||||||++|||++ |.+||......+....+........ ..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~---p~ 319 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---PE 319 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCC---CT
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCC---CC
Confidence 4332 123346788999999886 678999999999999999999 7888877766666666655443222 24
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
.++..+.++|.+||+.||.+|||+.+++++
T Consensus 320 ~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 320 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 679999999999999999999999999864
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=368.08 Aligned_cols=255 Identities=20% Similarity=0.326 Sum_probs=206.0
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
...++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++ ||||+++++++.+.
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLR----DGAKVALKRRTPES---SQGIEEFETEIETLSFCR-HPHLVSLIGFCDER 107 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECT----TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCC-CTTBCCEEEECCCT
T ss_pred HHHhccCccceeecCCCeeEEEEEEC----CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCC
Confidence 35678999999999999999999853 48899999986542 234577899999999997 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecc
Q 007253 232 DNVYVVMELCEGGELLDRILSRG---GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG 308 (611)
+..++|||||++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE---CTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE---CCCCCEEEeecc
Confidence 99999999999999998875443 258999999999999999999999999999999999999 677889999999
Q ss_pred cccccCCCC---cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHH-----HHhcCCC
Q 007253 309 LSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRA-----VLKADPS 379 (611)
Q Consensus 309 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~-----i~~~~~~ 379 (611)
++....... ......||+.|+|||++. +.++.++|||||||++|+|++|+.||........... .......
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 997654222 234457999999999885 6799999999999999999999999976433221100 0111111
Q ss_pred C--------CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCc
Q 007253 380 F--------DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHP 417 (611)
Q Consensus 380 ~--------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp 417 (611)
+ .....+..+..+.+++.+||+.||++|||+.+++++-
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 1 1111123456789999999999999999999998764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=353.56 Aligned_cols=254 Identities=21% Similarity=0.281 Sum_probs=205.3
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCC-eeEEEEEEee
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN-LVKFFDAYED 230 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~-iv~l~~~~~~ 230 (611)
.+.++|++++.||+|+||.||+|+... +|+.||||++...... +.+.+|+.+++.+. |++ +..+..++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~-~~~~i~~~~~~~~~ 76 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKTKH-----PQLHIESKIYKMMQ-GGVGIPTIRWCGAE 76 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEEESCSSC-----CHHHHHHHHHHHHT-TSTTCCCEEEEEEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcC---CCcEEEEEEecCCcch-----hHHHHHHHHHHHhh-cCCCCCccccccCC
Confidence 356889999999999999999999765 6899999998654322 34789999999998 555 5555555567
Q ss_pred CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 231 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
.+..++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 155 (296)
T 3uzp_A 77 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred CCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence 78899999999 89999999877778999999999999999999999999999999999999964456778999999999
Q ss_pred cccCCCCc--------ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCC
Q 007253 311 DFVRPDER--------LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE---SGIFRAVLKADP 378 (611)
Q Consensus 311 ~~~~~~~~--------~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~---~~~~~~i~~~~~ 378 (611)
........ .....||+.|+|||++. ..++.++|||||||++|+|++|+.||..... ...+..+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 3uzp_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence 87654322 24568999999999987 4689999999999999999999999976322 223333332211
Q ss_pred CCC-CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 379 SFD-EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 379 ~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
..+ ......+++++.+||.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 111 1112467899999999999999999999999865
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=355.46 Aligned_cols=242 Identities=33% Similarity=0.631 Sum_probs=194.6
Q ss_pred cCCceeEe-CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee-
Q 007253 153 FANKYELG-EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED- 230 (611)
Q Consensus 153 ~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~- 230 (611)
+.++|.+. +.||+|+||.||+|.... +++.||||++... ..+.+|+.++.++.+||||+++++++..
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 83 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL 83 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcC---CCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence 45668877 789999999999999766 6899999998532 3567899998666669999999999987
Q ss_pred ---CCeeEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEee
Q 007253 231 ---TDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (611)
Q Consensus 231 ---~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D 306 (611)
...+++|||||++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence 678999999999999999998764 3699999999999999999999999999999999999996544478899999
Q ss_pred cccccccCCCCcccccccCCCcCcchhhcCCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHh----cCCCCCC
Q 007253 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK----ADPSFDE 382 (611)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~----~~~~~~~ 382 (611)
||++..... ..++.++|||||||++|+|++|+.||...........+.. ....++.
T Consensus 164 fg~a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (299)
T 3m2w_A 164 FGFAKETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 223 (299)
T ss_dssp CTTCEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCH
T ss_pred ccccccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCc
Confidence 999865431 3467789999999999999999999976554332111111 1111111
Q ss_pred CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCC
Q 007253 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (611)
Q Consensus 383 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~ 425 (611)
..+..++.++.+||.+||+.||.+|||+.++|+||||+.....
T Consensus 224 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~ 266 (299)
T 3m2w_A 224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 266 (299)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGS
T ss_pred hhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccC
Confidence 1124689999999999999999999999999999999876543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=375.49 Aligned_cols=243 Identities=26% Similarity=0.407 Sum_probs=207.0
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC-
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD- 232 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~- 232 (611)
.++|++.+.||+|+||.||+|.. .|+.||||++.... ..+.+.+|+.++++|+ ||||+++++++.+.+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~-----~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 260 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY-----RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKG 260 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-----TTEEEEEEEESSCT-----TSHHHHHHHHHHHTCC-CTTBCCEEEEEECTTS
T ss_pred hHHeEEEeeecCcCCeeEEEEEe-----cCCeEEEEEeCCch-----HHHHHHHHHHHHHhcc-CCCEEEEEEEEEcCCC
Confidence 56899999999999999999975 36799999996542 3357889999999997 999999999987765
Q ss_pred eeEEEeeecCCCChHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGK-YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
.+|||||||++|+|.+++...... +++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+++
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~ 337 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTK 337 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTSCEEECCCTTCE
T ss_pred ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---CCCCCEEEeeCCCcc
Confidence 799999999999999999876543 7999999999999999999999999999999999999 577889999999998
Q ss_pred ccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 312 FVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
..... .....+++.|+|||++. +.++.++|||||||++|||++ |+.||......+....+..... . .....++
T Consensus 338 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-~--~~p~~~~ 412 (450)
T 1k9a_A 338 EASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-M--DAPDGCP 412 (450)
T ss_dssp ECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC-C--CCCTTCC
T ss_pred ccccc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-C--CCCCcCC
Confidence 65322 22346788999999986 668999999999999999998 9999988877777776665432 1 1224689
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
+++.+||.+||+.||.+|||+.++++
T Consensus 413 ~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 413 PAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=354.73 Aligned_cols=249 Identities=27% Similarity=0.456 Sum_probs=210.5
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
..+..+|++++.||+|+||.||+|+... +|+.||+|++.... +.+.+|+.++++++ ||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-------~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 75 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRI---DGKTYVIKRVKYNN-------EKAEREVKALAKLD-HVNIVHYNGCWDG 75 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETT---TCCEEEEEEEECCS-------GGGHHHHHHHHHCC-CTTBCCEEEEEEE
T ss_pred chhccccceeeeeccCCceEEEEEEEcC---CCeEEEEEEecccc-------HHHHHHHHHHHhCC-CCCEEEEeeeEec
Confidence 4566789999999999999999999765 58999999996542 24678999999997 9999999998865
Q ss_pred ----------------CCeeEEEeeecCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEE
Q 007253 231 ----------------TDNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLF 293 (611)
Q Consensus 231 ----------------~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll 293 (611)
...+++|||||++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 155 (284)
T 2a19_B 76 FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL 155 (284)
T ss_dssp EEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred cccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEE
Confidence 45589999999999999998764 3579999999999999999999999999999999999999
Q ss_pred eccCCCceEEEeecccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 007253 294 TTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRA 372 (611)
Q Consensus 294 ~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~ 372 (611)
+ .++.+||+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||... ......
T Consensus 156 ~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~ 230 (284)
T 2a19_B 156 V---DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTD 230 (284)
T ss_dssp E---ETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHH
T ss_pred c---CCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHH
Confidence 4 66789999999998876655556678999999999886 56899999999999999999999997432 222333
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCC
Q 007253 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 373 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
+.... + ...++..+.+||.+||+.||.+|||+.++++|.|.-.
T Consensus 231 ~~~~~--~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 231 LRDGI--I----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHTTC--C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred hhccc--c----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 32221 1 1357899999999999999999999999999987643
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=348.71 Aligned_cols=247 Identities=23% Similarity=0.382 Sum_probs=209.3
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|++++.||+|+||.||+|... .+..||||++..... ..+.+.+|+.++++++ ||||+++++++. .+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~ 80 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN----GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRLYAVVT-QE 80 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEEC-SS
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc----CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCC-CcCcceEEEEEc-CC
Confidence 3578999999999999999999854 367899999865432 2357889999999997 999999999986 45
Q ss_pred eeEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~ 157 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLAR 157 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCE
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE---cCCCCEEECCCcccc
Confidence 6899999999999999885432 269999999999999999999999999999999999999 577889999999998
Q ss_pred ccCCCC--cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 007253 312 FVRPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (611)
Q Consensus 312 ~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (611)
...... ......+++.|+|||++. +.++.++|||||||++|+|++ |+.||.+....+....+....... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 234 (279)
T 1qpc_A 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV---RPDN 234 (279)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTT
T ss_pred cccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCC---Cccc
Confidence 765433 223446788999999986 668999999999999999999 999999888887777776543221 2246
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
++.++.+||.+||..||++|||+.++++
T Consensus 235 ~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 235 CPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 8999999999999999999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=355.54 Aligned_cols=255 Identities=22% Similarity=0.290 Sum_probs=200.4
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+.++|++++.||+|+||.||+|+... +++.||||++...... ..+.+|+.+++.+.+|++|..+..++...
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEG 77 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcC---CCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCC
Confidence 356789999999999999999998765 6899999987543322 34778999999998444455555555778
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+..++||||+ +|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++.
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 78 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred CceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 8899999999 899999998777789999999999999999999999999999999999999654567789999999998
Q ss_pred ccCCCCc--------ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhcCCC
Q 007253 312 FVRPDER--------LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES---GIFRAVLKADPS 379 (611)
Q Consensus 312 ~~~~~~~--------~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~---~~~~~i~~~~~~ 379 (611)
....... .....||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.... ..+..+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence 7654322 23568999999999987 46899999999999999999999999764322 222222222111
Q ss_pred CC-CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 380 FD-EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 380 ~~-~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
.+ ......+++++.+||.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 11 1112357899999999999999999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=360.10 Aligned_cols=254 Identities=23% Similarity=0.363 Sum_probs=208.5
Q ss_pred CCceeEeCeeeeccceEEEEEEEec-CCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe--e
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE--D 230 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~--~ 230 (611)
.++|++++.||+|+||.||+|++.. +...++.||||++... .....+.+.+|+.++++++ ||||+++++++. +
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALH-SDFIVKYRGVSYGPG 97 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCC
Confidence 4689999999999999999998642 2236899999998653 4455677899999999997 999999999987 4
Q ss_pred CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 231 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
...+++|||||++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV---ESEAHVKIADFGLA 174 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCGGGC
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEE---CCCCCEEEcccccc
Confidence 567999999999999999998766679999999999999999999999999999999999999 46778999999999
Q ss_pred cccCCCC----cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChH--------------HHHH
Q 007253 311 DFVRPDE----RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES--------------GIFR 371 (611)
Q Consensus 311 ~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~--------------~~~~ 371 (611)
....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||...... ....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 8765433 223456888999999886 55889999999999999999999998543321 1112
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 372 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
......... .....+++++.+||.+||+.||.+|||+.+++++
T Consensus 255 ~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 255 ELLEEGQRL--PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhhcccCC--CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 222222222 2235789999999999999999999999999654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=350.44 Aligned_cols=251 Identities=22% Similarity=0.327 Sum_probs=208.0
Q ss_pred CCceeEeC-eeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 154 ANKYELGE-EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 154 ~~~y~~~~-~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..+|.+.+ .||+|+||.||+|.+... ..++.||||++.... ......+.+.+|+.+++.++ ||||+++++++ ..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMK-KVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLD-NPYIVRMIGIC-EAE 90 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECS-SSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEE-ESS
T ss_pred chhhhhccCccccccCeeeEeeeecCC-CceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE-CCC
Confidence 46799998 999999999999976432 257899999996543 23344678999999999997 99999999999 667
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
..++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKA 166 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCEE
T ss_pred CcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEe---CCCcEEEccCCccee
Confidence 789999999999999988664 5699999999999999999999999999999999999994 567899999999987
Q ss_pred cCCCCc----ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 007253 313 VRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 313 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (611)
...... .....+++.|+|||++. ..++.++|||||||++|+|++ |+.||......+....+....... ...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~ 243 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG---CPA 243 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCT
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---CCC
Confidence 654332 12235678899999986 568889999999999999999 999999888877776666543211 124
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 387 SLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
.++.++.++|.+||+.||.+|||+.++++
T Consensus 244 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 244 GCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 68999999999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=361.95 Aligned_cols=247 Identities=21% Similarity=0.304 Sum_probs=196.4
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC-
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD- 232 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~- 232 (611)
.++|++++.||+|+||.||+|+. .++.||||++... ........+|+.++++++ ||||+++++++.+..
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 92 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL-----LNEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMK-HENILQFIGAEKRGTS 92 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE-----TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECS
T ss_pred hhhchhhheecccCceEEEEEEE-----CCCEEEEEEeecC----chHHHHHHHHHHHHhcCC-CCCchhhcceeccCCC
Confidence 46899999999999999999975 3689999998542 223345667999999997 999999999998754
Q ss_pred ---eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc----------CCeeecCCCCceEEeccCCC
Q 007253 233 ---NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ----------GVVHRDLKPENFLFTTKDEN 299 (611)
Q Consensus 233 ---~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----------~iiHrDlkp~NIll~~~~~~ 299 (611)
.+++|||||++|+|.+++... .+++..++.++.||+.||.|||+. |||||||||+|||+ +.+
T Consensus 93 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~ 167 (322)
T 3soc_A 93 VDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNN 167 (322)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE---CTT
T ss_pred CCceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE---CCC
Confidence 479999999999999998654 599999999999999999999999 99999999999999 577
Q ss_pred ceEEEeecccccccCCCC---cccccccCCCcCcchhhcC------CCCCcchhhHHHHHHHHHHhCCCCCCCCCh----
Q 007253 300 SVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLHR------SYSTEADVWSIGVIAYILLCGSRPFWARTE---- 366 (611)
Q Consensus 300 ~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~------~~~~~~DiwSlGvil~el~~g~~Pf~~~~~---- 366 (611)
+.+||+|||+++...... .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+...
T Consensus 168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 247 (322)
T 3soc_A 168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247 (322)
T ss_dssp CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence 889999999998765433 2344689999999999864 355688999999999999999999965322
Q ss_pred ------------HHHHHHHHhcCCCCCCC-CC--CCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 367 ------------SGIFRAVLKADPSFDEA-PW--PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 367 ------------~~~~~~i~~~~~~~~~~-~~--~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
..+...+.......... .+ ...+.++.+||.+||+.||.+|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 12222222221111100 00 012356999999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=355.93 Aligned_cols=253 Identities=25% Similarity=0.363 Sum_probs=205.0
Q ss_pred cCCce-eEeCeeeeccceEEEEEEEec-CCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 153 FANKY-ELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 153 ~~~~y-~~~~~LG~G~fg~V~~~~~~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
+.++| ++++.||+|+||.||++.+.. ...+|+.||||++... ......+.+.+|+.++++++ ||||+++++++.+
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 104 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLY-HEHIIKYKGCCED 104 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEE
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCC-CcchhhEEEEEec
Confidence 44555 999999999999999987643 2236899999999754 34455678999999999998 9999999999988
Q ss_pred C--CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecc
Q 007253 231 T--DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (611)
Q Consensus 231 ~--~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG 308 (611)
. ..+++|||||++|+|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg 179 (318)
T 3lxp_A 105 AGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDFG 179 (318)
T ss_dssp TTTTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGG
T ss_pred CCCceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---cCCCCEEECCcc
Confidence 4 6789999999999999988543 59999999999999999999999999999999999999 577889999999
Q ss_pred cccccCCCCc----ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHH--------------H
Q 007253 309 LSDFVRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESG--------------I 369 (611)
Q Consensus 309 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~--------------~ 369 (611)
++........ .....||+.|+|||++. ..++.++|||||||++|+|++|..||....... .
T Consensus 180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 259 (318)
T 3lxp_A 180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259 (318)
T ss_dssp GCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHH
T ss_pred ccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHH
Confidence 9987754432 23456888999999986 568899999999999999999999996532210 1
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 370 FRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 370 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
.......... ......++.++.+||++||+.||.+|||+.++++
T Consensus 260 ~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 260 LTELLERGER--LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcccC--CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1122222222 2223468999999999999999999999999974
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=373.46 Aligned_cols=255 Identities=24% Similarity=0.389 Sum_probs=209.9
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|++.+.||+|+||.||+|.+.. +..||||++..... ..+.+.+|+.+|++|+ ||||+++++++.+ +
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-E 251 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT----TEEEEEEECCTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-S
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC----CceEEEEEeccCCC----CHHHHHHHHHHHHhCC-CCCEeeEEEEEcC-C
Confidence 45789999999999999999998754 56799999965432 2357899999999998 9999999999876 6
Q ss_pred eeEEEeeecCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 233 NVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
.++||||||++|+|.+++... ...+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+++
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~ 328 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLAR 328 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE---CCCCCEEECCCccce
Confidence 789999999999999998653 3469999999999999999999999999999999999999 567889999999998
Q ss_pred ccCCCCc--ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 007253 312 FVRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (611)
Q Consensus 312 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (611)
....... .....++..|+|||++. +.++.++|||||||++|||++ |+.||.+....++...+..... .+ ....
T Consensus 329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-~~--~~~~ 405 (452)
T 1fmk_A 329 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-MP--CPPE 405 (452)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-CC--CCTT
T ss_pred ecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CC--CCCC
Confidence 7653321 22345778999999886 679999999999999999999 9999998888887777765432 11 1246
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHc--CcccCCCC
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALS--HPWIKNSN 423 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~--hp~~~~~~ 423 (611)
+++.+.+||.+||+.||.+|||+.++++ +.++....
T Consensus 406 ~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 406 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 8999999999999999999999999986 36665443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=382.72 Aligned_cols=250 Identities=21% Similarity=0.342 Sum_probs=207.4
Q ss_pred CCceeEeC-eeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 154 ANKYELGE-EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 154 ~~~y~~~~-~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
.+++.+.+ +||+|+||.||+|.+.... .+..||||++.... .....+.+.+|+++|++|+ |||||++++++.+ +
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-E 408 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSS-CEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCC-CTTBCCEEEEEES-S
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCC-CcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEecc-C
Confidence 34566666 8999999999999876422 46789999997542 2234577899999999997 9999999999976 5
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.++||||||++|+|.+++......+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+|||+++.
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl---~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL---VNRHYAKISDFGLSKA 485 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCSTTTT
T ss_pred CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEE---cCCCcEEEeeccCccc
Confidence 6999999999999999987776779999999999999999999999999999999999999 4677899999999987
Q ss_pred cCCCCc----ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 007253 313 VRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 313 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (611)
+..... .....+|+.|+|||++. +.++.++|||||||++|||++ |+.||.+....++...+....... ...
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~ 562 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME---CPP 562 (613)
T ss_dssp CC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCC---CCT
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---CCC
Confidence 653322 12234568999999986 779999999999999999998 999999988888877776654211 124
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHH
Q 007253 387 SLSSEARDFVKRLLNKDPRKRLTAAQAL 414 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rpt~~~ll 414 (611)
.++.++.+||.+||+.||.+||++.+++
T Consensus 563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~ 590 (613)
T 2ozo_A 563 ECPPELYALMSDCWIYKWEDRPDFLTVE 590 (613)
T ss_dssp TCCHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 6899999999999999999999999975
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=358.67 Aligned_cols=251 Identities=22% Similarity=0.359 Sum_probs=203.0
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee---
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--- 230 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~--- 230 (611)
.++|++++.||+|+||.||+|+... +|+.||||++.. ......+.+.+|+.+++.+. ||||+++++++..
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 100 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLH---DGHFYALKRILC---HEQQDREEAQREADMHRLFN-HPNILRLVAYCLRERG 100 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETT---TCCEEEEEEEEE---SSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEEEET
T ss_pred CeEEEEEEEecCCCCeEEEEEEecC---CCcEEEEEEEec---CCHHHHHHHHHHHHHHhhcC-CCCeeeEEEEEEeccC
Confidence 5789999999999999999999765 689999999854 34456678899999999997 9999999999873
Q ss_pred -CCeeEEEeeecCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEee
Q 007253 231 -TDNVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (611)
Q Consensus 231 -~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D 306 (611)
....++||||+++|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~d 177 (317)
T 2buj_A 101 AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMD 177 (317)
T ss_dssp TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECC
T ss_pred CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---cCCCCEEEEe
Confidence 3478999999999999998876 35679999999999999999999999999999999999999 5777899999
Q ss_pred cccccccCCCCc----------ccccccCCCcCcchhhcC----CCCCcchhhHHHHHHHHHHhCCCCCCCCCh--HHHH
Q 007253 307 FGLSDFVRPDER----------LNDIVGSAYYVAPEVLHR----SYSTEADVWSIGVIAYILLCGSRPFWARTE--SGIF 370 (611)
Q Consensus 307 fG~a~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~DiwSlGvil~el~~g~~Pf~~~~~--~~~~ 370 (611)
||++........ .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||..... ....
T Consensus 178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 257 (317)
T 2buj_A 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257 (317)
T ss_dssp CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH
T ss_pred cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh
Confidence 999876532111 123467999999999863 268999999999999999999999953111 1111
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCc
Q 007253 371 RAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHP 417 (611)
Q Consensus 371 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp 417 (611)
. ........+ ..+.++.++.+||.+||+.||.+|||+.+++++-
T Consensus 258 ~-~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 258 L-AVQNQLSIP--QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp H-HHHCC--CC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred H-HhhccCCCC--ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 2 222222222 2356899999999999999999999999999863
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=366.65 Aligned_cols=259 Identities=20% Similarity=0.229 Sum_probs=197.1
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHH--------HHHHHHHHHHHHHHhcCCCCeeEE
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAI--------AIEDVRREVKILRALTGHNNLVKF 224 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~--------~~~~~~~E~~~l~~l~~h~~iv~l 224 (611)
..++|++++.||+|+||.||+|........+..||||++......... ....+.+|+.+++.+. ||||+++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~ni~~~ 113 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD-YLGIPLF 113 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS-CCCCCCE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc-ccCccee
Confidence 357899999999999999999998764446889999998754321100 1123557888888887 9999999
Q ss_pred EEEEee----CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCc
Q 007253 225 FDAYED----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS 300 (611)
Q Consensus 225 ~~~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~ 300 (611)
++++.+ ...+|+||||| +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+ ..+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~ 190 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK-NPD 190 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESS-STT
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccC-CCC
Confidence 999988 67899999999 999999876543 79999999999999999999999999999999999999642 223
Q ss_pred eEEEeecccccccCCCCc--------ccccccCCCcCcchhhcC-CCCCcchhhHHHHHHHHHHhCCCCCCCC--ChHHH
Q 007253 301 VLKAIDFGLSDFVRPDER--------LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWAR--TESGI 369 (611)
Q Consensus 301 ~vkl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~el~~g~~Pf~~~--~~~~~ 369 (611)
.+||+|||+++.+..... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+. .....
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 899999999987643321 245589999999999874 5899999999999999999999999653 22222
Q ss_pred HHHHHhcCCCCCC-----CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 370 FRAVLKADPSFDE-----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 370 ~~~i~~~~~~~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
...........+. .....++.++.+||.+||..||.+|||+.++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 271 QTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 2111111111111 001268899999999999999999999999876
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=358.33 Aligned_cols=248 Identities=23% Similarity=0.412 Sum_probs=187.4
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe----
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE---- 229 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~---- 229 (611)
..+|++.+.||+|+||.||+|++.. +|+.||||++... .....+.+.+|+.+++++.+||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 100 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVG---SGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred CceEEEEEEEccCCceEEEEEEECC---CCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence 4689999999999999999999766 6899999998543 34556778999999999977999999999994
Q ss_pred ----eCCeeEEEeeecCCCChHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeecCCCCceEEeccCCCce
Q 007253 230 ----DTDNVYVVMELCEGGELLDRILS--RGGKYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSV 301 (611)
Q Consensus 230 ----~~~~~~lv~E~~~~gsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NIll~~~~~~~~ 301 (611)
....+++||||+. |+|.+++.. ..+.+++..++.++.||+.||.|||+.| |+||||||+|||+ +.++.
T Consensus 101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~---~~~~~ 176 (337)
T 3ll6_A 101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGT 176 (337)
T ss_dssp TSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE---CTTSC
T ss_pred ccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE---CCCCC
Confidence 3445899999995 699998865 3456999999999999999999999999 9999999999999 56778
Q ss_pred EEEeecccccccCCCCcc-------------cccccCCCcCcchhhc----CCCCCcchhhHHHHHHHHHHhCCCCCCCC
Q 007253 302 LKAIDFGLSDFVRPDERL-------------NDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWAR 364 (611)
Q Consensus 302 vkl~DfG~a~~~~~~~~~-------------~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~el~~g~~Pf~~~ 364 (611)
+||+|||++......... ....||+.|+|||++. ..++.++|||||||++|+|++|+.||...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 999999999876543221 1456999999999873 45788999999999999999999999765
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCc
Q 007253 365 TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHP 417 (611)
Q Consensus 365 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp 417 (611)
....+.. .... .......+..+.+||.+||+.||.+|||+.++++|-
T Consensus 257 ~~~~~~~----~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 257 AKLRIVN----GKYS--IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp -------------CC--CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred hHHHhhc----Cccc--CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 4433222 2211 122245678899999999999999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=373.69 Aligned_cols=255 Identities=23% Similarity=0.283 Sum_probs=209.9
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+.++|+++++||+|+||.||+|++.. +++.||||++...... ..+.+|+++++.|.+|++|..+..++...
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~ 75 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEG 75 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETT---TCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEET
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECC---CCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeC
Confidence 456889999999999999999999765 6899999998654322 24778999999999667888888888888
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+..+|||||| +++|.+++......+++..++.|+.||+.||.|||++|||||||||+||||...+..+.+||+|||+++
T Consensus 76 ~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred CEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 9999999999 899999998777789999999999999999999999999999999999999655577889999999998
Q ss_pred ccCCCCc--------ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCC
Q 007253 312 FVRPDER--------LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE---SGIFRAVLKADPS 379 (611)
Q Consensus 312 ~~~~~~~--------~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~---~~~~~~i~~~~~~ 379 (611)
.+..... ....+||+.|+|||++. ..++.++|||||||++|||++|+.||.+... ...+..+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA 234 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence 7654332 22568999999999986 5689999999999999999999999976443 2333333222111
Q ss_pred -CCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 380 -FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 380 -~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
........++.++.+||.+||+.||.+||++.+|++
T Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 111111367899999999999999999999998765
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=361.52 Aligned_cols=263 Identities=19% Similarity=0.245 Sum_probs=206.6
Q ss_pred ccccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe
Q 007253 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (611)
Q Consensus 150 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 229 (611)
.....++|++.+.||+|+||.||+|+.. +|+.||||++...... .....+.+|+.+++.+. ||||+++++++.
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~ 97 (326)
T 3uim_A 25 LQVASDNFSNKNILGRGGFGKVYKGRLA----DGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAV-HRNLLRLRGFCM 97 (326)
T ss_dssp HHTTTTSSCSTTEEECCSSSEEEEECCS----SSCCEEEEECCC-------CCCHHHHHHHGGGTCC-CTTBCCCCEEEC
T ss_pred HHHHhhccccceeEecCCCcEEEEEEec----CCCEEEEEEeccccCc--hHHHHHHHHHHHHHhcc-CCCccceEEEEe
Confidence 3456788999999999999999999743 4789999998654322 12235889999999998 999999999999
Q ss_pred eCCeeEEEeeecCCCChHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CCeeecCCCCceEEeccCCCceEE
Q 007253 230 DTDNVYVVMELCEGGELLDRILSRG---GKYTEDDAKAVMIQILNVVAFCHLQ---GVVHRDLKPENFLFTTKDENSVLK 303 (611)
Q Consensus 230 ~~~~~~lv~E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NIll~~~~~~~~vk 303 (611)
+.+..++|||||++|+|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~---~~~~~~k 174 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAV 174 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE---CTTCCEE
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE---CCCCCEE
Confidence 9999999999999999999987643 2499999999999999999999999 99999999999999 5778899
Q ss_pred EeecccccccCCCC--cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHhc
Q 007253 304 AIDFGLSDFVRPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWAR----TESGIFRAVLKA 376 (611)
Q Consensus 304 l~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~----~~~~~~~~i~~~ 376 (611)
|+|||++....... ......||+.|+|||++. +.++.++|||||||++|+|++|+.||... ............
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 99999998765332 234456999999999885 66899999999999999999999999511 110011111111
Q ss_pred C---CCCC--------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 377 D---PSFD--------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 377 ~---~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
. .... .......+..+.+|+.+||+.||.+|||+.++++|-.-...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 0 0000 00011224679999999999999999999999998765443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=378.51 Aligned_cols=255 Identities=24% Similarity=0.390 Sum_probs=214.8
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|++.++||+|+||.||+|.+.. +..||||++..... ..+.+.+|+.+|++|+ ||||+++++++.+ +
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-E 334 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT----TEEEEEEEECTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-S
T ss_pred chhhhhhheecccCCCeEEEEEEECC----CceEEEEEeCCCCC----CHHHHHHHHHHHHhCC-CCCEeeEEEEEee-c
Confidence 35679999999999999999998754 56799999975432 2357899999999998 9999999999876 6
Q ss_pred eeEEEeeecCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 233 NVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
.+|||||||++|+|.+++... ...+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+|||+++
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~ 411 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLAR 411 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCTTSTT
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---cCCCcEEEcccccce
Confidence 799999999999999998653 3469999999999999999999999999999999999999 567789999999998
Q ss_pred ccCCCC--cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 007253 312 FVRPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (611)
Q Consensus 312 ~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (611)
...... ......++..|+|||++. +.++.++|||||||++|||++ |+.||.+....+++..+..... .+ ....
T Consensus 412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-~~--~~~~ 488 (535)
T 2h8h_A 412 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-MP--CPPE 488 (535)
T ss_dssp TCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC-CC--CCTT
T ss_pred ecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CC--CCCC
Confidence 765332 123345778999999886 679999999999999999999 9999998888887777765432 11 1246
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHcC--cccCCCC
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALSH--PWIKNSN 423 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~h--p~~~~~~ 423 (611)
++.++.+||.+||+.||++|||+.+|++. .+|....
T Consensus 489 ~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 489 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 89999999999999999999999999864 5665543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=352.07 Aligned_cols=248 Identities=24% Similarity=0.388 Sum_probs=196.6
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHH--hcCCCCeeEEEEEE
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA--LTGHNNLVKFFDAY 228 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~~h~~iv~l~~~~ 228 (611)
..+.++|++++.||+|+||.||+|+. +|+.||||++... ....+.+|.+++.. ++ ||||+++++++
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~-h~niv~~~~~~ 71 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW-----QGENVAVKIFSSR------DEKSWFRETELYNTVMLR-HENILGFIASD 71 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE-----TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCC-CTTBCCEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE-----CCEEEEEEEeccc------cchhhHHHHHHHHHhhcc-CcCeeeEEEee
Confidence 34578999999999999999999975 4789999998532 23456677777777 55 99999999987
Q ss_pred eeC----CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------HcCCeeecCCCCceEEecc
Q 007253 229 EDT----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH--------LQGVVHRDLKPENFLFTTK 296 (611)
Q Consensus 229 ~~~----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~iiHrDlkp~NIll~~~ 296 (611)
.+. ..+++|||||++|+|.+++. ...+++..++.++.||+.||.||| +.||+||||||+|||+
T Consensus 72 ~~~~~~~~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill--- 146 (301)
T 3q4u_A 72 MTSRHSSTQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV--- 146 (301)
T ss_dssp EEEETTEEEEEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---
T ss_pred ccccCCCceeEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE---
Confidence 653 46899999999999999883 357999999999999999999999 9999999999999999
Q ss_pred CCCceEEEeecccccccCCCCc-----ccccccCCCcCcchhhcCC-------CCCcchhhHHHHHHHHHHhC-------
Q 007253 297 DENSVLKAIDFGLSDFVRPDER-----LNDIVGSAYYVAPEVLHRS-------YSTEADVWSIGVIAYILLCG------- 357 (611)
Q Consensus 297 ~~~~~vkl~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~~DiwSlGvil~el~~g------- 357 (611)
+.++.+||+|||++........ ....+||+.|+|||++.+. ++.++|||||||++|||++|
T Consensus 147 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~ 226 (301)
T 3q4u_A 147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226 (301)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccc
Confidence 5778899999999976543322 2345899999999998743 34689999999999999999
Q ss_pred ---CCCCCCCC----hHHHHHHHHhcCCCCCCCCC----CCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 358 ---SRPFWART----ESGIFRAVLKADPSFDEAPW----PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 358 ---~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~----~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
..||.... .......+.......+..+. ...+.++.+||.+||+.||.+|||+.++++
T Consensus 227 ~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 227 EDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 88986532 22333333332222221110 124578999999999999999999999975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=364.35 Aligned_cols=250 Identities=18% Similarity=0.223 Sum_probs=197.4
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEec--CCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcC--CCCeeEEEEE
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG--HNNLVKFFDA 227 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~--~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~--h~~iv~l~~~ 227 (611)
...++|.+.+.||+|+||.||+|.... ....++.||||++.... ...+.+|+.++++|+. |+||++++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 346789999999999999999995332 12368999999986432 3457788888888753 8999999999
Q ss_pred EeeCCeeEEEeeecCCCChHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEec--------
Q 007253 228 YEDTDNVYVVMELCEGGELLDRILS----RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT-------- 295 (611)
Q Consensus 228 ~~~~~~~~lv~E~~~~gsL~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~-------- 295 (611)
+...+..|||||||+||+|.+++.. ....+++..++.|+.||+.||.|||++|||||||||+||||+.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999999875 3456999999999999999999999999999999999999953
Q ss_pred cCCCceEEEeecccccccC---CCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHH
Q 007253 296 KDENSVLKAIDFGLSDFVR---PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFR 371 (611)
Q Consensus 296 ~~~~~~vkl~DfG~a~~~~---~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~ 371 (611)
.+.++.+||+|||+|+.+. ........+||+.|||||++. ..++.++|||||||++|||++|+.||.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 1227889999999996543 233455678999999999987 458999999999999999999999996432210
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 372 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
......+.. ...++.+.+++..||+.+|.+|++..+.+.
T Consensus 293 --~~~~~~~~~---~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 293 --CKPEGLFRR---LPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp --EEECSCCTT---CSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred --eeechhccc---cCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 001111111 124678899999999999999976544444
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=349.90 Aligned_cols=242 Identities=31% Similarity=0.498 Sum_probs=193.1
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++.+.||+|+||.||+|+. .++.||||++... ...+.+.+|+.++++++ ||||+++++++. +.
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--~~ 73 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-----RAKDVAIKQIESE-----SERKAFIVELRQLSRVN-HPNIVKLYGACL--NP 73 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-----TTEEEEEEECSST-----THHHHHHHHHHHHHHCC-CTTBCCEEEBCT--TT
T ss_pred HhHeeeeeEeecCCCceEEEEEE-----CCeeEEEEEecCh-----hHHHHHHHHHHHHhcCC-CCCcCeEEEEEc--CC
Confidence 46799999999999999999975 3678999998432 24567889999999997 999999999886 44
Q ss_pred eEEEeeecCCCChHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---cCCeeecCCCCceEEeccCCCceEEEeecc
Q 007253 234 VYVVMELCEGGELLDRILSRGG--KYTEDDAKAVMIQILNVVAFCHL---QGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NIll~~~~~~~~vkl~DfG 308 (611)
.++||||+++|+|.+++..... .+++..++.++.||+.||.|||+ +||+||||||+|||++ .+...+||+|||
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~--~~~~~~kl~Dfg 151 (307)
T 2eva_A 74 VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV--AGGTVLKICDFG 151 (307)
T ss_dssp TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE--TTTTEEEECCCC
T ss_pred cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe--CCCCEEEEcccc
Confidence 8999999999999999875532 47899999999999999999999 8999999999999995 223358999999
Q ss_pred cccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhcCCCCCCCCC
Q 007253 309 LSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES--GIFRAVLKADPSFDEAPW 385 (611)
Q Consensus 309 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~ 385 (611)
++...... .....||+.|+|||++. ..++.++|||||||++|+|++|+.||...... .....+.... .....
T Consensus 152 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~ 226 (307)
T 2eva_A 152 TACDIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT---RPPLI 226 (307)
T ss_dssp C--------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC---CCCCB
T ss_pred cccccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC---CCCcc
Confidence 99765432 33457999999999987 46899999999999999999999999754332 2233333222 11223
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
..++..+.+||.+||+.||.+|||+.++++
T Consensus 227 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 578999999999999999999999999987
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=382.42 Aligned_cols=253 Identities=23% Similarity=0.374 Sum_probs=214.2
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|++++.||+|+||.||+|.+......+..||||++... ......+.+.+|+.++++++ ||||+++++++. ++
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-EN 463 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC-SS
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe-cC
Confidence 457899999999999999999998765446788999998643 34455678999999999997 999999999985 56
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.+|+|||||++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~---~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRY 540 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCCCCCS
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEe---CCCCEEEEecCCCee
Confidence 68999999999999999987766799999999999999999999999999999999999994 677899999999987
Q ss_pred cCCCCc--ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 313 VRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 313 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
...... .....+|+.|+|||++. ..++.++|||||||++|||++ |..||.+....+....+....... ..+.+
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~ 617 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPPNC 617 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC---CCTTC
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC---CCccc
Confidence 654332 22345778999999886 678999999999999999997 999999988888877776654221 12468
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
+..+.+||.+||..||.+|||+.++++
T Consensus 618 ~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 618 PPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=353.72 Aligned_cols=251 Identities=24% Similarity=0.320 Sum_probs=204.1
Q ss_pred eeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCC-cCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHK-MTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
|..++.||+|+||.||+|.. .++.||||++.... .......+.+.+|+.++++++ ||||+++++++.+.+..+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 106 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV-----NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDGDDLC 106 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES-----SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCE
T ss_pred cccCCccccCCCeEEEEEEE-----CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-CCCeEEEEEEEecCCceE
Confidence 55569999999999999974 47899999986543 223445678999999999997 999999999999999999
Q ss_pred EEeeecCCCChHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 236 VVMELCEGGELLDRILSR--GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~ 183 (307)
T 2nru_A 107 LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARAS 183 (307)
T ss_dssp EEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE---cCCCcEEEeeccccccc
Confidence 999999999999988643 3469999999999999999999999999999999999999 57788999999999866
Q ss_pred CCCC---cccccccCCCcCcchhhcCCCCCcchhhHHHHHHHHHHhCCCCCCCCChHH----HHHHHHhcCCCC------
Q 007253 314 RPDE---RLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESG----IFRAVLKADPSF------ 380 (611)
Q Consensus 314 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~----~~~~i~~~~~~~------ 380 (611)
.... ......||+.|+|||++.+.++.++|||||||++|+|++|..||....... +...+......+
T Consensus 184 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (307)
T 2nru_A 184 EKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDK 263 (307)
T ss_dssp CSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCS
T ss_pred ccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccc
Confidence 4332 233457999999999998889999999999999999999999997654332 222222211110
Q ss_pred -CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 381 -DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 381 -~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
........+..+.++|.+||+.||.+|||+.+++++
T Consensus 264 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 264 KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 001112345678999999999999999999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=346.74 Aligned_cols=243 Identities=25% Similarity=0.393 Sum_probs=199.4
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC-C
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT-D 232 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~-~ 232 (611)
.++|++.+.||+|+||.||+|+. .|+.||||++.... ..+.+.+|+.++++++ ||||+++++++.+. +
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 88 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-----RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKG 88 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-----TTEEEEEEECCCCC-------HHHHHTHHHHTTCC-CTTBCCEEEEECCC--
T ss_pred hhhceEEeEEecCCCceEEEEEE-----cCCEEEEEEecchh-----HHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCC
Confidence 47899999999999999999975 37899999986432 3467889999999997 99999999997654 4
Q ss_pred eeEEEeeecCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
.+++||||+++|+|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~ 165 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTK 165 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC--
T ss_pred ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE---eCCCcEEEeeccccc
Confidence 79999999999999999876533 38999999999999999999999999999999999999 567889999999987
Q ss_pred ccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 312 FVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
..... .....+++.|+|||++. ..++.++|||||||++|+|++ |+.||...........+..... ......++
T Consensus 166 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~ 240 (278)
T 1byg_A 166 EASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCP 240 (278)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC---CCCCTTCC
T ss_pred ccccc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCcccCC
Confidence 65432 23346789999999986 668999999999999999998 9999988877776666554321 22234689
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
+.+.++|.+||+.||.+|||+.++++
T Consensus 241 ~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 241 PAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 99999999999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=379.71 Aligned_cols=248 Identities=23% Similarity=0.329 Sum_probs=204.6
Q ss_pred eeE-eCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 157 YEL-GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 157 y~~-~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
+.+ .++||+|+||.||+|.+... ..++.||||++.... ......+.+.+|+.++++|+ |||||++++++.+ +.++
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~-~~~~ 445 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMK-KVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLD-NPYIVRMIGICEA-ESWM 445 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECS-SCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCC-CTTBCCEEEEEES-SSEE
T ss_pred ccccCCEeccCCCEEEEEEEEcCC-CcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec-CCEE
Confidence 444 35899999999999976542 246899999996543 33345678999999999998 9999999999864 5689
Q ss_pred EEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC
Q 007253 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~ 315 (611)
||||||++|+|.+++... ..+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+++.+..
T Consensus 446 lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl---~~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 446 LVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRA 521 (635)
T ss_dssp EEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCTTHHHHTTC
T ss_pred EEEEccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEE---eCCCCEEEEEcCCcccccc
Confidence 999999999999988654 579999999999999999999999999999999999999 4677899999999987654
Q ss_pred CCc----ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 316 DER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 316 ~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
... .....||+.|+|||++. ..++.++|||||||++|||++ |+.||.+....++...+....... ....++
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~ 598 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG---CPAGCP 598 (635)
T ss_dssp -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCC
T ss_pred CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCC
Confidence 332 22345678999999986 579999999999999999998 999999988888877776654221 124689
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
.++.+||.+||+.||.+|||+.++++
T Consensus 599 ~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 599 REMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 99999999999999999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=361.27 Aligned_cols=249 Identities=15% Similarity=0.176 Sum_probs=200.3
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCc-----cCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeE-----
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGEL-----KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVK----- 223 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~----- 223 (611)
.++|++++.||+|+||.||+|+...... .++.||||++... +.+.+|+.++++++ ||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~-h~niv~~~~~~ 111 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAA-KPLQVNKWKKL 111 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHC-CHHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhc-ccchhhhhhhh
Confidence 5789999999999999999999775211 3789999998653 34779999999998 998887
Q ss_pred ----------EEEEEee-CCeeEEEeeecCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCce
Q 007253 224 ----------FFDAYED-TDNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENF 291 (611)
Q Consensus 224 ----------l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NI 291 (611)
+++++.. ++..|+||||| +|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 190 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 6777776 67899999999 99999998765 35799999999999999999999999999999999999
Q ss_pred EEeccCCCc--eEEEeecccccccCCCCc--------ccccccCCCcCcchhhcC-CCCCcchhhHHHHHHHHHHhCCCC
Q 007253 292 LFTTKDENS--VLKAIDFGLSDFVRPDER--------LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRP 360 (611)
Q Consensus 292 ll~~~~~~~--~vkl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~el~~g~~P 360 (611)
|++ .++ .+||+|||++..+..... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.|
T Consensus 191 l~~---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 191 FVD---PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp EEE---TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred EEc---CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 994 555 899999999987653321 234589999999999874 689999999999999999999999
Q ss_pred CCCCC--hHHHHHHHH---hcCCCCC--CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 361 FWART--ESGIFRAVL---KADPSFD--EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 361 f~~~~--~~~~~~~i~---~~~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
|.... ...+..... .....+. ...+..++.++.+||.+||+.||.+|||+.++++
T Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 97653 222222222 2222111 1123467999999999999999999999999875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=389.45 Aligned_cols=262 Identities=26% Similarity=0.440 Sum_probs=210.6
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee---
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--- 230 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~--- 230 (611)
.++|++++.||+|+||.||+|.+.. +|+.||||++... ......+.+.+|+.++++++ ||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~---tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~~~~ 86 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQD---TGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQK 86 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTT---TTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCC-BTTBCCEEECCTTTCC
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECC---CCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCC-CCCCCceeeeeccccc
Confidence 4679999999999999999998665 6899999998654 34556678999999999997 9999999998765
Q ss_pred ---CCeeEEEeeecCCCChHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 231 ---TDNVYVVMELCEGGELLDRILSRGG--KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 231 ---~~~~~lv~E~~~~gsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
.+..++|||||+||+|.+++..... .+++..++.++.||+.||.|||+.||+||||||+|||++.++....+||+
T Consensus 87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEc
Confidence 6778999999999999998876432 59999999999999999999999999999999999999765566679999
Q ss_pred ecccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHH---------HH--
Q 007253 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFR---------AV-- 373 (611)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~---------~i-- 373 (611)
|||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.......... .+
T Consensus 167 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 167 DLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp SCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred ccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 999999887666666778999999999986 668999999999999999999999997643321100 00
Q ss_pred ---HhcCCCC------CCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCC
Q 007253 374 ---LKADPSF------DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 374 ---~~~~~~~------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
......+ +......++..+.+||.+||..||.+|||+.++++||||+.
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 0000011 11112236789999999999999999999999999999963
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=348.91 Aligned_cols=253 Identities=23% Similarity=0.341 Sum_probs=205.7
Q ss_pred CCceeEeCeeeeccceEEEEEEEec-CCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
.++|++++.||+|+||.||+|++.. ....|+.||||++... .....+.+.+|+.++++++ ||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAG 115 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCC-CTTBCCEEEEECC--
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEecC
Confidence 5679999999999999999998542 2236899999998653 3445678899999999997 999999999987654
Q ss_pred --eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 233 --NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 233 --~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
.+++||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~---~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLT 192 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTC
T ss_pred CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEc---CCCcEEEecCcch
Confidence 78999999999999999988777799999999999999999999999999999999999994 5678999999999
Q ss_pred cccCCCCc----ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChH------------H---HH
Q 007253 311 DFVRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES------------G---IF 370 (611)
Q Consensus 311 ~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~------------~---~~ 370 (611)
........ .....++..|+|||++. ..++.++|||||||++|+|++|..||...... . .+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 87754432 22346778899999886 55889999999999999999999998532110 0 11
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 371 RAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 371 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
...+......+ ....++.++.+||.+||+.||.+|||+.++++
T Consensus 273 ~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 273 IELLKNNGRLP--RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHTTCCCC--CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhhcCCCCC--CCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11222222222 22468999999999999999999999999874
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=356.04 Aligned_cols=249 Identities=22% Similarity=0.382 Sum_probs=205.8
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|++++.||+|+||.||+|+... .||+|++...... ....+.+.+|+.++++++ ||||+++++++.+.+
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG------EVAIRLIDIERDN-EDQLKAFKREVMAYRQTR-HENVVLFMGACMSPP 102 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS------SEEEEECCCCSCC-CCCCCCCCTTGGGGTTCC-CTTBCCCCEEEECSS
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC------eEEEEEeecCCCC-HHHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCC
Confidence 35789999999999999999998542 4999998654322 222345778999999997 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.+++||||++|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~----~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD----NGKVVITDFGLFSI 178 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCCC-
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe----CCCEEEeecCCccc
Confidence 99999999999999998876666799999999999999999999999999999999999993 56899999999876
Q ss_pred cCCC------CcccccccCCCcCcchhhcC----------CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 007253 313 VRPD------ERLNDIVGSAYYVAPEVLHR----------SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 376 (611)
Q Consensus 313 ~~~~------~~~~~~~gt~~y~aPE~~~~----------~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~ 376 (611)
.... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...........+...
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 258 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG 258 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC
Confidence 5321 22334569999999999853 3688999999999999999999999988887777666654
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 377 DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 377 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
.... .....++.++.++|.+||..||.+|||+.++++
T Consensus 259 ~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 259 MKPN--LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp CCCC--CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CCCC--CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 3222 222357889999999999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=362.14 Aligned_cols=251 Identities=19% Similarity=0.240 Sum_probs=198.0
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcC-----CHHHHHHHHHHHHHHHHhc--------CCCC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-----TAIAIEDVRREVKILRALT--------GHNN 220 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~--------~h~~ 220 (611)
.++|++++.||+|+||.||+|+. +|+.||||++...... .....+.+.+|+.+++.|+ .|||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~n 93 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-----DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEG 93 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-----TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCC
T ss_pred cccchheeeecccCceEEEEEEe-----CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCc
Confidence 46799999999999999999985 4789999999765321 2234467889999999986 5899
Q ss_pred eeEEEEEEe------------------------------eCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHH
Q 007253 221 LVKFFDAYE------------------------------DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQIL 270 (611)
Q Consensus 221 iv~l~~~~~------------------------------~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~ 270 (611)
||++++++. +.+.+|||||||++|++++.+.. ..+++..++.++.||+
T Consensus 94 iv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 94 FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLT 171 (336)
T ss_dssp BCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHH
T ss_pred hhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHH
Confidence 999888754 26789999999999988777743 5689999999999999
Q ss_pred HHHHHHH-HcCCeeecCCCCceEEeccC-----------------CCceEEEeecccccccCCCCcccccccCCCcCcch
Q 007253 271 NVVAFCH-LQGVVHRDLKPENFLFTTKD-----------------ENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPE 332 (611)
Q Consensus 271 ~~L~~LH-~~~iiHrDlkp~NIll~~~~-----------------~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE 332 (611)
.||.||| ++|||||||||+||||+..+ ....+||+|||+|+..... ..+||+.|||||
T Consensus 172 ~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE 247 (336)
T 2vuw_A 172 ASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSG
T ss_pred HHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChh
Confidence 9999999 99999999999999997433 1238999999999876532 458999999999
Q ss_pred hhcCCCCCcchhhHHHHH-HHHHHhCCCCCCCCCh-HHHHHHHHhcCC---CCCCCCCCCCCHHHHHHHHHhcccCccCC
Q 007253 333 VLHRSYSTEADVWSIGVI-AYILLCGSRPFWARTE-SGIFRAVLKADP---SFDEAPWPSLSSEARDFVKRLLNKDPRKR 407 (611)
Q Consensus 333 ~~~~~~~~~~DiwSlGvi-l~el~~g~~Pf~~~~~-~~~~~~i~~~~~---~~~~~~~~~~s~~~~~li~~~L~~dP~~R 407 (611)
++.+..+.++||||||++ .++++.|..||..... ......+..... ......++.+++++.+||++||++|
T Consensus 248 ~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d---- 323 (336)
T 2vuw_A 248 LFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS---- 323 (336)
T ss_dssp GGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred hhcCCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence 998777889999998777 7788899999843211 112223332211 1111112347889999999999977
Q ss_pred CCHHHHH-cCcccC
Q 007253 408 LTAAQAL-SHPWIK 420 (611)
Q Consensus 408 pt~~~ll-~hp~~~ 420 (611)
|+.|+| +||||+
T Consensus 324 -sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 -SATDLLCQHSLFK 336 (336)
T ss_dssp -SHHHHHHHCGGGC
T ss_pred -CHHHHHhcCCCcC
Confidence 999999 999995
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=347.92 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=193.5
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEe
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT-GHNNLVKFFDAYE 229 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-~h~~iv~l~~~~~ 229 (611)
..+.++|++++.||+|+||.||+|+. .|+.||||++... ......+|.+++..+. .||||+++++++.
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 101 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKW-----RGEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADI 101 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEE-----TTEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred cccccceEEEeEeecCCCeEEEEEEE-----CCceEEEEEEecc------ccchhhhHHHHHHHHhhcCCCeeeEEEEEc
Confidence 44568899999999999999999975 3789999998432 1233445666655441 4999999999998
Q ss_pred eC----CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeeecCCCCceEEeccC
Q 007253 230 DT----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ--------GVVHRDLKPENFLFTTKD 297 (611)
Q Consensus 230 ~~----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------~iiHrDlkp~NIll~~~~ 297 (611)
+. ..+++|||||++|+|.+++... .+++..++.++.||+.||.|||++ |||||||||+|||+ +
T Consensus 102 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~ 176 (337)
T 3mdy_A 102 KGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---K 176 (337)
T ss_dssp ESCGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---C
T ss_pred cCCCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE---C
Confidence 87 7899999999999999998654 699999999999999999999999 99999999999999 5
Q ss_pred CCceEEEeecccccccCCCCc-----ccccccCCCcCcchhhcCC-CCCc------chhhHHHHHHHHHHhC--------
Q 007253 298 ENSVLKAIDFGLSDFVRPDER-----LNDIVGSAYYVAPEVLHRS-YSTE------ADVWSIGVIAYILLCG-------- 357 (611)
Q Consensus 298 ~~~~vkl~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~------~DiwSlGvil~el~~g-------- 357 (611)
.++.+||+|||++........ ....+||+.|+|||++.+. +... +|||||||++|||++|
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~ 256 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256 (337)
T ss_dssp TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence 777899999999976643322 2356899999999998743 3443 8999999999999999
Q ss_pred --CCCCCCCC----hHHHHHHHHhcCCCCCCCC----CCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 358 --SRPFWART----ESGIFRAVLKADPSFDEAP----WPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 358 --~~Pf~~~~----~~~~~~~i~~~~~~~~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
..||.... ...............+..+ ...++.++.+||.+||+.||.+|||+.++++|
T Consensus 257 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 257 EYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 77775432 1222222222211111111 01356779999999999999999999999875
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=368.60 Aligned_cols=249 Identities=18% Similarity=0.223 Sum_probs=193.4
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCC-CCe-----------
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH-NNL----------- 221 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~~i----------- 221 (611)
...|.+++.||+|+||.||+|.+.. +|+.||||++...........+.+.+|+.+++.|. | .|+
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~---~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~-~~~~~~~~~~~~~~~~ 152 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQE---TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR-GIKNQKQAKVHLRFIF 152 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEECCSCC----CCHHHHHHHHGGGGST-TCCSHHHHHHHTCBCC
T ss_pred ceeEEEecccccCCCEEEEEEEecC---CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhc-cCCCHHHHHHhccccc
Confidence 3468999999999999999999776 68999999987544444445677899999999887 5 221
Q ss_pred ----------eEEEEEEee-----CCeeEEEeeecCCCChHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 007253 222 ----------VKFFDAYED-----TDNVYVVMELCEGGELLDRILS------RGGKYTEDDAKAVMIQILNVVAFCHLQG 280 (611)
Q Consensus 222 ----------v~l~~~~~~-----~~~~~lv~E~~~~gsL~~~l~~------~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 280 (611)
..++.++.. ...++++|+++ +++|.+++.. ....+++..++.++.||+.||.|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 231 (413)
T 3dzo_A 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 231 (413)
T ss_dssp CCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 111122222 22467888877 6799988742 2345888899999999999999999999
Q ss_pred CeeecCCCCceEEeccCCCceEEEeecccccccCCCCcccccccCCCcCcchhh----------c-CCCCCcchhhHHHH
Q 007253 281 VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL----------H-RSYSTEADVWSIGV 349 (611)
Q Consensus 281 iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~----------~-~~~~~~~DiwSlGv 349 (611)
||||||||+|||| +.++.+||+|||+++..... ....+| +.|+|||++ . ..++.++|||||||
T Consensus 232 iiHrDiKp~NILl---~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 232 LVHTYLRPVDIVL---DQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp EECSCCCGGGEEE---CTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred cccCCcccceEEE---ecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 9999999999999 57778999999998865432 455678 999999988 3 23778999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCC
Q 007253 350 IAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 350 il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
++|||++|+.||...........+.. .+..+++++.+||.+||+.||.+|||+.++++||||+.
T Consensus 306 il~elltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGSCSGGGGS--------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHHHHCCCCCCCcchhhhHHHHHh--------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 99999999999987655433332222 22467899999999999999999999999999999964
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=345.92 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=200.4
Q ss_pred ccccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHH--hcCCCCeeEEEEE
Q 007253 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA--LTGHNNLVKFFDA 227 (611)
Q Consensus 150 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~~h~~iv~l~~~ 227 (611)
...+.++|++.+.||+|+||.||+|+. .|+.||||++... ....+.+|++++.. ++ ||||++++++
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~-h~ni~~~~~~ 104 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSR------EERSWFREAEIYQTVMLR-HENILGFIAA 104 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE-----TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCC-CTTBCCEEEE
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE-----cCccEEEEEeCch------hHHHHHHHHHHHHHhhcC-CCcEEEEEee
Confidence 345668899999999999999999985 3789999998532 23567789999988 55 9999999999
Q ss_pred EeeCC----eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------HcCCeeecCCCCceEEec
Q 007253 228 YEDTD----NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH--------LQGVVHRDLKPENFLFTT 295 (611)
Q Consensus 228 ~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~iiHrDlkp~NIll~~ 295 (611)
+...+ .+++||||+++|+|.+++... .+++..++.++.||+.||.||| +.||+||||||+|||+
T Consensus 105 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll-- 180 (342)
T 1b6c_B 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV-- 180 (342)
T ss_dssp EECCCSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE--
T ss_pred ecccCCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE--
Confidence 98876 799999999999999998653 6899999999999999999999 8999999999999999
Q ss_pred cCCCceEEEeecccccccCCCC-----cccccccCCCcCcchhhcCC-------CCCcchhhHHHHHHHHHHhC------
Q 007253 296 KDENSVLKAIDFGLSDFVRPDE-----RLNDIVGSAYYVAPEVLHRS-------YSTEADVWSIGVIAYILLCG------ 357 (611)
Q Consensus 296 ~~~~~~vkl~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-------~~~~~DiwSlGvil~el~~g------ 357 (611)
+.++.+||+|||++....... ......||+.|+|||++.+. ++.++|||||||++|+|++|
T Consensus 181 -~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 259 (342)
T 1b6c_B 181 -KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259 (342)
T ss_dssp -CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred -CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence 577789999999998765433 23456899999999998754 23579999999999999999
Q ss_pred ----CCCCCCCC-----hHHHHHHHHhcCCC--CCCCC-CCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 358 ----SRPFWART-----ESGIFRAVLKADPS--FDEAP-WPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 358 ----~~Pf~~~~-----~~~~~~~i~~~~~~--~~~~~-~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
..||.... ...+...+...... ++... ....+..+.+||.+||+.||.+|||+.++++|
T Consensus 260 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 260 HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 88986542 22333333222211 11100 01234678999999999999999999999865
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=349.01 Aligned_cols=256 Identities=23% Similarity=0.350 Sum_probs=189.8
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHH--HHHhcCCCCeeEEEEEEee-
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKI--LRALTGHNNLVKFFDAYED- 230 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~--l~~l~~h~~iv~l~~~~~~- 230 (611)
.++|++++.||+|+||.||+|+. .++.||||++.... ...+..|..+ +..+. ||||+++++++..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~-h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-----DERPVAVKVFSFAN------RQNFINEKNIYRVPLME-HDNIARFIVGDERV 79 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-----TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-----CCeEEEEEEeeccc------hhhHHHHHHHHHHHhcc-Ccchhhheeccccc
Confidence 47899999999999999999964 47899999985431 2233344444 44465 9999999986543
Q ss_pred ----CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---------CCeeecCCCCceEEeccC
Q 007253 231 ----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ---------GVVHRDLKPENFLFTTKD 297 (611)
Q Consensus 231 ----~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---------~iiHrDlkp~NIll~~~~ 297 (611)
...+++|||||++|+|.+++... ..++..++.++.||+.||.|||+. |||||||||+|||+ +
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~ 154 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---K 154 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---C
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE---c
Confidence 23678999999999999998654 458999999999999999999999 99999999999999 5
Q ss_pred CCceEEEeecccccccCCCC---------cccccccCCCcCcchhhcC--------CCCCcchhhHHHHHHHHHHhCCCC
Q 007253 298 ENSVLKAIDFGLSDFVRPDE---------RLNDIVGSAYYVAPEVLHR--------SYSTEADVWSIGVIAYILLCGSRP 360 (611)
Q Consensus 298 ~~~~vkl~DfG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~--------~~~~~~DiwSlGvil~el~~g~~P 360 (611)
.++.+||+|||++..+.... .....+||+.|+|||++.+ .++.++|||||||++|||++|..|
T Consensus 155 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p 234 (336)
T 3g2f_A 155 NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234 (336)
T ss_dssp TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGG
T ss_pred CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCc
Confidence 67889999999998764322 2234579999999999864 356789999999999999999877
Q ss_pred CCCCCh-----------------HHHHHHHHhcC---CCCCCCC--CCCCCHHHHHHHHHhcccCccCCCCHHHH-----
Q 007253 361 FWARTE-----------------SGIFRAVLKAD---PSFDEAP--WPSLSSEARDFVKRLLNKDPRKRLTAAQA----- 413 (611)
Q Consensus 361 f~~~~~-----------------~~~~~~i~~~~---~~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rpt~~~l----- 413 (611)
|..... ........... +.++... ...++.++.+||.+||+.||++|||+.++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314 (336)
T ss_dssp GSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred CCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence 643211 11111111111 1111110 11244579999999999999999999999
Q ss_pred -HcCcccCCCCCCC
Q 007253 414 -LSHPWIKNSNDVK 426 (611)
Q Consensus 414 -l~hp~~~~~~~~~ 426 (611)
+-++|-++.....
T Consensus 315 ~ll~~~~~~~~~~~ 328 (336)
T 3g2f_A 315 ELMMIWERNKSVSP 328 (336)
T ss_dssp HHHHCCCC------
T ss_pred HHHHHHHhcccCCC
Confidence 4578888765443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=338.82 Aligned_cols=229 Identities=15% Similarity=0.080 Sum_probs=187.9
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+.++|++.+.||+|+||.||+|+... .|+.||||++...........+.+.+|+.++.++. ||||+++++++.++
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~ 103 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTA---LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVHTR 103 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETT---TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEET
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecC---CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCC-CCCcceeeEEEEEC
Confidence 456789999999999999999999765 68999999998766556667788999999999997 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+..|+|||||+|++|.+++.. + .....+..|+.||+.||.|||++||+||||||+|||++ .++.+||+++|
T Consensus 104 ~~~~lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~---~~g~~kl~~~~--- 174 (286)
T 3uqc_A 104 AGGLVVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS---IDGDVVLAYPA--- 174 (286)
T ss_dssp TEEEEEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---TTSCEEECSCC---
T ss_pred CcEEEEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEc---CCCCEEEEecc---
Confidence 999999999999999998732 2 46667889999999999999999999999999999994 67789997443
Q ss_pred ccCCCCcccccccCCCcCcchhhcCCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHH---HHHhcCCCCCCCCCCCC
Q 007253 312 FVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFR---AVLKADPSFDEAPWPSL 388 (611)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~ 388 (611)
|++| ++.++|||||||++|+|++|+.||.+......+. ..............+.+
T Consensus 175 ----------------~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T 3uqc_A 175 ----------------TMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDI 232 (286)
T ss_dssp ----------------CCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTS
T ss_pred ----------------ccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCC
Confidence 4433 6889999999999999999999998765432110 00111111111123568
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
+.++.+||.+||+.||.+| |+.++++.
T Consensus 233 ~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 233 PFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp CHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred CHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 9999999999999999999 99998763
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=378.41 Aligned_cols=247 Identities=26% Similarity=0.367 Sum_probs=203.2
Q ss_pred cccccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEE
Q 007253 149 FSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (611)
Q Consensus 149 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~ 228 (611)
....+.++|++++.||+|+||.||+|.+... +|+.||||++... ......+.+.+|+.++++++ ||||+++++++
T Consensus 74 ~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~--~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~ 148 (681)
T 2pzi_A 74 PGDIVAGQYEVKGCIAHGGLGWIYLALDRNV--NGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVV-HPSIVQIFNFV 148 (681)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEEGGG--TTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGCC-CTTBCCEEEEE
T ss_pred CCCEeCCceEEEEEEeeCCCeEEEEEEEcCC--CCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhcC-CCCcCeEeeeE
Confidence 3455678999999999999999999987642 4789999998643 34455677899999999998 99999999999
Q ss_pred eeCCe-----eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEE
Q 007253 229 EDTDN-----VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303 (611)
Q Consensus 229 ~~~~~-----~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vk 303 (611)
...+. .|||||||+|++|.+++.. .+++..++.|+.||+.||.|||++|||||||||+|||++ . +.+|
T Consensus 149 ~~~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~---~-~~~k 221 (681)
T 2pzi_A 149 EHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT---E-EQLK 221 (681)
T ss_dssp EEECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---S-SCEE
T ss_pred eecCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe---C-CcEE
Confidence 88665 7999999999999886633 699999999999999999999999999999999999994 3 3799
Q ss_pred EeecccccccCCCCcccccccCCCcCcchhhcCCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 007253 304 AIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA 383 (611)
Q Consensus 304 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 383 (611)
|+|||++...... ...+||+.|+|||++.+.++.++|||||||++|+|++|..||.+..... . ....
T Consensus 222 l~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------~--~~~~ 288 (681)
T 2pzi_A 222 LIDLGAVSRINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG--------L--PEDD 288 (681)
T ss_dssp ECCCTTCEETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECSS--------C--CTTC
T ss_pred EEecccchhcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccccc--------c--cccc
Confidence 9999999876533 4568999999999998777899999999999999999999986532110 0 0011
Q ss_pred CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccC
Q 007253 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420 (611)
Q Consensus 384 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~ 420 (611)
.....++.+.+||.+||+.||.+||+..+.+.|+|+.
T Consensus 289 ~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 289 PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 1112467899999999999999999999988888763
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=323.66 Aligned_cols=232 Identities=17% Similarity=0.146 Sum_probs=158.1
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcC-------CHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-------TAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
..++.|++|.+..++... .|+.||+|++.+.... .....+++.+|+++|+++..|+||+++++++++++.
T Consensus 240 ~~~~~~~~~~h~~~rr~~---fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~ 316 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYF---FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQS 316 (569)
T ss_dssp CC-C--------CCEEEE---ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSE
T ss_pred hccccCCccccccccccc---ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCE
Confidence 356778888776666554 6899999999764321 234556799999999999779999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|||||||+||+|.++|... +.+++. .|+.||+.||+|||++|||||||||+|||| +.++.|||+|||+|+..
T Consensus 317 ~yLVMEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 317 GWLVMEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV---DARQHARLIDFGSIVTT 389 (569)
T ss_dssp EEEEEECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE---CTTSCEEECCCTTEESC
T ss_pred EEEEEecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE---CCCCCEEEeecccCeeC
Confidence 99999999999999998654 567764 488999999999999999999999999999 57788999999999876
Q ss_pred CCC-CcccccccCCCcCcchhhcCCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 314 RPD-ERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
..+ ....+.+||+.|||||++.+.+...+|+||+|++++++.++..++ ...+... + .. ...+
T Consensus 390 ~~~~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~--------~~~l~~~-~---~~-----~~~~ 452 (569)
T 4azs_A 390 PQDCSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW--------LYAVWQE-P---VE-----RWNF 452 (569)
T ss_dssp C---CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHHH--------HHHHHTS-C---GG-----GCSH
T ss_pred CCCCccccCceechhhccHHHhCCCCCCcccccccccchhhhccccchh--------HHHhhcC-C---CC-----CCcH
Confidence 543 345667999999999999998899999999999998887665443 1111111 1 11 1124
Q ss_pred HHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 393 RDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
..+...+...+|..|+.......|+|.
T Consensus 453 ~~l~~~l~~~~~~~~~~~~~~~~~~~~ 479 (569)
T 4azs_A 453 VLLLALFEKKAKLPSAEQQRGATEQWI 479 (569)
T ss_dssp HHHHHHHHTGGGSCCGGGSSCCHHHHH
T ss_pred HHHHHHHhCCCCCCCCChhhhccchhH
Confidence 567777778888888776655555554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=269.28 Aligned_cols=185 Identities=21% Similarity=0.221 Sum_probs=145.2
Q ss_pred eEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHH-----HHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAI-----AIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 158 ~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
...+.||+|+||.||+|.. .++.+|+|+.......... ..+++.+|++++++++ ||||+++..++...+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~ 412 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-----LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFDVDLD 412 (540)
T ss_dssp ---------CCEEEEEEEC-----SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEEEETT
T ss_pred CCCCEEeeCCCEEEEEEEE-----CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEEEeCC
Confidence 4567899999999999942 4788999987543333222 2456899999999998 999996555566777
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
..|||||||+||+|.+++.. +..++.||+.||.|||++|||||||||+|||++ . .+||+|||+++.
T Consensus 413 ~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~---~--~~kL~DFGla~~ 478 (540)
T 3en9_A 413 NKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD---K--DLYIIDFGLGKI 478 (540)
T ss_dssp TTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES---S--SEEECCCTTCEE
T ss_pred ccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC---C--eEEEEECccCEE
Confidence 88999999999999998744 678999999999999999999999999999994 3 899999999998
Q ss_pred cCCCCc--------ccccccCCCcCcchhhc---CCCCCcchhhHHHHHHHHHHhCCCCCC
Q 007253 313 VRPDER--------LNDIVGSAYYVAPEVLH---RSYSTEADVWSIGVIAYILLCGSRPFW 362 (611)
Q Consensus 313 ~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~~~~DiwSlGvil~el~~g~~Pf~ 362 (611)
...... ....+||+.|||||++. ..|+..+|+||..+-.++.+.++.+|.
T Consensus 479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 764322 23678999999999986 457888999999999998888887763
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=214.41 Aligned_cols=182 Identities=21% Similarity=0.325 Sum_probs=147.6
Q ss_pred cCcccCCCCCCCCchhHHHHHHHHHHhhcchHHHHHHHhhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhc
Q 007253 415 SHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNA 494 (611)
Q Consensus 415 ~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~ 494 (611)
.|||.+......+++....+..+++|...+.+++..+..+...++.+++.+|+++|..+|.|++|.|+.+||..+|..++
T Consensus 8 ~~~~~~~~~~~~~~l~~~~~~~l~~f~~~~~lk~~~l~~i~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g 87 (197)
T 3pm8_A 8 SSGRENLYFQGHVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRNIFIALDVDNSGTLSSQEILDGLKKIG 87 (197)
T ss_dssp ---------CCSCCCCTTHHHHHHHTTTSCHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHC
T ss_pred cchHhhhccCCCCCCCHHHHHHHHHHHHccHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhC
Confidence 58999999888999888899999999999999999999999999999999999999999999999999999999998886
Q ss_pred ccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-C--CC
Q 007253 495 TDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-L--GP 571 (611)
Q Consensus 495 ~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~--~~ 571 (611)
. ..++.++..+|..+|.|++|.|+|+||+.++........ ++.++.+|+.||.|++|+|+.+||++++. . +.
T Consensus 88 ~-~~~~~~~~~l~~~~D~d~~g~I~~~EF~~~~~~~~~~~~----~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~ 162 (197)
T 3pm8_A 88 Y-QKIPPDIHQVLRDIDSNASGQIHYTDFLAATIDKQTYLK----KEVCLIPFKFFDIDGNGKISVEELKRIFGRDDIEN 162 (197)
T ss_dssp -----CHHHHHHHHC-------CEEHHHHHHTTCCHHHHCS----HHHHHHHHHHHCTTCSSEECHHHHHHHHC----CC
T ss_pred C-CCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHHhhhh----HHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCC
Confidence 5 577888999999999999999999999998877655444 66899999999999999999999999996 4 44
Q ss_pred Ccc---HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 572 AVP---VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 572 ~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
.++ ++.+|..+|.|+||.|+|+||+++|+.
T Consensus 163 ~~~~~~~~~l~~~~D~d~dG~Is~~EF~~~l~~ 195 (197)
T 3pm8_A 163 PLIDKAIDSLLQEVDLNGDGEIDFHEFMLMMSK 195 (197)
T ss_dssp HHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHC
T ss_pred CCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHc
Confidence 433 889999999999999999999999875
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A | Back alignment and structure |
|---|
Probab=99.91 E-value=5.1e-24 Score=202.08 Aligned_cols=179 Identities=22% Similarity=0.339 Sum_probs=150.7
Q ss_pred cCcccCCCCCCCCchhHHHHHHHHHHhhcchHHHHHHHhhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhc
Q 007253 415 SHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNA 494 (611)
Q Consensus 415 ~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~ 494 (611)
.|||+-.......++....+..+++|...+.+++..+..+...++++++.+|+++|..+|.|++|.|+.+||..++...+
T Consensus 3 ~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~l~~~~l~~~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~g 82 (191)
T 3k21_A 3 HHHHHSSGRENLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLVLDEDGKGYITKEQLKKGLEKDG 82 (191)
T ss_dssp -----------CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTT
T ss_pred CCccccCCccccccccHHHHHHHHHHHhhHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHcC
Confidence 68888888888889999999999999999999999999999999999999999999999999999999999999998887
Q ss_pred ccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc---CCC
Q 007253 495 TDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG---LGP 571 (611)
Q Consensus 495 ~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~---~~~ 571 (611)
. ..+ .++..+|..+|.|++|.|+|+||+.++..... .. ++.++.+|+.+|.|++|+|+.+||++++. .+.
T Consensus 83 ~-~~~-~~~~~l~~~~D~d~~g~i~~~EF~~~~~~~~~-~~----~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~ 155 (191)
T 3k21_A 83 L-KLP-YNFDLLLDQIDSDGSGKIDYTEFIAAALDRKQ-LS----KKLIYCAFRVFDVDNDGEITTAELAHILYNGNKKG 155 (191)
T ss_dssp C-CCC-TTHHHHHHHHCTTCSSSEEHHHHHHHHSCGGG-CC----HHHHHHHHHHHSTTCSSCBCHHHHHHHHHHSSSCS
T ss_pred C-CcH-HHHHHHHHHhCCCCCCeEeHHHHHHHHHhhhh-cc----HHHHHHHHHHhCCCCCCcCCHHHHHHHHHhcCCCC
Confidence 5 345 78999999999999999999999998866543 22 56788999999999999999999999994 333
Q ss_pred Ccc------HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007253 572 AVP------VHAVLHDWIRHTDGKLSFLGFVKLLH 600 (611)
Q Consensus 572 ~~~------~~~~~~~~D~~~dG~is~~eF~~~l~ 600 (611)
.++ ++.+|..+|.|+||.|+|+||+++|.
T Consensus 156 ~l~~~~~~~~~~~~~~~D~d~dG~Is~~EF~~~~~ 190 (191)
T 3k21_A 156 NITQRDVNRVKRMIRDVDKNNDGKIDFHEFSEMMK 190 (191)
T ss_dssp CCCHHHHHHHHHHHHHHCSSSSSSBCHHHHHHHHC
T ss_pred CCCHhHHHHHHHHHHHhcCCCCCeECHHHHHHHHc
Confidence 322 78899999999999999999999885
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.8e-25 Score=221.16 Aligned_cols=160 Identities=28% Similarity=0.291 Sum_probs=123.4
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCH---------------HHHHHHHHHHHHHHHhcCCC
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA---------------IAIEDVRREVKILRALTGHN 219 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~~h~ 219 (611)
..|.+++.||+|+||.||+|.. . +|+.||||++........ .....+.+|+.++++++ |.
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~---~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~~ 164 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-E---KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GL 164 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-T---TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TS
T ss_pred eEEEecCEeccCCCceEEEEEe-C---CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-CC
Confidence 4467779999999999999997 4 589999999864321110 24567889999999997 55
Q ss_pred CeeEEEEEEeeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCC
Q 007253 220 NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN 299 (611)
Q Consensus 220 ~iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~ 299 (611)
++..+ +. .+..|+|||||+||+|.+ + .......++.||+.||.|||++|||||||||+|||+ + +
T Consensus 165 ~v~~~---~~-~~~~~lvmE~~~g~~L~~-l-------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl---~-~ 228 (282)
T 1zar_A 165 AVPKV---YA-WEGNAVLMELIDAKELYR-V-------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV---S-E 228 (282)
T ss_dssp SSCCE---EE-EETTEEEEECCCCEEGGG-C-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---E-T
T ss_pred CcCeE---Ee-ccceEEEEEecCCCcHHH-c-------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE---E-C
Confidence 55544 33 356799999999999987 3 112355799999999999999999999999999999 4 7
Q ss_pred ceEEEeecccccccCCCCcccccccCCCcCcchhhc-----------CCCCCcchhhHH
Q 007253 300 SVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-----------RSYSTEADVWSI 347 (611)
Q Consensus 300 ~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-----------~~~~~~~DiwSl 347 (611)
+.+||+|||+|.. +..|+|||++. +.|+..+|+|.+
T Consensus 229 ~~vkl~DFG~a~~------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 229 EGIWIIDFPQSVE------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp TEEEECCCTTCEE------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred CcEEEEECCCCeE------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 7899999999853 34689999874 345666777653
|
| >2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=99.89 E-value=4.2e-23 Score=192.99 Aligned_cols=143 Identities=23% Similarity=0.383 Sum_probs=126.9
Q ss_pred hcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHh
Q 007253 456 KTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEA 535 (611)
Q Consensus 456 ~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~ 535 (611)
..|+++|+++|+++|..+|.|++|+|+.+||..+|..++. .+++.++..++..+|.+++|.|+|.||+.++........
T Consensus 3 ~~Lt~eqi~elk~~F~~~D~d~dG~I~~~El~~~l~~lg~-~~~~~~~~~~~~~~d~d~~~~i~~~ef~~~~~~~~~~~~ 81 (176)
T 2lhi_A 3 SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGL-SPSEAEVNDLMNEIDVDGNHQIEFSEFLALMSRQLKSND 81 (176)
T ss_dssp CCCCTTGGGHHHHHHHTTCSSCSSCBCHHHHHHHHHHHTC-CCCHHHHHHHHTTTCSSCSSSBCTTHHHHHHTSSCCSSH
T ss_pred CcCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHcCC-ChhHHHHHHHHHHhCcCCCccchHHHHHHHHHHhcccCC
Confidence 5789999999999999999999999999999999988876 688889999999999999999999999998876543322
Q ss_pred hHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 536 LDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 536 ~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
.++.++.+|+.||+|++|+|+.+||+++|. ++..++ ++++|+.+| |+||.|+|+||+++|.+-+
T Consensus 82 ---~~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~d-d~dG~I~~~EF~~~m~k~~ 149 (176)
T 2lhi_A 82 ---SEQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDDMLREVS-DGSGEINIQQFAALLSKGS 149 (176)
T ss_dssp ---HHHHHHHHHHHHCSSCSSSBCHHHHHHHHHTTTCCCCHHHHHHHHHHHH-TTSSCBCTTHHHHHHTCCS
T ss_pred ---cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCcccchHHHHHHHHhhc-CCCCeEeHHHHHHHHHhcC
Confidence 266899999999999999999999999994 666655 889999999 9999999999999997643
|
| >2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A | Back alignment and structure |
|---|
Probab=99.88 E-value=5.3e-23 Score=186.57 Aligned_cols=141 Identities=18% Similarity=0.365 Sum_probs=124.1
Q ss_pred cchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhh
Q 007253 457 TLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEAL 536 (611)
Q Consensus 457 ~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~ 536 (611)
.|+++++++|+++|..+|.|++|.|+.+||..++...+. .+++.++..++..+|.+++|.|++.||+..+.........
T Consensus 3 ~lt~eqi~el~~~F~~~D~d~~G~I~~~El~~~l~~~~~-~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~ 81 (148)
T 2lmt_A 3 ELTEEQIAEFKDAFVQFDKEGTGKIATRELGTLMRTLGQ-NPTEAELQDLIAEAENNNNGQLNFTEFCGIMAKQMRETDT 81 (148)
T ss_dssp SCCSHHHHHHHHHHHHHHCSSCCEEEGGGHHHHHHHHTC-CCCHHHHHHHHHHHHTTSTTEEEHHHHHHHHHHTTTTTTT
T ss_pred CCCHHHHHHHHHHHHHHcCCCCCeECHHHHHHHHHhcCC-CchHHHHHHHHHhcccCCCCcccHHHHHHHHHHHhcccCc
Confidence 478999999999999999999999999999999877775 5778889999999999999999999999877654433222
Q ss_pred HHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 537 DRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 537 ~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
++.++.+|+.||+|++|+|+.+||+++|. +|...+ ++.+|+.+|.|+||.|+|+||+++|.+
T Consensus 82 ---~~~l~~aF~~~D~d~~G~I~~~El~~~l~~~g~~~~~~e~~~l~~~~D~d~dG~I~~~EF~~~m~~ 147 (148)
T 2lmt_A 82 ---EEEMREAFKIFDRDGDGFISPAELRFVMINLGEKVTDEEIDEMIREADFDGDGMINYEEFVWMISQ 147 (148)
T ss_dssp ---HHHHHHHHHHHHSSCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCCSCCSSEEHHHHHHHHTT
T ss_pred ---HHHHHHHHHHHCCCCcCcCcHHHHHHHHHHcCccccHHHHHHHHHHhCCCCCCeEeHHHHHHHHhc
Confidence 56789999999999999999999999994 565555 899999999999999999999999864
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.87 E-value=4.9e-22 Score=187.82 Aligned_cols=171 Identities=22% Similarity=0.343 Sum_probs=149.5
Q ss_pred chhHHHHHHHHHHhhcchHHHHHHHhhhhcc-hhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhh----------ccc
Q 007253 428 PLDVIIFKLMKAYMRSSSLRKAALRALSKTL-TVDELFYLKEQYALLEPNKNGTISLENVKSALMKN----------ATD 496 (611)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~l-~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~----------~~~ 496 (611)
|+....+..++++...+.+++..+..++..+ +++++.+++++|..+|.|++|.|+.+||..++... .+.
T Consensus 3 ~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~ 82 (191)
T 3khe_A 3 HALTGALGNMKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKELIEGYRKLMQWKGDTVSDLDS 82 (191)
T ss_dssp CHHHHHHHHHHHCCCCCHHHHHHHHHHHHHSSCTTTTHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHC-----CCHHHH
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCHHHHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHHhhcccccccccc
Confidence 4556678888999999999999999999988 88999999999999999999999999999998776 122
Q ss_pred ccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhcCCCCcc--
Q 007253 497 AMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVP-- 574 (611)
Q Consensus 497 ~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~~~~~~~-- 574 (611)
..++.++..+|..+|.|++|.|+|+||+.++........ ++.++.+|+.+|.|++|+|+.+||++++. +...+
T Consensus 83 ~~~~~~~~~~~~~~D~d~~g~i~~~ef~~~~~~~~~~~~----~~~~~~~F~~~D~d~~G~I~~~E~~~~l~-~~~~~~~ 157 (191)
T 3khe_A 83 SQIEAEVDHILQSVDFDRNGYIEYSEFVTVCMDKQLLLS----RERLLAAFQQFDSDGSGKITNEELGRLFG-VTEVDDE 157 (191)
T ss_dssp HHHHHHHHHHHHHTCTTCSSSEEHHHHHHHHSCHHHHCC----HHHHHHHHHHHCTTCSSEECHHHHHHHTT-SSCCCHH
T ss_pred hhhHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhcccch----HHHHHHHHHHHCCCCcCcCCHHHHHHHHc-cCCCCHH
Confidence 466778899999999999999999999998876644444 56789999999999999999999999998 44444
Q ss_pred -HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 575 -VHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 575 -~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
++.+|..+|.|+||.|+|+||+++|..+.
T Consensus 158 ~~~~~~~~~D~~~dg~i~~~eF~~~~~~~~ 187 (191)
T 3khe_A 158 TWHQVLQECDKNNDGEVDFEEFVEMMQKIC 187 (191)
T ss_dssp HHHHHHHHHCTTCSSSEEHHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 88999999999999999999999998753
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A | Back alignment and structure |
|---|
Probab=99.87 E-value=4.4e-22 Score=179.33 Aligned_cols=137 Identities=19% Similarity=0.342 Sum_probs=119.6
Q ss_pred hhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHH
Q 007253 460 VDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRW 539 (611)
Q Consensus 460 ~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~ 539 (611)
++++.+|+++|..+|.|++|+|+.+||..+|..++. .+++.++..++..+|.|++|.|+|+||+.++........ .
T Consensus 2 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~---~ 77 (143)
T 2obh_A 2 EEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGF-EPKKEEIKKMISEIDKEGTGKMNFGDFLTVMTQKMSEKD---T 77 (143)
T ss_dssp HHHHHHHHHHHHTTCTTCCSEEEGGGHHHHHHHTTC-CCCHHHHHHHHHHHTTTCCSEEEHHHHHHHHHHHHHHHH---H
T ss_pred HHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCCCCCeeeHHHHHHHHHHHhcccc---H
Confidence 567889999999999999999999999999988775 577888999999999999999999999988755432211 2
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLH 600 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~ 600 (611)
.+.++.+|+.||+|++|+|+.+||++++. +|..++ ++++|..+|.|+||.|+|+||+.+|.
T Consensus 78 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~I~~~eF~~~~~ 142 (143)
T 2obh_A 78 KEEILKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEADRDGDGEVSEQEFLRIMK 142 (143)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHHC
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHc
Confidence 56789999999999999999999999994 665554 89999999999999999999999885
|
| >3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor} | Back alignment and structure |
|---|
Probab=99.87 E-value=3.6e-22 Score=204.72 Aligned_cols=142 Identities=22% Similarity=0.396 Sum_probs=124.4
Q ss_pred hhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHH
Q 007253 455 SKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLE 534 (611)
Q Consensus 455 ~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~ 534 (611)
..+++++|+++|+++|..+|.|++|+|+.+||..+|..++. .+++.++..+|..+|.|++|.|+|+||+.++.......
T Consensus 293 ~E~Lt~EEI~ELREaF~~fDkDgdG~IS~eELk~aLrsLG~-~~TeeEI~~Lf~~~D~DgDG~IdFeEFl~lms~~lk~~ 371 (440)
T 3u0k_A 293 RDQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQ-NPTEAELQDMINEVDADGDGTIDFPEFLIMMARKMKDT 371 (440)
T ss_dssp CBCCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTC-CCCHHHHHHHHHHHCSSCSSSEEHHHHHHHHHTC----
T ss_pred HhhhhHHHHHHHHHHHHHHcCCCCCEECHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcCC
Confidence 45789999999999999999999999999999999988875 68888999999999999999999999999886654333
Q ss_pred hhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007253 535 ALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLH 600 (611)
Q Consensus 535 ~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~ 600 (611)
.. +++++.+|+.||+|++|+|+.+||+++|. ++..++ ++++|+.+|.|+||.|+|+||+++|.
T Consensus 372 d~---eeeLreAFk~fDkDgdG~IS~eELr~vL~~lGe~LSdeEIdeLfke~D~DgDGkIsyeEFvkmMt 438 (440)
T 3u0k_A 372 DS---EEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMT 438 (440)
T ss_dssp -----CHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHC
T ss_pred Ch---HHHHHHHHHHHCCCCcCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHhC
Confidence 21 56789999999999999999999999994 565554 88999999999999999999999985
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.7e-21 Score=181.39 Aligned_cols=162 Identities=19% Similarity=0.338 Sum_probs=140.4
Q ss_pred HHHHHHHHHHhhcchHHHHHHHhhhhcch--hhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHh
Q 007253 431 VIIFKLMKAYMRSSSLRKAALRALSKTLT--VDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLS 508 (611)
Q Consensus 431 ~~~~~~~~~~~~~~~l~~~~l~~~~~~l~--~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~ 508 (611)
..++..++.|...+.+++..+..+...++ ++++.+++++|..+|.|++|.|+.+||..+|..++.. ..++..+|.
T Consensus 4 ~~~~~~l~~~~~~~~l~~~~l~~~~~~l~~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~g~~---~~~~~~~~~ 80 (180)
T 3mse_B 4 PNVLNNMKSYMKHSNIRNIIINIMAHELSVINNHIKYINELFYKLDTNHNGSLSHREIYTVLASVGIK---KWDINRILQ 80 (180)
T ss_dssp HHHHHHHHHHTTSCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTCC---HHHHHHHHH
T ss_pred HHHHHHHHHHHHHhHHHHHHHHHHHHHccCCHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCC---HHHHHHHHH
Confidence 45678899999999999999999999987 8999999999999999999999999999999877642 467889999
Q ss_pred hcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhcCCCCcc---HHHHHHHHhcC
Q 007253 509 SLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVP---VHAVLHDWIRH 585 (611)
Q Consensus 509 ~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~~~~~~~---~~~~~~~~D~~ 585 (611)
.+|.|++|.|+|+||+.++....... ++.++.+|+.+|+|++|+|+.+||++++. +..++ ++.+|..+|.|
T Consensus 81 ~~D~d~~g~i~~~Ef~~~~~~~~~~~-----~~~~~~~F~~~D~d~~G~I~~~El~~~l~-~~~~~~~~~~~~~~~~d~~ 154 (180)
T 3mse_B 81 ALDINDRGNITYTEFMAGCYRWKNIE-----STFLKAAFNKIDKDEDGYISKSDIVSLVH-DKVLDNNDIDNFFLSVHSI 154 (180)
T ss_dssp HHCTTCCSEECHHHHHHHHSCCTTC-------CHHHHHHHHHCTTCSSCBCHHHHHHHTT-TSSCCHHHHHHHHHHHHTC
T ss_pred HhCCCCCCcCcHHHHHHHHHhcccCC-----HHHHHHHHHHHCCCCCCCCCHHHHHHHHc-CCCCCHHHHHHHHHHhhhc
Confidence 99999999999999999887654322 35788999999999999999999999997 33333 89999999999
Q ss_pred CC--------CceeHHHHHHHHhh
Q 007253 586 TD--------GKLSFLGFVKLLHG 601 (611)
Q Consensus 586 ~d--------G~is~~eF~~~l~~ 601 (611)
+| |.|+|+||+.+|..
T Consensus 155 ~d~~~~~~~~G~i~~~eF~~~l~~ 178 (180)
T 3mse_B 155 KKGIPREHIINKISFQEFKDYMLS 178 (180)
T ss_dssp ---------CCCBCHHHHHHHHHT
T ss_pred cCcccccccCCeeeHHHHHHHHHh
Confidence 99 99999999999875
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... | Back alignment and structure |
|---|
Probab=99.86 E-value=2.1e-21 Score=175.84 Aligned_cols=142 Identities=21% Similarity=0.397 Sum_probs=123.3
Q ss_pred hcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHh
Q 007253 456 KTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEA 535 (611)
Q Consensus 456 ~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~ 535 (611)
..++++++.+++++|..+|.+++|.|+.+||..+|..++. .+++.++..+++.+|.|++|.|+|+||+.++........
T Consensus 2 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~ 80 (148)
T 1exr_A 2 EQLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQ-NPTEAELQDMINEVDADGNGTIDFPEFLSLMARKMKEQD 80 (148)
T ss_dssp CCCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTC-CCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHhcccCCC
Confidence 3578889999999999999999999999999999988775 567778999999999999999999999988765433222
Q ss_pred hHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 536 LDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 536 ~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
.++.++.+|+.||+|++|+|+.+||++++. +|..++ ++.+|..+|.|+||.|+|+||+.+|..
T Consensus 81 ---~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~d~dg~i~~~eF~~~~~~ 147 (148)
T 1exr_A 81 ---SEEELIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIREADIDGDGHINYEEFVRMMVS 147 (148)
T ss_dssp ---HHHHHHHHHHHHSTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSSSSSBCHHHHHHHHHC
T ss_pred ---cHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHcc
Confidence 256788999999999999999999999994 665554 899999999999999999999998853
|
| >3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C | Back alignment and structure |
|---|
Probab=99.85 E-value=4.8e-22 Score=182.47 Aligned_cols=143 Identities=15% Similarity=0.226 Sum_probs=119.9
Q ss_pred cchhhHHHHHHHHhhhcCC--CCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHH
Q 007253 457 TLTVDELFYLKEQYALLEP--NKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLE 534 (611)
Q Consensus 457 ~l~~~e~~~l~~~F~~~D~--d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~ 534 (611)
.|+++|+++|+++|..||. |++|+|+..||..+|..+|. ++++.++..++. .|.+++|.|+|+||+.++.......
T Consensus 2 qLt~eqi~elre~F~~fD~~~d~dG~I~~~El~~~lr~lG~-~~t~~el~~~~~-~d~~~~g~i~f~eFl~~~~~~~~~~ 79 (159)
T 3i5g_C 2 QLTKDEIEEVREVFDLFDFWDGRDGDVDAAKVGDLLRCLGM-NPTEAQVHQHGG-TKKMGEKAYKLEEILPIYEEMSSKD 79 (159)
T ss_dssp CCCHHHHHHHHHHHHHHHHHTTSSSCEEGGGHHHHHHHTTC-CCCHHHHHTTTC-CSSTTSCEECHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHHHHHHHCcCCCCCCeECHHHHHHHHHHcCC-CCCHHHHHHHHc-ccccCCCcccHHHHHHHHHHhhccc
Confidence 5789999999999999995 89999999999999988876 578888887765 4778899999999998876543221
Q ss_pred hhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhc--CCCCceeHHHHHHHHhhc
Q 007253 535 ALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIR--HTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 535 ~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~--~~dG~is~~eF~~~l~~~ 602 (611)
.. ..+++++.+|+.||+|++|+|+.+||+++|. +|..++ ++.+|+.+|. |+||.|+|+||+++|+.-
T Consensus 80 ~~-~~~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~ls~~e~~~l~~~~D~~~d~dG~I~~~EF~~~m~~~ 152 (159)
T 3i5g_C 80 TG-TAADEFMEAFKTFDREGQGLISSAEIRNVLKMLGERITEDQCNDIFTFCDIREDIDGNIKYEDLMKKVMAG 152 (159)
T ss_dssp TT-CCHHHHHHHHHHHCTTSSSEECHHHHHHHHHHSSSCCCHHHHHHHHHHTTCCCCSSCCEEHHHHHHHHHHC
T ss_pred cc-chHHHHHHHHHHHhcCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCcCCCCCCeEeHHHHHHHHHCC
Confidence 11 1156789999999999999999999999994 777666 8899999995 899999999999988653
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.85 E-value=2.9e-21 Score=178.11 Aligned_cols=161 Identities=27% Similarity=0.514 Sum_probs=132.6
Q ss_pred HHhhcchHHHHHHHhhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcc
Q 007253 439 AYMRSSSLRKAALRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRM 518 (611)
Q Consensus 439 ~~~~~~~l~~~~l~~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i 518 (611)
+|...+.+++..+..+...++++++.+++++|..+|.+++|.|+.+||..++..++. .+++.++..++..+|.|++|.|
T Consensus 2 ~f~~~~~~~~~~~~~~~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~-~~~~~~~~~~~~~~d~~~~g~i 80 (166)
T 2aao_A 2 QFSAMNKFKKMALRVIAESLSEEEIAGLKEMFNMIDADKSGQITFEELKAGLKRVGA-NLKESEILDLMQAADVDNSGTI 80 (166)
T ss_dssp ----CHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCTTCCSSBCHHHHHHHGGGGTC-CCCHHHHHHHHHHHCTTCCSSB
T ss_pred chhhHHHHHHHHHHHHHHhCCHHHHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCCCCCeE
Confidence 456678889999999999999999999999999999999999999999999877654 5677789999999999999999
Q ss_pred cHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCC-ccHHHHHHHHhcCCCCceeHHHHH
Q 007253 519 DFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPA-VPVHAVLHDWIRHTDGKLSFLGFV 596 (611)
Q Consensus 519 ~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~-~~~~~~~~~~D~~~dG~is~~eF~ 596 (611)
+|+||+.++........ .+.++.+|+.+|.|++|+|+.+||+.++. ++.. ..++.+|..+|.|+||.|+|+||+
T Consensus 81 ~~~ef~~~~~~~~~~~~----~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~d~~~dg~i~~~eF~ 156 (166)
T 2aao_A 81 DYKEFIAATLHLNKIER----EDHLFAAFTYFDKDGSGYITPDELQQACEEFGVEDVRIEELMRDVDQDNDGRIDYNEFV 156 (166)
T ss_dssp CHHHHHHHHTTCHHHHT----THHHHHHHHHHCTTCSSSBCHHHHHHHTCC--------CCHHHHHCTTCSSSBCHHHHH
T ss_pred cHHHHHHHHHHHhhccc----HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCHHHHHHHHHHhCCCCCCcEeHHHHH
Confidence 99999998876554333 56789999999999999999999999995 3322 227889999999999999999999
Q ss_pred HHHhhcch
Q 007253 597 KLLHGVSS 604 (611)
Q Consensus 597 ~~l~~~~~ 604 (611)
.++.+.+.
T Consensus 157 ~~~~~~~~ 164 (166)
T 2aao_A 157 AMMQKGSI 164 (166)
T ss_dssp HHHC----
T ss_pred HHHHhccc
Confidence 99987653
|
| >3i5g_B Myosin regulatory light chain LC-2, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_B 3i5h_B 3i5i_B | Back alignment and structure |
|---|
Probab=99.84 E-value=2.3e-21 Score=176.73 Aligned_cols=139 Identities=18% Similarity=0.283 Sum_probs=118.5
Q ss_pred hcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHh
Q 007253 456 KTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEA 535 (611)
Q Consensus 456 ~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~ 535 (611)
..|+++++++|+++|..||.|++|+|+..||..+|..++. .+++.++..++. +.+|.|+|.+|+.++........
T Consensus 8 ~~Lt~~qi~elk~~F~~~D~d~dG~I~~~El~~~l~~lg~-~~~~~~~~~~~~----~~~~~i~f~ef~~~~~~~~~~~~ 82 (153)
T 3i5g_B 8 VKLSQRQMQELKEAFTMIDQDRDGFIGMEDLKDMFSSLGR-VPPDDELNAMLK----ECPGQLNFTAFLTLFGEKVSGTD 82 (153)
T ss_dssp TTCCHHHHHHHHHHHHHHCCSTTSCCCHHHHHHHHHHTTS-CCCHHHHHHHHH----TSSSCCCSHHHHHTTTTTTTTCC
T ss_pred cCCCHHHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCC-CccHHHHHHHHH----hccCCccHHHHHHHHHhhhcccc
Confidence 3589999999999999999999999999999999988876 566666666654 45688999999998876554332
Q ss_pred hHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 536 LDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 536 ~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
. ++.++.+|+.||+|++|+|+.+||+++|. +|..++ ++.||+.+|.| ||.|+|+||+++|.+..
T Consensus 83 ~---~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~ls~~ei~~~~~~~D~~-dG~I~y~EF~~~m~~~~ 150 (153)
T 3i5g_B 83 P---EDALRNAFSMFDEDGQGFIPEDYLKDLLENMGDNFSKEEIKNVWKDAPLK-NKQFNYNKMVDIKGKAE 150 (153)
T ss_dssp C---HHHHHHHHHTTCSSCSSCCCHHHHHHHHHSSSSCCCHHHHHHHHTTCCEE-TTEECHHHHHHHHHCSC
T ss_pred c---HHHHHHHHhccccCCCCeEeHHHHHHHHHHcCCcCCHHHHHHHHHHhCCC-cCEEcHHHHHHHhcCCC
Confidence 2 66899999999999999999999999994 777766 89999999998 99999999999998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=2.7e-21 Score=192.32 Aligned_cols=141 Identities=16% Similarity=0.158 Sum_probs=107.5
Q ss_pred ceeEeCeeeeccceEEEEEEEecCCccCcE--EEEEEecCCCcC---------------------CHHHHHHHHHHHHHH
Q 007253 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQ--VAVKVIPKHKMT---------------------TAIAIEDVRREVKIL 212 (611)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~--vavK~~~~~~~~---------------------~~~~~~~~~~E~~~l 212 (611)
-|++.+.||+|+||.||+|.... +|+. ||||++...... .......+.+|+.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~---~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 124 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVF---DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNL 124 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEE---TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcC---CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHH
Confidence 37899999999999999998754 5788 999997543111 011224678999999
Q ss_pred HHhcCCCCe--eEEEEEEeeCCeeEEEeeecCC-C----ChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HcCCeee
Q 007253 213 RALTGHNNL--VKFFDAYEDTDNVYVVMELCEG-G----ELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH-LQGVVHR 284 (611)
Q Consensus 213 ~~l~~h~~i--v~l~~~~~~~~~~~lv~E~~~~-g----sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~iiHr 284 (611)
.+|. |++| ...+++ +..+|||||+.+ | +|.+.... .++..+..++.||+.||.||| +.|||||
T Consensus 125 ~~l~-~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHr 195 (258)
T 1zth_A 125 ERAK-EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHA 195 (258)
T ss_dssp HHHH-HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECS
T ss_pred HHHH-hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 9998 7653 444442 357899999942 3 66554322 345678899999999999999 9999999
Q ss_pred cCCCCceEEeccCCCceEEEeeccccccc
Q 007253 285 DLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 285 Dlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
||||+|||+. . .++|+|||+|...
T Consensus 196 Dlkp~NILl~---~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYI---D--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEES---S--SEEECCCTTCEET
T ss_pred CCCHHHEEEc---C--cEEEEECcccccC
Confidence 9999999994 3 7999999999764
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A | Back alignment and structure |
|---|
Probab=99.84 E-value=1.5e-20 Score=169.25 Aligned_cols=143 Identities=22% Similarity=0.394 Sum_probs=122.5
Q ss_pred hhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhH
Q 007253 454 LSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQL 533 (611)
Q Consensus 454 ~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~ 533 (611)
|+..++++++.+++++|..+|.+++|.|+.+||..++..++. ..+..++..++..+|.+++|.|+|+||+.++......
T Consensus 1 m~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~-~~~~~~~~~l~~~~d~~~~g~i~~~ef~~~~~~~~~~ 79 (147)
T 4ds7_A 1 MSQNLTEEQIAEFKEAFALFDKDNSGSISASELATVMRSLGL-SPSEAEVADLMNEIDVDGNHAIEFSEFLALMSRQLKC 79 (147)
T ss_dssp ---CCCHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHTTC-CCCHHHHHHHHHHHCTTSSSEEEHHHHHHHHHHHHHT
T ss_pred CCCcCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHhCC-CCCHHHHHHHHHHhccCCCCcCcHHHHHHHHHHhccC
Confidence 456789999999999999999999999999999999987665 5777889999999999999999999999988654332
Q ss_pred HhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 534 EALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 534 ~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
.. ..+.++.+|+.+|.|++|+|+.+||++++. ++..++ ++.++..+| |+||.|+|+||+++|.+
T Consensus 80 ~~---~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d-~~dg~i~~~eF~~~l~k 147 (147)
T 4ds7_A 80 ND---SEQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDEMLREVS-DGSGEINIKQFAALLSK 147 (147)
T ss_dssp HH---HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHS-SSCSSEEHHHHHHHTTC
T ss_pred CC---cHHHHHHHHHHhCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhc-CCCCcCcHHHHHHHHhC
Confidence 22 156789999999999999999999999995 665544 788999999 99999999999998763
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... | Back alignment and structure |
|---|
Probab=99.83 E-value=1e-20 Score=173.40 Aligned_cols=150 Identities=17% Similarity=0.346 Sum_probs=125.2
Q ss_pred HhhhhcchhhHHHHHHHHhhhcCCCC-CCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcch
Q 007253 452 RALSKTLTVDELFYLKEQYALLEPNK-NGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV 530 (611)
Q Consensus 452 ~~~~~~l~~~e~~~l~~~F~~~D~d~-~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~ 530 (611)
..+...+++.++.+++++|..+|.++ +|.|+.+||..++..++. .++..++..+|+.+|.|++|.|+|+||+.++...
T Consensus 6 ~~~~~~l~~~~~~~l~~~F~~~D~~~~~G~i~~~e~~~~l~~~~~-~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~ 84 (161)
T 1dtl_A 6 KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQ-NPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRS 84 (161)
T ss_dssp TTGGGGSCHHHHHHHHHHHHHHTTTCGGGSBCHHHHHHHHHHTTC-CCCHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHH
T ss_pred HHHHhhCCHHHHHHHHHHHHHHcCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHH
Confidence 34556789999999999999999999 999999999999988765 5677789999999999999999999999987665
Q ss_pred hhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 531 HQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 531 ~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
..........+.++.+|+.+|.|++|+|+.+||+.++. ++..++ ++.+|..+|.|+||.|+|+||+.+|.++
T Consensus 85 ~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~ 160 (161)
T 1dtl_A 85 MKDDSKGKSEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKGV 160 (161)
T ss_dssp HC-----CHHHHHHHHHHHHCTTCSSEEEHHHHGGGGTTC--CCCHHHHHHHHHHHCTTSSSEEEHHHHHHHHHC-
T ss_pred hcccccchHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHcC
Confidence 42100111256789999999999999999999999995 554444 8899999999999999999999999765
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A | Back alignment and structure |
|---|
Probab=99.83 E-value=2.5e-20 Score=172.36 Aligned_cols=144 Identities=21% Similarity=0.329 Sum_probs=124.3
Q ss_pred hcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHh
Q 007253 456 KTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEA 535 (611)
Q Consensus 456 ~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~ 535 (611)
..++++++.+|+++|..+|.|++|.|+.+||..+|..++. .++..++..++..+|.|++|.|+|+||+.++........
T Consensus 20 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~-~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~ 98 (169)
T 3qrx_A 20 VGLTEEQKQEIREAFDLFDTDGSGTIDAKELKVAMRALGF-EPKKEEIKKMISEIDKDGSGTIDFEEFLTMMTAKMGERD 98 (169)
T ss_dssp CCCCHHHHHHHHHHHHHHCTTCCSEECHHHHHHHHHHTSC-CCCHHHHHHHHHHHCSSSSSSEEHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHhcccC
Confidence 4578899999999999999999999999999999987775 577788999999999999999999999998865443222
Q ss_pred hHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 536 LDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 536 ~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
..+.+..+|+.+|+|++|+|+.+||++++. ++..++ ++.+|..+|.|+||.|+|+||+.+|.+..
T Consensus 99 ---~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~~ 167 (169)
T 3qrx_A 99 ---SREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDEDEFIRIMKKTS 167 (169)
T ss_dssp ---HHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCCSSSSCBCHHHHHHHHC---
T ss_pred ---cHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCCEeHHHHHHHHHhcc
Confidence 256788999999999999999999999994 665544 89999999999999999999999998653
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... | Back alignment and structure |
|---|
Probab=99.83 E-value=4.2e-20 Score=169.40 Aligned_cols=150 Identities=20% Similarity=0.366 Sum_probs=128.2
Q ss_pred HhhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchh
Q 007253 452 RALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVH 531 (611)
Q Consensus 452 ~~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~ 531 (611)
..+...++++++.+++++|..+|.+++|.|+..||..++..++. .+++.++..++..+|.+++|.|+|+||+.++....
T Consensus 8 ~~~~~~ls~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~-~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~ 86 (162)
T 1top_A 8 AEARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQ-NPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVRQM 86 (162)
T ss_dssp HHHHHHSCHHHHHHHHHHHHTTTCSCSSEEEGGGHHHHHHHTTC-CCCHHHHHHHHHHHCTTSCCEEEHHHHHHHHHHHH
T ss_pred HHhhhhcCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCC-CCCHHHHHHHHHHHcCCCCCcEeHHHHHHHHHHHh
Confidence 34556789999999999999999999999999999999987765 56778899999999999999999999998876554
Q ss_pred hHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 532 QLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 532 ~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
.........+.++.+|+.+|.|++|+|+.+||++++. ++..++ ++.+|..+|.|+||.|+|+||+++|.++
T Consensus 87 ~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~e~~~~l~~~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~~~ 161 (162)
T 1top_A 87 KEDAKGKSEEELANCFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKDSDKNNDGRIDFDEFLKMMEGV 161 (162)
T ss_dssp HHHHHHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHSC
T ss_pred ccccccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHhhc
Confidence 3222111366789999999999999999999999994 565444 8889999999999999999999999865
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A | Back alignment and structure |
|---|
Probab=99.83 E-value=2.7e-20 Score=173.99 Aligned_cols=145 Identities=21% Similarity=0.392 Sum_probs=121.2
Q ss_pred hhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHH
Q 007253 455 SKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLE 534 (611)
Q Consensus 455 ~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~ 534 (611)
+..++++++.+++++|..+|.+++|.|+.+||..+|..++. .+++.++..+|..+|.|++|.|+|+||+.++.......
T Consensus 2 ~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~-~~~~~~~~~l~~~~D~~~~g~i~~~EF~~~~~~~~~~~ 80 (179)
T 2f2o_A 2 ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQ-NPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDT 80 (179)
T ss_dssp ----CCSHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTTC-CCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHH
T ss_pred cccCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhccCCCCCCcHHHHHHHHHHHccCc
Confidence 45688899999999999999999999999999999987765 56777899999999999999999999999876554322
Q ss_pred hhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 535 ALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 535 ~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
. ..+.++.+|+.+|.|++|+|+.+||++++. ++..++ ++.+|..+|.|+||.|+|+||+.+|....
T Consensus 81 ~---~~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~~ 150 (179)
T 2f2o_A 81 D---SEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAKG 150 (179)
T ss_dssp H---HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHC--CCCHHHHHHHHHHHCTTCSSSEEHHHHHHHSCC--
T ss_pred c---cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCCCcCcHHHHHHHHHHcC
Confidence 2 256789999999999999999999999994 554444 88999999999999999999999997654
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A | Back alignment and structure |
|---|
Probab=99.82 E-value=3.1e-20 Score=170.04 Aligned_cols=144 Identities=18% Similarity=0.301 Sum_probs=125.5
Q ss_pred hhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhH
Q 007253 454 LSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQL 533 (611)
Q Consensus 454 ~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~ 533 (611)
....++++++.+|+++|..+|.+++|.|+.+||..+|..++. .+++.++..++..+|.+++|.|+|+||+.++......
T Consensus 13 ~~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~-~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~ 91 (161)
T 3fwb_A 13 LNSELLEEQKQEIYEAFSLFDMNNDGFLDYHELKVAMKALGF-ELPKREILDLIDEYDSEGRHLMKYDDFYIVMGEKILK 91 (161)
T ss_dssp TTTTSCHHHHHHHHHHHHHHCTTSSSEECHHHHHHHHHHTTC-CCCHHHHHHHHHHHCTTSSSCEEHHHHHHHHHHHHHT
T ss_pred CCCCCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhCcCCCCeEeHHHHHHHHHHHHhc
Confidence 345689999999999999999999999999999999988765 5777889999999999999999999999988654332
Q ss_pred HhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 534 EALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 534 ~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
... .+.++.+|+.+|.|++|+|+.+||++++. ++..++ ++.+|..+|.|+||.|+|+||+++|..
T Consensus 92 ~~~---~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~ 160 (161)
T 3fwb_A 92 RDP---LDEIKRAFQLFDDDHTGKISIKNLRRVAKELGETLTDEELRAMIEEFDLDGDGEINENEFIAICTD 160 (161)
T ss_dssp CCH---HHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCSSSSSSEEHHHHHHHHHH
T ss_pred CCc---HHHHHHHHHHHcCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHhc
Confidence 221 56788999999999999999999999995 665544 889999999999999999999999874
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A | Back alignment and structure |
|---|
Probab=99.82 E-value=2e-20 Score=169.57 Aligned_cols=147 Identities=19% Similarity=0.324 Sum_probs=124.1
Q ss_pred hhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhH
Q 007253 454 LSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQL 533 (611)
Q Consensus 454 ~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~ 533 (611)
|.+.++++++++|+++|..+|.+++|.|+.+||..++..++. .+++.++..++..+|.+++|.|+|+||+.++......
T Consensus 1 m~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~-~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~ 79 (153)
T 3ox6_A 1 MDRSLRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGY-MPTEMELIELSQQINMNLGGHVDFDDFVELMGPKLLA 79 (153)
T ss_dssp CCSCCCHHHHHHHHHHHHHHHHHCSSSCCHHHHHHHHHHTTC-CCCHHHHHHHHHHHHTTSTTCCCHHHHHHHHHHHHTT
T ss_pred CcccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCCCCccCcHHHHHHHHHHHhhc
Confidence 346789999999999999999999999999999999988765 5777889999999999999999999999887543322
Q ss_pred Hhh-HHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc--CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 534 EAL-DRWEQHARCAYELFEKDGNRAIVIEELASELG--LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 534 ~~~-~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~--~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
... ....+.++.+|+.+|.|++|+|+.+||++++. ++..++ ++.++..+|.|+||.|+|+||+.+|.+
T Consensus 80 ~~~~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~k 153 (153)
T 3ox6_A 80 ETADMIGVKELRDAFREFDTNGDGEISTSELREAMRALLGHQVGHRDIEEIIRDVDLNGDGRVDFEEFVRMMSR 153 (153)
T ss_dssp CCHHHHCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHSSCCCHHHHHHHHHHHCSSSSSSBCHHHHHHHTCC
T ss_pred cccccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHhC
Confidence 111 01145788999999999999999999999984 455544 889999999999999999999998753
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.2e-20 Score=167.44 Aligned_cols=137 Identities=18% Similarity=0.292 Sum_probs=118.0
Q ss_pred hhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHH
Q 007253 459 TVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDR 538 (611)
Q Consensus 459 ~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~ 538 (611)
+++++.+++++|..+|.+++|.|+.+||..+|..++. .++..++..++..+|.|++|.|+|+||+.++.........
T Consensus 1 ~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~-~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~-- 77 (142)
T 2bl0_C 1 GDDQVSEFKEAFELFDSERTGFITKEGLQTVLKQFGV-RVEPAAFNEMFNEADATGNGKIQFPEFLSMMGRRMKQTTS-- 77 (142)
T ss_dssp CCHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHTC-CCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHTTCCC--
T ss_pred CHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhCcCCCCeeeHHHHHHHHHHHhcCCCh--
Confidence 3567889999999999999999999999999988765 5777789999999999999999999999987653222111
Q ss_pred HHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007253 539 WEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLH 600 (611)
Q Consensus 539 ~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~ 600 (611)
.+.++.+|+.+|.|++|+|+.+||+.++. ++..++ ++.+|..+| |+||.|+|+||+++|.
T Consensus 78 -~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d-~~dg~i~~~eF~~~~~ 141 (142)
T 2bl0_C 78 -EDILRQAFRTFDPEGTGYIPKAALQDALLNLGDRLKPHEFAEFLGITE-TEKGQIRYDNFINTMF 141 (142)
T ss_dssp -HHHHHHHHHHTCCSSCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHHC-CSSSEECSHHHHTTTC
T ss_pred -HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCcEeHHHHHHHHc
Confidence 56789999999999999999999999994 665544 889999999 9999999999998764
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A | Back alignment and structure |
|---|
Probab=99.81 E-value=2.6e-20 Score=170.22 Aligned_cols=146 Identities=19% Similarity=0.352 Sum_probs=122.7
Q ss_pred hcchhhHHHHHHHHhhhcC-CCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHH
Q 007253 456 KTLTVDELFYLKEQYALLE-PNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLE 534 (611)
Q Consensus 456 ~~l~~~e~~~l~~~F~~~D-~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~ 534 (611)
..++++++.+++++|..+| .+++|.|+.+||..+|..++. .+++.++..+|+.+|.+++|.|+|+||+.++.......
T Consensus 5 ~~l~~~~~~~l~~~F~~~D~~~~~G~i~~~e~~~~l~~~~~-~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~~~~~ 83 (158)
T 2jnf_A 5 SKLSSNQVKLLETAFRDFETPEGSGRVSTDQIGIILEVLGI-QQTKSTIRQLIDEFDPFGNGDIDFDSFKIIGARFLGEE 83 (158)
T ss_dssp TTSCHHHHHHHHHHHHHSBCSSSCSSEEHHHHHHHHHHTTC-SCSHHHHHHHHHHHCTTCCSEECHHHHHHHHHHHCCCC
T ss_pred hhCCHHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhccc
Confidence 4578899999999999999 999999999999999988765 57778899999999999999999999999876543211
Q ss_pred h-hHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 535 A-LDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 535 ~-~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
. .....+.++.+|+.+|+|++|+|+.+||+.++. ++..++ ++.+|..+|.|+||.|+|+||+++|.+.
T Consensus 84 ~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~ 156 (158)
T 2jnf_A 84 VNPEQMQQELREAFRLYDKEGNGYISTDVMREILAELDETLSSEDLDAMIDEIDADGSGTVDFEEFMGVMTGG 156 (158)
T ss_dssp CCTTTTSSTHHHHHHHHCSSSSSSEEHHHHHHHHHHHCTTCCHHHHHHHHHHHCSSCCSEECSHHHHHHTSSC
T ss_pred cchhhHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhCCcCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHhcc
Confidence 0 000144688999999999999999999999994 454443 8899999999999999999999998753
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A | Back alignment and structure |
|---|
Probab=99.80 E-value=8.6e-20 Score=176.90 Aligned_cols=154 Identities=11% Similarity=0.127 Sum_probs=130.0
Q ss_pred HHHhhcchHHHHHHHhhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCc
Q 007253 438 KAYMRSSSLRKAALRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRR 517 (611)
Q Consensus 438 ~~~~~~~~l~~~~l~~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~ 517 (611)
..+.....+++.....+...++.++.++++++|..+|.|++|.|+.+||..+|...+. ..++.++..++..+|.|++|.
T Consensus 25 ~~~~~~~~~~~~~~~~~~~~l~~~e~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~-~~~~~~~~~l~~~~D~d~dg~ 103 (220)
T 3sjs_A 25 CIYQMPPSVRNTWWFPLLNTIPLDQYTRIYQWFMGVDRDRSGTLEINELMMGQFPGGI-RLSPQTALRMMRIFDTDFNGH 103 (220)
T ss_dssp HHHHSCHHHHTSTTGGGGGGCCHHHHHHHHHHHHHHCTTCCSSBCHHHHHHCCBGGGB-CCCHHHHHHHHHHHCTTCSSC
T ss_pred hccCCChhHHHHHHHHHHhcCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCCCCCc
Confidence 4444455556666667778899999999999999999999999999999999877654 577888999999999999999
Q ss_pred ccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHH
Q 007253 518 MDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFL 593 (611)
Q Consensus 518 i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~ 593 (611)
|+|+||+.++... +.++.+|+.+|+|++|+|+.+||++++. +|..++ ++.+++.+| |+||.|+|+
T Consensus 104 I~~~EF~~~~~~~----------~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~l~~~~d-d~dg~I~~~ 172 (220)
T 3sjs_A 104 ISFYEFMAMYKFM----------ELAYNLFVMNARARSGTLEPHEILPALQQLGFYINQRTSLLLHRLFA-RGMAFCDLN 172 (220)
T ss_dssp BCHHHHHHHHHHH----------HHHHHHHHHHCCSSTTEECHHHHHHHHHHHTCCCCHHHHHHHHHHHC---CCSEEHH
T ss_pred CCHHHHHHHHHHH----------HHHHHHHHHHCCCCCCCCcHHHHHHHHHHhCCCCCHHHHHHHHHHhc-CCCCcCcHH
Confidence 9999999877542 3578899999999999999999999994 555544 889999999 999999999
Q ss_pred HHHHHHhhcc
Q 007253 594 GFVKLLHGVS 603 (611)
Q Consensus 594 eF~~~l~~~~ 603 (611)
||++++..+.
T Consensus 173 eF~~~~~~l~ 182 (220)
T 3sjs_A 173 CWIAICAFAA 182 (220)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999998764
|
| >2lvv_A Flagellar calcium-binding protein TB-24; EF-hand, metal binding protein; NMR {Trypanosoma brucei brucei} | Back alignment and structure |
|---|
Probab=99.80 E-value=7.4e-20 Score=178.16 Aligned_cols=150 Identities=15% Similarity=0.183 Sum_probs=124.6
Q ss_pred HHHhhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhc---------CCCCCCcccH
Q 007253 450 ALRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSL---------NSLQYRRMDF 520 (611)
Q Consensus 450 ~l~~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~---------D~~~~g~i~~ 520 (611)
+...+...++++++.+|+++|..+|.|++|.|+.+||..++.+..+..++..++..++..+ |.|++|.|+|
T Consensus 37 l~~~l~~~ls~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~lg~~~~~~~~~~~~~~~f~~~~~~~~D~d~~G~I~~ 116 (226)
T 2lvv_A 37 IRCAIPRDKDAESKSRRIELFKQFDTNGTGKLGFREVLDGCYGILKLDEFTTHLPDIVQRAFDKAKDLGNKVKGVGEEDL 116 (226)
T ss_dssp HHHHSCSSCCHHHHHHHHHHHHHHGGGSCSCBCSHHHHHHHHHTTCCTTTSSSCHHHHHHHHHHHHHHHHHHSCCCCCSC
T ss_pred HHHHhchhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHhcccCCCCCCCCcCCH
Confidence 3344566789999999999999999999999999999996666655567777888888877 9999999999
Q ss_pred HHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-C---CCCcc-HHHHHHHHhcCCCCceeHHHH
Q 007253 521 EEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-L---GPAVP-VHAVLHDWIRHTDGKLSFLGF 595 (611)
Q Consensus 521 ~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~---~~~~~-~~~~~~~~D~~~dG~is~~eF 595 (611)
+||+.++........ ++.++.+|+.||+|++|+|+.+||+++|. + +.... ++.+|..+|.|+||.|+|+||
T Consensus 117 ~EF~~~~~~~~~~~~----~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~~~g~~~~e~~~~~~~~D~d~dG~Is~~EF 192 (226)
T 2lvv_A 117 VEFLEFRLMLCYIYD----IFELTVMFDTMDKDGSLLLELQEFKEALPKLKEWGVDITDATTVFNEIDTNGSGVVTFDEF 192 (226)
T ss_dssp BCHHHHHHHHHHHHH----HHHHHHHHHHHSCSSCCEECHHHHHHHHHHHHHHTCCCCSCHHHHHHHCCSCSSCEEHHHH
T ss_pred HHHHHHHHHHHhccC----HHHHHHHHHHHcCCCCCeEcHHHHHHHHHHHhhcCCCHHHHHHHHHHhCCCCCCcEeHHHH
Confidence 999986544333333 56889999999999999999999999983 2 33322 899999999999999999999
Q ss_pred HHHHhhcc
Q 007253 596 VKLLHGVS 603 (611)
Q Consensus 596 ~~~l~~~~ 603 (611)
+.+|....
T Consensus 193 ~~~~~~~~ 200 (226)
T 2lvv_A 193 SCWAVTKK 200 (226)
T ss_dssp HHHHHHHH
T ss_pred HHHHHhcC
Confidence 99997643
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A | Back alignment and structure |
|---|
Probab=99.80 E-value=2.2e-20 Score=168.74 Aligned_cols=138 Identities=12% Similarity=0.213 Sum_probs=113.8
Q ss_pred HHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhc-CCCCCCcccHHHHHHHHcchhhH---HhhH
Q 007253 462 ELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSL-NSLQYRRMDFEEFCAAALSVHQL---EALD 537 (611)
Q Consensus 462 e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~-D~~~~g~i~~~eF~~~~~~~~~~---~~~~ 537 (611)
++++|+++|..+|.|++|.|+.+||..+|..++. .+++.++..++..+ |.+++|.|+|+||+.++...... .. .
T Consensus 2 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~l~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~-~ 79 (148)
T 1m45_A 2 ATRANKDIFTLFDKKGQGAIAKDSLGDYLRAIGY-NPTNQLVQDIINADSSLRDASSLTLDQITGLIEVNEKELDATT-K 79 (148)
T ss_dssp -CCCCTTCHHHHCTTCCSEEEGGGHHHHHHHTTC-CCCHHHHHHHHHC--CC--CCEEEHHHHHHHHHHTHHHHHGGG-C
T ss_pred hHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhCC-CCCHHHHHHHHHHhhCCCCCCeEcHHHHHHHHHHHHhhccccc-c
Confidence 4567899999999999999999999999988765 57778899999999 99999999999999988665211 00 0
Q ss_pred HHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 538 RWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 538 ~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
...+.++.+|+.+|+|++|+|+.+||+.++. +|..++ ++.+|..+|.|+||.|+|+||+++|..
T Consensus 80 ~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~d~dg~i~~~eF~~~~~~ 147 (148)
T 1m45_A 80 AKTEDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFIEDVLR 147 (148)
T ss_dssp CCTHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSTTCCCHHHHHHHHTTCCCCTTSEEEHHHHHHHHHC
T ss_pred ccHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHhc
Confidence 1146789999999999999999999999994 665554 888999999999999999999998863
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... | Back alignment and structure |
|---|
Probab=99.80 E-value=7e-20 Score=167.03 Aligned_cols=141 Identities=18% Similarity=0.273 Sum_probs=122.2
Q ss_pred cchhhHHHHHHHHhhhcCC--CCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhH-
Q 007253 457 TLTVDELFYLKEQYALLEP--NKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQL- 533 (611)
Q Consensus 457 ~l~~~e~~~l~~~F~~~D~--d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~- 533 (611)
.++++++.+|+++|..+|. +++|.|+.+||..+|..++. .++..++..+ ..+|.+++|.|+|+||+.++......
T Consensus 2 ~ls~~~~~~l~~~F~~~D~~~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~l-~~~D~~~~g~i~~~eF~~~~~~~~~~~ 79 (156)
T 1wdc_C 2 KLSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGI-NPRNEDVFAV-GGTHKMGEKSLPFEEFLPAYEGLMDCE 79 (156)
T ss_dssp -CCHHHHHHHHHHHHHHHHHTCSSSCEEGGGHHHHHHHTTC-CCCHHHHHHT-TCCSSTTSCEECHHHHHHHHHHHTTSC
T ss_pred CCCHHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHcCC-CCCHHHHHHH-HhhCCCCCCeeeHHHHHHHHHHHhhcc
Confidence 4678899999999999999 99999999999999988775 5677788889 99999999999999999988665431
Q ss_pred -HhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHH--HhcCCCCceeHHHHHHHHhhcc
Q 007253 534 -EALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHD--WIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 534 -~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~--~D~~~dG~is~~eF~~~l~~~~ 603 (611)
.. .+.++.+|+.||.|++|+|+.+||+.++. +|..++ ++.+|.. +|.|+||.|+|+||+.+|....
T Consensus 80 ~~~----~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~~ 152 (156)
T 1wdc_C 80 QGT----FADYMEAFKTFDREGQGFISGAELRHVLTALGERLSDEDVDEIIKLTDLQEDLEGNVKYEDFVKKVMAGP 152 (156)
T ss_dssp CCC----HHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHHTCCCCTTSEEEHHHHHHHHHHCS
T ss_pred CCh----HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCCCcEeHHHHHHHHhcCC
Confidence 12 56789999999999999999999999994 665544 8889999 9999999999999999998753
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=99.79 E-value=6.6e-20 Score=164.51 Aligned_cols=137 Identities=17% Similarity=0.285 Sum_probs=115.8
Q ss_pred chhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhH
Q 007253 458 LTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALD 537 (611)
Q Consensus 458 l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~ 537 (611)
|+++++.+|+++|..+|.|++|.|+.+||..+|..++. .++..++..++.. ++|.|+|+||+.++.........
T Consensus 1 ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~~~~~----~~g~i~~~eF~~~~~~~~~~~~~- 74 (143)
T 3j04_B 1 FDQSQIQEFKEAFNMIDQNRDGFIDKEDLHDMLASMGK-NPTDEYLEGMMSE----APGPINFTMFLTMFGEKLNGTDP- 74 (143)
T ss_dssp CCHHHHHHHHHHHTTTCSSCTTCCCHHHHHHHHHHTSC-CCCHHHHHTTTTT----SSSCCCHHHHHHHHHHTTTSSCC-
T ss_pred CCHHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHHhCC-CCCHHHHHHHHHh----CCCCcCHHHHHHHHHHHhccCCc-
Confidence 56789999999999999999999999999999988775 5666666666655 78999999999988754332221
Q ss_pred HHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 538 RWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 538 ~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
.+.++.+|+.||+|++|+|+.+||++++. ++..++ ++.+|..+|.|+||.|+|+||+++|...
T Consensus 75 --~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~ 141 (143)
T 3j04_B 75 --EDVIRNAFACFDEEASGFIHEDHLRELLTTMGDRFTDEEVDEMYREAPIDKKGNFNYVEFTRILKHG 141 (143)
T ss_dssp --HHHHHHHHTTSCSSSCCCCCTTTHHHHHHTSSSCCCHHHHHHHHHHTTCCSSSCCCSTHHHHHHHSS
T ss_pred --HHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcCcHHHHHHHHhcc
Confidence 56789999999999999999999999994 565554 8999999999999999999999999753
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* | Back alignment and structure |
|---|
Probab=99.79 E-value=3.3e-19 Score=160.78 Aligned_cols=140 Identities=18% Similarity=0.266 Sum_probs=119.3
Q ss_pred chhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhc---CCCCCCcccHHHHHHHHcchhhHH
Q 007253 458 LTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSL---NSLQYRRMDFEEFCAAALSVHQLE 534 (611)
Q Consensus 458 l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~---D~~~~g~i~~~eF~~~~~~~~~~~ 534 (611)
++++++.+++++|..+|.+++|.|+..||..+|..++. .++..++..++..+ |.++ |.|+|+||+.++.......
T Consensus 2 l~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~~~~-~~~~~~~~~l~~~~~~~d~~~-g~i~~~eF~~~~~~~~~~~ 79 (149)
T 2mys_C 2 FSKAAADDFKEAFLLFDRTGDAKITASQVGDIARALGQ-NPTNAEINKILGNPSKEEMNA-AAITFEEFLPMLQAAANNK 79 (149)
T ss_pred CCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhhhccccC-CcCcHHHHHHHHHHHhccC
Confidence 67889999999999999999999999999999888765 57778899999999 9999 9999999998876542111
Q ss_pred hhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 535 ALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 535 ~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
. ....+.++.+|+.+|+|++|+|+.+||+.++. +|..++ ++.+|.. |.|+||.|+|+||+++|..
T Consensus 80 ~-~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~-d~~~dg~i~~~eF~~~~~~ 148 (149)
T 2mys_C 80 D-QGTFEDFVEGLRVFDKEGNGTVMGAELRHVLATLGEKMTEEEVEELMKG-QEDSNGCINYEAFVKHIMS 148 (149)
T ss_pred C-cchHHHHHHHHHHhCCCCCceEcHHHHHHHHHHhCCCCCHHHHHHHHhh-CCCCCCcEeHHHHHHHHhc
Confidence 1 11256789999999999999999999999994 555444 8889999 9999999999999999864
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.79 E-value=3.6e-20 Score=174.99 Aligned_cols=142 Identities=23% Similarity=0.480 Sum_probs=121.6
Q ss_pred hcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHh
Q 007253 456 KTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEA 535 (611)
Q Consensus 456 ~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~ 535 (611)
..++++++.+|+++|..+|.|++|.|+.+||..+|..++. .+++.++..+|..+|.|++|.|+|+||+.++........
T Consensus 2 ~~ls~~~~~~l~~~F~~~D~d~dG~I~~~E~~~~l~~~g~-~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~~~~~~~~~~ 80 (188)
T 1s6i_A 2 ERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGS-ELMESEIKDLMDAADIDKSGTIDYGEFIAATVHLNKLER 80 (188)
T ss_dssp CSSSCTTTCSHHHHHHTTSSSSSSCEEHHHHHHHHTTTTC-CCCHHHHHHHHHHTCTTCSSEECHHHHHHHHTTSSSSCC
T ss_pred CCCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCC-CCCHHHHHHHHHHcCCCCCCeEeHHHHHHHHHHHhccCH
Confidence 4578888999999999999999999999999999877764 567778999999999999999999999998765433222
Q ss_pred hHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCC-CccHHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 536 LDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGP-AVPVHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 536 ~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~-~~~~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
++.++.+|+.+|.|++|+|+.+||++++. ++. ...++.+|..+|.|+||.|+|+||+.+|...
T Consensus 81 ----~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~g~~~~~~~~~~~~~D~d~dG~Is~~EF~~~~~~~ 145 (188)
T 1s6i_A 81 ----EENLVSAFSYFDKDGSGYITLDEIQQACKDFGLDDIHIDDMIKEIDQDNDGQIDYGEFAAMMRKR 145 (188)
T ss_dssp ----CCSTHHHHHHTTTTCSSEEEHHHHHHTTTTTTCCTTHHHHHHHHHCSSSSSEEETTHHHHTTSCC
T ss_pred ----HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCHHHHHHHHHHHCCCCCCcEeHHHHHHHHHHc
Confidence 34678899999999999999999999995 432 2238999999999999999999999998653
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.8e-19 Score=170.73 Aligned_cols=150 Identities=15% Similarity=0.200 Sum_probs=115.8
Q ss_pred HhhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHH-----HHHHhhcccccccC-----ChhHHHhhcCCCCCCcccHH
Q 007253 452 RALSKTLTVDELFYLKEQYALLEPNKNGTISLENVK-----SALMKNATDAMKDS-----RIPDFLSSLNSLQYRRMDFE 521 (611)
Q Consensus 452 ~~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~-----~~l~~~~~~~~~~~-----~~~~~~~~~D~~~~g~i~~~ 521 (611)
+.+...++++++.+++++|..+|.|++|+|+.+||. .++..++. .+++. ++..++..+|.|++|.|+|+
T Consensus 8 ~~~~~~~s~~~~~~l~~~F~~~D~d~~G~i~~~El~~~~~~~~l~~~g~-~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~ 86 (195)
T 1qv0_A 8 KLKTDFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEA-TPEQTKRHQVCVEAFFRGCGMEYGKEIAFP 86 (195)
T ss_dssp CCSCCTTCHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTHHHHTTC-CHHHHHHHHHHHHHHHHHTTCCTTCCBCHH
T ss_pred hcCcccCCHHHHHHHHHHHhHcCCCCCCcCcHHHHHHHHHHHHHHHcCC-CccHHHHHHHHHHHHHHHcCCCCCceEcHH
Confidence 344555689999999999999999999999999999 56666654 34443 57889999999999999999
Q ss_pred HHHHHHcchhhHHh-------hHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCce
Q 007253 522 EFCAAALSVHQLEA-------LDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKL 590 (611)
Q Consensus 522 eF~~~~~~~~~~~~-------~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~i 590 (611)
||+.++........ .+.+...++.+|+.||+|++|+|+.+||++++. +|..++ ++.+|..+|.|+||.|
T Consensus 87 EF~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i 166 (195)
T 1qv0_A 87 QFLDGWKQLATSELKKWARNEPTLIREWGDAVFDIFDKDGSGTITLDEWKAYGKISGISPSQEDCEATFRHCDLDNAGDL 166 (195)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCHHHHHHHHHHHHTC----CEECHHHHHHHHHHHSSCCCHHHHHHHHHHSCCCTTSCE
T ss_pred HHHHHHHHHHhhhhhcccccHHHHHHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcC
Confidence 99987765432210 011122334899999999999999999999994 554433 8999999999999999
Q ss_pred eHHHHHHHHhhc
Q 007253 591 SFLGFVKLLHGV 602 (611)
Q Consensus 591 s~~eF~~~l~~~ 602 (611)
+|+||++++...
T Consensus 167 ~~~eF~~~~~~~ 178 (195)
T 1qv0_A 167 DVDEMTRQHLGF 178 (195)
T ss_dssp EHHHHHHHHHHH
T ss_pred CHHHHHHHHHHH
Confidence 999999998774
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=4.7e-19 Score=169.16 Aligned_cols=140 Identities=15% Similarity=0.265 Sum_probs=116.4
Q ss_pred hhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHH
Q 007253 459 TVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDR 538 (611)
Q Consensus 459 ~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~ 538 (611)
...++.+++++|..+|.|++|.|+.+||..+|..++. .+++.++..+|..+|.|++|.|+|+||+.++........
T Consensus 32 ~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~-~~~~~~~~~~~~~~D~d~dg~i~~~ef~~~~~~~~~~~~--- 107 (204)
T 3e3r_A 32 GASGIQGLARFFRQLDRDGSRSLDADEFRQGLAKLGL-VLDQAEAEGVCRKWDRNGSGTLDLEEFLRALRPPMSQAR--- 107 (204)
T ss_dssp --------CHHHHHHCTTCCSSBCHHHHHHHHHTTTC-CCCHHHHHHHHHHHCTTCSSSBCHHHHHHHTSCCCCHHH---
T ss_pred CchhHHHHHHHHHHHccCCCCCcCHHHHHHHHHHcCC-CCCHHHHHHHHHHhccCCCCcCcHHHHHHHHHhhcCchH---
Confidence 4567789999999999999999999999999988765 577788999999999999999999999998876554433
Q ss_pred HHHHHHHHHhHHhcCCCCcccHHHHHHHhc-C-------CCCcc---HHHHHHHHhc-CCCCceeHHHHHHHHhhcc
Q 007253 539 WEQHARCAYELFEKDGNRAIVIEELASELG-L-------GPAVP---VHAVLHDWIR-HTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 539 ~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~-------~~~~~---~~~~~~~~D~-~~dG~is~~eF~~~l~~~~ 603 (611)
++.++.+|+.+|.|++|+|+.+||++++. . +...+ ++.+|..+|. |+||.|+|+||+.++..++
T Consensus 108 -~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~D~~d~dg~Is~~EF~~~~~~~~ 183 (204)
T 3e3r_A 108 -EAVIAAAFAKLDRSGDGVVTVDDLRGVYSGRAHPKVRSGEWTEDEVLRRFLDNFDSSEKDGQVTLAEFQDYYSGVS 183 (204)
T ss_dssp -HHHHHHHHHHHCTTCSSEECHHHHHHHCCCTTCHHHHTTSSCHHHHHHHHHHHHSCSSCCSCEEHHHHHHHHHHHH
T ss_pred -HHHHHHHHHHhCcCCCCeEeHHHHHHHHccccCCccccCCCChHHHHHHHHHHhhccCCCCcCcHHHHHHHHHHcC
Confidence 66899999999999999999999999995 2 22222 7889999999 9999999999999998875
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B | Back alignment and structure |
|---|
Probab=99.78 E-value=4.4e-19 Score=163.60 Aligned_cols=142 Identities=13% Similarity=0.198 Sum_probs=118.8
Q ss_pred hhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHH
Q 007253 455 SKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLE 534 (611)
Q Consensus 455 ~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~ 534 (611)
...++++++.+|+++|..+|.|++|.|+.+||..+|..++...++..++..++... +|.|+|+||+.++.......
T Consensus 16 ~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~l~~~~----dg~i~~~eF~~~~~~~~~~~ 91 (166)
T 2mys_B 16 FSMFDETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNEELDAMIKEA----SGPINFTVFLTMFGEKLKGA 91 (166)
T ss_pred hhhCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHC----CCCcCHHHHHHHHHHHhccC
Confidence 34788999999999999999999999999999999977764146677788888764 79999999999876543221
Q ss_pred hhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 535 ALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 535 ~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
. ..+.++.+|+.||.|++|+|+.+||+.++. +|..++ ++.+|..+|.|+||.|+|+||+.+|....
T Consensus 92 ~---~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~I~~~eF~~~~~~~~ 161 (166)
T 2mys_B 92 D---PEDVIMGAFKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWAAFPPDVAGNVDYKNICYVITHGE 161 (166)
T ss_pred C---cHHHHHHHHHHhCCCCCcceeHHHHHHHHHHcCCCCCHHHHHHHHHhcCCCCCCeEeHHHHHHHHHhcc
Confidence 1 156789999999999999999999999994 555544 88999999999999999999999998754
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C | Back alignment and structure |
|---|
Probab=99.78 E-value=3.3e-20 Score=168.15 Aligned_cols=142 Identities=22% Similarity=0.333 Sum_probs=111.9
Q ss_pred cchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCC--CCCcccHHHHHHHHcchhhHH
Q 007253 457 TLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSL--QYRRMDFEEFCAAALSVHQLE 534 (611)
Q Consensus 457 ~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~--~~g~i~~~eF~~~~~~~~~~~ 534 (611)
.++++++.+++++|..+|.+++|+|+.+||..+|..++. .++..++..++..+|.+ ++|.|+|+||+.++.......
T Consensus 3 ~ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~l~~~~d~~~~~~g~i~~~eF~~~~~~~~~~~ 81 (151)
T 1w7j_B 3 EFNKDQLEEFKEAFELFDRVGDGKILYSQCGDVMRALGQ-NPTNAEVLKVLGNPKSDELKSRRVDFETFLPMLQAVAKNR 81 (151)
T ss_dssp --------CHHHHHHHHCCSSSSEEESTTHHHHHHHTTC-CCCHHHHHHHTTCCCHHHHTTCEEEHHHHHHHHHHHCC--
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhCcCcCCCCcCcHHHHHHHHHHHhccC
Confidence 467889999999999999999999999999999987765 56777899999999999 999999999999876543211
Q ss_pred hhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 535 ALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 535 ~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
. ....+.++.+|+.+|.|++|+|+.+||++++. +|..++ ++.+|..+| |+||.|+|+||+++|..
T Consensus 82 ~-~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d-~~dg~i~~~eF~~~~~~ 150 (151)
T 1w7j_B 82 G-QGTYEDYLEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLAGHE-DSNGCINYEAFLKHILS 150 (151)
T ss_dssp -------CCHHHHHTTCTTSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTTCC-CTTSEEEHHHHHHHTC-
T ss_pred C-CCcHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHhcc-CCCCeEeHHHHHHHHhc
Confidence 1 11145678899999999999999999999994 665544 888999999 99999999999998753
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=7.5e-19 Score=167.73 Aligned_cols=143 Identities=21% Similarity=0.301 Sum_probs=118.1
Q ss_pred cchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHh-
Q 007253 457 TLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEA- 535 (611)
Q Consensus 457 ~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~- 535 (611)
.++++++.+|+++|..+|.|++|+|+.+||..+ ..++. .. .+..+|..+|.|++|.|+|+||+.++........
T Consensus 22 ~ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~-~~lg~-~~---~~~~l~~~~D~d~dg~i~~~EF~~~~~~~~~~~~~ 96 (202)
T 2bec_A 22 GFSQASLLRLHHRFRALDRNKKGYLSRMDLQQI-GALAV-NP---LGDRIIESFFPDGSQRVDFPGFVRVLAHFRPVEDE 96 (202)
T ss_dssp CCCHHHHHHHHHHHHHHCSSCSSCCCHHHHHTC-HHHHH-ST---THHHHHHTTSCSSCCCCCHHHHHHHHGGGSCCCHH
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH-HhcCC-Cc---cHHHHHHHhCCCCCCcCcHHHHHHHHHHhcccchh
Confidence 578899999999999999999999999999998 55543 22 2899999999999999999999998876542000
Q ss_pred ------------hHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-C-CCCcc---HHHHHHH----HhcCCCCceeHHH
Q 007253 536 ------------LDRWEQHARCAYELFEKDGNRAIVIEELASELG-L-GPAVP---VHAVLHD----WIRHTDGKLSFLG 594 (611)
Q Consensus 536 ------------~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~-~~~~~---~~~~~~~----~D~~~dG~is~~e 594 (611)
.....+.++.+|+.||.|++|+|+.+||+.++. + |..++ ++.++.. +|.|+||.|+|+|
T Consensus 97 ~~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~~~~~~~~~~~~~~~~~D~d~dG~Is~~E 176 (202)
T 2bec_A 97 DTETQDPKKPEPLNSRRNKLHYAFQLYDLDRDGKISRHEMLQVLRLMVGVQVTEEQLENIADRTVQEADEDGDGAVSFVE 176 (202)
T ss_dssp HHC-----CCCCTTSHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHSCCSCCCHHHHHHHHHHHHHHHCSSCSSSEEHHH
T ss_pred cccccccccccccccHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHcCCCCCCcCcHHH
Confidence 011266789999999999999999999999995 5 65554 6667777 9999999999999
Q ss_pred HHHHHhhcch
Q 007253 595 FVKLLHGVSS 604 (611)
Q Consensus 595 F~~~l~~~~~ 604 (611)
|+.+|.....
T Consensus 177 F~~~~~~~~~ 186 (202)
T 2bec_A 177 FTKSLEKMDV 186 (202)
T ss_dssp HHHTTTTSCH
T ss_pred HHHHHHHhCc
Confidence 9999987643
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* | Back alignment and structure |
|---|
Probab=99.78 E-value=6.2e-19 Score=160.24 Aligned_cols=138 Identities=20% Similarity=0.353 Sum_probs=114.6
Q ss_pred hhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHH
Q 007253 459 TVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDR 538 (611)
Q Consensus 459 ~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~ 538 (611)
+++++++|+++|..+|.+++|.|+.+|| .++...+. ..++..++..+|.|++|.|+|+||+.++.........
T Consensus 1 s~~~~~~l~~~F~~~D~d~~G~i~~~el-~~l~~~~~----~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~-- 73 (155)
T 3ll8_B 1 DADEIKRLGKRFKKLDLDNSGSLSVEEF-MSLPELQQ----NPLVQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKGDK-- 73 (155)
T ss_dssp CCHHHHHHHHHHHHHCTTCSSSBCHHHH-TTSGGGTT----CTTHHHHHHHHCTTCSSSBCHHHHHHHHGGGCSSCCH--
T ss_pred CHHHHHHHHHHHHHhCcCCCCeEcHHHH-HHhhcccc----chHHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCH--
Confidence 3678899999999999999999999999 54544443 2378999999999999999999999988765322121
Q ss_pred HHHHHHHHHhHHhcCCCCcccHHHHHHHhc--CCCCcc---HHHHHHH----HhcCCCCceeHHHHHHHHhhcch
Q 007253 539 WEQHARCAYELFEKDGNRAIVIEELASELG--LGPAVP---VHAVLHD----WIRHTDGKLSFLGFVKLLHGVSS 604 (611)
Q Consensus 539 ~~~~~~~~F~~~D~d~~G~It~eEl~~~l~--~~~~~~---~~~~~~~----~D~~~dG~is~~eF~~~l~~~~~ 604 (611)
.+.++.+|+.+|.|++|+|+.+||++++. .+...+ +..++.. +|.|+||.|+|+||+.+|..+..
T Consensus 74 -~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~~~ 147 (155)
T 3ll8_B 74 -EQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVDKTIINADKDGDGRISFEEFCAVVGGLDI 147 (155)
T ss_dssp -HHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHCTTSSSSBCHHHHHHHHGGGCG
T ss_pred -HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhccCCCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHhccCc
Confidence 56789999999999999999999999984 244433 6667777 99999999999999999998765
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.78 E-value=8e-19 Score=163.11 Aligned_cols=145 Identities=12% Similarity=0.096 Sum_probs=117.8
Q ss_pred chhhHHHHHHHHhhhcCCCCCCcccHHHHHH----HHHhhcccccccCChh-----------HHHhhcCCCCCCcccHHH
Q 007253 458 LTVDELFYLKEQYALLEPNKNGTISLENVKS----ALMKNATDAMKDSRIP-----------DFLSSLNSLQYRRMDFEE 522 (611)
Q Consensus 458 l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~----~l~~~~~~~~~~~~~~-----------~~~~~~D~~~~g~i~~~e 522 (611)
++++++++++++|..+|.|++|.|+.+||.. ++..++. .++..++. .+|..+|.|++|.|+++|
T Consensus 1 ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~~~~~l~~~g~-~~~~~~~~~l~~~~~~~~~~lf~~~D~d~dg~i~~~E 79 (176)
T 1nya_A 1 TTAIASDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGK-DAGAAEVQTLKNAFGGLFDYLAKEAGVGSDGSLTEEQ 79 (176)
T ss_dssp CCSHHHHHHHHHHHHCCSSCCSSBCSHHHHHHHHHHHHHTSS-CSSSHHHHHHHHHHHHHHHHHHHHHTSCTTCCBCHHH
T ss_pred CcHHHHHHHHHHHHHHcCCCCCcccHHHHHHHHHHHHHHcCC-CCCcHHHHHHHHHHHHHHHHHHHHhCCCCCCeEcHHH
Confidence 4678899999999999999999999999999 4555554 56666665 788999999999999999
Q ss_pred HHHHHcchhhHHh----hHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCC-ccHHHHHHHHhcCCCCceeHHHHH
Q 007253 523 FCAAALSVHQLEA----LDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPA-VPVHAVLHDWIRHTDGKLSFLGFV 596 (611)
Q Consensus 523 F~~~~~~~~~~~~----~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~-~~~~~~~~~~D~~~dG~is~~eF~ 596 (611)
|+.++........ .+...+.++.+|+.+|.|++|+|+.+||+.++. +|.. ..++.+|..+|.|+||.|+|+||+
T Consensus 80 f~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~e~~~~l~~~g~~~~~~~~~~~~~D~d~dg~i~~~ef~ 159 (176)
T 1nya_A 80 FIRVTENLIFEQGEASFNRVLGPVVKGIVGMCDKNADGQINADEFAAWLTALGMSKAEAAEAFNQVDTNGNGELSLDELL 159 (176)
T ss_dssp HHHHHHHHHSSSCHHHHHHHHHHHHHHHHHHTCSSCCSEEEHHHHHHHHHHTTCCHHHHHHHHHHHCTTCSSEEEHHHHH
T ss_pred HHHHHHHHhcCCchhhHHHHHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhCCCHHHHHHHHHHhCCCCCCCCcHHHHH
Confidence 9988765432211 111245789999999999999999999999994 5521 128899999999999999999999
Q ss_pred HHHhhcc
Q 007253 597 KLLHGVS 603 (611)
Q Consensus 597 ~~l~~~~ 603 (611)
+++...-
T Consensus 160 ~~~~~~~ 166 (176)
T 1nya_A 160 TAVRDFH 166 (176)
T ss_dssp HHHSCCS
T ss_pred HHHHHHh
Confidence 9998764
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} | Back alignment and structure |
|---|
Probab=99.77 E-value=9.6e-19 Score=169.41 Aligned_cols=149 Identities=17% Similarity=0.184 Sum_probs=120.8
Q ss_pred HHHhhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhc---------CCCCCCcccH
Q 007253 450 ALRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSL---------NSLQYRRMDF 520 (611)
Q Consensus 450 ~l~~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~---------D~~~~g~i~~ 520 (611)
+...+...++++++.+++++|..+|.|++|.|+.+||..+|....+..++..++..++..+ |.|++|.|+|
T Consensus 34 l~~~~~~~ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~d~~g~I~~ 113 (219)
T 3cs1_A 34 IRQAIPREKTAEAKQRRIELFKKFDKNETGKLCYDEVYSGCLEVLKLDEFTSRVRDITKRAFDKSRTLGSKLENKGSEDF 113 (219)
T ss_dssp HHHHSCCSSSHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTTCGGGTCSCHHHHHHHHHHHHHHHHHHHHTSCCCSS
T ss_pred HHHHhcccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhCCCccHHHHHHHHHHHHHHHHhhhhccCCCCcCCH
Confidence 3344556788999999999999999999999999999999887433457777787765432 3478999999
Q ss_pred HHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CC----CCccHHHHHHHHhcCCCCceeHHHH
Q 007253 521 EEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LG----PAVPVHAVLHDWIRHTDGKLSFLGF 595 (611)
Q Consensus 521 ~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~----~~~~~~~~~~~~D~~~dG~is~~eF 595 (611)
.||+.++........ .+.++.+|+.||.|++|+|+.+||++++. +| ....++.+|..+|.|+||.|+|+||
T Consensus 114 ~EF~~~~~~~~~~~~----~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~e~~~l~~~~D~d~dG~I~~~EF 189 (219)
T 3cs1_A 114 VEFLEFRLMLCYIYD----FFELTVMFDEIDASGNMLVDEEEFKRAVPKLEAWGAKVEDPAALFKELDKNGTGSVTFDEF 189 (219)
T ss_dssp BCHHHHHHHHHHHHH----HHHHHHHHHTTCSSSSSEEEHHHHHHHHHHHHHHTCCCSCHHHHHHHHCTTSSSEEEHHHH
T ss_pred HHHHHHHHHHhccch----HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhcccCCCHHHHHHHHHHhCCCCCCcEeHHHH
Confidence 999987654433222 56799999999999999999999999993 22 2223999999999999999999999
Q ss_pred HHHHhhc
Q 007253 596 VKLLHGV 602 (611)
Q Consensus 596 ~~~l~~~ 602 (611)
+.+|...
T Consensus 190 ~~~~~~~ 196 (219)
T 3cs1_A 190 AAWASAV 196 (219)
T ss_dssp HHHHHHH
T ss_pred HHHHHHh
Confidence 9999764
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} | Back alignment and structure |
|---|
Probab=99.77 E-value=2e-18 Score=163.11 Aligned_cols=147 Identities=10% Similarity=0.073 Sum_probs=120.6
Q ss_pred hcchhhHHHHHHHHhhhc-CCCCCCcccHHHHHHHHHhhc---ccccccCChhHHH-----------hhcCCCCCCcccH
Q 007253 456 KTLTVDELFYLKEQYALL-EPNKNGTISLENVKSALMKNA---TDAMKDSRIPDFL-----------SSLNSLQYRRMDF 520 (611)
Q Consensus 456 ~~l~~~e~~~l~~~F~~~-D~d~~G~Is~~e~~~~l~~~~---~~~~~~~~~~~~~-----------~~~D~~~~g~i~~ 520 (611)
..+++.+.++++++|..+ |.|++|+|+.+||..++.... +...+..++..++ ..+|.|++|.|++
T Consensus 4 ~~ls~~~~~~l~~~F~~~~D~d~dG~i~~~E~~~~l~~~~~~~g~~~~~~~~~~l~~~~~~~~~~~~~~~D~d~dG~i~~ 83 (191)
T 2ccm_A 4 HQLSDFQRNKILRVFNTFYDCNHDGVIEWDDFELAIKKICNLHSWPTDGKKHNEARATLKLIWDGLRKYADENEDEQVTK 83 (191)
T ss_dssp CCCCHHHHHHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHTCCTTSHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEH
T ss_pred hhccHHHHHHHHHhccccccCCCCCeeeHHHHHHHHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCeECH
Confidence 456788899999999999 999999999999999988772 2246666777788 9999999999999
Q ss_pred HHHHHHHcchhhH-----HhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCC-ccHHHHHHHHhcCCCCceeHH
Q 007253 521 EEFCAAALSVHQL-----EALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPA-VPVHAVLHDWIRHTDGKLSFL 593 (611)
Q Consensus 521 ~eF~~~~~~~~~~-----~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~-~~~~~~~~~~D~~~dG~is~~ 593 (611)
+||+.++...... .........++.+|+.+|+|++|+|+.+||+.++. +|.. ..++.+|..+|.|+||.|+|+
T Consensus 84 ~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~I~~~E~~~~l~~~g~~~~~~~~~~~~~D~d~dG~i~~~ 163 (191)
T 2ccm_A 84 EEWLKMWAECVKSVEKGESLPEWLTKYMNFMFDVNDTSGDNIIDKHEYSTVYMSYGIPKSDCDAAFDTLSDGGKTMVTRE 163 (191)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHCTTCSSBCCHHHHHHHHHTTTCCHHHHHHHHHHHTTTTTSCCBHH
T ss_pred HHHHHHHHHHhccccchhhchHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCHHHHHHHHHHhCCCCCCCcCHH
Confidence 9999887654321 00112256789999999999999999999999994 4422 128899999999999999999
Q ss_pred HHHHHHhhc
Q 007253 594 GFVKLLHGV 602 (611)
Q Consensus 594 eF~~~l~~~ 602 (611)
||+.++...
T Consensus 164 Ef~~~~~~~ 172 (191)
T 2ccm_A 164 IFARLWTEY 172 (191)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999999764
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... | Back alignment and structure |
|---|
Probab=99.77 E-value=7.5e-19 Score=160.22 Aligned_cols=142 Identities=17% Similarity=0.325 Sum_probs=115.8
Q ss_pred hhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhh
Q 007253 453 ALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQ 532 (611)
Q Consensus 453 ~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~ 532 (611)
.....++++++.+|+++|..+|.+++|.|+.+||..+|..++. .++..++..++. +++|.|+|+||+.++.....
T Consensus 7 ~~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~~~~----~~~g~i~~~eF~~~~~~~~~ 81 (156)
T 1wdc_B 7 GVLTKLPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGR-APDDKELTAMLK----EAPGPLNFTMFLSIFSDKLS 81 (156)
T ss_dssp -----CCHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHHHHSS-CCCHHHHHHHHT----TSSSCCCHHHHHHHHHHHTC
T ss_pred chhccCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHH----hCCCcCcHHHHHHHHHHHhc
Confidence 3445688899999999999999999999999999999988765 566667777775 46899999999988765422
Q ss_pred HHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 533 LEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 533 ~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
.... .+.++.+|+.||+|++|+|+.+||+.++. +|..++ ++.+|..+|.| ||.|+|+||+++|....
T Consensus 82 ~~~~---~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~-dg~i~~~eF~~~~~~~~ 152 (156)
T 1wdc_B 82 GTDS---EETIRNAFAMFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFKEAPVE-GGKFDYVKFTAMIKGSG 152 (156)
T ss_dssp SCCC---HHHHHHHHHTTCTTCCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHCCEE-TTEECHHHHHHHHHTSC
T ss_pred CCCh---HHHHHHHHHHHCcCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHhcCCC-CCEEeHHHHHHHHhcCc
Confidence 1111 55788999999999999999999999994 665544 88999999999 99999999999997643
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A | Back alignment and structure |
|---|
Probab=99.77 E-value=8.5e-19 Score=165.35 Aligned_cols=144 Identities=15% Similarity=0.150 Sum_probs=116.1
Q ss_pred chhhHHHHHHHHhhhcCCCCCCcccHHHHH-----HHHHhhcccccccC-----ChhHHHhhcCCCCCCcccHHHHHHHH
Q 007253 458 LTVDELFYLKEQYALLEPNKNGTISLENVK-----SALMKNATDAMKDS-----RIPDFLSSLNSLQYRRMDFEEFCAAA 527 (611)
Q Consensus 458 l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~-----~~l~~~~~~~~~~~-----~~~~~~~~~D~~~~g~i~~~eF~~~~ 527 (611)
++++++.+++++|..+|.|++|.|+.+||. .++..++. .+++. ++..++..+|.|++|.|+|+||+.++
T Consensus 10 ~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~~~~~~l~~~g~-~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~EF~~~~ 88 (191)
T 1uhk_A 10 DNPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGA-TPEQAKRHKDAVEAFFGGAGMKYGVETDWPAYIEGW 88 (191)
T ss_dssp TCHHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHHHHTSCC-CHHHHHHHHHHHHHHHHHTTCCTTCEEEHHHHHHHH
T ss_pred CCHHHHHHHHHHHhhccCCCCCcCcHHHHHHHHHHHHHHHcCC-CchhHHHHHHHHHHHHHHhCcCCCCcCcHHHHHHHH
Confidence 477889999999999999999999999999 67666654 44444 57889999999999999999999877
Q ss_pred cchhhHHh-------hHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHH
Q 007253 528 LSVHQLEA-------LDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFV 596 (611)
Q Consensus 528 ~~~~~~~~-------~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~ 596 (611)
........ .+.....++.+|+.+|.|++|+|+.+||++++. +|..++ ++.+|..+|.|+||.|+|+||+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~i~~~eF~ 168 (191)
T 1uhk_A 89 KKLATDELEKYAKNEPTLIRIWGDALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCDIDESGQLDVDEMT 168 (191)
T ss_dssp HHHHHHHHHHHHTTCCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTSCCSHHHHHHHHHHSCCCTTSCEEHHHHH
T ss_pred HHHhcchhhhhhhhhHHHHHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 65432210 000111233899999999999999999999994 454443 8899999999999999999999
Q ss_pred HHHhhc
Q 007253 597 KLLHGV 602 (611)
Q Consensus 597 ~~l~~~ 602 (611)
.++...
T Consensus 169 ~~~~~~ 174 (191)
T 1uhk_A 169 RQHLGF 174 (191)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999874
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.3e-18 Score=153.65 Aligned_cols=130 Identities=18% Similarity=0.240 Sum_probs=111.5
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHc---chhhHHhhHHHHH
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAAL---SVHQLEALDRWEQ 541 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~---~~~~~~~~~~~~~ 541 (611)
+++++|..+|.+++|.|+.+||..++...+. ..++.++..+|+.+|.+++|.|+++||+.++. ....... .+
T Consensus 1 ~l~~~F~~~D~~~~g~i~~~e~~~~l~~~~~-~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~----~~ 75 (134)
T 1jfj_A 1 MAEALFKEIDVNGDGAVSYEEVKAFVSKKRA-IKNEQLLQLIFKSIDADGNGEIDQNEFAKFYGSIQGQDLSDD----KI 75 (134)
T ss_dssp CHHHHHHHHCTTCSSEEEHHHHHHHHHTTCC-SSHHHHHHHHHHHHCSSCCSEEEHHHHHHHTTCSSCCSSHHH----HH
T ss_pred CHHHHHHHHCCCCCCcCCHHHHHHHHHHcCC-CCCHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHhcccccCCC----HH
Confidence 3788999999999999999999999877664 56777899999999999999999999999885 2111112 44
Q ss_pred HHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCccHHHHHHHHhcCCCCceeHHHHHHHHh
Q 007253 542 HARCAYELFEKDGNRAIVIEELASELG-LGPAVPVHAVLHDWIRHTDGKLSFLGFVKLLH 600 (611)
Q Consensus 542 ~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~~~~~~~~~D~~~dG~is~~eF~~~l~ 600 (611)
.++.+|+.+|.|++|+|+.+||+.++. ++... +..+|..+|.|+||.|+|+||+++|.
T Consensus 76 ~~~~~f~~~D~d~~G~i~~~e~~~~l~~~~~~~-~~~~~~~~D~~~dg~i~~~ef~~~ll 134 (134)
T 1jfj_A 76 GLKVLYKLMDVDGDGKLTKEEVTSFFKKHGIEK-VAEQVMKADANGDGYITLEEFLEFSL 134 (134)
T ss_dssp HHHHHHHHHCCSSSSEEEHHHHHHHHTTTTCHH-HHHHHHHHHCSSSSEEEHHHHHHHHC
T ss_pred HHHHHHHHHCCCCCCccCHHHHHHHHHHhCHHH-HHHHHHHhCCCCCCcEeHHHHHHHhC
Confidence 589999999999999999999999995 55544 89999999999999999999999873
|
| >2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.77 E-value=2.4e-18 Score=161.20 Aligned_cols=145 Identities=12% Similarity=0.125 Sum_probs=117.9
Q ss_pred chhhHHHHHHHHhhhc-CCCCCCcccHHHHHHHHHhhcc---cccccCChhHH-----------HhhcCCCCCCcccHHH
Q 007253 458 LTVDELFYLKEQYALL-EPNKNGTISLENVKSALMKNAT---DAMKDSRIPDF-----------LSSLNSLQYRRMDFEE 522 (611)
Q Consensus 458 l~~~e~~~l~~~F~~~-D~d~~G~Is~~e~~~~l~~~~~---~~~~~~~~~~~-----------~~~~D~~~~g~i~~~e 522 (611)
+++.+.++++++|..+ |.|++|.|+.+||..++..++. ..++..++..+ |..+|.|++|.|+++|
T Consensus 2 ls~~~~~~l~~~F~~~~D~d~dG~i~~~E~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~f~~~D~d~dG~I~~~E 81 (185)
T 2sas_A 2 LNDFQKQKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASLEDEWRDLKGRADINKDDVVSWEE 81 (185)
T ss_dssp CCHHHHHHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHHH
T ss_pred cCHHHHHHHHHHHHHheeCCCCCeEcHHHHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCCeEcHHH
Confidence 5677889999999999 9999999999999999877661 24555556544 9999999999999999
Q ss_pred HHHHHcchhhH---Hh--hHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCC-CccHHHHHHHHhcCCCCceeHHHH
Q 007253 523 FCAAALSVHQL---EA--LDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGP-AVPVHAVLHDWIRHTDGKLSFLGF 595 (611)
Q Consensus 523 F~~~~~~~~~~---~~--~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~-~~~~~~~~~~~D~~~dG~is~~eF 595 (611)
|+.++...... .. ....++.++.+|+.+|.|++|+|+.+||++++. ++. ...+..+|..+|.|+||.|+|+||
T Consensus 82 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~g~~~~~~~~~~~~~D~d~dG~i~~~ef 161 (185)
T 2sas_A 82 YLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQLQCADVPAVYNVITDGGKVTFDLNRY 161 (185)
T ss_dssp HHHHHHHHHHTCCSGGGSCTTHHHHHHHHHHHHCTTSSSCCCHHHHHHHTTSSCCCCSSHHHHHHHHHTTTTSCCSHHHH
T ss_pred HHHHHHHHhccccchhhhhHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHhCCCHHHHHHHHHHhcCCCCCcCcHHHH
Confidence 99887654322 00 011256789999999999999999999999995 432 223999999999999999999999
Q ss_pred HHHHhhc
Q 007253 596 VKLLHGV 602 (611)
Q Consensus 596 ~~~l~~~ 602 (611)
+.++...
T Consensus 162 ~~~~~~~ 168 (185)
T 2sas_A 162 KELYYRL 168 (185)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998774
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=99.77 E-value=1e-18 Score=156.91 Aligned_cols=129 Identities=21% Similarity=0.346 Sum_probs=111.0
Q ss_pred HHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchh-hHHhhHHHHHHHH
Q 007253 466 LKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVH-QLEALDRWEQHAR 544 (611)
Q Consensus 466 l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~-~~~~~~~~~~~~~ 544 (611)
++++|..+|.+++|.|+.+||..+|..++. .++..++..++.. +++|.|+|+||+.++.... ..... .+.++
T Consensus 7 l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~-~~~~~~~~~~~~~---~~~g~i~~~eF~~~~~~~~~~~~~~---~~~l~ 79 (145)
T 2bl0_B 7 IQECFQIFDKDNDGKVSIEELGSALRSLGK-NPTNAELNTIKGQ---LNAKEFDLATFKTVYRKPIKTPTEQ---SKEML 79 (145)
T ss_dssp HHHHHHHHCTTCSSCEEGGGHHHHHHHTTC-CCCHHHHHHHHHH---HTSSEECHHHHHHHHTSCCCCGGGG---HHHHH
T ss_pred HHHHHHHhCCCCcCccCHHHHHHHHHHhCC-CCCHHHHHHHHHh---cCCCeEcHHHHHHHHHHHhhcCccc---HHHHH
Confidence 999999999999999999999999988765 5677778888887 7899999999999887653 22111 56789
Q ss_pred HHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 545 CAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 545 ~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
.+|+.+|.|++|+|+.+||+.++. ++..++ ++.+|..+|.|+||.|+|+||+.++..
T Consensus 80 ~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~~ 140 (145)
T 2bl0_B 80 DAFRALDKEGNGTIQEAELRQLLLNLGDALTSSEVEELMKEVSVSGDGAINYESFVDMLVT 140 (145)
T ss_dssp HHHHHHCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTTCCCCTTSEEEHHHHHHHHHH
T ss_pred HHHHHhCCCCCCeEcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcEeHHHHHHHHHh
Confidence 999999999999999999999994 554444 888999999999999999999999875
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} | Back alignment and structure |
|---|
Probab=99.76 E-value=4.2e-19 Score=168.83 Aligned_cols=141 Identities=15% Similarity=0.188 Sum_probs=120.0
Q ss_pred hhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHH
Q 007253 455 SKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLE 534 (611)
Q Consensus 455 ~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~ 534 (611)
...++..++.+|+++|..+|.|++|.|+..||..+|..++. .++..++..++..+ +|.|+|+||+.++.......
T Consensus 48 ~~~ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~lg~-~~~~~~~~~l~~~~----~g~i~~~eF~~~~~~~~~~~ 122 (196)
T 3dtp_E 48 FAMFTQHQVQEFKEAFQLIDQDKDGFISKNDIRATFDSLGR-LCTEQELDSMVAEA----PGPINFTMFLTIFGDRIAGT 122 (196)
T ss_dssp SCSSCTTTHHHHHHHHHHHCCSCSSBCCHHHHHHHHHTTSC-CCCHHHHHHHHTTS----SSCCBHHHHHHHHHHCCCSS
T ss_pred hhhCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCC-CCCHHHHHHHHHHc----cCCCcHHHHHHHHHHHhcCC
Confidence 34678899999999999999999999999999999988775 57777888888877 79999999999886533221
Q ss_pred hhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhcCCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 535 ALDRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 535 ~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
.. .+.+..+|+.||.|++|+|+.+||+++|.+|..++ ++.+|..+|.|+||.|+|+||+.+|....
T Consensus 123 ~~---~~~l~~~F~~~D~d~~G~Is~~El~~~l~~g~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~l~~~~ 191 (196)
T 3dtp_E 123 DE---EDVIVNAFNLFDEGDGKCKEETLKRSLTTWGEKFSQDEVDQALSEAPIDGNGLIDIKKFAQILTKGA 191 (196)
T ss_dssp CC---HHHHHHHHHTTCSSSSCCBHHHHHHHHHHSSSCCCHHHHHHHHHSSCEETTEECHHHHHHHHHSSCC
T ss_pred Cc---HHHHHHHHHHHCCCCCCcCcHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCEEeHHHHHHHHHcCC
Confidence 11 55788999999999999999999999995555554 88999999999999999999999998653
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.6e-19 Score=185.04 Aligned_cols=199 Identities=12% Similarity=0.160 Sum_probs=147.8
Q ss_pred CCCHHHHHHHHHhc---ccCccCCCCHHHHHcC------cccCCCC--------------------CCCCchhHHHHHHH
Q 007253 387 SLSSEARDFVKRLL---NKDPRKRLTAAQALSH------PWIKNSN--------------------DVKVPLDVIIFKLM 437 (611)
Q Consensus 387 ~~s~~~~~li~~~L---~~dP~~Rpt~~~ll~h------p~~~~~~--------------------~~~~~~~~~~~~~~ 437 (611)
.+++++.+|.+++. ..+|.+|.+.++.+.| +|+.... ..........+..+
T Consensus 16 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~a~g~~~~e~q~~~~v 95 (323)
T 1ij5_A 16 KVHENLEELQKKLDHTSFAHKEDRDRLEAQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAARGDAAAEKQRLASL 95 (323)
T ss_dssp HHHHHHHHHHHHHTTCCCC-----CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTSCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcChhhhhHHHHHHHHhhcCCCCCcchhhHHH
Confidence 45678889999998 8899999999999988 8886541 11111222221111
Q ss_pred H-----HHhhcchHHHHHHHhhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCC
Q 007253 438 K-----AYMRSSSLRKAALRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNS 512 (611)
Q Consensus 438 ~-----~~~~~~~l~~~~l~~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~ 512 (611)
- .+...+.+ +.+...++++++..|+++|..+|.|++|.|+..||..+|..++. .+++.++..++..+|.
T Consensus 96 l~~l~~~f~~~~~l-----kk~~~~Ls~~e~~~l~~~F~~~D~d~dG~Is~~El~~~L~~lg~-~~~~~~i~~l~~~~D~ 169 (323)
T 1ij5_A 96 LKDLEDDASGYNRL-----RPSKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYAD-TIPEGPLKKLFVMVEN 169 (323)
T ss_dssp HHHC------------------CCCCCHHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHHHHHT-TSCSSHHHHHHHHHHH
T ss_pred HHHHHHHHHHhhhH-----HHHHHhCCHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhcC
Confidence 1 22222222 22456789999999999999999999999999999999988765 6788899999999999
Q ss_pred CCCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhcCCCCcc---HHH-HHHHHhcCCCC
Q 007253 513 LQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVP---VHA-VLHDWIRHTDG 588 (611)
Q Consensus 513 ~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~~~~~~~---~~~-~~~~~D~~~dG 588 (611)
|++|.|+|.+|+.++ .. ...++.+|+.||.|++|+|+.+||..+| +|...+ +.. +|..+|.|+||
T Consensus 170 d~~G~I~f~ef~~l~------~~----~~~l~~~F~~~D~d~dG~Is~~El~~~l-~g~~~~~~ei~~~l~~~~D~d~dG 238 (323)
T 1ij5_A 170 DTKGRMSYITLVAVA------ND----LAALVADFRKIDTNSNGTLSRKEFREHF-VRLGFDKKSVQDALFRYADEDESD 238 (323)
T ss_dssp CCSSTHHHHHHTTSH------HH----HHTSCCCHHHHCTTCCSEECHHHHHHHH-HHTTCCCHHHHHHHHHHHCTTCSS
T ss_pred CCCCcCcHHHHHhhh------hH----HHHHHHHHHHHCCCCCCcCcHHHHHHHH-cCCCCCHHHHHHHHHHHhcCCCCC
Confidence 999999999997643 11 4567789999999999999999999998 544433 888 99999999999
Q ss_pred ceeHHHHHHHHhhc
Q 007253 589 KLSFLGFVKLLHGV 602 (611)
Q Consensus 589 ~is~~eF~~~l~~~ 602 (611)
.|+|+||+.++...
T Consensus 239 ~Is~~EF~~~l~~~ 252 (323)
T 1ij5_A 239 DVGFSEYVHLGLCL 252 (323)
T ss_dssp CEEHHHHHHHHHHH
T ss_pred EEeHHHHHHHHHHH
Confidence 99999999988654
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} | Back alignment and structure |
|---|
Probab=99.76 E-value=7.3e-19 Score=168.63 Aligned_cols=146 Identities=12% Similarity=0.151 Sum_probs=113.3
Q ss_pred hcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhccc-ccccCChhHHH-------hhcCCCCCCcccHHHHHHHH
Q 007253 456 KTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATD-AMKDSRIPDFL-------SSLNSLQYRRMDFEEFCAAA 527 (611)
Q Consensus 456 ~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~-~~~~~~~~~~~-------~~~D~~~~g~i~~~eF~~~~ 527 (611)
..++++++.+++++|..+|.|++|.|+.+||..++..++.. .+++.++..++ ..+|.|++|.|+|+||+.++
T Consensus 28 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~~~~~~~~~~~l~~~~~~lf~~~D~d~dg~i~~~EF~~~~ 107 (208)
T 2hpk_A 28 EDLHPKMLSRLYKRFDTFDLDSDGKMEMDEVLYWPDRMRQLVNATDEQVEKMRDAVRVFFLHKGVEPVNGLLREDWVEAN 107 (208)
T ss_dssp --------CHHHHHHHHHCTTCSSEECHHHHTHHHHHHHHHSCCCHHHHHHHHHHHHHHHHHTTCBTTTBEEGGGHHHHH
T ss_pred HHcCHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHhhcCCCHHHHHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHH
Confidence 46788889999999999999999999999999999877641 36667788888 99999999999999999887
Q ss_pred cc--------hhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCC-CccHHHHHHHHhcCCCCceeHHHHHH
Q 007253 528 LS--------VHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGP-AVPVHAVLHDWIRHTDGKLSFLGFVK 597 (611)
Q Consensus 528 ~~--------~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~-~~~~~~~~~~~D~~~dG~is~~eF~~ 597 (611)
.. .... .....++.++.+|+.+|+|++|+|+.+||++++. +|. ...++.+|..+|.|+||.|+|+||+.
T Consensus 108 ~~~~~~~~~~~~~~-~~~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~~~~D~d~dG~I~~~EF~~ 186 (208)
T 2hpk_A 108 RVFAEAERERERRG-EPSLIALLSNSYYDVLDDDGDGTVDVDELKTMMKAFDVPQEAAYTFFEKADTDKSGKLERTELVH 186 (208)
T ss_dssp HHHHHHHHHHHHTT-CCCHHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTSCTTHHHHHHHHHCTTCCSSBCHHHHHH
T ss_pred HHHhhhhhhhhccC-ChHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCcCHHHHHHHHHHhCCCCCCcCcHHHHHH
Confidence 51 1111 0011133378999999999999999999999994 441 22289999999999999999999999
Q ss_pred HHhhc
Q 007253 598 LLHGV 602 (611)
Q Consensus 598 ~l~~~ 602 (611)
++...
T Consensus 187 ~~~~~ 191 (208)
T 2hpk_A 187 LFRKF 191 (208)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99775
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A | Back alignment and structure |
|---|
Probab=99.75 E-value=3e-18 Score=180.30 Aligned_cols=142 Identities=22% Similarity=0.404 Sum_probs=120.8
Q ss_pred hcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHh
Q 007253 456 KTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEA 535 (611)
Q Consensus 456 ~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~ 535 (611)
..++++++++|+++|..+|.|++|.|+.+||..+|..++. .+++.++..+|+.+|.|++|.|+|+||+.++........
T Consensus 304 ~~ls~eei~el~~~F~~fD~D~dG~Is~~EL~~~L~~lg~-~~s~eel~~Lf~~~D~DgdG~IsfeEFl~ll~~~~~~~~ 382 (450)
T 3sg6_A 304 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQ-NPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTD 382 (450)
T ss_dssp -CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTC-CCCHHHHHHHHHTTCTTSSSSEEHHHHHHHHHC------
T ss_pred ccCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhccCCCCcccHHHHHHHHHhhccccc
Confidence 4577888899999999999999999999999999988765 577888999999999999999999999998876543322
Q ss_pred hHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 536 LDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 536 ~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
. ++.++.+|+.||+|++|+|+.+||+++|. ++..++ ++.+|..+|.|+||.|+|+||+.+|..
T Consensus 383 ~---~e~l~~aFk~fD~D~dG~Is~eELr~~L~~lG~~ls~eei~~Lf~~~D~D~DG~IsfdEFv~~L~~ 449 (450)
T 3sg6_A 383 S---EEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTA 449 (450)
T ss_dssp C---HHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTSSSSEEHHHHHHHHC-
T ss_pred h---hhHHHHHHHHhCCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHhc
Confidence 2 56789999999999999999999999994 554444 889999999999999999999999863
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A | Back alignment and structure |
|---|
Probab=99.75 E-value=3.6e-18 Score=158.48 Aligned_cols=142 Identities=16% Similarity=0.164 Sum_probs=114.1
Q ss_pred hhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcc---cccccCC-h--------hHHHhhcCCCCCCcccHHHHHHH
Q 007253 459 TVDELFYLKEQYALLEPNKNGTISLENVKSALMKNAT---DAMKDSR-I--------PDFLSSLNSLQYRRMDFEEFCAA 526 (611)
Q Consensus 459 ~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~---~~~~~~~-~--------~~~~~~~D~~~~g~i~~~eF~~~ 526 (611)
+++++.+|+++|..+|.|++|.|+.+||..++..++. ..++..+ + ..+|+.+| ++|.|+|+||+.+
T Consensus 1 s~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~l~~~~D--~~g~i~~~EF~~~ 78 (174)
T 1q80_A 1 SDLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTGVWDNFLTAVA--GGKGIDETTFINS 78 (174)
T ss_dssp CHHHHHHHHHHHHHHCTTCSSEESHHHHHHHHHHHHHHSSCCTTHHHHHHHHHHHHHHHTGGGTT--TTSCEEHHHHHHH
T ss_pred CHHHHHHHHHHHHhcCCCCCCcEeHHHHHHHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHhcC--CCCeEcHHHHHHH
Confidence 3567889999999999999999999999999887761 2455444 4 35788889 8999999999988
Q ss_pred HcchhhHHh-hHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCC-CccHHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 527 ALSVHQLEA-LDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGP-AVPVHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 527 ~~~~~~~~~-~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~-~~~~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
+........ .....+.++.+|+.+|+|++|+|+.+||++++. ++. ...++.+|..+|.|+||.|+|+||+.+|...
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~D~d~dg~i~~~ef~~~~~~~ 157 (174)
T 1q80_A 79 MKEMVKNPEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFFGMLGLDKTMAPASFDAIDTNNDGLLSLEEFVIAGSDF 157 (174)
T ss_dssp HHHHTTSTTCHHHHHTHHHHHHHHHCTTSSSSBCHHHHHHHHHHHTCCGGGHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred HHHHcCcccHHHHHHHHHHHHHHHhCCCCCCcccHHHHHHHHHHcCCCHHHHHHHHHHhCCCCCceEeHHHHHHHHHHH
Confidence 766543110 011256789999999999999999999999994 332 2238999999999999999999999999764
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A | Back alignment and structure |
|---|
Probab=99.75 E-value=4.5e-18 Score=162.94 Aligned_cols=141 Identities=19% Similarity=0.245 Sum_probs=115.7
Q ss_pred cchhhHHHHHHHHhhhcCCC--CCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHH
Q 007253 457 TLTVDELFYLKEQYALLEPN--KNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLE 534 (611)
Q Consensus 457 ~l~~~e~~~l~~~F~~~D~d--~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~ 534 (611)
.++.+++.+++++|..+|.+ ++|.|+.+||..+|.... ...+..+..+|..+|.|++|.|+|+||+.++.......
T Consensus 30 ~~s~~~~~~l~~~F~~~D~d~~~~G~i~~~e~~~~l~~~~--~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~ 107 (207)
T 2ehb_A 30 PFTVEEVEALYELFKKLSSSIIDDGLIHKEEFQLALFRNR--NRRNLFADRIFDVFDVKRNGVIEFGEFVRSLGVFHPSA 107 (207)
T ss_dssp SCCHHHHHHHHHHHHHHTTSSSCSSCEEHHHHHHHHHSCT--TCCCHHHHHHHHHHCTTCSSEECHHHHHHHHGGGSTTS
T ss_pred CCCHHHHHHHHHHHHHhccccCCCCccCHHHHHHHHhccc--cccHHHHHHHHHHhcCCCCCeEeHHHHHHHHHHHccCC
Confidence 68899999999999999999 999999999999986511 12223456799999999999999999999887654221
Q ss_pred hhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-----CCCCcc-------HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 535 ALDRWEQHARCAYELFEKDGNRAIVIEELASELG-----LGPAVP-------VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 535 ~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-----~~~~~~-------~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
. .++.++.+|+.+|.|++|+|+.+||++++. .+..++ +..+|..+|.|+||.|+|+||+.++...
T Consensus 108 ~---~~~~l~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~ 184 (207)
T 2ehb_A 108 P---VHEKVKFAFKLYDLRQTGFIEREELKEMVVALLHESELVLSEDMIEVMVDKAFVQADRKNDGKIDIDEWKDFVSLN 184 (207)
T ss_dssp C---HHHHHHHHHHHHCTTCCSSEEHHHHHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHC
T ss_pred C---HHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHcccccCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhC
Confidence 1 156789999999999999999999999883 344443 3455679999999999999999999764
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A | Back alignment and structure |
|---|
Probab=99.75 E-value=2.5e-18 Score=159.55 Aligned_cols=131 Identities=15% Similarity=0.279 Sum_probs=113.8
Q ss_pred HHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHH
Q 007253 462 ELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQ 541 (611)
Q Consensus 462 e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~ 541 (611)
+..+++++|..+|.+++|.|+.+||..+|...+....+..++..++..+|.|++|.|+|+||+.++.. .+
T Consensus 5 ~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~ef~~~~~~----------~~ 74 (172)
T 2znd_A 5 DQSFLWNVFQRVDKDRSGVISDTELQQALSNGTWTPFNPVTVRSIISMFDRENKAGVNFSEFTGVWKY----------IT 74 (172)
T ss_dssp -CHHHHHHHHHHCTTCSSCEEHHHHHHHCCCSSSSCCCHHHHHHHHHHHCSSSSSEECHHHHHHHHHH----------HH
T ss_pred chhHHHHHHHHhCCCCCCcCcHHHHHHHHHhcCCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHH----------HH
Confidence 45679999999999999999999999998776644577778999999999999999999999987642 23
Q ss_pred HHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 542 HARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 542 ~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
.++.+|+.+|.|++|+|+.+||+.++. ++...+ ++.++..+|.|+||.|+|+||+.++...
T Consensus 75 ~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~~~ 139 (172)
T 2znd_A 75 DWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFDRQGRGQIAFDDFIQGCIVL 139 (172)
T ss_dssp HHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHH
T ss_pred HHHHHHHHHCCCCCCccCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence 678899999999999999999999994 554444 8899999999999999999999988764
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A | Back alignment and structure |
|---|
Probab=99.75 E-value=3.9e-18 Score=165.94 Aligned_cols=149 Identities=17% Similarity=0.241 Sum_probs=118.4
Q ss_pred HHHHhhhh--cchhhHHHHHHHHhhhcCCC--CCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHH
Q 007253 449 AALRALSK--TLTVDELFYLKEQYALLEPN--KNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFC 524 (611)
Q Consensus 449 ~~l~~~~~--~l~~~e~~~l~~~F~~~D~d--~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~ 524 (611)
..+..+.+ .++.+++.+++++|..+|.+ ++|.|+.+||..+|.. .. ...+..+..+|+.+|.|++|.|+|+||+
T Consensus 31 ~~~~~l~~~~~ls~~ei~~l~~~F~~~D~d~~~~G~I~~~El~~~l~~-~~-~~~~~~~~~~f~~~D~d~dG~I~~~Ef~ 108 (226)
T 2zfd_A 31 GDPELLARDTVFSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFK-TN-KKESLFADRVFDLFDTKHNGILGFEEFA 108 (226)
T ss_dssp -CTHHHHHHSSCCHHHHHHHHHHHHHHHTSSSCSSSBCHHHHHHHHHS-CS-SCCCHHHHHHHHHHCSSCSSSBCHHHHH
T ss_pred HHHHHHHHhCCCCHHHHHHHHHHHHHhCcccCCCCeEcHHHHHHHHhc-cC-cccHHHHHHHHHHHcCCCCCcCcHHHHH
Confidence 33444433 57999999999999999999 9999999999999865 11 1222235679999999999999999999
Q ss_pred HHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHh-----cCCCCcc---H----HHHHHHHhcCCCCceeH
Q 007253 525 AAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASEL-----GLGPAVP---V----HAVLHDWIRHTDGKLSF 592 (611)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l-----~~~~~~~---~----~~~~~~~D~~~dG~is~ 592 (611)
.++........ .++.++.+|+.||.|++|+|+.+||+.++ ..|..++ + ..+|+.+|.|+||.|+|
T Consensus 109 ~~~~~~~~~~~---~~~~l~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~f~~~D~d~dG~I~~ 185 (226)
T 2zfd_A 109 RALSVFHPNAP---IDDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIEDIIDKTFEEADTKHDGKIDK 185 (226)
T ss_dssp HHHHHTSTTSC---HHHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSSCSSEECH
T ss_pred HHHHHHccCCC---HHHHHHHHHHHhCCCCCCcccHHHHHHHHHHHHHHcCCCCCHHHHHHHHHHHHHHhCCCCCCcCcH
Confidence 98765542211 15678999999999999999999999998 2555544 3 45566999999999999
Q ss_pred HHHHHHHhhc
Q 007253 593 LGFVKLLHGV 602 (611)
Q Consensus 593 ~eF~~~l~~~ 602 (611)
+||+.++...
T Consensus 186 ~EF~~~~~~~ 195 (226)
T 2zfd_A 186 EEWRSLVLRH 195 (226)
T ss_dssp HHHHHHHHHS
T ss_pred HHHHHHHHhC
Confidence 9999999764
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A | Back alignment and structure |
|---|
Probab=99.74 E-value=9.4e-18 Score=154.14 Aligned_cols=141 Identities=16% Similarity=0.149 Sum_probs=111.1
Q ss_pred HHHHHHHHhhhcCCCCCCcccHHHHHHHHHhh---cccccccCChhH-----------HHhhcCCCCCCcccHHHHHHHH
Q 007253 462 ELFYLKEQYALLEPNKNGTISLENVKSALMKN---ATDAMKDSRIPD-----------FLSSLNSLQYRRMDFEEFCAAA 527 (611)
Q Consensus 462 e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~---~~~~~~~~~~~~-----------~~~~~D~~~~g~i~~~eF~~~~ 527 (611)
++++|+++|..+|.|++|.|+.+||..++... .+..++..++.. +|..+|.|++|.|+++||+.++
T Consensus 2 ~~~~l~~~F~~~D~d~dG~i~~~E~~~~l~~~~~~~g~~~~~~~~~~l~~~~~~~~~~~f~~~D~d~~g~i~~~ef~~~~ 81 (166)
T 3akb_A 2 YERRIAARFTTFDQDGNGHIDRSDFSGAAKAMLAEFGVAARSDRGQALYGGAEALWQGLAGIADRDGDQRITREEFVTGA 81 (166)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHHTCCTTSHHHHHHHHHHHHHHHHHHHHHCTTSSSCEEHHHHHHTH
T ss_pred HHHHHHHHHhHHcCCCCCCcCHHHHHHHHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 45689999999999999999999999986432 233455655654 4799999999999999999877
Q ss_pred cchhhHHh---hHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCC-ccHHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 528 LSVHQLEA---LDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPA-VPVHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 528 ~~~~~~~~---~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~-~~~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
........ .+...+.++.+|+.+|.|++|+|+.+||+.++. ++.. ..++.+|..+|.|+||.|+|+||+.+|...
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~E~~~~l~~~~~~~~~~~~~~~~~D~d~dg~i~~~ef~~~~~~~ 161 (166)
T 3akb_A 82 VKRLRDKPDRFAEMARPFLHAALGVADTDGDGAVTVADTARALTAFGVPEDLARQAAAALDTDGDGKVGETEIVPAFARY 161 (166)
T ss_dssp HHHHHHSHHHHHHHHHHHHHHHHHHHCSSSSSCCBHHHHHHHHHHTTCCHHHHHHHHHHHCTTCSSBCCHHHHHHHHHHH
T ss_pred HHHhccCccchHHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence 65432211 011134589999999999999999999999994 5511 128899999999999999999999998764
|
| >3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A | Back alignment and structure |
|---|
Probab=99.74 E-value=8e-18 Score=164.10 Aligned_cols=141 Identities=13% Similarity=0.184 Sum_probs=117.8
Q ss_pred cchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhh
Q 007253 457 TLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEAL 536 (611)
Q Consensus 457 ~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~ 536 (611)
.++.+++..+++.|... +++|.|+.+||..++............+..+|+.+|.|++|.|+|+||+.++........
T Consensus 60 ~~s~~ei~~l~~~F~~~--d~~G~Is~~ef~~~l~~~~~~~~~~~~~~~lf~~~D~d~~G~I~~~Ef~~~l~~~~~~~~- 136 (229)
T 3dd4_A 60 KFTKKELQILYRGFKNE--CPSGVVNEETFKEIYSQFFPQGDSTTYAHFLFNAFDTDHNGAVSFEDFIKGLSILLRGTV- 136 (229)
T ss_dssp HHHHHHHHHHHHHHHTT--CCSCCCCHHHHHHHHHHHSCSSSHHHHHHHHHHTTCSSCCSSCCHHHHHHHHHHHHHSCH-
T ss_pred CCCHHHHHHHHHHHHhh--CCCCCcCHHHHHHHHHHHCCCCCcHHHHHHHHHHcCCCCCCeEeHHHHHHHHHHHcCCCh-
Confidence 57889999999999774 578999999999999886654555667889999999999999999999998876553333
Q ss_pred HHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-C------------CCC---ccHHHHHHHHhcCCCCceeHHHHHHHHh
Q 007253 537 DRWEQHARCAYELFEKDGNRAIVIEELASELG-L------------GPA---VPVHAVLHDWIRHTDGKLSFLGFVKLLH 600 (611)
Q Consensus 537 ~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~------------~~~---~~~~~~~~~~D~~~dG~is~~eF~~~l~ 600 (611)
++.++.+|+.||+|++|+|+.+||..++. + +.. ..++.+|..+|.|+||.|+|+||++++.
T Consensus 137 ---~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~Is~~EF~~~~~ 213 (229)
T 3dd4_A 137 ---QEKLNWAFNLYDINKDGYITKEEMLDIMKAIYDMMGKCTYPVLKEDAPRQHVETFFQKMDKNKDGVVTIDEFIESCQ 213 (229)
T ss_dssp ---HHHHHHHHHHHCTTCSSCCBHHHHHHHHHHHHHHCC-----------CCTHHHHHHHHHCSSCSSBCCHHHHHHHHH
T ss_pred ---HHHHHHHHHHhCCCCCCeECHHHHHHHHHHHHHHhccccCCCcchhhHHHHHHHHHHHhcCCCCCcEeHHHHHHHHH
Confidence 66899999999999999999999999884 2 222 2289999999999999999999999998
Q ss_pred hcc
Q 007253 601 GVS 603 (611)
Q Consensus 601 ~~~ 603 (611)
...
T Consensus 214 ~~~ 216 (229)
T 3dd4_A 214 KDE 216 (229)
T ss_dssp TCH
T ss_pred hCH
Confidence 643
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=99.74 E-value=8.2e-18 Score=159.13 Aligned_cols=129 Identities=19% Similarity=0.245 Sum_probs=112.0
Q ss_pred HHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHH
Q 007253 463 LFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQH 542 (611)
Q Consensus 463 ~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~ 542 (611)
.++++++|..+|.|++|.|+.+||..+|...+ ...++.++..+|..+|.|++|.|+|+||+.++.. .+.
T Consensus 26 ~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~~-~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~~~~----------~~~ 94 (191)
T 1y1x_A 26 NQELMEWFRAVDTDGSGAISVPELNAALSSAG-VPFSLATTEKLLHMYDKNHSGEITFDEFKDLHHF----------ILS 94 (191)
T ss_dssp TSCHHHHHHHHCTTCSSSBCHHHHHHHHCBTT-BCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHH----------HHH
T ss_pred HHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcC-CCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHH----------HHH
Confidence 45799999999999999999999999984333 3567788999999999999999999999987643 236
Q ss_pred HHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 543 ARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 543 ~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
++.+|+.+|.|++|+|+.+||+.++. ++..++ ++.+|..+|.|+||.|+|+||+.++...
T Consensus 95 ~~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~ 158 (191)
T 1y1x_A 95 MREGFRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKFDRQRRGSLGFDDYVELSIFV 158 (191)
T ss_dssp HHHHHHHHCTTSSSCBCHHHHHHHHHTTSCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCeEcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHH
Confidence 78899999999999999999999994 554444 8899999999999999999999998764
|
| >1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E | Back alignment and structure |
|---|
Probab=99.73 E-value=9.4e-18 Score=157.23 Aligned_cols=141 Identities=16% Similarity=0.221 Sum_probs=117.6
Q ss_pred cchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhh
Q 007253 457 TLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEAL 536 (611)
Q Consensus 457 ~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~ 536 (611)
.++.+++.++.+.|..+ |++|.|+.+||..++...+....++.++..+|+.+|.|++|.|+++||+.++........
T Consensus 14 ~~s~~~i~~l~~~fd~~--d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~- 90 (183)
T 1s6c_A 14 NFTKRELQVLYRGFKNE--XPSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTV- 90 (183)
T ss_dssp SCCHHHHHHHHHHHHHH--CTTSEECHHHHHHHHHHHSTTSCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHCCH-
T ss_pred CCCHHHHHHHHHHHHHh--CCCCcCCHHHHHHHHHHHcCCCChHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHHcCCCH-
Confidence 56888888787777776 588999999999999887754466778899999999999999999999998876543333
Q ss_pred HHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-C----CCC-----------ccHHHHHHHHhcCCCCceeHHHHHHHHh
Q 007253 537 DRWEQHARCAYELFEKDGNRAIVIEELASELG-L----GPA-----------VPVHAVLHDWIRHTDGKLSFLGFVKLLH 600 (611)
Q Consensus 537 ~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~----~~~-----------~~~~~~~~~~D~~~dG~is~~eF~~~l~ 600 (611)
++.++.+|+.+|.|++|+|+.+||+.++. + |.. ..++.+|+.+|.|+||.|+|+||+.++.
T Consensus 91 ---~~~~~~~f~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~i~~~Ef~~~~~ 167 (183)
T 1s6c_A 91 ---HEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESXQ 167 (183)
T ss_dssp ---HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC-----------CHHHHHHHHHHHCTTCSSEECHHHHHHHTT
T ss_pred ---HHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHHHHhccccCcCccHHHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHh
Confidence 66889999999999999999999999883 2 421 2288899999999999999999999987
Q ss_pred hcc
Q 007253 601 GVS 603 (611)
Q Consensus 601 ~~~ 603 (611)
...
T Consensus 168 ~~~ 170 (183)
T 1s6c_A 168 EDD 170 (183)
T ss_dssp SCC
T ss_pred cCh
Confidence 643
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A | Back alignment and structure |
|---|
Probab=99.73 E-value=5.1e-18 Score=162.80 Aligned_cols=143 Identities=20% Similarity=0.311 Sum_probs=115.9
Q ss_pred cchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhh
Q 007253 457 TLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEAL 536 (611)
Q Consensus 457 ~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~ 536 (611)
.++++++.+|+++|..+|.|++|+|+.+||..++ .++.. . ....++..+|.+++|.|+|+||+.++.........
T Consensus 22 ~ls~~~~~~l~~~F~~~D~d~dG~Is~~El~~~~-~lg~~-~---~~~~l~~~~d~~~~g~i~~~EF~~~~~~~~~~~~~ 96 (208)
T 2ct9_A 22 GFSHSQITRLYSRFTSLDKGENGTLSREDFQRIP-ELAIN-P---LGDRIINAFFSEGEDQVNFRGFMRTLAHFRPIEDN 96 (208)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCSSEECTGGGGGCH-HHHTS-T---THHHHHHTTSCTTCSCEEHHHHHHHHHTTSCCC--
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHH-HcCCC-C---cHHHHHHHHcCCCCCcCcHHHHHHHHHhhccccch
Confidence 5789999999999999999999999999999864 44432 2 34678999999999999999999988754321100
Q ss_pred H------------HHHHHHHHHHhHHhcCCCCcccHHHHHHHhc--CCCCcc---HHHH----HHHHhcCCCCceeHHHH
Q 007253 537 D------------RWEQHARCAYELFEKDGNRAIVIEELASELG--LGPAVP---VHAV----LHDWIRHTDGKLSFLGF 595 (611)
Q Consensus 537 ~------------~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~--~~~~~~---~~~~----~~~~D~~~dG~is~~eF 595 (611)
. ...+.++.+|+.||.|++|+|+.+||+.++. .|..++ ++.+ |..+|.|+||.|+|+||
T Consensus 97 ~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~s~~~~~~l~~~~~~~~D~d~dG~Is~~EF 176 (208)
T 2ct9_A 97 EKSKDVNGPEPLNSRSNKLHFAFRLYDLDKDDKISRDELLQVLRMMVGVNISDEQLGSIADRTIQEADQDGDSAISFTEF 176 (208)
T ss_dssp ---------CCTTSHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHSCTTCCHHHHHHHHHHHHHHHCSSSSSSEEHHHH
T ss_pred hhhcccccccccccHHHHHHHHHHHHCCCCCCEEcHHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHhCCCCCCcCcHHHH
Confidence 0 0266899999999999999999999999995 366555 4555 99999999999999999
Q ss_pred HHHHhhcch
Q 007253 596 VKLLHGVSS 604 (611)
Q Consensus 596 ~~~l~~~~~ 604 (611)
+.++.....
T Consensus 177 ~~~~~~~~~ 185 (208)
T 2ct9_A 177 VKVLEKVDV 185 (208)
T ss_dssp HHTTTTSCG
T ss_pred HHHHhccCh
Confidence 999877543
|
| >1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.72 E-value=2.9e-18 Score=153.17 Aligned_cols=133 Identities=18% Similarity=0.258 Sum_probs=109.5
Q ss_pred HHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHH
Q 007253 462 ELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQ 541 (611)
Q Consensus 462 e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~ 541 (611)
++.+++++|..+|.|++|.|+.+||..+|..++. .++..++..++. +++|.|+|+||+.++......... ...+
T Consensus 3 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~~~~----~~~g~i~~~eF~~~~~~~~~~~~~-~~~~ 76 (140)
T 1ggw_A 3 DDSPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQ-NPTLAEITEIES----TLPAEVDMEQFLQVLNRPNGFDMP-GDPE 76 (140)
T ss_dssp CCTTTHHHHHHTCSSSSSEECHHHHHHHHHHTSC-CCCHHHHHHHHT----TSCSSEEHHHHHHHHCTTSSSSSS-CCHH
T ss_pred hHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCC-CCCHHHHHHHHh----CCCCcCcHHHHHHHHHHHhcccCc-ccHH
Confidence 3467999999999999999999999999988775 466666777776 789999999999988765432110 0135
Q ss_pred HHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 542 HARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 542 ~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
.++.+|+.+|+|++|+|+.+||++++. +|..++ ++.+|..+|. +||.|+|+||+++|..
T Consensus 77 ~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~-~dg~i~~~eF~~~~~~ 139 (140)
T 1ggw_A 77 EFVKGFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLKGVPV-KDGMVNYHDFVQMILA 139 (140)
T ss_dssp HHHHHHHTTCSSCSSCCCHHHHHHHHHHHHSCSCHHHHHHHHHHTTC-SSCCSTTTHHHHHHHC
T ss_pred HHHHHHHHhCCCCCCcEeHHHHHHHHHHcCCCCCHHHHHHHHHhccC-CCCcEeHHHHHHHHhc
Confidence 788999999999999999999999994 444333 8999999999 9999999999998863
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.72 E-value=9.3e-18 Score=158.29 Aligned_cols=135 Identities=16% Similarity=0.200 Sum_probs=113.6
Q ss_pred HHHHHhhhcCCC-CCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHH
Q 007253 465 YLKEQYALLEPN-KNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHA 543 (611)
Q Consensus 465 ~l~~~F~~~D~d-~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~ 543 (611)
+++++|..+|.+ ++|.|+.+||..++...+....++.++..+|..+|.|++|.|+++||+.++........ ++.+
T Consensus 26 el~~~f~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~~----~~~~ 101 (190)
T 2l2e_A 26 ELQQWYKGFFKDCPSGHLNKSEFQKIYKQFFPFGDPSAFAEYVFNVFDADKNGYIDFKEFICALSVTSRGEL----NDKL 101 (190)
T ss_dssp HHHHHHHHHHHHSCCCEECHHHHHHHHHHHCCCSCHHHHHHHHHHHHCSSSTTCEEHHHHHHHHTTSSCSCS----HHHH
T ss_pred HHHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCCCccHHHHHHHHHhcCCCCCeEeHHHHHHHHHHHcCCCH----HHHH
Confidence 377789999999 89999999999999887654445567889999999999999999999998876654333 5678
Q ss_pred HHHHhHHhcCCCCcccHHHHHHHhcC-------------CCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 544 RCAYELFEKDGNRAIVIEELASELGL-------------GPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 544 ~~~F~~~D~d~~G~It~eEl~~~l~~-------------~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
+.+|+.+|.|++|+|+.+||..++.. +...+ +..+|..+|.|+||.|+++||+.++....
T Consensus 102 ~~~f~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~ 177 (190)
T 2l2e_A 102 IWAFQLYDLDNNGLISYDEMLRIVDAIYKMVGSMVKLPEDEDTPEKRVNKIFNMMDKNKDGQLTLEEFCEGSKRDP 177 (190)
T ss_dssp HHHHHHHCTTSCSCBCHHHHHHHHHHHHHHHHHHSCCCSSCCCTHHHHHHHHHHHTCCSSCCBCHHHHHHHHHTCT
T ss_pred HHHHhHccCCCCCcCcHHHHHHHHHHHHHHhccccCcccccccHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhCc
Confidence 89999999999999999999998832 11122 88999999999999999999999987653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=5.5e-18 Score=175.49 Aligned_cols=140 Identities=16% Similarity=0.229 Sum_probs=99.9
Q ss_pred eeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcC---------------CHH----HHHHHHHHHHHHHHhcC
Q 007253 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT---------------TAI----AIEDVRREVKILRALTG 217 (611)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~---------------~~~----~~~~~~~E~~~l~~l~~ 217 (611)
|++++.||.|+||.||+|... .|+.||||++...... ... ..-...+|...|.+|.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~----~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~- 171 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE----KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY- 171 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT----TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH-
T ss_pred EEecCEeeeCCceEEEEEECC----CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH-
Confidence 999999999999999999853 4899999987532110 000 0112346888888886
Q ss_pred CCCee--EEEEEEeeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEec
Q 007253 218 HNNLV--KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT 295 (611)
Q Consensus 218 h~~iv--~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~ 295 (611)
+.++. ..+++ ...+|||||++|++|.+.. .......++.||+.+|.|||+.|||||||||.|||+..
T Consensus 172 ~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~-------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 172 EEGFPVPEPIAQ----SRHTIVMSLVDALPMRQVS-------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIRE 240 (397)
T ss_dssp HTTCSCCCEEEE----ETTEEEEECCSCEEGGGCC-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEE
T ss_pred hcCCCCCeeeec----cCceEEEEecCCccHhhhc-------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeC
Confidence 44432 22322 2347999999988875421 22345678999999999999999999999999999975
Q ss_pred cCCC-------ceEEEeecccccc
Q 007253 296 KDEN-------SVLKAIDFGLSDF 312 (611)
Q Consensus 296 ~~~~-------~~vkl~DfG~a~~ 312 (611)
+++. ..+.|+||+-+..
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCcccccccccceEEEEeCCccc
Confidence 3321 1488999997643
|
| >1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A | Back alignment and structure |
|---|
Probab=99.72 E-value=7.1e-18 Score=156.72 Aligned_cols=130 Identities=18% Similarity=0.273 Sum_probs=112.0
Q ss_pred hHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcc-------cccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhH
Q 007253 461 DELFYLKEQYALLEPNKNGTISLENVKSALMKNAT-------DAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQL 533 (611)
Q Consensus 461 ~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~-------~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~ 533 (611)
+++++++++|..+| +++|.|+.+||..+|..+.+ ..++..++..+++.+|.|++|.|+|+||+.++..
T Consensus 1 e~~~~l~~~F~~~D-d~~G~i~~~el~~~l~~~~g~~~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~---- 75 (173)
T 1alv_A 1 EEVRQFRRLFAQLA-GDDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLWNN---- 75 (173)
T ss_dssp CHHHHHHHHHHHHH-GGGTSBCHHHHHHHHHHHHHTCSTTCCSCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHH----
T ss_pred CchhHHHHHHHHHh-CCCCCcCHHHHHHHHHHhhhcccccccCCCCHHHHHHHHHHHcCCCCCccCHHHHHHHHHH----
Confidence 35778999999999 99999999999999988722 3466778899999999999999999999887753
Q ss_pred HhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 534 EALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 534 ~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
.+.++.+|+.+|.|++|+|+.+||+.++. +|...+ ++.++..+| |+||.|+|+||+.++...
T Consensus 76 ------~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d-d~dg~i~~~eF~~~~~~~ 141 (173)
T 1alv_A 76 ------IKKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHLYSMIIRRYS-DEGGNMDFDNFISCLVRL 141 (173)
T ss_dssp ------HHHHHHHHHHHCTTCCSSBCTTTHHHHHHHHTCCCCHHHHHHHHHHHT-CSSSCBCHHHHHHHHHHH
T ss_pred ------HHHHHHHHHHHCCCCCCCCCHHHHHHHHHHcCCCCCHHHHHHHHHHhc-CCCCcCcHHHHHHHHHHH
Confidence 23678899999999999999999999994 454433 888999999 999999999999988764
|
| >1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.72 E-value=6.2e-18 Score=161.60 Aligned_cols=137 Identities=19% Similarity=0.227 Sum_probs=114.9
Q ss_pred hHHHHHHHHhhhcCCC-CCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHH
Q 007253 461 DELFYLKEQYALLEPN-KNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRW 539 (611)
Q Consensus 461 ~e~~~l~~~F~~~D~d-~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~ 539 (611)
-..++++++|..+|.+ ++|.|+.+||..++..++. ..+...+..+|..+|.|++|.|+++||+.++........
T Consensus 19 ~~~~el~~~f~~~D~~~~~G~i~~~e~~~~l~~~~~-~~~~~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~~~~---- 93 (204)
T 1jba_A 19 ADAAQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDN-EEATQYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTL---- 93 (204)
T ss_dssp HHHHHHHHHHHHHHSSSTTCCEEHHHHHHHHHCCSS-STTHHHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCC----
T ss_pred CCHHHHHHHHHHHHhhCCCCCcCHHHHHHHHHHhcC-CCcHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHHccCCH----
Confidence 3445688999999999 8999999999999987775 566677889999999999999999999998865543333
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhc-C----C----C--------C-c---cHHHHHHHHhcCCCCceeHHHHHHH
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELG-L----G----P--------A-V---PVHAVLHDWIRHTDGKLSFLGFVKL 598 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~----~----~--------~-~---~~~~~~~~~D~~~dG~is~~eF~~~ 598 (611)
++.++.+|+.+|.|++|+|+.+||+.++. + | . . . .+..+|..+|.|+||.|+|+||+.+
T Consensus 94 ~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~~~~~~g~~~~~~~~~~~~f~~~D~d~dG~Is~~Ef~~~ 173 (204)
T 1jba_A 94 EHKLKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAEQQGKLLTPEEVVDRIFLLVDENGDGQLSLNEFVEG 173 (204)
T ss_dssp THHHHHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTSSTTTCCCCHHHHHHHHHHHHCCSCCSCBCHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCccccccccCchhhHHHHHHHHHHHhCCCCCCeEcHHHHHHH
Confidence 55788999999999999999999999884 2 1 0 1 1 2788999999999999999999999
Q ss_pred Hhhc
Q 007253 599 LHGV 602 (611)
Q Consensus 599 l~~~ 602 (611)
+...
T Consensus 174 ~~~~ 177 (204)
T 1jba_A 174 ARRD 177 (204)
T ss_dssp HTTT
T ss_pred HHcC
Confidence 8753
|
| >3a8r_A Putative uncharacterized protein; EF-hand, membrane, oxidoreductase, transmembrane, calcium BI protein; 2.40A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.72 E-value=8.9e-18 Score=157.13 Aligned_cols=147 Identities=10% Similarity=0.175 Sum_probs=115.5
Q ss_pred HHHHHHhhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcC---CCCCCcccHHHH
Q 007253 447 RKAALRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLN---SLQYRRMDFEEF 523 (611)
Q Consensus 447 ~~~~l~~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D---~~~~g~i~~~eF 523 (611)
....+.++.+..+..++.+++++|..+| ++|+|+.+||..++ +. ..++..+..++..+| .+++|.|+++||
T Consensus 11 ~~~~l~~~~~~~~~~~~~~~~~~F~~~D--~dG~I~~~el~~~l---g~-~~~~~~~~~i~~~~d~~~~~~~~~i~~~ef 84 (179)
T 3a8r_A 11 ALKGLQFVTAKVGNDGWAAVEKRFNQLQ--VDGVLLRSRFGKCI---GM-DGSDEFAVQMFDSLARKRGIVKQVLTKDEL 84 (179)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHHHHHHC--BTTBEEGGGHHHHH---TC-CSCHHHHHHHHHHHHHHHTCCSSEECHHHH
T ss_pred hHHHHHHHHhccchhhHHHHHHHHhccC--CCCCCcHHHHHHHH---CC-CCcHHHHHHHHHHHHHhccCCCCCcCHHHH
Confidence 4455667777666677889999999999 89999999999965 32 344556778888777 467889999999
Q ss_pred HHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc--CCCC-c------c---HHHHHHHHhcCCCCcee
Q 007253 524 CAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG--LGPA-V------P---VHAVLHDWIRHTDGKLS 591 (611)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~--~~~~-~------~---~~~~~~~~D~~~dG~is 591 (611)
+.++....... .++.++.+|+.||+|++|+|+.+||+.+|. +|.. . + ++.+|..+|.|+||.|+
T Consensus 85 ~~~~~~~~~~~----~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~ 160 (179)
T 3a8r_A 85 KDFYEQLTDQG----FDNRLRTFFDMVDKNADGRLTAEEVKEIIALSASANKLSKIKERADEYTALIMEELDPTNLGYIE 160 (179)
T ss_dssp HHHHHHHHCCC----HHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHTTHHHHHHHHHHHHHHHHHHHHSTTCCSEEC
T ss_pred HHHHHHHcCCC----HHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccccccccccchHHHHHHHHHHhCCCCCCcCc
Confidence 98765432211 266899999999999999999999999985 4433 2 2 88999999999999999
Q ss_pred HHHHHHHHhhcc
Q 007253 592 FLGFVKLLHGVS 603 (611)
Q Consensus 592 ~~eF~~~l~~~~ 603 (611)
|+||+.++....
T Consensus 161 ~~EF~~~~~~~p 172 (179)
T 3a8r_A 161 MEDLEALLLQSP 172 (179)
T ss_dssp HHHHHHHHC---
T ss_pred HHHHHHHHHhCc
Confidence 999999998754
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=99.71 E-value=6.6e-18 Score=160.59 Aligned_cols=135 Identities=19% Similarity=0.252 Sum_probs=111.7
Q ss_pred HHHHHHHhhhcCCC-CCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHH
Q 007253 463 LFYLKEQYALLEPN-KNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQ 541 (611)
Q Consensus 463 ~~~l~~~F~~~D~d-~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~ 541 (611)
.++++++|..||.+ ++|.|+.+||..+|...+........+..+|..+|.|++|.|+++||+.++........ ++
T Consensus 13 ~~el~~~f~~fd~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~I~~~Ef~~~~~~~~~~~~----~~ 88 (198)
T 2r2i_A 13 ATECHQWYKKFMTECPSGQLTLYEFKQFFGLKNLSPSANKYVEQMFETFDFNKDGYIDFMEYVAALSLVLKGKV----DQ 88 (198)
T ss_dssp TSCHHHHHHHHHHHCTTSEECHHHHHHHHTCCSCCHHHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHSSCCH----HH
T ss_pred HHHHHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCcchHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHccCch----HH
Confidence 34578889999988 89999999999998766653333455889999999999999999999998865543333 56
Q ss_pred HHHHHHhHHhcCCCCcccHHHHHHHhc-CC------CCcc----HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 542 HARCAYELFEKDGNRAIVIEELASELG-LG------PAVP----VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 542 ~~~~~F~~~D~d~~G~It~eEl~~~l~-~~------~~~~----~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
.++.+|+.||.|++|+|+.+||+.++. ++ ...+ +..+|..+|.|+||.|+|+||+.++..
T Consensus 89 ~~~~~F~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~ 159 (198)
T 2r2i_A 89 KLRWYFKLYDVDGNGCIDRGELLNIIKAIRAINRCNEAMTAEEFTNMVFDKIDINGDGELSLEEFMEGVQK 159 (198)
T ss_dssp HHHHHHHHHCTTCSSCEEHHHHHHHHHHTTGGGGSSSCCCHHHHHHHHHHHHCTTCSSEECHHHHHHHHTT
T ss_pred HHHHHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHc
Confidence 789999999999999999999999984 32 2222 778999999999999999999999864
|
| >1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A | Back alignment and structure |
|---|
Probab=99.71 E-value=8.1e-18 Score=158.60 Aligned_cols=150 Identities=17% Similarity=0.251 Sum_probs=116.6
Q ss_pred HHHHHHHhhhh--cchhhHHHHHHHHhhhcCCC-CCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHH
Q 007253 446 LRKAALRALSK--TLTVDELFYLKEQYALLEPN-KNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEE 522 (611)
Q Consensus 446 l~~~~l~~~~~--~l~~~e~~~l~~~F~~~D~d-~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~e 522 (611)
+.+..+..+.+ .++.++ ++++|..||.+ ++|.|+.+||..++............+..+|..+|.|++|.|+++|
T Consensus 8 l~~~~l~~l~~~~~~~~~~---i~~~f~~fd~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~e 84 (190)
T 1g8i_A 8 LKPEVVEELTRKTYFTEKE---VQQWYKGFIKDCPSGQLDAAGFQKIYKQFFPFGDPTKFATFVFNVFDENKDGRIEFSE 84 (190)
T ss_dssp CCHHHHHHHHHTSSSCHHH---HHHHHHHHHHHCTTSEEEHHHHHHHHHHHCTTSCTHHHHHHHHHHHCTTCSSEEEHHH
T ss_pred CCHHHHHHHHHccCCCHHH---HHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCCChHHHHHHHHHHHhcCCCCeEeHHH
Confidence 33444444444 455555 55666667766 8999999999999987743234445688999999999999999999
Q ss_pred HHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-----CCC--------Ccc---HHHHHHHHhcCC
Q 007253 523 FCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-----LGP--------AVP---VHAVLHDWIRHT 586 (611)
Q Consensus 523 F~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-----~~~--------~~~---~~~~~~~~D~~~ 586 (611)
|+.++........ ++.++.+|+.+|.|++|+|+.+||+.++. .|. ..+ +..+|..+|.|+
T Consensus 85 f~~~~~~~~~~~~----~~~~~~~f~~~D~d~~G~i~~~e~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~ 160 (190)
T 1g8i_A 85 FIQALSVTSRGTL----DEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKNA 160 (190)
T ss_dssp HHHHHHHHHHCCH----HHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSSHHHHHHHHHHHHCSSC
T ss_pred HHHHHHHhcCCCH----HHHHHHHHHhhcCCCCCeECHHHHHHHHHHHHHHhCCccCCccccccHHHHHHHHHHHhcCCC
Confidence 9988766543333 66789999999999999999999999884 231 122 788999999999
Q ss_pred CCceeHHHHHHHHhhc
Q 007253 587 DGKLSFLGFVKLLHGV 602 (611)
Q Consensus 587 dG~is~~eF~~~l~~~ 602 (611)
||.|+++||+.++...
T Consensus 161 dG~i~~~ef~~~~~~~ 176 (190)
T 1g8i_A 161 DGKLTLQEFQEGSKAD 176 (190)
T ss_dssp SSEEEHHHHHHHHHHC
T ss_pred CCcEeHHHHHHHHHhC
Confidence 9999999999998764
|
| >1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.71 E-value=3.4e-17 Score=159.02 Aligned_cols=140 Identities=16% Similarity=0.215 Sum_probs=116.6
Q ss_pred cchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhh
Q 007253 457 TLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEAL 536 (611)
Q Consensus 457 ~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~ 536 (611)
.++.++++.+.+.|... +++|.|+.+||..++..++....++.++..+|+.+|.|++|.|+++||+.++........
T Consensus 47 ~~s~~ei~~l~~~Fd~~--d~~G~I~~~E~~~~l~~l~~~~~~~~~~~~~f~~~D~d~~G~I~~~Ef~~~l~~~~~~~~- 123 (224)
T 1s1e_A 47 NFTKRELQVLYRGFKNE--CPSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTV- 123 (224)
T ss_dssp SCCHHHHHHHHHHHHHH--CTTSCBCHHHHHHHHHTTCTTSCCHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHCCH-
T ss_pred CCCHHHHHHHHHHHHhh--CCCCCCCHHHHHHHHHHhcCCCCcHHHHHHHHHHhcCCCCCcEeHHHHHHHHHHHccCCH-
Confidence 37888877777777765 488999999999999887654456677899999999999999999999998876543333
Q ss_pred HHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-C----CCC-----------ccHHHHHHHHhcCCCCceeHHHHHHHHh
Q 007253 537 DRWEQHARCAYELFEKDGNRAIVIEELASELG-L----GPA-----------VPVHAVLHDWIRHTDGKLSFLGFVKLLH 600 (611)
Q Consensus 537 ~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~----~~~-----------~~~~~~~~~~D~~~dG~is~~eF~~~l~ 600 (611)
++.++.+|+.||.|++|+|+.+||+.++. + |.. ..++.+|+.+|.|+||.|+|+||+.++.
T Consensus 124 ---~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~Is~~EF~~~~~ 200 (224)
T 1s1e_A 124 ---HEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESCQ 200 (224)
T ss_dssp ---HHHHHHHHHHHCTTCCSEECHHHHHHHHHHHHHHHTTCCCGGGCSSSHHHHHHHHHHHHCTTCSSCEEHHHHHHHHH
T ss_pred ---HHHHHHHHHHHcCCCCCeECHHHHHHHHHHHHHHhcccCCCCCCHhHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHH
Confidence 66889999999999999999999999883 2 321 2288999999999999999999999987
Q ss_pred hc
Q 007253 601 GV 602 (611)
Q Consensus 601 ~~ 602 (611)
..
T Consensus 201 ~~ 202 (224)
T 1s1e_A 201 ED 202 (224)
T ss_dssp TC
T ss_pred hC
Confidence 64
|
| >2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A | Back alignment and structure |
|---|
Probab=99.70 E-value=1.2e-17 Score=150.29 Aligned_cols=132 Identities=11% Similarity=0.130 Sum_probs=111.9
Q ss_pred hhhHHHHHHHHhhhcCCCC-CCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhH
Q 007253 459 TVDELFYLKEQYALLEPNK-NGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALD 537 (611)
Q Consensus 459 ~~~e~~~l~~~F~~~D~d~-~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~ 537 (611)
..+++.+++++|..+|.++ +|.|+.+||..+|..++. .+++.++..++..+|.+ |+|+||+.++.........
T Consensus 9 ~~~~~~~l~~~F~~~D~d~~~G~i~~~el~~~l~~~g~-~~~~~~~~~l~~~~d~~----i~~~eF~~~~~~~~~~~~~- 82 (146)
T 2qac_A 9 QLEEKVDESDVRIYFNEKSSGGKISIDNASYNARKLGL-APSSIDEKKIKELYGDN----LTYEQYLEYLSICVHDKDN- 82 (146)
T ss_dssp HHHHHSCHHHHHHHHHHHCBTTBEEHHHHHHHHHHTTC-CCCHHHHHHHHHHHCSE----ECHHHHHHHHHHTCCTTCC-
T ss_pred HHHHHHHHHHHHHHhCccCCCCcccHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCC----CCHHHHHHHHHHHhcCcch-
Confidence 3456778999999999999 999999999999988775 57778899999999987 9999999988643322111
Q ss_pred HHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007253 538 RWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLH 600 (611)
Q Consensus 538 ~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~ 600 (611)
.+.++.+|+.||+|++|+|+.+||++++. +|..++ ++.+|..+ |+||.|+|+||+.+|.
T Consensus 83 --~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~--d~dg~i~~~eF~~~l~ 145 (146)
T 2qac_A 83 --VEELIKMFAHFDNNCTGYLTKSQMKNILTTWGDALTDQEAIDALNAF--SSEDNIDYKLFCEDIL 145 (146)
T ss_dssp --HHHHHHHHHTTCTTCSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHH--CSSSEEEHHHHHHHHT
T ss_pred --HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhCCCCCHHHHHHHHHHc--CCCCcCcHHHHHHHHh
Confidence 55788999999999999999999999994 665554 88899999 9999999999999886
|
| >1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.70 E-value=1.4e-17 Score=157.40 Aligned_cols=148 Identities=20% Similarity=0.278 Sum_probs=115.8
Q ss_pred HHHHHHhhhh--cchhhHHHHHHHHhhhcCCC-CCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHH
Q 007253 447 RKAALRALSK--TLTVDELFYLKEQYALLEPN-KNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEF 523 (611)
Q Consensus 447 ~~~~l~~~~~--~l~~~e~~~l~~~F~~~D~d-~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF 523 (611)
.+..+..+.+ .++.++ ++++|..||.+ ++|.|+.+||..++..++.....+..+..+|..+|.|++|.|++.||
T Consensus 9 ~~~~l~~l~~~~~~~~~~---i~~~f~~fd~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef 85 (193)
T 1bjf_A 9 RPEVMQDLLESTDFTEHE---IQEWYKGFLRDCPSGHLSMEEFKKIYGNFFPYGDASKFAEHVFRTFDANGDGTIDFREF 85 (193)
T ss_dssp CHHHHHHHHHHSSCCHHH---HHHHHHHHHHHSTTSEEEHHHHHHHHTTTSSSSCCHHHHHHHHHHHCSSCSSEEEHHHH
T ss_pred CHHHHHHHHHHcCCCHHH---HHHHHHHHHHHCCCCCcCHHHHHHHHHHhcCcCChHHHHHHHHHHhCCCCCCcCcHHHH
Confidence 3444444443 356665 56777888887 89999999999998776543333456789999999999999999999
Q ss_pred HHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-----CCC--Cc---------cHHHHHHHHhcCCC
Q 007253 524 CAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-----LGP--AV---------PVHAVLHDWIRHTD 587 (611)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-----~~~--~~---------~~~~~~~~~D~~~d 587 (611)
+.++........ ++.++.+|+.+|.|++|+|+.+||..++. +|. .+ .+..+|..+|.|+|
T Consensus 86 ~~~~~~~~~~~~----~~~~~~~f~~~D~d~~G~I~~~E~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~d 161 (193)
T 1bjf_A 86 IIALSVTSRGKL----EQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDTNRD 161 (193)
T ss_dssp HHHHHHHTSSCH----HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGGSSHHHHHHHHHHHSCTTCS
T ss_pred HHHHHHHcCCCH----HHHHHHHHhhcCCCCCCeECHHHHHHHHHHHHHHhccccCCCcccccHHHHHHHHHHHhCCCCC
Confidence 988765543323 56789999999999999999999999883 231 11 17889999999999
Q ss_pred CceeHHHHHHHHhh
Q 007253 588 GKLSFLGFVKLLHG 601 (611)
Q Consensus 588 G~is~~eF~~~l~~ 601 (611)
|.|+++||+.++..
T Consensus 162 G~I~~~Ef~~~~~~ 175 (193)
T 1bjf_A 162 GKLSLEEFIRGAKS 175 (193)
T ss_dssp SEECHHHHHHHHHH
T ss_pred CeEeHHHHHHHHhc
Confidence 99999999999864
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A | Back alignment and structure |
|---|
Probab=99.70 E-value=1.4e-17 Score=156.47 Aligned_cols=144 Identities=12% Similarity=0.138 Sum_probs=115.1
Q ss_pred hhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhh-----cccccccCChhHH---------HhhcCCCCCCccc
Q 007253 454 LSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKN-----ATDAMKDSRIPDF---------LSSLNSLQYRRMD 519 (611)
Q Consensus 454 ~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~-----~~~~~~~~~~~~~---------~~~~D~~~~g~i~ 519 (611)
+...++++++.+++++|..+|.|++|+|+.+||..++..+ .+..+++.++..+ |..+|.|++|.|+
T Consensus 4 ~~~~l~~~~~~~l~~~F~~~D~d~dG~i~~~El~~~l~~~~~~~~~g~~~~~~~~~~l~~~~~~~~~f~~~D~d~dg~I~ 83 (186)
T 2hps_A 4 ITESERAYHLRKMKTRMQRVDVTGDGFISREDYELIAVRIAKIAKLSAEKAEETRQEFLRVADQLGLAPGVRISVEEAAV 83 (186)
T ss_dssp CCHHHHHHHHHHHHHHHHTTCTTCSSEEEHHHHHHHHHHHHHHHTCCHHHHHHHHHHHHHHHHHHTCCTTCEEEHHHHHH
T ss_pred ccccccHHHHHHHHHHhhhcCCCCCCccCHHHHHHHHHHHHHHHHcCCCCCcHHHHHHHHHHHHHHHHHhcCCCCCCccc
Confidence 3456788899999999999999999999999999998765 1335666777777 5999999999999
Q ss_pred HHHHHHHHcchhhHHhhHHHHHHHHHHH--hHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHH
Q 007253 520 FEEFCAAALSVHQLEALDRWEQHARCAY--ELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFL 593 (611)
Q Consensus 520 ~~eF~~~~~~~~~~~~~~~~~~~~~~~F--~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~ 593 (611)
++| .++........ ..+.+..+| +.||.|++|+|+.+||++++. ++..++ ++.+|..+|.|+||.|+|+
T Consensus 84 ~~E--~~~~~~~~~~~---~~~~~~~~f~~~~fD~d~~G~I~~~E~~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~i~~~ 158 (186)
T 2hps_A 84 NAT--DSLLKMKGEEK---AMAVIQSLIMYDCIDTDKDGYVSLPEFKAFLQAVGPDLTDDKAITCFNTLDFNKNGQISRD 158 (186)
T ss_dssp HHH--HHHHHCCTHHH---HHTTHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHCTTCCHHHHHHHHHHHCTTCSSEEEHH
T ss_pred HHH--HHHHHhcCChH---HHHHHHHHHHHHHccCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHcCCCCCcCcHH
Confidence 999 33333221111 133455666 888999999999999999994 454443 8899999999999999999
Q ss_pred HHHHHHhhc
Q 007253 594 GFVKLLHGV 602 (611)
Q Consensus 594 eF~~~l~~~ 602 (611)
||+.++...
T Consensus 159 ef~~~~~~~ 167 (186)
T 2hps_A 159 EFLVTVNDF 167 (186)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999999875
|
| >1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A | Back alignment and structure |
|---|
Probab=99.70 E-value=3.3e-17 Score=154.41 Aligned_cols=151 Identities=15% Similarity=0.206 Sum_probs=116.0
Q ss_pred HHHHHHhhhh--cchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHH
Q 007253 447 RKAALRALSK--TLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFC 524 (611)
Q Consensus 447 ~~~~l~~~~~--~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~ 524 (611)
.+..+..+.. .++.+++.++.+.|... +++|.|+.+||..++...+........+..+|..+|.|++|.|+++||+
T Consensus 9 ~~~~l~~l~~~~~~~~~~i~~~~~~fd~~--~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~ef~ 86 (190)
T 1fpw_A 9 SKDDLTCLKQSTYFDRREIQQWHKGFLRD--CPSGQLAREDFVKIYKQFFPFGSPEDFANHLFTVFDKDNNGFIHFEEFI 86 (190)
T ss_dssp TTHHHHHHTTTCCSTHHHHHHHHHHHHHH--CTTCCEEHHHHHHHHHHHCTTSCCSHHHHHHHHTCCSSCSSEECHHHHH
T ss_pred CHHHHHHHHHhcCCCHHHHHHHHHHHHHH--CCCCcCcHHHHHHHHHHHcCCCCcHHHHHHHHHHHCCCCCCcEeHHHHH
Confidence 3344444443 46777755554444443 3899999999999998875433445568899999999999999999999
Q ss_pred HHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-----CCC--------Ccc---HHHHHHHHhcCCCC
Q 007253 525 AAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-----LGP--------AVP---VHAVLHDWIRHTDG 588 (611)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-----~~~--------~~~---~~~~~~~~D~~~dG 588 (611)
.++........ ++.++.+|+.+|.|++|+|+.+||..++. +|. ..+ +..+|+.+|.|+||
T Consensus 87 ~~~~~~~~~~~----~~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG 162 (190)
T 1fpw_A 87 TVLSTTSRGTL----EEKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKNEDG 162 (190)
T ss_dssp HHHHHHSCCCS----THHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCCCHHHHHHHHHHHHTTTCSS
T ss_pred HHHHHHccCCc----HHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHHHhccccCcccccchHHHHHHHHHHHhCCCCCC
Confidence 88765543333 55788999999999999999999999883 232 122 78899999999999
Q ss_pred ceeHHHHHHHHhhcc
Q 007253 589 KLSFLGFVKLLHGVS 603 (611)
Q Consensus 589 ~is~~eF~~~l~~~~ 603 (611)
.|+++||++++....
T Consensus 163 ~I~~~Ef~~~~~~~~ 177 (190)
T 1fpw_A 163 YITLDEFREGSKVDP 177 (190)
T ss_dssp EEEHHHHHHHHHSST
T ss_pred cCcHHHHHHHHHhCh
Confidence 999999999987643
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=7.9e-18 Score=161.91 Aligned_cols=133 Identities=21% Similarity=0.290 Sum_probs=108.0
Q ss_pred HHHHHhhhcCCC-CCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHH
Q 007253 465 YLKEQYALLEPN-KNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHA 543 (611)
Q Consensus 465 ~l~~~F~~~D~d-~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~ 543 (611)
+++++|..||.+ ++|.|+.+||..+|..++.......++..+|..+|.|++|.|+|+||+.++........ ++.+
T Consensus 20 ei~~~f~~fD~~~~~G~is~~El~~~l~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~----~~~l 95 (211)
T 2ggz_A 20 ETHVWYRTFMMEYPSGLQTLHEFKTLLGLQGLNQKANKHIDQVYNTFDTNKDGFVDFLEFIAAVNLIMQEKM----EQKL 95 (211)
T ss_dssp ----CCCSHHHHCTTSEEEHHHHHHHTTCCSCCHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHSCSSH----HHHH
T ss_pred HHHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCcchHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHhccCch----HHHH
Confidence 478899999988 89999999999998766653333456889999999999999999999998865443222 6678
Q ss_pred HHHHhHHhcCCCCcccHHHHHHHhc-CC-----CCcc----HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 544 RCAYELFEKDGNRAIVIEELASELG-LG-----PAVP----VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 544 ~~~F~~~D~d~~G~It~eEl~~~l~-~~-----~~~~----~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
+.+|+.||.|++|+|+.+||+.++. ++ ...+ ++.+|..+|.|+||.|+|+||+.++..
T Consensus 96 ~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~ 163 (211)
T 2ggz_A 96 KWYFKLYDADGNGSIDKNELLDMFMAVQALNGQQTLSPEEFINLVFHKIDINNDGELTLEEFINGMAK 163 (211)
T ss_dssp HHHHHHHCTTCSSSBCHHHHHHHHHHHTTSSCCCSCTHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHT
T ss_pred HHHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCccccHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHh
Confidence 9999999999999999999999984 32 2222 788999999999999999999999875
|
| >1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=3.1e-17 Score=153.81 Aligned_cols=138 Identities=15% Similarity=0.255 Sum_probs=113.5
Q ss_pred cchhhHHHHHHHHhhhcCC-----CC-C--CcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCc-ccHHHHHHHH
Q 007253 457 TLTVDELFYLKEQYALLEP-----NK-N--GTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRR-MDFEEFCAAA 527 (611)
Q Consensus 457 ~l~~~e~~~l~~~F~~~D~-----d~-~--G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~-i~~~eF~~~~ 527 (611)
.++.+++.+++++|..+|. ++ + |.|+.+||.. |..++. .+ ....++..+|.|++|. |+|+||+.++
T Consensus 13 ~ls~~~~~~l~~~F~~~D~~~~~~~~~~~~G~i~~~el~~-l~~~g~-~~---~~~~l~~~~D~d~~G~~I~~~EF~~~~ 87 (183)
T 1dgu_A 13 FLTKQEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILS-LPELKA-NP---FKERICRVFSTSPAKDSLSFEDFLDLL 87 (183)
T ss_dssp SCCHHHHHHHHHHHHHHSCSTTCSSCCCTTTCSCHHHHHT-STTSSS-CT---THHHHHHHHSCSSSSCCCCHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHhCccccccccccccCcCcHHHHHH-HHhhhc-Cc---HHHHHHHHhCCCCCCCEecHHHHHHHH
Confidence 5789999999999999999 68 8 9999999999 765554 22 2457889999999999 9999999988
Q ss_pred cchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCC-----Ccc---HH----HHHHHHhcCCCCceeHHH
Q 007253 528 LSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGP-----AVP---VH----AVLHDWIRHTDGKLSFLG 594 (611)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~-----~~~---~~----~~~~~~D~~~dG~is~~e 594 (611)
........ .++.++.+|+.||.|++|+|+.+||+.++. ++. .++ ++ .+|..+|.|+||.|+|+|
T Consensus 88 ~~~~~~~~---~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~E 164 (183)
T 1dgu_A 88 SVFSDTAT---PDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSE 164 (183)
T ss_dssp HHHSTTCC---HHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHSSSCCCHHHHHHHHHHHHHHHHHHCTTSSSEEEHHH
T ss_pred HHhcCCCC---HHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhcccccCCCCHHHHHHHHHHHHHHhCCCCCCeEcHHH
Confidence 65443222 145789999999999999999999999984 333 233 44 489999999999999999
Q ss_pred HHHHHhhc
Q 007253 595 FVKLLHGV 602 (611)
Q Consensus 595 F~~~l~~~ 602 (611)
|+.++...
T Consensus 165 F~~~~~~~ 172 (183)
T 1dgu_A 165 FQHVISRS 172 (183)
T ss_dssp HHHHHCSS
T ss_pred HHHHHHhC
Confidence 99999764
|
| >1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A | Back alignment and structure |
|---|
Probab=99.69 E-value=2.4e-17 Score=156.76 Aligned_cols=132 Identities=17% Similarity=0.241 Sum_probs=114.2
Q ss_pred chhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhccc----ccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhH
Q 007253 458 LTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATD----AMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQL 533 (611)
Q Consensus 458 l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~----~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~ 533 (611)
.+..++++|++ |..+|.|++|.|+.+||..+|..++.. .+++.++..+++.+|.|++|.|+|+||+.++...
T Consensus 27 ~~~~~~~~l~~-F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~eF~~~~~~~--- 102 (198)
T 1juo_A 27 FPGQTQDPLYG-YFAAVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELWAVL--- 102 (198)
T ss_dssp CTTCCCCTTHH-HHHHHHTTTTEECHHHHHHHHHHHTTTCSSCCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHH---
T ss_pred CCccccHHHHH-HHHHhCCCCCcCCHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhCCCCCCeECHHHHHHHHHHH---
Confidence 55667888999 999999999999999999999887642 4567788999999999999999999999877532
Q ss_pred HhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 534 EALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 534 ~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
+.++.+|+.+|.|++|+|+.+||++++. ++...+ ++.++..+ |+||.|+|+||+.++..+
T Consensus 103 -------~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~l~~~~--d~dg~i~~~eF~~~~~~~ 166 (198)
T 1juo_A 103 -------NGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAKRY--STNGKITFDDYIACCVKL 166 (198)
T ss_dssp -------HHHHHHHHTTCTTCCSEECHHHHHHHHHHTTCCCCHHHHHHHHHHT--CSSSSEEHHHHHHHHHHH
T ss_pred -------HHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHh--CCCCeEcHHHHHHHHHHH
Confidence 3678899999999999999999999994 554444 88889988 999999999999988765
|
| >2l4h_A Calcium and integrin-binding protein 1; metal binding protei; NMR {Homo sapiens} PDB: 2l4i_A 2lm5_A | Back alignment and structure |
|---|
Probab=99.68 E-value=2.1e-17 Score=159.33 Aligned_cols=138 Identities=15% Similarity=0.261 Sum_probs=113.0
Q ss_pred cchhhHHHHHHHHhhhcCC-----CC-C--CcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCc-ccHHHHHHHH
Q 007253 457 TLTVDELFYLKEQYALLEP-----NK-N--GTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRR-MDFEEFCAAA 527 (611)
Q Consensus 457 ~l~~~e~~~l~~~F~~~D~-----d~-~--G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~-i~~~eF~~~~ 527 (611)
.|+.+|+++|.++|..+|. |+ + |.|+.+||.. |..++.. + ....+|..+|.|++|. |+|+||+.++
T Consensus 44 ~~s~~ei~~l~~~F~~~D~~~~~~d~~~~dG~I~~~E~~~-l~~lg~~-~---~~~~lf~~~D~d~dG~~I~f~EF~~~~ 118 (214)
T 2l4h_A 44 FLTKQEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILS-LPELKAN-P---FKERICRVFSTSPAKDSLSFEDFLDLL 118 (214)
T ss_dssp SCCHHHHHHHHHHHHHHSCGGGCCHHHHTTSEECHHHHTT-CHHHHTS-T---THHHHHHHHCCSSSCCSEEHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHhCcccccccccccCCcCCHHHHHH-hhccCCC-h---HHHHHHHHhCcCCCCCEecHHHHHHHH
Confidence 5899999999999999998 55 6 9999999999 6665542 2 3567899999999999 9999999988
Q ss_pred cchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCC-----Ccc---HH----HHHHHHhcCCCCceeHHH
Q 007253 528 LSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGP-----AVP---VH----AVLHDWIRHTDGKLSFLG 594 (611)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~-----~~~---~~----~~~~~~D~~~dG~is~~e 594 (611)
........ .++.++.+|+.||.|++|+|+.+||+.++. ++. .++ ++ .+|..+|.|+||.|+|+|
T Consensus 119 ~~~~~~~~---~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~~~~~~~~~s~~e~~~~~~~~~~~~D~d~dG~Is~~E 195 (214)
T 2l4h_A 119 SVFSDTAT---PDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSE 195 (214)
T ss_dssp HHTSSCSC---HHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHSSSCTTCSCTHHHHHHHHHHHHHCCSCCSSBCSHH
T ss_pred HHHcCCCC---HHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhccccCCCCCHHHHHHHHHHHHHHhCCCCCCcCCHHH
Confidence 65443222 156789999999999999999999999983 221 222 44 499999999999999999
Q ss_pred HHHHHhhc
Q 007253 595 FVKLLHGV 602 (611)
Q Consensus 595 F~~~l~~~ 602 (611)
|+.++...
T Consensus 196 F~~~~~~~ 203 (214)
T 2l4h_A 196 FQHVISRS 203 (214)
T ss_dssp HHHHHHTC
T ss_pred HHHHHHhC
Confidence 99998764
|
| >2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A | Back alignment and structure |
|---|
Probab=99.68 E-value=2.4e-17 Score=157.83 Aligned_cols=138 Identities=19% Similarity=0.235 Sum_probs=113.1
Q ss_pred chhhHHHHHHHHhhhcCCC-CCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhh
Q 007253 458 LTVDELFYLKEQYALLEPN-KNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEAL 536 (611)
Q Consensus 458 l~~~e~~~l~~~F~~~D~d-~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~ 536 (611)
++.++ ++++|..+|.+ ++|.|+.+||..++...+....+..++..+|..+|.|++|.|+++||+.++........
T Consensus 30 ~~~~~---i~~~f~~~d~~~~~G~i~~~ef~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~~~~- 105 (207)
T 2d8n_A 30 FSEEE---LCSWYQSFLKDCPTGRITQQQFQSIYAKFFPDTDPKAYAQHVFRSFDSNLDGTLDFKEYVIALHMTTAGKT- 105 (207)
T ss_dssp CCHHH---HHHHHHHHHHHCTTSEEEHHHHHHHHHHTCTTSCCHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHSCSSS-
T ss_pred CCHHH---HHHHHHHHHhhCCCCCCCHHHHHHHHHHhccCCCcHHHHHHHHHHhcCCCCCeEeHHHHHHHHHHHcCCCH-
Confidence 45555 66677777777 79999999999999887653355667899999999999999999999988865543222
Q ss_pred HHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-C----C----CCc---------cHHHHHHHHhcCCCCceeHHHHHHH
Q 007253 537 DRWEQHARCAYELFEKDGNRAIVIEELASELG-L----G----PAV---------PVHAVLHDWIRHTDGKLSFLGFVKL 598 (611)
Q Consensus 537 ~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~----~----~~~---------~~~~~~~~~D~~~dG~is~~eF~~~ 598 (611)
++.++.+|+.+|.|++|+|+.+||+.++. + | ..+ .++.+|..+|.|+||.|+|+||+.+
T Consensus 106 ---~~~~~~~f~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~l~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~ 182 (207)
T 2d8n_A 106 ---NQKLEWAFSLYDVDGNGTISKNEVLEIVMAIFKMITPEDVKLLPDDENTPEKRAEKIWKYFGKNDDDKLTEKEFIEG 182 (207)
T ss_dssp ---STTHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHSCHHHHHTSCTTTSSHHHHHHHHHHHTTCCTTCCEEHHHHHHH
T ss_pred ---HHHHHHHHHHhcCCCCCeEcHHHHHHHHHHHHHHhccccCCCcccccccHHHHHHHHHHHcCCCCCCcCcHHHHHHH
Confidence 45688899999999999999999999884 2 5 221 2889999999999999999999999
Q ss_pred Hhhc
Q 007253 599 LHGV 602 (611)
Q Consensus 599 l~~~ 602 (611)
+...
T Consensus 183 ~~~~ 186 (207)
T 2d8n_A 183 TLAN 186 (207)
T ss_dssp HHHC
T ss_pred HHhC
Confidence 9764
|
| >1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=99.68 E-value=1.8e-16 Score=146.25 Aligned_cols=123 Identities=18% Similarity=0.261 Sum_probs=106.0
Q ss_pred HHhhhcCCCCCCcccHHHHHHHHHhhccc----ccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHH
Q 007253 468 EQYALLEPNKNGTISLENVKSALMKNATD----AMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHA 543 (611)
Q Consensus 468 ~~F~~~D~d~~G~Is~~e~~~~l~~~~~~----~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~ 543 (611)
+.|..+|.|++|.|+.+||..++..++.. .+++.++..+++.+|.|++|.|+|+||+.++... +.+
T Consensus 5 ~~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~----------~~~ 74 (167)
T 1gjy_A 5 YGYFASVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELWAVL----------NGW 74 (167)
T ss_dssp HHHHHHHCCTTSCBCHHHHHHHHHHHTCSTTSCCCCHHHHHHHHHHHCTTCCSCBCHHHHHHHHHHH----------HHH
T ss_pred HHHHHHHcCCCCcCCHHHHHHHHHhhcccCCCCCcCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHH----------HHH
Confidence 35889999999999999999999887742 4567788999999999999999999999877432 367
Q ss_pred HHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 544 RCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 544 ~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
+.+|+.+|.|++|+|+.+||+.++. +|...+ ++.++..+ |+||.|+|+||+.++...
T Consensus 75 ~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~--d~dg~i~~~eF~~~~~~~ 135 (167)
T 1gjy_A 75 RQHFISFDSDRSGTVDPQELQKALTTMGFRLNPQTVNSIAKRY--STSGKITFDDYIACCVKL 135 (167)
T ss_dssp HHHHHHHCTTCCSEECHHHHHHHHHTTTCCCCHHHHHHHHHHT--CBTTBEEHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHh--CcCCcCcHHHHHHHHHHH
Confidence 8899999999999999999999994 554444 78889888 999999999999988754
|
| >2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.1e-16 Score=148.82 Aligned_cols=120 Identities=15% Similarity=0.204 Sum_probs=101.1
Q ss_pred hhcCCCCCCcccHHHHHHHHHhhc-----ccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHHH
Q 007253 471 ALLEPNKNGTISLENVKSALMKNA-----TDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARC 545 (611)
Q Consensus 471 ~~~D~d~~G~Is~~e~~~~l~~~~-----~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~ 545 (611)
..-+.+++|+|+.+||+.+|..++ +..++..++..+++.+|.|++|.|+|+||+.++... +.++.
T Consensus 11 ~~~~~~~dG~I~~~EL~~~l~~l~~~~~~g~~~~~~~~~~l~~~~D~d~~G~I~f~EF~~~~~~~----------~~l~~ 80 (174)
T 2i7a_A 11 SSGLVPRGSDIDATQLQGLLNQELLTGPPGDMFSLDECRSLVALMELKVNGRLDQEEFARLWKRL----------VHYQH 80 (174)
T ss_dssp -CCSCC-CCCEEHHHHHHHHHHHHC-----CCCCHHHHHHHHHHHCSSCSSEECHHHHHHHHHHH----------HHHHH
T ss_pred ccccCCCCCcCCHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHH----------HHHHH
Confidence 345788999999999999998872 335667789999999999999999999999876432 35788
Q ss_pred HHhHHhcCCCCcccHHHHHHHhc-C----CCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 546 AYELFEKDGNRAIVIEELASELG-L----GPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 546 ~F~~~D~d~~G~It~eEl~~~l~-~----~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
+|+.|| |++|+|+.+||+.++. + |...+ ++.++..+| |+||.|+|+||+.++...
T Consensus 81 aF~~fD-d~~G~I~~~El~~~l~~l~~~~G~~~~~~~~~~l~~~~d-d~dG~I~~~EF~~~~~~~ 143 (174)
T 2i7a_A 81 VFQKVQ-TSPGVLLSSDLWKAIENTDFLRGIFISRELLHLVTLRYS-DSVGRVSFPSLVCFLMRL 143 (174)
T ss_dssp HHHHHC-SBTTBEEGGGHHHHHHTCGGGTTCCCCHHHHHHHHHHHS-CTTSEECHHHHHHHHHHH
T ss_pred HHHHhc-CCCCcCCHHHHHHHHHHhHhccCCCCCHHHHHHHHHHHc-CCCCeEcHHHHHHHHHHH
Confidence 999999 9999999999999995 6 66554 788999999 999999999999988764
|
| >1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.5e-16 Score=146.44 Aligned_cols=123 Identities=14% Similarity=0.291 Sum_probs=106.3
Q ss_pred HHhhhcCCCCCCcccHHHHHHHHHhhccc----ccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHH
Q 007253 468 EQYALLEPNKNGTISLENVKSALMKNATD----AMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHA 543 (611)
Q Consensus 468 ~~F~~~D~d~~G~Is~~e~~~~l~~~~~~----~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~ 543 (611)
..|..+|.|++|.|+.+||..+|..++.. .+++.++..+++.+|.|++|.|+|+||+.++... +.+
T Consensus 3 ~~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~----------~~~ 72 (165)
T 1k94_A 3 YTYFSAVAGQDGEVDAEELQRCLTQSGINGTYSPFSLETCRIMIAMLDRDHTGKMGFNAFKELWAAL----------NAW 72 (165)
T ss_dssp HHHHHHHHGGGTSBCHHHHHHHHHHHTTTTTSCCCCHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHH----------HHH
T ss_pred HHHHHHhCCCCCcCCHHHHHHHHHHhccccCCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHH----------HHH
Confidence 45999999999999999999999887752 4567788999999999999999999999876432 357
Q ss_pred HHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 544 RCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 544 ~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
+.+|+.+|.|++|+|+.+||+.++. +|...+ ++.++..+ |+||.|+|+||+.++...
T Consensus 73 ~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~--d~dg~i~~~eF~~~~~~~ 133 (165)
T 1k94_A 73 KENFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVKRY--SKNGRIFFDDYVACCVKL 133 (165)
T ss_dssp HHHHHHHCTTCCSBCCHHHHHHHHHHTTCCCCHHHHHHHHHHH--CBTTBCBHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCceECHHHHHHHHHHhCCCCCHHHHHHHHHHh--CCCCeEcHHHHHHHHHHH
Confidence 8899999999999999999999994 555444 78889988 999999999999998765
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A | Back alignment and structure |
|---|
Probab=99.66 E-value=7e-17 Score=160.28 Aligned_cols=141 Identities=16% Similarity=0.203 Sum_probs=116.6
Q ss_pred hcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhccccccc------CChhHHHhhcCCCCCCcccHHHHHHHHcc
Q 007253 456 KTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKD------SRIPDFLSSLNSLQYRRMDFEEFCAAALS 529 (611)
Q Consensus 456 ~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~------~~~~~~~~~~D~~~~g~i~~~eF~~~~~~ 529 (611)
..+++.+..+|+++|..+|.|++|.|+.+||..+|..++.. ++. ..+..++..+|.|++|.|+|+||+.++..
T Consensus 8 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~l~~~-~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~Ef~~~~~~ 86 (263)
T 2f33_A 8 LQSSLITASQFFEIWLHFDADGSGYLEGKELQNLIQELLQA-RKKAGLELSPEMKTFVDQYGQRDDGKIGIVELAHVLPT 86 (263)
T ss_dssp TTTSCCCHHHHHHHHHHHCTTCSSSBCSHHHHHHHHHHHHH-HHHHTCCCCHHHHHHHHHHTTGGGCCBCHHHHHHHTTS
T ss_pred hhcCcccHHHHHHHHHHhCCCCCCCcCHHHHHHHHHHHHhh-cCCCccchHHHHHHHHHHhCCCCCCcCcHHHHHHHHhh
Confidence 45777888899999999999999999999999999877642 322 55678999999999999999999998754
Q ss_pred h---------hhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-C----CCCcc---HHH----HHHHHhcCCCC
Q 007253 530 V---------HQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-L----GPAVP---VHA----VLHDWIRHTDG 588 (611)
Q Consensus 530 ~---------~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~----~~~~~---~~~----~~~~~D~~~dG 588 (611)
. ..... .+.++.+|+.+|.|++|+|+.+||+.++. + +...+ +.. ++..+|.|+||
T Consensus 87 ~~~~~~~~~~~~~~~----~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~d~~~dg 162 (263)
T 2f33_A 87 EENFLLLFRCQQLKS----CEEFMKTWRKYDTDHSGFIETEELKNFLKDLLEKANKTVDDTKLAEYTDLMLKLFDSNNDG 162 (263)
T ss_dssp CTTHHHHHGGGTSSC----HHHHHHHHTTSSTTTCSSBCHHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHTCSSSSS
T ss_pred hhhHHHHHHHhhccH----HHHHHHHHHHHCCCCCCCcCHHHHHHHHHHHHhhcCCCCCHHHHHHHHHHHHHhcCCCCCC
Confidence 3 11111 56789999999999999999999999984 3 55444 443 89999999999
Q ss_pred ceeHHHHHHHHhh
Q 007253 589 KLSFLGFVKLLHG 601 (611)
Q Consensus 589 ~is~~eF~~~l~~ 601 (611)
.|+|+||+.++..
T Consensus 163 ~i~~~ef~~~~~~ 175 (263)
T 2f33_A 163 KLELTEMARLLPV 175 (263)
T ss_dssp CBCHHHHHHHSCT
T ss_pred eEcHHHHHHHHHH
Confidence 9999999998764
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A | Back alignment and structure |
|---|
Probab=99.65 E-value=1.7e-16 Score=157.51 Aligned_cols=140 Identities=17% Similarity=0.255 Sum_probs=111.0
Q ss_pred HHHHHHHhhhcCCCCCCcccHHHHHHHHHhhc---ccccccCChhH----HHhhcCCCCCCcccHHHHHHHHcchh----
Q 007253 463 LFYLKEQYALLEPNKNGTISLENVKSALMKNA---TDAMKDSRIPD----FLSSLNSLQYRRMDFEEFCAAALSVH---- 531 (611)
Q Consensus 463 ~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~---~~~~~~~~~~~----~~~~~D~~~~g~i~~~eF~~~~~~~~---- 531 (611)
..+++++|..+|.+++|+|+.+||..+|.... +..+++.++.. ++..+|.|++|.|+|+||+.++....
T Consensus 102 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~~~~ 181 (263)
T 2f33_A 102 CEEFMKTWRKYDTDHSGFIETEELKNFLKDLLEKANKTVDDTKLAEYTDLMLKLFDSNNDGKLELTEMARLLPVQENFLL 181 (263)
T ss_dssp HHHHHHHHTTSSTTTCSSBCHHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHTCSSSSSCBCHHHHHHHSCTTTCSHH
T ss_pred HHHHHHHHHHHCCCCCCCcCHHHHHHHHHHHHhhcCCCCCHHHHHHHHHHHHHhcCCCCCCeEcHHHHHHHHHHHHHHHH
Confidence 45689999999999999999999999987762 33566666665 99999999999999999998876410
Q ss_pred hHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCC----Ccc---HHHHHHH-HhcCCCCceeHHHHHHHHhhc
Q 007253 532 QLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGP----AVP---VHAVLHD-WIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 532 ~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~----~~~---~~~~~~~-~D~~~dG~is~~eF~~~l~~~ 602 (611)
.........+.++.+|+.||+|++|+|+.+||++++. ++. .++ ++.++.. +|.|+||.|+|+||+.+|...
T Consensus 182 ~~~~~~~~~~~~~~~F~~~D~d~~G~is~~El~~~l~~~~~~~~~~~~~~e~~~~~~~~~D~d~dG~i~~~EF~~~~~~~ 261 (263)
T 2f33_A 182 KFQGIKMCGKEFNKAFELYDQDGNGYIDENELDALLKDLCEKNKQELDINNISTYKKNIMALSDGGKLYRTDLALILSAG 261 (263)
T ss_dssp HHHHTCCCHHHHHHHHHHHCCSSSSCEEHHHHHHHHHHHHHHCTTTCCTTTHHHHHHHHHTTSBTTEECGGGTHHHHCCS
T ss_pred HhcCcchHHHHHHHHHHHhCCCCCCcccHHHHHHHHHHHHHhcCCCCCHHHHHHHHHHhhccCCCCeEcHHHHHHHHhcc
Confidence 0000001156789999999999999999999999983 221 222 8888887 799999999999999998753
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A | Back alignment and structure |
|---|
Probab=99.65 E-value=2.2e-16 Score=161.73 Aligned_cols=129 Identities=18% Similarity=0.239 Sum_probs=112.8
Q ss_pred hHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhH-HHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHH
Q 007253 461 DELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPD-FLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRW 539 (611)
Q Consensus 461 ~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~-~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~ 539 (611)
.....++.+|..+|.+++|+|+.+||..+| .+ ..++..++.. +|..+|.|++|.|+|+||+.++....
T Consensus 185 ~~~~~l~~~F~~~D~d~dG~Is~~El~~~l--~g-~~~~~~ei~~~l~~~~D~d~dG~Is~~EF~~~l~~~~-------- 253 (323)
T 1ij5_A 185 NDLAALVADFRKIDTNSNGTLSRKEFREHF--VR-LGFDKKSVQDALFRYADEDESDDVGFSEYVHLGLCLL-------- 253 (323)
T ss_dssp HHHHTSCCCHHHHCTTCCSEECHHHHHHHH--HH-TTCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHH--------
T ss_pred hHHHHHHHHHHHHCCCCCCcCcHHHHHHHH--cC-CCCCHHHHHHHHHHHhcCCCCCEEeHHHHHHHHHHHH--------
Confidence 456678999999999999999999999988 43 3577778999 99999999999999999998875543
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHh-c-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASEL-G-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l-~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
.+..+|+.||.|++|+|+.+||+.++ . +|..++ ++.+|..+|.|+||.|+|+||+.+|...
T Consensus 254 --~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~ls~~e~~~l~~~~D~d~dG~Is~~EF~~~~~~~ 319 (323)
T 1ij5_A 254 --VLRILYAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVVDVDDSKSLSYQEFVMLVLLM 319 (323)
T ss_dssp --HHHHHHHHTCSSSCSSEEHHHHHHHHHHTTCCGGGCSTHHHHHHHHTTTTCSEECHHHHHHHHHHH
T ss_pred --HHHHHHHHhCCCCCCCccHHHHHHHHHHHcCCCCCHHHHHHHHHHHCCCCCCcEeHHHHHHHHHHh
Confidence 46779999999999999999999999 5 554443 8999999999999999999999998764
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.64 E-value=2.3e-16 Score=156.39 Aligned_cols=140 Identities=15% Similarity=0.222 Sum_probs=114.7
Q ss_pred cchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhh
Q 007253 457 TLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEAL 536 (611)
Q Consensus 457 ~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~ 536 (611)
.++.+++..+.+.|... +++|.|+.+||..++..++.....+..+..+|..+|.|++|.|+++||+.++........
T Consensus 87 ~~s~~ei~~l~~~fd~~--~~~G~I~~~ef~~~l~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~l~~~~~~~~- 163 (256)
T 2jul_A 87 KFTKKELQSLYRGFKNE--CPTGLVDEDTFKLIYSQFFPQGDATTYAHFLFNAFDADGNGAIHFEDFVVGLSILLRGTV- 163 (256)
T ss_dssp TSCHHHHHHHHHHHHHH--CTTSSEEHHHHHHHHHHHCCSSCCHHHHHHHHHHSSCSCCSEECSHHHHHHHHHHHSCCH-
T ss_pred CCCHHHHHHHHHHHHhh--CCCCcCCHHHHHHHHHHHcccCCcHHHHHHHHHHhccCCCCcCcHHHHHHHHHHHhccCh-
Confidence 47788877766666643 379999999999999887654455667889999999999999999999998866543333
Q ss_pred HHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-C----C--------CCcc---HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007253 537 DRWEQHARCAYELFEKDGNRAIVIEELASELG-L----G--------PAVP---VHAVLHDWIRHTDGKLSFLGFVKLLH 600 (611)
Q Consensus 537 ~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~----~--------~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~ 600 (611)
++.++.+|+.+|.|++|+|+.+||..++. + | .... ++.+|..+|.|+||.|+|+||+.++.
T Consensus 164 ---~~~l~~~F~~~D~d~dG~I~~~Ef~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~Is~~Ef~~~~~ 240 (256)
T 2jul_A 164 ---HEKLKWAFNLYDINKDGCITKEEMLAIMKSIYDMMGRHTYPILREDAPLEHVERFFQKMDRNQDGVVTIDEFLETCQ 240 (256)
T ss_dssp ---HHHHHHHHHHTCCSSSSCBCHHHHHHHHHHHHHHCCCCCSCCSCCCCHHHHHHHHHHHSCCSTTCSBCHHHHHHHHH
T ss_pred ---HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCCcccchhhHHHHHHHHHHHHCCCCCCcEeHHHHHHHHH
Confidence 66889999999999999999999999883 2 4 1112 88999999999999999999999987
Q ss_pred hc
Q 007253 601 GV 602 (611)
Q Consensus 601 ~~ 602 (611)
..
T Consensus 241 ~~ 242 (256)
T 2jul_A 241 KD 242 (256)
T ss_dssp HC
T ss_pred hC
Confidence 64
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A | Back alignment and structure |
|---|
Probab=99.63 E-value=2.5e-16 Score=157.08 Aligned_cols=139 Identities=11% Similarity=0.147 Sum_probs=109.0
Q ss_pred HHHHHHHhhhcCCCCCCcccHHHHHHHHHhhc---ccccccCChh----HHHhhcCCCCCCcccHHHHHHHHcch-----
Q 007253 463 LFYLKEQYALLEPNKNGTISLENVKSALMKNA---TDAMKDSRIP----DFLSSLNSLQYRRMDFEEFCAAALSV----- 530 (611)
Q Consensus 463 ~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~---~~~~~~~~~~----~~~~~~D~~~~g~i~~~eF~~~~~~~----- 530 (611)
..+++++|..+|.+++|.|+.+||..++.... +..+++.++. .+|..+|.|++|.|+|+||+.++...
T Consensus 103 ~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~~~~~~~~~~ 182 (272)
T 2be4_A 103 SVEFMKIWRKYDADSSGYISAAELKNFLKDLFLQHKKKIPPNKLDEYTDAMMKIFDKNKDGRLDLNDLARILALQENFLL 182 (272)
T ss_dssp HHHHHHHHHHHCTTCCSEEEGGGHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSSCSSEEEHHHHGGGSCCSSCSST
T ss_pred HHHHHHHHHHhCCCCCCccCHHHHHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHhccCCCCcCcHHHHHHHHhhhHHHHh
Confidence 44689999999999999999999999987762 2345555554 49999999999999999999877541
Q ss_pred -hh--HHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CC----CCcc---HHH----HHHHHhcCCCCceeHHHH
Q 007253 531 -HQ--LEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LG----PAVP---VHA----VLHDWIRHTDGKLSFLGF 595 (611)
Q Consensus 531 -~~--~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~----~~~~---~~~----~~~~~D~~~dG~is~~eF 595 (611)
.. ........+.++.+|+.+|+|++|+|+.+||++++. ++ +.++ ++. +|..+|.|+||.|+|+||
T Consensus 183 ~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~~D~d~dG~is~~EF 262 (272)
T 2be4_A 183 QFKMDASSQVERKRDFEKIFAHYDVSRTGALEGPEVDGFVKDMMELVRPSISGGDLDKFRECLLTHCDMNKDGKIQKSEL 262 (272)
T ss_dssp TSCCCHHHHHHHHHHHHHHHHHHCTTCCSEEETHHHHHHHHHHHHHHSSSCCHHHHHHHHHHHHHHHCCSTTCEEEHHHH
T ss_pred hhhhhhccccccHHHHHHHHHHhCCCCCCeecHHHHHHHHHHHHHHcCCCCCHHHHHHHHHHHHHHhCCCCCCcCcHHHH
Confidence 00 001112266799999999999999999999999983 22 2333 444 999999999999999999
Q ss_pred HHHHhh
Q 007253 596 VKLLHG 601 (611)
Q Consensus 596 ~~~l~~ 601 (611)
+++|..
T Consensus 263 ~~~~~~ 268 (272)
T 2be4_A 263 ALCLGL 268 (272)
T ss_dssp HHHTTC
T ss_pred HHHHcc
Confidence 998864
|
| >3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L | Back alignment and structure |
|---|
Probab=99.60 E-value=1.3e-15 Score=171.99 Aligned_cols=134 Identities=15% Similarity=0.201 Sum_probs=116.9
Q ss_pred cchhhH-HHHHHHHhhhcCCCCCCcccHHHHHHHHHhhc-------ccccccCChhHHHhhcCCCCCCcccHHHHHHHHc
Q 007253 457 TLTVDE-LFYLKEQYALLEPNKNGTISLENVKSALMKNA-------TDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAAL 528 (611)
Q Consensus 457 ~l~~~e-~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~-------~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~ 528 (611)
.+++++ .++|+++|..+| +++|.|+.+||+.+|..+. +..+++.++..+++.+|.|++|+|+|+||+.++.
T Consensus 524 ~ls~~e~~~~l~~~F~~~D-d~dG~Is~~El~~~L~~l~~~~~~~~g~~~s~~~~~~l~~~~D~d~~G~I~f~EF~~l~~ 602 (714)
T 3bow_A 524 EANEEDIGDGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFSIETCKIMVDMLDEDGSGKLGLKEFYILWT 602 (714)
T ss_dssp CCSGGGCCHHHHHHHHHHH-GGGTSBCHHHHHHHHHHHHTTCTTSCCSCCCHHHHHHHHHHHCCSSCSSBCHHHHHHHHH
T ss_pred CCChhhHHHHHHHHHHHHc-CCCCcCCHHHHHHHHHHHhhhcccccCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 367777 889999999999 9999999999999998861 3357778899999999999999999999998775
Q ss_pred chhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 529 SVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
.. +.++.+|+.||+|++|+|+.+||+.+|. +|..++ ++.+|..+| |+||.|+|+||+.+|..+
T Consensus 603 ~~----------~~l~~~F~~~D~d~dG~Is~~El~~~L~~~G~~ls~~~~~~l~~~~D-d~dG~Isf~EF~~~l~~~ 669 (714)
T 3bow_A 603 KI----------QKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLPCQLHQVIVARFA-DDELIIDFDNFVRCLVRL 669 (714)
T ss_dssp HH----------HHHHHHHHHHCTTCCSSEEHHHHHHHHHHTTEECCHHHHHHHHHHHS-CTTCEECHHHHHHHHHHH
T ss_pred HH----------HHHHHHHHHhCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCeEcHHHHHHHHHHH
Confidence 43 3578899999999999999999999994 554333 899999999 999999999999998765
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A | Back alignment and structure |
|---|
Probab=99.59 E-value=4.1e-16 Score=155.58 Aligned_cols=145 Identities=18% Similarity=0.260 Sum_probs=112.6
Q ss_pred cchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHH----hhccc-ccccCChhH----HHhhcCCCCCCcccHHHHHHHH
Q 007253 457 TLTVDELFYLKEQYALLEPNKNGTISLENVKSALM----KNATD-AMKDSRIPD----FLSSLNSLQYRRMDFEEFCAAA 527 (611)
Q Consensus 457 ~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~----~~~~~-~~~~~~~~~----~~~~~D~~~~g~i~~~eF~~~~ 527 (611)
.++..+.++|+++|..+|.|++|.|+.+||..+|. .++.. .+++.++.. +|..+|.|++|.|+|+||+.++
T Consensus 4 ~~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~lg~~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~~ 83 (272)
T 2be4_A 4 AFANLDAAGFLQIWQHFDADDNGYIEGKELDDFFRHMLKKLQPKDKITDERVQQIKKSFMSAYDATFDGRLQIEELANMI 83 (272)
T ss_dssp CCCCCCHHHHHHHHHHHCTTCCSEEEGGGHHHHHHHHHHHHSTTSCCCHHHHHHHHHHHSCHHHHTCCSEEEHHHHHHHH
T ss_pred HHHhcCHHHHHHHHHHhcCCCCCCcCHHHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhcCCCCCcEeHHHHHHHH
Confidence 35566677899999999999999999999999987 55531 455555654 5588999999999999999985
Q ss_pred cch-------hhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-C----CCCcc---H----HHHHHHHhcCCCC
Q 007253 528 LSV-------HQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-L----GPAVP---V----HAVLHDWIRHTDG 588 (611)
Q Consensus 528 ~~~-------~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~----~~~~~---~----~~~~~~~D~~~dG 588 (611)
... ..........+.++.+|+.+|.|++|+|+.+||+.++. + |...+ + ..++..+|.|+||
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~D~~~dg 163 (272)
T 2be4_A 84 LPQEENFLLIFRREAPLDNSVEFMKIWRKYDADSSGYISAAELKNFLKDLFLQHKKKIPPNKLDEYTDAMMKIFDKNKDG 163 (272)
T ss_dssp SCHHHHHHHHHHHHSCCCCHHHHHHHHHHHCTTCCSEEEGGGHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSSCSS
T ss_pred hhhhHHHHHHHhhccCcccHHHHHHHHHHhCCCCCCccCHHHHHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHhccCCCC
Confidence 431 10100001156789999999999999999999999984 3 55444 3 4489999999999
Q ss_pred ceeHHHHHHHHhh
Q 007253 589 KLSFLGFVKLLHG 601 (611)
Q Consensus 589 ~is~~eF~~~l~~ 601 (611)
.|+|+||+.++..
T Consensus 164 ~i~~~ef~~~~~~ 176 (272)
T 2be4_A 164 RLDLNDLARILAL 176 (272)
T ss_dssp EEEHHHHGGGSCC
T ss_pred cCcHHHHHHHHhh
Confidence 9999999998754
|
| >1djx_A PLC-D1, phosphoinositide-specific phospholipase C, isozyme delta1; phosphoric diester hydrolase, hydrolase, lipid degradation, transducer; HET: I3P; 2.30A {Rattus norvegicus} SCOP: a.39.1.7 b.7.1.1 c.1.18.1 PDB: 1djg_A 1dji_A 1djh_A* 1djw_A* 1djy_A* 1djz_A* 2isd_A 1qas_A 1qat_A | Back alignment and structure |
|---|
Probab=99.53 E-value=2.4e-15 Score=166.15 Aligned_cols=130 Identities=13% Similarity=0.168 Sum_probs=60.2
Q ss_pred HHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHH
Q 007253 464 FYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHA 543 (611)
Q Consensus 464 ~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~ 543 (611)
.+|+++|..+|.|++|+|+.+||+.+|..++. ..++.++..+|..+|.|++|.|+|+||+.++..... ++++
T Consensus 11 ~~l~~~F~~fD~d~dG~Is~~El~~~l~~lg~-~~s~~el~~lf~~~D~d~~G~I~f~EF~~~~~~l~~-------~~el 82 (624)
T 1djx_A 11 HWIHSCLRKADKNKDNKMNFKELKDFLKELNI-QVDDGYARKIFRECDHSQTDSLEDEEIETFYKMLTQ-------RAEI 82 (624)
T ss_dssp ----------------------------------------------------------CTTHHHHHHTC-------CHHH
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHhcc-------HHHH
Confidence 47899999999999999999999999987765 578889999999999999999999999988765432 3468
Q ss_pred HHHHhHHhcCCCCcccHHHHHHHhc--CCCC-cc---HHHHHHHHhcC----CCCceeHHHHHHHHhhc
Q 007253 544 RCAYELFEKDGNRAIVIEELASELG--LGPA-VP---VHAVLHDWIRH----TDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 544 ~~~F~~~D~d~~G~It~eEl~~~l~--~~~~-~~---~~~~~~~~D~~----~dG~is~~eF~~~l~~~ 602 (611)
+.+|+.||.+ +|+|+.+||+++|. .+.. ++ +++||+.+|.| +||.|+|+||+.+|...
T Consensus 83 ~~aF~~fD~~-~G~Is~~EL~~fL~~~qge~~ls~ee~~~ii~~~d~d~~~~~dG~Is~deF~~~L~s~ 150 (624)
T 1djx_A 83 DRAFEEAAGS-AETLSVERLVTFLQHQQREEEAGPALALSLIERYEPSETAKAQRQMTKDGFLMYLLSA 150 (624)
T ss_dssp HHHHHHHHTT-SSSEEHHHHHHHHHHTSCCSSCSHHHHHHHHHHHCCCHHHHHTTEECHHHHHHHHHST
T ss_pred HHHHHHhcCC-CCeecHHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCChhhccCCCCCHHHHHHHhcCc
Confidence 8999999985 89999999999995 3443 33 88999999998 79999999999999753
|
| >1sjj_A Actinin; 3-helix bundle, calponin homology domain, calmodulin-like domain, actin binding protein, contractIle protein; 20.00A {Gallus gallus} SCOP: i.15.1.1 | Back alignment and structure |
|---|
Probab=99.53 E-value=4.2e-15 Score=172.79 Aligned_cols=145 Identities=14% Similarity=0.270 Sum_probs=122.9
Q ss_pred HHhhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcch
Q 007253 451 LRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV 530 (611)
Q Consensus 451 l~~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~ 530 (611)
+......++..++..++++|..||.|++|+|+.+||..+|..++. .+++.++..+|..+|.|++|.|+|+||+.++...
T Consensus 712 l~~~~~~l~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~g~-~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~ 790 (863)
T 1sjj_A 712 LTRDAKGISQEQMNEFRASFNHFDRKKTGMMDCEDFRACLISMGY-NMGEAEFARIMSIVDPNRMGVVTFQAFIDFMSRE 790 (863)
T ss_dssp HHCCCCCSSHHHHHHHHHHHTTTCSSSSSEEESTTHHHHHHHHTC-CCCTHHHHHHHHHHCTTSCSEEETTHHHHTHHHH
T ss_pred HHhhccCCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence 344456678888999999999999999999999999999988775 5778889999999999999999999999877554
Q ss_pred hhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhcCCCCccHHHHHHHHhcC-----CCCceeHHHHHHHHhhcc
Q 007253 531 HQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRH-----TDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 531 ~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~~~~~~~~~~~~~~~D~~-----~dG~is~~eF~~~l~~~~ 603 (611)
...... .+.++.+|+.| .|++|+|+.+||+++|. +..++.+|..+|.+ +||.|+|+||+.+|.+.+
T Consensus 791 ~~~~~~---~~~l~~aF~~~-~d~~G~Is~~El~~~l~---~~~~~~l~~~~d~~~~~~~~dg~I~~~eF~~~~~~~~ 861 (863)
T 1sjj_A 791 TADTDT---ADQVMASFKIL-AGDKNYITVDELRRELP---PDQAEYCIARMAPYNGRDAVPGALDYMSFSTALYGES 861 (863)
T ss_dssp STTCSS---SHHHHHHHHGG-GTSSSEEEHHHHHHHSC---HHHHHHHHHHSEECCSSCCCTTEEESHHHHHHHSCCS
T ss_pred hcCCCC---HHHHHHHHHHH-hCCCCcCcHHHHHHHCC---HHHHHHHHHHcchhcCCCCCCCceeHHHHHHHHhcCC
Confidence 321111 45788999999 89999999999999996 33389999999987 799999999999997643
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=99.52 E-value=2.9e-14 Score=134.55 Aligned_cols=124 Identities=17% Similarity=0.156 Sum_probs=105.2
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHH
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHAR 544 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~ 544 (611)
++..+|..+|.|++|.|+++||..++... .++..+|..+|.|++|.|+.+||..++........ ++++.
T Consensus 64 ~~~~l~~~~D~d~dG~I~~~EF~~~~~~~-------~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~----~~~~~ 132 (191)
T 1y1x_A 64 TTEKLLHMYDKNHSGEITFDEFKDLHHFI-------LSMREGFRKRDSSGDGRLDSNEVRAALLSSGYQVS----EQTFQ 132 (191)
T ss_dssp HHHHHHHHHCTTCSSSBCHHHHHHHHHHH-------HHHHHHHHHHCTTSSSCBCHHHHHHHHHTTSCCCC----HHHHH
T ss_pred HHHHHHHHhCCCCCCeEcHHHHHHHHHHH-------HHHHHHHHHhCCCCCCeEcHHHHHHHHHHhCCCCC----HHHHH
Confidence 46788999999999999999999987542 35788999999999999999999998876543333 56788
Q ss_pred HHHhHHhcCCCCcccHHHHHHHhcCCCCccHHHHHHHHhcCCCCc--eeHHHHHHHHhh
Q 007253 545 CAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGK--LSFLGFVKLLHG 601 (611)
Q Consensus 545 ~~F~~~D~d~~G~It~eEl~~~l~~~~~~~~~~~~~~~D~~~dG~--is~~eF~~~l~~ 601 (611)
.+|+.+|.|++|.|+.+||..++.... .+..+|+.+|.|+||. ++|+||+.++..
T Consensus 133 ~~~~~~D~d~dg~i~~~eF~~~~~~~~--~~~~~F~~~D~d~dG~i~~~~~eF~~~~~~ 189 (191)
T 1y1x_A 133 ALMRKFDRQRRGSLGFDDYVELSIFVC--RVRNVFAFYDRERTGQVTFTFDTFIGGSVS 189 (191)
T ss_dssp HHHHHHCTTCSSSBCHHHHHHHHHHHH--HHHHHHHHHCTTCCSEEEEEHHHHHHHHHH
T ss_pred HHHHHhCCCCCCeEeHHHHHHHHHHHH--HHHHHHHHhCcCCCceEEeeHHHHHHHHHh
Confidence 999999999999999999999885221 2778999999999999 789999998764
|
| >3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.51 E-value=1.5e-14 Score=128.47 Aligned_cols=99 Identities=17% Similarity=0.229 Sum_probs=62.7
Q ss_pred ChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CC-CCcc---HH
Q 007253 502 RIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LG-PAVP---VH 576 (611)
Q Consensus 502 ~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~-~~~~---~~ 576 (611)
.+.++|+.+|.|++|.|+|+||+.++........ ..+.++.+|+.||+|++|+|+.+||+.++. +| ..++ ++
T Consensus 4 ~~~~l~~~~D~d~~G~I~~~EF~~~~~~~~~~~~---~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~e~~ 80 (135)
T 3h4s_E 4 TEKSMLLETTSTTKMETKYEDMLPVMAEKMDVEE---FVSELCKGFSLLADPERHLITAESLRRNSGILGIEGMSKEDAQ 80 (135)
T ss_dssp ---------------CCCC-----------CHHH---HHHHHHHHHHHHSBTTTTBBCHHHHHHHGGGGTCCCCCHHHHH
T ss_pred hHHHHHHHHcCCCCCcEeHHHHHHHHHHHccccc---hHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHH
Confidence 4567999999999999999999998766433222 266899999999999999999999999995 66 3554 89
Q ss_pred HHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 577 AVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 577 ~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
.+|..+|.|+||.|+|+||+.+|....
T Consensus 81 ~~~~~~D~d~dG~I~~~EF~~~~~~~~ 107 (135)
T 3h4s_E 81 GMVREGDLDGDGALNQTEFCVLMVRLS 107 (135)
T ss_dssp HHHHHHCSSCSSSBCHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCCcHHHHHHHHHHhC
Confidence 999999999999999999999998764
|
| >5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=99.50 E-value=4.1e-14 Score=120.44 Aligned_cols=98 Identities=21% Similarity=0.308 Sum_probs=83.6
Q ss_pred ccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-C---CCC
Q 007253 497 AMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-L---GPA 572 (611)
Q Consensus 497 ~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~---~~~ 572 (611)
.+++.++..+++.+|. +|.|+|+||+.++..... . .+.++.+|+.||+|++|+|+.+||+.++. + +..
T Consensus 5 ~~s~~ei~~~~~~~d~--~g~i~~~eF~~~~~~~~~--~----~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~g~~ 76 (109)
T 5pal_A 5 VLKADDINKAISAFKD--PGTFDYKRFFHLVGLKGK--T----DAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRD 76 (109)
T ss_dssp TSCHHHHHHHHHHTCS--TTCCCHHHHHHHHTCTTC--C----HHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCC
T ss_pred cCCHHHHHHHHHHhCC--CCcCcHHHHHHHHhhccC--c----HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHHHcCCC
Confidence 4677888999999987 899999999998865321 2 55789999999999999999999999984 4 555
Q ss_pred cc---HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 573 VP---VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 573 ~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
.+ ++.+|..+|.|+||.|+|+||+.+|..+
T Consensus 77 ~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~ 109 (109)
T 5pal_A 77 LNDTETKALLAAGDSDHDGKIGADEFAKMVAQA 109 (109)
T ss_dssp CCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHC
T ss_pred CCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhC
Confidence 55 8889999999999999999999998753
|
| >3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} SCOP: a.39.1.4 PDB: 2kqy_A | Back alignment and structure |
|---|
Probab=99.50 E-value=5.1e-14 Score=119.86 Aligned_cols=96 Identities=19% Similarity=0.246 Sum_probs=82.7
Q ss_pred ccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-C---CCC
Q 007253 497 AMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-L---GPA 572 (611)
Q Consensus 497 ~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~---~~~ 572 (611)
.++++++..+++.+| ++|.|+|+||+.++..... . .+.++.+|+.||+|++|+|+.+||+.++. + +..
T Consensus 6 ~~~~~ei~~~~~~~D--~~g~i~~~eF~~~~~~~~~--~----~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~ 77 (109)
T 3fs7_A 6 ILSAKDIESALSSCQ--AADSFNYKSFFSTVGLSSK--T----PDQIKKVFGILDQDKSGFIEEEELQLFLKNFSSSARV 77 (109)
T ss_dssp TSCHHHHHHHHHHTC--STTCCCHHHHHHHHTCTTC--C----HHHHHHHHHHHSTTCSSSBCHHHHHTTGGGTCTTSCC
T ss_pred cCCHHHHHHHHHhcC--CCCcCcHHHHHHHHhcCCC--c----HHHHHHHHHHHCCCCCCeEeHHHHHHHHHHHhccccc
Confidence 577788999999998 7999999999998865321 2 56789999999999999999999999995 5 555
Q ss_pred cc---HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007253 573 VP---VHAVLHDWIRHTDGKLSFLGFVKLLH 600 (611)
Q Consensus 573 ~~---~~~~~~~~D~~~dG~is~~eF~~~l~ 600 (611)
.+ ++.+|..+|.|+||.|+|+||+++|+
T Consensus 78 ~~~~~~~~~~~~~D~~~dg~i~~~EF~~~~~ 108 (109)
T 3fs7_A 78 LTSAETKAFLAAGDTDGDGKIGVEEFQSLVK 108 (109)
T ss_dssp CCHHHHHHHHHHHCTTCSSSBCHHHHHHHHT
T ss_pred CCHHHHHHHHHHhCCCCCCcCcHHHHHHHHh
Confidence 44 88999999999999999999999886
|
| >2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A | Back alignment and structure |
|---|
Probab=99.47 E-value=1e-13 Score=117.76 Aligned_cols=96 Identities=20% Similarity=0.267 Sum_probs=81.3
Q ss_pred cccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-C---CCCc
Q 007253 498 MKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-L---GPAV 573 (611)
Q Consensus 498 ~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~---~~~~ 573 (611)
+++.++..+++.+| ++|.|+|+||+.++.... .. .+.++.+|+.||+|++|+|+.+||++++. + +...
T Consensus 6 ~~~~e~~~l~~~~d--~~g~i~~~eF~~~~~~~~--~~----~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~ 77 (108)
T 2pvb_A 6 LKDADVAAALAACS--AADSFKHKEFFAKVGLAS--KS----LDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARAL 77 (108)
T ss_dssp SCHHHHHHHHHHTC--STTCCCHHHHHHHHTGGG--SC----HHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCC
T ss_pred CCHHHHHHHHHHhC--CCCcCcHHHHHHHHhCCh--hH----HHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccCCCC
Confidence 66778889999998 789999999999874321 12 56789999999999999999999999995 5 4444
Q ss_pred c---HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 574 P---VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 574 ~---~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
+ ++.+|..+|.|+||.|+|+||+.++.+
T Consensus 78 ~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~ 108 (108)
T 2pvb_A 78 TDAETKAFLADGDKDGDGMIGVDEFAAMIKA 108 (108)
T ss_dssp CHHHHHHHHHHHCTTCSSSBCHHHHHHHHHC
T ss_pred CHHHHHHHHHHhCCCCCCcEeHHHHHHHHhC
Confidence 4 889999999999999999999998863
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A | Back alignment and structure |
|---|
Probab=99.47 E-value=6.6e-14 Score=129.54 Aligned_cols=124 Identities=7% Similarity=0.161 Sum_probs=103.6
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHH
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHAR 544 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~ 544 (611)
++..+|..+|.+++|.|+++||..++... ..+..+|..+|.|++|.|+.+||..++........ ++++.
T Consensus 45 ~~~~l~~~~D~~~~g~i~~~ef~~~~~~~-------~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~----~~~~~ 113 (172)
T 2znd_A 45 TVRSIISMFDRENKAGVNFSEFTGVWKYI-------TDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLS----DQFHD 113 (172)
T ss_dssp HHHHHHHHHCSSSSSEECHHHHHHHHHHH-------HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCC----HHHHH
T ss_pred HHHHHHHHhCCCCCCcCCHHHHHHHHHHH-------HHHHHHHHHHCCCCCCccCHHHHHHHHHHcCCCCC----HHHHH
Confidence 46778999999999999999999976442 34778999999999999999999988865543223 56788
Q ss_pred HHHhHHhcCCCCcccHHHHHHHhcCCCCccHHHHHHHHhcCCCCcee--HHHHHHHHhh
Q 007253 545 CAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGKLS--FLGFVKLLHG 601 (611)
Q Consensus 545 ~~F~~~D~d~~G~It~eEl~~~l~~~~~~~~~~~~~~~D~~~dG~is--~~eF~~~l~~ 601 (611)
.+|+.+|.|++|.|+.+||..++... ..+..+|+.+|.|+||.|+ ++||+.++..
T Consensus 114 ~~~~~~d~~~dg~i~~~eF~~~~~~~--~~~~~~F~~~D~d~dG~i~~~~~ef~~~~~~ 170 (172)
T 2znd_A 114 ILIRKFDRQGRGQIAFDDFIQGCIVL--QRLTDIFRRYDTDQDGWIQVSYEQYLSMVFS 170 (172)
T ss_dssp HHHHHHCTTCSSSEEHHHHHHHHHHH--HHHHHHHHHHCTTSSSCCCCCHHHHHHHHHT
T ss_pred HHHHHhCCCCCCcCcHHHHHHHHHHH--HHHHHHHHHhCCCCCCeEeeeHHHHHHHHHh
Confidence 99999999999999999999988522 2278899999999999995 7999988764
|
| >1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A | Back alignment and structure |
|---|
Probab=99.46 E-value=9.4e-14 Score=118.16 Aligned_cols=97 Identities=15% Similarity=0.255 Sum_probs=82.1
Q ss_pred ccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-C---CCC
Q 007253 497 AMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-L---GPA 572 (611)
Q Consensus 497 ~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~---~~~ 572 (611)
.+++.++..+++.+| ++|.|+|+||+.++.... .. .+.++.+|+.||+|++|+|+.+||++++. + +..
T Consensus 5 ~~t~~e~~~~~~~~d--~~g~i~~~eF~~~~~~~~--~~----~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~ 76 (109)
T 1rwy_A 5 LLSAEDIKKAIGAFT--AADSFDHKKFFQMVGLKK--KS----ADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARD 76 (109)
T ss_dssp HSCHHHHHHHHHTTC--STTCCCHHHHHHHHTGGG--SC----HHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCC
T ss_pred cCCHHHHHHHHHHcC--CCCcEeHHHHHHHHhcCc--ch----HHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHhccCCC
Confidence 567788999999998 889999999999874321 12 56789999999999999999999999994 3 444
Q ss_pred cc---HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 573 VP---VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 573 ~~---~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
.+ ++.++..+|.|+||.|+|+||+.++..
T Consensus 77 ~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~ 108 (109)
T 1rwy_A 77 LSAKETKTLMAAGDKDGDGKIGVEEFSTLVAE 108 (109)
T ss_dssp CCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHT
T ss_pred CCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHc
Confidence 44 889999999999999999999998864
|
| >2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.46 E-value=7.2e-14 Score=129.69 Aligned_cols=121 Identities=11% Similarity=0.082 Sum_probs=100.3
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcch----hhHHhhHHHH
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV----HQLEALDRWE 540 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~----~~~~~~~~~~ 540 (611)
+++.+|..+|.+++|.|+++||..++... .++..+|+.+| |++|.|+.+||..++... ..... +
T Consensus 47 ~~~~l~~~~D~d~~G~I~f~EF~~~~~~~-------~~l~~aF~~fD-d~~G~I~~~El~~~l~~l~~~~G~~~~----~ 114 (174)
T 2i7a_A 47 ECRSLVALMELKVNGRLDQEEFARLWKRL-------VHYQHVFQKVQ-TSPGVLLSSDLWKAIENTDFLRGIFIS----R 114 (174)
T ss_dssp HHHHHHHHHCSSCSSEECHHHHHHHHHHH-------HHHHHHHHHHC-SBTTBEEGGGHHHHHHTCGGGTTCCCC----H
T ss_pred HHHHHHHHHCCCCCCcCCHHHHHHHHHHH-------HHHHHHHHHhc-CCCCcCCHHHHHHHHHHhHhccCCCCC----H
Confidence 47789999999999999999999876443 35788999999 999999999999988766 32223 5
Q ss_pred HHHHHHHhHHhcCCCCcccHHHHHHHhcCCCCccHHHHHHHHhcCCCC-ceeHHHHHHHHh
Q 007253 541 QHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDG-KLSFLGFVKLLH 600 (611)
Q Consensus 541 ~~~~~~F~~~D~d~~G~It~eEl~~~l~~~~~~~~~~~~~~~D~~~dG-~is~~eF~~~l~ 600 (611)
++++.+++.+| |++|.|+.+||..++.... .+..+|+.+|+|+|| .++++||+.++.
T Consensus 115 ~~~~~l~~~~d-d~dG~I~~~EF~~~~~~~~--~~~~~F~~~D~d~~GI~~~~~Ef~~~~~ 172 (174)
T 2i7a_A 115 ELLHLVTLRYS-DSVGRVSFPSLVCFLMRLE--AMAKTFRNLSKDGKGLYLTEMEWMSLVM 172 (174)
T ss_dssp HHHHHHHHHHS-CTTSEECHHHHHHHHHHHH--HHHHHHHHHCSSSSCCCCCHHHHHHHHH
T ss_pred HHHHHHHHHHc-CCCCeEcHHHHHHHHHHHH--HHHHHHHHhCCCCCCceecHHHHHHHHH
Confidence 67888999999 9999999999999884211 278899999999999 349999998754
|
| >1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A | Back alignment and structure |
|---|
Probab=99.46 E-value=1.2e-13 Score=117.81 Aligned_cols=97 Identities=21% Similarity=0.264 Sum_probs=82.3
Q ss_pred ccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-C---CCC
Q 007253 497 AMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-L---GPA 572 (611)
Q Consensus 497 ~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~---~~~ 572 (611)
.+++.++..+++.+| ++|.|+|+||+.++.... .. .+.++.+|+.||+|++|+|+.+||+.++. + +..
T Consensus 6 ~~t~~e~~~~~~~~d--~~g~i~~~ef~~~~~~~~--~~----~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~ 77 (110)
T 1pva_A 6 LLKADDIKKALDAVK--AEGSFNHKKFFALVGLKA--MS----ANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRD 77 (110)
T ss_dssp HSCHHHHHHHHHHTC--STTCCCHHHHHHHHTCTT--SC----HHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCC
T ss_pred cCCHHHHHHHHHhcC--CCCcCcHHHHHHHHccCc--ch----HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhhcCCC
Confidence 577788999999998 789999999999874321 12 56789999999999999999999999995 4 444
Q ss_pred cc---HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 573 VP---VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 573 ~~---~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
.+ ++.+|..+|.|+||.|+|+||+.++..
T Consensus 78 ~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~~ 109 (110)
T 1pva_A 78 LTDAETKAFLKAADKDGDGKIGIDEFETLVHE 109 (110)
T ss_dssp CCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHC
T ss_pred CCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHh
Confidence 44 889999999999999999999999865
|
| >1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=99.45 E-value=1.3e-13 Score=117.35 Aligned_cols=96 Identities=17% Similarity=0.228 Sum_probs=81.7
Q ss_pred ccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-C---CCC
Q 007253 497 AMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-L---GPA 572 (611)
Q Consensus 497 ~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~---~~~ 572 (611)
.+++.++..+++.+| ++|.|+|+||+.++.... .. .+.++.+|+.||+|++|+|+.+||++++. + +..
T Consensus 6 ~~~~~e~~~~~~~~d--~~g~i~~~eF~~~~~~~~--~~----~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~ 77 (109)
T 1bu3_A 6 ILADADVAAALKACE--AADSFNYKAFFAKVGLTA--KS----ADDIKKAFFVIDQDKSGFIEEDELKLFLQVFSAGARA 77 (109)
T ss_dssp SSCHHHHHHHHHHTC--STTCCCHHHHHHHHTGGG--SC----HHHHHHHHHHHCTTCSSSEEHHHHHTHHHHHSTTCCC
T ss_pred cCCHHHHHHHHHHhC--CCCcCcHHHHHHHHHcCh--hh----HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCC
Confidence 577888999999998 789999999999775321 12 56789999999999999999999999995 4 444
Q ss_pred cc---HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007253 573 VP---VHAVLHDWIRHTDGKLSFLGFVKLLH 600 (611)
Q Consensus 573 ~~---~~~~~~~~D~~~dG~is~~eF~~~l~ 600 (611)
.+ ++.+|..+|.|+||.|+|+||+.++.
T Consensus 78 ~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~ 108 (109)
T 1bu3_A 78 LTDAETKAFLKAGDSDGDGAIGVDEWAALVK 108 (109)
T ss_dssp CCHHHHHHHHHHHCTTCSSEECHHHHHHHHT
T ss_pred CCHHHHHHHHHHhCCCCCCcEeHHHHHHHHh
Confidence 44 88999999999999999999999875
|
| >1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A | Back alignment and structure |
|---|
Probab=99.45 E-value=1.8e-13 Score=116.17 Aligned_cols=96 Identities=13% Similarity=0.179 Sum_probs=81.1
Q ss_pred ccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-C---CCC
Q 007253 497 AMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-L---GPA 572 (611)
Q Consensus 497 ~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~---~~~ 572 (611)
.+++.++..+++.+| ++|.|+|+||+.++... ... .+.++.+|+.||.|++|+|+.+||++++. + +..
T Consensus 5 ~~t~~e~~~~~~~~d--~~g~i~~~eF~~~~~~~--~~~----~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~ 76 (108)
T 1rro_A 5 ILSAEDIAAALQECQ--DPDTFEPQKFFQTSGLS--KMS----ASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARE 76 (108)
T ss_dssp TSCHHHHHHHHHHTC--STTCCCHHHHHHHHSGG--GSC----HHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCC
T ss_pred cCCHHHHHHHHHHcc--CCCCcCHHHHHHHHhcC--ccc----HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhccCC
Confidence 467788889999998 88999999999987432 112 56789999999999999999999999995 4 344
Q ss_pred cc---HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007253 573 VP---VHAVLHDWIRHTDGKLSFLGFVKLLH 600 (611)
Q Consensus 573 ~~---~~~~~~~~D~~~dG~is~~eF~~~l~ 600 (611)
.+ ++.+|..+|.|+||.|+|+||+.++.
T Consensus 77 ~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~ 107 (108)
T 1rro_A 77 LTESETKSLMDAADNDGDGKIGADEFQEMVH 107 (108)
T ss_dssp CCHHHHHHHHHHHCCSSSSSEEHHHHHHHHT
T ss_pred CCHHHHHHHHHHhCCCCCCcCcHHHHHHHHc
Confidence 44 88999999999999999999999875
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A | Back alignment and structure |
|---|
Probab=99.44 E-value=6.3e-14 Score=135.45 Aligned_cols=124 Identities=10% Similarity=0.071 Sum_probs=103.2
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHH
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHAR 544 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~ 544 (611)
++..+|..+|.|++|.|+++||..++... ..+..+|..+|.|++|.|+.+||..++........ ++++.
T Consensus 88 ~~~~l~~~~D~d~dg~I~~~EF~~~~~~~-------~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~----~~~~~ 156 (220)
T 3sjs_A 88 TALRMMRIFDTDFNGHISFYEFMAMYKFM-------ELAYNLFVMNARARSGTLEPHEILPALQQLGFYIN----QRTSL 156 (220)
T ss_dssp HHHHHHHHHCTTCSSCBCHHHHHHHHHHH-------HHHHHHHHHHCCSSTTEECHHHHHHHHHHHTCCCC----HHHHH
T ss_pred HHHHHHHHhCCCCCCcCCHHHHHHHHHHH-------HHHHHHHHHHCCCCCCCCcHHHHHHHHHHhCCCCC----HHHHH
Confidence 47788999999999999999999987553 34788999999999999999999998876543333 55788
Q ss_pred HHHhHHhcCCCCcccHHHHHHHhcCCCCccHHHHHHHH-hcCCCC------ceeHHHHHHHHhhc
Q 007253 545 CAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDW-IRHTDG------KLSFLGFVKLLHGV 602 (611)
Q Consensus 545 ~~F~~~D~d~~G~It~eEl~~~l~~~~~~~~~~~~~~~-D~~~dG------~is~~eF~~~l~~~ 602 (611)
.+|+.+| |++|.|+.+||.+++.... .+..+|+.+ |.+++| .|+|+||+.++..+
T Consensus 157 ~l~~~~d-d~dg~I~~~eF~~~~~~l~--~~~~~F~~~~D~~~~G~i~~~~~i~~~ef~~~~~~~ 218 (220)
T 3sjs_A 157 LLHRLFA-RGMAFCDLNCWIAICAFAA--QTRSAYQMIFMNPYYGPMKPFNPMEFGKFLDVVTSL 218 (220)
T ss_dssp HHHHHHC---CCSEEHHHHHHHHHHHH--HHHHHHHHHHTSGGGCSCCCCCHHHHHHHHHHHHHT
T ss_pred HHHHHhc-CCCCcCcHHHHHHHHHHHH--HHHHHHHHhcccCCCCCcccccceeHHHHHHHHHHh
Confidence 9999999 9999999999999884222 278899999 999999 89999999988764
|
| >1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3 | Back alignment and structure |
|---|
Probab=99.42 E-value=2.4e-14 Score=166.64 Aligned_cols=133 Identities=14% Similarity=0.213 Sum_probs=100.7
Q ss_pred chhhH-HHHHHHHhhhcCCCCCCcccHHHHHHHHHhhccc-------ccccCChhHHHhhcCCCCCCcccHHHHHHHHcc
Q 007253 458 LTVDE-LFYLKEQYALLEPNKNGTISLENVKSALMKNATD-------AMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALS 529 (611)
Q Consensus 458 l~~~e-~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~-------~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~ 529 (611)
+++++ .++|+++|..+| +++|.|+.+||+.+|..++.. .+++.++..+++.+|.|++|.|+|+||+.++..
T Consensus 527 l~~~e~~~~l~~~F~~~D-~~dG~Is~~El~~~L~~~~~~~~~~~~~~~s~~~~~~l~~~~D~d~~G~I~~~EF~~~~~~ 605 (900)
T 1qxp_A 527 LSEEEIDDNFKTLFSKLA-GDDMEISVKELQTILNRIISKHKDLRTNGFSLESCRSMVNLMDRDGNGKLGLVEFNILWNR 605 (900)
T ss_dssp --------------CCCC-CSSSSCCCSCTTTTTCC---------CCCCCHHHHHHHHHHHCC--CCCCCSSSHHHHHHH
T ss_pred CCcchHHHHHHHHHHHHc-CCCCcCCHHHHHHHHHHhhcccccccCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHH
Confidence 44444 789999999999 999999999999998776531 467778999999999999999999999987754
Q ss_pred hhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 530 VHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 530 ~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
. +.++.+|+.||.|++|+|+.+||+.+|. +|..++ ++.++..+| |+||.|+|+||+.++...
T Consensus 606 ~----------~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~~l~~~~~~~l~~~~d-d~dg~I~~~eF~~~~~~~ 671 (900)
T 1qxp_A 606 I----------RNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPCQLHQVIVARFA-DDELIIDFDNFVRCLVRL 671 (900)
T ss_dssp H----------HHHHHHHGGGCTTCCSCCBHHHHHHHHHHTTEECCHHHHHHHHHHTS-CSSSBCCHHHHHHHHHHH
T ss_pred H----------HHHHHHHHhhCCCCCCeECHHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCeEcHHHHHHHHHHH
Confidence 3 3678899999999999999999999994 554333 888999999 999999999999998754
|
| >2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A | Back alignment and structure |
|---|
Probab=99.41 E-value=2.7e-13 Score=129.43 Aligned_cols=124 Identities=10% Similarity=0.151 Sum_probs=103.7
Q ss_pred hcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCC-CCCcccHHHHHHHHcchhhH-HhhHHHHHHHHHHHhH
Q 007253 472 LLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSL-QYRRMDFEEFCAAALSVHQL-EALDRWEQHARCAYEL 549 (611)
Q Consensus 472 ~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~-~~g~i~~~eF~~~~~~~~~~-~~~~~~~~~~~~~F~~ 549 (611)
.++.+++|.|+.+++..++...+ ++..++..+|..+|.+ ++|.|+++||..++...... .. .+.+..+|+.
T Consensus 7 ~mg~~~~g~l~~~el~~~~~~~~---~~~~~i~~~f~~~d~~~~~G~i~~~ef~~~l~~~~~~~~~----~~~~~~~f~~ 79 (207)
T 2d8n_A 7 GMGNSKSGALSKEILEELQLNTK---FSEEELCSWYQSFLKDCPTGRITQQQFQSIYAKFFPDTDP----KAYAQHVFRS 79 (207)
T ss_dssp -CTTCCTTCCCHHHHHHHHHHSS---CCHHHHHHHHHHHHHHCTTSEEEHHHHHHHHHHTCTTSCC----HHHHHHHHHH
T ss_pred hhccccCCCCCHHHHHHHHHHcC---CCHHHHHHHHHHHHhhCCCCCCCHHHHHHHHHHhccCCCc----HHHHHHHHHH
Confidence 37889999999999999886655 4677899999999998 79999999999988665322 22 5578899999
Q ss_pred HhcCCCCcccHHHHHHHhc-CCC---CccHHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 550 FEKDGNRAIVIEELASELG-LGP---AVPVHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 550 ~D~d~~G~It~eEl~~~l~-~~~---~~~~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
+|.|++|.|+.+||..++. ++. ...+..+|+.+|.|+||.|+++||..++..+
T Consensus 80 ~D~d~~G~i~~~Ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~I~~~E~~~~l~~~ 136 (207)
T 2d8n_A 80 FDSNLDGTLDFKEYVIALHMTTAGKTNQKLEWAFSLYDVDGNGTISKNEVLEIVMAI 136 (207)
T ss_dssp HCTTCCSEEEHHHHHHHHHHHSCSSSSTTHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred hcCCCCCeEeHHHHHHHHHHHcCCCHHHHHHHHHHHhcCCCCCeEcHHHHHHHHHHH
Confidence 9999999999999999883 221 2238999999999999999999999998764
|
| >1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.41 E-value=1e-13 Score=130.57 Aligned_cols=123 Identities=11% Similarity=0.173 Sum_probs=92.1
Q ss_pred HHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhh-------HHhh
Q 007253 464 FYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQ-------LEAL 536 (611)
Q Consensus 464 ~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~-------~~~~ 536 (611)
..+.++|..+|.+++|.|+++||..++...+. .....++..+|..+|.|++|.|+++||..++..... ....
T Consensus 63 ~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~-~~~~~~~~~~f~~~D~d~~G~I~~~E~~~~~~~~~~~~g~~~~~~~~ 141 (193)
T 1bjf_A 63 KFAEHVFRTFDANGDGTIDFREFIIALSVTSR-GKLEQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPED 141 (193)
T ss_dssp HHHHHHHHHHCSSCSSEEEHHHHHHHHHHHTS-SCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGG
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHHcC-CCHHHHHHHHHhhcCCCCCCeECHHHHHHHHHHHHHHhccccCCCcc
Confidence 45789999999999999999999999876654 355667889999999999999999999987754311 1110
Q ss_pred -HHHHHHHHHHHhHHhcCCCCcccHHHHHHHhcCCCCccHHHHHHHHhcCCCCce
Q 007253 537 -DRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGKL 590 (611)
Q Consensus 537 -~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~~~~~~~~~~~~~~~D~~~dG~i 590 (611)
...++.+..+|+.+|.|++|.|+.+||.+++.-.+. +..+| .+|.|+||.|
T Consensus 142 ~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~--~~~~~-~~D~~~dG~i 193 (193)
T 1bjf_A 142 ESTPEKRTEKIFRQMDTNRDGKLSLEEFIRGAKSDPS--IVRLL-QCDPSSAGQF 193 (193)
T ss_dssp GSSHHHHHHHHHHHSCTTCSSEECHHHHHHHHHHCTH--HHHTT-CC--------
T ss_pred cccHHHHHHHHHHHhCCCCCCeEeHHHHHHHHhcCHH--HHHHh-ccCCCCCCCC
Confidence 012557889999999999999999999999853222 78888 9999999986
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.39 E-value=7.3e-13 Score=126.99 Aligned_cols=130 Identities=10% Similarity=0.189 Sum_probs=104.0
Q ss_pred hhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchh-----hHH
Q 007253 460 VDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVH-----QLE 534 (611)
Q Consensus 460 ~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~-----~~~ 534 (611)
......++++|..+|.|++|.|+++||..++..... ...+.++..+|..+|.|++|.|+++||..++.... ...
T Consensus 53 ~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~-~~~~~~l~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~~~~~~ 131 (211)
T 2ggz_A 53 QKANKHIDQVYNTFDTNKDGFVDFLEFIAAVNLIMQ-EKMEQKLKWYFKLYDADGNGSIDKNELLDMFMAVQALNGQQTL 131 (211)
T ss_dssp HHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHSC-SSHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHTTSSCCCSC
T ss_pred cchHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHhcc-CchHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCccc
Confidence 344556899999999999999999999999876654 34566788999999999999999999998886543 111
Q ss_pred hhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhcCCCCccHHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 535 ALDRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 535 ~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~~~~~~~~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
.. ++.+..+|+.+|.|++|.|+.+||.+++.-.+. +.++|.. .++|+||+.+|...
T Consensus 132 ~~---~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~--~~~~~~~-------~~d~~~f~~~~~~~ 187 (211)
T 2ggz_A 132 SP---EEFINLVFHKIDINNDGELTLEEFINGMAKDQD--LLEIVYK-------SFDFSNVLRVICNG 187 (211)
T ss_dssp TH---HHHHHHHHHHHCTTCSSSBCHHHHHHHHHTTTT--THHHHHH-------HSCTTHHHHHHHHH
T ss_pred cH---HHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCHH--HHHHHhc-------cCCHHHHHHHHhcC
Confidence 11 456889999999999999999999999974444 6666763 24489999999764
|
| >1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A | Back alignment and structure |
|---|
Probab=99.38 E-value=4.5e-13 Score=124.02 Aligned_cols=122 Identities=10% Similarity=0.071 Sum_probs=99.9
Q ss_pred HHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHH
Q 007253 464 FYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHA 543 (611)
Q Consensus 464 ~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~ 543 (611)
..+..+|..+|.+++|.|+++||..++... ..+..+|..+|.|++|.|+.+||..++........ ++++
T Consensus 47 ~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~-------~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~----~~~~ 115 (173)
T 1alv_A 47 DTCRSMVAVMDSDTTGKLGFEEFKYLWNNI-------KKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLN----EHLY 115 (173)
T ss_dssp HHHHHHHHHHCTTCSSSBCHHHHHHHHHHH-------HHHHHHHHHHCTTCCSSBCTTTHHHHHHHHTCCCC----HHHH
T ss_pred HHHHHHHHHHcCCCCCccCHHHHHHHHHHH-------HHHHHHHHHHCCCCCCCCCHHHHHHHHHHcCCCCC----HHHH
Confidence 347788999999999999999999887542 35788999999999999999999988865543333 5678
Q ss_pred HHHHhHHhcCCCCcccHHHHHHHhcCCCCccHHHHHHHHhcCCCCceeHHHHHHHHh
Q 007253 544 RCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGKLSFLGFVKLLH 600 (611)
Q Consensus 544 ~~~F~~~D~d~~G~It~eEl~~~l~~~~~~~~~~~~~~~D~~~dG~is~~eF~~~l~ 600 (611)
..+|+.+| |++|.|+.+||..++... ..+..+|+.+|.|+||.|+.+ |.++|.
T Consensus 116 ~~~~~~~d-d~dg~i~~~eF~~~~~~~--~~~~~~F~~~D~d~~G~i~~~-~~~~l~ 168 (173)
T 1alv_A 116 SMIIRRYS-DEGGNMDFDNFISCLVRL--DAMFRAFKSLDKDGTGQIQVN-IQEWLQ 168 (173)
T ss_dssp HHHHHHHT-CSSSCBCHHHHHHHHHHH--HHHHHHHHHHSSSCCSEEEEE-HHHHHH
T ss_pred HHHHHHhc-CCCCcCcHHHHHHHHHHH--HHHHHHHHHhCCCCCCeecHh-HHHHHH
Confidence 88999999 999999999999988522 227889999999999999866 665553
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=1.4e-12 Score=129.35 Aligned_cols=141 Identities=17% Similarity=0.147 Sum_probs=111.3
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
..|++...+|.|+++.||++.. .|+.+++|+........ ...+.+|+.+++.|.++..+.++++++.+.+..
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~-----~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~ 85 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG-----ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC-----SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred ccceeEeeccCCCCCeEEEEEC-----CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence 4588889999999999999862 36789999985421111 135889999999997677888999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL------------------------------------ 278 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~------------------------------------ 278 (611)
|+||||++|.+|.+.+. +......++.+++.+|..||+
T Consensus 86 ~lv~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEEEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 99999999988876421 223345788999999999998
Q ss_pred -----------------------cCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 279 -----------------------QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 279 -----------------------~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
..++|+|+++.|||+. +...+.|+||+.+..
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEEEEEEchhccc
Confidence 4589999999999994 445667999998743
|
| >2zkm_X 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-2; phospholipase C, phosphoinositide phospholipase, PLC-beta-2, calcium, coiled coil; 1.62A {Homo sapiens} SCOP: a.39.1.7 b.7.1.1 b.55.1.1 c.1.18.1 PDB: 2fju_B | Back alignment and structure |
|---|
Probab=99.36 E-value=4.6e-13 Score=151.45 Aligned_cols=127 Identities=15% Similarity=0.208 Sum_probs=94.3
Q ss_pred HHHHHHHHhh--hcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCC-------CCCCcccHHHHHHHHcchhh
Q 007253 462 ELFYLKEQYA--LLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNS-------LQYRRMDFEEFCAAALSVHQ 532 (611)
Q Consensus 462 e~~~l~~~F~--~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~-------~~~g~i~~~eF~~~~~~~~~ 532 (611)
...+|+++|. .||.|++|+|+..|+..+|.. .+.++..++..+|. +++|.|+|+||+.++.....
T Consensus 144 ~~~~Lk~~F~~~~fD~d~dG~Is~~EL~~~l~~------~~~ev~~li~~~d~~~~~~D~d~~g~idf~EF~~~~~~l~~ 217 (799)
T 2zkm_X 144 RSTFLDKILVKLKMQLNSEGKIPVKNFFQMFPA------DRKRVEAALSACHLPKGKNDAINPEDFPEPVYKSFLMSLCP 217 (799)
T ss_dssp HHHHHHHHHHHHHHSCCTTSCEEHHHHHHHSCS------CHHHHHHHHHHTTCCCCTTCEECGGGCCHHHHHHHHHHHSC
T ss_pred HHHHHHHHhHHhccCCCCCCeECHHHHHHHHhh------hHHHHHHHHHHhCcCccccccCCCCcCCHHHHHHHHHHccC
Confidence 4557999999 899999999999999998733 24678889988884 88899999999998865431
Q ss_pred HHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-C-CCC---------cc---HHHHHHHHhcC----CCCceeHHH
Q 007253 533 LEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-L-GPA---------VP---VHAVLHDWIRH----TDGKLSFLG 594 (611)
Q Consensus 533 ~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~-~~~---------~~---~~~~~~~~D~~----~dG~is~~e 594 (611)
.++++.+|+.||+|++|+||.+||+++|. . |.. ++ +++||+++|.| +||.|+|+|
T Consensus 218 -------r~el~~aF~~fD~d~~g~Is~~eL~~fL~~~Qge~~~~~~~~~~~t~ee~~~iI~~~d~d~~~~~dg~is~ee 290 (799)
T 2zkm_X 218 -------RPEIDEIFTSYHAKAKPYMTKEHLTKFINQKQRDSRLNSLLFPPARPDQVQGLIDKYEPSGINAQRGQLSPEG 290 (799)
T ss_dssp -------CHHHHTTCC--------CCCHHHHHHHHHHTCC---------------CHHHHHHHHCCC--------CCHHH
T ss_pred -------HHHHHHHHHHhccCCCCeEcHHHHHHHHHHhcCCcccccccccCCCHHHHHHHHHHhhcccccccCCccchhh
Confidence 34688999999999999999999999995 3 443 22 89999999999 999999999
Q ss_pred HHHHHhh
Q 007253 595 FVKLLHG 601 (611)
Q Consensus 595 F~~~l~~ 601 (611)
|+++|..
T Consensus 291 F~~~L~S 297 (799)
T 2zkm_X 291 MVWFLCG 297 (799)
T ss_dssp HHHHHHS
T ss_pred hhhcccC
Confidence 9999975
|
| >1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=99.33 E-value=1.9e-12 Score=119.05 Aligned_cols=119 Identities=12% Similarity=0.105 Sum_probs=97.2
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHH
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHAR 544 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~ 544 (611)
++..+|..+|.+++|.|+++||..++... ..+..+|..+|.|++|.|+.+||..++........ ++++.
T Consensus 43 ~~~~l~~~~D~~~~g~i~~~eF~~~~~~~-------~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~----~~~~~ 111 (167)
T 1gjy_A 43 TCRLMVSMLDRDMSGTMGFNEFKELWAVL-------NGWRQHFISFDSDRSGTVDPQELQKALTTMGFRLN----PQTVN 111 (167)
T ss_dssp HHHHHHHHHCTTCCSCBCHHHHHHHHHHH-------HHHHHHHHHHCTTCCSEECHHHHHHHHHTTTCCCC----HHHHH
T ss_pred HHHHHHHHHCCCCCCcCCHHHHHHHHHHH-------HHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCC----HHHHH
Confidence 47788999999999999999999987543 35788999999999999999999998876543333 55788
Q ss_pred HHHhHHhcCCCCcccHHHHHHHhcCCCCccHHHHHHHHhcCCCCceeHH--HHHHH
Q 007253 545 CAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGKLSFL--GFVKL 598 (611)
Q Consensus 545 ~~F~~~D~d~~G~It~eEl~~~l~~~~~~~~~~~~~~~D~~~dG~is~~--eF~~~ 598 (611)
.+|+.+ |++|.|+.+||..++... ..+..+|+.+|.|+||.|+.+ +|+.+
T Consensus 112 ~~~~~~--d~dg~i~~~eF~~~~~~~--~~~~~~F~~~D~d~~G~i~~~~~~~l~~ 163 (167)
T 1gjy_A 112 SIAKRY--STSGKITFDDYIACCVKL--RALTDSFRRRDSAQQGMVNFSYDDFIQC 163 (167)
T ss_dssp HHHHHT--CBTTBEEHHHHHHHHHHH--HHHHHHHHHHCTTCCSEEEEEHHHHHHH
T ss_pred HHHHHh--CcCCcCcHHHHHHHHHHH--HHHHHHHHHhCCCCCeeEEeeHHHHHHH
Confidence 888888 889999999999988522 227889999999999999965 55444
|
| >1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A | Back alignment and structure |
|---|
Probab=99.33 E-value=1.8e-12 Score=118.95 Aligned_cols=121 Identities=11% Similarity=0.120 Sum_probs=98.9
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHH
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHAR 544 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~ 544 (611)
++..+|..+|.+++|.|+++||..++... ..+..+|..+|.|++|.|+.+||..++........ ++++.
T Consensus 41 ~~~~l~~~~D~~~~g~i~~~eF~~~~~~~-------~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~----~~~~~ 109 (165)
T 1k94_A 41 TCRIMIAMLDRDHTGKMGFNAFKELWAAL-------NAWKENFMTVDQDGSGTVEHHELRQAIGLMGYRLS----PQTLT 109 (165)
T ss_dssp HHHHHHHHHCTTCSSCBCHHHHHHHHHHH-------HHHHHHHHHHCTTCCSBCCHHHHHHHHHHTTCCCC----HHHHH
T ss_pred HHHHHHHHhCCCCCCcCCHHHHHHHHHHH-------HHHHHHHHHhCCCCCceECHHHHHHHHHHhCCCCC----HHHHH
Confidence 47788999999999999999999876543 35788999999999999999999988866543333 55778
Q ss_pred HHHhHHhcCCCCcccHHHHHHHhcCCCCccHHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 545 CAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 545 ~~F~~~D~d~~G~It~eEl~~~l~~~~~~~~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
.+|+.+ |++|.|+.+||..++... ..+..+|+.+|.|+||.|+.+ |.++|.-
T Consensus 110 ~~~~~~--d~dg~i~~~eF~~~~~~~--~~~~~~F~~~D~d~~G~i~~~-~~~~l~~ 161 (165)
T 1k94_A 110 TIVKRY--SKNGRIFFDDYVACCVKL--RALTDFFRKRDHLQQGSANFI-YDDFLQG 161 (165)
T ss_dssp HHHHHH--CBTTBCBHHHHHHHHHHH--HHHHHHHHTTCTTCCSEEEEE-HHHHHHH
T ss_pred HHHHHh--CCCCeEcHHHHHHHHHHH--HHHHHHHHHhCCCCCCeEeee-HHHHHHH
Confidence 888888 889999999999988522 227889999999999999877 7766653
|
| >2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A | Back alignment and structure |
|---|
Probab=99.32 E-value=8.7e-14 Score=118.21 Aligned_cols=97 Identities=14% Similarity=0.186 Sum_probs=80.1
Q ss_pred ccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-C---CCC
Q 007253 497 AMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-L---GPA 572 (611)
Q Consensus 497 ~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~---~~~ 572 (611)
.+++.++..+++.+| ++|.|+|+||+.++.... .. .+.++.+|+.||.|++|+|+.+||++++. + +..
T Consensus 5 ~~~~~e~~~l~~~~d--~~g~i~~~eF~~~~~~~~--~~----~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~ 76 (108)
T 2kyc_A 5 ILSPSDIAAALRDCQ--APDSFSPKKFFQISGMSK--KS----SSQLKEIFRILDNDQSGFIEEDELKYFLQRFESGARV 76 (108)
T ss_dssp SSCHHHHHHHHTTSC--STTTCCHHHHHHHHTCTT--CC----SSSHHHHCSSSCSCCSSCCCGGGTTTSHHHHSSSCCC
T ss_pred cCCHHHHHHHHHHcC--CCCcCCHHHHHHHHhhCc--cc----HHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHhhccCC
Confidence 467778888999988 889999999999874321 11 44688899999999999999999999884 3 433
Q ss_pred cc---HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 573 VP---VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 573 ~~---~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
.+ ++.++..+|.|+||.|+|+||+.++.+
T Consensus 77 ~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~ 108 (108)
T 2kyc_A 77 LTASETKTFLAAADHDGDGKIGAEEFQEMVQS 108 (108)
T ss_dssp CCTTTTHHHHTTTCCSSSSCCCSSHHHHHHHC
T ss_pred CCHHHHHHHHHHhCCCCCCcCCHHHHHHHHhC
Confidence 33 899999999999999999999998863
|
| >1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A | Back alignment and structure |
|---|
Probab=99.31 E-value=3.3e-12 Score=121.01 Aligned_cols=120 Identities=12% Similarity=0.115 Sum_probs=98.1
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHH
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHAR 544 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~ 544 (611)
++..+|..+|.+++|.|+++||..++... ..+..+|..+|.|++|.|+.+||..++........ ++++.
T Consensus 74 ~~~~l~~~~D~d~~g~i~~~eF~~~~~~~-------~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~----~~~~~ 142 (198)
T 1juo_A 74 TCRLMVSMLDRDMSGTMGFNEFKELWAVL-------NGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLS----PQAVN 142 (198)
T ss_dssp HHHHHHHHHCTTCSSCEEHHHHHHHHHHH-------HHHHHHHHTTCTTCCSEECHHHHHHHHHHTTCCCC----HHHHH
T ss_pred HHHHHHHHhCCCCCCeECHHHHHHHHHHH-------HHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCCCCC----HHHHH
Confidence 47788999999999999999999987543 35788999999999999999999988865543333 55788
Q ss_pred HHHhHHhcCCCCcccHHHHHHHhcCCCCccHHHHHHHHhcCCCCceeH--HHHHHHH
Q 007253 545 CAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGKLSF--LGFVKLL 599 (611)
Q Consensus 545 ~~F~~~D~d~~G~It~eEl~~~l~~~~~~~~~~~~~~~D~~~dG~is~--~eF~~~l 599 (611)
.+|+.+ |++|.|+.+||..++.... .+..+|+.+|.|+||.|+. .+|+.++
T Consensus 143 ~l~~~~--d~dg~i~~~eF~~~~~~~~--~~~~~F~~~D~d~~G~is~~~~~~l~~~ 195 (198)
T 1juo_A 143 SIAKRY--STNGKITFDDYIACCVKLR--ALTDSFRRRDTAQQGVVNFPYDDFIQCV 195 (198)
T ss_dssp HHHHHT--CSSSSEEHHHHHHHHHHHH--HHHHHHHHTCTTCCSEEEEEHHHHHHHH
T ss_pred HHHHHh--CCCCeEcHHHHHHHHHHHH--HHHHHHHHhCCCCCCeEeecHHHHHHHH
Confidence 888888 8899999999999884222 2788999999999999987 6666554
|
| >1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3 | Back alignment and structure |
|---|
Probab=99.29 E-value=5.3e-12 Score=146.82 Aligned_cols=136 Identities=15% Similarity=0.174 Sum_probs=100.7
Q ss_pred HHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHH---------
Q 007253 464 FYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLE--------- 534 (611)
Q Consensus 464 ~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~--------- 534 (611)
.+++++|..+|.|++|+|+.+||..+|..++. .+++.++..++..+| |++|.|+|+||+.++.......
T Consensus 607 ~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~-~l~~~~~~~l~~~~d-d~dg~I~~~eF~~~~~~~~~l~~~F~~~D~d 684 (900)
T 1qxp_A 607 RNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGF-KLPCQLHQVIVARFA-DDELIIDFDNFVRCLVRLEILFKIFKQLDPE 684 (900)
T ss_dssp HHHHHHHGGGCTTCCSCCBHHHHHHHHHHTTE-ECCHHHHHHHHHHTS-CSSSBCCHHHHHHHHHHHHHHHHHHHHSCSS
T ss_pred HHHHHHHHhhCCCCCCeECHHHHHHHHHHhCC-CCCHHHHHHHHHHhC-CCCCeEcHHHHHHHHHHHHHHHHHHHhhCCC
Confidence 67999999999999999999999999988765 577888999999999 9999999999988765321000
Q ss_pred ----------------------------------------hhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCC--
Q 007253 535 ----------------------------------------ALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGP-- 571 (611)
Q Consensus 535 ----------------------------------------~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~-- 571 (611)
......+.++.+|+.+|.+ +|.|+.+||+++|. ++.
T Consensus 685 ~~G~It~~~~efl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~~-~G~Is~~El~~~L~~~~~~~ 763 (900)
T 1qxp_A 685 NTGTIQLDLISWLSFSVLGKLAAAIEHHHHHHMHYSNIEANESEEERQFRKLFVQLAGD-DMEVSATELMNILNKVVTRH 763 (900)
T ss_dssp CCSCEEEEHHHHHHHTCC--------------CCCCCC--------------CCCCTTC-SSCBCHHHHTTTSCC----C
T ss_pred CCceEEecHHHHHHHhhhccccccccccccccccccCCCCCChHHHHHHHHHHHHhcCC-CCccCHHHHHHHHHHhcccc
Confidence 0001133455566666665 67778999999885 331
Q ss_pred ------Ccc---HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 572 ------AVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 572 ------~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
..+ ++.+|+.+|.|+||.|+|+||..++..+
T Consensus 764 ~~~~~~~~s~~~~~~l~~~~D~d~dG~Is~~EF~~l~~~~ 803 (900)
T 1qxp_A 764 PDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLWNNI 803 (900)
T ss_dssp CSCC--CCCHHHHHHHHHHHCCSSSSSBCSHHHHHHHHHH
T ss_pred cccccCCCCHHHHHHHHHHHCCCCCCeECHHHHHHHHHHH
Confidence 222 7889999999999999999999988654
|
| >3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C | Back alignment and structure |
|---|
Probab=99.28 E-value=2e-12 Score=115.86 Aligned_cols=95 Identities=20% Similarity=0.197 Sum_probs=47.1
Q ss_pred HHHhhcCCCCCCcccHHHHHHHHcchhhHH-hhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CC--------CCcc
Q 007253 505 DFLSSLNSLQYRRMDFEEFCAAALSVHQLE-ALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LG--------PAVP 574 (611)
Q Consensus 505 ~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~-~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~--------~~~~ 574 (611)
.+|..+|.|++|.|+++||+.++....... .....++.++.+|+.||.|++|+|+.+||+.++. ++ ..++
T Consensus 31 ~~f~~~D~d~dG~I~~~Ef~~~l~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~g~~~s 110 (143)
T 3a4u_B 31 SQPGSMGLDKNTVHDQEHIMEHLEGVINKPEAEMSPQELQLHYFKMHDYDGNNLLDGLELSTAITHVHKEEGSEQAPLMS 110 (143)
T ss_dssp --------------------------------CCCHHHHHHHHHHHTCTTCSSCEEHHHHHHTCC-------------CC
T ss_pred HHHHHhCCCCCCcCcHHHHHHHHHHHhcccccccCHHHHHHHHHHHhCCCCCCccCHHHHHHHHHHHHhhhccccCCCCC
Confidence 467777888888888888877665432210 0001155788899999999999999999999985 32 2333
Q ss_pred ---H----HHHHHHHhcCCCCceeHHHHHHHH
Q 007253 575 ---V----HAVLHDWIRHTDGKLSFLGFVKLL 599 (611)
Q Consensus 575 ---~----~~~~~~~D~~~dG~is~~eF~~~l 599 (611)
+ +.+|..+|.|+||.|+|+||+.+|
T Consensus 111 ~~e~~~~~~~~f~~~D~d~dG~Is~~EF~~~~ 142 (143)
T 3a4u_B 111 EDELINIIDGVLRDDDKNNDGYIDYAEFAKSL 142 (143)
T ss_dssp HHHHHHHHHHHHHHHCTTCSSEECHHHHHC--
T ss_pred HHHHHHHHHHHHHHcCCCCCCcEeHHHHHHHH
Confidence 4 445599999999999999999876
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.27 E-value=8.3e-12 Score=117.17 Aligned_cols=120 Identities=10% Similarity=0.187 Sum_probs=98.8
Q ss_pred CCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCC-CCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCC
Q 007253 476 NKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSL-QYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDG 554 (611)
Q Consensus 476 d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~-~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~ 554 (611)
+.+|.|+.+++..+....+ .+..++..+|..+|.+ ++|.|+++||..++......... .+.++.+|+.+|.|+
T Consensus 3 ~~~~~l~~~el~~~~~~~~---~~~~el~~~f~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~---~~~~~~~f~~~D~d~ 76 (190)
T 2l2e_A 3 KSQSKLSQDQLQDLVRSTR---FDKKELQQWYKGFFKDCPSGHLNKSEFQKIYKQFFPFGDP---SAFAEYVFNVFDADK 76 (190)
T ss_dssp CSSCCSCHHHHHHHHHHHC---SCSHHHHHHHHHHHHHSCCCEECHHHHHHHHHHHCCCSCH---HHHHHHHHHHHCSSS
T ss_pred cccccCCHHHHHHHHHhcC---CCHHHHHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCCCc---cHHHHHHHHHhcCCC
Confidence 3578999999999765543 5778899999999999 89999999999987654321111 457889999999999
Q ss_pred CCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 555 NRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 555 ~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
+|.|+.+||..++. ++.... +..+|..+|.|+||.|+++||..++..
T Consensus 77 ~G~i~~~ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~e~~~~~~~ 127 (190)
T 2l2e_A 77 NGYIDFKEFICALSVTSRGELNDKLIWAFQLYDLDNNGLISYDEMLRIVDA 127 (190)
T ss_dssp TTCEEHHHHHHHHTTSSCSCSHHHHHHHHHHHCTTSCSCBCHHHHHHHHHH
T ss_pred CCeEeHHHHHHHHHHHcCCCHHHHHHHHHhHccCCCCCcCcHHHHHHHHHH
Confidence 99999999999995 433322 788999999999999999999999876
|
| >1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A | Back alignment and structure |
|---|
Probab=99.27 E-value=1.2e-11 Score=116.05 Aligned_cols=116 Identities=14% Similarity=0.257 Sum_probs=93.8
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHH--------hh
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLE--------AL 536 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~--------~~ 536 (611)
.++++|..+|.+++|.|+++||..++...+. ..++.++..+|..+|.|++|.|+++||..++....... ..
T Consensus 64 ~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~-~~~~~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~g~~~~~~~~~ 142 (190)
T 1fpw_A 64 FANHLFTVFDKDNNGFIHFEEFITVLSTTSR-GTLEEKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDE 142 (190)
T ss_dssp HHHHHHHTCCSSCSSEECHHHHHHHHHHHSC-CCSTHHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCC
T ss_pred HHHHHHHHHCCCCCCcEeHHHHHHHHHHHcc-CCcHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHHHhccccCccccc
Confidence 4889999999999999999999999877664 45667889999999999999999999998876531100 00
Q ss_pred HHHHHHHHHHHhHHhcCCCCcccHHHHHHHhcCCCCccHHHHHHHHh
Q 007253 537 DRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWI 583 (611)
Q Consensus 537 ~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~~~~~~~~~~~~~~~D 583 (611)
...++.+..+|+.+|.|++|.|+.+||.+++.-.+. +..+|..+|
T Consensus 143 ~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~--~~~~~~~~d 187 (190)
T 1fpw_A 143 ATPEMRVKKIFKLMDKNEDGYITLDEFREGSKVDPS--IIGALNLYD 187 (190)
T ss_dssp CCHHHHHHHHHHHHTTTCSSEEEHHHHHHHHHSSTT--HHHHHHHHH
T ss_pred chHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhChH--HHHHHhhcc
Confidence 012567899999999999999999999999975554 666777766
|
| >2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.27 E-value=6.6e-12 Score=104.81 Aligned_cols=72 Identities=21% Similarity=0.295 Sum_probs=66.6
Q ss_pred hcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHc
Q 007253 456 KTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAAL 528 (611)
Q Consensus 456 ~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~ 528 (611)
..+++++.++|+++|+.+|.|++|+|+.+||+.+|..++. .+++.++..+|+.+|.|++|.|+|+||+.++.
T Consensus 28 ~~l~~~~~~el~~~F~~~D~d~~G~I~~~El~~~l~~lg~-~~~~~ei~~l~~~~D~d~dG~I~~~EF~~~m~ 99 (100)
T 2lv7_A 28 VDIPEDELEEIREAFKVFDRDGNGFISKQELGTAMRSLGY-MPNEVELEVIIQRLDMDGDGQVDFEEFVTLLG 99 (100)
T ss_dssp CCCCGGGHHHHHHHHHHTCSSCSSCBCHHHHHHHHHHHTC-CCCTTTHHHHHHHHCSSCSSSBCHHHHHHHTC
T ss_pred ccCCHHHHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCC-CCCHHHHHHHHHHHCCCCCCeEeHHHHHHHhC
Confidence 4578899999999999999999999999999999988875 68899999999999999999999999998763
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=99.24 E-value=1.5e-11 Score=116.47 Aligned_cols=108 Identities=13% Similarity=0.198 Sum_probs=87.7
Q ss_pred hhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHH---hh
Q 007253 460 VDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLE---AL 536 (611)
Q Consensus 460 ~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~---~~ 536 (611)
......++++|..+|.+++|.|++.||..++...+. .....++..+|..+|.|++|.|+++||..++....... ..
T Consensus 48 ~~~~~~~~~~f~~~D~d~~G~I~~~Ef~~~~~~~~~-~~~~~~~~~~F~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~ 126 (198)
T 2r2i_A 48 PSANKYVEQMFETFDFNKDGYIDFMEYVAALSLVLK-GKVDQKLRWYFKLYDVDGNGCIDRGELLNIIKAIRAINRCNEA 126 (198)
T ss_dssp HHHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHSS-CCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHTTGGGGSSSC
T ss_pred cchHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHcc-CchHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCCch
Confidence 344556999999999999999999999999877664 35566788999999999999999999999886553211 00
Q ss_pred HHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 537 DRWEQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 537 ~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
...++.+..+|+.+|.|++|.|+.+||.+++.
T Consensus 127 ~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~ 158 (198)
T 2r2i_A 127 MTAEEFTNMVFDKIDINGDGELSLEEFMEGVQ 158 (198)
T ss_dssp CCHHHHHHHHHHHHCTTCSSEECHHHHHHHHT
T ss_pred hhHHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 00145688999999999999999999999986
|
| >1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E | Back alignment and structure |
|---|
Probab=99.23 E-value=2e-11 Score=113.74 Aligned_cols=118 Identities=11% Similarity=0.155 Sum_probs=91.9
Q ss_pred HHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhH--------H
Q 007253 463 LFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQL--------E 534 (611)
Q Consensus 463 ~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~--------~ 534 (611)
...++++|..+|.+++|.|+++||..++..... .....++..+|+.+|.|++|.|+++||..++...... .
T Consensus 55 ~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~-~~~~~~~~~~f~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~ 133 (183)
T 1s6c_A 55 STYAHYLFNAFDTTQTGSVKFEDFVTALSILLR-GTVHEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVL 133 (183)
T ss_dssp HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHH-CCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC-------
T ss_pred HHHHHHHHHHhCCCCCCcEeHHHHHHHHHHHcC-CCHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHHHHhccccCcCc
Confidence 345788999999999999999999999876653 3556678899999999999999999999888654211 1
Q ss_pred hhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhcCCCCccHHHHHHHHh
Q 007253 535 ALDRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWI 583 (611)
Q Consensus 535 ~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~~~~~~~~~~~~~~~D 583 (611)
.....++.+..+|+.+|.|++|.|+.+||..++...+. +-..|..+|
T Consensus 134 ~~~~~~~~~~~~f~~~D~d~dG~i~~~Ef~~~~~~~~~--~~~~l~~~d 180 (183)
T 1s6c_A 134 KEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESXQEDDN--IMRSLQLFQ 180 (183)
T ss_dssp ----CHHHHHHHHHHHCTTCSSEECHHHHHHHTTSCCH--HHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHhcChH--HHHHHHHhh
Confidence 11111367899999999999999999999999975444 455566554
|
| >1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.23 E-value=5.9e-11 Score=112.82 Aligned_cols=116 Identities=15% Similarity=0.167 Sum_probs=92.0
Q ss_pred HHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHh------
Q 007253 462 ELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEA------ 535 (611)
Q Consensus 462 e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~------ 535 (611)
....++.+|..+|.|++|.|+++||..++..... .....++..+|..+|.|++|.|+++||..++........
T Consensus 57 ~~~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~-~~~~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~ 135 (204)
T 1jba_A 57 ATQYVEAMFRAFDTNGDNTIDFLEYVAALNLVLR-GTLEHKLKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEV 135 (204)
T ss_dssp THHHHHHHHHHHCCSSSSEECHHHHHHHHHHHSS-CCCTHHHHHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCT
T ss_pred cHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHHcc-CCHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCccc
Confidence 3446888999999999999999999999877654 455667889999999999999999999998866532110
Q ss_pred -------hHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhcCCCCccHHHHHH
Q 007253 536 -------LDRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLH 580 (611)
Q Consensus 536 -------~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~~~~~~~~~~~~~ 580 (611)
....++.+..+|+.+|.|++|.|+.+||.+++.-.+. +..+|.
T Consensus 136 ~~~~~g~~~~~~~~~~~~f~~~D~d~dG~Is~~Ef~~~~~~~~~--~~~~~~ 185 (204)
T 1jba_A 136 EAEQQGKLLTPEEVVDRIFLLVDENGDGQLSLNEFVEGARRDKW--VMKMLQ 185 (204)
T ss_dssp TSSTTTCCCCHHHHHHHHHHHHCCSCCSCBCHHHHHHHHTTTTT--HHHHHH
T ss_pred cccccCchhhHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHcChH--HHHHHH
Confidence 0012567899999999999999999999999975444 555554
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A | Back alignment and structure |
|---|
Probab=99.22 E-value=2.2e-11 Score=108.84 Aligned_cols=110 Identities=11% Similarity=0.223 Sum_probs=86.7
Q ss_pred HHhhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcch
Q 007253 451 LRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV 530 (611)
Q Consensus 451 l~~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~ 530 (611)
+..++...+..+ +..+|..+|.+++|.|+++||..++...........++..+|+.+|.|++|.|+.+||..++...
T Consensus 32 l~~~g~~~~~~~---~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~ 108 (143)
T 2obh_A 32 MRALGFEPKKEE---IKKMISEIDKEGTGKMNFGDFLTVMTQKMSEKDTKEEILKAFKLFDDDETGKISFKNLKRVAKEL 108 (143)
T ss_dssp HHHTTCCCCHHH---HHHHHHHHTTTCCSEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHT
T ss_pred HHHcCCCCCHHH---HHHHHHHhCCCCCCeeeHHHHHHHHHHHhccccHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHh
Confidence 344455555555 66788899999999999999998875543322234568889999999999999999999888655
Q ss_pred hhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHh
Q 007253 531 HQLEALDRWEQHARCAYELFEKDGNRAIVIEELASEL 567 (611)
Q Consensus 531 ~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l 567 (611)
..... ++++..+|+.+|.|++|.|+.+||..++
T Consensus 109 g~~~~----~~~~~~~~~~~D~d~dG~I~~~eF~~~~ 141 (143)
T 2obh_A 109 GENLT----DEELQEMIDEADRDGDGEVSEQEFLRIM 141 (143)
T ss_dssp TCCCC----HHHHHHHHHHHCTTSSSSBCHHHHHHHH
T ss_pred CCCCC----HHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 43333 5678899999999999999999999876
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.22 E-value=3.6e-11 Score=118.68 Aligned_cols=136 Identities=13% Similarity=0.113 Sum_probs=98.5
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCC-eeEEEEEEeeCCe
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN-LVKFFDAYEDTDN 233 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~-iv~l~~~~~~~~~ 233 (611)
..|.+....+.|..+.||++... .|..+++|+..... ...+.+|+.+++.|..+.- +.+++++...++.
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~----~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~ 89 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQ----GRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGR 89 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECT----TSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC
T ss_pred CCCceEecccCCCCceEEEEecC----CCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCC
Confidence 34565444455666899998642 36779999975431 1347789999999985522 5668888888888
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---------------------------------
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG--------------------------------- 280 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--------------------------------- 280 (611)
.++||||++|.+|. + .... ...++.+++..|..||+..
T Consensus 90 ~~~v~e~i~G~~l~--~----~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (264)
T 1nd4_A 90 DWLLLGEVPGQDLL--S----SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE 160 (264)
T ss_dssp EEEEEECCSSEETT--T----SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred CEEEEEecCCcccC--c----CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence 99999999998873 2 1122 2356777888888888643
Q ss_pred -------------------------CeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 281 -------------------------VVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 281 -------------------------iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
++|+|++|.|||+. .+..++|+|||.+..
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSGFIDCGRLGV 214 (264)
T ss_dssp GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEEEEcchhccc
Confidence 99999999999994 445677999998754
|
| >4drw_A Protein S100-A10/annexin A2 chimeric protein; atypical EF-hand, heteropentameric complex, membrane repair; 3.50A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.21 E-value=1.7e-11 Score=105.28 Aligned_cols=107 Identities=11% Similarity=0.160 Sum_probs=74.6
Q ss_pred hhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhh----cccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHh
Q 007253 460 VDELFYLKEQYALLEPNKNGTISLENVKSALMKN----ATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEA 535 (611)
Q Consensus 460 ~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~----~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~ 535 (611)
+..++.|+++|+.||.| +|+|+..||+.+|... .+...++.++.+||..+|.|+||.|+|+||+.++........
T Consensus 11 E~~ie~l~~~F~~yd~d-dG~Is~~EL~~~l~~~~~~~l~~~~~~~~v~~~i~~~D~d~DG~IdF~EF~~lm~~l~~~~h 89 (121)
T 4drw_A 11 EHAMETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLIAGLTIACN 89 (121)
T ss_dssp HHHHHHHHHTTGGGSCT-TCSCCHHHHHHHTTTSCHHHHTTSSCTTHHHHHHHHHCTTCSSCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCC-CCEEcHHHHHHHHHHHhhhhcccCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHHH
Confidence 45578999999999987 8999999999998652 233567788999999999999999999999998876543322
Q ss_pred hHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhcCCCCccHHHHHHHHhcCCC
Q 007253 536 LDRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTD 587 (611)
Q Consensus 536 ~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~~~~~~~~~~~~~~~D~~~d 587 (611)
..|....+..+.+.. ++.++.++|+++|.|||
T Consensus 90 ---------e~f~~~~k~~~~~~~-----------~d~~~~e~~~~~d~~gd 121 (121)
T 4drw_A 90 ---------DYFVVHMKQENLYFQ-----------GDSTVHEILSKLSLEGD 121 (121)
T ss_dssp ---------HHHTTSCC--------------------CCHHHHHHHCCC---
T ss_pred ---------HHHHHHHHHhccCCC-----------CchHHHHHHHHhcccCC
Confidence 244444443333332 23337788888887775
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.21 E-value=2.8e-11 Score=111.72 Aligned_cols=113 Identities=13% Similarity=0.152 Sum_probs=89.8
Q ss_pred HHHhhhhcchhhHHHHH--------HHHhhhcCCCCCCcccHHHHHHHHHhhcccccc-------cCChhHHHhhcCCCC
Q 007253 450 ALRALSKTLTVDELFYL--------KEQYALLEPNKNGTISLENVKSALMKNATDAMK-------DSRIPDFLSSLNSLQ 514 (611)
Q Consensus 450 ~l~~~~~~l~~~e~~~l--------~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~-------~~~~~~~~~~~D~~~ 514 (611)
++..++...+..++..+ ..+|..+|.+++|.|+++||..++......... ...+..+|..+|.|+
T Consensus 36 ~l~~~g~~~~~~~~~~l~~~~~~~~~~lf~~~D~d~dg~i~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~ 115 (176)
T 1nya_A 36 IAEAFGKDAGAAEVQTLKNAFGGLFDYLAKEAGVGSDGSLTEEQFIRVTENLIFEQGEASFNRVLGPVVKGIVGMCDKNA 115 (176)
T ss_dssp HHHHTSSCSSSHHHHHHHHHHHHHHHHHHHHHTSCTTCCBCHHHHHHHHHHHHSSSCHHHHHHHHHHHHHHHHHHTCSSC
T ss_pred HHHHcCCCCCcHHHHHHHHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHhcCCchhhHHHHHHHHHHHHHHHhcCCC
Confidence 34445555666665544 489999999999999999999988765532211 245788999999999
Q ss_pred CCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 515 YRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 515 ~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
+|.|+++||..++.... .. ++++..+|+.+|.|++|.|+.+||.+++.
T Consensus 116 ~G~I~~~e~~~~l~~~g--~~----~~~~~~~~~~~D~d~dg~i~~~ef~~~~~ 163 (176)
T 1nya_A 116 DGQINADEFAAWLTALG--MS----KAEAAEAFNQVDTNGNGELSLDELLTAVR 163 (176)
T ss_dssp CSEEEHHHHHHHHHHTT--CC----HHHHHHHHHHHCTTCSSEEEHHHHHHHHS
T ss_pred CCCCCHHHHHHHHHHhC--CC----HHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Confidence 99999999998886654 22 56789999999999999999999999984
|
| >3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A | Back alignment and structure |
|---|
Probab=99.19 E-value=1.1e-10 Score=113.30 Aligned_cols=117 Identities=12% Similarity=0.157 Sum_probs=92.2
Q ss_pred HHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHH--------h
Q 007253 464 FYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLE--------A 535 (611)
Q Consensus 464 ~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~--------~ 535 (611)
..+.++|..+|.|++|.|+++||..++..... ...+..+..+|+.+|.|++|.|+++||..++....... .
T Consensus 102 ~~~~~lf~~~D~d~~G~I~~~Ef~~~l~~~~~-~~~~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~~~~~~~~~~ 180 (229)
T 3dd4_A 102 TYAHFLFNAFDTDHNGAVSFEDFIKGLSILLR-GTVQEKLNWAFNLYDINKDGYITKEEMLDIMKAIYDMMGKCTYPVLK 180 (229)
T ss_dssp HHHHHHHHTTCSSCCSSCCHHHHHHHHHHHHH-SCHHHHHHHHHHHHCTTCSSCCBHHHHHHHHHHHHHHCC--------
T ss_pred HHHHHHHHHcCCCCCCeEeHHHHHHHHHHHcC-CChHHHHHHHHHHhCCCCCCeECHHHHHHHHHHHHHHhccccCCCcc
Confidence 34678999999999999999999998876653 34556788999999999999999999998886643110 0
Q ss_pred hHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhcCCCCccHHHHHHHHh
Q 007253 536 LDRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWI 583 (611)
Q Consensus 536 ~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~~~~~~~~~~~~~~~D 583 (611)
....++.+..+|+.+|.|+||.|+.+||.+++.-.+. +..+|..+|
T Consensus 181 ~~~~~~~~~~~f~~~D~d~dG~Is~~EF~~~~~~~~~--~~~~~~~~D 226 (229)
T 3dd4_A 181 EDAPRQHVETFFQKMDKNKDGVVTIDEFIESCQKDEN--IMRSMQLFE 226 (229)
T ss_dssp ---CCTHHHHHHHHHCSSCSSBCCHHHHHHHHHTCHH--HHHHHHHHT
T ss_pred hhhHHHHHHHHHHHhcCCCCCcEeHHHHHHHHHhCHH--HHHHHHhcc
Confidence 0111457889999999999999999999999975443 666777776
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.18 E-value=3.6e-11 Score=118.87 Aligned_cols=117 Identities=12% Similarity=0.136 Sum_probs=93.3
Q ss_pred HHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHH--------h
Q 007253 464 FYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLE--------A 535 (611)
Q Consensus 464 ~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~--------~ 535 (611)
..+.++|..+|.|++|.|+++||..++...+. ...+.++..+|..+|.|++|.|+++||..++....... .
T Consensus 129 ~~~~~~f~~~D~d~dG~I~~~Ef~~~l~~~~~-~~~~~~l~~~F~~~D~d~dG~I~~~Ef~~~l~~~~~~~g~~~~~~~~ 207 (256)
T 2jul_A 129 TYAHFLFNAFDADGNGAIHFEDFVVGLSILLR-GTVHEKLKWAFNLYDINKDGCITKEEMLAIMKSIYDMMGRHTYPILR 207 (256)
T ss_dssp HHHHHHHHHSSCSCCSEECSHHHHHHHHHHHS-CCHHHHHHHHHHHTCCSSSSCBCHHHHHHHHHHHHHHCCCCCSCCSC
T ss_pred HHHHHHHHHhccCCCCcCcHHHHHHHHHHHhc-cChHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCCcccc
Confidence 45889999999999999999999999877653 35567788999999999999999999998886543110 0
Q ss_pred hHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhcCCCCccHHHHHHHHh
Q 007253 536 LDRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWI 583 (611)
Q Consensus 536 ~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~~~~~~~~~~~~~~~D 583 (611)
....++.+..+|+.+|.|++|.|+.+||.+++...+. +.+.|..+|
T Consensus 208 ~~~~~~~~~~~f~~~D~d~dG~Is~~Ef~~~~~~~~~--l~~~l~~~d 253 (256)
T 2jul_A 208 EDAPLEHVERFFQKMDRNQDGVVTIDEFLETCQKDEN--IMNSMQLFE 253 (256)
T ss_dssp CCCHHHHHHHHHHHSCCSTTCSBCHHHHHHHHHHCSS--HHHHHHHHH
T ss_pred hhhHHHHHHHHHHHHCCCCCCcEeHHHHHHHHHhCHH--HHHHHHhhc
Confidence 0012668899999999999999999999999965444 556666665
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A | Back alignment and structure |
|---|
Probab=99.18 E-value=5.2e-11 Score=104.30 Aligned_cols=98 Identities=16% Similarity=0.159 Sum_probs=82.0
Q ss_pred ChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc----CCCCcc---
Q 007253 502 RIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG----LGPAVP--- 574 (611)
Q Consensus 502 ~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~----~~~~~~--- 574 (611)
++.++|..+|.|++|.|+++||..++........ .+.+..+|+.+|.|++|.|+.+||..++. .....+
T Consensus 1 ~l~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~----~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~ 76 (134)
T 1jfj_A 1 MAEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKN----EQLLQLIFKSIDADGNGEIDQNEFAKFYGSIQGQDLSDDKIG 76 (134)
T ss_dssp CHHHHHHHHCTTCSSEEEHHHHHHHHHTTCCSSH----HHHHHHHHHHHCSSCCSEEEHHHHHHHTTCSSCCSSHHHHHH
T ss_pred CHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCC----HHHHHHHHHHHcCCCCCeEcHHHHHHHHHHhcccccCCCHHH
Confidence 3678999999999999999999998876543333 56788999999999999999999999984 222111
Q ss_pred HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 575 VHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 575 ~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
+..+|+.+|.|+||.|+++||..++..+.
T Consensus 77 ~~~~f~~~D~d~~G~i~~~e~~~~l~~~~ 105 (134)
T 1jfj_A 77 LKVLYKLMDVDGDGKLTKEEVTSFFKKHG 105 (134)
T ss_dssp HHHHHHHHCCSSSSEEEHHHHHHHHTTTT
T ss_pred HHHHHHHHCCCCCCccCHHHHHHHHHHhC
Confidence 78899999999999999999999998654
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A | Back alignment and structure |
|---|
Probab=99.17 E-value=9.3e-11 Score=106.24 Aligned_cols=109 Identities=10% Similarity=0.132 Sum_probs=88.7
Q ss_pred hhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccc----cccCChhHHHhhcCCCCCCcccHHHHHHHHcc
Q 007253 454 LSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDA----MKDSRIPDFLSSLNSLQYRRMDFEEFCAAALS 529 (611)
Q Consensus 454 ~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~----~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~ 529 (611)
+...++..+ +..+|..+|.+++|.|+++||..++....... .....+..+|..+|.|++|.|+.+||..++..
T Consensus 43 ~~~~~~~~~---~~~l~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~ 119 (158)
T 2jnf_A 43 LGIQQTKST---IRQLIDEFDPFGNGDIDFDSFKIIGARFLGEEVNPEQMQQELREAFRLYDKEGNGYISTDVMREILAE 119 (158)
T ss_dssp TTCSCSHHH---HHHHHHHHCTTCCSEECHHHHHHHHHHHCCCCCCTTTTSSTHHHHHHHHCSSSSSSEEHHHHHHHHHH
T ss_pred hCCCCCHHH---HHHHHHHhCCCCCCcCcHHHHHHHHHHHhccccchhhHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHH
Confidence 333445444 67889999999999999999999887665432 44567899999999999999999999998876
Q ss_pred hhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhcC
Q 007253 530 VHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELGL 569 (611)
Q Consensus 530 ~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~~ 569 (611)
...... ++++..+|+.+|.|++|.|+.+||.+++.-
T Consensus 120 ~g~~~~----~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~ 155 (158)
T 2jnf_A 120 LDETLS----SEDLDAMIDEIDADGSGTVDFEEFMGVMTG 155 (158)
T ss_dssp HCTTCC----HHHHHHHHHHHCSSCCSEECSHHHHHHTSS
T ss_pred hCCcCC----HHHHHHHHHHhCCCCCCcEeHHHHHHHHhc
Confidence 543333 567889999999999999999999998853
|
| >1eg3_A Dystrophin; EF-hand like domain, WW domain, structural protein; 2.00A {Homo sapiens} SCOP: a.39.1.7 a.39.1.7 b.72.1.1 PDB: 1eg4_A | Back alignment and structure |
|---|
Probab=99.17 E-value=1.6e-10 Score=112.25 Aligned_cols=134 Identities=11% Similarity=0.075 Sum_probs=99.8
Q ss_pred hHHHHHHHHhhhcCC-CCCCcccHHHHHHHHHhhccc----ccc--------cCChhHHHhhcCCCCCCcccHHHHHHHH
Q 007253 461 DELFYLKEQYALLEP-NKNGTISLENVKSALMKNATD----AMK--------DSRIPDFLSSLNSLQYRRMDFEEFCAAA 527 (611)
Q Consensus 461 ~e~~~l~~~F~~~D~-d~~G~Is~~e~~~~l~~~~~~----~~~--------~~~~~~~~~~~D~~~~g~i~~~eF~~~~ 527 (611)
-++..+.++|+...- .++..|+..++..+|..+... .+. +.-+..+|+.+|.|++|+|+|.||+.++
T Consensus 79 v~l~~~~~~f~~~~l~~~~~~l~~~~l~~~L~~lY~~l~~~~p~~v~~~~~~~~~a~~lf~~FD~~~~G~I~f~ef~~aL 158 (261)
T 1eg3_A 79 LSLSAACDALDQHNLKQNDQPMDILQIINCLTTIYDRLEQEHNNLVNVPLCVDMCLNWLLNVYDTGRTGRIRVLSFKTGI 158 (261)
T ss_dssp CCHHHHHHHHHHTTCCCTTSEEEHHHHHHHHHHHHHHHHHHSTTTCCHHHHHHHHHHHHHHHHCTTCCSEEEHHHHHHHH
T ss_pred eeHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHHHHHHHhhCcCcCCchhhHHHHHHHHHHHccCCCCceEeHHHHHHHH
Confidence 345556666766543 356678999988877655421 010 1112358999999999999999999988
Q ss_pred cchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc--------CCCC-------c--cHHHHHHHHhcCCCCce
Q 007253 528 LSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG--------LGPA-------V--PVHAVLHDWIRHTDGKL 590 (611)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~--------~~~~-------~--~~~~~~~~~D~~~dG~i 590 (611)
....+... ++.++.+|++|| |+||+|+.+||..++. +|+. . .++.+|..+| +||+|
T Consensus 159 s~l~rG~l----eeKL~w~F~lyD-D~~G~I~~~El~~il~~i~~i~~~vge~~~~~~~~~e~~v~~~F~~~d--~dg~I 231 (261)
T 1eg3_A 159 ISLCKAHL----EDKYRYLFKQVA-SSTGFCDQRRLGLLLHDSIQIPRQLGEVASFGGSNIEPSVRSCFQFAN--NKPEI 231 (261)
T ss_dssp HHTSSSCH----HHHHHHHHHHHS-CTTSCBCHHHHHHHHHHHHHHHHHTTCGGGGTCSCCHHHHHHHHHHTT--TCSCB
T ss_pred HHHcCCCH----HHHHHHHHheee-CCCCCCcHHHHHHHHHHHHHHHHhcCCcccCCCCCHHHHHHHHHHhCC--CCCcC
Confidence 77766555 779999999999 9999999999999881 2321 1 1788898885 89999
Q ss_pred eHHHHHHHHhh
Q 007253 591 SFLGFVKLLHG 601 (611)
Q Consensus 591 s~~eF~~~l~~ 601 (611)
+.+||+..++.
T Consensus 232 t~~EFl~~~~~ 242 (261)
T 1eg3_A 232 EAALFLDWMRL 242 (261)
T ss_dssp CHHHHHHHHHT
T ss_pred CHHHHHHHHHh
Confidence 99999998765
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A | Back alignment and structure |
|---|
Probab=99.16 E-value=5e-11 Score=109.35 Aligned_cols=108 Identities=11% Similarity=0.146 Sum_probs=87.6
Q ss_pred hhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhH
Q 007253 454 LSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQL 533 (611)
Q Consensus 454 ~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~ 533 (611)
++..++..+ +..+|..+|.+++|.|+++||..++............+..+|..+|.|++|.|+.+||..++......
T Consensus 57 ~~~~~~~~~---~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~ 133 (169)
T 3qrx_A 57 LGFEPKKEE---IKKMISEIDKDGSGTIDFEEFLTMMTAKMGERDSREEILKAFRLFDDDNSGTITIKDLRRVAKELGEN 133 (169)
T ss_dssp TSCCCCHHH---HHHHHHHHCSSSSSSEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCC
T ss_pred cCCCCCHHH---HHHHHHHhcCCCCCcCCHHHHHHHHHHHhcccCcHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCC
Confidence 333444444 77889999999999999999999886654433345568889999999999999999999988765433
Q ss_pred HhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 534 EALDRWEQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 534 ~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
.. ++++..+|+.+|.|++|.|+.+||..++.
T Consensus 134 ~~----~~~~~~~~~~~D~~~dg~i~~~eF~~~~~ 164 (169)
T 3qrx_A 134 LT----EEELQEMIAEADRNDDNEIDEDEFIRIMK 164 (169)
T ss_dssp CC----HHHHHHHHHHHCCSSSSCBCHHHHHHHHC
T ss_pred CC----HHHHHHHHHHhCCCCCCCEeHHHHHHHHH
Confidence 33 56788999999999999999999999885
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... | Back alignment and structure |
|---|
Probab=99.16 E-value=6e-11 Score=106.49 Aligned_cols=108 Identities=14% Similarity=0.185 Sum_probs=86.1
Q ss_pred hhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhh
Q 007253 453 ALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQ 532 (611)
Q Consensus 453 ~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~ 532 (611)
.++...+..+ +..+|..+|.+++|.|+++||..++...........++..+|..+|.|++|.|+.+||..++.....
T Consensus 38 ~~g~~~~~~~---~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~ 114 (148)
T 1exr_A 38 SLGQNPTEAE---LQDMINEVDADGNGTIDFPEFLSLMARKMKEQDSEEELIEAFKVFDRDGNGLISAAELRHVMTNLGE 114 (148)
T ss_dssp HHTCCCCHHH---HHHHHHHHCTTCSSSEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHSTTCSSCBCHHHHHHHHHHTTC
T ss_pred HcCCCCCHHH---HHHHHHHHCCCCCCcCcHHHHHHHHHhcccCCCcHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCC
Confidence 3444444444 6788999999999999999999887654432334456788999999999999999999988866543
Q ss_pred HHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHh
Q 007253 533 LEALDRWEQHARCAYELFEKDGNRAIVIEELASEL 567 (611)
Q Consensus 533 ~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l 567 (611)
... ++++..+|+.+|.|++|.|+.+||.+++
T Consensus 115 ~~~----~~~~~~~~~~~d~d~dg~i~~~eF~~~~ 145 (148)
T 1exr_A 115 KLT----DDEVDEMIREADIDGDGHINYEEFVRMM 145 (148)
T ss_dssp CCC----HHHHHHHHHHHCSSSSSSBCHHHHHHHH
T ss_pred CCC----HHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 333 5678899999999999999999999876
|
| >3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.15 E-value=1.7e-11 Score=108.64 Aligned_cols=99 Identities=11% Similarity=-0.010 Sum_probs=62.3
Q ss_pred HHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchh-hHHhhHHHHHHHH
Q 007253 466 LKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVH-QLEALDRWEQHAR 544 (611)
Q Consensus 466 l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~-~~~~~~~~~~~~~ 544 (611)
.+++|..+|.|++|.|+++||..++...........++..+|..+|.|++|.|+.+||..++.... .... .+++.
T Consensus 5 ~~~l~~~~D~d~~G~I~~~EF~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~----~~e~~ 80 (135)
T 3h4s_E 5 EKSMLLETTSTTKMETKYEDMLPVMAEKMDVEEFVSELCKGFSLLADPERHLITAESLRRNSGILGIEGMS----KEDAQ 80 (135)
T ss_dssp --------------CCCC-----------CHHHHHHHHHHHHHHHSBTTTTBBCHHHHHHHGGGGTCCCCC----HHHHH
T ss_pred HHHHHHHHcCCCCCcEeHHHHHHHHHHHccccchHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCC----HHHHH
Confidence 467899999999999999999998765443333456788999999999999999999999887665 2333 56789
Q ss_pred HHHhHHhcCCCCcccHHHHHHHhc
Q 007253 545 CAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 545 ~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
.+|+.+|.|++|.|+.+||..++.
T Consensus 81 ~~~~~~D~d~dG~I~~~EF~~~~~ 104 (135)
T 3h4s_E 81 GMVREGDLDGDGALNQTEFCVLMV 104 (135)
T ss_dssp HHHHHHCSSCSSSBCHHHHHHHHH
T ss_pred HHHHHhCCCCCCCCcHHHHHHHHH
Confidence 999999999999999999999884
|
| >3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor} | Back alignment and structure |
|---|
Probab=99.14 E-value=6.3e-11 Score=121.73 Aligned_cols=111 Identities=14% Similarity=0.205 Sum_probs=88.1
Q ss_pred HHhhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcch
Q 007253 451 LRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV 530 (611)
Q Consensus 451 l~~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~ 530 (611)
++.+...+++++ +.++|..+|.|++|.|+++||..++.........++++.++|+.+|.|++|.|+.+||..++...
T Consensus 328 LrsLG~~~TeeE---I~~Lf~~~D~DgDG~IdFeEFl~lms~~lk~~d~eeeLreAFk~fDkDgdG~IS~eELr~vL~~l 404 (440)
T 3u0k_A 328 MRSLGQNPTEAE---LQDMINEVDADGDGTIDFPEFLIMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNL 404 (440)
T ss_dssp HHHTTCCCCHHH---HHHHHHHHCSSCSSSEEHHHHHHHHHTC------CHHHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred HHHcCCCCCHHH---HHHHHHHhCCCCCCcCcHHHHHHHHHHHhcCCChHHHHHHHHHHHCCCCcCcCCHHHHHHHHHHh
Confidence 445555666665 67889999999999999999999876654433445678899999999999999999999988765
Q ss_pred hhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 531 HQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 531 ~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
..... ++++..+|+.+|.|+||.|+.+||.++|.
T Consensus 405 Ge~LS----deEIdeLfke~D~DgDGkIsyeEFvkmMt 438 (440)
T 3u0k_A 405 GEKLT----DEEVDEMIREADIDGDGQVNYEEFVQMMT 438 (440)
T ss_dssp TCCCC----HHHHHHHHHHHCTTCSSSEEHHHHHHHHC
T ss_pred CCCCC----HHHHHHHHHHhCCCCCCcEeHHHHHHHhC
Confidence 54334 56788999999999999999999999873
|
| >3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} SCOP: a.39.1.4 PDB: 2kqy_A | Back alignment and structure |
|---|
Probab=99.14 E-value=5.5e-11 Score=100.84 Aligned_cols=103 Identities=12% Similarity=0.155 Sum_probs=81.8
Q ss_pred hhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcch---
Q 007253 454 LSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV--- 530 (611)
Q Consensus 454 ~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~--- 530 (611)
++..++.++ +.++|..+| ++|.|+++||..++... .....++..+|..+|.|++|.|+.+||..++...
T Consensus 3 l~~~~~~~e---i~~~~~~~D--~~g~i~~~eF~~~~~~~---~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~ 74 (109)
T 3fs7_A 3 ITDILSAKD---IESALSSCQ--AADSFNYKSFFSTVGLS---SKTPDQIKKVFGILDQDKSGFIEEEELQLFLKNFSSS 74 (109)
T ss_dssp GGGTSCHHH---HHHHHHHTC--STTCCCHHHHHHHHTCT---TCCHHHHHHHHHHHSTTCSSSBCHHHHHTTGGGTCTT
T ss_pred ccCcCCHHH---HHHHHHhcC--CCCcCcHHHHHHHHhcC---CCcHHHHHHHHHHHCCCCCCeEeHHHHHHHHHHHhcc
Confidence 445566665 667777788 79999999999976431 2344568889999999999999999999887765
Q ss_pred hhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 531 HQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 531 ~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
..... +++++.+|+.+|.|++|.|+.+||.+++.
T Consensus 75 ~~~~~----~~~~~~~~~~~D~~~dg~i~~~EF~~~~~ 108 (109)
T 3fs7_A 75 ARVLT----SAETKAFLAAGDTDGDGKIGVEEFQSLVK 108 (109)
T ss_dssp SCCCC----HHHHHHHHHHHCTTCSSSBCHHHHHHHHT
T ss_pred cccCC----HHHHHHHHHHhCCCCCCcCcHHHHHHHHh
Confidence 32233 56788999999999999999999998863
|
| >2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A | Back alignment and structure |
|---|
Probab=99.14 E-value=6.5e-11 Score=106.46 Aligned_cols=111 Identities=15% Similarity=0.184 Sum_probs=90.0
Q ss_pred HHhhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcch
Q 007253 451 LRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV 530 (611)
Q Consensus 451 l~~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~ 530 (611)
++.+....+..+ +..+|..+|.+++|.|++.||...+.........+.++..+|+.+|.|++|.|+.+||..++...
T Consensus 36 l~~~~~~~~~~~---~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~El~~~l~~~ 112 (148)
T 2lmt_A 36 MRTLGQNPTEAE---LQDLIAEAENNNNGQLNFTEFCGIMAKQMRETDTEEEMREAFKIFDRDGDGFISPAELRFVMINL 112 (148)
T ss_dssp HHHHTCCCCHHH---HHHHHHHHHTTSTTEEEHHHHHHHHHHTTTTTTTHHHHHHHHHHHHSSCSSEECHHHHHHHHHHH
T ss_pred HHhcCCCchHHH---HHHHHHhcccCCCCcccHHHHHHHHHHHhcccCcHHHHHHHHHHHCCCCcCcCcHHHHHHHHHHc
Confidence 344444555544 67888999999999999999999876665444555678899999999999999999999888765
Q ss_pred hhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 531 HQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 531 ~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
..... .+++..+|+.+|.|++|.|+.+||.++|.
T Consensus 113 g~~~~----~~e~~~l~~~~D~d~dG~I~~~EF~~~m~ 146 (148)
T 2lmt_A 113 GEKVT----DEEIDEMIREADFDGDGMINYEEFVWMIS 146 (148)
T ss_dssp TCCCC----HHHHHHHHHHHCCSCCSSEEHHHHHHHHT
T ss_pred Ccccc----HHHHHHHHHHhCCCCCCeEeHHHHHHHHh
Confidence 54444 56788999999999999999999999874
|
| >2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.14 E-value=6e-11 Score=110.37 Aligned_cols=105 Identities=15% Similarity=0.189 Sum_probs=83.4
Q ss_pred cchhhHHHHHH--------HHhhhcCCCCCCcccHHHHHHHHHhhccc--------ccccCChhHHHhhcCCCCCCcccH
Q 007253 457 TLTVDELFYLK--------EQYALLEPNKNGTISLENVKSALMKNATD--------AMKDSRIPDFLSSLNSLQYRRMDF 520 (611)
Q Consensus 457 ~l~~~e~~~l~--------~~F~~~D~d~~G~Is~~e~~~~l~~~~~~--------~~~~~~~~~~~~~~D~~~~g~i~~ 520 (611)
.++..+...++ .+|..+|.|++|.|+++||..++...... ......+..+|..+|.|++|.|++
T Consensus 45 ~~~~~~~~~l~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~ 124 (185)
T 2sas_A 45 SLSDADYKSMQASLEDEWRDLKGRADINKDDVVSWEEYLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGIVDL 124 (185)
T ss_dssp GSCHHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHTCCSGGGSCTTHHHHHHHHHHHHCTTSSSCCCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHhcCCCCCCeEcHHHHHHHHHHHhccccchhhhhHHHHHHHHHHHHHHcCCCCCeEcH
Confidence 44555555553 56999999999999999999988665421 112245678999999999999999
Q ss_pred HHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHh
Q 007253 521 EEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASEL 567 (611)
Q Consensus 521 ~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l 567 (611)
+||..++.... .. ++++..+|+.+|.|++|.|+.+||..++
T Consensus 125 ~E~~~~l~~~g--~~----~~~~~~~~~~~D~d~dG~i~~~ef~~~~ 165 (185)
T 2sas_A 125 EEFQNYCKNFQ--LQ----CADVPAVYNVITDGGKVTFDLNRYKELY 165 (185)
T ss_dssp HHHHHHTTSSC--CC----CSSHHHHHHHHHTTTTSCCSHHHHHHHH
T ss_pred HHHHHHHHHhC--CC----HHHHHHHHHHhcCCCCCcCcHHHHHHHH
Confidence 99999886553 12 4467889999999999999999999987
|
| >1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.14 E-value=8.8e-11 Score=113.58 Aligned_cols=108 Identities=11% Similarity=0.157 Sum_probs=87.1
Q ss_pred HHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhH--------H
Q 007253 463 LFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQL--------E 534 (611)
Q Consensus 463 ~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~--------~ 534 (611)
..+++++|..+|.|++|.|+++||..++..... ...+.++..+|+.+|.|++|.|+++||..++...... .
T Consensus 88 ~~~~~~~f~~~D~d~~G~I~~~Ef~~~l~~~~~-~~~~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~g~~~~~~~ 166 (224)
T 1s1e_A 88 STYAHYLFNAFDTTQTGSVKFEDFVTALSILLR-GTVHEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVL 166 (224)
T ss_dssp HHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHH-CCHHHHHHHHHHHHCTTCCSEECHHHHHHHHHHHHHHHTTCCCGGG
T ss_pred HHHHHHHHHHhcCCCCCcEeHHHHHHHHHHHcc-CCHHHHHHHHHHHHcCCCCCeECHHHHHHHHHHHHHHhcccCCCCC
Confidence 345788999999999999999999999876653 3456678899999999999999999999887654211 1
Q ss_pred hhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhcCCC
Q 007253 535 ALDRWEQHARCAYELFEKDGNRAIVIEELASELGLGP 571 (611)
Q Consensus 535 ~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~~~~ 571 (611)
.....++.+..+|+.+|.|++|.|+.+||.+++...+
T Consensus 167 ~~~~~~~~~~~~f~~~D~d~dG~Is~~EF~~~~~~~~ 203 (224)
T 1s1e_A 167 KEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESCQEDD 203 (224)
T ss_dssp CSSSHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHTCH
T ss_pred CHhHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhCH
Confidence 1111246789999999999999999999999986433
|
| >3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L | Back alignment and structure |
|---|
Probab=99.14 E-value=2.8e-11 Score=136.59 Aligned_cols=124 Identities=13% Similarity=0.056 Sum_probs=103.6
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHH
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHAR 544 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~ 544 (611)
+++.+|..+|.|++|.|+++||..++... .++..+|..+|.|++|.|+.+||..++........ ++++.
T Consensus 576 ~~~~l~~~~D~d~~G~I~f~EF~~l~~~~-------~~l~~~F~~~D~d~dG~Is~~El~~~L~~~G~~ls----~~~~~ 644 (714)
T 3bow_A 576 TCKIMVDMLDEDGSGKLGLKEFYILWTKI-------QKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLP----CQLHQ 644 (714)
T ss_dssp HHHHHHHHHCCSSCSSBCHHHHHHHHHHH-------HHHHHHHHHHCTTCCSSEEHHHHHHHHHHTTEECC----HHHHH
T ss_pred HHHHHHHHhCCCCCCcCcHHHHHHHHHHH-------HHHHHHHHHhCCCCCCeECHHHHHHHHHHcCCCCC----HHHHH
Confidence 47788999999999999999999987553 45788999999999999999999988865543333 56788
Q ss_pred HHHhHHhcCCCCcccHHHHHHHhcCCCCccHHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 545 CAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 545 ~~F~~~D~d~~G~It~eEl~~~l~~~~~~~~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
.+|+.+| |++|.|+.+||..++.-.. .+..+|+.+|.|+||.|+++|+..++..+
T Consensus 645 ~l~~~~D-d~dG~Isf~EF~~~l~~~~--~l~~~F~~~D~d~dG~Is~~el~~l~~~~ 699 (714)
T 3bow_A 645 VIVARFA-DDELIIDFDNFVRCLVRLE--ILFKIFKQLDPENTGTIQLDLISWLSFSV 699 (714)
T ss_dssp HHHHHHS-CTTCEECHHHHHHHHHHHH--HHHHHHSSSCSSCCSEEEEEHHHHHHHHH
T ss_pred HHHHHhC-CCCCeEcHHHHHHHHHHHH--HHHHHHHHhCCCCCCcEEHHHHHHHHHHH
Confidence 9999999 9999999999999884211 27788999999999999999988766544
|
| >2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.14 E-value=4.2e-11 Score=99.90 Aligned_cols=61 Identities=30% Similarity=0.497 Sum_probs=53.9
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLH 600 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~ 600 (611)
.++++.+|+.||+|++|+|+.+||+.+|. +|...+ ++.+|+.+|.|+||.|+|+||+++|.
T Consensus 35 ~~el~~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~ei~~l~~~~D~d~dG~I~~~EF~~~m~ 99 (100)
T 2lv7_A 35 LEEIREAFKVFDRDGNGFISKQELGTAMRSLGYMPNEVELEVIIQRLDMDGDGQVDFEEFVTLLG 99 (100)
T ss_dssp HHHHHHHHHHTCSSCSSCBCHHHHHHHHHHHTCCCCTTTHHHHHHHHCSSCSSSBCHHHHHHHTC
T ss_pred HHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCeEeHHHHHHHhC
Confidence 55789999999999999999999999994 444333 99999999999999999999999873
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A | Back alignment and structure |
|---|
Probab=99.14 E-value=6.9e-11 Score=112.58 Aligned_cols=121 Identities=15% Similarity=0.143 Sum_probs=85.2
Q ss_pred CCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCC--CCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhc
Q 007253 475 PNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSL--QYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEK 552 (611)
Q Consensus 475 ~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~--~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~ 552 (611)
+|++|.|+.+++..+..........-.++..+|..+|.| ++|.|+++||..++.... ... +..+..+|+.+|.
T Consensus 11 ~~~~g~l~~~el~~l~~~~~~s~~~~~~l~~~F~~~D~d~~~~G~i~~~e~~~~l~~~~-~~~----~~~~~~~f~~~D~ 85 (207)
T 2ehb_A 11 KNAMRPPGYEDPELLASVTPFTVEEVEALYELFKKLSSSIIDDGLIHKEEFQLALFRNR-NRR----NLFADRIFDVFDV 85 (207)
T ss_dssp ----------CHHHHHHHSSCCHHHHHHHHHHHHHHTTSSSCSSCEEHHHHHHHHHSCT-TCC----CHHHHHHHHHHCT
T ss_pred hccccccCHHHHHHHHHhCCCCHHHHHHHHHHHHHhccccCCCCccCHHHHHHHHhccc-ccc----HHHHHHHHHHhcC
Confidence 367899999999987654433222223456789999999 999999999998875421 111 3356779999999
Q ss_pred CCCCcccHHHHHHHhc-CCCC----ccHHHHHHHHhcCCCCceeHHHHHHHHh
Q 007253 553 DGNRAIVIEELASELG-LGPA----VPVHAVLHDWIRHTDGKLSFLGFVKLLH 600 (611)
Q Consensus 553 d~~G~It~eEl~~~l~-~~~~----~~~~~~~~~~D~~~dG~is~~eF~~~l~ 600 (611)
|++|.|+.+||..++. .... ..+..+|+.+|.|+||.|+++||..++.
T Consensus 86 d~~g~i~~~Ef~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~E~~~~l~ 138 (207)
T 2ehb_A 86 KRNGVIEFGEFVRSLGVFHPSAPVHEKVKFAFKLYDLRQTGFIEREELKEMVV 138 (207)
T ss_dssp TCSSEECHHHHHHHHGGGSTTSCHHHHHHHHHHHHCTTCCSSEEHHHHHHHHH
T ss_pred CCCCeEeHHHHHHHHHHHccCCCHHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 9999999999999985 3221 1178899999999999999999999985
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... | Back alignment and structure |
|---|
Probab=99.14 E-value=6e-11 Score=107.81 Aligned_cols=107 Identities=13% Similarity=0.202 Sum_probs=84.6
Q ss_pred hhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcc---cccccCChhHHHhhcCCCCCCcccHHHHHHHHcchh
Q 007253 455 SKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNAT---DAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVH 531 (611)
Q Consensus 455 ~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~---~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~ 531 (611)
+..++..+ +..+|..+|.+++|.|+++||..++..... .......+..+|..+|.|++|.|+.+||..++....
T Consensus 49 ~~~~~~~~---~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~El~~~l~~~g 125 (161)
T 1dtl_A 49 GQNPTPEE---LQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELSDLFRMFDKNADGYIDLEELKIMLQATG 125 (161)
T ss_dssp TCCCCHHH---HHHHHHHHCTTSSSSBCHHHHHHHHHHHHC-----CHHHHHHHHHHHHCTTCSSEEEHHHHGGGGTTC-
T ss_pred CCCCCHHH---HHHHHHHhCCCCCCeEcHHHHHHHHHHHhcccccchHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhC
Confidence 33444444 778899999999999999999998766542 223345678899999999999999999998886654
Q ss_pred hHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 532 QLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 532 ~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
.... ++++..+|+.+|.|++|.|+.+||..++.
T Consensus 126 ~~~~----~~~~~~~~~~~D~d~dg~i~~~eF~~~~~ 158 (161)
T 1dtl_A 126 ETIT----EDDIEELMKDGDKNNDGRIDYDEFLEFMK 158 (161)
T ss_dssp -CCC----HHHHHHHHHHHCTTSSSEEEHHHHHHHHH
T ss_pred CCCC----HHHHHHHHHHhCCCCCCcEeHHHHHHHHH
Confidence 3333 56788999999999999999999998873
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.13 E-value=1.8e-10 Score=116.89 Aligned_cols=182 Identities=17% Similarity=0.246 Sum_probs=124.4
Q ss_pred eCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCC--eeEEEEEEeeCC---ee
Q 007253 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN--LVKFFDAYEDTD---NV 234 (611)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~--iv~l~~~~~~~~---~~ 234 (611)
.+.++.|....||++. ..+++|+.. .......+.+|+.+++.|..+.. +.+.+......+ ..
T Consensus 25 i~~~~~G~~n~v~~v~--------~~~vlR~~~-----~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~ 91 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN--------RDFIFKFPK-----HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMS 91 (304)
T ss_dssp CCEEEECSSEEEEEST--------TSEEEEEES-----SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCS
T ss_pred eEecCCCCcceEEEEC--------CEEEEEecC-----CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcc
Confidence 3568999999998753 458899853 22445678999999999853433 345554443333 35
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL------------------------------------ 278 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~------------------------------------ 278 (611)
|+|||+++|.+|.+... ..++......++.+++..|..||+
T Consensus 92 ~~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (304)
T 3sg8_A 92 FAGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGP 168 (304)
T ss_dssp CEEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHH
T ss_pred eEEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcc
Confidence 89999999988865433 247888888899999999999996
Q ss_pred ----------------------cCCeeecCCCCceEEeccCCCceEEEeecccccccCCCCcccccccCCCc---Ccchh
Q 007253 279 ----------------------QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY---VAPEV 333 (611)
Q Consensus 279 ----------------------~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y---~aPE~ 333 (611)
..++|+|+++.||++..+ ....+.|+||+.+....+.... .....+ ..|+.
T Consensus 169 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~~~~~~~iD~~~~~~~~~~~Dl---~~~~~~~~~~~~~~ 244 (304)
T 3sg8_A 169 QMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-KNTICGIIDFGDAAISDPDNDF---ISLMEDDEEYGMEF 244 (304)
T ss_dssp HHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-TTEEEEECCCTTCEEECTTHHH---HTTCCTTTSCCHHH
T ss_pred cHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC-CCCEEEEEeCCCCccCChHHHH---HHHHhhccccCHHH
Confidence 136999999999999531 1567899999998664322111 111111 23332
Q ss_pred hc---CCCCC------------cchhhHHHHHHHHHHhCCCCC
Q 007253 334 LH---RSYST------------EADVWSIGVIAYILLCGSRPF 361 (611)
Q Consensus 334 ~~---~~~~~------------~~DiwSlGvil~el~~g~~Pf 361 (611)
.. ..|.. ..+.|++|.++|.+.+|..+|
T Consensus 245 ~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 245 VSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 21 11221 258999999999999999887
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.13 E-value=1.7e-10 Score=119.97 Aligned_cols=143 Identities=24% Similarity=0.397 Sum_probs=104.7
Q ss_pred EeCeeeeccceEEEEEEEecCCccCcEEEEEEec--CCCcCCHHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeeC---C
Q 007253 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIP--KHKMTTAIAIEDVRREVKILRALTG-HNNLVKFFDAYEDT---D 232 (611)
Q Consensus 159 ~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~--~~~~~~~~~~~~~~~E~~~l~~l~~-h~~iv~l~~~~~~~---~ 232 (611)
..+.|+.|.++.||++... +..+++|+.. .... ......+.+|+.+++.|.. +..+.+++.++.+. +
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-----~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g 114 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-----GQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIG 114 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-----SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTS
T ss_pred eEEEcCCcccceEEEEEEC-----CceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccC
Confidence 3567899999999998742 4578899875 3221 1123467899999999974 34578899888776 4
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL---------------------------------- 278 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~---------------------------------- 278 (611)
..|+||||++|..+.+. ....++......++.+++..|..||+
T Consensus 115 ~~~~vme~v~G~~l~~~---~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (359)
T 3dxp_A 115 RAFYIMEFVSGRVLWDQ---SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET 191 (359)
T ss_dssp SCEEEEECCCCBCCCCT---TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred CeEEEEEecCCeecCCC---ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence 58999999998776431 12347888899999999999999997
Q ss_pred ------------------------cCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 279 ------------------------QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 279 ------------------------~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.++||+|+++.|||+..++ ...+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~-~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTE-PRVLAVLDWELSTL 248 (359)
T ss_dssp SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSS-SCEEEECCCTTCEE
T ss_pred cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCC-CcEEEEECcccccc
Confidence 3589999999999995321 13578999998764
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A | Back alignment and structure |
|---|
Probab=99.13 E-value=1.1e-10 Score=106.51 Aligned_cols=109 Identities=14% Similarity=0.114 Sum_probs=86.1
Q ss_pred hhhhcchhhHHHHH--------HHHhhhcCCCCCCcccHHHHHHHHHhhcccccc------cCChhHHHhhcCCCCCCcc
Q 007253 453 ALSKTLTVDELFYL--------KEQYALLEPNKNGTISLENVKSALMKNATDAMK------DSRIPDFLSSLNSLQYRRM 518 (611)
Q Consensus 453 ~~~~~l~~~e~~~l--------~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~------~~~~~~~~~~~D~~~~g~i 518 (611)
.++..++..++..+ ..+|..+|.+++|.|+++||..++......... ...+..+|..+|.|++|.|
T Consensus 36 ~~g~~~~~~~~~~l~~~~~~~~~~~f~~~D~d~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i 115 (166)
T 3akb_A 36 EFGVAARSDRGQALYGGAEALWQGLAGIADRDGDQRITREEFVTGAVKRLRDKPDRFAEMARPFLHAALGVADTDGDGAV 115 (166)
T ss_dssp HHTCCTTSHHHHHHHHHHHHHHHHHHHHHCTTSSSCEEHHHHHHTHHHHHHHSHHHHHHHHHHHHHHHHHHHCSSSSSCC
T ss_pred HcCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhccCccchHHHHHHHHHHHHHHhCCCCCCcC
Confidence 33445555555554 488999999999999999999987665431100 2237889999999999999
Q ss_pred cHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHh
Q 007253 519 DFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASEL 567 (611)
Q Consensus 519 ~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l 567 (611)
+++||..++.... .. ++++..+|+.+|.|++|.|+.+||..++
T Consensus 116 ~~~E~~~~l~~~~--~~----~~~~~~~~~~~D~d~dg~i~~~ef~~~~ 158 (166)
T 3akb_A 116 TVADTARALTAFG--VP----EDLARQAAAALDTDGDGKVGETEIVPAF 158 (166)
T ss_dssp BHHHHHHHHHHTT--CC----HHHHHHHHHHHCTTCSSBCCHHHHHHHH
T ss_pred CHHHHHHHHHHhC--CC----HHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 9999998886654 22 5678899999999999999999999987
|
| >1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A | Back alignment and structure |
|---|
Probab=99.13 E-value=6.8e-11 Score=110.79 Aligned_cols=104 Identities=13% Similarity=0.186 Sum_probs=85.1
Q ss_pred HHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhH--------Hh
Q 007253 464 FYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQL--------EA 535 (611)
Q Consensus 464 ~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~--------~~ 535 (611)
..+.++|..+|.+++|.|+++||..++...+. .....++..+|..+|.|++|.|+++||..++...... ..
T Consensus 63 ~~~~~~f~~~D~d~~g~i~~~ef~~~~~~~~~-~~~~~~~~~~f~~~D~d~~G~i~~~e~~~~l~~~~~~~g~~~~~~~~ 141 (190)
T 1g8i_A 63 KFATFVFNVFDENKDGRIEFSEFIQALSVTSR-GTLDEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEE 141 (190)
T ss_dssp HHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHH-CCHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGG
T ss_pred HHHHHHHHHHhcCCCCeEeHHHHHHHHHHhcC-CCHHHHHHHHHHhhcCCCCCeECHHHHHHHHHHHHHHhCCccCCccc
Confidence 34889999999999999999999998876654 3556678899999999999999999999887653210 00
Q ss_pred hHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 536 LDRWEQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 536 ~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
....++.+..+|+.+|.|++|.|+.+||.+++.
T Consensus 142 ~~~~~~~~~~~f~~~D~d~dG~i~~~ef~~~~~ 174 (190)
T 1g8i_A 142 ENTPEKRVDRIFAMMDKNADGKLTLQEFQEGSK 174 (190)
T ss_dssp GSSHHHHHHHHHHHHCSSCSSEEEHHHHHHHHH
T ss_pred cccHHHHHHHHHHHhcCCCCCcEeHHHHHHHHH
Confidence 011266789999999999999999999999885
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A | Back alignment and structure |
|---|
Probab=99.13 E-value=8e-11 Score=106.90 Aligned_cols=107 Identities=11% Similarity=0.122 Sum_probs=87.1
Q ss_pred hhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhH
Q 007253 454 LSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQL 533 (611)
Q Consensus 454 ~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~ 533 (611)
++..++..+ +..+|..+|.+++|.|+++||..++............+..+|..+|.|++|.|+.+||..++......
T Consensus 52 ~~~~~~~~~---~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~ 128 (161)
T 3fwb_A 52 LGFELPKRE---ILDLIDEYDSEGRHLMKYDDFYIVMGEKILKRDPLDEIKRAFQLFDDDHTGKISIKNLRRVAKELGET 128 (161)
T ss_dssp TTCCCCHHH---HHHHHHHHCTTSSSCEEHHHHHHHHHHHHHTCCHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCC
T ss_pred cCCCCCHHH---HHHHHHHhCcCCCCeEeHHHHHHHHHHHHhcCCcHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHhCCC
Confidence 344445544 77889999999999999999999886654333345568889999999999999999999988765433
Q ss_pred HhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHh
Q 007253 534 EALDRWEQHARCAYELFEKDGNRAIVIEELASEL 567 (611)
Q Consensus 534 ~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l 567 (611)
.. ++++..+|+.+|.|++|.|+.+||.+++
T Consensus 129 ~~----~~~~~~~~~~~d~~~~g~i~~~eF~~~~ 158 (161)
T 3fwb_A 129 LT----DEELRAMIEEFDLDGDGEINENEFIAIC 158 (161)
T ss_dssp CC----HHHHHHHHHTTCSSSSSSEEHHHHHHHH
T ss_pred CC----HHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 33 6678999999999999999999999876
|
| >1wy9_A Allograft inflammatory factor 1; EF-hand, calucium binding, metal binding protein; 2.10A {Mus musculus} PDB: 2g2b_A | Back alignment and structure |
|---|
Probab=99.13 E-value=3.7e-11 Score=108.05 Aligned_cols=89 Identities=16% Similarity=0.215 Sum_probs=74.4
Q ss_pred hhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHH
Q 007253 460 VDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRW 539 (611)
Q Consensus 460 ~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~ 539 (611)
.++..+++++|..+|.|++|+|+.+||..+|...+. .+++.++..+|..+|.|++|.|+|+||+.++....
T Consensus 44 ~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~g~-~~~~~~~~~l~~~~D~d~dg~I~~~eF~~~~~~~~-------- 114 (147)
T 1wy9_A 44 PSKLEAFKVKYMEFDLNGNGDIDIMSLKRMLEKLGV-PKTHLELKRLIREVSSGSEETFSYSDFLRMMLGKR-------- 114 (147)
T ss_dssp HHHHHHHHHHHTTSCCCTTSSEEHHHHHHHHHHTTC-CCCHHHHHHHHHHHCSSCTTEECHHHHHHHHCSSG--------
T ss_pred HHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHhH--------
Confidence 577889999999999999999999999999987764 57788899999999999999999999999887641
Q ss_pred HHHHHHHHhHHhcCCCCcc
Q 007253 540 EQHARCAYELFEKDGNRAI 558 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~I 558 (611)
+.+..+|+.||.|++|..
T Consensus 115 -~~~~~aF~~~D~d~~g~~ 132 (147)
T 1wy9_A 115 -SAILRMILMYEEKNKEHK 132 (147)
T ss_dssp -GGGGGGGGGCCCC-----
T ss_pred -HHHHHHHHHHccCCCCCC
Confidence 246679999999999984
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} | Back alignment and structure |
|---|
Probab=99.13 E-value=1.4e-10 Score=108.70 Aligned_cols=96 Identities=9% Similarity=0.088 Sum_probs=78.8
Q ss_pred HHHHhhhcCCCCCCcccHHHHHHHHHhhcc--------cccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhH
Q 007253 466 LKEQYALLEPNKNGTISLENVKSALMKNAT--------DAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALD 537 (611)
Q Consensus 466 l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~--------~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~ 537 (611)
+..+|..+|.|++|.|+++||..++..... .......+..+|..+|.|++|.|+++||..++.... ..
T Consensus 66 ~~~~~~~~D~d~dG~i~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~I~~~E~~~~l~~~g--~~-- 141 (191)
T 2ccm_A 66 WDGLRKYADENEDEQVTKEEWLKMWAECVKSVEKGESLPEWLTKYMNFMFDVNDTSGDNIIDKHEYSTVYMSYG--IP-- 141 (191)
T ss_dssp HHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHCTTCSSBCCHHHHHHHHHTTT--CC--
T ss_pred HHHHHHhcCCCCCCeECHHHHHHHHHHHhccccchhhchHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhC--CC--
Confidence 345669999999999999999998866532 112234577899999999999999999999886654 22
Q ss_pred HHHHHHHHHHhHHhcCCCCcccHHHHHHHh
Q 007253 538 RWEQHARCAYELFEKDGNRAIVIEELASEL 567 (611)
Q Consensus 538 ~~~~~~~~~F~~~D~d~~G~It~eEl~~~l 567 (611)
++++..+|+.+|.|++|.|+.+||.+++
T Consensus 142 --~~~~~~~~~~~D~d~dG~i~~~Ef~~~~ 169 (191)
T 2ccm_A 142 --KSDCDAAFDTLSDGGKTMVTREIFARLW 169 (191)
T ss_dssp --HHHHHHHHHHHTTTTTSCCBHHHHHHHH
T ss_pred --HHHHHHHHHHhCCCCCCCcCHHHHHHHH
Confidence 5578899999999999999999999987
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=99.12 E-value=7.1e-11 Score=104.95 Aligned_cols=107 Identities=8% Similarity=0.105 Sum_probs=85.4
Q ss_pred hhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhh
Q 007253 453 ALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQ 532 (611)
Q Consensus 453 ~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~ 532 (611)
.+...++..+ +..+|..+|.+++|.|+++||..++............+..+|..+|.|++|.|+.+||..++.....
T Consensus 34 ~~~~~~~~~~---~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~ 110 (142)
T 2bl0_C 34 QFGVRVEPAA---FNEMFNEADATGNGKIQFPEFLSMMGRRMKQTTSEDILRQAFRTFDPEGTGYIPKAALQDALLNLGD 110 (142)
T ss_dssp HHTCCCCHHH---HHHHHHHHCTTCSSEEEHHHHHHHHHHHHTTCCCHHHHHHHHHHTCCSSCSCEEHHHHHHHHHHSSS
T ss_pred HhCCCCCHHH---HHHHHHHhCcCCCCeeeHHHHHHHHHHHhcCCChHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCC
Confidence 3444455444 7788999999999999999999988664332334556888999999999999999999998865543
Q ss_pred HHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHh
Q 007253 533 LEALDRWEQHARCAYELFEKDGNRAIVIEELASEL 567 (611)
Q Consensus 533 ~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l 567 (611)
... ++++..+|+.+| |++|.|+.+||.+++
T Consensus 111 ~~~----~~~~~~~~~~~d-~~dg~i~~~eF~~~~ 140 (142)
T 2bl0_C 111 RLK----PHEFAEFLGITE-TEKGQIRYDNFINTM 140 (142)
T ss_dssp CCC----HHHHHHHHHHHC-CSSSEECSHHHHTTT
T ss_pred CCC----HHHHHHHHHHhC-CCCCcEeHHHHHHHH
Confidence 333 567889999999 999999999998876
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A | Back alignment and structure |
|---|
Probab=99.12 E-value=9.4e-11 Score=104.58 Aligned_cols=107 Identities=11% Similarity=0.124 Sum_probs=86.3
Q ss_pred hhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhH
Q 007253 454 LSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQL 533 (611)
Q Consensus 454 ~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~ 533 (611)
+...++..+ +..+|..+|.+++|.|+++||..++............+..+|..+|.|++|.|+.+||..++......
T Consensus 40 ~~~~~~~~~---~~~l~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~ 116 (147)
T 4ds7_A 40 LGLSPSEAE---VADLMNEIDVDGNHAIEFSEFLALMSRQLKCNDSEQELLEAFKVFDKNGDGLISAAELKHVLTSIGEK 116 (147)
T ss_dssp TTCCCCHHH---HHHHHHHHCTTSSSEEEHHHHHHHHHHHHHTHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCC
T ss_pred hCCCCCHHH---HHHHHHHhccCCCCcCcHHHHHHHHHHhccCCCcHHHHHHHHHHhCCCCCCeECHHHHHHHHHHcCCC
Confidence 333444444 77888999999999999999999886654333445678889999999999999999999988765433
Q ss_pred HhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 534 EALDRWEQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 534 ~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
.. ++++..+|+.+| |++|.|+.+||.+++.
T Consensus 117 ~~----~~~~~~~~~~~d-~~dg~i~~~eF~~~l~ 146 (147)
T 4ds7_A 117 LT----DAEVDEMLREVS-DGSGEINIKQFAALLS 146 (147)
T ss_dssp CC----HHHHHHHHHHHS-SSCSSEEHHHHHHHTT
T ss_pred CC----HHHHHHHHHHhc-CCCCcCcHHHHHHHHh
Confidence 33 567889999999 9999999999998863
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A | Back alignment and structure |
|---|
Probab=99.12 E-value=1e-10 Score=108.48 Aligned_cols=100 Identities=12% Similarity=0.179 Sum_probs=83.1
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHH
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHAR 544 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~ 544 (611)
++..+|..+|.+++|.|+++||..++............+..+|..+|.|++|.|+.+||..++........ ++++.
T Consensus 48 ~~~~l~~~~D~~~~g~i~~~EF~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~g~~~~----~~~~~ 123 (179)
T 2f2o_A 48 ELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLT----DEEVD 123 (179)
T ss_dssp HHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHC--CCC----HHHHH
T ss_pred HHHHHHHHhccCCCCCCcHHHHHHHHHHHccCcccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCC----HHHHH
Confidence 37789999999999999999999987665432334456888999999999999999999998866543333 56788
Q ss_pred HHHhHHhcCCCCcccHHHHHHHhc
Q 007253 545 CAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 545 ~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
.+|+.+|.|++|.|+.+||..++.
T Consensus 124 ~~~~~~D~~~dg~i~~~eF~~~~~ 147 (179)
T 2f2o_A 124 EMIREADIDGDGQVNYEEFVQMMT 147 (179)
T ss_dssp HHHHHHCTTCSSSEEHHHHHHHSC
T ss_pred HHHHHcCCCCCCcCcHHHHHHHHH
Confidence 999999999999999999999994
|
| >2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A | Back alignment and structure |
|---|
Probab=99.12 E-value=3.7e-11 Score=108.49 Aligned_cols=89 Identities=18% Similarity=0.271 Sum_probs=70.0
Q ss_pred hhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHH
Q 007253 460 VDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRW 539 (611)
Q Consensus 460 ~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~ 539 (611)
.++..+++++|..+|.|++|+|+.+||..+|..++. ..++.++..++..+|.|++|.|+|+||+.++....
T Consensus 46 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~~~~e~~~l~~~~D~d~dg~I~~~eF~~~~~~~~-------- 116 (150)
T 2jjz_A 46 PEKLTAFKEKYMEFDLNNEGEIDLMSLKRMMEKLGV-PKTHLEMKKMISEVTGGVSDTISYRDFVNMMLGKR-------- 116 (150)
T ss_dssp HHHHHHHHHHHTTSCCCTTSSBCHHHHHHHHHHTTC-CCCHHHHHHHHHHHHTTSCSSBCHHHHHHHHHSSS--------
T ss_pred HHHHHHHHHHHHHhCCCCcCcCCHHHHHHHHHHcCC-CCCHHHHHHHHHHHCCCCCCcEeHHHHHHHHHHhH--------
Confidence 566788999999999999999999999999987764 57778899999999999999999999999886541
Q ss_pred HHHHHHHHhHHhcCCCCcc
Q 007253 540 EQHARCAYELFEKDGNRAI 558 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~I 558 (611)
..+..+|+.||.|++|+.
T Consensus 117 -~~i~~aF~~~D~d~~G~~ 134 (150)
T 2jjz_A 117 -SAVLKLVMMFEGKANESS 134 (150)
T ss_dssp -CCHHHHHHC---------
T ss_pred -HHHHHHHHHHcCCCCCCC
Confidence 247789999999999984
|
| >2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A | Back alignment and structure |
|---|
Probab=99.11 E-value=6.6e-11 Score=95.68 Aligned_cols=75 Identities=15% Similarity=0.220 Sum_probs=64.9
Q ss_pred hhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchh
Q 007253 455 SKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVH 531 (611)
Q Consensus 455 ~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~ 531 (611)
+..+++++..+++++|..+|.+++|+|+.+||..++...+ ..++.++..++..+|.|++|.|+|+||+.++....
T Consensus 2 ~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g--~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~~ 76 (86)
T 2opo_A 2 AAEDTPQDIADRERIFKRFDTNGDGKISSSELGDALKTLG--SVTPDEVRRMMAEIDTDGDGFISFDEFTDFARANR 76 (86)
T ss_dssp ----CHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTT--TCCHHHHHHHHHHHCTTCSSEECHHHHHHHHHHCT
T ss_pred CccCCHhhHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHcC--CCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHCc
Confidence 4567888999999999999999999999999999998776 57788899999999999999999999999876543
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A | Back alignment and structure |
|---|
Probab=99.11 E-value=1.2e-10 Score=104.24 Aligned_cols=109 Identities=10% Similarity=0.110 Sum_probs=84.6
Q ss_pred HhhhhcchhhHHHHHHHHhhhc-CCCCCCcccHHHHHHHHHhh--c---ccccccCChhHHHhhcCCCCCCcccHHHHHH
Q 007253 452 RALSKTLTVDELFYLKEQYALL-EPNKNGTISLENVKSALMKN--A---TDAMKDSRIPDFLSSLNSLQYRRMDFEEFCA 525 (611)
Q Consensus 452 ~~~~~~l~~~e~~~l~~~F~~~-D~d~~G~Is~~e~~~~l~~~--~---~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~ 525 (611)
..++..++..+ +..+|..+ |.+++|.|+++||..++... . ........+..+|..+|.|++|.|+.+||..
T Consensus 31 ~~~g~~~~~~~---~~~l~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~ 107 (148)
T 1m45_A 31 RAIGYNPTNQL---VQDIINADSSLRDASSLTLDQITGLIEVNEKELDATTKAKTEDFVKAFQVFDKESTGKVSVGDLRY 107 (148)
T ss_dssp HHTTCCCCHHH---HHHHHHC--CC--CCEEEHHHHHHHHHHTHHHHHGGGCCCTHHHHHHHHTTCSSSSSEEEHHHHHH
T ss_pred HHhCCCCCHHH---HHHHHHHhhCCCCCCeEcHHHHHHHHHHHHhhccccccccHHHHHHHHHHhCCCCCCcCCHHHHHH
Confidence 34444455544 77889999 99999999999999988665 1 2233445688999999999999999999999
Q ss_pred HHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHh
Q 007253 526 AALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASEL 567 (611)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l 567 (611)
++........ ++++..+|+.+|.|++|.|+.+||..++
T Consensus 108 ~l~~~g~~~~----~~~~~~~~~~~d~d~dg~i~~~eF~~~~ 145 (148)
T 1m45_A 108 MLTGLGEKLT----DAEVDELLKGVEVDSNGEIDYKKFIEDV 145 (148)
T ss_dssp HHHHSTTCCC----HHHHHHHHTTCCCCTTSEEEHHHHHHHH
T ss_pred HHHHcCCCCC----HHHHHHHHHHhCCCCCCeEeHHHHHHHH
Confidence 8876543333 5678899999999999999999999877
|
| >3nso_A Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, metal binding protein; 1.45A {Homo sapiens} SCOP: a.39.1.2 PDB: 3nsi_A 1kso_A 3nsk_A 3nsl_A | Back alignment and structure |
|---|
Probab=99.11 E-value=1.6e-10 Score=96.17 Aligned_cols=64 Identities=14% Similarity=0.257 Sum_probs=55.6
Q ss_pred HHHHHHHHhHHh-cCCC-CcccHHHHHHHhc------CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 540 EQHARCAYELFE-KDGN-RAIVIEELASELG------LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 540 ~~~~~~~F~~~D-~d~~-G~It~eEl~~~l~------~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
.+.++.+|+.|| +||+ |+|+.+||+++|. ++...+ ++++|+.+|.|+||.|+|+||+.+|..++
T Consensus 9 i~~l~~aF~~fd~~dg~~G~Is~~EL~~~l~~~l~~~lg~~~~~~ev~~~i~~~D~dgDG~Idf~EF~~~~~~~~ 83 (101)
T 3nso_A 9 VAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFVEYVRSLACLC 83 (101)
T ss_dssp HHHHHHHHHHHHTTSSCTTEECHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHCCCSCEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhcCCCCCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHH
Confidence 567899999998 8997 9999999999994 344433 89999999999999999999999998764
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* | Back alignment and structure |
|---|
Probab=99.10 E-value=1.7e-10 Score=103.98 Aligned_cols=104 Identities=12% Similarity=0.136 Sum_probs=81.4
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcch-hhHHhhHHHHHHH
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV-HQLEALDRWEQHA 543 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~-~~~~~~~~~~~~~ 543 (611)
.+.++|..+|.+++|.|+++||..++............+..+|..+|.|++|.|+.+||..++... ..........+.+
T Consensus 39 ~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~ 118 (155)
T 3ll8_B 39 LVQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIV 118 (155)
T ss_dssp THHHHHHHHCTTCSSSBCHHHHHHHHGGGCSSCCHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHGGGSCHHHHHHHH
T ss_pred HHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhccCCCHHHHHHHH
Confidence 577899999999999999999999886654433445668899999999999999999999888663 3333322223444
Q ss_pred HHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 544 RCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 544 ~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
..+|+.+|.|++|.|+.+||..++.
T Consensus 119 ~~~~~~~D~~~dg~i~~~eF~~~~~ 143 (155)
T 3ll8_B 119 DKTIINADKDGDGRISFEEFCAVVG 143 (155)
T ss_dssp HHHHHHHCTTSSSSBCHHHHHHHHG
T ss_pred HHHHHHhCCCCCCcCcHHHHHHHHh
Confidence 4455559999999999999999984
|
| >3ohm_B 1-phosphatidylinositol-4,5-bisphosphate phosphodi beta-3; PH domain, EF hand, TIM barrel, C2 domain, GTPase, lipase, C binding, GTP binding; HET: GDP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.10 E-value=1.2e-10 Score=131.57 Aligned_cols=126 Identities=16% Similarity=0.248 Sum_probs=104.7
Q ss_pred HHHHHHHhhh--cCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCC-------CCCcccHHHHHHHHcchhhH
Q 007253 463 LFYLKEQYAL--LEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSL-------QYRRMDFEEFCAAALSVHQL 533 (611)
Q Consensus 463 ~~~l~~~F~~--~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~-------~~g~i~~~eF~~~~~~~~~~ 533 (611)
...|+++|.. +|.|++|+|+..|+..+|.. ...++..+|..+|.+ ++|.|+|+||+.++.....
T Consensus 149 ~~~L~kaf~~~~~D~n~dGkIs~kel~~~l~~------~~~~v~~l~~~~d~~~~~~d~~~~g~i~feEF~~f~~~l~~- 221 (885)
T 3ohm_B 149 NTFLRKAYTKLKLQVNQDGRIPVKNILKMFSA------DKKRVETALESCGLKFNRSESIRPDEFSLEIFERFLNKLCL- 221 (885)
T ss_dssp HHHHHHHHHHHHHSCCTTSCEEHHHHHHTTGG------GHHHHHHHHHTTTCCCSTTCEECGGGCCHHHHHHHHHHHSC-
T ss_pred HHHHHHHHHHhcCccCCCCccCHHHHHHHHhc------CHHHHHHHHHHhCCCccccccCCCCcCCHHHHHHHHHhcCC-
Confidence 4578899998 89999999999999887643 234678889888876 7899999999998865432
Q ss_pred HhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc--CCCC---------cc---HHHHHHHHhcC----CCCceeHHHH
Q 007253 534 EALDRWEQHARCAYELFEKDGNRAIVIEELASELG--LGPA---------VP---VHAVLHDWIRH----TDGKLSFLGF 595 (611)
Q Consensus 534 ~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~--~~~~---------~~---~~~~~~~~D~~----~dG~is~~eF 595 (611)
..+++.+|+.||.+++|+||.+||+++|. .+.. .+ +.+||+.++.+ ++|.|++++|
T Consensus 222 ------R~EI~eiF~~ydsd~~g~mT~~EL~~FL~~~Q~e~~~~e~~~~~~t~e~~~~iI~k~e~~~~~~~~g~LsldgF 295 (885)
T 3ohm_B 222 ------RPDIDKILLEIGAKGKPYLTLEQLMDFINQKQRDPRLNEVLYPPLRPSQARLLIEKYEPNQQFLERDQMSMEGF 295 (885)
T ss_dssp ------CHHHHHHHHHTTCCSTTCEEHHHHHHHHHHHSSCTTSCTTTSCCCCHHHHHHHHHHHCCCHHHHHTTEECHHHH
T ss_pred ------HHHHHHHHHHHhcCCCCccCHHHHHHHHHHhcCcccccccccccCCHHHHHHHHHHhcCChhhhccCccchhhh
Confidence 34689999999999999999999999994 2221 22 88899999998 8999999999
Q ss_pred HHHHhh
Q 007253 596 VKLLHG 601 (611)
Q Consensus 596 ~~~l~~ 601 (611)
..+|..
T Consensus 296 ~~yL~S 301 (885)
T 3ohm_B 296 SRYLGG 301 (885)
T ss_dssp HHHHTS
T ss_pred hhhccC
Confidence 999975
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... | Back alignment and structure |
|---|
Probab=99.10 E-value=1.8e-10 Score=104.61 Aligned_cols=108 Identities=14% Similarity=0.207 Sum_probs=85.9
Q ss_pred hhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhccccc---ccCChhHHHhhcCCCCCCcccHHHHHHHHcch
Q 007253 454 LSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAM---KDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV 530 (611)
Q Consensus 454 ~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~---~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~ 530 (611)
+...++..+ +..+|..+|.+++|.|+++||..++........ ....+..+|..+|.|++|.|+.+||..++...
T Consensus 49 ~~~~~~~~~---~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~e~~~~l~~~ 125 (162)
T 1top_A 49 LGQNPTKEE---LDAIIEEVDEDGSGTIDFEEFLVMMVRQMKEDAKGKSEEELANCFRIFDKNADGFIDIEELGEILRAT 125 (162)
T ss_dssp TTCCCCHHH---HHHHHHHHCTTSCCEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHTT
T ss_pred cCCCCCHHH---HHHHHHHHcCCCCCcEeHHHHHHHHHHHhccccccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHh
Confidence 333444444 678899999999999999999998765432212 34567889999999999999999999988765
Q ss_pred hhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 531 HQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 531 ~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
..... ++++..+|+.+|.|++|.|+.+||..++.
T Consensus 126 g~~~~----~~~~~~~~~~~d~~~dg~i~~~eF~~~~~ 159 (162)
T 1top_A 126 GEHVT----EEDIEDLMKDSDKNNDGRIDFDEFLKMME 159 (162)
T ss_dssp TCCCC----HHHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred CCCCC----HHHHHHHHHHhCCCCCCcCcHHHHHHHHh
Confidence 43333 56788999999999999999999999873
|
| >2kld_A Polycystin-2; PC2, PKD2, calcium binding domain, EF hand, cytosolic, calcium, coiled coil, disease mutation, glycoprotein, ION transport; NMR {Homo sapiens} PDB: 2kle_A 2kq6_A 2y4q_A | Back alignment and structure |
|---|
Probab=99.09 E-value=7.4e-12 Score=108.88 Aligned_cols=102 Identities=11% Similarity=0.099 Sum_probs=50.3
Q ss_pred HHhhcccccccCChhHHHhhcCCCCCCcccHHHHHH-----HHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHH
Q 007253 490 LMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCA-----AALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELA 564 (611)
Q Consensus 490 l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~-----~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~ 564 (611)
|..++. ++++.++..++..+ +|.|+|+||+. ++........ ..++++.+|+.|| |+|+.+||+
T Consensus 2 lr~lG~-~~t~~ei~~~~~~~----~g~i~f~EF~~~~~~~~~~~~~~~~~---~~~~l~~aF~~fD----G~I~~~El~ 69 (123)
T 2kld_A 2 STAIGI-NDTYSEVKSDLAQQ----KAEMELSDLIRKGYHKALVKLKLKKN---TVDDISESLRQGG----GKLNFDELR 69 (123)
T ss_dssp ---------------------------------------------------------CCSCSSTTTT----TCEEHHHHH
T ss_pred hhhcCC-CCCHHHHHHHHHHc----CCCccHHHHHhHhHHHHHHHhhcChh---HHHHHHHHHHHhC----CCCCHHHHH
Confidence 334443 67888898888876 78999999998 5543321111 1456788999998 999999999
Q ss_pred HHhc-CCCC-ccHHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 565 SELG-LGPA-VPVHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 565 ~~l~-~~~~-~~~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
.+|. +|.. ..++.+|+.+|.|+||.|+|+||+.+|..+.
T Consensus 70 ~~l~~lG~t~~ei~~~~~~~D~d~dG~I~~~EF~~~~~~~~ 110 (123)
T 2kld_A 70 QDLKGKGHTDAEIEAIFTKYDQDGDQELTEHEHQQMRDDLE 110 (123)
T ss_dssp HHTTTCCSSHHHHHHHHHHHSSSSCCEECSHHHHHCSCTTT
T ss_pred HHHHHhCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHH
Confidence 9995 5642 2289999999999999999999999987654
|
| >3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C | Back alignment and structure |
|---|
Probab=99.09 E-value=3.4e-11 Score=107.75 Aligned_cols=102 Identities=17% Similarity=0.057 Sum_probs=50.5
Q ss_pred HHHHhhhcCCCCCCcccHHHHHHHHHhhccc----ccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhh--------H
Q 007253 466 LKEQYALLEPNKNGTISLENVKSALMKNATD----AMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQ--------L 533 (611)
Q Consensus 466 l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~----~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~--------~ 533 (611)
-..+|..+|.|++|.|+++||..++...... ...++++..+|+.+|.|++|.|+++||..++..... .
T Consensus 29 ~~~~f~~~D~d~dG~I~~~Ef~~~l~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~g~~ 108 (143)
T 3a4u_B 29 SFSQPGSMGLDKNTVHDQEHIMEHLEGVINKPEAEMSPQELQLHYFKMHDYDGNNLLDGLELSTAITHVHKEEGSEQAPL 108 (143)
T ss_dssp ----------------------------------CCCHHHHHHHHHHHTCTTCSSCEEHHHHHHTCC-------------
T ss_pred CHHHHHHhCCCCCCcCcHHHHHHHHHHHhcccccccCHHHHHHHHHHHhCCCCCCccCHHHHHHHHHHHHhhhccccCCC
Confidence 3468999999999999999999987655321 112345778899999999999999999988766531 1
Q ss_pred HhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHh
Q 007253 534 EALDRWEQHARCAYELFEKDGNRAIVIEELASEL 567 (611)
Q Consensus 534 ~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l 567 (611)
...+...+.+..+|+.+|.|++|.|+.+||..++
T Consensus 109 ~s~~e~~~~~~~~f~~~D~d~dG~Is~~EF~~~~ 142 (143)
T 3a4u_B 109 MSEDELINIIDGVLRDDDKNNDGYIDYAEFAKSL 142 (143)
T ss_dssp CCHHHHHHHHHHHHHHHCTTCSSEECHHHHHC--
T ss_pred CCHHHHHHHHHHHHHHcCCCCCCcEeHHHHHHHH
Confidence 2222334455778899999999999999998765
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.09 E-value=1.4e-10 Score=109.94 Aligned_cols=111 Identities=14% Similarity=0.145 Sum_probs=85.5
Q ss_pred hhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhH
Q 007253 454 LSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQL 533 (611)
Q Consensus 454 ~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~ 533 (611)
++..++..+ +..+|..+|.+++|.|+++||..++..... ......+..+|..+|.|++|.|+++||..++......
T Consensus 66 ~~~~~~~~~---~~~~~~~~D~d~dg~i~~~ef~~~~~~~~~-~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~ 141 (204)
T 3e3r_A 66 LGLVLDQAE---AEGVCRKWDRNGSGTLDLEEFLRALRPPMS-QAREAVIAAAFAKLDRSGDGVVTVDDLRGVYSGRAHP 141 (204)
T ss_dssp TTCCCCHHH---HHHHHHHHCTTCSSSBCHHHHHHHTSCCCC-HHHHHHHHHHHHHHCTTCSSEECHHHHHHHCCCTTCH
T ss_pred cCCCCCHHH---HHHHHHHhccCCCCcCcHHHHHHHHHhhcC-chHHHHHHHHHHHhCcCCCCeEeHHHHHHHHccccCC
Confidence 334445444 788899999999999999999998754433 2345568899999999999999999999988753211
Q ss_pred H---hhHHHHHHHHHHHhHHhc-CCCCcccHHHHHHHhc
Q 007253 534 E---ALDRWEQHARCAYELFEK-DGNRAIVIEELASELG 568 (611)
Q Consensus 534 ~---~~~~~~~~~~~~F~~~D~-d~~G~It~eEl~~~l~ 568 (611)
. .....++.+..+|+.+|. |++|.|+.+||..++.
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~D~~d~dg~Is~~EF~~~~~ 180 (204)
T 3e3r_A 142 KVRSGEWTEDEVLRRFLDNFDSSEKDGQVTLAEFQDYYS 180 (204)
T ss_dssp HHHTTSSCHHHHHHHHHHHHSCSSCCSCEEHHHHHHHHH
T ss_pred ccccCCCChHHHHHHHHHHhhccCCCCcCcHHHHHHHHH
Confidence 0 001125678999999998 9999999999999884
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A | Back alignment and structure |
|---|
Probab=99.07 E-value=2e-10 Score=111.22 Aligned_cols=104 Identities=16% Similarity=0.107 Sum_probs=83.6
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcch----hhHHhhHHHH
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV----HQLEALDRWE 540 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~----~~~~~~~~~~ 540 (611)
.+.++|..+|.|++|.|+++||..++...........++..+|..+|.|++|.|+++||..++... ......+..+
T Consensus 86 ~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~g~~~~~~~~~ 165 (226)
T 2zfd_A 86 FADRVFDLFDTKHNGILGFEEFARALSVFHPNAPIDDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIE 165 (226)
T ss_dssp HHHHHHHHHCSSCSSSBCHHHHHHHHHHTSTTSCHHHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHH
T ss_pred HHHHHHHHHcCCCCCcCcHHHHHHHHHHHccCCCHHHHHHHHHHHhCCCCCCcccHHHHHHHHHHHHHHcCCCCCHHHHH
Confidence 467799999999999999999999887665433445668899999999999999999999887522 1112222335
Q ss_pred HHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 541 QHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 541 ~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
+.+..+|+.+|.|++|.|+.+||..++.
T Consensus 166 ~~~~~~f~~~D~d~dG~I~~~EF~~~~~ 193 (226)
T 2zfd_A 166 DIIDKTFEEADTKHDGKIDKEEWRSLVL 193 (226)
T ss_dssp HHHHHHHHHHCSSCSSEECHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 5678899999999999999999999984
|
| >5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=99.07 E-value=1.7e-10 Score=97.84 Aligned_cols=101 Identities=14% Similarity=0.175 Sum_probs=80.2
Q ss_pred hhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcch---h
Q 007253 455 SKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV---H 531 (611)
Q Consensus 455 ~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~---~ 531 (611)
+..++.++ ++++|..+|. +|.|+++||..++... .....++..+|..+|.|++|.|+.+||..++... .
T Consensus 3 ~~~~s~~e---i~~~~~~~d~--~g~i~~~eF~~~~~~~---~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~g 74 (109)
T 5pal_A 3 TKVLKADD---INKAISAFKD--PGTFDYKRFFHLVGLK---GKTDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHG 74 (109)
T ss_dssp GGTSCHHH---HHHHHHHTCS--TTCCCHHHHHHHHTCT---TCCHHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTC
T ss_pred CCcCCHHH---HHHHHHHhCC--CCcCcHHHHHHHHhhc---cCcHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHHHcC
Confidence 44556666 6777788886 8999999999976432 2344568899999999999999999998877654 3
Q ss_pred hHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHh
Q 007253 532 QLEALDRWEQHARCAYELFEKDGNRAIVIEELASEL 567 (611)
Q Consensus 532 ~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l 567 (611)
.... +++++.+|+.+|.|++|.|+.+||..++
T Consensus 75 ~~~~----~~~~~~~~~~~D~~~dg~i~~~eF~~~~ 106 (109)
T 5pal_A 75 RDLN----DTETKALLAAGDSDHDGKIGADEFAKMV 106 (109)
T ss_dssp CCCC----HHHHHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred CCCC----HHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 2233 5678899999999999999999999876
|
| >1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.07 E-value=2.6e-11 Score=98.31 Aligned_cols=81 Identities=12% Similarity=0.198 Sum_probs=62.7
Q ss_pred CCCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCC
Q 007253 513 LQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDG 588 (611)
Q Consensus 513 ~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG 588 (611)
|++|.|+|+|++ +........ .+.++.+|+.||+|++|+|+.+||+.++. ++...+ ++.++..+|.|+||
T Consensus 1 ~~~G~i~~~e~~--~~~~l~~~~----~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~~~~g 74 (87)
T 1s6j_A 1 HSSGHIDDDDKH--MAERLSEEE----IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSG 74 (87)
T ss_dssp CCSSSSSSHHHH--SSSSSCSSS----TTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHCTTCSS
T ss_pred CCCCccCccHHH--HHHHCCHHH----HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCC
Confidence 578999999932 222221111 33578899999999999999999999994 554444 88899999999999
Q ss_pred ceeHHHHHHHH
Q 007253 589 KLSFLGFVKLL 599 (611)
Q Consensus 589 ~is~~eF~~~l 599 (611)
.|+|+||+.++
T Consensus 75 ~i~~~eF~~~~ 85 (87)
T 1s6j_A 75 TIDYGEFIAAT 85 (87)
T ss_dssp EECHHHHTTCC
T ss_pred cCcHHHHHHHH
Confidence 99999998765
|
| >2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=99.06 E-value=1.7e-10 Score=107.06 Aligned_cols=111 Identities=12% Similarity=0.153 Sum_probs=90.0
Q ss_pred HHhhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcch
Q 007253 451 LRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV 530 (611)
Q Consensus 451 l~~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~ 530 (611)
+..++..+++.+ +.++|..+|.+++|.|++.||..++.........++++..+|+.+|.|++|.|+.+||..++...
T Consensus 37 l~~lg~~~~~~~---~~~~~~~~d~d~~~~i~~~ef~~~~~~~~~~~~~~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~ 113 (176)
T 2lhi_A 37 MRSLGLSPSEAE---VNDLMNEIDVDGNHQIEFSEFLALMSRQLKSNDSEQELLEAFKVFDKNGDGLISAAELKHVLTSI 113 (176)
T ss_dssp HHHHTCCCCHHH---HHHHHTTTCSSCSSSBCTTHHHHHHTSSCCSSHHHHHHHHHHHHHCSSCSSSBCHHHHHHHHHTT
T ss_pred HHHcCCChhHHH---HHHHHHHhCcCCCccchHHHHHHHHHHhcccCCcHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHc
Confidence 445555566655 67889999999999999999998775544433345668899999999999999999999988776
Q ss_pred hhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhcC
Q 007253 531 HQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELGL 569 (611)
Q Consensus 531 ~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~~ 569 (611)
..... ++++..+|+.+| |+||.|+.+||.++|.-
T Consensus 114 g~~~~----~~ei~~l~~~~d-d~dG~I~~~EF~~~m~k 147 (176)
T 2lhi_A 114 GEKLT----DAEVDDMLREVS-DGSGEINIQQFAALLSK 147 (176)
T ss_dssp TCCCC----HHHHHHHHHHHH-TTSSCBCTTHHHHHHTC
T ss_pred Ccccc----hHHHHHHHHhhc-CCCCeEeHHHHHHHHHh
Confidence 55444 567888999999 99999999999999953
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} | Back alignment and structure |
|---|
Probab=99.05 E-value=1.6e-10 Score=109.29 Aligned_cols=99 Identities=11% Similarity=0.085 Sum_probs=74.1
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcch--hhHHhhHHHHHH
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV--HQLEALDRWEQH 542 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~--~~~~~~~~~~~~ 542 (611)
++..+|..+|.+++|.|+++||..++..... ...++.+..+|..+|.|++|.|+.+||..++... ..... +++
T Consensus 94 ~~~~l~~~~D~d~~g~I~~~EF~~~~~~~~~-~~~~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~~~~----~~~ 168 (197)
T 3pm8_A 94 DIHQVLRDIDSNASGQIHYTDFLAATIDKQT-YLKKEVCLIPFKFFDIDGNGKISVEELKRIFGRDDIENPLI----DKA 168 (197)
T ss_dssp HHHHHHHC-------CEEHHHHHHTTCCHHH-HCSHHHHHHHHHHHCTTCSSEECHHHHHHHHC----CCHHH----HHH
T ss_pred HHHHHHHHhCCCCCCeEcHHHHHHHHHHHHh-hhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCC----HHH
Confidence 4778899999999999999999887644322 2345578899999999999999999999988766 22223 567
Q ss_pred HHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 543 ARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 543 ~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
+..+|+.+|.|++|.|+.+||..+|.
T Consensus 169 ~~~l~~~~D~d~dG~Is~~EF~~~l~ 194 (197)
T 3pm8_A 169 IDSLLQEVDLNGDGEIDFHEFMLMMS 194 (197)
T ss_dssp HHHHHHHHCTTCSSSEEHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCcCcHHHHHHHHH
Confidence 89999999999999999999999885
|
| >1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=99.05 E-value=2e-10 Score=97.30 Aligned_cols=103 Identities=12% Similarity=0.093 Sum_probs=79.9
Q ss_pred hhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcch---
Q 007253 454 LSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV--- 530 (611)
Q Consensus 454 ~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~--- 530 (611)
++..++.++ +.++|..+| ++|.|+++||..++... .....++..+|..+|.|++|.|+.+||..++...
T Consensus 3 lg~~~~~~e---~~~~~~~~d--~~g~i~~~eF~~~~~~~---~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~ 74 (109)
T 1bu3_A 3 FSGILADAD---VAAALKACE--AADSFNYKAFFAKVGLT---AKSADDIKKAFFVIDQDKSGFIEEDELKLFLQVFSAG 74 (109)
T ss_dssp CSCSSCHHH---HHHHHHHTC--STTCCCHHHHHHHHTGG---GSCHHHHHHHHHHHCTTCSSSEEHHHHHTHHHHHSTT
T ss_pred ccccCCHHH---HHHHHHHhC--CCCcCcHHHHHHHHHcC---hhhHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHccc
Confidence 344455555 667777788 88999999999876321 2234567889999999999999999998877655
Q ss_pred hhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 531 HQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 531 ~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
..... ++++..+|+.+|.|++|.|+.+||..++.
T Consensus 75 g~~~~----~~~~~~~~~~~D~~~dg~i~~~eF~~~~~ 108 (109)
T 1bu3_A 75 ARALT----DAETKAFLKAGDSDGDGAIGVDEWAALVK 108 (109)
T ss_dssp CCCCC----HHHHHHHHHHHCTTCSSEECHHHHHHHHT
T ss_pred CCCCC----HHHHHHHHHHhCCCCCCcEeHHHHHHHHh
Confidence 22223 56788999999999999999999998763
|
| >1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A | Back alignment and structure |
|---|
Probab=99.05 E-value=2.3e-10 Score=96.89 Aligned_cols=101 Identities=10% Similarity=0.146 Sum_probs=79.7
Q ss_pred hhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcch---h
Q 007253 455 SKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV---H 531 (611)
Q Consensus 455 ~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~---~ 531 (611)
+..+++++ +.++|..+| ++|.|+++||..++... .....++..+|..+|.|++|.|+.+||..++... .
T Consensus 3 g~~~t~~e---~~~~~~~~d--~~g~i~~~eF~~~~~~~---~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g 74 (109)
T 1rwy_A 3 TDLLSAED---IKKAIGAFT--AADSFDHKKFFQMVGLK---KKSADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDA 74 (109)
T ss_dssp HHHSCHHH---HHHHHHTTC--STTCCCHHHHHHHHTGG---GSCHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTC
T ss_pred CCcCCHHH---HHHHHHHcC--CCCcEeHHHHHHHHhcC---cchHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHhccC
Confidence 34456665 667788888 89999999999876321 2334567889999999999999999998877655 2
Q ss_pred hHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHh
Q 007253 532 QLEALDRWEQHARCAYELFEKDGNRAIVIEELASEL 567 (611)
Q Consensus 532 ~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l 567 (611)
.... ++++..+|+.+|.|++|.|+.+||..++
T Consensus 75 ~~~~----~~~~~~~~~~~D~~~dg~i~~~eF~~~~ 106 (109)
T 1rwy_A 75 RDLS----AKETKTLMAAGDKDGDGKIGVEEFSTLV 106 (109)
T ss_dssp CCCC----HHHHHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred CCCC----HHHHHHHHHHHCCCCCCcCCHHHHHHHH
Confidence 2223 5578899999999999999999999876
|
| >2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A | Back alignment and structure |
|---|
Probab=99.05 E-value=2.7e-10 Score=96.29 Aligned_cols=98 Identities=9% Similarity=0.073 Sum_probs=78.2
Q ss_pred chhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcch---hhHH
Q 007253 458 LTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV---HQLE 534 (611)
Q Consensus 458 l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~---~~~~ 534 (611)
++.++ +.++|..+| ++|.|+++||..++... .....++..+|..+|.|++|.|+.+||..++... ....
T Consensus 6 ~~~~e---~~~l~~~~d--~~g~i~~~eF~~~~~~~---~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~ 77 (108)
T 2pvb_A 6 LKDAD---VAAALAACS--AADSFKHKEFFAKVGLA---SKSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARAL 77 (108)
T ss_dssp SCHHH---HHHHHHHTC--STTCCCHHHHHHHHTGG---GSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCC
T ss_pred CCHHH---HHHHHHHhC--CCCcCcHHHHHHHHhCC---hhHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccCCCC
Confidence 45554 667788888 78999999999876321 2334567889999999999999999999888765 2222
Q ss_pred hhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHh
Q 007253 535 ALDRWEQHARCAYELFEKDGNRAIVIEELASEL 567 (611)
Q Consensus 535 ~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l 567 (611)
. ++++..+|+.+|.|++|.|+.+||..++
T Consensus 78 ~----~~~~~~~~~~~D~~~dg~i~~~eF~~~~ 106 (108)
T 2pvb_A 78 T----DAETKAFLADGDKDGDGMIGVDEFAAMI 106 (108)
T ss_dssp C----HHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred C----HHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 3 5678899999999999999999999876
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A | Back alignment and structure |
|---|
Probab=99.04 E-value=4.3e-10 Score=100.88 Aligned_cols=107 Identities=11% Similarity=0.105 Sum_probs=83.6
Q ss_pred hhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhccccc----ccCChhHHHhhcCCCCCCcccHHHHHHHHcc
Q 007253 454 LSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAM----KDSRIPDFLSSLNSLQYRRMDFEEFCAAALS 529 (611)
Q Consensus 454 ~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~----~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~ 529 (611)
+...++..+ +..+|..+|.+++|.|+++||..++........ ....+..+|..+|.|++|.|+.+||..++..
T Consensus 40 ~~~~~~~~~---~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~ 116 (153)
T 3ox6_A 40 MGYMPTEME---LIELSQQINMNLGGHVDFDDFVELMGPKLLAETADMIGVKELRDAFREFDTNGDGEISTSELREAMRA 116 (153)
T ss_dssp TTCCCCHHH---HHHHHHHHHTTSTTCCCHHHHHHHHHHHHTTCCHHHHCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHH
T ss_pred cCCCCCHHH---HHHHHHHhCCCCCccCcHHHHHHHHHHHhhccccccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence 333445444 677888999999999999999998755432111 1345778999999999999999999998866
Q ss_pred -hhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHh
Q 007253 530 -VHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASEL 567 (611)
Q Consensus 530 -~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l 567 (611)
...... ++++..+|+.+|.|++|.|+.+||..++
T Consensus 117 ~~~~~~~----~~~~~~~~~~~d~~~dg~i~~~eF~~~~ 151 (153)
T 3ox6_A 117 LLGHQVG----HRDIEEIIRDVDLNGDGRVDFEEFVRMM 151 (153)
T ss_dssp HHSSCCC----HHHHHHHHHHHCSSSSSSBCHHHHHHHT
T ss_pred HhcCCCC----HHHHHHHHHHhCCCCCCeEeHHHHHHHH
Confidence 332233 5678899999999999999999999876
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A | Back alignment and structure |
|---|
Probab=99.04 E-value=5e-10 Score=104.78 Aligned_cols=113 Identities=11% Similarity=0.115 Sum_probs=84.9
Q ss_pred HHhhhhcchhhHH--HHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccc-----ccc-CChh----HHHhhcCCCCCCcc
Q 007253 451 LRALSKTLTVDEL--FYLKEQYALLEPNKNGTISLENVKSALMKNATDA-----MKD-SRIP----DFLSSLNSLQYRRM 518 (611)
Q Consensus 451 l~~~~~~l~~~e~--~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~-----~~~-~~~~----~~~~~~D~~~~g~i 518 (611)
+..++...+..+. ..+..+|..+|.+++|.|+++||..++....... ... +.+. .+|..+|.|++|.|
T Consensus 47 l~~~g~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~EF~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I 126 (191)
T 1uhk_A 47 INNLGATPEQAKRHKDAVEAFFGGAGMKYGVETDWPAYIEGWKKLATDELEKYAKNEPTLIRIWGDALFDIVDKDQNGAI 126 (191)
T ss_dssp HHTSCCCHHHHHHHHHHHHHHHHHTTCCTTCEEEHHHHHHHHHHHHHHHHHHHHTTCCCHHHHHHHHHHHHHCTTCSSEE
T ss_pred HHHcCCCchhHHHHHHHHHHHHHHhCcCCCCcCcHHHHHHHHHHHhcchhhhhhhhhHHHHHHHHHHHHHHhcCCCCCcC
Confidence 3344444444432 1588899999999999999999999876543211 112 2233 89999999999999
Q ss_pred cHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHh
Q 007253 519 DFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASEL 567 (611)
Q Consensus 519 ~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l 567 (611)
+.+||..++........ ++++..+|+.+|.|++|.|+.+||..++
T Consensus 127 s~~El~~~l~~~g~~~~----~~~~~~~~~~~D~d~dG~i~~~eF~~~~ 171 (191)
T 1uhk_A 127 TLDEWKAYTKAAGIIQS----SEDCEETFRVCDIDESGQLDVDEMTRQH 171 (191)
T ss_dssp CHHHHHHHHHHHTSCCS----HHHHHHHHHHSCCCTTSCEEHHHHHHHH
T ss_pred cHHHHHHHHHHhCCCCC----HHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 99999988865443223 5678899999999999999999999877
|
| >1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A | Back alignment and structure |
|---|
Probab=99.03 E-value=3.7e-10 Score=95.80 Aligned_cols=103 Identities=15% Similarity=0.197 Sum_probs=80.7
Q ss_pred hhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcch---
Q 007253 454 LSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV--- 530 (611)
Q Consensus 454 ~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~--- 530 (611)
++..++.++ +.++|..+| ++|.|+++||..++. .. .....++..+|..+|.|++|.|+.+||..++...
T Consensus 3 lG~~~t~~e---~~~~~~~~d--~~g~i~~~ef~~~~~-~~--~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~ 74 (110)
T 1pva_A 3 AKDLLKADD---IKKALDAVK--AEGSFNHKKFFALVG-LK--AMSANDVKKVFKAIDADASGFIEEEELKFVLKSFAAD 74 (110)
T ss_dssp HHHHSCHHH---HHHHHHHTC--STTCCCHHHHHHHHT-CT--TSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTT
T ss_pred ccccCCHHH---HHHHHHhcC--CCCcCcHHHHHHHHc-cC--cchHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhhc
Confidence 445566666 667777788 889999999998762 21 2334567889999999999999999999888765
Q ss_pred hhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 531 HQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 531 ~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
..... ++++..+|+.+|.|++|.|+.+||..++.
T Consensus 75 g~~~~----~~~~~~~~~~~d~~~dg~i~~~eF~~~~~ 108 (110)
T 1pva_A 75 GRDLT----DAETKAFLKAADKDGDGKIGIDEFETLVH 108 (110)
T ss_dssp CCCCC----HHHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred CCCCC----HHHHHHHHHHhCCCCCCeEcHHHHHHHHH
Confidence 22223 56788999999999999999999998763
|
| >1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A | Back alignment and structure |
|---|
Probab=99.02 E-value=3.5e-10 Score=95.62 Aligned_cols=102 Identities=13% Similarity=0.152 Sum_probs=79.6
Q ss_pred hhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchh---
Q 007253 455 SKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVH--- 531 (611)
Q Consensus 455 ~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~--- 531 (611)
...+++++ +.++|..+| ++|.|+++||..++. .. .....++..+|..+|.|++|.|+.+||..++....
T Consensus 3 ~~~~t~~e---~~~~~~~~d--~~g~i~~~eF~~~~~-~~--~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g 74 (108)
T 1rro_A 3 TDILSAED---IAAALQECQ--DPDTFEPQKFFQTSG-LS--KMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDA 74 (108)
T ss_dssp GGTSCHHH---HHHHHHHTC--STTCCCHHHHHHHHS-GG--GSCHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTS
T ss_pred cccCCHHH---HHHHHHHcc--CCCCcCHHHHHHHHh-cC--cccHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhcc
Confidence 34455555 667777787 889999999998763 21 23345678899999999999999999998887652
Q ss_pred hHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 532 QLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 532 ~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
.... ++++..+|+.+|.|++|.|+.+||..++.
T Consensus 75 ~~~~----~~~~~~~~~~~D~~~dg~i~~~eF~~~~~ 107 (108)
T 1rro_A 75 RELT----ESETKSLMDAADNDGDGKIGADEFQEMVH 107 (108)
T ss_dssp CCCC----HHHHHHHHHHHCCSSSSSEEHHHHHHHHT
T ss_pred CCCC----HHHHHHHHHHhCCCCCCcCcHHHHHHHHc
Confidence 2222 55788999999999999999999998763
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* | Back alignment and structure |
|---|
Probab=99.02 E-value=5.7e-10 Score=104.83 Aligned_cols=99 Identities=8% Similarity=0.103 Sum_probs=75.6
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhcccc-----ccc-CChh----HHHhhcCCCCCCcccHHHHHHHHcchhhHH
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNATDA-----MKD-SRIP----DFLSSLNSLQYRRMDFEEFCAAALSVHQLE 534 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~-----~~~-~~~~----~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~ 534 (611)
.+..+|..+|.+++|.|+++||..++....... ... ..+. .+|..+|.|++|.|+.+||..++.......
T Consensus 67 ~~~~l~~~~D~d~~g~i~~~EF~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~ 146 (195)
T 1qv0_A 67 CVEAFFRGCGMEYGKEIAFPQFLDGWKQLATSELKKWARNEPTLIREWGDAVFDIFDKDGSGTITLDEWKAYGKISGISP 146 (195)
T ss_dssp HHHHHHHHTTCCTTCCBCHHHHHHHHHHHHHHHHHHHHTTCCCHHHHHHHHHHHHTC----CEECHHHHHHHHHHHSSCC
T ss_pred HHHHHHHHcCCCCCceEcHHHHHHHHHHHHhhhhhcccccHHHHHHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHhCCCC
Confidence 588899999999999999999999875543211 112 2233 899999999999999999998886554332
Q ss_pred hhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHh
Q 007253 535 ALDRWEQHARCAYELFEKDGNRAIVIEELASEL 567 (611)
Q Consensus 535 ~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l 567 (611)
. ++++..+|+.+|.|++|.|+.+||.+++
T Consensus 147 ~----~~~~~~~~~~~D~d~dg~i~~~eF~~~~ 175 (195)
T 1qv0_A 147 S----QEDCEATFRHCDLDNAGDLDVDEMTRQH 175 (195)
T ss_dssp C----HHHHHHHHHHSCCCTTSCEEHHHHHHHH
T ss_pred C----HHHHHHHHHHhCCCCCCcCCHHHHHHHH
Confidence 3 5578899999999999999999998876
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.01 E-value=4.6e-10 Score=105.06 Aligned_cols=98 Identities=11% Similarity=0.113 Sum_probs=81.6
Q ss_pred HHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHH
Q 007253 464 FYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHA 543 (611)
Q Consensus 464 ~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~ 543 (611)
..+..+|..+|.+++|.|+++||..++..... ......+..+|..+|.|++|.|+++||..++.. .... ++++
T Consensus 87 ~~~~~~~~~~D~d~~g~i~~~ef~~~~~~~~~-~~~~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~--~~~~----~~~~ 159 (191)
T 3khe_A 87 AEVDHILQSVDFDRNGYIEYSEFVTVCMDKQL-LLSRERLLAAFQQFDSDGSGKITNEELGRLFGV--TEVD----DETW 159 (191)
T ss_dssp HHHHHHHHHTCTTCSSSEEHHHHHHHHSCHHH-HCCHHHHHHHHHHHCTTCSSEECHHHHHHHTTS--SCCC----HHHH
T ss_pred HHHHHHHHHhCCCCCCcCCHHHHHHHHHHhcc-cchHHHHHHHHHHHCCCCcCcCCHHHHHHHHcc--CCCC----HHHH
Confidence 45888999999999999999999998744332 344567889999999999999999999998872 1222 5678
Q ss_pred HHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 544 RCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 544 ~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
..+|+.+|.|++|.|+.+||..++.
T Consensus 160 ~~~~~~~D~~~dg~i~~~eF~~~~~ 184 (191)
T 3khe_A 160 HQVLQECDKNNDGEVDFEEFVEMMQ 184 (191)
T ss_dssp HHHHHHHCTTCSSSEEHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 8899999999999999999999883
|
| >2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max} | Back alignment and structure |
|---|
Probab=99.01 E-value=3.7e-10 Score=92.45 Aligned_cols=89 Identities=16% Similarity=0.277 Sum_probs=71.7
Q ss_pred chhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhH
Q 007253 458 LTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALD 537 (611)
Q Consensus 458 l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~ 537 (611)
.+.++..+++++|..+|.+++|+|+.+||..+|..++. .+++.++..+|..+|.|++|.|+|+||+.++..........
T Consensus 3 ~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~l~~~~d~~~dg~i~~~eF~~~~~~~~~~~~~~ 81 (92)
T 2kn2_A 3 MDTDAEEELKEAFKVFDKDQNGYISASELRHVMINLGE-KLTDEEVEQMIKEADLDGDGQVNYEEFVKMMMTVRGGGGGN 81 (92)
T ss_dssp CCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTC-CCCHHHHHHHHHHHCSSCCSSEEHHHHHHHHHHHTTTCCCH
T ss_pred CCccHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhccCCCCCc
Confidence 45667788999999999999999999999999987764 57788899999999999999999999999886554322111
Q ss_pred HHHHHHHHHHh
Q 007253 538 RWEQHARCAYE 548 (611)
Q Consensus 538 ~~~~~~~~~F~ 548 (611)
..++++.+|+
T Consensus 82 -~~~~l~~aF~ 91 (92)
T 2kn2_A 82 -GWSRLRRKFS 91 (92)
T ss_dssp -HHHHHHHHHT
T ss_pred -hHHHHHHHhc
Confidence 1456777774
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A | Back alignment and structure |
|---|
Probab=99.01 E-value=6e-10 Score=104.76 Aligned_cols=102 Identities=9% Similarity=0.083 Sum_probs=80.8
Q ss_pred HHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchh--hHHhhHHHHH
Q 007253 464 FYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVH--QLEALDRWEQ 541 (611)
Q Consensus 464 ~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~--~~~~~~~~~~ 541 (611)
..+..+|..+|.|++|.|+++||..++.... ...+..+..+|..+|.|++|.|+.+||..++.... ..... ...+
T Consensus 87 ~~~~~l~~~~D~d~~g~i~~~EF~~~~~~~~--~~~~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~~l~~-~~~~ 163 (191)
T 3k21_A 87 YNFDLLLDQIDSDGSGKIDYTEFIAAALDRK--QLSKKLIYCAFRVFDVDNDGEITTAELAHILYNGNKKGNITQ-RDVN 163 (191)
T ss_dssp TTHHHHHHHHCTTCSSSEEHHHHHHHHSCGG--GCCHHHHHHHHHHHSTTCSSCBCHHHHHHHHHHSSSCSCCCH-HHHH
T ss_pred HHHHHHHHHhCCCCCCeEeHHHHHHHHHhhh--hccHHHHHHHHHHhCCCCCCcCCHHHHHHHHHhcCCCCCCCH-hHHH
Confidence 4578899999999999999999999763332 24455678899999999999999999999885421 11111 0135
Q ss_pred HHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 542 HARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 542 ~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
++..+|+.+|.|++|.|+.+||..++.
T Consensus 164 ~~~~~~~~~D~d~dG~Is~~EF~~~~~ 190 (191)
T 3k21_A 164 RVKRMIRDVDKNNDGKIDFHEFSEMMK 190 (191)
T ss_dssp HHHHHHHHHCSSSSSSBCHHHHHHHHC
T ss_pred HHHHHHHHhcCCCCCeECHHHHHHHHc
Confidence 688999999999999999999999874
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... | Back alignment and structure |
|---|
Probab=99.00 E-value=5e-10 Score=101.17 Aligned_cols=109 Identities=7% Similarity=0.011 Sum_probs=86.0
Q ss_pred HhhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhccc-ccccCChhHHHhhcCCCCCCcccHHHHHHHHcch
Q 007253 452 RALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATD-AMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV 530 (611)
Q Consensus 452 ~~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~-~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~ 530 (611)
..++..++..+ +..+ ..+|.+++|.|+++||..++...... ......+..+|..+|.|++|.|+.+||..++...
T Consensus 38 ~~~g~~~~~~~---~~~l-~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~ 113 (156)
T 1wdc_C 38 RCLGINPRNED---VFAV-GGTHKMGEKSLPFEEFLPAYEGLMDCEQGTFADYMEAFKTFDREGQGFISGAELRHVLTAL 113 (156)
T ss_dssp HHTTCCCCHHH---HHHT-TCCSSTTSCEECHHHHHHHHHHHTTSCCCCHHHHHHHHHTTCSSSSSEEEHHHHHHHHHHS
T ss_pred HHcCCCCCHHH---HHHH-HhhCCCCCCeeeHHHHHHHHHHHhhccCChHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHc
Confidence 33444555555 4555 78999999999999999988665432 2334567889999999999999999999988765
Q ss_pred hhHHhhHHHHHHHHHHHhH--HhcCCCCcccHHHHHHHhc
Q 007253 531 HQLEALDRWEQHARCAYEL--FEKDGNRAIVIEELASELG 568 (611)
Q Consensus 531 ~~~~~~~~~~~~~~~~F~~--~D~d~~G~It~eEl~~~l~ 568 (611)
..... ++++..+|+. +|.|++|.|+.+||..++.
T Consensus 114 g~~~~----~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~ 149 (156)
T 1wdc_C 114 GERLS----DEDVDEIIKLTDLQEDLEGNVKYEDFVKKVM 149 (156)
T ss_dssp SSCCC----HHHHHHHHHHHTCCCCTTSEEEHHHHHHHHH
T ss_pred CCCCC----HHHHHHHHHHhCCCCCCCCcEeHHHHHHHHh
Confidence 43333 5678899999 9999999999999999884
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.00 E-value=4.4e-10 Score=106.51 Aligned_cols=103 Identities=10% Similarity=0.062 Sum_probs=78.7
Q ss_pred HHHHhhhcCCCCCCcccHHHHHHHHHhhcc----------------cccccCChhHHHhhcCCCCCCcccHHHHHHHHcc
Q 007253 466 LKEQYALLEPNKNGTISLENVKSALMKNAT----------------DAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALS 529 (611)
Q Consensus 466 l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~----------------~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~ 529 (611)
+..+|..+|.+++|.|+++||..++..... .......+..+|..+|.|++|.|+.+||..++..
T Consensus 63 ~~~l~~~~D~d~dg~i~~~EF~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~ 142 (202)
T 2bec_A 63 GDRIIESFFPDGSQRVDFPGFVRVLAHFRPVEDEDTETQDPKKPEPLNSRRNKLHYAFQLYDLDRDGKISRHEMLQVLRL 142 (202)
T ss_dssp HHHHHHTTSCSSCCCCCHHHHHHHHGGGSCCCHHHHC-----CCCCTTSHHHHHHHHHHHHCTTCSSEECHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCcCcHHHHHHHHHHhcccchhcccccccccccccccHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHH
Confidence 778999999999999999999998765542 1223345778999999999999999999998866
Q ss_pred h-hhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 530 V-HQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 530 ~-~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
. ......+..+..+..+|+.+|.|++|.|+.+||..++.
T Consensus 143 ~~g~~~~~~~~~~~~~~~~~~~D~d~dG~Is~~EF~~~~~ 182 (202)
T 2bec_A 143 MVGVQVTEEQLENIADRTVQEADEDGDGAVSFVEFTKSLE 182 (202)
T ss_dssp SCCSCCCHHHHHHHHHHHHHHHCSSCSSSEEHHHHHHTTT
T ss_pred hcCCCCCHHHHHHHHHHHHHHcCCCCCCcCcHHHHHHHHH
Confidence 5 32223222233344455559999999999999999884
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=99.00 E-value=6.5e-10 Score=104.26 Aligned_cols=98 Identities=9% Similarity=0.101 Sum_probs=82.5
Q ss_pred CChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CC---CCccHH
Q 007253 501 SRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LG---PAVPVH 576 (611)
Q Consensus 501 ~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~---~~~~~~ 576 (611)
.++..+|..+|.|++|.|+++||..++........ ++++..+|+.+|.|++|.|+.+||..++. +. ....+.
T Consensus 10 ~~l~~~F~~~D~d~dG~I~~~E~~~~l~~~g~~~~----~~~~~~l~~~~D~d~dG~I~~~EF~~~~~~~~~~~~~~~l~ 85 (188)
T 1s6i_A 10 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSELM----ESEIKDLMDAADIDKSGTIDYGEFIAATVHLNKLEREENLV 85 (188)
T ss_dssp CSHHHHHHTTSSSSSSCEEHHHHHHHHTTTTCCCC----HHHHHHHHHHTCTTCSSEECHHHHHHHHTTSSSSCCCCSTH
T ss_pred HHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCC----HHHHHHHHHHcCCCCCCeEeHHHHHHHHHHHhccCHHHHHH
Confidence 45788999999999999999999998876643333 55788999999999999999999999884 21 122388
Q ss_pred HHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 577 AVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 577 ~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
.+|..+|.|+||.|+.+||..++..+
T Consensus 86 ~~F~~~D~d~dG~Is~~El~~~l~~~ 111 (188)
T 1s6i_A 86 SAFSYFDKDGSGYITLDEIQQACKDF 111 (188)
T ss_dssp HHHHHTTTTCSSEEEHHHHHHTTTTT
T ss_pred HHHHHHCCCCCCcCcHHHHHHHHHHc
Confidence 99999999999999999999998764
|
| >2l4h_A Calcium and integrin-binding protein 1; metal binding protei; NMR {Homo sapiens} PDB: 2l4i_A 2lm5_A | Back alignment and structure |
|---|
Probab=98.99 E-value=6e-10 Score=106.86 Aligned_cols=102 Identities=11% Similarity=0.051 Sum_probs=81.2
Q ss_pred HHhhhcCCCCCCc-ccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhh-----HHhhHHHHH
Q 007253 468 EQYALLEPNKNGT-ISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQ-----LEALDRWEQ 541 (611)
Q Consensus 468 ~~F~~~D~d~~G~-Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~-----~~~~~~~~~ 541 (611)
++|..+|.+++|. |+++||..++.........+..+..+|+.+|.|++|.|+.+||..++..... ....+..++
T Consensus 95 ~lf~~~D~d~dG~~I~f~EF~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~~~~~~~~~s~~e~~~ 174 (214)
T 2l4h_A 95 RICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQ 174 (214)
T ss_dssp HHHHHHCCSSSCCSEEHHHHHHHHHHTSSCSCHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHSSSCTTCSCTHHHH
T ss_pred HHHHHhCcCCCCCEecHHHHHHHHHHHcCCCCHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhccccCCCCCHHHHHH
Confidence 5788899999999 9999999988665432233456889999999999999999999988866543 222222344
Q ss_pred HHHHHHhHHhcCCCCcccHHHHHHHhcC
Q 007253 542 HARCAYELFEKDGNRAIVIEELASELGL 569 (611)
Q Consensus 542 ~~~~~F~~~D~d~~G~It~eEl~~~l~~ 569 (611)
.+..+|+.+|.|++|.|+.+||..++.-
T Consensus 175 ~~~~~~~~~D~d~dG~Is~~EF~~~~~~ 202 (214)
T 2l4h_A 175 LIDNILEESDIDRDGTINLSEFQHVISR 202 (214)
T ss_dssp HHHHHHHHHCCSCCSSBCSHHHHHHHHT
T ss_pred HHHHHHHHhCCCCCCcCCHHHHHHHHHh
Confidence 5667999999999999999999998854
|
| >1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A* | Back alignment and structure |
|---|
Probab=98.98 E-value=9e-10 Score=102.53 Aligned_cols=103 Identities=11% Similarity=0.052 Sum_probs=80.0
Q ss_pred HHhhhcCCCCCCc-ccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhh-----HHhhHHHHH
Q 007253 468 EQYALLEPNKNGT-ISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQ-----LEALDRWEQ 541 (611)
Q Consensus 468 ~~F~~~D~d~~G~-Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~-----~~~~~~~~~ 541 (611)
++|..+|.+++|. |+++||..++.........+..+..+|..+|.|++|.|+.+||..++..... ....+....
T Consensus 64 ~l~~~~D~d~~G~~I~~~EF~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~ 143 (183)
T 1dgu_A 64 RICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQ 143 (183)
T ss_dssp HHHHHHSCSSSSCCCCHHHHHHHHHHHSTTCCHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHSSSCCCHHHHHHHHH
T ss_pred HHHHHhCCCCCCCEecHHHHHHHHHHhcCCCCHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhcccccCCCCHHHHHH
Confidence 4677789999999 9999999988665432233456889999999999999999999988866543 233222233
Q ss_pred HHHHHHhHHhcCCCCcccHHHHHHHhcCC
Q 007253 542 HARCAYELFEKDGNRAIVIEELASELGLG 570 (611)
Q Consensus 542 ~~~~~F~~~D~d~~G~It~eEl~~~l~~~ 570 (611)
.+..+|+.+|.|++|.|+.+||..++.-.
T Consensus 144 ~~~~~~~~~D~d~dG~I~~~EF~~~~~~~ 172 (183)
T 1dgu_A 144 LIDNILEESDIDRDGTINLSEFQHVISRS 172 (183)
T ss_dssp HHHHHHHHHCTTSSSEEEHHHHHHHHCSS
T ss_pred HHHHHHHHhCCCCCCeEcHHHHHHHHHhC
Confidence 34459999999999999999999998543
|
| >3zwh_A Protein S100-A4; Ca-binding protein-motor protein complex, S100 proteins, EF-; 1.94A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.98 E-value=9e-10 Score=92.21 Aligned_cols=65 Identities=14% Similarity=0.263 Sum_probs=54.8
Q ss_pred HHHHHHHHhHHh-cCCC-CcccHHHHHHHhc--CC----CCc---cHHHHHHHHhcCCCCceeHHHHHHHHhhcch
Q 007253 540 EQHARCAYELFE-KDGN-RAIVIEELASELG--LG----PAV---PVHAVLHDWIRHTDGKLSFLGFVKLLHGVSS 604 (611)
Q Consensus 540 ~~~~~~~F~~~D-~d~~-G~It~eEl~~~l~--~~----~~~---~~~~~~~~~D~~~dG~is~~eF~~~l~~~~~ 604 (611)
.+.++.+|+.|| +||+ |+|+.+||+++|. ++ ... .++++|+.+|.|+||.|+|+||+.+|..+..
T Consensus 12 ~~~l~~aF~~fD~~dgd~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~dgDG~Idf~EF~~~m~~~~~ 87 (104)
T 3zwh_A 12 LDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSWLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSSIAM 87 (104)
T ss_dssp HHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGSCSSCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHcchhccCCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHHH
Confidence 567899999998 7885 8999999999994 33 222 2899999999999999999999999987643
|
| >4eto_A Protein S100-A4; calcium-binding protein, EF-hand, structural genomics, PSI-B protein structure initiative, NEW YORK structural genomics consortium; 1.54A {Homo sapiens} PDB: 1m31_A 2q91_A 3cga_A 3ko0_A* 3m0w_A* | Back alignment and structure |
|---|
Probab=98.98 E-value=9.2e-10 Score=90.33 Aligned_cols=65 Identities=14% Similarity=0.251 Sum_probs=54.5
Q ss_pred HHHHHHHHhHHh-cCCC-CcccHHHHHHHhc--CC----CC---ccHHHHHHHHhcCCCCceeHHHHHHHHhhcch
Q 007253 540 EQHARCAYELFE-KDGN-RAIVIEELASELG--LG----PA---VPVHAVLHDWIRHTDGKLSFLGFVKLLHGVSS 604 (611)
Q Consensus 540 ~~~~~~~F~~~D-~d~~-G~It~eEl~~~l~--~~----~~---~~~~~~~~~~D~~~dG~is~~eF~~~l~~~~~ 604 (611)
.+.++.+|+.|| +||+ |+|+.+||++++. ++ .. ..++++|+.+|.|+||.|+|+||+.+|..++.
T Consensus 9 ~~~l~~~F~~fd~~dg~~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~d~DG~Idf~EF~~~~~~~~~ 84 (93)
T 4eto_A 9 LDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCIAM 84 (93)
T ss_dssp HHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGC---CCHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcccCCCCCeECHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHHHH
Confidence 567899999998 6885 8999999999994 43 22 22899999999999999999999999988654
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C | Back alignment and structure |
|---|
Probab=98.97 E-value=6e-10 Score=100.01 Aligned_cols=108 Identities=13% Similarity=0.060 Sum_probs=83.9
Q ss_pred hhhhcchhhHHHHHHHHhhhcCCC--CCCcccHHHHHHHHHhhccc--ccccCChhHHHhhcCCCCCCcccHHHHHHHHc
Q 007253 453 ALSKTLTVDELFYLKEQYALLEPN--KNGTISLENVKSALMKNATD--AMKDSRIPDFLSSLNSLQYRRMDFEEFCAAAL 528 (611)
Q Consensus 453 ~~~~~l~~~e~~~l~~~F~~~D~d--~~G~Is~~e~~~~l~~~~~~--~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~ 528 (611)
.++..++.. ++..+|..+|.+ ++|.|+++||..++...... ......+..+|..+|.|++|.|+.+||..++.
T Consensus 38 ~~g~~~~~~---~~~~l~~~~d~~~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~ 114 (151)
T 1w7j_B 38 ALGQNPTNA---EVLKVLGNPKSDELKSRRVDFETFLPMLQAVAKNRGQGTYEDYLEGFRVFDKEGNGKVMGAELRHVLT 114 (151)
T ss_dssp HTTCCCCHH---HHHHHTTCCCHHHHTTCEEEHHHHHHHHHHHCC--------CCHHHHHTTCTTSSSEEEHHHHHHHHH
T ss_pred HcCCCCCHH---HHHHHHHHhCcCcCCCCcCcHHHHHHHHHHHhccCCCCcHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 344445544 478899999999 99999999999988665421 12345678899999999999999999999886
Q ss_pred chhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 529 SVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
....... ++++..+|+.+| |++|.|+.+||.+++.
T Consensus 115 ~~g~~~~----~~~~~~~~~~~d-~~dg~i~~~eF~~~~~ 149 (151)
T 1w7j_B 115 TLGEKMT----EEEVETVLAGHE-DSNGCINYEAFLKHIL 149 (151)
T ss_dssp HSSSCCC----HHHHHHHHTTCC-CTTSEEEHHHHHHHTC
T ss_pred HcCCCCC----HHHHHHHHHhcc-CCCCeEeHHHHHHHHh
Confidence 6543333 567889999999 9999999999998873
|
| >1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A | Back alignment and structure |
|---|
Probab=98.97 E-value=5.7e-10 Score=91.00 Aligned_cols=77 Identities=13% Similarity=0.247 Sum_probs=68.3
Q ss_pred hhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcch
Q 007253 453 ALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV 530 (611)
Q Consensus 453 ~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~ 530 (611)
.+...+++++..+++++|..+|.+++|+|+.+||..+|..++. .+++.++..+|..+|.|++|.|+|+||+.++...
T Consensus 9 ~~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~l~~~~D~~~dg~i~~~eF~~~~~~~ 85 (90)
T 1avs_A 9 EARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQ-NPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVRQ 85 (90)
T ss_dssp SHHHHBCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTC-CCCHHHHHHHHHHHCTTCCSSEEHHHHHHHHHHH
T ss_pred HHHHhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHH
Confidence 3555688999999999999999999999999999999988765 5778889999999999999999999999877543
|
| >2lnk_A Protein S100-A4; EF-hand, calcium binding, all alpha, metal binding protein, binding protein; NMR {Homo sapiens} PDB: 3c1v_A | Back alignment and structure |
|---|
Probab=98.96 E-value=9.7e-10 Score=93.33 Aligned_cols=64 Identities=16% Similarity=0.335 Sum_probs=55.0
Q ss_pred HHHHHHHHhHHh-cCCCC-cccHHHHHHHhc------CCCCc---cHHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 540 EQHARCAYELFE-KDGNR-AIVIEELASELG------LGPAV---PVHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 540 ~~~~~~~F~~~D-~d~~G-~It~eEl~~~l~------~~~~~---~~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
.++++.+|+.|| +|++| +|+.+||+.+|. ++... .++++|..+|.|+||.|+|+||+.+|....
T Consensus 21 ~~~l~~aF~~fD~~dgdGG~Is~~EL~~~l~~~l~~~lg~~~t~~ev~~li~~~D~dgdG~Idf~EF~~~m~~~~ 95 (113)
T 2lnk_A 21 LDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCIA 95 (113)
T ss_dssp HHHHHHHHHHTTTTTSCTTCBCHHHHHHHHHHHCGGGGTTCCCTTHHHHHHHHHCSSSSSCBCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcchhcCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHHH
Confidence 567899999999 89997 999999999983 33322 389999999999999999999999987653
|
| >2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus} | Back alignment and structure |
|---|
Probab=98.96 E-value=5.5e-10 Score=88.01 Aligned_cols=72 Identities=19% Similarity=0.341 Sum_probs=64.2
Q ss_pred chhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcch
Q 007253 458 LTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV 530 (611)
Q Consensus 458 l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~ 530 (611)
+++++..+++++|..+|.+++|+|+.+||..++...+. .+++.++..+|..+|.|++|.|+|+||+.++...
T Consensus 1 ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~-~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~ 72 (77)
T 2joj_A 1 LSEEQKQEIKEAFDLFDTNKTGSIDYHELKVAMRALGF-DVKKPEILELMNEYDREGNGYIGFDDFLDIMTEK 72 (77)
T ss_dssp CCHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHHHHTC-CCHHHHHHHHHHHHCCSSSSEEEHHHHHHHHTHH
T ss_pred CCHHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhCC-CCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHH
Confidence 35778889999999999999999999999999988764 5777889999999999999999999999887643
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* | Back alignment and structure |
|---|
Probab=98.95 E-value=1.8e-09 Score=96.43 Aligned_cols=106 Identities=15% Similarity=0.089 Sum_probs=83.0
Q ss_pred hhhcchhhHHHHHHHHhhhc---CCCCCCcccHHHHHHHHHhh--cccccccCChhHHHhhcCCCCCCcccHHHHHHHHc
Q 007253 454 LSKTLTVDELFYLKEQYALL---EPNKNGTISLENVKSALMKN--ATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAAL 528 (611)
Q Consensus 454 ~~~~l~~~e~~~l~~~F~~~---D~d~~G~Is~~e~~~~l~~~--~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~ 528 (611)
++..++..+ +..+|..+ |.++ |.|+++||..++... .........+..+|..+|.+++|.|+.+||..++.
T Consensus 37 ~~~~~~~~~---~~~l~~~~~~~d~~~-g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~ 112 (149)
T 2mys_C 37 LGQNPTNAE---INKILGNPSKEEMNA-AAITFEEFLPMLQAAANNKDQGTFEDFVEGLRVFDKEGNGTVMGAELRHVLA 112 (149)
T ss_pred hCCCCCHHH---HHHHHHHhhhccccC-CcCcHHHHHHHHHHHhccCCcchHHHHHHHHHHhCCCCCceEcHHHHHHHHH
Confidence 344445544 66677777 9999 999999999988665 22223345678899999999999999999999887
Q ss_pred chhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 529 SVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
....... ++++..+|+. |.|++|.|+.+||..++.
T Consensus 113 ~~g~~~~----~~~~~~~~~~-d~~~dg~i~~~eF~~~~~ 147 (149)
T 2mys_C 113 TLGEKMT----EEEVEELMKG-QEDSNGCINYEAFVKHIM 147 (149)
T ss_pred HhCCCCC----HHHHHHHHhh-CCCCCCcEeHHHHHHHHh
Confidence 6543333 5678899999 999999999999998873
|
| >1iq3_A Ralbp1-interacting protein (partner of ralbp1); EF-hand domain, POB1 EH domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=98.95 E-value=1.3e-09 Score=92.36 Aligned_cols=65 Identities=11% Similarity=0.023 Sum_probs=56.3
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCC-CccHHHHHHHHhcCCCCceeHHHHHHHHhhcch
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELG-LGP-AVPVHAVLHDWIRHTDGKLSFLGFVKLLHGVSS 604 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~-~~~~~~~~~~~D~~~dG~is~~eF~~~l~~~~~ 604 (611)
.++++.+|+.||+|++|+|+.+||+.+|. ++. ...++++++.+|.|+||.|+|+||+.+|+....
T Consensus 21 ~~~~~~~F~~~D~d~dG~Is~~el~~~l~~~gl~~~el~~i~~~~D~d~dG~I~~~EF~~~m~~~~~ 87 (110)
T 1iq3_A 21 REYYVNQFRSLQPDPSSFISGSVAKNFFTKSKLSIPELSYIWELSDADCDGALTLPEFCAAFHLIVA 87 (110)
T ss_dssp HHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSSCSSCCHHHHHHHHCSSSCSEEEHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHH
Confidence 45788999999999999999999999995 432 223999999999999999999999999987654
|
| >1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=98.94 E-value=7.7e-10 Score=90.74 Aligned_cols=70 Identities=21% Similarity=0.298 Sum_probs=62.1
Q ss_pred chhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcch
Q 007253 458 LTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV 530 (611)
Q Consensus 458 l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~ 530 (611)
++.++..+++++|..+|.|++|+|+.+|++.+|...+ .+++++..++..+|.|++|.|+|+||+.++...
T Consensus 3 ls~~~~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g---~~~~~~~~i~~~~D~d~dG~i~~~EF~~~~~~~ 72 (92)
T 1fi6_A 3 ITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSK---LPILELSHIWELSDFDKDGALTLDEFCAAFHLV 72 (92)
T ss_dssp CCHHHHHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHS---SCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcC---CCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Confidence 4678889999999999999999999999999997764 456789999999999999999999999877543
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.93 E-value=1.1e-09 Score=100.00 Aligned_cols=97 Identities=9% Similarity=0.093 Sum_probs=77.2
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHH
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHAR 544 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~ 544 (611)
++..+|..+|.+++|.|+++||..++..... ......+..+|..+|.|++|.|+.+||..++.... .. ++++.
T Consensus 64 ~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~-~~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~--~~----~~~~~ 136 (166)
T 2aao_A 64 EILDLMQAADVDNSGTIDYKEFIAATLHLNK-IEREDHLFAAFTYFDKDGSGYITPDELQQACEEFG--VE----DVRIE 136 (166)
T ss_dssp HHHHHHHHHCTTCCSSBCHHHHHHHHTTCHH-HHTTHHHHHHHHHHCTTCSSSBCHHHHHHHTCC--------------C
T ss_pred HHHHHHHHhCCCCCCeEcHHHHHHHHHHHhh-cccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcC--CC----HHHHH
Confidence 3778899999999999999999988744332 23445688999999999999999999999887653 22 45688
Q ss_pred HHHhHHhcCCCCcccHHHHHHHhc
Q 007253 545 CAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 545 ~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
.+|+.+|.|++|.|+.+||..++.
T Consensus 137 ~~~~~~d~~~dg~i~~~eF~~~~~ 160 (166)
T 2aao_A 137 ELMRDVDQDNDGRIDYNEFVAMMQ 160 (166)
T ss_dssp CHHHHHCTTCSSSBCHHHHHHHHC
T ss_pred HHHHHhCCCCCCcEeHHHHHHHHH
Confidence 899999999999999999999884
|
| >2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A | Back alignment and structure |
|---|
Probab=98.93 E-value=3e-10 Score=102.45 Aligned_cols=61 Identities=15% Similarity=0.254 Sum_probs=33.3
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLH 600 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~ 600 (611)
.+.++.+|+.||+|++|+|+.+||+.+|. +|...+ ++.+|..+|.|+||.|+|+||+.++.
T Consensus 49 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~~D~d~dg~I~~~eF~~~~~ 113 (150)
T 2jjz_A 49 LTAFKEKYMEFDLNNEGEIDLMSLKRMMEKLGVPKTHLEMKKMISEVTGGVSDTISYRDFVNMML 113 (150)
T ss_dssp HHHHHHHHTTSCCCTTSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHHTTSCSSBCHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCcCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHCCCCCCcEeHHHHHHHHH
Confidence 33455556666666666666666655552 333222 55555555656666666666655554
|
| >4drw_A Protein S100-A10/annexin A2 chimeric protein; atypical EF-hand, heteropentameric complex, membrane repair; 3.50A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.93 E-value=6.8e-10 Score=95.33 Aligned_cols=64 Identities=22% Similarity=0.369 Sum_probs=55.1
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhc------CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhcch
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELG------LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGVSS 604 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~------~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~~~ 604 (611)
.+.++.+|..||.| +|+|+.+||+++|. ++...+ ++.+|+.+|.|+||.|+|+||+.+|.+++.
T Consensus 14 ie~l~~~F~~yd~d-dG~Is~~EL~~~l~~~~~~~l~~~~~~~~v~~~i~~~D~d~DG~IdF~EF~~lm~~l~~ 86 (121)
T 4drw_A 14 METMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLIAGLTI 86 (121)
T ss_dssp HHHHHHTTGGGSCT-TCSCCHHHHHHHTTTSCHHHHTTSSCTTHHHHHHHHHCTTCSSCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCC-CCEEcHHHHHHHHHHHhhhhcccCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHH
Confidence 45788999999988 89999999999984 233322 899999999999999999999999988764
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} | Back alignment and structure |
|---|
Probab=98.93 E-value=1.1e-09 Score=104.14 Aligned_cols=94 Identities=11% Similarity=0.032 Sum_probs=74.8
Q ss_pred HhhhcCCCCCCcccHHHHHHHHH---------hhcccccccCC-hhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHH
Q 007253 469 QYALLEPNKNGTISLENVKSALM---------KNATDAMKDSR-IPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDR 538 (611)
Q Consensus 469 ~F~~~D~d~~G~Is~~e~~~~l~---------~~~~~~~~~~~-~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~ 538 (611)
+|..+|.|++|.|+++||..++. ..........+ +..+|..+|.|++|.|+.+||..++.... ..
T Consensus 86 lf~~~D~d~dg~i~~~EF~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~g--~~--- 160 (208)
T 2hpk_A 86 FFLHKGVEPVNGLLREDWVEANRVFAEAERERERRGEPSLIALLSNSYYDVLDDDGDGTVDVDELKTMMKAFD--VP--- 160 (208)
T ss_dssp HHHHTTCBTTTBEEGGGHHHHHHHHHHHHHHHHHTTCCCHHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTT--SC---
T ss_pred HHHHhCCCCCCeEcHHHHHHHHHHHhhhhhhhhccCChHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhC--cC---
Confidence 44999999999999999999875 22211111222 67899999999999999999999886554 22
Q ss_pred HHHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 539 WEQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 539 ~~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
++++..+|+.+|.|++|.|+.+||..++.
T Consensus 161 -~~~~~~~~~~~D~d~dG~I~~~EF~~~~~ 189 (208)
T 2hpk_A 161 -QEAAYTFFEKADTDKSGKLERTELVHLFR 189 (208)
T ss_dssp -TTHHHHHHHHHCTTCCSSBCHHHHHHHHH
T ss_pred -HHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 45688899999999999999999999883
|
| >1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.93 E-value=1.1e-09 Score=83.46 Aligned_cols=60 Identities=15% Similarity=0.281 Sum_probs=52.7
Q ss_pred HHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 542 HARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 542 ~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
+++.+|+.+|+|++|+|+.+||+.++. ++...+ ++.+|..+|.|+||.|+|+||+.++..
T Consensus 2 ~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~~~~ 65 (67)
T 1tiz_A 2 SAKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGELNADEFTSCIEK 65 (67)
T ss_dssp THHHHHHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHCCSSSSEECHHHHHHHHHT
T ss_pred HHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH
Confidence 467899999999999999999999994 554444 888999999999999999999999865
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A | Back alignment and structure |
|---|
Probab=98.92 E-value=4.6e-10 Score=104.65 Aligned_cols=94 Identities=12% Similarity=0.099 Sum_probs=74.3
Q ss_pred HHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHH--hhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHHH
Q 007253 468 EQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFL--SSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARC 545 (611)
Q Consensus 468 ~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~--~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~ 545 (611)
++|..+|.+++|.|+++| .++...........++...| ..+|.|++|.|+++||..++........ ++++..
T Consensus 69 ~~f~~~D~d~dg~I~~~E--~~~~~~~~~~~~~~~~~~~f~~~~fD~d~~G~I~~~E~~~~l~~~g~~~~----~~~~~~ 142 (186)
T 2hps_A 69 GLAPGVRISVEEAAVNAT--DSLLKMKGEEKAMAVIQSLIMYDCIDTDKDGYVSLPEFKAFLQAVGPDLT----DDKAIT 142 (186)
T ss_dssp TCCTTCEEEHHHHHHHHH--HHHHHCCTHHHHHTTHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHCTTCC----HHHHHH
T ss_pred HHHHhcCCCCCCcccHHH--HHHHHhcCChHHHHHHHHHHHHHHccCCCCCcCCHHHHHHHHHHhCCCCC----HHHHHH
Confidence 668999999999999999 55555543223334544444 6779999999999999998876543333 667899
Q ss_pred HHhHHhcCCCCcccHHHHHHHh
Q 007253 546 AYELFEKDGNRAIVIEELASEL 567 (611)
Q Consensus 546 ~F~~~D~d~~G~It~eEl~~~l 567 (611)
+|+.+|.|++|.|+.+||..++
T Consensus 143 ~~~~~D~d~dG~i~~~ef~~~~ 164 (186)
T 2hps_A 143 CFNTLDFNKNGQISRDEFLVTV 164 (186)
T ss_dssp HHHHHCTTCSSEEEHHHHHHHH
T ss_pred HHHHHcCCCCCcCcHHHHHHHH
Confidence 9999999999999999999987
|
| >3nso_A Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, metal binding protein; 1.45A {Homo sapiens} SCOP: a.39.1.2 PDB: 3nsi_A 1kso_A 3nsk_A 3nsl_A | Back alignment and structure |
|---|
Probab=98.92 E-value=5.8e-10 Score=92.73 Aligned_cols=72 Identities=14% Similarity=0.187 Sum_probs=61.0
Q ss_pred hhHHHHHHHHhhhcC-CCCC-CcccHHHHHHHHHh-hc---ccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchh
Q 007253 460 VDELFYLKEQYALLE-PNKN-GTISLENVKSALMK-NA---TDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVH 531 (611)
Q Consensus 460 ~~e~~~l~~~F~~~D-~d~~-G~Is~~e~~~~l~~-~~---~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~ 531 (611)
+..+..|+++|+.|| .||+ |+|+.+||+.+|.. ++ +...++.+++++++.+|.|+||.|+|+||+.++....
T Consensus 6 e~~i~~l~~aF~~fd~~dg~~G~Is~~EL~~~l~~~l~~~lg~~~~~~ev~~~i~~~D~dgDG~Idf~EF~~~~~~~~ 83 (101)
T 3nso_A 6 EQAVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFVEYVRSLACLC 83 (101)
T ss_dssp HHHHHHHHHHHHHHHTTSSCTTEECHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHCCCSCEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhcCCCCCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHH
Confidence 455788999999997 8887 99999999999976 32 3456778899999999999999999999998776543
|
| >2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.92 E-value=9.2e-10 Score=85.13 Aligned_cols=62 Identities=24% Similarity=0.568 Sum_probs=54.9
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
++.++.+|+.+|.|++|+|+.+||+.++. ++...+ ++.++..+|.|+||.|+|+||+.++..
T Consensus 5 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~ 70 (71)
T 2b1u_A 5 LEDLQVAFRAFDQDGDGHITVDELRRAMAGLGQPLPQEELDAMIREADVDQDGRVNYEEFARMLAQ 70 (71)
T ss_dssp HHHHHHHHTTSCCSSSSEEEHHHHHHHGGGTTCSSCHHHHHHHHHHCCSSSSSEEETTHHHHHHTC
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHhh
Confidence 56789999999999999999999999995 554444 888999999999999999999999864
|
| >2h2k_A Protein S100-A13; calcium binding protein, metal binding protein; 2.00A {Homo sapiens} PDB: 1yur_A 1yus_A 1yut_A 1yuu_A 2egd_A 2k8m_B 2ki4_B* 2ki6_C* 2kot_A* 2l5x_B 2cxj_A | Back alignment and structure |
|---|
Probab=98.92 E-value=1.3e-09 Score=91.57 Aligned_cols=73 Identities=10% Similarity=0.182 Sum_probs=60.3
Q ss_pred hhHHHHHHHHhhhcC-CCCC-CcccHHHHHHHHHhhccccc-ccCChhHHHhhcCCCCCCcccHHHHHHHHcchhh
Q 007253 460 VDELFYLKEQYALLE-PNKN-GTISLENVKSALMKNATDAM-KDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQ 532 (611)
Q Consensus 460 ~~e~~~l~~~F~~~D-~d~~-G~Is~~e~~~~l~~~~~~~~-~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~ 532 (611)
++++.+|+++|..|| .|++ |+|+.+||+.+|....+... ++.++..+++.+|.|++|.|+|+||+.++.....
T Consensus 18 e~~~~~l~~aF~~fD~~dg~~G~Is~~EL~~~l~~~lg~~~~~~~ev~~li~~~D~d~dG~Idf~EF~~~~~~~~~ 93 (106)
T 2h2k_A 18 EESIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKFNEYWRLIGELAK 93 (106)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCTTTTTTCCCHHHHHHHHCTTCSSSEEHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcCcCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHHHH
Confidence 345778999999999 7886 79999999999876433233 3578999999999999999999999998865543
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A | Back alignment and structure |
|---|
Probab=98.92 E-value=1.6e-09 Score=114.00 Aligned_cols=108 Identities=14% Similarity=0.199 Sum_probs=85.0
Q ss_pred hhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhH
Q 007253 454 LSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQL 533 (611)
Q Consensus 454 ~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~ 533 (611)
+...++.++ ++++|..+|.|++|.|+++||..++..........+.+..+|..+|.|++|.|+.+||..++......
T Consensus 341 lg~~~s~ee---l~~Lf~~~D~DgdG~IsfeEFl~ll~~~~~~~~~~e~l~~aFk~fD~D~dG~Is~eELr~~L~~lG~~ 417 (450)
T 3sg6_A 341 LGQNPTEAE---LQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEK 417 (450)
T ss_dssp TTCCCCHHH---HHHHHHTTCTTSSSSEEHHHHHHHHHC------CHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCC
T ss_pred hCCCCCHHH---HHHHHHHhccCCCCcccHHHHHHHHHhhccccchhhHHHHHHHHhCCCCCCeEeHHHHHHHHHHhCCC
Confidence 334445444 77889999999999999999999876554433445568899999999999999999999988765443
Q ss_pred HhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 534 EALDRWEQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 534 ~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
.. ++++..+|+.+|.|++|.|+.+||..+|.
T Consensus 418 ls----~eei~~Lf~~~D~D~DG~IsfdEFv~~L~ 448 (450)
T 3sg6_A 418 LT----DEEVDEMIREADIDGDGQVNYEEFVQMMT 448 (450)
T ss_dssp CC----HHHHHHHHHHHCTTSSSSEEHHHHHHHHC
T ss_pred CC----HHHHHHHHHHhCCCCCCcEeHHHHHHHHh
Confidence 33 56788999999999999999999999874
|
| >1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=98.92 E-value=1.3e-09 Score=89.99 Aligned_cols=65 Identities=17% Similarity=0.042 Sum_probs=56.3
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc-HHHHHHHHhcCCCCceeHHHHHHHHhhcch
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP-VHAVLHDWIRHTDGKLSFLGFVKLLHGVSS 604 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~-~~~~~~~~D~~~dG~is~~eF~~~l~~~~~ 604 (611)
.++++.+|+.||+|++|+|+.+||+.++. ++.... +++++..+|.|+||.|+|+||+.+|+....
T Consensus 9 ~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g~~~~~~~~i~~~~D~d~dG~i~~~EF~~~~~~~~~ 75 (95)
T 1c07_A 9 KAKYDEIFLKTDKDMDGFVSGLEVREIFLKTGLPSTLLAHIWSLCDTKDCGKLSKDQFALAFHLISQ 75 (95)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHTTTCCHHHHHHHHHHHCTTCSSSEETTTHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcEeHHHHHHHHHHcCCCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHHH
Confidence 56788999999999999999999999994 443322 889999999999999999999999977654
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} | Back alignment and structure |
|---|
Probab=98.91 E-value=1.8e-09 Score=100.39 Aligned_cols=97 Identities=6% Similarity=0.083 Sum_probs=78.5
Q ss_pred HHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHH
Q 007253 464 FYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHA 543 (611)
Q Consensus 464 ~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~ 543 (611)
.++..+|..+|.+++|.|+++||..++..... ..+..+..+|..+|.|++|.|+.+||..++... ... ++++
T Consensus 73 ~~~~~~~~~~D~d~~g~i~~~Ef~~~~~~~~~--~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~--~~~----~~~~ 144 (180)
T 3mse_B 73 WDINRILQALDINDRGNITYTEFMAGCYRWKN--IESTFLKAAFNKIDKDEDGYISKSDIVSLVHDK--VLD----NNDI 144 (180)
T ss_dssp HHHHHHHHHHCTTCCSEECHHHHHHHHSCCTT--C--CHHHHHHHHHCTTCSSCBCHHHHHHHTTTS--SCC----HHHH
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHhccc--CCHHHHHHHHHHHCCCCCCCCCHHHHHHHHcCC--CCC----HHHH
Confidence 45889999999999999999999987754332 334678899999999999999999999988732 122 5678
Q ss_pred HHHHhHHhcCCC--------CcccHHHHHHHhc
Q 007253 544 RCAYELFEKDGN--------RAIVIEELASELG 568 (611)
Q Consensus 544 ~~~F~~~D~d~~--------G~It~eEl~~~l~ 568 (611)
..+|+.+|.|++ |.|+.+||..+|.
T Consensus 145 ~~~~~~~d~~~d~~~~~~~~G~i~~~eF~~~l~ 177 (180)
T 3mse_B 145 DNFFLSVHSIKKGIPREHIINKISFQEFKDYML 177 (180)
T ss_dssp HHHHHHHHTC---------CCCBCHHHHHHHHH
T ss_pred HHHHHHhhhccCcccccccCCeeeHHHHHHHHH
Confidence 899999999988 9999999999873
|
| >1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=98.91 E-value=1.4e-09 Score=89.20 Aligned_cols=65 Identities=15% Similarity=0.044 Sum_probs=55.9
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCC-ccHHHHHHHHhcCCCCceeHHHHHHHHhhcch
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELG-LGPA-VPVHAVLHDWIRHTDGKLSFLGFVKLLHGVSS 604 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~-~~~~~~~~~~D~~~dG~is~~eF~~~l~~~~~ 604 (611)
.++++.+|+.||+|++|+|+.+||+.++. .+.. ..+++++..+|.|+||.|+|+||+.+|.....
T Consensus 8 ~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g~~~~~~~~i~~~~D~d~dG~i~~~EF~~~~~~~~~ 74 (92)
T 1fi6_A 8 RQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSKLPILELSHIWELSDFDKDGALTLDEFCAAFHLVVA 74 (92)
T ss_dssp HHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHSSCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHH
Confidence 55788999999999999999999999984 4432 22889999999999999999999999987643
|
| >2lnk_A Protein S100-A4; EF-hand, calcium binding, all alpha, metal binding protein, binding protein; NMR {Homo sapiens} PDB: 3c1v_A | Back alignment and structure |
|---|
Probab=98.91 E-value=2.4e-09 Score=90.95 Aligned_cols=72 Identities=14% Similarity=0.284 Sum_probs=60.9
Q ss_pred hhhHHHHHHHHhhhcC-CCCCC-cccHHHHHHHHHhhc----ccccccCChhHHHhhcCCCCCCcccHHHHHHHHcch
Q 007253 459 TVDELFYLKEQYALLE-PNKNG-TISLENVKSALMKNA----TDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV 530 (611)
Q Consensus 459 ~~~e~~~l~~~F~~~D-~d~~G-~Is~~e~~~~l~~~~----~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~ 530 (611)
...++.+|+++|..|| .|++| +|+.+||+.+|.... +...++.++.++++.+|.|++|.|+|+||+.++...
T Consensus 17 ~~~~~~~l~~aF~~fD~~dgdGG~Is~~EL~~~l~~~l~~~lg~~~t~~ev~~li~~~D~dgdG~Idf~EF~~~m~~~ 94 (113)
T 2lnk_A 17 LEKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCI 94 (113)
T ss_dssp HHHHHHHHHHHHHHTTTTTSCTTCBCHHHHHHHHHHHCGGGGTTCCCTTHHHHHHHHHCSSSSSCBCHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcchhcCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHH
Confidence 3456788999999999 89997 999999999987522 234677889999999999999999999999987543
|
| >1xk4_C Calgranulin B; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1irj_A* | Back alignment and structure |
|---|
Probab=98.91 E-value=1.2e-09 Score=93.37 Aligned_cols=89 Identities=10% Similarity=0.110 Sum_probs=61.8
Q ss_pred hhHHHHHHHHhhhcCC-CCCC-cccHHHHHHHHH-hhcc---cc-cccCChhHHHhhcCCCCCCcccHHHHHHHHcchhh
Q 007253 460 VDELFYLKEQYALLEP-NKNG-TISLENVKSALM-KNAT---DA-MKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQ 532 (611)
Q Consensus 460 ~~e~~~l~~~F~~~D~-d~~G-~Is~~e~~~~l~-~~~~---~~-~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~ 532 (611)
++++..|+++|..||. |++| +|+.+||+.+|. .++. .. .++.++..+|..+|.|++|.|+|+||+.++.....
T Consensus 8 ~~~~~~l~~~F~~fD~~dgdG~~Is~~El~~~l~~~lg~~~~~~~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~~~~~~ 87 (113)
T 1xk4_C 8 ERNIETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFIMLMARLTW 87 (113)
T ss_dssp HHHHHHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhhcccccCHHHHHHHHHHhCCCCCCCEeHHHHHHHHHHHHH
Confidence 3456789999999995 9999 999999999997 4442 11 46678999999999999999999999998864431
Q ss_pred HHhhHHHHHHHHHHHhHHhcCCCCcc
Q 007253 533 LEALDRWEQHARCAYELFEKDGNRAI 558 (611)
Q Consensus 533 ~~~~~~~~~~~~~~F~~~D~d~~G~I 558 (611)
.....|...| +++|.-
T Consensus 88 ---------~~~~~f~~~~-~~~g~~ 103 (113)
T 1xk4_C 88 ---------ASHEKMHEGD-EGPGHH 103 (113)
T ss_dssp ---------HHHC-------------
T ss_pred ---------HHHHHHhhCC-CCCccc
Confidence 3455788888 888764
|
| >2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.91 E-value=9e-10 Score=90.13 Aligned_cols=74 Identities=16% Similarity=0.248 Sum_probs=63.6
Q ss_pred hhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcc
Q 007253 453 ALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALS 529 (611)
Q Consensus 453 ~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~ 529 (611)
.+...+++++..+++++|..+|.|++|+|+.+||..+|..++ .+..++..+|..+|.|++|.|+|+||+.++..
T Consensus 16 ~~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g---~~~~~~~~~~~~~D~d~dg~I~~~EF~~~~~~ 89 (91)
T 2pmy_A 16 FQGADGDGEELARLRSVFAACDANRSGRLEREEFRALCTELR---VRPADAEAVFQRLDADRDGAITFQEFARGFLG 89 (91)
T ss_dssp ---CHHHHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHTT---CCHHHHHHHHHHHCTTCSSEECHHHHTHHHHH
T ss_pred HHhccCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHcC---cCHHHHHHHHHHhCCCCCCCEeHHHHHHHHHH
Confidence 345668889999999999999999999999999999987775 45677899999999999999999999887643
|
| >1j7q_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1j7r_A | Back alignment and structure |
|---|
Probab=98.91 E-value=9.8e-10 Score=88.70 Aligned_cols=74 Identities=9% Similarity=0.024 Sum_probs=66.1
Q ss_pred hhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCC---hhHHHhhcCCCCCCcccHHHHHHHHcc
Q 007253 454 LSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSR---IPDFLSSLNSLQYRRMDFEEFCAAALS 529 (611)
Q Consensus 454 ~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~---~~~~~~~~D~~~~g~i~~~eF~~~~~~ 529 (611)
+...++++++.+++++|..+|.+++|+|+..||..+|..++. .+++.+ +..++..+|.|++|.|+| ||+.++..
T Consensus 4 ~~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~~~~~~~~~~~~~~~~d~~~~g~i~~-eF~~~~~~ 80 (86)
T 1j7q_A 4 KARALGPEEKDECMKIFDIFDRNAENIAPVSDTMDMLTKLGQ-TYTKRETEAIMKEARGPKGDKKNIGPE-EWLTLCSK 80 (86)
T ss_dssp CCCCCSSTHHHHHHHHHHHHSTTTTSCBCHHHHHHHHHHTSC-CCSHHHHHHHHHHHHCSSCSSCCBCTT-HHHHHHHH
T ss_pred ccccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHcC-CCCHHHHHHHHHHHHHhCCCCCCcCCH-HHHHHHHH
Confidence 445678889999999999999999999999999999988775 577788 999999999999999999 99987754
|
| >2h2k_A Protein S100-A13; calcium binding protein, metal binding protein; 2.00A {Homo sapiens} PDB: 1yur_A 1yus_A 1yut_A 1yuu_A 2egd_A 2k8m_B 2ki4_B* 2ki6_C* 2kot_A* 2l5x_B 2cxj_A | Back alignment and structure |
|---|
Probab=98.91 E-value=2.8e-09 Score=89.53 Aligned_cols=64 Identities=13% Similarity=0.255 Sum_probs=54.9
Q ss_pred HHHHHHHHhHHh-cCCC-CcccHHHHHHHhc--CCC----CccHHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 540 EQHARCAYELFE-KDGN-RAIVIEELASELG--LGP----AVPVHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 540 ~~~~~~~F~~~D-~d~~-G~It~eEl~~~l~--~~~----~~~~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
.++++.+|+.|| +|++ |+|+.+||+.+|. ++. ...++++|..+|.|+||.|+|+||+.+|....
T Consensus 21 ~~~l~~aF~~fD~~dg~~G~Is~~EL~~~l~~~lg~~~~~~~ev~~li~~~D~d~dG~Idf~EF~~~~~~~~ 92 (106)
T 2h2k_A 21 IETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKFNEYWRLIGELA 92 (106)
T ss_dssp HHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCTTTTTTCCCHHHHHHHHCTTCSSSEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcCcCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHHH
Confidence 567999999999 7986 7999999999984 442 23499999999999999999999999987653
|
| >3qr0_A Phospholipase C-beta (PLC-beta); PH domain, EF hand, C2 domain, TIM barrel domain, hydrolase, calcium binding, phospholipid binding; 2.00A {Sepia officinalis} PDB: 3qr1_A | Back alignment and structure |
|---|
Probab=98.90 E-value=9.8e-10 Score=123.61 Aligned_cols=120 Identities=15% Similarity=0.300 Sum_probs=95.6
Q ss_pred hcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhc-------CCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHH
Q 007253 472 LLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSL-------NSLQYRRMDFEEFCAAALSVHQLEALDRWEQHAR 544 (611)
Q Consensus 472 ~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~-------D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~ 544 (611)
.+|.|+||.|+..|+...|..... ...++.+++... |.+++|.|+|+||+.++..... ..+++
T Consensus 163 ~fd~n~dG~Is~kEl~~~l~~~~~---~~~el~~~~~~~~~~~~k~D~~~~g~L~FeEF~~f~~~L~~-------R~EI~ 232 (816)
T 3qr0_A 163 TTVEMEKNKIPVKAIQKCLSKDKD---DRARISKALEKIGWPSGKNDAIDLKAFDFDTFFKFYLALLE-------RSEIE 232 (816)
T ss_dssp HHTSCCSSEEEHHHHHHHHCSCHH---HHHHHHHHHHHHTSCCSTTCEEETTTCCHHHHHHHHHHHCC-------CTHHH
T ss_pred hccCCCCCCCCHHHHHHHHHhcCC---hHHHHHHHHHHhcccccccccCCCCcCCHHHHHHHHHhcCC-------HHHHH
Confidence 478999999999999997744321 134577787776 6788999999999998866432 33688
Q ss_pred HHHhHHhcCCCCcccHHHHHHHhc-CC-CC---------cc---HHHHHHHHhc--C----CCCceeHHHHHHHHhhc
Q 007253 545 CAYELFEKDGNRAIVIEELASELG-LG-PA---------VP---VHAVLHDWIR--H----TDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 545 ~~F~~~D~d~~G~It~eEl~~~l~-~~-~~---------~~---~~~~~~~~D~--~----~dG~is~~eF~~~l~~~ 602 (611)
.+|+.||.|++|+||. ||+++|. .. .. .+ +.+||..++. | ++|.|++++|..+|..-
T Consensus 233 eiF~~y~~dg~~~mT~-eL~~FL~~~Q~E~~~~~~~~~~~t~e~~~~iI~kye~~~~~~~~~~g~LsldgF~~yL~S~ 309 (816)
T 3qr0_A 233 GIFKELSKNKGNITTV-MFRDFLNDMQRHPSLHKTLFPLYTDAQCEALINDYESAVNKKGKKKGQLTKEGLLYFLMCE 309 (816)
T ss_dssp HHHHHHTTTSSSEEHH-HHHHHHHHTSSCTTSCTTTSCCCCHHHHHHHHHHHHHHHHGGGCBTTEECHHHHHHHHHSG
T ss_pred HHHHHHccCCCCcccH-HHHHHHHHhCCccccccccccccCHHHHHHHHHHhccccchhhhccCCccHHHHHHHhhcc
Confidence 9999999999999999 9999994 32 22 22 7889999887 5 79999999999999753
|
| >2y5i_A S100Z, S100 calcium binding protein Z; metal-binding protein, EF-hand, calcium regulation, oligomer neuronal development, spine2; 2.03A {Danio rerio} | Back alignment and structure |
|---|
Probab=98.90 E-value=2.6e-09 Score=88.79 Aligned_cols=64 Identities=19% Similarity=0.330 Sum_probs=54.9
Q ss_pred HHHHHHHHhHHh-cCCCC-cccHHHHHHHhc------CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 540 EQHARCAYELFE-KDGNR-AIVIEELASELG------LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 540 ~~~~~~~F~~~D-~d~~G-~It~eEl~~~l~------~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
.+.++.+|+.|| +|++| +|+.+||+.+|. ++...+ ++.+|..+|.|+||.|+|+||+.+|....
T Consensus 9 ~~~l~~~F~~fDd~dg~gG~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~~~~~ 83 (99)
T 2y5i_A 9 MDALITVFHNYSGSEGDKYKLSKGELKELLNAELTDFLMSQKDPMLVEKIMNDLDSNKDNEVDFNEFVVLVAALT 83 (99)
T ss_dssp HHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSGGGGTTSCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHhhhhccccccHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHH
Confidence 567899999998 89998 999999999984 343333 89999999999999999999999987653
|
| >1j55_A S-100P protein; metal binding protein; 2.00A {Homo sapiens} SCOP: a.39.1.2 PDB: 1ozo_A | Back alignment and structure |
|---|
Probab=98.90 E-value=2.6e-09 Score=88.12 Aligned_cols=64 Identities=16% Similarity=0.292 Sum_probs=52.7
Q ss_pred HHHHHHHHhHHh-cCC-CCcccHHHHHHHhc------CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 540 EQHARCAYELFE-KDG-NRAIVIEELASELG------LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 540 ~~~~~~~F~~~D-~d~-~G~It~eEl~~~l~------~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
.++++.+|+.|| +|+ +|+|+.+||+.+|. +|...+ ++.+|+.+|.|+||.|+|+||+.+|....
T Consensus 8 ~~~l~~~F~~fD~~dgd~G~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~~~~~ 82 (95)
T 1j55_A 8 MGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDANGDAQVDFSEFIVFVAAIT 82 (95)
T ss_dssp HHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCSSSSSSEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCCCcCCHHHHHHHHHHHhHhhcccccCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHH
Confidence 567899999999 798 58999999999984 332222 89999999999999999999999987643
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=98.90 E-value=1.4e-09 Score=96.72 Aligned_cols=106 Identities=17% Similarity=0.126 Sum_probs=81.8
Q ss_pred hhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhc-ccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchh
Q 007253 453 ALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNA-TDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVH 531 (611)
Q Consensus 453 ~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~-~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~ 531 (611)
.+...++..+ +..+|.. +++|.|+++||..++.... ........+..+|..+|.|++|.|+.+||..++....
T Consensus 33 ~~~~~~~~~~---~~~~~~~---~~~g~i~~~eF~~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~g 106 (145)
T 2bl0_B 33 SLGKNPTNAE---LNTIKGQ---LNAKEFDLATFKTVYRKPIKTPTEQSKEMLDAFRALDKEGNGTIQEAELRQLLLNLG 106 (145)
T ss_dssp HTTCCCCHHH---HHHHHHH---HTSSEECHHHHHHHHTSCCCCGGGGHHHHHHHHHHHCSSSSSEEEHHHHHHHHHHSS
T ss_pred HhCCCCCHHH---HHHHHHh---cCCCeEcHHHHHHHHHHHhhcCcccHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHcC
Confidence 3444455555 4455555 7899999999999875543 2233445678899999999999999999999886654
Q ss_pred hHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 532 QLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 532 ~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
.... ++++..+|+.+|.|++|.|+.+||..++.
T Consensus 107 ~~~~----~~~~~~~~~~~d~~~dg~i~~~eF~~~~~ 139 (145)
T 2bl0_B 107 DALT----SSEVEELMKEVSVSGDGAINYESFVDMLV 139 (145)
T ss_dssp SCCC----HHHHHHHHTTCCCCTTSEEEHHHHHHHHH
T ss_pred CCCC----HHHHHHHHHHcCCCCCCcEeHHHHHHHHH
Confidence 3333 56788999999999999999999999884
|
| >2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus} | Back alignment and structure |
|---|
Probab=98.89 E-value=2.2e-09 Score=88.40 Aligned_cols=62 Identities=27% Similarity=0.465 Sum_probs=54.4
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
++.++.+|+.||.|++|+|+.+||+.++. ++...+ ++.+|+.+|.|+||.|+|+||+.++..
T Consensus 28 ~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~e~~~l~~~~D~d~dG~I~~~EF~~~~~~ 93 (94)
T 2kz2_A 28 EEEIREAFRVEDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTA 93 (94)
T ss_dssp HHHHHHHHHHHCTTCCSCBCHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHC
T ss_pred HHHHHHHHHHHCCCCcCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHhc
Confidence 56789999999999999999999999994 454433 889999999999999999999998863
|
| >2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus} | Back alignment and structure |
|---|
Probab=98.89 E-value=2.5e-09 Score=84.13 Aligned_cols=63 Identities=22% Similarity=0.457 Sum_probs=55.7
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
.+.++.+|+.||.|++|+|+.+||+.++. ++...+ ++.+|..+|.|+||.|+|+||+.++...
T Consensus 6 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~ 72 (77)
T 2joj_A 6 KQEIKEAFDLFDTNKTGSIDYHELKVAMRALGFDVKKPEILELMNEYDREGNGYIGFDDFLDIMTEK 72 (77)
T ss_dssp HHHHHHHHHHHCCSSSSEEEHHHHHHHHHHHTCCCHHHHHHHHHHHHCCSSSSEEEHHHHHHHHTHH
T ss_pred HHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHH
Confidence 56789999999999999999999999994 554444 8889999999999999999999998764
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=98.89 E-value=1.2e-09 Score=97.11 Aligned_cols=106 Identities=9% Similarity=0.051 Sum_probs=82.4
Q ss_pred hhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhh
Q 007253 453 ALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQ 532 (611)
Q Consensus 453 ~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~ 532 (611)
.++..++..+ +..+|.. ++|.|+++||..++............+..+|..+|.|++|.|+.+||..++.....
T Consensus 35 ~~g~~~~~~~---~~~~~~~----~~g~i~~~eF~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~ 107 (143)
T 3j04_B 35 SMGKNPTDEY---LEGMMSE----APGPINFTMFLTMFGEKLNGTDPEDVIRNAFACFDEEASGFIHEDHLRELLTTMGD 107 (143)
T ss_dssp HTSCCCCHHH---HHTTTTT----SSSCCCHHHHHHHHHHTTTSSCCHHHHHHHHTTSCSSSCCCCCTTTHHHHHHTSSS
T ss_pred HhCCCCCHHH---HHHHHHh----CCCCcCHHHHHHHHHHHhccCCcHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCC
Confidence 3444555555 3344433 88999999999988765443344566889999999999999999999998876654
Q ss_pred HHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhcC
Q 007253 533 LEALDRWEQHARCAYELFEKDGNRAIVIEELASELGL 569 (611)
Q Consensus 533 ~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~~ 569 (611)
... ++++..+|+.+|.|++|.|+.+||.+++.-
T Consensus 108 ~~~----~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~ 140 (143)
T 3j04_B 108 RFT----DEEVDEMYREAPIDKKGNFNYVEFTRILKH 140 (143)
T ss_dssp CCC----HHHHHHHHHHTTCCSSSCCCSTHHHHHHHS
T ss_pred CCC----HHHHHHHHHHcCCCCCCcCcHHHHHHHHhc
Confidence 434 567889999999999999999999998853
|
| >2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.89 E-value=2.7e-09 Score=90.76 Aligned_cols=64 Identities=16% Similarity=0.163 Sum_probs=55.4
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhcCCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhcch
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELGLGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGVSS 604 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~~~ 604 (611)
.+.++.+|+.||+|++|+|+.+||+.+|. +...+ ++.++..+|.|+||.|+|+||+.+|.....
T Consensus 13 ~~~l~~~F~~~D~d~dG~I~~~El~~~l~-~~~~~~~~~~~i~~~~D~d~dG~I~~~EF~~~~~~~~~ 79 (111)
T 2kgr_A 13 RLKYRQLFNSHDKTMSGHLTGPQARTILM-QSSLPQAQLASIWNLSDIDQDGKLTAEEFILAMHLIDV 79 (111)
T ss_dssp HHHHHHHHHTTSCSSCCEEEHHHHHHHHH-TTCCCHHHHHHHHHHHCSSCCSEEEHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHHH-hCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHHHH
Confidence 56788999999999999999999999996 22222 888999999999999999999999876543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=98.89 E-value=2e-09 Score=116.58 Aligned_cols=99 Identities=12% Similarity=0.126 Sum_probs=83.8
Q ss_pred HHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHH
Q 007253 463 LFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQH 542 (611)
Q Consensus 463 ~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~ 542 (611)
..++.++|..+|.|++|.|+++||..++..... ...++++..+|..+|.|++|.|+++||..++... ... +++
T Consensus 381 ~~~~~~~~~~~D~d~~g~i~~~Ef~~~~~~~~~-~~~~~~~~~~F~~~D~d~dG~I~~~El~~~l~~~--~~~----~~~ 453 (484)
T 3nyv_A 381 EHEVDQVLDAVDFDKNGYIEYSEFVTVAMDRKT-LLSRERLERAFRMFDSDNSGKISSTELATIFGVS--DVD----SET 453 (484)
T ss_dssp HHHHHHHHHHHTCCTTSEEEHHHHHHHHHHHHH-HHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHT--TCC----HHH
T ss_pred HHHHHHHHHHhCCCCCCeEeHHHHHHHHHhccc-cCcHHHHHHHHHHHCCCCCCcCCHHHHHHHHHhc--CCC----HHH
Confidence 356889999999999999999999998766532 4556778999999999999999999999887541 112 567
Q ss_pred HHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 543 ARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 543 ~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
++.+|+.+|.|+||.|+.+||.+++.
T Consensus 454 ~~~~~~~~D~d~dG~i~~~Ef~~~~~ 479 (484)
T 3nyv_A 454 WKSVLSEVDKNNDGEVDFDEFQQMLL 479 (484)
T ss_dssp HHHHHHHHCTTCCSEEEHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCcCCHHHHHHHHH
Confidence 88999999999999999999999883
|
| >1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=98.88 E-value=8.5e-10 Score=91.07 Aligned_cols=69 Identities=13% Similarity=0.190 Sum_probs=61.5
Q ss_pred chhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcc
Q 007253 458 LTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALS 529 (611)
Q Consensus 458 l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~ 529 (611)
++.++.++++++|..+|.|++|+|+.+|++.+|...+ .++.++.++++.+|.|++|.|+|+||+.++..
T Consensus 4 ls~~~~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g---~~~~~~~~i~~~~D~d~dG~i~~~EF~~~~~~ 72 (95)
T 1c07_A 4 VSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTG---LPSTLLAHIWSLCDTKDCGKLSKDQFALAFHL 72 (95)
T ss_dssp SCSHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHTTT---CCHHHHHHHHHHHCTTCSSSEETTTHHHHHHH
T ss_pred CCHHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHcC---CCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHH
Confidence 4677889999999999999999999999999987764 45678999999999999999999999887744
|
| >4eto_A Protein S100-A4; calcium-binding protein, EF-hand, structural genomics, PSI-B protein structure initiative, NEW YORK structural genomics consortium; 1.54A {Homo sapiens} PDB: 1m31_A 2q91_A 3cga_A 3ko0_A* 3m0w_A* | Back alignment and structure |
|---|
Probab=98.88 E-value=1.7e-09 Score=88.79 Aligned_cols=73 Identities=14% Similarity=0.249 Sum_probs=59.3
Q ss_pred hhHHHHHHHHhhhcC-CCCC-CcccHHHHHHHHHh-hc---ccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhh
Q 007253 460 VDELFYLKEQYALLE-PNKN-GTISLENVKSALMK-NA---TDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQ 532 (611)
Q Consensus 460 ~~e~~~l~~~F~~~D-~d~~-G~Is~~e~~~~l~~-~~---~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~ 532 (611)
+..+..|+++|+.|| .||+ |+|+.+||+.+|.. ++ +...++.+++++++.+|.|+||.|+|+||+.++.....
T Consensus 6 e~~~~~l~~~F~~fd~~dg~~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~d~DG~Idf~EF~~~~~~~~~ 84 (93)
T 4eto_A 6 EKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCIAM 84 (93)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGC---CCHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcccCCCCCeECHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHHHH
Confidence 456788999999998 5775 89999999999976 43 12345678999999999999999999999998866543
|
| >3zwh_A Protein S100-A4; Ca-binding protein-motor protein complex, S100 proteins, EF-; 1.94A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.88 E-value=1.7e-09 Score=90.54 Aligned_cols=73 Identities=15% Similarity=0.258 Sum_probs=60.1
Q ss_pred hhHHHHHHHHhhhcC-CCCC-CcccHHHHHHHHHh-hc---ccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhh
Q 007253 460 VDELFYLKEQYALLE-PNKN-GTISLENVKSALMK-NA---TDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQ 532 (611)
Q Consensus 460 ~~e~~~l~~~F~~~D-~d~~-G~Is~~e~~~~l~~-~~---~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~ 532 (611)
+..+.+|+++|+.|| .||+ |+|+.+||+.+|.. ++ +...++.+++++|+.+|.|+||.|+|+||+.++.....
T Consensus 9 e~~~~~l~~aF~~fD~~dgd~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~dgDG~Idf~EF~~~m~~~~~ 87 (104)
T 3zwh_A 9 EKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSWLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSSIAM 87 (104)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGSCSSCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHcchhccCCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHHH
Confidence 456788999999997 6775 89999999999976 43 12345678999999999999999999999998866543
|
| >3nxa_A Protein S100-A16; S100 family, calcium binding protein, APO, EF-hand calcium binding proteins, S100 proteins, protein dynamics, binding protein; 2.10A {Homo sapiens} SCOP: a.39.1.0 PDB: 2l0u_A 2l0v_A 2l50_A 2l51_A | Back alignment and structure |
|---|
Probab=98.88 E-value=4.6e-09 Score=87.34 Aligned_cols=73 Identities=14% Similarity=0.230 Sum_probs=60.6
Q ss_pred hhHHHHHHHHhhhcCCCC---CCcccHHHHHHHHHhhcccccc----cCChhHHHhhcCCCCCCcccHHHHHHHHcchhh
Q 007253 460 VDELFYLKEQYALLEPNK---NGTISLENVKSALMKNATDAMK----DSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQ 532 (611)
Q Consensus 460 ~~e~~~l~~~F~~~D~d~---~G~Is~~e~~~~l~~~~~~~~~----~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~ 532 (611)
+..+++|+++|+.||.++ +|+|+.+||+.+|...++..++ +.++.++++.+|.|++|.|+|+||+.++.....
T Consensus 7 e~~i~~l~~~F~~fD~~~g~~~G~Is~~EL~~~l~~~~~~~l~~~~~~~ev~~~i~~~D~d~DG~Idf~EF~~~m~~~~~ 86 (100)
T 3nxa_A 7 EKAVIVLVENFYKYVSKYSLVKNKISKSSFREMLQKELNHMLSDTGNRKAADKLIQNLDANHDGRISFDEYWTLIGGITG 86 (100)
T ss_dssp HHHHHHHHHHHHHTSCTTCSCTTCBCHHHHHHHHHHHSTTTTCSSHHHHHHHHHHHHSCCCSSCCBCHHHHHHHHHHHHG
T ss_pred HHHHHHHHHHHHHHcCcCCCCCCeEcHHHHHHHHHHHccccccccccHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHHH
Confidence 456778999999999964 7999999999999876543333 457899999999999999999999998866543
|
| >3nxa_A Protein S100-A16; S100 family, calcium binding protein, APO, EF-hand calcium binding proteins, S100 proteins, protein dynamics, binding protein; 2.10A {Homo sapiens} SCOP: a.39.1.0 PDB: 2l0u_A 2l0v_A 2l50_A 2l51_A | Back alignment and structure |
|---|
Probab=98.88 E-value=2.4e-09 Score=89.00 Aligned_cols=65 Identities=14% Similarity=0.198 Sum_probs=54.6
Q ss_pred HHHHHHHHhHHhcCC---CCcccHHHHHHHhc--CCCC-------ccHHHHHHHHhcCCCCceeHHHHHHHHhhcch
Q 007253 540 EQHARCAYELFEKDG---NRAIVIEELASELG--LGPA-------VPVHAVLHDWIRHTDGKLSFLGFVKLLHGVSS 604 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~---~G~It~eEl~~~l~--~~~~-------~~~~~~~~~~D~~~dG~is~~eF~~~l~~~~~ 604 (611)
.++++.+|+.||.++ +|+|+.+||+.+|. .+.. ..++++|+.+|.|+||.|+|+||+.+|..+..
T Consensus 10 i~~l~~~F~~fD~~~g~~~G~Is~~EL~~~l~~~~~~~l~~~~~~~ev~~~i~~~D~d~DG~Idf~EF~~~m~~~~~ 86 (100)
T 3nxa_A 10 VIVLVENFYKYVSKYSLVKNKISKSSFREMLQKELNHMLSDTGNRKAADKLIQNLDANHDGRISFDEYWTLIGGITG 86 (100)
T ss_dssp HHHHHHHHHHTSCTTCSCTTCBCHHHHHHHHHHHSTTTTCSSHHHHHHHHHHHHSCCCSSCCBCHHHHHHHHHHHHG
T ss_pred HHHHHHHHHHHcCcCCCCCCeEcHHHHHHHHHHHccccccccccHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHHH
Confidence 567899999999964 79999999999984 2221 12899999999999999999999999987653
|
| >3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C | Back alignment and structure |
|---|
Probab=98.88 E-value=2.2e-09 Score=97.80 Aligned_cols=110 Identities=11% Similarity=0.099 Sum_probs=85.5
Q ss_pred HHHhhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhccc--ccccCChhHHHhhcCCCCCCcccHHHHHHHH
Q 007253 450 ALRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATD--AMKDSRIPDFLSSLNSLQYRRMDFEEFCAAA 527 (611)
Q Consensus 450 ~l~~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~--~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~ 527 (611)
+++.++...++.++.. ++. .|.+++|.|+++||..++...... .....++..+|+.+|.|++|.|+.+||..++
T Consensus 36 ~lr~lG~~~t~~el~~---~~~-~d~~~~g~i~f~eFl~~~~~~~~~~~~~~~~~l~~aF~~fD~d~~G~I~~~el~~~l 111 (159)
T 3i5g_C 36 LLRCLGMNPTEAQVHQ---HGG-TKKMGEKAYKLEEILPIYEEMSSKDTGTAADEFMEAFKTFDREGQGLISSAEIRNVL 111 (159)
T ss_dssp HHHHTTCCCCHHHHHT---TTC-CSSTTSCEECHHHHHHHHHHHTTCCTTCCHHHHHHHHHHHCTTSSSEECHHHHHHHH
T ss_pred HHHHcCCCCCHHHHHH---HHc-ccccCCCcccHHHHHHHHHHhhcccccchHHHHHHHHHHHhcCCCCcCcHHHHHHHH
Confidence 4556777777777554 333 477899999999999987665432 1233457889999999999999999999988
Q ss_pred cchhhHHhhHHHHHHHHHHHhHHhc--CCCCcccHHHHHHHh
Q 007253 528 LSVHQLEALDRWEQHARCAYELFEK--DGNRAIVIEELASEL 567 (611)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~F~~~D~--d~~G~It~eEl~~~l 567 (611)
........ ++++..+++.+|. |++|.|+.+||.++|
T Consensus 112 ~~~g~~ls----~~e~~~l~~~~D~~~d~dG~I~~~EF~~~m 149 (159)
T 3i5g_C 112 KMLGERIT----EDQCNDIFTFCDIREDIDGNIKYEDLMKKV 149 (159)
T ss_dssp HHSSSCCC----HHHHHHHHHHTTCCCCSSCCEEHHHHHHHH
T ss_pred HHhCCCCC----HHHHHHHHHHhCcCCCCCCeEeHHHHHHHH
Confidence 76654444 6678899999994 889999999998877
|
| >2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A | Back alignment and structure |
|---|
Probab=98.88 E-value=2.8e-10 Score=96.21 Aligned_cols=100 Identities=11% Similarity=0.092 Sum_probs=78.4
Q ss_pred hcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcch---hh
Q 007253 456 KTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV---HQ 532 (611)
Q Consensus 456 ~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~---~~ 532 (611)
..+++++ +.++|..+| ++|.|+++||..++. .. .....++..+|..+|.|++|.|+.+||..++... ..
T Consensus 4 ~~~~~~e---~~~l~~~~d--~~g~i~~~eF~~~~~-~~--~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~ 75 (108)
T 2kyc_A 4 DILSPSD---IAAALRDCQ--APDSFSPKKFFQISG-MS--KKSSSQLKEIFRILDNDQSGFIEEDELKYFLQRFESGAR 75 (108)
T ss_dssp SSSCHHH---HHHHHTTSC--STTTCCHHHHHHHHT-CT--TCCSSSHHHHCSSSCSCCSSCCCGGGTTTSHHHHSSSCC
T ss_pred ccCCHHH---HHHHHHHcC--CCCcCCHHHHHHHHh-hC--cccHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHhhccC
Confidence 3455555 667788888 889999999998763 21 2445678999999999999999999998766544 22
Q ss_pred HHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHh
Q 007253 533 LEALDRWEQHARCAYELFEKDGNRAIVIEELASEL 567 (611)
Q Consensus 533 ~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l 567 (611)
... ++++..+|+.+|.|++|.|+.+||..++
T Consensus 76 ~~~----~~~~~~~~~~~D~d~dg~i~~~eF~~~~ 106 (108)
T 2kyc_A 76 VLT----ASETKTFLAAADHDGDGKIGAEEFQEMV 106 (108)
T ss_dssp CCC----TTTTHHHHTTTCCSSSSCCCSSHHHHHH
T ss_pred CCC----HHHHHHHHHHhCCCCCCcCCHHHHHHHH
Confidence 222 4467889999999999999999999876
|
| >1iq3_A Ralbp1-interacting protein (partner of ralbp1); EF-hand domain, POB1 EH domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=98.88 E-value=9.5e-10 Score=93.28 Aligned_cols=71 Identities=20% Similarity=0.243 Sum_probs=62.7
Q ss_pred cchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcch
Q 007253 457 TLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV 530 (611)
Q Consensus 457 ~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~ 530 (611)
.++.++..+++++|..||.|++|+|+.+|++.+|...+ .+++++.+|++.+|.|++|.|+|+||+.++...
T Consensus 15 ~ls~~~~~~~~~~F~~~D~d~dG~Is~~el~~~l~~~g---l~~~el~~i~~~~D~d~dG~I~~~EF~~~m~~~ 85 (110)
T 1iq3_A 15 RITEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTKSK---LSIPELSYIWELSDADCDGALTLPEFCAAFHLI 85 (110)
T ss_dssp CCSSSSHHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSS---CSSCCHHHHHHHHCSSSCSEEEHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcC---CCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHH
Confidence 35778889999999999999999999999999886653 567889999999999999999999999877543
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A | Back alignment and structure |
|---|
Probab=98.88 E-value=4.5e-09 Score=96.57 Aligned_cols=94 Identities=7% Similarity=0.150 Sum_probs=77.3
Q ss_pred HHHHhhhcCCCCCCcccHHHHHHHHHhhccc----ccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHH
Q 007253 466 LKEQYALLEPNKNGTISLENVKSALMKNATD----AMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQ 541 (611)
Q Consensus 466 l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~----~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~ 541 (611)
+..+|..+| ++|.|+++||..++...... ......+..+|..+|.|++|.|+.+||..++.... .. ++
T Consensus 57 ~~~l~~~~D--~~g~i~~~EF~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~g--~~----~~ 128 (174)
T 1q80_A 57 WDNFLTAVA--GGKGIDETTFINSMKEMVKNPEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFFGMLG--LD----KT 128 (174)
T ss_dssp HHHTGGGTT--TTSCEEHHHHHHHHHHHTTSTTCHHHHHTHHHHHHHHHCTTSSSSBCHHHHHHHHHHHT--CC----GG
T ss_pred HHHHHHhcC--CCCeEcHHHHHHHHHHHcCcccHHHHHHHHHHHHHHHhCCCCCCcccHHHHHHHHHHcC--CC----HH
Confidence 467899999 99999999999987665431 12246678899999999999999999998876652 22 44
Q ss_pred HHHHHHhHHhcCCCCcccHHHHHHHh
Q 007253 542 HARCAYELFEKDGNRAIVIEELASEL 567 (611)
Q Consensus 542 ~~~~~F~~~D~d~~G~It~eEl~~~l 567 (611)
++..+|+.+|.|++|.|+.+||..++
T Consensus 129 ~~~~~~~~~D~d~dg~i~~~ef~~~~ 154 (174)
T 1q80_A 129 MAPASFDAIDTNNDGLLSLEEFVIAG 154 (174)
T ss_dssp GHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred HHHHHHHHhCCCCCceEeHHHHHHHH
Confidence 68889999999999999999999877
|
| >1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A | Back alignment and structure |
|---|
Probab=98.87 E-value=4.7e-09 Score=85.43 Aligned_cols=63 Identities=21% Similarity=0.433 Sum_probs=55.8
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
.+.++.+|+.||+|++|+|+.+||+.++. +|...+ ++.+|..+|.|+||.|+|+||+.++...
T Consensus 19 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~D~~~dg~i~~~eF~~~~~~~ 85 (90)
T 1avs_A 19 IAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVRQ 85 (90)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCCSSEEHHHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHH
Confidence 56788999999999999999999999994 555444 8899999999999999999999988764
|
| >2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.87 E-value=1.8e-09 Score=91.88 Aligned_cols=70 Identities=11% Similarity=0.208 Sum_probs=61.6
Q ss_pred chhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcch
Q 007253 458 LTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV 530 (611)
Q Consensus 458 l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~ 530 (611)
+++++.++++++|..+|.|++|+|+.+||+.+|.. ..+++.++..+++.+|.|++|.|+|+||+.++...
T Consensus 8 ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~---~~~~~~~~~~i~~~~D~d~dG~I~~~EF~~~~~~~ 77 (111)
T 2kgr_A 8 VPQSSRLKYRQLFNSHDKTMSGHLTGPQARTILMQ---SSLPQAQLASIWNLSDIDQDGKLTAEEFILAMHLI 77 (111)
T ss_dssp SCHHHHHHHHHHHHTTSCSSCCEEEHHHHHHHHHT---TCCCHHHHHHHHHHHCSSCCSEEEHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHh---CCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHH
Confidence 57788899999999999999999999999999862 34677789999999999999999999999877543
|
| >1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7 | Back alignment and structure |
|---|
Probab=98.87 E-value=2.3e-09 Score=90.03 Aligned_cols=81 Identities=11% Similarity=0.103 Sum_probs=63.9
Q ss_pred cccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeH
Q 007253 517 RMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSF 592 (611)
Q Consensus 517 ~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~ 592 (611)
.++++++...+...... . .+.++.+|+.||+|++|+|+.+||+.+|. ++...+ ++.++..+|.|+||.|+|
T Consensus 5 ~~~~~~~~~~l~~~~~~-~----~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~e~~~l~~~~d~~~~g~i~~ 79 (105)
T 1wlz_A 5 ATADRDILARLHKAVTS-H----YHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPVNAKGRLKY 79 (105)
T ss_dssp TTCCHHHHHHHHHHHHH-T----HHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTSCBCTTSCBCH
T ss_pred chhHHHHHHHHHHHHHc-h----HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCCCCCcH
Confidence 45667777765543321 1 56789999999999999999999999994 454444 888999999999999999
Q ss_pred HHHHHHHhhc
Q 007253 593 LGFVKLLHGV 602 (611)
Q Consensus 593 ~eF~~~l~~~ 602 (611)
+||+.++...
T Consensus 80 ~eF~~~~~~~ 89 (105)
T 1wlz_A 80 PDFLSRFSSE 89 (105)
T ss_dssp HHHHHHHC--
T ss_pred HHHHHHHhcc
Confidence 9999999764
|
| >3rm1_A Protein S100-B; alpha-helical, EF hand, metal binding protein-protein bindin; 1.24A {Bos taurus} PDB: 3rlz_A 1cfp_A 3cr2_A 3cr4_X* 3cr5_X* 3gk1_A* 3gk2_A* 3gk4_X* 3iqo_A 3iqq_A 3lle_A* 1psb_A 3czt_X 2h61_A 3d0y_A* 3d10_A* 3hcm_A* 3lk1_A* 3lk0_A* 1b4c_A ... | Back alignment and structure |
|---|
Probab=98.87 E-value=3.5e-09 Score=86.78 Aligned_cols=64 Identities=14% Similarity=0.204 Sum_probs=54.9
Q ss_pred HHHHHHHHhHHhcCCCC---cccHHHHHHHhc------CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhcch
Q 007253 540 EQHARCAYELFEKDGNR---AIVIEELASELG------LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGVSS 604 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G---~It~eEl~~~l~------~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~~~ 604 (611)
.+.++.+|+.|| +++| +|+.+||+.+|. ++...+ ++.+|+.+|.|+||.|+|+||+.+|..+..
T Consensus 8 ~~~l~~~F~~~D-~~dG~~g~Is~~EL~~~l~~~~~~~lg~~~~~~~v~~~~~~~D~d~dG~I~f~EF~~~~~~l~~ 83 (92)
T 3rm1_A 8 VVALIDVFHQYS-GREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSNGDGECDFQEFMAFVAMITT 83 (92)
T ss_dssp HHHHHHHHHHHH-TSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHc-cCCCCcCeECHHHHHHHHHHHhhhhccCcccHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHHH
Confidence 457889999999 7766 999999999983 555444 899999999999999999999999987653
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A | Back alignment and structure |
|---|
Probab=98.86 E-value=3e-09 Score=101.34 Aligned_cols=102 Identities=9% Similarity=0.053 Sum_probs=77.5
Q ss_pred HHHhhhcCCCCCCcccHHHHHHHHHhhcccc---------------cccCChhHHHhhcCCCCCCcccHHHHHHHHcch-
Q 007253 467 KEQYALLEPNKNGTISLENVKSALMKNATDA---------------MKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV- 530 (611)
Q Consensus 467 ~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~---------------~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~- 530 (611)
.++|..+|.+++|.|+++||..++....... .....+..+|..+|.|++|.|+.+||..++...
T Consensus 64 ~~l~~~~d~~~~g~i~~~EF~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~ 143 (208)
T 2ct9_A 64 DRIINAFFSEGEDQVNFRGFMRTLAHFRPIEDNEKSKDVNGPEPLNSRSNKLHFAFRLYDLDKDDKISRDELLQVLRMMV 143 (208)
T ss_dssp HHHHHTTSCTTCSCEEHHHHHHHHHTTSCCC-----------CCTTSHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHS
T ss_pred HHHHHHHcCCCCCcCcHHHHHHHHHhhccccchhhhcccccccccccHHHHHHHHHHHHCCCCCCEEcHHHHHHHHHHHh
Confidence 3578889999999999999999876543210 133457789999999999999999999888654
Q ss_pred hhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 531 HQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 531 ~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
......+..++.+..+|+.+|.|++|.|+.+||..++.
T Consensus 144 g~~~s~~~~~~l~~~~~~~~D~d~dG~Is~~EF~~~~~ 181 (208)
T 2ct9_A 144 GVNISDEQLGSIADRTIQEADQDGDSAISFTEFVKVLE 181 (208)
T ss_dssp CTTCCHHHHHHHHHHHHHHHCSSSSSSEEHHHHHHTTT
T ss_pred CCCCCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHh
Confidence 32223222233344459999999999999999999885
|
| >1k9u_A Polcalcin PHL P 7; pollen allergen, calcium-binding, EF-hand, cross-reactivity; 1.75A {Phleum pratense} SCOP: a.39.1.10 | Back alignment and structure |
|---|
Probab=98.86 E-value=1.3e-09 Score=86.14 Aligned_cols=65 Identities=17% Similarity=0.278 Sum_probs=58.7
Q ss_pred HHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcch
Q 007253 464 FYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV 530 (611)
Q Consensus 464 ~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~ 530 (611)
++++++|..+|.+++|+|+.+||..++...+ ..++.++..++..+|.|++|.|+|+||+.++...
T Consensus 3 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~~g--~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~~~~~ 67 (78)
T 1k9u_A 3 DDMERIFKRFDTNGDGKISLSELTDALRTLG--STSADEVQRMMAEIDTDGDGFIDFNEFISFCNAN 67 (78)
T ss_dssp CHHHHHHHHHCTTCSSEECHHHHHHHHHHHH--TCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHC
T ss_pred HHHHHHHHHHCCCCCCcCcHHHHHHHHHHhC--CCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHC
Confidence 3688999999999999999999999998876 5778889999999999999999999999987654
|
| >1j55_A S-100P protein; metal binding protein; 2.00A {Homo sapiens} SCOP: a.39.1.2 PDB: 1ozo_A | Back alignment and structure |
|---|
Probab=98.86 E-value=3.1e-09 Score=87.60 Aligned_cols=71 Identities=13% Similarity=0.227 Sum_probs=56.7
Q ss_pred hhHHHHHHHHhhhcC-CCC-CCcccHHHHHHHHHhhc----ccccccCChhHHHhhcCCCCCCcccHHHHHHHHcch
Q 007253 460 VDELFYLKEQYALLE-PNK-NGTISLENVKSALMKNA----TDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV 530 (611)
Q Consensus 460 ~~e~~~l~~~F~~~D-~d~-~G~Is~~e~~~~l~~~~----~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~ 530 (611)
++++.+|+++|..|| .|+ +|+|+.+||+.+|.... +...++.++..+++.+|.|++|.|+|+||+.++...
T Consensus 5 ~~~~~~l~~~F~~fD~~dgd~G~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~~~~ 81 (95)
T 1j55_A 5 ETAMGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDANGDAQVDFSEFIVFVAAI 81 (95)
T ss_dssp HHHHHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCSSSSSSEEHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhccCCCCCcCCHHHHHHHHHHHhHhhcccccCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHH
Confidence 456778999999999 688 58999999999997632 234677889999999999999999999999987654
|
| >1qjt_A EH1, epidermal growth factor receptor substrate substrate 15, EPS15; EH domain, EF-hand, solution structure, S100 protein; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=98.86 E-value=1.7e-09 Score=89.86 Aligned_cols=64 Identities=17% Similarity=0.073 Sum_probs=55.0
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCC-ccHHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELG-LGPA-VPVHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~-~~~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
.++++.+|+.||+|++|+|+.+|++.+|. .+.. ..+++++..+|.|+||.|+|+||+.+|....
T Consensus 10 ~~~~~~~F~~~D~d~dG~Is~~el~~~l~~~~l~~~~l~~i~~~~D~d~dG~i~~~EF~~~~~~~~ 75 (99)
T 1qjt_A 10 NPVYEKYYRQVEAGNTGRVLALDAAAFLKKSGLPDLILGKIWDLADTDGKGVLSKQEFFVALRLVA 75 (99)
T ss_dssp CTHHHHHHHHHCCTTSSCCCSHHHHHHHHTSSSCHHHHHHHHHHHCCSSSSSCCSHHHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHH
Confidence 34688999999999999999999999994 4432 2289999999999999999999999997654
|
| >2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A | Back alignment and structure |
|---|
Probab=98.86 E-value=5.1e-09 Score=84.37 Aligned_cols=63 Identities=24% Similarity=0.379 Sum_probs=56.2
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
.+.++.+|+.+|.|++|+|+.+||+.++. +| ..+ ++.++..+|.|+||.|+|+||+.++....
T Consensus 10 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g-~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~~ 76 (86)
T 2opo_A 10 IADRERIFKRFDTNGDGKISSSELGDALKTLG-SVTPDEVRRMMAEIDTDGDGFISFDEFTDFARANR 76 (86)
T ss_dssp HHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTT-TCCHHHHHHHHHHHCTTCSSEECHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHCCCCCCCcCHHHHHHHHHHcC-CCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHCc
Confidence 56789999999999999999999999995 56 444 88999999999999999999999987754
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B | Back alignment and structure |
|---|
Probab=98.85 E-value=5.3e-09 Score=95.49 Aligned_cols=101 Identities=9% Similarity=0.032 Sum_probs=78.1
Q ss_pred cchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhh
Q 007253 457 TLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEAL 536 (611)
Q Consensus 457 ~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~ 536 (611)
.++..+ +..+|.. .+|.|+++||..++............+..+|..+|.|++|.|+.+||..++........
T Consensus 58 ~~~~~~---~~~l~~~----~dg~i~~~eF~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~- 129 (166)
T 2mys_B 58 NVKNEE---LDAMIKE----ASGPINFTVFLTMFGEKLKGADPEDVIMGAFKVLDPDGKGSIKKSFLEELLTTGGGRFT- 129 (166)
T ss_pred CCCHHH---HHHHHHH----CCCCcCHHHHHHHHHHHhccCCcHHHHHHHHHHhCCCCCcceeHHHHHHHHHHcCCCCC-
Confidence 445555 3444443 37999999999987665433334566888999999999999999999998876543333
Q ss_pred HHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 537 DRWEQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 537 ~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
++++..+|+.+|.|++|.|+.+||..++.
T Consensus 130 ---~~~~~~~~~~~D~d~dg~I~~~eF~~~~~ 158 (166)
T 2mys_B 130 ---PEEIKNMWAAFPPDVAGNVDYKNICYVIT 158 (166)
T ss_pred ---HHHHHHHHHhcCCCCCCeEeHHHHHHHHH
Confidence 56788999999999999999999999884
|
| >1eh2_A EPS15; calcium binding, signaling domain, NPF binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 PDB: 2jxc_A 1f8h_A 1ff1_A | Back alignment and structure |
|---|
Probab=98.85 E-value=3.1e-09 Score=89.33 Aligned_cols=69 Identities=19% Similarity=0.228 Sum_probs=61.8
Q ss_pred chhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcch
Q 007253 458 LTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV 530 (611)
Q Consensus 458 l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~ 530 (611)
++.++..+++++|..+|+ ++|+|+.+|++.+|...+ .++.++.+|+...|.|++|.|+|+||+.++...
T Consensus 9 ls~~e~~~~~~~F~~~D~-~dG~Is~~el~~~l~~~g---l~~~el~~i~~~~D~d~dG~id~~EF~~~m~~~ 77 (106)
T 1eh2_A 9 VKPEDKAKYDAIFDSLSP-VNGFLSGDKVKPVLLNSK---LPVDILGRVWELSDIDHDGMLDRDEFAVAMFLV 77 (106)
T ss_dssp SCHHHHHHHHHHHTTSCC-SSSCCBHHHHHHHHHTTT---CCHHHHHHHHHHHCSSCSSBCCHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHhCC-CCCeEcHHHHHHHHHHcC---CCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHH
Confidence 577889999999999999 999999999999998764 567789999999999999999999999877543
|
| >2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max} | Back alignment and structure |
|---|
Probab=98.85 E-value=5.7e-09 Score=85.26 Aligned_cols=64 Identities=28% Similarity=0.455 Sum_probs=56.4
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
.+.++.+|+.||.|++|+|+.+||+.+|. ++...+ ++.+|..+|.|+||.|+|+||+.++....
T Consensus 8 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~~dg~i~~~eF~~~~~~~~ 75 (92)
T 2kn2_A 8 EEELKEAFKVFDKDQNGYISASELRHVMINLGEKLTDEEVEQMIKEADLDGDGQVNYEEFVKMMMTVR 75 (92)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSCCSSEEHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHCCCCCCeEcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhcc
Confidence 56789999999999999999999999994 665444 88999999999999999999999887653
|
| >1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A | Back alignment and structure |
|---|
Probab=98.84 E-value=3.4e-09 Score=84.38 Aligned_cols=63 Identities=19% Similarity=0.414 Sum_probs=55.4
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhc-CC-CCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELG-LG-PAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~-~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
++.++ +|+.||.|++|+|+.+||+.++. ++ ...+ +..+|..+|.|+||.|+|+||+.++....
T Consensus 8 ~~~l~-~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~~ 75 (81)
T 1c7v_A 8 EEILR-AFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVIDIPEFMDLIKKSK 75 (81)
T ss_dssp HHHHH-HHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCSSGGGSEEHHHHHHHHHCC-
T ss_pred HHHHH-HHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhhh
Confidence 56789 99999999999999999999995 66 4444 88999999999999999999999987654
|
| >2kax_A Protein S100-A5; EF-hand, calcium binding protien, calcium, polymorphism, structural genomics, spine2, structural proteomics in europe, spine; NMR {Homo sapiens} PDB: 2kay_A | Back alignment and structure |
|---|
Probab=98.83 E-value=6.9e-09 Score=84.97 Aligned_cols=64 Identities=13% Similarity=0.336 Sum_probs=55.0
Q ss_pred HHHHHHHHhHHh-cCCCC-cccHHHHHHHhc----CCC--CccHHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 540 EQHARCAYELFE-KDGNR-AIVIEELASELG----LGP--AVPVHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 540 ~~~~~~~F~~~D-~d~~G-~It~eEl~~~l~----~~~--~~~~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
.+.++.+|+.|| +|++| +|+.+||+.+|. ++. ...++.+|..+|.|+||.|+|+||+.++....
T Consensus 9 ~~~l~~~F~~~D~~d~dG~~I~~~El~~~l~~~~~~~~~~~~~i~~~~~~~D~d~dG~I~f~EF~~~~~~~~ 80 (92)
T 2kax_A 9 LTTMVTTFHKYSGREGSKLTLSRKELKELIKKELCLGEMKESSIDDLMKSLDKNSDQEIDFKEYSVFLTMLC 80 (92)
T ss_dssp HHHHHHHHHHHHTTSSCSSEEEHHHHHHHHHHHSCCTTTCCTTHHHHHHHHTTTCSSEEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhCCCCCeeCHHHHHHHHHHHcCCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHH
Confidence 567899999999 99999 999999999984 222 22299999999999999999999999997654
|
| >1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.83 E-value=2.5e-09 Score=81.56 Aligned_cols=64 Identities=16% Similarity=0.314 Sum_probs=56.2
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcc
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALS 529 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~ 529 (611)
+++++|..+|.+++|.|+.+||..++...+. ..++.++..+|..+|.|++|.|+|+||+.++..
T Consensus 2 ~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~-~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~~~~ 65 (67)
T 1tiz_A 2 SAKRVFEKFDKNKDGKLSLDEFREVALAFSP-YFTQEDIVKFFEEIDVDGNGELNADEFTSCIEK 65 (67)
T ss_dssp THHHHHHHHCTTSSSCEEHHHHHHHHHHTCT-TSCHHHHHHHHHHHCCSSSSEECHHHHHHHHHT
T ss_pred HHHHHHHHHCCCCCCcCcHHHHHHHHHHhCC-CCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH
Confidence 5789999999999999999999999877764 567778899999999999999999999987753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 611 | ||||
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-87 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-87 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-85 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-84 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-83 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-81 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-80 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-77 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-77 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-77 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-76 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-76 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-75 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-73 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-72 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-72 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-72 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-72 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-71 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-68 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-67 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-66 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-65 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-64 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-64 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-64 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-62 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-62 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-62 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-61 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-61 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-61 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-61 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-60 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-59 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-59 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-59 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-59 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-58 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-58 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-58 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-57 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-54 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-54 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-54 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-53 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-53 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-52 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-52 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-50 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-48 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-46 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-42 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-20 | |
| d1lkja_ | 146 | a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom | 4e-14 | |
| d1topa_ | 162 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 4e-10 | |
| d1exra_ | 146 | a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetr | 7e-10 | |
| d1dtla_ | 156 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 3e-08 | |
| d1s6ia_ | 182 | a.39.1.5 (A:) Calcium-dependent protein kinase sk5 | 8e-08 | |
| d1s6ja_ | 87 | a.39.1.5 (A:) Calcium-dependent protein kinase sk5 | 3e-06 | |
| d1uhka1 | 187 | a.39.1.5 (A:3-189) Calcium-regulated photoprotein | 1e-05 | |
| d2obha1 | 141 | a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapien | 4e-05 | |
| d1jc2a_ | 75 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 6e-05 | |
| d2scpa_ | 174 | a.39.1.5 (A:) Sarcoplasmic calcium-binding protein | 6e-05 | |
| d1j7la_ | 263 | d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phos | 1e-04 | |
| d1w7jb1 | 139 | a.39.1.5 (B:11-149) Myosin Essential Chain {Human | 1e-04 | |
| d1f54a_ | 77 | a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom | 2e-04 | |
| d1bjfa_ | 181 | a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId | 5e-04 | |
| d1qxpa2 | 188 | a.39.1.8 (A:515-702) Calpain large subunit, C-term | 6e-04 | |
| d1qxpa2 | 188 | a.39.1.8 (A:515-702) Calpain large subunit, C-term | 0.004 | |
| d1qv0a_ | 189 | a.39.1.5 (A:) Calcium-regulated photoprotein {Hydr | 6e-04 | |
| d1c7va_ | 68 | a.39.1.5 (A:) Calcium vector protein {Amphioxus (B | 8e-04 | |
| d1c7va_ | 68 | a.39.1.5 (A:) Calcium vector protein {Amphioxus (B | 0.004 | |
| d2pq3a1 | 73 | a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [T | 9e-04 | |
| d1nyaa_ | 176 | a.39.1.5 (A:) Calerythrin {Saccharopolyspora eryth | 0.002 | |
| d1pvaa_ | 109 | a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [Tax | 0.002 | |
| d2zkmx1 | 170 | a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human | 0.003 | |
| d1wdcb_ | 142 | a.39.1.5 (B:) Myosin Essential Chain {Bay scallop | 0.003 | |
| d1rwya_ | 109 | a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [Ta | 0.003 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 272 bits (696), Expect = 2e-87
Identities = 114/301 (37%), Positives = 168/301 (55%), Gaps = 8/301 (2%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
++ + Y+ + +G G F A+ K+ + VA+K I K + + E+
Sbjct: 4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRT---QKLVAIKCIAKKALEGKE--GSMENEI 58
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
+L + H N+V D YE ++Y++M+L GGEL DRI+ +G YTE DA ++ Q+
Sbjct: 59 AVLHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQV 116
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
L+ V + H G+VHRDLKPEN L+ + DE+S + DFGLS P L+ G+ YV
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYV 176
Query: 330 APEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388
APEVL + YS D WSIGVIAYILLCG PF+ ++ +F +LKA+ FD W +
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 236
Query: 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRK 448
S A+DF++ L+ KDP KR T QAL HPWI + + + + +K S ++
Sbjct: 237 SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQ 296
Query: 449 A 449
A
Sbjct: 297 A 297
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 273 bits (698), Expect = 4e-87
Identities = 97/333 (29%), Positives = 158/333 (47%), Gaps = 13/333 (3%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
H + Y++ EE+G G FG + G A K + + E VR+E++
Sbjct: 22 DHVLDHYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTPHES---DKETVRKEIQ 75
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQIL 270
+ L H LV DA+ED + + ++ E GGEL +++ K +ED+A M Q+
Sbjct: 76 TMSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 134
Query: 271 NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVA 330
+ H VH DLKPEN +FTT ++ LK IDFGL+ + P + + G+A + A
Sbjct: 135 KGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAA 193
Query: 331 PEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
PEV + D+WS+GV++YILL G PF + R V D + D++ + +S
Sbjct: 194 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS 253
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDV---IIFKLMKAYMRSSSL 446
+ +DF+++LL DP R+T QAL HPW+ N + K+ +
Sbjct: 254 EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDA 313
Query: 447 RKAALRALSKTLTVDELF-YLKEQYALLEPNKN 478
L L + L + ++Y++ + +
Sbjct: 314 WPEPLPPLGRISNYSSLRKHRPQEYSIRDAFWD 346
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 268 bits (686), Expect = 3e-85
Identities = 98/307 (31%), Positives = 153/307 (49%), Gaps = 10/307 (3%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ Y++ EE+G G FG K G+ K I + V+ E+ I+
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTPYP---LDKYTVKNEISIMNQ 82
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L H L+ DA+ED + +++E GGEL DRI + K +E + M Q +
Sbjct: 83 LH-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL 334
H +VH D+KPEN + TK +SV K IDFGL+ + PDE + +A + APE++
Sbjct: 142 HMHEHSIVHLDIKPENIMCETKKASSV-KIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 200
Query: 335 HRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393
R D+W+IGV+ Y+LL G PF + + V + D FDE + S+S EA+
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260
Query: 394 DFVKRLLNKDPRKRLTAAQALSHPWIK-NSNDVKVPLDVIIFKLMKAYMRSSSLRKAALR 452
DF+K LL K+PRKRLT AL HPW+K + +++ + + ++ ++ A +
Sbjct: 261 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQ 320
Query: 453 ALSKTLT 459
+
Sbjct: 321 PAIGRIA 327
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 262 bits (670), Expect = 5e-84
Identities = 95/281 (33%), Positives = 142/281 (50%), Gaps = 20/281 (7%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIA------IEDVR 206
F YE E +GRG K ++ AVK+I + A E
Sbjct: 1 FYENYEPKEILGRGVSSVVRRCIHKPT---CKEYAVKIIDVTGGGSFSAEEVQELREATL 57
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
+EV ILR ++GH N+++ D YE ++V +L + GEL D + + +E + + +M
Sbjct: 58 KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIM 116
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSA 326
+L V+ H +VHRDLKPEN L D++ +K DFG S + P E+L ++ G+
Sbjct: 117 RALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTP 173
Query: 327 YYVAPEVL-------HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 379
Y+APE++ H Y E D+WS GVI Y LL GS PFW R + + R ++ +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233
Query: 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
F W S +D V R L P+KR TA +AL+HP+ +
Sbjct: 234 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 262 bits (670), Expect = 2e-83
Identities = 89/323 (27%), Positives = 156/323 (48%), Gaps = 13/323 (4%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
K KY + E++GRG FG + K + V++E+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSS---KKTYMAKFVKVKGTDQ----VLVKKEIS 53
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQIL 270
IL H N++ +++E + + ++ E G ++ +RI + + E + + + Q+
Sbjct: 54 ILNIA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC 112
Query: 271 NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVA 330
+ F H + H D++PEN ++ T +S +K I+FG + ++P + + + Y A
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171
Query: 331 PEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
PEV H ST D+WS+G + Y+LL G PF A T I ++ A+ +FDE + +S
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS 231
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKA 449
EA DFV RLL K+ + R+TA++AL HPW+K + +V VI + +K +L K
Sbjct: 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE-RVSTKVI--RTLKHRRYYHTLIKK 288
Query: 450 ALRALSKTLTVDELFYLKEQYAL 472
L + + ++ Q +
Sbjct: 289 DLNMVVSAARISCGGAIRSQKGV 311
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 254 bits (651), Expect = 2e-81
Identities = 81/270 (30%), Positives = 138/270 (51%), Gaps = 14/270 (5%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+E+G +G+G FG A+ K+ +A+KV+ K ++ A +RREV+I
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQS---KFILALKVLFKAQLEKAGVEHQLRREVEIQSH 62
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L H N+++ + + D VY+++E G + R L + K+ E + ++ N ++
Sbjct: 63 L-RHPNILRLYGYFHDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALS 120
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL 334
+CH + V+HRD+KPEN L LK DFG S P R + G+ Y+ PE++
Sbjct: 121 YCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMI 176
Query: 335 -HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393
R + + D+WS+GV+ Y L G PF A T ++ + + + +F ++ AR
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF----PDFVTEGAR 232
Query: 394 DFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423
D + RLL +P +R + L HPWI ++
Sbjct: 233 DLISRLLKHNPSQRPMLREVLEHPWITANS 262
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 252 bits (644), Expect = 6e-80
Identities = 84/284 (29%), Positives = 135/284 (47%), Gaps = 20/284 (7%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+ E+G G FG A+ K+ A KVI +ED E+ IL +
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKET---SVLAAAKVIDTKSEE---ELEDYMVEIDILASCD 67
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N+VK DA+ +N+++++E C GG + +L TE + V Q L+ + +
Sbjct: 68 -HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 126
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLH 335
H ++HRDLK N LF + +K DFG+S R +R + +G+ Y++APEV+
Sbjct: 127 HDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 183
Query: 336 ------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
R Y +ADVWS+G+ + P + + K++P P S
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRWS 242
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVII 433
S +DF+K+ L K+ R T +Q L HP++ D P+ +I
Sbjct: 243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVT--VDSNKPIRELI 284
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 246 bits (629), Expect = 1e-77
Identities = 100/281 (35%), Positives = 157/281 (55%), Gaps = 11/281 (3%)
Query: 149 FSK-HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA---IAIED 204
F + + + Y+ GEE+G G F + K G Q A K I K + ++ ++ ED
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKKRRTKSSRRGVSRED 59
Query: 205 VRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKA 264
+ REV IL+ + H N++ + YE+ +V +++EL GGEL D + + TE++A
Sbjct: 60 IEREVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATE 117
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE-NSVLKAIDFGLSDFVRPDERLNDIV 323
+ QILN V + H + H DLKPEN + ++ +K IDFGL+ + +I
Sbjct: 118 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 177
Query: 324 GSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 382
G+ +VAPE++ + EAD+WSIGVI YILL G+ PF T+ V + F++
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 237
Query: 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423
+ + S+ A+DF++RLL KDP+KR+T +L HPWIK +
Sbjct: 238 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 246 bits (628), Expect = 3e-77
Identities = 79/315 (25%), Positives = 129/315 (40%), Gaps = 22/315 (6%)
Query: 149 FSKH-FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR 207
F K + E+G G FG A+ + + VA+K + + +D+ +
Sbjct: 8 FFKDDPEKLFSDLREIGHGSFGAVYFARDVRN---SEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
EV+ L+ L H N +++ Y ++VME C G D + E + AV
Sbjct: 65 EVRFLQKLR-HPNTIQYRGCYLREHTAWLVMEYCLGS-ASDLLEVHKKPLQEVEIAAVTH 122
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY 327
L +A+ H ++HRD+K N L E ++K DFG + + P N VG+ Y
Sbjct: 123 GALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA---NSFVGTPY 176
Query: 328 YVAPEVL----HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA 383
++APEV+ Y + DVWS+G+ L P + + + +
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PAL 234
Query: 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRS 443
S R+FV L K P+ R T+ L H ++ V +D+I + K +R
Sbjct: 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI--QRTKDAVR- 291
Query: 444 SSLRKAALRALSKTL 458
L R + K L
Sbjct: 292 -ELDNLQYRKMKKIL 305
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (623), Expect = 7e-77
Identities = 80/275 (29%), Positives = 138/275 (50%), Gaps = 16/275 (5%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
K ++ G+ +G G F A+ ++ A+K++ K + + V RE
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELAT---SREYAIKILEKRHIIKENKVPYVTRERD 60
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQIL 270
++ L H VK + ++D + +Y + + GELL I + G + E + +I+
Sbjct: 61 VMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIV 118
Query: 271 NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAY 327
+ + + H +G++HRDLKPEN L +E+ ++ DFG + + P+ R N VG+A
Sbjct: 119 SALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175
Query: 328 YVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386
YV+PE+L +S +D+W++G I Y L+ G PF A E IF+ ++K + F E
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE---- 231
Query: 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
+ARD V++LL D KRL + + +K
Sbjct: 232 KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (620), Expect = 1e-76
Identities = 83/273 (30%), Positives = 134/273 (49%), Gaps = 16/273 (5%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
F ++L + +G G +G A + + VAVK++ + E++++E+ I
Sbjct: 3 FVEDWDLVQTLGEGAYGEVQLAVNRVT---EEAVAVKIVDMKRAVDCP--ENIKKEICIN 57
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
+ L H N+VKF+ + + Y+ +E C GGEL DRI G E DA+ Q++
Sbjct: 58 KMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAG 115
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYV 329
V + H G+ HRD+KPEN L DE LK DFGL+ R + R LN + G+ YV
Sbjct: 116 VVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 330 APEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
APE+L R ++ DVWS G++ +L G P+ ++S + K ++ PW
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN-PWKK 231
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
+ S + ++L ++P R+T W
Sbjct: 232 IDSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (618), Expect = 4e-76
Identities = 75/280 (26%), Positives = 135/280 (48%), Gaps = 15/280 (5%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
KY E++G+G G A GQ+VA++ + + E + E+ ++R
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQP---KKELIINEILVMRE 73
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
+ N+V + D+Y D ++VVME GG L D + E AV + L +
Sbjct: 74 N-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALE 130
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEV 333
F H V+HRD+K +N L + +K DFG + P++ + + +VG+ Y++APEV
Sbjct: 131 FLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 334 L-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392
+ ++Y + D+WS+G++A ++ G P+ + + + + LS+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLSAIF 246
Query: 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVI 432
RDF+ R L+ D KR +A + L H ++K + + +I
Sbjct: 247 RDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLI 286
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (619), Expect = 1e-75
Identities = 95/330 (28%), Positives = 152/330 (46%), Gaps = 22/330 (6%)
Query: 151 KHFANKYELGEEV-GRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
+ Y++ +V G G G K+ ++ A+K++ RREV
Sbjct: 7 NAIIDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQDCPK--------ARREV 55
Query: 210 KILRALTGHNNLVKFFDAYEDT----DNVYVVMELCEGGELLDRILSRGGK-YTEDDAKA 264
++ + ++V+ D YE+ + +VME +GGEL RI RG + +TE +A
Sbjct: 56 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 115
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVG 324
+M I + + H + HRD+KPEN L+T+K N++LK DFG + L
Sbjct: 116 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 175
Query: 325 SAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPS 379
+ YYVAPEVL Y D+WS+GVI YILLCG PF++ G+ +
Sbjct: 176 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235
Query: 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKA 439
F W +S E + ++ LL +P +R+T + ++HPWI S V L +
Sbjct: 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKED 295
Query: 440 YMRSSSLRKAALRALSKTLTVDELFYLKEQ 469
R +++ AL+ E +K+
Sbjct: 296 KERWEDVKEEMTSALATMRVDYEQIKIKKI 325
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 235 bits (600), Expect = 1e-73
Identities = 72/276 (26%), Positives = 119/276 (43%), Gaps = 11/276 (3%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
H +++YELGE +G G A+ + + VAVKV+ RRE +
Sbjct: 3 SHLSDRYELGEILGFGGMSEVHLARDLR---LHRDVAVKVLRADLARDPSFYLRFRREAQ 59
Query: 211 ILRALTGHNNLVKFFDAYEDTDN----VYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
AL H +V +D E Y+VME +G L D I+ G T A V+
Sbjct: 60 NAAAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTPKRAIEVI 117
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG-LSDFVRPDERLNDIVGS 325
+ F H G++HRD+KP N + + + V+ ++D + ++G+
Sbjct: 118 ADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
Query: 326 AYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384
A Y++PE S +DV+S+G + Y +L G PF + + ++ DP A
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 237
Query: 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
LS++ V + L K+P R A + ++
Sbjct: 238 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (591), Expect = 2e-72
Identities = 59/271 (21%), Positives = 113/271 (41%), Gaps = 18/271 (6%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ E+GRG F + +VA + K+T + + + E ++L+ L
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTET---TVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQ 66
Query: 217 GHNNLVKFFDAYEDT----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
H N+V+F+D++E T + +V EL G L L R ++ QIL
Sbjct: 67 -HPNIVRFYDSWESTVKGKKCIVLVTELMTSG-TLKTYLKRFKVMKIKVLRSWCRQILKG 124
Query: 273 VAFCHLQG--VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVA 330
+ F H + ++HRDLK +N T +K D GL+ R ++G+ ++A
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMA 181
Query: 331 PEVLHRSYSTEADVWSIGVIAYILLCGSRPFW-ARTESGIFRAVLKADPSFDEAPWPSLS 389
PE+ Y DV++ G+ + P+ + + I+R V
Sbjct: 182 PEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS--FDKVAI 239
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
E ++ ++ + ++ +R + L+H + +
Sbjct: 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 5e-72
Identities = 73/317 (23%), Positives = 126/317 (39%), Gaps = 53/317 (16%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ +E E+G G+ G K G +A K+I + RE+++L
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPS---GLVMARKLIHLEIKPAIR--NQIIRELQVLHE 60
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
+V F+ A+ + + ME +GG L D++L + G+ E V I ++ +
Sbjct: 61 CN-SPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLT 118
Query: 275 FCH-LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV 333
+ ++HRD+KP N L + +K DFG+S + D N VG+ Y++PE
Sbjct: 119 YLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPER 174
Query: 334 LH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES---GIFRAVLKADPSF--------- 380
L YS ++D+WS+G+ + G P +F ++ D +
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 381 ----------------------------DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQ 412
+ P S E +DFV + L K+P +R Q
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294
Query: 413 ALSHPWIKNSNDVKVPL 429
+ H +IK S+ +V
Sbjct: 295 LMVHAFIKRSDAEEVDF 311
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (592), Expect = 5e-72
Identities = 79/272 (29%), Positives = 131/272 (48%), Gaps = 14/272 (5%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ L + +G+G FG A+FKK Q A+K + K + +E E ++L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 58
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
H L F ++ +N++ VME GG+L+ I K+ A +I+ +
Sbjct: 59 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQ 117
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEV 333
F H +G+V+RDLK +N L D++ +K DFG+ + + D + N G+ Y+APE+
Sbjct: 118 FLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 174
Query: 334 L-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392
L + Y+ D WS GV+ Y +L G PF + E +F ++ +P + L EA
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY----PRWLEKEA 230
Query: 393 RDFVKRLLNKDPRKRLTAAQA-LSHPWIKNSN 423
+D + +L ++P KRL HP + N
Sbjct: 231 KDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 262
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (587), Expect = 8e-72
Identities = 74/275 (26%), Positives = 130/275 (47%), Gaps = 22/275 (8%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIED---VRREV 209
++Y++G +G G FG + VA+K + K +++ + + V EV
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSD---NLPVAIKHVEKDRISDWGELPNGTRVPMEV 58
Query: 210 KILRAL-TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQ 268
+L+ + +G + +++ D +E D+ +++E E + L ++ G E+ A++ Q
Sbjct: 59 VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 118
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
+L V CH GV+HRD+K EN L LK IDFG + D D G+ Y
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALL-KDTVYTDFDGTRVY 175
Query: 329 VAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386
PE + HR + A VWS+G++ Y ++CG PF E +++ F
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFR----Q 225
Query: 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
+SSE + ++ L P R T + +HPW+++
Sbjct: 226 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (584), Expect = 2e-71
Identities = 81/278 (29%), Positives = 128/278 (46%), Gaps = 23/278 (8%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
A YE+ +G G +G + K G+ + K + MT A + + EV +LR
Sbjct: 3 AEDYEVLYTIGTGSYGRCQKIRRKSD---GKILVWKELDYGSMTEA-EKQMLVSEVNLLR 58
Query: 214 ALTGHNNLVKFFDAYEDTDN--VYVVMELCEGGELLDRI---LSRGGKYTEDDAKAVMIQ 268
L H N+V+++D D N +Y+VME CEGG+L I E+ VM Q
Sbjct: 59 ELK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 117
Query: 269 ILNVVAFCHLQG-----VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDI 322
+ + CH + V+HRDLKP N D +K DFGL+ + D
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKAF 174
Query: 323 VGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381
VG+ YY++PE ++R SY+ ++D+WS+G + Y L PF A ++ + + +
Sbjct: 175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR- 233
Query: 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
S E + + R+LN R + + L +P I
Sbjct: 234 --IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 2e-68
Identities = 61/271 (22%), Positives = 109/271 (40%), Gaps = 21/271 (7%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ +G+ +G G FG KG+ G VAVK++ T ++ + EV +LR
Sbjct: 8 GQITVGQRIGSGSFG-----TVYKGKWHGD-VAVKMLNVTAPTPQ-QLQAFKNEVGVLRK 60
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
H N++ F Y + +V + CEG L + K+ + Q +
Sbjct: 61 TR-HVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAP 331
+ H + ++HRDLK N E+ +K DFGL+ + + GS ++AP
Sbjct: 119 YLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 332 EVL----HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP--W 385
EV+ YS ++DV++ G++ Y L+ G P+ ++ +
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235
Query: 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416
+ + + L K +R Q L+
Sbjct: 236 SNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 221 bits (564), Expect = 3e-67
Identities = 69/278 (24%), Positives = 125/278 (44%), Gaps = 18/278 (6%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
N + + +GRG FG + G+ A+K + K ++ E +L
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 215 LT--GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
++ +V A+ D + +++L GG+L LS+ G ++E D + +I+
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL-HYHLSQHGVFSEADMRFYAAEIILG 119
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPE 332
+ H + VV+RDLKP N L DE+ ++ D GL+ ++ + VG+ Y+APE
Sbjct: 120 LEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPE 175
Query: 333 VLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390
VL + +Y + AD +S+G + + LL G PF + + + S S
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSP 234
Query: 391 EARDFVKRLLNKDPRKRLT-----AAQALSHPWIKNSN 423
E R ++ LL +D +RL A + P+ ++ +
Sbjct: 235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 216 bits (552), Expect = 4e-66
Identities = 70/275 (25%), Positives = 132/275 (48%), Gaps = 20/275 (7%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+++ +G G FG + + G+ A+KV+ K + +E E +L
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 60
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
+T H +++ + ++D ++++M+ EGGEL +L + ++ AK ++ +
Sbjct: 61 VT-HPFIIRMWGTFQDAQQIFMIMDYIEGGELFS-LLRKSQRFPNPVAKFYAAEVCLALE 118
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL 334
+ H + +++RDLKPEN L D+N +K DFG + +V + + G+ Y+APEV+
Sbjct: 119 YLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVV 173
Query: 335 -HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393
+ Y+ D WS G++ Y +L G PF+ + +L A+ F P + + +
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----PPFFNEDVK 229
Query: 394 DFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423
D + RL+ +D +RL +HPW K
Sbjct: 230 DLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 264
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 8e-65
Identities = 78/298 (26%), Positives = 122/298 (40%), Gaps = 37/298 (12%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+YE E+G G +G A+ K G+ VA+K + + REV +LR
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLK--NGGRFVALKRVRVQTGEEGMP-LSTIREVAVLRH 63
Query: 215 LTG--HNNLVKFFDAYEDTDN-----VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
L H N+V+ FD + + +V E + + K +M
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY 327
Q+L + F H VVHRDLKP+N L + +K DFGL+ L +V + +
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLW 180
Query: 328 YVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386
Y APEVL +S Y+T D+WS+G I + F ++ +L E WP
Sbjct: 181 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 387 -----------------------SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
+ +D + + L +P KR++A ALSHP+ ++
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 1e-64
Identities = 77/276 (27%), Positives = 133/276 (48%), Gaps = 19/276 (6%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
N ++ + +G+G FG + K G+ A+K++ K + + E ++L+
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
H L A++ D + VME GGEL + SR +TE+ A+ +I++ +
Sbjct: 62 TR-HPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALE 119
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERLNDIVGSAYYVAPEV 333
+ H + VV+RD+K EN + D++ +K DFGL + G+ Y+APEV
Sbjct: 120 YLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176
Query: 334 LHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392
L + Y D W +GV+ Y ++CG PF+ + +F +L + F +LS EA
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----PRTLSPEA 232
Query: 393 RDFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423
+ + LL KDP++RL A + + H + + N
Sbjct: 233 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 3e-64
Identities = 77/280 (27%), Positives = 132/280 (47%), Gaps = 15/280 (5%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-TAIAIEDVRREVKILR 213
+EL + +G G +G + G G+ A+KV+ K + A E R E ++L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
+ LV A++ ++++++ GGEL LS+ ++TE + + + +I+ +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGEL-FTHLSQRERFTEHEVQIYVGEIVLAL 142
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP--DERLNDIVGSAYYVAP 331
H G+++RD+K EN L D N + DFGLS ER D G+ Y+AP
Sbjct: 143 EHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199
Query: 332 EVL---HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388
+++ + D WS+GV+ Y LL G+ PF E + + + +
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 259
Query: 389 SSEARDFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423
S+ A+D ++RLL KDP+KRL A + H + + N
Sbjct: 260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 210 bits (534), Expect = 5e-64
Identities = 83/294 (28%), Positives = 132/294 (44%), Gaps = 38/294 (12%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
KY E++G G +G A+ G + A+K I K I RE+ IL+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYG----ETFALKKIRLEKEDEGI-PSTTIREISILKE 56
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L H+N+VK +D + +V E + +L + G AK+ ++Q+LN +A
Sbjct: 57 LK-HSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERLNDIVGSAYYVAPEV 333
+CH + V+HRDLKP+N L + LK DFGL+ P + + + +Y AP+V
Sbjct: 115 YCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171
Query: 334 LHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP----- 386
L S YST D+WS+G I ++ G+ F +E+ + + + + WP
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231
Query: 387 --------------------SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
L D + ++L DP +R+TA QAL H + K
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 1e-62
Identities = 59/266 (22%), Positives = 100/266 (37%), Gaps = 13/266 (4%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
L E++G G FG ++ K VAVK + ++ A++D REV + +L
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H NL++ + + +V EL G LLDR+ G + +Q+ + +
Sbjct: 70 -HRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE----RLNDIVGSAYYVAPE 332
+ +HRDL N L ++K DFGL + ++ + APE
Sbjct: 128 ESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 333 VL-HRSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390
L R++S +D W GV + + G P+ S I + K
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PEDCPQ 242
Query: 391 EARDFVKRLLNKDPRKRLTAAQALSH 416
+ + + + P R T
Sbjct: 243 DIYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 207 bits (526), Expect = 3e-62
Identities = 77/305 (25%), Positives = 133/305 (43%), Gaps = 53/305 (17%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ Y+L ++GRG + A ++V VK++ K + ++RE+KIL
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITN---NEKVVVKILKPVKK------KKIKREIKILEN 85
Query: 215 LTGHNNLVKFFDAYEDTDN--VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
L G N++ D +D + +V E + T+ D + M +IL
Sbjct: 86 LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKA 141
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPE 332
+ +CH G++HRD+KP N + E+ L+ ID+GL++F P + N V S Y+ PE
Sbjct: 142 LDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 199
Query: 333 VL--HRSYSTEADVWSIGVIAYILLCGSRPFWA------------------RTESGIFRA 372
+L ++ Y D+WS+G + ++ PF+ I +
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259
Query: 373 VLKADPSFDE----------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416
++ DP F++ +S EA DF+ +LL D + RLTA +A+ H
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319
Query: 417 PWIKN 421
P+
Sbjct: 320 PYFYT 324
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 3e-62
Identities = 78/293 (26%), Positives = 119/293 (40%), Gaps = 37/293 (12%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA--IAIEDVRREVKILRAL 215
E + +G G F A+ K Q VA+K I + A RE+K+L+ L
Sbjct: 1 EKLDFLGEGQFATVYKARDKNT---NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 57
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
+ H N++ DA+ N+ +V + E + I T KA M+ L + +
Sbjct: 58 S-HPNIIGLLDAFGHKSNISLVFDFMETDLEVI-IKDNSLVLTPSHIKAYMLMTLQGLEY 115
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL 334
H ++HRDLKP N L DEN VLK DFGL+ F P+ V + +Y APE+L
Sbjct: 116 LHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELL 172
Query: 335 --HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP------ 386
R Y D+W++G I LL ++ + + + E WP
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232
Query: 387 ------------------SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
+ + D ++ L +P R+TA QAL + N
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 2e-61
Identities = 62/266 (23%), Positives = 104/266 (39%), Gaps = 23/266 (8%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ +L + +G+G FG G+ +G +VAVK I + E ++
Sbjct: 7 KELKLLQTIGKGEFG-----DVMLGDYRGNKVAVKCIKNDAT-----AQAFLAEASVMTQ 56
Query: 215 LTGHNNLVKFFDA-YEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNV 272
L H+NLV+ E+ +Y+V E G L+D + SRG D + +
Sbjct: 57 LR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 115
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPE 332
+ + VHRDL N L E++V K DFGL+ + + APE
Sbjct: 116 MEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEA--SSTQDTGKLPVKWTAPE 170
Query: 333 VL-HRSYSTEADVWSIGVIAYILL-CGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390
L + +ST++DVWS G++ + + G P+ + V K +
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---GYKMDAPDGCPP 227
Query: 391 EARDFVKRLLNKDPRKRLTAAQALSH 416
+ +K + D R + Q
Sbjct: 228 AVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 4e-61
Identities = 78/310 (25%), Positives = 126/310 (40%), Gaps = 52/310 (16%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+KYE ++G+G FG A+ +K GQ+VA+K + I RE+KIL+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMENEKEGFPIT-ALREIKILQL 65
Query: 215 LTGHNNLVKFFDAYEDTD--------NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
L H N+V + ++Y+V + CE L + + K+T + K VM
Sbjct: 66 L-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLLSNVLVKFTLSEIKRVM 123
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-----RLND 321
+LN + + H ++HRD+K N L + VLK DFGL+ + R +
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYTN 180
Query: 322 IVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 379
V + +Y PE+L R Y D+W G I + S TE + + S
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240
Query: 380 FDEAPWPSL----------------------------SSEARDFVKRLLNKDPRKRLTAA 411
WP++ A D + +LL DP +R+ +
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300
Query: 412 QALSHPWIKN 421
AL+H + +
Sbjct: 301 DALNHDFFWS 310
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 6e-61
Identities = 79/297 (26%), Positives = 126/297 (42%), Gaps = 36/297 (12%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
++ E++G G +G A+ K G+ VA+K I T + RE+ +L+ L
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKL---TGEVVALKKIRLDTETEGV-PSTAIREISLLKEL 58
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N+VK D + +Y+V E S K+ + Q+L +AF
Sbjct: 59 -NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV-RPDERLNDIVGSAYYVAPEVL 334
CH V+HRDLKP+N L + +K DFGL+ P V + +Y APE+L
Sbjct: 118 CHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 335 HRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS----- 387
YST D+WS+G I ++ F +E + + + DE WP
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 388 --------------------LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424
L + R + ++L+ DP KR++A AL+HP+ ++
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 9e-61
Identities = 77/306 (25%), Positives = 123/306 (40%), Gaps = 50/306 (16%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+Y +G G +G C+A +VA+K I + T + RE+KIL
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVN---KVRVAIKKISPFEHQTYC--QRTLREIKILL 61
Query: 214 ALTGHNNLVKFFDAYEDTD-----NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQ 268
H N++ D +VY+V L G +L + + + D + Q
Sbjct: 62 RFR-HENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLL--KTQHLSNDHICYFLYQ 117
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE----RLNDIVG 324
IL + + H V+HRDLKP N L + LK DFGL+ PD L + V
Sbjct: 118 ILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174
Query: 325 SAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 382
+ +Y APE++ S Y+ D+WS+G I +L F + +L S +
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234
Query: 383 APW---------------------------PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
P+ S+A D + ++L +P KR+ QAL+
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
Query: 416 HPWIKN 421
HP+++
Sbjct: 295 HPYLEQ 300
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 201 bits (511), Expect = 2e-60
Identities = 55/293 (18%), Positives = 104/293 (35%), Gaps = 25/293 (8%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
N+Y LG ++G G FG G++VA+K+ + E KI +
Sbjct: 6 GNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKTK-----HPQLHIESKIYK 57
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
+ G + + D +VMEL L D K++ + Q+++ +
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPS-LEDLFNFCSRKFSLKTVLLLADQMISRI 116
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--------RLNDIVGS 325
+ H + +HRD+KP+NFL + +++ IDFGL+ R ++ G+
Sbjct: 117 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 326 AYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384
A Y + S D+ S+G + GS P+ + + + P
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236
Query: 385 ----WPSLSSEARDFVKRLLNKDPRKRLTAA---QALSHPWIKNSNDVKVPLD 430
SE ++ + + + Q + + + D
Sbjct: 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFD 289
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 3e-60
Identities = 57/267 (21%), Positives = 110/267 (41%), Gaps = 21/267 (7%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELK-GQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+E+G G FG K G+ + VA+K+I + M+ ++ E K++
Sbjct: 4 KDLTFLKELGTGQFG-----VVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMM 54
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
L+ H LV+ + ++++ E G LL+ + ++ + + +
Sbjct: 55 NLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 113
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAP 331
+ + +HRDL N L ++ V+K DFGLS +V DE + P
Sbjct: 114 EYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170
Query: 332 EVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
EVL + +S+++D+W+ GV+ + I G P+ T S + + + S
Sbjct: 171 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLAS 227
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSH 416
+ + ++ +R T LS+
Sbjct: 228 EKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 1e-59
Identities = 68/291 (23%), Positives = 113/291 (38%), Gaps = 36/291 (12%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
E G+ +G G FG A QVAVK++ + ++ E + E+K++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER--EALMSELKMM 94
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTED------------ 260
L H N+V A + +Y++ E C G+LL+ + S+ K++ED
Sbjct: 95 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 261 ----------DAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310
D Q+ + F + VHRDL N L V+K DFGL+
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGLA 211
Query: 311 DFVRPDERL---NDIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAY-ILLCGSRPFWART 365
+ D + ++APE L Y+ ++DVWS G++ + I G P+
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271
Query: 366 ESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416
F +++ D + E ++ D RKR + S
Sbjct: 272 VDANFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 2e-59
Identities = 74/308 (24%), Positives = 117/308 (37%), Gaps = 48/308 (15%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
Y + +G G FG AK G+ VA+K + + K RE++I+R L
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQDK-------RFKNRELQIMRKL- 70
Query: 217 GHNNLVKFFDAY------EDTDNVYVVMELCEGG--ELLDRILSRGGKYTEDDAKAVMIQ 268
H N+V+ + +D + +V++ + K M Q
Sbjct: 71 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
+ +A+ H G+ HRD+KP+N L + +VLK DFG + + E + S YY
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188
Query: 329 VAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA---------- 376
APE++ + Y++ DVWS G + LL G F + ++K
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248
Query: 377 ---------------DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
+ + P EA RLL P RLT +A +H +
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308
Query: 422 SNDVKVPL 429
D V L
Sbjct: 309 LRDPNVKL 316
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 199 bits (507), Expect = 4e-59
Identities = 77/275 (28%), Positives = 132/275 (48%), Gaps = 20/275 (7%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
++++ + +G G FG K K+ G A+K++ K K+ IE E +IL+A
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
+ LVK +++D N+Y+VME GGE+ L R G+++E A+ QI+
Sbjct: 98 V-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS-HLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL 334
+ H +++RDLKPEN L D+ ++ DFG + R R + G+ +APE++
Sbjct: 156 YLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEII 210
Query: 335 -HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393
+ Y+ D W++GV+ Y + G PF+A I+ ++ F SS+ +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF----PSHFSSDLK 266
Query: 394 DFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423
D ++ LL D KR +H W ++
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 5e-59
Identities = 68/306 (22%), Positives = 131/306 (42%), Gaps = 42/306 (13%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
Y + VG G +G C+A + G +VA+K + + + A + RE+++L
Sbjct: 16 VRAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYRPFQSELFA-KRAYRELRLL 71
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRI---LSRGGKYTEDDAKAVMIQI 269
+ + H N++ D + + + + + L + K ED + ++ Q+
Sbjct: 72 KHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQM 130
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
L + + H G++HRDLKP N +E+ LK +DFGL+ D + V + +Y
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQ--ADSEMTGYVVTRWYR 185
Query: 330 APEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW-- 385
APEV+ Y+ D+WS+G I ++ G F + ++K +
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245
Query: 386 -------------------------PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
+ S A + ++++L D +R+TA +AL+HP+ +
Sbjct: 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305
Query: 421 NSNDVK 426
+ +D +
Sbjct: 306 SLHDTE 311
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 1e-58
Identities = 80/296 (27%), Positives = 129/296 (43%), Gaps = 38/296 (12%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
KYE E++G G +G AK ++ + VA+K + + RE+ +L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRET---HEIVALKRVRLDDDDEGV-PSSALREICLLKE 57
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L H N+V+ D + +V E C+ G + K+ + Q+L +
Sbjct: 58 LK-HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLG 115
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEV 333
FCH + V+HRDLKP+N L + N LK +FGL+ F P + V + +Y P+V
Sbjct: 116 FCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172
Query: 334 LHRS--YSTEADVWSIGVIAYILLCGSRP-FWARTESGIFRAVLKADPSFDEAPWPS--- 387
L + YST D+WS G I L RP F + + + + E WPS
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 388 ----------------------LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
L++ RD ++ LL +P +R++A +AL HP+ +
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 1e-58
Identities = 59/266 (22%), Positives = 112/266 (42%), Gaps = 19/266 (7%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
++ +E+G G FG + +VA+K I + M+ ED E +++
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNK----DKVAIKTIREGAMSE----EDFIEEAEVMMK 56
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L+ H LV+ + + + +V E E G L D + ++ G + + + + + +A
Sbjct: 57 LS-HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND--IVGSAYYVAPE 332
+ V+HRDL N L EN V+K DFG++ FV D+ + + +PE
Sbjct: 116 YLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 172
Query: 333 VL-HRSYSTEADVWSIGVIAYILLCGSRPFW-ARTESGIFRAVLKADPSFDEAPWPSLSS 390
V YS+++DVWS GV+ + + + + R+ S + + + S+
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLAST 229
Query: 391 EARDFVKRLLNKDPRKRLTAAQALSH 416
+ + P R ++ L
Sbjct: 230 HVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 5e-58
Identities = 60/266 (22%), Positives = 105/266 (39%), Gaps = 14/266 (5%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ ELG +G G FG + E VA+K T+ E +E +R
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEALTMRQ 64
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
H ++VK + + V+++MELC GEL + R Q+ +A
Sbjct: 65 F-DHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAPE 332
+ + VHRD+ N L N +K DFGLS ++ + + ++APE
Sbjct: 123 YLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 333 VL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390
+ R +++ +DVW GV + IL+ G +PF + + + + P+
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---LPMPPNCPP 236
Query: 391 EARDFVKRLLNKDPRKRLTAAQALSH 416
+ + DP +R + +
Sbjct: 237 TLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (492), Expect = 1e-57
Identities = 67/290 (23%), Positives = 114/290 (39%), Gaps = 20/290 (6%)
Query: 148 GFSKHF-ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR 206
F+K + ++ + +G G FG C+ K + VA+K + T D
Sbjct: 18 EFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL--KSGYTEKQRRDFL 75
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
E I+ H N++ + V ++ E E G L + G++T ++
Sbjct: 76 SEASIMGQFD-HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGML 134
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND----- 321
I + + VHRDL N L + N V K DFGLS F+ D
Sbjct: 135 RGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSAL 191
Query: 322 -IVGSAYYVAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADP 378
+ APE + +R +++ +DVWS G++ + ++ G RP+W T + A+ +
Sbjct: 192 GGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ--- 248
Query: 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH--PWIKNSNDVK 426
+ P S + KD R Q ++ I+N N +K
Sbjct: 249 DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLK 298
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 1e-57
Identities = 62/281 (22%), Positives = 110/281 (39%), Gaps = 23/281 (8%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
L ++G+G FG + +VA+K + M + E +E ++++
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGT----TRVAIKTLKPGTM----SPEAFLQEAQVMKK 68
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYT-EDDAKAVMIQILNVV 273
L H LV+ + + + +Y+V E G LLD + GKY + QI + +
Sbjct: 69 L-RHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 126
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAP 331
A+ VHRDL+ N L EN V K DFGL+ + +E + AP
Sbjct: 127 AYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 183
Query: 332 EVL-HRSYSTEADVWSIGVIAYILLCGSRPFW-ARTESGIFRAVLKADPSFDEAPWPSLS 389
E + ++ ++DVWS G++ L R + + V + + P
Sbjct: 184 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECP 240
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALS--HPWIKNSNDVKVP 428
D + + K+P +R T + + ++ P
Sbjct: 241 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 4e-57
Identities = 57/281 (20%), Positives = 109/281 (38%), Gaps = 21/281 (7%)
Query: 155 NKYELGE-EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+ + + E+G G+FG ++ + K VA+KV+ + T E++ RE +I+
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRK-KQIDVAIKVL--KQGTEKADTEEMMREAQIMH 64
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
L + +V+ + + + +VME+ GG L ++ + + + ++ Q+ +
Sbjct: 65 QLD-NPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 122
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND----IVGSAYYV 329
+ + VHRDL N L K DFGLS + D+ +
Sbjct: 123 KYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 330 APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
APE + R +S+ +DVWS GV + L G +P+ + + + P
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---MECPPE 236
Query: 388 LSSEARDFVKRLLNKDPRKRLTAA---QALSHPWIKNSNDV 425
E + R Q + + ++ V
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 8e-56
Identities = 59/272 (21%), Positives = 111/272 (40%), Gaps = 20/272 (7%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
E+G G+FG ++ ++ + VAVK++ A+ +++ E +++ L + +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKV-VKTVAVKILKNEANDPAL-KDELLAEANVMQQLD-NPYI 70
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
V+ E ++ +VME+ E G L ++ L + + + ++ Q+ + +
Sbjct: 71 VRMIGICEA-ESWMLVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND----IVGSAYYVAPEVL-HR 336
VHRDL N L K DFGLS +R DE + APE + +
Sbjct: 129 VHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 337 SYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395
+S+++DVWS GV+ + G +P+ S + + K + E D
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---MGCPAGCPREMYDL 242
Query: 396 VKRLLNKDPRKRLTAAQ---ALSHPWIKNSND 424
+ D R A L + + N+
Sbjct: 243 MNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 4e-55
Identities = 61/279 (21%), Positives = 110/279 (39%), Gaps = 26/279 (9%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
N + + +G G+FG A+ KK G ++ + + + D E+++L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKD---GLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 66
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRIL---------------SRGGKYTE 259
L H N++ A E +Y+ +E G LLD + S +
Sbjct: 67 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 260 DDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL 319
+ + + + +HRDL N L EN V K DFGLS +
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKK 183
Query: 320 NDIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILL-CGSRPFWARTESGIFRAVLKAD 377
++A E L+ S Y+T +DVWS GV+ + ++ G P+ T + ++ + +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG- 242
Query: 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416
+ + E D +++ + P +R + AQ L
Sbjct: 243 --YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 1e-54
Identities = 64/284 (22%), Positives = 104/284 (36%), Gaps = 31/284 (10%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELK--GQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
N+ G+ +G G FG A VAVK++ T E + E+K+L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EALMSELKVL 80
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY--------------- 257
L H N+V A V+ E C G+LL+ + + +
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 258 --TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
+D + Q+ +AF + +HRDL N L + K DFGL+ ++
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL---LTHGRITKICDFGLARDIKN 197
Query: 316 DERL---NDIVGSAYYVAPEVLHRSY-STEADVWSIGVIAYILLCGSRP-FWARTESGIF 370
D + ++APE + + E+DVWS G+ + L + F
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257
Query: 371 RAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
++K +E D +K + DP KR T Q +
Sbjct: 258 YKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 4e-54
Identities = 57/266 (21%), Positives = 108/266 (40%), Gaps = 21/266 (7%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+L E +G G FG + +VAVK + + M+ + E +++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGH----TKVAVKSLKQGSMSP----DAFLAEANLMKQ 64
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVV 273
L H LV+ + + +Y++ E E G L+D + + G K T + + QI +
Sbjct: 65 LQ-HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAP 331
AF + +HRDL+ N L + K DFGL+ + +E + AP
Sbjct: 123 AFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179
Query: 332 EVL-HRSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
E + + +++ ++DVWS G++ ++ G P+ T + + + + +
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR---PDNCP 236
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALS 415
E ++ + P R T S
Sbjct: 237 EELYQLMRLCWKERPEDRPTFDYLRS 262
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 8e-54
Identities = 72/315 (22%), Positives = 126/315 (40%), Gaps = 57/315 (18%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+Y+ + +G G G CAA + VA+K + + + RE+ +++
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQNQT-HAKRAYRELVLMKC 72
Query: 215 LTGHNNLVKFFDAY------EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQ 268
+ H N++ + + E+ +VY+VMEL + + + ++ Q
Sbjct: 73 V-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYLLYQ 127
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
+L + H G++HRDLKP N + + LK +DFGL+ + V + YY
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 184
Query: 329 VAPE-VLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA----------- 376
APE +L Y D+WS+G I ++ F R + V++
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 377 -----------DPSFDEAPWPSL----------------SSEARDFVKRLLNKDPRKRLT 409
P + +P L +S+ARD + ++L DP KR++
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304
Query: 410 AAQALSHPWIKNSND 424
AL HP+I D
Sbjct: 305 VDDALQHPYINVWYD 319
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 1e-53
Identities = 54/283 (19%), Positives = 113/283 (39%), Gaps = 26/283 (9%)
Query: 155 NKYELGEEVGRGHFGYTCAAKF----KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
++ LG+ +G G FG A+ K + +VAVK++ T + D+ E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEME 70
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG---------------G 255
+++ + H N++ A +YV++E G L + + +R
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 256 KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
+ + D + Q+ + + + +HRDL N L T + + +
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 316 DERLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
++ + ++APE L R Y+ ++DVWS GV+ + I G P+ +F+ +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 374 LKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416
+ + ++E ++ + P +R T Q +
Sbjct: 251 KEGHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-53
Identities = 76/306 (24%), Positives = 132/306 (43%), Gaps = 46/306 (15%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
+Y+ VG G +G CAA K G +VAVK + + + I + RE+++L
Sbjct: 16 VPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSI-IHAKRTYRELRLL 71
Query: 213 RALTGHNNLVKFFDAYED-----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
+ + H N++ D + N ++ G +L + + + K T+D + ++
Sbjct: 72 KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--IVKCQKLTDDHVQFLIY 128
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY 327
QIL + + H ++HRDLKP N +E+ LK +DFGL+ D+ + V + +
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 183
Query: 328 YVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385
Y APE++ Y+ D+WS+G I LL G F + +L+ +
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 386 ---------------------------PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
+ A D ++++L D KR+TAAQAL+H +
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303
Query: 419 IKNSND 424
+D
Sbjct: 304 FAQYHD 309
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 181 bits (459), Expect = 5e-53
Identities = 55/275 (20%), Positives = 107/275 (38%), Gaps = 19/275 (6%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ ++G G +G +KK VAVK + + M +E+ +E +++
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKY---SLTVAVKTLKEDTM----EVEEFLKEAAVMKE 69
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVV 273
+ H NLV+ Y++ E G LLD + + + + QI + +
Sbjct: 70 IK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 128
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAP 331
+ + +HRDL N L EN ++K DFGLS + D + AP
Sbjct: 129 EYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 185
Query: 332 EVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390
E L + +S ++DVW+ GV+ + + + + +L+ D +
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME--RPEGCPE 243
Query: 391 EARDFVKRLLNKDPRKRLTAAQALS--HPWIKNSN 423
+ + ++ +P R + A+ + S+
Sbjct: 244 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 180 bits (456), Expect = 1e-52
Identities = 55/277 (19%), Positives = 100/277 (36%), Gaps = 24/277 (8%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
Y++G +G G FG QQVA+K P+ +R E + +
Sbjct: 4 GVHYKVGRRIGEGSFGVIFEGTNLL---NNQQVAIKFEPRRSD-----APQLRDEYRTYK 55
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
L G + + ++ + +V++L G L D + G K++ Q+L V
Sbjct: 56 LLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARV 114
Query: 274 AFCHLQGVVHRDLKPENFLFTTKD--ENSVLKAIDFGLSDFVRPDE--------RLNDIV 323
H + +V+RD+KP+NFL + +++ +DFG+ F R ++
Sbjct: 115 QSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174
Query: 324 GSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESG----IFRAVLKADP 378
G+A Y++ R S D+ ++G + L GS P+ + R K
Sbjct: 175 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234
Query: 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ E ++ N
Sbjct: 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (454), Expect = 4e-52
Identities = 56/291 (19%), Positives = 104/291 (35%), Gaps = 39/291 (13%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
N E ++G G FG + A VAVK++ + D +RE ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQREAALM 70
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY--------------- 257
+ N+VK + ++ E G+L + + S
Sbjct: 71 AEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129
Query: 258 --------TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309
+ + + Q+ +A+ + VHRDL N L EN V+K DFGL
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGL 186
Query: 310 SDFVRPDERL---NDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSR-PFWAR 364
S + + + ++ PE + + Y+TE+DVW+ GV+ + + P++
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246
Query: 365 TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ V + A + E + ++ +K P R +
Sbjct: 247 AHEEVIYYVRDGNI---LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 9e-52
Identities = 54/266 (20%), Positives = 106/266 (39%), Gaps = 16/266 (6%)
Query: 157 YELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
++ + +G G FG + GE VA+K + + T+ A +++ E ++ ++
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASV 68
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
+ ++ + V ++ +L G LLD + +QI + +
Sbjct: 69 D-NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPE 332
+ +VHRDL N L +K DFGL+ + +E+ ++A E
Sbjct: 127 LEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 333 VL-HRSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390
+ HR Y+ ++DVWS GV + L+ GS+P+ S I + K + P +
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER---LPQPPICTI 240
Query: 391 EARDFVKRLLNKDPRKRLTAAQALSH 416
+ + + D R + +
Sbjct: 241 DVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 3e-50
Identities = 55/269 (20%), Positives = 103/269 (38%), Gaps = 17/269 (6%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
E +GRGHFG + K AVK + +++T + E I++
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDF 85
Query: 216 TGHNNLVKFFDAYEDTDN-VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
+ H N++ ++ VV+ + G+L + I + T D +Q+ +
Sbjct: 86 S-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 144
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-----RLNDIVGSAYYV 329
F + VHRDL N + DE +K DFGL+ + E ++
Sbjct: 145 FLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 330 APEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLKADPSFDEAPWPS 387
A E L + ++T++DVWS GV+ + L+ P + I +L+
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP---EY 258
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALSH 416
+ + + + R + ++ +S
Sbjct: 259 CPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 3e-48
Identities = 58/281 (20%), Positives = 110/281 (39%), Gaps = 18/281 (6%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+ + +G G FG K K VA+K + T D E I+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEAGIMG 64
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
H+N+++ + ++ E E G L + + G+++ ++ I +
Sbjct: 65 QF-SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER----LNDIVGSAYYV 329
+ VHRDL N L + N V K DFGLS + D + +
Sbjct: 124 KYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 330 APEVL-HRSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
APE + +R +++ +DVWS G++ + ++ G RP+W + + +A+ + F
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI---NDGFRLPTPMD 237
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALS--HPWIKNSNDVK 426
S + + ++ +R A +S I+ + +K
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 278
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-47
Identities = 61/318 (19%), Positives = 117/318 (36%), Gaps = 60/318 (18%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
A L E +G+G FG + +G+ +G++VAVK+ + RE +I +
Sbjct: 2 ARTIVLQESIGKGRFG-----EVWRGKWRGEEVAVKIFSSREE------RSWFREAEIYQ 50
Query: 214 -ALTGHNNLVKFFDAYEDTDN----VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQ 268
+ H N++ F A + +++V + E G L D + T + + +
Sbjct: 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALS 108
Query: 269 ILNVVAFCHLQ--------GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--- 317
+ +A H++ + HRDLK +N L +N D GL+
Sbjct: 109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTI 165
Query: 318 --RLNDIVGSAYYVAPEVL-------HRSYSTEADVWSIGVIAYILLCGSRPFWARTESG 368
N VG+ Y+APEVL H AD++++G++ + + +
Sbjct: 166 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225
Query: 369 I-FRAVLKADPSFDE-----------------APWPSLSSEARDFVKRLLNKDPRKRLTA 410
+ + ++ +DPS +E ++ + RLTA
Sbjct: 226 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 285
Query: 411 AQALSH-PWIKNSNDVKV 427
+ + +K+
Sbjct: 286 LRIKKTLSQLSQQEGIKM 303
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 5e-47
Identities = 51/291 (17%), Positives = 111/291 (38%), Gaps = 31/291 (10%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
K + E+G+G FG Y AK + +VA+K + + + E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 77
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGG---------KYTEDDAK 263
+ +++V+ V+MEL G+L + S +
Sbjct: 78 KEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL---N 320
+ +I + +A+ + VHRDL N + E+ +K DFG++ + +
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGG 193
Query: 321 DIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSR-PFWARTESGIFRAVLKADP 378
+ +++PE L ++T +DVWS GV+ + + + P+ + + R V++
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 253
Query: 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS------HPWIKNSN 423
+ + ++ +P+ R + + +S P + +
Sbjct: 254 ---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 301
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 2e-46
Identities = 65/285 (22%), Positives = 115/285 (40%), Gaps = 30/285 (10%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
++ +LG+ +GRG FG A + VAVK++ + + + E+KIL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 70
Query: 213 RALTGHNNLVKFFDA-YEDTDNVYVVMELCEGGELLDRILSRGGKY-------------- 257
+ H N+V A + + V++E C+ G L + S+ ++
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 258 -TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316
T + Q+ + F + +HRDL N L E +V+K DFGL+ + D
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKD 187
Query: 317 E---RLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSR-PFWARTESGIFR 371
R D ++APE + R Y+ ++DVWS GV+ + + P+ F
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
Query: 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416
LK + E + + +P +R T ++ + H
Sbjct: 248 RRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 154 bits (390), Expect = 2e-42
Identities = 72/333 (21%), Positives = 120/333 (36%), Gaps = 68/333 (20%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+Y L ++G GHF AK VA+K++ K+ T E E+K+L+
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVN---NTHVAMKIVRGDKVYT----EAAEDEIKLLQR 65
Query: 215 L----------TGHNNLVK----FFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTED 260
+ G N+++K F + +V +V E+ L
Sbjct: 66 VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLI 125
Query: 261 DAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAI-DFGLSDFVRPDER 318
K + Q+L + + H + G++H D+KPEN L D L I L + DE
Sbjct: 126 YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 185
Query: 319 LNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIF------- 370
+ + + Y +PEVL + AD+WS + + L+ G F
Sbjct: 186 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245
Query: 371 --------------------------RAVLKADPSFDEAPW-----------PSLSSEAR 393
R +L+ P + E
Sbjct: 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 305
Query: 394 DFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVK 426
DF+ +L DPRKR A ++HPW+K++ ++
Sbjct: 306 DFLSPMLQLDPRKRADAGGLVNHPWLKDTLGME 338
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 85.2 bits (210), Expect = 9e-20
Identities = 45/214 (21%), Positives = 74/214 (34%), Gaps = 41/214 (19%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT---------------TAIA 201
+G+ +G G +K + VK + + +A
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKF----GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLA 57
Query: 202 IEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDD 261
I R E + L+ L + K + + V+MEL + + ++
Sbjct: 58 IRSARNEFRALQKL-QGLAVPKVYAWEGN----AVLMELIDAK--------ELYRVRVEN 104
Query: 262 AKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLN 320
V+ IL VA + +G+VH DL N L + + + IDF S V E
Sbjct: 105 PDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG----IWIIDFPQS--VEVGEEGWR 158
Query: 321 DIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYIL 354
+I+ R+Y TE D+ S I IL
Sbjct: 159 EILERDVRNIITYFSRTYRTEKDINS--AIDRIL 190
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 146 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 67.6 bits (164), Expect = 4e-14
Identities = 33/148 (22%), Positives = 65/148 (43%), Gaps = 7/148 (4%)
Query: 455 SKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQ 514
S LT +++ KE +AL + + NG+IS + + + ++ + D ++ ++
Sbjct: 1 SSNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLS-PSEAEVNDLMNEIDVDG 59
Query: 515 YRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVP 574
+++F EF A + EQ A+++F+K+G+ I EL L
Sbjct: 60 NHQIEFSEFLALMSRQLKSND---SEQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKL 116
Query: 575 VHAVLHDWIRHT---DGKLSFLGFVKLL 599
A + D +R G+++ F LL
Sbjct: 117 TDAEVDDMLREVSDGSGEINIQQFAALL 144
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 162 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 56.9 bits (136), Expect = 4e-10
Identities = 31/163 (19%), Positives = 71/163 (43%), Gaps = 6/163 (3%)
Query: 444 SSLRKAALRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRI 503
+S+ A + L+ + + K + + + + G IS + + + + + K+ +
Sbjct: 1 ASMTDQQAEARAF-LSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKE-EL 58
Query: 504 PDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEEL 563
+ ++ +DFEEF + + +A + E+ + +F+K+ + I IEEL
Sbjct: 59 DAIIEEVDEDGSGTIDFEEFLVMMVRQMKEDAKGKSEEELANCFRIFDKNADGFIDIEEL 118
Query: 564 ASELGLGPAVPVHAVLHDWIRHTD----GKLSFLGFVKLLHGV 602
L + D ++ +D G++ F F+K++ GV
Sbjct: 119 GEILRATGEHVTEEDIEDLMKDSDKNNDGRIDFDEFLKMMEGV 161
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} Length = 146 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Score = 55.7 bits (133), Expect = 7e-10
Identities = 29/146 (19%), Positives = 68/146 (46%), Gaps = 8/146 (5%)
Query: 458 LTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRR 517
LT +++ KE +AL + + +GTI+ + + + + + ++ + D ++ +++
Sbjct: 3 LTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQN-PTEAELQDMINEVDADGNGT 61
Query: 518 MDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHA 577
+DF EF + + E+ A+++F++DGN I EL +
Sbjct: 62 IDFPEFLSLMARKMK---EQDSEEELIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDD 118
Query: 578 VLHDWIRHTD----GKLSFLGFVKLL 599
+ + IR D G +++ FV+++
Sbjct: 119 EVDEMIREADIDGDGHINYEEFVRMM 144
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 156 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 51.1 bits (121), Expect = 3e-08
Identities = 25/156 (16%), Positives = 66/156 (42%), Gaps = 6/156 (3%)
Query: 452 RALSKTLTVDELFYLKEQYALLEPN-KNGTISLENVKSALMKNATDAMKDSRIPDFLSSL 510
+A + LT ++ K + + ++G+IS + + M+ + + + +
Sbjct: 2 KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKV-MRMLGQNPTPEELQEMIDEV 60
Query: 511 NSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELGLG 570
+ +DF+EF + + ++ + E+ + +F+K+ + I +EEL L
Sbjct: 61 DEDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELSDLFRMFDKNADGYIDLEELKIMLQAT 120
Query: 571 PAVPVHAVLHDWIRHTD----GKLSFLGFVKLLHGV 602
+ + ++ D G++ + F++ + GV
Sbjct: 121 GETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKGV 156
|
| >d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} Length = 182 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Score = 50.4 bits (119), Expect = 8e-08
Identities = 28/162 (17%), Positives = 67/162 (41%), Gaps = 15/162 (9%)
Query: 458 LTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRR 517
L+ +E+ LKE + +++ + +GTI+ + +K L + ++ M+ ++
Sbjct: 4 LSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTI 63
Query: 518 MDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEEL---ASELGLGPAVP 574
E E++ A+ F+KDG+ I ++E+ + GL
Sbjct: 64 DYGEFIA-----ATVHLNKLEREENLVSAFSYFDKDGSGYITLDEIQQACKDFGLDDI-H 117
Query: 575 VHAVLHDWIRHTDGKLSFLGFVKLLH------GVSSRALAKA 610
+ ++ + + DG++ + F ++ G+ R + K
Sbjct: 118 IDDMIKEIDQDNDGQIDYGEFAAMMRKRKGNGGIGRRTMRKT 159
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} Length = 87 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Score = 43.4 bits (102), Expect = 3e-06
Identities = 18/77 (23%), Positives = 46/77 (59%), Gaps = 1/77 (1%)
Query: 452 RALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLN 511
+ +++ L+ +E+ LKE + +++ + +GTI+ + +K L + ++ + +S I D + + +
Sbjct: 11 KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSE-LMESEIKDLMDAAD 69
Query: 512 SLQYRRMDFEEFCAAAL 528
+ +D+ EF AA +
Sbjct: 70 IDKSGTIDYGEFIAATV 86
|
| >d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} Length = 187 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]
Score = 44.2 bits (103), Expect = 1e-05
Identities = 22/156 (14%), Positives = 43/156 (27%), Gaps = 20/156 (12%)
Query: 466 LKEQYALLEPNKNGTISLENVKSALMKNATDAM---------KDSRIPDFLSSLNSLQYR 516
K + L+ N NG ISL+ + + + + F
Sbjct: 14 HKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHKDAVEAFFGGAGMKYGV 73
Query: 517 RMDFEEFC-------AAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELGL 569
D+ + L + +++ +KD N AI ++E +
Sbjct: 74 ETDWPAYIEGWKKLATDELEKYAKNEPTLIRIWGDALFDIVDKDQNGAITLDEWKAYTKA 133
Query: 570 GPAVPVHAVLHDWIRHTD----GKLSFLGFVKLLHG 601
+ + R D G+L + G
Sbjct: 134 AGIIQSSEDCEETFRVCDIDESGQLDVDEMTRQHLG 169
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} Length = 141 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (97), Expect = 4e-05
Identities = 30/146 (20%), Positives = 61/146 (41%), Gaps = 10/146 (6%)
Query: 459 TVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRM 518
T ++ ++E + L + + GTI ++ +K M+ K I +S ++ +M
Sbjct: 1 TEEQKQEIREAFDLFDADGTGTIDVKELK-VAMRALGFEPKKEEIKKMISEIDKEGTGKM 59
Query: 519 DFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELAS-ELGLGPAVPVHA 577
+F +F + D E+ A++LF+ D I + L LG +
Sbjct: 60 NFGDFLTVMTQKMSEK--DTKEEI-LKAFKLFDDDETGKISFKNLKRVAKELGENLT-DE 115
Query: 578 VLHDWIRHTD----GKLSFLGFVKLL 599
L + I D G++S F++++
Sbjct: 116 ELQEMIDEADRDGDGEVSEQEFLRIM 141
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 75 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 39.5 bits (92), Expect = 6e-05
Identities = 17/67 (25%), Positives = 33/67 (49%), Gaps = 4/67 (5%)
Query: 540 EQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTD----GKLSFLGF 595
E+ + +F+K+ + I IEEL L + + D ++ +D G++ F F
Sbjct: 8 EEELANCFRIFDKNADGFIDIEELGEILRATGEHVIEEDIEDLMKDSDKNNDGRIDFDEF 67
Query: 596 VKLLHGV 602
+K++ GV
Sbjct: 68 LKMMEGV 74
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} Length = 174 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Score = 42.0 bits (97), Expect = 6e-05
Identities = 20/148 (13%), Positives = 46/148 (31%), Gaps = 13/148 (8%)
Query: 466 LKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYR--------- 516
+K + ++ +K+G I+ + +S + A ++ + L + +
Sbjct: 8 MKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTGVWDNFLTAVAGG 67
Query: 517 -RMDFEEFCAAALSVHQLEALDRWEQH-ARCAYELFEKDGNRAIVIEELASELGLGPAVP 574
+D F + + + + + + + + I +E G+
Sbjct: 68 KGIDETTFINSMKEMVKNPEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFFGMLGLDK 127
Query: 575 VHAVLHDWIRHT--DGKLSFLGFVKLLH 600
A T DG LS FV
Sbjct: 128 TMAPASFDAIDTNNDGLLSLEEFVIAGS 155
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Score = 41.9 bits (97), Expect = 1e-04
Identities = 22/184 (11%), Positives = 53/184 (28%), Gaps = 4/184 (2%)
Query: 172 CAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231
AK K + + + +K+ T DV RE ++ L G + K
Sbjct: 26 SPAKVYKLVGENENLYLKMTDSRYKGTT---YDVEREKDMMLWLEGKLPVPKVLHFERHD 82
Query: 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENF 291
++M +G + + A I++ + + D +
Sbjct: 83 GWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAEL 142
Query: 292 LFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVI 350
+ ++ + + ++ + L D + + V H G +
Sbjct: 143 DYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKV 202
Query: 351 AYIL 354
+ +
Sbjct: 203 SGFI 206
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} Length = 139 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (93), Expect = 1e-04
Identities = 19/137 (13%), Positives = 43/137 (31%), Gaps = 3/137 (2%)
Query: 466 LKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCA 525
KE + L + +G I + + + + + R E
Sbjct: 2 FKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKSDELKSRRVDFETFL 61
Query: 526 AALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEEL---ASELGLGPAVPVHAVLHDW 582
L + + +F+K+GN ++ EL + LG +
Sbjct: 62 PMLQAVAKNRGQGTYEDYLEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLAG 121
Query: 583 IRHTDGKLSFLGFVKLL 599
++G +++ F+K +
Sbjct: 122 HEDSNGCINYEAFLKHI 138
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 77 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 38.1 bits (88), Expect = 2e-04
Identities = 17/71 (23%), Positives = 39/71 (54%), Gaps = 1/71 (1%)
Query: 455 SKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQ 514
S LT +++ KE +AL + + NG+IS + + M++ + ++ + D ++ ++
Sbjct: 1 SSNLTEEQIAEFKEAFALFDKDNNGSISSSELATV-MRSLGLSPSEAEVNDLMNEIDVDG 59
Query: 515 YRRMDFEEFCA 525
+++F EF A
Sbjct: 60 NHQIEFSEFLA 70
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} Length = 181 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Score = 39.4 bits (91), Expect = 5e-04
Identities = 31/174 (17%), Positives = 60/174 (34%), Gaps = 24/174 (13%)
Query: 444 SSLRKAALRALSKT--LTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDS 501
S LR ++ L ++ T E+ + + L +G +S+E K
Sbjct: 2 SKLRPEVMQDLLESTDFTEHEIQEWYKGF--LRDCPSGHLSMEEFKKIYGNFFPYGDASK 59
Query: 502 RIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIE 561
+ ++ +DF EF A + + EQ + A+ +++ DGN I
Sbjct: 60 FAEHVFRTFDANGDGTIDFREFIIALSVTSR----GKLEQKLKWAFSMYDLDGNGYISKA 115
Query: 562 EL-------------ASELGLGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLL 599
E+ ++ + P + + DGKLS F++
Sbjct: 116 EMLEIVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDTNRDGKLSLEEFIRGA 169
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} Length = 188 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Score = 38.9 bits (90), Expect = 6e-04
Identities = 23/137 (16%), Positives = 49/137 (35%), Gaps = 7/137 (5%)
Query: 466 LKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCA 525
K ++ L + IS++ ++ ++ KD R F SL S + +
Sbjct: 22 FKTLFSKLA-GDDMEISVKELQ-TILNRIISKHKDLRTNGF--SLESCRSMVNLMDRDGN 77
Query: 526 AALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEEL---ASELGLGPAVPVHAVLHDW 582
L + + L ++ + F+ D + ++ E+ G +H V+
Sbjct: 78 GKLGLVEFNILWNRIRNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPCQLHQVIVAR 137
Query: 583 IRHTDGKLSFLGFVKLL 599
+ + F FV+ L
Sbjct: 138 FADDELIIDFDNFVRCL 154
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} Length = 188 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Score = 36.6 bits (84), Expect = 0.004
Identities = 10/99 (10%), Positives = 34/99 (34%), Gaps = 12/99 (12%)
Query: 464 FYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEF 523
+ + +K+G++S ++ A+ A ++ + + + +DF+ F
Sbjct: 93 RNYLTIFRKFDLDKSGSMSAYEMRMAI--EAAGFKLPCQLHQVIVARFADDELIIDFDNF 150
Query: 524 CAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEE 562
+ + L ++ + + I ++
Sbjct: 151 VRCLVRLEIL----------FKIFKQLDPENTGTIQLDL 179
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} Length = 189 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Score = 39.2 bits (90), Expect = 6e-04
Identities = 24/156 (15%), Positives = 47/156 (30%), Gaps = 20/156 (12%)
Query: 466 LKEQYALLEPNKNGTISLENVKSALMKNATDAM---------KDSRIPDFLSSLNSLQYR 516
K + L+ N NG I+L+ + S + + + F +
Sbjct: 16 HKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTKRHQVCVEAFFRGCGMEYGK 75
Query: 517 RMDFEEFCAAALSVHQL-------EALDRWEQHARCAYELFEKDGNRAIVIEELASELGL 569
+ F +F + + +++F+KDG+ I ++E + +
Sbjct: 76 EIAFPQFLDGWKQLATSELKKWARNEPTLIREWGDAVFDIFDKDGSGTITLDEWKAYGKI 135
Query: 570 GPAVPVHAVLHDWIRHTD----GKLSFLGFVKLLHG 601
P RH D G L + G
Sbjct: 136 SGISPSQEDCEATFRHCDLDNAGDLDVDEMTRQHLG 171
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 68 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Score = 36.0 bits (83), Expect = 8e-04
Identities = 9/60 (15%), Positives = 24/60 (40%)
Query: 466 LKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCA 525
+ + + + N +G I + K + K + + D+ + + + + +D EF
Sbjct: 4 ILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVIDIPEFMD 63
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 68 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Score = 34.0 bits (78), Expect = 0.004
Identities = 12/65 (18%), Positives = 29/65 (44%), Gaps = 5/65 (7%)
Query: 540 EQHARCAYELFEKDGNRAIVIEELASEL-GLGPAVPVHAVLHDWIRHTD----GKLSFLG 594
E+ A+++F+ +G+ I +E + +G A + + ++ D G +
Sbjct: 1 EEEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVIDIPE 60
Query: 595 FVKLL 599
F+ L+
Sbjct: 61 FMDLI 65
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} Length = 73 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Score = 36.1 bits (83), Expect = 9e-04
Identities = 13/68 (19%), Positives = 36/68 (52%), Gaps = 1/68 (1%)
Query: 458 LTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRR 517
LT +++ KE ++L + + +GTI+ + + + + + ++ + D ++ +++
Sbjct: 2 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQN-PTEAELQDMINEVDADGNGT 60
Query: 518 MDFEEFCA 525
+DF EF
Sbjct: 61 IDFPEFLT 68
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} Length = 176 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Score = 37.7 bits (86), Expect = 0.002
Identities = 16/157 (10%), Positives = 40/157 (25%), Gaps = 24/157 (15%)
Query: 466 LKEQYALLEPNKNGTISLENVKSALMK--------------NATDAMKDSRIPDFLSSLN 511
LK+++ + + NG + + +
Sbjct: 9 LKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFDYLAKEAG 68
Query: 512 SLQYRRMDFEEFCAAALSV----HQLEALDRWEQHARCAYELFEKDGNRAIVIEELASEL 567
+ E+F ++ + + + +K+ + I +E A+ L
Sbjct: 69 VGSDGSLTEEQFIRVTENLIFEQGEASFNRVLGPVVKGIVGMCDKNADGQINADEFAAWL 128
Query: 568 GLGPAVPVHAVLHDWIRHTD----GKLSFLGFVKLLH 600
A + D G+LS + +
Sbjct: 129 TALG--MSKAEAAEAFNQVDTNGNGELSLDELLTAVR 163
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} Length = 109 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Score = 36.0 bits (83), Expect = 0.002
Identities = 18/113 (15%), Positives = 36/113 (31%), Gaps = 15/113 (13%)
Query: 495 TDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDG 554
D +K I L ++ + + ++F A + + ++ + D
Sbjct: 3 KDLLKADDIKKALDAVKA--EGSFNHKKFFAL------VGLKAMSANDVKKVFKAIDADA 54
Query: 555 NRAIVIEELA---SELGLGPAVPVHAVLHDWIRHTD----GKLSFLGFVKLLH 600
+ I EEL A +++ D GK+ F L+H
Sbjct: 55 SGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAADKDGDGKIGIDEFETLVH 107
|
| >d2zkmx1 a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]} Length = 170 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Phospholipase C-beta-2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.9 bits (85), Expect = 0.003
Identities = 23/158 (14%), Positives = 44/158 (27%), Gaps = 32/158 (20%)
Query: 465 YLKEQYA--LLEPNKNGTISLENVKSAL---MKNATDAMKDSRIPDFLSSLNSLQYRRMD 519
+L + ++ N G I ++N K A+ +P +++
Sbjct: 6 FLDKILVKLKMQLNSEGKIPVKNFFQMFPADRKRVEAALSACHLP--KGKNDAINPEDFP 63
Query: 520 FEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELA------------SEL 567
+ + +S+ +D + + + E L + L
Sbjct: 64 EPVYKSFLMSLCPRPEIDE-------IFTSYHAKAKPYMTKEHLTKFINQKQRDSRLNSL 116
Query: 568 GLGPAVPVHA------VLHDWIRHTDGKLSFLGFVKLL 599
PA P I G+LS G V L
Sbjct: 117 LFPPARPDQVQGLIDKYEPSGINAQRGQLSPEGMVWFL 154
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} Length = 142 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Score = 36.1 bits (82), Expect = 0.003
Identities = 12/147 (8%), Positives = 46/147 (31%), Gaps = 11/147 (7%)
Query: 458 LTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRR 517
L ++ +KE +++++ +++G +S E++K+ + + L +
Sbjct: 1 LPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLKEAPGPLNFTM 60
Query: 518 MDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHA 577
+ + + + + + + + ++
Sbjct: 61 FLSIFSDKLSGTDSEETIRNAFAMFDEQETKKLNIEYIKDLLENM--------GDNFNKD 112
Query: 578 VLHDWIRHTD---GKLSFLGFVKLLHG 601
+ + GK ++ F ++ G
Sbjct: 113 EMRMTFKEAPVEGGKFDYVKFTAMIKG 139
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} Length = 109 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Score = 35.3 bits (81), Expect = 0.003
Identities = 16/113 (14%), Positives = 33/113 (29%), Gaps = 15/113 (13%)
Query: 495 TDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDG 554
TD + I + + + D ++F + + + + + +KD
Sbjct: 3 TDLLSAEDIKKAIGAFTAAD--SFDHKKFFQM------VGLKKKSADDVKKVFHILDKDK 54
Query: 555 NRAIVIEELAS---ELGLGPAVPVHAVLHDWIRHTD----GKLSFLGFVKLLH 600
+ I +EL S + D GK+ F L+
Sbjct: 55 SGFIEEDELGSILKGFSSDARDLSAKETKTLMAAGDKDGDGKIGVEEFSTLVA 107
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 611 | |||
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1exra_ | 146 | Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI | 99.86 | |
| d1topa_ | 162 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 99.85 | |
| d1dtla_ | 156 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 99.84 | |
| d1lkja_ | 146 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 99.83 | |
| d1wdcb_ | 142 | Myosin Essential Chain {Bay scallop (Aequipecten i | 99.83 | |
| d2obha1 | 141 | Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | 99.81 | |
| d1auib_ | 165 | Calcineurin regulatory subunit (B-chain) {Human (H | 99.81 | |
| d1jfja_ | 134 | EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: | 99.81 | |
| d2mysc_ | 145 | Myosin Regulatory Chain {Chicken (Gallus gallus) [ | 99.8 | |
| d2mysb_ | 145 | Myosin Essential Chain {Chicken (Gallus gallus) [T | 99.8 | |
| d1wdcc_ | 152 | Myosin Regulatory Chain {Bay scallop (Aequipecten | 99.79 | |
| d1s6ia_ | 182 | Calcium-dependent protein kinase sk5 CLD {Soybean | 99.78 | |
| d1ggwa_ | 140 | Cdc4p {Fission yeast (Schizosaccharomyces pombe) [ | 99.75 | |
| d2zfda1 | 183 | Calcineurin B-like protein 2 {Thale cress (Arabido | 99.74 | |
| d1y1xa_ | 182 | Programmed cell death 6 protein-like protein {Leis | 99.74 | |
| d1g8ia_ | 187 | Frequenin (neuronal calcium sensor 1) {Human (Homo | 99.73 | |
| d1m45a_ | 146 | Myosin Light Chain Mlc1p {Baker's yeast (Saccharom | 99.73 | |
| d1omra_ | 201 | Recoverin {Cow (Bos taurus) [TaxId: 9913]} | 99.73 | |
| d1bjfa_ | 181 | Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | 99.72 | |
| d1hqva_ | 181 | Apoptosis-linked protein alg-2 {Mouse (Mus musculu | 99.72 | |
| d1fpwa_ | 190 | Frequenin (neuronal calcium sensor 1) {Baker's yea | 99.72 | |
| d1w7jb1 | 139 | Myosin Essential Chain {Human (Homo sapiens) [TaxI | 99.72 | |
| d1jbaa_ | 189 | Guanylate cyclase activating protein 2, GCAP-2 {Co | 99.7 | |
| d1df0a1 | 186 | Calpain large subunit, C-terminal domain (domain I | 99.67 | |
| d1s6ca_ | 178 | Kchip1, Kv4 potassium channel-interacting protein | 99.67 | |
| d1k94a_ | 165 | Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | 99.65 | |
| d2scpa_ | 174 | Sarcoplasmic calcium-binding protein {Sandworm (Ne | 99.65 | |
| d1alva_ | 173 | Calpain small (regulatory) subunit (domain VI) {Pi | 99.65 | |
| d2sasa_ | 185 | Sarcoplasmic calcium-binding protein {Amphioxus (B | 99.64 | |
| d1ij5a_ | 321 | Cbp40 (plasmodial specific CaII-binding protein LA | 99.64 | |
| d1xo5a_ | 180 | Calcium- and integrin-binding protein, CIB {Human | 99.64 | |
| d1qxpa2 | 188 | Calpain large subunit, C-terminal domain (domain I | 99.62 | |
| d1juoa_ | 172 | Sorcin {Human (Homo sapiens) [TaxId: 9606]} | 99.6 | |
| d1qv0a_ | 189 | Calcium-regulated photoprotein {Hydrozoa (Obelia l | 99.59 | |
| d1pvaa_ | 109 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 99.58 | |
| d1uhka1 | 187 | Calcium-regulated photoprotein {Jellyfish (Aequore | 99.57 | |
| d1nyaa_ | 176 | Calerythrin {Saccharopolyspora erythraea [TaxId: 1 | 99.56 | |
| d5pala_ | 109 | Parvalbumin {Leopard shark (Triakis semifasciata) | 99.56 | |
| d1rwya_ | 109 | Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | 99.46 | |
| d2pvba_ | 107 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 99.44 | |
| d1rroa_ | 108 | Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116 | 99.41 | |
| d1k94a_ | 165 | Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | 99.36 | |
| d1juoa_ | 172 | Sorcin {Human (Homo sapiens) [TaxId: 9606]} | 99.33 | |
| d1hqva_ | 181 | Apoptosis-linked protein alg-2 {Mouse (Mus musculu | 99.33 | |
| d1f54a_ | 77 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 99.32 | |
| d1y1xa_ | 182 | Programmed cell death 6 protein-like protein {Leis | 99.32 | |
| d1wrka1 | 82 | Troponin C {Human (Homo sapiens), cardiac isoform | 99.3 | |
| d2opoa1 | 81 | Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta | 99.29 | |
| d1jc2a_ | 75 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 99.28 | |
| d1avsa_ | 81 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 99.28 | |
| d2zkmx1 | 170 | Phospholipase C-beta-2 {Human (Homo sapiens) [TaxI | 99.27 | |
| d1fi5a_ | 81 | Troponin C {Chicken (Gallus gallus), cardiac isofo | 99.26 | |
| d1df0a1 | 186 | Calpain large subunit, C-terminal domain (domain I | 99.25 | |
| d1alva_ | 173 | Calpain small (regulatory) subunit (domain VI) {Pi | 99.25 | |
| d2pq3a1 | 73 | Calmodulin {Rattus norvegicus [TaxId: 10116]} | 99.25 | |
| d1c7va_ | 68 | Calcium vector protein {Amphioxus (Branchiostoma l | 99.23 | |
| d1fw4a_ | 65 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 99.22 | |
| d1s6ja_ | 87 | Calcium-dependent protein kinase sk5 CLD {Soybean | 99.19 | |
| d1tiza_ | 67 | Calmodulin-related protein T21P5.17 {Thale cress ( | 99.19 | |
| d1oqpa_ | 77 | Caltractin (centrin 2) {Green algae (Chlamydomonas | 99.18 | |
| d1qxpa2 | 188 | Calpain large subunit, C-terminal domain (domain I | 99.17 | |
| d1fpwa_ | 190 | Frequenin (neuronal calcium sensor 1) {Baker's yea | 99.16 | |
| d2fcea1 | 61 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 99.14 | |
| d1avsa_ | 81 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 99.13 | |
| d1jbaa_ | 189 | Guanylate cyclase activating protein 2, GCAP-2 {Co | 99.12 | |
| d1fw4a_ | 65 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 99.12 | |
| d1c7va_ | 68 | Calcium vector protein {Amphioxus (Branchiostoma l | 99.11 | |
| d1jfja_ | 134 | EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: | 99.11 | |
| d1jc2a_ | 75 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 99.1 | |
| d2opoa1 | 81 | Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta | 99.09 | |
| d1qx2a_ | 76 | Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | 99.09 | |
| d2pq3a1 | 73 | Calmodulin {Rattus norvegicus [TaxId: 10116]} | 99.08 | |
| d1s6ja_ | 87 | Calcium-dependent protein kinase sk5 CLD {Soybean | 99.08 | |
| d2fcea1 | 61 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 99.08 | |
| d1f54a_ | 77 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 99.07 | |
| d1wrka1 | 82 | Troponin C {Human (Homo sapiens), cardiac isoform | 99.06 | |
| d1fi5a_ | 81 | Troponin C {Chicken (Gallus gallus), cardiac isofo | 99.05 | |
| d1tiza_ | 67 | Calmodulin-related protein T21P5.17 {Thale cress ( | 99.04 | |
| d1oqpa_ | 77 | Caltractin (centrin 2) {Green algae (Chlamydomonas | 99.04 | |
| d1exra_ | 146 | Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI | 99.03 | |
| d1xo5a_ | 180 | Calcium- and integrin-binding protein, CIB {Human | 99.02 | |
| d1omra_ | 201 | Recoverin {Cow (Bos taurus) [TaxId: 9913]} | 99.02 | |
| d1s6ca_ | 178 | Kchip1, Kv4 potassium channel-interacting protein | 99.02 | |
| d2zfda1 | 183 | Calcineurin B-like protein 2 {Thale cress (Arabido | 99.0 | |
| d1g8ia_ | 187 | Frequenin (neuronal calcium sensor 1) {Human (Homo | 98.99 | |
| d5pala_ | 109 | Parvalbumin {Leopard shark (Triakis semifasciata) | 98.98 | |
| d1pvaa_ | 109 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 98.98 | |
| d2obha1 | 141 | Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | 98.94 | |
| d1wlza1 | 83 | DJ-1-binding protein, DJBP {Human (Homo sapiens) [ | 98.91 | |
| d1bjfa_ | 181 | Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | 98.9 | |
| d1rwya_ | 109 | Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | 98.9 | |
| d1auib_ | 165 | Calcineurin regulatory subunit (B-chain) {Human (H | 98.89 | |
| d1qx2a_ | 76 | Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | 98.88 | |
| d2pvba_ | 107 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 98.87 | |
| d1rroa_ | 108 | Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116 | 98.86 | |
| d1cb1a_ | 78 | Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | 98.86 | |
| d1wlza1 | 83 | DJ-1-binding protein, DJBP {Human (Homo sapiens) [ | 98.85 | |
| d1a4pa_ | 92 | Calcyclin (S100) {Human (Homo sapiens), P11 s100a1 | 98.84 | |
| d1c07a_ | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 98.84 | |
| d1zfsa1 | 93 | Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 | 98.84 | |
| d1fi6a_ | 92 | Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | 98.84 | |
| d1snla_ | 99 | Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax | 98.82 | |
| d1yuta1 | 98 | Calcyclin (S100) {Human (Homo sapiens), s100a13 [T | 98.82 | |
| d1ksoa_ | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a3 [Ta | 98.81 | |
| d1yuta1 | 98 | Calcyclin (S100) {Human (Homo sapiens), s100a13 [T | 98.81 | |
| d1xk4a1 | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 98.79 | |
| d1dtla_ | 156 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.79 | |
| d1topa_ | 162 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.79 | |
| d1cb1a_ | 78 | Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | 98.78 | |
| d1c07a_ | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 98.78 | |
| d3c1va1 | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a4 [Ta | 98.77 | |
| d1a4pa_ | 92 | Calcyclin (S100) {Human (Homo sapiens), P11 s100a1 | 98.76 | |
| d1lkja_ | 146 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 98.76 | |
| d2mysc_ | 145 | Myosin Regulatory Chain {Chicken (Gallus gallus) [ | 98.75 | |
| d1wdcb_ | 142 | Myosin Essential Chain {Bay scallop (Aequipecten i | 98.75 | |
| d1xk4a1 | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 98.74 | |
| d1zfsa1 | 93 | Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 | 98.72 | |
| d2mysb_ | 145 | Myosin Essential Chain {Chicken (Gallus gallus) [T | 98.68 | |
| d1wdcc_ | 152 | Myosin Regulatory Chain {Bay scallop (Aequipecten | 98.68 | |
| d1k8ua_ | 89 | Calcyclin (S100) {Human (Homo sapiens), s100a6 [Ta | 98.67 | |
| d1m45a_ | 146 | Myosin Light Chain Mlc1p {Baker's yeast (Saccharom | 98.67 | |
| d1ggwa_ | 140 | Cdc4p {Fission yeast (Schizosaccharomyces pombe) [ | 98.66 | |
| d2jxca1 | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 98.66 | |
| d1psra_ | 100 | Calcyclin (S100) {Human (Homo sapiens), psoriasin | 98.66 | |
| d1ksoa_ | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a3 [Ta | 98.65 | |
| d1s6ia_ | 182 | Calcium-dependent protein kinase sk5 CLD {Soybean | 98.64 | |
| d3c1va1 | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a4 [Ta | 98.64 | |
| d1iq3a_ | 110 | Pob1 {Human (Homo sapiens) [TaxId: 9606]} | 98.62 | |
| d1fi6a_ | 92 | Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | 98.62 | |
| d1k8ua_ | 89 | Calcyclin (S100) {Human (Homo sapiens), s100a6 [Ta | 98.59 | |
| d1psra_ | 100 | Calcyclin (S100) {Human (Homo sapiens), psoriasin | 98.58 | |
| d2hf5a1 | 33 | Troponin C {Human (Homo sapiens), cardiac isoform | 98.56 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.56 | |
| d1iq3a_ | 110 | Pob1 {Human (Homo sapiens) [TaxId: 9606]} | 98.56 | |
| d2sasa_ | 185 | Sarcoplasmic calcium-binding protein {Amphioxus (B | 98.56 | |
| d1snla_ | 99 | Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax | 98.55 | |
| d1e8aa_ | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 98.5 | |
| d2jxca1 | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 98.48 | |
| d1w7jb1 | 139 | Myosin Essential Chain {Human (Homo sapiens) [TaxI | 98.47 | |
| d1uhka1 | 187 | Calcium-regulated photoprotein {Jellyfish (Aequore | 98.43 | |
| d1qjta_ | 99 | Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | 98.43 | |
| d2scpa_ | 174 | Sarcoplasmic calcium-binding protein {Sandworm (Ne | 98.42 | |
| d1qv0a_ | 189 | Calcium-regulated photoprotein {Hydrozoa (Obelia l | 98.42 | |
| d1e8aa_ | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 98.37 | |
| d1nyaa_ | 176 | Calerythrin {Saccharopolyspora erythraea [TaxId: 1 | 98.34 | |
| d2zkmx1 | 170 | Phospholipase C-beta-2 {Human (Homo sapiens) [TaxI | 98.3 | |
| d1qjta_ | 99 | Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | 98.29 | |
| d1qlsa_ | 95 | Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s1 | 98.16 | |
| d3cr5x1 | 90 | Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: | 98.15 | |
| d1ij5a_ | 321 | Cbp40 (plasmodial specific CaII-binding protein LA | 98.1 | |
| d1ctda_ | 34 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.06 | |
| d3cr5x1 | 90 | Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: | 98.06 | |
| d2hf5a1 | 33 | Troponin C {Human (Homo sapiens), cardiac isoform | 97.99 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.99 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.92 | |
| d1j55a_ | 94 | Calcyclin (S100) {Human (Homo sapiens), s100p [Tax | 97.91 | |
| d1qlsa_ | 95 | Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s1 | 97.89 | |
| d1xk4c1 | 83 | Calcyclin (S100) {Human (Homo sapiens), s100a9 (mr | 97.88 | |
| d1j55a_ | 94 | Calcyclin (S100) {Human (Homo sapiens), s100p [Tax | 97.75 | |
| d1xk4c1 | 83 | Calcyclin (S100) {Human (Homo sapiens), s100a9 (mr | 97.7 | |
| d1ctda_ | 34 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 97.63 | |
| d1tuza_ | 118 | Diacylglycerol kinase alpha, N-terminal domain {Hu | 97.21 | |
| d1tuza_ | 118 | Diacylglycerol kinase alpha, N-terminal domain {Hu | 97.18 | |
| d1sraa_ | 151 | C-terminal (EC) domain of BM-40/SPARC/osteonectin | 97.14 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.05 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.63 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.59 | |
| d1sraa_ | 151 | C-terminal (EC) domain of BM-40/SPARC/osteonectin | 94.87 | |
| d1h8ba_ | 73 | alpha-Actinin {Human (Homo sapiens) [TaxId: 9606]} | 93.73 | |
| d1qasa1 | 94 | Phosphoinositide-specific phospholipase C, isozyme | 92.28 | |
| d2cclb1 | 59 | Endo-1,4-beta-xylanase Y {Clostridium thermocellum | 90.43 | |
| d1qasa1 | 94 | Phosphoinositide-specific phospholipase C, isozyme | 88.01 | |
| d1pula1 | 103 | Hypothetical protein c32e8.3 {Caenorhabditis elega | 80.86 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-60 Score=486.49 Aligned_cols=287 Identities=39% Similarity=0.725 Sum_probs=232.6
Q ss_pred cccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
+.+.+.|++++.||+|+||.||+|+.+. +|+.||||++.+..... ..+.+.+|+.+|++|+ |||||++++++.+
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~ 78 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKR---TQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIK-HPNIVALDDIYES 78 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETT---TCCEEEEEEEEC------------CHHHHHHHTCC-CTTBCCEEEEEEC
T ss_pred CCCccceEEEEEEeeccCeEEEEEEECC---CCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCC-CCCCCcEEEEEEE
Confidence 3456789999999999999999999776 68999999997654332 2356889999999997 9999999999999
Q ss_pred CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 231 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
++.+|||||||+||+|.+++... +.+++..++.++.||+.||.|||++|||||||||+|||+...++++.+||+|||+|
T Consensus 79 ~~~~~lvmE~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 79 GGHLYLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred CCEEEEEEeccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEecccee
Confidence 99999999999999999988654 57999999999999999999999999999999999999976667889999999999
Q ss_pred cccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 311 DFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
+.........+.+||+.|||||++. +.|+.++|||||||++|+|++|+.||.+....+....+......++...++.+|
T Consensus 158 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 237 (307)
T d1a06a_ 158 KMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS 237 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred EEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCC
Confidence 9887666667789999999999987 569999999999999999999999999999999999999988888777778899
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCCCCchhHHHHHHHHHHhhcc
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSS 444 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (611)
+++.+||.+||++||.+|||+.|+|+||||++...............+++....+
T Consensus 238 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (307)
T d1a06a_ 238 DSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKS 292 (307)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSCCCCCCCHHHHHHHHHHHSCCC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCccccccchhHHHHHHHHHHHh
Confidence 9999999999999999999999999999999766555555554444455444433
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-59 Score=468.15 Aligned_cols=255 Identities=31% Similarity=0.612 Sum_probs=228.7
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++++.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|++++++++ |||||++++++.+++.
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~ 80 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATR 80 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECC---CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC-CCCCCeEEEEEEECCE
Confidence 4689999999999999999999876 68999999986543333344567899999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|||||||+||+|.+++... +.+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|...
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~~kl~DFG~a~~~ 156 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHA 156 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCSCSCC
T ss_pred EEEEEeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee---cCCCCEeecccceeeec
Confidence 99999999999999988765 569999999999999999999999999999999999999 57788999999999876
Q ss_pred CCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 314 RPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
.. ......+||+.|||||++. ..|+.++|||||||++|+|++|+.||.+.+..+++..+.+....++. .+++++
T Consensus 157 ~~-~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~ 231 (263)
T d2j4za1 157 PS-SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGA 231 (263)
T ss_dssp CC-CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----TSCHHH
T ss_pred CC-CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCc----cCCHHH
Confidence 53 3445678999999999997 45899999999999999999999999999999999988887766553 589999
Q ss_pred HHHHHHhcccCccCCCCHHHHHcCcccCC
Q 007253 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
.+||.+||+.||++|||+.|+|+||||+.
T Consensus 232 ~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 232 RDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 99999999999999999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-58 Score=478.83 Aligned_cols=263 Identities=35% Similarity=0.644 Sum_probs=239.6
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
+.++|++++.||+|+||.||+|+.+. +|+.||||++.+. .....+.+.+|+.+|++|+ |||||++++++.+++
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~---~g~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~ 96 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTP---HESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDN 96 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECCC---SHHHHHHHHHHHHHHHHTC-CTTBCCEEEEEEETT
T ss_pred CccCeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEccc---chhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence 45789999999999999999999876 6899999999654 3445678899999999998 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.+|||||||+||+|.+++....+.+++..++.|+.||+.||.|||++|||||||||+|||+.. +.++.+||+|||+|+.
T Consensus 97 ~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~-~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 97 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAH 175 (350)
T ss_dssp EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc-CCCCeEEEeecchhee
Confidence 999999999999999998777678999999999999999999999999999999999999963 2457899999999998
Q ss_pred cCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 313 VRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
+.........+||+.|||||++. ..|+.++|||||||++|+|++|+.||.+.+..+++..+......++...++.++++
T Consensus 176 ~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 255 (350)
T d1koaa2 176 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 255 (350)
T ss_dssp CCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHH
T ss_pred cccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 87766677789999999999987 56899999999999999999999999999999999999998887777777789999
Q ss_pred HHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
+++||.+||+.||++|||+.|+|+||||+..+
T Consensus 256 ~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 256 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999999999999998765
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-59 Score=466.17 Aligned_cols=260 Identities=31% Similarity=0.563 Sum_probs=218.4
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
+.++|++++.||+|+||.||+|+++. +|+.||||++.+... ....+.+.+|+.++++|+ |||||++++++.+++
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~~~~ 76 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGN 76 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC---------CHHHHHHHHHTCC-CTTBCCEEEEEEETT
T ss_pred CCcceEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCC-CCCEeeEeeeeccCc
Confidence 35789999999999999999999876 689999999976532 223467899999999998 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.+|||||||+||+|.+++.. .+.+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+.
T Consensus 77 ~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl---~~~~~~KL~DFG~a~~ 152 (271)
T d1nvra_ 77 IQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATV 152 (271)
T ss_dssp EEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred eeEEEEeccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE---CCCCCEEEccchhhee
Confidence 99999999999999998743 4579999999999999999999999999999999999999 5677899999999987
Q ss_pred cCCCC---cccccccCCCcCcchhhcC-CC-CCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 007253 313 VRPDE---RLNDIVGSAYYVAPEVLHR-SY-STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (611)
Q Consensus 313 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (611)
+.... .....+||+.|||||++.+ .+ +.++|||||||++|||++|+.||.................. ....+..
T Consensus 153 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (271)
T d1nvra_ 153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-YLNPWKK 231 (271)
T ss_dssp CEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT-TSTTGGG
T ss_pred eccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCcccc
Confidence 65332 3456789999999999864 44 67899999999999999999999776554433333333322 2334567
Q ss_pred CCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
+++++.+||.+||+.||++|||++|+|+||||+..-
T Consensus 232 ~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l 267 (271)
T d1nvra_ 232 IDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 267 (271)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence 899999999999999999999999999999998643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.8e-58 Score=475.06 Aligned_cols=262 Identities=36% Similarity=0.619 Sum_probs=239.3
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++++.||+|+||.||+|+... +|+.||||++.+.. ....+.+.+|+.+|++|+ |||||+++++|.+++.
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~ 100 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTPY---PLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYE 100 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSE
T ss_pred ccceEEEEEEecCCCeEEEEEEECC---CCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCE
Confidence 4679999999999999999999776 68999999996542 334567889999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|||||||+||+|.+++.....++++..++.|+.||+.||.|||++|||||||||+||||.. ...+.+||+|||+|..+
T Consensus 101 ~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKL 179 (352)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc-cCCCeEEEeecccceec
Confidence 99999999999999988777778999999999999999999999999999999999999953 24678999999999998
Q ss_pred CCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 314 RPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
..+.......||+.|||||++. ..|+.++|||||||++|+|++|+.||.+.+..+.+..+......++...++.+++++
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 259 (352)
T d1koba_ 180 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 259 (352)
T ss_dssp CTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred CCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 8777777789999999999987 558999999999999999999999999999999999999998888888888999999
Q ss_pred HHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.+||.+||++||.+|||+.|+|+||||+...
T Consensus 260 ~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 260 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 9999999999999999999999999998653
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-58 Score=464.23 Aligned_cols=258 Identities=31% Similarity=0.505 Sum_probs=227.0
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.+.|++++.||+|+||.||+|+++. +|+.||||++.+.. ....+.+.+|+++|++|+ |||||++++++.+++.
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~ 83 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKE---TSVLAAAKVIDTKS---EEELEDYMVEIDILASCD-HPNIVKLLDAFYYENN 83 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECC---CCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCe
Confidence 3569999999999999999999876 68999999997542 233467889999999998 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|||||||+||+|.+++.+..+.+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|...
T Consensus 84 ~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~ 160 (288)
T d2jfla1 84 LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKN 160 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE---CCCCCEEEEechhhhcc
Confidence 999999999999999888777789999999999999999999999999999999999999 57788999999999765
Q ss_pred CCC-CcccccccCCCcCcchhhc------CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 007253 314 RPD-ERLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (611)
... ......+||+.|||||++. +.|+.++|||||||++|||++|+.||.+....+.+..+....+.... ...
T Consensus 161 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~ 239 (288)
T d2jfla1 161 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA-QPS 239 (288)
T ss_dssp HHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCS-SGG
T ss_pred CCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC-ccc
Confidence 432 2345678999999999873 45889999999999999999999999998888888888877643322 234
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
.+++++.+||++||+.||++|||+.|+|+||||+..
T Consensus 240 ~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 240 RWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 689999999999999999999999999999999853
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-58 Score=461.71 Aligned_cols=256 Identities=29% Similarity=0.500 Sum_probs=223.9
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++.++||+|+||.||+|+... +|+.||||++....... .+.+.+|+.++++++ |||||+++++|.+++.
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~---~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~ 91 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQPK---KELIINEILVMRENK-NPNIVNYLDSYLVGDE 91 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTT---TCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred ccccEEEEEEecCcCcEEEEEEECC---CCCEEEEEEEecccChH---HHHHHHHHHHHHhCC-CCCEeeEeEEEEECCE
Confidence 4579999999999999999999766 68999999997543332 467899999999998 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|||||||+||+|.+++.. +.+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+.+
T Consensus 92 ~~ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~vkl~DFG~a~~~ 166 (293)
T d1yhwa1 92 LWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQI 166 (293)
T ss_dssp EEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE---CCCCcEeeccchhheee
Confidence 9999999999999987754 469999999999999999999999999999999999999 56788999999999877
Q ss_pred CCCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 314 RPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
..+. .....+||+.|||||++. +.|+.++|||||||++|+|++|+.||.+......+..+....... ...+..++++
T Consensus 167 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~ 245 (293)
T d1yhwa1 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE-LQNPEKLSAI 245 (293)
T ss_dssp CSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC-CSSGGGSCHH
T ss_pred ccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC-CCCcccCCHH
Confidence 5443 456678999999999987 558999999999999999999999999888877777666554321 1223568999
Q ss_pred HHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
+++||.+||++||++|||+.|+|+||||+..
T Consensus 246 ~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999999999854
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-58 Score=464.88 Aligned_cols=257 Identities=31% Similarity=0.591 Sum_probs=226.1
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++++.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|++++++|+ |||||++++++.+++.+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC-CCCeeEEEEEEEECCEE
Confidence 679999999999999999999876 68999999996543333344567899999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
|||||||+||+|.+++... +.+++..++.++.||+.||.|||++|||||||||+|||+ ++++.+||+|||+|+.+.
T Consensus 84 ~ivmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc---CCCceEEecccccceecc
Confidence 9999999999999987665 579999999999999999999999999999999999999 677889999999998775
Q ss_pred CCC---cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 315 PDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 315 ~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
... .....+||+.|||||++. ..|+.++|||||||++|+|++|+.||.+.+..+++..+.+....++ ..+++
T Consensus 160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 235 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFP 235 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC----TTCCH
T ss_pred cCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCC----ccCCH
Confidence 332 345678999999999986 5689999999999999999999999999999999999988876655 36899
Q ss_pred HHHHHHHHhcccCccCCCCHHH------HHcCcccCCCC
Q 007253 391 EARDFVKRLLNKDPRKRLTAAQ------ALSHPWIKNSN 423 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~~------ll~hp~~~~~~ 423 (611)
++++||++||+.||++|||++| +++||||++.+
T Consensus 236 ~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 236 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274 (288)
T ss_dssp HHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence 9999999999999999999987 68999998764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-58 Score=463.38 Aligned_cols=267 Identities=37% Similarity=0.684 Sum_probs=236.8
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCC---HHHHHHHHHHHHHHHHhcCCCCeeEEEEEE
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT---AIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~ 228 (611)
.+.++|++++.||+|+||.||+|+.+. +|+.||||++.+..... ....+.+.+|+.+|++|+ |||||+++++|
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~ 82 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVY 82 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEEE
Confidence 356789999999999999999999876 68999999997654322 224578999999999997 99999999999
Q ss_pred eeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccC-CCceEEEeec
Q 007253 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAIDF 307 (611)
Q Consensus 229 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~-~~~~vkl~Df 307 (611)
.+++.+|||||||+||+|.+++... +.+++..++.++.||+.||.|||++|||||||||+|||+...+ ....+||+||
T Consensus 83 ~~~~~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 83 ENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EECCEEEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecch
Confidence 9999999999999999999988765 5799999999999999999999999999999999999996433 2336999999
Q ss_pred ccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 007253 308 GLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 308 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (611)
|+|............+||+.|||||++. +.++.++|||||||++|||++|+.||.+.+..+.+..+......++...++
T Consensus 162 G~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (293)
T d1jksa_ 162 GLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241 (293)
T ss_dssp TTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred hhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcC
Confidence 9999887666777789999999999997 568999999999999999999999999999999999998887777665567
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.+|.++.+||++||+.||++|||+.|+|+||||+..+
T Consensus 242 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 8999999999999999999999999999999998653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.2e-57 Score=453.77 Aligned_cols=263 Identities=35% Similarity=0.644 Sum_probs=237.3
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCC------HHHHHHHHHHHHHHHHhcCCCCeeEEEE
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT------AIAIEDVRREVKILRALTGHNNLVKFFD 226 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~~h~~iv~l~~ 226 (611)
|.++|++++.||+|+||.||+|+... +|+.||||++.+..... ....+.+.+|+.++++|..|||||++++
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~---~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 77 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKP---TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 77 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECC---CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEe
Confidence 35789999999999999999999766 68999999997654332 2234568899999999988999999999
Q ss_pred EEeeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEee
Q 007253 227 AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (611)
Q Consensus 227 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D 306 (611)
++.+++.+|||||||+||+|.+++..+ +.+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|
T Consensus 78 ~~~~~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~~kl~D 153 (277)
T d1phka_ 78 TYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTD 153 (277)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECC
T ss_pred ecccCcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---cCCCCeEEcc
Confidence 999999999999999999999999765 579999999999999999999999999999999999999 6788899999
Q ss_pred cccccccCCCCcccccccCCCcCcchhhc-------CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC
Q 007253 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 379 (611)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~ 379 (611)
||+++.+.........+||+.|+|||++. ..++.++||||+||++|+|++|+.||.+.........+......
T Consensus 154 FG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~ 233 (277)
T d1phka_ 154 FGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233 (277)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred chheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCC
Confidence 99999887666667789999999999874 24688999999999999999999999999999999999988877
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 380 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
++...++.+|+++++||++||+.||++|||+.|+|+||||+..
T Consensus 234 ~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 234 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 7777777899999999999999999999999999999999863
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-57 Score=452.88 Aligned_cols=253 Identities=22% Similarity=0.382 Sum_probs=215.7
Q ss_pred eeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee----CC
Q 007253 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED----TD 232 (611)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~----~~ 232 (611)
|++.++||+|+||.||+|++.. +++.||+|++..... .....+.+.+|+++|++|+ |||||+++++|.+ +.
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~---~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~ 85 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKK 85 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCE
T ss_pred EEeeeEEecCcCcEEEEEEECC---CCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeccccCC
Confidence 4778899999999999999876 689999999876543 3445678999999999998 9999999999875 34
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
.+|||||||+||+|.+++.+. ..+++..++.++.||+.||.|||+++ ||||||||+||||+ +.++.+||+|||+|
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLA 162 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGG
T ss_pred EEEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEeecCcc
Confidence 689999999999999988665 57999999999999999999999998 99999999999995 34678999999999
Q ss_pred cccCCCCcccccccCCCcCcchhhcCCCCCcchhhHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCCCCCCCCCCC
Q 007253 311 DFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s 389 (611)
+.... ......+||+.|||||++.+.|+.++|||||||++|||++|+.||.+.... .+...+..... +......++
T Consensus 163 ~~~~~-~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~ 239 (270)
T d1t4ha_ 163 TLKRA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAI 239 (270)
T ss_dssp GGCCT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCC
T ss_pred eeccC-CccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC--CcccCccCC
Confidence 87543 344567999999999999989999999999999999999999999765544 44444443322 122234678
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHcCcccC
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~ 420 (611)
+++.+||.+||+.||++|||+.|+|+|||||
T Consensus 240 ~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 9999999999999999999999999999996
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-57 Score=453.32 Aligned_cols=255 Identities=31% Similarity=0.503 Sum_probs=213.1
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee--C
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--T 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~--~ 231 (611)
.++|++++.||+|+||.||+|+.+. +|+.||||++..... .....+.+.+|++++++|+ |||||++++++.+ +
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~ 77 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKS---DGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTN 77 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC---
T ss_pred chhCEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEeCCC
Confidence 4689999999999999999999876 689999999977654 3445678899999999998 9999999999975 4
Q ss_pred CeeEEEeeecCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC-----CeeecCCCCceEEeccCCCceEE
Q 007253 232 DNVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQG-----VVHRDLKPENFLFTTKDENSVLK 303 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----iiHrDlkp~NIll~~~~~~~~vk 303 (611)
+.+|||||||+||+|.+++.. ....+++..++.++.||+.||.|||+.| ||||||||+|||| +.++.+|
T Consensus 78 ~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vk 154 (269)
T d2java1 78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVK 154 (269)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE---CTTSCEE
T ss_pred CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEE
Confidence 568999999999999998864 3467999999999999999999999976 9999999999999 5778899
Q ss_pred EeecccccccCCCC-cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Q 007253 304 AIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381 (611)
Q Consensus 304 l~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~ 381 (611)
|+|||+|+.+..+. .....+||+.|||||++. ..|+.++|||||||++|||++|+.||.+.+..++...+.......
T Consensus 155 l~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~- 233 (269)
T d2java1 155 LGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR- 233 (269)
T ss_dssp ECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC-
T ss_pred EeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence 99999998876443 345678999999999986 569999999999999999999999999998888888887765432
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCccc
Q 007253 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (611)
Q Consensus 382 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~ 419 (611)
....+++++.+||.+||+.||.+|||+.|+|+|||+
T Consensus 234 --~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 234 --IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred --CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 124689999999999999999999999999999996
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-57 Score=460.28 Aligned_cols=257 Identities=26% Similarity=0.413 Sum_probs=226.5
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.+.|+++++||+|+||.||+|+... +|+.||||++.+.........+.+.+|+.+|++|+ |||||++++++.+++.
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~ 89 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHT 89 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECC---CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEECCE
Confidence 3469999999999999999999876 68999999998776666667788999999999998 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|||||||.+|+|..++ ...+.+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+|||+|...
T Consensus 90 ~~iv~E~~~~g~l~~~~-~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~~Kl~DFG~a~~~ 165 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLE-VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIM 165 (309)
T ss_dssp EEEEEECCSEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSS
T ss_pred EEEEEEecCCCchHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---CCCCCEEEeeccccccc
Confidence 99999999998876544 445679999999999999999999999999999999999999 57789999999999876
Q ss_pred CCCCcccccccCCCcCcchhhc----CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 314 RPDERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
.. ....+||+.|||||++. +.|+.++|||||||++|||++|+.||.+....+.+..+........ ....++
T Consensus 166 ~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s 240 (309)
T d1u5ra_ 166 AP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWS 240 (309)
T ss_dssp SS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--SCTTSC
T ss_pred CC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--CCCCCC
Confidence 43 34568999999999984 3589999999999999999999999999888888877777653332 234689
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
+++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 241 ~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 241 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence 9999999999999999999999999999998643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-57 Score=464.56 Aligned_cols=257 Identities=29% Similarity=0.540 Sum_probs=231.1
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++++.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|+.+|++++ |||||+++++|.+++.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~ 79 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDR 79 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeeeccccc
Confidence 4689999999999999999999776 69999999997643333334577889999999998 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+..
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl---~~~g~vkl~DFG~a~~~ 155 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCS
T ss_pred cccceeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe---cCCCCEEEeeccccccc
Confidence 99999999999999987665 579999999999999999999999999999999999999 67789999999999876
Q ss_pred CC-CCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 314 RP-DERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 314 ~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
.. .......+||+.|||||++. +.|+.++|||||||++|||++|+.||.+.+..+++..+......++ ..+|++
T Consensus 156 ~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 231 (337)
T d1o6la_ 156 ISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPE 231 (337)
T ss_dssp CCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHH
T ss_pred ccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHH
Confidence 43 34556789999999999986 5699999999999999999999999999999999999998876665 368999
Q ss_pred HHHHHHHhcccCccCCCC-----HHHHHcCcccCCC
Q 007253 392 ARDFVKRLLNKDPRKRLT-----AAQALSHPWIKNS 422 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rpt-----~~~ll~hp~~~~~ 422 (611)
+++||++||++||.+|++ +.++++||||++.
T Consensus 232 ~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 999999999999999994 9999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-57 Score=463.54 Aligned_cols=262 Identities=30% Similarity=0.583 Sum_probs=237.3
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+.++|++++.||+|+||.||+|.++. +|+.||||++.+.. .....+.+|+++|+.++ |||||+++++|.++
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~---~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~ 73 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETS---SKKTYMAKFVKVKG----TDQVLVKKEISILNIAR-HRNILHLHESFESM 73 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCCT----HHHHHHHHHHHHHHHSC-CTTBCCEEEEEEET
T ss_pred CCccceEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCC-CCCCCeEEEEEEEC
Confidence 356789999999999999999999876 68999999996542 22356889999999998 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
+.+|||||||+||+|.+++...+..+++..++.|+.||+.||.|||++|||||||||+|||++. +....+||+|||++.
T Consensus 74 ~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~-~~~~~ikl~DFG~~~ 152 (321)
T d1tkia_ 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQAR 152 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCE
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC-CCceEEEEcccchhh
Confidence 9999999999999999998777668999999999999999999999999999999999999953 245689999999999
Q ss_pred ccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 312 FVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
...........+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.+..+.+..+.+....++...++.+++
T Consensus 153 ~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 232 (321)
T d1tkia_ 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232 (321)
T ss_dssp ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCH
Confidence 877666667788999999999886 5689999999999999999999999999999999999999888887777778999
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
++++||++||.+||.+|||+.|+|+||||+..
T Consensus 233 ~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 99999999999999999999999999999764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-57 Score=463.47 Aligned_cols=263 Identities=26% Similarity=0.418 Sum_probs=217.5
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
..++|+++++||+|+||.||+|+... +|+.||+|++.+.. .....+.+.+|+.+|++|+ |||||+++++|.+++
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 77 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKP---SGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDG 77 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETT---TTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCC-CTTBCCEEEEEECSS
T ss_pred CccCCEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence 35789999999999999999999776 68999999997643 2334577899999999998 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
++|||||||+||+|.+++.+. +.+++..++.++.||+.||.|||+ +|||||||||+|||| +.++.+||+|||+|+
T Consensus 78 ~~~iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~ 153 (322)
T d1s9ja_ 78 EISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSG 153 (322)
T ss_dssp EEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCH
T ss_pred EEEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE---CCCCCEEEeeCCCcc
Confidence 999999999999999988765 569999999999999999999997 599999999999999 577889999999998
Q ss_pred ccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHH-------------------
Q 007253 312 FVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFR------------------- 371 (611)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~------------------- 371 (611)
.+.. ....+.+||+.|||||++. ..|+.++|||||||++|||++|+.||.+........
T Consensus 154 ~~~~-~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 154 QLID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp HHHH-HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred ccCC-CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence 7643 3345679999999999987 569999999999999999999999997654332110
Q ss_pred -----------------------HHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCCCCc
Q 007253 372 -----------------------AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVP 428 (611)
Q Consensus 372 -----------------------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~~~~ 428 (611)
.+... ..+..+...++.++.+||.+||+.||.+|||++|+|+||||+......+-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~~~d 310 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNE--PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVD 310 (322)
T ss_dssp -------------CCCCHHHHHHHHHTS--CCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHSCCC
T ss_pred ccccccccccccccchhHHHHHhhhhcc--CCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCccccc
Confidence 00000 01111123468999999999999999999999999999999865444333
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-56 Score=457.69 Aligned_cols=256 Identities=27% Similarity=0.582 Sum_probs=228.2
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++++.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|+.++++++ |||||++++++.+++.
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~ 78 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQ 78 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECC---CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc-CcChhheeeeEeeCCe
Confidence 3579999999999999999999876 68999999996543333344577899999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|+|||||+||+|..++... ..+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+..
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl---~~~g~vkL~DFG~a~~~ 154 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYV 154 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEEC
T ss_pred eeeEeeecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE---cCCCCEEEecCccceEe
Confidence 99999999999988876544 678999999999999999999999999999999999999 67888999999999886
Q ss_pred CCCCcccccccCCCcCcchhhcC-CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHH
Q 007253 314 RPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (611)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 392 (611)
.. ...+.+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+.+..+.+..+......++ +.+++++
T Consensus 155 ~~--~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 228 (316)
T d1fota_ 155 PD--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDV 228 (316)
T ss_dssp SS--CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHH
T ss_pred cc--ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CCCCHHH
Confidence 53 3456799999999999974 599999999999999999999999999999999999998876554 3689999
Q ss_pred HHHHHHhcccCccCCC-----CHHHHHcCcccCCCC
Q 007253 393 RDFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423 (611)
Q Consensus 393 ~~li~~~L~~dP~~Rp-----t~~~ll~hp~~~~~~ 423 (611)
.++|.+||.+||.+|+ |++++|+||||++.+
T Consensus 229 ~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~ 264 (316)
T d1fota_ 229 KDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 264 (316)
T ss_dssp HHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred HHHHHHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence 9999999999999996 999999999998753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.7e-56 Score=459.40 Aligned_cols=254 Identities=30% Similarity=0.568 Sum_probs=228.2
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++++.||+|+||.||+|+++. +|+.||||++.+.........+.+.+|+++|+.++ |||||++++++.+...+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~---~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~ 116 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECC---CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC-CCcEeeccccccccccc
Confidence 689999999999999999999876 68999999996543333344567889999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++|||||.||+|.+++... +.+++..++.|+.||+.||.|||++|||||||||+|||| +.++++||+|||+|+.+.
T Consensus 117 ~~v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl---~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECS
T ss_pred ccccccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc---CCCCCEEeeeceeeeecc
Confidence 9999999999999988765 579999999999999999999999999999999999999 577889999999998775
Q ss_pred CCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 007253 315 PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (611)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 393 (611)
. .....+||+.|||||++. +.|+.++|||||||++|||++|+.||.+.+...++..+....+.++ ..+++++.
T Consensus 193 ~--~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~ 266 (350)
T d1rdqe_ 193 G--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLK 266 (350)
T ss_dssp S--CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHH
T ss_pred c--ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHHH
Confidence 3 345678999999999987 5689999999999999999999999999999899999988876554 36899999
Q ss_pred HHHHHhcccCccCCC-----CHHHHHcCcccCCC
Q 007253 394 DFVKRLLNKDPRKRL-----TAAQALSHPWIKNS 422 (611)
Q Consensus 394 ~li~~~L~~dP~~Rp-----t~~~ll~hp~~~~~ 422 (611)
+||++||++||.+|+ |++++++||||++.
T Consensus 267 ~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 999999999999995 99999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-56 Score=460.19 Aligned_cols=261 Identities=33% Similarity=0.630 Sum_probs=220.3
Q ss_pred cCCceeEeC-eeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee-
Q 007253 153 FANKYELGE-EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED- 230 (611)
Q Consensus 153 ~~~~y~~~~-~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~- 230 (611)
+.++|++.+ .||+|+||.||+|++.. +|+.||||++.+. ..+.+|+.++.++.+|||||+++++|.+
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~ 77 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL 77 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECC---CCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence 457899875 59999999999999776 6899999998542 3577899998777569999999999976
Q ss_pred ---CCeeEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEee
Q 007253 231 ---TDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (611)
Q Consensus 231 ---~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D 306 (611)
+..+|||||||+||+|.+++..++ ..+++..++.|+.||+.||+|||++|||||||||+|||++..+..+.+||+|
T Consensus 78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccc
Confidence 467999999999999999997654 4699999999999999999999999999999999999997666678899999
Q ss_pred cccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHH----hcCCCCC
Q 007253 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL----KADPSFD 381 (611)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~----~~~~~~~ 381 (611)
||+|+...........+||+.|||||++. ..|+.++|||||||++|+|+||+.||.+.........+. .....++
T Consensus 158 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~ 237 (335)
T d2ozaa1 158 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237 (335)
T ss_dssp CTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCC
T ss_pred cceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence 99999887777777789999999999987 459999999999999999999999997766544443333 2333344
Q ss_pred CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCC
Q 007253 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (611)
Q Consensus 382 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~ 424 (611)
...+..+|+++.+||++||+.||++|||+.|+|+||||+...+
T Consensus 238 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 280 (335)
T d2ozaa1 238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280 (335)
T ss_dssp TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTS
T ss_pred CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCC
Confidence 4444568999999999999999999999999999999976543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=450.75 Aligned_cols=256 Identities=31% Similarity=0.543 Sum_probs=225.4
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHH-HhcCCCCeeEEEEEEeeCCe
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR-ALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~~h~~iv~l~~~~~~~~~ 233 (611)
++|++++.||+|+||.||+|+++. +|+.||||++.+.........+.+..|+.++. .++ |||||++++++.+++.
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~---t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~-hp~Iv~~~~~~~~~~~ 77 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE-HPFLTHMFCTFQTKEN 77 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTT-CTTBCCEEEEEECSSE
T ss_pred CCeEEeeEEecCCCcEEEEEEECC---CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCC-CCcEEEEEEEEccCCc
Confidence 579999999999999999999876 68999999996543222333456677887776 455 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|||||||+||+|.+++... ..+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+++..
T Consensus 78 ~yivmEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~---~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 78 LFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCC
T ss_pred eeEEEeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee---cCCCceeccccchhhhc
Confidence 99999999999999988655 569999999999999999999999999999999999999 67788999999999876
Q ss_pred CCC-CcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHH
Q 007253 314 RPD-ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (611)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (611)
... ......+||+.|+|||++. +.|+.++|||||||++|+|++|+.||.+.+..+++..+....+.++ ..++++
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~ 229 (320)
T d1xjda_ 154 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKE 229 (320)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHH
T ss_pred ccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHH
Confidence 543 3445578999999999987 5799999999999999999999999999999999999988876655 368999
Q ss_pred HHHHHHHhcccCccCCCCHH-HHHcCcccCCC
Q 007253 392 ARDFVKRLLNKDPRKRLTAA-QALSHPWIKNS 422 (611)
Q Consensus 392 ~~~li~~~L~~dP~~Rpt~~-~ll~hp~~~~~ 422 (611)
+.+||++||++||.+|||+. ++++||||++.
T Consensus 230 ~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 230 AKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp HHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 99999999999999999996 89999999874
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.5e-55 Score=455.87 Aligned_cols=259 Identities=25% Similarity=0.413 Sum_probs=215.0
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHH---HHHHHHhcCCCCeeEEEEEEee
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRRE---VKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E---~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
.++|++++.||+|+||.||+|+... +|+.||||++.+...........+.+| +.+++.+. |||||+++++|.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~---t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~-hpnIv~l~~~~~~ 78 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHT 78 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEEEEC
T ss_pred HHhCeeeeEEecCCCeEEEEEEECC---CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCC-CCcEEEEEEEEEE
Confidence 3679999999999999999999776 689999999865433222223334445 55555555 9999999999999
Q ss_pred CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccc
Q 007253 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (611)
Q Consensus 231 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a 310 (611)
++.+|||||||+||+|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+|||+|
T Consensus 79 ~~~~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl---~~~g~iKl~DFGla 154 (364)
T d1omwa3 79 PDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLA 154 (364)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CSSSCEEECCCTTC
T ss_pred CCEEEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE---cCCCcEEEeeecee
Confidence 99999999999999999988765 578999999999999999999999999999999999999 67788999999999
Q ss_pred cccCCCCcccccccCCCcCcchhhc-C-CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 311 DFVRPDERLNDIVGSAYYVAPEVLH-R-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
+.+... .....+||+.|||||++. + .|+.++|||||||++|||++|+.||.+........ +...........+..+
T Consensus 155 ~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~ 232 (364)
T d1omwa3 155 CDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSF 232 (364)
T ss_dssp EECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSCCCCCCSSS
T ss_pred eecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccCCCCCCCCC
Confidence 877543 445678999999999985 3 48999999999999999999999998765443322 2222222333334578
Q ss_pred CHHHHHHHHHhcccCccCCCC-----HHHHHcCcccCCC
Q 007253 389 SSEARDFVKRLLNKDPRKRLT-----AAQALSHPWIKNS 422 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt-----~~~ll~hp~~~~~ 422 (611)
++++.+||.+||++||++||| ++++++||||++.
T Consensus 233 s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 233 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred CHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 999999999999999999999 7999999999874
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-54 Score=439.16 Aligned_cols=262 Identities=30% Similarity=0.494 Sum_probs=219.1
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|+++++||+|+||.||+|++.. +|+.||||++.... ......+.+.+|++++++++ |||||+++++|.+++++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKL---TGEVVALKKIRLDT-ETEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEC--------CCHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECC---CCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCC-CCcEEEeccccccccce
Confidence 589999999999999999999876 68999999996543 22334567889999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 235 YVVMELCEGGELLDRIL-SRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
|+|||||.+ ++.+++. .....+++..++.++.||+.||.|||++|||||||||+|||+ +.++++||+|||+|+..
T Consensus 77 ~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 77 YLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAF 152 (298)
T ss_dssp EEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTHHHHH
T ss_pred eEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee---cccCcceeccCCcceec
Confidence 999999965 5555554 345679999999999999999999999999999999999999 57788999999999876
Q ss_pred CCC-CcccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC------
Q 007253 314 RPD-ERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP------ 384 (611)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~------ 384 (611)
... ......+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+.+..+........+..
T Consensus 153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred cCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 543 3455678999999999875 3468899999999999999999999998888777776655322222111
Q ss_pred -------------------CCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCCC
Q 007253 385 -------------------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (611)
Q Consensus 385 -------------------~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~~ 425 (611)
.+.+++++++||++||+.||++|||+.|+|+||||++..++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 23568999999999999999999999999999999987654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-54 Score=439.71 Aligned_cols=258 Identities=28% Similarity=0.415 Sum_probs=214.1
Q ss_pred eEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCC--HHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT--AIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 158 ~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
+.+++||+|+||.||+|+++. +|+.||||++....... ....+.+.+|+.++++++ |||||++++++.+++.+|
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~~~~~~~~ 76 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKN---TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNIS 76 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSS---CCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTCCE
T ss_pred CcceEeccCcCeEEEEEEECC---CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeeeccCCcee
Confidence 356899999999999999776 68999999996543222 122356889999999998 999999999999999999
Q ss_pred EEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCC
Q 007253 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (611)
Q Consensus 236 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~ 315 (611)
||||||.++++. .+......+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+....
T Consensus 77 ivmE~~~~~~~~-~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli---~~~~~~KL~DFG~a~~~~~ 152 (299)
T d1ua2a_ 77 LVFDFMETDLEV-IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGS 152 (299)
T ss_dssp EEEECCSEEHHH-HHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTTS
T ss_pred ehhhhhcchHHh-hhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe---cCCCccccccCccccccCC
Confidence 999999886654 445556779999999999999999999999999999999999999 6778899999999987654
Q ss_pred CC-cccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC--------
Q 007253 316 DE-RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP-------- 384 (611)
Q Consensus 316 ~~-~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------- 384 (611)
.. .....+||+.|||||++. ..|+.++|||||||++|||++|..||.+.+..+.+..+.+.........
T Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 153 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred CcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence 43 445678999999999885 4589999999999999999999999999998888877765321111111
Q ss_pred ----------------CCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 385 ----------------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 385 ----------------~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
++.+++++.+||++||+.||++|||+.|+|+||||++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 135689999999999999999999999999999999754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-54 Score=431.25 Aligned_cols=253 Identities=29% Similarity=0.540 Sum_probs=212.6
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCH---HHHHHHHHHHHHHHHhc-CCCCeeEEEEEE
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA---IAIEDVRREVKILRALT-GHNNLVKFFDAY 228 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~-~h~~iv~l~~~~ 228 (611)
+.++|++++.||+|+||.||+|+... +|+.||||++.+...... ....++.+|+.++++++ +|||||++++++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~ 78 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVS---DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 78 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECC---CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE
Confidence 35789999999999999999999876 689999999975433221 11234668999999996 489999999999
Q ss_pred eeCCeeEEEeeecCC-CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeec
Q 007253 229 EDTDNVYVVMELCEG-GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (611)
Q Consensus 229 ~~~~~~~lv~E~~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~Df 307 (611)
.+.+.+|+||||+.+ +++.+++... ..+++..++.++.||+.||.|||++|||||||||+|||++ .+.+.+||+||
T Consensus 79 ~~~~~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~--~~~~~vkl~DF 155 (273)
T d1xwsa_ 79 ERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDF 155 (273)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCC
T ss_pred eeCCeEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe--cCCCeEEECcc
Confidence 999999999999986 4666766554 5799999999999999999999999999999999999995 24578999999
Q ss_pred ccccccCCCCcccccccCCCcCcchhhc-CC-CCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 007253 308 GLSDFVRPDERLNDIVGSAYYVAPEVLH-RS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (611)
Q Consensus 308 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~-~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (611)
|+|..... ....+.+||+.|||||++. .. ++.++|||||||++|+|++|+.||.+. ..+......++
T Consensus 156 G~a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~---- 224 (273)
T d1xwsa_ 156 GSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFR---- 224 (273)
T ss_dssp TTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCS----
T ss_pred ccceeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCC----
Confidence 99987643 3445678999999999986 33 467899999999999999999999753 23455544433
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
..+|+++++||++||+.||++|||++|+|+||||++.
T Consensus 225 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 225 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred CCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 4689999999999999999999999999999999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-54 Score=428.90 Aligned_cols=251 Identities=23% Similarity=0.393 Sum_probs=208.6
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++++.||+|+||.||+|+. ...||||++..... .....+.+.+|+.++++++ |||||++++++. ++.
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~-~~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKW------HGDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTR-HVNILLFMGYST-APQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEES------SSEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEC-SSS
T ss_pred cccEEEEEEEeeCCCcEEEEEEE------CCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CCCEeeeeEEEe-ccE
Confidence 46799999999999999999974 23599999975543 3445678999999999997 999999999875 456
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
++||||||+||+|.+++......+++..+..|+.||+.||+|||+++||||||||+|||| +.++.+||+|||+|+..
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl---~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVK 154 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTSSEEECCCCCSCC-
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE---cCCCCEEEccccceeec
Confidence 899999999999999998777789999999999999999999999999999999999999 57788999999999876
Q ss_pred CCCC---cccccccCCCcCcchhhc----CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--CCC
Q 007253 314 RPDE---RLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD--EAP 384 (611)
Q Consensus 314 ~~~~---~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~--~~~ 384 (611)
.... ......||+.|||||++. +.|+.++|||||||++|||+||+.||.+......+..+.......+ ...
T Consensus 155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 234 (276)
T d1uwha_ 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGS
T ss_pred cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhc
Confidence 5332 345678999999999985 3478899999999999999999999988766655544444332222 223
Q ss_pred CCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 385 ~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
...+++++.+||.+||+.||++|||+.+++++
T Consensus 235 ~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 45789999999999999999999999999876
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=435.62 Aligned_cols=265 Identities=29% Similarity=0.404 Sum_probs=219.8
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhc--CCCCeeEEEEEEee-
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT--GHNNLVKFFDAYED- 230 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~iv~l~~~~~~- 230 (611)
.++|+++++||+|+||.||+|++... .++.||||++....... .....+.+|+.+++.|. +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~--~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECC--CCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 47899999999999999999997652 36789999986533221 12234567888888773 49999999999863
Q ss_pred ----CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEee
Q 007253 231 ----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (611)
Q Consensus 231 ----~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D 306 (611)
...++++||||.+|.+..........+++..++.++.||+.||+|||++|||||||||+|||+ +..+.+||+|
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi---~~~~~~kl~d 159 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLAD 159 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECS
T ss_pred ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE---cCCCCeeecc
Confidence 346899999998877655555556679999999999999999999999999999999999999 6778899999
Q ss_pred cccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----
Q 007253 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD---- 381 (611)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~---- 381 (611)
||++............+||+.|||||++. ..|+.++|||||||++|||++|+.||.+.+..+.+..+........
T Consensus 160 fg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 160 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 99998877666677889999999999886 6699999999999999999999999999988887777765321111
Q ss_pred -------------------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCCC
Q 007253 382 -------------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (611)
Q Consensus 382 -------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~~ 424 (611)
...+..+++++.+||++||++||++|||+.|+|+||||++..+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 1113467899999999999999999999999999999997643
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.3e-53 Score=428.60 Aligned_cols=261 Identities=28% Similarity=0.471 Sum_probs=221.7
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.+.++|++.+.||+|+||.||+|++.. +|+.||||++.+....+....+.+.+|+++++.++ |||||++++++...
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~~ 79 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLR---LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAE 79 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEE
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECC---CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC-CCCCCcccceeeec
Confidence 356889999999999999999999776 68999999998776667777788999999999997 99999999999875
Q ss_pred C----eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeec
Q 007253 232 D----NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (611)
Q Consensus 232 ~----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~Df 307 (611)
+ .+|||||||+||+|.+++... +.+++..++.++.||+.||.|||++|||||||||+|||+ +.++.++|+||
T Consensus 80 ~~~~~~~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll---~~~~~~~l~d~ 155 (277)
T d1o6ya_ 80 TPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDF 155 (277)
T ss_dssp CSSSEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ETTSCEEECCC
T ss_pred cCCCceEEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccccc---Cccccceeehh
Confidence 4 389999999999999887655 579999999999999999999999999999999999999 46777999999
Q ss_pred ccccccCCCC----cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC
Q 007253 308 GLSDFVRPDE----RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 382 (611)
Q Consensus 308 G~a~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 382 (611)
|.+....... .....+||+.|||||++. +.|+.++|||||||++|+|+||+.||.+.+..+.+..+....+..+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 235 (277)
T d1o6ya_ 156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 235 (277)
T ss_dssp TTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGG
T ss_pred hhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCc
Confidence 9987654322 345568999999999987 45899999999999999999999999999988888888888877776
Q ss_pred CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccC
Q 007253 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420 (611)
Q Consensus 383 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~ 420 (611)
..++.+|+++.+||.+||++||.+||+..+.|.|+|++
T Consensus 236 ~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 236 ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 77788999999999999999999999544455566654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.8e-53 Score=428.45 Aligned_cols=254 Identities=24% Similarity=0.391 Sum_probs=208.3
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++.++||+|+||.||+|+++........||||.+... ......+.+.+|+.+|++|+ |||||++++++.+++.
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTKSTP 101 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS--CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCCE
Confidence 46799999999999999999998764333457899988543 34455678999999999997 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+++|||||++|+|.+++....+.+++..+..|+.||+.||.|||+++||||||||+|||| +.++++||+|||+++.+
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE---CCCCcEEECCcccceEc
Confidence 999999999999999888777789999999999999999999999999999999999999 67889999999999877
Q ss_pred CCCCcc------cccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCC
Q 007253 314 RPDERL------NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPW 385 (611)
Q Consensus 314 ~~~~~~------~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (611)
...... ....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+....++...+..... .+ ..
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~-~~--~~ 255 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR-LP--PP 255 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-CC--CC
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CC--CC
Confidence 543321 2246789999999986 679999999999999999998 8999999988888877766432 11 22
Q ss_pred CCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 386 ~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
..+++++.+||.+||+.||++|||+.+++++
T Consensus 256 ~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 4689999999999999999999999998764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-53 Score=419.90 Aligned_cols=247 Identities=25% Similarity=0.442 Sum_probs=205.3
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++++.||+|+||.||+|++.. ++.||||++.+.... .+.+.+|++++++++ |||||+++++|.+++.+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~----~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~ 75 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLN----KDKVAIKTIREGAMS----EEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPI 75 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETT----TEEEEEEECCSSSSC----HHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECC----CCEEEEEEECCCcCc----HHHHHHHHHHHHhcC-CCCcccccceeccCCce
Confidence 579999999999999999998653 678999999754322 357899999999998 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
+||||||++|+|.+++......+++..+..++.||+.||.|||+++||||||||+|||| +.++++||+|||+++...
T Consensus 76 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~ 152 (263)
T d1sm2a_ 76 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVL 152 (263)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE---CGGGCEEECSCC------
T ss_pred EEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee---cCCCCeEecccchheecc
Confidence 99999999999999998877789999999999999999999999999999999999999 678889999999998775
Q ss_pred CCCc--ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 315 PDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 315 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
.... .....||+.|||||++. +.|+.++|||||||++|||+| |.+||......+++..+........ ....++
T Consensus 153 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~---p~~~~~ 229 (263)
T d1sm2a_ 153 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLAST 229 (263)
T ss_dssp ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC---CTTSCH
T ss_pred CCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC---ccccCH
Confidence 4432 33467999999999987 569999999999999999999 5777777777777777776533222 235789
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 391 EARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
++.+||.+||+.||++|||++++++|
T Consensus 230 ~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 230 HVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999999999876
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-53 Score=423.38 Aligned_cols=256 Identities=21% Similarity=0.340 Sum_probs=216.5
Q ss_pred CCceeEeCe-eeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 154 ANKYELGEE-VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 154 ~~~y~~~~~-LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
.++|.+.+. ||+|+||.||+|.++.. ..+..||||++... ......+.+.+|+++|++|+ |||||++++++.+ +
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~-~~~~~vAvK~l~~~--~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-E 81 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC----CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEES-S
T ss_pred ccCeEECCcEEecccCeEEEEEEEecC-CCcEEEEEEEEChh--cCHHHHHHHHHHHHHHHhCC-CCCEeeEeeeecc-C
Confidence 356888884 99999999999987542 24668999999654 34456678999999999997 9999999999865 4
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.+|||||||++|+|.+++......+++..+..++.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+.
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKA 158 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---EETTEEEECCCTTCEE
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheee---ccCCceeeccchhhhc
Confidence 6899999999999999887777789999999999999999999999999999999999999 4677899999999987
Q ss_pred cCCCCc----ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 007253 313 VRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 313 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (611)
+..... .....||+.|||||++. +.++.++|||||||++|||+| |+.||.+....++...+...... ...+
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~ 235 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPP 235 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---CCCT
T ss_pred ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCC
Confidence 754332 23457899999999986 679999999999999999998 99999988888887777665421 1224
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHH---HcCcccC
Q 007253 387 SLSSEARDFVKRLLNKDPRKRLTAAQA---LSHPWIK 420 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rpt~~~l---l~hp~~~ 420 (611)
.+++++.+||.+||+.||++|||+.++ |+|+|+.
T Consensus 236 ~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 789999999999999999999999887 5677763
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=431.15 Aligned_cols=256 Identities=25% Similarity=0.385 Sum_probs=214.9
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCc--cCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGEL--KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.++|+++++||+|+||.||+|++..... ....||+|++.... .......+.+|+.++.++.+|||||++++++.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 4689999999999999999999875322 23579999986542 2334467889999999995599999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCC
Q 007253 232 DNVYVVMELCEGGELLDRILSRG----------------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPE 289 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~----------------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~ 289 (611)
+.+|||||||++|+|.+++..+. ..+++..++.|+.||+.||.|||+++||||||||+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence 99999999999999999997653 24899999999999999999999999999999999
Q ss_pred ceEEeccCCCceEEEeecccccccCCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCC
Q 007253 290 NFLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWAR 364 (611)
Q Consensus 290 NIll~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~ 364 (611)
|||+ +.++++||+|||+|+....... ..+..||+.|||||++. +.|+.++|||||||++|||++ |+.||.+.
T Consensus 194 Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 194 NVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp GEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred cccc---ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 9999 5778999999999987654432 23567899999999886 779999999999999999997 89999887
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 365 TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 365 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
.....+..+......++. ...+++++.+||.+||+.||++|||++||++|
T Consensus 271 ~~~~~~~~~~~~~~~~~~--p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 271 PVDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CCSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCC--CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 776666667665544332 24689999999999999999999999999876
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-52 Score=422.80 Aligned_cols=248 Identities=22% Similarity=0.365 Sum_probs=210.9
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|+++++||+|+||.||+|++.. +|+.||||++..... ..+++.+|+.+|++|+ |||||+++++|.+++.
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPP 87 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGG---GTEEEEEEECCTTCS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECC---CCeEEEEEEECCccc----hHHHHHHHHHHHHhCC-CCCEecCCccEeeCCe
Confidence 4689999999999999999999876 689999999865432 2457899999999998 9999999999999999
Q ss_pred eEEEeeecCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 234 VYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
++||||||++|+|.+++... ...+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+.
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRL 164 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCCTTT
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE---CCCCcEEEccccceee
Confidence 99999999999999998764 4569999999999999999999999999999999999999 6778899999999998
Q ss_pred cCCCCc--ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 313 VRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWAR-TESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 313 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
...+.. .....||+.|||||++. +.|+.++|||||||++|||++|..||... ....+...+ ...... .....+
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i-~~~~~~--~~~~~~ 241 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRM--ERPEGC 241 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HTTCCC--CCCTTC
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH-hcCCCC--CCCccc
Confidence 764432 23456899999999886 77999999999999999999977666544 444444444 333222 223478
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
++++.+||.+||+.||++|||+.++++
T Consensus 242 ~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 242 PEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 999999999999999999999999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.4e-52 Score=423.34 Aligned_cols=257 Identities=30% Similarity=0.493 Sum_probs=214.3
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|+++++||+|+||.||+|+++ +|+.||||++..... .....+.+.+|+.+|++++ |||||+++++|.+++..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN----YGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC----CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCC-CCcEEeeeeecccCCce
Confidence 68999999999999999999864 478999999966532 2334567899999999998 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
+++|||+.++ ++..+....+.+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||++....
T Consensus 76 ~i~~e~~~~~-~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~ 151 (286)
T d1ob3a_ 76 VLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFG 151 (286)
T ss_dssp EEEEECCSEE-HHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHC
T ss_pred eEEEEeehhh-hHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE---cCCCCEEecccccceecc
Confidence 9999999764 555566666789999999999999999999999999999999999999 677889999999998765
Q ss_pred CCC-cccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---------
Q 007253 315 PDE-RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE--------- 382 (611)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--------- 382 (611)
... .....+|++.|+|||++. ..++.++|||||||++|||++|+.||.+....+.+..+.........
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred cCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh
Confidence 433 345567999999999885 45799999999999999999999999988887777666542211111
Q ss_pred ----------------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCC
Q 007253 383 ----------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 383 ----------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
...+.+++++.+||++||++||++|||+.|+|+||||++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 112457899999999999999999999999999999974
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-52 Score=413.38 Aligned_cols=247 Identities=22% Similarity=0.384 Sum_probs=218.3
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|+++++||+|+||.||+|+++ +++.||||++++.... .+.+.+|+.++++++ |||||+++++|.+++.+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~-HpnIv~~~g~~~~~~~~ 74 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR----GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPI 74 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET----TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCC-CTTBCCEEEEECCSSSE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC----CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcC-CCceeeEEEEEeeCCce
Confidence 57999999999999999999974 3788999999765432 356899999999998 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++|||||++|+|.+++......+++..++.++.||++||.|||++||+||||||+|||+ ++++.+||+|||+++...
T Consensus 75 ~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~ 151 (258)
T d1k2pa_ 75 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVL 151 (258)
T ss_dssp EEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCS
T ss_pred EEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE---cCCCcEEECcchhheecc
Confidence 99999999999999988877889999999999999999999999999999999999999 678899999999998765
Q ss_pred CCCc--ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCH
Q 007253 315 PDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (611)
Q Consensus 315 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (611)
.... .....||+.|+|||++. +.++.++|||||||++|||+| |+.||.+.+..++...+....... .....++
T Consensus 152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~ 228 (258)
T d1k2pa_ 152 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY---RPHLASE 228 (258)
T ss_dssp SSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---CCTTCCH
T ss_pred CCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC---CcccccH
Confidence 4432 23457999999999986 679999999999999999998 899999999888888887654322 2246789
Q ss_pred HHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 391 EARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 391 ~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
++.+||++||+.||++|||+.++++|
T Consensus 229 ~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 229 KVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999999999987
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=418.44 Aligned_cols=252 Identities=22% Similarity=0.377 Sum_probs=212.4
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++++.||+|+||.||+|+++ .++.||||++..... ..+.+.+|+.++++++ |||||++++++.+ +.
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~-~~ 81 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN----GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EP 81 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SS
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC----CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCC-CCCEeEEEeeecc-CC
Confidence 468999999999999999999864 367899999965432 2357899999999997 9999999998754 56
Q ss_pred eEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 234 VYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
++||||||++|+|.+++.... ..+++..+..|+.||+.||.|||+++||||||||+|||| ++++.+||+|||+|+.
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll---~~~~~~Kl~DFGla~~ 158 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARL 158 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee---ecccceeeccccceEE
Confidence 799999999999998775432 359999999999999999999999999999999999999 6788999999999998
Q ss_pred cCCCC--cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 313 VRPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCG-SRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 313 ~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
+.... ......||+.|||||++. +.++.++|||||||++|||+|| .+||......+++..+........ ...+
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~---p~~~ 235 (272)
T d1qpca_ 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR---PDNC 235 (272)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTC
T ss_pred ccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---cccC
Confidence 76443 234567999999999986 6799999999999999999995 555666667677777765432221 2468
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHc--CcccCC
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALS--HPWIKN 421 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~--hp~~~~ 421 (611)
++++.+||.+||+.||++|||+.++++ |+||..
T Consensus 236 ~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 999999999999999999999999998 788753
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-52 Score=418.76 Aligned_cols=248 Identities=23% Similarity=0.349 Sum_probs=206.0
Q ss_pred CeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeEEEeee
Q 007253 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (611)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~lv~E~ 240 (611)
++||+|+||.||+|.+.... .++.||||++.... .+....+.+.+|+++|++|+ |||||+++++|.+ +..+|||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~~~-~~~~lvmE~ 88 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKK-VVKTVAVKILKNEA-NDPALKDELLAEANVMQQLD-NPYIVRMIGICEA-ESWMLVMEM 88 (277)
T ss_dssp EEEEECSSEEEEEEEEECSS-SEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEES-SSEEEEEEC
T ss_pred CCcccCCCeEEEEEEEccCC-cCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCC-CCCCceEEEEecc-CCEEEEEEc
Confidence 47999999999999876432 46889999996543 33445678999999999997 9999999999865 457899999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCCCc--
Q 007253 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER-- 318 (611)
Q Consensus 241 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~-- 318 (611)
|++|+|.+++... ..+++..+..|+.||+.||.|||+++||||||||+|||| +.++.+||+|||+++.+.....
T Consensus 89 ~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill---~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 89 AELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp CTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCSEE
T ss_pred CCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc---cccCcccccchhhhhhcccccccc
Confidence 9999999987654 579999999999999999999999999999999999999 5678899999999987654432
Q ss_pred --ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 007253 319 --LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARD 394 (611)
Q Consensus 319 --~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 394 (611)
.....||+.|||||++. +.++.++|||||||++|||++ |+.||.+....++...+.+.... .....+++++.+
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~~~~~~~ 241 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAGCPREMYD 241 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCHHHHH
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCC---CCCcccCHHHHH
Confidence 23457999999999886 668999999999999999997 89999998888887777664321 112468999999
Q ss_pred HHHHhcccCccCCCCHHHH---HcCccc
Q 007253 395 FVKRLLNKDPRKRLTAAQA---LSHPWI 419 (611)
Q Consensus 395 li~~~L~~dP~~Rpt~~~l---l~hp~~ 419 (611)
||.+||+.||++|||+.++ |+|+|+
T Consensus 242 li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 242 LMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 9999999999999999998 456665
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-52 Score=415.07 Aligned_cols=253 Identities=23% Similarity=0.389 Sum_probs=208.3
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++++.||+|+||.||+|++......+..||||++... ......+.+.+|+.++++++ |||||++++++. ++.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~-~~~ 81 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-ENP 81 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-SSS
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe-cCe
Confidence 46899999999999999999998765445678999998543 34556678999999999997 999999999986 567
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
+|+|||||++|+|.+++......+++..++.++.||+.||.|||+++||||||||+|||+ +.++.+||+|||+|+..
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll---~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECC-------
T ss_pred EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheee---cCCCcEEEccchhheec
Confidence 899999999999999888877889999999999999999999999999999999999999 46778999999999876
Q ss_pred CCCC--cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 314 RPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 314 ~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
.... ......||+.|+|||++. +.|+.++|||||||++|||++ |.+||.+....+++..+...... ..++.++
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~~ 235 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPNCP 235 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTTCC
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCC
Confidence 5433 334557899999999986 679999999999999999997 89999998888888888765422 2235789
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
+++.+||.+||+.||.+|||+.+|++|
T Consensus 236 ~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 236 PTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999999765
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.9e-51 Score=421.90 Aligned_cols=254 Identities=29% Similarity=0.531 Sum_probs=211.6
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC--
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT-- 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~-- 231 (611)
.++|+++++||+|+||+||+|+... +|+.||||++++.. .+++.+|+.+|+++.+||||++++++|...
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~ 104 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINIT---NNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVS 104 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CcCeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCC
Confidence 4689999999999999999999776 68999999996432 356889999999998799999999999854
Q ss_pred CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
..+++|||||.+|+|... .+.+++..++.++.||+.||.|||++|||||||||+|||++ .+++.+||+|||+|.
T Consensus 105 ~~~~~v~e~~~~~~L~~~----~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~--~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 105 RTPALVFEHVNNTDFKQL----YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAE 178 (328)
T ss_dssp CSEEEEEECCCSCBGGGT----TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCGGGCE
T ss_pred CceeEEEeecCCCcHHHH----hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEc--CCCCeeeecccccce
Confidence 569999999999998664 35699999999999999999999999999999999999996 244579999999999
Q ss_pred ccCCCCcccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChH-HHHHHHHh-------------
Q 007253 312 FVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLK------------- 375 (611)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~-~~~~~i~~------------- 375 (611)
...........+||+.|+|||++. ..++.++||||+||++|+|++|+.||...... .....+..
T Consensus 179 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 179 FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp ECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred eccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 887777777889999999999875 35899999999999999999999999765432 22211111
Q ss_pred cCCC--------------------CCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 376 ADPS--------------------FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 376 ~~~~--------------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
.... .....+..+++++.+||++||+.||++|||++|+|+||||+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 0000 0111123478999999999999999999999999999999874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-51 Score=424.48 Aligned_cols=255 Identities=28% Similarity=0.423 Sum_probs=212.0
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC---
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT--- 231 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~--- 231 (611)
.+|..+++||+|+||+||+|++.. +|+.||||++.+.... ..+|+.+|++|+ |||||+++++|...
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~-h~niv~~~~~~~~~~~~ 88 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQDKRF-------KNRELQIMRKLD-HCNIVRLRYFFYSSGEK 88 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCSSS-------CCHHHHHHHHCC-CTTBCCEEEEEEEC--C
T ss_pred CCcEeeeEEeeCcCeEEEEEEECC---CCCEEEEEEECccchH-------HHHHHHHHHhcC-CCCCCcEEEEEEecCcc
Confidence 369999999999999999999876 6899999999765322 347999999997 99999999998643
Q ss_pred ---CeeEEEeeecCCCChHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 232 ---DNVYVVMELCEGGELLDRIL---SRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 232 ---~~~~lv~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
.++|||||||++| +.+.+. .....+++..++.++.||+.||+|||++|||||||||+|||+. .+...+||+
T Consensus 89 ~~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~--~~~~~~kl~ 165 (350)
T d1q5ka_ 89 KDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLC 165 (350)
T ss_dssp CSCCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC--TTTCCEEEC
T ss_pred CCceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEe--cCCCceeEe
Confidence 3589999999765 433332 3456799999999999999999999999999999999999994 233479999
Q ss_pred ecccccccCCCCcccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-----
Q 007253 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP----- 378 (611)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~----- 378 (611)
|||++..........+.+||+.|+|||++. ..|+.++|||||||++|||++|+.||......+.+..+.+...
T Consensus 166 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 245 (350)
T d1q5ka_ 166 DFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245 (350)
T ss_dssp CCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHH
Confidence 999999887666677789999999999875 4689999999999999999999999998888777666653211
Q ss_pred ------------CCC--------CCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 379 ------------SFD--------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 379 ------------~~~--------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.++ ....+.+++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 111 111345789999999999999999999999999999998653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-51 Score=419.14 Aligned_cols=260 Identities=29% Similarity=0.467 Sum_probs=213.4
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee---
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--- 230 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~--- 230 (611)
.++|+++++||+|+||.||+|++.. +|+.||||++...... ......+.+|+.+|++++ ||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~ 83 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMENEK-EGFPITALREIKILQLLK-HENVVNLIEICRTKAS 83 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC---
T ss_pred cCCEEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhc-CCCccceEeeeecccc
Confidence 4789999999999999999999876 6899999998655332 334466889999999998 9999999999865
Q ss_pred -----CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEe
Q 007253 231 -----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (611)
Q Consensus 231 -----~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~ 305 (611)
++.+|+|||||.++. ...+......+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+
T Consensus 84 ~~~~~~~~~~iv~e~~~~~~-~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl---~~~~~~kl~ 159 (318)
T d3blha1 84 PYNRCKGSIYLVFDFCEHDL-AGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLA 159 (318)
T ss_dssp -------CEEEEEECCCEEH-HHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEEC
T ss_pred cccccCceEEEEEeccCCCc-cchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee---cCCCcEEee
Confidence 356899999997654 45555566789999999999999999999999999999999999999 577889999
Q ss_pred ecccccccCCCC-----cccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Q 007253 306 DFGLSDFVRPDE-----RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (611)
Q Consensus 306 DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~ 378 (611)
|||++..+.... .....+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+.........+.....
T Consensus 160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~ 239 (318)
T d3blha1 160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 239 (318)
T ss_dssp CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999997664322 234468999999999885 4689999999999999999999999998888777766665443
Q ss_pred CCCCCCCCC----------------------------CCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCC
Q 007253 379 SFDEAPWPS----------------------------LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (611)
Q Consensus 379 ~~~~~~~~~----------------------------~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~ 422 (611)
.+....+.. .++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 333322211 26788999999999999999999999999999864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=412.71 Aligned_cols=254 Identities=23% Similarity=0.383 Sum_probs=209.5
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|++.+.||+|+||.||+|++.........||||++.+.........+.+.+|+.+|++++ |||||++++++.+ +.+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEee-cch
Confidence 57999999999999999999887644345679999998766566667788999999999997 9999999999975 568
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++|||||++|+|.+++..+.+.+++..+..++.||+.||.|||++||+||||||+||||+ .++.+||+|||+++.+.
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~---~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccc---cccceeeccchhhhhcc
Confidence 899999999999999888877899999999999999999999999999999999999994 56789999999999775
Q ss_pred CCCc----ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 315 PDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 315 ~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
.... .....|+..|+|||++. +.++.++|||||||++|||++ |+.||.+.+..+....+.+....++. ...+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~ 240 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PEDC 240 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CTTC
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCC--cccc
Confidence 4432 23456888999999886 568999999999999999998 89999999999988888777544432 3578
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
++++.+||.+||+.||++|||+.+|++
T Consensus 241 ~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 241 PQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999999863
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-52 Score=425.02 Aligned_cols=265 Identities=29% Similarity=0.474 Sum_probs=218.7
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcC-CHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-TAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
.++|++++.||+|+||.||+|+...+..+|+.||||++.+.... .....+.+.+|+++++++.+||||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 47799999999999999999998766667999999998654321 12234567899999999985689999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.+++|||||.+|+|.+++... +.+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+++.
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEE
T ss_pred ceeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee---cCCCCEEEeeccchhh
Confidence 999999999999999988665 468899999999999999999999999999999999999 5778899999999987
Q ss_pred cCCCC--cccccccCCCcCcchhhcC---CCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 007253 313 VRPDE--RLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (611)
Q Consensus 313 ~~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (611)
+.... ......|++.|+|||++.+ .++.++|||||||+||+|++|+.||.+.........+.+............
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 258 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence 64332 3456789999999998853 478899999999999999999999977654443333333221111122246
Q ss_pred CCHHHHHHHHHhcccCccCCC-----CHHHHHcCcccCCC
Q 007253 388 LSSEARDFVKRLLNKDPRKRL-----TAAQALSHPWIKNS 422 (611)
Q Consensus 388 ~s~~~~~li~~~L~~dP~~Rp-----t~~~ll~hp~~~~~ 422 (611)
+++++.+||++||++||.+|| |++|+|+||||+..
T Consensus 259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 899999999999999999999 58999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-51 Score=410.42 Aligned_cols=259 Identities=24% Similarity=0.387 Sum_probs=210.8
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.++|++++.||+|+||.||+|+... ++.||||++..... ..+.+.+|+.++++++ |||||++++++. ++.
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~----~~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~-h~nIv~~~g~~~-~~~ 85 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVS-EEP 85 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT----TEEEEEEECCTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEEC-SSS
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECC----CCEEEEEEECcccC----CHHHHHHHHHHHHhcc-cCCEeEEEEEEe-cCC
Confidence 3689999999999999999998754 56799999965432 2357899999999998 999999999985 456
Q ss_pred eEEEeeecCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 234 VYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
+++|||||++|+|..++... ...+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+++.
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll---~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARL 162 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC-
T ss_pred eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE---CCCCcEEEcccchhhh
Confidence 89999999999999887654 3569999999999999999999999999999999999999 5778899999999987
Q ss_pred cCCCC--cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCC-CCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 313 VRPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSR-PFWARTESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 313 ~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~-Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
+.... ......||+.|+|||++. +.++.++|||||||++|||++|.. ||......+++..+..... .+ ..+.+
T Consensus 163 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~-~~--~~~~~ 239 (285)
T d1fmka3 163 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-MP--CPPEC 239 (285)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-CC--CCTTS
T ss_pred ccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-CC--CCccc
Confidence 65443 234467999999999886 779999999999999999999654 4556666667776665432 12 23578
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHc--CcccCCCCCCCCc
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALS--HPWIKNSNDVKVP 428 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~--hp~~~~~~~~~~~ 428 (611)
++++.+||.+||+.||++|||+.+|++ ++||........|
T Consensus 240 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p 281 (285)
T d1fmka3 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281 (285)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCC
Confidence 999999999999999999999999998 8999876544444
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=408.46 Aligned_cols=253 Identities=21% Similarity=0.342 Sum_probs=205.7
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCc-cCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGEL-KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
.+.|++.++||+|+||.||+|.++.... ....||||++... ........+.+|++++++|+ |||||+++|++.+.+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYK 82 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc--cChHHHHHHHHHHHHHHhcC-CCCEeeeeEEEecCC
Confidence 3579999999999999999999875321 2357999998654 33445567899999999998 999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
.+++|||||.+|++.+.+......+++..+..++.||+.||.|||+++||||||||+|||| +.++++||+|||+++.
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC---
T ss_pred ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE---CCCCeEEEcccchhhc
Confidence 9999999999999999888887889999999999999999999999999999999999999 6788999999999987
Q ss_pred cCCCC----cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCC-CCCCCCChHHHHHHHHhcCCCCCCCCCC
Q 007253 313 VRPDE----RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGS-RPFWARTESGIFRAVLKADPSFDEAPWP 386 (611)
Q Consensus 313 ~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~-~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (611)
+.... ......||+.|||||++. +.++.++|||||||++|||++|. +||......+++..+..... .+ ...
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~-~~--~~~ 236 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-LP--TPM 236 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-CC--CCT
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC-CC--Cch
Confidence 65432 123356899999999886 67999999999999999999965 45555666666666654422 21 224
Q ss_pred CCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 387 SLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 387 ~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
.++.++.+||.+||+.||++|||+.++++
T Consensus 237 ~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 237 DCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp TCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 68899999999999999999999999875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-51 Score=423.17 Aligned_cols=258 Identities=27% Similarity=0.515 Sum_probs=212.0
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
+.++|+++++||+|+||.||+|+.+. +|+.||||++.+.. ......+.+.+|+++|+.|+ |||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-hpniv~l~~~~~~~~ 90 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDE 90 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETT---TCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCS
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcC-CCCeeEEEEEeccCc
Confidence 56899999999999999999999776 69999999997653 34556678899999999997 999999999998654
Q ss_pred ------eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEee
Q 007253 233 ------NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (611)
Q Consensus 233 ------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D 306 (611)
.+||||||| +++|...+.. ..+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|
T Consensus 91 ~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~---~~~~~~kl~D 164 (346)
T d1cm8a_ 91 TLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILD 164 (346)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECC
T ss_pred cccccceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc---cccccccccc
Confidence 579999999 5677665533 469999999999999999999999999999999999999 6788899999
Q ss_pred cccccccCCCCcccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC------
Q 007253 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP------ 378 (611)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~------ 378 (611)
||+|+.... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus 165 fg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 165 FGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp CTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccceeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence 999987643 345678999999999885 3578999999999999999999999988877665544433211
Q ss_pred -----------------CCCCC----CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 379 -----------------SFDEA----PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 379 -----------------~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
..... ....+++++.+||++||..||.+|||+.|+|+||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 11111 1246789999999999999999999999999999998754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=407.76 Aligned_cols=260 Identities=29% Similarity=0.488 Sum_probs=217.8
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCee
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~ 234 (611)
++|+++++||+|+||.||+|++.. +|+.||||+++... ......+.+.+|+.+++.++ ||||++++++|.+....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~---~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDD-DDEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECC---CCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcC-cCCEEeeccccccccce
Confidence 589999999999999999999876 68999999997654 34456688999999999997 99999999999999999
Q ss_pred EEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccC
Q 007253 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (611)
Q Consensus 235 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~ 314 (611)
++|+|++.+++|..++ ...+.+++..++.++.|++.||+|||++|||||||||+|||+ +.++.+||+|||.+....
T Consensus 77 ~iv~~~~~~~~l~~~~-~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~ 152 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFG 152 (292)
T ss_dssp EEEEECCSEEHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred eEEeeecccccccccc-ccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc---ccCCceeeeecchhhccc
Confidence 9999999887776654 555789999999999999999999999999999999999999 567789999999998775
Q ss_pred CCC-cccccccCCCcCcchhhcC--CCCCcchhhHHHHHHHHHHhCCCCCC-CCChHHHHHHHHhcCCCCCC--------
Q 007253 315 PDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFW-ARTESGIFRAVLKADPSFDE-------- 382 (611)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el~~g~~Pf~-~~~~~~~~~~i~~~~~~~~~-------- 382 (611)
... ......+++.|+|||++.+ .++.++|||||||++|||++|+.||. +....+.+..+.........
T Consensus 153 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred CCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 443 3445578899999998863 47899999999999999999999864 44555555554432211111
Q ss_pred -----------------CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 383 -----------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 383 -----------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
...+.+++.+.+||++||+.||++|||++|+|+||||++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 11245789999999999999999999999999999998754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=419.29 Aligned_cols=261 Identities=27% Similarity=0.463 Sum_probs=212.4
Q ss_pred ccCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.++.+|+++++||+|+||.||+|+... +|+.||||++.+. ......+.+.+|+.+|+.|+ ||||+++++++...
T Consensus 5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~--~~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~~~ 78 (345)
T d1pmea_ 5 DVGPRYTNLSYIGEGAYGMVCSAYDNV---NKVRVAIKKISPF--EHQTYCQRTLREIKILLRFR-HENIIGINDIIRAP 78 (345)
T ss_dssp CCCTTEEEEEECC---CCCEEEEEETT---TCSEEEEEEECCT--TCHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCS
T ss_pred CcCCCeEEEEEEeeccCeEEEEEEECC---CCcEEEEEEEehh--cChHHHHHHHHHHHHHHHcC-CCCCCcEEEEEeec
Confidence 356789999999999999999999765 6899999999654 34555678899999999997 99999999999765
Q ss_pred C----eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeec
Q 007253 232 D----NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (611)
Q Consensus 232 ~----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~Df 307 (611)
. ..+++++|+.||+|.+++... .+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||+||
T Consensus 79 ~~~~~~~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl---~~~~~~kl~Df 153 (345)
T d1pmea_ 79 TIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDF 153 (345)
T ss_dssp STTTCCCEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCC
T ss_pred cccccceEEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE---CCCCCEEEccc
Confidence 3 234455566699999988654 69999999999999999999999999999999999999 67788999999
Q ss_pred ccccccCCCC----cccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC---
Q 007253 308 GLSDFVRPDE----RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP--- 378 (611)
Q Consensus 308 G~a~~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~--- 378 (611)
|++....... .....+||+.|+|||++. ..++.++||||+||++|+|++|+.||.+...............
T Consensus 154 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~ 233 (345)
T d1pmea_ 154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 233 (345)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred CceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCC
Confidence 9998765432 245568999999999884 4578999999999999999999999988776655444332111
Q ss_pred --------------------CCCC----CCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 379 --------------------SFDE----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 379 --------------------~~~~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.... ..++.+++++++||.+||+.||.+|||+.|+|+||||+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 1111 11356789999999999999999999999999999998543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=409.65 Aligned_cols=256 Identities=26% Similarity=0.378 Sum_probs=205.2
Q ss_pred CCceeEeCeeeeccceEEEEEEEecC--CccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.++|+++++||+|+||.||+|++... ..+++.||||++... ......+.+.+|+.++.++.+|+|||.+++++...
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc--cCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 46899999999999999999997653 235689999998654 23445567888999999987799999999998765
Q ss_pred -CeeEEEeeecCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEec
Q 007253 232 -DNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT 295 (611)
Q Consensus 232 -~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~ 295 (611)
+.+++|||||++|+|.+++.... ..+++..++.++.||+.||.|||+++||||||||+||||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl-- 167 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL-- 167 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE--
Confidence 46899999999999999987542 348999999999999999999999999999999999999
Q ss_pred cCCCceEEEeecccccccCCCC---cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhC-CCCCCCCChHHHH
Q 007253 296 KDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCG-SRPFWARTESGIF 370 (611)
Q Consensus 296 ~~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g-~~Pf~~~~~~~~~ 370 (611)
+.++++||+|||+|+...... .....+||+.|||||++. +.++.++|||||||++|||++| ..||.+....+.+
T Consensus 168 -~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~ 246 (299)
T d1ywna1 168 -SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246 (299)
T ss_dssp -CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred -CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 677889999999998764332 234568999999999886 6699999999999999999986 5678776655555
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 371 RAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 371 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
..++........ ...+++++.+||.+||+.||++|||+.++++|
T Consensus 247 ~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 247 CRRLKEGTRMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCCCC--CccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 555544333322 24689999999999999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=413.66 Aligned_cols=252 Identities=20% Similarity=0.288 Sum_probs=209.5
Q ss_pred CceeEeCeeeeccceEEEEEEEecCC-ccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
.+|+++++||+|+||.||+|.+.... .....||+|.+.... .....+.+.+|+.++++|+ |||||+++++|.++ .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCC-CTTBCCEEEEEESS-S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC-C
Confidence 46999999999999999999876521 123468999885432 3334578999999999997 99999999999865 5
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccccc
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~ 313 (611)
.+++||||.+|+|.+.+......+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+..
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll---~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCCSHHHHT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhccee---CCCCCeEeeccccceec
Confidence 778899999999999998888889999999999999999999999999999999999999 56778999999999877
Q ss_pred CCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC
Q 007253 314 RPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (611)
Q Consensus 314 ~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (611)
..... .....||+.|||||++. +.|+.++|||||||++|||+| |..||.+....++...+..... .+ ..+.+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~-~~--~p~~~ 238 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-LP--QPPIC 238 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC-CC--CCTTB
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-CC--CCccc
Confidence 54432 23457899999999886 679999999999999999998 8999988888777776665432 11 12468
Q ss_pred CHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 389 SSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 389 s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
++++.+||.+||+.||.+|||+.++++|
T Consensus 239 ~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 239 TIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 9999999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-49 Score=403.65 Aligned_cols=254 Identities=22% Similarity=0.306 Sum_probs=216.3
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecC--CccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~ 230 (611)
..++|++++.||+|+||.||+|+.+.. ..+++.||||++... ......+.+.+|+.++++++ ||||++++++|.+
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~ 87 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFD-NPNIVKLLGVCAV 87 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh--cChHHHHHHHHHHHHHHhcC-CCCcccceeeecc
Confidence 357899999999999999999997642 235688999998654 34455678999999999997 9999999999999
Q ss_pred CCeeEEEeeecCCCChHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCC
Q 007253 231 TDNVYVVMELCEGGELLDRILSRG-----------------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLK 287 (611)
Q Consensus 231 ~~~~~lv~E~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlk 287 (611)
.+..++|||||++|+|.+++.... ..+++..+..|+.||+.||+|||+++|||||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK 167 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence 999999999999999999986532 248999999999999999999999999999999
Q ss_pred CCceEEeccCCCceEEEeecccccccCCCC---cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCC-CCCC
Q 007253 288 PENFLFTTKDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGS-RPFW 362 (611)
Q Consensus 288 p~NIll~~~~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~-~Pf~ 362 (611)
|+|||| +.++++||+|||+|+...... ...+..||+.|||||++. ..|+.++|||||||++|||++|. +||.
T Consensus 168 p~NILl---d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 168 TRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp GGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred ccceEE---CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 999999 677889999999998764433 234567999999999886 67999999999999999999985 6899
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 363 ARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 363 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
+....++...+...... .....+++++.+||.+||+.||++|||+.+|++
T Consensus 245 ~~~~~e~~~~v~~~~~~---~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 245 GMAHEEVIYYVRDGNIL---ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TSCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHcCCCC---CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 88888888887765422 122468999999999999999999999999854
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-50 Score=416.38 Aligned_cols=259 Identities=29% Similarity=0.490 Sum_probs=214.9
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC-
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~- 231 (611)
+.++|+++++||+|+||+||+|++.. +|+.||||++.+.. ......+.+.+|+.+|++|+ |||||++++++...
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-h~~iv~~~~~~~~~~ 90 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPAR 90 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETT---TTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCS
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECC---CCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeecc
Confidence 46789999999999999999999776 69999999997654 34455677899999999997 99999999998643
Q ss_pred ----CeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeec
Q 007253 232 ----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (611)
Q Consensus 232 ----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~Df 307 (611)
...+++|+|+.||+|.+++. .+++++..++.++.||+.||+|||++|||||||||+|||+ +.++.+|++||
T Consensus 91 ~~~~~~~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi---~~~~~~kl~df 165 (348)
T d2gfsa1 91 SLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDF 165 (348)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCC
T ss_pred ccccCceEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc---ccccccccccc
Confidence 34567777888999999773 3579999999999999999999999999999999999999 67788999999
Q ss_pred ccccccCCCCcccccccCCCcCcchhhc--CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----
Q 007253 308 GLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD---- 381 (611)
Q Consensus 308 G~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~---- 381 (611)
|++.... ....+..||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+.......+........
T Consensus 166 g~a~~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 166 GLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp ----CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred chhcccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 9997653 3445678999999999865 3478999999999999999999999998888777666654432211
Q ss_pred -------------------CC----CCCCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCCCC
Q 007253 382 -------------------EA----PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (611)
Q Consensus 382 -------------------~~----~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~~~ 423 (611)
.. .+..+++++++||++||+.||.+|||+.|+|+||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 11 1246789999999999999999999999999999998654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=402.45 Aligned_cols=254 Identities=23% Similarity=0.422 Sum_probs=212.3
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCC----ccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGE----LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~ 229 (611)
.++|++++.||+|+||.||+|+..... ..+..||||++.+. ........+.+|+..+.++.+|||||+++++|.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc--cChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 478999999999999999999876432 23468999999654 344556788999999999966999999999999
Q ss_pred eCCeeEEEeeecCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEe
Q 007253 230 DTDNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294 (611)
Q Consensus 230 ~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~ 294 (611)
+++.+++|||||++|+|.++|..+. ..+++..++.++.||+.||.|||+++||||||||+|||+
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl- 168 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV- 168 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee-
Confidence 9999999999999999999997553 358999999999999999999999999999999999999
Q ss_pred ccCCCceEEEeecccccccCCCC---cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHH
Q 007253 295 TKDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGI 369 (611)
Q Consensus 295 ~~~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~ 369 (611)
+.++.+||+|||+++...... .....+||+.|+|||++. +.|+.++|||||||++|||++ |.+||.+.....+
T Consensus 169 --~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~ 246 (299)
T d1fgka_ 169 --TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246 (299)
T ss_dssp --CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred --cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence 677889999999998775433 234467999999999886 789999999999999999997 7999988888877
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 370 FRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 370 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
+..+.... .++. ...+++++.+||.+||+.||++|||+.|+++
T Consensus 247 ~~~i~~~~-~~~~--p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 247 FKLLKEGH-RMDK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHTTC-CCCC--CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCC-CCCC--CccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 77666543 2222 2468999999999999999999999999976
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-50 Score=407.91 Aligned_cols=251 Identities=24% Similarity=0.365 Sum_probs=210.8
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCc--EEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQ--QVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
++|+++++||+|+||.||+|+++. +|. .||||.+.... .....+.+.+|+++|.++.+|||||+++++|.+++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~---~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKK---DGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE---TTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred HHcEEEEEEeeCCCcEEEEEEECC---CCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 689999999999999999999876 344 57788875432 23345678999999999955999999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccC
Q 007253 233 NVYVVMELCEGGELLDRILSR---------------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD 297 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~ 297 (611)
.++||||||+||+|.+++... ...+++..+..++.||+.||.|||+++||||||||+|||+ +
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~ 161 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---G 161 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---C
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE---c
Confidence 999999999999999998643 3579999999999999999999999999999999999999 5
Q ss_pred CCceEEEeecccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCC-CCCCCCChHHHHHHHHh
Q 007253 298 ENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGS-RPFWARTESGIFRAVLK 375 (611)
Q Consensus 298 ~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~-~Pf~~~~~~~~~~~i~~ 375 (611)
.++.+||+|||+++............||..|+|||++. +.|+.++|||||||++|||++|. +||.+.+..+++..+.+
T Consensus 162 ~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~ 241 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241 (309)
T ss_dssp GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred CCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 77889999999998776555555668999999999986 67999999999999999999965 57888888888777765
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 376 ADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 376 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
... + ..+..+++++.+||.+||+.||++|||+.++++|
T Consensus 242 ~~~-~--~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 242 GYR-L--EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp TCC-C--CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCC-C--CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 421 1 2234689999999999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=414.20 Aligned_cols=257 Identities=27% Similarity=0.475 Sum_probs=202.4
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee--
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-- 230 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~-- 230 (611)
+.++|+++++||+|+||+||+|++.. +|+.||||++.+.. .......++.+|+.++++++ |||||+++++|..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~---t~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~f~~~~ 89 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQK 89 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETT---TTEEEEEEEEESTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCC
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECC---CCCEEEEEEEChhh-cCHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeccc
Confidence 34789999999999999999999776 68999999997654 34556678899999999997 9999999999964
Q ss_pred ----CCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEee
Q 007253 231 ----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (611)
Q Consensus 231 ----~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D 306 (611)
...+|+|||||.+ ++++.+ ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|++|
T Consensus 90 ~~~~~~~~~iv~Ey~~~-~l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~---~~~~~~kl~d 162 (355)
T d2b1pa1 90 TLEEFQDVYLVMELMDA-NLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILD 162 (355)
T ss_dssp STTTCCEEEEEEECCSE-EHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECC
T ss_pred ccccCceeEEEEeccch-HHHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc---ccccceeeec
Confidence 3679999999965 555544 2468999999999999999999999999999999999999 5678899999
Q ss_pred cccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-------
Q 007253 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP------- 378 (611)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~------- 378 (611)
||+++...........+||+.|+|||++. ..++.++||||+||++|+|++|+.||.+.+.......+.....
T Consensus 163 f~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 163 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp CCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence 99998877666677789999999999986 5689999999999999999999999988877665555432211
Q ss_pred ---------------CCCCCCC----------------CCCCHHHHHHHHHhcccCccCCCCHHHHHcCcccCC
Q 007253 379 ---------------SFDEAPW----------------PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (611)
Q Consensus 379 ---------------~~~~~~~----------------~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~hp~~~~ 421 (611)
......+ ...++++.+||++||..||++|||++|+|+||||+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 1111100 113678899999999999999999999999999985
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=394.85 Aligned_cols=244 Identities=25% Similarity=0.396 Sum_probs=201.0
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee-CC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-TD 232 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~-~~ 232 (611)
.++|++++.||+|+||.||+|++ .|..||||++++.. ..+.+.+|++++++++ |||||++++++.+ .+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-----RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKG 74 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-----TTEEEEEEECCCCC-------HHHHHTHHHHTTCC-CTTBCCEEEEECCC--
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-----CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCC-CCCEeeEEEEEEecCC
Confidence 36799999999999999999986 36789999996532 3367889999999997 9999999999965 45
Q ss_pred eeEEEeeecCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
.+|+|||||++|+|.+++..+. ..+++..+..|+.||+.||.|||+.+||||||||+|||+ +.++++||+|||+++
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~ 151 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTK 151 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC--
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee---cCCCCEeecccccce
Confidence 6899999999999999987653 358999999999999999999999999999999999999 678899999999998
Q ss_pred ccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 312 FVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
..... .....+|+.|+|||++. +.++.++|||||||++|||+| |+.||......++...+.+.... .....++
T Consensus 152 ~~~~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~ 226 (262)
T d1byga_ 152 EASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGCP 226 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC---CCCTTCC
T ss_pred ecCCC--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCccCC
Confidence 76432 34457899999999885 779999999999999999998 79999888888887777653211 1124688
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
+++.+||++||+.||.+|||+.+++++
T Consensus 227 ~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 227 PAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 999999999999999999999999763
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=398.66 Aligned_cols=255 Identities=26% Similarity=0.372 Sum_probs=215.8
Q ss_pred CCceeEeCeeeeccceEEEEEEEecC--CccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.++|+++++||+|+||.||+|++... ...++.||||++.... .......+.+|+.+++++.+|||||++++++.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 47899999999999999999987542 2367899999997543 3445567899999999996699999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcC-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEe
Q 007253 232 DNVYVVMELCEGGELLDRILSRG-----------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~-----------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~ 294 (611)
+.++||||||++|+|.+++.... ..+++..+..++.||+.||.|||+++||||||||+|||+
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~- 178 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL- 178 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc-
Confidence 99999999999999999987543 258999999999999999999999999999999999999
Q ss_pred ccCCCceEEEeecccccccCCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHh-CCCCCCCCChHHH
Q 007253 295 TKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGI 369 (611)
Q Consensus 295 ~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~-g~~Pf~~~~~~~~ 369 (611)
+.++.+||+|||+++....... ....+||+.|+|||++. +.++.++|||||||++|||+| |.+||......+.
T Consensus 179 --~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 179 --THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp --ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred --cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 5778899999999987754332 24468999999999886 678999999999999999998 6666767666666
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 370 FRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 370 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
+..+......... ...+++++.+||.+||+.||++|||+.+|++
T Consensus 257 ~~~~i~~~~~~~~--~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 257 FYKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCCCCCC--cccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 6666555433322 2467999999999999999999999999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=396.72 Aligned_cols=253 Identities=19% Similarity=0.299 Sum_probs=216.8
Q ss_pred CCceeEeCeeeeccceEEEEEEEecC--CccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeC
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~ 231 (611)
.++|+++++||+|+||.||+|.+... ...++.||||++.+. ........+.+|+.++++++ |||||++++++..+
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~--~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQG 95 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCC-CTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc--cChHHHHHHHHHHHHHHHcC-CCCEeeeeeEEecC
Confidence 47899999999999999999987531 224678999999654 34455567899999999998 99999999999999
Q ss_pred CeeEEEeeecCCCChHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceE
Q 007253 232 DNVYVVMELCEGGELLDRILSRG---------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVL 302 (611)
Q Consensus 232 ~~~~lv~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~v 302 (611)
+..++|||||++|+|.+++.... ..+++..+..++.||+.||.|||+++||||||||+|||| +.++++
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---d~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee---cCCceE
Confidence 99999999999999999886432 347999999999999999999999999999999999999 678899
Q ss_pred EEeecccccccCCCCc---ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhcC
Q 007253 303 KAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCG-SRPFWARTESGIFRAVLKAD 377 (611)
Q Consensus 303 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g-~~Pf~~~~~~~~~~~i~~~~ 377 (611)
||+|||+++.+..... .....||+.|+|||.+. +.++.++|||||||++|||++| +.||.+.+..+++..+....
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~ 252 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC
Confidence 9999999987654332 34457899999999886 6688899999999999999998 58888888888888877654
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHHc
Q 007253 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (611)
Q Consensus 378 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~ 415 (611)
... ..+.+++.+.+||.+||+.||++|||+.+|++
T Consensus 253 ~~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 253 LLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC---CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 221 12468999999999999999999999999997
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.3e-49 Score=398.13 Aligned_cols=270 Identities=21% Similarity=0.266 Sum_probs=214.3
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
.+++|++++.||+|+||.||+|++.. +|+.||||++...... +.+..|+++++.+++|++|+.+.+++.+.+
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~ 76 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGD 76 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECC---CCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCC
Confidence 45789999999999999999999766 6899999998654322 246789999999985666777777778889
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
..++||||| +|+|.+.+....+.+++..+..++.||+.||+|||++|||||||||+|||+...+.+..+||+|||+|+.
T Consensus 77 ~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 77 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 999999999 6688888877778899999999999999999999999999999999999997666777899999999987
Q ss_pred cCCCC--------cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChHHHHHHHH---hcCC-C
Q 007253 313 VRPDE--------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL---KADP-S 379 (611)
Q Consensus 313 ~~~~~--------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~~~~~~i~---~~~~-~ 379 (611)
+.... .....+||+.|||||++. ..++.++|||||||++|||++|+.||...........+. .... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence 65432 234568999999999987 458999999999999999999999997655443322221 1110 1
Q ss_pred CCCCCCCCCCHHHHHHHHHhcccCccCCCCHH---HHHcCcccCCCCCCCCchhH
Q 007253 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAA---QALSHPWIKNSNDVKVPLDV 431 (611)
Q Consensus 380 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~---~ll~hp~~~~~~~~~~~~~~ 431 (611)
........+++++.+||.+||+.||++||++. ++|+|+|.+.......+.++
T Consensus 236 ~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw 290 (299)
T d1ckia_ 236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDW 290 (299)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHH
T ss_pred ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCc
Confidence 11112346899999999999999999999986 55788877655444555544
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=394.97 Aligned_cols=250 Identities=22% Similarity=0.311 Sum_probs=206.0
Q ss_pred eEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEee-CCeeEE
Q 007253 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-TDNVYV 236 (611)
Q Consensus 158 ~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~-~~~~~l 236 (611)
...++||+|+||.||+|++..+......||||++++. ......+.+.+|+++|++|+ |||||+++|++.+ ++.+++
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~l 106 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLV 106 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEETTTEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCC-CCCEeEEeEEEEecCCceEE
Confidence 3467899999999999998764334457999998643 35566788999999999998 9999999999876 468999
Q ss_pred EeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCceEEEeecccccccCCC
Q 007253 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316 (611)
Q Consensus 237 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~ 316 (611)
|||||++|+|.+++......+++..+..++.||+.||.|||+.+|+||||||+|||| ++++.+||+|||+++.+...
T Consensus 107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTT
T ss_pred EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE---CCCCCEEEecccchhhcccc
Confidence 999999999999988777789999999999999999999999999999999999999 67889999999999876543
Q ss_pred Cc-----ccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcCCCCCCCCCCCCC
Q 007253 317 ER-----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART-ESGIFRAVLKADPSFDEAPWPSLS 389 (611)
Q Consensus 317 ~~-----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s 389 (611)
.. .....||+.|+|||++. +.++.++|||||||++|||++|..||.... ..++...+....... . ...++
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~-~--p~~~~ 260 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL-Q--PEYCP 260 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC-C--CTTCC
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-C--cccCc
Confidence 32 23357899999999876 779999999999999999999888776543 334455555443221 1 14678
Q ss_pred HHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 390 SEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 390 ~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
+++.+||.+||+.||++|||+.|+++|
T Consensus 261 ~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 261 DPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.6e-46 Score=378.13 Aligned_cols=253 Identities=21% Similarity=0.311 Sum_probs=208.0
Q ss_pred cCCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC
Q 007253 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (611)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~ 232 (611)
+.++|+++++||+|+||.||+|++.. +|+.||||++...... ..+.+|+++++.|.+|+||+.+++++..+.
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 74 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLL---NNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGL 74 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CCCceEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCC
Confidence 46789999999999999999999776 6899999998654322 346789999999987799999999999999
Q ss_pred eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccC--CCceEEEeecccc
Q 007253 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD--ENSVLKAIDFGLS 310 (611)
Q Consensus 233 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~--~~~~vkl~DfG~a 310 (611)
..++||||| +|+|.+++......+++..+..++.|++.||+|||++|||||||||+|||++... ..+.+||+|||+|
T Consensus 75 ~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 75 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred ccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEccccee
Confidence 999999999 7899999888777899999999999999999999999999999999999996432 3567999999999
Q ss_pred cccCCCC--------cccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCC
Q 007253 311 DFVRPDE--------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE---SGIFRAVLKADP 378 (611)
Q Consensus 311 ~~~~~~~--------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~---~~~~~~i~~~~~ 378 (611)
+...... .....+||+.|||||++. +.++.++|||||||++|||++|+.||.+... ...+..+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence 8764321 234568999999999987 5599999999999999999999999975433 233333332211
Q ss_pred C-CCCCCCCCCCHHHHHHHHHhcccCccCCCCHHHHH
Q 007253 379 S-FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414 (611)
Q Consensus 379 ~-~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll 414 (611)
. ......+.+++++.+++..|+..+|.+||+++.+.
T Consensus 234 ~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 234 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 1 11112246889999999999999999999977653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=379.05 Aligned_cols=248 Identities=23% Similarity=0.301 Sum_probs=189.6
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCC-
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD- 232 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~- 232 (611)
.++|.+.++||+|+||.||+|+. .|+.||||++.... ........|+..+..++ |||||++++++.+++
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-----~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~-HpnIv~~~~~~~~~~~ 71 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLR-HENILGFIAADNKDNG 71 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-----TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-----CCEEEEEEEECccc----hhHHHHHHHHHHHhhCC-CCcCcceEEEEEeCCC
Confidence 46799999999999999999984 47899999985321 11122334555556776 999999999998754
Q ss_pred ---eeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--------cCCeeecCCCCceEEeccCCCce
Q 007253 233 ---NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL--------QGVVHRDLKPENFLFTTKDENSV 301 (611)
Q Consensus 233 ---~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~--------~~iiHrDlkp~NIll~~~~~~~~ 301 (611)
.+|+|||||++|+|.+++.+. .+++..++.++.|++.||.|||+ +|||||||||+|||| +.++.
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~ 146 (303)
T d1vjya_ 72 TWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGT 146 (303)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSC
T ss_pred cceEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCC
Confidence 589999999999999999654 68999999999999999999996 599999999999999 67889
Q ss_pred EEEeecccccccCCCC-----cccccccCCCcCcchhhcCC-------CCCcchhhHHHHHHHHHHhCCCCCCCCC----
Q 007253 302 LKAIDFGLSDFVRPDE-----RLNDIVGSAYYVAPEVLHRS-------YSTEADVWSIGVIAYILLCGSRPFWART---- 365 (611)
Q Consensus 302 vkl~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-------~~~~~DiwSlGvil~el~~g~~Pf~~~~---- 365 (611)
+||+|||+++...... .....+||+.|||||++.+. ++.++|||||||++|||+||..||....
T Consensus 147 ~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~ 226 (303)
T d1vjya_ 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp EEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred eEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc
Confidence 9999999998764432 23456899999999998643 4668999999999999999988773211
Q ss_pred ----------hHHHHHHHHhcCC---CCCCCC-CCCCCHHHHHHHHHhcccCccCCCCHHHHHcC
Q 007253 366 ----------ESGIFRAVLKADP---SFDEAP-WPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (611)
Q Consensus 366 ----------~~~~~~~i~~~~~---~~~~~~-~~~~s~~~~~li~~~L~~dP~~Rpt~~~ll~h 416 (611)
............. .++... .......+.+|+.+||+.||++|||+.||+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1122222322211 111110 01123468899999999999999999998763
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.4e-43 Score=366.42 Aligned_cols=259 Identities=27% Similarity=0.425 Sum_probs=196.6
Q ss_pred CceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhc----------CCCCeeEE
Q 007253 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT----------GHNNLVKF 224 (611)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----------~h~~iv~l 224 (611)
++|+++++||+|+||+||+|+.+. +|+.||||++.+. ....+.+.+|+++++.+. +|+||+++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~---~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~ 85 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMV---NNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 85 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred CcEEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence 469999999999999999999776 6899999999643 234467788999998886 26889999
Q ss_pred EEEEee--CCeeEEEeeecCCCChHHHH--HhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeecCCCCceEEeccCCC
Q 007253 225 FDAYED--TDNVYVVMELCEGGELLDRI--LSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDEN 299 (611)
Q Consensus 225 ~~~~~~--~~~~~lv~E~~~~gsL~~~l--~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NIll~~~~~~ 299 (611)
++++.. ....+++|+++..+...... ......+++..++.++.||+.||.|||+ .||+||||||+||||...+..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred EEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcc
Confidence 998865 45677777777665433322 2334579999999999999999999998 899999999999999643222
Q ss_pred ---ceEEEeecccccccCCCCcccccccCCCcCcchhhc-CCCCCcchhhHHHHHHHHHHhCCCCCCCCChH------HH
Q 007253 300 ---SVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES------GI 369 (611)
Q Consensus 300 ---~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el~~g~~Pf~~~~~~------~~ 369 (611)
..+||+|||.+.... ......+||+.|+|||++. ..|+.++||||+||++++|++|+.||...... ..
T Consensus 166 ~~~~~~kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp TTEEEEEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cccceeeEeecccccccc--cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 359999999997654 2345678999999999876 66999999999999999999999999654321 11
Q ss_pred HHHHHhcCC------------------------CCCC--------------CCCCCCCHHHHHHHHHhcccCccCCCCHH
Q 007253 370 FRAVLKADP------------------------SFDE--------------APWPSLSSEARDFVKRLLNKDPRKRLTAA 411 (611)
Q Consensus 370 ~~~i~~~~~------------------------~~~~--------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 411 (611)
......... .... ..+...++++.+||.+||+.||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 111110000 0000 00112467899999999999999999999
Q ss_pred HHHcCcccCCC
Q 007253 412 QALSHPWIKNS 422 (611)
Q Consensus 412 ~ll~hp~~~~~ 422 (611)
|+|+||||++.
T Consensus 324 e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 324 GLVNHPWLKDT 334 (362)
T ss_dssp HHHTCGGGTTC
T ss_pred HHhcCcccCCC
Confidence 99999999854
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=9.1e-26 Score=211.90 Aligned_cols=167 Identities=26% Similarity=0.254 Sum_probs=122.7
Q ss_pred eeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcC---------------CHHHHHHHHHHHHHHHHhcCCCCe
Q 007253 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT---------------TAIAIEDVRREVKILRALTGHNNL 221 (611)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~---------------~~~~~~~~~~E~~~l~~l~~h~~i 221 (611)
+.++++||+|+||.||+|+.. +|+.||||++...... .......+.+|...+.++. |.++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~----~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~v 76 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE----KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAV 76 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET----TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSS
T ss_pred chhCCEeeeCcceEEEEEECC----CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc-CCCc
Confidence 468999999999999999864 4889999987532110 0112234567899999997 9999
Q ss_pred eEEEEEEeeCCeeEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCeeecCCCCceEEeccCCCce
Q 007253 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301 (611)
Q Consensus 222 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~ 301 (611)
+..+++. ..+++|||++++.+. .+++..+..++.||+.+|.|||++||+||||||+|||++ + ..
T Consensus 77 ~~~~~~~----~~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~---~-~~ 140 (191)
T d1zara2 77 PKVYAWE----GNAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS---E-EG 140 (191)
T ss_dssp CCEEEEE----TTEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE---T-TE
T ss_pred ceEEEec----CCEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee---C-CC
Confidence 9887653 237999999876542 255666788999999999999999999999999999995 2 34
Q ss_pred EEEeecccccccCCCCcccccccCCCcCc------chhhcCCCCCcchhhHHHHHH
Q 007253 302 LKAIDFGLSDFVRPDERLNDIVGSAYYVA------PEVLHRSYSTEADVWSIGVIA 351 (611)
Q Consensus 302 vkl~DfG~a~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~DiwSlGvil 351 (611)
++|+|||+|......... .|.. .+.+.+.|+.++|+||+.--+
T Consensus 141 ~~liDFG~a~~~~~~~~~-------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 141 IWIIDFPQSVEVGEEGWR-------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EEECCCTTCEETTSTTHH-------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred EEEEECCCcccCCCCCcH-------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 899999998765422211 1211 123356789999999976543
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Probab=99.86 E-value=1.6e-21 Score=174.23 Aligned_cols=140 Identities=21% Similarity=0.402 Sum_probs=123.5
Q ss_pred cchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhh
Q 007253 457 TLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEAL 536 (611)
Q Consensus 457 ~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~ 536 (611)
+|+++|+.+|+++|..+|.+++|+|+.+||..++...+. .+++..+..++..+|.+++|.|+|+||+..+.........
T Consensus 2 ~lt~~e~~~l~~~F~~~D~~~~G~Is~~e~~~~l~~~~~-~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~ 80 (146)
T d1exra_ 2 QLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQ-NPTEAELQDMINEVDADGNGTIDFPEFLSLMARKMKEQDS 80 (146)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTC-CCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHHcCCCCCeECHHHHHHHHHhcCC-CCCHHHHHHHHHhcCCCCCCcccHHHHHHHHHHHhhccCh
Confidence 578999999999999999999999999999999987765 5777888999999999999999999999987654433221
Q ss_pred HHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007253 537 DRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLH 600 (611)
Q Consensus 537 ~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~ 600 (611)
.+.++.+|+.+|.|++|+|+.+||+.++. ++..++ ++.+|+.+|.|+||+|+|+||+++|+
T Consensus 81 ---~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~i~~~~D~d~dG~i~~~eF~~~l~ 145 (146)
T d1exra_ 81 ---EEELIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIREADIDGDGHINYEEFVRMMV 145 (146)
T ss_dssp ---HHHHHHHHHHHSTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSSSSSBCHHHHHHHHH
T ss_pred ---HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhcCCHHHHHHHHHHhCCCCCCeEeHHHHHHHhc
Confidence 56889999999999999999999999994 665554 89999999999999999999999885
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.85 E-value=2.2e-21 Score=176.58 Aligned_cols=147 Identities=20% Similarity=0.378 Sum_probs=127.3
Q ss_pred hcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHh
Q 007253 456 KTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEA 535 (611)
Q Consensus 456 ~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~ 535 (611)
..|+++++.+|+++|..+|.+++|+|+.+||..++...+. ..++..+..++..+|.+++|.+++.||+..+........
T Consensus 12 ~~ls~~~i~el~~~F~~~D~d~~G~Is~~el~~~l~~~~~-~~~~~~~~~~~~~~d~~~~~~~~~~e~~~~~~~~~~~~~ 90 (162)
T d1topa_ 12 AFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQ-NPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVRQMKEDA 90 (162)
T ss_dssp HHSCHHHHHHHHHHHHTTTCSCSSEEEGGGHHHHHHHTTC-CCCHHHHHHHHHHHCTTSCCEEEHHHHHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHhccCC-chhHHHHHhhhheeccCCCCCeeeehhhhhhhhhhhhhc
Confidence 4578899999999999999999999999999998877665 577888999999999999999999999887765544433
Q ss_pred hHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 536 LDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 536 ~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
...+++.++.+|+.+|.|++|+|+.+||+++|. .+...+ ++.+|+.+|.|+||+|+|+||+++|+|+.
T Consensus 91 ~~~~~~~~~~aF~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~l~~~~D~d~dG~Is~~EF~~~l~~~~ 162 (162)
T d1topa_ 91 KGKSEEELANCFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKDSDKNNDGRIDFDEFLKMMEGVQ 162 (162)
T ss_dssp HHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHSCC
T ss_pred ccCcHHHHHHHHHHHCCCCCCCCcHHHHHHHHHhhCCCCCHHHHHHHHHHhCCCCCCcEEHHHHHHHHHcCC
Confidence 344577889999999999999999999999994 444433 88999999999999999999999999874
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.84 E-value=5.4e-21 Score=172.78 Aligned_cols=148 Identities=17% Similarity=0.339 Sum_probs=123.3
Q ss_pred hhhcchhhHHHHHHHHhhhcCCCC-CCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhh
Q 007253 454 LSKTLTVDELFYLKEQYALLEPNK-NGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQ 532 (611)
Q Consensus 454 ~~~~l~~~e~~~l~~~F~~~D~d~-~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~ 532 (611)
....|+++++++|+++|..+|.++ +|.|+..||..+|..++. .+++.++..++..++.+++|.+++.+|.........
T Consensus 4 ~~~~Lt~~~~~~l~~~F~~~D~d~~dG~I~~~e~~~~l~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (156)
T d1dtla_ 4 AVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQ-NPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMK 82 (156)
T ss_dssp GGGGSCHHHHHHHHHHHHHHTTTCGGGSBCHHHHHHHHHHTTC-CCCHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHHC
T ss_pred HHHHCCHHHHHHHHHHHHHHcCCCCCCeECHHHHHHHHHHcCC-CCCHHHHHHHHHHhhccCCCccchhhhhhhhhhccc
Confidence 345789999999999999999995 899999999999988775 678888999999999999999999999775543322
Q ss_pred HHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 533 LEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 533 ~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
.......++.++.+|+.||.|++|+|+.+||++++. ++..++ ++.+|+.+|.|+||.|+|+||+++|+|+
T Consensus 83 ~~~~~~~~~~l~~~F~~~D~d~~G~I~~~e~~~~~~~~~~~ls~~e~~~i~~~~D~d~dG~I~~~eF~~~l~g~ 156 (156)
T d1dtla_ 83 DDSKGKSEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKGV 156 (156)
T ss_dssp -----CHHHHHHHHHHHHCTTCSSEEEHHHHGGGGTTC--CCCHHHHHHHHHHHCTTSSSEEEHHHHHHHHHC-
T ss_pred ccccccHHHHHHHHHHHhCcCCCCcCcHHHHHHHHhhcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHcCC
Confidence 211112367889999999999999999999999995 666655 8999999999999999999999999985
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.83 E-value=4.8e-21 Score=171.10 Aligned_cols=141 Identities=23% Similarity=0.391 Sum_probs=122.7
Q ss_pred hcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHh
Q 007253 456 KTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEA 535 (611)
Q Consensus 456 ~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~ 535 (611)
..++++++.+|+++|+.+|.|++|+|+.+||..++...+. .+++..+..++...+.++.+.++|++|...+........
T Consensus 2 ~~ls~~~i~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~g~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (146)
T d1lkja_ 2 SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGL-SPSEAEVNDLMNEIDVDGNHQIEFSEFLALMSRQLKSND 80 (146)
T ss_dssp CCCCHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHHHHTC-CCCHHHHHHHHHHHCSSSCCEEEHHHHHHHHHHHTCCCC
T ss_pred CCCCHHHHHHHHHHHHHHCCCCCCcEeHHHHHHHHHhcCC-CCCHHHHHHHHHHhccCCcccccHHHHHHHHHHhhcccc
Confidence 5789999999999999999999999999999999988775 677778888999999999999999999887755443322
Q ss_pred hHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 536 LDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 536 ~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
+++.++.+|+.||+|++|+|+.+||+++|. +|..++ ++.+|..+| |+||+|+|+||+++|.+
T Consensus 81 ---~~~~~~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d-d~dG~I~~~eF~~~m~k 146 (146)
T d1lkja_ 81 ---SEQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDDMLREVS-DGSGEINIQQFAALLSK 146 (146)
T ss_dssp ---HHHHHHHHHHHHCSSSSCEEEHHHHHHHHHHHTCSCCHHHHHHHHHHHC-CSSSEEEHHHHHHHHCC
T ss_pred ---HHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCcccHHHHHHHHHhcc-CCCCeEeHHHHHHHhCC
Confidence 256789999999999999999999999994 555554 899999999 99999999999999863
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=99.83 E-value=4.8e-21 Score=170.20 Aligned_cols=136 Identities=18% Similarity=0.337 Sum_probs=116.9
Q ss_pred chhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhH
Q 007253 458 LTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALD 537 (611)
Q Consensus 458 l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~ 537 (611)
|+++++++|+++|..+|.+++|.|+..||..+|..++. .+++.++..++. +++|.|+|++|+.++.........
T Consensus 1 L~~~qi~e~~~~F~~~D~d~~G~I~~~el~~~l~~lg~-~~~~~el~~~~~----~~~~~i~~~eF~~~~~~~~~~~~~- 74 (142)
T d1wdcb_ 1 LPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGR-APDDKELTAMLK----EAPGPLNFTMFLSIFSDKLSGTDS- 74 (142)
T ss_dssp CCHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHHHHSS-CCCHHHHHHHHT----TSSSCCCHHHHHHHHHHHTCSCCC-
T ss_pred CCHHHHHHHHHHHHHHcCCCCCcCChHHHHHHHHHhhc-CCCHHHHHHHHH----hccCccccccccccccccccccch-
Confidence 57899999999999999999999999999999988876 577777777775 467999999999988654433222
Q ss_pred HHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 538 RWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 538 ~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
++.++.+|+.||+|++|+|+.+||+++|. +|..++ ++++|+.+|.| +|+|+|+||+++|++.
T Consensus 75 --~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~lt~~e~~~l~~~~d~~-~G~I~y~eF~~~l~~~ 140 (142)
T d1wdcb_ 75 --EETIRNAFAMFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFKEAPVE-GGKFDYVKFTAMIKGS 140 (142)
T ss_dssp --HHHHHHHHHTTCTTCCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHCCEE-TTEECHHHHHHHHHTS
T ss_pred --hhhHHHhhhhhcccCCCcccHHHHHHHHHHccccCCHHHHHHHHHHhCCC-CCEEcHHHHHHHHhcC
Confidence 56789999999999999999999999994 776665 89999999998 6999999999999874
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=4.1e-20 Score=163.74 Aligned_cols=137 Identities=20% Similarity=0.347 Sum_probs=120.3
Q ss_pred hhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHH
Q 007253 459 TVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDR 538 (611)
Q Consensus 459 ~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~ 538 (611)
++++.++|+++|..+|.+++|+|+..||..++...+. .+++..+..++..+|.+++|.|++.||+..+........
T Consensus 1 t~~~~~elk~~F~~~D~~~~G~Is~~e~~~~l~~~~~-~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~--- 76 (141)
T d2obha1 1 TEEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGF-EPKKEEIKKMISEIDKEGTGKMNFGDFLTVMTQKMSEKD--- 76 (141)
T ss_dssp CHHHHHHHHHHHHTTCTTCCSEEEGGGHHHHHHHTTC-CCCHHHHHHHHHHHTTTCCSEEEHHHHHHHHHHHHHHHH---
T ss_pred CHHHHHHHHHHHHHHcCCCCCeEeHHHHHHHHHhcCC-chhHHHHHHHHHhhccCCCCeechHHHHHHHHHHHhhhc---
Confidence 4678889999999999999999999999999877765 577888899999999999999999999987765443322
Q ss_pred HHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHH
Q 007253 539 WEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLL 599 (611)
Q Consensus 539 ~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l 599 (611)
..+.++.+|+.+|.+++|+|+.+||+.++. ++..++ +..+|+.+|.|+||.|+|+||+++|
T Consensus 77 ~~~~l~~~f~~~d~~~~G~i~~~el~~~l~~~g~~l~~~e~~~l~~~~D~d~dG~i~~~EF~~~m 141 (141)
T d2obha1 77 TKEEILKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEADRDGDGEVSEQEFLRIM 141 (141)
T ss_dssp HHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHH
T ss_pred cHHHHHHHHHHhcccCCCCccHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCCEeHHHHHHhC
Confidence 266889999999999999999999999994 666666 8999999999999999999999986
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=5.7e-20 Score=167.56 Aligned_cols=144 Identities=20% Similarity=0.334 Sum_probs=120.8
Q ss_pred hhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhH
Q 007253 454 LSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQL 533 (611)
Q Consensus 454 ~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~ 533 (611)
|...++++|+++|+++|..+|.+++|.|+.+||..++.. . ....++.++..+|.+++|.|+|+||+..+......
T Consensus 6 ~~t~ft~eei~~l~~~F~~~D~d~~G~I~~~E~~~~~~~-~----~~~~~~~l~~~~d~~~~g~i~~~EFl~~~~~~~~~ 80 (165)
T d1auib_ 6 MCSHFDADEIKRLGKRFKKLDLDNSGSLSVEEFMSLPEL-Q----QNPLVQRVIDIFDTDGNGEVDFKEFIEGVSQFSVK 80 (165)
T ss_dssp CCCSCCHHHHHHHHHHHHHHCTTCCSEECHHHHTTSHHH-H----TCTTHHHHHHHHCTTCSSSEEHHHHHHHHGGGCTT
T ss_pred HcCCCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHhhhc-c----CCHHHHHHHHHHccccchhhhhhhhhhhccccccc
Confidence 456789999999999999999999999999999875432 2 23457889999999999999999999988776533
Q ss_pred HhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc--CCCCcc-------HHHHHHHHhcCCCCceeHHHHHHHHhhcch
Q 007253 534 EALDRWEQHARCAYELFEKDGNRAIVIEELASELG--LGPAVP-------VHAVLHDWIRHTDGKLSFLGFVKLLHGVSS 604 (611)
Q Consensus 534 ~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~--~~~~~~-------~~~~~~~~D~~~dG~is~~eF~~~l~~~~~ 604 (611)
... .+.++.+|+.+|.|++|+|+.+||.+++. .+.... ++.+|..+|.|+||+|+++||+++|.++..
T Consensus 81 ~~~---~~~~~~~f~~~d~d~~g~Is~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~D~~~dG~Is~~EF~~i~~~~~~ 157 (165)
T d1auib_ 81 GDK---EQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVDKTIINADKDGDGRISFEEFCAVVGGLDI 157 (165)
T ss_dssp CCH---HHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHTTSSCHHHHHHHHHHHHHHHCTTSSSSEEHHHHHHHHGGGCG
T ss_pred hhh---HHHHHHHHHHhcccccccccHHHHHHHHHHhccccCchHHHHHHHHHHHHHcCCCCCCcEeHHHHHHHHhcCCh
Confidence 322 55789999999999999999999999983 333322 678999999999999999999999998875
Q ss_pred h
Q 007253 605 R 605 (611)
Q Consensus 605 ~ 605 (611)
.
T Consensus 158 ~ 158 (165)
T d1auib_ 158 H 158 (165)
T ss_dssp G
T ss_pred h
Confidence 3
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Probab=99.81 E-value=5e-20 Score=161.59 Aligned_cols=132 Identities=18% Similarity=0.246 Sum_probs=112.4
Q ss_pred HHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHHH
Q 007253 466 LKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARC 545 (611)
Q Consensus 466 l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~ 545 (611)
..++|+.+|.|++|.|+..||..++..++. ..++.++..+|..+|.+++|.|+|+||+.++........ ...+..++.
T Consensus 2 ae~~F~~~D~d~dG~is~~E~~~~l~~~~~-~~~~~~~~~~~~~~D~~~~g~i~~~Ef~~~~~~~~~~~~-~~~~~~~~~ 79 (134)
T d1jfja_ 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRA-IKNEQLLQLIFKSIDADGNGEIDQNEFAKFYGSIQGQDL-SDDKIGLKV 79 (134)
T ss_dssp HHHHHHHHCTTCSSEEEHHHHHHHHHTTCC-SSHHHHHHHHHHHHCSSCCSEEEHHHHHHHTTCSSCCSS-HHHHHHHHH
T ss_pred HHHHHHHHcCCCcCCCcHHHHHHHHHHcCC-CCCHHHHHHHHHHhhhccccccccccccccccccccccc-ccccccccc
Confidence 357999999999999999999999977775 567778999999999999999999999998865433221 122567889
Q ss_pred HHhHHhcCCCCcccHHHHHHHhc-CCCCccHHHHHHHHhcCCCCceeHHHHHHHHh
Q 007253 546 AYELFEKDGNRAIVIEELASELG-LGPAVPVHAVLHDWIRHTDGKLSFLGFVKLLH 600 (611)
Q Consensus 546 ~F~~~D~d~~G~It~eEl~~~l~-~~~~~~~~~~~~~~D~~~dG~is~~eF~~~l~ 600 (611)
+|+.+|.|++|+|+.+||++++. .+.. .+.++|..+|.|+||+|+|+||+++|.
T Consensus 80 ~F~~~D~~~~g~i~~~el~~~~~~~~~~-~~~~~~~~~D~d~dG~is~~EF~~~~l 134 (134)
T d1jfja_ 80 LYKLMDVDGDGKLTKEEVTSFFKKHGIE-KVAEQVMKADANGDGYITLEEFLEFSL 134 (134)
T ss_dssp HHHHHCCSSSSEEEHHHHHHHHTTTTCH-HHHHHHHHHHCSSSSEEEHHHHHHHHC
T ss_pred cccccccccCCcccHHHHHHHHHhcCcH-HHHHHHHHHCCCCCCCCCHHHHHHHhC
Confidence 99999999999999999999996 4433 388899999999999999999999874
|
| >d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.80 E-value=7.8e-20 Score=162.87 Aligned_cols=136 Identities=18% Similarity=0.255 Sum_probs=112.7
Q ss_pred HHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCC--CCCcccHHHHHHHHcchhhHHhhHHHH
Q 007253 463 LFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSL--QYRRMDFEEFCAAALSVHQLEALDRWE 540 (611)
Q Consensus 463 ~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~--~~g~i~~~eF~~~~~~~~~~~~~~~~~ 540 (611)
.++|+++|..+|.+++|+|+.+||..+|..++. .++..++..++..++.+ ++|.|+|+||+.++......... ...
T Consensus 3 ~eelke~F~~~D~d~~G~I~~~el~~~l~~lg~-~~~~~e~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~-~~~ 80 (145)
T d2mysc_ 3 ADDFKEAFLLFDRTGDAKITASQVGDIARALGQ-NPTNAEINKILGNPSKEEMNAAAITFEEFLPMLQAAANNKDQ-GTF 80 (145)
T ss_pred HHHHHHHHHHHcCCCCCeECHHHHHHHHHHhhh-cchhhhhHHHHHHHhhcccccCccchhHHHHHHhhhhhcccc-chH
Confidence 467999999999999999999999999988776 67888899998877554 68899999999887654332211 115
Q ss_pred HHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 541 QHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 541 ~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
+.++.+|+.||+|++|+|+.+||+++|. +|..++ ++.+++ .|.|+||+|+|+||+++|+.
T Consensus 81 ~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~-~~~d~dG~I~y~eF~~~ll~ 144 (145)
T d2mysc_ 81 EDFVEGLRVFDKEGNGTVMGAELRHVLATLGEKMTEEEVEELMK-GQEDSNGCINYEAFVKHIMS 144 (145)
T ss_pred HHHHHHHHHhhcCCCCEEcHHHHHHHHHHhCCCCCHHHHHHHHh-hcCCCCCeEEHHHHHHHHhc
Confidence 5788999999999999999999999994 666655 777776 48899999999999998864
|
| >d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.80 E-value=7.4e-20 Score=163.01 Aligned_cols=138 Identities=14% Similarity=0.207 Sum_probs=115.8
Q ss_pred chhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhH
Q 007253 458 LTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALD 537 (611)
Q Consensus 458 l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~ 537 (611)
|+++++.+|+++|..+|.+++|+|+.+||..+|..++....+. +++..++.+.+|.|+|.+|+.++.........
T Consensus 1 f~~~qi~el~e~F~~~D~~~~G~I~~~e~~~~l~~lg~~~~~~----~~~~~~~~~~~g~i~~~eF~~~~~~~~~~~~~- 75 (145)
T d2mysb_ 1 FDETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKN----EELDAMIKEASGPINFTVFLTMFGEKLKGADP- 75 (145)
T ss_pred CCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhCCCcchH----HHHHHHHHhccCceeechhhhhhhhcccccch-
Confidence 5788999999999999999999999999999998877533333 34555666788999999999987654433222
Q ss_pred HHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 538 RWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 538 ~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
++.++.+|+.||.+++|+|+.+||+++|. +|..++ ++.++..+|.|+||+|+|.||+++|++.
T Consensus 76 --~~~l~~aF~~fD~~~~g~I~~~el~~~l~~~g~~ls~~e~~~~~~~~d~d~dg~I~y~eF~~~l~~~ 142 (145)
T d2mysb_ 76 --EDVIMGAFKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWAAFPPDVAGNVDYKNICYVITHG 142 (145)
T ss_pred --HHHHHHHHHhhhhcccchhhHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHhccC
Confidence 56799999999999999999999999995 676666 8899999999999999999999999763
|
| >d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=99.79 E-value=7.9e-20 Score=164.20 Aligned_cols=140 Identities=19% Similarity=0.244 Sum_probs=115.9
Q ss_pred chhhHHHHHHHHhhhcCC--CCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHh
Q 007253 458 LTVDELFYLKEQYALLEP--NKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEA 535 (611)
Q Consensus 458 l~~~e~~~l~~~F~~~D~--d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~ 535 (611)
|+++|+.+|+++|..||. +++|.|+..||..+|..++. .+++.++..+. ..|.+++|.|+|+||+.++........
T Consensus 1 Ls~eqi~~l~~~F~~fD~~~~~dG~I~~~el~~~l~~lG~-~~t~~e~~~~~-~~~~~~~~~i~~~eFl~~~~~~~~~~~ 78 (152)
T d1wdcc_ 1 LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGI-NPRNEDVFAVG-GTHKMGEKSLPFEEFLPAYEGLMDCEQ 78 (152)
T ss_dssp CCHHHHHHHHHHHHHHHHHTCSSSCEEGGGHHHHHHHTTC-CCCHHHHHHTT-CCSSTTSCEECHHHHHHHHHHHTTSCC
T ss_pred CCHHHHHHHHHHHHHHCcCCCCCCeECHHHHHHHHHHhcc-CccHhhhhhhh-hhhccccccccccccccccccccccch
Confidence 578899999999999994 88999999999999988876 57777777654 458889999999999998765443221
Q ss_pred hHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcC--CCCceeHHHHHHHHhh
Q 007253 536 LDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRH--TDGKLSFLGFVKLLHG 601 (611)
Q Consensus 536 ~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~--~dG~is~~eF~~~l~~ 601 (611)
. ..+.++.+|+.||.+++|+|+.+||+++|. +|..++ ++.+++.+|.+ ++|.|+|+||+++|+.
T Consensus 79 ~--~~~~l~~aF~~~D~~~~G~I~~~el~~~l~~~g~~ls~~e~~~l~~~~d~~~d~~G~I~y~eF~~~~~~ 148 (152)
T d1wdcc_ 79 G--TFADYMEAFKTFDREGQGFISGAELRHVLTALGERLSDEDVDEIIKLTDLQEDLEGNVKYEDFVKKVMA 148 (152)
T ss_dssp C--CHHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHHTCCCCTTSEEEHHHHHHHHHH
T ss_pred h--HHHhhhhhhhccccccCccchHHHHHHHHHHcCCCCCHHHHHHHHHHhccCCCCCCEEEHHHHHHHHhc
Confidence 1 155788999999999999999999999994 666665 88999999975 5689999999998863
|
| >d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=99.78 E-value=3.9e-20 Score=171.45 Aligned_cols=142 Identities=23% Similarity=0.484 Sum_probs=124.5
Q ss_pred hcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHh
Q 007253 456 KTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEA 535 (611)
Q Consensus 456 ~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~ 535 (611)
..|+++|+.+|+++|+.+|.+++|+|+.+||..+|..++. .+++.++..++..+|.+++|.|+|.+|+.++........
T Consensus 2 ~~Lt~~ei~~l~~~F~~~D~d~dG~Is~~e~~~~l~~l~~-~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~ 80 (182)
T d1s6ia_ 2 ERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGS-ELMESEIKDLMDAADIDKSGTIDYGEFIAATVHLNKLER 80 (182)
T ss_dssp CSSSCTTTCSHHHHHHTTSSSSSSCEEHHHHHHHHTTTTC-CCCHHHHHHHHHHTCTTCSSEECHHHHHHHHTTSSSSCC
T ss_pred CCCCHHHHHHHHHHHHHHcCCCcCCCCHHHHHHHHHHcCC-ccccccchhhhhhhhccccccchHHHHHHHHHhhccccc
Confidence 4688999999999999999999999999999999977765 577888999999999999999999999998776554443
Q ss_pred hHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CC-CCccHHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 536 LDRWEQHARCAYELFEKDGNRAIVIEELASELG-LG-PAVPVHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 536 ~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~-~~~~~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
.+.++.+|+.+|.+++|+|+.+||++++. ++ ....++.+|+.+|.|+||.|+|+||+++|+..
T Consensus 81 ----~e~l~~aF~~~D~d~~G~i~~~el~~~l~~~gl~~~ev~~~f~~~D~d~DG~Is~~EF~~~m~~~ 145 (182)
T d1s6ia_ 81 ----EENLVSAFSYFDKDGSGYITLDEIQQACKDFGLDDIHIDDMIKEIDQDNDGQIDYGEFAAMMRKR 145 (182)
T ss_dssp ----CCSTHHHHHHTTTTCSSEEEHHHHHHTTTTTTCCTTHHHHHHHHHCSSSSSEEETTHHHHTTSCC
T ss_pred ----HHHHHHHHHHHhhcCCCccchhhhhhhhhhcCccHHHHHHHHHHhhcCCCCeEeHHHHHHHHHhC
Confidence 44678899999999999999999999995 33 23338999999999999999999999999865
|
| >d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Cdc4p species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.75 E-value=2.1e-19 Score=158.95 Aligned_cols=131 Identities=18% Similarity=0.274 Sum_probs=107.6
Q ss_pred HHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHH
Q 007253 464 FYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHA 543 (611)
Q Consensus 464 ~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~ 543 (611)
.+++++|..+|.+++|+|+..||..+|..++. ++++.++. .++.+.+|.|+|++|+.++......... ...+.+
T Consensus 5 ~~fke~F~~~D~d~dG~I~~~el~~~l~~lg~-~~t~~ei~----~~~~~~~~~i~~~eF~~~~~~~~~~~~~-~~~~~l 78 (140)
T d1ggwa_ 5 SPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQ-NPTLAEIT----EIESTLPAEVDMEQFLQVLNRPNGFDMP-GDPEEF 78 (140)
T ss_dssp TTTHHHHHHTCSSSSSEECHHHHHHHHHHTSC-CCCHHHHH----HHHTTSCSSEEHHHHHHHHCTTSSSSSS-CCHHHH
T ss_pred HHHHHHHHHHCCCCCCeECHHHHHHHHHHHHh-hhHHHhhh----hhhccccccccchhhhhhhhhhhhcchh-hHHHHH
Confidence 57899999999999999999999999988775 56655544 4467788999999999988654322111 115578
Q ss_pred HHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 544 RCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 544 ~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
+.+|+.||.|++|+|+.+||+++|. +|..++ ++++|+.+|.| ||.|+|+||+++|..
T Consensus 79 ~~aF~~~D~d~~G~I~~~el~~~l~~~g~~lt~~e~~~l~~~~d~~-dG~I~y~eF~~~m~s 139 (140)
T d1ggwa_ 79 VKGFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLKGVPVK-DGMVNYHDFVQMILA 139 (140)
T ss_dssp HHHHHTTCSSCSSCCCHHHHHHHHHHHHSCSCHHHHHHHHHHTTCS-SCCSTTTHHHHHHHC
T ss_pred HHHHHHHhccCCCcchHHHHHHHHHHcCCCCCHHHHHHHHHhhCCC-CCEEeHHHHHHHHhc
Confidence 9999999999999999999999994 555554 89999999988 999999999998863
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.74 E-value=3.7e-18 Score=158.17 Aligned_cols=143 Identities=17% Similarity=0.245 Sum_probs=116.5
Q ss_pred hhcchhhHHHHHHHHhhhcCCC--CCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhh
Q 007253 455 SKTLTVDELFYLKEQYALLEPN--KNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQ 532 (611)
Q Consensus 455 ~~~l~~~e~~~l~~~F~~~D~d--~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~ 532 (611)
...|+..|+..|++.|..+|.+ ++|.|+.+||+.++...+. .....+..+|+.+|.|++|.|+|.||+.++.....
T Consensus 8 ~t~Fs~~ei~~L~~~F~~~d~~~~~~G~i~~~ef~~~l~~~~~--~~~~~~~~lf~~~d~~~dg~I~f~EFl~~l~~~~~ 85 (183)
T d2zfda1 8 DTVFSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFKTNK--KESLFADRVFDLFDTKHNGILGFEEFARALSVFHP 85 (183)
T ss_dssp HSSCCHHHHHHHHHHHHHHHTSSSCSSSBCHHHHHHHHHSCSS--CCCHHHHHHHHHHCSSCSSSBCHHHHHHHHHHTST
T ss_pred hCCCCHHHHHHHHHHHHHHCcCCCCCCcCcHHHHHHHHHhcCC--CCCHHHHHHHHHHccCCCCcCcHHHHHHHHHhhhc
Confidence 4578999999999999999876 6899999999998755443 22334688999999999999999999987755432
Q ss_pred HHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-----CCCCcc-------HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007253 533 LEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-----LGPAVP-------VHAVLHDWIRHTDGKLSFLGFVKLLH 600 (611)
Q Consensus 533 ~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-----~~~~~~-------~~~~~~~~D~~~dG~is~~eF~~~l~ 600 (611)
.... ++.++.+|+.||.|++|+|+.+|+++++. .+.... ++.+|..+|.|+||.|+|+||.+++.
T Consensus 86 ~~~~---~~~~~~~F~~~D~d~~G~Is~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~dG~Is~~EF~~~~~ 162 (183)
T d2zfda1 86 NAPI---DDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIEDIIDKTFEEADTKHDGKIDKEEWRSLVL 162 (183)
T ss_dssp TSCH---HHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSSCSSEECHHHHHHHHH
T ss_pred cCcH---HHHHHHhhcccccCCCCCccHHHHHHHHHHHHhhhhcccchHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHHH
Confidence 2221 56789999999999999999999999872 333322 67789999999999999999999987
Q ss_pred hc
Q 007253 601 GV 602 (611)
Q Consensus 601 ~~ 602 (611)
..
T Consensus 163 ~~ 164 (183)
T d2zfda1 163 RH 164 (183)
T ss_dssp HS
T ss_pred HC
Confidence 53
|
| >d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Programmed cell death 6 protein-like protein species: Leishmania major [TaxId: 5664]
Probab=99.74 E-value=2.7e-18 Score=158.85 Aligned_cols=129 Identities=19% Similarity=0.252 Sum_probs=113.0
Q ss_pred HHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHH
Q 007253 463 LFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQH 542 (611)
Q Consensus 463 ~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~ 542 (611)
.++|+++|..+|.|++|+|+.+||..+|..++. .+++.++..++..+|.|++|+|+|.+|...+.. ...
T Consensus 17 ~~~l~~~F~~~D~d~dG~Is~~El~~~l~~l~~-~~s~~~~~~l~~~~d~d~~~~i~~~ef~~~~~~----------~~~ 85 (182)
T d1y1xa_ 17 NQELMEWFRAVDTDGSGAISVPELNAALSSAGV-PFSLATTEKLLHMYDKNHSGEITFDEFKDLHHF----------ILS 85 (182)
T ss_dssp TSCHHHHHHHHCTTCSSSBCHHHHHHHHCBTTB-CCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHH----------HHH
T ss_pred HHHHHHHHHHHcCCCcCCCCHHHHHHHHHHhcc-cCchhhhhhhhcccccccccccccccccccccc----------ccc
Confidence 357999999999999999999999999877654 688888999999999999999999999886532 235
Q ss_pred HHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 543 ARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 543 ~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
++.+|+.+|.+++|+|+.+||+++|. +|...+ ++.+|+.+|.|+||.|+|+||++++..+
T Consensus 86 ~~~~F~~~D~~~~g~I~~~el~~~l~~~g~~ls~~e~~~i~~~~d~~~dg~I~~~eF~~~~~~l 149 (182)
T d1y1xa_ 86 MREGFRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKFDRQRRGSLGFDDYVELSIFV 149 (182)
T ss_dssp HHHHHHHHCTTSSSCBCHHHHHHHHHTTSCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred cccchhccccccchhhhhHHHHHHHHHhCCchhHHHHHHHHhhcccCCCCCcCHHHHHHHHHHH
Confidence 67799999999999999999999884 665554 8999999999999999999999988655
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=6e-18 Score=157.29 Aligned_cols=154 Identities=16% Similarity=0.193 Sum_probs=123.0
Q ss_pred cchHHHHHHHhhhh--cchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccH
Q 007253 443 SSSLRKAALRALSK--TLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDF 520 (611)
Q Consensus 443 ~~~l~~~~l~~~~~--~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~ 520 (611)
++++....+..+.+ .++..|+..|.+.|...+ ++|.|+..+|..++...+........+..+|+.+|.+++|.|+|
T Consensus 2 nskl~~e~i~~l~~~t~fs~~Ei~~l~~~F~~~~--~~g~i~~~ef~~~~~~~~~~~~~~~~~~~if~~~d~~~dg~I~~ 79 (187)
T d1g8ia_ 2 NSKLKPEVVEELTRKTYFTEKEVQQWYKGFIKDC--PSGQLDAAGFQKIYKQFFPFGDPTKFATFVFNVFDENKDGRIEF 79 (187)
T ss_dssp CCSCCHHHHHHHHHTSSSCHHHHHHHHHHHHHHC--TTSEEEHHHHHHHHHHHCTTSCTHHHHHHHHHHHCTTCSSEEEH
T ss_pred CccCCHHHHHHHHHhcCCCHHHHHHHHHHHHHHC--CCCCcCHHHHHHHHHHhcCCCCHHHHHHHHHHHhCcCCCCCCcH
Confidence 45566666766655 479999999999998765 67999999999998777653222333567999999999999999
Q ss_pred HHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-----CC----CC-------ccHHHHHHHHhc
Q 007253 521 EEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-----LG----PA-------VPVHAVLHDWIR 584 (611)
Q Consensus 521 ~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-----~~----~~-------~~~~~~~~~~D~ 584 (611)
.||+.++........ ++.++.+|+.||.|++|+|+.+||..++. .+ .. ..++.+|+.+|.
T Consensus 80 ~EF~~~l~~~~~~~~----~e~l~~~F~~~D~d~dG~i~~~El~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~if~~~D~ 155 (187)
T d1g8ia_ 80 SEFIQALSVTSRGTL----DEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDK 155 (187)
T ss_dssp HHHHHHHHHHHHCCH----HHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSSHHHHHHHHHHHHCS
T ss_pred HHHHHHHHHhccCch----hhhHHHHHHHHhcCCCCeEcHHHHHHHHHHHhhhhcccccCchhhccHHHHHHHHHHHhCC
Confidence 999998876654433 66899999999999999999999999872 11 11 117889999999
Q ss_pred CCCCceeHHHHHHHHhhc
Q 007253 585 HTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 585 ~~dG~is~~eF~~~l~~~ 602 (611)
|+||.|||+||.+++...
T Consensus 156 d~dG~Is~~EF~~~~~~~ 173 (187)
T d1g8ia_ 156 NADGKLTLQEFQEGSKAD 173 (187)
T ss_dssp SCSSEEEHHHHHHHHHHC
T ss_pred CCCCcEeHHHHHHHHHHC
Confidence 999999999999988764
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.73 E-value=9.9e-19 Score=155.80 Aligned_cols=135 Identities=13% Similarity=0.224 Sum_probs=109.9
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhh-cCCCCCCcccHHHHHHHHcchhhHHh--hHHHHH
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSS-LNSLQYRRMDFEEFCAAALSVHQLEA--LDRWEQ 541 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~-~D~~~~g~i~~~eF~~~~~~~~~~~~--~~~~~~ 541 (611)
.++++|..+|.+++|+|+.+||..+|..++. .+++.++..++.. .+.+.+|.|+|++|..++........ .....+
T Consensus 3 ~~k~~F~~~D~d~~G~I~~~el~~~l~~lg~-~~s~~ei~~l~~~~~~~~~~~~i~~~ef~~~~~~~~~~~~~~~~~~~~ 81 (146)
T d1m45a_ 3 ANKDIFTLFDKKGQGAIAKDSLGDYLRAIGY-NPTNQLVQDIINADSSLRDASSLTLDQITGLIEVNEKELDATTKAKTE 81 (146)
T ss_dssp CCTTCHHHHCTTCCSEEEGGGHHHHHHHTTC-CCCHHHHHHHHHC--CC--CCEEEHHHHHHHHHHTHHHHHGGGCCCTH
T ss_pred HHHHHHHHHcCCCcCCCCHHHHHHHHHHcCC-chhHHHHhhhhccccccccccccccchhhhhhhhhcccccccccchHH
Confidence 4789999999999999999999999988865 6788889998864 56667799999999987754432211 111145
Q ss_pred HHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007253 542 HARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLH 600 (611)
Q Consensus 542 ~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~ 600 (611)
.+..+|+.||.+++|+|+.+||+.+|. +|..++ ++.+|..+|.|+||.|+|+||+++|.
T Consensus 82 ~l~~~F~~~D~~~~G~I~~~el~~~l~~~g~~l~~~ei~~l~~~~D~d~dG~I~y~eF~~~i~ 144 (146)
T d1m45a_ 82 DFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFIEDVL 144 (146)
T ss_dssp HHHHHHHTTCSSSSSEEEHHHHHHHHHHSTTCCCHHHHHHHHTTCCCCTTSEEEHHHHHHHHH
T ss_pred HHHHHHHhhccccccccchhhhhhhhcccCCcchHHHHHHHHHHhCCCCCCcEEHHHHHHHHH
Confidence 789999999999999999999999994 666665 88999999999999999999998775
|
| >d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Recoverin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.73 E-value=3.7e-18 Score=160.70 Aligned_cols=152 Identities=18% Similarity=0.210 Sum_probs=120.3
Q ss_pred chHHHHHHHhhhh--cchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHH
Q 007253 444 SSLRKAALRALSK--TLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFE 521 (611)
Q Consensus 444 ~~l~~~~l~~~~~--~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ 521 (611)
..+....+..+.+ .++..|+..|.+.|...+ ++|.|+.+||..+|...+.....+..++.+|+.+|.|++|.|+|.
T Consensus 6 ~~l~~e~l~~l~~~t~f~~~ei~~l~~~F~~~~--~~G~is~~EF~~~l~~~~~~~~~~~~~~~if~~~D~~~~G~I~f~ 83 (201)
T d1omra_ 6 GALSKEILEELQLNTKFTEEELSSWYQSFLKEC--PSGRITRQEFQTIYSKFFPEADPKAYAQHVFRSFDANSDGTLDFK 83 (201)
T ss_dssp CTHHHHHHHHHGGGCSSCHHHHHHHHHHHHHHC--TTSEEEHHHHHHHHHHHCTTSCCHHHHHHHHHTTTSCSSSEEEHH
T ss_pred CCCCHHHHHHHHHhCCCCHHHHHHHHHHHHHHC--cCCCccHHHHHHHHHHhcCCCCHHHHHHHHHHHhccCCCCeEeeh
Confidence 3455555565544 479999999999996554 679999999999998877643444456789999999999999999
Q ss_pred HHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc----CCC---------C-c----cHHHHHHHHh
Q 007253 522 EFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG----LGP---------A-V----PVHAVLHDWI 583 (611)
Q Consensus 522 eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~----~~~---------~-~----~~~~~~~~~D 583 (611)
||+.++........ ++.++.+|+.||.|++|+|+.+|+..++. ... . . .++.+|..+|
T Consensus 84 EF~~~~~~~~~~~~----~~~l~~~F~~~D~d~~G~is~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D 159 (201)
T d1omra_ 84 EYVIALHMTSAGKT----NQKLEWAFSLYDVDGNGTISKNEVLEIVTAIFKMISPEDTKHLPEDENTPEKRAEKIWGFFG 159 (201)
T ss_dssp HHHHHHHHHHSSCG----GGSHHHHHHHHCTTCSSSBCHHHHHHHHHHHHTTSCHHHHTTSCGGGSSHHHHHHHHHHHTT
T ss_pred hHHHHHHhhcccch----HHHHHHHHHHHccCCCCccCHHHHHHHHHHHHhhcChhhhhhhhhhhccHHHHHHHHHHHhC
Confidence 99987765544333 55788999999999999999999998872 110 0 0 1678999999
Q ss_pred cCCCCceeHHHHHHHHhh
Q 007253 584 RHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 584 ~~~dG~is~~eF~~~l~~ 601 (611)
.|+||.|||+||++++..
T Consensus 160 ~d~dG~Is~~EF~~~~~~ 177 (201)
T d1omra_ 160 KKDDDKLTEKEFIEGTLA 177 (201)
T ss_dssp CCTTCCBCHHHHHHHHHH
T ss_pred CCCCCCCcHHHHHHHHHH
Confidence 999999999999997755
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.72 E-value=4.7e-18 Score=157.14 Aligned_cols=153 Identities=20% Similarity=0.248 Sum_probs=122.6
Q ss_pred chHHHHHHHhhhh--cchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHH
Q 007253 444 SSLRKAALRALSK--TLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFE 521 (611)
Q Consensus 444 ~~l~~~~l~~~~~--~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ 521 (611)
+.++...+..+.+ .++.+|++.+++.|... +++|.|+..||..+|...+........++++|+.+|.+++|.|+|+
T Consensus 2 s~l~~~~~~~L~~~t~fs~~ei~~l~~~F~~~--~~~g~i~~~ef~~~l~~~~~~~~~~~~~~~lf~~~d~~~~g~i~~~ 79 (181)
T d1bjfa_ 2 SKLRPEVMQDLLESTDFTEHEIQEWYKGFLRD--CPSGHLSMEEFKKIYGNFFPYGDASKFAEHVFRTFDANGDGTIDFR 79 (181)
T ss_dssp CCCCHHHHHHHHHHSSCCHHHHHHHHHHHHHH--STTSEEEHHHHHHHHTTTSSSSCCHHHHHHHHHHHCSSCSSEEEHH
T ss_pred CCCCHHHHHHHHHhcCCCHHHHHHHHHHHHhh--CCCCCcCHHHHHHHHHHhCCCCCHHHHHHHHHHhcCCCCCCcEeHH
Confidence 3455666666655 48999999999998665 4689999999999987776432233446889999999999999999
Q ss_pred HHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc----C-----CC----Ccc---HHHHHHHHhcC
Q 007253 522 EFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG----L-----GP----AVP---VHAVLHDWIRH 585 (611)
Q Consensus 522 eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~----~-----~~----~~~---~~~~~~~~D~~ 585 (611)
||+..+....+... ++.++.+|+.||.|++|+|+.+|+..++. . +. ... ++.+|..+|.|
T Consensus 80 eFl~~~~~~~~~~~----~~~~~~~f~~~D~d~dg~i~~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d 155 (181)
T d1bjfa_ 80 EFIIALSVTSRGKL----EQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDTN 155 (181)
T ss_dssp HHHHHHHHHTSSCH----HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGGSSHHHHHHHHHHHSCTT
T ss_pred HHHHHHHHHhhhch----HHHHHHHHHHhccCCCCeecHHHHHHHHHHHhhhccccccCCcccccHHHHHHHHHHHhCCC
Confidence 99998876654444 66889999999999999999999999882 1 11 111 78899999999
Q ss_pred CCCceeHHHHHHHHhhc
Q 007253 586 TDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 586 ~dG~is~~eF~~~l~~~ 602 (611)
+||.|||+||.+++...
T Consensus 156 ~dG~Is~~EF~~~~~~~ 172 (181)
T d1bjfa_ 156 RDGKLSLEEFIRGAKSD 172 (181)
T ss_dssp CSSEECHHHHHHHHHHC
T ss_pred CCCcEeHHHHHHHHHhC
Confidence 99999999999998764
|
| >d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Apoptosis-linked protein alg-2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.72 E-value=4.5e-18 Score=157.22 Aligned_cols=132 Identities=15% Similarity=0.292 Sum_probs=112.8
Q ss_pred hHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHH
Q 007253 461 DELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWE 540 (611)
Q Consensus 461 ~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~ 540 (611)
.+..+|..+|..+|.+++|+|+.+||..+|...+....+...+..+++.+|.+++|.|+|+||+.++...
T Consensus 16 ~~~~~L~~iF~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~EFl~~~~~~---------- 85 (181)
T d1hqva_ 16 PDQSFLWNVFQRVDKDRSGVISDNELQQALSNGTWTPFNPVTVRSIISMFDRENKAGVNFSEFTGVWKYI---------- 85 (181)
T ss_dssp SCHHHHHHHHHHHCTTCCSSBCHHHHHHHCCCSSSSCCCHHHHHHHHHHHCCSSSSSBCHHHHHHHHHHH----------
T ss_pred ccHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCcccHHHHHHHhhccccccccchhhhHHHhhhhhc----------
Confidence 3456799999999999999999999999987776655667788999999999999999999999876432
Q ss_pred HHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 541 QHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 541 ~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
..++.+|+.+|++++|+|+.+||++++. .+..++ ++.++..+|.+++|+|+|+||+.++..+
T Consensus 86 ~~~~~~f~~~D~~~~G~i~~~el~~~l~~~~~~l~~e~~~~~~~~~d~~~dg~Is~~eF~~~~~~l 151 (181)
T d1hqva_ 86 TDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFDRQGRGQIAFDDFIQGCIVL 151 (181)
T ss_dssp HHHHHHHHHHCTTCCSSBCHHHHHHHHHHHTBCCCHHHHHHHHHHHCSSCSSCBCHHHHHHHHHHH
T ss_pred cccccccccccccccchhhhHHHHHHHHHcCCcchhHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence 2466799999999999999999999994 443333 8899999999999999999999988554
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.72 E-value=8.5e-18 Score=156.63 Aligned_cols=151 Identities=15% Similarity=0.184 Sum_probs=120.0
Q ss_pred HHHHHHHhhhh--cchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHH
Q 007253 446 LRKAALRALSK--TLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEF 523 (611)
Q Consensus 446 l~~~~l~~~~~--~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF 523 (611)
+.+..+..+.+ .++..|+..|.+.|...+ ++|.|+..||..++...+........++.+|..+|.+++|.|+|.||
T Consensus 8 l~~e~l~~l~~~t~fs~~Ei~~l~~~F~~~~--~~G~i~~~ef~~~~~~~~~~~~~~~~~~~if~~~D~~~~G~I~~~Ef 85 (190)
T d1fpwa_ 8 LSKDDLTCLKQSTYFDRREIQQWHKGFLRDC--PSGQLAREDFVKIYKQFFPFGSPEDFANHLFTVFDKDNNGFIHFEEF 85 (190)
T ss_dssp STTHHHHHHTTTCCSTHHHHHHHHHHHHHHC--TTCCEEHHHHHHHHHHHCTTSCCSHHHHHHHHTCCSSCSSEECHHHH
T ss_pred CCHHHHHHHHHHcCCCHHHHHHHHHHHHHHC--CCCCccHHHHHHHHHHHCCCCChHHHHHHHHHHhCcCCCCcccHHHH
Confidence 33444555544 489999999999997665 57999999999998877653333334688999999999999999999
Q ss_pred HHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-----CC----CC-------ccHHHHHHHHhcCCC
Q 007253 524 CAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-----LG----PA-------VPVHAVLHDWIRHTD 587 (611)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-----~~----~~-------~~~~~~~~~~D~~~d 587 (611)
+.++........ ++.++.+|+.||.|++|+|+.+|+..++. .+ .. ..++.+|+.+|.|+|
T Consensus 86 ~~~~~~~~~~~~----~e~~~~~F~~~D~d~dG~is~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~if~~~D~d~d 161 (190)
T d1fpwa_ 86 ITVLSTTSRGTL----EEKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKNED 161 (190)
T ss_dssp HHHHHHHSCCCS----THHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCCCHHHHHHHHHHHHTTTCS
T ss_pred HHHHHHHccCch----HHHHHHHHHHhccCCCCcCcHHHHHHHHHHHHHhcccccCCCchhhhHHHHHHHHHHHhCCCCC
Confidence 988776554333 66889999999999999999999999882 11 10 117889999999999
Q ss_pred CceeHHHHHHHHhhc
Q 007253 588 GKLSFLGFVKLLHGV 602 (611)
Q Consensus 588 G~is~~eF~~~l~~~ 602 (611)
|.|+|+||+++++.-
T Consensus 162 G~Is~~EF~~~~~~~ 176 (190)
T d1fpwa_ 162 GYITLDEFREGSKVD 176 (190)
T ss_dssp SEEEHHHHHHHHHSS
T ss_pred CcCcHHHHHHHHHHC
Confidence 999999999988763
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=9.9e-19 Score=154.37 Aligned_cols=133 Identities=23% Similarity=0.347 Sum_probs=107.0
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCC--CCCCcccHHHHHHHHcchhhHHhhHHHHHH
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNS--LQYRRMDFEEFCAAALSVHQLEALDRWEQH 542 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~--~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~ 542 (611)
+|+++|..+|.+++|.|+.+||..+|..++. .+++.++..++..++. +++|.|+|.+|..++.......... ..+.
T Consensus 1 e~ke~F~~~D~d~~G~I~~~el~~~l~~lg~-~~t~~e~~~~~~~~~~~~~~~~~i~~~ef~~~~~~~~~~~~~~-~~~~ 78 (139)
T d1w7jb1 1 EFKEAFELFDRVGDGKILYSQCGDVMRALGQ-NPTNAEVLKVLGNPKSDELKSRRVDFETFLPMLQAVAKNRGQG-TYED 78 (139)
T ss_dssp CHHHHHHHHCCSSSSEEESTTHHHHHHHTTC-CCCHHHHHHHTTCCCHHHHTTCEEEHHHHHHHHHHHCC---------C
T ss_pred CHHHHHHHHhCCCCCeECHHHHHHHHHHhcc-CCCHHHHHHHHHHHhcccccCCceeeeccchhhHhhhhhcccc-HHHH
Confidence 4799999999999999999999999988776 6788889999888764 6789999999988775443222211 1456
Q ss_pred HHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007253 543 ARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLH 600 (611)
Q Consensus 543 ~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~ 600 (611)
+..+|+.+|+|++|+|+.+||+++|. +|...+ ++.++. .|.|+||.|+|+||+++|+
T Consensus 79 l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~-~~~d~dg~I~~~eF~~~ll 139 (139)
T d1w7jb1 79 YLEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLA-GHEDSNGCINYEAFLKHIL 139 (139)
T ss_dssp CHHHHHTTCTTSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHT-TCCCTTSEEEHHHHHHHTC
T ss_pred HHHhhhhccCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHh-hCCCCCCeEeHHHHHHHhC
Confidence 88899999999999999999999994 665555 667665 4889999999999999863
|
| >d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Guanylate cyclase activating protein 2, GCAP-2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.70 E-value=1.7e-17 Score=154.36 Aligned_cols=140 Identities=19% Similarity=0.212 Sum_probs=110.2
Q ss_pred chhhHHHHHHHHhhhcCCC-CCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhh
Q 007253 458 LTVDELFYLKEQYALLEPN-KNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEAL 536 (611)
Q Consensus 458 l~~~e~~~l~~~F~~~D~d-~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~ 536 (611)
.+.....+|+++|..|+.+ ++|+|+.+||+.+|...+. ..+...+..+|+.+|.|++|.|+|.||+..+........
T Consensus 15 ~~~~~~~ei~~~~~~F~~~~~~G~i~~~Ef~~~l~~~~~-~~~~~~~~~lf~~~D~d~dG~I~f~Ef~~~l~~~~~~~~- 92 (189)
T d1jbaa_ 15 VGAADAAQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDN-EEATQYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTL- 92 (189)
T ss_dssp CCHHHHHHHHHHHHHHHSSSTTCCEEHHHHHHHHHCCSS-STTHHHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCC-
T ss_pred cCccCHHHHHHHHHHhcccCCCCeeeHHHHHHHHHHcCC-CccHHHHHHHHHHhccCCCCeEeehhHHHHHHhhcccch-
Confidence 3444445566666666544 5899999999999865443 456667899999999999999999999998876554433
Q ss_pred HHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc--------C-C--------CCc----cHHHHHHHHhcCCCCceeHHHH
Q 007253 537 DRWEQHARCAYELFEKDGNRAIVIEELASELG--------L-G--------PAV----PVHAVLHDWIRHTDGKLSFLGF 595 (611)
Q Consensus 537 ~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~--------~-~--------~~~----~~~~~~~~~D~~~dG~is~~eF 595 (611)
++.++.+|+.||.|++|.|+.+|+..++. . . ... .++.+|+.+|.|+||.|||+||
T Consensus 93 ---~~~~~~~F~~~D~d~~g~i~~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~if~~~D~d~dG~Is~~EF 169 (189)
T d1jbaa_ 93 ---EHKLKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAEQQGKLLTPEEVVDRIFLLVDENGDGQLSLNEF 169 (189)
T ss_dssp ---THHHHHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTSSTTTCCCCHHHHHHHHHHHHCCSCCSCBCHHHH
T ss_pred ---HHHHHHHHhhhccCCCCcccHhHHHHHHHHHHHhhccccccchhhhhccccchHHHHHHHHHHhCCCCCCcEeHHHH
Confidence 56789999999999999999999998761 0 0 111 1678999999999999999999
Q ss_pred HHHHhhc
Q 007253 596 VKLLHGV 602 (611)
Q Consensus 596 ~~~l~~~ 602 (611)
+++++..
T Consensus 170 ~~~~~~~ 176 (189)
T d1jbaa_ 170 VEGARRD 176 (189)
T ss_dssp HHHHTTT
T ss_pred HHHHHhC
Confidence 9999764
|
| >d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), M-type [TaxId: 10116]
Probab=99.67 E-value=1.7e-17 Score=154.05 Aligned_cols=135 Identities=16% Similarity=0.199 Sum_probs=110.5
Q ss_pred chhhHH-HHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccc-------cccCChhHHHhhcCCCCCCcccHHHHHHHHcc
Q 007253 458 LTVDEL-FYLKEQYALLEPNKNGTISLENVKSALMKNATDA-------MKDSRIPDFLSSLNSLQYRRMDFEEFCAAALS 529 (611)
Q Consensus 458 l~~~e~-~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~-------~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~ 529 (611)
++++++ +.++++|..+| +++|.|+..||+.+|...+... .+...+..+++.+|.|++|.|+|+||+.++..
T Consensus 11 ~~~~~~~~~~r~~F~~~d-~~dG~Is~~EL~~~L~~~~~~~~~~~~~~~s~~~~~~l~~~~D~d~~G~I~~~EF~~~~~~ 89 (186)
T d1df0a1 11 ANEEDIGDGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFSIETCKIMVDMLDEDGSGKLGLKEFYILWTK 89 (186)
T ss_dssp CCCSCSCHHHHHHHHHHH-GGGTCEEHHHHHHHHHHHHHC----CCCCCCHHHHHHHHHHHCCSSSSEECHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHc-CCCCeEcHHHHHHHHHHhcccccccccccCCHHHHHHHHHHHcCCCCCcccHHHHHHHHHh
Confidence 344554 45999999998 8999999999999997766421 23445788999999999999999999887643
Q ss_pred hhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc--HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 530 VHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP--VHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 530 ~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~--~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
.+.++.+|+.||+|++|+|+.+||+.+|. .|...+ +.+++..+|.|+||.|+|+||+.+|..+.
T Consensus 90 ----------~~~~~~~F~~~D~d~sG~I~~~El~~~l~~~g~~~~~~~~~~~~~~d~d~dg~I~f~eFi~~~~~l~ 156 (186)
T d1df0a1 90 ----------IQKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLPCQLHQVIVARFADDELIIDFDNFVRCLVRLE 156 (186)
T ss_dssp ----------HHHHHHHHHHHCTTCCSCEEGGGHHHHHHHTTEECCHHHHHHHHHHHCCSTTEECHHHHHHHHHHHH
T ss_pred ----------HHHHHHHHHhhCCCCCCcccHHHHHHHHHHHHhcccHHHHHHHHHHHcCCCCeEeHHHHHHHHHHHH
Confidence 23567899999999999999999999994 554444 66677889999999999999999887653
|
| >d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Kchip1, Kv4 potassium channel-interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.67 E-value=1.2e-16 Score=147.09 Aligned_cols=141 Identities=16% Similarity=0.224 Sum_probs=112.9
Q ss_pred hcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHh
Q 007253 456 KTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEA 535 (611)
Q Consensus 456 ~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~ 535 (611)
..++..|++.+.+.|...| ++|.|+.+||..+|...+........+..+|..+|.|++|.|+|.||+.++........
T Consensus 8 t~ft~~ei~~l~~~F~~~~--~~G~is~~ef~~~l~~~~~~~~~~~~~~~lf~~~D~~~~g~I~~~EFl~~~~~~~~~~~ 85 (178)
T d1s6ca_ 8 TNFTKRELQVLYRGFKNEC--PSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTV 85 (178)
T ss_dssp SSCCHHHHHHHHHHHHHHC--TTSEECHHHHHHHHHHHSTTSCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHCCH
T ss_pred CCCCHHHHHHHHHHHHHHC--cCCCccHHHHHHHHHHhCCCCCHHHHHHHHHHHHCCCCCCcccHHHHHHHHHHHhccch
Confidence 3578999998888886655 57999999999999877653223334588999999999999999999988765544333
Q ss_pred hHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-----CCC----Cc-------cHHHHHHHHhcCCCCceeHHHHHHHH
Q 007253 536 LDRWEQHARCAYELFEKDGNRAIVIEELASELG-----LGP----AV-------PVHAVLHDWIRHTDGKLSFLGFVKLL 599 (611)
Q Consensus 536 ~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-----~~~----~~-------~~~~~~~~~D~~~dG~is~~eF~~~l 599 (611)
++.++.+|+.||.|++|.|+.+|+..++. ++. .. .++.+|+.+|.|+||.|||+||.+++
T Consensus 86 ----~~~~~~~f~~~D~~~~g~i~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~DG~Is~~EF~~~i 161 (178)
T d1s6ca_ 86 ----HEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESC 161 (178)
T ss_dssp ----HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC-----------CHHHHHHHHHHHCTTCSSEECHHHHHHHT
T ss_pred ----HHHHHHHHHhhccCCCCeecHHHHHHHHHHHHhhcccccccCCcHHHHHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 66789999999999999999999988762 111 11 16789999999999999999999988
Q ss_pred hhc
Q 007253 600 HGV 602 (611)
Q Consensus 600 ~~~ 602 (611)
...
T Consensus 162 ~~~ 164 (178)
T d1s6ca_ 162 QED 164 (178)
T ss_dssp TSC
T ss_pred HHC
Confidence 764
|
| >d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Grancalcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.65 E-value=2.1e-16 Score=142.85 Aligned_cols=125 Identities=13% Similarity=0.283 Sum_probs=102.7
Q ss_pred HHHHhhhcCCCCCCcccHHHHHHHHHhhccccc----ccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHH
Q 007253 466 LKEQYALLEPNKNGTISLENVKSALMKNATDAM----KDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQ 541 (611)
Q Consensus 466 l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~----~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~ 541 (611)
+..+|..+ .+.+|.|+.+||+++|...+.... +.+.+..+++.+|.|++|.|+|+||+.++.. .+
T Consensus 2 ~~~~F~~~-a~~dG~I~~~EL~~~L~~~g~~~~~~~~s~~~~~~li~~~D~~~~G~i~~~EF~~l~~~----------~~ 70 (165)
T d1k94a_ 2 VYTYFSAV-AGQDGEVDAEELQRCLTQSGINGTYSPFSLETCRIMIAMLDRDHTGKMGFNAFKELWAA----------LN 70 (165)
T ss_dssp HHHHHHHH-HGGGTSBCHHHHHHHHHHHTTTTTSCCCCHHHHHHHHHHHCTTCSSCBCHHHHHHHHHH----------HH
T ss_pred hHHHHHHh-cCCCCCCCHHHHHHHHHHcCCCCCcccCCHHHHHHHHHHhCCCCCCcCcHHHHHHHhhc----------cc
Confidence 45677777 568999999999999988775322 2245788999999999999999999887633 34
Q ss_pred HHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 542 HARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 542 ~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
.++.+|+.||+|++|+|+.+||+.+|. +|..++ ++.++..+| +||.|+|+||+.+|..+.
T Consensus 71 ~~~~~F~~fD~d~sG~I~~~El~~~l~~~G~~l~~~~~~~l~~~~d--~~g~i~~~eFi~~~~~l~ 134 (165)
T d1k94a_ 71 AWKENFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVKRYS--KNGRIFFDDYVACCVKLR 134 (165)
T ss_dssp HHHHHHHHHCTTCCSBCCHHHHHHHHHHTTCCCCHHHHHHHHHHHC--BTTBCBHHHHHHHHHHHH
T ss_pred hhHHHHHHhCCCCCCeEcHHHHHHHHHHhhhcCCHHHHHHHHHHcC--CCCcCcHHHHHHHHHHHH
Confidence 577899999999999999999999994 666655 888999986 568999999999887653
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Probab=99.65 E-value=5e-16 Score=142.18 Aligned_cols=142 Identities=17% Similarity=0.122 Sum_probs=106.4
Q ss_pred hhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhccc-ccccCChh-------HHHh--hcCCCCCCcccHHHHHHHHcc
Q 007253 460 VDELFYLKEQYALLEPNKNGTISLENVKSALMKNATD-AMKDSRIP-------DFLS--SLNSLQYRRMDFEEFCAAALS 529 (611)
Q Consensus 460 ~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~-~~~~~~~~-------~~~~--~~D~~~~g~i~~~eF~~~~~~ 529 (611)
+-..++|+++|+.+|.|++|.|+.+||..++.+.... ........ .++. ..+.+++|.|+++||+..+..
T Consensus 2 ~~~~~~l~~~F~~~D~d~dG~Is~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ef~~~~~~ 81 (174)
T d2scpa_ 2 DLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTGVWDNFLTAVAGGKGIDETTFINSMKE 81 (174)
T ss_dssp HHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHSCCCTTHHHHHHHHHHHHHHHTGGGTTTTSCEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHccCCCCcEeHHHHHHHHHHHhccccchhHHHHHhHHhhhhhccccccccCCCCcCcHHHHHHHHHh
Confidence 4567889999999999999999999999987665421 11111111 1222 236778999999999887754
Q ss_pred hhhHH-hhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCc-cHHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 530 VHQLE-ALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAV-PVHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 530 ~~~~~-~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~-~~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
..... ........++.+|+.+|+|++|+|+.+||+.++. ++... .+..+|..+|.|+||.|+++||++++..
T Consensus 82 ~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~~~~~~~f~~~D~d~dG~Is~~Ef~~~~~~ 156 (174)
T d2scpa_ 82 MVKNPEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFFGMLGLDKTMAPASFDAIDTNNDGLLSLEEFVIAGSD 156 (174)
T ss_dssp HTSCGGGTHHHHTHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTCCGGGHHHHHHHHCTTCSSEECHHHHHHHHHH
T ss_pred hhcchhhHHHHHHHHHHHHHHHCCCccccCCHHHHHHHHHHHhhhhHHHHHHHhhcCCCCCCcEeHHHHHHHHHH
Confidence 32221 1122255688999999999999999999999884 44332 3899999999999999999999998865
|
| >d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain small (regulatory) subunit (domain VI) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=99.65 E-value=9.6e-17 Score=147.02 Aligned_cols=131 Identities=18% Similarity=0.233 Sum_probs=107.1
Q ss_pred hHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccc-------cccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhH
Q 007253 461 DELFYLKEQYALLEPNKNGTISLENVKSALMKNATDA-------MKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQL 533 (611)
Q Consensus 461 ~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~-------~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~ 533 (611)
+|+++|+++|..+|. +||.|+..||+.+|.+.+... .+.+.+..++..+|.|++|.|+|+||+.++..
T Consensus 1 ee~~~~r~~F~~~d~-~dg~I~~~EL~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~~d~d~~g~i~~~ef~~~~~~---- 75 (173)
T d1alva_ 1 EEVRQFRRLFAQLAG-DDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLWNN---- 75 (173)
T ss_dssp CHHHHHHHHHHHHHG-GGTSBCHHHHHHHHHHHHHTCSTTCCSCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHH----
T ss_pred ChHHHHHHHHHHHcC-CCCcCCHHHHHHHHHHhCCCcchhhhccCCHHHHHHHHHHhccCCCCcccchhhhhhhhh----
Confidence 467889999999995 589999999999998776421 22345778999999999999999999887633
Q ss_pred HhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc--HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 534 EALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP--VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 534 ~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~--~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
...++.+|+.||.|++|+|+.+||+.+|. ++..++ +-..|..+|.|+||.|+|+||+.+|..+
T Consensus 76 ------~~~~~~~f~~~D~d~~G~I~~~el~~~L~~~g~~~~~~~~~~~~~~d~d~~G~i~~~EF~~~~~~~ 141 (173)
T d1alva_ 76 ------IKKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHLYSMIIRRYSDEGGNMDFDNFISCLVRL 141 (173)
T ss_dssp ------HHHHHHHHHHHCTTCCSSBCTTTHHHHHHHHTCCCCHHHHHHHHHHHTCSSSCBCHHHHHHHHHHH
T ss_pred ------hhHHHHHHHHhccCCCCeecHHHHHHHHHHHHHhhHHHHHHHhhccccCCCCeEeHHHHHHHHHHH
Confidence 33567799999999999999999999994 455444 4455667788999999999999988664
|
| >d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=99.64 E-value=3.7e-16 Score=144.45 Aligned_cols=145 Identities=12% Similarity=0.125 Sum_probs=111.2
Q ss_pred chhhHHHHHHHHhhh-cCCCCCCcccHHHHHHHHHhhcccc---cc-----------cCChhHHHhhcCCCCCCcccHHH
Q 007253 458 LTVDELFYLKEQYAL-LEPNKNGTISLENVKSALMKNATDA---MK-----------DSRIPDFLSSLNSLQYRRMDFEE 522 (611)
Q Consensus 458 l~~~e~~~l~~~F~~-~D~d~~G~Is~~e~~~~l~~~~~~~---~~-----------~~~~~~~~~~~D~~~~g~i~~~e 522 (611)
|++.+..+++++|+. +|.|++|.|+.+||..++.++.... .. ......++...|.+++|.|++++
T Consensus 2 lt~~q~~~i~~~F~~~~D~d~dG~Is~~Ef~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~i~~~~ 81 (185)
T d2sasa_ 2 LNDFQKQKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASLEDEWRDLKGRADINKDDVVSWEE 81 (185)
T ss_dssp CCHHHHHHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHHH
T ss_pred cCHHHHHHHHHHHHHhhcCCCCCcCCHHHHHHHHHHhccccCCCcccHHHHHHHHHHHHHHHHHHHHhCcCCCCcEeeeH
Confidence 678889999999997 5999999999999999887654210 00 01123456778999999999999
Q ss_pred HHHHHcchhhH-----HhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCC-CccHHHHHHHHhcCCCCceeHHHH
Q 007253 523 FCAAALSVHQL-----EALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGP-AVPVHAVLHDWIRHTDGKLSFLGF 595 (611)
Q Consensus 523 F~~~~~~~~~~-----~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~-~~~~~~~~~~~D~~~dG~is~~eF 595 (611)
|..++...... .........+..+|+.+|.|++|+|+.+||+.++. ++- ...++.+|..+|.|+||.|+|+||
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~l~~~~~~~~f~~~D~d~dG~i~~~EF 161 (185)
T d2sasa_ 82 YLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQLQCADVPAVYNVITDGGKVTFDLNRY 161 (185)
T ss_dssp HHHHHHHHHHTCCSGGGSCTTHHHHHHHHHHHHCTTSSSCCCHHHHHHHTTSSCCCCSSHHHHHHHHHTTTTSCCSHHHH
T ss_pred hhHHHHHHhhhhhhhhhhhHHHHHHHHHHHHHHccCCCccCCHHHHHHHHHHcCCCHHHHHHHHHHcCCCCCCCCcHHHH
Confidence 98877543211 00111245688899999999999999999999995 332 223999999999999999999999
Q ss_pred HHHHhhc
Q 007253 596 VKLLHGV 602 (611)
Q Consensus 596 ~~~l~~~ 602 (611)
..+++..
T Consensus 162 ~~~~~~f 168 (185)
T d2sasa_ 162 KELYYRL 168 (185)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9988764
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Probab=99.64 E-value=4.2e-16 Score=157.17 Aligned_cols=146 Identities=16% Similarity=0.170 Sum_probs=116.1
Q ss_pred hhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchh--
Q 007253 454 LSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVH-- 531 (611)
Q Consensus 454 ~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~-- 531 (611)
....++.++...++++|..+|.|++|.|+.+||+.+|...+. .+++.++..++..+|.|++|.|+|.||+..+....
T Consensus 112 ~~~~l~~~~~~~~~~~F~~~D~~~~g~i~~~e~~~~l~~~~~-~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~ 190 (321)
T d1ij5a_ 112 SKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYAD-TIPEGPLKKLFVMVENDTKGRMSYITLVAVANDLAAL 190 (321)
T ss_dssp -CCCCCHHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHHHHHT-TSCSSHHHHHHHHHHHCCSSTHHHHHHTTSHHHHHTS
T ss_pred ccccCCHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHcCC-cccHHHHHHHHHHHhhcCCccccchhhhhhhhhhhhh
Confidence 334567888899999999999999999999999999987765 68889999999999999999999999964332100
Q ss_pred -------------------------------hH----------------------HhhHHHHHHHHHHHhHHhcCCCCcc
Q 007253 532 -------------------------------QL----------------------EALDRWEQHARCAYELFEKDGNRAI 558 (611)
Q Consensus 532 -------------------------------~~----------------------~~~~~~~~~~~~~F~~~D~d~~G~I 558 (611)
.. .........+..+|..+|.|++|+|
T Consensus 191 ~~~F~~~d~d~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ef~~~~~~~~~~~~~F~~~D~d~~G~I 270 (321)
T d1ij5a_ 191 VADFRKIDTNSNGTLSRKEFREHFVRLGFDKKSVQDALFRYADEDESDDVGFSEYVHLGLCLLVLRILYAFADFDKSGQL 270 (321)
T ss_dssp CCCHHHHCTTCCSEECHHHHHHHHHHTTCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHHHHHHHTCSSSCSSE
T ss_pred hHHHHHHhhcccccchhHHHhhhhhcccccchHHHHHHHHhhhcccccccccccccchhhhhhHHHHHHHHHhcCCCCCC
Confidence 00 0000012334568999999999999
Q ss_pred cHHHHHHHhc-CCC-Cc---cHHHHHHHHhcCCCCceeHHHHHHHHh
Q 007253 559 VIEELASELG-LGP-AV---PVHAVLHDWIRHTDGKLSFLGFVKLLH 600 (611)
Q Consensus 559 t~eEl~~~l~-~~~-~~---~~~~~~~~~D~~~dG~is~~eF~~~l~ 600 (611)
+.+||+++|. ++. .. .+..+|..+|.|+||.|+|+||+++|.
T Consensus 271 s~~E~~~~l~~~~~~~~~~~~~~~l~~~~D~d~dG~Is~~EF~~~ml 317 (321)
T d1ij5a_ 271 SKEEVQKVLEDAHIPESARKKFEHQFSVVDVDDSKSLSYQEFVMLVL 317 (321)
T ss_dssp EHHHHHHHHHHTTCCGGGCSTHHHHHHHHTTTTCSEECHHHHHHHHH
T ss_pred cHHHHHHHHHHcCCCcCcHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 9999999994 442 23 289999999999999999999999885
|
| >d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium- and integrin-binding protein, CIB species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.64 E-value=3.2e-16 Score=144.26 Aligned_cols=138 Identities=14% Similarity=0.267 Sum_probs=105.9
Q ss_pred cchhhHHHHHHHHhhhcCCCCCCc--------ccHHHHHHHHHhhcccccccCChhHHHhhcCCC-CCCcccHHHHHHHH
Q 007253 457 TLTVDELFYLKEQYALLEPNKNGT--------ISLENVKSALMKNATDAMKDSRIPDFLSSLNSL-QYRRMDFEEFCAAA 527 (611)
Q Consensus 457 ~l~~~e~~~l~~~F~~~D~d~~G~--------Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~-~~g~i~~~eF~~~~ 527 (611)
.|+.+|+..|.+.|..++++++|. +++++|.... .. -...-++++|..+|.+ ++|.|+|+||+.++
T Consensus 10 ~ft~~EI~~l~~~F~~l~~~~~~~~~~~~~~~i~~~e~~~~~-~l----~~~~~~~rif~~fd~~~~~g~I~f~EFv~~l 84 (180)
T d1xo5a_ 10 FLTKQEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILSLP-EL----KANPFKERICRVFSTSPAKDSLSFEDFLDLL 84 (180)
T ss_dssp CSCHHHHHHHHHHHHTTSCGGGCSHHHHHHCCEEHHHHHTSH-HH----HTCTTHHHHHHHHCCSTTCCEECHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHHCcCccccccccccceEcHHHHhcCc-cc----ccChHHHHHHHhccCCCCCCcCcHHHHHHHH
Confidence 688999999999999999988765 4555554321 11 1123467899999987 68999999999887
Q ss_pred cchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-C-----CCCcc-------HHHHHHHHhcCCCCceeHHH
Q 007253 528 LSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-L-----GPAVP-------VHAVLHDWIRHTDGKLSFLG 594 (611)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~-----~~~~~-------~~~~~~~~D~~~dG~is~~e 594 (611)
......... ++.++.+|+.||.|++|+|+.+||.+++. + +...+ ++.+|..+|.|+||+|||+|
T Consensus 85 ~~~~~~~~~---~~kl~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~v~~~~~~~D~d~dG~Is~~E 161 (180)
T d1xo5a_ 85 SVFSDTATP---DIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSE 161 (180)
T ss_dssp HHHSTTSCH---HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHC------CCCCTTHHHHHHHHHHHHCTTCSSSBCHHH
T ss_pred HHHhhcCCH---HHHHHHhhccccCCCCCeeeHHHHHHHHHHHHhccccccccHHHHHHHHHHHHHHhCCCCCCcCcHHH
Confidence 655422221 66899999999999999999999999873 1 22211 56789999999999999999
Q ss_pred HHHHHhhc
Q 007253 595 FVKLLHGV 602 (611)
Q Consensus 595 F~~~l~~~ 602 (611)
|.+++...
T Consensus 162 F~~~~~~~ 169 (180)
T d1xo5a_ 162 FQHVISRS 169 (180)
T ss_dssp HHHHHHHC
T ss_pred HHHHHHhC
Confidence 99998764
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Probab=99.62 E-value=2.3e-17 Score=152.64 Aligned_cols=135 Identities=15% Similarity=0.219 Sum_probs=93.3
Q ss_pred cchhhHH-HHHHHHhhhcCCCCCCcccHHHHHHHHHhhccc-------ccccCChhHHHhhcCCCCCCcccHHHHHHHHc
Q 007253 457 TLTVDEL-FYLKEQYALLEPNKNGTISLENVKSALMKNATD-------AMKDSRIPDFLSSLNSLQYRRMDFEEFCAAAL 528 (611)
Q Consensus 457 ~l~~~e~-~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~-------~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~ 528 (611)
.++++++ +.++++|..+|. ++|.|+..||+.+|.+.+.. ..+.+.++.++..+|.|++|.|+|+||..++.
T Consensus 12 ~ls~~~~~~~~r~~F~~~d~-~dG~Is~~EL~~~L~~~~~~~~~~~~~~~s~e~~~~li~~~D~d~~G~i~~~EF~~l~~ 90 (188)
T d1qxpa2 12 VLSEEEIDDNFKTLFSKLAG-DDMEISVKELQTILNRIISKHKDLRTNGFSLESCRSMVNLMDRDGNGKLGLVEFNILWN 90 (188)
T ss_dssp ---------------CCCCC-SSSSCCCSCTTTTTCC---------CCCCCHHHHHHHHHHHCC--CCCCCSSSHHHHHH
T ss_pred CCCHHHHHHHHHHHHHHHcC-CCCEECHHHHHHHHHHhCccccccccccCCHHHHHHHHHHhcCCCCCcccHHHHHHHHh
Confidence 3566665 469999999995 58999999999987655432 12334578899999999999999999998764
Q ss_pred chhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc--HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 529 SVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP--VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~--~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
. .+.++.+|+.||+|++|+|+.+||+.+|. +|..++ +.+++...|.|+||.|+|+||+.+|..+
T Consensus 91 ~----------~~~~~~~F~~~D~d~sG~i~~~El~~~l~~~g~~~~~~~~~~l~~~~~~~dg~i~f~eFi~~~~~l 157 (188)
T d1qxpa2 91 R----------IRNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPCQLHQVIVARFADDELIIDFDNFVRCLVRL 157 (188)
T ss_dssp H----------HHHHHHHHGGGCTTCCSCCBHHHHHHHHHHTTEECCHHHHHHHHHHTSCSSSBCCHHHHHHHHHHH
T ss_pred h----------hHHHHHHHHHhCCCCCCEECHHHHHHHHHHhhhcCCHHHHHHHHHHhcCCCCcCCHHHHHHHHHHH
Confidence 3 23567899999999999999999999994 555433 4445555577999999999999988665
|
| >d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Sorcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=6.8e-16 Score=141.08 Aligned_cols=131 Identities=18% Similarity=0.247 Sum_probs=102.6
Q ss_pred hhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccc----cccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHH
Q 007253 459 TVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDA----MKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLE 534 (611)
Q Consensus 459 ~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~----~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~ 534 (611)
+.++...|++.|..++ ++||.|+..||+.+|.+.+... .+.+.+..+++.+|.|++|.|+|+||+.++...
T Consensus 2 p~~~~~~~~~~F~~~~-~~dG~Is~~EL~~~L~~~g~~~~~~~~~~~~v~~l~~~~D~d~~G~I~f~EF~~~~~~~---- 76 (172)
T d1juoa_ 2 PGQTQDPLYGYFAAVA-GQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELWAVL---- 76 (172)
T ss_dssp TTCCCCTTHHHHHHHH-TTTTEECHHHHHHHHHHHTTTCSSCCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHH----
T ss_pred CcchHHHHHHHHHHhC-CCCCCCCHHHHHHHHHHcCCCCCcccCCHHHHHHHHHHHCCCCCCceehHHHHHHHHhh----
Confidence 3455667999999997 7899999999999998877532 234567889999999999999999999876432
Q ss_pred hhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 535 ALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 535 ~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
.....+|+.||.|++|+|+.+||+.+|. ++..++ +..+++.+| .+|.|+|+||+.+|..+
T Consensus 77 ------~~~~~~f~~~D~d~sG~i~~~El~~~l~~~g~~ls~~~~~~l~~~~d--~~g~i~~~eF~~~~~~~ 140 (172)
T d1juoa_ 77 ------NGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAKRYS--TNGKITFDDYIACCVKL 140 (172)
T ss_dssp ------HHHHHHHHTTCTTCCSEECHHHHHHHHHHTTCCCCHHHHHHHHHHTC--SSSSEEHHHHHHHHHHH
T ss_pred ------hhhhHHHHHhCcCCCCcCCHHHHHHHHHHHHHhhhHHHHHHHHHHHH--hcCCcCHHHHHHHHHHH
Confidence 2456789999999999999999999994 555544 666777764 55677777777766543
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Probab=99.59 E-value=2e-15 Score=140.11 Aligned_cols=143 Identities=16% Similarity=0.223 Sum_probs=104.1
Q ss_pred hhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhc----ccccccCChh-----HHHhhcCCCCCCcccHHHHHHHHcc
Q 007253 459 TVDELFYLKEQYALLEPNKNGTISLENVKSALMKNA----TDAMKDSRIP-----DFLSSLNSLQYRRMDFEEFCAAALS 529 (611)
Q Consensus 459 ~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~----~~~~~~~~~~-----~~~~~~D~~~~g~i~~~eF~~~~~~ 529 (611)
.++++++++++|..+|.|++|+|+.+||..++.... +...+..+.. ..+...+....+.|++++|+..+..
T Consensus 9 ~~~~i~r~k~~F~~~D~d~dG~I~~~E~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~e~~~~~~~ 88 (189)
T d1qv0a_ 9 NPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTKRHQVCVEAFFRGCGMEYGKEIAFPQFLDGWKQ 88 (189)
T ss_dssp CHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTHHHHTTCCHHHHHHHHHHHHHHHHHTTCCTTCCBCHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHHcCCCchhHHHHHHHHHHHhhhccccCCCceehHHHHHHHHH
Confidence 457788999999999999999999999988654322 1122222222 2345567888899999999887754
Q ss_pred hhhHHh-------hHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHH
Q 007253 530 VHQLEA-------LDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKL 598 (611)
Q Consensus 530 ~~~~~~-------~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~ 598 (611)
...... .....+.+..+|+.+|+|++|+|+.+||+.++. ++..++ ++.+|+.+|.|+||.|+|+||+++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~is~~E~~~~l~~~g~~~~~~~~~~lf~~~D~d~dG~Is~~EF~~~ 168 (189)
T d1qv0a_ 89 LATSELKKWARNEPTLIREWGDAVFDIFDKDGSGTITLDEWKAYGKISGISPSQEDCEATFRHCDLDNAGDLDVDEMTRQ 168 (189)
T ss_dssp HHHHHHHHHHTTCCCHHHHHHHHHHHHTC----CEECHHHHHHHHHHHSSCCCHHHHHHHHHHSCCCTTSCEEHHHHHHH
T ss_pred HHHHhhhccccccHHHHHHHHHHHHHHHccCCCCcccchhhHHHHHhcCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHH
Confidence 322210 112244677899999999999999999999994 444444 899999999999999999999998
Q ss_pred Hhh
Q 007253 599 LHG 601 (611)
Q Consensus 599 l~~ 601 (611)
+.+
T Consensus 169 ~~~ 171 (189)
T d1qv0a_ 169 HLG 171 (189)
T ss_dssp HHH
T ss_pred HHH
Confidence 876
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=99.58 E-value=2.1e-15 Score=125.80 Aligned_cols=96 Identities=21% Similarity=0.263 Sum_probs=78.2
Q ss_pred cccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-C---CCCc
Q 007253 498 MKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-L---GPAV 573 (611)
Q Consensus 498 ~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~---~~~~ 573 (611)
++++++.+++..+| ++|.|+|+||+.++...... ++.++.+|+.||+|++|+|+.+||+.+|. + +..+
T Consensus 6 l~~eeI~~~~~~~d--~dG~idf~EF~~~~~~~~~~------~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~l 77 (109)
T d1pvaa_ 6 LKADDIKKALDAVK--AEGSFNHKKFFALVGLKAMS------ANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDL 77 (109)
T ss_dssp SCHHHHHHHHHHTC--STTCCCHHHHHHHHTCTTSC------HHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCC
T ss_pred CCHHHHHHHHHhcC--CCCCCcHHHHHHHHHHccCC------HHHHHHHhhCccCCCcCeEcHHHHHHHHHHhhhcCCCC
Confidence 34556777777665 56889999999887654322 45688999999999999999999999984 3 4444
Q ss_pred c---HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 574 P---VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 574 ~---~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
+ ++.+|+.+|.|+||.|+|+||+++|..
T Consensus 78 s~~ev~~~~~~~D~d~dG~I~~~EF~~~m~~ 108 (109)
T d1pvaa_ 78 TDAETKAFLKAADKDGDGKIGIDEFETLVHE 108 (109)
T ss_dssp CHHHHHHHHHHHCTTCSSSBCHHHHHHHHHC
T ss_pred CHHHHHHHHHHHCCCCcCcEeHHHHHHHHHh
Confidence 4 889999999999999999999999875
|
| >d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]
Probab=99.57 E-value=9.2e-15 Score=135.18 Aligned_cols=143 Identities=15% Similarity=0.141 Sum_probs=106.2
Q ss_pred hhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcc----cccccCChhH-----HHhhcCCCCCCcccHHHHHHHHcc
Q 007253 459 TVDELFYLKEQYALLEPNKNGTISLENVKSALMKNAT----DAMKDSRIPD-----FLSSLNSLQYRRMDFEEFCAAALS 529 (611)
Q Consensus 459 ~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~----~~~~~~~~~~-----~~~~~D~~~~g~i~~~eF~~~~~~ 529 (611)
++.++++++++|+.+|.|++|+|+++||..++..... ...+..++.. .........++.+++.+|+..+..
T Consensus 7 ~p~~~~~~k~~F~~~D~d~dG~Is~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (187)
T d1uhka1 7 NPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHKDAVEAFFGGAGMKYGVETDWPAYIEGWKK 86 (187)
T ss_dssp CHHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHTTCCTTCEEEHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHHhccCccHHHHHHHHHHhhhhcccccccccccHHHHHHHHHH
Confidence 3566789999999999999999999999887655321 1222222222 233445566778999999876655
Q ss_pred hhhHHhh-------HHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHH
Q 007253 530 VHQLEAL-------DRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKL 598 (611)
Q Consensus 530 ~~~~~~~-------~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~ 598 (611)
....... ......++.+|+.+|+|++|+|+.+||+++|. ++...+ ++.+|..+|.|+||+|+|+||+++
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~lf~~~D~d~dG~Is~~EF~~~ 166 (187)
T d1uhka1 87 LATDELEKYAKNEPTLIRIWGDALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCDIDESGQLDVDEMTRQ 166 (187)
T ss_dssp HHHHHHHHHHTTCCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTSCCSHHHHHHHHHHSCCCTTSCEEHHHHHHH
T ss_pred HHHHHHHhhhhhhHHHHHHHHHHHHHHHccCCCcccchHHHHHHHHHhCCCccHHHHHHHHHHhCCCCCCCEeHHHHHHH
Confidence 4322211 11245578899999999999999999999994 444444 899999999999999999999998
Q ss_pred Hhh
Q 007253 599 LHG 601 (611)
Q Consensus 599 l~~ 601 (611)
+.+
T Consensus 167 ~~~ 169 (187)
T d1uhka1 167 HLG 169 (187)
T ss_dssp HHH
T ss_pred HHH
Confidence 866
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Probab=99.56 E-value=8.6e-15 Score=133.67 Aligned_cols=141 Identities=12% Similarity=0.120 Sum_probs=107.4
Q ss_pred HHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcc---cccccCCh-----------hHHHhhcCCCCCCcccHHHHHHHH
Q 007253 462 ELFYLKEQYALLEPNKNGTISLENVKSALMKNAT---DAMKDSRI-----------PDFLSSLNSLQYRRMDFEEFCAAA 527 (611)
Q Consensus 462 e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~---~~~~~~~~-----------~~~~~~~D~~~~g~i~~~eF~~~~ 527 (611)
..++|+++|..+|.|++|.|+.+||+.++..+.. ......++ ..++...|.+++|.|++.++...+
T Consensus 5 ~~~~l~~~F~~~D~d~dG~Is~~Ef~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 84 (176)
T d1nyaa_ 5 ASDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFDYLAKEAGVGSDGSLTEEQFIRVT 84 (176)
T ss_dssp HHHHHHHHHHHCCSSCCSSBCSHHHHHHHHHHHHHTSSCSSSHHHHHHHHHHHHHHHHHHHHHTSCTTCCBCHHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHcCCcccHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccHHHHHHHH
Confidence 3456999999999999999999999999866542 11211111 345677789999999999998765
Q ss_pred cchh----hHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCC-ccHHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 528 LSVH----QLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPA-VPVHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 528 ~~~~----~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~-~~~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
.... .........+.++.+|..||.|++|+|+.+||+.++. ++-. ..++.+|..+|.|+||.|+++||+++++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~E~~~~~~~~~~~~~~~~~~f~~~D~d~dG~i~~~Ef~~~~~~ 164 (176)
T d1nyaa_ 85 ENLIFEQGEASFNRVLGPVVKGIVGMCDKNADGQINADEFAAWLTALGMSKAEAAEAFNQVDTNGNGELSLDELLTAVRD 164 (176)
T ss_dssp HHHHSSSCHHHHHHHHHHHHHHHHHHTCSSCCSEEEHHHHHHHHHHTTCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHSC
T ss_pred hhhhhhhhhhhhHHHHHHHHHHHHHHHccCCChhhhHHHHHHHHHhcCCcHHHHHHHHHHHCCCCCCcEeHHHHHHHHHH
Confidence 4321 1111122245788999999999999999999999984 4322 22899999999999999999999999876
Q ss_pred c
Q 007253 602 V 602 (611)
Q Consensus 602 ~ 602 (611)
.
T Consensus 165 ~ 165 (176)
T d1nyaa_ 165 F 165 (176)
T ss_dssp C
T ss_pred H
Confidence 3
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Probab=99.56 E-value=3.9e-15 Score=124.19 Aligned_cols=96 Identities=22% Similarity=0.301 Sum_probs=78.5
Q ss_pred cccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc----CCCCc
Q 007253 498 MKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG----LGPAV 573 (611)
Q Consensus 498 ~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~----~~~~~ 573 (611)
+++.++.+++..+| .+|.|+|+||+.++....+ . ++.++.+|+.||+|++|+|+.+||+++|. .|..+
T Consensus 6 l~~~di~~~~~~~~--~~G~idf~eF~~~~~~~~~--~----~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~~ 77 (109)
T d5pala_ 6 LKADDINKAISAFK--DPGTFDYKRFFHLVGLKGK--T----DAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDL 77 (109)
T ss_dssp SCHHHHHHHHHHTC--STTCCCHHHHHHHHTCTTC--C----HHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCC
T ss_pred ccHHHHHHHHHhcC--CCCcCcHHHHHHHHHhcCC--C----HHHHHHHHhhhcCCCCCeEcHHHHHHHHHHhhhccCcC
Confidence 34556777787776 4688999999987754322 2 55799999999999999999999999883 35454
Q ss_pred c---HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 574 P---VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 574 ~---~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
+ ++++|+.+|.|+||.|+|+||+++|.+
T Consensus 78 ~~~e~~~~~~~~D~d~dG~I~~~EF~~~m~~ 108 (109)
T d5pala_ 78 NDTETKALLAAGDSDHDGKIGADEFAKMVAQ 108 (109)
T ss_dssp CHHHHHHHHHHHCTTCSSSEEHHHHHHHHHH
T ss_pred CHHHHHHHHHHhCCCCCCCEeHHHHHHHHHh
Confidence 4 899999999999999999999999875
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Probab=99.46 E-value=8.2e-14 Score=116.30 Aligned_cols=96 Identities=16% Similarity=0.268 Sum_probs=77.9
Q ss_pred cccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-C---CCCc
Q 007253 498 MKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-L---GPAV 573 (611)
Q Consensus 498 ~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~---~~~~ 573 (611)
+++.++.+++..++. +|.|+|+||+.++..... . ++.++.+|+.||+|++|+|+.+||+.+|. + +..+
T Consensus 6 ~~~~~i~~~~~~~~~--~~~i~f~eF~~~~~~~~~--~----~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~~ 77 (109)
T d1rwya_ 6 LSAEDIKKAIGAFTA--ADSFDHKKFFQMVGLKKK--S----ADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDL 77 (109)
T ss_dssp SCHHHHHHHHHTTCS--TTCCCHHHHHHHHTGGGS--C----HHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCCC
T ss_pred cCHHHHHHHHHhccc--CCCcCHHHHHHHHccccC--C----HHHHHHHhhcccCCCCCcCcHHHHHHHHHHhccccccC
Confidence 455667778877754 578999999998754332 2 55788999999999999999999999983 2 3333
Q ss_pred c---HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 574 P---VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 574 ~---~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
+ ++.+|+.+|.|+||+|+|+||+++|.+
T Consensus 78 ~~~e~~~~~~~~D~d~dG~i~~~EF~~~m~~ 108 (109)
T d1rwya_ 78 SAKETKTLMAAGDKDGDGKIGVEEFSTLVAE 108 (109)
T ss_dssp CHHHHHHHHHHHCTTCSSSEEHHHHHHHHHT
T ss_pred CHHHHHHHHHHhCCCCCCeEeHHHHHHHHHh
Confidence 3 889999999999999999999999875
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=99.44 E-value=1.3e-13 Score=114.51 Aligned_cols=95 Identities=20% Similarity=0.273 Sum_probs=77.8
Q ss_pred cccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-C---CCCc
Q 007253 498 MKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-L---GPAV 573 (611)
Q Consensus 498 ~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~---~~~~ 573 (611)
+++.++..++...+. +|.|+|.||+..+.... .. +++++.+|+.||+|++|+|+.+||+.++. + +..+
T Consensus 5 ls~~di~~~~~~~~~--~gsi~~~eF~~~~~l~~--~~----~~~l~~~F~~~D~d~~G~I~~~el~~~l~~l~~~~~~~ 76 (107)
T d2pvba_ 5 LKDADVAAALAACSA--ADSFKHKEFFAKVGLAS--KS----LDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARAL 76 (107)
T ss_dssp SCHHHHHHHHHHTCS--TTCCCHHHHHHHHTGGG--SC----HHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCC
T ss_pred CCHHHHHHHHHhccC--CCCcCHHHHHHHHhccc--CC----HHHHHHHHHhhccCCCCcCcHHHHHHHHHHhhcccccC
Confidence 566678888888765 46799999998775332 22 55799999999999999999999999984 3 3334
Q ss_pred c---HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007253 574 P---VHAVLHDWIRHTDGKLSFLGFVKLLH 600 (611)
Q Consensus 574 ~---~~~~~~~~D~~~dG~is~~eF~~~l~ 600 (611)
+ ++.+|+.+|.|+||+|+|+||+++|+
T Consensus 77 ~~~~~~~l~~~~D~d~dG~I~~~EF~~~m~ 106 (107)
T d2pvba_ 77 TDAETKAFLADGDKDGDGMIGVDEFAAMIK 106 (107)
T ss_dssp CHHHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred CHHHHHHHHHHhCCCCCCcEeHHHHHHHHc
Confidence 4 89999999999999999999999885
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.41 E-value=2.2e-13 Score=113.30 Aligned_cols=96 Identities=13% Similarity=0.192 Sum_probs=76.7
Q ss_pred ccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-C---CCC
Q 007253 497 AMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-L---GPA 572 (611)
Q Consensus 497 ~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~---~~~ 572 (611)
.+++.++..++...+ .+|.++|.+|+..+..... . .+.++.+|+.||+|++|+|+.+||+++|. + +..
T Consensus 5 ~ls~~dI~~~l~~~~--~~~s~~~~~F~~~~~~~~~--~----~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~ 76 (108)
T d1rroa_ 5 ILSAEDIAAALQECQ--DPDTFEPQKFFQTSGLSKM--S----ASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARE 76 (108)
T ss_dssp TSCHHHHHHHHHHTC--STTCCCHHHHHHHHSGGGS--C----HHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCC
T ss_pred hCCHHHHHHHHHhcc--cCCCccHHHHHHHHccCcC--C----HHHHHHHHhhhcCCCCCeEcHHHHHHHHHHHHhccCC
Confidence 455666777776665 4567999999876643221 2 55789999999999999999999999984 3 334
Q ss_pred cc---HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007253 573 VP---VHAVLHDWIRHTDGKLSFLGFVKLLH 600 (611)
Q Consensus 573 ~~---~~~~~~~~D~~~dG~is~~eF~~~l~ 600 (611)
++ ++.+|..+|.|+||.|+|+||+++|+
T Consensus 77 l~~~~~~~~~~~~D~d~dG~I~~~EF~~~m~ 107 (108)
T d1rroa_ 77 LTESETKSLMDAADNDGDGKIGADEFQEMVH 107 (108)
T ss_dssp CCHHHHHHHHHHHCCSSSSSEEHHHHHHHHT
T ss_pred CCHHHHHHHHHHhCCCCCCeEeHHHHHHHHc
Confidence 33 89999999999999999999999986
|
| >d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Grancalcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.36 E-value=8.1e-13 Score=118.93 Aligned_cols=123 Identities=10% Similarity=0.057 Sum_probs=98.9
Q ss_pred HHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHH
Q 007253 464 FYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHA 543 (611)
Q Consensus 464 ~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~ 543 (611)
+.++.++..+|.+++|.|++.||..++... ..+..+|..+|.|++|.|+..||..++....-... .+++
T Consensus 40 ~~~~~li~~~D~~~~G~i~~~EF~~l~~~~-------~~~~~~F~~fD~d~sG~I~~~El~~~l~~~G~~l~----~~~~ 108 (165)
T d1k94a_ 40 ETCRIMIAMLDRDHTGKMGFNAFKELWAAL-------NAWKENFMTVDQDGSGTVEHHELRQAIGLMGYRLS----PQTL 108 (165)
T ss_dssp HHHHHHHHHHCTTCSSCBCHHHHHHHHHHH-------HHHHHHHHHHCTTCCSBCCHHHHHHHHHHTTCCCC----HHHH
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHhhcc-------chhHHHHHHhCCCCCCeEcHHHHHHHHHHhhhcCC----HHHH
Confidence 346778888999999999999999876433 24678999999999999999999988876644333 5578
Q ss_pred HHHHhHHhcCCCCcccHHHHHHHhcCCCCccHHHHHHHHhcCCCCce--eHHHHHHHHhh
Q 007253 544 RCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGKL--SFLGFVKLLHG 601 (611)
Q Consensus 544 ~~~F~~~D~d~~G~It~eEl~~~l~~~~~~~~~~~~~~~D~~~dG~i--s~~eF~~~l~~ 601 (611)
..+|+.+|+ +|.|+.+||.+++.-.. .+.+.|+.+|.|++|.| +++||+++++.
T Consensus 109 ~~l~~~~d~--~g~i~~~eFi~~~~~l~--~~~~~F~~~D~d~~G~i~l~~~ef~~~~~~ 164 (165)
T d1k94a_ 109 TTIVKRYSK--NGRIFFDDYVACCVKLR--ALTDFFRKRDHLQQGSANFIYDDFLQGTMA 164 (165)
T ss_dssp HHHHHHHCB--TTBCBHHHHHHHHHHHH--HHHHHHHTTCTTCCSEEEEEHHHHHHHHHT
T ss_pred HHHHHHcCC--CCcCcHHHHHHHHHHHH--HHHHHHHHhCCCCCCcEEecHHHHHHHHHc
Confidence 889999976 48999999998773111 16678999999999977 78999998765
|
| >d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Sorcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.33 E-value=1.6e-12 Score=118.20 Aligned_cols=123 Identities=11% Similarity=0.092 Sum_probs=99.6
Q ss_pred HHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHH
Q 007253 464 FYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHA 543 (611)
Q Consensus 464 ~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~ 543 (611)
+.++.++..+|.|++|.|++.||...+.... .....|+.+|.+++|.|+.+|+..++........ .+.+
T Consensus 47 ~~v~~l~~~~D~d~~G~I~f~EF~~~~~~~~-------~~~~~f~~~D~d~sG~i~~~El~~~l~~~g~~ls----~~~~ 115 (172)
T d1juoa_ 47 ETCRLMVSMLDRDMSGTMGFNEFKELWAVLN-------GWRQHFISFDTDRSGTVDPQELQKALTTMGFRLS----PQAV 115 (172)
T ss_dssp HHHHHHHHHHCTTCSSCEEHHHHHHHHHHHH-------HHHHHHHTTCTTCCSEECHHHHHHHHHHTTCCCC----HHHH
T ss_pred HHHHHHHHHHCCCCCCceehHHHHHHHHhhh-------hhhHHHHHhCcCCCCcCCHHHHHHHHHHHHHhhh----HHHH
Confidence 4477889999999999999999998764332 2557899999999999999999988766544333 5678
Q ss_pred HHHHhHHhcCCCCcccHHHHHHHhcCCCCccHHHHHHHHhcCCCCce--eHHHHHHHHhh
Q 007253 544 RCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGKL--SFLGFVKLLHG 601 (611)
Q Consensus 544 ~~~F~~~D~d~~G~It~eEl~~~l~~~~~~~~~~~~~~~D~~~dG~i--s~~eF~~~l~~ 601 (611)
..+|+.+|. +|.|+.+||.+++.-.. .+..+|+.+|+|+||.| +|+||+.+++.
T Consensus 116 ~~l~~~~d~--~g~i~~~eF~~~~~~~~--~~~~~f~~~D~d~~G~Itl~~~eFl~~~l~ 171 (172)
T d1juoa_ 116 NSIAKRYST--NGKITFDDYIACCVKLR--ALTDSFRRRDTAQQGVVNFPYDDFIQCVMS 171 (172)
T ss_dssp HHHHHHTCS--SSSEEHHHHHHHHHHHH--HHHHHHHHTCTTCCSEEEEEHHHHHHHHTT
T ss_pred HHHHHHHHh--cCCcCHHHHHHHHHHHH--HHHHHHHHhCCCCCCcEEecHHHHHHHHHc
Confidence 889999975 58899999999884211 26788999999999997 88999998865
|
| >d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Apoptosis-linked protein alg-2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.33 E-value=1.6e-12 Score=119.19 Aligned_cols=124 Identities=8% Similarity=0.164 Sum_probs=101.6
Q ss_pred HHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHH
Q 007253 463 LFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQH 542 (611)
Q Consensus 463 ~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~ 542 (611)
.+.++.+|..+|.+++|.|+++||..++... ..+..++..+|.+++|.|+.+||..++........ +++
T Consensus 55 ~~~~~~l~~~~D~d~~g~i~~~EFl~~~~~~-------~~~~~~f~~~D~~~~G~i~~~el~~~l~~~~~~l~----~e~ 123 (181)
T d1hqva_ 55 PVTVRSIISMFDRENKAGVNFSEFTGVWKYI-------TDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLS----DQF 123 (181)
T ss_dssp HHHHHHHHHHHCCSSSSSBCHHHHHHHHHHH-------HHHHHHHHHHCTTCCSSBCHHHHHHHHHHHTBCCC----HHH
T ss_pred HHHHHHHhhccccccccchhhhHHHhhhhhc-------cccccccccccccccchhhhHHHHHHHHHcCCcch----hHH
Confidence 3457788899999999999999999876432 23567899999999999999999988876544444 667
Q ss_pred HHHHHhHHhcCCCCcccHHHHHHHhcCCCCccHHHHHHHHhcCCCCce--eHHHHHHHH
Q 007253 543 ARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGKL--SFLGFVKLL 599 (611)
Q Consensus 543 ~~~~F~~~D~d~~G~It~eEl~~~l~~~~~~~~~~~~~~~D~~~dG~i--s~~eF~~~l 599 (611)
+..+++.+|.+++|.|+.+||.+++..... +..+|+.+|.++||.| +++||+.++
T Consensus 124 ~~~~~~~~d~~~dg~Is~~eF~~~~~~l~~--l~~~F~~~D~~~dG~i~~~~~ef~~~~ 180 (181)
T d1hqva_ 124 HDILIRKFDRQGRGQIAFDDFIQGCIVLQR--LTDIFRRYDTDQDGWIQVSYEQYLSMV 180 (181)
T ss_dssp HHHHHHHHCSSCSSCBCHHHHHHHHHHHHH--HHHHHHHHCTTCSSCCCCCHHHHHHHH
T ss_pred HHHHHHHhCCCCCCcCcHHHHHHHHHHHHH--HHHHHHHhCCCCCCCEEecHHHHHHHh
Confidence 888999999999999999999988742222 6788999999999966 799999876
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.32 E-value=5.9e-13 Score=103.59 Aligned_cols=74 Identities=20% Similarity=0.388 Sum_probs=68.6
Q ss_pred hcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcch
Q 007253 456 KTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV 530 (611)
Q Consensus 456 ~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~ 530 (611)
..|+++++.+|+++|..+|.+++|+|+..||..+|..++. .+++.++..+++.+|.+++|.|+|+||+.++...
T Consensus 2 ~~lt~eqi~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~t~~e~~~~~~~~D~~~~g~I~~~eF~~~m~~~ 75 (77)
T d1f54a_ 2 SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGL-SPSEAEVNDLMNEIDVDGNHQIEFSEFLALMSRQ 75 (77)
T ss_dssp CCCCHHHHHHHHHHHHHTCTTCSSEEEHHHHHHHHHHHTC-CCCHHHHHHHHHTTCCSSCCEEEHHHHHHHHTTS
T ss_pred CCCCHHHHHHHHHHHHHHcCCCCCeEChHHHHHHHHHhCC-CCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHh
Confidence 5789999999999999999999999999999999988876 6888899999999999999999999999988654
|
| >d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Programmed cell death 6 protein-like protein species: Leishmania major [TaxId: 5664]
Probab=99.32 E-value=2.5e-12 Score=117.99 Aligned_cols=130 Identities=16% Similarity=0.172 Sum_probs=103.8
Q ss_pred hhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhh
Q 007253 453 ALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQ 532 (611)
Q Consensus 453 ~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~ 532 (611)
.+...++..+ ++++|..+|.+++|.|++.+|...+... ..+...|..+|.+++|.|+.+||..++.....
T Consensus 46 ~l~~~~s~~~---~~~l~~~~d~d~~~~i~~~ef~~~~~~~-------~~~~~~F~~~D~~~~g~I~~~el~~~l~~~g~ 115 (182)
T d1y1xa_ 46 SAGVPFSLAT---TEKLLHMYDKNHSGEITFDEFKDLHHFI-------LSMREGFRKRDSSGDGRLDSNEVRAALLSSGY 115 (182)
T ss_dssp BTTBCCCHHH---HHHHHHHHCTTCSSSBCHHHHHHHHHHH-------HHHHHHHHHHCTTSSSCBCHHHHHHHHHTTSC
T ss_pred HhcccCchhh---hhhhhccccccccccccccccccccccc-------cccccchhccccccchhhhhHHHHHHHHHhCC
Confidence 3444556665 5677888999999999999998865432 23567899999999999999999988876654
Q ss_pred HHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhcCCCCccHHHHHHHHhcCCCCce--eHHHHHHH
Q 007253 533 LEALDRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGKL--SFLGFVKL 598 (611)
Q Consensus 533 ~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~~~~~~~~~~~~~~~D~~~dG~i--s~~eF~~~ 598 (611)
... ++++..+|+.+|.|++|.|+.+||.+++..... +.++|+.+|.+++|.| +|+||+..
T Consensus 116 ~ls----~~e~~~i~~~~d~~~dg~I~~~eF~~~~~~l~~--~~~~F~~~D~~~~G~is~~~~~f~~~ 177 (182)
T d1y1xa_ 116 QVS----EQTFQALMRKFDRQRRGSLGFDDYVELSIFVCR--VRNVFAFYDRERTGQVTFTFDTFIGG 177 (182)
T ss_dssp CCC----HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHH--HHHHHHHHCTTCCSEEEEEHHHHHHH
T ss_pred chh----HHHHHHHHhhcccCCCCCcCHHHHHHHHHHHHH--HHHHHHHhCCCCCCcEEeeHHHHHHH
Confidence 444 567889999999999999999999998842222 6788999999999995 78999874
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=99.30 E-value=1.1e-12 Score=103.02 Aligned_cols=77 Identities=14% Similarity=0.262 Sum_probs=69.7
Q ss_pred HhhhhcchhhHHHHHHHHhhhcCCCC-CCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcc
Q 007253 452 RALSKTLTVDELFYLKEQYALLEPNK-NGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALS 529 (611)
Q Consensus 452 ~~~~~~l~~~e~~~l~~~F~~~D~d~-~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~ 529 (611)
+.....++++++++++++|..||.++ +|+|+..||+.+|..++. .+++.++.++++.+|.|++|.|+|+||+.++..
T Consensus 3 k~~~~~ls~eq~~~~~~~F~~fD~d~~~G~I~~~el~~~l~~lg~-~~t~~el~~~i~~~D~d~~G~I~f~eFl~im~~ 80 (82)
T d1wrka1 3 KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQ-NPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVR 80 (82)
T ss_dssp HHHHHHCCHHHHHHHHHHHHHHTTTCTTSSBCHHHHHHHHHHTTC-CCCHHHHHHHHHTTCTTCCSSBCHHHHHHHHHH
T ss_pred HHHHhhCCHHHHHHHHHHHHHHcCcCCCCeEeHHHHHHHHHHcCC-CCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHh
Confidence 34556799999999999999999996 799999999999988876 688999999999999999999999999998764
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Probab=99.29 E-value=1.1e-12 Score=102.90 Aligned_cols=70 Identities=16% Similarity=0.248 Sum_probs=63.5
Q ss_pred hhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcch
Q 007253 459 TVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV 530 (611)
Q Consensus 459 ~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~ 530 (611)
+++++++++++|..+|.|++|+|+..||+.+|..++ .+++.++..+|+.+|.|++|.|+|+||+.++...
T Consensus 1 T~ee~~e~~~~F~~~D~d~~G~I~~~El~~~l~~lg--~~~~~ei~~~~~~~D~d~~G~I~~~EF~~~~~~~ 70 (81)
T d2opoa1 1 TPQDIADRERIFKRFDTNGDGKISSSELGDALKTLG--SVTPDEVRRMMAEIDTDGDGFISFDEFTDFARAN 70 (81)
T ss_dssp CHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTT--TCCHHHHHHHHHHHCTTCSSEECHHHHHHHHHHC
T ss_pred CHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhh--cCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHC
Confidence 468899999999999999999999999999998876 3677889999999999999999999999977543
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.28 E-value=2.8e-12 Score=98.90 Aligned_cols=63 Identities=30% Similarity=0.558 Sum_probs=57.8
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
+++++.+|+.||+|++|+|+.+||+.+|. +|...+ ++.+|..+|.|+||.|+|+||+++|.++
T Consensus 8 eeel~~~F~~fD~~~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~D~d~dg~I~~~EF~~~m~~~ 74 (75)
T d1jc2a_ 8 EEELANCFRIFDKNADGFIDIEELGEILRATGEHVIEEDIEDLMKDSDKNNDGRIDFDEFLKMMEGV 74 (75)
T ss_dssp HHHHHHHHHHHCCSTTSSEEHHHHHHHHHHSSSCCCHHHHHHHHHHHCSSSCSEECHHHHHHHHHTC
T ss_pred HHHHHHHHHHHcCCCcCeEcHHHHHHHHHhcCCCccHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhC
Confidence 66899999999999999999999999994 666665 8999999999999999999999999875
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.28 E-value=1.4e-12 Score=102.30 Aligned_cols=73 Identities=14% Similarity=0.268 Sum_probs=67.4
Q ss_pred cchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcch
Q 007253 457 TLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV 530 (611)
Q Consensus 457 ~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~ 530 (611)
.|+++++++|+++|..||.+++|+|+..||+.+|..++. .+++.++.++++.+|.|++|.|+|+||+.++...
T Consensus 7 ~Lt~~~i~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~s~~e~~~~~~~~D~d~~g~I~~~eF~~~m~~k 79 (81)
T d1avsa_ 7 FLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQ-NPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVRQ 79 (81)
T ss_dssp HBCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTC-CCCHHHHHHHHHHHCTTCCSSEEHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHHHHHcCCCCCeEchhHHHHHHHHcCC-CCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHh
Confidence 478999999999999999999999999999999988876 6888999999999999999999999999988643
|
| >d2zkmx1 a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Phospholipase C-beta-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=3.6e-13 Score=122.15 Aligned_cols=130 Identities=13% Similarity=0.144 Sum_probs=88.1
Q ss_pred HHHHHhhh--cCCCCCCcccHHHHHHHHHhhccc-ccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHH
Q 007253 465 YLKEQYAL--LEPNKNGTISLENVKSALMKNATD-AMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQ 541 (611)
Q Consensus 465 ~l~~~F~~--~D~d~~G~Is~~e~~~~l~~~~~~-~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~ 541 (611)
.|+.+|.. +|.|++|+|+..||.++|...... ......+..++...|.+++|.|+|+||..++..... ..
T Consensus 6 ~l~k~~~k~~~d~n~dG~Is~~el~k~l~~~~~~~~~~~~~~~~~~~~~D~~~~~~i~F~eF~~~~~~l~~-------r~ 78 (170)
T d2zkmx1 6 FLDKILVKLKMQLNSEGKIPVKNFFQMFPADRKRVEAALSACHLPKGKNDAINPEDFPEPVYKSFLMSLCP-------RP 78 (170)
T ss_dssp HHHHHHHHHHHSCCTTSCEEHHHHHHHSCSCHHHHHHHHHHTTCCCCTTCEECGGGCCHHHHHHHHHHHSC-------CH
T ss_pred HHHHHHHHHhcccCCCCCCcHHHHHHHHHHhhhhHHHHHHHHhhhhccccccCCCccCHHHHHHHHhccCC-------HH
Confidence 35555555 799999999999999987443221 112235566788899999999999999998865442 33
Q ss_pred HHHHHHhHHhcCCCCcccHHHHHHHhc--CCC------------CccHHHHHHHHhcCC----CCceeHHHHHHHHhh
Q 007253 542 HARCAYELFEKDGNRAIVIEELASELG--LGP------------AVPVHAVLHDWIRHT----DGKLSFLGFVKLLHG 601 (611)
Q Consensus 542 ~~~~~F~~~D~d~~G~It~eEl~~~l~--~~~------------~~~~~~~~~~~D~~~----dG~is~~eF~~~l~~ 601 (611)
++..+|+.||.|++|+||.+||+++|. .+. ...+.++|..+..+. +|.|++++|+.+|..
T Consensus 79 ei~~~F~~~d~d~~~~it~~el~~fL~~~Q~~~~~~e~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ls~d~F~~fL~S 156 (170)
T d2zkmx1 79 EIDEIFTSYHAKAKPYMTKEHLTKFINQKQRDSRLNSLLFPPARPDQVQGLIDKYEPSGINAQRGQLSPEGMVWFLCG 156 (170)
T ss_dssp HHHTTCC--------CCCHHHHHHHHHHTCC---------------CHHHHHHHHCCC--------CCHHHHHHHHHS
T ss_pred HHHHHHHHHcCCCCCcccHHHHHHHHHHHhcchhhhhhccccCCHHHHHHHHHHHccccccccCCeECHHHHHHHHcC
Confidence 577899999999999999999999994 111 112788899987754 488999999998865
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Probab=99.26 E-value=4.4e-12 Score=99.41 Aligned_cols=63 Identities=24% Similarity=0.521 Sum_probs=57.3
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
+++++.+|+.||.|++|+|+.+||+.+|. +|...+ ++.+|..+|.|+||+|+|+||+++|.++
T Consensus 14 ee~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~ev~~~~~~~D~d~dg~I~~~EF~~~m~~~ 80 (81)
T d1fi5a_ 14 EEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKGV 80 (81)
T ss_dssp HHHHHHHHHHHCSSCSSEECHHHHHHHHHTSSSCCCHHHHHHHHHHHCSSSSSSEEHHHHHHHHSCC
T ss_pred HHHHHHHHHHHcCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHHCCCCCCcEeHHHHHHHHHhc
Confidence 56789999999999999999999999994 666555 8999999999999999999999999875
|
| >d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), M-type [TaxId: 10116]
Probab=99.25 E-value=3.9e-12 Score=117.16 Aligned_cols=121 Identities=10% Similarity=0.051 Sum_probs=97.1
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHH
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHAR 544 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~ 544 (611)
.++.++..+|.|++|.|+++||...+... ..+..+|..+|.|++|.|+.+|+..++........ . ++.
T Consensus 62 ~~~~l~~~~D~d~~G~I~~~EF~~~~~~~-------~~~~~~F~~~D~d~sG~I~~~El~~~l~~~g~~~~----~-~~~ 129 (186)
T d1df0a1 62 TCKIMVDMLDEDGSGKLGLKEFYILWTKI-------QKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLP----C-QLH 129 (186)
T ss_dssp HHHHHHHHHCCSSSSEECHHHHHHHHHHH-------HHHHHHHHHHCTTCCSCEEGGGHHHHHHHTTEECC----H-HHH
T ss_pred HHHHHHHHHcCCCCCcccHHHHHHHHHhH-------HHHHHHHHhhCCCCCCcccHHHHHHHHHHHHhccc----H-HHH
Confidence 47788999999999999999998875332 23678999999999999999999998876544333 2 344
Q ss_pred HHHhHHhcCCCCcccHHHHHHHhcCCCCccHHHHHHHHhcCCCCce--eHHHHHHHH
Q 007253 545 CAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGKL--SFLGFVKLL 599 (611)
Q Consensus 545 ~~F~~~D~d~~G~It~eEl~~~l~~~~~~~~~~~~~~~D~~~dG~i--s~~eF~~~l 599 (611)
.+|..+|.|++|.|+.+||.+++.-.. .+..+|+.+|.|++|.| ++.||+.+.
T Consensus 130 ~~~~~~d~d~dg~I~f~eFi~~~~~l~--~~~~~F~~~D~~~~G~i~l~~~ef~~~~ 184 (186)
T d1df0a1 130 QVIVARFADDELIIDFDNFVRCLVRLE--ILFKIFKQLDPENTGTIQLDLISWLSFS 184 (186)
T ss_dssp HHHHHHHCCSTTEECHHHHHHHHHHHH--HHHHHHHHHCTTCCSEEEEEHHHHHHHH
T ss_pred HHHHHHHcCCCCeEeHHHHHHHHHHHH--HHHHHHHHhCCCCCCcEEecHHHHHHHh
Confidence 577778999999999999988773111 16778999999999987 899999875
|
| >d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain small (regulatory) subunit (domain VI) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=99.25 E-value=5.8e-12 Score=114.52 Aligned_cols=123 Identities=11% Similarity=0.070 Sum_probs=96.9
Q ss_pred HHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHH
Q 007253 464 FYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHA 543 (611)
Q Consensus 464 ~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~ 543 (611)
+..+.++..+|.+++|.|+++||..++.... .+..+|+.+|.|++|.|+..||..++........ + +.
T Consensus 47 ~~~~~l~~~~d~d~~g~i~~~ef~~~~~~~~-------~~~~~f~~~D~d~~G~I~~~el~~~L~~~g~~~~----~-~~ 114 (173)
T d1alva_ 47 DTCRSMVAVMDSDTTGKLGFEEFKYLWNNIK-------KWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLN----E-HL 114 (173)
T ss_dssp HHHHHHHHHHCTTCSSSBCHHHHHHHHHHHH-------HHHHHHHHHCTTCCSSBCTTTHHHHHHHHTCCCC----H-HH
T ss_pred HHHHHHHHHhccCCCCcccchhhhhhhhhhh-------HHHHHHHHhccCCCCeecHHHHHHHHHHHHHhhH----H-HH
Confidence 3467889999999999999999988764332 2567899999999999999999988866543333 2 33
Q ss_pred HHHHhHHhcCCCCcccHHHHHHHhcCCCCccHHHHHHHHhcCCCCce--eHHHHHHHHh
Q 007253 544 RCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGKL--SFLGFVKLLH 600 (611)
Q Consensus 544 ~~~F~~~D~d~~G~It~eEl~~~l~~~~~~~~~~~~~~~D~~~dG~i--s~~eF~~~l~ 600 (611)
..+|..+|.|++|.|+.+||.+++.... .+..+|+.+|.|+||.| +|+||+.+..
T Consensus 115 ~~~~~~~d~d~~G~i~~~EF~~~~~~~~--~~~~~f~~~D~d~~G~it~~~~efl~~~~ 171 (173)
T d1alva_ 115 YSMIIRRYSDEGGNMDFDNFISCLVRLD--AMFRAFKSLDKDGTGQIQVNIQEWLQLTM 171 (173)
T ss_dssp HHHHHHHHTCSSSCBCHHHHHHHHHHHH--HHHHHHHHHSSSCCSEEEEEHHHHHHHHH
T ss_pred HHHhhccccCCCCeEeHHHHHHHHHHHH--HHHHHHHHhCCCCCCcEEecHHHHHHHHH
Confidence 4566677789999999999999883211 16678999999999988 6899998753
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Probab=99.25 E-value=1.6e-12 Score=99.82 Aligned_cols=71 Identities=18% Similarity=0.387 Sum_probs=66.0
Q ss_pred cchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHc
Q 007253 457 TLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAAL 528 (611)
Q Consensus 457 ~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~ 528 (611)
.|+++|+.+++++|..||.+++|+|+..||..+|..++. .+++.++..+++.+|.|++|.|+|+||+.++.
T Consensus 1 qLs~eei~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~s~~~~~~~~~~~D~d~~g~I~f~eF~~~m~ 71 (73)
T d2pq3a1 1 QLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQ-NPTEAELQDMINEVDADGNGTIDFPEFLTMMA 71 (73)
T ss_dssp CCCHHHHHHHHHHHHHTCTTSSSEEEGGGHHHHHHHTTC-CCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHHHHcCCCCceEeHHHHHHHHHHhCC-CCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHh
Confidence 378899999999999999999999999999999988876 68888999999999999999999999998774
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=99.23 E-value=3.7e-12 Score=96.12 Aligned_cols=61 Identities=16% Similarity=0.378 Sum_probs=54.6
Q ss_pred HHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCC-cc---HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 541 QHARCAYELFEKDGNRAIVIEELASELG-LGPA-VP---VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 541 ~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~-~~---~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
++++.+|+.||+|++|+|+.+||+++|. +|.. ++ ++.+|+.+|.|+||.|+|+||+.+|.+
T Consensus 2 eel~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~s~~e~~~~~~~~D~d~dG~i~~~EF~~~m~r 67 (68)
T d1c7va_ 2 EEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVIDIPEFMDLIKK 67 (68)
T ss_dssp HHHHHHHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCSSGGGSEEHHHHHHHHHC
T ss_pred HHHHHHHHHHcCCCcCeEcHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHh
Confidence 4688999999999999999999999995 5543 44 899999999999999999999999875
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.22 E-value=4.2e-12 Score=95.05 Aligned_cols=60 Identities=30% Similarity=0.540 Sum_probs=54.1
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHH
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLL 599 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l 599 (611)
+++++.+|+.||+|++|+|+.+||+.++. +|...+ +..++..+|.|+||.|+|+||+++|
T Consensus 2 eeel~~aF~~fD~d~~G~I~~~el~~~l~~lg~~~~~~e~~~l~~~~D~d~~g~I~~~eF~~~m 65 (65)
T d1fw4a_ 2 EEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMM 65 (65)
T ss_dssp CHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTCSSSEEHHHHHHHC
T ss_pred HHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCCCcEeHHHHHHHC
Confidence 45789999999999999999999999994 666665 8899999999999999999999875
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=99.19 E-value=1.3e-12 Score=103.96 Aligned_cols=75 Identities=24% Similarity=0.485 Sum_probs=68.9
Q ss_pred HhhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHH
Q 007253 452 RALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAA 527 (611)
Q Consensus 452 ~~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~ 527 (611)
+.++..++++++.+|+++|..+|.+++|+|+..||+.+|..++. .+++.++..+++.+|.|++|.|+|+||+.++
T Consensus 11 ~~ma~~l~~~~i~~l~~~F~~~D~d~~G~I~~~el~~~l~~lg~-~~s~~e~~~l~~~~D~d~~g~I~~~EFl~am 85 (87)
T d1s6ja_ 11 KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGS-ELMESEIKDLMDAADIDKSGTIDYGEFIAAT 85 (87)
T ss_dssp HHSSSSSCSSSTTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTS-SCCHHHHHHHHHHHCTTCSSEECHHHHTTCC
T ss_pred HHHHhhCCHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHcCCCCCCeEeHHHHHHHH
Confidence 46778899999999999999999999999999999999988775 6888899999999999999999999998754
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.19 E-value=1.4e-11 Score=92.69 Aligned_cols=60 Identities=15% Similarity=0.291 Sum_probs=54.3
Q ss_pred HHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 543 ARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 543 ~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
++.+|+.||+|++|+|+.+||+.++. +|...+ ++.+|..+|.|+||.|+|+||+.+|.++
T Consensus 3 ~r~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~~i~~~~~~~D~d~dg~I~~~EF~~~m~~~ 66 (67)
T d1tiza_ 3 AKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGELNADEFTSCIEKM 66 (67)
T ss_dssp HHHHHHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHCCSSSSEECHHHHHHHHHTC
T ss_pred HHHHHHHHCCCCcCcCcHHHHHHHHHHhccccchHHHHHHHHHhCCCCCCeEeHHHHHHHHHHh
Confidence 67899999999999999999999994 666555 8999999999999999999999998764
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.18 E-value=1.6e-11 Score=95.23 Aligned_cols=64 Identities=20% Similarity=0.396 Sum_probs=57.3
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
+++++.+|+.||+|++|+|+.+||+++|. ++...+ +..+|..+|.|+||.|+|+||+++|.+.+
T Consensus 8 ~e~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~~~~~~D~d~~G~I~~~EF~~~m~k~~ 75 (77)
T d1oqpa_ 8 REEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDEDEFIRIMKKTS 75 (77)
T ss_dssp HHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCCSSSSEECHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHcCCCCCEechHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHccC
Confidence 66899999999999999999999999994 555544 89999999999999999999999997754
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Probab=99.17 E-value=1.3e-11 Score=113.31 Aligned_cols=121 Identities=10% Similarity=0.065 Sum_probs=87.9
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHH
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHAR 544 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~ 544 (611)
.++.++..+|.|++|.|+++||..++... ..+..+|..+|.|++|.|+..||..++........ .+.+.
T Consensus 64 ~~~~li~~~D~d~~G~i~~~EF~~l~~~~-------~~~~~~F~~~D~d~sG~i~~~El~~~l~~~g~~~~----~~~~~ 132 (188)
T d1qxpa2 64 SCRSMVNLMDRDGNGKLGLVEFNILWNRI-------RNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLP----CQLHQ 132 (188)
T ss_dssp HHHHHHHHHCC--CCCCCSSSHHHHHHHH-------HHHHHHHGGGCTTCCSCCBHHHHHHHHHHTTEECC----HHHHH
T ss_pred HHHHHHHHhcCCCCCcccHHHHHHHHhhh-------HHHHHHHHHhCCCCCCEECHHHHHHHHHHhhhcCC----HHHHH
Confidence 46788888999999999999998865433 23667899999999999999999887765443333 33455
Q ss_pred HHHhHHhcCCCCcccHHHHHHHhcCCCCccHHHHHHHHhcCCCCce--eHHHHHHHH
Q 007253 545 CAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIRHTDGKL--SFLGFVKLL 599 (611)
Q Consensus 545 ~~F~~~D~d~~G~It~eEl~~~l~~~~~~~~~~~~~~~D~~~dG~i--s~~eF~~~l 599 (611)
.+++. |.|++|.|+.+||..++..... +..+|+.+|.+++|.| +++||+.+.
T Consensus 133 ~l~~~-~~~~dg~i~f~eFi~~~~~l~~--~~~~F~~~D~~~~G~i~l~~~efl~~~ 186 (188)
T d1qxpa2 133 VIVAR-FADDELIIDFDNFVRCLVRLEI--LFKIFKQLDPENTGTIQLDLISWLSFS 186 (188)
T ss_dssp HHHHH-TSCSSSBCCHHHHHHHHHHHHH--HHHHHHHSCSSCCSCEEEEHHHHHHHT
T ss_pred HHHHH-hcCCCCcCCHHHHHHHHHHHHH--HHHHHHHhCCCCCCeEEeeHHHHHHHH
Confidence 55555 4588999999999887731111 5567888899999966 888988753
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.16 E-value=3.9e-11 Score=110.65 Aligned_cols=116 Identities=14% Similarity=0.257 Sum_probs=91.8
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHH--------hh
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLE--------AL 536 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~--------~~ 536 (611)
...++|..+|.+++|.|++.||..++..+.. ...++.+..+|+.+|.|++|.|+++||..++....... ..
T Consensus 64 ~~~~if~~~D~~~~G~I~~~Ef~~~~~~~~~-~~~~e~~~~~F~~~D~d~dG~is~~E~~~~~~~~~~~~~~~~~~~~~~ 142 (190)
T d1fpwa_ 64 FANHLFTVFDKDNNGFIHFEEFITVLSTTSR-GTLEEKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDE 142 (190)
T ss_dssp HHHHHHHTCCSSCSSEECHHHHHHHHHHHSC-CCSTHHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCC
T ss_pred HHHHHHHHhCcCCCCcccHHHHHHHHHHHcc-CchHHHHHHHHHHhccCCCCcCcHHHHHHHHHHHHHhcccccCCCchh
Confidence 3567999999999999999999999876654 45677789999999999999999999988775432210 01
Q ss_pred HHHHHHHHHHHhHHhcCCCCcccHHHHHHHhcCCCCccHHHHHHHHh
Q 007253 537 DRWEQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWI 583 (611)
Q Consensus 537 ~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~~~~~~~~~~~~~~~D 583 (611)
...++.+..+|+.+|.|+||.|+.+||++++...+. +-..|.-+|
T Consensus 143 ~~~~~~v~~if~~~D~d~dG~Is~~EF~~~~~~~p~--i~~~l~~~d 187 (190)
T d1fpwa_ 143 ATPEMRVKKIFKLMDKNEDGYITLDEFREGSKVDPS--IIGALNLYD 187 (190)
T ss_dssp CCHHHHHHHHHHHHTTTCSSEEEHHHHHHHHHSSTT--HHHHHHHHH
T ss_pred hhHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHCHH--HHHHhhhhc
Confidence 112567889999999999999999999999976555 445555554
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.14 E-value=1.8e-11 Score=90.15 Aligned_cols=57 Identities=19% Similarity=0.432 Sum_probs=51.6
Q ss_pred HHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHH
Q 007253 541 QHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVK 597 (611)
Q Consensus 541 ~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~ 597 (611)
++++.+|+.||++++|+|+.+||+.+|. +|..++ ++.+|+.+|.|+||.|+|+||++
T Consensus 1 Eel~~aF~~fD~~~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~D~d~dg~I~~~eFl~ 61 (61)
T d2fcea1 1 EDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFIE 61 (61)
T ss_dssp HHHHHHHHHHCTTCCSCEEHHHHHHHHHHTTCCCCHHHHHHHHTTCCCCTTSEECHHHHHH
T ss_pred ChHHHHHHHHCCCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcEeHHHhcC
Confidence 3678899999999999999999999994 666665 89999999999999999999985
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.13 E-value=5.4e-11 Score=93.03 Aligned_cols=62 Identities=21% Similarity=0.448 Sum_probs=55.8
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
.++++.+|+.||.|++|+|+.+||+.+|. +|...+ ++.+|..+|.|+||.|+|+||+.+|.+
T Consensus 13 i~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~e~~~~~~~~D~d~~g~I~~~eF~~~m~~ 78 (81)
T d1avsa_ 13 IAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVR 78 (81)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCCSSEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCeEchhHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence 45688999999999999999999999995 666666 899999999999999999999998864
|
| >d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Guanylate cyclase activating protein 2, GCAP-2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.12 E-value=1.5e-10 Score=106.46 Aligned_cols=108 Identities=13% Similarity=0.141 Sum_probs=86.0
Q ss_pred HHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhh-------
Q 007253 464 FYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEAL------- 536 (611)
Q Consensus 464 ~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~------- 536 (611)
..+.++|..+|.|++|.|++.||..++..... ...+..+..+|..+|.|++|.|++.||..++.........
T Consensus 58 ~~~~~lf~~~D~d~dG~I~f~Ef~~~l~~~~~-~~~~~~~~~~F~~~D~d~~g~i~~~E~~~~~~~~~~~~~~~~~~~~~ 136 (189)
T d1jbaa_ 58 QYVEAMFRAFDTNGDNTIDFLEYVAALNLVLR-GTLEHKLKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEA 136 (189)
T ss_dssp HHHHHHHHHHCCSSSSEECHHHHHHHHHHHSS-CCCTHHHHHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTS
T ss_pred HHHHHHHHHhccCCCCeEeehhHHHHHHhhcc-cchHHHHHHHHhhhccCCCCcccHhHHHHHHHHHHHhhccccccchh
Confidence 34778999999999999999999999876653 4556678889999999999999999998766543321110
Q ss_pred ------HHHHHHHHHHHhHHhcCCCCcccHHHHHHHhcCCCC
Q 007253 537 ------DRWEQHARCAYELFEKDGNRAIVIEELASELGLGPA 572 (611)
Q Consensus 537 ------~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~~~~~ 572 (611)
...++.+..+|+.+|+|++|.|+.+||.+++.-.+.
T Consensus 137 ~~~~~~~~~e~~~~~if~~~D~d~dG~Is~~EF~~~~~~~p~ 178 (189)
T d1jbaa_ 137 EQQGKLLTPEEVVDRIFLLVDENGDGQLSLNEFVEGARRDKW 178 (189)
T ss_dssp STTTCCCCHHHHHHHHHHHHCCSCCSCBCHHHHHHHHTTTTT
T ss_pred hhhccccchHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhCHH
Confidence 001456788999999999999999999999976554
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.12 E-value=2.4e-11 Score=90.76 Aligned_cols=63 Identities=14% Similarity=0.338 Sum_probs=57.7
Q ss_pred HHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHH
Q 007253 464 FYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAA 527 (611)
Q Consensus 464 ~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~ 527 (611)
++|+++|..||.+++|+|+.+||+.++..++. .+++.++..++..+|.|++|.|+|+||+.++
T Consensus 3 eel~~aF~~fD~d~~G~I~~~el~~~l~~lg~-~~~~~e~~~l~~~~D~d~~g~I~~~eF~~~m 65 (65)
T d1fw4a_ 3 EEIREAFRVFDKDGNGYISAAELRHVMTNLGE-KLTDEEVDEMIREADIDGDGQVNYEEFVQMM 65 (65)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTC-CCCHHHHHHHHHTTCTTCSSSEEHHHHHHHC
T ss_pred HHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCC-CCCHHHHHHHHHHcCCCCCCcEeHHHHHHHC
Confidence 35899999999999999999999999988875 6888899999999999999999999999763
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=99.11 E-value=8.3e-12 Score=94.18 Aligned_cols=65 Identities=14% Similarity=0.275 Sum_probs=59.6
Q ss_pred HHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHc
Q 007253 464 FYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAAL 528 (611)
Q Consensus 464 ~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~ 528 (611)
++|+++|..||.+++|+|+..||..+|..++..++++.++..|++.+|.|++|.|+|+||+.++.
T Consensus 2 eel~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~s~~e~~~~~~~~D~d~dG~i~~~EF~~~m~ 66 (68)
T d1c7va_ 2 EEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVIDIPEFMDLIK 66 (68)
T ss_dssp HHHHHHHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCSSGGGSEEHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCcCeEcHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHH
Confidence 35899999999999999999999999988876567889999999999999999999999998774
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Probab=99.11 E-value=1.1e-10 Score=100.72 Aligned_cols=98 Identities=17% Similarity=0.217 Sum_probs=82.4
Q ss_pred hhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-C-CCCcc-----H
Q 007253 503 IPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-L-GPAVP-----V 575 (611)
Q Consensus 503 ~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~-~~~~~-----~ 575 (611)
.+++|+.+|.|++|.|+++||..++........ ++.+..+|+.+|.+++|.|+.+||..++. . ..... +
T Consensus 2 ae~~F~~~D~d~dG~is~~E~~~~l~~~~~~~~----~~~~~~~~~~~D~~~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~ 77 (134)
T d1jfja_ 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKN----EQLLQLIFKSIDADGNGEIDQNEFAKFYGSIQGQDLSDDKIGL 77 (134)
T ss_dssp HHHHHHHHCTTCSSEEEHHHHHHHHHTTCCSSH----HHHHHHHHHHHCSSCCSEEEHHHHHHHTTCSSCCSSHHHHHHH
T ss_pred HHHHHHHHcCCCcCCCcHHHHHHHHHHcCCCCC----HHHHHHHHHHhhhcccccccccccccccccccccccccccccc
Confidence 467999999999999999999988876654444 66788899999999999999999999884 2 22211 6
Q ss_pred HHHHHHHhcCCCCceeHHHHHHHHhhcch
Q 007253 576 HAVLHDWIRHTDGKLSFLGFVKLLHGVSS 604 (611)
Q Consensus 576 ~~~~~~~D~~~dG~is~~eF~~~l~~~~~ 604 (611)
..+|+.+|.|++|.|+.+||..++..++.
T Consensus 78 ~~~F~~~D~~~~g~i~~~el~~~~~~~~~ 106 (134)
T d1jfja_ 78 KVLYKLMDVDGDGKLTKEEVTSFFKKHGI 106 (134)
T ss_dssp HHHHHHHCCSSSSEEEHHHHHHHHTTTTC
T ss_pred cccccccccccCCcccHHHHHHHHHhcCc
Confidence 77899999999999999999999988754
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.10 E-value=3.4e-11 Score=92.67 Aligned_cols=65 Identities=20% Similarity=0.345 Sum_probs=59.9
Q ss_pred HHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcc
Q 007253 464 FYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALS 529 (611)
Q Consensus 464 ~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~ 529 (611)
++|+++|..||.+++|+|+..||+.+|..++. .+++.++..+++.+|.|++|+|+|+||+.++..
T Consensus 9 eel~~~F~~fD~~~~G~I~~~el~~~l~~lg~-~~~~~e~~~~~~~~D~d~dg~I~~~EF~~~m~~ 73 (75)
T d1jc2a_ 9 EELANCFRIFDKNADGFIDIEELGEILRATGE-HVIEEDIEDLMKDSDKNNDGRIDFDEFLKMMEG 73 (75)
T ss_dssp HHHHHHHHHHCCSTTSSEEHHHHHHHHHHSSS-CCCHHHHHHHHHHHCSSSCSEECHHHHHHHHHT
T ss_pred HHHHHHHHHHcCCCcCeEcHHHHHHHHHhcCC-CccHHHHHHHHHHhCCCCCCcEeHHHHHHHHHh
Confidence 36999999999999999999999999988876 688889999999999999999999999998754
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Probab=99.09 E-value=9.4e-11 Score=91.65 Aligned_cols=63 Identities=24% Similarity=0.375 Sum_probs=55.5
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
.++++.+|+.||+|++|+|+.+||+++|. +|. .+ +.++|+.+|.|+||.|+|+||+.+|....
T Consensus 5 ~~e~~~~F~~~D~d~~G~I~~~El~~~l~~lg~-~~~~ei~~~~~~~D~d~~G~I~~~EF~~~~~~~~ 71 (81)
T d2opoa1 5 IADRERIFKRFDTNGDGKISSSELGDALKTLGS-VTPDEVRRMMAEIDTDGDGFISFDEFTDFARANR 71 (81)
T ss_dssp HHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTTT-CCHHHHHHHHHHHCTTCSSEECHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhhc-CCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHCc
Confidence 56789999999999999999999999994 552 33 89999999999999999999999987653
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.09 E-value=4.4e-11 Score=92.38 Aligned_cols=64 Identities=25% Similarity=0.472 Sum_probs=53.7
Q ss_pred HHHHHHHHhHHhcC--CCCcccHHHHHHHhc-CCC-----CccHHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 540 EQHARCAYELFEKD--GNRAIVIEELASELG-LGP-----AVPVHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 540 ~~~~~~~F~~~D~d--~~G~It~eEl~~~l~-~~~-----~~~~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
+++++.+|+.||.+ ++|+|+.+||+++|. +|. ...++.+|..+|.|+||.|+|+||+++|.+++
T Consensus 4 ~eel~~~F~~fd~~~~~~G~I~~~El~~~l~~lg~~~~~~~~ei~~~~~~~D~d~dG~I~f~EF~~~m~~~~ 75 (76)
T d1qx2a_ 4 PEEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGEVSFEEFLVMMKKIS 75 (76)
T ss_dssp HHHHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCTTCSSEECHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHcccCCCCCEECHHHHHHHHHHhCCcCCCCHHHHHHHHHHhhcCCCCcCcHHHHHHHHHHHc
Confidence 56789999999765 469999999999994 332 22389999999999999999999999998764
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Probab=99.08 E-value=5e-11 Score=91.32 Aligned_cols=62 Identities=23% Similarity=0.470 Sum_probs=55.6
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
.++++.+|+.||.|++|+|+.+||+.+|. +|...+ +..++..+|.|+||.|+|+||+.+|.+
T Consensus 7 i~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~~~~~~~~~~D~d~~g~I~f~eF~~~m~~ 72 (73)
T d2pq3a1 7 IAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMAR 72 (73)
T ss_dssp HHHHHHHHHHTCTTSSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCceEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHhc
Confidence 45788999999999999999999999994 666655 899999999999999999999998753
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=99.08 E-value=1e-11 Score=98.65 Aligned_cols=81 Identities=12% Similarity=0.198 Sum_probs=62.8
Q ss_pred CCCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCC
Q 007253 513 LQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDG 588 (611)
Q Consensus 513 ~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG 588 (611)
+++|.|+.++... ........ ...++.+|+.||+|++|+|+.+||+.+|. +|...+ ++.+|+.+|.|+||
T Consensus 1 ~~~g~id~~~~~m--a~~l~~~~----i~~l~~~F~~~D~d~~G~I~~~el~~~l~~lg~~~s~~e~~~l~~~~D~d~~g 74 (87)
T d1s6ja_ 1 HSSGHIDDDDKHM--AERLSEEE----IGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSG 74 (87)
T ss_dssp CCSSSSSSHHHHS--SSSSCSSS----TTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHCTTCSS
T ss_pred CCCCccCchHHHH--HhhCCHHH----HHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCC
Confidence 3578888887542 22111111 23578899999999999999999999994 666555 89999999999999
Q ss_pred ceeHHHHHHHH
Q 007253 589 KLSFLGFVKLL 599 (611)
Q Consensus 589 ~is~~eF~~~l 599 (611)
.|+|+||+.+|
T Consensus 75 ~I~~~EFl~am 85 (87)
T d1s6ja_ 75 TIDYGEFIAAT 85 (87)
T ss_dssp EECHHHHTTCC
T ss_pred eEeHHHHHHHH
Confidence 99999998755
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.08 E-value=5e-11 Score=87.73 Aligned_cols=61 Identities=11% Similarity=0.332 Sum_probs=56.6
Q ss_pred HHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHH
Q 007253 464 FYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCA 525 (611)
Q Consensus 464 ~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~ 525 (611)
++|+++|..+|++++|+|+..||+.+|..++. .+++.++..+++.+|.|++|.|+|+||+.
T Consensus 1 Eel~~aF~~fD~~~~G~I~~~el~~~l~~~g~-~~~~~ei~~l~~~~D~d~dg~I~~~eFl~ 61 (61)
T d2fcea1 1 EDFVKAFQVFDKESTGKVSVGDLRYMLTGLGE-KLTDAEVDELLKGVEVDSNGEIDYKKFIE 61 (61)
T ss_dssp HHHHHHHHHHCTTCCSCEEHHHHHHHHHHTTC-CCCHHHHHHHHTTCCCCTTSEECHHHHHH
T ss_pred ChHHHHHHHHCCCCCCeEeHHHHHHHHHHcCC-CCCHHHHHHHHHHcCCCCCCcEeHHHhcC
Confidence 46899999999999999999999999988876 68889999999999999999999999974
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.07 E-value=7.5e-11 Score=91.38 Aligned_cols=62 Identities=26% Similarity=0.415 Sum_probs=55.3
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
.++++.+|+.||.|++|+|+.+||+.+|. +|...+ +.+++..+|.|+||.|+|+||+.+|.+
T Consensus 9 i~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~t~~e~~~~~~~~D~~~~g~I~~~eF~~~m~~ 74 (77)
T d1f54a_ 9 IAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEFLALMSR 74 (77)
T ss_dssp HHHHHHHHHHTCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHTTCCSSCCEEEHHHHHHHHTT
T ss_pred HHHHHHHHHHHcCCCCCeEChHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence 45788999999999999999999999994 555554 899999999999999999999999864
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=99.06 E-value=1.2e-10 Score=91.00 Aligned_cols=62 Identities=16% Similarity=0.364 Sum_probs=55.5
Q ss_pred HHHHHHHHhHHhcCC-CCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 540 EQHARCAYELFEKDG-NRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~-~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
.++++.+|+.||.|+ +|+|+..||+++|. +|...+ ++.+|..+|.|+||.|+|+||+.+|.+
T Consensus 14 ~~~~~~~F~~fD~d~~~G~I~~~el~~~l~~lg~~~t~~el~~~i~~~D~d~~G~I~f~eFl~im~~ 80 (82)
T d1wrka1 14 KNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVR 80 (82)
T ss_dssp HHHHHHHHHHHTTTCTTSSBCHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTCCSSBCHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCcCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHh
Confidence 467889999999996 79999999999994 776655 899999999999999999999999865
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Probab=99.05 E-value=6.7e-11 Score=92.50 Aligned_cols=65 Identities=20% Similarity=0.375 Sum_probs=59.7
Q ss_pred HHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcc
Q 007253 464 FYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALS 529 (611)
Q Consensus 464 ~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~ 529 (611)
++|+++|..||.+++|+|+..||..+|..++. .+++.++..+|+.+|.|++|+|+|+||+.++..
T Consensus 15 e~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~~~~ev~~~~~~~D~d~dg~I~~~EF~~~m~~ 79 (81)
T d1fi5a_ 15 EELSDLFRMFDKNADGYIDLEELKIMLQATGE-TITEDDIEELMKDGDKNNDGRIDYDEFLEFMKG 79 (81)
T ss_dssp HHHHHHHHHHCSSCSSEECHHHHHHHHHTSSS-CCCHHHHHHHHHHHCSSSSSSEEHHHHHHHHSC
T ss_pred HHHHHHHHHHcCCCCCcccHHHHHHHHHhcCC-CCCHHHHHHHHHHHCCCCCCcEeHHHHHHHHHh
Confidence 46999999999999999999999999988775 688889999999999999999999999998754
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.04 E-value=7.7e-11 Score=88.57 Aligned_cols=64 Identities=16% Similarity=0.314 Sum_probs=57.8
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcc
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALS 529 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~ 529 (611)
.++++|..+|.|++|+|+..||+.++..++. ..++.++..+|..+|.|++|+|+|+||+.++..
T Consensus 2 ~~r~~F~~~D~d~~G~I~~~El~~~l~~lg~-~~~~~~i~~~~~~~D~d~dg~I~~~EF~~~m~~ 65 (67)
T d1tiza_ 2 SAKRVFEKFDKNKDGKLSLDEFREVALAFSP-YFTQEDIVKFFEEIDVDGNGELNADEFTSCIEK 65 (67)
T ss_dssp THHHHHHHHCTTSSSCEEHHHHHHHHHHTCT-TSCHHHHHHHHHHHCCSSSSEECHHHHHHHHHT
T ss_pred hHHHHHHHHCCCCcCcCcHHHHHHHHHHhcc-ccchHHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence 3689999999999999999999999987775 688889999999999999999999999987754
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.04 E-value=8.9e-11 Score=90.94 Aligned_cols=67 Identities=10% Similarity=0.278 Sum_probs=60.5
Q ss_pred HHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcc
Q 007253 462 ELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALS 529 (611)
Q Consensus 462 e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~ 529 (611)
..++|+++|..+|.+++|+|+.+||..+|..++. .++..++..+|+.+|.|++|.|+|+||+.++..
T Consensus 7 ~~e~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~-~~~~~e~~~~~~~~D~d~~G~I~~~EF~~~m~k 73 (77)
T d1oqpa_ 7 SREEILKAFRLFDDDNSGTITIKDLRRVAKELGE-NLTEEELQEMIAEADRNDDNEIDEDEFIRIMKK 73 (77)
T ss_dssp HHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHTC-CCCHHHHHHHHHHHCCSSSSEECHHHHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCCEechHHHHHHHHHhCC-CCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHc
Confidence 4457999999999999999999999999988876 578888999999999999999999999988743
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Probab=99.03 E-value=2e-10 Score=100.81 Aligned_cols=100 Identities=12% Similarity=0.153 Sum_probs=83.3
Q ss_pred HHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHH
Q 007253 464 FYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHA 543 (611)
Q Consensus 464 ~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~ 543 (611)
..+..+|..+|.+++|.|++.+|..++............+..+|+.+|.|++|.|+..||..++........ ++++
T Consensus 45 ~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~----~~~~ 120 (146)
T d1exra_ 45 AELQDMINEVDADGNGTIDFPEFLSLMARKMKEQDSEEELIEAFKVFDRDGNGLISAAELRHVMTNLGEKLT----DDEV 120 (146)
T ss_dssp HHHHHHHHHHCTTCSSSEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHSTTCSSCBCHHHHHHHHHHTTCCCC----HHHH
T ss_pred HHHHHHHHhcCCCCCCcccHHHHHHHHHHHhhccChHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhcCC----HHHH
Confidence 346788899999999999999999987655443334557889999999999999999999988876554434 5688
Q ss_pred HHHHhHHhcCCCCcccHHHHHHHh
Q 007253 544 RCAYELFEKDGNRAIVIEELASEL 567 (611)
Q Consensus 544 ~~~F~~~D~d~~G~It~eEl~~~l 567 (611)
..+|+.+|.|++|.|+.+||.++|
T Consensus 121 ~~i~~~~D~d~dG~i~~~eF~~~l 144 (146)
T d1exra_ 121 DEMIREADIDGDGHINYEEFVRMM 144 (146)
T ss_dssp HHHHHHHCSSSSSSBCHHHHHHHH
T ss_pred HHHHHHhCCCCCCeEeHHHHHHHh
Confidence 899999999999999999999876
|
| >d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium- and integrin-binding protein, CIB species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.02 E-value=1.7e-10 Score=105.27 Aligned_cols=106 Identities=11% Similarity=0.084 Sum_probs=82.9
Q ss_pred HHHHhhhcCCC-CCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhh-----HHhhHHH
Q 007253 466 LKEQYALLEPN-KNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQ-----LEALDRW 539 (611)
Q Consensus 466 l~~~F~~~D~d-~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~-----~~~~~~~ 539 (611)
..++|+.+|.+ ++|.|+++||..++..+......++.+..+|+.+|.|++|.|+.+|+..++..... ....+..
T Consensus 59 ~~rif~~fd~~~~~g~I~f~EFv~~l~~~~~~~~~~~kl~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~ 138 (180)
T d1xo5a_ 59 KERICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEM 138 (180)
T ss_dssp HHHHHHHHCCSTTCCEECHHHHHHHHHHHSTTSCHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHC------CCCCTTH
T ss_pred HHHHHHhccCCCCCCcCcHHHHHHHHHHHhhcCCHHHHHHHhhccccCCCCCeeeHHHHHHHHHHHHhccccccccHHHH
Confidence 45789999987 69999999999988666543345567888999999999999999999887654321 1112223
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhcCCC
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELGLGP 571 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~~~~ 571 (611)
++.+..+|+.+|.|++|.|+.+||.+++.-.|
T Consensus 139 ~~~v~~~~~~~D~d~dG~Is~~EF~~~~~~~P 170 (180)
T d1xo5a_ 139 KQLIDNILEESDIDRDGTINLSEFQHVISRSP 170 (180)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHCH
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHhCH
Confidence 55678899999999999999999999886433
|
| >d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Recoverin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.02 E-value=4.3e-10 Score=104.48 Aligned_cols=103 Identities=13% Similarity=0.184 Sum_probs=82.6
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHh---------
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEA--------- 535 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~--------- 535 (611)
.+..+|..+|.+++|.|++.||..++..... ...+..+..+|..+|.|++|.|+++||..++........
T Consensus 64 ~~~~if~~~D~~~~G~I~f~EF~~~~~~~~~-~~~~~~l~~~F~~~D~d~~G~is~~E~~~~~~~~~~~~~~~~~~~~~~ 142 (201)
T d1omra_ 64 YAQHVFRSFDANSDGTLDFKEYVIALHMTSA-GKTNQKLEWAFSLYDVDGNGTISKNEVLEIVTAIFKMISPEDTKHLPE 142 (201)
T ss_dssp HHHHHHHTTTSCSSSEEEHHHHHHHHHHHHS-SCGGGSHHHHHHHHCTTCSSSBCHHHHHHHHHHHHTTSCHHHHTTSCG
T ss_pred HHHHHHHHhccCCCCeEeehhHHHHHHhhcc-cchHHHHHHHHHHHccCCCCccCHHHHHHHHHHHHhhcChhhhhhhhh
Confidence 4578999999999999999999998866654 456677899999999999999999999877654322110
Q ss_pred -hHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 536 -LDRWEQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 536 -~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
....++.+..+|+.+|.|+||.|+.+||.+.+.
T Consensus 143 ~~~~~~~~~~~if~~~D~d~dG~Is~~EF~~~~~ 176 (201)
T d1omra_ 143 DENTPEKRAEKIWGFFGKKDDDKLTEKEFIEGTL 176 (201)
T ss_dssp GGSSHHHHHHHHHHHTTCCTTCCBCHHHHHHHHH
T ss_pred hhccHHHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Confidence 011245678899999999999999999998773
|
| >d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Kchip1, Kv4 potassium channel-interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.02 E-value=3.8e-10 Score=102.63 Aligned_cols=106 Identities=10% Similarity=0.151 Sum_probs=82.3
Q ss_pred HHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHH--------hhH
Q 007253 466 LKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLE--------ALD 537 (611)
Q Consensus 466 l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~--------~~~ 537 (611)
+..+|+.+|.+++|.|+++||..++..... ...+..+..+|+.+|.|++|.|+.+|+..++....... ...
T Consensus 53 ~~~lf~~~D~~~~g~I~~~EFl~~~~~~~~-~~~~~~~~~~f~~~D~~~~g~i~~~e~~~~~~~~~~~~~~~~~~~~~~~ 131 (178)
T d1s6ca_ 53 AHYLFNAFDTTQTGSVKFEDFVTALSILLR-GTVHEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKED 131 (178)
T ss_dssp HHHHHHHHCTTCSSCEEHHHHHHHHHHHHH-CCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC----------
T ss_pred HHHHHHHHCCCCCCcccHHHHHHHHHHHhc-cchHHHHHHHHHhhccCCCCeecHHHHHHHHHHHHhhcccccccCCcHH
Confidence 577999999999999999999988755443 34556788899999999999999999977655432211 111
Q ss_pred HHHHHHHHHHhHHhcCCCCcccHHHHHHHhcCCCC
Q 007253 538 RWEQHARCAYELFEKDGNRAIVIEELASELGLGPA 572 (611)
Q Consensus 538 ~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~~~~~ 572 (611)
..++.+..+|+.+|.|+||.||.+||.+++.-.+.
T Consensus 132 ~~~~~~~~if~~~D~d~DG~Is~~EF~~~i~~~~~ 166 (178)
T d1s6ca_ 132 TPRQHVDVFFQKMDKNKDGIVTLDEFLESCQEDDN 166 (178)
T ss_dssp -CHHHHHHHHHHHCTTCSSEECHHHHHHHTTSCCH
T ss_pred HHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHCHH
Confidence 12456778999999999999999999999875544
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.00 E-value=4.3e-10 Score=102.82 Aligned_cols=104 Identities=16% Similarity=0.108 Sum_probs=82.9
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhH----HhhHHHH
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQL----EALDRWE 540 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~----~~~~~~~ 540 (611)
....+|..+|.+++|.|++.||..++.........+..+..+|+.+|.|++|.|+.+|+..++...... ......+
T Consensus 55 ~~~~lf~~~d~~~dg~I~f~EFl~~l~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~e~~~~~~~~~~~~~~~~~~~~~~ 134 (183)
T d2zfda1 55 FADRVFDLFDTKHNGILGFEEFARALSVFHPNAPIDDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIE 134 (183)
T ss_dssp HHHHHHHHHCSSCSSSBCHHHHHHHHHHTSTTSCHHHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHH
T ss_pred HHHHHHHHHccCCCCcCcHHHHHHHHHhhhccCcHHHHHHHhhcccccCCCCCccHHHHHHHHHHHHhhhhcccchHHHH
Confidence 356899999999999999999999886654333345567889999999999999999998876543211 1222336
Q ss_pred HHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 541 QHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 541 ~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
+.+..+|+.+|.|++|.|+.+||.+++.
T Consensus 135 ~~~~~if~~~D~d~dG~Is~~EF~~~~~ 162 (183)
T d2zfda1 135 DIIDKTFEEADTKHDGKIDKEEWRSLVL 162 (183)
T ss_dssp HHHHHHHHHHCSSCSSEECHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeEcHHHHHHHHH
Confidence 6788899999999999999999999884
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.99 E-value=5.2e-10 Score=102.59 Aligned_cols=104 Identities=12% Similarity=0.159 Sum_probs=82.3
Q ss_pred HHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHH--------hhH
Q 007253 466 LKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLE--------ALD 537 (611)
Q Consensus 466 l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~--------~~~ 537 (611)
...+|+.+|.+++|.|++.||..++..... ...++.+..+|+.+|.|++|.|+.+|+..++....... ...
T Consensus 62 ~~~if~~~d~~~dg~I~~~EF~~~l~~~~~-~~~~e~l~~~F~~~D~d~dG~i~~~El~~~~~~~~~~~~~~~~~~~~~~ 140 (187)
T d1g8ia_ 62 ATFVFNVFDENKDGRIEFSEFIQALSVTSR-GTLDEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEEN 140 (187)
T ss_dssp HHHHHHHHCTTCSSEEEHHHHHHHHHHHHH-CCHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGS
T ss_pred HHHHHHHhCcCCCCCCcHHHHHHHHHHhcc-CchhhhHHHHHHHHhcCCCCeEcHHHHHHHHHHHhhhhcccccCchhhc
Confidence 466999999999999999999998866543 34455688899999999999999999987765432210 111
Q ss_pred HHHHHHHHHHhHHhcCCCCcccHHHHHHHhcCC
Q 007253 538 RWEQHARCAYELFEKDGNRAIVIEELASELGLG 570 (611)
Q Consensus 538 ~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~~~ 570 (611)
..++.+..+|+.+|.|+||.|+.+||.+++.-.
T Consensus 141 ~~~~~v~~if~~~D~d~dG~Is~~EF~~~~~~~ 173 (187)
T d1g8ia_ 141 TPEKRVDRIFAMMDKNADGKLTLQEFQEGSKAD 173 (187)
T ss_dssp SHHHHHHHHHHHHCSSCSSEEEHHHHHHHHHHC
T ss_pred cHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHC
Confidence 125678899999999999999999999988543
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Probab=98.98 E-value=4e-10 Score=93.21 Aligned_cols=102 Identities=14% Similarity=0.191 Sum_probs=75.4
Q ss_pred hhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchh--
Q 007253 454 LSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVH-- 531 (611)
Q Consensus 454 ~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~-- 531 (611)
++..++.+++ .+++..+| .+|.|++.||...+ ... ..+++++..+|+.+|.|++|.|+.+|+..++....
T Consensus 2 ~~~~l~~~di---~~~~~~~~--~~G~idf~eF~~~~-~~~--~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~ 73 (109)
T d5pala_ 2 MTKVLKADDI---NKAISAFK--DPGTFDYKRFFHLV-GLK--GKTDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAH 73 (109)
T ss_dssp GGGTSCHHHH---HHHHHHTC--STTCCCHHHHHHHH-TCT--TCCHHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTT
T ss_pred hhhHccHHHH---HHHHHhcC--CCCcCcHHHHHHHH-Hhc--CCCHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHhhhc
Confidence 3455666664 45555555 45889999998754 222 23456788999999999999999999987664431
Q ss_pred -hHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHh
Q 007253 532 -QLEALDRWEQHARCAYELFEKDGNRAIVIEELASEL 567 (611)
Q Consensus 532 -~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l 567 (611)
.... +++++.+|+.+|.|++|.|+.+||..++
T Consensus 74 g~~~~----~~e~~~~~~~~D~d~dG~I~~~EF~~~m 106 (109)
T d5pala_ 74 GRDLN----DTETKALLAAGDSDHDGKIGADEFAKMV 106 (109)
T ss_dssp CCCCC----HHHHHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred cCcCC----HHHHHHHHHHhCCCCCCCEeHHHHHHHH
Confidence 1122 5678899999999999999999999876
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=98.98 E-value=3.5e-10 Score=93.54 Aligned_cols=99 Identities=15% Similarity=0.207 Sum_probs=74.6
Q ss_pred chhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhh---HH
Q 007253 458 LTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQ---LE 534 (611)
Q Consensus 458 l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~---~~ 534 (611)
++.++ +.+++..+| ++|.|++.||...+. .. ..+..++..+|+.+|.|++|.|+.+|+..++..... ..
T Consensus 6 l~~ee---I~~~~~~~d--~dG~idf~EF~~~~~-~~--~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~l 77 (109)
T d1pvaa_ 6 LKADD---IKKALDAVK--AEGSFNHKKFFALVG-LK--AMSANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDL 77 (109)
T ss_dssp SCHHH---HHHHHHHTC--STTCCCHHHHHHHHT-CT--TSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCC
T ss_pred CCHHH---HHHHHHhcC--CCCCCcHHHHHHHHH-Hc--cCCHHHHHHHhhCccCCCcCeEcHHHHHHHHHHhhhcCCCC
Confidence 34444 445555554 568899999987642 22 234566889999999999999999999887765421 12
Q ss_pred hhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 535 ALDRWEQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 535 ~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
. +++++.+|+.+|.|+||.|+.+||.+++.
T Consensus 78 s----~~ev~~~~~~~D~d~dG~I~~~EF~~~m~ 107 (109)
T d1pvaa_ 78 T----DAETKAFLKAADKDGDGKIGIDEFETLVH 107 (109)
T ss_dssp C----HHHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred C----HHHHHHHHHHHCCCCcCcEeHHHHHHHHH
Confidence 2 56788999999999999999999999873
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.94 E-value=8.4e-10 Score=96.02 Aligned_cols=108 Identities=10% Similarity=0.204 Sum_probs=87.0
Q ss_pred hhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhh
Q 007253 453 ALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQ 532 (611)
Q Consensus 453 ~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~ 532 (611)
.+...++..+ +...+..+|.+++|.|++.||...+...........++..+|..+|.+++|.|+.++|..++.....
T Consensus 34 ~~~~~~~~~~---~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~l~~~f~~~d~~~~G~i~~~el~~~l~~~g~ 110 (141)
T d2obha1 34 ALGFEPKKEE---IKKMISEIDKEGTGKMNFGDFLTVMTQKMSEKDTKEEILKAFKLFDDDETGKISFKNLKRVAKELGE 110 (141)
T ss_dssp HTTCCCCHHH---HHHHHHHHTTTCCSEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTC
T ss_pred hcCCchhHHH---HHHHHHhhccCCCCeechHHHHHHHHHHHhhhccHHHHHHHHHHhcccCCCCccHHHHHHHHHHhCC
Confidence 3444455544 5667888899999999999999987655443344566889999999999999999999998876654
Q ss_pred HHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHh
Q 007253 533 LEALDRWEQHARCAYELFEKDGNRAIVIEELASEL 567 (611)
Q Consensus 533 ~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l 567 (611)
... .+++..+|+.+|.|++|.|+.+||.++|
T Consensus 111 ~l~----~~e~~~l~~~~D~d~dG~i~~~EF~~~m 141 (141)
T d2obha1 111 NLT----DEELQEMIDEADRDGDGEVSEQEFLRIM 141 (141)
T ss_dssp CCC----HHHHHHHHHHHCTTSSSSBCHHHHHHHH
T ss_pred CCC----HHHHHHHHHHHCCCCCCCEeHHHHHHhC
Confidence 444 6678999999999999999999999875
|
| >d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: DJ-1-binding protein, DJBP species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.91 E-value=1e-09 Score=86.12 Aligned_cols=65 Identities=12% Similarity=0.264 Sum_probs=59.7
Q ss_pred HHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHH
Q 007253 462 ELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAA 527 (611)
Q Consensus 462 e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~ 527 (611)
....++++|..+|.+++|.|+.+||+.+|..++. .+++.++..++..+|.|++|.|+|.||+..+
T Consensus 18 ~~~~l~~~F~~~D~~~~G~i~~~ef~~~l~~~~~-~l~~~e~~~l~~~~d~~~~g~I~y~eFl~~f 82 (83)
T d1wlza1 18 HYHAITQEFENFDTMKTNTISREEFRAICNRRVQ-ILTDEQFDRLWNEMPVNAKGRLKYPDFLSRF 82 (83)
T ss_dssp THHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHTC-CCCHHHHHHHHTTSCBCTTSCBCHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCceEChhHHHHHHHHhCC-CCChhHHHHHhhccccCCCCcEeHHHHHHHh
Confidence 3467999999999999999999999999988876 6899999999999999999999999999865
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.90 E-value=1e-09 Score=100.04 Aligned_cols=103 Identities=12% Similarity=0.171 Sum_probs=82.5
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhH--------Hhh
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQL--------EAL 536 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~--------~~~ 536 (611)
...++|+.+|.+++|.|+++||..++..... ...+..+..+|+.+|.|++|.|+..||..++...... ...
T Consensus 60 ~~~~lf~~~d~~~~g~i~~~eFl~~~~~~~~-~~~~~~~~~~f~~~D~d~dg~i~~~E~~~~~~~~~~~~~~~~~~~~~~ 138 (181)
T d1bjfa_ 60 FAEHVFRTFDANGDGTIDFREFIIALSVTSR-GKLEQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDE 138 (181)
T ss_dssp HHHHHHHHHCSSCSSEEEHHHHHHHHHHHTS-SCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGG
T ss_pred HHHHHHHhcCCCCCCcEeHHHHHHHHHHHhh-hchHHHHHHHHHHhccCCCCeecHHHHHHHHHHHhhhccccccCCccc
Confidence 3578999999999999999999998766543 3445567889999999999999999998877643221 001
Q ss_pred HHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 537 DRWEQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 537 ~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
...++.+..+|+.+|.|+||.|+.+||.+++.
T Consensus 139 ~~~~~~~~~if~~~D~d~dG~Is~~EF~~~~~ 170 (181)
T d1bjfa_ 139 STPEKRTEKIFRQMDTNRDGKLSLEEFIRGAK 170 (181)
T ss_dssp SSHHHHHHHHHHHSCTTCSSEECHHHHHHHHH
T ss_pred ccHHHHHHHHHHHhCCCCCCcEeHHHHHHHHH
Confidence 11256788999999999999999999999885
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Probab=98.90 E-value=1.2e-09 Score=90.33 Aligned_cols=106 Identities=10% Similarity=0.142 Sum_probs=76.0
Q ss_pred hhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhH
Q 007253 454 LSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQL 533 (611)
Q Consensus 454 ~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~ 533 (611)
|+..++.+++ .+++..++ .+|.|++.+|..++. .. ..++.++..+|+.+|.|++|.|+.+||..++......
T Consensus 2 ~~~~~~~~~i---~~~~~~~~--~~~~i~f~eF~~~~~-~~--~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~ 73 (109)
T d1rwya_ 2 MTDLLSAEDI---KKAIGAFT--AADSFDHKKFFQMVG-LK--KKSADDVKKVFHILDKDKSGFIEEDELGSILKGFSSD 73 (109)
T ss_dssp HHHHSCHHHH---HHHHHTTC--STTCCCHHHHHHHHT-GG--GSCHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTT
T ss_pred hhhhcCHHHH---HHHHHhcc--cCCCcCHHHHHHHHc-cc--cCCHHHHHHHhhcccCCCCCcCcHHHHHHHHHHhccc
Confidence 3445666664 44555554 457899999987652 22 2345567889999999999999999998877654321
Q ss_pred HhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 534 EALDRWEQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 534 ~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
.. ...++++..+|+.+|.|+||.|+.+||.+++.
T Consensus 74 ~~-~~~~~e~~~~~~~~D~d~dG~i~~~EF~~~m~ 107 (109)
T d1rwya_ 74 AR-DLSAKETKTLMAAGDKDGDGKIGVEEFSTLVA 107 (109)
T ss_dssp CC-CCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHH
T ss_pred cc-cCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHH
Confidence 10 00155788899999999999999999998873
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.89 E-value=1.2e-09 Score=97.84 Aligned_cols=103 Identities=12% Similarity=0.130 Sum_probs=81.1
Q ss_pred HHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhH-HhhHHHHHHHH
Q 007253 466 LKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQL-EALDRWEQHAR 544 (611)
Q Consensus 466 l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~-~~~~~~~~~~~ 544 (611)
+.++|..+|.+++|.|+++||..++............+..+|+.+|.|++|.|+.+|+..++...... .....+++.+.
T Consensus 50 ~~~l~~~~d~~~~g~i~~~EFl~~~~~~~~~~~~~~~~~~~f~~~d~d~~g~Is~~el~~~l~~~~~~~~~~~~~~~~~~ 129 (165)
T d1auib_ 50 VQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVD 129 (165)
T ss_dssp HHHHHHHHCTTCSSSEEHHHHHHHHGGGCTTCCHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHTTSSCHHHHHHHHH
T ss_pred HHHHHHHHccccchhhhhhhhhhhccccccchhhHHHHHHHHHHhcccccccccHHHHHHHHHHhccccCchHHHHHHHH
Confidence 45689999999999999999999875554322233457889999999999999999998877543211 12233466788
Q ss_pred HHHhHHhcCCCCcccHHHHHHHhc
Q 007253 545 CAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 545 ~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
.+|..+|.|++|.|+.+||.+++.
T Consensus 130 ~~~~~~D~~~dG~Is~~EF~~i~~ 153 (165)
T d1auib_ 130 KTIINADKDGDGRISFEEFCAVVG 153 (165)
T ss_dssp HHHHHHCTTSSSSEEHHHHHHHHG
T ss_pred HHHHHcCCCCCCcEeHHHHHHHHh
Confidence 999999999999999999999884
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.88 E-value=1.4e-09 Score=83.74 Aligned_cols=67 Identities=15% Similarity=0.217 Sum_probs=55.4
Q ss_pred HHHHHHhhhcCCC--CCCcccHHHHHHHHHhhcccc-cccCChhHHHhhcCCCCCCcccHHHHHHHHcch
Q 007253 464 FYLKEQYALLEPN--KNGTISLENVKSALMKNATDA-MKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV 530 (611)
Q Consensus 464 ~~l~~~F~~~D~d--~~G~Is~~e~~~~l~~~~~~~-~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~ 530 (611)
++|+++|+.||.+ ++|+|+.+||+.+|..++... ..+.++.+++..+|.|++|.|+|+||+.++...
T Consensus 5 eel~~~F~~fd~~~~~~G~I~~~El~~~l~~lg~~~~~~~~ei~~~~~~~D~d~dG~I~f~EF~~~m~~~ 74 (76)
T d1qx2a_ 5 EEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGEVSFEEFLVMMKKI 74 (76)
T ss_dssp HHHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred HHHHHHHHHHcccCCCCCEECHHHHHHHHHHhCCcCCCCHHHHHHHHHHhhcCCCCcCcHHHHHHHHHHH
Confidence 4688999999654 479999999999998877532 235579999999999999999999999987543
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=98.87 E-value=7.6e-10 Score=91.19 Aligned_cols=93 Identities=10% Similarity=0.069 Sum_probs=56.6
Q ss_pred HHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhh---HHhhHHHHHH
Q 007253 466 LKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQ---LEALDRWEQH 542 (611)
Q Consensus 466 l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~---~~~~~~~~~~ 542 (611)
|..++...+.+ |.|++.||..++. +. ....+++..+|..+|.+++|.|+.+||..++..... ... +++
T Consensus 10 i~~~~~~~~~~--gsi~~~eF~~~~~-l~--~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~l~~~~~~~~----~~~ 80 (107)
T d2pvba_ 10 VAAALAACSAA--DSFKHKEFFAKVG-LA--SKSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALT----DAE 80 (107)
T ss_dssp HHHHHHHTCST--TCCCHHHHHHHHT-GG--GSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCC----HHH
T ss_pred HHHHHHhccCC--CCcCHHHHHHHHh-cc--cCCHHHHHHHHHhhccCCCCcCcHHHHHHHHHHhhcccccCC----HHH
Confidence 33445555443 4577777766432 22 223345677777777777777777777766554421 122 456
Q ss_pred HHHHHhHHhcCCCCcccHHHHHHHh
Q 007253 543 ARCAYELFEKDGNRAIVIEELASEL 567 (611)
Q Consensus 543 ~~~~F~~~D~d~~G~It~eEl~~~l 567 (611)
++.+|+.+|.|++|.|+.+||..++
T Consensus 81 ~~~l~~~~D~d~dG~I~~~EF~~~m 105 (107)
T d2pvba_ 81 TKAFLADGDKDGDGMIGVDEFAAMI 105 (107)
T ss_dssp HHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred HHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 6777777777777777777777665
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.86 E-value=1.6e-09 Score=89.39 Aligned_cols=106 Identities=12% Similarity=0.126 Sum_probs=72.3
Q ss_pred hhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhH
Q 007253 454 LSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQL 533 (611)
Q Consensus 454 ~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~ 533 (611)
+...++.+++..+ ....+ .+|.+++.+|...+ +.......++.++|+.+|.|++|+|+++||..++......
T Consensus 2 ~~d~ls~~dI~~~---l~~~~--~~~s~~~~~F~~~~---~~~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~ 73 (108)
T d1rroa_ 2 ITDILSAEDIAAA---LQECQ--DPDTFEPQKFFQTS---GLSKMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSD 73 (108)
T ss_dssp GGGTSCHHHHHHH---HHHTC--STTCCCHHHHHHHH---SGGGSCHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTT
T ss_pred hhhhCCHHHHHHH---HHhcc--cCCCccHHHHHHHH---ccCcCCHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHHHhc
Confidence 3455666665443 33343 45678888886543 2223444567889999999999999999998877654221
Q ss_pred HhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 534 EALDRWEQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 534 ~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
... ..+++++.+|+.+|.|+||.|+.+||.+++.
T Consensus 74 ~~~-l~~~~~~~~~~~~D~d~dG~I~~~EF~~~m~ 107 (108)
T d1rroa_ 74 ARE-LTESETKSLMDAADNDGDGKIGADEFQEMVH 107 (108)
T ss_dssp SCC-CCHHHHHHHHHHHCCSSSSSEEHHHHHHHHT
T ss_pred cCC-CCHHHHHHHHHHhCCCCCCeEeHHHHHHHHc
Confidence 100 0155788899999999999999999988763
|
| >d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Pig (Sus scrofa) [TaxId: 9823]
Probab=98.86 E-value=1.5e-09 Score=83.83 Aligned_cols=64 Identities=19% Similarity=0.345 Sum_probs=52.7
Q ss_pred HHHHHHHHhHHhc-CC-CCcccHHHHHHHhc-C--CC---CccHHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 540 EQHARCAYELFEK-DG-NRAIVIEELASELG-L--GP---AVPVHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 540 ~~~~~~~F~~~D~-d~-~G~It~eEl~~~l~-~--~~---~~~~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
.++++.+|..||. ++ +|+|+.+||+++|. . +. ...++.+|..+|.|+||.|+|+||+.+|.++.
T Consensus 6 ~~~l~~~F~~y~~~d~~~g~is~~Elk~ll~~~~~~~~~~~~~v~~~~~~~D~d~dG~Idf~EF~~l~~~la 77 (78)
T d1cb1a_ 6 PAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGDGEVSFEEFQVLVKKIS 77 (78)
T ss_dssp HHHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCCCSSSSEEHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHccCCCCCCEECHHHHHHHHHHHcCCCCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHh
Confidence 4578999999975 44 58999999999993 2 21 22289999999999999999999999998764
|
| >d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: DJ-1-binding protein, DJBP species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.85 E-value=1.8e-09 Score=84.69 Aligned_cols=60 Identities=13% Similarity=0.200 Sum_probs=52.7
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHH
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELG-LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLL 599 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l 599 (611)
...++.+|+.||.+++|+|+.+||+++|. ++..++ ++.++..+|.|+||.|+|.||++++
T Consensus 19 ~~~l~~~F~~~D~~~~G~i~~~ef~~~l~~~~~~l~~~e~~~l~~~~d~~~~g~I~y~eFl~~f 82 (83)
T d1wlza1 19 YHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPVNAKGRLKYPDFLSRF 82 (83)
T ss_dssp HHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTSCBCTTSCBCHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCceEChhHHHHHHHHhCCCCChhHHHHHhhccccCCCCcEeHHHHHHHh
Confidence 34688899999999999999999999994 444444 8999999999999999999999876
|
| >d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]
Probab=98.84 E-value=2.3e-09 Score=85.41 Aligned_cols=63 Identities=22% Similarity=0.412 Sum_probs=53.4
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhc------CC---CCccHHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELG------LG---PAVPVHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~------~~---~~~~~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
.+.+..+|..||.| +|+|+.+||.++|. ++ ....++.+|..+|.|+||+|+|+||..+|.+++
T Consensus 8 ie~l~~~F~~yd~d-dG~is~~El~~~l~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I~F~EF~~li~~l~ 79 (92)
T d1a4pa_ 8 METMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLIAGLT 79 (92)
T ss_dssp HHHHHHHHHHHHGG-GCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHCTTSSSCBCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCC-CCEEcHHHHHHHHHHhccccccccCCHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHH
Confidence 45788999999987 89999999999983 11 122289999999999999999999999998875
|
| >d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.84 E-value=7e-10 Score=89.39 Aligned_cols=68 Identities=13% Similarity=0.203 Sum_probs=61.3
Q ss_pred chhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHc
Q 007253 458 LTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAAL 528 (611)
Q Consensus 458 l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~ 528 (611)
++.+|.++++++|+.+|.|++|+|+.+|+..+|.+.+ ++.+++..+++.+|.|++|.|+++||+.++.
T Consensus 4 lt~~e~~~~~~~F~~~D~d~~G~is~~e~~~~l~~~~---l~~~~l~~i~~~~D~d~dG~l~~~EF~~am~ 71 (95)
T d1c07a_ 4 VSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTG---LPSTLLAHIWSLCDTKDCGKLSKDQFALAFH 71 (95)
T ss_dssp SCSHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHTTT---CCHHHHHHHHHHHCTTCSSSEETTTHHHHHH
T ss_pred CCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHhcC---CCHHHHHHHHHHhCCCCCCeEcHHHHHHHHH
Confidence 6788999999999999999999999999999987654 4567899999999999999999999988764
|
| >d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]
Probab=98.84 E-value=3.3e-09 Score=84.93 Aligned_cols=65 Identities=18% Similarity=0.290 Sum_probs=53.6
Q ss_pred HHHHHHHHhHH-hcCCC-CcccHHHHHHHhc-C-----CCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhcch
Q 007253 540 EQHARCAYELF-EKDGN-RAIVIEELASELG-L-----GPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGVSS 604 (611)
Q Consensus 540 ~~~~~~~F~~~-D~d~~-G~It~eEl~~~l~-~-----~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~~~ 604 (611)
-+.+..+|..| |+||+ |+|+.+||+++|. . ....+ +..+|+.+|.|+||.|+|+||+.+|.++..
T Consensus 8 i~~l~~~F~~y~d~dg~~G~is~~El~~~L~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~Idf~EF~~lm~~l~~ 83 (93)
T d1zfsa1 8 METLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDENGDGEVDFQEFVVLVAALTV 83 (93)
T ss_dssp HHHHHHHHHHHGGGSSCCSSEEHHHHHHHHHHHSTTTSCCSSCHHHHHHHHHHHTTTCCSEECSHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcccCCCCCEecHHHHHHHHHHhcccccccCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHHH
Confidence 35678899888 89985 9999999999993 1 11222 889999999999999999999999988753
|
| >d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Reps1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.84 E-value=1.4e-09 Score=87.06 Aligned_cols=68 Identities=21% Similarity=0.301 Sum_probs=61.4
Q ss_pred chhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHc
Q 007253 458 LTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAAL 528 (611)
Q Consensus 458 l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~ 528 (611)
++++|..+++++|..+|.|++|+|+.+|+..+|.+.+ ++..++..|++.+|.|++|.|+|+||+.++.
T Consensus 3 ls~ee~~~y~~~F~~~D~d~~G~i~~~e~~~~l~~~~---l~~~~l~~i~~~~D~d~dG~l~~~EF~~a~~ 70 (92)
T d1fi6a_ 3 ITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSK---LPILELSHIWELSDFDKDGALTLDEFCAAFH 70 (92)
T ss_dssp CCHHHHHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHS---SCHHHHHHHHHHHCTTCSSEEEHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHhCCCcccchhHHHHHHHHHHcc---CCHHHHHHHHHHhCCCCCCeecHHHHHHHHH
Confidence 6788999999999999999999999999999998764 5667899999999999999999999987654
|
| >d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Nucleobindin 1 (CALNUC) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.82 E-value=2.6e-09 Score=86.73 Aligned_cols=59 Identities=10% Similarity=0.105 Sum_probs=46.4
Q ss_pred HHHHHhHHhcCCCCcccHHHHHHHhc-----CCC----Cc-----------cHHHHHHHHhcCCCCceeHHHHHHHHhh
Q 007253 543 ARCAYELFEKDGNRAIVIEELASELG-----LGP----AV-----------PVHAVLHDWIRHTDGKLSFLGFVKLLHG 601 (611)
Q Consensus 543 ~~~~F~~~D~d~~G~It~eEl~~~l~-----~~~----~~-----------~~~~~~~~~D~~~dG~is~~eF~~~l~~ 601 (611)
++.+|+.||.||||+|+.+||..++. +.. .. .++.+|..+|.|+||.||++||+++++.
T Consensus 18 ~r~~F~~~D~DgdG~i~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~D~d~DG~Is~~EF~~~~~~ 96 (99)
T d1snla_ 18 PKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNVDTNQDRLVTLEEFLASTQR 96 (99)
T ss_dssp HHHHHHHHCSSCCSEEEHHHHHHHHHHHHHTTSCCSSCSSHHHHTTHHHHHHHHHHHHHTCSSCSSEEEHHHHHHHHHC
T ss_pred HHHHHHHHCCCCCCcCCHHHHHHHHHHHHHhcchhhhhhhhhhhhHHHHHHHHHHHHHHcCCCCCCcCcHHHHHHHHhc
Confidence 46688888888888888888888772 110 00 0678999999999999999999999865
|
| >d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a13 [TaxId: 9606]
Probab=98.82 E-value=2.7e-09 Score=86.13 Aligned_cols=64 Identities=11% Similarity=0.216 Sum_probs=52.4
Q ss_pred HHHHHHHHhHH-hcCCC-CcccHHHHHHHhc-CC-----CCccHHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 540 EQHARCAYELF-EKDGN-RAIVIEELASELG-LG-----PAVPVHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 540 ~~~~~~~F~~~-D~d~~-G~It~eEl~~~l~-~~-----~~~~~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
.+.+..+|..| |+||+ |+|+.+||+++|. .+ ....++++|..+|.|+||.|+|+||+.+|.++.
T Consensus 13 i~~l~~vF~~y~d~dg~~g~is~~El~~~l~~~~~~~~~~~~~v~~l~~~~D~d~DG~IdF~EF~~l~~~l~ 84 (98)
T d1yuta1 13 IETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKFNEYWRLIGELA 84 (98)
T ss_dssp HHHHHHHHHHHHTTSSSSSCBCHHHHHHHHHHHCTTTTCCSSCHHHHHHHHCTTCCSCBCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcccCCCCCEEcHHHHHHHHHHhccccCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHH
Confidence 34677888887 78875 9999999999993 11 112299999999999999999999999998763
|
| >d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a3 [TaxId: 9606]
Probab=98.81 E-value=3.9e-09 Score=84.01 Aligned_cols=65 Identities=14% Similarity=0.261 Sum_probs=53.8
Q ss_pred HHHHHHHHhHH-hcCCCC-cccHHHHHHHhc------CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhcch
Q 007253 540 EQHARCAYELF-EKDGNR-AIVIEELASELG------LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGVSS 604 (611)
Q Consensus 540 ~~~~~~~F~~~-D~d~~G-~It~eEl~~~l~------~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~~~ 604 (611)
-+.+..+|..| |+||+| +|+.+||+++|. ++.+.+ ++.+|..+|.|+||.|+|+||+.+|.+++.
T Consensus 8 i~~i~~vF~kya~~dGd~~~ls~~Elk~ll~~~~~~~~~~~~~~~~~~~~~~~lD~n~Dg~IdF~EF~~l~~~l~~ 83 (93)
T d1ksoa_ 8 VAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFVEYVRSLACLCL 83 (93)
T ss_dssp HHHHHHHHHHHHTSSSCTTCEEHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHTTTCEECHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCcCCCCCeECHHHHHHHHHHhhhcccccCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHHH
Confidence 34577788877 999999 599999999993 222222 899999999999999999999999998764
|
| >d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a13 [TaxId: 9606]
Probab=98.81 E-value=5.3e-09 Score=84.34 Aligned_cols=72 Identities=10% Similarity=0.176 Sum_probs=60.1
Q ss_pred hHHHHHHHHhhhc-CCCCC-CcccHHHHHHHHHhhccc-ccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhh
Q 007253 461 DELFYLKEQYALL-EPNKN-GTISLENVKSALMKNATD-AMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQ 532 (611)
Q Consensus 461 ~e~~~l~~~F~~~-D~d~~-G~Is~~e~~~~l~~~~~~-~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~ 532 (611)
..+..+.++|+.| |.+|+ |+|+..||+.+|...+.. ..+...++.+|..+|.|+||.|+|+||+.++....+
T Consensus 11 ~~i~~l~~vF~~y~d~dg~~g~is~~El~~~l~~~~~~~~~~~~~v~~l~~~~D~d~DG~IdF~EF~~l~~~l~~ 85 (98)
T d1yuta1 11 ESIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKFNEYWRLIGELAK 85 (98)
T ss_dssp HHHHHHHHHHHHHHTTSSSSSCBCHHHHHHHHHHHCTTTTCCSSCHHHHHHHHCTTCCSCBCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcccCCCCCEEcHHHHHHHHHHhccccCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHHH
Confidence 4577899999998 77775 999999999999876543 235567999999999999999999999998876543
|
| >d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]
Probab=98.79 E-value=4.1e-09 Score=82.86 Aligned_cols=72 Identities=13% Similarity=0.158 Sum_probs=62.3
Q ss_pred hhHHHHHHHHhhhc-CCCCCCc-ccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchh
Q 007253 460 VDELFYLKEQYALL-EPNKNGT-ISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVH 531 (611)
Q Consensus 460 ~~e~~~l~~~F~~~-D~d~~G~-Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~ 531 (611)
+..++.+.++|+.+ |.+|+|. ++.+||+.++....+...+++++++++..+|.|+||+|+|+||+.++....
T Consensus 6 E~ai~~ii~~F~kya~~dG~~~~l~~~Elk~ll~~e~~~~~~~~~v~~i~~~~D~n~DG~IdF~EF~~l~~~la 79 (87)
T d1xk4a1 6 EKALNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELDINTDGAVNFQEFLILVIKMG 79 (87)
T ss_dssp HHHHHHHHHHHHHHHTSSSCTTCBCHHHHHHHHHHHSCHHHHTTCHHHHHHHHCTTCSSSBCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcccCCCCCccCHHHHHHHHHHhcCCccchHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHH
Confidence 44567899999998 8899986 599999999887666678889999999999999999999999999887644
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.79 E-value=3.9e-09 Score=93.47 Aligned_cols=111 Identities=15% Similarity=0.240 Sum_probs=84.6
Q ss_pred HHhhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhccc---ccccCChhHHHhhcCCCCCCcccHHHHHHHH
Q 007253 451 LRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATD---AMKDSRIPDFLSSLNSLQYRRMDFEEFCAAA 527 (611)
Q Consensus 451 l~~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~---~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~ 527 (611)
++.++...+..+ +.+++..++.+++|.++..++...+...... ...++.+..+|+.+|.+++|.|+.+||..++
T Consensus 41 l~~lg~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~e~~~~~ 117 (156)
T d1dtla_ 41 MRMLGQNPTPEE---LQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELSDLFRMFDKNADGYIDLEELKIML 117 (156)
T ss_dssp HHHTTCCCCHHH---HHHHHHHHCTTSSSSBCHHHHHHHHHHHHC-----CHHHHHHHHHHHHCTTCSSEEEHHHHGGGG
T ss_pred HHHcCCCCCHHH---HHHHHHHhhccCCCccchhhhhhhhhhcccccccccHHHHHHHHHHHhCcCCCCcCcHHHHHHHH
Confidence 344555555555 6677888899999999999988765443321 1233457789999999999999999998887
Q ss_pred cchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 528 LSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
........ ++++..+|+.+|.|++|.|+.+||.++|.
T Consensus 118 ~~~~~~ls----~~e~~~i~~~~D~d~dG~I~~~eF~~~l~ 154 (156)
T d1dtla_ 118 QATGETIT----EDDIEELMKDGDKNNDGRIDYDEFLEFMK 154 (156)
T ss_dssp TTC--CCC----HHHHHHHHHHHCTTSSSEEEHHHHHHHHH
T ss_pred hhcCCCCC----HHHHHHHHHHhCCCCCCeEeHHHHHHHHc
Confidence 76655444 66889999999999999999999999873
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.79 E-value=6.1e-09 Score=92.76 Aligned_cols=100 Identities=12% Similarity=0.170 Sum_probs=79.8
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhcc---cccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHH
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNAT---DAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQ 541 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~---~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~ 541 (611)
.+..+|..+|.+++|.++..++...+..... .......+..+|+.+|.|++|.|+.+||..++........ .+
T Consensus 57 ~~~~~~~~~d~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~aF~~~D~d~~G~Is~~e~~~~l~~~~~~~~----~~ 132 (162)
T d1topa_ 57 ELDAIIEEVDEDGSGTIDFEEFLVMMVRQMKEDAKGKSEEELANCFRIFDKNADGFIDIEELGEILRATGEHVT----EE 132 (162)
T ss_dssp HHHHHHHHHCTTSCCEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHTTTCCCC----HH
T ss_pred HHHhhhheeccCCCCCeeeehhhhhhhhhhhhhcccCcHHHHHHHHHHHCCCCCCCCcHHHHHHHHHhhCCCCC----HH
Confidence 4667888999999999999998776533321 1123445677899999999999999999998876654444 56
Q ss_pred HHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 542 HARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 542 ~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
++..+|+.+|.|++|.|+.+||.++|.
T Consensus 133 ~~~~l~~~~D~d~dG~Is~~EF~~~l~ 159 (162)
T d1topa_ 133 DIEDLMKDSDKNNDGRIDFDEFLKMME 159 (162)
T ss_dssp HHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCcEEHHHHHHHHH
Confidence 788999999999999999999999873
|
| >d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Pig (Sus scrofa) [TaxId: 9823]
Probab=98.78 E-value=1.8e-09 Score=83.36 Aligned_cols=71 Identities=15% Similarity=0.168 Sum_probs=58.3
Q ss_pred hhHHHHHHHHhhhcCC-C-CCCcccHHHHHHHHHhhcc-cccccCChhHHHhhcCCCCCCcccHHHHHHHHcch
Q 007253 460 VDELFYLKEQYALLEP-N-KNGTISLENVKSALMKNAT-DAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV 530 (611)
Q Consensus 460 ~~e~~~l~~~F~~~D~-d-~~G~Is~~e~~~~l~~~~~-~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~ 530 (611)
+...++|+.+|+.||. + +.|+|+..||+.+|..... ...+..+++.++..+|.|+||.|+|+||+.++...
T Consensus 3 e~~~~~l~~~F~~y~~~d~~~g~is~~Elk~ll~~~~~~~~~~~~~v~~~~~~~D~d~dG~Idf~EF~~l~~~l 76 (78)
T d1cb1a_ 3 QKSPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGDGEVSFEEFQVLVKKI 76 (78)
T ss_dssp SCCHHHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCCCSSSSEEHHHHHHHHHHH
T ss_pred hhhHHHHHHHHHHHccCCCCCCEECHHHHHHHHHHHcCCCCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHH
Confidence 3456789999999975 3 4589999999999988753 23456779999999999999999999999887543
|
| >d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.78 E-value=3.7e-09 Score=85.05 Aligned_cols=64 Identities=17% Similarity=0.039 Sum_probs=54.0
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCC-CccHHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELG-LGP-AVPVHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~-~~~~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
.+.++.+|+.+|+|++|+|+.+|++.++. .+- ...++.++..+|.|+||.|+++||+.+|+=+.
T Consensus 9 ~~~~~~~F~~~D~d~~G~is~~e~~~~l~~~~l~~~~l~~i~~~~D~d~dG~l~~~EF~~am~Li~ 74 (95)
T d1c07a_ 9 KAKYDEIFLKTDKDMDGFVSGLEVREIFLKTGLPSTLLAHIWSLCDTKDCGKLSKDQFALAFHLIS 74 (95)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHTTTCCHHHHHHHHHHHCTTCSSSEETTTHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCCcHHHHHHHHHhcCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHH
Confidence 45678899999999999999999999994 332 22389999999999999999999998876443
|
| >d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a4 [TaxId: 9606]
Probab=98.77 E-value=5.6e-09 Score=83.31 Aligned_cols=65 Identities=15% Similarity=0.313 Sum_probs=53.1
Q ss_pred HHHHHHHHhHH-hcCCCC-cccHHHHHHHhc------CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhcch
Q 007253 540 EQHARCAYELF-EKDGNR-AIVIEELASELG------LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGVSS 604 (611)
Q Consensus 540 ~~~~~~~F~~~-D~d~~G-~It~eEl~~~l~------~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~~~ 604 (611)
.+.+..+|..| |.||+| +|+.+||+++|. ++...+ ++++|+.+|.|+||.|+|+||+.+|.++..
T Consensus 8 i~~l~~~F~~ya~~dg~~~~L~~~Elk~~l~~~~~~~~~~~~~~~~~~~i~~~~D~n~DG~I~F~EF~~lm~~l~~ 83 (93)
T d3c1va1 8 LDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCIAM 83 (93)
T ss_dssp HHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCHHHHTTCCSHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHccCCCCCCeeCHHHHHHHHHHhchhccccCCCHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHHH
Confidence 45678899998 667654 799999999993 222222 899999999999999999999999988764
|
| >d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]
Probab=98.76 E-value=3.2e-09 Score=84.55 Aligned_cols=73 Identities=8% Similarity=0.185 Sum_probs=60.0
Q ss_pred hhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcc----cccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhH
Q 007253 460 VDELFYLKEQYALLEPNKNGTISLENVKSALMKNAT----DAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQL 533 (611)
Q Consensus 460 ~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~----~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~ 533 (611)
+..++.|.++|+.+|.+ +|+|+.+||+++|..... ...+...++++|..+|.|+||+|+|+||+.++......
T Consensus 5 E~~ie~l~~~F~~yd~d-dG~is~~El~~~l~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I~F~EF~~li~~l~~~ 81 (92)
T d1a4pa_ 5 EHAMETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLIAGLTIA 81 (92)
T ss_dssp HHHHHHHHHHHHHHHGG-GCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHCTTSSSCBCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCC-CCEEcHHHHHHHHHHhccccccccCCHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHH
Confidence 45578899999999986 899999999999876442 22355678999999999999999999999888665433
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.76 E-value=7.2e-09 Score=90.60 Aligned_cols=108 Identities=11% Similarity=0.140 Sum_probs=82.8
Q ss_pred hhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhh
Q 007253 453 ALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQ 532 (611)
Q Consensus 453 ~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~ 532 (611)
..+...+..+ +..++..++.++++.++++++...+.........++.+..+|+.+|.+++|.|+.+||..++.....
T Consensus 38 ~~g~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aF~~~D~d~~G~I~~~el~~~l~~~g~ 114 (146)
T d1lkja_ 38 SLGLSPSEAE---VNDLMNEIDVDGNHQIEFSEFLALMSRQLKSNDSEQELLEAFKVFDKNGDGLISAAELKHVLTSIGE 114 (146)
T ss_dssp HHTCCCCHHH---HHHHHHHHCSSSCCEEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHCSSSSCEEEHHHHHHHHHHHTC
T ss_pred hcCCCCCHHH---HHHHHHHhccCCcccccHHHHHHHHHHhhccccHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCC
Confidence 3344444443 6677888888999999999998877655543334456788999999999999999999888866554
Q ss_pred HHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 533 LEALDRWEQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 533 ~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
... ++++..+|+.+| |++|.|+.+||.++|.
T Consensus 115 ~~~----~~~~~~~~~~~d-d~dG~I~~~eF~~~m~ 145 (146)
T d1lkja_ 115 KLT----DAEVDDMLREVS-DGSGEINIQQFAALLS 145 (146)
T ss_dssp SCC----HHHHHHHHHHHC-CSSSEEEHHHHHHHHC
T ss_pred ccc----HHHHHHHHHhcc-CCCCeEeHHHHHHHhC
Confidence 444 567888999999 9999999999998873
|
| >d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.75 E-value=6.4e-09 Score=90.81 Aligned_cols=100 Identities=11% Similarity=0.045 Sum_probs=78.4
Q ss_pred CChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcC--CCCcccHHHHHHHhc--CCC-----
Q 007253 501 SRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKD--GNRAIVIEELASELG--LGP----- 571 (611)
Q Consensus 501 ~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d--~~G~It~eEl~~~l~--~~~----- 571 (611)
++++++|..+|.|++|+|+++||..++........ ..++..++..+|.+ ++|.|+.+||..++. +..
T Consensus 4 eelke~F~~~D~d~~G~I~~~el~~~l~~lg~~~~----~~e~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~ 79 (145)
T d2mysc_ 4 DDFKEAFLLFDRTGDAKITASQVGDIARALGQNPT----NAEINKILGNPSKEEMNAAAITFEEFLPMLQAAANNKDQGT 79 (145)
T ss_pred HHHHHHHHHHcCCCCCeECHHHHHHHHHHhhhcch----hhhhHHHHHHHhhcccccCccchhHHHHHHhhhhhccccch
Confidence 45778899999999999999999988866543333 45677777777655 689999999999883 111
Q ss_pred CccHHHHHHHHhcCCCCceeHHHHHHHHhhcch
Q 007253 572 AVPVHAVLHDWIRHTDGKLSFLGFVKLLHGVSS 604 (611)
Q Consensus 572 ~~~~~~~~~~~D~~~dG~is~~eF~~~l~~~~~ 604 (611)
...+..+|+.+|.|++|.|+.+||.++|..+..
T Consensus 80 ~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~ 112 (145)
T d2mysc_ 80 FEDFVEGLRVFDKEGNGTVMGAELRHVLATLGE 112 (145)
T ss_pred HHHHHHHHHHhhcCCCCEEcHHHHHHHHHHhCC
Confidence 112778899999999999999999999987643
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=98.75 E-value=6.8e-09 Score=90.39 Aligned_cols=106 Identities=8% Similarity=0.106 Sum_probs=80.3
Q ss_pred HHhhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcch
Q 007253 451 LRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV 530 (611)
Q Consensus 451 l~~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~ 530 (611)
++.++..++..++ .+++ .+++|.|++.+|..++.........++++..+|+.+|.+++|.|+.+||..++...
T Consensus 33 l~~lg~~~~~~el---~~~~----~~~~~~i~~~eF~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~ 105 (142)
T d1wdcb_ 33 SEQLGRAPDDKEL---TAML----KEAPGPLNFTMFLSIFSDKLSGTDSEETIRNAFAMFDEQETKKLNIEYIKDLLENM 105 (142)
T ss_dssp HHHHSSCCCHHHH---HHHH----TTSSSCCCHHHHHHHHHHHTCSCCCHHHHHHHHHTTCTTCCSCEEHHHHHHHHHHS
T ss_pred HHHhhcCCCHHHH---HHHH----HhccCccccccccccccccccccchhhhHHHhhhhhcccCCCcccHHHHHHHHHHc
Confidence 4455566666653 3444 25789999999999876655433445668889999999999999999999888766
Q ss_pred hhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 531 HQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 531 ~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
..... ++++..+|+.+|.| +|.|+.+||.++|.
T Consensus 106 g~~lt----~~e~~~l~~~~d~~-~G~I~y~eF~~~l~ 138 (142)
T d1wdcb_ 106 GDNFN----KDEMRMTFKEAPVE-GGKFDYVKFTAMIK 138 (142)
T ss_dssp SSCCC----HHHHHHHHHHCCEE-TTEECHHHHHHHHH
T ss_pred cccCC----HHHHHHHHHHhCCC-CCEEcHHHHHHHHh
Confidence 54444 56788899999998 59999999999884
|
| >d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]
Probab=98.74 E-value=4.6e-09 Score=82.60 Aligned_cols=63 Identities=17% Similarity=0.204 Sum_probs=52.4
Q ss_pred HHHHHHHhHH-hcCCCCcc-cHHHHHHHhc--CCCCcc---HHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 541 QHARCAYELF-EKDGNRAI-VIEELASELG--LGPAVP---VHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 541 ~~~~~~F~~~-D~d~~G~I-t~eEl~~~l~--~~~~~~---~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
+.+..+|..| |+||+|.+ +.+||++++. ++...+ ++++|+.+|.|+||+|+|+||+.+|.++.
T Consensus 10 ~~ii~~F~kya~~dG~~~~l~~~Elk~ll~~e~~~~~~~~~v~~i~~~~D~n~DG~IdF~EF~~l~~~la 79 (87)
T d1xk4a1 10 NSIIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELDINTDGAVNFQEFLILVIKMG 79 (87)
T ss_dssp HHHHHHHHHHHTSSSCTTCBCHHHHHHHHHHHSCHHHHTTCHHHHHHHHCTTCSSSBCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcccCCCCCccCHHHHHHHHHHhcCCccchHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHH
Confidence 4567788777 99999865 9999999984 443222 99999999999999999999999998865
|
| >d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]
Probab=98.72 E-value=4e-09 Score=84.42 Aligned_cols=72 Identities=13% Similarity=0.182 Sum_probs=59.6
Q ss_pred hhHHHHHHHHhhhc-CCCCC-CcccHHHHHHHHHhhccc----ccccCChhHHHhhcCCCCCCcccHHHHHHHHcchh
Q 007253 460 VDELFYLKEQYALL-EPNKN-GTISLENVKSALMKNATD----AMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVH 531 (611)
Q Consensus 460 ~~e~~~l~~~F~~~-D~d~~-G~Is~~e~~~~l~~~~~~----~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~ 531 (611)
+..++.|.++|..+ |.||+ |+|+.+||+.+|...... ..++..+.++|+.+|.|++|.|+|+||+.++....
T Consensus 5 E~~i~~l~~~F~~y~d~dg~~G~is~~El~~~L~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~Idf~EF~~lm~~l~ 82 (93)
T d1zfsa1 5 ETAMETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDENGDGEVDFQEFVVLVAALT 82 (93)
T ss_dssp HHHHHHHHHHHHHHGGGSSCCSSEEHHHHHHHHHHHSTTTSCCSSCHHHHHHHHHHHTTTCCSEECSHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcccCCCCCEecHHHHHHHHHHhcccccccCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHH
Confidence 34567899999998 88875 999999999999876532 34456788999999999999999999999886654
|
| >d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.68 E-value=9.2e-09 Score=89.86 Aligned_cols=95 Identities=8% Similarity=0.029 Sum_probs=75.6
Q ss_pred cCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhc
Q 007253 473 LEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEK 552 (611)
Q Consensus 473 ~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~ 552 (611)
++.+++|.|++.+|..++...........++..+|+.+|.+++|.|+.+||..++........ ++++..+|+.+|.
T Consensus 49 ~~~~~~g~i~~~eF~~~~~~~~~~~~~~~~l~~aF~~fD~~~~g~I~~~el~~~l~~~g~~ls----~~e~~~~~~~~d~ 124 (145)
T d2mysb_ 49 MIKEASGPINFTVFLTMFGEKLKGADPEDVIMGAFKVLDPDGKGSIKKSFLEELLTTGGGRFT----PEEIKNMWAAFPP 124 (145)
T ss_pred HHHhccCceeechhhhhhhhcccccchHHHHHHHHHhhhhcccchhhHHHHHHHHHHcCCCCC----HHHHHHHHHHhCC
Confidence 445678999999999887665544445567888899999999999999999988866554444 5678889999999
Q ss_pred CCCCcccHHHHHHHhcCCC
Q 007253 553 DGNRAIVIEELASELGLGP 571 (611)
Q Consensus 553 d~~G~It~eEl~~~l~~~~ 571 (611)
|++|.|+.+||.++|.-|.
T Consensus 125 d~dg~I~y~eF~~~l~~~~ 143 (145)
T d2mysb_ 125 DVAGNVDYKNICYVITHGE 143 (145)
T ss_pred CCCCeEeHHHHHHHhccCC
Confidence 9999999999999886544
|
| >d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=98.68 E-value=1.8e-08 Score=88.76 Aligned_cols=112 Identities=8% Similarity=0.045 Sum_probs=84.8
Q ss_pred HHHHHhhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcc-cccccCChhHHHhhcCCCCCCcccHHHHHHH
Q 007253 448 KAALRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNAT-DAMKDSRIPDFLSSLNSLQYRRMDFEEFCAA 526 (611)
Q Consensus 448 ~~~l~~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~-~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~ 526 (611)
+.+++.++...++.++..+ ...|.+++|.|++++|..++..... ......++.++|+.+|.+++|.|+.+||..+
T Consensus 32 ~~~l~~lG~~~t~~e~~~~----~~~~~~~~~~i~~~eFl~~~~~~~~~~~~~~~~l~~aF~~~D~~~~G~I~~~el~~~ 107 (152)
T d1wdcc_ 32 GDVCRCLGINPRNEDVFAV----GGTHKMGEKSLPFEEFLPAYEGLMDCEQGTFADYMEAFKTFDREGQGFISGAELRHV 107 (152)
T ss_dssp HHHHHHTTCCCCHHHHHHT----TCCSSTTSCEECHHHHHHHHHHHTTSCCCCHHHHHHHHHTTCSSSSSEEEHHHHHHH
T ss_pred HHHHHHhccCccHhhhhhh----hhhhccccccccccccccccccccccchhHHHhhhhhhhccccccCccchHHHHHHH
Confidence 3445566666777775443 3467889999999999998765542 1233345788999999999999999999998
Q ss_pred HcchhhHHhhHHHHHHHHHHHhHHhc--CCCCcccHHHHHHHh
Q 007253 527 ALSVHQLEALDRWEQHARCAYELFEK--DGNRAIVIEELASEL 567 (611)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~F~~~D~--d~~G~It~eEl~~~l 567 (611)
+........ ++++..+++.+|. |++|.|+.+||.+.|
T Consensus 108 l~~~g~~ls----~~e~~~l~~~~d~~~d~~G~I~y~eF~~~~ 146 (152)
T d1wdcc_ 108 LTALGERLS----DEDVDEIIKLTDLQEDLEGNVKYEDFVKKV 146 (152)
T ss_dssp HHHSSSCCC----HHHHHHHHHHHTCCCCTTSEEEHHHHHHHH
T ss_pred HHHcCCCCC----HHHHHHHHHHhccCCCCCCEEEHHHHHHHH
Confidence 876654444 6678889999986 456899999999876
|
| >d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a6 [TaxId: 9606]
Probab=98.67 E-value=1.3e-08 Score=80.12 Aligned_cols=65 Identities=15% Similarity=0.368 Sum_probs=53.5
Q ss_pred HHHHHHHHhHH-hcCCCC-cccHHHHHHHhc----CC---CCccHHHHHHHHhcCCCCceeHHHHHHHHhhcch
Q 007253 540 EQHARCAYELF-EKDGNR-AIVIEELASELG----LG---PAVPVHAVLHDWIRHTDGKLSFLGFVKLLHGVSS 604 (611)
Q Consensus 540 ~~~~~~~F~~~-D~d~~G-~It~eEl~~~l~----~~---~~~~~~~~~~~~D~~~dG~is~~eF~~~l~~~~~ 604 (611)
-..+..+|..| |+||+| +|+..||++++. .+ .+..++.+|+.+|.|+||.|+|+||+.++.++..
T Consensus 8 i~~ii~vF~kya~~dg~~~~ls~~Elk~Ll~~e~~~~~~~~~~~~~~~~~~lD~d~Dg~IdF~EF~~l~~~la~ 81 (89)
T d1k8ua_ 8 IGLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLDRNKDQEVNFQEYVTFLGALAL 81 (89)
T ss_dssp HHHHHHHHHHHHTSSSCTTEEEHHHHHHHHHHHSCCGGGTTSHHHHHHHHHHHHTTTCEEEHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcccCCCCCeecHHHHHHHHHHHHHhhccCCHHHHHHHHHHhcCCCCCCCcHHHHHHHHHHHHH
Confidence 34577788777 999998 699999999983 22 2233899999999999999999999999988753
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.67 E-value=2e-08 Score=87.74 Aligned_cols=112 Identities=11% Similarity=0.103 Sum_probs=80.0
Q ss_pred HHHhhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhccc-----ccccCChhHHHhhcCCCCCCcccHHHHH
Q 007253 450 ALRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATD-----AMKDSRIPDFLSSLNSLQYRRMDFEEFC 524 (611)
Q Consensus 450 ~l~~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~-----~~~~~~~~~~~~~~D~~~~g~i~~~eF~ 524 (611)
+++.++..++.+++..+.. ...+.+.+|.|++.+|...+...... .....++..+|..+|.+++|.|+.+||.
T Consensus 27 ~l~~lg~~~s~~ei~~l~~--~~~~~~~~~~i~~~ef~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~~~~G~I~~~el~ 104 (146)
T d1m45a_ 27 YLRAIGYNPTNQLVQDIIN--ADSSLRDASSLTLDQITGLIEVNEKELDATTKAKTEDFVKAFQVFDKESTGKVSVGDLR 104 (146)
T ss_dssp HHHHTTCCCCHHHHHHHHH--C--CC--CCEEEHHHHHHHHHHTHHHHHGGGCCCTHHHHHHHHTTCSSSSSEEEHHHHH
T ss_pred HHHHcCCchhHHHHhhhhc--cccccccccccccchhhhhhhhhcccccccccchHHHHHHHHHhhccccccccchhhhh
Confidence 3445666677777544322 34556677999999999876443211 1223456778999999999999999999
Q ss_pred HHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHh
Q 007253 525 AAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASEL 567 (611)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l 567 (611)
.++........ ++++..+|..+|.|++|.|+.+||.+.+
T Consensus 105 ~~l~~~g~~l~----~~ei~~l~~~~D~d~dG~I~y~eF~~~i 143 (146)
T d1m45a_ 105 YMLTGLGEKLT----DAEVDELLKGVEVDSNGEIDYKKFIEDV 143 (146)
T ss_dssp HHHHHSTTCCC----HHHHHHHHTTCCCCTTSEEEHHHHHHHH
T ss_pred hhhcccCCcch----HHHHHHHHHHhCCCCCCcEEHHHHHHHH
Confidence 98876654444 6678899999999999999999997654
|
| >d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Cdc4p species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.66 E-value=1.6e-08 Score=87.72 Aligned_cols=105 Identities=10% Similarity=0.076 Sum_probs=78.6
Q ss_pred HHhhhhcchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhccccc--ccCChhHHHhhcCCCCCCcccHHHHHHHHc
Q 007253 451 LRALSKTLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAM--KDSRIPDFLSSLNSLQYRRMDFEEFCAAAL 528 (611)
Q Consensus 451 l~~~~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~--~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~ 528 (611)
++.++..++.+++. .++.+++|.|++++|..++........ ...++.++|+.+|.+++|.|+.+||..++.
T Consensus 31 l~~lg~~~t~~ei~-------~~~~~~~~~i~~~eF~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~ 103 (140)
T d1ggwa_ 31 LRACGQNPTLAEIT-------EIESTLPAEVDMEQFLQVLNRPNGFDMPGDPEEFVKGFQVFDKDATGMIGVGELRYVLT 103 (140)
T ss_dssp HHHTSCCCCHHHHH-------HHHTTSCSSEEHHHHHHHHCTTSSSSSSCCHHHHHHHHHTTCSSCSSCCCHHHHHHHHH
T ss_pred HHHHHhhhHHHhhh-------hhhccccccccchhhhhhhhhhhhcchhhHHHHHHHHHHHHhccCCCcchHHHHHHHHH
Confidence 44566666666643 246678999999999988754433221 223477889999999999999999999887
Q ss_pred chhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHh
Q 007253 529 SVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASEL 567 (611)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l 567 (611)
....... .+++..+|+.+|.+ +|.|+.+||.++|
T Consensus 104 ~~g~~lt----~~e~~~l~~~~d~~-dG~I~y~eF~~~m 137 (140)
T d1ggwa_ 104 SLGEKLS----NEEMDELLKGVPVK-DGMVNYHDFVQMI 137 (140)
T ss_dssp HHHSCSC----HHHHHHHHHHTTCS-SCCSTTTHHHHHH
T ss_pred HcCCCCC----HHHHHHHHHhhCCC-CCEEeHHHHHHHH
Confidence 6544334 56788899999988 8999999998875
|
| >d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.66 E-value=7.3e-09 Score=83.13 Aligned_cols=68 Identities=16% Similarity=0.174 Sum_probs=60.0
Q ss_pred chhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcc
Q 007253 458 LTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALS 529 (611)
Q Consensus 458 l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~ 529 (611)
++.+|..+++++|..+| +++|+|+.+|++.+|.+.+ ++.+++..|++.+|.|++|.|+++||+.++..
T Consensus 4 ls~ee~~~y~~~F~~~D-~~~G~i~~~el~~~l~~~g---l~~~~L~~Iw~~~D~~~dG~l~~~EF~~a~~L 71 (95)
T d2jxca1 4 VKPEDKAKYDAIFDSLS-PVNGFLSGDKVKPVLLNSK---LPVDILGRVWELSDIDHDGMLDRDEFAVAMFL 71 (95)
T ss_dssp SCHHHHHHHHHHHHHTC-CBTTEEEHHHHHHHHTTSS---CCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHhC-CCCCceeHHHHHHHHHHcC---CCHHHHHHHHHHhcCCCCCeEcHHHHHHHHHH
Confidence 67889999999999999 7999999999999987654 45667999999999999999999999876643
|
| >d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]
Probab=98.66 E-value=2e-08 Score=81.30 Aligned_cols=72 Identities=10% Similarity=0.217 Sum_probs=59.9
Q ss_pred hhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhccc------ccccCChhHHHhhcCCCCCCcccHHHHHHHHcchh
Q 007253 459 TVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATD------AMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVH 531 (611)
Q Consensus 459 ~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~------~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~ 531 (611)
.+..+..+.++|+.+| +++|.|+..||+++|...+.. ......++++|..+|.|+||+|+|+||+.++....
T Consensus 5 ~E~~i~~l~~~F~~y~-~~dG~i~~~El~~ll~~~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I~F~EF~~li~~l~ 82 (100)
T d1psra_ 5 AERSIIGMIDMFHKYT-RRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNEDKKIDFSEFLSLLGDIA 82 (100)
T ss_dssp HHHHHHHHHHHHHHTC-CTTSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCTTCSSCBCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHc-CCCCcccHHHHHHHHHHHccccccccccCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHH
Confidence 4566788999999998 689999999999998776532 23556789999999999999999999999886543
|
| >d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a3 [TaxId: 9606]
Probab=98.65 E-value=7.9e-09 Score=82.18 Aligned_cols=72 Identities=13% Similarity=0.200 Sum_probs=59.6
Q ss_pred hhHHHHHHHHhhhc-CCCCCC-cccHHHHHHHHHhhccc----ccccCChhHHHhhcCCCCCCcccHHHHHHHHcchh
Q 007253 460 VDELFYLKEQYALL-EPNKNG-TISLENVKSALMKNATD----AMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVH 531 (611)
Q Consensus 460 ~~e~~~l~~~F~~~-D~d~~G-~Is~~e~~~~l~~~~~~----~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~ 531 (611)
++.++.|.++|+.+ |.+|+| +|+..||+++|...... ...+.++.+++..+|.|+||.|+|+||+.++....
T Consensus 5 E~~i~~i~~vF~kya~~dGd~~~ls~~Elk~ll~~~~~~~~~~~~~~~~~~~~~~~lD~n~Dg~IdF~EF~~l~~~l~ 82 (93)
T d1ksoa_ 5 EQAVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFVEYVRSLACLC 82 (93)
T ss_dssp HHHHHHHHHHHHHHHTSSSCTTCEEHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHTTTCEECHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCcCCCCCeECHHHHHHHHHHhhhcccccCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHH
Confidence 45678899999998 999999 59999999998776532 23455688999999999999999999998776543
|
| >d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=98.64 E-value=2.6e-08 Score=90.55 Aligned_cols=99 Identities=8% Similarity=0.078 Sum_probs=82.3
Q ss_pred CChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhcC----CCCccHH
Q 007253 501 SRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELGL----GPAVPVH 576 (611)
Q Consensus 501 ~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~~----~~~~~~~ 576 (611)
.++.++|..+|.|++|.|+++||..++........ ...+..+|+.+|.+++|.|+.+|+..++.. .....+.
T Consensus 10 ~~l~~~F~~~D~d~dG~Is~~e~~~~l~~l~~~~~----~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~e~l~ 85 (182)
T d1s6ia_ 10 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSELM----ESEIKDLMDAADIDKSGTIDYGEFIAATVHLNKLEREENLV 85 (182)
T ss_dssp CSHHHHHHTTSSSSSSCEEHHHHHHHHTTTTCCCC----HHHHHHHHHHTCTTCSSEECHHHHHHHHTTSSSSCCCCSTH
T ss_pred HHHHHHHHHHcCCCcCCCCHHHHHHHHHHcCCccc----cccchhhhhhhhccccccchHHHHHHHHHhhcccccHHHHH
Confidence 35678899999999999999999998877644333 567889999999999999999999987732 2222378
Q ss_pred HHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 577 AVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 577 ~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
.+|..+|.+++|.|+..||.++++.+.
T Consensus 86 ~aF~~~D~d~~G~i~~~el~~~l~~~g 112 (182)
T d1s6ia_ 86 SAFSYFDKDGSGYITLDEIQQACKDFG 112 (182)
T ss_dssp HHHHHTTTTCSSEEEHHHHHHTTTTTT
T ss_pred HHHHHHhhcCCCccchhhhhhhhhhcC
Confidence 899999999999999999999987643
|
| >d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a4 [TaxId: 9606]
Probab=98.64 E-value=1.6e-08 Score=80.52 Aligned_cols=72 Identities=14% Similarity=0.282 Sum_probs=57.9
Q ss_pred hhHHHHHHHHhhhc-CCCCCC-cccHHHHHHHHHhhc----ccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchh
Q 007253 460 VDELFYLKEQYALL-EPNKNG-TISLENVKSALMKNA----TDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVH 531 (611)
Q Consensus 460 ~~e~~~l~~~F~~~-D~d~~G-~Is~~e~~~~l~~~~----~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~ 531 (611)
+..++.|.++|..+ |.||+| +|+.+||+.+|.... .....+++++++|..+|.|+||.|+|+||+.++....
T Consensus 5 E~~i~~l~~~F~~ya~~dg~~~~L~~~Elk~~l~~~~~~~~~~~~~~~~~~~i~~~~D~n~DG~I~F~EF~~lm~~l~ 82 (93)
T d3c1va1 5 EKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCIA 82 (93)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCHHHHTTCCSHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHccCCCCCCeeCHHHHHHHHHHhchhccccCCCHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Confidence 34567899999998 666654 799999999987753 2235567789999999999999999999999886544
|
| >d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Pob1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.62 E-value=8.7e-09 Score=84.98 Aligned_cols=70 Identities=20% Similarity=0.232 Sum_probs=62.1
Q ss_pred cchhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcc
Q 007253 457 TLTVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALS 529 (611)
Q Consensus 457 ~l~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~ 529 (611)
.++.+|.++++++|..+|+|++|+|+.+|+..+|.+.+ ++.+++..|++..|.|++|.|+++||+.++.-
T Consensus 15 ~lt~ee~~~y~~lF~~~D~d~~G~Is~~e~~~~l~~s~---L~~~~L~~Iw~l~D~d~dG~l~~~EF~~am~L 84 (110)
T d1iq3a_ 15 RITEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTKSK---LSIPELSYIWELSDADCDGALTLPEFCAAFHL 84 (110)
T ss_dssp CCSSSSHHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSS---CSSCCHHHHHHHHCSSSCSEEEHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHHHHhCCCcccchhHHHHHHHHHhhc---cchHHHHHHHHHhccCCCCeECHHHHHHHHHH
Confidence 46788999999999999999999999999999885543 66788999999999999999999999876643
|
| >d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Reps1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.62 E-value=1.7e-08 Score=80.58 Aligned_cols=64 Identities=17% Similarity=0.085 Sum_probs=53.7
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhc-CC-CCccHHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELG-LG-PAVPVHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~-~~~~~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
.+.++.+|+.+|+|++|+|+.+|++.++. .+ +...+..++..+|.|+||.|+|+||+.+|+=+.
T Consensus 8 ~~~y~~~F~~~D~d~~G~i~~~e~~~~l~~~~l~~~~l~~i~~~~D~d~dG~l~~~EF~~a~~li~ 73 (92)
T d1fi6a_ 8 RQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSKLPILELSHIWELSDFDKDGALTLDEFCAAFHLVV 73 (92)
T ss_dssp HHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHSSCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCcccchhHHHHHHHHHHccCCHHHHHHHHHHhCCCCCCeecHHHHHHHHHHHH
Confidence 45688899999999999999999999994 22 233389999999999999999999997776444
|
| >d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a6 [TaxId: 9606]
Probab=98.59 E-value=1.6e-08 Score=79.64 Aligned_cols=72 Identities=14% Similarity=0.243 Sum_probs=59.7
Q ss_pred hhHHHHHHHHhhhc-CCCCCC-cccHHHHHHHHHhhc--ccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchh
Q 007253 460 VDELFYLKEQYALL-EPNKNG-TISLENVKSALMKNA--TDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVH 531 (611)
Q Consensus 460 ~~e~~~l~~~F~~~-D~d~~G-~Is~~e~~~~l~~~~--~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~ 531 (611)
+..+..|.++|+.+ |++|+| +|+..||++++.... +...++.+++++++.+|.|+||+|+|+||+.++....
T Consensus 5 E~ai~~ii~vF~kya~~dg~~~~ls~~Elk~Ll~~e~~~~~~~~~~~~~~~~~~lD~d~Dg~IdF~EF~~l~~~la 80 (89)
T d1k8ua_ 5 DQAIGLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLDRNKDQEVNFQEYVTFLGALA 80 (89)
T ss_dssp HHHHHHHHHHHHHHHTSSSCTTEEEHHHHHHHHHHHSCCGGGTTSHHHHHHHHHHHHTTTCEEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcccCCCCCeecHHHHHHHHHHHHHhhccCCHHHHHHHHHHhcCCCCCCCcHHHHHHHHHHHH
Confidence 45677899999998 999998 699999999987643 2235566789999999999999999999998876543
|
| >d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]
Probab=98.58 E-value=2.3e-08 Score=80.93 Aligned_cols=60 Identities=15% Similarity=0.154 Sum_probs=47.4
Q ss_pred HHHHHhHHhcCCCCcccHHHHHHHhc-CC----------CCccHHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 543 ARCAYELFEKDGNRAIVIEELASELG-LG----------PAVPVHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 543 ~~~~F~~~D~d~~G~It~eEl~~~l~-~~----------~~~~~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
+..+|..|| +++|.|+.+||+++|. .. ....++.+|..+|.|+||.|+|+||+.+|.++.
T Consensus 12 l~~~F~~y~-~~dG~i~~~El~~ll~~~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I~F~EF~~li~~l~ 82 (100)
T d1psra_ 12 MIDMFHKYT-RRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNEDKKIDFSEFLSLLGDIA 82 (100)
T ss_dssp HHHHHHHTC-CTTSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCTTCSSCBCHHHHHHHHHHHH
T ss_pred HHHHHHHHc-CCCCcccHHHHHHHHHHHccccccccccCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHH
Confidence 444455554 7899999999999994 11 122289999999999999999999999998763
|
| >d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=98.56 E-value=2.8e-08 Score=61.29 Aligned_cols=29 Identities=38% Similarity=0.574 Sum_probs=27.1
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
+++++.||++||+|++|+|+.+||+.+|.
T Consensus 2 eeel~eAF~~FDkDg~G~Is~~EL~~vm~ 30 (33)
T d2hf5a1 2 EEEIREAFRVFDKDGNGYISAAELRHVMT 30 (33)
T ss_dssp HHHHHHHHHHHSSSCCSCBCHHHHHHHTT
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 56899999999999999999999999985
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.56 E-value=8.8e-08 Score=92.04 Aligned_cols=142 Identities=17% Similarity=0.147 Sum_probs=95.3
Q ss_pred CCceeEeCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCe
Q 007253 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (611)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~ 233 (611)
...|+..+..+-|+.+.||+... .++.+++|+........ ...+.+|...++.|.++--+.+++.+..+++.
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~-----~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVG-----ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEEC-----SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred hhceEEEEcCCCCCCCcEEEEEe-----CCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 34577766655555568998752 36678889875432221 23467899999988766557788888888899
Q ss_pred eEEEeeecCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH------------------------------------
Q 007253 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH------------------------------------ 277 (611)
Q Consensus 234 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH------------------------------------ 277 (611)
.++||++++|.++.+.+.. ......++.++...|..||
T Consensus 85 ~~lv~~~l~G~~~~~~~~~------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEEECCSSEEHHHHTTT------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred eEEEEEecccccccccccc------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 9999999998777553311 1112233444444455554
Q ss_pred -----------------H------cCCeeecCCCCceEEeccCCCceEEEeecccccc
Q 007253 278 -----------------L------QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (611)
Q Consensus 278 -----------------~------~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~ 312 (611)
. ..++|+|+.|.|||+. +++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~---~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeec---CCceEEEeechhccc
Confidence 1 1279999999999994 455567999998754
|
| >d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Pob1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.56 E-value=5.7e-08 Score=79.95 Aligned_cols=63 Identities=11% Similarity=0.038 Sum_probs=53.4
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhc-CC-CCccHHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELG-LG-PAVPVHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~-~~~~~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
.+.++.+|+.+|+|++|+|+.+|++.+|. .+ +...++.+++.+|.|+||.|+++||..+|+=+
T Consensus 21 ~~~y~~lF~~~D~d~~G~Is~~e~~~~l~~s~L~~~~L~~Iw~l~D~d~dG~l~~~EF~~am~Li 85 (110)
T d1iq3a_ 21 REYYVNQFRSLQPDPSSFISGSVAKNFFTKSKLSIPELSYIWELSDADCDGALTLPEFCAAFHLI 85 (110)
T ss_dssp HHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSSCSSCCHHHHHHHHCSSSCSEEEHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCcccchhHHHHHHHHHhhccchHHHHHHHHHhccCCCCeECHHHHHHHHHHH
Confidence 44678899999999999999999999994 22 23339999999999999999999999877643
|
| >d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=98.56 E-value=5.6e-08 Score=88.16 Aligned_cols=97 Identities=15% Similarity=0.208 Sum_probs=76.2
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccc--------cCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhh
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNATDAMK--------DSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEAL 536 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~--------~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~ 536 (611)
.+..++...|.+++|.|+++++..++......... ...+..+|..+|.|++|.|+.+||..++.... . .
T Consensus 61 ~~~~~~~~~d~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~-l-~- 137 (185)
T d2sasa_ 61 EWRDLKGRADINKDDVVSWEEYLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQ-L-Q- 137 (185)
T ss_dssp HHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHTCCSGGGSCTTHHHHHHHHHHHHCTTSSSCCCHHHHHHHTTSSC-C-C-
T ss_pred HHHHHHHHhCcCCCCcEeeeHhhHHHHHHhhhhhhhhhhhHHHHHHHHHHHHHHccCCCccCCHHHHHHHHHHcC-C-C-
Confidence 34567788899999999999999887554421110 11256789999999999999999999886543 2 2
Q ss_pred HHHHHHHHHHHhHHhcCCCCcccHHHHHHHh
Q 007253 537 DRWEQHARCAYELFEKDGNRAIVIEELASEL 567 (611)
Q Consensus 537 ~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l 567 (611)
.++++.+|+.+|.|++|.|+.+||.+++
T Consensus 138 ---~~~~~~~f~~~D~d~dG~i~~~EF~~~~ 165 (185)
T d2sasa_ 138 ---CADVPAVYNVITDGGKVTFDLNRYKELY 165 (185)
T ss_dssp ---CSSHHHHHHHHHTTTTSCCSHHHHHHHH
T ss_pred ---HHHHHHHHHHcCCCCCCCCcHHHHHHHH
Confidence 4468889999999999999999999876
|
| >d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Nucleobindin 1 (CALNUC) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.55 E-value=2.2e-08 Score=81.14 Aligned_cols=30 Identities=17% Similarity=0.294 Sum_probs=26.6
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhc
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNA 494 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~ 494 (611)
.++.+|..+|.|++|+|+.+||..++...+
T Consensus 17 ~~r~~F~~~D~DgdG~i~~~El~~~l~~~~ 46 (99)
T d1snla_ 17 NPKTFFILHDINSDGVLDEQELEALFTKEL 46 (99)
T ss_dssp CHHHHHHHHCSSCCSEEEHHHHHHHHHHHH
T ss_pred CHHHHHHHHCCCCCCcCCHHHHHHHHHHHH
Confidence 478899999999999999999999886654
|
| >d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]
Probab=98.50 E-value=8.8e-08 Score=74.79 Aligned_cols=64 Identities=13% Similarity=0.222 Sum_probs=51.0
Q ss_pred HHHHHHHhHH-hcCCCC-cccHHHHHHHhc------CCCC---ccHHHHHHHHhcCCCCceeHHHHHHHHhhcch
Q 007253 541 QHARCAYELF-EKDGNR-AIVIEELASELG------LGPA---VPVHAVLHDWIRHTDGKLSFLGFVKLLHGVSS 604 (611)
Q Consensus 541 ~~~~~~F~~~-D~d~~G-~It~eEl~~~l~------~~~~---~~~~~~~~~~D~~~dG~is~~eF~~~l~~~~~ 604 (611)
+.+..+|..| +++|++ +|+.+||+++|. ++.. ..++.+|+.+|.|+||.|+|+||+.++.++..
T Consensus 8 ~~li~vF~kya~~~g~~~~Lsk~Elk~ll~~e~~~~~~~~~~~~~v~~~~~~lD~n~Dg~idF~EF~~li~~l~~ 82 (87)
T d1e8aa_ 8 EGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQVDFQEFISLVAIALK 82 (87)
T ss_dssp HHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSTTTSTTTTSHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcccCCCCCeEcHHHHHHHHHHHccccccCCCCHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHHHH
Confidence 4567788777 566664 799999999993 2212 22999999999999999999999999988753
|
| >d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.48 E-value=1.1e-07 Score=76.14 Aligned_cols=62 Identities=15% Similarity=0.009 Sum_probs=52.1
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCc-cHHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELG-LGPAV-PVHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~-~~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
...++.+|+.+| +++|+|+.+|++.+|. .|-.. .++.|+..+|.|+||.|+++||..+|+=+
T Consensus 9 ~~~y~~~F~~~D-~~~G~i~~~el~~~l~~~gl~~~~L~~Iw~~~D~~~dG~l~~~EF~~a~~Li 72 (95)
T d2jxca1 9 KAKYDAIFDSLS-PVNGFLSGDKVKPVLLNSKLPVDILGRVWELSDIDHDGMLDRDEFAVAMFLV 72 (95)
T ss_dssp HHHHHHHHHHTC-CBTTEEEHHHHHHHHTTSSCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHH
T ss_pred HHHHHHHHHHhC-CCCCceeHHHHHHHHHHcCCCHHHHHHHHHHhcCCCCCeEcHHHHHHHHHHH
Confidence 456889999999 8999999999999994 33322 28999999999999999999998776544
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.47 E-value=1e-07 Score=82.17 Aligned_cols=111 Identities=14% Similarity=0.090 Sum_probs=79.2
Q ss_pred HHHHhhhhcchhhHHHHHHHHhhhcCC--CCCCcccHHHHHHHHHhhcccc--cccCChhHHHhhcCCCCCCcccHHHHH
Q 007253 449 AALRALSKTLTVDELFYLKEQYALLEP--NKNGTISLENVKSALMKNATDA--MKDSRIPDFLSSLNSLQYRRMDFEEFC 524 (611)
Q Consensus 449 ~~l~~~~~~l~~~e~~~l~~~F~~~D~--d~~G~Is~~e~~~~l~~~~~~~--~~~~~~~~~~~~~D~~~~g~i~~~eF~ 524 (611)
.+++.++..++..+ +.+++..++. +++|.|++.+|...+....... ....++.++|+.+|.+++|.|+.+||.
T Consensus 24 ~~l~~lg~~~t~~e---~~~~~~~~~~~~~~~~~i~~~ef~~~~~~~~~~~~~~~~~~l~~aF~~~D~d~~G~I~~~el~ 100 (139)
T d1w7jb1 24 DVMRALGQNPTNAE---VLKVLGNPKSDELKSRRVDFETFLPMLQAVAKNRGQGTYEDYLEGFRVFDKEGNGKVMGAELR 100 (139)
T ss_dssp HHHHHTTCCCCHHH---HHHHTTCCCHHHHTTCEEEHHHHHHHHHHHCC--------CCHHHHHTTCTTSSSEEEHHHHH
T ss_pred HHHHHhccCCCHHH---HHHHHHHHhcccccCCceeeeccchhhHhhhhhccccHHHHHHHhhhhccCCCCCeEeHHHHH
Confidence 34556666777766 4455555553 5789999999988776544321 223567889999999999999999999
Q ss_pred HHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHh
Q 007253 525 AAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASEL 567 (611)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l 567 (611)
.++........ ++++..+++. |.|++|.|+.+||.++|
T Consensus 101 ~~l~~~g~~~~----~~e~~~l~~~-~~d~dg~I~~~eF~~~l 138 (139)
T d1w7jb1 101 HVLTTLGEKMT----EEEVETVLAG-HEDSNGCINYEAFLKHI 138 (139)
T ss_dssp HHHHHSSSCCC----HHHHHHHHTT-CCCTTSEEEHHHHHHHT
T ss_pred HHHHHhCCCCC----HHHHHHHHhh-CCCCCCeEeHHHHHHHh
Confidence 88866543334 5567777775 88999999999998865
|
| >d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]
Probab=98.43 E-value=1.3e-07 Score=85.87 Aligned_cols=70 Identities=11% Similarity=0.181 Sum_probs=60.8
Q ss_pred hhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcc
Q 007253 459 TVDELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALS 529 (611)
Q Consensus 459 ~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~ 529 (611)
.......++.+|..+|.|++|+|+.+||+.+|..++. ..+++++..+|..+|.|++|+|+|+||+.++..
T Consensus 100 ~~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~g~-~~~~~~~~~lf~~~D~d~dG~Is~~EF~~~~~~ 169 (187)
T d1uhka1 100 PTLIRIWGDALFDIVDKDQNGAITLDEWKAYTKAAGI-IQSSEDCEETFRVCDIDESGQLDVDEMTRQHLG 169 (187)
T ss_dssp CCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTS-CCSHHHHHHHHHHSCCCTTSCEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHccCCCcccchHHHHHHHHHhCC-CccHHHHHHHHHHhCCCCCCCEeHHHHHHHHHH
Confidence 3444566889999999999999999999999987765 577888999999999999999999999876644
|
| >d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.43 E-value=9.9e-08 Score=76.93 Aligned_cols=62 Identities=19% Similarity=0.121 Sum_probs=51.3
Q ss_pred HHHHHHhHHhcCCCCcccHHHHHHHhc-CC-CCccHHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 542 HARCAYELFEKDGNRAIVIEELASELG-LG-PAVPVHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 542 ~~~~~F~~~D~d~~G~It~eEl~~~l~-~~-~~~~~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
..+.+|+.+|+|++|+|+.+|+++++. .+ +...+..++..+|.|+||.|+++||..+|+=+.
T Consensus 12 ~y~~~F~~~D~d~~G~i~~~e~~~~l~~s~L~~~~L~~i~~~~D~d~dG~L~~~EF~~am~Li~ 75 (99)
T d1qjta_ 12 VYEKYYRQVEAGNTGRVLALDAAAFLKKSGLPDLILGKIWDLADTDGKGVLSKQEFFVALRLVA 75 (99)
T ss_dssp HHHHHHHHHCCTTSSCCCSHHHHHHHHTSSSCHHHHHHHHHHHCCSSSSSCCSHHHHHHHHHHH
T ss_pred HHHHHHHHHCCCCCCcccHHHHHHHHHHcCCcHHHHHHHHHHHcCCCCCccCHHHHHHHHHHHH
Confidence 456789999999999999999999994 33 222388999999999999999999998886443
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Probab=98.42 E-value=1.3e-07 Score=84.74 Aligned_cols=88 Identities=8% Similarity=0.154 Sum_probs=68.0
Q ss_pred CCCCCCcccHHHHHHHHHhhccccc----ccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhH
Q 007253 474 EPNKNGTISLENVKSALMKNATDAM----KDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYEL 549 (611)
Q Consensus 474 D~d~~G~Is~~e~~~~l~~~~~~~~----~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~ 549 (611)
|.+++|.|+.++|...+........ ....+..+|+.+|.|++|.|+.+||..++....- . .+++..+|+.
T Consensus 63 ~~~~~~~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~~~-~-----~~~~~~~f~~ 136 (174)
T d2scpa_ 63 AVAGGKGIDETTFINSMKEMVKNPEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFFGMLGL-D-----KTMAPASFDA 136 (174)
T ss_dssp GTTTTSCEEHHHHHHHHHHHTSCGGGTHHHHTHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTC-C-----GGGHHHHHHH
T ss_pred ccCCCCcCcHHHHHHHHHhhhcchhhHHHHHHHHHHHHHHHCCCccccCCHHHHHHHHHHHhh-h-----hHHHHHHHhh
Confidence 5678899999999988766543211 1233567899999999999999999887654321 1 3357789999
Q ss_pred HhcCCCCcccHHHHHHHh
Q 007253 550 FEKDGNRAIVIEELASEL 567 (611)
Q Consensus 550 ~D~d~~G~It~eEl~~~l 567 (611)
+|.|++|.|+.+||.+++
T Consensus 137 ~D~d~dG~Is~~Ef~~~~ 154 (174)
T d2scpa_ 137 IDTNNDGLLSLEEFVIAG 154 (174)
T ss_dssp HCTTCSSEECHHHHHHHH
T ss_pred cCCCCCCcEeHHHHHHHH
Confidence 999999999999999876
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Probab=98.42 E-value=1.3e-07 Score=86.11 Aligned_cols=68 Identities=12% Similarity=0.105 Sum_probs=55.2
Q ss_pred hHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcc
Q 007253 461 DELFYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALS 529 (611)
Q Consensus 461 ~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~ 529 (611)
.....+..+|..+|.|++|+|+.+||..++...+. .++++++..+|..+|.|++|.|+|+||+.++..
T Consensus 104 ~~~~~~~~~F~~~D~d~~G~is~~E~~~~l~~~g~-~~~~~~~~~lf~~~D~d~dG~Is~~EF~~~~~~ 171 (189)
T d1qv0a_ 104 LIREWGDAVFDIFDKDGSGTITLDEWKAYGKISGI-SPSQEDCEATFRHCDLDNAGDLDVDEMTRQHLG 171 (189)
T ss_dssp HHHHHHHHHHHHTC----CEECHHHHHHHHHHHSS-CCCHHHHHHHHHHSCCCTTSCEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHccCCCCcccchhhHHHHHhcCC-CCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHH
Confidence 33456778999999999999999999999877765 578888999999999999999999999887754
|
| >d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]
Probab=98.37 E-value=2e-07 Score=72.64 Aligned_cols=71 Identities=18% Similarity=0.222 Sum_probs=55.9
Q ss_pred hhHHHHHHHHhhhc-CCCCCC-cccHHHHHHHHHhhccc----ccccCChhHHHhhcCCCCCCcccHHHHHHHHcch
Q 007253 460 VDELFYLKEQYALL-EPNKNG-TISLENVKSALMKNATD----AMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV 530 (611)
Q Consensus 460 ~~e~~~l~~~F~~~-D~d~~G-~Is~~e~~~~l~~~~~~----~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~ 530 (611)
+..+..|.++|+.+ +.+|++ +|+.+||+++|...... ......++++|..+|.|+||.|+|+||+.++...
T Consensus 4 E~ai~~li~vF~kya~~~g~~~~Lsk~Elk~ll~~e~~~~~~~~~~~~~v~~~~~~lD~n~Dg~idF~EF~~li~~l 80 (87)
T d1e8aa_ 4 EEHLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQVDFQEFISLVAIA 80 (87)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSTTTSTTTTSHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcccCCCCCeEcHHHHHHHHHHHccccccCCCCHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHH
Confidence 45577899999998 445554 69999999998775432 2234568999999999999999999999887654
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Probab=98.34 E-value=4.4e-07 Score=81.09 Aligned_cols=97 Identities=11% Similarity=0.159 Sum_probs=76.2
Q ss_pred HHHHhhhcCCCCCCcccHHHHHHHHHhhcccc-------cccCChhHHHhhcCCCCCCcccHHHHHHHHcchhhHHhhHH
Q 007253 466 LKEQYALLEPNKNGTISLENVKSALMKNATDA-------MKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQLEALDR 538 (611)
Q Consensus 466 l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~-------~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~ 538 (611)
+...+...|.+++|.|+..++...+....... .....+..+|..+|.|++|.|+.+||..++.... ..
T Consensus 60 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~E~~~~~~~~~--~~--- 134 (176)
T d1nyaa_ 60 FDYLAKEAGVGSDGSLTEEQFIRVTENLIFEQGEASFNRVLGPVVKGIVGMCDKNADGQINADEFAAWLTALG--MS--- 134 (176)
T ss_dssp HHHHHHHHTSCTTCCBCHHHHHHHHHHHHSSSCHHHHHHHHHHHHHHHHHHTCSSCCSEEEHHHHHHHHHHTT--CC---
T ss_pred HHHHHHHhcCCCCCcccHHHHHHHHhhhhhhhhhhhhHHHHHHHHHHHHHHHccCCChhhhHHHHHHHHHhcC--Cc---
Confidence 44677888999999999999888765543211 1123456789999999999999999998775432 12
Q ss_pred HHHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 539 WEQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 539 ~~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
+++++.+|+.+|.|++|.|+.+||.+++.
T Consensus 135 -~~~~~~~f~~~D~d~dG~i~~~Ef~~~~~ 163 (176)
T d1nyaa_ 135 -KAEAAEAFNQVDTNGNGELSLDELLTAVR 163 (176)
T ss_dssp -HHHHHHHHHHHCTTCSSEEEHHHHHHHHS
T ss_pred -HHHHHHHHHHHCCCCCCcEeHHHHHHHHH
Confidence 55788999999999999999999999984
|
| >d2zkmx1 a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Phospholipase C-beta-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.30 E-value=5.6e-08 Score=87.08 Aligned_cols=92 Identities=7% Similarity=-0.021 Sum_probs=67.6
Q ss_pred cCCCCCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhc-CCCCccHHHHHHHHhcCCCC
Q 007253 510 LNSLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELG-LGPAVPVHAVLHDWIRHTDG 588 (611)
Q Consensus 510 ~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~-~~~~~~~~~~~~~~D~~~dG 588 (611)
+|.|++|+|++.|+..++........ ...+.+...|...|.+++|.|+.+||..++. +...-.+..+|..+|.|++|
T Consensus 16 ~d~n~dG~Is~~el~k~l~~~~~~~~--~~~~~~~~~~~~~D~~~~~~i~F~eF~~~~~~l~~r~ei~~~F~~~d~d~~~ 93 (170)
T d2zkmx1 16 MQLNSEGKIPVKNFFQMFPADRKRVE--AALSACHLPKGKNDAINPEDFPEPVYKSFLMSLCPRPEIDEIFTSYHAKAKP 93 (170)
T ss_dssp HSCCTTSCEEHHHHHHHSCSCHHHHH--HHHHHTTCCCCTTCEECGGGCCHHHHHHHHHHHSCCHHHHTTCC--------
T ss_pred cccCCCCCCcHHHHHHHHHHhhhhHH--HHHHHHhhhhccccccCCCccCHHHHHHHHhccCCHHHHHHHHHHHcCCCCC
Confidence 69999999999999998865543221 1145667779999999999999999999985 44444488899999999999
Q ss_pred ceeHHHHHHHHhhcc
Q 007253 589 KLSFLGFVKLLHGVS 603 (611)
Q Consensus 589 ~is~~eF~~~l~~~~ 603 (611)
.||.+||..+|...+
T Consensus 94 ~it~~el~~fL~~~Q 108 (170)
T d2zkmx1 94 YMTKEHLTKFINQKQ 108 (170)
T ss_dssp CCCHHHHHHHHHHTC
T ss_pred cccHHHHHHHHHHHh
Confidence 999999999998654
|
| >d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.29 E-value=2.1e-07 Score=74.89 Aligned_cols=63 Identities=14% Similarity=0.128 Sum_probs=53.9
Q ss_pred HHHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcc
Q 007253 464 FYLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALS 529 (611)
Q Consensus 464 ~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~ 529 (611)
..++++|+.+|.+++|+|+.+|+.++|...+ ++..++..|++..|.|++|.|+++||+.++..
T Consensus 11 ~~y~~~F~~~D~d~~G~i~~~e~~~~l~~s~---L~~~~L~~i~~~~D~d~dG~L~~~EF~~am~L 73 (99)
T d1qjta_ 11 PVYEKYYRQVEAGNTGRVLALDAAAFLKKSG---LPDLILGKIWDLADTDGKGVLSKQEFFVALRL 73 (99)
T ss_dssp THHHHHHHHHCCTTSSCCCSHHHHHHHHTSS---SCHHHHHHHHHHHCCSSSSSCCSHHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCcccHHHHHHHHHHcC---CcHHHHHHHHHHHcCCCCCccCHHHHHHHHHH
Confidence 3577899999999999999999999887654 56678899999999999999999999876643
|
| >d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]
Probab=98.16 E-value=1.8e-06 Score=67.95 Aligned_cols=64 Identities=19% Similarity=0.314 Sum_probs=50.8
Q ss_pred HHHHHHHhHH-hcCCC-CcccHHHHHHHhc---------CCCCccHHHHHHHHhcCCCCceeHHHHHHHHhhcch
Q 007253 541 QHARCAYELF-EKDGN-RAIVIEELASELG---------LGPAVPVHAVLHDWIRHTDGKLSFLGFVKLLHGVSS 604 (611)
Q Consensus 541 ~~~~~~F~~~-D~d~~-G~It~eEl~~~l~---------~~~~~~~~~~~~~~D~~~dG~is~~eF~~~l~~~~~ 604 (611)
..+..+|..| .++|+ ++++..||+++|. ...+..++.+|+.+|.|+||.|+|+||+.++.++..
T Consensus 9 ~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~im~~LD~n~Dg~vdF~EF~~li~~la~ 83 (95)
T d1qlsa_ 9 ESLIAIFQKHAGRDGNNTKISKTEFLIFMNTELAAFTQNQKDPGVLDRMMKKLDLDSDGQLDFQEFLNLIGGLAI 83 (95)
T ss_dssp HHHHHHHHHHHTTSSCTTCBCHHHHHHHHTTTSHHHHHHCCCTHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCcCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHH
Confidence 3566678666 55665 6899999999993 233334999999999999999999999999988753
|
| >d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Cow (Bos taurus), s100b [TaxId: 9913]
Probab=98.15 E-value=1.6e-06 Score=67.66 Aligned_cols=63 Identities=16% Similarity=0.276 Sum_probs=50.2
Q ss_pred HHHHHHHhHH-hcCCC-CcccHHHHHHHhc------CCCC---ccHHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 541 QHARCAYELF-EKDGN-RAIVIEELASELG------LGPA---VPVHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 541 ~~~~~~F~~~-D~d~~-G~It~eEl~~~l~------~~~~---~~~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
+.+..+|..| .++|+ ++++..||++++. +... ..++.+|+.+|.|+||.|+|+||+.++.++.
T Consensus 9 ~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~~d~~m~~LD~n~Dg~vdF~EF~~li~~la 82 (90)
T d3cr5x1 9 VALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGECDFQEFMAFVAMIT 82 (90)
T ss_dssp HHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHH
Confidence 4566788877 55665 5899999999993 2211 2289999999999999999999999998875
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Probab=98.10 E-value=1.8e-06 Score=85.09 Aligned_cols=92 Identities=7% Similarity=0.070 Sum_probs=66.7
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhcccccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhh-HHhhHHHHHHH
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNATDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQ-LEALDRWEQHA 543 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~-~~~~~~~~~~~ 543 (611)
...+.+..+|.+++|.+...+|........ .+..+|..+|.|++|.|+..||..++....- ... .+.+
T Consensus 224 ~~~~~~~~~~~~~~~~i~~~ef~~~~~~~~-------~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~~~----~~~~ 292 (321)
T d1ij5a_ 224 VQDALFRYADEDESDDVGFSEYVHLGLCLL-------VLRILYAFADFDKSGQLSKEEVQKVLEDAHIPESA----RKKF 292 (321)
T ss_dssp HHHHHHHHHCTTCSSCEEHHHHHHHHHHHH-------HHHHHHHHTCSSSCSSEEHHHHHHHHHHTTCCGGG----CSTH
T ss_pred HHHHHHHhhhcccccccccccccchhhhhh-------HHHHHHHHHhcCCCCCCcHHHHHHHHHHcCCCcCc----HHHH
Confidence 345667778888888888888876543322 2456788888888888888888877755432 122 3467
Q ss_pred HHHHhHHhcCCCCcccHHHHHHHh
Q 007253 544 RCAYELFEKDGNRAIVIEELASEL 567 (611)
Q Consensus 544 ~~~F~~~D~d~~G~It~eEl~~~l 567 (611)
..+|+.+|.|++|+|+.+||.++|
T Consensus 293 ~~l~~~~D~d~dG~Is~~EF~~~m 316 (321)
T d1ij5a_ 293 EHQFSVVDVDDSKSLSYQEFVMLV 316 (321)
T ss_dssp HHHHHHHTTTTCSEECHHHHHHHH
T ss_pred HHHHHHhCCCCCCcCcHHHHHHHH
Confidence 778888888888888888888876
|
| >d1ctda_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.06 E-value=1.5e-06 Score=50.94 Aligned_cols=29 Identities=34% Similarity=0.515 Sum_probs=26.6
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhc
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELG 568 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~ 568 (611)
++++..+|+.||+|+||+|+.+||..+++
T Consensus 3 EeELae~FRifDkNaDGyiD~eEl~~ilr 31 (34)
T d1ctda_ 3 EEELANAFRIFDKNADGYIDIEELGEILR 31 (34)
T ss_dssp HHHHHHHHHTTCCSSSSCBCHHHHHHHHH
T ss_pred HHHHHHHHHHHccCCcccccHHHHHHHHH
Confidence 67889999999999999999999998874
|
| >d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Cow (Bos taurus), s100b [TaxId: 9913]
Probab=98.06 E-value=2.8e-06 Score=66.26 Aligned_cols=72 Identities=13% Similarity=0.214 Sum_probs=54.5
Q ss_pred hhHHHHHHHHhhhcC-CCCC-CcccHHHHHHHHHhhccc---cc-ccCChhHHHhhcCCCCCCcccHHHHHHHHcchh
Q 007253 460 VDELFYLKEQYALLE-PNKN-GTISLENVKSALMKNATD---AM-KDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVH 531 (611)
Q Consensus 460 ~~e~~~l~~~F~~~D-~d~~-G~Is~~e~~~~l~~~~~~---~~-~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~ 531 (611)
+..+..+-++|+.+. .+|+ ++++..||++.|.+-... .. ....++++|..+|.|+||.|+|+||+.++....
T Consensus 5 E~ai~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~~d~~m~~LD~n~Dg~vdF~EF~~li~~la 82 (90)
T d3cr5x1 5 EKAVVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGECDFQEFMAFVAMIT 82 (90)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHH
Confidence 344667889999984 4444 579999999998774321 11 223488999999999999999999998776544
|
| >d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=97.99 E-value=1.3e-06 Score=53.69 Aligned_cols=30 Identities=17% Similarity=0.363 Sum_probs=26.9
Q ss_pred HHHHHHhhhcCCCCCCcccHHHHHHHHHhh
Q 007253 464 FYLKEQYALLEPNKNGTISLENVKSALMKN 493 (611)
Q Consensus 464 ~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~ 493 (611)
++|+++|+.||+|++|+|+..||+.+|..+
T Consensus 3 eel~eAF~~FDkDg~G~Is~~EL~~vm~~l 32 (33)
T d2hf5a1 3 EEIREAFRVFDKDGNGYISAAELRHVMTNL 32 (33)
T ss_dssp HHHHHHHHHHSSSCCSCBCHHHHHHHTTSC
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHc
Confidence 369999999999999999999999987544
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.99 E-value=8.2e-06 Score=77.33 Aligned_cols=75 Identities=12% Similarity=0.115 Sum_probs=52.0
Q ss_pred eeeeccc-eEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCC-CeeEEEEEEeeCCeeEEEee
Q 007253 162 EVGRGHF-GYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN-NLVKFFDAYEDTDNVYVVME 239 (611)
Q Consensus 162 ~LG~G~f-g~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-~iv~l~~~~~~~~~~~lv~E 239 (611)
.+..|.. +.||+.... .+..+++|....... ..+..|...++.|..+. .+.+++.+..+++..++||+
T Consensus 17 ~~~~G~s~~~v~r~~~~----~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~ 86 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ----GRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 86 (255)
T ss_dssp ECSCTTSSCEEEEEECT----TSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred EcCCcccCCeEEEEEeC----CCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEE
Confidence 3444543 578887643 366789998754322 23678888888887432 35678888888888999999
Q ss_pred ecCCCCh
Q 007253 240 LCEGGEL 246 (611)
Q Consensus 240 ~~~~gsL 246 (611)
+++|.++
T Consensus 87 ~i~G~~~ 93 (255)
T d1nd4a_ 87 EVPGQDL 93 (255)
T ss_dssp CCSSEET
T ss_pred eeecccc
Confidence 9988654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.92 E-value=8.4e-06 Score=82.81 Aligned_cols=82 Identities=20% Similarity=0.238 Sum_probs=51.1
Q ss_pred eCeeeeccceEEEEEEEecCCccCcEEEEEEecCCCc----CCHHHHHHHHHHHHHHHHhcCC--CCeeEEEEEEeeCCe
Q 007253 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM----TTAIAIEDVRREVKILRALTGH--NNLVKFFDAYEDTDN 233 (611)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~~~~E~~~l~~l~~h--~~iv~l~~~~~~~~~ 233 (611)
.+.||.|....||++.... .++.|+||.-..... .-.....+...|..+|+.+..+ ..+.+++.+ +++.
T Consensus 31 ~~eig~G~~N~vfrV~~~~---~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~ 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQE---HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC-------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT
T ss_pred EEEeCCCceEeEEEEEeCC---CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCC
Confidence 4568999999999987554 467899996432110 0011234566788888877644 245566644 4556
Q ss_pred eEEEeeecCCCCh
Q 007253 234 VYVVMELCEGGEL 246 (611)
Q Consensus 234 ~~lv~E~~~~gsL 246 (611)
.++|||++.+..+
T Consensus 106 ~~lvmE~L~~~~~ 118 (392)
T d2pula1 106 AVTVMEDLSHLKI 118 (392)
T ss_dssp TEEEECCCTTSEE
T ss_pred CEEEEeccCCccc
Confidence 6899999977554
|
| >d1j55a_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100p [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100p [TaxId: 9606]
Probab=97.91 E-value=9.6e-06 Score=63.62 Aligned_cols=64 Identities=16% Similarity=0.283 Sum_probs=49.3
Q ss_pred HHHHHHHHhHH-hcCCC-CcccHHHHHHHhc------CCC---CccHHHHHHHHhcCCCCceeHHHHHHHHhhcc
Q 007253 540 EQHARCAYELF-EKDGN-RAIVIEELASELG------LGP---AVPVHAVLHDWIRHTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 540 ~~~~~~~F~~~-D~d~~-G~It~eEl~~~l~------~~~---~~~~~~~~~~~D~~~dG~is~~eF~~~l~~~~ 603 (611)
...+..+|..| .++|+ ++++.+||++++. +.. +..++.+|..+|.|+||.|+|+||+.++.++.
T Consensus 8 i~~ii~vFhkYa~~~g~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~~m~~LD~n~Dg~vdF~EF~~li~~la 82 (94)
T d1j55a_ 8 MGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDANGDAQVDFSEFIVFVAAIT 82 (94)
T ss_dssp HHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCSSSSSSEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcccCCCcccCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHH
Confidence 34566788777 44554 5899999999993 221 22399999999999999999999999998764
|
| >d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]
Probab=97.89 E-value=7.7e-06 Score=64.28 Aligned_cols=72 Identities=13% Similarity=0.086 Sum_probs=54.2
Q ss_pred hHHHHHHHHhhhcCC-CCC-CcccHHHHHHHHHhhcc----cccccCChhHHHhhcCCCCCCcccHHHHHHHHcchhh
Q 007253 461 DELFYLKEQYALLEP-NKN-GTISLENVKSALMKNAT----DAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVHQ 532 (611)
Q Consensus 461 ~e~~~l~~~F~~~D~-d~~-G~Is~~e~~~~l~~~~~----~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~ 532 (611)
..+..+-.+|..+.. +|+ ++++..||+..|..... .......++++|..+|.|+||.|+|+||+.++.....
T Consensus 6 ~ai~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~im~~LD~n~Dg~vdF~EF~~li~~la~ 83 (95)
T d1qlsa_ 6 RCIESLIAIFQKHAGRDGNNTKISKTEFLIFMNTELAAFTQNQKDPGVLDRMMKKLDLDSDGQLDFQEFLNLIGGLAI 83 (95)
T ss_dssp HHHHHHHHHHHHHHTTSSCTTCBCHHHHHHHHTTTSHHHHHHCCCTHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCcCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHH
Confidence 346678889988754 444 67999999998866332 1122345899999999999999999999988766543
|
| >d1xk4c1 a.39.1.2 (C:4-86) Calcyclin (S100) {Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]
Probab=97.88 E-value=1.9e-05 Score=60.30 Aligned_cols=62 Identities=18% Similarity=0.295 Sum_probs=47.9
Q ss_pred HHHHHHHhHHh-cCCC-CcccHHHHHHHhc------CCCC----ccHHHHHHHHhcCCCCceeHHHHHHHHhhc
Q 007253 541 QHARCAYELFE-KDGN-RAIVIEELASELG------LGPA----VPVHAVLHDWIRHTDGKLSFLGFVKLLHGV 602 (611)
Q Consensus 541 ~~~~~~F~~~D-~d~~-G~It~eEl~~~l~------~~~~----~~~~~~~~~~D~~~dG~is~~eF~~~l~~~ 602 (611)
..+..+|..|. ++|+ ++++..||++++. +... ..++.+|..+|.|+||.|+|+||+.++.++
T Consensus 10 ~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~~d~~~vd~~m~~LD~n~Dg~vdF~EF~~li~~L 83 (83)
T d1xk4c1 10 ETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFIMLMARL 83 (83)
T ss_dssp HHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCcCCCcccCCHHHHHHHHHHHhHHHhcCCCCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHhhC
Confidence 45667887774 4443 7999999999993 2211 118999999999999999999999988653
|
| >d1j55a_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100p [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100p [TaxId: 9606]
Probab=97.75 E-value=2.4e-05 Score=61.26 Aligned_cols=71 Identities=13% Similarity=0.227 Sum_probs=53.1
Q ss_pred hHHHHHHHHhhhcCC-CCC-CcccHHHHHHHHHhhcc----cccccCChhHHHhhcCCCCCCcccHHHHHHHHcchh
Q 007253 461 DELFYLKEQYALLEP-NKN-GTISLENVKSALMKNAT----DAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSVH 531 (611)
Q Consensus 461 ~e~~~l~~~F~~~D~-d~~-G~Is~~e~~~~l~~~~~----~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~ 531 (611)
..+..+-.+|..+.. +|+ ++++..||++.+..-.. .......++++|..+|.|+||.|+|+||+.++....
T Consensus 6 ~ai~~ii~vFhkYa~~~g~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~~m~~LD~n~Dg~vdF~EF~~li~~la 82 (94)
T d1j55a_ 6 TAMGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDANGDAQVDFSEFIVFVAAIT 82 (94)
T ss_dssp HHHHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCSSSSSSEEHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcccCCCcccCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHH
Confidence 446678899999854 333 58999999998876432 122345689999999999999999999998876544
|
| >d1xk4c1 a.39.1.2 (C:4-86) Calcyclin (S100) {Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]
Probab=97.70 E-value=3.2e-05 Score=58.98 Aligned_cols=68 Identities=15% Similarity=0.231 Sum_probs=51.3
Q ss_pred hHHHHHHHHhhhcCC-CC-CCcccHHHHHHHHHhhccccc----cc-CChhHHHhhcCCCCCCcccHHHHHHHHc
Q 007253 461 DELFYLKEQYALLEP-NK-NGTISLENVKSALMKNATDAM----KD-SRIPDFLSSLNSLQYRRMDFEEFCAAAL 528 (611)
Q Consensus 461 ~e~~~l~~~F~~~D~-d~-~G~Is~~e~~~~l~~~~~~~~----~~-~~~~~~~~~~D~~~~g~i~~~eF~~~~~ 528 (611)
..+..+-.+|+.+.. +| .++++..||++.+..-.+.-+ .+ ..++++|..+|.|+||.|+|+||+.++.
T Consensus 7 ~ai~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~~d~~~vd~~m~~LD~n~Dg~vdF~EF~~li~ 81 (83)
T d1xk4c1 7 RNIETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFIMLMA 81 (83)
T ss_dssp HHHHHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCcCCCcccCCHHHHHHHHHHHhHHHhcCCCCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHh
Confidence 345678889988864 22 368999999999877543211 12 2378999999999999999999998764
|
| >d1ctda_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.63 E-value=2.9e-05 Score=45.43 Aligned_cols=30 Identities=20% Similarity=0.376 Sum_probs=26.3
Q ss_pred HHHHHHhhhcCCCCCCcccHHHHHHHHHhh
Q 007253 464 FYLKEQYALLEPNKNGTISLENVKSALMKN 493 (611)
Q Consensus 464 ~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~ 493 (611)
++|.+.|+.||+++||+|+.+||...|...
T Consensus 4 eELae~FRifDkNaDGyiD~eEl~~ilr~t 33 (34)
T d1ctda_ 4 EELANAFRIFDKNADGYIDIEELGEILRAT 33 (34)
T ss_dssp HHHHHHHHTTCCSSSSCBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCcccccHHHHHHHHHhc
Confidence 468899999999999999999999987543
|
| >d1tuza_ a.39.1.7 (A:) Diacylglycerol kinase alpha, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Diacylglycerol kinase alpha, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.21 E-value=7e-05 Score=61.58 Aligned_cols=74 Identities=7% Similarity=-0.016 Sum_probs=41.2
Q ss_pred cchhhHHHHHHHHhhhcCC---CCCCcccHHHHHHHHHhhcccc-cccCChhHHHhhcCCCCC--------CcccHHHHH
Q 007253 457 TLTVDELFYLKEQYALLEP---NKNGTISLENVKSALMKNATDA-MKDSRIPDFLSSLNSLQY--------RRMDFEEFC 524 (611)
Q Consensus 457 ~l~~~e~~~l~~~F~~~D~---d~~G~Is~~e~~~~l~~~~~~~-~~~~~~~~~~~~~D~~~~--------g~i~~~eF~ 524 (611)
+++..|++.|.+.|..... ..+|.|+.++|+.++....... .++.-++.+|+.+|.|++ |.|+|.||+
T Consensus 21 ~fs~~ei~~l~~~Fk~~~~~~~~p~g~i~~~~F~~~~~~~f~~~~~~~~l~~rlF~~FD~~~d~~~~~~~~g~I~f~efv 100 (118)
T d1tuza_ 21 EYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVS 100 (118)
T ss_dssp HHCCCCHHHHHHHHHTSGGGGGEETTEECHHHHHHHHHHHTTCSSCCHHHHHHHHHHSCCCCCTTCCCCCSCCEEHHHHH
T ss_pred CCCHHHHHHHHHHHhccccccCCcccccCHHHHHHHHHHhCCCCCchHHHHHHHHHHHccccccccccCCCceeeHHHHH
Confidence 3566666666666653321 2456677777766665544311 122334566666666654 667777766
Q ss_pred HHHcch
Q 007253 525 AAALSV 530 (611)
Q Consensus 525 ~~~~~~ 530 (611)
..+...
T Consensus 101 ~~LS~l 106 (118)
T d1tuza_ 101 CYFSLL 106 (118)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 655443
|
| >d1tuza_ a.39.1.7 (A:) Diacylglycerol kinase alpha, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Diacylglycerol kinase alpha, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.18 E-value=0.00022 Score=58.50 Aligned_cols=86 Identities=13% Similarity=0.227 Sum_probs=56.4
Q ss_pred CCCcccHHHHHHHHHhhcccccccCChhHHHhhcC------CCCCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHH
Q 007253 477 KNGTISLENVKSALMKNATDAMKDSRIPDFLSSLN------SLQYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELF 550 (611)
Q Consensus 477 ~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~~D------~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~ 550 (611)
..+.|+.+++.+.. +.. ..+..++..+++.+- ...+|.|++++|..++.......... ..-++.+|+.|
T Consensus 4 ~~s~l~p~~l~~L~-~~T--~fs~~ei~~l~~~Fk~~~~~~~~p~g~i~~~~F~~~~~~~f~~~~~~--~~l~~rlF~~F 78 (118)
T d1tuza_ 4 ERGLISPSDFAQLQ-KYM--EYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVP--RHLSLALFQSF 78 (118)
T ss_dssp CCSCSCHHHHHHHH-HHH--HHCCCCHHHHHHHHHTSGGGGGEETTEECHHHHHHHHHHHTTCSSCC--HHHHHHHHHHS
T ss_pred ccCCCCHHHHHHHH-HHc--CCCHHHHHHHHHHHhccccccCCcccccCHHHHHHHHHHhCCCCCch--HHHHHHHHHHH
Confidence 56779999998853 333 367778887777662 23578899999988776544322110 34677889999
Q ss_pred hcCCC--------CcccHHHHHHHh
Q 007253 551 EKDGN--------RAIVIEELASEL 567 (611)
Q Consensus 551 D~d~~--------G~It~eEl~~~l 567 (611)
|++++ |.|+.+|+...|
T Consensus 79 D~~~d~~~~~~~~g~I~f~efv~~L 103 (118)
T d1tuza_ 79 ETGHCLNETNVTKDVVCLNDVSCYF 103 (118)
T ss_dssp CCCCCTTCCCCCSCCEEHHHHHHHH
T ss_pred ccccccccccCCCceeeHHHHHHHH
Confidence 98876 555555555544
|
| >d1sraa_ a.39.1.3 (A:) C-terminal (EC) domain of BM-40/SPARC/osteonectin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Osteonectin domain: C-terminal (EC) domain of BM-40/SPARC/osteonectin species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.14 E-value=0.00015 Score=61.29 Aligned_cols=60 Identities=10% Similarity=0.048 Sum_probs=50.1
Q ss_pred HHHHHHHhHHhcC-CCCcccHHHHHHHhc-CCCCcc-HHHHHHHHhcCCCCceeHHHHHHHHh
Q 007253 541 QHARCAYELFEKD-GNRAIVIEELASELG-LGPAVP-VHAVLHDWIRHTDGKLSFLGFVKLLH 600 (611)
Q Consensus 541 ~~~~~~F~~~D~d-~~G~It~eEl~~~l~-~~~~~~-~~~~~~~~D~~~dG~is~~eF~~~l~ 600 (611)
..+...|..+|.| .||+|+..||..+.. +.+... +...+..+|.|+||.||+.|+...+.
T Consensus 77 ~~v~W~F~~LD~n~~D~~L~~~EL~~l~~~L~~~e~C~~~F~~~CD~n~D~~Is~~EW~~Cf~ 139 (151)
T d1sraa_ 77 FPVHWQFGQLDQHPIDGYLSHTELAPLRAPLIPMEHCTTRFFETCDLDNDKYIALDEWAGCFG 139 (151)
T ss_dssp HHHHHHHHHHCCTTCSSEECTTTTGGGGSTTSTTGGGHHHHHHHHCTTCSSSEEHHHHHHHTT
T ss_pred ccceeehhhcCCCCCCCccCHHHHHHHHHhhcCCchHHHHHHHHhcCCCCCcCCHHHHHHHcC
Confidence 3567789999999 599999999999775 333333 88899999999999999999998874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.05 E-value=0.00048 Score=69.45 Aligned_cols=78 Identities=13% Similarity=0.075 Sum_probs=52.0
Q ss_pred eCeeeeccceEEEEEEEecCC----ccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeeCCeeE
Q 007253 160 GEEVGRGHFGYTCAAKFKKGE----LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (611)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~l~~~~~~~~~~~ 235 (611)
++.|+-|--=.+|++....+. ...+.|.+++.... .. .-...+|..+++.+..+.-..++++++.+ .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--ch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 356776777799998876532 13466888876421 12 12456899999999866545578877642 6
Q ss_pred EEeeecCCCCh
Q 007253 236 VVMELCEGGEL 246 (611)
Q Consensus 236 lv~E~~~~gsL 246 (611)
+||||++|..|
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 89999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.63 E-value=0.0022 Score=62.50 Aligned_cols=68 Identities=9% Similarity=0.097 Sum_probs=43.4
Q ss_pred eEEEEEEEecCCccCcEEEEEEecCCCcCCHHHHHHHHHHHHHHHHhcCCC-CeeEEE-----EEEeeCCeeEEEeeecC
Q 007253 169 GYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN-NLVKFF-----DAYEDTDNVYVVMELCE 242 (611)
Q Consensus 169 g~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-~iv~l~-----~~~~~~~~~~lv~E~~~ 242 (611)
-.||++... .|+.|++|+...... ..+++..|...+..|..+. -++..+ ..+..++..+.++++++
T Consensus 36 N~vy~v~~~----dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~ 107 (325)
T d1zyla1 36 NRVYQFQDE----DRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 107 (325)
T ss_dssp SEEEEECCT----TCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred ceeEEEEcC----CCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence 478888754 478899999754322 2356788999998887321 111111 12234667889999997
Q ss_pred CC
Q 007253 243 GG 244 (611)
Q Consensus 243 ~g 244 (611)
|.
T Consensus 108 G~ 109 (325)
T d1zyla1 108 GR 109 (325)
T ss_dssp CE
T ss_pred Cc
Confidence 64
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.59 E-value=0.009 Score=57.50 Aligned_cols=30 Identities=33% Similarity=0.538 Sum_probs=25.1
Q ss_pred cCCeeecCCCCceEEeccCCCceEEEeeccccc
Q 007253 279 QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (611)
Q Consensus 279 ~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~ 311 (611)
.|+||+|+.++||++. .+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~---~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFL---GDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcc---cccceeEecccccc
Confidence 4799999999999994 55566899999874
|
| >d1sraa_ a.39.1.3 (A:) C-terminal (EC) domain of BM-40/SPARC/osteonectin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Osteonectin domain: C-terminal (EC) domain of BM-40/SPARC/osteonectin species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.87 E-value=0.032 Score=46.62 Aligned_cols=62 Identities=15% Similarity=0.216 Sum_probs=42.6
Q ss_pred hhHHHhhcCCC-CCCcccHHHHHHHHcchhhHHhhHHHHHHHHHHHhHHhcCCCCcccHHHHHHHhcCC
Q 007253 503 IPDFLSSLNSL-QYRRMDFEEFCAAALSVHQLEALDRWEQHARCAYELFEKDGNRAIVIEELASELGLG 570 (611)
Q Consensus 503 ~~~~~~~~D~~-~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~It~eEl~~~l~~~ 570 (611)
+..+|..+|.| .||.++..|+..+....... +.=++..|+..|.|+||.|+..|+...|++.
T Consensus 79 v~W~F~~LD~n~~D~~L~~~EL~~l~~~L~~~------e~C~~~F~~~CD~n~D~~Is~~EW~~Cf~v~ 141 (151)
T d1sraa_ 79 VHWQFGQLDQHPIDGYLSHTELAPLRAPLIPM------EHCTTRFFETCDLDNDKYIALDEWAGCFGIK 141 (151)
T ss_dssp HHHHHHHHCCTTCSSEECTTTTGGGGSTTSTT------GGGHHHHHHHHCTTCSSSEEHHHHHHHTTCC
T ss_pred ceeehhhcCCCCCCCccCHHHHHHHHHhhcCC------chHHHHHHHHhcCCCCCcCCHHHHHHHcCCC
Confidence 55678888888 47888888876654322221 2234567788888888888888888888654
|
| >d1h8ba_ a.39.1.7 (A:) alpha-Actinin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: alpha-Actinin species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.73 E-value=0.039 Score=39.66 Aligned_cols=60 Identities=22% Similarity=0.361 Sum_probs=47.5
Q ss_pred HHHHHHHHhHHhcCCCCcccHHHHHHHhcCCCCccHHHHHHHHhc-----CCCCceeHHHHHHHHhhcc
Q 007253 540 EQHARCAYELFEKDGNRAIVIEELASELGLGPAVPVHAVLHDWIR-----HTDGKLSFLGFVKLLHGVS 603 (611)
Q Consensus 540 ~~~~~~~F~~~D~d~~G~It~eEl~~~l~~~~~~~~~~~~~~~D~-----~~dG~is~~eF~~~l~~~~ 603 (611)
.+++..+|+.+ .++..+||.+||++.|. ++ .++.++..+-. -..|.++|..|++.|-+.+
T Consensus 7 aEqv~~aFr~l-A~~KpyVT~~dL~~~L~--pe-qaeyc~~~M~~y~~~~~~~~ayDY~sF~~~l~ges 71 (73)
T d1h8ba_ 7 AEQVIASFRIL-ASDKPYILAEELRRELP--PD-QAQYCIKRMPAYSGPGSVPGALDYAAFSSALYGES 71 (73)
T ss_dssp HHHHHHHHHHH-TTSCSSBCHHHHHHHSC--HH-HHHHHHHHSCSCCCSSCCTTCBCHHHHHHHHTCCS
T ss_pred HHHHHHHHHHH-hCCCCeeCHHHHHhhcC--HH-HHHHHHHHCcccCCCCCCCCcccHHHHHHHHhccc
Confidence 67889999999 46789999999999875 22 27777777743 2578899999999987754
|
| >d1qasa1 a.39.1.7 (A:205-298) Phosphoinositide-specific phospholipase C, isozyme D1 (PLC-D!) {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Phosphoinositide-specific phospholipase C, isozyme D1 (PLC-D!) species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=92.28 E-value=0.082 Score=40.58 Aligned_cols=60 Identities=13% Similarity=0.174 Sum_probs=45.6
Q ss_pred HHHHHHHhHHhcCCCCcccHHHHHHHhc--CCC-Ccc---HHHHHHHHhcCC----CCceeHHHHHHHHhh
Q 007253 541 QHARCAYELFEKDGNRAIVIEELASELG--LGP-AVP---VHAVLHDWIRHT----DGKLSFLGFVKLLHG 601 (611)
Q Consensus 541 ~~~~~~F~~~D~d~~G~It~eEl~~~l~--~~~-~~~---~~~~~~~~D~~~----dG~is~~eF~~~l~~ 601 (611)
.++..+|+.+-. +.+.+|.++|.++|. .+. ..+ +..+|..+..+. .|.+|+++|+.+|..
T Consensus 8 ~ei~~if~~ys~-~~~~mt~~~f~~FL~~eQ~~~~~~~~~~~~ii~~~e~~~~~~~~~~ls~~gF~~fL~S 77 (94)
T d1qasa1 8 AEIDRAFEEAAG-SAETLSVERLVTFLQHQQREEEAGPALALSLIERYEPSETAKAQRQMTKDGFLMYLLS 77 (94)
T ss_dssp HHHHHHHHHHHT-TSSSCBHHHHHHHHHHTSCCTTCSHHHHHHHHHHHCCCHHHHHTTBCCHHHHHHHHHS
T ss_pred HHHHHHHHHHhC-CCCccCHHHHHHHHHHHcCCccCCHHHHHHHHHHHcccHhhhhcCCcCHHHHHHHHcC
Confidence 367889999954 457899999999994 332 223 678888886643 477999999999965
|
| >d2cclb1 a.139.1.1 (B:1-59) Endo-1,4-beta-xylanase Y {Clostridium thermocellum [TaxId: 1515]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Type I dockerin domain superfamily: Type I dockerin domain family: Type I dockerin domain domain: Endo-1,4-beta-xylanase Y species: Clostridium thermocellum [TaxId: 1515]
Probab=90.43 E-value=0.17 Score=34.86 Aligned_cols=50 Identities=12% Similarity=0.078 Sum_probs=28.5
Q ss_pred hcCCCCcccHHHHHHHhc--CCCCccHHHHHHHHhcCCCCceeHHHHHHHHh
Q 007253 551 EKDGNRAIVIEELASELG--LGPAVPVHAVLHDWIRHTDGKLSFLGFVKLLH 600 (611)
Q Consensus 551 D~d~~G~It~eEl~~~l~--~~~~~~~~~~~~~~D~~~dG~is~~eF~~~l~ 600 (611)
|.|+||.|+.-++..+.. ++....-+.-+...|.|+||.|+..+...+++
T Consensus 2 DvN~Dg~vni~D~~~l~~~il~~~~~~~~~~~aaDvn~Dg~i~i~D~~~l~~ 53 (59)
T d2cclb1 2 DVNGDGTINSTDLTMLKRSVLRAITLTDDAKARADVDKNGSINAADVLLLSR 53 (59)
T ss_dssp CTTCSSSCCHHHHHHHHHHHTTSSCCCHHHHHHHCTTCSSCCSHHHHHHHHH
T ss_pred CCCCCCCCcHHHHHHHHHHHhCCCCCChhhhhccccCCCCCCCHHHHHHHHH
Confidence 456667777776666553 22211123345666777777777776665543
|
| >d1qasa1 a.39.1.7 (A:205-298) Phosphoinositide-specific phospholipase C, isozyme D1 (PLC-D!) {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Phosphoinositide-specific phospholipase C, isozyme D1 (PLC-D!) species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=88.01 E-value=0.19 Score=38.43 Aligned_cols=65 Identities=14% Similarity=0.171 Sum_probs=40.1
Q ss_pred HHHHHhhhcCCCCCCcccHHHHHHHHHhhccc-ccccCChhHHHhhcCCCC----CCcccHHHHHHHHcch
Q 007253 465 YLKEQYALLEPNKNGTISLENVKSALMKNATD-AMKDSRIPDFLSSLNSLQ----YRRMDFEEFCAAALSV 530 (611)
Q Consensus 465 ~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~~~-~~~~~~~~~~~~~~D~~~----~g~i~~~eF~~~~~~~ 530 (611)
++.++|..+-. +.+.++.++|...|..--.. ..++..+..++..+..+. .+.++++.|...+.+.
T Consensus 9 ei~~if~~ys~-~~~~mt~~~f~~FL~~eQ~~~~~~~~~~~~ii~~~e~~~~~~~~~~ls~~gF~~fL~S~ 78 (94)
T d1qasa1 9 EIDRAFEEAAG-SAETLSVERLVTFLQHQQREEEAGPALALSLIERYEPSETAKAQRQMTKDGFLMYLLSA 78 (94)
T ss_dssp HHHHHHHHHHT-TSSSCBHHHHHHHHHHTSCCTTCSHHHHHHHHHHHCCCHHHHHTTBCCHHHHHHHHHSS
T ss_pred HHHHHHHHHhC-CCCccCHHHHHHHHHHHcCCccCCHHHHHHHHHHHcccHhhhhcCCcCHHHHHHHHcCc
Confidence 46677777744 34578888888887665432 233444566777665542 2567777777766543
|
| >d1pula1 a.39.1.11 (A:18-120) Hypothetical protein c32e8.3 {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: p25-alpha domain: Hypothetical protein c32e8.3 species: Caenorhabditis elegans [TaxId: 6239]
Probab=80.86 E-value=2.8 Score=31.96 Aligned_cols=71 Identities=10% Similarity=0.077 Sum_probs=52.3
Q ss_pred hhhHHHHHHHHhhhcCCCCCCcccHHHHHHHHHhhc---ccccccCChhHHHhhcCCCCCCcccHHHHHHHHcch
Q 007253 459 TVDELFYLKEQYALLEPNKNGTISLENVKSALMKNA---TDAMKDSRIPDFLSSLNSLQYRRMDFEEFCAAALSV 530 (611)
Q Consensus 459 ~~~e~~~l~~~F~~~D~d~~G~Is~~e~~~~l~~~~---~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~ 530 (611)
...+++...+.|..|-....-.++-..|..++...+ ++..+..+++-+|..+-..+ .+|+|++|..++...
T Consensus 3 ~~~~l~~~F~aF~~FG~~~~~em~~~~f~Kl~kdc~lid~K~~T~tdvDIiF~K~k~k~-~ri~f~~F~~aL~~l 76 (103)
T d1pula1 3 DDADVKKRWDAFTKFGAATATEMTGKNFDKWLKDAGVLDNKAITGTMTGIAFSKVTGPK-KKATFDETKKVLAFV 76 (103)
T ss_dssp CHHHHHHHHHHHHHHTCSSSSCCCHHHHHHHHHHHTSCCSSSSCHHHHHHHHHHHTCSS-SCCCHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHhcCCCCcCCCHHHHHHHHHHcCCCcCCCCCccchhhhhHhhcCCC-CCcCHHHHHHHHHHH
Confidence 456778888889998753334699999999876643 34466677888999886544 569999998877543
|